PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Ciccia, AH; Lundine, JP; Coreno, A				Ciccia, Angela Hein; Lundine, Jennifer P.; Coreno, Alyssa			Referral Patterns as a Contextual Variable in Pediatric Brain Injury: A Retrospective Analysis	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							INPATIENT REHABILITATION CARE; COGNITIVE-COMMUNICATION; POSTTRAUMATIC AMNESIA; LONG-TERM; CHILDREN; SCHOOL; TBI; INTERVENTION; LANGUAGE; QUALITY	Purpose: Access to speech-language pathology (SLP) services is a critical variable in the rehabilitation of pediatric brain injury. In this study, we examined patterns of SLP referral and factors affecting referral during the acute period following brain injury in 2 large pediatric specialty hospitals. Method: In a retrospective, cohort chart review study, data collection focused on referrals made during the acute period using International Classification of Diseases, Ninth Revision, Clinical Modification codes for primary diagnoses of brain injury between 2007 and 2014 (Centers for Disease Control and Prevention [CDC], 2014). A total of 200 charts were reviewed. Data extraction included demographic and injury-related variables, referral for rehabilitation across disciplines, and plans of care following assessment. Results: Samples for both facilities were similar except for primary mechanism of traumatic brain injuries and severity. SLP referral rate at Hospital 1 was 36% and only 2% at Hospital 2. Regression revealed that individuals were less likely to receive an SLP referral if injury severity was classified as unknown or mild or if they were younger in age. Conclusion: SLP referral rates in the early acute period for children with brain injury were poor, creating a barrier to rehabilitation. This not only limits access to SLP services, but also may have broader and long-term impact.	[Ciccia, Angela Hein; Coreno, Alyssa] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Columbus, OH USA; [Lundine, Jennifer P.] Ohio State Univ, Columbus, OH USA		Ciccia, AH (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	angela.ciccia@case.edu	Lundine, Jennifer P/P-5184-2018; Ciccia, Angela/J-5967-2019	Lundine, Jennifer P/0000-0002-9113-7875; 			American Speech-Language-Hearing Association, 2005, ROL SPEECH LANG PATH; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Bergman Karen, 2010, J Trauma Nurs, V17, P102, DOI 10.1097/JTN.0b013e3181ecc452; Blakemore SJ, 2008, Q J EXP PSYCHOL, V61, P40, DOI 10.1080/17470210701508715; Bonds B, 2021, J NEUROTRAUM, V38, P1168, DOI 10.1089/neu.2014.3742; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brown BE, 2014, BRAIN INJURY, V28, P838; Catroppa C, 2009, DEV NEUROREHABIL, V12, P361, DOI 10.3109/17518420903087335; Centers for Disease Control and Prevention, 2015, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Chan V, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-102; Ciccia AH, 2015, INT J LANG COMM DIS, V50, P436, DOI 10.1111/1460-6984.12153; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Davis K., 2015, J HEAD TRAUMA REHAB, V23, P286; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; Dettmer JL, 2007, J HEAD TRAUMA REHAB, V22, P339, DOI 10.1097/01.HTR.0000300229.13490.c7; Dise-Lewis JE, 2009, J HEAD TRAUMA REHAB, V24, P166, DOI 10.1097/HTR.0b013e3181a7ecb0; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Faul M, 2010, TRAUMATIC BRAIN INJU; Gamino JF, 2009, TOP LANG DISORD, V29, P224, DOI 10.1097/TLD.0b013e3181b531da; Glang A, 2008, NEUROREHABILITATION, V23, P477; GODBOLT AK, 2015, THE JOURNAL OF HEAD, V30, pE41, DOI DOI 10.1097/HTR.0000000000000050; Hartman M, 2008, PEDIATRICS, V122, pE172, DOI 10.1542/peds.2007-3399; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Hwang V, 2014, J TRAUMA ACUTE CARE, V77, P117, DOI 10.1097/TA.0000000000000275; Jenkins L., 2006, BRAIN INJURY MED, P81; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Manley G., 2015, HDB CLIN NEUROLOGY, V127, P12; Masel B, 2009, CONCEPTUALIZING BRAI; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McLeod S, 2008, INT J SPEECH-LANG PA, V10, P92, DOI 10.1080/17549500701834690; Noggle CA, 2010, APPL NEUROPSYCHOL, V17, P110, DOI 10.1080/09084281003708977; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Schutz LE, 2010, INT J SPEC EDUC, V25, P55; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Steel J, 2015, NEUROREHABILITATION, V37, P221, DOI 10.3233/NRE-151255; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Vassar M, 2013, J EDUC EVAL HEALTH P, V10, DOI 10.3352/jeehp.2013.10.12; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	56	6	6	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2016	25	4					508	518		10.1044/2016_AJSLP-15-0087			11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	EG9RG	WOS:000391396400005	27681533				2022-02-06	
J	Constantine, G; Buligas, M; Miz, Q; Constantine, F; Abboud, A; Zamora, R; Puccio, A; Okonkwo, D; Vodovotz, Y				Constantine, Gregory; Buligas, Marius; Miz, Qi; Constantine, Florica; Abboud, Andrew; Zamora, Ruben; Puccio, Ava; Okonkwo, David; Vodovotz, Yoram			Dynamic Profiling: Modeling the Dynamics of Inflammation and Predicting Outcomes in Traumatic Brain Injury Patients	FRONTIERS IN PHARMACOLOGY			English	Article						TBI; TBI outcome; Inflammation; mathematical modeling; precision medicine	ACTIVATION; MARKERS; IMPACT; ROLES	Inflammation induced by traumatic brain injury (TBI) is complex, individual-specific, and associated with morbidity and mortality. We sought to develop dynamic, data-driven, predictive computational models of TBI-induced inflammation based on cerebrospinal fluid (CSF) biomarkers. Thirteen inflammatory mediators were determined in serial CSF samples from 27 severe TBI patients. The Glasgow Coma Scale (GCS) score quantifies the initial severity of the neurological status of the patient on a numerical scale from 3 to 15. The 6-month Glasgow Outcome Scale (GOS) score, the outcome variable, was taken as the variable to express and predict as a function of the other input variables. Data on each subject consisting of ten clinical (one-dimensional) variables, such as age, gender, and presence of infection, along with inflammatory biomarker time series were used to generate both multinomial logistic as well as probit models that predict low (poor outcome) or high (favorable outcome) levels of the GOS score. To determine if CSF inflammation biomarkers could predict TBI outcome, a logistic model for low (<= 3; poor neurological outcome) or high levels (>= 4; favorable neurological outcome) of the GOS score involving a full effect of the pro-inflammatory cytokine tumor necrosis factor-alpha and both linear and quadratic effects of the anti-inflammatory cytokine interleukin-10 was obtained. To better stratify patients as their pathology progresses over time, a technique called "Dynamic Profiling" was developed in which patients were clustered, using the spectral Laplacian and Hartigan's k-means method, into disjoint groups at different stages. Initial clustering was based on GCS score; subsequent clustering was performed based on clinical and demographic information and then further, sequential clustering based on the levels of individual inflammatory mediators over time. These clusters assess the risk of mortality of a new patient after each inflammatory mediator reading, based on the existing information in the previous data in the cluster to which the new patient belongs at the time, in essence acting as a "virtual clinician." Using the Dynamic Profiling method, we show examples that suggest that severe TBI patient neurological outcomes could be predicted as a function of time post-TBI using CSF inflammatory mediators.	[Constantine, Gregory] Univ Pittsburgh, Dept Math, Pittsburgh, PA USA; [Constantine, Gregory] Univ Pittsburgh, Dept Stat, Pittsburgh, PA USA; [Constantine, Gregory; Miz, Qi; Vodovotz, Yoram] Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA 15219 USA; [Buligas, Marius] Univ Pittsburgh, Dept Math, Bradford, PA USA; [Miz, Qi] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA USA; [Constantine, Florica] Johns Hopkins Univ, Dept Appl Math & Stat, Baltimore, MD USA; [Abboud, Andrew; Zamora, Ruben; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15261 USA; [Puccio, Ava; Okonkwo, David] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA		Vodovotz, Y (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA 15219 USA.; Vodovotz, Y (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15261 USA.	vodovotzy@upmc.edu		Abboud, Andrew/0000-0003-1527-1535	Commonwealth of Pennsylvania grant SAP [4100068505]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50GM53789]; Walter Copeland Fund of the Pittsburgh Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM053789] Funding Source: NIH RePORTER	This work was supported in part by Commonwealth of Pennsylvania grant SAP#4100068505 and by National Institutes of Health grant P50GM53789 to YV, and the Walter Copeland Fund of the Pittsburgh Foundation to AP.	Abboud A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00342; Aerts JM, 2014, J CRIT CARE, V29, P604, DOI 10.1016/j.jcrc.2014.03.018; CDC, 2013, CDC GRAND ROUNDS, V62, P549; Cheng ZQ, 2016, JOURNAL PRACT, V10, P744, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Emr B, 2014, SHOCK, V41, P317, DOI 10.1097/SHK.0000000000000121; Forde CT, 2014, BRIT J NEUROSURG, V28, P8, DOI 10.3109/02688697.2013.815317; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Namas RA, 2015, ANTIOXID REDOX SIGN, V23, P1370, DOI 10.1089/ars.2015.6398; Newell E, 2015, PEDIATR CRIT CARE ME, V16, P549, DOI 10.1097/PCC.0000000000000400; Sadowsky D, 2015, INT J BURNS TRAUMA, V5, P22; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; US National Research Council, 2011, PREC MED BUILD KNOWL; Velazquez A, 2015, BRAIN INJURY, V29, P1126, DOI 10.3109/02699052.2015.1018325; Vodovotz Y., 2013, COMPLEX SYSTEMS COMP, DOI [10.1007/978-1-4614-8008-2, DOI 10.1007/978-1-4614-8008-2]; Vodovotz Y, 2013, CRIT CARE MED, V41, P2008, DOI 10.1097/CCM.0b013e31829a6eb4; Vodovotz Y, 2010, IMMUNOPHARM IMMUNOT, V32, P181, DOI 10.3109/08923970903369867; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002	31	6	6	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	NOV 1	2016	7								383	10.3389/fphar.2016.00383			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	EA3MN	WOS:000386507000001	27847476	Green Published, gold			2022-02-06	
J	Dixon, RR; Nocera, M; Zolotor, AJ; Keenan, HT				Dixon, Rebecca R.; Nocera, Maryalice; Zolotor, Adam J.; Keenan, Heather T.			Intracranial Pressure Monitoring in Infants and Young Children With Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						brain edema; inflicted head injury; intracranial hypertension; intracranial pressure; pediatrics; traumatic brain injury	HEAD-INJURY; OUTCOMES; THERAPY; PLASTICITY; CHILDHOOD; AGE	Objective: To examine the use of intracranial pressure monitors and treatment for elevated intracranial pressure in children 24 months old or younger with traumatic brain injury in North Carolina between April 2009 and March 2012 and compare this with a similar cohort recruited 2000-2001. Design: Prospective, observational cohort study. Setting: Twelve PICUs in North Carolina. Patients: All children 24 months old or younger with traumatic brain injury, admitted to an included PICU. Interventions: None. Measurement and Main Results: The use of intracranial pressure monitors and treatments for elevated intracranial pressure were evaluated in 238 children with traumatic brain injury. Intracranial pressure monitoring (risk ratio, 3.7; 95% CI, 1.5-9.3) and intracranial pressure therapies were more common in children with Glasgow Coma Scale less than or equal to 8 compared with Glasgow Coma Scale greater than 8. However, only 17% of children with Glasgow Coma Scale less than or equal to 8 received a monitoring device. Treatments for elevated intracranial pressure were more common in children with monitors; yet, some children without monitors received therapies traditionally used to lower intracranial pressure. Unadjusted predictors of monitoring were Glasgow Coma Scale less than or equal to 8, receipt of cardiopulmonary resuscitation, nonwhite race. Logistic regression showed no strong predictors of intracranial pressure monitor use. Compared with the 2000 cohort, children in the 2010 cohort with Glasgow Coma Scale less than or equal to 8 were less likely to receive monitoring (risk ratio, 0.5; 95% CI, 0.3-1.0), although the estimate was not precise, or intracranial pressure management therapies. Conclusion: Children in the 2010 cohort with a Glasgow Coma Scale less than or equal to 8 were less likely to receive an intracranial pressure monitor or hyperosmolar therapy than children in the 2000 cohort; however, about 10% of children without monitors received therapies to decrease intracranial pressure. This suggests treatment heterogeneity in children 24 months old or younger with traumatic brain injury and a need for better evidence to support treatment recommendations for this group of children.	[Dixon, Rebecca R.; Keenan, Heather T.] Univ Utah, Sch Med, Dept Pediat, Pediat Crit Care, Salt Lake City, UT 84112 USA; [Nocera, Maryalice; Zolotor, Adam J.] Univ North Carolina Chapel Hill, Univ North Carolina Injury Prevent Res Ctr, Chapel Hill, NC USA; [Zolotor, Adam J.] Univ N Carolina, Sch Med, Dept Family Med, Chapel Hill, NC USA		Dixon, RR (corresponding author), Univ Utah, Sch Med, Dept Pediat, Pediat Crit Care, Salt Lake City, UT 84112 USA.	Rebecca.Dixon@hsc.utah.edu		Zolotor, Adam/0000-0002-9007-223X	Centers for Disease Control and Prevention, National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [5U49CF001275]; Centers for Disease Control and Prevention (CDC) National Center for Injury Prevention; CDC NCIPCUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Duke Endowment; Blue Cross Blue Shield of NC Foundation; Kate B Reynolds Charitable Trust; Winston-Salem Foundation; CDCCentre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U49CE001275] Funding Source: NIH RePORTER	Supported, in part, by a grant to Dr. Zolotor from the Centers for Disease Control and Prevention, National Center for Injury Prevention and Control (5U49CF001275).; Ms. Nocera received support for article research from Centers for Disease Control and Prevention (CDC) National Center for Injury Prevention. Her institution received funding from CDC NCIPC. Dr. Zolotor's institution receives grants which support his work and a portion of his salary from the following entities: the Duke Endowment, Blue Cross Blue Shield of NC Foundation, Kate B Reynolds Charitable Trust, and the Winston-Salem Foundation. His institution received funding from the CDC and the Duke Endowment Dr. Keenan received funding as a paid consultant to the grant that generated these data (Shaken Baby Prevention grant from the CDC to the University of North Carolina [principal investigator [PI], Dr. Zolotar]). She received support for article research from the CDC as a consultant for this grant (co-author Dr. Zolotar was the PI), and received funding from the National Institute of Child Health and Human Development (NICHD) (travel/accommodations/and honorarium). Her institution received funding from NICHD (Dr. Keenan has two grants from the CDC). Dr. Dixon disclosed that she does not have any potential conflicts of interest.	Adelson P D, 2000, Clin Neurosurg, V47, P319; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Bailey BM, 2012, J TRAUMA ACUTE CARE, V72, P263, DOI 10.1097/TA.0b013e31822a9512; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Bennett TD, 2012, CRIT CARE MED, V40, P208, DOI 10.1097/CCM.0b013e31822e9d31; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M, 2010, TRAUMATIC BRAIN INJU; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS36, DOI 10.1097/PCC.0b013e31823f6621; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS11, DOI 10.1097/PCC.0b013e31823f440c; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Murphy S, 2012, NEUROTHERAPEUTICS, V9, P3, DOI 10.1007/s13311-011-0093-6; Potts Mathew B, 2006, NeuroRx, V3, P143; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Stocchetti N, 2010, MINERVA ANESTESIOL, V76, P1052; Tasker RC, 2011, BRIT J NEUROSURG, V25, P68, DOI 10.3109/02688697.2010.538770; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	32	6	6	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	NOV	2016	17	11					1064	1072		10.1097/PCC.0000000000000937			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	EF2ES	WOS:000390138100013	27632060	Green Accepted, Green Submitted			2022-02-06	
J	Heinemann, AW; Lai, JS; Wong, A; Dashner, J; Magasi, S; Hahn, EA; Carlozzi, NE; Tulsky, DS; Jerousek, S; Semik, P; Miskovic, A; Gray, DB				Heinemann, Allen W.; Lai, Jin-Shei; Wong, Alex; Dashner, Jessica; Magasi, Susan; Hahn, Elizabeth A.; Carlozzi, Noelle E.; Tulsky, David S.; Jerousek, Sara; Semik, Patrick; Miskovic, Ana; Gray, David B.			Using the ICF's environmental factors framework to develop an item bank measuring built and natural environmental features affecting persons with disabilities	QUALITY OF LIFE RESEARCH			English	Article						Environment; Patient-reported outcomes; Questionnaires; Health-related quality of life; Disability populations	QUALITY-OF-LIFE; INTERNATIONAL CLASSIFICATION; INSIDER PERSPECTIVE; PARTICIPATION; PEOPLE; HEALTH; BARRIERS; CALIBRATION; STROKE; PROMIS	To develop a measure of natural environment and human-made change features (Chapter 2 of the international classification of functioning, disability, and health) and evaluate the influence of perceived barriers on health-related quality of life. A sample of 570 adults with stroke, spinal cord injury, and traumatic brain injury residing in community settings reported their functioning in home, outdoor, and community settings (mean age = 47.0 years, SD = 16.1). They rated 18 items with a 5-point rating scale to describe the influence of barriers to moving around, seeing objects, hearing sounds, hearing conversations, feeling safe, and regulating temperature and indicated whether any difficulties were due to environmental features. We used Rasch analysis to identify misfitting items and evaluate differential item functioning (DIF) across impairment groups. We computed correlations between barriers and patient-reported outcomes measurement information system (PROMIS) social domain measures and community participation indicators (CPI) measures. The 18 items demonstrated person reliability of .70, discriminating nearly three levels of barriers. All items fit the Rasch model; impairment-related DIF was negligible. Ceiling effects were negligible, but 25 % of the respondents were at the floor, indicating that they did not experience barriers that they attributed to the built and natural environment. As anticipated, barriers correlated moderately with PROMIS and CPI variables, suggesting that although this new item bank measures a construct that is related to participation and health-related quality of life, it also captures something unique. Known-groups validity was supported by wheelchair users reporting a higher level of barriers than did ambulatory respondents. Preliminary evidence supports the reliability and validity of this new measure of barriers to the built and natural environment. This measure allows investigators and clinicians to measure perceptions of the natural environment and human-made changes, providing information that can guide interventions to reduce barriers. Moderate relationships between barriers and PROMIS and CPI variables provide support for the measurement and theory of environmental influences on social health and participation.	[Heinemann, Allen W.; Jerousek, Sara; Semik, Patrick; Miskovic, Ana] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, 345 E Super St, Chicago, IL 60611 USA; [Lai, Jin-Shei] Northwestern Univ, Dept Med Social Sci, 633 N St Clair,19th Floor, Chicago, IL 60611 USA; [Wong, Alex; Dashner, Jessica; Gray, David B.] Washington Univ, Dept Neurol, Program Occupat Therapy, Sch Med, 4444 Forest Pk Ave,Campus Box 8505, St Louis, MO 63108 USA; [Magasi, Susan] Univ Illinois, Dept Occupat Therapy, 1919 W Taylor St,Room 327, Chicago, IL 60612 USA; [Hahn, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Ctr Patient Ctr Outcomes, Dept Med Social Sci, Chicago, IL 60611 USA; [Carlozzi, Noelle E.] Univ Michigan Hlth Syst, Ctr Clin Outcomes Dev & Applicat CODA, Phys Med & Rehabil, Ann Arbor, MI USA; [Carlozzi, Noelle E.] North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Tulsky, David S.] Univ Delaware, Coll Hlth Sci, Ctr Assessment Res & Translat, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Psychol & Brain Sci, Newark, DE USA; [Tulsky, David S.] Kessler Fdn, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA		Heinemann, AW (corresponding author), Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA.; Heinemann, AW (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, 345 E Super St, Chicago, IL 60611 USA.	a-heinemann@northwestern.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Wong, Alex/0000-0002-4423-2685; Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation Research through a Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes [H133B090024]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133F140037]; Craig H. Neilsen Foundation [290474]	This study was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (H133B090024) through a Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes grant awarded to the Rehabilitation Institute of Chicago. The National Institute on Disability, Independent Living, and Rehabilitation Research (H133F140037) and Craig H. Neilsen Foundation (290474) supported a portion of Alex Wong's effort.	Albrecht G. L., 2001, HDB DISABILITY STUDI; Alvarelhao J, 2012, J REHABIL MED, V44, P1, DOI 10.2340/16501977-0905; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Baker, 2001, BASICS ITEM RESPONSE; Bricout JC, 2006, SCAND J DISABIL RES, V8, P1, DOI 10.1080/15017410500335229; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cerniauskaite M, 2011, DISABIL REHABIL, V33, P281, DOI 10.3109/09638288.2010.529235; CHOPPIN B, 1968, NATURE, V219, P870, DOI 10.1038/219870a0; Choppin B., 1981, ISSUES EVALUATION AC, P204; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Clarke P, 2008, AM J EPIDEMIOL, V168, P506, DOI 10.1093/aje/kwn185; Coffey CE, 2000, AM PSYCHIAT PRESS TX; Commission on Social Determinants of Health, 2013, CLOS GAP GEN HLTH EQ; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Dickinson HO, 2010, ARCH PHYS MED REHAB, V91, P1310, DOI 10.1016/j.apmr.2010.03.012; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Enderby PM, 1986, DISABIL REHABIL, V8, P166, DOI DOI 10.3109/03790798709166209; Field M.J., 2007, FUTURE DISABILITY AM; Fisher Jr WP, 2007, RASCH MEAS TRANS, V21, P1095, DOI DOI 10.1111/J.1600-0528.2012.00694.X; Fisher W., 1992, RASCH MEAS T, V6, P238; Garcia SF, 2015, ARCH PHYS MED REHAB, V96, P596, DOI 10.1016/j.apmr.2014.06.019; Gray DB, 2003, J ARCHIT PLAN RES, V20, P29; Hahn EA, 2014, HEALTH PSYCHOL, V33, P490, DOI 10.1037/hea0000055; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Hollingsworth H, 2010, ARCH PHYS MED REHAB, V91, P1174, DOI 10.1016/j.apmr.2010.04.019; Lai JS, 2011, J PEDIATR PSYCHOL, V36, P766, DOI 10.1093/jpepsy/jsr005; Lawton MP., 1973, PSYCHOL ADULT DEV AG, P619, DOI [DOI 10.1037/10044-020, 10.1037/10044-020]; Levasseur Melanie, 2007, Can J Occup Ther, V74 Spec No., P233; Lewin K., 1951, FIELD THEORY SOCIAL; Linacre J. M., 2016, WINSTEPS RASCH MEASU; Magasi S, 2015, ARCH PHYS MED REHAB, V96, P569, DOI 10.1016/j.apmr.2014.12.002; Magasi S, 2009, J REHABIL MED, V41, P936, DOI 10.2340/16501977-0450; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; National Spinal Cord Injury Statistical Center, 2015, FACTS FIG GLANC; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Schneidert M, 2003, DISABIL REHABIL, V25, P588, DOI 10.1080/0963828031000137090; Stark S, 2007, DISABIL REHABIL, V29, P123, DOI 10.1080/09638280600731631; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tulsky DS, 2015, ARCH PHYS MED REHAB, V96, P604, DOI 10.1016/j.apmr.2014.02.030; United Nations General Assembly, 2003, FIN REP AD HOC COMM; Velozo CA, 2012, ARCH PHYS MED REHAB, V93, pS154, DOI 10.1016/j.apmr.2012.06.001; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; WHO, 2001, IR DDEFICIENCY AN AS, P1; Wilkinson GaryS, 2006, WRAT4 WIDE RANGE ACH; Wright BA., 1983, PHYS DISABILITY PSYC	48	6	8	3	16	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	NOV	2016	25	11					2775	2786		10.1007/s11136-016-1314-6			12	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	EA1NO	WOS:000386359200008	27207589				2022-02-06	
J	Holmes, J; Phillips, J; Morris, R; Bedekar, Y; Tyerman, R; Radford, K				Holmes, Jain; Phillips, Julie; Morris, Richard; Bedekar, Yashashree; Tyerman, Ruth; Radford, Kate			Development and evaluation of an early specialised traumatic brain injury vocational rehabilitation training package	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Vocational rehabilitation; traumatic brain injury; implementation	RETURN; WORK; INTERVENTIONS; THERAPY; STROKE	Background: In a feasibility randomised controlled trial, training was developed to equip occupational therapists to deliver early specialised traumatic brain injury vocational rehabilitation in the English National Health Service (NHS). Method: The package was developed by experts in vocational rehabilitation and traumatic brain injury, and included a manual, direct instruction by six trainers and opportunity for mentorship by four therapists. Following training, therapists were interviewed regarding the effectiveness and ease of use of the package. Interviews were analysed using the framework approach. Results: Five trained therapists were interviewed regarding the package. Results were organised into six categories: (1) motivation to participate in research; (2) impact of the learning environment; (3) changing confidence levels over time; (4) growing appreciation of complexities about the intervention; (5) acceptability of the training package; and (6) lessons for future implementation. Conclusion: The therapists reported acquiring the knowledge necessary to implement the intervention. The data indicate that the training packages require detailed descriptions of the interventions being taught for local implementation in the NHS and for future research. The training materials are valued by therapists but require time for familiarisation, and reminders from mentors help put training into practice. The therapists have concerns about implementing the interventions within a research context, which researchers should address.	[Holmes, Jain] UKOTRF, London, England; [Holmes, Jain; Phillips, Julie; Morris, Richard] Univ Nottingham, Nottingham NG7 2RD, England; [Bedekar, Yashashree] Neurol Rehabil Specialist, London, England; [Tyerman, Ruth] Buckinghamshire Healthcare Trust, Amersham, Bucks, England; [Radford, Kate] Univ Nottingham, Rehabil Res Long Term Condit, Nottingham, England		Holmes, J (corresponding author), Univ Nottingham, Div Rehabil & Ageing, Sch Med, Queens Med Ctr,Med Sch B109, Nottingham NG7 2UH, England.	jain.holmes@nottingham.ac.uk	Radford, Kate A/F-8571-2013; Holmes, Jain A/K-2125-2016	Radford, Kate A/0000-0001-6246-3180; Holmes, Jain A/0000-0003-2465-102X	National Institute for Health Research HTA Programme [11/66/02]; UK Occupational Therapy Research Fund (UKOTRF); University of Nottingham	This project was funded by the National Institute for Health Research HTA Programme (project number 11/66/02). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of HTA, NIHR, NHS or the Department of Health. PhD funding for J Holmes provided by UK Occupational Therapy Research Fund (UKOTRF) and University of Nottingham.	Albrecht L, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-52; Cancelliere C, 2013, HDB WORK DISABILITY, P303; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; College of Occupational Therapists, 2010, OCC THER EMPL; College of Occupational Therapists, 2008, ADV OV WORK REL STRE; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; das Nair R, 2012, REHABILITATION MEMOR; Department for Work and Pensions, 2013, 2010 2015 GOV POL EM; Department of Health, 2010, NHS OUTC FRAM 2011 1; Escorpizo R, 2011, J OCCUP REHABIL, V21, P147, DOI 10.1007/s10926-010-9276-y; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Frost D., 2011, HLTH WORK INDEPENDEN; Garfield A, 2013, LOW MOOD MS GROUP AD; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Hallberg, 2015, COMPLEX INTERVENTION, P1; Hasson H, 2015, COMPLEX INTERVENTION, P232; Hoffmann TC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3755; Kothari A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-20; Logan PA, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18290; McCormack B, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-107; Medical Research Council (MRC), 2008, DEV EVALUATING COMPL; NHS England, 2015, GUID EXC TREATM COST; O'Brien R, 2013, MUSCULOSKELET CARE, V11, P99, DOI 10.1002/msc.1050; Petzold A, 2010, J CONTIN EDUC HEALTH, V30, P167, DOI 10.1002/chp.20077; Phillips J, 2010, BRIT J OCCUP THER, V73, P422, DOI 10.4276/030802210X12839367526138; Phillips Justin, 2013, THESIS; Playford D, 2010, WORKING YET WORRIED; Playford ED, 2011, MAPPING VOCATIONAL R; Radford K, 2013, FRESH FACILITATING R; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Ritchie J., 2002, ANAL QUALITATIVE DAT, P305, DOI 10.4135/9781412986274; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; The Royal College of Physicians and The British Society of Rehabilitation Medicine, 2003, REH FOLL AXQ BRAIN I; Walker MF, 2012, CLIN REHABIL, V26, P675, DOI 10.1177/0269215511431089	34	6	6	0	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	NOV	2016	79	11					693	702		10.1177/0308022616651645			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	ED2UQ	WOS:000388705700008		Green Submitted			2022-02-06	
J	Inamasu, J; Nakae, S; Ohmi, T; Kogame, H; Kawazoe, Y; Kumai, T; Tanaka, R; Wakako, A; Kuwahara, K; Ganaha, T; Hirose, Y				Inamasu, Joji; Nakae, Shunsuke; Ohmi, Tatsuo; Kogame, Hirotaka; Kawazoe, Yushi; Kumai, Tadashi; Tanaka, Riki; Wakako, Akira; Kuwahara, Kiyonori; Ganaha, Tsukasa; Hirose, Yuichi			The outcomes of early aneurysm repair in World Federation of Neurosurgical Societies grade V subarachnoid haemorrhage patients with emphasis on those presenting with a Glasgow Coma Scale score of 3	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						General anaesthesia; Glasgow Coma Scale; Grade V; Outcome; Subarachnoid haemorrhage	NEUROGENIC PULMONARY-EDEMA; WALL-MOTION ABNORMALITY; TRAUMATIC BRAIN-INJURY; PATHOGENESIS; PREDICTION; MANAGEMENT; MORTALITY; ARREST	Grade V subarachnoid haemorrhage (SAH) patients may be dichotomised into those with temporary deterioration and those with irreversible injury, and only the former have a chance of favourable outcomes by aneurysm obliteration. One method of differentiating the two conditions is to wait and observe potential recovery for 12-48 hours. However, early rebleeding and non-convulsive seizures may occur during this period. In our institution, grade V SAH patients receive immediate treatment (general anaesthesia induction and aneurysm obliteration within 24 hours of onset) to minimise those risks. We focused on therapeutic outcomes in SAH patients presenting with a Glasgow Coma Scale score of 3 (GCS-3). Between January 2006 and December 2013, 82 GCS-3 SAH patients were admitted, among whom 51 (62%) underwent immediate aneurysm obliteration. Their outcomes 90 days after onset were evaluated with the Glasgow Outcome Scale, with either good recovery or moderate disability regarded as favourable outcomes. Multivariate logistic regression analysis was performed to identify variables correlated with favourable outcomes. Among the 51 patients, 11 (22%) had favourable 90-day outcomes. Age (odds ratio [OR], 0.838; 95% confidence interval [CI], 0.733-0.959; p = 0.010) and intact pupillary light reflex (OR, 21.939; 95% CI, 1.465-328.576; p = 0.025) were correlated with favourable outcomes. By contrast, neither intact respiratory pattern nor isocoric pupils was correlated with favourable outcomes. The current results indicate that vigorous intervention may be worth attempting in young GCS-3 SAH patients with intact pupillary light reflex. It remains unclear, however, whether the seemingly high frequency of favourable outcomes was truly due to reduction in early rebleeding or seizures. (C) 2016 Elsevier Ltd. All rights reserved.	[Inamasu, Joji; Nakae, Shunsuke; Ohmi, Tatsuo; Kogame, Hirotaka; Kawazoe, Yushi; Kumai, Tadashi; Tanaka, Riki; Wakako, Akira; Kuwahara, Kiyonori; Ganaha, Tsukasa; Hirose, Yuichi] Fujita Hlth Univ Hosp, Dept Neurosurg, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan		Inamasu, J (corresponding author), Fujita Hlth Univ Hosp, Dept Neurosurg, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	inamasu@fujita-hu.ac.jp	Hirose, Yuichi/P-1731-2019; Inamasu, Joji/R-7314-2019	Hirose, Yuichi/0000-0002-1305-1830; chuan fu, xiong shi/0000-0003-4891-5261	Japan Society for the Promotion of Science (JSPS KAKENHI)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26462173]	The corresponding author (JI) received a research grant from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 26462173).	Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; Ducruet AF, 2013, WORLD NEUROSURG, V80, pE347, DOI 10.1016/j.wneu.2012.05.029; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Hwang GJ, 2013, J KOREAN MED SCI, V28, P962, DOI 10.3346/jkms.2013.28.6.962; Inamasu J, 2001, RESUSCITATION, V51, P207, DOI 10.1016/S0300-9572(01)00429-4; Inamasu J, 2014, CLIN AUTON RES, V24, P259, DOI 10.1007/s10286-014-0256-8; Inamasu J, 2012, ACTA NEUROCHIR, V154, P2179, DOI 10.1007/s00701-012-1515-x; Inamasu J, 2012, NEUROL MED-CHIR, V52, P49, DOI 10.2176/nmc.52.49; Komotar RJ, 2009, NEUROSURGERY, V64, P397, DOI 10.1227/01.NEU.0000338946.42939.C7; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; Mack WJ, 2008, NEUROCRIT CARE, V8, P374, DOI 10.1007/s12028-007-9031-1; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Morrison LJ, 2010, CIRCULATION, V122, P8345, DOI 10.1161/CIRCULATIONAHA.110.971051; Oshiro EM, 1997, NEUROSURGERY, V41, P140, DOI 10.1097/00006123-199707000-00029; Sano H, 2015, WORLD NEUROSURG, V83, P801, DOI 10.1016/j.wneu.2014.12.032; SCHIEVINK WI, 1995, J NEUROSURG, V82, P791, DOI 10.3171/jns.1995.82.5.0791; Shapiro S, 1996, STROKE, V27, P1780, DOI 10.1161/01.STR.27.10.1780; Shirao S, 2010, CEREBROVASC DIS, V30, P105, DOI 10.1159/000314713; Starke RM, 2009, J CLIN NEUROSCI, V16, P894, DOI 10.1016/j.jocn.2008.10.010; Starke RM, 2009, J CLIN NEUROSCI, V16, P26, DOI 10.1016/j.jocn.2008.02.010; Sugimoto K, 2012, STROKE, V43, P1897, DOI 10.1161/STROKEAHA.111.646893; Suzuki M, 2000, NEUROSURGERY, V47, P1098, DOI 10.1097/00006123-200011000-00014; Takagi K, 1999, J NEUROSURG, V90, P680, DOI 10.3171/jns.1999.90.4.0680; van Heuven AW, 2008, STROKE, V39, P1347, DOI 10.1161/STROKEAHA.107.498345; Wostrack M, 2013, ACTA NEUROCHIR, V155, P579, DOI 10.1007/s00701-013-1634-z	25	6	6	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2016	33						142	147		10.1016/j.jocn.2016.03.035			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ9JW	WOS:000386192200024	27450281				2022-02-06	
J	Matsumoto-Miyazaki, J; Asano, Y; Yonezawa, S; Nomura, Y; Ikegame, Y; Aki, T; Takenaka, S; Shinoda, J				Matsumoto-Miyazaki, Jun; Asano, Yoshitaka; Yonezawa, Shingo; Nomura, Yuichi; Ikegame, Yuka; Aki, Tatsuki; Takenaka, Shunsuke; Shinoda, Jun			Acupuncture Increases the Excitability of the Cortico-Spinal System in Patients with Chronic Disorders of Consciousness Following Traumatic Brain Injury	JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE			English	Article						acupuncture; disorder of consciousness; brain injury; transcranial magnetic stimulation; cortico-spinal tract	TRANSCRANIAL MAGNETIC STIMULATION; CEREBRAL-BLOOD-FLOW; PERIPHERAL-NERVE STIMULATION; MOTOR CORTEX EXCITABILITY; ELECTROACUPUNCTURE; MODULATION; INHIBITION; RECOVERY; STATE	Objective: To evaluate the immediate effect of acupuncture on cortico spinal tract (CST) activity in patients with chronic disorders of consciousness (DOC) after traumatic brain injury (TBI) by measuring motor-evoked potential (MEP) using transcranial magnetic stimulation (TMS). Design: Changes in several variables in the acupuncture session were compared with those in the control session without acupuncture in the same patients. Setting: Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Gifu, Japan. Patients: Fourteen patients (mean age +/- standard deviation, 39 +/- 17 years; 12 men) with chronic DOC (5 in a vegetative state and 9 in a minimally conscious state) following severe TBI. Intervention: Acupuncture treatment was performed at GV 26, Ex-HN 3, bilateral LI 4, and ST 36 for 10 minutes. Outcome measures: Main outcome measure was MEP amplitude. MEP amplitude, measured by using TMS on the primary motor cortex, was recorded from the abductor pollicis brevis muscle. MEP recordings were performed before acupuncture (baseline), 10 minutes after needle insertion (phase 1), and 10 minutes after needle removal (phase 2). As a control, the same procedure without acupuncture was performed on another day with the order randomized. MEP amplitude and latency were calculated. Evoked F-wave measurements were also performed to calculate maximum M-wave amplitude (Mmax), M-wave latency, and F-wave latency in the same muscle. Central motor conduction time (CMCT) and MEP/Mmax ratio were also calculated from the MEP and F-wave measurement data. Results: MEP amplitude and MEP/Mmax were increased significantly in the acupuncture session at phases 1 and 2 compared with the control session (p < 0.001, p < 0.001, p < 0.001, and p = 0.001, respectively). CMCTs were reduced at phases 1 and 2 in the acupuncture session compared with the control session, and the change at phase 1 was statistically significant (P = 0.002). Conclusions: Acupuncture treatment increased the CST activity of patients with chronic DOC after severe TBI.	[Matsumoto-Miyazaki, Jun; Asano, Yoshitaka; Yonezawa, Shingo; Nomura, Yuichi; Ikegame, Yuka; Aki, Tatsuki; Takenaka, Shunsuke; Shinoda, Jun] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, 630 Shimo Kobi,Kobi Cho, Gifu 5050034, Japan; [Asano, Yoshitaka; Shinoda, Jun] Gifu Univ, Grad Sch Med, Dept Clin Brain Sci, Gifu, Japan		Matsumoto-Miyazaki, J (corresponding author), Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, 630 Shimo Kobi,Kobi Cho, Gifu 5050034, Japan.	jmiyamatsu@gmail.com	Ikegame, Yuka/AAU-8880-2020	Ikegame, Yuka/0000-0002-8932-9798			An YS, 2009, J ALTERN COMPLEM MED, V15, P1075, DOI 10.1089/acm.2009.0257; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Chang CL, 1995, NEUROSCI LETT, V202, P93, DOI 10.1016/0304-3940(95)12214-1; Charlton CS, 2003, J NEUROL SCI, V208, P79, DOI 10.1016/S0022-510X(02)00443-4; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Chen R, 2008, CLIN NEUROPHYSIOL, V119, P504, DOI 10.1016/j.clinph.2007.10.014; Chuang CH, 2013, ACUPUNCT MED, V31, P395, DOI 10.1136/acupmed-2013-010406; Cohen J., 2013, STAT POWER ANAL BEHA; Conforto AB, 2004, CLIN NEUROPHYSIOL, V115, P812, DOI 10.1016/j.clinph.2003.11.010; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Farina S, 2001, NEUROSCI LETT, V314, P97, DOI 10.1016/S0304-3940(01)02297-2; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Han L, 2010, ACUPUNCTURE ELECTRO, V35, P29, DOI 10.3727/036012910803860986; Hsu CH, 2006, EMERG MED J, V23, DOI 10.1136/emj.2004.023218; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Kaelin-Lang A, 2002, J PHYSIOL-LONDON, V540, P623, DOI 10.1113/jphysiol.2001.012801; Kim YS, 2008, AM J CHINESE MED, V36, P45, DOI 10.1142/S0192415X08005576; Lapitskaya N, 2013, BRAIN STIMUL, V6, P590, DOI 10.1016/j.brs.2013.01.002; Lapitskaya N, 2009, PROG BRAIN RES, V177, P191, DOI 10.1016/S0079-6123(09)17713-0; Lapitskaya N, 2009, REV NEUROSCIENCE, V20, P235; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Le Pera D, 2001, CLIN NEUROPHYSIOL, V112, P1633, DOI 10.1016/S1388-2457(01)00631-9; Lee JD, 2003, NEURORADIOLOGY, V45, P780, DOI 10.1007/s00234-003-1080-3; Lo YL, 2005, NEUROSCI LETT, V384, P145, DOI 10.1016/j.neulet.2005.04.083; Lo YL, 2003, NEUROREPORT, V14, P1229, DOI 10.1097/00001756-200307010-00008; Maioli C, 2006, EUR J NEUROSCI, V23, P1931, DOI 10.1111/j.1460-9568.2006.04698.x; Moosavi SH, 1999, J NEUROL SCI, V164, P179, DOI 10.1016/S0022-510X(99)00065-9; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; Samii A, 1998, MUSCLE NERVE, V21, P1445, DOI 10.1002/(SICI)1097-4598(199811)21:11<1445::AID-MUS12>3.3.CO;2-4; Sheu SY, 2010, COMPLEMENT THER MED, V18, P265, DOI 10.1016/j.ctim.2010.08.001; Streitberger K, 2005, AM J EMERG MED, V23, P90, DOI 10.1016/j.ajem.2003.12.027; Tamai Hideaki, 2009, Masui, V58, P349; Tseng YJ, 2013, J ALTERN COMPLEM MED, V19, P474, DOI 10.1089/acm.2012.0163; Uchida S, 2000, JPN J PHYSIOL, V50, P495, DOI 10.2170/jjphysiol.50.495; Wang ZF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/608430; World Health Organization, 2008, WHO STAND AC POINT L; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zheng Y, 2012, ACUPUNCT MED, V30, P307, DOI 10.1136/acupmed-2011-010123; Zunhammer M, 2012, NEUROPHYSIOL CLIN, V42, P225, DOI 10.1016/j.neucli.2012.02.134	42	6	6	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1075-5535	1557-7708		J ALTERN COMPLEM MED	J. Altern. Complement Med.	NOV	2016	22	11					887	894		10.1089/acm.2014.0356			8	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	EC4QQ	WOS:000388118900009	27662495				2022-02-06	
J	Matsumoto-Miyazaki, J; Asano, Y; Ikegame, Y; Kawasaki, T; Nomura, Y; Shinoda, J				Matsumoto-Miyazaki, Jun; Asano, Yoshitaka; Ikegame, Yuka; Kawasaki, Tomohiro; Nomura, Yuichi; Shinoda, Jun			Acupuncture Reduces Excitability of Spinal Motor Neurons in Patients with Spastic Muscle Overactivity and Chronic Disorder of Consciousness Following Traumatic Brain Injury	JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE			English	Article						acupuncture; spasticity; hypertonia; disorder of consciousness; brain injury; spinal motor neuron	MODIFIED ASHWORTH SCALE; POSTSTROKE PATIENTS; UPPER-LIMB; VIBRATORY STIMULI; HEMIPLEGIC LIMBS; F-WAVES; STROKE; STATES; CHILDREN; CONTRACTURES	Background and Objective: Spastic hypertonia usually occurs in patients with chronic disorders of consciousness (DOC) following severe traumatic brain injury (TBI). Spinal motor neuron excitability has been reported to increase in patients with brain damage. The aim of this study was to evaluate the immediate effects of acupuncture on spinal motor neuron excitability in patients with DOC following TBI by using evoked electromyography. Setting and Participants: Eleven male patients (mean age, 33 +/- 14 years) with refractory muscle spasticity of the upper extremity accompanying chronic DOC following TBI and admitted to Chubu Medical Center for Prolonged Traumatic Brain Dysfunction were included. Design: A crossover study design was used. Changes in variables in the acupuncture session were compared with those in the control session in the same patients. Intervention: Acupuncture treatment was performed at GV26, Ex-HN3, bilateral LI 4, and ST 36 for 10 minutes. Outcome measures: F-wave was recorded from the abductor pollicis brevis muscle. The main outcome measure was F/M amplitude ratio (F-wave amplitude/M-wave amplitude), calculated as an index for spinal motor neuron excitability. F-waves were recorded before treatment (baseline), 10 minutes after needle insertion (phase 1), and 10 minutes after needle removal (phase 2). The same procedure was followed in the control session without acupuncture on a separate day. Results: F/M ratio was significantly reduced from baseline to phase 1 (p < 0.001) and phase 2 (p < 0.001) in the acupuncture session, whereas no significant changes were observed in the control session. Changes in F/M ratio from baseline to phase 1 and phase 2 were greater in the acupuncture session than the control session (p = 0.001 and < 0.001, respectively). Conclusion: The excitability of the spinal motor neurons in patients with DOC following TBI was reduced after acupuncture treatment, suggesting that it is beneficial for reducing spastic muscle hypertonia in these patients.	[Matsumoto-Miyazaki, Jun; Asano, Yoshitaka; Ikegame, Yuka; Kawasaki, Tomohiro; Nomura, Yuichi; Shinoda, Jun] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, 630 Shimo Kobi Kobi Cho, Gifu 5050034, Japan; [Asano, Yoshitaka; Shinoda, Jun] Gifu Univ, Grad Sch Med, Dept Clin Brain Sci, Gifu, Japan		Matsumoto-Miyazaki, J (corresponding author), Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, 630 Shimo Kobi Kobi Cho, Gifu 5050034, Japan.	jmiyamatsu@gmail.com	Ikegame, Yuka/AAU-8880-2020	Ikegame, Yuka/0000-0002-8932-9798	ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives)	A part of this study was funded by ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives).	Acar HV, 2013, J ALTERN COMPLEM MED, V19, P420, DOI 10.1089/acm.2012.0494; Ada L, 2006, DISABIL REHABIL, V28, P891, DOI 10.1080/09638280500535165; Ansari NN, 2015, NEUROREHABILITATION, V36, P61, DOI 10.3233/NRE-141192; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Drory V E, 1993, Electromyogr Clin Neurophysiol, V33, P441; FISHER MA, 1994, MUSCLE NERVE, V17, P1185, DOI 10.1002/mus.880171009; Fisher MA, 2007, THESCIENTIFICWORLDJO, V7, P144, DOI 10.1100/tsw.2007.49; Fleuren JFM, 2010, J NEUROL NEUROSUR PS, V81, P46, DOI 10.1136/jnnp.2009.177071; Ganapathy Vaidyanathan, 2015, Clin Interv Aging, V10, P1793, DOI 10.2147/CIA.S91123; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Gracies JM, 2010, EUR J PHYS REHAB MED, V46, P411; Habbal D, 2014, BRAIN INJURY, V28, P1171, DOI 10.3109/02699052.2014.920519; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Leong B, 2002, BRAIN INJURY, V16, P169, DOI 10.1080/02699050110103292; Leong B, 2002, BRAIN INJURY, V16, P217, DOI 10.1080/02699050110103283; Lim SM, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/870398; Lo YL, 2005, NEUROSCI LETT, V384, P145, DOI 10.1016/j.neulet.2005.04.083; Maioli C, 2006, EUR J NEUROSCI, V23, P1931, DOI 10.1111/j.1460-9568.2006.04698.x; Malhotra S, 2011, CLIN REHABIL, V25, P184, DOI 10.1177/0269215510381620; Malhotra S, 2009, CLIN REHABIL, V23, P651, DOI 10.1177/0269215508101747; Matsumoto J, 2012, BRAIN INJURY, V26, P504; Matsumoto S, 2010, INT J BIOMETEOROL, V54, P465, DOI 10.1007/s00484-009-0300-x; Mehrholz J, 2005, CLIN REHABIL, V19, P63, DOI 10.1191/0269215505cr824oa; MILANOV IG, 1992, CAN J NEUROL SCI, V19, P64, DOI 10.1017/S0317167100042554; Miranov IG, 1992, ELECTROMYPGR CLIN NE, V32, P11; Noma T, 2012, J REHABIL MED, V44, P325, DOI 10.2340/16501977-0946; Noma T, 2009, BRAIN INJURY, V23, P623, DOI 10.1080/02699050902997896; Park SW, 2014, J ALTERN COMPLEM MED, V20, P672, DOI 10.1089/acm.2014.0097; Pilon M, 1996, BRAIN INJURY, V10, P421, DOI 10.1080/026990596124287; Preston N, 2011, J REHABIL MED, V43, P1010, DOI 10.2340/16501977-0893; Rekand T, 2010, ACTA NEUROL SCAND, V122, P62, DOI 10.1111/j.1600-0404.2010.01378.x; Saout V., 2010, Annals of Physical and Rehabilitation Medicine, V53, P96, DOI 10.1016/j.rehab.2010.01.002; Tamai Hideaki, 2007, Masui, V56, P1206; Tamai Hideaki, 2007, Masui, V56, P203; Thibaut A, 2015, EUR J PHYS REHAB MED, V51, P389; Tsai Kuen-Horng, 2001, Proceedings of the National Science Council Republic of China Part B Life Sciences, V25, P76; Tseng YJ, 2013, J ALTERN COMPLEM MED, V19, P474, DOI 10.1089/acm.2012.0163; World Health Organization, 2008, WHO STAND AC POINT L; Wupuer S, 2013, NEUROMODULATION, V16, P206, DOI 10.1111/j.1525-1403.2012.00520.x; Yablon SA, 2004, AM J PHYS MED REHAB, V83, pS10, DOI 10.1097/01.PHM.0000141126.11008.7D; Yan TB, 2009, J REHABIL MED, V41, P312, DOI 10.2340/16501977-0325; Yelnik AP, 2010, J REHABIL MED, V42, P801, DOI 10.2340/16501977-0613; Yu Y H, 1995, Zhonghua Yi Xue Za Zhi (Taipei), V56, P258; Zhao WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116976; Zheng X, 2012, ACUPUNCT MED, V30, P78, DOI 10.1136/acupmed-2011-010095; Zorowitz RD, 2013, NEUROLOGY, V80, pS45, DOI 10.1212/WNL.0b013e3182764c86	49	6	7	2	25	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1075-5535	1557-7708		J ALTERN COMPLEM MED	J. Altern. Complement Med.	NOV	2016	22	11					895	902		10.1089/acm.2016.0180			8	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Integrative & Complementary Medicine	EC4QQ	WOS:000388118900010	27575577				2022-02-06	
J	Muballe, KD; Hardcastle, T; Kiratu, E				Muballe, Kadhaya David; Hardcastle, Timothy; Kiratu, Erastus			Neurological findings in pediatric penetrating head injury at a university teaching hospital in Durban, South Africa: a 23-year retrospective study	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						penetrating traumatic brain injury; gunshot; head; stab wound; neurological sequelae; trauma	STAB WOUNDS; BRAIN; EPILEPSY; SEIZURES; CHILDREN	OBJECTIVES Penetrating traumatic brain injuries (TBIs) can be divided into gunshot wounds or stab wounds based on the mechanisms of injury. Pediatric penetrating TBIs are of major concern as many parental and social factors may be involved in the causation. The authors describe the penetrating cranial injuries in pediatric patient subgroups at risk and presenting to the Department of Neurosurgery at the University of KwaZulu-Natal, by assessment of the Glasgow Coma Scale (GCS) score and review of the common neurological manifestations including cranial nerve abnormalities. METHODS The authors performed a retrospective chart review of children who presented with penetrating TBIs between 1985 and 2007 at a university teaching hospital. Descriptive statistical analysis with univariate and multivariate logistic regression was used to assess the variables. RESULTS Out of 223 children aged 16 years and younger with penetrating TBIs seen during the study period, stab wounds were causal in 127 (57%) of the patients, while gunshot injuries were causal in 96 (43%). Eighty-four percent of the patients were male. Apart from abnormal GCS scores, other neurological abnormalities were noted in 109 (48.9%) of the patients, the most common being cranial nerve deficits (22.4%) and hemiparesis. There was a strong correlation between left-sided stab wounds and development of seizures. The mean age of patients with neurological abnormalities was 11.72 years whereas that of patients with no neurological abnormalities was 8.96 years. CONCLUSIONS Penetrating head injuries in children are not as uncommon as previously thought. There was no correlation between the age group of the patients and the mechanism of injury, which implies that stab or gunshot injuries could occur in any of our pediatric population with the same frequency. While gunshot injuries accounted for 56% of the patient population, stab injuries still accounted for 44%. Following penetrating head injuries, neurological abnormalities tend to occur in the older subgroup of the pediatric patients. The most common neurological abnormalities were hemiparesis followed by cranial nerve deficits. Facial nerve deficits were the most commonly seen cranial nerve abnormality. Immediate convulsions were a significant feature in patients with stab injuries to the head compared to those with gunshot injuries.	[Muballe, Kadhaya David; Kiratu, Erastus] Inkosi Albert Luthuli Cent Hosp, Dept Neurosurg, Durban, Kwazulu Natal, South Africa; [Hardcastle, Timothy] Inkosi Albert Luthuli Cent Hosp, Dept Trauma Surg, Durban, Kwazulu Natal, South Africa; Univ KwaZulu Natal, Durban, Kwazulu Natal, South Africa		Muballe, KD (corresponding author), Univ KwaZulu Natal, Dept Neurosurg, 800 Vusi Mzimela Rd, ZA-4091 Durban, Kwazulu Natal, South Africa.	kmuballe@yahoo.co.uk		Hardcastle, Timothy/0000-0002-3967-0234			AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS60; Amirjamshidi A, 1997, SURG NEUROL, V47, P331, DOI 10.1016/S0090-3019(96)00357-6; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Ascroft PB, 1943, LANCET, V2, P211; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CAMPBELL EH, 1945, ANN SURG, V122, P375, DOI 10.1097/00000658-194509000-00004; Cushing H, 1918, BRIT J SURG, V5, P558; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; DUJOVNY M, 1975, J TRAUMA, V15, P981, DOI 10.1097/00005373-197511000-00007; Dutcher S, 2001, PEDIATRIC NEUROSURGE, V99, P573; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; Fieggen AG, 2004, SAMJ S AFR MED J, V94, P293; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; HAWORTH CS, 1988, NEUROSURGERY, V23, P431, DOI 10.1227/00006123-198810000-00004; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; Koestler J, 2001, J EMERG MED, V21, P145, DOI 10.1016/S0736-4679(01)00363-8; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Kumar A, 2006, PEDIATR NEUROSURG, V42, P391, DOI 10.1159/000095572; MARTIN J, 1946, J NEUROSURG, V3, P58, DOI 10.3171/jns.1946.3.1.0058; RISH BL, 1973, J NEUROSURG, V38, P155, DOI 10.3171/jns.1973.38.2.0155; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SWANSON SJ, 1995, BRAIN, V118, P91, DOI 10.1093/brain/118.1.91; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013	28	6	8	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2016	18	5					550	557		10.3171/2016.5.PEDS167			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DZ8FL	WOS:000386106200005	27472666	Bronze			2022-02-06	
J	Rossano, C; Terrier, P				Rossano, Cathia; Terrier, Philippe			Visually-guided gait training in paretic patients during the first rehabilitation phase: study protocol for a randomized controlled trial	TRIALS			English	Article						Stroke; Traumatic brain injury; Spinal cord injury; Rehabilitation; Augmented reality; Randomized controlled trial	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; STROKE REHABILITATION; CLINICAL-TRIALS; WALKING; BALANCE; FALLS; METAANALYSIS; IMPAIRMENTS; PERFORMANCE	Background: After a lesion to the central nervous system, many patients suffer from reduced walking capability. In the first rehabilitation phase, repeated walking exercises facilitate muscular strength and stimulate brain plasticity and motor relearning. However, marked limping, an unsteady gait, and poor management of obstacle clearance may persist, which increases a patient's risk of falling. Gait training with augmented reality has been recommended to improve gait coordination. The objective of this study is to test whether a gait rehabilitation program using augmented reality is superior to a conventional treadmill training program of equivalent intensity. Methods/design: The GASPAR trial (Gait Adaptation for Stroke Patients with Augmented Reality) is a pragmatic, parallel-arm, single-center, nonblind, superiority randomized control trial in neurorehabilitation. The setting is a rehabilitation clinic in Switzerland. The planned number of participants is 70-100. The intervention uses instrumented treadmills equipped with projectors that display shapes on the walking surface. The principle is that patients must adapt their gait to the image that unfolds in front of them. Specific exercises for gait symmetry, coordination enhancement, and gait agility are provided. The program includes twenty 30-min sessions spanning 4 weeks. The comparator group receives standard treadmill training of a similar frequency and intensity. The main outcome to be measured in the trial is walking speed, which is assessed with the 2-min Walk Test. Moreover, gait parameters are recorded during the gait training sessions. Other outcomes are balance control (Berg Balance Scale) and the fear of falling (Falls Efficacy Scale). The statistical analyses will compare the baseline assessment for each participant (before the intervention) with a post-intervention assessment (taken a few days after the end of the program). Furthermore, a follow-up assessment will take place 3 months after discharge. Discussion: The study results will provide new knowledge about recovery in neurological patients and will contribute to the design of better rehabilitation programs to accompany this process. The findings will also help health care funders to decide whether treadmills equipped with augmented reality capabilities are a worthwhile investment.	[Rossano, Cathia; Terrier, Philippe] IRR, Sion, Switzerland; [Terrier, Philippe] Clin Romande Readaptat SUVACare, Ave Gd Champsec 90, CH-1951 Sion, Switzerland		Terrier, P (corresponding author), IRR, Sion, Switzerland.; Terrier, P (corresponding author), Clin Romande Readaptat SUVACare, Ave Gd Champsec 90, CH-1951 Sion, Switzerland.	Philippe.Terrier@crr-suva.ch	Terrier, Philippe/H-3831-2012	Terrier, Philippe/0000-0002-3693-4505	Swiss Heart Foundation; CRR; Institute for Research in Rehabilitation (IRR); Canton du Valais; City of Sion	This study is funded by a grant from the Swiss Heart Foundation [35] that covers the staff's salaries (i.e., research assistants and statistician). Access to the treadmills is kindly provided by the CRR, which also provides human resources and logistic and administrative support. The salary of the principal investigator is paid by the CRR and by the Institute for Research in Rehabilitation (IRR). The IRR is funded by the Canton du Valais and the City of Sion. The study funders play no role in study design; collection, management, analysis, and interpretation of data; writing of the report; or the decision to submit the report for publication. The study is undertaken independently of Zebris Medical GmbH and MotekForce Link.	Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Breceda EY, 2013, CURR OPIN NEUROL, V26, P595, DOI 10.1097/WCO.0000000000000024; Brotherton SS, 2007, SPINAL CORD, V45, P37, DOI 10.1038/sj.sc.3101909; Buella CJ, 2008, ARCH PHYS MED REHAB, V89, P291, DOI 10.1016/j.apmr.2007.08.152; Chamberlain JD, 2015, INJURY EPIDEMIOLOGY, V2, P1, DOI DOI 10.1186/S40621-014-0032-1; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Dickstein R, 2008, NEUROREHAB NEURAL RE, V22, P649, DOI [10.1177/15459683080220060201, 10.1177/1545968308315997]; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Heeren A, 2013, J REHABIL MED, V45, P616, DOI 10.2340/16501977-1180; Hollands KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139261; Hollands KL, 2012, GAIT POSTURE, V35, P349, DOI 10.1016/j.gaitpost.2011.10.355; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kenzie JM, 2014, J NEUROL SCI, V342, P52, DOI 10.1016/j.jns.2014.04.025; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Lam Tania, 2007, Top Spinal Cord Inj Rehabil, V13, P32, DOI 10.1310/sci1301-32; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lawrence ES, 2001, STROKE, V32, P1279, DOI 10.1161/01.STR.32.6.1279; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Meyer K, 2009, SWISS MED WKLY, V139, P65, DOI smw-12448; Mills EJ, 2006, LANCET ONCOL, V7, P141, DOI 10.1016/S1470-2045(06)70576-9; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nascimento LR, 2015, J PHYSIOTHER, V61, P10, DOI 10.1016/j.jphys.2014.11.015; NYBERG L, 1995, STROKE, V26, P838, DOI 10.1161/01.STR.26.5.838; Patterson KK, 2015, NEUROREHAB NEURAL RE, V29, P153, DOI 10.1177/1545968314533614; Peurala SH, 2014, J REHABIL MED, V46, P387, DOI 10.2340/16501977-1805; Pin TW, 2014, ARCH PHYS MED REHAB, V95, P1759, DOI 10.1016/j.apmr.2014.03.034; Polese JC, 2013, J PHYSIOTHER, V59, P73, DOI 10.1016/S1836-9553(13)70159-0; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schlick C, 2016, CLIN REHABIL, V30, P463, DOI 10.1177/0269215515588836; Smania N, 2008, NEUROL SCI, V29, P313, DOI 10.1007/s10072-008-0988-0; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; van Hedel HJA, 2010, RESTOR NEUROL NEUROS, V28, P123, DOI 10.3233/RNN-2010-0508; van Ooijen MW, 2015, EXP BRAIN RES, V233, P1007, DOI 10.1007/s00221-014-4175-7; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X	37	6	6	0	15	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1745-6215			TRIALS	Trials	OCT 27	2016	17								523	10.1186/s13063-016-1630-8			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EA6KE	WOS:000386736200001	27788679	Green Published, gold			2022-02-06	
J	Blanco, MMB; Prashant, GN; Vespa, PM				Blanco, Manuel M. Buitrago; Prashant, Giyarpuram N.; Vespa, Paul M.			Cerebral Metabolism and the Role of Glucose Control in Acute Traumatic Brain Injury	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Glucose control; Metabolism; Neurovascular unit; Metabolic crisis; Outcome; Hyperglycolysis; Cerebral microdialysis	INTENSIVE INSULIN THERAPY; TIGHT GLYCEMIC CONTROL; BLOOD-FLOW; HYPERGLYCEMIA MANAGEMENT; COMBINED MICRODIALYSIS; MORTALITY; ADMISSION; STROKE; TRIAL; ASSOCIATION	This article reviews key concepts of cerebral glucose metabolism, neurologic outcomes in clinical trials, the biology of the neurovascular unit and its involvement in secondary brain injury after traumatic brain insults, and current scientific and clinical data that demonstrate a better understanding of the biology of metabolic dysfunction in the brain, a concept now known as cerebral metabolic energy crisis. The use of neuromonitoring techniques to better understand the pathophysiology of the metabolic crisis is reviewed and a model that summarizes the triphasic view of cerebral metabolic disturbance supported by existing scientific data is outlined. The evidence is summarized, and a template for future research is provided.	[Blanco, Manuel M. Buitrago; Prashant, Giyarpuram N.; Vespa, Paul M.] Univ Calif Los Angeles, Dept Neurosurg, Div Neurocrit Care, 757 Westwood Blvd, Los Angeles, CA 90095 USA		Blanco, MMB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Div Neurocrit Care, 757 Westwood Blvd, Los Angeles, CA 90095 USA.	mblanco@mednet.ucla.edu					Ainla T, 2005, DIABETIC MED, V22, P1321, DOI 10.1111/j.1464-5491.2005.01625.x; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Badjatia N, 2014, NEUROCRIT CARE, V21, P159, DOI 10.1007/s12028-014-0036-2; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bolk J, 2001, INT J CARDIOL, V79, P207, DOI 10.1016/S0167-5273(01)00422-3; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Bruno A, 2002, NEUROLOGY, V59, P669, DOI 10.1212/WNL.59.5.669; Bruno A, 2014, INT J STROKE, V9, P246, DOI 10.1111/ijs.12045; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chaurasia CS, 2007, J CLIN PHARMACOL, V47, P589, DOI 10.1177/0091270006299091; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Garg R, 2006, STROKE, V37, P267, DOI 10.1161/01.STR.0000195175.29487.30; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Graffagnino C, 2010, NEUROCRIT CARE, V13, P307, DOI 10.1007/s12028-010-9469-4; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; Holbein M, 2009, CRIT CARE, V13, DOI 10.1186/cc7711; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hutchinson P, 2014, NEUROCRIT CARE, V21, P148, DOI 10.1007/s12028-014-0035-3; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Johnston KC, 2009, STROKE, V40, P3804, DOI 10.1161/STROKEAHA.109.561498; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kavanagh BP, 2010, NEW ENGL J MED, V363, P2540, DOI 10.1056/NEJMcp1001115; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Kurtz P, 2014, CRIT CARE, V18, DOI 10.1186/cc13857; Kurtz P, 2013, NEUROCRIT CARE, V19, P311, DOI 10.1007/s12028-013-9919-x; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Latorre JGS, 2009, STROKE, V40, P1644, DOI 10.1161/STROKEAHA.108.535534; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; McEwen BS, 2004, EUR J PHARMACOL, V490, P13, DOI 10.1016/j.ejphar.2004.02.041; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; Norhammar AM, 1999, DIABETES CARE, V22, P1827, DOI 10.2337/diacare.22.11.1827; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Passero S, 2003, NEUROLOGY, V61, P1351, DOI 10.1212/01.WNL.0000094326.30791.2D; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; Rady MY, 2005, MAYO CLIN PROC, V80, P1558, DOI 10.4065/80.12.1558; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Romano AH, 1996, RES MICROBIOL, V147, P448, DOI 10.1016/0923-2508(96)83998-2; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Saadat SMS, 2012, CHILD NERV SYST, V28, P1773, DOI 10.1007/s00381-012-1753-5; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Song EC, 2003, STROKE, V34, P2215, DOI 10.1161/01.STR.0000088060.83709.2C; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Sparks S, 1997, SCIENCE, V277, P459; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; UNGERSTEDT U, 1974, B SCHWEIZ AKAD MED, V30, P44; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; WELSH FA, 1980, STROKE, V11, P355, DOI 10.1161/01.STR.11.4.355; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	75	6	6	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	OCT	2016	27	4					453	+		10.1016/j.nec.2016.05.003			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DY9SQ	WOS:000385475800007	27637395				2022-02-06	
J	Busingye, DS; Turner, RJ; Vink, R				Busingye, Diana S.; Turner, Renee J.; Vink, Robert			Combined Magnesium/Polyethylene Glycol Facilitates the Neuroprotective Effects of Magnesium in Traumatic Brain Injury at a Reduced Magnesium Dose	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Blood-brain barrier; Edema; Magnesium; Neurotrauma; Treatment	SPINAL-CORD-INJURY; POLYETHYLENE-GLYCOL; MOTOR DEFICITS; CEREBRAL EDEMA; RATS; SULFATE; THERAPY; TRIAL	AimsWhile a number of studies have shown that free magnesium (Mg) decline is a feature of traumatic brain injury (TBI), poor central penetration of Mg has potentially limited clinical translation. This study examines whether polyethylene glycol (PEG) facilitates central penetration of Mg after TBI, increasing neuroprotection while simultaneously reducing the dose requirements for Mg. MethodsRats were exposed to diffuse TBI and administered intravenous MgCl2 either alone (254 mol/kg or 25.4 mol/kg) or in combination with PEG (1 g/kg PEG) at 30-min postinjury. Vehicle-treated (saline or PEG) and sham animals served as controls. All animals were subsequently assessed for blood-brain barrier permeability and edema at 5 h, and functional outcome for 1 week postinjury. ResultsOptimal dose (254 mol/kg) MgCl2 or Mg PEG significantly improved all outcome parameters compared to vehicle or PEG controls. Intravenous administration of 10% MgCl2 alone (25.4 mol/kg) had no beneficial effect on any of the outcome parameters, whereas 10% Mg in PEG had the same beneficial effects as optimal dose Mg administration. ConclusionPolyethylene glycol facilitates central penetration of Mg following TBI, reducing the concentration of Mg required to confer neuroprotection while simultaneously reducing the risks associated with high peripheral Mg concentration.	[Busingye, Diana S.; Turner, Renee J.] Univ Adelaide, Sch Med, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia; [Vink, Robert] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia		Vink, R (corresponding author), Univ South Australia, Div Hlth Sci, Adelaide, SA 5000, Australia.	robert.vink@unisa.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667	Neurosurgical Research Foundation, Australia	Supported, in part, by the Neurosurgical Research Foundation, Australia.	Auer RN, 2004, FORENSIC SCI INT, V146, P105, DOI 10.1016/j.forsciint.2004.08.001; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Brewer RP, 2001, CLIN NEUROPHARMACOL, V24, P341, DOI 10.1097/00002826-200111000-00005; Dhandapani SS, 2008, INDIAN J NEUROTRAUM, V5, P27, DOI 10.1016/S0973-0508(08)80025-1; Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Esen F, 2003, J NEUROSURG ANESTH, V15, P119, DOI 10.1097/00008506-200304000-00009; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harford-Wright E, 2010, NEUROSCI LETT, V481, P26, DOI 10.1016/j.neulet.2010.06.044; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoane MR, 2007, MAGNESIUM RES, V20, P229; Imer M, 2009, NEUROL RES, V31, P977, DOI 10.1179/174313209X385617; Kim SW, 2011, 15 INT S BRAIN ED CE, P82; Koob Andrew O, 2008, J Biol Eng, V2, P9, DOI 10.1186/1754-1611-2-9; Kwon BK, 2009, J NEUROTRAUM, V26, P1379, DOI [10.1089/neu.2009.0884, 10.1089/neu.2009-0884]; Lee JH, 1976, SPINE, V35, P2041; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Smucker P, 2009, NEUROSURGERY, V64, P984, DOI 10.1227/01.NEU.0000342406.43816.13; Stippler M, 2007, J NEUROTRAUM, V24, P1347, DOI 10.1089/neu.2007.0277; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; VINK R, 1988, J BIOL CHEM, V263, P757; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Vink R, 2012, MAGNESIUM CENTRAL NE	34	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	OCT	2016	22	10					854	859		10.1111/cns.12591			6	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DW4QL	WOS:000383628000006	27421816	Green Published, Bronze			2022-02-06	
J	Du, YQ; Yang, JH; Yan, B; Bai, Y; Zhang, LF; Zheng, LL; Cai, Y				Du, Yanqiu; Yang, Jinghua; Yan, Bo; Bai, Yan; Zhang, Lifeng; Zheng, Linlin; Cai, Yuan			Lanthanum enhances glutamate-nitric oxide-3,5-cyclic guanosine monophosphate pathway in the hippocampus of rats	TOXICOLOGY AND INDUSTRIAL HEALTH			English	Article						Lanthanum; glutamate; NMDAR; nitric oxide; cGMP	TRAUMATIC BRAIN-INJURY; MOLECULAR-MECHANISMS; SPATIAL MEMORY; EXPRESSION; RECEPTOR; ASPARTATE; CHLORIDE; CALCIUM; EXCITOTOXICITY; ISCHEMIA	Lanthanum (La) appears to impair learning and memory and increase the toxicity of excitatory amino acids in the central nervous system. The mechanism underlying excitotoxicity induced by La is still unclear. The purpose of this study was to investigate the hippocampal impairment of La exposure and possible mechanism involving the glutamate-nitric oxide (NO)-3-5-cyclic guanosine monophosphate (cGMP) pathway. In this study, lactating rats were exposed to 0, 0.25, 0.50, and 1.0% lanthanum chloride (LaCl3) in drinking water, respectively. Their offsprings were exposed to LaCl3 by parental lactation and then administrated with 0, 0.25, 0.50, and 1.0% LaCl3 in drinking water for 1 month. The results showed that La exposure impaired the neuronal ultrastructure and significantly increased the glutamate level, intracellular calcium ion concentrations, and NR1 and NR2B expression in the hippocampi. La exposure significantly enhanced messenger RNA expression and activity levels of inducible NO synthase and increased NO and cGMP levels in the hippocampi in a dose-dependent manner. These results indicate that the mechanism underlying excitotoxicity induced by La is possibly due to alterations of the glutamate-NO-cGMP signaling pathway in the hippocampus. The study provides new findings that may help prevent and improve treatments for La-induced neurotoxicity.	[Du, Yanqiu; Yang, Jinghua; Zhang, Lifeng; Cai, Yuan] China Med Univ, Sch Publ Hlth, Dept Toxicol, Shenyang 110122, Peoples R China; [Du, Yanqiu; Yan, Bo; Bai, Yan] Shenyang Ninth Peoples Hosp, Shenyang, Peoples R China; [Yang, Jinghua; Cai, Yuan] China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang 110122, Peoples R China; [Zheng, Linlin] Eastern Liaoning Univ, Sch Med, Liaoning, Peoples R China		Cai, Y (corresponding author), China Med Univ, Sch Publ Hlth, Dept Toxicol, Shenyang North New Area, 77 Puhe Rd, Shenyang 110122, Peoples R China.	cmuycai@163.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30800925, 81072316, 81273117, 81373024]; Science Project of Education Department in Province Liaoning, China [L2010702, L2012290]	This work was supported by National Nature Science Foundation of China (No. 30800925, 81072316, 81273117, and 81373024); Science Project of Education Department in Province Liaoning, China (No. L2010702 and L2012290).	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bartus K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057292; BASU A, 1984, TOXICOL LETT, V20, P303, DOI 10.1016/0378-4274(84)90164-4; Belousov AB, 2012, BRAIN RES, V1487, P123, DOI 10.1016/j.brainres.2012.05.063; Bernstein HG, 2014, ACTA HISTOCHEM, V116, P182, DOI 10.1016/j.acthis.2013.07.006; Brahma MK, 2009, J NEUROSCI RES, V87, P1400, DOI 10.1002/jnr.21960; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Cano-Abad MF, 2001, J BIOL CHEM, V276, P39695, DOI 10.1074/jbc.M102334200; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Feng LX, 2006, TOXICOL LETT, V165, P112, DOI 10.1016/j.toxlet.2006.02.003; Feng LX, 2006, NEUROTOXICOL TERATOL, V28, P119, DOI 10.1016/j.ntt.2005.10.007; Huettner JE, 1998, NEUROPHARMACOLOGY, V37, P1239, DOI 10.1016/S0028-3908(98)00082-3; Kang Xiao-nan, 2003, Zhonghua Yi Xue Za Zhi, V83, P1603; KANGRGA I, 1991, BRAIN RES, V553, P347, DOI 10.1016/0006-8993(91)90848-P; Lipton SA, 1998, CELL CALCIUM, V23, P165, DOI 10.1016/S0143-4160(98)90115-4; Liu P, 2003, HIPPOCAMPUS, V13, P561, DOI 10.1002/hipo.10112; Monfort P, 2005, METAB BRAIN DIS, V20, P265, DOI 10.1007/s11011-005-7905-5; Monfort P, 2002, NEUROCHEM INT, V41, P95, DOI 10.1016/S0197-0186(02)00029-3; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Nakagomi S, 1999, EUR J NEUROSCI, V11, P2160, DOI 10.1046/j.1460-9568.1999.00634.x; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; Peng Rui-ling, 2003, Zhonghua Yufang Yixue Zazhi, V37, P20; Udayabanu M, 2008, BRAIN RES, V1230, P138, DOI 10.1016/j.brainres.2008.06.081; Vranken Jan H., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P304; Wang X, 1997, J NEUROCHEM, V68, P443; Wu J, 2013, BIOL TRACE ELEM RES, V152, P125, DOI 10.1007/s12011-013-9601-3; Yang JH, 2013, BIOMETALS, V26, P43, DOI 10.1007/s10534-012-9593-z; Yang Jinghua, 2011, Wei Sheng Yan Jiu, V40, P299; Yang Jinghua, 2009, Wei Sheng Yan Jiu, V38, P348; Yang JH, 2009, TOXICOL LETT, V190, P208, DOI 10.1016/j.toxlet.2009.07.016; Zhang Li, 2006, Shengli Xuebao, V58, P442	33	6	6	3	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0748-2337	1477-0393		TOXICOL IND HEALTH	Toxicol. Ind. Health	OCT	2016	32	10					1791	1800		10.1177/0748233715590517			10	Public, Environmental & Occupational Health; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Toxicology	DY1CB	WOS:000384831400008	26071434				2022-02-06	
J	Kendrick, D; Zou, K; Ablewhite, J; Watson, M; Coupland, C; Kay, B; Hawkins, A; Reading, R				Kendrick, D.; Zou, K.; Ablewhite, J.; Watson, M.; Coupland, C.; Kay, B.; Hawkins, A.; Reading, R.			Risk and protective factors for falls on stairs in young children: multicentre case-control study	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							SAFETY; TEMPERAMENT; INJURIES	Aim To investigate risk and protective factors for stair falls in children aged <5 years. Methods Multicentre case-control study at hospitals, minor injury units and general practices in and around four UK study centres. Cases were children with medically attended stair fall injuries. Controls were matched on age, sex, calendar time and study centre. A total of 610 cases and 2658 controls participated. Results Cases' most common injuries were bangs on the head (66%), cuts/grazes not requiring stitches (14%) and fractures (12%). Parents of cases were significantly more likely not to have stair gates (adjusted OR (AOR) 2.50, 95% CI 1.90 to 3.29; population attributable fraction (PAF) 21%) or to leave stair gates open (AOR 3.09, 95% CI 2.39 to 4.00; PAF 24%) both compared with having closed stair gates. They were more likely not to have carpeted stairs (AOR 1.52, 95% CI 1.09 to 2.10; PAF 5%) and not to have a landing part-way up their stairs (AOR 1.34, 95% CI 1.08 to 1.65; PAF 18%). They were more likely to consider their stairs unsafe to use (AOR 1.46, 95% CI 1.07 to 1.99; PAF 5%) or to be in need of repair (AOR 1.71, 95% CI 1.16 to 2.50; PAF 5%). Conclusion Structural factors including having landings part-way up the stairs and keeping stairs in good repair were associated with reduced stair fall injury risk. Family factors including having stair gates, not leaving gates open and having stair carpets were associated with reduced injury risk. If these associations are causal, addressing these factors in housing policy and routine child health promotion could reduce stair fall injuries.	[Kendrick, D.; Zou, K.; Ablewhite, J.; Coupland, C.] Sch Med, Div Primary Care, Floor 13,Tower Bldg,Univ Pk, Nottingham NG7 2RD, England; [Watson, M.] Univ Nottingham, Queens Med Ctr, Sch Hlth Sci, Nottingham, England; [Kay, B.] Bristol Childrens Hosp, Emergency Dept, Bristol, Avon, England; [Hawkins, A.] NHS Fdn Trust, Newcastle Upon Tyne Hosp, Great North Childrens Hosp, Res Unit Level 2, Newcastle Upon Tyne, Tyne & Wear, England; [Reading, R.] Norfolk Community Hlth & Care NHS Trust, Norfolk & Norwich Univ Hosp, Jenny Lind Paediat Dept, Norwich, Norfolk, England		Kendrick, D (corresponding author), Sch Med, Div Primary Care, Floor 13,Tower Bldg,Univ Pk, Nottingham NG7 2RD, England.	denise.kendrick@nottingham.ac.uk	Watson, Michael Craig/B-9331-2008	Watson, Michael Craig/0000-0003-1628-2746; Coupland, Carol/0000-0002-2327-3306; Kendrick, Denise/0000-0003-3603-6542	National Institute for Health Research (NIHR)National Institute for Health Research (NIHR) [RP-PG-0407-10231]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [RP-PG-0407-10231] Funding Source: researchfish	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (RP-PG-0407-10231). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Clamp M, 1998, BRIT MED J, V316, P1576, DOI 10.1136/bmj.316.7144.1576; CRNIC KA, 1990, CHILD DEV, V61, P1628, DOI 10.1111/j.1467-8624.1990.tb02889.x; CRNIC KA, 1991, J MARRIAGE FAM, V53, P1042, DOI 10.2307/353007; Department of Trade and Industry, 2003, 24 FIN REP HOM LEIS; Edwards P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub3; Elkington J, 1999, NSW PUBLIC HLTH B, V10, P82; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Gielen AC, 2012, PEDIATRICS, V130, P1053, DOI 10.1542/peds.2012-1531; Health and Social Care Information Centre, HOSP EP STAT ADM PAT; Kendrick D, 2012, INJURY PREV, V18, DOI 10.1136/injuryprev-2012-040394; Peden M, 2008, WORLD REPORT CHILD I; Putnam SP, 2006, J PERS ASSESS, V87, P102, DOI 10.1207/s15327752jpa8701_09; Putnam SP, 2006, INFANT BEHAV DEV, V29, P386, DOI 10.1016/j.infbeh.2006.01.004; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rubin D.B., 1987, MULTIPLE IMPUTATION; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Watson M, 2005, BMJ-BRIT MED J, V330, P178, DOI 10.1136/bmj.38309.664444.8F; Young B, 2013, ACCIDENT ANAL PREV, V60, P158, DOI 10.1016/j.aap.2013.08.001; Zielinski AE, 2012, PEDIATRICS, V129, P721, DOI 10.1542/peds.2011-2314	20	6	6	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	OCT	2016	101	10					909	916		10.1136/archdischild-2015-308486			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DX0QQ	WOS:000384069600008	26662926	Green Published, hybrid			2022-02-06	
J	Shaabani, M; Lotfi, Y; Karimian, SM; Rahgozar, M; Hooshmandi, M				Shaabani, Moslem; Lotfi, Yones; Karimian, Seyed Morteza; Rahgozar, Mehdi; Hooshmandi, Mehdi			Short-term galvanic vestibular stimulation promotes functional recovery and neurogenesis in unilaterally labyrinthectomized rats	BRAIN RESEARCH			English	Article						Vestibular; Galvanic; Labyrinthectomy; BrdU; Neurogenesis; Rat	CENTRAL NEURODEGENERATIVE DISORDERS; TRAUMATIC BRAIN-INJURY; SQUIRREL-MONKEY; NERVE AFFERENTS; VESTIBULOOCULAR REFLEX; ADULT NEUROGENESIS; SENSORY NEURONS; RHESUS-MONKEY; RESPONSES; COMPENSATION	Current experimental research on the therapeutic effects of galvanic vestibular stimulation (GVS) has mainly focused on neurodegenerative disorders. However, it primarily stimulates the vestibular nuclei and could be potentially effective in modulating imbalance between them in the case of unilateral labyrinthectomy (UL). Fifty male Wistar rats (180-220 g) were used in 5 groups of 10: intact, sham, right-UL (RUL; without intervention), and two other right-UL groups with GVS intervention [one group treated with low rate GVS (GVS.LF; 6-7 Hz), and the other treated with high rate GVS (GVS.HF; 17-18 Hz)]. The UL models were prepared by intratympanic injection of sodium arsanilate. GVS protocols were implemented 30 min/day and continued for 14 days via ring-shaped copper electrodes inserted subcutaneously over each mastoid. Functional recovery was assessed by several postural tests including support surface area, landing and air-righting reflexes, and rotarod procedure. Immunohistochemical investigations were performed on ipsi- and contra-lesional medial vestibular nuclei (MVN) using bromodeoxyuridine (BrdU) and Ki67, as markers of cell proliferation. Behavioral evaluations showed significant functional recovery of GVS-treated groups compared to RUL group. The percent of marked cells with BrdU and Ki67 were significantly higher in the ipsilesional MVN of both GVS-treated groups compared with other groups. Our findings confirmed the effectiveness of GVS-intervention in accelerating static and dynamic vestibular compensation. This could be explained by the cell proliferation in ipsilesional MVN cells and rapid rebalancing of the VNs and the modulation of their motor outputs. Therefore, GVS could be promising for rehabilitating patients with unilateral vestibular weakness. (C) 2016 Elsevier B.V. All rights reserved.	[Shaabani, Moslem; Lotfi, Yones] Univ Social Welf & Rehabil Sci, Dept Audiol, Tehran, Iran; [Karimian, Seyed Morteza] Univ Tehran Med Sci, Sch Med, Dept Physiol, Tehran, Iran; [Rahgozar, Mehdi] Univ Social Welf & Rehabil Sci, Biostat Dept, Tehran, Iran; [Hooshmandi, Mehdi] Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran		Lotfi, Y (corresponding author), Univ Social Welf & Rehabil Sci, Dept Audiol, Tehran, Iran.	yones1333@gmail.com	Shaabani, Moslem/A-1518-2018; rahgozar, mehdi/P-4913-2017; Shaabani, Moslem/X-3142-2019; lotfi, yones/J-5012-2017	Shaabani, Moslem/0000-0002-3614-1011; 	University of Social Welfare and Rehabilitation Sciences [18591/1/801/93]	The authors would like to appreciate kind assistance and rich laboratory condition provided by the physiology department of Tehran University of Medical Sciences. Also, we want to appreciate the sincere cooperation of Dr. Gholam Reza Kaka in preparing the immunohistochemistry part of the article. Financial support from the University of Social Welfare and Rehabilitation Sciences, Grant no. 18591/1/801/93, is gratefully acknowledged. The authors declare no conflicts of interest.	Abe C, 2008, J APPL PHYSIOL, V104, P34, DOI 10.1152/japplphysiol.00454.2007; Andersson L, 1997, J NEURAL TRANSP PLAS, V6, P105, DOI 10.1155/NP.1997.105; Besnard S, 2012, HIPPOCAMPUS, V22, P814, DOI 10.1002/hipo.20942; Brugeaud A, 2007, J NEUROSCI, V27, P3503, DOI 10.1523/JNEUROSCI.5185-06.2007; Campos-Torres A, 2005, NEUROSCIENCE, V130, P853, DOI 10.1016/j.neuroscience.2004.08.052; Christensen JR, 2007, ANAT REC, V290, P330, DOI 10.1002/ar.20504; COURJON JH, 1987, EXP BRAIN RES, V66, P41; Cullen KE, 2009, J VESTIBUL RES-EQUIL, V19, P171, DOI 10.3233/VES-2009-0357; Curthoys I S, 1995, J Vestib Res, V5, P67; Curthoys Ian S, 2012, Front Neurol, V3, P117, DOI 10.3389/fneur.2012.00117; Curthoys IS, 2010, CLIN NEUROPHYSIOL, V121, P132, DOI 10.1016/j.clinph.2009.09.027; Dakin CJ, 2007, J PHYSIOL-LONDON, V583, P1117, DOI 10.1113/jphysiol.2007.133264; Dieterich M, 2008, BRAIN, V131, P2538, DOI 10.1093/brain/awn042; Dilda V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112131; Dutheil S, 2009, NEUROSCIENCE, V164, P1444, DOI 10.1016/j.neuroscience.2009.09.048; Dutheil S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022262; Dutia MB, 2010, CURR OPIN OTOLARYNGO, V18, P420, DOI 10.1097/MOO.0b013e32833de71f; Eatock RA, 2008, J EXP BIOL, V211, P1764, DOI 10.1242/jeb.017350; FETTER M, 1988, J NEUROPHYSIOL, V59, P370, DOI 10.1152/jn.1988.59.2.370; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; GOLDBERG JM, 1982, BRAIN RES, V252, P156, DOI 10.1016/0006-8993(82)90990-8; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HIGHSTEIN SM, 1987, J NEUROPHYSIOL, V58, P719, DOI 10.1152/jn.1987.58.4.719; HORN KM, 1981, PHYSIOL PSYCHOL, V9, P371; HUNT MA, 1987, BEHAV NEUROSCI, V101, P427, DOI 10.1037/0735-7044.101.3.427; Idoux E., 2012, FRONT NEUROL, V28, P3; Jamon M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00011; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kim DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069055; Kim J, 2004, BRAIN RES BULL, V64, P265, DOI 10.1016/j.brainresbull.2004.07.008; Kim MS, 2002, NEUROSCI LETT, V319, P9, DOI 10.1016/S0304-3940(01)02422-3; Kittel B, 2004, EXP TOXICOL PATHOL, V55, P413, DOI 10.1078/0940-2993-00349; KOHUT RI, 1974, LARYNGOSCOPE, V84, P1627, DOI 10.1288/00005537-197410000-00002; Lacour M, 2015, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00285; Lambert FM, 2013, J NEUROSCI, V33, P6845, DOI 10.1523/JNEUROSCI.4842-12.2013; Lambert Francois M, 2012, Front Neurol, V3, P42, DOI 10.3389/fneur.2012.00042; Lasker DM, 2000, J NEUROPHYSIOL, V83, P2482, DOI 10.1152/jn.2000.83.5.2482; Liberge M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-91; Magnusson M, 2011, NEUROREHABILITATION, V29, P153, DOI 10.3233/NRE-2011-0689; Mian OS, 2010, J PHYSIOL-LONDON, V588, P4441, DOI 10.1113/jphysiol.2010.195222; Minasyan A, 2009, J STEROID BIOCHEM, V114, P161, DOI 10.1016/j.jsbmb.2009.01.020; MINOR LB, 1991, J NEUROSCI, V11, P1636; Moore ST, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00088; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; OSSENKOPP KP, 1990, PHARMACOL BIOCHEM BE, V36, P875, DOI 10.1016/0091-3057(90)90093-W; Pan WD, 2008, J NEUROL, V255, P1657, DOI 10.1007/s00415-008-0950-3; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Rorsman I, 1999, SCAND J REHABIL MED, V31, P117; Sadeghi SG, 2007, J NEUROPHYSIOL, V97, P1503, DOI 10.1152/jn.00829.2006; Samoudi G, 2015, BRAIN STIMUL, V8, P474, DOI 10.1016/j.brs.2014.11.019; Samoudi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029308; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; Schlecker C, 2011, GENE THER, V18, P884, DOI 10.1038/gt.2011.33; SIRKIN DW, 1980, EXP NEUROL, V69, P435, DOI 10.1016/0014-4886(80)90044-8; SMITH PF, 1989, BRAIN RES REV, V14, P155, DOI 10.1016/0165-0173(89)90013-1; TIGHILET B, 1995, J VESTIBUL RES-EQUIL, V5, P187; Tighilet B, 2007, EUR J NEUROSCI, V25, P47, DOI 10.1111/j.1460-9568.2006.05267.x; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vignaux G, 2012, TOXICOL APPL PHARM, V258, P61, DOI 10.1016/j.taap.2011.10.008; Wardman DL, 2002, ADV EXP MED BIOL, V508, P119; Wilkinson D, 2005, J INT NEUROPSYCH SOC, V11, P925, DOI 10.1017/S1355617705051076; Wilkinson D, 2010, J NEUROPSYCHOL, V4, P107, DOI 10.1348/174866409X468205; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Yamamoto Y, 2005, ANN NEUROL, V58, P175, DOI 10.1002/ana.20574; Zheng YW, 2014, HIPPOCAMPUS, V24, P541, DOI 10.1002/hipo.22247	70	6	7	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 1	2016	1648		A				152	162		10.1016/j.brainres.2016.07.029			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DY7OI	WOS:000385318400017	27444558				2022-02-06	
J	Sundberg, ML				Sundberg, Mark L.			Verbal Stimulus Control and the Intraverbal Relation	ANALYSIS OF VERBAL BEHAVIOR			English	Article						Aphasia; Dementia; Evocative and function-altering effects; Intraverbal; Skinner; Verbal behavior; Verbal stimulus control	BEHAVIOR; CHILDREN; RESPONSES; DISCRIMINATION; ACQUISITION	The importance of the intraverbal relation is missed in most theories of language. Skinner (1957) attributes this to traditional semantic theories of meaning that focus on the nonverbal referents of words and neglect verbal stimuli as separate sources of control for linguistic behavior. An analysis of verbal stimulus control is presented, along with its distinction from nonverbal stimulus control and motivational control. It is suggested that there are at least four different types of increasingly complex verbal discriminations relevant to speaker and listener behavior: simple, compound, verbal conditional, and verbal function-altering (Eikeseth & Smith, 2013; Schlinger & Blakely, 1994). Separate but interlocking accounts of how these specific types of verbal stimuli produce different evocative and function-altering effects for the speaker and for the listener are provided. Finally, the effects of weakening verbal stimulus control and the loss of intraverbal behavior are considered, especially as they relate to dementia, aphasia, and traumatic brain injury.	[Sundberg, Mark L.] Sundberg & Associates, Concord, CA USA		Sundberg, ML (corresponding author), Sundberg & Associates, Concord, CA USA.	marksundberg@astound.net					Aguirre AA, 2016, ANAL VERBAL BEHAV, V32, P139, DOI 10.1007/s40616-016-0064-4; Perez-Gonzalez LA, 2016, PSYCHOL REC, V66, P351, DOI 10.1007/s40732-016-0177-0; Axe JB, 2008, ANAL VERBAL BEHAV, V24, P159, DOI 10.1007/BF03393064; Baker JC, 2008, ANAL VERBAL BEHAV, V24, P147, DOI 10.1007/BF03393063; Bloom L., 1974, LANGUAGE PERSPECTIVE, P285; Brown R., 1973, 1 LANGUAGE EARLY STA; Catania A.C., 2013, LEARNING, V5th Edn.; Chase P. N., 1991, DIALOGUES VERBAL BEH, P261; Chomsky Noam, 1957, SYNTACTIC STRUCTURES; Coon JT, 2012, J APPL BEHAV ANAL, V45, P657, DOI 10.1901/jaba.2012.45-657; Dixon M, 2011, BEHAV THER, V42, P120, DOI 10.1016/j.beth.2010.05.002; Eikeseth S, 2013, ANAL VERBAL BEHAV, V29, P125, DOI 10.1007/BF03393130; Esch B.E., 2010, J SPEECH LANGUAGE PA, V5, P166, DOI [10.1037/h0100270, DOI 10.1037/H0100270]; Greer RD, 2005, ANAL VERBAL BEHAV, V21, P99, DOI 10.1007/BF03393012; Gross AC, 2013, ANAL VERBAL BEHAV, V29, P85, DOI 10.1007/BF03393126; Hegde M.N., 2010, J SPEECH LANGUAGE PA, V5, P90, DOI [10.1037/h0100268, DOI 10.1037/H0100268]; Heward, 2007, APPL BEHAV ANAL, P374, DOI DOI 10.1901/JABA.2010.43-161; Ingvarsson ET, 2007, J APPL BEHAV ANAL, V40, P411, DOI 10.1901/jaba.2007.40-411; Ingvarsson ET, 2011, ANAL VERBAL BEHAV, V27, P75, DOI 10.1007/BF03393093; Kisamore AN, 2013, ANAL VERBAL BEHAV, V29, P101, DOI 10.1007/BF03393127; Kodak T, 2012, J APPL BEHAV ANAL, V45, P155, DOI 10.1901/jaba.2012.45-155; Leaf R., 1999, A WORK IN PROGR; LeBlanc L. A., 2011, HDB APPL BEHAV ANAL, P472; Lechago SA, 2015, ANAL VERBAL BEHAV, V31, P76, DOI 10.1007/s40616-015-0027-1; Lovaas O. I., 2003, TEACHING INDIVIDUALS; LOWENKRON B, 1984, J EXP ANAL BEHAV, V42, P1, DOI 10.1901/jeab.1984.42-1; Lowenkron B, 1998, J EXP ANAL BEHAV, V69, P327, DOI 10.1901/jeab.1998.69-327; Lowenkron B, 2006, ANAL VERBAL BEHAV, V22, P129, DOI 10.1007/BF03393035; Michael, 2004, CONCEPTS PRINCIPLES; MICHAEL J, 1982, J EXP ANAL BEHAV, V37, P149, DOI 10.1901/jeab.1982.37-149; Michael J, 1985, Anal Verbal Behav, V3, P1; MICHAEL J, 1993, BEHAV ANALYST, V16, P191, DOI 10.1007/BF03392623; Michael J, 2000, J APPL BEHAV ANAL, V33, P401, DOI 10.1901/jaba.2000.33-401; Michael J., 1995, BEHAV ANAL, V18, P272; Michael J, 2011, ANAL VERBAL BEHAV, V27, P3, DOI 10.1007/BF03393089; Miguel CF, 2005, ANAL VERBAL BEHAV, V21, P27, DOI 10.1007/BF03393008; Oah S Z, 1989, Anal Verbal Behav, V7, P53; Oleson CR, 2014, ANAL VERBAL BEHAV, V30, P113, DOI 10.1007/s40616-014-0018-7; Palmer DC, 2016, ANAL VERBAL BEHAV, V32, P96, DOI 10.1007/s40616-016-0061-7; Palmer DC, 2012, BEHAV ANALYST, V35, P59, DOI 10.1007/BF03392266; Palmer DC, 2004, J EXP ANAL BEHAV, V81, P189, DOI 10.1901/jeab.2004.81-189; Partington JW., 1998, TEACHING LANGUAGE CH; Pinker S., 1994, LANGUAGE INSTINCT MI; Sautter RA, 2006, ANAL VERBAL BEHAV, V22, P35, DOI 10.1007/BF03393025; Sautter RA, 2011, J APPL BEHAV ANAL, V44, P227, DOI 10.1901/jaba.2011.44-227; SCHLINGER H, 1987, BEHAV ANALYST, V10, P41, DOI 10.1007/BF03392405; SCHLINGER HD, 1994, BEHAV ANALYST, V17, P43, DOI 10.1007/BF03392652; Schlinger HD, 2008, BEHAV ANALYST, V31, P145, DOI 10.1007/BF03392168; Schoenfeld W.N., 1950, PRINCIPLES PSYCHOL; Skinner, 1957, VERBAL BEHAV; Skinner BF., 1969, CONTINGENCIES REINFO; Skinner BF., 1938, BEHAV ORG; Skinner BF., 1953, SCI HUMAN BEHAV; Slobin D. I., 1973, STUDIES CHILD LANGUA, P175; Sundberg, 2014, VERBAL BEHAV MILESTO; Sundberg C T, 1990, Anal Verbal Behav, V8, P31; Sundberg M L, 1990, Anal Verbal Behav, V8, P83; Sundberg ML, 2011, ANAL VERBAL BEHAV, V27, P23, DOI 10.1007/BF03393090; Valentino AL, 2012, J APPL BEHAV ANAL, V45, P431, DOI 10.1901/jaba.2012.45-431	59	6	6	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0889-9401			ANAL VERBAL BEHAV	Anal. Verbal Behav.	OCT	2016	32	2					107	124		10.1007/s40616-016-0065-3			18	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	ER0DG	WOS:000398456400003	30800620	Green Published			2022-02-06	
J	Vedrenne, N; Sarrazy, V; Battu, S; Bordeau, N; Richard, L; Billet, F; Coronas, V; Desmouliere, A				Vedrenne, Nicolas; Sarrazy, Vincent; Battu, Serge; Bordeau, Nelly; Richard, Laurence; Billet, Fabrice; Coronas, Valerie; Desmouliere, Alexis			Neural Stem Cell Properties of an Astrocyte Subpopulation Sorted by Sedimentation Field-Flow Fractionation	REJUVENATION RESEARCH			English	Article						astrocyte; stemness; vimentin; nestin; injured nerve; traumatic brain damage	CENTRAL-NERVOUS-SYSTEM; GLIA-LIKE CELLS; REACTIVE GLIOSIS; RADIAL GLIA; PERIPHERAL-NERVES; INJURED BRAIN; REGENERATION; VIMENTIN	Astrocytes encompass a heterogeneous cell population. Using sedimentation field-flow fractionation (SdFFF) method, different, almost pure, astrocyte subpopulations were isolated. Cells were collected from cortex of newborn rats and sorted by SdFFF to obtain different fractions, which were subjected to protein analysis and characterized by immunocytofluorescence. The behavior of the cells was analyzed in vitro, under culture conditions used for neural stem cells. These culture conditions were also applied to cells derived from an adult cortical tissue after traumatic brain injury (TBI). Finally, the astrocytic neural stem-like cells were transplanted in damaged sciatic nerve. Protein analysis indicated a high expression of glial fibrillary acidic protein (GFAP) and vimentin in fraction F3-derived cells. These cells formed neurospheres when cultured with epidermal growth factor and large colonies in a collagen-containing semi-solid matrix. Neurospheres expressed GFAP and nestin and were able in addition to generate neurons expressing MAP2 and oligodendrocytes expressing Olig2. When transplanted in a damaged nerve, cells of F3-derived neurospheres colonized the damaged area. Finally, after TBI in adult rats, cells able to form neurospheres containing a subpopulation of astrocytes expressing vimentin were obtained. Using the SdFFF method, an astrocyte subpopulation presenting stem cell properties was isolated from a newborn rat cortex and from an injured adult rat cortex. The specific activation of this astrocyte subpopulation may provide a potential therapeutic approach to restore lost neuronal function in injured or diseased brain.	[Vedrenne, Nicolas; Sarrazy, Vincent; Bordeau, Nelly; Richard, Laurence; Billet, Fabrice; Desmouliere, Alexis] Univ Limoges, EA Myelin Maintenance & Peripheral Neuropathies 6, Limoges, France; [Battu, Serge] Univ Limoges, EA Cell Homeostasis & Pathol 3842, Limoges, France; [Richard, Laurence] CHU Limoges, Dept Neurol, Limoges, France; [Coronas, Valerie] Univ Poitiers, CNRS, ERL Signalisat & Transports Ion Membranaires 7368, Poitiers, France; [Sarrazy, Vincent] Univ Nice Sophia Antipolis, Mediterranean Ctr Mol Med, INSERM, U1065, Nice, France		Desmouliere, A (corresponding author), Univ Limoges, Fac Pharm, Dept Physiol, 2 Rue Dr Marcland, F-87025 Limoges, France.	alexis.desmouliere@unilim.fr		VEDRENNE, Nicolas/0000-0001-6210-2254; Coronas, Valerie/0000-0002-8571-8796; Sarrazy, Vincent/0000-0003-4598-6005	Conseil Regional du LimousinRegion Nouvelle-Aquitaine	The authors kindly thank Karine Vuillier-Devillers and Emilie Pinault (Proteomic Department, University of Limoges, France) for the protein analysis and Claire Carrion (Confocal Microscopy Facility, University of Limoges, France) for confocal microscopy analysis. Nicolas Vedrenne and Vincent Sarrazy were supported by fellowships from the "Conseil Regional du Limousin."	Azari H, 2011, JOVE-J VIS EXP, DOI 10.3791/2639; Battu S, 2001, BBA-GEN SUBJECTS, V1528, P89, DOI 10.1016/S0304-4165(01)00174-X; Begaud-Grimaud G, 2012, FIELD FLOW FRACTIONA, P223; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bramanti Vincenzo, 2010, Front Biosci (Schol Ed), V2, P558; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Comte I, 2006, J CHROMATOGR B, V843, P175, DOI 10.1016/j.jchromb.2006.05.039; Darby IA, 2011, CANCER MICROENVIRON, V4, P73, DOI 10.1007/s12307-010-0047-2; Dimou L, 2014, PHYSIOL REV, V94, P709, DOI 10.1152/physrev.00036.2013; Doetsch F, 1997, J NEUROSCI, V17, P5046; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Gubert F, 2009, BRAIN RES, V1258, P43, DOI 10.1016/j.brainres.2008.12.021; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lee EJ, 2012, BIOMATERIALS, V33, P7039, DOI 10.1016/j.biomaterials.2012.06.047; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2013, DEVELOPMENT, V140, P483, DOI 10.1242/dev.085852; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Ninkovic J, 2015, CELL TISSUE RES, V359, P5, DOI 10.1007/s00441-014-2048-9; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Okano-Uchida T, 2013, NEUROSCI LETT, V552, P15, DOI 10.1016/j.neulet.2013.07.021; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Richard L, 2014, J HISTOCHEM CYTOCHEM, V62, P424, DOI 10.1369/0022155414530994; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Sarrazy V, 2013, J CHROMATOGR A, V1289, P88, DOI 10.1016/j.chroma.2013.03.029; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sundholm-Peters NL, 2004, J NEUROCYTOL, V33, P153, DOI 10.1023/B:NEUR.0000029654.70632.3a; Varejao ASP, 2004, J NEUROTRAUM, V21, P1652, DOI 10.1089/neu.2004.21.1652; Wang K, 2004, BRAIN RES, V1024, P193, DOI 10.1016/j.brainres.2004.07.086; Yang H, 2010, CELL MOL NEUROBIOL, V30, P483, DOI 10.1007/s10571-009-9474-3; Yang H, 2009, CELL MOL NEUROBIOL, V29, P455, DOI 10.1007/s10571-008-9337-3; Zujovic V, 2011, P NATL ACAD SCI USA, V108, P10714, DOI 10.1073/pnas.1018687108	36	6	6	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1549-1684	1557-8577		REJUV RES	Rejuv. Res.	OCT	2016	19	5					362	372		10.1089/rej.2015.1776			11	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	EA8AQ	WOS:000386856500003	26650259				2022-02-06	
J	Li, S; Li, H; He, XF; Li, G; Zhang, Q; Liang, FY; Jia, HH; Li, JC; Huang, R; Pei, Z; Wang, LJ; Zhang, Y				Li, Shuai; Li, Hang; He, Xiao-fei; Li, Ge; Zhang, Qun; Liang, Feng-ying; Jia, Huan-huan; Li, Jiang-chao; Huang, Ren; Pei, Zhong; Wang, Li-jing; Zhang, Yu			Transgenic over-expression of slit2 enhances disruption of blood-brain barrier and increases cell death after traumatic brain injury in mice	NEUROSCIENCE LETTERS			English	Article						Silt2; Transgenic mice; Micro traumatic brain injury (TBI); Blood brain barrier (BBB); Cell death	ALZHEIMERS-DISEASE; ANGIOGENESIS; PERMEABILITY; RECEPTORS; INDUCTION; PATHWAYS; ISCHEMIA	Traumatic brain injury (TBI) is the leading cause of mortality and disability among male adolescents and young adults; and mild traumatic brain injury is the most common type of traumatic brain injury. The disruption of blood-brain barrier (BBB) plays an important role in brain trauma. Previously, we have found that slit2, a member of slit protein family, increases permeability of BBB. In the present study, we examined the role of slit2 in the pathogenesis of mild TBI in a mouse model of micro TBI. Rhodamine BandPl (Propidiumlodide) staining were used to detect the permeability of BBB and cell death, respectively. The leakage of Rhodamine B and cell death were significantly increased in Slit2-Tg mice than in C57 control mice after micro TBI. The present results suggest that over expression of slit2 plays a detrimental role in the pathophysiology of mild TBI. (C) 2016 The Author(s). Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Li, Shuai; Li, Hang; Li, Ge; Jia, Huan-huan; Huang, Ren; Zhang, Yu] Guangdong Prov Key Lab Lab Anim, Guangdong Lab Anim Monitoring Inst, Guangzhou, Guangdong, Peoples R China; [He, Xiao-fei; Liang, Feng-ying; Pei, Zhong] Sun Yat Sen Univ, Natl Key Clin Dept, Dept Neurol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [He, Xiao-fei; Liang, Feng-ying; Pei, Zhong] Sun Yat Sen Univ, Key Discipline Neurol, Guangdong Key Lab Diag & Treatment Major Neurol D, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Li, Shuai; Li, Jiang-chao; Wang, Li-jing] Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Sch Basic Course, Guangzhou, Guangdong, Peoples R China; [Zhang, Qun] Sun Yat Sen Univ, Dept Rehabil Med, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China		Zhang, Y (corresponding author), Guangdong Lab Anim Monitoring Inst, 11 Fengxin Rd, Guangzhou 510663, Guangdong, Peoples R China.; Wang, LJ (corresponding author), Guangdong Pharmaceut Univ, Vasc Biol Res Inst, 280 E Rd, Guangzhou 510006, Guangdong, Peoples R China.	wanglijing62@163.com; zhangyugzh@hotmail.com	Li, Shuai/ABC-5377-2021; Li, Jiangchao/AAF-4515-2021	Li, Jiangchao/0000-0002-0947-7580	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31472061]; National Key Clinical Department, National Key Discipline, Guangdong Key Laboratory For Diagnosis and Treatment of Major Neurological Diseases	This work is supported by the National Natural Science Foundation of China (No. 31472061), the National Key Clinical Department, National Key Discipline, Guangdong Key Laboratory For Diagnosis and Treatment of Major Neurological Diseases.	Benedek A, 2006, BRAIN RES, V1116, P159, DOI 10.1016/j.brainres.2006.07.123; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Cho EE, 2011, J CEREBR BLOOD F MET, V31, P1852, DOI 10.1038/jcbfm.2011.59; Fujiwara M, 2006, VASC MED, V11, P115, DOI 10.1191/1358863x06vm658ra; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Hanand H. X., 2011, ACTA PHARMACOL SIN, V32, P1327; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li JC, 2015, J ALZHEIMERS DIS, V43, P535, DOI 10.3233/JAD-141215; Liang FY, 2015, NEUROSCI LETT, V598, P29, DOI 10.1016/j.neulet.2015.05.006; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mukovozov I, 2015, J IMMUNOL, V195, P3334, DOI 10.4049/jimmunol.1500640; Park JH, 2016, BRAIN RES, V1634, P45, DOI 10.1016/j.brainres.2015.12.056; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wolff RA, 2000, J MOL CELL CARDIOL, V32, P225, DOI 10.1006/jmcc.1999.1074; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Yang YC, 2015, ANGIOGENESIS, V18, P301, DOI 10.1007/s10456-015-9467-4; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	22	6	6	1	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 19	2016	631						85	90		10.1016/j.neulet.2016.08.013			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DY0KV	WOS:000384786600014	27521753	hybrid			2022-02-06	
J	Albano, AW; Senter, C; Adler, RH; Herring, SA; Asif, IM				Albano, Andrew W., Jr.; Senter, Carlin; Adler, Richard H.; Herring, Stanley A.; Asif, Irfan M.			The Legal Landscape of Concussion: Implications for Sports Medicine Providers	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						sports medicine; sports concussion; Lystedt law; concussion legislation	YOUTH SPORTS; LEGISLATION	Context: Concussion legislation has been enacted in all 50 of the United States, aiming to prevent mild traumatic brain injuries and the potential long-term sequelae of these injuries in youth athletics. Sports medicine providers, in addressing this major public health concern, are tasked with adhering to the established standards of medical care while also considering the legal implications. Evidence Acquisition: The PubMed (2011-2016) database was searched using the following search terms: concussion, sports concussion, legislation, and concussion legislation. References from consensus statements, review articles, and book chapters were also utilized. Study Design: Clinical review. Level of Evidence: Level 4. Results: The Lystedt law and its progeny have increased awareness of the signs and symptoms of sports concussion, but adherence to state legislation can pose some challenges. Conclusion: The presence of concussion legislation places a responsibility on the sports medicine provider to have a firm understanding of the legality of concussion management in the state(s) in which they practice.	[Albano, Andrew W., Jr.] Univ South Carolina, Sch Med Greenville, Greenville Hlth Syst, Dept Family Med, Greenville, SC USA; [Senter, Carlin] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Senter, Carlin] Univ Calif San Francisco, Dept Orthopaed, San Francisco, CA 94143 USA; [Adler, Richard H.] Adler Giersch PS, Seattle, WA USA; [Adler, Richard H.] Brain Injury Alliance Washington, Seattle, WA USA; [Herring, Stanley A.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Dept Orthopaed, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Dept Sports Med & Neurol Surg, Seattle, WA 98195 USA; [Asif, Irfan M.] Clemson Univ, Sch Hlth Res, Clemson, SC USA		Albano, AW (corresponding author), 877 West Faris Rd, Greenville, SC 29605 USA.	aalbano@ghs.org	Albano, Andrew/K-9471-2019	Albano, Andrew/0000-0002-7196-1269			Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Harmon KG, 2012, BRIT J SPORT MED, V46, P158, DOI 10.1136/bjsports-2012-090999; Hsu AC, 2012, MED SCI SPORT EXER, V44, P178, DOI 10.1249/MSS.0b013e318275044f; Ira Casson H, 2015, NEUROLOGY, V84, P861, DOI [10.1212/WNL.0000000000001355, 10.1212/01.wnl.0000461938.49936.52]; Laker SR, 2014, OXFORD HDB SPORTS RE; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280	15	6	6	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	SEP-OCT	2016	8	5					465	468		10.1177/1941738116662025			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EG8DE	WOS:000391285100010	27530613	Green Published			2022-02-06	
J	Burdon, P; Dipper, L; Cocks, N				Burdon, Paul; Dipper, Lucy; Cocks, Naomi			Exploration of older and younger British adults' performance on The Awareness of Social Inference Test (TASIT)	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						older adults; social perception; British	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; AGE; PERCEPTION; COMMUNICATION; EDUCATION; EMOTIONS; ABILITY	BackgroundSocial perception is an important skill. One assessment that is commonly used to assess social perception abilities is The Awareness of Social Inference Test (TASIT). The only normative data available for this test are for Australian younger adults. Despite no normative data being available for British adults, the test is widely used in the UK with older and younger adults. There is a growing body of research that suggests that older adults have difficulty with skills associated with social perception. There is therefore a need to determine whether British adults, and more specifically British older adults, perform similarly to the Australian normative TASIT scores available in the manual. AimsTo explore the differences between older and younger British adults' performance on TASIT, and to determine whether younger and older British adults perform similarly to the data from Australian adults in TASIT manual. Methods & ProceduresTASIT was administered to a total of 42 native British English speaking participants. The participants were split into two age groups 18-45 and 60-90 years. Comparisons were made between the two groups and the Australian data in TASIT manual. Outcomes & ResultsThe younger British and Australian adults obtained similar scores on all parts of TASIT. The older British adults though, obtained significantly lower scores than the Australian younger adults on all parts of TASIT and when education was controlled for they obtained significantly lower scores than the British younger adults. Conclusions & ImplicationsThe findings are discussed in the light of previous research that has found that older adults are worse than younger adults at social inferences. The findings of the current study suggest that caution should be used when using TASIT with older British adults to assess social perception abilities.	[Burdon, Paul; Dipper, Lucy] City Univ London, London, England; [Cocks, Naomi] Curtin Univ, GPO Box U1987, Perth, WA 6845, Australia		Cocks, N (corresponding author), Curtin Univ, GPO Box U1987, Perth, WA 6845, Australia.	naomi.cocks@curtin.edu.au		Cocks, Naomi/0000-0002-1744-6979; Dipper, Lucy/0000-0002-5918-3898			BOICE R, 1983, PSYCHOL BULL, V93, P3, DOI 10.1037/0033-2909.93.1.3; Bryan K., 1995, RIGHT HEMISPHERE LAN, V2nd ed.; EDINGER JA, 1983, PSYCHOL BULL, V93, P30; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Greenaway D, 2003, ECON J, V113, pF150, DOI 10.1111/1468-0297.00102; Happe FGE, 1998, DEV PSYCHOL, V34, P358, DOI 10.1037/0012-1649.34.2.358; Hess TM, 2005, PSYCHOL BULL, V131, P383, DOI 10.1037/0033-2909.131.3.383; Kucharska-Pietura K, 2003, NEUROPSYCHOLOGIA, V41, P1082, DOI 10.1016/S0028-3932(02)00294-4; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; MacPherson SE, 2002, PSYCHOL AGING, V17, P598, DOI 10.1037//0882-7974.17.4.598; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Moraitou D, 2013, PSYCHOGERIATRICS, V13, P139, DOI 10.1111/psyg.12016; Orbelo DM, 2003, J GERIATR PSYCH NEUR, V16, P44, DOI 10.1177/0891988702250565; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Tyerman A, 2008, PSYCHOL APPROACHES R; Zanini S, 2005, APHASIOLOGY, V19, P1107, DOI 10.1080/02687030500268977	18	6	6	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	SEP-OCT	2016	51	5					589	593		10.1111/1460-6984.12233			5	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	DW2BG	WOS:000383447300009	27074887	Green Accepted			2022-02-06	
J	Clark, AL; Sorg, SF; Schiehser, DM; Bigler, ED; Bondi, MW; Jacobson, MW; Jak, AJ; Delano-Wood, L				Clark, Alexandra L.; Sorg, Scott F.; Schiehser, Dawn M.; Bigler, Erin D.; Bondi, Mark W.; Jacobson, Mark W.; Jak, Amy J.; Delano-Wood, Lisa			White Matter Associations With Performance Validity Testing in Veterans With Mild Traumatic Brain Injury: The Utility of Biomarkers in Complicated Assessment	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						diffusion tensor imaging; effort testing; mild traumatic brain injury; performance validity; white matter	WORD MEMORY TEST; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; SYMPTOM VALIDITY; CORPUS-CALLOSUM; HEAD-INJURY; COGNITIVE IMPAIRMENT; EXTERNAL INCENTIVES; MILITARY PERSONNEL; CLINICAL INTERVIEW; TBI IDENTIFICATION	Objective: Failure on performance validity tests (PVTs) is common in Veterans with histories of mild traumatic brain injury (mTBI), leading to questionable validity of clinical presentations. Participants: Using diffusion tensor imaging, we investigated white matter (WM) integrity and cognition in 79 Veterans with history of mTBI who passed PVTs (n = 43; traumatic brain injury [TBI]-passed), history of mTBI who failed at least 1 PVT (n = 13; TBI-failed), and military controls (n = 23; MCs) with no history of TBI. Results: The TBI-failed group demonstrated significantly lower cognitive scores relative to MCs and the TBI-passed group; however, no such differences were observed between MCs and the TBI-passed group. On a global measure of WM integrity (ie, WM burden), the TBI-failed group showed more overall WM abnormalities than the other groups. However, no differences were observed between the MCs and TBI-passed group on WM burden. Interestingly, regional WM analyses revealed abnormalities in the anterior internal capsule and cingulum of both TBI subgroups relative to MCs. Moreover, compared with the TBI-passed group, the TBI-failed group demonstrated significantly decreased WM integrity in the corpus callosum. Conclusions: Findings revealed that, within our sample, WM abnormalities are evident in those who fail PVTs. This study adds to the burgeoning PVT literature by suggesting that poor PVT performance does not negate the possibility of underlying WM abnormalities in military personnel with history of mTBI.	[Clark, Alexandra L.] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Clark, Alexandra L.; Sorg, Scott F.; Schiehser, Dawn M.; Bondi, Mark W.; Jacobson, Mark W.; Jak, Amy J.; Delano-Wood, Lisa] VASDHS, San Diego, CA USA; [Schiehser, Dawn M.; Jak, Amy J.; Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Sorg, Scott F.; Schiehser, Dawn M.; Bondi, Mark W.; Jacobson, Mark W.; Jak, Amy J.; Delano-Wood, Lisa] Univ Calif San Diego, Dept Psychiat, Sch Med, San Diego, CA 92103 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Brain Inst Utah, Salt Lake City, UT USA		Delano-Wood, L (corresponding author), Univ Calif San Diego, Sch Med, Dept Psychiat, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ldelano@ucsd.edu			Veterans AffairsUS Department of Veterans Affairs; Department of DefenseUnited States Department of Defense; Veterans AffairsUS Department of Veterans Affairs [I01CX000842] Funding Source: NIH RePORTER	This work was supported by grants awarded by the Veterans Affairs (Career Development Awards [CDA]: L.D.-W., D.S.; Merit Award; L.D.-W.) as well as the Department of Defense (Investigator-Initiated Research Grant [IIRG]: L.D.-W.). This material is further supported with resources of the Veterans Affairs Center of Excellence for Stress and Mental Health (CESAMH: L.D.-W.). The authors thank all OEF/OIF/OND Veterans for their service and are extremely appreciative of those who volunteered to participate in this study. In addition, a special thanks is owed to the Veterans Affairs CESAMH at the Veterans Affairs San Diego Healthcare System for their organizational assistance and to the wonderful research assistants (R.K., E.L., N.L.), who dedicate their time to our research laboratory.	Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Dalby RB, 2010, PSYCHIAT RES-NEUROIM, V184, P38, DOI 10.1016/j.pscychresns.2010.06.008; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; DeBeuckelaer A, 1996, STAT PAP, V37, P291, DOI 10.1007/BF02926110; Delis D., 2001, D KEFS EXAMINERS TEC; Delis D.C., 2000, CALIFORNIA VERBAL LE; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; Elhai JD, 2012, PTSD MILD TRAUMATIC; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Fortier CB, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000008; Frueh BC, 2005, BRIT J PSYCHIAT, V186, P467, DOI 10.1192/bjp.186.6.467; Gervais RO, 2001, J RHEUMATOL, V28, P1892; Gfeller JD, 2013, BEHAV SCI LAW, V31, P833, DOI 10.1002/bsl.2084; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Hall VL, 2014, J NEUROPSYCHOL, V8, P216, DOI 10.1111/jnp.12021; Heaton R., 2000, WISCONSIN CARD SORTI; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; IBM Corporation, 2013, IBM SPSS STAT MAC VE; Iglewicz B., 1993, DETECT HANDLE OUTLIE; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Khan A., 2003, Journal of Applied Mathematics and Decision Sciences, V7, P187, DOI 10.1207/S15327612JAMD0704_1; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larsen JD, 2010, BRAIN INJURY, V24, P89, DOI 10.3109/02699050903508218; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levy K. J., 1978, Journal of Statistical Computation and Simulation, V8, P49, DOI 10.1080/00949657808810247; Lippa SM, 2014, REHABIL PSYCHOL, V59, P306, DOI 10.1037/a0037217; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Roth R. S., 2013, J PALLIATIVE CARE ME, V1, P2; Ruff RM, 1999, BRAIN INJURY, V13, P943; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Schneider PJ, 1997, J EXP EDUC, V65, P271, DOI 10.1080/00220973.1997.9943459; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Traumatic Brain Injury Task Force, 2008, REP SURG GEN TBI TAS; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vassar RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115426; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Willis PF, 2011, MIL MED, V176, P1426, DOI 10.7205/MILMED-D-11-00168; Wisdom NM, 2012, ARCH CLIN NEUROPSYCH, V27, P208, DOI 10.1093/arclin/acr107; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Zabecki DT, 2000, MIL REV, V80, P106; Zimmerman DW, 2000, J GEN PSYCHOL, V127, P354, DOI 10.1080/00221300009598589	100	6	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					346	359		10.1097/HTR.0000000000000183			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600013	26360002	Green Accepted			2022-02-06	
J	Dong, L; Chen, L; Shi, T; Wei, M; Zhang, HZ; Li, YP; She, L; Yan, ZC				Dong, L.; Chen, L.; Shi, T.; Wei, M.; Zhang, H. Z.; Li, Y. P.; She, L.; Yan, Z. C.			Combined monitoring of intracranial pressure and bispectral index in patients with severe craniocerebral trauma post-operatively	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Brain injury; Bispectral index (BIS); Intracranial pressure (ICP); Monitoring; Craniocerebral injury; Prognosis	BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; MANAGEMENT; STROKE; COMA; BIS	Objective: To investigate the value of simultaneous bispectral index (BIS) and intracranial pressure (ICP) monitoring to evaluate postoperative consciousness and short-term prognosis in patients with severe traumatic brain injury. Methods: We evaluated 30 brain trauma coma patients in the People's Hospital of Northern Jiangsu Province from January 2014 to December 2014 and evaluated Glasgow Coma Scale (GCS) scores at 8-h intervals for 3 days after surgery. BIS and ICP values were recorded at the same time. Based on the GCS score, patients were divided into two groups: group A (GCS score 3-<= 5) and group B (>5-<= 8). Natural survival rates were analyzed statistically and compared between groups. Results: Chi-square testing revealed a significant difference in survival rates between the groups (P < 0.05). Spearman's rank correlation analysis revealed that BIS value was positively correlated with coma degree post-operatively in patients with severe traumatic brain injury, and negatively correlated with ICP values (r = 0.532, P < 0.05; r = 0.521, P < 0.05, respectively). Conclusion: In patients with severe craniocerebral injury, higher severity, higher ICP, and lower BIS were associated with a worse prognosis. Combined monitoring of BIS and ICP is very useful when evaluating the coma degree and prognosis of patients with severe craniocerebral injury post-operatively. (C) 2016 Published by Elsevier B.V.	[Dong, L.; Chen, L.; Shi, T.; Wei, M.; Zhang, H. Z.; Li, Y. P.; She, L.; Yan, Z. C.] Yangzhou Univ, Clin Med Coll, Dept Neurosurg, Yangzhou 225001, Jiangsu, Peoples R China		Zhang, HZ (corresponding author), Yangzhou Univ, Clin Med Coll, Dept Neurosurg, Yangzhou 225001, Jiangsu, Peoples R China.	dongluen@163.com; chenlangdoctor@hotmail.com; zhanghengzhu@sina.com	Li, Yuping/C-4122-2014	Li, Yuping/0000-0002-4527-2582			Bleeker CP, 2010, CASE REP MED, V2010, DOI 10.1155/2010/697185; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Cooper DJ, 2012, J NEUROTRAUM, V29, P2595, DOI 10.1089/neu.2011.2279; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Dou L, 2014, WORLD J EMERG MED, V5, P53, DOI [10.5847/wjem.j.issn.1920-8642.2014.01.009, 10.5847/wjem.j.1920-8642.2014.01.009]; Dunham CM, 2006, CRIT CARE, V10, DOI 10.1186/cc5097; Haenggi M, 2008, CRIT CARE, V12, DOI 10.1186/cc7015; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Lehmann A, 2003, ANESTH ANALG, V96, P336, DOI 10.1097/00000539-200302000-00008; Merat S, 2001, CAN J ANAESTH, V48, P1066, DOI 10.1007/BF03020370; Myles PS, 2009, ANESTHESIOLOGY, V110, P1106, DOI 10.1097/ALN.0b013e31819daef6; Ropper AE, 2013, NEUROSURGERY, V72, pN19, DOI 10.1227/01.neu.0000428424.83867.87; Schnakers C, 2008, BRAIN INJURY, V22, P926, DOI 10.1080/02699050802530565; Selig C, 2014, RESUSCITATION, V85, P221, DOI 10.1016/j.resuscitation.2013.11.008; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Stammet P, 2009, RESUSCITATION, V80, P437, DOI 10.1016/j.resuscitation.2009.01.008; Wang Z.C., 2009, CHIN MED ASS BRANCH	19	6	10	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	SEP	2016	148						42	44		10.1016/j.clineuro.2016.06.004			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DT9TA	WOS:000381844000008	27388137				2022-02-06	
J	Kroshus, E; Baugh, CM; Daneshvar, DH				Kroshus, Emily; Baugh, Christine M.; Daneshvar, Daniel H.			Content, Delivery, and Effectiveness of Concussion Education for US College Coaches	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; college; coach; education	FOR-DISEASE-CONTROL; ICE HOCKEY; SPORTS CONCUSSION; ATHLETIC TRAINERS; CDC HEADS; KNOWLEDGE; MANAGEMENT; IMPLEMENTATION; LEGISLATION; STRATEGIES	Objective:The primary objective of this study was to examine the proportion of US college coaches who receive annual concussion education from their institution and to describe the content and delivery modalities of this education. This study also tested the hypothesis that coaches receiving concussion education from their institution will have greater knowledge about concussions independent of other individual and institutional characteristics.Design:Cross-sectional online survey.Setting:US college sport.Participants:College coaches in National Collegiate Athletic Association Division I, II, and III (n = 1818).Independent Variables:Self-reported receipt of education from institution, sex, sport coached, division of competition.Main Outcome Measures:Concussion identification and management knowledge.Results:Two-thirds of coaches reported receiving informational materials about concussion from their institution. The content of the education most frequently referred to symptoms of a concussion and information about proper management of a concussion. Coaches who received educational materials from their institution were better able to identify symptoms and had more conservative responses to concussion management scenarios. Male coaches of male contact or collision teams less frequently endorsed safe or correct response as compared with female coaches of noncontact or collision teams.Conclusions:Not all US college coaches receive concussion education from their institution. Male Division I coaches of male contact/collision sport are a population for whom targeted educational outreach may be particularly valuable.Clinical Relevance:Education for coaches, delivered by clinicians at many institutions, is an important component of ensuring that coaches are prepared to be informed partners in supporting concussion safety.	[Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Ctr Child Hlth Behav & Dev, Seattle Childrens Res Inst, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA; [Kroshus, Emily] Harborview Injury Prevent Res Ctr, Seattle, WA USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Baugh, Christine M.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Daneshvar, Daniel H.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA		Kroshus, E (corresponding author), Ctr Child Hlth Behav & Dev, Seattle Childrens Res Inst, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@u.washington.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Daneshvar, Daniel/0000-0003-3691-9513			Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Borden BP, 2007, AM J SPORTS MED, V35, P1075; Bramley H, 2012, CLIN PEDIATR, V51, P283, DOI 10.1177/0009922811422434; Broglio S. P., 2014, CONCUSSIONS ATHLETIC, P313; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Echemendia RJ, 2013, POSITIVE NEUROPSYCHO, P57; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Esquivel A, 2013, SPORTS HEALTH, V5, P258, DOI 10.1177/1941738113476850; Faure C, 2010, AM SECONDARY ED, V39, P5; Faure C, 2011, SPORT J, V14, P1; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Marar M, 2012, AM J SPORTS MED, V20, P1; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; National Collegiate Athletic Association, 2013, 2013 2014 NCAA SPORT, V24, P58; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Williams N, 2012, FRONT NEUROL, V3, P1; Wolverton B, 2013, CHRONICLE HIGHER ED	45	6	6	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2016	26	5					391	397		10.1097/JSM.0000000000000272			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	DW8LH	WOS:000383906800010	26540598				2022-02-06	
J	Srienc, AI; Biesecker, KR; Shimoda, AM; Kur, J; Newman, EA				Srienc, Anja I.; Biesecker, Kyle R.; Shimoda, Angela M.; Kur, Joanna; Newman, Eric A.			Ischemia-induced spreading depolarization in the retina	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Branch retinal vein occlusion; hypoxia; NMDA antagonist; retinal ischemia; spreading depolarization	ANOXIC DEPOLARIZATION; MIGRAINE AURA; BLOOD-FLOW; DEPRESSION; RAT; GLUTAMATE; STROKE; CORTEX; HEMORRHAGE; DAMAGE	Cortical spreading depolarization is a metabolically costly phenomenon that affects the brain in both health and disease. Following severe stroke, subarachnoid hemorrhage, or traumatic brain injury, cortical spreading depolarization exacerbates tissue damage and enlarges infarct volumes. It is not known, however, whether spreading depolarization also occurs in the retina invivo. We report now that spreading depolarization episodes are generated in the invivo rat retina following retinal vessel occlusion produced by photothrombosis. The properties of retinal spreading depolarization are similar to those of cortical spreading depolarization. Retinal spreading depolarization waves propagate at a velocity of 3.0 +/- 0.1mm/min and are associated with a negative shift in direct current potential, a transient cessation of neuronal spiking, arteriole constriction, and a decrease in tissue O-2 tension. The frequency of retinal spreading depolarization generation invivo is reduced by administration of the NMDA antagonist MK-801 and the 5-HT(1D) agonist sumatriptan. Branch retinal vein occlusion is a leading cause of vision loss from vascular disease. Our results suggest that retinal spreading depolarization could contribute to retinal damage in acute retinal ischemia and demonstrate that pharmacological agents can reduce retinal spreading depolarization frequency after retinal vessel occlusion. Blocking retinal spreading depolarization generation may represent a therapeutic strategy for preserving vision in branch retinal vein occlusion patients.	[Srienc, Anja I.; Biesecker, Kyle R.] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA; [Srienc, Anja I.] Univ Minnesota, Med Scientist Training Program, Minneapolis, MN 55455 USA; [Shimoda, Angela M.; Kur, Joanna; Newman, Eric A.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA		Newman, EA (corresponding author), 321 Church St SE,Jackson Hall 3-159, Minneapolis, MN 55455 USA.	ean@umn.edu		Srienc, Anja/0000-0003-1038-2156	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 EY004077, P30-EY011374]; Winston and Maxine Wallin Neuroscience Discovery Fund; American Heart Association Predoctoral FellowshipAmerican Heart Association [13PRE16960081]; CTSI TRDP Award [NIHUL1TR000114]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY011374, R01EY004077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008471] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by NIH RO1 EY004077 (EAN), NIH P30-EY011374 (EAN), the Winston and Maxine Wallin Neuroscience Discovery Fund (EAN), American Heart Association Predoctoral Fellowship 13PRE16960081 (AIS), and CTSI TRDP Award NIHUL1TR000114 (AIS).	Anderson TR, 2002, J NEUROPHYSIOL, V88, P2713, DOI 10.1152/jn.00321.2002; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Bogdanov VB, 2016, J NEUROSCI, V36, P4733, DOI 10.1523/JNEUROSCI.3694-15.2016; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Charles AC, 2013, NAT REV NEUROL, V9, P637, DOI 10.1038/nrneurol.2013.192; Dahlem YA, 2005, BRAIN RES, V1049, P15, DOI 10.1016/j.brainres.2005.04.059; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2013, ACTA NEUROCHIR SUPPL, V115, P125, DOI 10.1007/978-3-7091-1192-5_26; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fordsmann JC, 2013, J NEUROSCI, V33, P2562, DOI 10.1523/JNEUROSCI.2308-12.2013; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; Girouard H, 2010, P NATL ACAD SCI USA, V107, P3811, DOI 10.1073/pnas.0914722107; Hanke W, 2008, PHILOS T R SOC A, V366, P359, DOI 10.1098/rsta.2007.2094; Hansen JM, 2013, BRAIN, V136, P3589, DOI 10.1093/brain/awt309; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; HIGASHIDA H, 1977, BRAIN RES, V120, P67, DOI 10.1016/0006-8993(77)90498-X; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Hultman D, 2011, EXP EYE RES, V93, P767, DOI 10.1016/j.exer.2011.08.010; Ivanova E, 2014, INVEST OPHTH VIS SCI, V55, P78, DOI 10.1167/iovs.13-13196; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Joshi I, 2001, J NEUROPHYSIOL, V85, P414, DOI 10.1152/jn.2001.85.1.414; Kornfield TE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0005-15.2015; Kudo C, 2008, EXP NEUROL, V212, P201, DOI 10.1016/j.expneurol.2008.03.026; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; LAURITZEN M, 1982, ANN NEUROL, V12, P469, DOI 10.1002/ana.410120510; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEUBA G, 1989, EXP BRAIN RES, V77, P31; Malkov A, 2014, J CEREBR BLOOD F MET, V34, P1540, DOI 10.1038/jcbfm.2014.121; Maranhao PA, 1997, CEPHALALGIA, V17, P822, DOI 10.1046/j.1468-2982.1997.1708822.x; Mead B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110612; MORI S, 1976, P NATL ACAD SCI USA, V73, P1351, DOI 10.1073/pnas.73.4.1351; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; Netto M, 1999, BRAIN RES, V827, P221, DOI 10.1016/S0006-8993(99)01296-2; NETTO M, 1989, PHOTOCHEM PHOTOBIOL, V50, P229, DOI 10.1111/j.1751-1097.1989.tb04153.x; Newman EA, 1999, J NEUROSCI METH, V93, P169, DOI 10.1016/S0165-0270(99)00138-7; NEWMAN EA, 1984, SCIENCE, V225, P1174, DOI 10.1126/science.6474173; OLSEN JS, 1977, J NEUROPHYSIOL, V40, P752, DOI 10.1152/jn.1977.40.4.752; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; REICHENBACH A, 1986, J NEUROCYTOL, V15, P451, DOI 10.1007/BF01611728; Sadeghian H, 2012, EXP NEUROL, V233, P438, DOI 10.1016/j.expneurol.2011.11.017; Seidel JL, 2016, GLIA, V64, P5, DOI 10.1002/glia.22824; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Srienc Anja I, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00128; Takagaki M, 2014, EXP NEUROL, V252, P12, DOI 10.1016/j.expneurol.2013.11.003; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Yu YF, 2012, P NATL ACAD SCI USA, V109, P2585, DOI 10.1073/pnas.1121111109; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113	52	6	6	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	2016	36	9					1579	1591		10.1177/0271678X16657836			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	DV5UU	WOS:000382996800009	27389181	Green Published, Bronze			2022-02-06	
J	Vermetten, E; Baker, DG; Jetly, R; McFarlane, AC				Vermetten, Eric; Baker, Dewleen G.; Jetly, Rakesh; McFarlane, Alexander C.			Concerns Over Divergent Approaches in the Diagnostics of Posttraumatic Stress Disorder	PSYCHIATRIC ANNALS			English	Article							MAJOR DEPRESSIVE DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; PRIMARY-CARE; UNINTENDED CONSEQUENCES; PTSD; VETERANS; DSM-5; PREVALENCE; CRITERIA	Since the inception of posttraumatic stress disorder (PTSD) in the Diagnostic and Statistical Manual of Mental Disorders, third edition (DSM-III), there has been an ongoing polemic debate about the veracity, assessment, neurobiology, and longitudinal course of the disorder. As a consequence, its clinical utility has been the subject of a significant amount of conflicting opinion due to the competing interests involving clinicians, insurance companies, victim's groups, and governments. This article reviews some of the current divergent approaches in the diagnosis of PTSD, including the debate on the condition itself, claims that it is overdiagnosed, the usefulness of the "A" criterion, equivalence of cluster criteria, the role of combat and civilian PTSD, the role of biomarkers, incongruences in diagnostic practice, and the need for a consistent approach that ensures diagnostic congruence. Critical drivers of divergent diagnostic systems are that they should not produce significantly different rates or produce high levels of discordance. However, one of the concerns is that the anticipated International Statistical Classification of Diseases and Related Health Problems, eleventh edition (ICD-11) has moved away from this primary aim and taken a markedly divergent approach that is incompatible with the advancement of consensus within this critical field. This article explores some of the primary arguments and evidence cited for this approach in ICD-11 and recent changes in DSM-5.	[Vermetten, Eric] Leiden Univ, Dept Psychiat, Psychiat, NL-2300 RA Leiden, Netherlands; [Baker, Dewleen G.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Jetly, Rakesh] Univ Ottawa, Dept Psychiat, Mil Mental Hlth, Ottawa, ON K1N 6N5, Canada; [McFarlane, Alexander C.] Univ Adelaide, Psychiat, Adelaide, SA 5005, Australia		Vermetten, E (corresponding author), Leiden Univ, Med Ctr, Dept Psychiat, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	e.vermetten@lumc.nl	Baker, Dewleen/O-4957-2019; Vermetten, Eric/B-1335-2008	Baker, Dewleen/0000-0002-1736-9838; Vermetten, Eric/0000-0003-0579-4404			Agorastos A, 2013, STRESS, V16, P300, DOI 10.3109/10253890.2012.751369; Aleccia, 2012, NBC NEWS; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, 1968, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arnberg FK, 2013, J ANXIETY DISORD, V27, P347, DOI 10.1016/j.janxdis.2013.03.011; Baker DG, 2012, NEUROPHARMACOLOGY, V62, P663, DOI 10.1016/j.neuropharm.2011.02.027; Bedard-Gilligan M, 2015, J CLIN PSYCHOL, V71, P725, DOI 10.1002/jclp.22163; Bhugra D, 2014, J ROY SOC MED, V107, P183, DOI 10.1177/0141076814525069; Blease C, 2014, J MED ETHICS, V40, P225, DOI 10.1136/medethics-2012-101122; Brewin CR, 2008, J TRAUMA STRESS, V21, P3, DOI 10.1002/jts.20310; Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3; Brunet A, 2007, CAN J PSYCHIAT, V52, P501, DOI 10.1177/070674370705200805; Dalenberg C, 2012, PSYCHOL TRAUMA-US, V4, P551, DOI 10.1037/a0027900; Denning LA., 2014, PREVENTING PSYCHOL D; Elhai JD, 2011, J ANXIETY DISORD, V25, P404, DOI 10.1016/j.janxdis.2010.11.003; Elzinga BM, 2002, J AFFECT DISORDERS, V70, P1, DOI 10.1016/S0165-0327(01)00351-2; Erbes CR, 2012, J AFFECT DISORDERS, V142, P269, DOI 10.1016/j.jad.2012.05.013; Farr OM, 2015, NUTR METAB CARDIOVAS, V25, P479, DOI 10.1016/j.numecd.2015.01.007; Fetzner MG, 2012, DEPRESS ANXIETY, V29, P958, DOI 10.1002/da.21976; Flory JD, 2015, DIALOGUES CLIN NEURO, V17, P141; Friedman MJ, 2011, DEPRESS ANXIETY, V28, P750, DOI 10.1002/da.20767; Geracioti TD, 2008, PSYCHONEUROENDOCRINO, V33, P416, DOI 10.1016/j.psyneuen.2007.12.012; Grasso D, 2009, CHILD WELFARE, V88, P157; Grossman LS, 1997, PSYCHIAT SERV, V48, P393; Guina J, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0686-1; Hamner MB, 1998, PSYCHIAT RES, V77, P175, DOI 10.1016/S0165-1781(98)00002-X; Hayes JP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00089; Hermes EDA, 2014, PSYCHIAT SERV, V65, P830, DOI 10.1176/appi.ps.201300232; Hoeber P.B., 1941, TRAUMATIC NEUROSES W; Hoge CW, 2016, JAMA PSYCHIAT, V73, P750, DOI 10.1001/jamapsychiatry.2016.0647; Hoge CW, 2014, LANCET PSYCHIAT, V1, P269, DOI 10.1016/S2215-0366(14)70235-4; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Hyland P, 2016, J ANXIETY DISORD, V37, P48, DOI 10.1016/j.janxdis.2015.11.002; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Jones E, 2007, J ANXIETY DISORD, V21, P164, DOI 10.1016/j.janxdis.2006.09.009; Jovanovic T, 2010, DEPRESS ANXIETY, V27, P244, DOI 10.1002/da.20663; Kawakami N, 2014, J PSYCHIATR RES, V53, P157, DOI 10.1016/j.jpsychires.2014.01.015; Kim CH, 2002, AM J MED GENET, V108, P140, DOI 10.1002/ajmg.10196; Kornfield SL, 2012, PSYCHOL SERV, V9, P383, DOI 10.1037/a0028082; Lanius RA, 2010, EUR J PSYCHOTRAUMATO, V1, DOI 10.3402/ejpt.v1i0.5467; Lehrner A, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23797; Liberzon I, 2006, ANN NY ACAD SCI, V1071, P87, DOI 10.1196/annals.1364.009; Liebschutz J, 2007, J GEN INTERN MED, V22, P719, DOI 10.1007/s11606-007-0161-0; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; Logue MW, 2015, NEUROPSYCHOPHARMACOL, V40, P2287, DOI 10.1038/npp.2015.118; MACKENZIE TB, 1983, HOSP COMMUNITY PSYCH, V34, P628; Maercker A, 2013, LANCET, V381, P1683, DOI 10.1016/S0140-6736(12)62191-6; Marmar CR, 2015, JAMA PSYCHIAT, V72, P875, DOI 10.1001/jamapsychiatry.2015.0803; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McFarlane AC, 2001, J TRAUMA STRESS, V14, P633, DOI 10.1023/A:1013077702520; McFarlane AC, 2015, AUSTRALAS PSYCHIATRY, V23, P392, DOI 10.1177/1039856215588211; McFarlane AC, 2014, LANCET PSYCHIAT, V1, P246, DOI 10.1016/S2215-0366(14)70321-9; McHugh PR, 2007, J ANXIETY DISORD, V21, P211, DOI 10.1016/j.janxdis.2006.09.003; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; Meltzer EC, 2012, J BEHAV HEALTH SER R, V39, P190, DOI 10.1007/s11414-011-9263-x; Michopoulos V, 2015, BIOL PSYCHIAT, V78, P344, DOI 10.1016/j.biopsych.2015.01.005; Miele D, 2010, J TRAUMA STRESS, V23, P591, DOI 10.1002/jts.20572; Miller LN, 2011, J ANXIETY DISORD, V25, P639, DOI 10.1016/j.janxdis.2011.02.004; Moreau C, 2002, PSYCHIAT CLIN N AM, V25, P775, DOI 10.1016/S0193-953X(02)00019-9; Mustapic M, 2007, AM J MED GENET B, V144B, P1087, DOI 10.1002/ajmg.b.30526; Mustapic M, 2014, HUM MOL GENET, V23, P6375, DOI 10.1093/hmg/ddu332; Neylan TC, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23938; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; O'Donnell ML, 2014, BRIT J PSYCHIAT, V205, P230, DOI 10.1192/bjp.bp.113.135285; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P739, DOI 10.1002/da.20574; Roberts Andrea L, 2012, J Clin Psychiatry, V73, pe264, DOI 10.4088/JCP.11m07054; Rodriguez BF, 2003, J CLIN PSYCHIAT, V64, P1230, DOI 10.4088/JCP.v64n1014; Rosen GM, 2008, CLIN PSYCHOL REV, V28, P837, DOI 10.1016/j.cpr.2007.12.002; Rosen GM, 2007, J ANXIETY DISORD, V21, P161, DOI 10.1016/j.janxdis.2006.09.007; Rubin DC, 2008, PSYCHOL REV, V115, P985, DOI 10.1037/a0013397; Sachser C, 2016, J TRAUMA STRESS, V29, P120, DOI 10.1002/jts.22080; Sayer NA, 2004, SOC SCI MED, V58, P2133, DOI 10.1016/j.socscimed.2003.08.009; Schmidt U, 2015, PSYCHONEUROENDOCRINO, V51, P444, DOI 10.1016/j.psyneuen.2014.08.020; Soltis K, 2014, J LAW MED ETHICS, V42, P147, DOI 10.1111/jlme.12130; Spiegel D, 2007, LANCET, V369, P992, DOI 10.1016/S0140-6736(07)60494-2; Sriram K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002379; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Stein DJ, 2007, LANCET, V369, P139, DOI 10.1016/S0140-6736(07)60075-0; Stein DJ, 2014, DEPRESS ANXIETY, V31, P494, DOI 10.1002/da.22279; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Summerfield D, 2001, BRIT MED J, V322, P95, DOI 10.1136/bmj.322.7278.95; Tagay S, 2005, J PSYCHOSOM RES, V58, P439, DOI 10.1016/j.jpsychores.2004.09.007; Tikkinen KAO, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001632; Vermetten E, 2015, PSYCHONEUROENDOCRINO, V51, P441, DOI 10.1016/j.psyneuen.2014.11.017; *WHO, INT CLASS DIS REL HL; Wingenfeld K, 2015, PSYCHONEUROENDOCRINO, V51, P282, DOI 10.1016/j.psyneuen.2014.10.009; Wise EA, 2015, PSYCHOL TRAUMA-US, V7, P500, DOI 10.1037/tra0000039; World Health Organization, 1992, INT CLASS DIS REL HL; YEHUDA R, 1995, AM J PSYCHIAT, V152, P1705; Yehuda R, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0048; Yehuda R, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25322; Young A, 2007, J ANXIETY DISORD, V21, P230, DOI 10.1016/j.janxdis.2006.09.001; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zimmerman M, 1999, J NERV MENT DIS, V187, P420, DOI 10.1097/00005053-199907000-00005	97	6	6	1	13	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713	1938-2456		PSYCHIAT ANN	Psychiatr. Ann.	SEP	2016	46	9					498	509		10.3928/00485713-20160728-02			12	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	EC9EY	WOS:000388448400004		Green Submitted			2022-02-06	
J	Wang, XT; Seekaew, P; Gao, X; Chen, JH				Wang, Xiaoting; Seekaew, Pich; Gao, Xiang; Chen, Jinhui			Traumatic Brain Injury Stimulates Neural Stem Cell Proliferation via Mammalian Target of Rapamycin Signaling Pathway Activation	ENEURO			English	Article						mammalian target of rapamycin; neural stem/progenitor cells; proliferation; quiescence; traumatic brain injury	CONTROLLED CORTICAL IMPACT; PROGENITOR CELLS; DENTATE GYRUS; ADULT NEUROGENESIS; COGNITIVE RECOVERY; GRANULE CELLS; UP-REGULATION; HIPPOCAMPAL NEUROGENESIS; NEURONAL DIFFERENTIATION; ENHANCED NEUROGENESIS	Neural stem cells in the adult brain possess the ability to remain quiescent until needed in tissue homeostasis or repair. It was previously shown that traumatic brain injury (TBI) stimulated neural stem cell (NSC) proliferation in the adult hippocampus, indicating an innate repair mechanism, but it is unknown how TBI promotes NSC proliferation. In the present study, we observed dramatic activation of mammalian target of rapamycin complex 1 (mTORC1) in the hippocampus of mice with TBI from controlled cortical impact (CCI). The peak of mTORC1 activation in the hippocampal subgranular zone, where NSCs reside, is 24-48 h after trauma, correlating with the peak of TBI-enhanced NSC proliferation. By use of a Nestin-GFP transgenic mouse, in which GFP is ectopically expressed in the NSCs, we found that TBI activated mTORC1 in NSCs. With 5-bromo-2'-deoxyuridine labeling, we observed that TBI increased mTORC1 activation in proliferating NSCs. Furthermore, administration of rapamycin abolished TBI-promoted NSC proliferation. Taken together, these data indicate that mTORC1 activation is required for NSC proliferation postinjury, and thus might serve as a therapeutic target for interventions to augment neurogenesis for brain repair after TBI.	[Wang, Xiaoting; Seekaew, Pich; Gao, Xiang; Chen, Jinhui] Indiana Univ, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN 46202 USA; [Wang, Xiaoting; Seekaew, Pich; Gao, Xiang; Chen, Jinhui] Indiana Univ, Stark Neurosci Res Inst, Neurosci Res Bldg,320 W 15th St, Indianapolis, IN 46202 USA; [Wang, Xiaoting; Seekaew, Pich; Gao, Xiang; Chen, Jinhui] Indiana Univ, Dept Neurol Surg, Neurosci Res Bldg,320 W 15th St, Indianapolis, IN 46202 USA		Chen, JH (corresponding author), Indiana Univ, Stark Neurosci Res Inst, Neurosci Res Bldg,320 W 15th St, Indianapolis, IN 46202 USA.; Chen, JH (corresponding author), Indiana Univ, Dept Neurol Surg, Neurosci Res Bldg,320 W 15th St, Indianapolis, IN 46202 USA.	chen204@iupui.edu			Indiana Spinal Cord and Brain Injury Research Grants; Ralph W. and Grace M. Showalter Research Award; Indiana University Biological Research Grant	This work was supported by funding from the Indiana Spinal Cord and Brain Injury Research Grants, the Ralph W. and Grace M. Showalter Research Award, and Indiana University Biological Research Grant.	Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Coller HA, 2011, SCIENCE, V334, P1074, DOI 10.1126/science.1216242; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Encinas JM, 2008, EXP NEUROL, V210, P274, DOI 10.1016/j.expneurol.2007.10.021; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Faul M, 2010, TRAUMATIC BRAIN INJU; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hartman NW, 2013, CELL REP, V5, P433, DOI 10.1016/j.celrep.2013.09.017; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hilpert M, 2014, STEM CELL REP, V3, P1085, DOI 10.1016/j.stemcr.2014.10.005; Infante A, 2008, CELL CYCLE, V7, P3915, DOI 10.4161/cc.7.24.7379; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lin SP, 2014, STEM CELL REP, V3, P975, DOI 10.1016/j.stemcr.2014.10.002; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Magri L, 2011, CELL STEM CELL, V9, P447, DOI 10.1016/j.stem.2011.09.008; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nikolaeva I, 2015, J NEUROTRAUMA; Nottebohm F, 2002, BRAIN RES BULL, V57, P737, DOI 10.1016/S0361-9230(02)00750-5; Paliouras GN, 2012, J NEUROSCI, V32, P15012, DOI 10.1523/JNEUROSCI.2248-12.2012; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Perry DC, 2015, J NEUROSURG, P1; PRIGATANO GP, 1987, J LEARN DISABIL-US, V20, P603, DOI 10.1177/002221948702001006; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Romine J, 2015, NEUROBIOL AGING, V36, P1716, DOI 10.1016/j.neurobiolaging.2015.01.003; Rozas NS, 2015, J NEUROTRAUM, V32, P149, DOI 10.1089/neu.2014.3469; Rumman M, 2015, STEM CELLS, V33, P2903, DOI 10.1002/stem.2056; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sierra A, 2015, CELL STEM CELL, V16, P488, DOI 10.1016/j.stem.2015.04.003; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	83	6	7	0	4	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	SEP-OCT	2016	3	5							e0162	10.1523/ENEURO.0162-16.2016			14	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	EH7CL	WOS:000391930400019		Green Published, gold			2022-02-06	
J	Tsalach, A; Ratner, E; Lokshin, S; Silman, Z; Breskin, I; Budin, N; Kamar, M				Tsalach, Adi; Ratner, Eliahu; Lokshin, Stas; Silman, Zmira; Breskin, Ilan; Budin, Nahum; Kamar, Moshe			Cerebral Autoregulation Real-Time Monitoring	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; BLOOD-FLOW AUTOREGULATION; TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR AUTOREGULATION; HEAD-INJURY; PRESSURE AUTOREGULATION; CARDIOPULMONARY BYPASS; INTRACRANIAL-PRESSURE; REACTIVITY; CIRCULATION	Cerebral autoregulation is a mechanism which maintains constant cerebral blood flow (CBF) despite changes in mean arterial pressure (MAP). Assessing whether this mechanism is intact or impaired and determining its boundaries is important in many clinical settings, where primary or secondary injuries to the brain may occur. Herein we describe the development of a new ultrasound tagged near infra red light monitor which tracks CBF trends, in parallel, it continuously measures blood pressure and correlates them to produce a real time autoregulation index. Its performance is validated in both in-vitro experiment and a pre-clinical case study. Results suggest that using such a tool, autoregulation boundaries as well as its impairment or functioning can be identified and assessed. It may therefore assist in individualized MAP management to ensure adequate organ perfusion and reduce the risk of postoperative complications, and might play an important role in patient care.	[Tsalach, Adi; Ratner, Eliahu; Lokshin, Stas; Silman, Zmira; Breskin, Ilan; Budin, Nahum; Kamar, Moshe] Ornim Med Ltd, Kefar Sava, Israel		Tsalach, A (corresponding author), Ornim Med Ltd, Kefar Sava, Israel.	adi@ornim.com			Ornim Medical LTD.; Ornim Medical LTD	The study was sponsored by Ornim Medical LTD. Ornim Medical LTD provided support in the form of salaries for authors [AT, ER, SL, ZS, IB, NB, MK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Brady K, 2015, ANESTH ANALG, V121, P1121, DOI 10.1213/ANE.0000000000000952; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Christensen DA., 1988, ULTRASONIC BIOINSTRU, V1; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 1997, J NEUROSURGICAL ANES, V9, P200; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; GERMON TJ, 1994, BRIT J ANAESTH, V73, P503, DOI 10.1093/bja/73.4.503; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; GOBIET W, 1975, ACTA NEUROCHIR, V32, P13, DOI 10.1007/BF01405899; Hori D, 2016, J CARDIOTHORACIC VAS; Hori D, 2016, INTERACT CARDIOV TH; Hori D, 2015, ANESTH ANALG, V121, P1187, DOI 10.1213/ANE.0000000000000930; Immink RV, 2005, STROKE, V36, P2595, DOI 10.1161/01.STR.0000189624.06836.03; Joshi B, 2010, ANESTH ANALG, V110, P321, DOI 10.1213/ANE.0b013e3181c6fd12; Kirkham SK, 2001, PHYSIOL MEAS, V22, P461, DOI 10.1088/0967-3334/22/3/305; Lagerkranser M, 1997, J NEUROSURG ANESTH, V9, P188, DOI 10.1097/00008506-199704000-00015; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Lassen NA, 1959, CEREBRAL BLOOD FLOW; Lee JK, 2011, CRIT CARE MED, V39, P2337, DOI 10.1097/CCM.0b013e318223b910; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Murkin JM, 2015, J CARDIOTHORACIC VAS; Ono M, 2012, J CARDIOTHOR VASC AN, V26, P1022, DOI 10.1053/j.jvca.2012.07.014; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Paulson O.B., 1989, CEREBROVAS BRAIN MET, V2, P161; PAULSON OB, 1991, BLOOD VESSELS, V28, P231; Pesek M, 2014, NEUROSURGERY, V75, P163, DOI 10.1227/NEU.0000000000000367; Racheli N, 2012, SPIE BIOS; Schwarz M, 2015, NEUROCRIT CARE, P1; Schytz HW, 2012, NEUROCRIT CARE, V17, P139, DOI 10.1007/s12028-012-9720-2; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; Strandgaard S, 1975, LOWER UPPER LIMITS A, P3; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tsalach A, 2015, BIOMED OPT EXPRESS, V6, P4871, DOI 10.1364/BOE.6.004871; Utley J.R., 2000, CARDIOPULMONARY BYPA; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13	44	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161907	10.1371/journal.pone.0161907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	WOS:000382876700043	27571474	Green Published, Green Submitted, gold			2022-02-06	
J	Bray, RM; Engel, CC; Williams, J; Jaycox, LH; Lane, ME; Morgan, JK; Unutzer, J				Bray, Robert M.; Engel, Charles C.; Williams, Jason; Jaycox, Lisa H.; Lane, Marian E.; Morgan, Jessica K.; Unuetzer, Juergen			Posttraumatic Stress Disorder in US Military Primary Care: Trajectories and Predictors of One-Year Prognosis	JOURNAL OF TRAUMATIC STRESS			English	Article							MENTAL-HEALTH PROBLEMS; COMORBIDITY SURVEY REPLICATION; PROSPECTIVE COHORT; TRAUMA SYMPTOMS; FEMALE VETERANS; PTSD CHECKLIST; SOLDIERS; DEPRESSION; IRAQ; RESILIENCE	We examined the longitudinal course of primary care patients in the active duty Army with posttraumatic stress disorder (PTSD) and identified prognostic indicators of PTSD severity. Data were drawn from a 6-site randomized trial of collaborative primary care for PTSD and dpression in the military. Subjects were 474 soldiers with PTSD (scores 50 on the PTSD Checklist -Civilian Version). Four assessments were completed at U.S. Army installations: baseline, and follow-ups at 3 months (92.8% response rate [RR]), 6 months (90.1% RR), and 12 months (87.1% RR). Combat exposure and 7 validated indicators of baseline clinical status (alcohol misuse, depression, pain, somatic symptoms, low mental health functioning, low physical health functioning, mild traumatic brain injury) were used to predict PTSD symptom severity on the Posttraumatic Diagnostic Scale (Cronbach's = .87, .92, .95, .95, at assessments 1-4, respectively). Growth mixture modeling identified 2 PTSD symptom trajectories: subjects reporting persistent symptoms (Persisters, 81.9%, n = 388), and subjects reporting improved symptoms (Improvers 18.1%, n = 86). Logistic regression modeling examined baseline predictors of symptom trajectories, adjusting for demographics, installation, and treatment condition. Subjects who reported moderate combat exposure, adjusted odds ratio (OR) = 0.44, 95% CI [0.20, 0.98], or who reported high exposure, OR = 0.39, 95% CI [0.17, 0.87], were less likely to be Improvers. Other baseline clinical problems were not related to symptom trajectories. Findings suggested that most military primary care patients with PTSD experience persistent symptoms, highlighting the importance of improving the effectiveness of their care. Most indicators of clinical status offered little prognostic information beyond the brief assessment of combat exposure. Resumen Trayectorias de TEPT y Predictores Pronosticos Evaluamos el curso longitudinal en la atencion primaria de pacientes con Trastorno por Estres Postraumatico (TEPT) activos en el ejercito e identificamos indicadores pronosticos de severidad de TEPT. La informacion se recolecto de un estudio randomizado de 6 lugares de atencion primaria para TEPT/Depresion en el Ejercito. Los sujetos fueron 474 soldados con TEPT (puntajes 50 en PTSD Checklist version civil). Cuatro evaluaciones se realizaron en instalaciones del Ejercito de Estados Unidos: en la linea de base, con seguimientos a 3 meses (92.8% tasa de respuesta [RR]), 6 meses (90.1% RR), y 12 meses (87.1% RR). La exposicion al combate y 7 indicadores validados del estado clinico en la linea de base (abuso de alcohol, depresion, dolor, sintomas somaticos, funcionamiento de salud mental bajo, funcionamiento de salud fisica bajo, lesion cerebral traumatica leve) se utilizaron para predecir la severidad de sintomas TEPT en la Escala Diagnostica Postraumatica (Cronbach's : .87, .92, .95, .95 en evaluaciones 1-4, respectivamente). El modelo de crecimiento de mezcla identifico dos trayectorias de sintomas de TEPT: sujetos que reportaron sintomas persistentes (Persistidores, 81.9%, n:388), y sujetos que reportaron mejoria de los sintomas (Mejoradores 18.1%, n: 86). Modelos de regresion logistico evaluaron predictores de la trayectoria de sintomas en la linea de base, controlando aspectos demograficos, implementacion y condicion del tratamiento. Los sujetos que reportaron exposicion al combate moderado (OR ajustado: 0.44, 95% CI: [0.20, 0.98]) o mas alto (OR: 0.39, 95% CI: [0.17, 0.87]) tuvieron menos probabilidades de ser Mejoradores. Otros problemas clinicos en la linea de base no se relacionaron a trayectorias de sintomas. Los hallazgos sugieren que la mayoria de los pacientes de atencion primaria en el ejercito con TEPT experimentan sintomas persistentes, resaltando la importancia de mejorar la efectividad de su cuidado. La mayoria de los indicadores de estado clinico ofrecieron informacion pronostica escasa mas alla de la evaluacion breve de exposicion a combate.	[Bray, Robert M.; Williams, Jason; Lane, Marian E.; Morgan, Jessica K.] RTI Int, Behav Hlth & Criminal Justice Div, 3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA; [Engel, Charles C.; Jaycox, Lisa H.] RAND Corp, Behav & Policy Sci, Arlington, VA USA; [Unuetzer, Juergen] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Bray, RM (corresponding author), RTI Int, 3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	rmb@rti.org	Morgan, Jessica/Q-2066-2019; Unutzer, Jurgen/N-4048-2018	Morgan, Jessica/0000-0003-2071-2681; Engel, Charles/0000-0002-9232-3389; Williams, Jason/0000-0002-3804-2594	U.S. Department of Defense Deployment Related Medical Research Program award [DR080409]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc [W81XWH-09-2-0077]; Research Triangle Institute [W81XWH-09-2-0078]; RAND Corporation [W81XWH-09-2-0079]	This study was supported by a U.S. Department of Defense Deployment Related Medical Research Program award (Grant DR080409). The award was a joint award to the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (award W81XWH-09-2-0077), Research Triangle Institute (award W81XWH-09-2-0078), and the RAND Corporation (award W81XWH-09-2-0079). The sponsor had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The views expressed in this article are those of the authors and do not necessarily represent the views of the U.S. Department of Defense, Department of Veterans Affairs, or any U.S. government agency.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersen SB, 2014, J CLIN PSYCHIAT, V75, P1001, DOI 10.4088/JCP.13m08914; Babor T.F., 2001, AUDIT THE ALCOHOL US; Bliese P.D., 2007, PSYCHOL SERV, V4, P141, DOI DOI 10.1037/1541-1559.4.3.141; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Bray RM., 2009, 2008 DEP DEFENSE SUR; Cleeland C. S., 1994, ANN ACAD MED SINGAP, V23, P29; Currier JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101741; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Engel CC, 2016, JAMA INTERN MED, V176, P948, DOI 10.1001/jamainternmed.2016.2402; Engel CC, 2014, CONTEMP CLIN TRIALS, V39, P310, DOI 10.1016/j.cct.2014.10.002; Foa E., 1995, POSTTRAUMATIC DIAGNO; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Fortney JC, 2015, JAMA PSYCHIAT, V72, P58, DOI 10.1001/jamapsychiatry.2014.1575; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Institute of Medicine, 2014, TREATM POSTTR STRESS; Jaycox, 2008, INVISIBLE WOUNDS WAR; Kelly JM, 2015, J CLIN PSYCHIAT, V76, P267, DOI 10.4088/JCP.13m08922; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; King D. W., 2003, MANUAL DEPLOYMENT RI; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Luxton DD, 2015, TELEMED E-HEALTH, V21, P880, DOI 10.1089/tmj.2014.0235; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mott JM, 2014, PSYCHIAT SERV, V65, P106, DOI 10.1176/appi.ps.201300056; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Nash WP, 2015, J ABNORM PSYCHOL, V124, P155, DOI 10.1037/abn0000020; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Orcutt HK, 2004, J TRAUMA STRESS, V17, P195, DOI 10.1023/B:JOTS.0000029262.42865.c2; Osenbach JE, 2014, PSYCHIATRY, V77, P386, DOI 10.1521/psyc.2014.77.4.386; Pietrzak RH, 2014, PSYCHOL MED, V44, P205, DOI 10.1017/S0033291713000597; REGIER DA, 1978, ARCH GEN PSYCHIAT, V35, P685; REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85; Solomon Z, 2012, PSYCHIAT RES, V199, P188, DOI 10.1016/j.psychres.2012.03.035; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P603, DOI 10.1001/archpsyc.62.6.603; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weathers F. W., 1994, PTSD CHECKLIST CIVIL	44	6	6	0	34	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	AUG	2016	29	4					340	348		10.1002/jts.22119			9	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	DW2MW	WOS:000383477500008	27447948				2022-02-06	
J	Dalkin, W; Taetzsch, T; Valdez, G				Dalkin, William; Taetzsch, Thomas; Valdez, Gregorio			The Fibular Nerve Injury Method: A Reliable Assay to Identify and Test Factors That Repair Neuromuscular Junctions	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 114; NNJ; Synapse; Repair; Nerve Injury; Nerve Regeneration; Degeneration; Fibular Nerve; Peroneal Nerve; EDL	WALLERIAN DEGENERATION; MOLECULAR-MECHANISMS; REGENERATION; MUSCLE	The neuromuscular junction (NMJ) undergoes deleterious structural and functional changes as a result of aging, injury and disease. Thus, it is imperative to understand the cellular and molecular changes involved in maintaining and repairing NMJs. For this purpose, we have developed a method to reliably and consistently examine regenerating NMJs in mice. This nerve injury method involves crushing the common fibular nerve as it passes over the lateral head of the gastrocnemius muscle tendon near the knee. Using 70 day old female mice, we demonstrate that motor axons begin to reinnervate previous postsynaptic targets within 7 days post-crush. They completely reoccupy their previous synaptic areas by 12 days. To determine the reliability of this injury method, we compared reinnervation rates between individual 70 day old female mice. We found that the number of reinnervated postsynaptic sites was similar between mice at 7, 9, and 12 days post-crush. To determine if this injury assay can also be used to compare molecular changes in muscles, we examined levels of the gamma-subunit of the muscle nicotinic receptor (gamma-AChR) and the muscle-specific kinase (MuSK). The gamma-AChR subunit and MuSK to are highly upregulated following denervation and return to normal levels following reinnervation of NMJs. We found a close relationship between transcript levels for these genes and innervation status of muscles. We believe that this method will accelerate our understanding of the cellular and molecular changes involved in repairing the NMJ and other synapses.	[Dalkin, William; Taetzsch, Thomas; Valdez, Gregorio] Virginia Tech, Caril Res Inst, Blacksburg, VA 24061 USA; [Dalkin, William; Valdez, Gregorio] Virginia Tech, Caril Sch Med, Blacksburg, VA 24061 USA; [Valdez, Gregorio] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA		Valdez, G (corresponding author), Virginia Tech, Caril Sch Med, Blacksburg, VA 24061 USA.; Valdez, G (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	gvaldez1@vtc.vt.edu					Apel PJ, 2009, J ORTHOP RES, V27, P385, DOI 10.1002/jor.20773; BaliceGordon RJ, 1997, MUSCLE NERVE, pS83; Batt JAE, 2013, JOVE-J VIS EXP, DOI 10.3791/50657; Bowen DC, 1998, DEV BIOL, V199, P309, DOI 10.1006/dbio.1998.8936; Chen PW, 2015, ACTA NEUROPATHOL, V130, P605, DOI 10.1007/s00401-015-1482-4; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Darabid H, 2014, NAT REV NEUROSCI, V15, P703, DOI 10.1038/nrn3821; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Gay S, 2012, MUSCLE NERVE, V45, P698, DOI 10.1002/mus.23242; Geuna S, 2015, J NEUROSCI METH, V243, P39, DOI 10.1016/j.jneumeth.2015.01.021; Kang H, 2013, J NEUROSCI, V33, P19480, DOI 10.1523/JNEUROSCI.4067-13.2013; Kury P, 2001, CURR OPIN NEUROL, V14, P635, DOI 10.1097/00019052-200110000-00013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moloney EB, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00252; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Savastano LE, 2014, J NEUROSCI METH, V227, P166, DOI 10.1016/j.jneumeth.2014.01.020; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640	21	6	6	0	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	AUG	2016		114							e54186	10.3791/54186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH4LM	WOS:000391742700033	27585036	Green Published			2022-02-06	
J	Gilchrist, I; Moglo, K; Storr, M; Pelland, L				Gilchrist, Ian; Moglo, Kodjo; Storr, Michael; Pelland, Lucie			Effects of head flexion posture on the multidirectional static force capacity of the neck	CLINICAL BIOMECHANICS			English	Article						Neck strength; Cervical spine; Dynamometry; Neck injury; Concussions	SEGMENT DYNAMIC STABILIZATION; WHIPLASH-ASSOCIATED DISORDERS; CERVICAL MUSCLE STRENGTH; SPINE; BIOMECHANICS; CONCUSSION; RELIABILITY; ACTIVATION; COLLEGIATE; EXTENSION	Background: Neck muscle force protects vertebral alignment and resists potentially injurious loading of osteoligamentous structures during head impacts. As the majority of neck muscles generate moments about all three planes of motion, it is not clear how the force capacity of the neck might be modulated by direction of force application and head posture. The aim of our study was to measure the multidirectional moment generating capacity of the neck and to evaluate effects of 20 of head flexion, a common head position in contact sports, on the measured capacity. Methods: We conducted a cross-sectional study, with 25 males, 20-30 years old, performing maximum voluntary contractions, with ballistic intent, along eight directions, set at 45 intervals in the horizontal plane of the head. Three-dimensional moments at C-3 and T-1 were calculated using equations of static equilibrium. The variable of interest was the impulse of force generated from 0-50 ms. Effects of direction of force application and head posture, neutral and 20 flexion, were evaluated by two-way analysis of variance and linear regression. Findings: Impulse of force was lower along diagonal planes, at 45 from the mid-sagittal plane, compared to orthogonal planes (P<0.001). Compared to neutral posture, head flexion produced a 55.2% decrease in impulse capacity at C-3 and 45.9% at T-1. Interpretation: The risk of injury with head impact would intrinsically be higher along diagonal planes and with a 20 head down position due to a lower moment generating capacity of the neck in the first 50 ms of force application. (C) 2016 Elsevier Ltd. All rights reserved.	[Gilchrist, Ian; Pelland, Lucie] Queens Univ, Sch Rehabil Therapy, Louise D Acton Bldg,31 George St, Kingston, ON K7L 3N6, Canada; [Gilchrist, Ian; Pelland, Lucie] Queens Univ, Human Mobil Res Ctr, Kingston, ON, Canada; [Moglo, Kodjo] Royal Mil Coll Canada, Kingston, ON, Canada; [Storr, Michael] Kingston Gen Hosp, Dept Pediat, Kingston, ON, Canada		Pelland, L (corresponding author), Queens Univ, Sch Rehabil Therapy, Louise D Acton Bldg,31 George St, Kingston, ON K7L 3N6, Canada.	Lucie.Pelland@queensu.ca		Moglo, Kodjo/0000-0001-7293-0125	Department of National Defence (Canada) - DTAES Human System Integration/Human Factors Section [140403]	This is a collaborative project with the Department of National Defence (Canada) - DTAES Human System Integration/Human Factors Section (140403) which provided partial funding and guidance.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Ackland DC, 2011, J BIOMECH, V44, P475, DOI 10.1016/j.jbiomech.2010.09.036; Almosnino S, 2010, J ATHL TRAINING, V45, P453, DOI 10.4085/1062-6050-45.5.453; Anderst W, 2013, SPINE, V38, pE594, DOI 10.1097/BRS.0b013e31828ca5c7; Auerbach JD, 2009, SPINE, V34, P1006, DOI 10.1097/BRS.0b013e31819f2a03; Bogduk N, 2000, CLIN BIOMECH, V15, P633, DOI 10.1016/S0268-0033(00)00034-6; Borst J, 2011, CLIN BIOMECH, V26, P343, DOI 10.1016/j.clinbiomech.2010.11.019; Burkhart TA, 2011, J BIOMECH, V44, P2728, DOI 10.1016/j.jbiomech.2011.08.011; Chancey VC, 2007, J BIOMECH, V40, P1953, DOI 10.1016/j.jbiomech.2006.09.007; Chiu TTW, 2002, CLIN REHABIL, V16, P772, DOI 10.1191/0269215502cr552oa; Choi H, 2000, MED SCI SPORT EXER, V32, P830, DOI 10.1097/00005768-200004000-00016; Choi H, 2003, MED ENG PHYS, V25, P133, DOI 10.1016/S1350-4533(02)00151-0; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; DESMEDT JE, 1977, J PHYSIOL-LONDON, V264, P673, DOI 10.1113/jphysiol.1977.sp011689; Duchateau J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00234; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Gabriel DA, 2004, CLIN BIOMECH, V19, P653, DOI 10.1016/j.clinbiomech.2004.04.016; Gilchrist I., 2015, J ATHL ENHANC, V4; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; HARMSRINGDAHL K, 1986, ERGONOMICS, V29, P1539, DOI 10.1080/00140138608967267; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; KESHNER EA, 1989, EXP BRAIN RES, V75, P335; Kietrys DM, 1998, PHYS THER, V78, P395, DOI 10.1093/ptj/78.4.395; Kumar S, 2000, ACCIDENT ANAL PREV, V32, P233, DOI 10.1016/S0001-4575(99)00114-1; Lisman P., 2012, INT J SPORTS SCI ENG, V6, P131; Mansell J, 2005, J ATHL TRAINING, V40, P310; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Myran R, 2011, SPINE, V36, pE862, DOI 10.1097/BRS.0b013e3181ff1dde; Novo J.M., 2015, 6 INT C COMP BIOENG; Ono K, 1996, ACCIDENT ANAL PREV, V28, P493, DOI 10.1016/0001-4575(96)00019-X; Pearson I, 2009, J ORTHOP SPORT PHYS, V39, P179, DOI 10.2519/jospt.2009.2950; Rezasoltani A, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.040709; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI26, DOI 10.1136/bjsm.2005.019042; Swartz EE, 2005, J ATHL TRAINING, V40, P155; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tsianos GA, 2013, SCHOLARPEDIA, V8, P12388, DOI DOI 10.4249/SCH0LARPEDIA.12388; Valkeinen H, 2002, EUR J APPL PHYSIOL, V88, P247, DOI 10.1007/s00421-002-0709-y; van der Helm FCT, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P164; VANMAMEREN H, 1992, SPINE, V17, P467, DOI 10.1097/00007632-199205000-00001; Vasavada AN, 2001, SPINE, V26, P1904, DOI 10.1097/00007632-200109010-00018; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; ZANGEMEISTER WH, 1981, BIOL CYBERN, V41, P33, DOI 10.1007/BF01836125; Zepa I, 1998, EUR J ORTHODONT, V20, P694, DOI 10.1093/ejo/20.6.694	50	6	6	1	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	AUG	2016	37						44	52		10.1016/j.clinbiomech.2016.05.016			9	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	DV3CL	WOS:000382798500007	27289496				2022-02-06	
J	Jang, SH; Kim, TH; Kwon, YH; Lee, MY; Do Lee, H				Jang, Sung Ho; Kim, Tae Ho; Kwon, Yong Hyun; Lee, Mi Young; Do Lee, Han			Postural Instability in Patients With Injury of Corticoreticular Pathway Following Mild Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Corticoreticular Pathway; Diffusion Tensor Tractography; Mild Traumatic Brain Injury; Postural Instability	DIFFUSION TENSOR TRACTOGRAPHY; PROXIMAL WEAKNESS; BALANCE DEFICITS; HEAD-INJURY; STABILITY; SWAY; GAIT	Objective: We attempted to investigate postural instability in patients with injury of the corticoreticular pathway (CRP) after mild traumatic brain injury. Methods: The CRP was reconstructed, and the fractional anisotropy value, apparent diffusion coefficient value, and fiber volume of the CRP were measured. For evaluation of postural instability, both the Balance Error Scoring System score and the displacement of center of pressure were measured. Result: Significantly lower tract volume of the CRP was observed in the patient group than in the control group with no significant difference in fractional anisotropy and apparent diffusion coefficient values(P > 0.05). The results of the Balance Error Scoring System shown on a firm and foam surface were significantly higher in the patient group than in the control group (P < 0.05). Significant increments in displacement of center of pressure for 3 stances of double-leg, single-leg, and tandem stances in distance, maximum distance, and path length were observed in the patient group compared with the control group (P < 0.05). By contrast, no significant difference in the double stance on the x axis of the distance was observed between the patient and control groups (P > 0.05). Conclusion: We demonstrated postural instability in patients with injury of the CRP following mild traumatic brain injury.	[Jang, Sung Ho; Do Lee, Han] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Daegu 705717, South Korea; [Kim, Tae Ho] Daegu Univ, Coll Rehabil Sci, Dept Phys Therapy, Gyongsan, South Korea; [Kwon, Yong Hyun] Yeungnam Coll Sci & Technol, Dept Phys Therapy, Daegu, South Korea; [Lee, Mi Young] Daegu Haany Univ, Coll Hlth & Therapy, Dept Phys Therapy, Gyongsan, South Korea		Do Lee, H (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Daegu 705717, South Korea.				Yeungnam University	This work was supported by the 2014 Yeungnam University Research Grant. Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chaudhry H, 2011, J BODYW MOV THER, V15, P82, DOI 10.1016/j.jbmt.2008.03.003; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Dehail P, 2007, J REHABIL MED, V39, P531, DOI 10.2340/16501977-0096; Do KH, 2013, NEUROSCI LETT, V546, P21, DOI 10.1016/j.neulet.2013.04.040; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P325; Jang SH, 2015, J REHABIL MED, V47, P133, DOI 10.2340/16501977-1896; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Lee HD, 2015, BRAIN INJURY, V29, P1219, DOI 10.3109/02699052.2015.1045028; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Lin Chia-Cheng, 2015, J Nat Sci, V1, pe43; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736; NEWTON RA, 1995, BRAIN INJURY, V9, P445, DOI 10.3109/02699059509008204; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Park DS, 2013, JKAIS, V14, P2767; Paternostro-Sluga T, 2008, J REHABIL MED, V40, P665, DOI 10.2340/16501977-0235; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2013, NEUROREHABILITATION, V32, P665, DOI 10.3233/NRE-130889; Yeo SS, 2012, NEUROSCI LETT, V508, P9, DOI 10.1016/j.neulet.2011.11.030	34	6	6	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2016	95	8					580	587		10.1097/PHM.0000000000000446			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DR9NH	WOS:000380222900011	26829086				2022-02-06	
J	Jusue-Torres, I; Burks, SS; Levine, CG; Bhatia, RG; Casiano, R; Bullock, R				Jusue-Torres, Ignacio; Burks, S. Shelby; Levine, Corinna G.; Bhatia, Rita G.; Casiano, Roy; Bullock, Ross			Wooden Foreign Body in the Skull Base: How Did We Miss It?	WORLD NEUROSURGERY			English	Article						Air mimicking; CT; Intraorbital wooden foreign body; MRI; Skull base	COMPUTED-TOMOGRAPHY; BRAIN-ABSCESS; BODIES; CT; AIR; APPEARANCE; INJURIES; INTRA	BACKGROUND: Timely detection of intraorbital and skull base wooden foreign bodies is crucial. Wooden foreign bodies are difficult to detect on imaging. The radiologist may fail to identify wooden foreign bodies on two thirds of initial scans and can miss them in almost one third of total cases. CASE DESCRIPTION: A 66-year-old woman sustained a penetrating injury through the left upper eyelid with a small tree branch. The branch was immediately removed in the field, and she was provided with prompt medical care at a local hospital. Initial computed tomography (CT) scan diagnosis was "post-traumatic sinusitis," and this was treated empirically with vancomycin and piperacillin/tazobactam. On the eighth day after injury, she developed progressive swelling and pain of her eyelid with left trigeminal/supraorbital numbness and complete left ophthalmoplegia. A new CT scan showed an open "track" from the region of the left upper orbit/superior rectus to the contralateral sphenoid sinus, which raised suspicion for a retained foreign body. Further imaging confirmed the suspicion. Endoscopic sinus surgery was performed with extraction of the wooden object and evacuation of the left orbital infection. CONCLUSIONS: This case indicates that intraorbital and skull base wooden foreign bodies are elusive, demanding a high index of suspicion from both clinicians and radiologists to identify retained material in the setting of ocular or sinus trauma. For better identification of wooden foreign bodies, bone windows on CT should have a width of -1000 Hounsfield units with a soft tissue window level of -500 Hounsfield units.	[Jusue-Torres, Ignacio; Burks, S. Shelby; Bullock, Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Neurotrauma, Miami, FL 33136 USA; [Levine, Corinna G.; Casiano, Roy] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Bhatia, Rita G.] Univ Miami, Miller Sch Med, Dept Diagnost Radiol, Div Neuroradiol, Miami, FL 33136 USA		Bullock, R (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Neurotrauma, Miami, FL 33136 USA.	rbullock@med.miami.edu	Jusue-Torres, Ignacio/C-5979-2013	Jusue-Torres, Ignacio/0000-0002-9749-1912			Adesanya OO, 2007, EMERG RADIOL, V14, P45, DOI 10.1007/s10140-007-0576-2; Arifin Muhammad Zafrullah, 2012, Asian J Neurosurg, V7, P131, DOI 10.4103/1793-5482.103716; BERT F, 1995, J CLIN MICROBIOL, V33, P1950, DOI 10.1128/JCM.33.7.1950-1953.1995; Boncoeur-Martel MP, 2001, NEURORADIOLOGY, V43, P165, DOI 10.1007/s002340000458; BURSICK DM, 1981, SURG NEUROL, V16, P427, DOI 10.1016/0090-3019(81)90235-4; DALLEY RW, 1995, AM J ROENTGENOL, V164, P434, DOI 10.2214/ajr.164.2.7839984; Dunn IF, 2009, NEUROSURGERY, V65, P383, DOI 10.1227/01.NEU.0000347474.69080.A1; GLATT HJ, 1990, OPHTHALMIC PLAST REC, V6, P108, DOI 10.1097/00002341-199006000-00005; Hamilton A, 2014, INT OPHTHALMOL, V34, P337, DOI 10.1007/s10792-013-9786-7; HANSEN JE, 1988, J NEUROSURG, V68, P752, DOI 10.3171/jns.1988.68.5.0752; Ho VT, 1996, AM J NEURORADIOL, V17, P134; John SS, 2008, INDIAN J OPHTHALMOL, V56, P322, DOI 10.4103/0301-4738.41416; Liu D, 2010, OPHTHAL PLAST RECONS, V26, P454, DOI 10.1097/IOP.0b013e3181d92903; Loganathan Kamaraj, 2012, J Oral Biol Craniofac Res, V2, P210, DOI 10.1016/j.jobcr.2012.10.011; MUTLUKAN E, 1991, BRIT J OPHTHALMOL, V75, P374, DOI 10.1136/bjo.75.6.374; Nagae LM, 2011, PEDIATR EMERG CARE, V27, P895, DOI 10.1097/PEC.0b013e31822d3df2; Nishio Y, 2004, ACTA NEUROCHIR, V146, P847, DOI 10.1007/s00701-004-0283-7; Peterson JJ, 2002, AM J ROENTGENOL, V178, P557, DOI 10.2214/ajr.178.3.1780557; Prabhu Shailesh M, 2014, Indian J Radiol Imaging, V24, P72, DOI 10.4103/0971-3026.130703; ROBERTS CF, 1992, RADIOLOGY, V185, P507, DOI 10.1148/radiology.185.2.1410363; Sanli AM, 2012, TURK NEUROSURG, V22, P393, DOI 10.5137/1019-5149.JTN.3771-10.0; Shelsta HN, 2010, OPHTHAL PLAST RECONS, V26, P238, DOI 10.1097/IOP.0b013e3181bd7509; SPECHT CS, 1992, SURV OPHTHALMOL, V36, P341, DOI 10.1016/0039-6257(92)90110-F; Tas S, 2014, ULUS TRAVMA ACIL CER, V20, P51, DOI 10.5505/tjtes.2014.93876; Yamashita K, 2007, EMERG RADIOL, V14, P41, DOI 10.1007/s10140-007-0597-x	25	6	8	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2016	92								580.e5	10.1016/j.wneu.2016.06.057			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DX1XI	WOS:000384160300094	27354291				2022-02-06	
J	Key-DeLyria, SE				Key-DeLyria, Sarah E.			Sentence Processing in Traumatic Brain Injury: Evidence From the P600	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							EVENT-RELATED POTENTIALS; CLOSED-HEAD-INJURY; BROCAS APHASIA; IMPAIRMENT; COMPREHENSION; INDEPENDENCE; VIOLATIONS; ANOMALIES; LANGUAGE; FAMILY	Purpose: Sentence processing can be affected following a traumatic brain injury (TBI) due to linguistic or cognitive deficits. Language-related event-related potentials (ERPs), particularly the P600, have not been described in individuals with TBI history. Method: Four young adults with a history of closed head injury participated. Two had severe injuries, and 2 had mild-moderate injuries more than 24 months prior to testing. ERPs were recorded while participants read sentences designed to be grammatically correct or incorrect. Participants also completed cognitive and sentence comprehension measures. Results: One participant with TBI was significantly different than the control group on several behavioral sentence measures and 1 cognitive measure. However, none of the participants with TBI had a reliable P600 effect. Nonparametric bootstrapping indicated that the ERP was reliable in 10 control participants but no participants with TBI history. Conclusions: There were few behavioral differences between individuals with TBI history and the control group, though all reported subjective difficulty with reading. The P600 was absent in the TBI group in this study. Given the heterogeneity of individuals with TBI and the difficulty in assessing subtle language impairments, exploring the P600 further may provide useful insight into language processing difficulties.	[Key-DeLyria, Sarah E.] Portland State Univ, Portland, OR 97207 USA		Key-DeLyria, SE (corresponding author), Portland State Univ, Portland, OR 97207 USA.	keydel@pdx.edu		Key-DeLyria, Sarah/0000-0002-1202-7871			Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BUTLERHINZ S, 1990, J SPEECH HEAR RES, V33, P269, DOI 10.1044/jshr.3302.269; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Crawford JR, 2011, CORTEX, V47, P1166, DOI 10.1016/j.cortex.2011.02.017; Di Nocera F, 2000, BEHAV RES METH INS C, V32, P111, DOI 10.3758/BF03200793; Dobel C, 2001, EXP BRAIN RES, V140, P77, DOI 10.1007/s002210100794; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Frisch S, 2003, CLIN NEUROPHYSIOL, V114, P336, DOI 10.1016/S1388-2457(02)00366-8; Golden CJ, 1978, STROOP COLOR WORD TE; Gunter TC, 2003, J COGNITIVE NEUROSCI, V15, P643, DOI 10.1162/jocn.2003.15.5.643; Hagoort P, 1996, BRAIN, V119, P627, DOI 10.1093/brain/119.2.627; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1531, DOI 10.1016/S0028-3932(00)00053-1; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Hamsher K., 1989, MULTILINGUAL APHASIA; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kertesz A., 1982, W APHASIA BATTERY TE; Krause M, 2014, BRAIN INJURY, V28, P1301, DOI 10.3109/02699052.2014.916416; Kuera H., 1967, COMPUTATIONAL ANAL P; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P350, DOI 10.1097/00001199-200607000-00006; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; McDonald S., 2000, COMMUNICATION DISORD; Nelson H.E., 1982, NATL ADULT READING T; NICHOLAS LE, 1995, J SPEECH HEAR RES, V38, P146, DOI 10.1044/jshr.3801.145; Osterhout L, 1999, LANG COGNITIVE PROC, V14, P1, DOI 10.1080/016909699386356; Osterhout L, 1999, LANG COGNITIVE PROC, V14, P283, DOI 10.1080/016909699386310; Osterhout L, 1996, J COGNITIVE NEUROSCI, V8, P507, DOI 10.1162/jocn.1996.8.6.507; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Schneider W., 2002, E PRIME REFERENCE GU; Shipley WC, 1940, J PSYCHOL, V9, P371, DOI 10.1080/00223980.1940.9917704; Speilberger C, 1983, MANUAL STATE TRAIT A; Swaab T, 1997, J COGNITIVE NEUROSCI, V9, P39, DOI 10.1162/jocn.1997.9.1.39; Viggiano MP, 1996, J CLIN EXP NEUROPSYC, V18, P631, DOI 10.1080/01688639608408288; Wassenaar M, 2004, J COGNITIVE NEUROSCI, V16, P553, DOI 10.1162/089892904323057290; Wassenaar M, 2007, NEUROPSYCHOLOGIA, V45, P716, DOI 10.1016/j.neuropsychologia.2006.08.016; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wiig E. H., 1989, TLC EXPANDED TEST LA	43	6	6	0	7	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	AUG	2016	59	4					759	771		10.1044/2016_JSLHR-L-15-0104			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	EA7BR	WOS:000386783600012	27387526				2022-02-06	
J	Lawson, BD; Kass, SJ; Dhillon, MKK; Milam, LS; Cho, TH; Rupert, AH				Lawson, Ben D.; Kass, Steven J.; Dhillon, Maj Kieran K.; Milam, Lana S.; Cho, Timothy H.; Rupert, Angus H.			Military Occupations Most Affected by Head/Sensory Injuries and the Potential Job Impact of Those Injuries	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; SOLDIERS; RETURN	Objective: Identifying Department of Defense (DoD) occupations affected by injuries to the head and sensory systems. Methods: We explored the Defense Medical Epidemiology Database to identify occupations with the highest incidence of injured personnel, then ranked how frequently they occurred in a top 10 list for each of four injury categories (head/brain, visual, auditory, vestibular) encompassing 25 injury codes. Across all four categories, the most affected occupations were identified, among which we chose three Army combat-related military occupational specialties (MOSs) for detailed study. We identified skills needed to perform these MOSs and explored whether MOS-critical deficits could be expected following the injuries. Results: Some DoD occupations are more likely to suffer from these injuries, including Infantry, Combat Operations Control, Artillery/Gunnery, Motor Vehicle Operator, Combat Engineering, and Armor/Amphibious. Within these DoD occupations, we explored three Army combatant MOSs: Infantry (11B), Cavalry Scout (19D), and Artillery (13B), confirming that these jobs are likely to be disrupted by injuries within the four categories. Conclusions: Head and sensory injuries disproportionately affect certain military occupations. Relatively few injuries disrupt combat-related abilities that are job critical (e.g., firearms operation) and job specific (e.g., Artillery gunnery problems); these should be the focus of efforts to improve rehabilitation and RTD outcomes.	[Lawson, Ben D.; Milam, Lana S.; Cho, Timothy H.; Rupert, Angus H.] US Army, Aeromed Res Lab, Bldg 6901, Ft Rucker, AL 36362 USA; [Kass, Steven J.; Dhillon, Maj Kieran K.] Univ West Florida, Dept Psychol, Bldg 41, Pensacola, FL 32514 USA		Lawson, BD (corresponding author), US Army, Aeromed Res Lab, Bldg 6901, Ft Rucker, AL 36362 USA.			Lawson, Ben/0000-0003-1405-8951	United States Army Medical Research and Materiel Command (USAMRMC), Fort Detrick, MD [12820]	The funding sponsor was the United States Army Medical Research and Materiel Command (USAMRMC), Fort Detrick, MD, under Project 12820, Injury Prevention and Reduction Program Area (Return-to-Duty Task P).	[Anonymous], 2013, US TODAY; [Anonymous], 2008, MED SERV STAND MED F; Balaban C, MILD TBI VESTIBULAR; BLOOD CC, 1995, MIL MED, V160, P258, DOI 10.1093/milmed/160.5.258; Carter R, 2005, MED SCI SPORT EXER, V37, P1338, DOI 10.1249/01.mss.0000174895.19639.ed; Defense Centers of Excellence for Psychological Health and TBI, 2010, DEP DEF ICD IN PRESS; DeGroot DW, 2003, AVIAT SPACE ENVIR MD, V74, P564; Department of Defense, 2010, JOINT IMPR EXPL DEV; Department of the Army, 2004, PUBL STP; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Eibner C., 2008, INVISIBLE WOUNDS WAR, P169, DOI 10.7249/mg720ccf; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gubata ME, 2013, MIL MED, V178, P708, DOI 10.7205/MILMED-D-12-00542; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hollander I. E., 2008, USARIEMTRT0806 SOC S; Lawson B.D., 2010, PEER REV P INT C HUM, P367; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; McNamee S, 2009, J REHABIL RES DEV, V46, P893, DOI 10.1682/JRRD.2008.08.0106; National Center for Injury Prevention and Control, 2003, REP C MILD TBI US ST; Radomski MV, 2013, MIL MED, V178, P246, DOI 10.7205/MILMED-D-12-00144; Safety Occupational, 2002, JOB HAZ AN; Whitecar PS, 2010, ICD 9 CODES FAMILY M	24	6	6	0	3	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2016	181	8					887	894		10.7205/MILMED-D-15-00184			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5MI	WOS:000383688900036	27483529	Bronze			2022-02-06	
J	Liou, DZ; Ko, A; Volod, O; Barmparas, G; Harada, MY; Martin, MJ; Salim, A; Dhillon, N; Thomsen, GM; Ley, EJ				Liou, Douglas Z.; Ko, Ara; Volod, Oksana; Barmparas, Galinos; Harada, Megan Y.; Martin, Matthew J.; Salim, Ali; Dhillon, Navpreet; Thomsen, Gretchen M.; Ley, Eric J.			Thromboelastography After Murine TBI and Implications of Beta-Adrenergic Receptor Knockout	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Thromboelastography; Coagulopathy; Beta-adrenergic receptor	TRAUMATIC BRAIN-INJURY; ADMISSION RAPID THROMBELASTOGRAPHY; ACUTE COAGULOPATHY; INFLAMMATORY RESPONSE; PLATELET DYSFUNCTION; COAGULATION TESTS; CLOT FORMATION; BLOCKERS; MORTALITY; BLOCKADE	The source of coagulopathy in traumatic brain injury (TBI) is multifactorial and may include adrenergic stimulation. The aim of this study was to assess coagulopathy after TBI using thromboelastography (TEG), and to investigate the implications of beta-adrenergic receptor knockout. Adult male wild type c57/bl6 (WT) and beta(1)/beta(2)-adrenergic receptor knockout (BKO) mice were assigned to either TBI (WT-TBI, BKO-TBI) or sham injury (WT-sham, BKO-sham). Mice assigned to TBI were subject to controlled cortical impact (CCI). At 24 h post-injury, whole blood samples were obtained and taken immediately for TEG. At 24 h after injury, a trend toward increased fibrinolysis was seen in WT-TBI compared to WT-sham although this did not reach significance (EPL 8.1 vs. 0 %, p = 0.18). No differences were noted in fibrinolysis in BKO-TBI compared to BKO-sham (LY30 2.6 vs. 2.5 %, p = 0.61; EPL 3.4 vs. 2.9 %, p = 0.61). In addition BKO-TBI demonstrated increased clot strength compared to BKO-sham (MA 76.6 vs. 68.6, p = 0.03; G 18.2 vs. 11.3, p = 0.03). In a mouse TBI model, WT mice sustaining TBI demonstrated a trend toward increased fibrinolysis at 24 h after injury while BKO mice did not. These findings suggest beta-blockade may attenuate the coagulopathy of TBI and minimize progression of intracranial hemorrhage by reducing fibrinolysis and increasing clot strength.	[Liou, Douglas Z.; Ko, Ara; Barmparas, Galinos; Harada, Megan Y.; Dhillon, Navpreet; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA; [Volod, Oksana] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Thomsen, Gretchen M.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA; [Martin, Matthew J.] Madigan Army Med Ctr, Dept Surg, Tacoma, WA 98431 USA; [Salim, Ali] Brigham & Womens Hosp, Dept Surg, Div Trauma Burn & Surg Crit Care, 75 Francis St, Boston, MA 02115 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	megan.harada@cshs.org; Eric.Ley@cshs.org	Barmparas, Galinos/L-6530-2019; Martin, Matthew/B-2676-2014; Volod, Oksana/AAE-8453-2021	Martin, Matthew/0000-0002-9169-9069; 			Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Cotton BA, 2012, J TRAUMA ACUTE CARE, V73, P365, DOI 10.1097/TA.0b013e31825c1234; Cotton BA, 2012, J TRAUMA ACUTE CARE, V72, P1470, DOI 10.1097/TA.0b013e31824d56ad; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Enderson BL, 2007, J TRAUMA, V62, P33; Friese RS, 2008, J TRAUMA, V64, P1061, DOI 10.1097/TA.0b013e3181684cf0; Garlichs CD, 1999, EUR J CLIN INVEST, V29, P12; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Harr JN, 2011, J SURG RES, V170, P319, DOI 10.1016/j.jss.2011.03.047; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; HJEMDAHL P, 1991, CIRCULATION, V84, P44; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Ives C, 2012, J AM COLL SURGEONS, V215, P496, DOI 10.1016/j.jamcollsurg.2012.06.005; Jankun J, 2010, BJU INT, V105, P1469, DOI 10.1111/j.1464-410X.2009.08962.x; Johansson PI, 2010, MED HYPOTHESES, V75, P564, DOI 10.1016/j.mehy.2010.07.031; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Johansson PI, 2012, J TRAUMA ACUTE CARE, V72, P428, DOI 10.1097/TA.0b013e31821e0f93; Kashuk JL, 2012, TRANSFUSION, V52, P23, DOI 10.1111/j.1537-2995.2011.03264.x; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kashuk JL, 2010, ANN SURG, V251, P604, DOI 10.1097/SLA.0b013e3181d3599c; Kashuk JL, 2009, SURGERY, V146, P764, DOI 10.1016/j.surg.2009.06.054; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Knight CJ, 1997, CIRCULATION, V95, P125, DOI 10.1161/01.CIR.95.1.125; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Martini WZ, 2008, J TRAUMA, V65, P535, DOI 10.1097/TA.0b013e31818379a6; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Ostrowski SR, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-64; Park MS, 2009, J TRAUMA, V67, P266, DOI 10.1097/TA.0b013e3181ae6f1c; Pierce A, 2014, CURR OPIN ANESTHESIO, V27, P246, DOI 10.1097/ACO.0000000000000047; Plotkin AJ, 2008, J TRAUMA, V64, pS64, DOI 10.1097/TA.0b013e318160772d; Schreiber M, 2009, J TRAUMA, V67, P275; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Schwencke C, 2005, J CARDIOVASC PHARM, V45, P253, DOI 10.1097/01.fjc.0000154372.03531.e1; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tran TY, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E8; Wohlauer MV, 2011, SHOCK, V36, P524, DOI 10.1097/SHK.0b013e31822dc518	44	6	6	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2016	25	1					145	152		10.1007/s12028-015-0223-9			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DR8LZ	WOS:000380150700020	26666545				2022-02-06	
J	Liu, X; Huang, YW; Zhang, YY; Li, XH; Liu, C; Huang, S; Xu, DZ; Wu, Y; Liu, XJ				Liu, Xia; Huang, Yuwei; Zhang, Yuanyuan; Li, Xiaohong; Liu, Chun; Huang, Shen; Xu, Dezhi; Wu, Yang; Liu, Xiaojuan			T-cell factor (TCF/LEF1) binding elements (TBEs) of FasL (Fas ligand or CD95 ligand) bind and cluster Fas (CD95) and form complexes with the TCF-4 and b-catenin transcription factors in vitro and in vivo which result in triggering cell death and/or cell activation	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Rat; T-cell factor 4 (TCF4); Apoptosis; Proliferation; Cell cycle protein	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; CYCLIN D1; NEURONAL DEATH; BETA-CATENIN; C-MYC; PROLIFERATION; REGULATORS; INDUCTION; MICROGLIA	T-cell factor 4 (TCF4) is an important transcription factor of the Wnt signaling system. beta-catenin, an upstream protein of TCF4, accumulates in the cytoplasm, then translocates to the nucleus to activate the beta-catenin/T-cell factor/lymphoid enhancer factor (TCF/LEF) transcriptional machinery and regulates target genes. Previous studies showed that TCF4 was involved in cell proliferation and apoptosis. However, its expression and function in central nervous system injury are unclear. We performed a traumatic brain injury (TBI) model in adult rats. The expression of TCF4 in the brain cortex detected by Western blot increased after TBI. Double immunofluorescence staining revealed that TCF4 was expressed by neurons and microglia. In addition, co-localization of TCF4 with active caspase-3 or proliferating cell nuclear antigen was observed in neurons and microglia, respectively, suggesting that TCF4 might participate in neuronal apoptosis and microglial proliferation after TBI. To further investigate the functions of TCF4, PC12 and HAPI cells were employed to establish a neuronal apoptosis and microglial proliferation model in vitro, respectively. Knocking down TCF4 with siRNA proved the pro-apoptotic and pro-proliferation effect of TCF4 in PC12 and HAPI cells, respectively. Taken together, TCF4 might promote neuronal apoptosis and microglial proliferation after TBI.	[Liu, Xia] Nantong Univ, Coll Med, Dept Pathophysiol, Nantong 226001, Jiangsu, Peoples R China; [Huang, Yuwei; Wu, Yang] Nantong Univ, Inst Naut Med, Nantong 226001, Jiangsu, Peoples R China; [Zhang, Yuanyuan] Nantong Univ, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China; [Li, Xiaohong] Nantong Univ, Affiliated Hosp, Surg Comprehens Lab, Nantong 226001, Jiangsu, Peoples R China; [Liu, Chun] Nantong Univ, Lab Anim Ctr, Nantong 226001, Jiangsu, Peoples R China; [Huang, Shen] Nantong Univ, Affiliated Hosp 2, Dept Osteol, Nantong 226001, Jiangsu, Peoples R China; [Xu, Dezhi] Nanjing Med Univ, Wuxi Hosp 2, Dept Neurosurg, Wuxi 214002, Jiangsu, Peoples R China; [Liu, Chun; Liu, Xiaojuan] Nantong Univ, Coll Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China; [Liu, Xia; Huang, Yuwei; Li, Xiaohong; Huang, Shen; Xu, Dezhi; Liu, Xiaojuan] Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Jiangsu, Peoples R China		Wu, Y (corresponding author), Nantong Univ, Inst Naut Med, Nantong 226001, Jiangsu, Peoples R China.; Liu, XJ (corresponding author), Nantong Univ, Coll Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China.; Liu, XJ (corresponding author), Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Jiangsu, Peoples R China.	wy@ntu.edu.cn; ntlxj0305@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401365, 81373223, 81200918, 81172879, 30770666, 30973143, 31201083]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported in part by the National Natural Science Foundation of China (nos. 81401365, 81373223, 81200918, 81172879, 30770666, 30973143, 31201083), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Antony L, 2014, PROSTATE, V74, P1118, DOI 10.1002/pros.22828; Archbold HC, 2012, ACTA PHYSIOL, V204, P74, DOI 10.1111/j.1748-1716.2011.02293.x; Bera A, 2013, CELL SIGNAL, V25, P2575, DOI 10.1016/j.cellsig.2013.08.005; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Cai FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113727; Camac KS, 2007, DIGEST DIS SCI, V52, P1242, DOI 10.1007/s10620-006-9200-7; Dai ZM, 2014, J NEUROSCI, V34, P8467, DOI 10.1523/JNEUROSCI.0311-14.2014; Fanti M, 2014, HEPATOLOGY, V59, P2309, DOI 10.1002/hep.26775; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Geng YT, 2014, J BIOL CHEM, V289, P11230, DOI 10.1074/jbc.M113.544999; Grossman R, 2012, FUTUR NEUROL, V7, P329, DOI 10.2217/FNL.12.25; Gu XF, 2014, NEURO-ONCOLOGY, V16, P217, DOI 10.1093/neuonc/not194; Guo Y, 2012, STROKE, V43, P1240, DOI 10.1161/STROKEAHA.111.647263; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Irmady K, 2014, J NEUROSCI, V34, P3419, DOI 10.1523/JNEUROSCI.1982-13.2014; Koch JC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.191; Komuta Y, 2010, CELL MOL NEUROBIOL, V30, P101, DOI 10.1007/s10571-009-9435-x; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lazarus RC, 2015, FREE RADICAL BIO MED, V78, P89, DOI 10.1016/j.freeradbiomed.2014.10.507; Lee HP, 2011, NEUROSCI LETT, V505, P124, DOI 10.1016/j.neulet.2011.10.004; Lien WH, 2014, NAT CELL BIOL, V16, P179, DOI 10.1038/ncb2903; Loncarevic-Vasiljkovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037215; Ma B, 2013, J BIOL CHEM, V288, P17552, DOI 10.1074/jbc.M113.453985; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Nobs L, 2013, GLIA, V61, P1443, DOI 10.1002/glia.22533; Park DS, 2000, NEUROBIOL AGING, V21, P771, DOI 10.1016/S0197-4580(00)00220-7; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; Saegusa M, 2010, J PATHOL, V222, P410, DOI 10.1002/path.2773; Schmidt-Edelkraut U, 2014, MOL CELL BIOL, V34, P1020, DOI 10.1128/MCB.01195-13; Schreiber S, 2012, J CEREBR BLOOD F MET, V32, P278, DOI 10.1038/jcbfm.2011.122; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shin HW, 2014, GASTROENTEROLOGY, V147, P430, DOI 10.1053/j.gastro.2014.04.047; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Takayama S, 2006, J BIOL CHEM, V281, P17856, DOI 10.1074/jbc.M602290200; Turtzo LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126551; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026143; Yoo JH, 2010, FOOD CHEM TOXICOL, V48, P2247, DOI 10.1016/j.fct.2010.05.056; Zhang HY, 2014, CARCINOGENESIS, V35, P1863, DOI 10.1093/carcin/bgu113	45	6	6	2	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	AUG	2016	36	6					1001	1013		10.1007/s10571-015-0290-7			13	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DP8UI	WOS:000378773000017	27090258				2022-02-06	
J	Nentwich, LM; Grimmnitz, B				Nentwich, Lauren M.; Grimmnitz, Benjamin			Neurologic Emergencies in the Elderly	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Neurologic diseases; Geriatric patients; Neurologic emergencies	CHRONIC SUBDURAL-HEMATOMA; TRANSIENT ISCHEMIC ATTACK; MIDDLE-CEREBRAL-ARTERY; HEALTH-CARE PROFESSIONALS; TRAUMATIC BRAIN-INJURY; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; ACQUIRED BACTERIAL-MENINGITIS; REFRACTORY STATUS EPILEPTICUS; ASSOCIATION-STROKE-COUNCIL; BLOOD-PRESSURE REDUCTION	Neurologic diseases are a major cause of death and disability in elderly patients. Due to the physiologic changes and increased comorbidities that occur as people age, neurologic diseases are more common in geriatric patients and a major cause of death and disability in this population. This article discusses the elderly patient presenting to the emergency department with acute ischemic stroke, transient ischemic attack, intracerebral hemorrhage, subarachnoid hemorrhage, chronic subdural hematoma, traumatic brain injury, seizures, and central nervous system infections. This article reviews the subtle presentations, difficult workups, and complicated treatment decisions as they pertain to our older patients."	[Nentwich, Lauren M.; Grimmnitz, Benjamin] Boston Med Ctr, Dept Emergency Med, Dowling 1 South,1 Boston Med Ctr Pl, Boston, MA 02143 USA		Nentwich, LM (corresponding author), Boston Med Ctr, Dept Emergency Med, Dowling 1 South,1 Boston Med Ctr Pl, Boston, MA 02143 USA.	lauren.nentwich@bmc.org					Abo-Salem E, 2016, CURR OPIN PHARMACOL, V27, P86, DOI 10.1016/j.coph.2016.02.008; Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Brodie MJ, 2009, LANCET NEUROL, V8, P1019, DOI 10.1016/S1474-4422(09)70240-6; Brodie MJ, 2005, BMJ-BRIT MED J, V331, P1317, DOI 10.1136/bmj.331.7528.1317; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cabellos C, 2009, MEDICINE, V88, P115, DOI 10.1097/MD.0b013e31819d50ef; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2016, STROKE, V47, P798, DOI 10.1161/STROKEAHA.115.012360; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cruz-Flores S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003435.pub2; Darouiche RO, 2006, NEW ENGL J MED, V355, P2012, DOI 10.1056/NEJMra055111; de Assis TMR, 2012, NEUROL INT, V4, P78, DOI 10.4081/ni.2012.e17; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Domingo P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-108; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; Faught E, 2012, NEUROLOGY, V78, P448, DOI 10.1212/WNL.0b013e3182477edc; Ferlazzo E, 2016, PHARMACOL RES, V106, P21, DOI 10.1016/j.phrs.2016.02.013; Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Hauser WA, 2008, EPILEPSIA, V49, P8, DOI 10.1111/j.1528-1167.2008.01443.x; HAUSER WA, 1992, EPILEPSIA, V33, pS6; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hemphill JC, 2005, NEUROLOGY, V65, P1690, DOI 10.1212/01.wnl.0000192631.39824.93; Hofinger D, 2013, CURR TREAT OPTION NE, V15, P477, DOI 10.1007/s11940-013-0244-7; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; Howard G, 2012, ANN NY ACAD SCI, V1268, P14, DOI 10.1111/j.1749-6632.2012.06665.x; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Johnston SC, 2006, ANN NEUROL, V60, P301, DOI 10.1002/ana.20942; Johnston SC, 2011, ANN NEUROL, V69, P872, DOI 10.1002/ana.22332; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kleindorfer D, 2005, STROKE, V36, P720, DOI 10.1161/01.STR.0000158917.59233.b7; Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163; Kothari R, 1997, STROKE, V28, P1871, DOI 10.1161/01.STR.28.10.1871; Kulchycki LK, 2006, EMERG MED CLIN N AM, V24, P273, DOI 10.1016/j.emc.2006.01.013; Lai WA, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-91; Lee CC, 2013, AM J EMERG MED, V31, P282, DOI 10.1016/j.ajem.2012.07.024; Longstreth WT, 2010, AM J EMERG MED, V28, P359, DOI 10.1016/j.ajem.2009.01.025; Lowenstein DH, 2006, EPILEPSIA, V47, P35, DOI 10.1111/j.1528-1167.2006.00658.x; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; Mishra NK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6046; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Muangpaisan W, 2008, AGE AGEING, V37, P473, DOI 10.1093/ageing/afn096; Nentwich LM, 2013, VASCULAR EMERGENCIES: EXPERT MANAGEMENT FOR THE EMERGENCY PHYSICIAN, P18; Nentwich LM, 2012, EMERG MED CLIN N AM, V30, P659, DOI 10.1016/j.emc.2012.06.005; Nentwich LM, 2014, GERIATRIC EMERGENCY, P170; Pare JR, 2012, EMERG MED CLIN N AM, V30, P601, DOI 10.1016/j.emc.2012.05.004; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Pope JV, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/949275; POTTER JF, 1977, GERIATRICS, V32, P61; Poza Juan Jose, 2007, Neuropsychiatr Dis Treat, V3, P723; Pundik Svetlna, 2008, J Stroke Cerebrovasc Dis, V17, P266, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.003; Qureshi AI, 2010, ARCH NEUROL-CHICAGO, V67, P570, DOI 10.1001/archneurol.2010.61; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Ramsay RE, 2004, NEUROLOGY, V62, pS24, DOI 10.1212/WNL.62.5_suppl_2.S24; Rerkasem K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001081.pub2; Rossetti AO, 2011, LANCET NEUROL, V10, P922, DOI 10.1016/S1474-4422(11)70187-9; Rothwell PM, 2005, NEUROLOGY, V64, P817, DOI 10.1212/01.WNL.0000152985.32732.EE; Runchey S, 2010, JAMA-J AM MED ASSOC, V303, P2280, DOI 10.1001/jama.2010.754; Russo Tommasina, 2011, J Aging Res, V2011, P108785, DOI 10.4061/2011/108785; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Sedat J, 2005, NEUROCRIT CARE, V2, P119, DOI 10.1385/NCC:2:2:119; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; Siket MS, 2012, EMERG MED CLIN N AM, V30, P745, DOI 10.1016/j.emc.2012.05.001; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Stephen LJ, 2000, LANCET, V355, P1441, DOI 10.1016/S0140-6736(00)02149-8; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Sylaja PN, 2006, J NEUROL NEUROSUR PS, V77, P826, DOI 10.1136/jnnp.2005.086595; Thigpen MC, 2011, NEW ENGL J MED, V364, P2016, DOI 10.1056/NEJMoa1005384; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tompkins M, 2010, J EMERG MED, V39, P384, DOI 10.1016/j.jemermed.2009.11.001; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Verellen RM, 2011, AGING DIS, V2, P278; Wang AY, 2014, J AM GERIATR SOC, V62, P2064, DOI 10.1111/jgs.13110; Weigele JB, 2008, RADIOL CLIN N AM, V46, P819, DOI 10.1016/j.rcl.2008.04.006; Weisfelt M, 2006, J AM GERIATR SOC, V54, P1500, DOI 10.1111/j.1532-5415.2006.00878.x; Woodford HJ, 2015, POSTGRAD MED J, V91, P655, DOI 10.1136/postgradmedj-2015-133537; Wu CM, 2007, ARCH INTERN MED, V167, P2417, DOI 10.1001/archinte.167.22.2417; Yates S, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-014-0504-2; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72; Zweckberger K, 2014, CEREBROVASC DIS, V38, P313, DOI 10.1159/000365864	107	6	8	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	AUG	2016	34	3					575	+		10.1016/j.emc.2016.04.009			26	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DU3HF	WOS:000382100700011	27475016				2022-02-06	
J	Shiloh, S; Heruti, I; Leichtentritt, R				Shiloh, Shoshana; Heruti, Irit; Leichtentritt, Ronit			A common-sense model of injury perceptions	JOURNAL OF HEALTH PSYCHOLOGY			English	Article						beliefs; disability; health psychology; model; phenomenology; qualitative methods	POSTTRAUMATIC-STRESS-DISORDER; SPINAL-CORD-INJURY; TRAUMATIC INJURY; ILLNESS REPRESENTATIONS; SELF-REGULATION; SPORT INJURY; BRAIN-INJURY; HEALTH; DISABILITIES; RESILIENCE	The aim of this study was to clarify the difference between perceptions of injury and illness. A qualitative study using semi-structured interviews was conducted with 38 individuals who had been injured in the past, 8 medical psychologists, 62 graduate psychology students, and 19 health professionals treating injured patients. Data were analyzed by modified analytic induction and constant comparison methods. Common-sense perceptions of injury overlapped with some perceptions of illness, and 4 new themes were elicited. It was concluded that there are themes unique to injury perceptions that should be recognized in research as well as in clinical interventions.	[Shiloh, Shoshana; Heruti, Irit; Leichtentritt, Ronit] Tel Aviv Univ, Tel Aviv, Israel; [Heruti, Irit] Tel Aviv Yaffo Acad Coll, Tel Aviv, Israel		Shiloh, S (corresponding author), Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel.	shoshi@freud.tau.ac.il					Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Brewin CR, 2002, J PSYCHOPHARMACOL, V16, pA5; Bryant RA, 2011, DEPRESS ANXIETY, V28, P99, DOI 10.1002/da.20786; Carleton RN, 2006, DEPRESS ANXIETY, V23, P340, DOI 10.1002/da.20138; Chaboyer W, 2010, J ADV NURS, V66, P2743, DOI 10.1111/j.1365-2648.2010.05431.x; de Almeida IM, 2000, INT J HEALTH SERV, V30, P71, DOI 10.2190/WDP4-2KGW-H4ER-QV6A; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Dickson A, 2008, PSYCHOL HEALTH, V23, P407, DOI 10.1080/14768320701219136; Doering BK, 2011, NEUROPSYCHOL REHABIL, V21, P42, DOI 10.1080/09602011.2010.525947; Fauerbach JA, 2002, HEALTH PSYCHOL, V21, P115, DOI 10.1037//0278-6133.21.2.115; Faugier J, 1997, J ADV NURS, V26, P790, DOI 10.1046/j.1365-2648.1997.00371.x; Gil S, 2006, CNS SPECTRUMS, V11, P603, DOI 10.1017/S1092852900013651; Haden SC, 2007, PERS INDIV DIFFER, V42, P1187, DOI 10.1016/j.paid.2006.09.030; Hagger MS, 2005, J APPL SOC PSYCHOL, V35, P2345, DOI 10.1111/j.1559-1816.2005.tb02106.x; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Henderson CJ, 2009, HEALTH PSYCHOL, V28, P101, DOI 10.1037/a0013690; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hurley DT, 2012, HISPANIC J BEHAV SCI, V34, P474, DOI 10.1177/0739986312448316; Johnston M, 2001, SOC SCI MED, V53, P1261, DOI 10.1016/S0277-9536(00)00384-1; Jones JM, 2012, BRIT J HEALTH PSYCH, V17, P798, DOI 10.1111/j.2044-8287.2012.02074.x; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Leventhal H, 1999, J Natl Cancer Inst Monogr, P81; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; LEVENTHAL H, 1985, MED CARE, V23, P556, DOI 10.1097/00005650-198505000-00015; Littleton HL, 2007, J APPL SOC PSYCHOL, V37, P515, DOI 10.1111/j.1559-1816.2007.00172.x; Livneh H, 2001, REHABIL COUNS BULL, V44, P151, DOI 10.1177/003435520104400305; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P899, DOI 10.1080/09602011.2010.517688; Milligan MS, 2001, SEX DISABIL, V19, P91, DOI 10.1023/A:1010621705591; Molloy GJ, 2009, PSYCHOL HEALTH, V24, P271, DOI 10.1080/08870440701684548; Patton M.Q., 1990, QUALITATIVE EVALUATI; Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007; Practice Management Information Corporation (PMIC), 1997, INT CLASS DIS; Robinson EM, 2006, TOP STROKE REHABIL, V13, P54, DOI 10.1310/tsr1304-54; Robinson WS, 1951, AM SOCIOL REV, V16, P812, DOI 10.2307/2087508; Sherr L, 2011, PSYCHOL HEALTH MED, V16, P612, DOI 10.1080/13548506.2011.579991; Shiloh S, 2011, INT J REHABIL RES, V34, P321, DOI 10.1097/MRR.0b013e32834d2048; Sleet DA, 2012, J SAFETY RES, V43, P233, DOI 10.1016/j.jsr.2012.09.002; Smith J.A., 2008, QUALITATIVE PSYCHOL, V2nd; SMITH RB, 1982, HDB SOCIAL SCI METHO; Wadey R, 2012, BRIT J HEALTH PSYCH, V17, P103, DOI 10.1111/j.2044-8287.2011.02025.x; Wadey R, 2011, J APPL SPORT PSYCHOL, V23, P142, DOI 10.1080/10413200.2010.543119; WALLER JA, 1987, ACCIDENT ANAL PREV, V19, P13, DOI 10.1016/0001-4575(87)90013-3; Wong EC, 2011, PSYCHOL TRAUMA-US, V3, P67, DOI 10.1037/a0020587; World Health Organization, 2008, GLOBAL BURDEN DIS; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	45	6	7	1	22	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1359-1053	1461-7277		J HEALTH PSYCHOL	J. Health Psychol.	AUG	2016	21	8					1516	1526		10.1177/1359105314557876			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DS7UL	WOS:000380988300002	25432457				2022-02-06	
J	Sinha, S; Raheja, A; Samson, N; Bhoi, S; Selvi, A; Sharma, P; Sharma, BS				Sinha, Sumit; Raheja, Amol; Samson, Neha; Bhoi, Sanjeev; Selvi, Arul; Sharma, Pushpa; Sharma, Bhawani Shankar			Blood mitochondrial enzymatic assay as a predictor of long-term outcome in severe traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Blood mitochondrial enzymes; Complex I; Complex IV; Predictors of outcome; Pyruvate dehydrogenase complex; Severe traumatic brain injury	PYRUVATE-DEHYDROGENASE; CELL-DEATH; CEREBRAL-CORTEX; DYSFUNCTION; EXPRESSION; RATS	Recent studies have observed the central role of mitochondrial dysfunction in severe traumatic brain injury (sTBI). One hundred and seven sTBI patients (18-65 years old, presenting within 8 hours of injury) were randomised for a placebo controlled phase II trial of progesterone with or without hypothermia. We serially analysed blood mitochondrial enzymes (Complex I [C1], Complex IV [C4] and pyruvate dehydrogenase complex [PDH]) using a dipstick assay at admission and 7 days later for 37 patients, irrespective of assigned group. Favorable Glasgow Outcome Scale (GOS) at 1 year was associated with admission Cl levels above 0.19 mu g, admission C4 levels above 0.19 mu g and day 7 C1 levels above 0.17 mu g, all per 25 mu l of blood. Unfavorable GOS at 1 year was associated with admission serum PDH levels above 0.23 mu g/25 mu l of blood. Survivors at 1 year had significantly higher admission serum C1 levels above 0.19 mu g/25 mu l and day 7 C1 levels above 0.17 mu g/25 mu l. To our knowledge this is the first clinical trial associating blood mitochondrial enzymes with long-term outcome in sTBI. Serial monitoring and optimisation of blood C1, C4 and PDH levels could aid in prognostication and potentially guide in using mitochondrial targeted therapies. Blood mitochondrial enzymatic assay might suggest global reduction-oxidation status. (C) 2016 Elsevier Ltd. All rights reserved.	[Sinha, Sumit; Raheja, Amol; Samson, Neha; Sharma, Bhawani Shankar] All India Inst Med Sci, Dept Neurosurg, Room 715, New Delhi 110029, India; [Bhoi, Sanjeev] All India Inst Med Sci, Dept Emergency Med, New Delhi, India; [Selvi, Arul] All India Inst Med Sci, Dept Lab Med, New Delhi, India; [Sharma, Pushpa] Uniformed Serv Univ Hlth Sci, Dept Anesthesiol, Bethesda, MD 20814 USA		Sinha, S (corresponding author), All India Inst Med Sci, Dept Neurosurg, Room 715, New Delhi 110029, India.	sumitneuro@gmail.com	Sharma, Pushpa/AAY-8756-2020		Department of Biotechnology, Ministry of Science and Technology, India	National Trial registry number CTRI/2009/091/000893. Funded by Department of Biotechnology, Ministry of Science and Technology, India.	Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; BOGAERT YE, 1994, FREE RADICAL BIO MED, V16, P811, DOI 10.1016/0891-5849(94)90197-X; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; Kilbaugh TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130927; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tabatabaie T, 1996, ARCH BIOCHEM BIOPHYS, V336, P290, DOI 10.1006/abbi.1996.0560; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Xing GQ, 2012, NEUROSCI LETT, V525, P140, DOI 10.1016/j.neulet.2012.07.055; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Zhu KJ, 2014, WORLD J GASTROENTERO, V20, P9585, DOI 10.3748/wjg.v20.i28.9585	20	6	6	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	AUG	2016	30						31	38		10.1016/j.jocn.2015.10.051			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DR4QY	WOS:000379888500005	27262871				2022-02-06	
J	Zhu, F; Kalra, A; Saif, T; Yang, ZH; Yang, KH; King, AI				Zhu, Feng; Kalra, Anil; Saif, Tal; Yang, Zaihan; Yang, King H.; King, Albert I.			Parametric analysis of the biomechanical response of head subjected to the primary blast loading - a data mining approach	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						decision tree; Primary blast induced TBI; finite element analysis; data mining; DOCE	PRESSURE; EXPOSURE; INJURY; MODEL; WAVE	Traumatic brain injury due to primary blast loading has become a signature injury in recent military conflicts and terrorist activities. Extensive experimental and computational investigations have been conducted to study the interrelationships between intracranial pressure response and intrinsic or 'input' parameters such as the head geometry and loading conditions. However, these relationships are very complicated and are usually implicit and 'hidden' in a large amount of simulation/test data. In this study, a data mining method is proposed to explore such underlying information from the numerical simulation results. The heads of different species are described as a highly simplified two-part (skull and brain) finite element model with varying geometric parameters. The parameters considered include peak incident pressure, skull thickness, brain radius and snout length. Their interrelationship and coupling effect are discovered by developing a decision tree based on the large simulation data-set. The results show that the proposed data-driven method is superior to the conventional linear regression method and is comparable to the nonlinear regression method. Considering its capability of exploring implicit information and the relatively simple relationships between response and input variables, the data mining method is considered to be a good tool for an in-depth understanding of the mechanisms of blast-induced brain injury. As a general method, this approach can also be applied to other nonlinear complex biomechanical systems.	[Zhu, Feng] Embry Riddle Aeronaut Univ, Dept Mech Engn, Daytona Beach, FL USA; [Zhu, Feng; Kalra, Anil; Saif, Tal; Yang, King H.; King, Albert I.] Wayne State Univ, Ctr Bioengn, Detroit, MI USA; [Yang, Zaihan] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA		Zhu, F (corresponding author), Embry Riddle Aeronaut Univ, Dept Mech Engn, Daytona Beach, FL USA.; Zhu, F (corresponding author), Wayne State Univ, Ctr Bioengn, Detroit, MI USA.	feng.zhu@erau.edu			Medical Research and Materiel Command of US Army [W81X-WH-12-2-0038]	This work was partially supported by the Medical Research and Materiel Command of the US Army [contract number W81X-WH-12-2-0038].	Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; [ConWep] Conventional Weapons Effects program, 1991, WAT EXP STAT; Han J, 2006, MINING CONCEPTS TECH; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; Kantardzic M., 2003, DATA MINING CONCEPTS, P123; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Long J. B., 2009, J NEUROTRAUM, V26, P1; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tille Y., 2006, SPR S STAT; University of Waikato, 2013, WEKA US MAN; Witten IH, 2011, MOR KAUF D, P1; Zhu F, 2014, P I MECH ENG H, V228, P439, DOI 10.1177/0954411914530882; Zhu F, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500656; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2; Zhu Feng, 2010, Stapp Car Crash J, V54, P211	28	6	6	0	30	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	JUL 26	2016	19	10					1053	1059		10.1080/10255842.2015.1091887			7	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	DJ1BI	WOS:000373937700003	26442779				2022-02-06	
J	Ganti, L; Daneshvar, Y; Ayala, S; Bodhit, AN; Peters, KR				Ganti, Latha; Daneshvar, Yasamin; Ayala, Sarah; Bodhit, Aakash N.; Peters, Keith R.			The value of neurocognitive testing for acute outcomes after mild traumatic brain injury	MILITARY MEDICAL RESEARCH			English	Article						Neurocognitive testing; Mild traumatic brain injury; Treatment outcome	MENTAL-STATE-EXAMINATION; EMERGENCY-DEPARTMENT	Background: Traditionally, neurocognitive testing is performed weeks to months after head injury and is mostly performed on patients who continue to have symptoms or difficulties. In this study, we sought to determine whether these tests, when administered acutely, could assist in predicting short-term outcomes after acute traumatic brain injury (TBI). Methods: This is an IRB-approved prospective study of adult patients who came to the emergency department of our Level-1 trauma center with TBI. Patients were enrolled prospectively after providing written informed consent and underwent three separate neurocognitive tests: the Galveston Orientation Amnesia Test (GOAT) the Rivermead Post-Concussion Survey Questionnaire (RPCSQ) and the Mini Mental Status Examination (MMSE). Results: A lower GOAT score was significantly associated with hospitalization (P = 0.0212) and the development of post-concussion syndrome (P = 0.0081) at late follow-up. A higher RPCSQ score was significantly associated with hospital admission (P = 0.0098), re-admission within 30 days of discharge (P = 0.0431) and evidence of post-concussion syndrome (PCS) at early follow-up (P = 0.0004). A higher MMSE score was significantly associated with not being admitted to the hospital (P = 0.0002) and not returning to the emergency department (ED) within 72 hours of discharge (P = 0.0078). Lower MMSE was also significantly associated with bleeding or a fracture on the brain CT (P = 0.0431). Conclusions: While neurocognitive testing is not commonly performed in the ED in the setting of acute head injury, it is both feasible and appears to have value in predicting hospital admission and PCS. These data are especially important in terms of helping patients understand what to expect, thus, aiding in their recovery.	[Ganti, Latha] Univ Cent Florida, Coll Med, Orlando, FL 32827 USA; [Daneshvar, Yasamin] NYU, New York, NY USA; [Bodhit, Aakash N.] St Louis Univ, St Louis, MO 63103 USA; [Peters, Keith R.] Univ Florida, Gainesville, FL USA; [Ayala, Sarah] Univ Calif San Diego, San Diego, CA 92103 USA		Ganti, L (corresponding author), Univ Cent Florida, Coll Med, Orlando, FL 32827 USA.	latha.ganti@ucf.edu	Bodhit, Aakash/AAM-5786-2021; Ganti, Latha/AAF-6268-2020	Bodhit, Aakash/0000-0003-2722-025X; Ganti, Latha/0000-0001-7717-3864	Toral Family Foundation, Davie, Florida, USA	This work was supported by an endowment from The Toral Family Foundation, 13131 SW 19th Street, Davie, Florida 33325, USA (toralfamilyfoundation.org).	DICK JPR, 1984, J NEUROL NEUROSUR PS, V47, P496, DOI 10.1136/jnnp.47.5.496; Elhan AH, 2005, J REHABIL MED, V37, P306, DOI 10.1080/16501970510037573; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faul M, 2010, TRAUMATIC BRAIN INJU; Ganti L, 2015, WEST J EMERG MED, V16, P481, DOI 10.5811/westjem.2015.2.23546; Ganti L, 2015, MIL MED, V180, P380, DOI 10.7205/MILMED-D-14-00316; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; O'Neil B, 2014, MIL MED, V179, P1250, DOI 10.7205/MILMED-D-13-00585; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x	14	6	7	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2095-7467	2054-9369		MILITARY MED RES	MILITARY MED. RES.	JUL 22	2016	3								23	10.1186/s40779-016-0091-4			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	DU3CR	WOS:000382088900001	27453788	Green Published, gold			2022-02-06	
J	Sun, JL; Jacobs, KM				Sun, Jianli; Jacobs, Kimberle M.			Knockout of Cyclophilin-D Provides Partial Amelioration of Intrinsic and Synaptic Properties Altered by Mild Traumatic Brain Injury	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						mild traumatic brain injury; intrinsic excitability; excitatory synaptic transmission; cyclophilin-D; cyclophilin-D knockout	MITOCHONDRIAL PERMEABILITY TRANSITION; FLUID PERCUSSION INJURY; CYCLOSPORINE-A; ELECTROPHYSIOLOGICAL PROPERTIES; EXTRACELLULAR POTASSIUM; GLUTAMATE RELEASE; PYRAMIDAL NEURONS; AXONAL DAMAGE; PORE; RAT	Mitochondria are central to cell survival and Ca2+ homeostasis due to their intracellular buffering capabilities. Mitochondrial dysfunction resulting in mitochondrial permeability transition pore (mPTP) opening has been reported after mild traumatic brain injury (mTBI). Cyclosporine A provides protection against the mPTP opening through its interaction with cyclophilin-D (CypD). A recent study has found that the extent of axonal injury after mTBI was diminished in neocortex in cyclophilin-D knockout (CypDKO) mice. Here we tested whether this CypDKO could also provide protection from the increased intrinsic and synaptic neuronal excitability previously described after mTBI in a mild central fluid percussion injury mice model. CypDKO mice were crossed with mice expressing yellow fluorescent protein (YFP) in layer V pyramidal neurons in neocortex to create CypDKO/YFP-H mice. Whole cell patch clamp recordings from axotomized (AX) and intact (IN) YFP+ layer V pyramidal neurons were made 1 and 2 days after sham or mTBI in slices from CypDKO/YFP-H mice. Both excitatory post synaptic currents (EPSCs) recorded in voltage clamp and intrinsic cellular properties, including action potential (AP), afterhyperpolarization (AHP), and depolarizing after potential (DAP) characteristics recorded in current clamp were evaluated. There was no significant difference between sham and mTBI for either spontaneous or miniature EPSC frequency, suggesting that CypDKO ameliorates excitatory synaptic abnormalities. There was a partial amelioration of intrinsic properties altered by mTBI. Alleviated were the increased slope of the AP frequency vs. injected current plot, the increased AP, AHP and DAP amplitudes. Other properties that saw a reversal that became significant in the opposite direction include the current rheobase and AP overshoot. The AP threshold remained depolarized and the input resistance remained increased in mTBI compared to sham. Additional altered properties suggest that the CypDKO likely has a direct effect on membrane properties, rather than producing a selective reduction of the effects of mTBI. These results suggest that inhibiting CypD after TBI is an effective strategy to reduce synaptic hyperexcitation, making it a continued target for potential treatment of network abnormalities.	[Sun, Jianli; Jacobs, Kimberle M.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA		Jacobs, KM (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	kimberle.jacobs@vcuhealth.org	Jacobs, Kimberle/AAW-7526-2020		National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS077675]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077675] Funding Source: NIH RePORTER	We thank Michael Forte who supplied this mouse strain and John Povlishock for making these mice available to us. We greatly appreciate the help of Anders Hanell in developing the analysis program for intrinsic properties. This study was supported by National Institutes of Health (NIH) grant NS077675.	Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barsukova A, 2011, EUR J NEUROSCI, V33, P831, DOI 10.1111/j.1460-9568.2010.07576.x; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Bigler E.D, 2015, BRAIN NEUROTRAUMA MO, P433; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brenner C, 2012, CIRC RES, V111, P1237, DOI 10.1161/CIRCRESAHA.112.265942; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dittman JS, 2000, J NEUROSCI, V20, P1374; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fernandez FR, 2005, J NEUROPHYSIOL, V94, P3836, DOI 10.1152/jn.00653.2005; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; Gainutdinov T, 2015, ARCH BIOCHEM BIOPHYS, V579, P40, DOI 10.1016/j.abb.2015.05.009; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; Hains BC, 2005, BRAIN, V128, P2359, DOI 10.1093/brain/awh623; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Huang XJ, 2013, J NEUROTRAUM, V30, P39, DOI 10.1089/neu.2012.2508; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Koura SS, 1998, ACT NEUR S, V71, P244; Kramer DR, 2016, J CLIN NEUROSCI, V24, P22, DOI 10.1016/j.jocn.2015.08.004; Lampert A, 2006, EXP BRAIN RES, V174, P660, DOI 10.1007/s00221-006-0511-x; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lee SY, 2012, J CLIN NEUROL, V8, P224, DOI 10.3988/jcn.2012.8.3.224; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Luvisetto S, 2008, NEUROSCIENCE, V155, P585, DOI 10.1016/j.neuroscience.2008.06.030; Mao Q, 2010, NEUROSURGERY, V66, P1134, DOI 10.1227/01.NEU.0000369612.31946.A2; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Menazza S, 2013, J MOL CELL CARDIOL, V56, P81, DOI 10.1016/j.yjmcc.2012.12.004; Monjaraz E, 2000, J PHYSIOL-LONDON, V523, P45, DOI 10.1111/j.1469-7793.2000.00045.x; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Mouri A, 2010, HIPPOCAMPUS, V20, P293, DOI 10.1002/hipo.20625; Mozzachiodi R, 2008, NAT NEUROSCI, V11, P1146, DOI 10.1038/nn.2184; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Rao VK, 2014, BBA-MOL BASIS DIS, V1842, P1267, DOI 10.1016/j.bbadis.2013.09.003; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shijo K, 2015, BRAIN RES, V1614, P94, DOI 10.1016/j.brainres.2015.04.022; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; SUN FY, 1994, BRAIN RES, V661, P63, DOI 10.1016/0006-8993(94)91181-9; SUN FY, 1995, BRAIN RES, V673, P133, DOI 10.1016/0006-8993(94)01413-C; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Takahashi R, 2013, J UROLOGY, V190, P2296, DOI 10.1016/j.juro.2013.07.058; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vega AV, 2003, MOL BRAIN RES, V116, P115, DOI 10.1016/S0169-328X(03)00279-1; Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113	93	6	6	0	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5137		FRONT SYST NEUROSCI	Front. Syst. Neurosci.	JUL 20	2016	10								63	10.3389/hsys.2015.00063			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DR5UL	WOS:000379967800001	27489538				2022-02-06	
J	Howell, DR; Meehan, WP				Howell, David R.; Meehan, William P., III			Normative values for a video-force plate assessment of postural control in athletic children	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						athletes; balance; Balance Error Scoring System; concussion; postural stability; sports	ERROR SCORING SYSTEM; GAIT BALANCE CONTROL; HIGH-SCHOOL; ANKLE INSTABILITY; INJURIES; CONCUSSION; EPIDEMIOLOGY; PERFORMANCE; DEFICITS	The objective of this study was to provide normative data for young athletes during the three stances of the modified Balance Error Scoring System (mBESS) using an objective video-force plate system. Postural control was measured in 398 athletes between 8 and 18 years of age during the three stances of the mBESS using a video-force plate rating system. Girls exhibited better postural control than boys during each stance of the mBESS. Age was not significantly associated with postural control. We provide normative data for a video-force plate assessment of postural stability in pediatric athletes during the three stances of the mBESS. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, 9 Hope Ave,Suite 100, Waltham, MA 02453 USA; [Howell, David R.; Meehan, William P., III] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Orthopaed,Div Sports Med, Boston, MA USA; [Howell, David R.; Meehan, William P., III] Harvard Univ, Sch Med, Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Meehan, William P., III] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Univ, Sch Med, Dept Orthoped Surg, Boston, MA USA		Howell, DR (corresponding author), Micheli Ctr Sports Injury Prevent, 9 Hope Ave,Suite 100, Waltham, MA 02453 USA.	david.howell2@childrens.harvard.edu		Howell, David/0000-0002-2955-0191	National Football League Players Association	W.P.M. receives royalties from ABC-Clio publishing for the sale of his book, Kids, Sports, and Concussion: A guide for coaches and parents, as well as from Wolters Kluwer for working as an author for UpToDate. He is under contract with ABC-Clio publishing for a future book entitled Concussions and with Springer International publishing for a future book entitled Head and Neck Injuries in Young Athletes. His research is funded, in part, by a grant from the National Football League Players Association and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament. D.R.H. has no conflicts of interest.	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Caccese JB, 2014, J SPORT REHABIL; Condon C, 2014, PHYSIOTHER RES INT, V19, P1, DOI 10.1002/pri.1549; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Lee AJY, 2007, J APPL BIOMECH, V23, P173, DOI 10.1123/jab.23.3.173; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; McKeon PO, 2008, J ATHL TRAINING, V43, P293, DOI 10.4085/1062-6050-43.3.293; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; TROPP H, 1984, MED SCI SPORT EXER, V16, P64; Wang HK, 2006, ARCH PHYS MED REHAB, V87, P821, DOI 10.1016/j.apmr.2006.02.024; Weinberg S. L., 2002, DATA ANAL BEHAV SCI, P136; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	25	6	6	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JUL	2016	25	4					310	314		10.1097/BPB.0000000000000275			5	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	DN9QV	WOS:000377416000005	26863482				2022-02-06	
J	Junaid, M; Mamoon-ur-Rashid; Afsheen, A; Tahir, A; Bukhari, SS; Kalsoom, A				Junaid, Muhammad; Mamoon-ur-Rashid; Afsheen, Afeera; Tahir, Ayesha; Bukhari, Syed Sarmad; Kalsoom, Anisa			Changing spectrum of traumatic head injuries: Demographics and outcome analysis in a tertiary care referral center	JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION			English	Article						Head trauma; Cortical contusions; Traumatic brain injuries; Blast injuries	BRAIN-INJURY	Objective: To determine the causes, epidemiological characteristics and clinical outcomes related to cases of head trauma. Methods: The retrospective study was conducted at Combined Military Hospital, Quetta, and comprised data from September, 2007, to September, 2011. Treatments offered to each patient and their outcomes were recorded. Glasgow coma scale score was noted on admission and Glasgow outcome scale was used to determine the outcome at 6-month follow-up. Data was analysed using IBM SPSS statistics 21. Results: Of the 1056 patients in the study, 805(76%) were males. Majority of patients 498(47.2%) belonged to 21-40 years age group, with average age of 27 +/- 16 years. The most common cause identified were road traffic accidents 461(43.6%), followed by fall injuries 266(25%). Bomb blast injuries were 60(5.6%). The commonest finding on computed tomography scan was contusion in 124(11.7%) patients. Of the total, 709(63.9%) patients were treated conservatively. Major surgical procedure was done in 125 (11.8%) patients. Excellent recovery was seen in 907(85.8%) patients. Conclusions: In our environment, risk of head injury is increasing. The government should take measures for the improvement of infrastructure and strict implementation of traffic laws. Trauma centres with trained staff need to be ensured.	[Junaid, Muhammad; Afsheen, Afeera] Combined Mil Hosp, Peshawar, Pakistan; [Mamoon-ur-Rashid; Tahir, Ayesha; Bukhari, Syed Sarmad] Khyber Teaching Hosp, Peshawar, Pakistan; [Kalsoom, Anisa] Fauji Fdn Hosp, Rawalpindi, Pakistan		Mamoon-ur-Rashid (corresponding author), Khyber Teaching Hosp, Peshawar, Pakistan.	mamoon3344@Gmail.com	Rashid, Mamoon/N-9353-2019				Afzal I, 2014, HEAD INJURY ITS CONS, V25, P1029; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Greenfield LJ, 1993, SURG SCI PRINCIPLES, P267; Greenwald BD, ARCH PHYS MED REH S1, V84, pS3; JACOBS G, 2000, 445 TRL; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kirmani MA, 1986, THESIS; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Krug, 2002, INJURY LEADING CAUSE; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manjul J, 2004, REGIONAL HLTH FORM W, V8, P29; Nantulya Vinand M, 2003, Inj Control Saf Promot, V10, P3, DOI 10.1076/icsp.10.1.3.14109; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Sample PL, 2004, BRAIN INJURY, V18, P1177, DOI 10.1080/02699050410001719925; Shulman Joshua, TRAUMATIC BRAIN INJU; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WHO, 2004, WORLD REP ROAD TRAFF; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	25	6	6	0	3	PAKISTAN MEDICAL ASSOC	KARACHI	PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN	0030-9982			J PAK MED ASSOC	J. Pak. Med. Assoc.	JUL	2016	66	7					864	868					5	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	DP0ZZ	WOS:000378221200016	27427137				2022-02-06	
J	Makar, JK; Gauli, B; Jain, K; Jain, D; Batra, YK				Makar, Jeetinder Kaur; Gauli, Basanta; Jain, Kajal; Jain, Divya; Batra, Yatinder Kumar			Comparison of erythromycin versus metoclopramide for gastric feeding intolerance in patients with traumatic brain injury: A randomized double-blind study	SAUDI JOURNAL OF ANAESTHESIA			English	Article						Erythromycin; gastric feeding intolerance; traumatic brain injury	ENTERAL NUTRITION; GUIDELINES; THERAPY; SUPPORT; TRIAL; CARE	Background: No randomized controlled trial demonstrates the efficacy of erythromycin or metoclopramide in patients with traumatic brain injury (TBI). This study was conducted to determine the efficacy of metoclopramide and erythromycin for improving gastric aspirate volume (GAV) in patients with TBI. Materials and Methods: Patients with Glasgow coma score more than 5 admitted to trauma Intensive Care Unit within 72 h of head injury were assessed for eligibility. 115 patients were prospectively randomized to receive metoclopramide, erythromycin, or placebo eighth hourly. Gastric feeding intolerance was defined as GAV more than 150 ml with abdominal symptoms. Two consecutive high GAV was defined as feeding failure. Feeding failure was treated by increasing the frequency of dose to 6 hourly in metoclopramide and erythromycin group. Combination therapy with both drugs was given as rescue in the placebo group. Results: Incidence of high GAV was as high as 60.5% in placebo group. Use of erythromycin was associated with a decrease in the incidence of feeding intolerance to 28.9% (P = 0.006). Although feed intolerance decreased to 43.6% in metoclopramide group, values did not reach statistical significance. The proportion of patients not having high GAV at different days were significantly higher in erythromycin group (P = 0.027, log-rank test). There was no difference in the proportion of patients not having feeding failure in three groups with increasing number of days. Conclusion: There was a significant decrease in the incidence of high GAV with the use of erythromycin when compared to metoclopramide and placebo.	[Makar, Jeetinder Kaur; Gauli, Basanta; Jain, Kajal; Jain, Divya; Batra, Yatinder Kumar] Postgrad Inst Med Educ & Res, Dept Anesthesia & Intens Care, Chandigarh, India		Makar, JK (corresponding author), Postgrad Inst Med Educ & Res, Dept Anesthesia, Chandigarh, India.	jeet1516@gmail.com		jain, Divya/0000-0003-3085-1802			Acosta Escribano J A, 2001, Nutr Hosp, V16, P262; Berne JD, 2002, J TRAUMA, V53, P422, DOI 10.1097/00005373-200209000-00004; Dickerson RN, 2009, JPEN-PARENTER ENTER, V33, P646, DOI 10.1177/0148607109335307; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Kirby D F, 1996, JPEN J Parenter Enteral Nutr, V20, P1, DOI 10.1177/014860719602000101; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Marino LV, 2003, BRIT J NEUROSURG, V17, P24, DOI 10.1080/026889031000093708; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Mentec H, 2001, CRIT CARE MED, V29, P1955, DOI 10.1097/00003246-200110000-00018; Nguyen NQ, 2007, CRIT CARE MED, V35, P483, DOI 10.1097/01.CCM.0000253410.36492.E9; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; Nursal TZ, 2007, J CLIN NEUROSCI, V14, P344, DOI 10.1016/j.jocn.2005.11.011; Ott L, 1999, J NEUROTRAUM, V16, P233, DOI 10.1089/neu.1999.16.233; Perel P, 2006, COCHRANE DB SYST REV, V18; Pinto TF, 2012, BRAIN INJURY, V26, P1113, DOI 10.3109/02699052.2012.666369	17	6	7	0	2	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1658-354X	0975-3125		SAUDI J ANAESTH	Saudi J. Anaesth.	JUL-SEP	2016	10	3					308	313		10.4103/1658-354X.174902			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	EA6RD	WOS:000386755600012	27375386	Green Published, gold			2022-02-06	
J	Mrkobrada, S; Wei, XC; Gnanakumar, V				Mrkobrada, Serge; Wei, Xing-Chang; Gnanakumar, Vithya			Magnetic resonance imaging findings of bilateral thalamic involvement in severe paroxysmal sympathetic hyperactivity: a pediatric case series	CHILDS NERVOUS SYSTEM			English	Article						Dysautonomia; Paroxysmal sympathetic hyperactivity; Pediatrics; Acquired brain injury	FATAL FAMILIAL INSOMNIA; TRAUMATIC BRAIN-INJURY; DYSAUTONOMIA; DYSTONIA	Paroxysmal sympathetic hyperactivity is a complication of brain injury that has mainly been described in the adult brain injury literature. We present a case series of three pediatric patients that developed paroxysmal sympathetic hyperactivity of varying severity following hypoxic brain injury. Comparison of brain magnetic resonance imaging revealed bilateral and symmetric global ischemic changes in all three cases. However, the thalamus was not affected in the patient with the mild case of paroxysmal sympathetic hyperactivity. In contrast, bilateral and symmetric damage to the thalamus was observed in the two severe cases. Our case series suggests that in hypoxic brain injury, evidence of bilateral ischemic injury to the thalamus on magnetic resonance imaging may be an important early predictor of severity and length of paroxysmal sympathetic hyperactivity. While this is an interesting observation, definite proof of our hypothesis requires further research including analysis of larger numbers of patients and comparison of MRI findings in children with hypoxic brain injury that do not develop paroxysmal sympathetic hyperactivity.	[Mrkobrada, Serge; Wei, Xing-Chang; Gnanakumar, Vithya] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Mrkobrada, Serge; Wei, Xing-Chang; Gnanakumar, Vithya] Univ Calgary, Calgary, AB, Canada; [Gnanakumar, Vithya] Foothills Med Ctr, Calgary, AB, Canada		Mrkobrada, S (corresponding author), Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada.; Mrkobrada, S (corresponding author), Univ Calgary, Calgary, AB, Canada.	mrkobrada@gmail.com; xingchang.wei@albertahealthservices.ca; vithya.gnanakumar@albertahealthservices.ca					Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Benarroch EE, 1998, BRAIN PATHOL, V8, P527; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Krach LE, 1997, J NEUROL REHABIL, V11, P41; Lemke DM, 2007, CRIT CARE NURSE, V27, P30; LUGARESI E, 1986, NEW ENGL J MED, V315, P997, DOI 10.1056/NEJM198610163151605; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Mrkobrada S, 2014, PEDIATR NEUROL, V51, P573, DOI 10.1016/j.pediatrneurol.2014.06.012; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Stotz-Potter E, 1998, NEUROSCI LETT, V247, P127, DOI 10.1016/S0304-3940(98)00291-2	11	6	6	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2016	32	7					1299	1303		10.1007/s00381-015-2931-z			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DR7CC	WOS:000380056600020	26463401				2022-02-06	
J	Shi, YH; Quan, RF; Li, CM; Zhang, L; Du, MX; Xu, JW; Yang, ZB; Yang, DS				Shi, Yihui; Quan, Renfu; Li, Changming; Zhang, Liang; Du, Mengxuan; Xu, Jinwei; Yang, Zongbao; Yang, Disheng			The study of traditional Chinese medical elongated-needle therapy promoting neurological recovery mechanism after spinal cord injury in rats	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						ENT; BL54 and ST28 points; Nerve injury; Inflammatory reaction; Apoptosis; Mechanism	TRAUMATIC BRAIN-INJURY; INDUCED APOPTOSIS; KINASE; NEUROPROTECTION; ACTIVATION; PATHWAY	Ethnopharmacological relevance: Acupuncture is a key part of traditional Chinese medicine, shown to induce favorable neuroplasticity for injuries in the central and peripheral nervous systems. Recent studies report elongated needle therapy (ENT) with BL54 and ST28 may restore acute spinal cord injury (ASCI). However, the precise mechanism for this has not been elucidated. Aim of the study: In our current study, we investigated the effects of ENT on inflammation and neuronal apoptosis induced by ASCI, and whether PI3K/Akt and MAPK/ERK signaling pathways are involved in the ENT restoration effect. Materials and methods: Rat models of moderate SCI were established in accordance with the modified Allen's method and were treated with ENT continuously for 7 days. Spontaneous activities were evaluated by the Basso Beattie and Bresnahan locomotor scale. Levels of inflammatory cytokines, such as tumor necrosis factor alpha, interleukin-6, IL-1 beta, and nuclear factor kappa-beta, were determined by enzyme-linked immunosorbent assay. Cell apoptosis was examined by the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. The proportions of cells with positive Bcl-2 and Bax expression were determined by immunohistochemical assays, whilst the expression profiles of p-ART and p-ERR in spinal cord tissues were evaluated by western blotting. Furthermore, the expression profiles of Cytochrome-C (Cyt-C) and caspase-3 in vivo were analyzed by reverse transcription polymerase chain reaction. The potential inhibitory effects downstream of the Akt and ERIC signaling pathways were examined by administration of specific inhibitors LY294002 and PD98059 in vivo. Results: As indicated by this study, inflammation as well as PI3K/Akt- and MAPK/ERK signaling pathway mediated neuronal apoptosis were involved in the course of SCI in rats. The neuro-protective effect of ENT was associated with reduced Bax protein-positive neurons and increased Bcl-2 protein-positive neurons. ENT enhanced recovery of rat activities. Activation of p-Akt and p-ERIC in the PI3K/Akt and MAPK/ERK signaling pathways, inhibited expression of the critical component Cyt-C. Cyt-C is required for the mitochondrial apoptosis pathway and cascade of caspase-3, which is involved in activation of neuronal apoptosis through down-regulation of Bax protein and up-regulation of Bcl-2, as determined by TUNEL. The administration of PI3R/Akt and MAPK/ERK signaling pathway specific inhibitors, LY294002 and PD98059, suppressed expression of both p-Akt and p-ERK. Conclusion: ENT with BL54 and ST28 points can promote the recovery of ASCI. And the neuro-protective effect of ENT during the restoration of SCI may be associated with the suppression of both inflammation and activation of PI3K/Akt and MAPK/ERK signaling pathways, resulting from down-regulation of Bax protein, up-regulation of Bcl-2, and inhibition of the mitochondrial apoptosis pathway. (C) 2016 Published by Elsevier Ireland Ltd.	[Shi, Yihui; Zhang, Liang] Zhejiang Chinese Med Univ, Res Inst Acupuncture & Moxibust, Hangzhou 31012, Zhejiang, Peoples R China; [Quan, Renfu; Li, Changming; Du, Mengxuan; Xu, Jinwei] Zhejiang Chinese Med Univ, Affiliated Jiangnan Hosp, Res Inst Acupuncture & Moxibust, Hangzhou 31012, Zhejiang, Peoples R China; [Yang, Zongbao] Xiamen Univ, Coll Med, Res Inst Acupuncture & Moxibust, Xiamen, Fujian, Peoples R China; [Yang, Disheng] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China		Quan, RF (corresponding author), Zhejiang Chinese Med Univ, Affiliated Jiangnan Hosp, Res Inst Acupuncture & Moxibust, Hangzhou 31012, Zhejiang, Peoples R China.	quanrenf@263.net	Li, Chang Ming/F-9340-2017	Li, Chang Ming/0000-0002-4041-2574	Chinese Medicine Research Foundation of Zhejiang Province [2015ZZ017]; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY15H270003]	This study was supported by the Chinese Medicine Research Foundation of Zhejiang Province (Grant no 2015ZZ017 to Quan Renfu) and Natural Science Foundation of Zhejiang Province (Grant no LY15H270003 to Quan Renfu).	Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bleicken S, 2013, BIOPHYS J, V104, P421, DOI 10.1016/j.bpj.2012.12.010; Cha MH, 2010, NEUROL RES, V32, pS96, DOI 10.1179/016164109X12537002794363; Changming Li, 2014, EFFECT ELECTROACUPUN, V26, P3; [陈虹 Chen Hong], 2012, [中国康复理论与实践, Chinese Journal of Rehabilitation Theory and Practice], V18, P33; Chen Rong-Liang, 2014, Zhen Ci Yan Jiu, V39, P259; Chen Yu-He, 2013, CHIN J REHABIL, V28, P430; Chu Kai-Bo, 2009, CHIN J INF TRADIT CH, V4, P98; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fu J, 2014, J SURG RES, V188, P222, DOI 10.1016/j.jss.2013.11.1118; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Gok HB, 2007, J CLIN NEUROSCI, V14, P138, DOI 10.1016/j.jocn.2006.10.016; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; Irles C, 2014, STRESS, V17, P275, DOI 10.3109/10253890.2014.913017; Jung SY, 2014, EXP THER MED, V7, P587, DOI 10.3892/etm.2013.1451; Khan T, 1999, LAB ANIM SCI, V49, P161; Liu F, 2013, J MOL NEUROSCI, V51, P629, DOI 10.1007/s12031-013-0035-3; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Luchetti F, 2009, FREE RADICAL BIO MED, V46, P339, DOI 10.1016/j.freeradbiomed.2008.09.017; Mazzucchelli C, 2000, CELL MOL LIFE SCI, V57, P604, DOI 10.1007/PL00000722; Paola FA, 2003, J SPINAL CORD MED, V26, P12; Quan Ren-Fu, 2013, Zhongguo Gu Shang, V26, P54; Quan Ren-Fu, 2012, DISCUSS EFFECTS POIN, V24, P3; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Rapson LM, 2003, J SPINAL CORD MED, V26, P21, DOI 10.1080/10790268.2003.11753655; Shehadah A, 2010, NEUROBIOL DIS, V40, P277, DOI 10.1016/j.nbd.2010.05.034; Wiener Z, 2014, P NATL ACAD SCI USA, V111, pE2229, DOI 10.1073/pnas.1406444111; World Health Organization, 2008, WHO STAND AC POINT L; Wu Y, 2007, APOPTOSIS, V12, P1365, DOI 10.1007/s10495-007-0065-9; Xiang Hui-Zhu, 2014, CHIN MANIP REHABIL M, V5, P32; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yu LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048074; Zhang Hong, 2014, GUIDE CHINA MED, V12, P73; Zhonghe Liu, 2005, CHIN ACUPUNCT MOXI S, V51, P144; Zhu Y, 2004, NEUROSCIENCE, V123, P897, DOI 10.1016/j.neuroscience.2003.10.037; Zhuang S. G., 2006, JPET FAST FORW, V7, P1067	38	6	9	0	21	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741	1872-7573		J ETHNOPHARMACOL	J. Ethnopharmacol.	JUL 1	2016	187						28	41		10.1016/j.jep.2016.04.019			14	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	DP0OZ	WOS:000378190400004	27085942				2022-02-06	
J	Walton, M; Harrison, R; Chevalier, A; Esguerra, E; Duong, DV; Chinh, ND; Giang, H				Walton, Merrilyn; Harrison, Reema; Chevalier, Anna; Esguerra, Esmond; Dang Van Duong; Nguyen Duc Chinh; Giang, Huong			Improving hospital death certification in Viet Nam: results of a pilot study implementing an adapted WHO hospital death report form in two national hospitals	BMJ GLOBAL HEALTH			English	Article							CIVIL REGISTRATION SYSTEMS; VERBAL AUTOPSY; STATISTICS	Background: Viet Nam does not have a system for the national collection of death data that meets international requirements for mortality reporting. It is identified as a 'no-report' country by the WHO. Verbal autopsy reports are used in the community but exclude deaths in hospitals. Methods: This project was undertaken in Bach Mai National General Hospital and Viet Duc Surgical and Trauma Hospital in Viet Nam from 1 March 2013 to 31 March 2015. In phase 1, a modified hospital death report form, consistent with the International Statistical Classification of Diseases and Related Health Problems, 10th Revision, was developed. Small group training in use of the report form was delivered to 427 doctors. In phase two, death data were collected, collated and analysed. In phase three, a random sample (7%) of all report forms was checked for accuracy and completeness against medical records. Findings: During the 23 months of the study, 3956 deaths were recorded. Across both hospitals, 222 distinct causes of deaths were recorded. Traumatic cerebral oedema was the immediate cause of death (15% of cases, 575/3956 patients), followed by septic shock (13%, 528/3956), brain compression (11%, 416/3956), intracerebral haemorrhage (8%, 336/3956) and pneumonia (5%, 186/3956); 67% (2639/3956) of patients were discharged home to die and 33% (1314/3956) of deaths were due to a road traffic accident, or injury at home or at work. Conclusions: This study confirms the viability of implementing a death report form system compliant with international standards in hospitals in Viet Nam and provides the foundation for introducing a national death report form scheme. These data are critical to comprehensive knowledge of causes of death in Viet Nam. Death data about patients discharged home to die is presented for the first time, with implications for countries where this is a cultural preference.	[Walton, Merrilyn; Harrison, Reema; Esguerra, Esmond] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Chevalier, Anna] Univ Sydney, George Inst Global Hlth, Injury Prevent Unit, Sydney, NSW, Australia; [Dang Van Duong; Giang, Huong] Bach Mai Hosp, Dept Planning, Hanoi, Vietnam; [Nguyen Duc Chinh] Viet Duc Hosp, Dept Planning, Hanoi, Vietnam		Harrison, R (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia.	reema.harrison@sydney.edu.au	Harrison, Reema/K-7951-2019; Walton, Merrilyn/AAJ-7117-2020	Harrison, Reema/0000-0002-8609-9827; 	Australian Government Public Sector Linkages Program AusAIDAustralian Government [ROU62149]	This work was funded by the Australian Government Public Sector Linkages Program AusAID. Grant number: ROU62149. Project title: "Improving Hospital Death Data Collection in Vietnam".	[Administration of Preventive Medicine Ministry of Health Medicine AoP], 2009, INJ MORT STAT 2008; Choprapawon C, 2005, Asia Pac J Public Health, V17, P110, DOI 10.1177/101053950501700209; Huong DL, 2006, PUBLIC HEALTH, V120, P497, DOI 10.1016/j.puhe.2006.03.003; Huong DL, 2003, SCAND J PUBLIC HEALT, V31, P19, DOI 10.1080/14034950310015068; Huong NTL, 2008, INJURY, V39, P1026, DOI 10.1016/j.injury.2008.03.011; Johansson LA, 2002, J EPIDEMIOL COMMUN H, V56, P301, DOI 10.1136/jech.56.4.301; KALTER HD, 1990, INT J EPIDEMIOL, V19, P380, DOI 10.1093/ije/19.2.380; Lakkireddy DR, 2004, AM J MED, V117, P492, DOI 10.1016/j.amjmed.2004.04.018; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Ministry of Health, 2006, VIETN HLTH INF SYST, P1; Ngo Anh D, 2010, BMC Res Notes, V3, P78, DOI 10.1186/1756-0500-3-78; Nguyen D, 2007, THAI J SURG, V28, P83; Nguyen H, 2012, INJURY PREV, V19, P9; Rao C, 2010, B WORLD HEALTH ORGAN, V88, P58, DOI 10.2471/BLT.08.061630; Sibai AM, 2004, B WORLD HEALTH ORGAN, V82, P83; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Swift B, 2005, J CLIN PATHOL, V5, P275; Walton M, 2015, IMPROVING HOSP DEATH; WHO, 2014, GLOB HLTH OBS GHO; World Health Organisation, 1993, MORT GUID CERT RUL C	20	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2059-7908			BMJ GLOB HEALTH	BMJ Glob. Health	JUL	2016	1	1							e000014	10.1136/bmjgh-2015-000014			10	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	FF2ER	WOS:000408711200009	28588910	gold, Green Published			2022-02-06	
J	Yokota, H; Ida, Y				Yokota, Hiroshi; Ida, Yuki			Acute Subdural Hematoma in a Judo Player with Repeated Head Injuries	WORLD NEUROSURGERY			English	Article						Acute subdural hematoma; Concussion; Head injury; Judo	2ND IMPACT	BACKGROUND: Acute subdural hematoma (ASDH) is the most important cause of severe head injuries occurring during judo practice in Japan. Repeated head injuries have been reported as a cause of fatal ASDH, although the mechanism remains unknown. CASE DESCRIPTION: A 16-year-old boy visited an emergency department with vomiting 3 days after a strong blow to the occipital region during judo practice. Although computed tomography was performed at that time, a small interhemispheric ASDH was overlooked. The patient sustained another head injury 19 days after the first, which led to convulsions and disturbance of consciousness. The ASDH was increased in size on computed tomography. We performed a surgical evacuation, which revealed tearing of a bridging vein, after which the patient showed a good recovery. CONCLUSIONS: It is important to be aware of the possibility of a small ASDH in concussed judo players after an initial impact, which may lead to subsequent fatal ASDH after another impact incident.	[Yokota, Hiroshi; Ida, Yuki] Nabari City Hosp, Dept Neurosurg, Nabari, Mie, Japan		Yokota, H (corresponding author), Nabari City Hosp, Dept Neurosurg, Nabari, Mie, Japan.	hyokota0001@gmail.com					Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Nagahiro S, 2014, NEUROL MED-CHIR, V54, P878, DOI 10.2176/nmc.ra.2014-0224; Nagahiro Shinji, 2011, No Shinkei Geka, V39, P1139; Nambu S, 2014, CURR SPORT MED REP, V13, P11, DOI 10.1249/JSR.0000000000000024; Nishimura K, 1988, Neurol Med Chir (Tokyo), V28, P991, DOI 10.2176/nmc.28.991; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538	9	6	6	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2016	91								6710	10.1016/j.wneu.2016.03.101			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DS1OH	WOS:000380365000121	27060521				2022-02-06	
J	Baggett, TP; Campbell, EG; Chang, YC; Magid, LM; Rigotti, NA				Baggett, Travis P.; Campbell, Eric G.; Chang, Yuchiao; Magid, Leah M.; Rigotti, Nancy A.			Posttraumatic Stress Symptoms and Their Association With Smoking Outcome Expectancies Among Homeless Smokers in Boston	NICOTINE & TOBACCO RESEARCH			English	Article							ADDICTION SEVERITY INDEX; SUBSTANCE USE DISORDERS; PTSD CHECKLIST PCL; TRAUMATIC BRAIN-INJURY; LOS-ANGELES-COUNTY; PSYCHOMETRIC PROPERTIES; HEALTH-CARE; CIGARETTE-SMOKING; ADULTS PREVALENCE; SCHIZOPHRENIA	Introduction: Cigarette smoking and traumatic life experiences are each common among homeless adults, but the prevalence and correlates of posttraumatic stress disorder (PTSD) symptoms among homeless smokers are not known. We assessed symptoms of PTSD and their association with smoking outcome expectancies in a sample of homeless smokers in Boston. Methods: We used time-location sampling to conduct an in-person survey of homeless adult smokers using Boston Health Care for the Homeless Program clinical services. We assessed symptoms of PTSD with the PTSD Checklist-Civilian version and considered scores at least 14 as positive. We used the Smoking Effects Questionnaire to assess positive and negative smoking outcome expectancies. We modeled the associations between PTSD screening status and smoking expectancies using design-adjusted linear regression. Results: Eighty-six percent of eligible individuals participated (N = 306). Sixty-eight percent of participants screened positive for PTSD. Screen-positive respondents were younger (P=.001), more likely to report fair/poor health (P=.01), chronic obstructive pulmonary disease (P=.02), and past-month hallucinations (P=.004), and had greater drug (P<.001) and alcohol (P<.001) use severity and cigarette dependence (P=.002). In analyses controlling for these confounders, PTSD screen-positive participants more strongly endorsed smoking to reduce negative affect (P=.01), smoking for social benefits (P=.002), and smoking for weight control (P=.03). Exploratory analyses suggested that these associations were driven by avoidance/numbing and re-experiencing symptoms. Conclusions: Symptoms of posttraumatic stress are common among homeless smokers and strongly associated with positive smoking outcome expectancies. Tobacco cessation programs for this population should consider screening for PTSD and fostering a trauma-sensitive treatment environment. Implications: In this study of homeless cigarette smokers in Boston, over two-thirds of participants screened positive for PTSD. PTSD screen-positive respondents more strongly endorsed multiple positive smoking outcome expectancies than screen-negative individuals. These findings suggest that the psychological sequelae of trauma may be a pervasive but under-recognized factor impacting the persistence of smoking among homeless people. Tobacco cessation programs for this population should consider screening for PTSD, fostering a trauma-sensitive treatment environment, and incorporating strategies that have shown promise in smokers with PTSD.	[Baggett, Travis P.; Chang, Yuchiao; Rigotti, Nancy A.] Massachusetts Gen Hosp, Div Gen Internal Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA; [Baggett, Travis P.; Campbell, Eric G.; Chang, Yuchiao; Rigotti, Nancy A.] Harvard Med Sch, Dept Med, Boston, MA USA; [Baggett, Travis P.] Boston Hlth Care Homeless Program, Boston, MA USA; [Campbell, Eric G.; Rigotti, Nancy A.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, 50 Staniford St,9th Floor, Boston, MA 02114 USA; [Magid, Leah M.] Boston Univ, Coll Hlth & Rehabil Sci, Boston, MA 02215 USA; [Magid, Leah M.] Boston Univ, Sch Publ Hlth, Boston, MA USA		Baggett, TP (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	tbaggett@mgh.harvard.edu			National Institute on Drug Abuse at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [K23DA034008]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K23DA034008] Funding Source: NIH RePORTER	This study was funded by the National Institute on Drug Abuse at the National Institutes of Health under award number K23DA034008 to TPB. The funding agency had no role in any aspect of this study. The study content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aakre JM, 2014, PSYCHIAT RES, V220, P840, DOI 10.1016/j.psychres.2014.10.004; Achim AM, 2011, SCHIZOPHRENIA BULL, V37, P811, DOI 10.1093/schbul/sbp148; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; ARGERIOU M, 1994, J SUBST ABUSE TREAT, V11, P359, DOI 10.1016/0740-5472(94)90046-9; Ashare RL, 2011, ADDICT BEHAV, V36, P1333, DOI 10.1016/j.addbeh.2011.07.022; Baggett TP, 2010, AM J PREV MED, V39, P164, DOI 10.1016/j.amepre.2010.03.024; Beckham JC, 2008, NICOTINE TOB RES, V10, P1149, DOI 10.1080/14622200802123302; Bender K, 2010, J TRAUMA STRESS, V23, P161, DOI 10.1002/jts.20501; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Buckley PF, 2009, SCHIZOPHRENIA BULL, V35, P383, DOI 10.1093/schbul/sbn135; Bureau of Primary Health Care Health Resources and Services Administration, 1999, PROGR ASS LETT 99 12; Calhoun PS, 2011, J TRAUMA STRESS, V24, P303, DOI 10.1002/jts.20634; Carlson EB, 2013, MIL MED, V178, P970, DOI 10.7205/MILMED-D-13-00080; Carmody TP, 2012, NICOTINE TOB RES, V14, P919, DOI 10.1093/ntr/ntr304; Chau S, 2002, CANCER EPIDEM BIOMAR, V11, P431; Connor SE, 2002, J GEN INTERN MED, V17, P369, DOI 10.1046/j.1525-1497.2002.10630.x; DRAKE RE, 1995, J STUD ALCOHOL, V56, P161, DOI 10.15288/jsa.1995.56.161; Feldner MT, 2007, ADDICT BEHAV, V32, P214, DOI 10.1016/j.addbeh.2006.03.032; Feldner MT, 2007, CLIN PSYCHOL REV, V27, P14, DOI 10.1016/j.cpr.2006.08.004; Fu SS, 2007, NICOTINE TOB RES, V9, P1071, DOI 10.1080/14622200701488418; Grinman MN, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-94; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hopper E., 2010, OPEN HLTH SERVICES P, V3, DOI [DOI 10.2174/1874924001003020080, 10.2174/1874924001003020080, DOI 10.2174/1874924001003010080]; Houston E, 2013, J HEALTH PSYCHOL, V18, P1330, DOI 10.1177/1359105312464674; Hruska B, 2014, ADDICT BEHAV, V39, P273, DOI 10.1016/j.addbeh.2013.10.002; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Jamal A., 2014, MMWR-MORBID MORTAL W, V63, P1108; Kertesz SG, 2009, J GEN INTERN MED, V24, P841, DOI 10.1007/s11606-009-0990-0; Kushel MB, 2003, ARCH INTERN MED, V163, P2492, DOI 10.1001/archinte.163.20.2492; Lang AJ, 2005, BEHAV RES THER, V43, P585, DOI 10.1016/j.brat.2004.04.005; Lang AJ, 2012, GEN HOSP PSYCHIAT, V34, P332, DOI 10.1016/j.genhosppsych.2012.02.003; Lebrun-Harris LA, 2013, HEALTH SERV RES, V48, P992, DOI 10.1111/1475-6773.12009; Marshall EC, 2008, J ANXIETY DISORD, V22, P1214, DOI 10.1016/j.janxdis.2008.01.003; McFall M, 2010, JAMA-J AM MED ASSOC, V304, P2485, DOI 10.1001/jama.2010.1769; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Meinbresse M, 2014, VIOLENCE VICTIMS, V29, P122, DOI 10.1891/0886-6708.VV-D-12-00069; Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Nierkens V, 2006, PREV MED, V43, P306, DOI 10.1016/j.ypmed.2006.05.005; O'Connell JJ, 2010, AM J PUBLIC HEALTH, V100, P1400, DOI 10.2105/AJPH.2009.173609; Okuyemi KS, 2013, NICOTINE TOB RES, V15, P22, DOI 10.1093/ntr/nts030; Raymond H, 2010, RESOURCE GUIDE TIME; Rohsenow DJ, 2003, ADDICT BEHAV, V28, P1257, DOI 10.1016/S0306-4603(02)00254-X; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Snyder LD, 2004, CHEST, V125, P1719, DOI 10.1378/chest.125.5.1719; Szerlip MI, 2002, AM J MED SCI, V324, P243, DOI 10.1097/00000441-200211000-00002; Taylor KM, 2008, AUST NZ J PSYCHIAT, V42, P206, DOI 10.1080/00048670701827218; Tidey JW, 2009, SCHIZOPHR RES, V115, P310, DOI 10.1016/j.schres.2009.09.032; Torchalla I, 2014, PSYCHOL ADDICT BEHAV, V28, P443, DOI 10.1037/a0033674; Tsai J, 2012, PSYCHIAT SERV, V63, P569, DOI 10.1176/appi.ps.201100398; Tucker JS, 2014, NICOTINE TOB RES, V16, P1522, DOI [10.1093/ntr/ntt281, 10.1093/ntr/ntu133, 10.1093/ntr/ntu040, 10.1093/ntr/ntt283, 10.1093/ntr/ntu032]; U. K. Department for Communities and Local Government, 2010, EV EXT ROUGH SLEEP N; Weathers F.W., 1993, 9 ANN C ISTSS; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; ZANIS DA, 1994, J SUBST ABUSE TREAT, V11, P541, DOI 10.1016/0740-5472(94)90005-1	56	6	6	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203	1469-994X		NICOTINE TOB RES	Nicotine Tob. Res.	JUN	2016	18	6					1526	1532		10.1093/ntr/ntv238			7	Substance Abuse; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Public, Environmental & Occupational Health	DR3TU	WOS:000379826300019	26508393	Green Published			2022-02-06	
J	Keays, G; Friedman, D; Gagnon, I				Keays, Glenn; Friedman, Debbie; Gagnon, Isabelle			A 20-Year Comparison of Football-Related Injuries in American and Canadian Youth Aged 6 to 17 Years: A Replication Study	CLINICAL PEDIATRICS			English	Article						children; adolescent; football; sports; injuries; Canada; United States	SPORTS-RELATED INJURIES; HIGH-SCHOOL; RISK-FACTORS; EMERGENCY-DEPARTMENTS; CONCUSSION; SYMPTOMS; CHILDREN; EPIDEMIOLOGY; VALIDITY; YOUNG	Introduction. Little is known about Canadian youth football injuries. The objectives of this study were (a) to contrast the injuries in Canadian and American football players aged 6 to 17 years and (b) compare the injuries sustained during organized football with those in nonorganized football. Methods. Using a retrospective cohort design based on data from the Canadian Hospitals Injury Reporting and Prevention Program and the National Electronic Injury Surveillance System a comparison of injuries was made. Results. Trends in injuries were comparable. Proportions and odds of injuries were similar, except for a few exceptions. In Canada, more girls were injured and fractures were more prevalent. Compared with nonorganized football, organized football players were older, involved more males, and suffered more traumatic brain injuries and injuries to their lower extremities. Conclusion. Canadian and American youth football injuries were similar. The type of football, be it organized or nonorganized, has an impact on injuries.	[Keays, Glenn; Friedman, Debbie; Gagnon, Isabelle] Montreal Childrens Hosp, McGill Hlth Ctr, 2300 Tupper,Room CB-27, Montreal, PQ H3H 1P3, Canada		Keays, G (corresponding author), Montreal Childrens Hosp, McGill Hlth Ctr, 2300 Tupper,Room CB-27, Montreal, PQ H3H 1P3, Canada.	Glenn.Keays@muhc.mcgill.ca		Keays, Glenn/0000-0001-6720-9536; Gagnon, Isabelle/0000-0003-2043-1644	Canadian Hospitals Injury Reporting and Prevention Program through the Public Health Agency of Canada	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the Canadian Hospitals Injury Reporting and Prevention Program through the Public Health Agency of Canada. The role of the sponsors and funding bodies was to provide financial support for this research and the translation of the findings to all community partners.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Belechri M, 2001, EUR J EPIDEMIOL, V17, P1005, DOI 10.1023/A:1020078522493; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Dompier TP, 2007, J ATHL TRAINING, V42, P395; Fridman L, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-30; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Graves JM, 2015, INJURY, V46, P891, DOI 10.1016/j.injury.2014.11.012; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Health Canada, 2011, CHIRPP UN SOURC CHIL; Hilts N, 2013, CALGARY J       0225; Ifedi F., 2008, SPORT PARTICIPATION; Kang J, 2013, INT J INJ CONTROL SA, V20, P19, DOI 10.1080/17457300.2012.656315; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Levis T, MCGILL DAILY; Macarthur C, 1999, AM J EPIDEMIOL, V149, P586; Macarthur C, 1999, Inj Prev, V5, P214; Macarthur C, 1997, AM J EPIDEMIOL, V145, P834; Mackenzie S G, 1999, Inj Prev, V5, P208; Macpherson AK, 2008, INJURY PREV, V14, P262, DOI 10.1136/ip.2008.018374; McFaull SR, 2013, CHRON DIS INJ CAN, V33, P129; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mello MJ, 2009, ACAD EMERG MED, V16, P243, DOI 10.1111/j.1553-2712.2009.00357.x; Monroe KW, 2011, CLIN PEDIATR, V50, P17, DOI 10.1177/0009922810378735; Nation AD, 2011, CLIN PEDIATR, V50, P200, DOI 10.1177/0009922810388511; Pickett W, 2000, Inj Prev, V6, P9, DOI 10.1136/ip.6.1.9; Powell JW, 1999, J ATHL TRAINING, V34, P277; Quinlan KP, 1999, ANN EMERG MED, V34, P637, DOI 10.1016/S0196-0644(99)70166-6; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; Ramirez M, 2006, AM J SPORT MED, V34, P1147, DOI 10.1177/0363546505284385; Schroeder T., 2001, NEISS SAMPLE DESIGN; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Sportsknowhow, 2015, FOOTB FIELD DIM; Statistic Canada, 2013, SPORT PART 2010; Steinberg SR, 2010, BOY CULTURE ENCY; Swan B., 2009, FOOTBALL FOR LIFE; The National Federation of State High Schools Associations, 2014, 2012 13 HIGH SCH ATH; The National Federation of State High Schools Associations, 2014, 2009 10 HIGH SCH ATH; Thompson MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092052; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801	45	6	6	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JUN	2016	55	7					603	613		10.1177/0009922815602631			11	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	DP3OS	WOS:000378405300004	26316542				2022-02-06	
J	Klein, RC; Acheson, SK; Qadri, LH; Dawson, AA; Rodriguiz, RM; Wetsel, WC; Moore, SD; Laskowitz, DT; Dawson, HN				Klein, Rebecca C.; Acheson, Shawn K.; Qadri, Laura H.; Dawson, Alina A.; Rodriguiz, Ramona M.; Wetsel, William C.; Moore, Scott D.; Laskowitz, Daniel T.; Dawson, Hana N.			Opposing effects of traumatic brain injury on excitatory synaptic function in the lateral amygdala in the absence and presence of preinjury stress	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; stress; amygdala; electrophysiology; hyperexcitability	CLOSED-HEAD INJURY; CENTRAL-NERVOUS-SYSTEM; BASOLATERAL AMYGDALA; PRINCIPAL NEURONS; ANXIETY DISORDERS; CONDITIONED FEAR; BASAL NUCLEI; TNF-ALPHA; I-H; MICE	Traumatic brain injury (TBI) is a leading cause of death and disability among young adults and is highly prevalent among recently deployed military personnel. Survivors of TBI often experience cognitive and emotional deficits, suggesting that long-term effects of injury may disrupt neuronal function in critical brain regions, including the amygdala, which is involved in emotion and fear memory. Amygdala hyperexcitability has been reported in both TBI and posttraumatic stress disorder patients, yet little is known regarding the effects of combined stress and TBI on amygdala structure and function at the neuronal level. The present study seeks to determine how the long-term effects of preinjury foot-shock stress and TBI interact to influence synaptic plasticity in the lateral amygdala (LA) of adult male C57BL/6J mice by using whole-cell patch clamp electrophysiology 2-3 months postinjury. In the absence of stress, TBI resulted in a significant increase in membrane excitability and spontaneous excitatory postsynaptic currents (sEPSCs) in LA pyramidal-like neurons. Foot-shock stress in the absence of TBI also resulted in increased sEPSC activity. In contrast, when preinjury stress and TBI occurred in combination, sEPSC activity was significantly decreased compared with either condition alone. There were no significant differences in inhibitory activity or total dendritic length among any of the treatment groups. These results demonstrate that stress and TBI may be contributing to amygdala hyperexcitability via different mechanisms and that these pathways may counterbalance each other with respect to long-term pathophysiology in the LA. (c) 2015 Wiley Periodicals, Inc.	[Klein, Rebecca C.; Acheson, Shawn K.; Qadri, Laura H.; Rodriguiz, Ramona M.; Wetsel, William C.; Moore, Scott D.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Klein, Rebecca C.; Moore, Scott D.] Durham Vet Affairs Med Ctr, VISN MIRECC 6, Durham, NC USA; [Acheson, Shawn K.] Durham Vet Affairs Med Ctr, Neurobiol Res Lab, Durham, NC 27705 USA; [Dawson, Alina A.; Laskowitz, Daniel T.; Dawson, Hana N.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA		Klein, RC (corresponding author), Durham VA Med Ctr, 508 Fulton St,Bldg 15,Room 506, Durham, NC 27705 USA.	rck11@duke.edu			Department of Veterans Affairs Rehabilitation and Research Development [I21RX001771]; Department of Veterans Affairs Biomedical Laboratory Research and DevelopmentUS Department of Veterans Affairs [IK2BX001267]; VISN 6 MIRECC	Contract grant sponsor: Department of Veterans Affairs Rehabilitation and Research Development; Contract grant number: I21RX001771 (to R.C.K); Contract grant sponsor: Department of Veterans Affairs Biomedical Laboratory Research and Development; Contract grant number: IK2BX001267 (to S.K.A); Contract grant sponsor: VISN 6 MIRECC (to R.C.K., S.D.M.)	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Aroniadou-Anderjaska V, 2007, AMINO ACIDS, V32, P305, DOI 10.1007/s00726-006-0415-x; Beattie MS, 2010, EUR J NEUROSCI, V32, P290, DOI 10.1111/j.1460-9568.2010.07343.x; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bryant RA, 2008, PSYCHOL MED, V38, P555, DOI 10.1017/S0033291707002231; Bryant RA, 2008, HUM BRAIN MAPP, V29, P517, DOI 10.1002/hbm.20415; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Capehart B, 2012, J REHABIL RES DEV, V49, P789, DOI 10.1682/JRRD.2011.10.0185; Chen J, 2013, NEUROSCI LETT, V541, P275, DOI 10.1016/j.neulet.2013.02.005; Chen MF, 2013, J PHYSIOL-LONDON, V591, P985, DOI 10.1113/jphysiol.2012.241125; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Christensen KV, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-9; Deng P, 2011, J NEUROTRAUM, V28, P1173, DOI 10.1089/neu.2010.1683; El Khoury-Malhame M, 2011, NEUROPSYCHOLOGIA, V49, P1969, DOI 10.1016/j.neuropsychologia.2011.03.025; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hayes JP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00089; Holli-Helenius K, 2014, J NEUROTRAUM, V31, P1153, DOI 10.1089/neu.2013.2978; Hubert GW, 2014, BRAIN STRUCT FUNCT, V219, P1169, DOI 10.1007/s00429-013-0557-z; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; Kenney K., 2015, EXP NEUROL; Klein RC, 2010, NEUROSCIENCE, V171, P1265, DOI 10.1016/j.neuroscience.2010.10.027; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; Liu ZP, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-32; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Mahanty NK, 1999, EUR J NEUROSCI, V11, P1217, DOI 10.1046/j.1460-9568.1999.00528.x; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Miller MW, 2011, PSYCHONEUROENDOCRINO, V36, P970, DOI 10.1016/j.psyneuen.2010.12.009; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Newsome MR, 2013, J INT NEUROPSYCH SOC, V19, P911, DOI 10.1017/S1355617713000817; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Padival MA, 2015, NEUROSCIENCE, V291, P128, DOI 10.1016/j.neuroscience.2015.02.012; Padival MA, 2013, NEUROSCIENCE, V246, P230, DOI 10.1016/j.neuroscience.2013.04.061; Padival M, 2013, NEUROPSYCHOPHARMACOL, V38, P1748, DOI 10.1038/npp.2013.74; Park K, 2007, BIOCHEM BIOPH RES CO, V361, P718, DOI 10.1016/j.bbrc.2007.07.064; Park K, 2011, BIOCHEM BIOPH RES CO, V404, P952, DOI 10.1016/j.bbrc.2010.12.087; Pego JM, 2010, CURR TOP BEHAV NEURO, V2, P97, DOI 10.1007/7854_2009_13; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Porton B, 2010, GENES BRAIN BEHAV, V9, P257, DOI 10.1111/j.1601-183X.2009.00555.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Rao RP, 2012, BIOL PSYCHIAT, V72, P466, DOI 10.1016/j.biopsych.2012.04.008; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Roquilly A, 2013, CRIT CARE, V17, DOI 10.1186/cc13138; Rosenkranz JA, 2010, BIOL PSYCHIAT, V67, P1128, DOI 10.1016/j.biopsych.2010.02.008; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Surges R, 2004, J NEUROSCI RES, V76, P475, DOI 10.1002/jnr.20075; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Tsolaki M, 2009, AM J ALZHEIMERS DIS, V24, P85, DOI 10.1177/1533317508329813; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; van Winsen LML, 2010, MULT SCLER J, V16, P500, DOI 10.1177/1352458509359721; Vyas A, 2006, NEUROSCIENCE, V143, P387, DOI 10.1016/j.neuroscience.2006.08.003; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2003, BRAIN RES, V965, P290, DOI 10.1016/S0006-8993(02)04162-8; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Whitaker AM, 2014, BEHAV PHARMACOL, V25, P398, DOI 10.1097/FBP.0000000000000069; Zohar J, 2011, EUR NEUROPSYCHOPHARM, V21, P796, DOI 10.1016/j.euroneuro.2011.06.001	74	6	6	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2016	94	6			SI		579	589		10.1002/jnr.23702			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK1RR	WOS:000374691900013	26707710				2022-02-06	
J	McCutcheon, V; Park, E; Liu, E; Wang, YD; Wen, XY; Baker, AJ				McCutcheon, Victoria; Park, Eugene; Liu, Elaine; Wang, Youdong; Wen, Xiao-Yan; Baker, Andrew J.			A Model of Excitotoxic Brain Injury in Larval Zebrafish: Potential Application for High-Throughput Drug Evaluation to Treat Traumatic Brain Injury	ZEBRAFISH			English	Article							NEUROSCIENCE RESEARCH; MECHANISMS; CELLS	Traumatic brain injury (TBI) is a leading cause of death and morbidity with no effective therapeutic treatments for secondary injury. Preclinical drug evaluation in rodent models of TBI is a lengthy process. In this regard, the zebrafish has numerous advantages to address the technical and time-dependent obstacles associated with drug evaluation. We developed a reproducible brain injury using glutamate excitoxicity in zebrafish larvae, a known initiator of delayed cell death in TBI. Glutamate challenge resulted in dose-dependent lethality over an 84-h observation period. We report significant decrease in locomotion (p < 0.0001) and mean velocity (p < 0.001) with 10 mu M glutamate application as measured through automated 96-well plate behavioral analysis. Application of the NMDA receptor antagonist MK-801 (400 nM) or the calpain inhibitor, MDL-28170 (20 mu M), resulted in significant recovery of locomotor function. A secA5-YFP transgenic line was used to visualize the localization of cell death due to glutamate exposure in vivo using confocal fluorescence microscopy. Our results indicate that zebrafish larvae exhibit responses to excitotoxic injury and pharmacotherapeutic intervention with pathophysiological relevance to mammalian excitotoxic brain injury. This system has potential to be applied as a high-throughput drug screening model to quickly identify candidate lead compounds for further evaluation.	[McCutcheon, Victoria; Wen, Xiao-Yan; Baker, Andrew J.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [McCutcheon, Victoria; Park, Eugene; Liu, Elaine; Wang, Youdong; Baker, Andrew J.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, 209 Victoria St,LKSKI Room 6-656, Toronto, ON M5B 1T8, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; [Wen, Xiao-Yan] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, Dept Surg, Toronto, ON, Canada		Park, E (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, 209 Victoria St,LKSKI Room 6-656, Toronto, ON M5B 1T8, Canada.	parke@smh.ca		Peterson, Victoria/0000-0003-1627-0526; Wen, Xiao-Yan/0000-0001-6728-0025	Brain Canada Foundation; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; National Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)	The authors acknowledge funding support from the Brain Canada Foundation (Dr. Baker & Dr. Wen) Canada Foundation for Innovation (Dr. Wen) and National Sciences and Engineering Research Council of Canada (Dr. Wen).	Ahmad F, 2012, BEHAVIOUR, V149, P1241, DOI 10.1163/1568539X-00003020; Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Chen John, 2010, Int J Comp Psychol, V23, P82; Clausen F, 2011, ACTA NEUROCHIR, V153, P653, DOI 10.1007/s00701-010-0871-7; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleming A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077548; Gerlai Robert, 2012, Curr Top Behav Neurosci, V12, P3, DOI 10.1007/7854_2011_180; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gonzales APW, 2014, METHOD ENZYMOL, V546, P377, DOI 10.1016/B978-0-12-801185-0.00018-0; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Hoppmann V, 2008, DEV DYNAM, V237, P788, DOI 10.1002/dvdy.21447; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kalueff AV, 2014, PROG NEURO-PSYCHOPH, V55, P1, DOI 10.1016/j.pnpbp.2014.01.022; Kalueff AV, 2014, TRENDS PHARMACOL SCI, V35, P63, DOI 10.1016/j.tips.2013.12.002; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Menezes FP, 2015, ZEBRAFISH, V12, P137, DOI 10.1089/zeb.2014.1018; Naska S, 2006, J NEUROSCI, V26, P13344, DOI 10.1523/JNEUROSCI.4462-06.2006; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Oosterhof N, 2015, GLIA, V63, P719, DOI 10.1002/glia.22780; Ota S, 2014, CONGENIT ANOM, V54, P8, DOI 10.1111/cga.12040; Panula P, 2010, NEUROBIOL DIS, V40, P46, DOI 10.1016/j.nbd.2010.05.010; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Park KJ, 2014, J CEREBR BLOOD F MET, V34, P357, DOI 10.1038/jcbfm.2013.216; Stewart AM, 2014, TRENDS NEUROSCI, V37, P264, DOI 10.1016/j.tins.2014.02.011; van Ham TJ, 2010, FASEB J, V24, P4336, DOI 10.1096/fj.10-161018; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	35	6	6	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1545-8547	1557-8542		ZEBRAFISH	Zebrafish	JUN	2016	13	3					161	169		10.1089/zeb.2015.1188			9	Developmental Biology; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Zoology	DN6UW	WOS:000377213000002	27028704				2022-02-06	
J	Strazzer, S; Pozzi, M; Avantaggiato, P; Zanotta, N; Epifanio, R; Beretta, E; Formica, F; Locatelli, F; Galbiati, S; Clementi, E; Zucca, C				Strazzer, Sandra; Pozzi, Marco; Avantaggiato, Paolo; Zanotta, Nicoletta; Epifanio, Roberta; Beretta, Elena; Formica, Francesca; Locatelli, Federica; Galbiati, Sara; Clementi, Emilio; Zucca, Claudio			Late Post-traumatic Epilepsy in Children and Young Adults: Impropriety of Long-Term Antiepileptic Prophylaxis and Risks in Tapering	PEDIATRIC DRUGS			English	Article							HEAD-INJURY; SEIZURES; EPIDEMIOLOGY; MECHANISMS; TRAUMA; DRUGS	Background After traumatic brain injury, epilepsy affects up to 20 % of children. It is a risk factor, for both clinical recovery and cognitive performance; therefore pharmacological therapy is advisable. Current guidelines recommend prophylaxis to be initiated as soon as possible and tapered 1 week after trauma. However, no guideline exists for paediatric patients and the clinical practice is heterogeneous. Objective In our institute, prophylaxis was routinely tapered 6 months after trauma. Therefore we investigated whether this prophylaxis or its tapering influenced the development of post-traumatic epilepsy, together with several clinical-demographic factors. Methods The study population comprised all patients with post-traumatic brain injury referred to this institute between 2002 and 2009 who consented to participate. Clinical, epileptological and pharmacological data were collected. The role of prophylaxis and several other predictors on occurrence of post-traumatic epilepsy was analysed through logistic regressions. Results Two hundred and three patients (145 paediatric) were followed for 57 months on average. Risk factors for epilepsy were past neurosurgery [odds ratio (OR) = 2.61, 95 % confidence interval (CI) 1.15-5.96], presence of epileptiform anomalies (OR = 6.92, 95 % CI 3.02-15.86) and the presence of prophylaxis (OR = 2.49, 95 % CI 1.12-5.52), while higher intelligence quotient (IQ) was protective (OR = 0.96, 95 % CI 0.95-0.98). While evaluating possible different effects within and after 6 months (tapering, for those under prophylaxis), we found that epileptiform anomalies (OR = 7.61, 95 % CI 2.33-24.93, and OR = 8.21, 95 % CI 3.00-22.44) and IQ (OR = 0.96, 95 % CI 0.94-0.98, and OR = 0.97, 95 % CI 0.95-0.98) were always significant predictors of epilepsy, while neurosurgery (OR = 4.38, 95 % CI 1.10-17.45) was significant only within 6 months from trauma, and prophylaxis (OR = 3.98, 95 % CI 1.62-9.75) only afterwards. Conclusions These results suggest that prophylaxis was irrelevant when present; furthermore its tapering increased the risk of epilepsy. Since the presence of epileptiform anomalies was the main predictor of post-traumatic epilepsy, such anomalies may be useful to better direct the choice of prophylaxis.	[Strazzer, Sandra; Pozzi, Marco; Avantaggiato, Paolo; Zanotta, Nicoletta; Epifanio, Roberta; Beretta, Elena; Formica, Francesca; Locatelli, Federica; Galbiati, Sara; Clementi, Emilio; Zucca, Claudio] Sci Inst IRCCS Eugenio Medea, Bosisio Parini, I-23842 Bosisio Parini, Lecco, Italy; [Clementi, Emilio] Univ Milan, L Sacco Univ Hosp, CNR, Unit Clin Pharmacol,Inst Neurosci,Dept Biomed & C, Via GB Grassi 74, I-20157 Milan, Italy		Clementi, E (corresponding author), Sci Inst IRCCS Eugenio Medea, Bosisio Parini, I-23842 Bosisio Parini, Lecco, Italy.; Clementi, E (corresponding author), Univ Milan, L Sacco Univ Hosp, CNR, Unit Clin Pharmacol,Inst Neurosci,Dept Biomed & C, Via GB Grassi 74, I-20157 Milan, Italy.	emilio.clementi@unimi.it	Beretta, Elena/AAH-5369-2019; AVANTAGGIATO, PAOLO/AAA-6387-2020; formica, francesca/AAA-6043-2020; Galbiati, Sara/AAA-7115-2020; Pozzi, Marco/J-7915-2016; Zanotta, Nicoletta/AAV-2244-2020; Pozzi, Marco/Z-2684-2019; Strazzer, Sandra/AAH-5712-2019; FEDERICA, LOCATELLI/AAA-5601-2020; Zucca, Claudio/AAV-2162-2020; epifanio, roberta/AAA-2238-2020	Beretta, Elena/0000-0002-8036-7624; AVANTAGGIATO, PAOLO/0000-0002-6076-6812; Galbiati, Sara/0000-0001-6810-359X; Pozzi, Marco/0000-0002-3800-5697; Zanotta, Nicoletta/0000-0002-2563-8209; Pozzi, Marco/0000-0002-3800-5697; Strazzer, Sandra/0000-0001-8414-6565; FEDERICA, LOCATELLI/0000-0002-8243-5483; Zucca, Claudio/0000-0001-7621-2542; epifanio, roberta/0000-0002-9177-8998; formica, francesca/0000-0002-4423-8200	Agenzia Italiana del Farmaco; Italian Ministry of HealthMinistry of Health, Italy	This work was supported by Agenzia Italiana del Farmaco and the Italian Ministry of Health (Ricerca Corrente 2016, to S.S. and E.C. and C.Z.). The funding public institutions had no role in any part of the work.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Brodie MJ, 2012, EPILEPSIA, V53, P40, DOI 10.1111/epi.12027; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Colorado Division of Workers' Compensation, 2012, TRAUM BRAIN INJ MED, P119; Dichter MA, 2009, EPILEPSIA, V50, P41, DOI 10.1111/j.1528-1167.2008.02009.x; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Formisano R, 2007, BRAIN INJURY, V21, P499, DOI 10.1080/02699050701310994; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Grisar T, 2005, ACTA NEUROL BELG, V105, P5; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Ijff DM, 2013, HAND CLINIC, V111, P707, DOI 10.1016/B978-0-444-52891-9.00073-7; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Janz D., 1982, B LEGA IT EPIL, V39, P37; JENSEN FE, 2009, EPILEPSIA S2, V50, P1, DOI DOI 10.1111/J.1528-1167.2008.02003.X; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; Munoz-Sanchez M, 2005, CHILD NERV SYST, V21, P128, DOI 10.1007/s00381-004-1036-x; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Weston J, 2015, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.00007286.PUB3; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; YOUNG B, 1983, CHILD BRAIN, V10, P185; Zhang LL, 2011, EPILEPTIC DISORD, V13, P349, DOI 10.1684/epd.2011.0444	36	6	7	0	7	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1174-5878	1179-2019		PEDIATR DRUGS	Pediatr. Drugs	JUN	2016	18	3					235	242		10.1007/s40272-016-0167-3			8	Pediatrics; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Pharmacology & Pharmacy	DM7AE	WOS:000376503400008	26913859	Green Submitted			2022-02-06	
J	Tu, Y; Miao, XM; Yi, TL; Chen, XY; Sun, HT; Cheng, SX; Zhang, S				Tu, Yue; Miao, Xiao-mei; Yi, Tai-long; Chen, Xu-yi; Sun, Hong-tao; Cheng, Shi-xiang; Zhang, Sai			Neuroprotective effects of bloodletting at Jing points combined with mild induced hypothermia in acute severe traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; Jing points; bloodletting; mild induced hypothermia; acute severe traumatic brain injury; brain edema; brain water content; blood-brain barrier; neural regeneration	THERAPEUTIC HYPOTHERMIA; HEAD-INJURY; RATS; STROKE; HIPPOCAMPUS; HEMORRHAGE; GLUTAMATE	Bloodletting at Jing points has been used to treat coma in traditional Chinese medicine. Mild induced hypothermia has also been shown to have neuroprotective effects. However, the therapeutic effects of bloodletting at Jing points and mild induced hypothermia alone are limited. Therefore, we investigated whether combined treatment might have clinical effectiveness for the treatment of acute severe traumatic brain injury. Using a rat model of traumatic brain injury, combined treatment substantially alleviated cerebral edema and blood-brain barrier dysfunction. Furthermore, neurological function was ameliorated, and cellular necrosis and the inflammatory response were lessened. These findings suggest that the combined effects of bloodletting at Jing points (20 L, twice a day, for 2 days) and mild induced hypothermia (6 hours) are better than their individual effects alone. Their combined application may have marked neuroprotective effects in the clinical treatment of acute severe traumatic brain injury.	[Tu, Yue; Miao, Xiao-mei; Yi, Tai-long; Chen, Xu-yi; Sun, Hong-tao; Cheng, Shi-xiang; Zhang, Sai] Univ Chinese Peoples Armed Police Forces, Affiliated Hosp Logist, Tianjin Key Lab Neurotrauma Repair, Inst Traumat Brain Injury & Neurosci,Chinese Peop, Tianjin, Peoples R China; [Tu, Yue; Miao, Xiao-mei; Cheng, Shi-xiang; Zhang, Sai] Tianjin Univ Tradit Chinese Med, Grad Sch, Tianjin, Peoples R China		Cheng, SX; Zhang, S (corresponding author), Univ Chinese Peoples Armed Police Forces, Affiliated Hosp Logist, Tianjin Key Lab Neurotrauma Repair, Inst Traumat Brain Injury & Neurosci,Chinese Peop, Tianjin, Peoples R China.; Cheng, SX; Zhang, S (corresponding author), Tianjin Univ Tradit Chinese Med, Grad Sch, Tianjin, Peoples R China.	shixiangcheng@vip.126.com; zhangsai718@vip.126.com		Cheng, Shi-xiang/0000-0003-2529-719X; Zhang, Sai/0000-0002-8028-4183	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31200809]	This work was supported by the National Natural Science Foundation of China, No. 31200809.	Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Cheng SX, 2013, THER HYPOTHERMIA TEM, V3, P132, DOI 10.1089/ther.2013.0005; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; Deng H, 2003, STROKE, V34, P2495, DOI 10.1161/01.STR.0000091269.67384.E7; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Gao J, 2014, MED SCI MONITOR, V20, P499, DOI 10.12659/MSM.890589; Gao L, 2012, J TRADIT CHIN MED, V32, P471, DOI 10.1016/S0254-6272(13)60057-6; Garling RJ, 2014, NEURAL REGEN RES, V9, P1891, DOI 10.4103/1673-5374.145355; Guo Y., 2003, TIANJIN J TRADIT CHI, V20, P35; He SQ, 2002, ZHEN JIU LIN CHUANG, V18, P43; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jiang LY, 2013, ZHENJIU LINCHUANG ZA, V29, P54; Kabadi SV, 2014, NEURAL REGEN RES, V9, P1578, DOI 10.4103/1673-5374.141779; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li YH, 2015, MOL MED REP, V11, P1991, DOI 10.3892/mmr.2014.2928; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Oddo M, 2009, STROKE, V40, P1913, DOI 10.1161/STROKEAHA.108.534115; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schreckinger M, 2009, NEUROCRIT CARE, V11, P427, DOI 10.1007/s12028-009-9256-2; Shin SS, 2015, NEURAL REGEN RES, V10, P1552, DOI 10.4103/1673-5374.165309; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; Sun HW, 2013, BIOL CHEM, V394, P1317, DOI 10.1515/hsz-2013-0142; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Wilson M, 2007, BRIT J ANAESTH, V99, P43, DOI 10.1093/bja/aem142	28	6	8	1	5	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUN	2016	11	6					931	936		10.4103/1673-5374.184491			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DS9QU	WOS:000381119200025	27482221	Green Published, gold			2022-02-06	
J	Moreira, NB; Mazzardo, O; Vagetti, GC; De Oliveira, V; De Campos, W				Moreira, Natalia Boneti; Mazzardo, Oldemar; Vagetti, Gislaine Cristina; De Oliveira, Valdomiro; De Campos, Wagner			Quality of life perception of basketball master athletes: association with physical activity level and sports injuries	JOURNAL OF SPORTS SCIENCES			English	Article						Quality of life; sports; athletes; basketball; athletic injuries	PROFESSIONAL FOOTBALL; HEALTH; PLAYERS; RISK; EPIDEMIOLOGY; POPULATION; PREVALENCE; CONCUSSION; IMPACT; SF-36	This study aimed to verify the prevalence and characteristics of sports injuries (SI) and determine the association between the physical activity level (PA) and SI with perception of health-related quality of life (HRQoL) in Brazilian basketball master athletes. A cross-sectional study was conducted with 410 male master athletes, between 35 and 85years of age (mean 52.26, SD +/- 11.83). The HRQoL was assessed using the Medical Outcomes Study - Short Form-36. The PA was evaluated using the International Physical Activity Questionnaire. Information regarding SI was collected using the Reported Morbidity Survey. Poisson regression, as estimated by the prevalence ratio (PR), was used as a measure of the association of PA and SI with HRQoL. The majority of athletes showed a high SI prevalence (58.3%) and reported one injury (67.8%) that occurred during training (61.1%) and primarily affected a lower limb (74.6%). The adjusted regression models showed a positive association of PA with the Functional Capacity (PR=1.46, 95% confidence interval [CI]=1.12-1.90) and Physical Component (PR=1.32, 95% CI=1.03-1.70) of HRQoL. Furthermore, the SI were negatively associated with HRQoL in Functional Capacity (PR=1.85, 95% CI=1.51-2.27), Physical Aspects (PR=3.99, 95% CI=3.08-5.18), Pain (PR=1.65, 95% CI=1.26-2.16), Social Functioning (PR=1.79, 95% CI=1.41-2.27), Emotional Aspects (PR=4.40, 95% CI=3.35-5.78), Mental Health domains (PR=1.37, 95% CI=1.06-1.68), Physical Component (PR=2.35, 95% CI=1.90-2.90) and Mental Component (PR=2.65, 95% CI=2.14-3.29). These results highlighted that master athletes showed a high SI prevalence, primarily in the lower limbs. PA positively correlates with the physical HRQoL domain, whereas SI may decrease the HRQoL levels of both physical and mental domains.	[Moreira, Natalia Boneti] Fac Dom Bosco, Physiotherapy Dept, Curitiba, Parana, Brazil; [Mazzardo, Oldemar; De Oliveira, Valdomiro; De Campos, Wagner] Univ Fed Parana, Dept Phys Educ, BR-80060000 Curitiba, Parana, Brazil; [Vagetti, Gislaine Cristina] Univ Estadual Parana, Mus Therapy Dept, Curitiba, Parana, Brazil		Moreira, NB (corresponding author), Rua Paulo Martins,314 Campus Merces, BR-80710010 Curitiba, Parana, Brazil.	nataliaboneti@hotmail.com	Campos, Wagner De/AAY-7103-2021; Vagetti, Gislaine Cristina/AAW-5949-2020; De Oliveira, Valdomiro/ABH-3246-2020	Campos, Wagner De/0000-0003-3979-1017; Vagetti, Gislaine Cristina/0000-0003-0704-1297; Boneti Moreira, Natalia/0000-0003-1975-6708	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Universidade Federal do Parana (UFPR)	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Universidade Federal do Parana (UFPR).	Andrew NE, 2010, SPORTS MED, V40, P141, DOI 10.2165/11319750-000000000-00000; Associacao Brasileira de Empresas de Pesquisa, 2008, CRIT CLASS EC BRAS; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Berczik K, 2012, SUBST USE MISUSE, V47, P403, DOI 10.3109/10826084.2011.639120; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Brown DW, 2004, MED SCI SPORT EXER, V36, P890, DOI 10.1249/01.MSS.0000126778.77049.76; Byberg L., 2009, BRIT MED J, V341, P1; Ciconelli R.M., 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Cooper Leslie W, 2007, Curr Sports Med Rep, V6, P392, DOI 10.1007/s11932-007-0058-z; Cumps E, 2007, J SPORT SCI MED, V6, P204; de Moraes SA, 2013, REV LAT-AM ENFERM, V21, P835, DOI 10.1590/S0104-11692013000400002; Deitch JR, 2006, AM J SPORT MED, V34, P1077, DOI 10.1177/0363546505285383; Del Duca GF, 2012, CAD SAUDE PUBLICA, V28, P75, DOI 10.1590/S0102-311X2012000100008; Hino AAF, 2009, REV BRAS MED ESPORTE, V15, P36, DOI 10.1590/S1517-86922009000100008; Gomes I., 2013, PAJAR, V1, P20; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hoshi RA, 2008, REV BRAS MED ESPORTE, V14, P440, DOI 10.1590/S1517-86922008000500008; Huffman GR, 2008, J BONE JOINT SURG AM, V90A, P471, DOI 10.2106/JBJS.G.00325; Irgens A, 2007, OCCUP MED-OXFORD, V57, P349, DOI 10.1093/occmed/kqm032; Jacobsson J, 2013, BRIT J SPORT MED, V47, DOI 10.1136/bjsports-2012-091651; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Laguardia Josué, 2013, Rev. bras. epidemiol., V16, P889, DOI 10.1590/S1415-790X2013000400009; Lam KC, 2013, J ATHL TRAINING, V48, P233, DOI 10.4085/1062-6050-48.2.12; Lee J, 2009, ANN ACAD MED SINGAP, V38, P714; Longo UG, 2012, AM J SPORT MED, V40, P996, DOI 10.1177/0363546512438761; Maffulli N, 2011, BRIT MED BULL, V97, P47, DOI 10.1093/bmb/ldq026; Matsudo SMM, 2001, REV BRAS ATIV FIS SA, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; McAllister DR, 2001, AM J SPORT MED, V29, P806, DOI 10.1177/03635465010290062201; McCarthy MM, 2013, AM J SPORT MED, V41, P645, DOI 10.1177/0363546512474223; McLeod TCV, 2009, J ATHL TRAINING, V44, P603, DOI 10.4085/1062-6050-44.6.603; Moreira NB, 2014, APUNTS-MED ESPORT, V49, P123, DOI 10.1016/j.apunts.2014.06.003; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; Omorou YA, 2013, QUAL LIFE RES, V22, P2021, DOI 10.1007/s11136-013-0355-3; Pardini R., 2001, VALIDACAO QUESTIONAR, P45; Parsons JT, 2011, J SPORT REHABIL, V20, P17, DOI 10.1123/jsr.20.1.17; Pastre Carlos Marcelo, 2005, Rev Bras Med Esporte, V11, P43, DOI 10.1590/S1517-86922005000100005; Pastre Carlos Marcelo, 2004, Rev Bras Med Esporte, V10, P01, DOI 10.1590/S1517-86922004000100001; Pucci G, 2012, QUAL LIFE RES, V21, P1537, DOI 10.1007/s11136-011-0083-5; Rosenbloom C., 2006, NUTR TODAY, V40, P267; Sguizzatto Guilherme Turolla, 2006, Sao Paulo Med. J., V124, P304, DOI 10.1590/S1516-31802006000500014; Simon JE, 2014, AM J SPORT MED, V42, P423, DOI 10.1177/0363546513510393; Snyder AR, 2010, J SPORT REHABIL, V19, P237, DOI 10.1123/jsr.19.3.237; Tanaka H, 2008, J PHYSIOL-LONDON, V586, P55, DOI 10.1113/jphysiol.2007.141879; Turner AP, 2000, BRIT J SPORT MED, V34, P332, DOI 10.1136/bjsm.34.5.332; Vagetti GC, 2014, REV BRAS PSIQUIATR, V36, P76, DOI 10.1590/1516-4446-2012-0895; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, 2000, TECHN REP SER, V894; Wilks DC, 2009, J MUSCULOSKEL NEURON, V9, P236	52	6	6	2	49	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.	MAY 18	2016	34	10					988	996		10.1080/02640414.2015.1082615			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	DF0DM	WOS:000371009200013	26323316				2022-02-06	
J	Tomaszewski, R; Mitrushina, M				Tomaszewski, Robert; Mitrushina, Maura			Utility of the Community Integration Questionnaire in a sample of adults with neurological and neuropsychiatric disorders receiving prevocational training	DISABILITY AND REHABILITATION			English	Article						CIQ psychometrics; Community Integration Questionnaire; neurological; outcome assessment (health care)	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; PSYCHOMETRIC PROPERTIES; PARTICIPATION; VALIDITY; OUTCOMES; APHASIA; PEOPLE; CIQ	Purpose: To investigate utility of the Community Integration Questionnaire (CIQ) in a mixed sample of adults with neurological and neuropsychiatric disorders. Method: Cross-sectional, interview-based study. Participants were community-dwelling adults with disabilities resulting from neurological and neuropsychiatric disorders (N=54), who participated in a pre-vocational readiness and social skills training program. Psychometric properties of the Community Integration Questionnaire (CIQ) were assessed and validated against Mayo-Portland Adaptability Inventory (MPAI) and The Problem Checklist from the New York University Head Injury Family Interview (PCL). Results: Based on the revised scoring procedures, psychometric properties of the CIQ Home Competency scale were excellent, followed by the Total score and Social Integration scale. Productive Activity scale had low content validity and a weak association with the total score. Convergent and discriminant validity of the CIQ were demonstrated by correlation patterns with MPAI scales in the expected direction. Significant relationship was found with PCL Physical/Dependency scale. Significant associations were found with sex, living status, and record of subsequent employment. Conclusions: The results provide support for the use of the CIQ as a measure of participation in individuals with neurological and neuropsychiatric diagnoses and resulting disabilities.Implications for RehabilitationAn important goal of rehabilitation and training programs for individuals with dysfunction of the central nervous system is to promote their participation in social, vocational, and domestic activities.The Community Integration Questionnaire (CIQ) is a brief and efficient instrument for measuring these participation domains.This study demonstrated good psychometric properties and high utility of the CIQ in a sample of 54 individuals participating in a prevocational training program.	[Tomaszewski, Robert; Mitrushina, Maura] Calif State Univ Northridge, Dept Psychol, Northridge, CA 91330 USA; [Tomaszewski, Robert; Mitrushina, Maura] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA		Tomaszewski, R (corresponding author), 21053 Devonshire St,Ste 101, Chatsworth, CA 91311 USA.	tomaszewskibob@aol.com					Dalemans R, 2008, CLIN REHABIL, V22, P542, DOI 10.1177/0269215507087462; Dalemans RJ, 2010, ARCH PHYS MED REHAB, V91, P395, DOI 10.1016/j.apmr.2009.10.021; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Ehde DM, 2006, MULT SCLER J, V12, P629, DOI 10.1177/1352458506071346; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Johnston Mark, 2002, J Spinal Cord Med, V25, P11; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Kratz AL, 2015, J SPINAL CORD MED, V38, P446, DOI 10.1179/2045772313Y.0000000182; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Lequerica AH, 2013, J HEAD TRAUMA REHAB, V28, pE14, DOI 10.1097/HTR.0b013e31826e3ca8; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; McVeigh SA, 2009, J SPINAL CORD MED, V32, P115, DOI 10.1080/10790268.2009.11760762; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; SCHMIDT MF, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199508000-00003; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Strauser DR, 2012, INT J REHABIL RES, V35, P311, DOI 10.1097/MRR.0b013e3283559b4e; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; van der Slot WMA, 2007, DISABIL REHABIL, V29, P179, DOI 10.1080/09638280600747686; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 1993, INT CLASS IMP DIS HA; World Health Organization, 2007, INT CLASS FUNCT DIS	28	6	6	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAY 7	2016	38	10					1016	1022		10.3109/09638288.2015.1070296			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DG1HE	WOS:000371815900011	26289368				2022-02-06	
J	Jamjoom, AAB; Chari, A; Salijevska, J; Meacher, R; Brennan, P; Statham, P				Jamjoom, Aimun A. B.; Chari, Aswin; Salijevska, Julita; Meacher, Roseanne; Brennan, Paul; Statham, Patrick			A national survey of thromboprophylaxis in traumatic brain injury in the United Kingdom	BRITISH JOURNAL OF NEUROSURGERY			English	Article						National survey; thromboprophylaxis; traumatic brain injury	INTERMITTENT PNEUMATIC COMPRESSION; DEEP-VEIN THROMBOSIS; ENOXAPARIN PROPHYLAXIS; VENOUS THROMBOEMBOLISM; PREVENTION; HEPARIN; SAFETY; STOCKINGS; EFFICACY; TRIAL	Introduction: Patients with traumatic brain injury (TBI) are at increased risk of venous thromboembolic events (VTE). In this survey, we aimed to assess current practice in the United Kingdom and identify areas of variation for further investigation. Methods: We distributed a case-based survey to neurosurgical consultants and trainees via e-mail. The survey included four index TBI cases commonly seen: a surgically treated acute extradural haematoma, bilateral frontal contusions treated conservatively, diffuse axonal injury requiring critical care and a conservatively managed small acute subdural haematoma. Each case vignette included questions looking at a range of areas regarding thromboprophylaxis. Results: Sixty-two responses were collected among UK neurosurgeons with a good geographic distribution. In each case, over 90% of respondents would initiate mechanical prophylaxis (MTP) at admission. There was greater variation on the decision to commence pharmacological prophylaxis (PTP). Consultants showed a higher willing to commence PTP across all cases (84%) compared to trainees (77.4%). Low molecular weight heparin (LMWH) was the favoured PTP agent in over 90% of respondents. There was significant variability in the timing of initiation of PTP within and between cases. The median times to commence PTP across all four cases ranged from 1 to 7 days. Conclusion: This survey highlighted broad consensus on the use of MTP and choice of PTP agent, when used. However, the survey also demonstrated wide intra-case variation on whether to start PTP and particularly the timing of initiation. This discordance in practice shines light on the lack of evidence guiding thromboprophyalxis in TBI and adds weight to the need for prospective randomised trials to guide clinical management.	[Jamjoom, Aimun A. B.; Brennan, Paul; Statham, Patrick] Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Chari, Aswin; Salijevska, Julita; Meacher, Roseanne] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Intens Care Unit, London, England		Jamjoom, AAB (corresponding author), Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	aabjamjoom@googlemail.com		Brennan, Paul/0000-0002-7347-830X	National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2014-21-011] Funding Source: researchfish		Arabi YM, 2013, CHEST, V144, P152, DOI 10.1378/chest.12-2028; Arnold JD, 2010, AM SURGEON, V76, P563; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Collen JF, 2008, CHEST, V134, P237, DOI 10.1378/chest.08-0023; Cupitt JM, 2001, ANAESTHESIA, V56, P780; Dennis M, 2013, LANCET, V382, P516, DOI 10.1016/S0140-6736(13)61050-8; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Jamjoom AAB, 2013, J NEUROTRAUM, V30, P503, DOI 10.1089/neu.2012.2584; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Revill A, 2014, J INTENSIVE CARE SOC, V15, P328; Shackford SR, 2004, ANN SURG, V240, P496; TURPIE AGG, 1989, ARCH INTERN MED, V149, P679, DOI 10.1001/archinte.149.3.679; VANDENBELT AG, 2000, COCHRANE DB SYST REV; Wahl WL, 2011, J TRAUMA, V71, P399	18	6	6	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAY 3	2016	30	2					240	245		10.3109/02688697.2016.1161170			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI3LK	WOS:000373399900015	26999404	Green Submitted			2022-02-06	
J	Boyd, B; Rodgers, C; Aupperle, R; Jak, A				Boyd, Briana; Rodgers, Carie; Aupperle, Robin; Jak, Amy			Case Report on the Effects of Cognitive Processing Therapy on Psychological, Neuropsychological, and Speech Symptoms in Comorbid PTSD and TBI	COGNITIVE AND BEHAVIORAL PRACTICE			English	Article						PTSD; posttraumatic stress disorder; traumatic brain injury; cognitive processing therapy	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; VETERANS; MEMORY; HISTORY; AFGHANISTAN; OUTCOMES; IRAQ	Both posttraumatic stress disorder (PTSD) and history of traumatic brain injury (TBI) are prevalent conditions in military veterans, frequently co-occur in this population, and have substantial symptom overlap. Cognitive processing therapy (CPT) is an empirically supported treatment for PTSD but questions have arisen about its efficacy for individuals with a history of TBI, particularly those experiencing cognitive or other neurologic symptoms. Research examining the generalizability of CPT to veterans with both PTSD and a history of TBI has been limited. We describe the use of CPT with a veteran who presented with PTSD, a history of mild TBI, subjective cognitive complaints, objective cognitive deficits, and speech disturbance (stuttering). This case study demonstrates that CPT can effectively and significantly reduce core PTSD symptoms as well as cognitive symptoms and speech disturbances in this comorbid presentation.	[Boyd, Briana; Rodgers, Carie] Vet Med Res Fdn, San Diego, CA USA; [Rodgers, Carie] Univ Calif San Diego, VA Ctr Excellence Stress & Mental Hlth, San Diego, CA 92103 USA; [Aupperle, Robin] Laureate Inst Brain Res, Tulsa, OK USA; [Jak, Amy] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA; [Jak, Amy] VA Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Jak, Amy] Univ Calif San Diego, San Diego, CA 92103 USA		Jak, A (corresponding author), 3350 La Jolla Village Dr 116B, San Diego, CA 92161 USA.	ajak@ucsd.edu	Aupperle, Robin/AAU-8550-2020		Department of Defense awardUnited States Department of Defense [W81XWH-11-1-0641]	No authors have any actual or potential conflicts of interest. Funding was provided by Department of Defense award W81XWH-11-1-0641.	Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Bagalman, 2013, TRAUMATIC BRAIN INJU; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catalano G, 2009, J PSYCHIATR PRACT, V15, P484, DOI 10.1097/01.pra.0000364292.93704.65; *CDCP, 2006, FACTS TRAUM BRAIN IN; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Congressional Research Service, 2007, US MIL CAS STAT OP I; Cook J. M., 2014, ADM POLICY MENTAL HL; Corrigan JD, 2005, PSYCHOL ADDICT BEHAV, V19, P131, DOI 10.1037/0893-164X.19.2.131; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Veterans Affairs/ Department of Defense ( VA/ DoD), 2009, VA DOD CLIN PRACT GU; Devineni T, 2004, J ANXIETY DISORD, V18, P211, DOI 10.1016/S0887-6185(02)00247-5; Foa EB, 2006, J CLIN PSYCHIAT, V67, P40; Government Accountability Office, 2005, VET DIS BEN CLAIMS P; Heaton R.K., 1981, WISCONSIN CARD SORTI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jak A. J., 2015, ENHANCESD COGN UNPUB; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Keane, 2004, ASSESSING PSYCHOL TR, P63; Kennedy C M, 2001, CNS Spectr, V6, P787; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lundgren K, 2010, J NEUROLINGUIST, V23, P447, DOI 10.1016/j.jneuroling.2009.08.008; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mittenberg W, 2008, TXB CLIN NEUROPSYCHO, P430; Monson C. M., 2007, COGNITIVE PROCESSING; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Moore SA, 2009, CURR OPIN PSYCHIATR, V22, P19, DOI 10.1097/YCO.0b013e328314e3bb; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; RESICK PA, 1992, J CONSULT CLIN PSYCH, V60, P748, DOI 10.1037/0022-006X.60.5.748; Roebuck-Spencer T, 2008, TXB CLIN NEUROPSYCHO, P411; ROTHBAUM BO, 1991, BEHAV THER, V22, P449, DOI 10.1016/S0005-7894(05)80377-6; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stein DJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002795.pub2; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stringer AY, 2011, BRAIN INJURY, V25, P169, DOI 10.3109/02699052.2010.541894; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Twamley E. W., COGSMART CO IN PRESS; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; Vasterling JJ, 2011, J INT NEUROPSYCH SOC, V17, P1, DOI 10.1017/S1355617710001116; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Wald Jaye, 2004, Cognitive Behaviour Therapy, V33, P12, DOI 10.1080/16506070310005141; Walter KH, 2010, J TRAUMA STRESS, V23, P292, DOI 10.1002/jts.20506; Wang Y., 2004, JOURNAL OF COMMUNICA, V38, P231; Weathers F.W., 1993, ANN CONV INT SOC TRA; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler, 2008, WAIS 4 ADM SCORING M; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	70	6	6	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1077-7229	1878-187X		COGN BEHAV PRACT	Cogn. Behav. Pract.	MAY	2016	23	2					173	183		10.1016/j.cbpra.2015.10.001			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DK6HM	WOS:000375023300004					2022-02-06	
J	Harwell, DM; Gibson, JL; Fessler, RD; Holtz, J; Pettigrew, DB; Kuntz, C				Harwell, Daniel M.; Gibson, Justin L.; Fessler, Richard David; Holtz, Jeffrey; Pettigrew, David B.; Kuntz, Charles			Pia Mater Significantly Contributes to Spinal Cord Intraparenchymal Pressure in a Simulated Model of Edema	SPINE			English	Article						craniectomy; degeneration; hyperosmolar; hyperosmotic; interstitial pressure; intracranial pressure; intramedullary pressure; laminectomy; meninges; Monro-Kellie; spinal cord injury; swelling; syringomyelia; traumatic brain injury	TRAUMATIC BRAIN-INJURY; EARLY DECOMPRESSIVE CRANIECTOMY; THORACIC KYPHOTIC DEFORMITY; CEREBRAL-ARTERY INFARCTION; SEVERE HEAD-INJURY; INTRAMEDULLARY PRESSURE; SURGICAL DECOMPRESSION; MULTICENTER; DURAPLASTY; CHILDREN	Study Design. Intraparenchymal pressure (IPP) measurements in an in vitro cadaveric model of CNS edema. Objective. To assess the contribution of pia mater to PP and the effect of piotomy. Summary of Background Data. Multicenter randomized control trials have shown that decompression with durotomy/ duroplasty significantly decreases intracranial pressure (ICP). There is a paucity of evidence regarding the effectiveness of decompression of the spinal cord by piotomy. Methods. The supratentorial brain and spinal cord were removed from six fresh cadavers. Dura and arachnoid mater were removed. ICP monitors were placed bilaterally in the frontal and parietal lobes, and centrally in the cervical and thoracic spinal cord. To simulate edema, specimens were submerged in hypotonic solution. IPP was recorded for 5 days. A complete dorsal midline piotomy was performed on the spinal cord and resulting IPP was recorded. Results. Brain and spinal cord both increased in weight. IPP significantly increased in both brain and spinal cord. The IPP increase within the spinal cord was substantially greater (averages: all four lobes=4.0mm Hg; cervical-73.7mm Hg; thoracic= 49.3 mm Hg). After piotomy, cervical and thoracic spinal cord IPP decreased immediately (avg. postpiotomy IPP= 9.7 and 10.3, respectively). Conclusion. There were differential effects on brain and spinal cord IPP. Brain IPP increased only slightly, possibly because of the absence of the cranium and dura mater. In contrast, spinal cord IPP increased substantially even in the absence of the laminae, dura, and arachnoid mater. Piotomy immediately and dramatically reduced spinal cord IPP. These data are consistent with the hypothesis that spinal cord IPP is primarily dependent on constraints imposed by the pia mater. Conversely, in the absence of the cranium and dura mater, the sulci may permit the pia-invested brain to better acc.ommodate edema without significant increases in IPP.	[Harwell, Daniel M.; Gibson, Justin L.; Fessler, Richard David; Holtz, Jeffrey; Pettigrew, David B.; Kuntz, Charles] Univ Cincinnati, Coll Med, Dept Neurosurg, Mayfield Clin & Spine Inst,UC Neurosci Inst, Cincinnati, OH 45221 USA; [Pettigrew, David B.] Univ Cincinnati, Coll Med, Dept Med Educ, Cincinnati, OH 45221 USA		Pettigrew, DB (corresponding author), Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30907 USA.; Pettigrew, DB (corresponding author), Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30907 USA.	pettigdb@live.com			DePuy/Synthes	DePuy/Synthes grant funds were received in support of this work. Relevant financial activities outside the submitted work: grants, employment.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bor-Seng-Shu E, 2004, ARQ NEURO-PSIQUIAT, V62, P715, DOI 10.1590/S0004-282X2004000400028; Chavanne A, 2011, SPINE, V36, P1619, DOI 10.1097/BRS.0b013e3181fc17b0; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Elsberg CA, 1911, AM J MED SCI, V142, P636; Farley CW, 2012, SPINE, V37, pE224, DOI 10.1097/BRS.0b013e31822dd69b; Figaji AA, 2007, CHILD NERV SYST, V23, P1331, DOI 10.1007/s00381-007-0388-4; Figaji AA, 2006, SAMJ S AFR MED J, V96, P969; FREEMAN LW, 1953, ANN SURG, V137, P433, DOI 10.1097/00000658-195304000-00001; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Huang X, 2010, INT J MED SCI, V7, P385; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Smith JS, 2010, J BONE JOINT SURG AM, V92A, P1206, DOI 10.2106/JBJS.I.00740; Staykov D, 2011, STROKE, V42, P513, DOI 10.1161/STROKEAHA.110.605642; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Winestone JS, 2012, J NEUROSURG-SPINE, V16, P195, DOI 10.3171/2011.10.SPINE11377; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	19	6	8	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAY	2016	41	9					E524	E529		10.1097/BRS.0000000000001306			6	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	DL4QV	WOS:000375623200003	27128257				2022-02-06	
J	Jones, A				Jones, Alvin			Repeatable Battery for the Assessment of Neuropsychological Status: Effort Index Cutoff Scores for Psychometrically Defined Malingering Groups in a Military Sample	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						RBANS; Effort Index; Performance validity testing; Malingering; military	SYMPTOM VALIDITY TEST; HENRY-HEILBRONNER INDEX; TRAUMATIC BRAIN-INJURY; RESPONSE BIAS SCALE; FAKE BAD SCALE; CLASSIFICATION ACCURACY; NEUROCOGNITIVE DYSFUNCTION; TEST-PERFORMANCE; DIGIT SPAN; BASE RATES	Objective. This research examined cutoff scores for the Effort Index (EI), an embedded measure of performance validity, for the Repeatable Battery for the Assessment of Neuropsychological Status. EI cutoffs were explored for an active-duty military sample composed mostly of patients with traumatic brain injury. Method. Four psychometrically defined malingering groups including a definite malingering, probable to definite malingering, probable malingering, and a combined group were formed based on the number of validity tests failed. Results. Excellent specificities (0.97 or greater) were found for all cutoffs examined (EI >= 1 to EI >= 3). Excellent sensitivities (0.80 to 0.89) were also found for the definite malingering group. Sensitivities were 0.49 or below for the other groups. Positive and negative predictive values and likelihood ratios indicated that the cutoffs for EI were much stronger for ruling-in than ruling-out malingering. Analyses indicated the validity tests used to form the malingering groups were uncorrelated, which serves to enhance the validity of the formation of the malingering groups. Conclusions. Cutoffs were similar to other research using samples composed predominantly of head-injured individuals.	[Jones, Alvin] Womack Army Med Ctr, Ft Bragg, NC USA		Jones, A (corresponding author), Dept Behav Hlth, 2817 Riley Rd,Bldg 4-2817, Ft Bragg, NC 28310 USA.	alrobj@googlemail.com					Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Barker MD, 2010, CLIN NEUROPSYCHOL, V24, P1064, DOI 10.1080/13854046.2010.486009; Barth J. T., 2010, ACUTE BATTLEFIELD AS, P127; Beatty WW, 2004, ARCH CLIN NEUROPSYCH, V19, P825, DOI 10.1016/j.acn.2003.12.001; Beatty WW, 2003, ARCH CLIN NEUROPSYCH, V18, P509, DOI 10.1016/S0887-6177(02)00148-8; Ben-Porath Y. S., 2011, MMPI 2 RF MINNESOTA; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Binder LM, 2014, CLIN NEUROPSYCHOL, V28, P1366, DOI 10.1080/13854046.2014.978383; Burton RL, 2015, ARCH CLIN NEUROPSYCH, V30, P1, DOI 10.1093/arclin/acu070; Crawford JR, 2009, CLIN NEUROPSYCHOL, V23, P624, DOI 10.1080/13854040802524229; Crighton AH, 2015, ARCH CLIN NEUROPSYCH, V30, P181, DOI 10.1093/arclin/acv002; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Department of Defense, 2012, 2012 DEM REP PROF MI; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Dionysus KE, 2011, ARCH CLIN NEUROPSYCH, V26, P81, DOI 10.1093/arclin/acq096; Duff K, 2011, APPL NEUROPSYCHOL, V18, P11, DOI 10.1080/09084282.2010.523354; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Green P, 2008, TEST MANUAL NONVERBA; Green P., 2003, MANUAL WORD MEMORY T; Green P., 2004, TEST MANUAL MED SYMP; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Hayden SR, 1999, ANN EMERG MED, V33, P575, DOI 10.1016/S0196-0644(99)70346-X; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Henry GK, 2013, CLIN NEUROPSYCHOL, V27, P509, DOI 10.1080/13854046.2012.739644; Holzer L, 2007, SCHIZOPHR RES, V95, P48, DOI 10.1016/j.schres.2007.06.013; Hook JN, 2009, ARCH CLIN NEUROPSYCH, V24, P231, DOI 10.1093/arclin/acp026; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1373, DOI 10.1080/13854046.2013.851740; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Jones A, 2011, CLIN NEUROPSYCHOL, V25, P1207, DOI 10.1080/13854046.2011.600726; Kaemmer, 1989, MINNESOTA MULTIPHASI; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GJ, 2007, ASSESSMENT MALINGERE, P3; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Larson EB, 2005, J CLIN EXP NEUROPSYC, V27, P16, DOI 10.1080/138033990513564; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lippa SM, 2013, BRAIN INJURY, V27, P689, DOI 10.3109/02699052.2013.771793; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Novitski J, 2012, ARCH CLIN NEUROPSYCH, V27, P190, DOI 10.1093/arclin/acr119; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Peck CP, 2013, CLIN NEUROPSYCHOL, V27, P693, DOI 10.1080/13854046.2013.779032; Randolph C., 1998, REPEATABLE BATTERY A; Randolph C., 2012, REPEATABLE BATTERY A; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tsushima WT, 2011, CLIN NEUROPSYCHOL, V25, P1403, DOI 10.1080/13854046.2011.613854; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Whitney KA, 2013, ARCH CLIN NEUROPSYCH, V28, P222, DOI 10.1093/arclin/act012; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015	70	6	6	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2016	31	3					273	283		10.1093/arclin/acw006			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DL1WX	WOS:000375424900008	26972457	hybrid			2022-02-06	
J	Larres, DT; Carr, W; Gonzales, EG; Hawley, JS				Larres, David T.; Carr, Walter; Gonzales, Elizandro G.; Hawley, Jason S.			The Natural History of Acute Recovery of Blast-Induced Mild Traumatic Brain Injury: A Case Series During War	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium	AUG 17-21, 2014	Fort Lauderdale, FL				ACUTE CONCUSSION; EXPLOSIVE BLAST; TBI; NEUROTRAUMA; MANAGEMENT; EXPOSURE; UTILITY; MATTER; MODEL	Traumatic brain injury (TBI) secondary to blast exposure is a common injury in the Global War on Terrorism, but little is known about the acute effects, recovery, pathophysiology, and neuropathology of blast-induced mild TBI (mTBI) in humans in a battlefield environment. Moreover, there is ongoing debate whether blast-induced mTBI is a different injury with a unique pathophysiology compared with mTBI from blunt trauma. In the case series reported here from Craig Joint Theater Hospital at Bagram Airfield, Afghanistan, 15 military service members with acute concussion/mTBI associated with blast exposure were evaluated within the first 24 hours after concussion and on days 2, 3, 5, and 7 with a Graded Symptom Checklist and a balance assessment, the Balance Error Scoring System. These data suggest that the recovery in blast-induced mTBI follows the pattern of recovery in sports-related concussion reported in The National Collegiate Athletic Association Concussion Study. In this retrospective case series, we provide the first description of the natural history of acute recovery in blast-induced mTBI, and we suspect, given our experience treating military service members, that further observations of the natural history of recovery in blast-induced mTBI will continue to mirror the natural history of recovery in sports concussion.	[Larres, David T.] Tripler Army Med Ctr, Occupat Therapy Clin, 1 Jarrett White Rd, Honolulu, HI 96859 USA; [Carr, Walter] Walter Reed Army Inst Res, Dept Behav Biol, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Gonzales, Elizandro G.] Guthrie Army Hlth Clin, Occupat Therapy, 11050 Mt Belvedere Blvd, Ft Drum, NY 13602 USA; [Hawley, Jason S.] Walter Reed Natl Mil Med Ctr, Dept Neurol, 8901 Rockville Pike, Bethesda, MD 20889 USA		Larres, DT (corresponding author), Tripler Army Med Ctr, Occupat Therapy Clin, 1 Jarrett White Rd, Honolulu, HI 96859 USA.						Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; U. S. Department of Defense, POL GUID MAN CONC MI; U. S. Department of Defense, 2014, OP IR FREED OIF OP E; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060	36	6	6	1	2	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY	2016	181	5		S			23	27		10.7205/MILMED-D-15-00152			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	DW5LJ	WOS:000383686400006	27168549	Bronze			2022-02-06	
J	Ng, AJH; Arora, V; Tang, HHF; Treseder, T; Jain, A; Wagner, T				Ng, Andrew Jin-Hean; Arora, Varun; Tang, Howard Ho-Fung; Treseder, Thomas; Jain, Arvind; Wagner, Timothy			Axillary Artery Injury Associated with Proximal Humeral Fractures: Review of Long-Term Vascular, Orthopedic, and Neurologic Outcomes	ANNALS OF VASCULAR SURGERY			English	Article							BRACHIAL-PLEXUS; SHOULDER DISLOCATION; BLUNT; MANAGEMENT; NECK; PAIN	Background: Fracture and dislocation of the proximal humerus is common. It is associated with a number of vascular, neurologic, and orthopedic complications; these include brachial plexopathy and avascular necrosis (AVN) of the humeral head. These complications are rare but can potentially cause severe disability to patients; however, they remain poorly described in the literature. To describe vascular, orthopedic, and neurologic outcomes after axillary artery repair, in patients with proximal humeral fractures or dislocations. Methods: We conducted a retrospective review of patients admitted to 2 tertiary trauma centers in Victoria, Australia, with fracture or dislocation of the proximal humerus and associated axillary artery injury. Patients were selected according to guidelines for trauma call or alert and the presence of high-risk mechanism of injury. Data on vascular, orthopedic, and neurologic complications were collected. Results: Twenty-one patients were identified. Injury to the first part of the axillary artery was noted in 11 patients (52%). Brachial plexus exploration was performed in 17 patients (81%). Four patients (19%) underwent nerve repair. Long-term neurologic recovery was universally poor. Major orthopedic complications included AVN of the humeral head, delayed union, and the need for prosthesis or arthrodesis. Eleven patients (52%) received upper limb fasciotomy. Five patients (24%) underwent delayed secondary upper limb amputation. Conclusions: There was an unusually high rate of injuries to the first part of the axillary artery. Close clinical observation is recommended for such patients. AVN of the humeral head and brachial plexopathy remain significant and debilitating complications.	[Ng, Andrew Jin-Hean; Treseder, Thomas; Wagner, Timothy] Royal Melbourne Hosp, Dept Vasc Surg, 300 Grattan St, Melbourne, Vic 3050, Australia; [Arora, Varun; Jain, Arvind] Alfred Hosp, Dept Vasc Surg, Melbourne, Vic, Australia; [Tang, Howard Ho-Fung] Univ Melbourne, Melbourne, Vic, Australia		Ng, AJH (corresponding author), Royal Melbourne Hosp, Dept Vasc Surg, 300 Grattan St, Melbourne, Vic 3050, Australia.	ajhng.89@gmail.com		Ng, Andrew/0000-0003-4249-1453; Tang, Howard/0000-0001-6422-0270			Allie B, 2005, EUR J EMERG MED, V12, P121, DOI 10.1097/00063110-200506000-00005; [Anonymous], 2010, J HAND SURG; Birch R, 2015, J HAND SURG-EUR VOL, V40, P562, DOI 10.1177/1753193414539865; BIRCH R, 1993, J BONE JOINT SURG BR, V75, P346, DOI 10.1302/0301-620X.75B3.8496196; BROOKS CH, 1993, J BONE JOINT SURG BR, V75, P132, DOI 10.1302/0301-620X.75B1.8421010; Cox CS, 1999, J TRAUMA, V46, P445, DOI 10.1097/00005373-199903000-00017; Giuffre JL, 2010, J HAND SURG-AM, V35A, P678, DOI 10.1016/j.jhsa.2010.01.021; Gorthi V., 2010, ORTHOPEDICS, V33; HAYES JM, 1983, J TRAUMA, V23, P431, DOI 10.1097/00005373-198305000-00014; Hofman M, 2011, EMERG MED INT, V2011, DOI 10.1155/2011/742870; Htut M, 2006, J HAND SURG-BRIT EUR, V31B, P596, DOI 10.1016/j.jhsb.2006.04.027; Inui Atsuyuki, 2009, J Shoulder Elbow Surg, V18, pe14, DOI 10.1016/j.jse.2008.07.004; JOHNSON SF, 1991, J TRAUMA, V31, P1546, DOI 10.1097/00005373-199111000-00016; Karkos CD, 2010, AM J EMERG MED, V28; Kato N, 2006, J BONE JOINT SURG BR, V88B, P756, DOI 10.1302/0301-620X.88B6.16995; Kelley SP, 2004, INJURY, V35, P1128, DOI 10.1016/j.injury.2003.08.009; LAVERICK MD, 1990, J TRAUMA, V30, P360, DOI 10.1097/00005373-199003000-00022; McLaughlin JA, 1998, J SHOULDER ELB SURG, V7, P292, DOI 10.1016/S1058-2746(98)90058-1; McMinn RMH, 1994, LASTS ANATOMY REGION, P65; Modi C S, 2008, J Orthop Surg (Hong Kong), V16, P243; Palm DS, 2013, INJURY EXTRA, V44, P67; Piffaretti G, 2007, INJURY, V38, P1091, DOI 10.1016/j.injury.2007.02.044; Plaga BR, 2010, J EMERG MED, V39, P599, DOI 10.1016/j.jemermed.2008.01.018; Rangdal SS, 2012, CHIN J TRAUMATOL, V15, P244, DOI 10.3760/cma.j.issn.1008-1275.2012.04.011; Razif M A Mohamed, 2002, Med J Malaysia, V57, P496; Reid D, 2009, EMERG MED AUSTRALAS, V21, P515, DOI 10.1111/j.1742-6723.2009.01235.x; RICH N, 2004, VASCULAR TRAUMA; RINDELL K, 1987, ANN CHIR GYNAECOL FE, V76, P283; Suso S, 1992, Acta Orthop Belg, V58, P457; Yagubyan Marineh, 2004, Vasc Endovascular Surg, V38, P175, DOI 10.1177/153857440403800210	30	6	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	MAY	2016	33						210	219		10.1016/j.avsg.2015.10.038			10	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	DL7MG	WOS:000375824200033	26965805				2022-02-06	
J	Schneider, AL; Hostetter, TA; Homaifar, BY; Forster, JE; Olson-Madden, JH; Matarazzo, BB; Huggins, J; Brenner, LA				Schneider, Alexandra L.; Hostetter, Trisha A.; Homaifar, Beeta Y.; Forster, Jeri E.; Olson-Madden, Jennifer H.; Matarazzo, Bridget B.; Huggins, Joe; Brenner, Lisa A.			Responses to Traumatic Brain Injury Screening Questions and Suicide Attempts among Those Seeking Veterans Health Administration Mental Health Service	FRONTIERS IN PSYCHIATRY			English	Article						traumatic brain injury; suicide; Veteran; psychometrics; predictive validity; screening	PREVALENCE; DIAGNOSIS; SYMPTOMS; HISTORY; TBI	Background: Psychometrically sound screening tools available to aid in the identification of lifetime history of traumatic brain injury (TBI) are limited. As such, the Traumatic Brain Injury-4 (TBI-4) was developed and implemented in a Veterans Health Administration (VHA) mental health clinic. To provide information regarding both the predictive validity and clinical utility of the TBI-4, the relationship between screening results and future suicide attempts was evaluated. Objective: The aim of this study was to determine whether a positive screen on the TBI-4 was associated with increased risk for suicide attempt within 1-year post screening. Methods: The TBI-4 was administered to 1,097 Veterans at the time of mental health intake. Follow-up data regarding suicide attempts for the year post-mental health intake were obtained from suicide behavior reports (SBRs) in Veteran electronic medical records (EMRs). Fisher's exact tests were used to determine the proportion of suicide attempts by TBI-4 status. Results: In the year post TBI-4 screening, significantly more Veterans who screened positive had a documented suicide attempt as compared to those who screened negative (rho = 0.003). Conclusion: Those with a positive TBI screen at mental health intake had a higher proportion of SBRs than those who screened negative for TBI. Findings provided further psychometric support for the TBI-4. Moreover, results suggest the inclusion of this screen could prove to be helpful in identifying those who may be at risk for future suicide attempt within 1-year post screening.	[Schneider, Alexandra L.; Hostetter, Trisha A.; Homaifar, Beeta Y.; Forster, Jeri E.; Olson-Madden, Jennifer H.; Matarazzo, Bridget B.; Huggins, Joe; Brenner, Lisa A.] US Dept Vet Affairs, Rocky Mt Mental Illness Res Educ & Clin Ctr, Denver, CO 80246 USA; [Homaifar, Beeta Y.; Olson-Madden, Jennifer H.; Matarazzo, Bridget B.; Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Psychiat, Anschutz Med Campus, Aurora, CO 80045 USA; [Homaifar, Beeta Y.; Forster, Jeri E.; Olson-Madden, Jennifer H.; Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO 80045 USA; [Forster, Jeri E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Neurol, Anschutz Med Campus, Aurora, CO 80045 USA		Brenner, LA (corresponding author), US Dept Vet Affairs, Rocky Mt Mental Illness Res Educ & Clin Ctr, Denver, CO 80246 USA.; Brenner, LA (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Anschutz Med Campus, Aurora, CO 80045 USA.; Brenner, LA (corresponding author), Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO 80045 USA.; Brenner, LA (corresponding author), Univ Colorado, Sch Med, Dept Neurol, Anschutz Med Campus, Aurora, CO 80045 USA.	Lisa.Brenner@va.gov	Brenner, Lisa A./AAG-2442-2019	Huggins, Joe/0000-0001-8151-5062	Colorado Traumatic Brain Injury Trust Fund Program; Rocky Mountain Mental Illness Research, Education, and Clinical Center (MIRECC)	This study was supported by the Colorado Traumatic Brain Injury Trust Fund Program and the Rocky Mountain Mental Illness Research, Education, and Clinical Center (MIRECC).	Affairs DoV, 2015, POL TBI SYST CAR HOM; Bahraini N, 2013, J HEAD TRAUMA REHAB, V28, P223, DOI 10.1097/HTR.0b013e318291dab7; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Bossarte R.M., 2013, SUICIDE DATA REPORT; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2011, J CLIN PSYCHOL MED S, V18, P116, DOI 10.1007/s10880-011-9240-9; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Olson-Madden JH, 2014, ARCH PHYS MED REHAB, V95, P925, DOI 10.1016/j.apmr.2014.01.008; Prevention CfDCa, 2016, FASTSTATS MENT HLTH; Romesser J, 2011, MIL MED, V176, P246, DOI 10.7205/MILMED-D-10-00056; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Skopp Nancy A, 2012, MSMR, V19, P7; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; US Department of Health and Human Services Centers for Disease Control and Prevention, 2012, HEADS FACTS PHYS MIL; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013	21	6	6	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	APR 19	2016	7								59	10.3389/fpsyt.2016.00059			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	VF7SC	WOS:000443547800001	27148088	Green Published, gold			2022-02-06	
J	Hung, TY; Lee, YK; Huang, MY; Hsu, CY; Su, YC				Hung, Tzu-Yao; Lee, Yi-Kung; Huang, Ming-Yuan; Hsu, Chen-Yang; Su, Yung-Cheng			Increased risk of ischemic stroke in patients with burn injury: a nationwide cohort study in Taiwan	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Burns; Ischemic stroke; Cohort studies	TRAUMATIC BRAIN-INJURY; PREVALENCE; INFARCTION; STATES	Background: Conflicting results have been obtained by studies attempting to assess the risks of ischemic stroke in patients with burn injury, while the long-term risk of stroke in survivors of burn injury remains unexplored. We evaluated whether the risk of ischemic stroke in patients hospitalized with burn injury in Taiwan is higher when compared to the general population. Methods: The data from one million National Health Insurance (NHI) adult beneficiaries were evaluated from January 1, 2005 until December 31, 2012 to identify those who developed ischemic stroke. Each identified patient with burn injury was matched with one hundred unexposed patients based on a high-dimensional propensity score. Cox regression models were applied to compare the risks of the development of ischemic stroke in the matched cohorts. Results: A total of 743,237 patients were enrolled. After matching, 1,763 burn injury patients and 176,300 unexposed patients were selected and compared. The adjusted hazard ratio of ischemic stroke was significantly increased in burn injury patients (1.84; 95 % CI, 1.43-2.36). A subgroup analysis based on patients who survived longer than 12 months in the matched cohort also revealed higher hazard ratio in the burn injury patients (1.54; 95 % CI, 1.11-2.13). Conclusion: The risk of ischemic stroke is significantly higher in patients hospitalized with burn injury than in the general population, and these risks may extend longer than expected.	[Hung, Tzu-Yao] Taipei City Hosp, Zhongxing Branch, Emergency Dept, Taipei, Taiwan; [Lee, Yi-Kung; Su, Yung-Cheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Yi-Kung; Su, Yung-Cheng] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Emergency Dept, 2 Minsheng Rd, Dalin Township 622, Chiayi County, Taiwan; [Huang, Ming-Yuan] Mackay Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Hsu, Chen-Yang] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan		Su, YC (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Su, YC (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Emergency Dept, 2 Minsheng Rd, Dalin Township 622, Chiayi County, Taiwan.	drsu119@gmail.com					Bang OY, 2011, J CLIN NEUROL, V7, P53, DOI 10.3988/jcn.2011.7.2.53; Bijker JB, 2012, ANESTHESIOLOGY, V116, P658, DOI 10.1097/ALN.0b013e3182472320; Brusselaers N, 2010, CRIT CARE, V14, DOI 10.1186/cc9300; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Cho SJ, 2007, CEREBROVASC DIS, V24, P261, DOI 10.1159/000104488; Dalager-Pedersen M, 2014, CIRCULATION, V129, P1387, DOI 10.1161/CIRCULATIONAHA.113.006699; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Grau AJ, 2010, NAT REV NEUROL, V6, P681, DOI 10.1038/nrneurol.2010.163; Guan H-L, 2013, ISRN EMERG MED, V2013, P1, DOI DOI 10.1155/2013/839126; Hou SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071801; Hsieh FI, 2014, J STROKE, V16, P59, DOI 10.5853/jos.2014.16.2.59; Ingall Timothy, 2004, J Insur Med, V36, P143; Lee YK, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0066-y; Lee YK, 2013, EMERG MED J, V30, P620, DOI 10.1136/emermed-2012-201440; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lee YK, 2012, AM J EMERG MED, V30, P1352, DOI 10.1016/j.ajem.2011.09.024; Levine SR, 2005, CNS SPECTRUMS, V10, P567, DOI 10.1017/S109285290001021X; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Momjian-Mayor I, 2005, STROKE, V36, P567, DOI 10.1161/01.STR.0000155727.82242.e1; Ng KJ, 2015, J THROMB HAEMOST, V13, P206, DOI 10.1111/jth.12805; Schneeweiss S, 2009, EPIDEMIOLOGY, V20, P512, DOI 10.1097/EDE.0b013e3181a663cc; Sebastian Raul, 2015, Burns, V41, pe4, DOI 10.1016/j.burns.2014.06.018; SYRJANEN J, 1993, EUR HEART J, V14, P17; Van Haren RM, 2013, J TRAUMA ACUTE CARE, V75, P37, DOI 10.1097/TA.0b013e3182984911; WINKELMAN MD, 1992, MEDICINE, V71, P271, DOI 10.1097/00005792-199209000-00002	25	6	7	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	APR 6	2016	24								44	10.1186/s13049-016-0236-1			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DI7FT	WOS:000373665400003	27052491	Green Published, gold			2022-02-06	
J	Ernst, WJ; Gallo, AB; Sellers, AL; Mulrine, J; MacNamara, L; Abrahamson, A; Kneavel, M				Ernst, William J.; Gallo, Adrienne B.; Sellers, Amanda L.; Mulrine, Jessica; MacNamara, Luciana; Abrahamson, Allison; Kneavel, Meredith			Knowledge of Traumatic Brain Injury among Educators	EXCEPTIONALITY			English	Article							MISCONCEPTIONS		[Ernst, William J.; Gallo, Adrienne B.; Sellers, Amanda L.; Mulrine, Jessica; MacNamara, Luciana; Abrahamson, Allison; Kneavel, Meredith] Chestnut Hill Coll, Room 450,St Josephs Hall,9601 Germantown Ave, Philadelphia, PA 19118 USA		Ernst, WJ (corresponding author), Chestnut Hill Coll, Room 450,St Josephs Hall,9601 Germantown Ave, Philadelphia, PA 19118 USA.	ernstw@chc.edu	Kneavel, Meredith/ABG-5233-2021	Kneavel, Meredith/0000-0002-9820-6909			Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Centers for Disease Control and Prevention, 2010, HEADS SCH KNOW YOUR; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Chapman J. K., 2000, RURAL SPECIAL ED Q, V19, P3; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; Dennis M., 2000, PEDIAT NEUROPSYCHOLO, P25; Ernst WJ, 2008, CLIN NEUROPSYCHOL, V22, P953, DOI 10.1080/13854040701676591; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Faul M, 2010, TRAUMATIC BRAIN INJU; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Hux K, 2013, SUPPORT LEARN, V28, P109, DOI 10.1111/1467-9604.12028; Lewandowski LJ, 2009, J APPL SCH PSYCHOL, V25, P95, DOI 10.1080/15377900802484547; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; National Center for Education Statistics, 2013, DIG ED STAT; O'Jile JR., 1997, INT J REHABILITATION, V3, P61, DOI [10.1007/BF02766798, DOI 10.1007/BF02766798]; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Stuck S., 2012, THESIS U IOWA IOWA C; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92	27	6	6	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0936-2835	1532-7035		EXCEPTIONALITY	Exceptionality	APR 2	2016	24	2					123	136		10.1080/09362835.2015.1107832			14	Education, Special	Social Science Citation Index (SSCI)	Education & Educational Research	DG2WZ	WOS:000371932800005					2022-02-06	
J	Dong-Creste, KE; Baraldi-Tornisielo, T; Caetano, AL; Gobeil, F; Montor, WR; Viel, TA; Buck, HS				Dong-Creste, Karis Ester; Baraldi-Tornisielo, Ticiana; Caetano, Ariadiny Lima; Gobeil, Fernand; Montor, Wagner Ricardo; Viel, Tania Araujo; Buck, Hudson Sousa			Kinin B1 receptor mediates memory impairment in the rat hippocampus	BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	International Meeting on Kinin System and Peptide Receptors	JUN 28-JUL 01, 2015	Sao Paulo, BRAZIL	Frey Werle Fdn, Sao Paulo Res Fdn, Natl Council Technol & Sci Dev, Coordinat Improvement Higher Educ Personnel, Congres Sci Quebec		bradykinin; B1R; B2R; cognitive processes; memory impairment	BRADYKININ BINDING-SITES; TRAUMATIC BRAIN-INJURY; B-2 RECEPTORS; B2 RECEPTOR; TERM-MEMORY; DIFFERENTIAL INVOLVEMENT; CHROMOSOMAL LOCALIZATION; EXPRESSION; MODEL; IDENTIFICATION	The bradykinin (BK) receptors B1R and B2R are involved in inflammatory responses and their activation can enhance tissue damage. The B2R is constitutively expressed and mediates the physiologic effects of BK, whereas B1R expression is induced after tissue damage. Recently, they have been involved with Alzheimer's disease, ischemic stroke and traumatic brain injury (TBI). In this study, we investigated the role of bradykinin in short and long-term memory consolidation (STM and LTM). It was observed that bilateral injection of BK (300 pmol/mu l) disrupted the STM consolidation but not LTM, both evaluated by inhibitory avoidance test. The STM disruption due to BK injection was blocked by the previous injection of the B1R antagonist des-Arg(10)-HOE140 but not by the B2R antagonist HOE140. Additionally, the injection of the B1 agonist desArg(9)-BK disrupted STM and LTM consolidation at doses close to physiological concentration of the peptide (2.3 and 37.5 pmol, respectively) which could be reached during tissue injury. The presence of B1R located on glial cells around the implanted guide cannula used for peptide injection was confirmed by immunofluorescence. These data imply in a possible participation of B1R in the STM impairment observed in TBI, neuroinflammation and neurodegeneration.	[Dong-Creste, Karis Ester; Baraldi-Tornisielo, Ticiana; Caetano, Ariadiny Lima; Montor, Wagner Ricardo; Buck, Hudson Sousa] Santa Casa Sao Paulo Sch Med Sci, Dept Physiol Sci, R Dr Cesario Motta Jr 61,11 Andar, BR-01221020 Sao Paulo, SP, Brazil; [Viel, Tania Araujo; Buck, Hudson Sousa] Res Grp Neuropharmacol Aging, Sao Paulo, Brazil; [Gobeil, Fernand] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1K 2R1, Canada; [Gobeil, Fernand] Univ Sherbrooke, Inst Pharmacol IPS, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada; [Viel, Tania Araujo] Univ Sao Paulo, Inst Biomed Sci, Grad Course Pharmacol, Ave Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil; [Viel, Tania Araujo] Univ Sao Paulo, Sch Arts Sci & Humanities, Av Arlindo Bettio 1000, BR-03828080 Sao Paulo, SP, Brazil		Buck, HS (corresponding author), Santa Casa Sao Paulo Sch Med Sci, Dept Physiol Sci, R Dr Cesario Motta Jr 61,11 Andar, BR-01221020 Sao Paulo, SP, Brazil.; Buck, HS (corresponding author), Res Grp Neuropharmacol Aging, Sao Paulo, Brazil.	hudson.buck@fcmsantacasasp.edu.br	Buck, Hudson/E-7664-2013; Viel, Tania/K-2909-2016; Caetano, Ariadiny Lima/B-4225-2013; Montor, Wagner/AAF-2538-2021; Montor, Wagner/J-2568-2012; Caetano, Ariadiny L/H-9375-2016	Buck, Hudson/0000-0002-1867-2441; Viel, Tania/0000-0002-4015-785X; Montor, Wagner/0000-0003-3746-9366; CAETANO, ARIADINY de LIMA/0000-0002-3619-6485			Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; ALMEIDAESILVA TC, 1978, AGENTS ACTIONS, V8, P102, DOI 10.1007/BF01972410; Amaral FA, 2010, NEUROPEPTIDES, V44, P93, DOI 10.1016/j.npep.2009.10.006; Ataei N, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.164831; Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; BASCANDS JL, 1993, AM J PHYSIOL, V264, pF548, DOI 10.1152/ajprenal.1993.264.3.F548; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; BUCCAFUSCO JJ, 1985, EUR J PHARMACOL, V113, P43, DOI 10.1016/0014-2999(85)90341-3; Buck HD, 2002, CAN J PHYSIOL PHARM, V80, P249, DOI 10.1139/Y02-050; Caetano AL, 2015, NEUROPEPTIDES, V53, P51, DOI 10.1016/j.npep.2015.09.001; Caetano AL, 2010, AUTON NEUROSCI-BASIC, V158, P71, DOI 10.1016/j.autneu.2010.06.013; Campos MM, 2005, SYNAPSE, V57, P29, DOI 10.1002/syn.20150; Chai KX, 1996, GENOMICS, V31, P51, DOI 10.1006/geno.1996.0008; CHOLEWINSKI AJ, 1991, J NEUROCHEM, V57, P1456, DOI 10.1111/j.1471-4159.1991.tb08314.x; Cloutier F, 2004, BRIT J PHARMACOL, V142, P285, DOI 10.1038/sj.bjp.0705759; CORREA FMA, 1979, P NATL ACAD SCI USA, V76, P1489, DOI 10.1073/pnas.76.3.1489; Dutra RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027875; ELROD K, 1986, NEUROCHEM RES, V11, P1463, DOI 10.1007/BF00966225; Fujiwara Y., 1998, EUR J PHARMACOL, V147, P487; Gobel K, 2011, J AUTOIMMUN, V36, P106, DOI 10.1016/j.jaut.2010.11.004; Hidalgo C, 2007, IUBMB LIFE, V59, P280, DOI 10.1080/15216540701222906; HORI S, 1968, JPN J PHYSIOL, V18, P772; Ifuku M, 2007, J NEUROSCI, V27, P13065, DOI 10.1523/JNEUROSCI.3467-07.2007; Iores-Marcal LM, 2006, PEPTIDES, V27, P3363, DOI 10.1016/j.peptides.2006.08.012; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Izquierdo I, 1998, BEHAV PHARMACOL, V9, P421; IZQUIERDO I, 2002, MEMORIA; KARIYA K, 1981, JPN J PHARMACOL, V31, P261, DOI 10.1254/jjp.31.261; KOZLOWSKI MR, 1988, NEUROPEPTIDES, V12, P207, DOI 10.1016/0143-4179(88)90056-X; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lindsey CJ, 1997, J PHYSIOL-LONDON, V502, P119, DOI 10.1111/j.1469-7793.1997.119bl.x; Liu P, 2013, BRAIN RES, V1522, P67, DOI 10.1016/j.brainres.2013.05.032; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; MA JX, 1994, GENE, V149, P283, DOI 10.1016/0378-1119(94)90167-8; MA JX, 1994, GENOMICS, V23, P362, DOI 10.1006/geno.1994.1512; Marceau F, 1998, CLIN REV ALLERG IMMU, V16, P385, DOI 10.1007/BF02737658; Mathis SA, 1996, MOL PHARMACOL, V50, P128; Naffah-Mazzacoratti Maria da Graca, 2014, World J Biol Chem, V5, P130, DOI 10.4331/wjbc.v5.i2.130; OKADA Y, 1977, NEUROPHARMACOLOGY, V16, P381; Ongali B, 2003, AM J PHYSIOL-HEART C, V284, pH1949, DOI 10.1152/ajpheart.01113.2002; Ongali R, 2006, J NEUROTRAUM, V23, P696, DOI 10.1089/neu.2006.23.696; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PEARSON L, 1969, EUR J PHARMACOL, V8, P153, DOI 10.1016/0014-2999(69)90070-3; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; PERRY DC, 1984, J NEUROCHEM, V43, P1072, DOI 10.1111/j.1471-4159.1984.tb12846.x; Plesnila N, 2001, J NEUROTRAUM, V18, P1049, DOI 10.1089/08977150152693746; Prado GN, 2002, J CELL PHYSIOL, V193, P275, DOI 10.1002/jcp.10175; Prat A, 1999, NEUROLOGY, V53, P2087, DOI 10.1212/WNL.53.9.2087; Prat A, 2000, J NEUROPATH EXP NEUR, V59, P896, DOI 10.1093/jnen/59.10.896; Raidoo DM, 1996, IMMUNOPHARMACOLOGY, V33, P104, DOI 10.1016/0162-3109(96)00021-5; Raidoo DM, 1997, J NEUROIMMUNOL, V77, P39, DOI 10.1016/S0165-5728(97)00048-9; Regoli D, 2001, BIOL CHEM, V382, P31, DOI 10.1515/BC.2001.005; Regoli D, 1998, EUR J PHARMACOL, V348, P1, DOI 10.1016/S0014-2999(98)00165-4; REGOLI D, 1980, PHARMACOL REV, V32, P1; Savard M, 2013, BIOL CHEM, V394, P353, DOI 10.1515/hsz-2012-0295; Schilling L, 1999, ADV EXP MED BIOL, V474, P123; Schulze-Topphoff U, 2009, NAT MED, V15, P788, DOI 10.1038/nm.1980; SHARIF NA, 1991, NEUROCHEM INT, V18, P89, DOI 10.1016/0197-0186(91)90041-B; Simoes HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080348; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Unger T., 1981, CENTRAL NERVOUS SYST, P115; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; Vianna MRM, 2000, PSYCHOPHARMACOLOGY, V150, P77, DOI 10.1007/s002130000396; Viel TA, 2011, CURR ALZHEIMER RES, V8, P59; Viel TA, 2008, NEUROBIOL AGING, V29, P1805, DOI 10.1016/j.neurobiolaging.2007.04.019; Wang Hui-Lin, 2015, J Cell Death, V8, P9, DOI 10.4137/JCD.S30596; Wang QB, 2002, CHINESE MED J-PEKING, V115, P884; Wotherspoon G, 2000, NEUROSCI LETT, V294, P175, DOI 10.1016/S0304-3940(00)01561-5; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yang XG, 2001, J CELL BIOCHEM, V82, P163, DOI 10.1002/jcb.1116; Zamberletti E., 2015, EUR NEUROPSYCHOPHARM	73	6	6	0	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1431-6730	1437-4315		BIOL CHEM	Biol. Chem.	APR	2016	397	4					353	364		10.1515/hsz-2015-0235			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	DK5QO	WOS:000374975000009	26669247				2022-02-06	
J	McDermott, MJ; Fulwiler, JC; Smitherman, TA; Gratz, KL; Connolly, KM; Tull, MT				McDermott, Michael J.; Fulwiler, Joshua C.; Smitherman, Todd A.; Gratz, Kim L.; Connolly, Kevin M.; Tull, Matthew T.			The relation of PTSD symptoms to migraine and headache-related disability among substance dependent inpatients	JOURNAL OF BEHAVIORAL MEDICINE			English	Article						PTSD; Migraine; Substance use disorder; Alcohol use disorder; Headache-related disability	POSTTRAUMATIC-STRESS-DISORDER; COMORBIDITY SURVEY REPLICATION; CHRONIC MUSCULOSKELETAL PAIN; TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; PRIMARY-CARE; PSYCHIATRIC COMORBIDITY; MUTUAL MAINTENANCE; COMMUNITY SAMPLE; LATENT STRUCTURE	Despite emerging evidence for the comorbidity of posttraumatic stress disorder (PTSD) and migraine, few studies have examined the relation of PTSD and migraine, particularly among clinical populations at-risk for both conditions (e.g., substance-dependent patients). This study examined the role of PTSD symptoms in migraine and headache-related disability within a sample of 153 substance-dependent inpatients (37.25 % female, Mean age 36.46). PTSD symptoms predicted both migraine and headache-related disability above and beyond gender, depression and anxiety symptoms, the experience of a Criterion A traumatic event, and current alcohol use disorder. Findings highlight the strong association between migraine and PTSD symptoms in a unique population at risk for both conditions.	[McDermott, Michael J.] Univ Louisiana Lafayette, Lafayette, LA 70504 USA; [Fulwiler, Joshua C.; Smitherman, Todd A.] Univ Mississippi, Oxford, MS USA; [Gratz, Kim L.; Connolly, Kevin M.; Tull, Matthew T.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Connolly, Kevin M.] GV Sonny Montgomery Vet Adm Hosp, Jackson, MS USA		McDermott, MJ (corresponding author), Univ Louisiana Lafayette, Lafayette, LA 70504 USA.	mcderm1@gmail.com	Tull, Matthew/AAP-6442-2020; Tull, Matthew/ABD-6066-2020	Tull, Matthew/0000-0002-1382-117X; Gratz, Kim/0000-0002-2659-6784	National Institute on Drug Abuse of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R21 DA022383]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R21DA022383] Funding Source: NIH RePORTER	Support for this study was provided in part by R21 DA022383 from the National Institute on Drug Abuse of the National Institutes of Health awarded to the third author (MTT).	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; Asmundson GJG, 2009, DEPRESS ANXIETY, V26, P888, DOI 10.1002/da.20600; Baskin SM, 2006, HEADACHE, V46, pS76, DOI 10.1111/j.1526-4610.2006.00559.x; Bigal ME, 2008, NEUROLOGY, V71, P559, DOI 10.1212/01.wnl.0000323925.29520.e7; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brady KT, 2004, CURR DIR PSYCHOL SCI, V13, P206, DOI 10.1111/j.0963-7214.2004.00309.x; Broman-Fulks JJ, 2006, BEHAV THER, V37, P364, DOI 10.1016/j.beth.2006.02.006; Brown PJ, 1996, PSYCHOL ADDICT BEHAV, V10, P124, DOI 10.1037/0893-164X.10.2.124; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Chen KW, 2011, DRUG ALCOHOL DEPEN, V118, P92, DOI 10.1016/j.drugalcdep.2011.03.003; Cripe SM, 2011, HEADACHE, V51, P208, DOI 10.1111/j.1526-4610.2010.01777.x; de Leeuw R, 2005, HEADACHE, V45, P1365, DOI 10.1111/j.1526-4610.2005.00269.x; ELMALLAKH RS, 1991, HEADACHE, V31, P584; First M, 1991, DRUG USE QUEST UNPUB; First M. B., 1996, STRUCTURED CLI UNPUB; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes D, 2005, J TRAUMA STRESS, V18, P647, DOI 10.1002/jts.20073; Ford S, 2008, HEADACHE, V48, P523, DOI 10.1111/j.1526-4610.2008.00859.x; Friedmann PD, 1999, J SUBST ABUSE TREAT, V16, P71, DOI 10.1016/S0740-5472(98)00018-X; Gratz KL, 2014, PSYCHOL MED, V44, P2099, DOI 10.1017/S0033291713002134; Gratz KL, 2015, CURR OPIN PSYCHOL, V3, P85, DOI 10.1016/j.copsyc.2015.02.010; Guidetti V, 1998, CEPHALALGIA, V18, P455, DOI 10.1046/j.1468-2982.1998.1807455.x; Hamelsky SW, 2006, HEADACHE, V46, P1327, DOI 10.1111/j.1526-4610.2006.00576.x; International Headache Society Classification Subcommittee, 2004, CEPHALALGIA S1, V24, pS1; Keefe FJ, 2001, J CLIN PSYCHOL, V57, P587, DOI 10.1002/jclp.1030; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Lejuez CW, 2007, EXP CLIN PSYCHOPHARM, V15, P165, DOI 10.1037/1064-1297.15.2.165; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Lipton RB, 2003, NEUROLOGY, V61, P375, DOI 10.1212/01.WNL.0000078940.53438.83; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Maizels M, 2003, HEADACHE, V43, P441, DOI 10.1046/j.1526-4610.2003.03088.x; Maizels M, 2008, HEADACHE, V48, P385, DOI 10.1111/j.1526-4610.2007.00946.x; Martin VT, 2005, HEADACHE, V45, P1102, DOI 10.1111/j.1526-4610.2005.00234.x; McDermott MJ, 2014, HEADACHE, V54, P290, DOI 10.1111/head.12171; McDermott MJ, 2009, J ANXIETY DISORD, V23, P591, DOI 10.1016/j.janxdis.2009.01.006; Nash JM, 2006, J BEHAV MED, V29, P61, DOI 10.1007/s10865-005-9033-4; Ouimette PC, 1997, J CONSULT CLIN PSYCH, V65, P230, DOI 10.1037/0022-006X.65.2.230; Ouimette PC, 1999, PSYCHOL ADDICT BEHAV, V13, P105, DOI 10.1037/0893-164X.13.2.105; Ouimette PC, 1997, PSYCHOL ADDICT BEHAV, V11, P34, DOI 10.1037/0893-164X.11.1.34; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Panconesi A, 2008, J HEADACHE PAIN, V9, P19, DOI 10.1007/s10194-008-0006-1; Peterlin BL, 2008, HEADACHE, V48, P517, DOI 10.1111/j.1526-4610.2008.00917.x; Peterlin BL, 2011, CEPHALALGIA, V31, P235, DOI 10.1177/0333102410378051; Peterlin BL, 2009, HEADACHE, V49, P541, DOI 10.1111/j.1526-4610.2009.01368.x; Reynolds DJ, 2000, HEADACHE, V40, P111, DOI 10.1046/j.1526-4610.2000.00016.x; Ruscio AM, 2002, J ABNORM PSYCHOL, V111, P290, DOI 10.1037//0021-843X.111.2.290; Sareen J, 2007, PSYCHOSOM MED, V69, P242, DOI 10.1097/PSY.0b013e31803146d8; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Saunders K, 2008, NEUROLOGY, V70, P538, DOI 10.1212/01.wnl.0000297192.84581.21; Seng EK, 2013, HEADACHE, V53, P1312, DOI 10.1111/head.12155; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Smitherman TA, 2013, HEADACHE, V53, P775, DOI 10.1111/head.12063; Smitherman TA, 2011, HEADACHE, V51, P581, DOI 10.1111/j.1526-4610.2011.01857.x; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Tietjen GE, 2012, HEADACHE, V52, P920, DOI [10.1111/j.1526-4610.2012.02179.x, 10.1111/j.1526-4610.2012.02165.x]; Tull MT, 2007, BEHAV THER, V38, P303, DOI 10.1016/j.beth.2006.10.001; Tull MT, 2013, PSYCHOL ADDICT BEHAV, V27, P763, DOI 10.1037/a0029911; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Watkins KE, 2001, PSYCHIAT SERV, V52, P1062, DOI 10.1176/appi.ps.52.8.1062; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	70	6	6	0	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0160-7715	1573-3521		J BEHAV MED	J. Behav. Med.	APR	2016	39	2					300	309		10.1007/s10865-015-9697-3			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DH7ZS	WOS:000373013500012	26611236				2022-02-06	
J	Presley, CS; Abidi, AH; Moore, BM				Presley, Chaela S.; Abidi, Ammaar H.; Moore, Bob M., II			Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system	ANALYTICAL BIOCHEMISTRY			English	Article						Cannabinoid receptor 1; ACTOne; Cannabinoid; Pharmacology	TRAUMATIC BRAIN-INJURY; CB1 RECEPTOR; INVERSE AGONISM; RISK-FACTORS; IN-VITRO; ENDOGENOUS CANNABINOIDS; SIGNAL-TRANSDUCTION; METABOLIC STABILITY; OVERWEIGHT PATIENTS; MOLECULAR-CLONING	In vitro cannabinoid pharmacology has evolved over time from simple receptor binding to include [S-35] GTP gamma, beta-arrestin, and CAMP assays. Each assay has benefits and drawbacks; however, no single functional system has been used for high-throughput evaluation of compounds from binding to pharmacological functionality and antagonist assessment in a well-characterized human cell line. In this study, we evaluated and validated one system-ACTOne human embryonic kidney cells transfected with a cyclic nucleotide gated channel and cannabinoid receptor 1 (CB1)-and compared human CB1 affinity, functional, and antagonistic effects on cAMP with previously published results. The study was conducted on a diverse group of CB1 ligands, including endocannabinoids and related compounds, 2-AG, AEA, MAEA, and ACEA, the phytocannabinoid Delta(9) THC, and synthetic cannabinoids CP 55,940, WIN 55,212-2, SR 141716A, CP 945,598, and WIN 55,212-3. Our results were compared with literature values where human CB1 was used for affinity determination and cAMP was used as a functional readout. Here we report the first detailed evaluation of the ACTOne assay for the pharmacological evaluation of CB1 ligands. The results from the study reveal some interesting deviations from previously reported functional activities of the aforementioned ligands. (C) 2016 Elsevier Inc. All rights reserved.	[Presley, Chaela S.; Abidi, Ammaar H.; Moore, Bob M., II] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA		Moore, BM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	bmoore@uthsc.edu		Abidi, Ammaar/0000-0003-1826-9377	University of Tennessee College of Pharmacy; Neuroscience Institute	We thank the University of Tennessee College of Pharmacy and Neuroscience Institute for funding Chaela Presley. Anton Reiner provided AEA and 2-AG, for which we are grateful. Jimmy Lu from Codex BioSolutions was instrumental in establishing the ACTOne assay.	ABADJI V, 1994, J MED CHEM, V37, P1889, DOI 10.1021/jm00038a020; Appendino G, 2006, J MED CHEM, V49, P2333, DOI 10.1021/jm051240y; Aronne LJ, 2011, OBESITY, V19, P1404, DOI 10.1038/oby.2010.352; Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Auld D.S., 2004, ASSAY GUIDANCE MANUA; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Bobrov M, 2005, LIFE SCI, V77, P1425, DOI 10.1016/j.lfs.2005.02.011; Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Brighton PJ, 2011, BRIT J PHARMACOL, V164, P1479, DOI 10.1111/j.1476-5381.2011.01425.x; Brizzi A, 2005, J MED CHEM, V48, P7343, DOI 10.1021/jm0501533; Brusco A, 2008, ANN NY ACAD SCI, V1139, P450, DOI 10.1196/annals.1432.037; Buczynski MW, 2010, BRIT J PHARMACOL, V160, P423, DOI 10.1111/j.1476-5381.2010.00787.x; Cassol OJ, 2010, BRAIN RES, V1348, P128, DOI 10.1016/j.brainres.2010.06.023; Chin CN, 1998, J NEUROCHEM, V70, P366; Collin C, 2010, NEUROL RES, V32, P451, DOI 10.1179/016164109X12590518685660; COMPTON DR, 1993, J PHARMACOL EXP THER, V265, P218; Garcia MC, 2015, NEUROSCI LETT, V587, P1, DOI 10.1016/j.neulet.2014.12.003; D'Antona AM, 2006, BIOCHEMISTRY-US, V45, P5606, DOI 10.1021/bi060067k; de Ligt RAF, 2000, BRIT J PHARMACOL, V130, P1, DOI 10.1038/sj.bjp.0703311; DeJesus Edwin, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P95, DOI 10.1177/1545109707300157; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, BIOCHEM J, V331, P15; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; Dinh TP, 2002, CHEM PHYS LIPIDS, V121, P149, DOI 10.1016/S0009-3084(02)00150-0; Duntsch C, 2006, J NEURO-ONCOL, V77, P143, DOI 10.1007/s11060-005-9031-y; Fakhfouri G, 2012, NEUROPHARMACOLOGY, V63, P653, DOI 10.1016/j.neuropharm.2012.05.013; Felder CC, 1998, J PHARMACOL EXP THER, V284, P291; FELDER CC, 1995, MOL PHARMACOL, V48, P443; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Gallily R, 1997, J PHARMACOL EXP THER, V283, P918; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; GERARD CM, 1991, BIOCHEM J, V279, P129, DOI 10.1042/bj2790129; Glass M, 1997, J NEUROSCI, V17, P5327, DOI 10.1523/jneurosci.17-14-05327.1997; Govaerts SJ, 2004, EUR J PHARM SCI, V23, P233, DOI 10.1016/j.ejps.2004.07.013; Griffith DA, 2009, J MED CHEM, V52, P234, DOI 10.1021/jm8012932; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurley SN, 2012, J NEURO-ONCOL, V110, P163, DOI 10.1007/s11060-012-0958-5; Hadcock JR, 2010, BIOCHEM BIOPH RES CO, V394, P366, DOI 10.1016/j.bbrc.2010.03.015; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; HERMAN TS, 1979, NEW ENGL J MED, V300, P1295, DOI 10.1056/NEJM197906073002302; Hill AJ, 2012, BRIT J PHARMACOL, V167, P1629, DOI 10.1111/j.1476-5381.2012.02207.x; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Hilliard A., 2012, ISRN NEUROL, V2012, DOI DOI 10.5402/2012/802649; Iannotti FA, 2014, ACS CHEM NEUROSCI, V5, P1131, DOI 10.1021/cn5000524; Iwamura H, 2001, J PHARMACOL EXP THER, V296, P420; Kadoi Yuji, 2006, J Anesth, V20, P284, DOI 10.1007/s00540-006-0428-3; Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13; Kanyonyo M, 1999, BIOORG MED CHEM LETT, V9, P2233, DOI 10.1016/S0960-894X(99)00353-4; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Khanolkar AD, 1996, J MED CHEM, V39, P4515, DOI 10.1021/jm960152y; Khilnani G, 2011, INDIAN J PHARMACOL, V43, P492, DOI 10.4103/0253-7613.84947; Li J, 1999, PAIN, V81, P25, DOI 10.1016/S0304-3959(98)00263-2; Lin SY, 1998, J MED CHEM, V41, P5353, DOI 10.1021/jm970257g; LITTLE PJ, 1988, J PHARMACOL EXP THER, V247, P1046; MacLennan SJ, 1998, BRIT J PHARMACOL, V124, P619, DOI 10.1038/sj.bjp.0701915; Martin-Moreno AM, 2011, MOL PHARMACOL, V79, P964, DOI 10.1124/mol.111.071290; Martin-Couce L, 2011, J MED CHEM, V54, P5265, DOI 10.1021/jm2004392; Martinez-Martinez Esther, 2015, Oncoscience, V2, P131; Mato S, 2002, EUR J PHARMACOL, V443, P43, DOI 10.1016/S0014-2999(02)01575-3; Mauler F, 2002, J PHARMACOL EXP THER, V302, P359, DOI 10.1124/jpet.302.1.359; McAllister SD, 2002, BIOCHEM PHARMACOL, V63, P2121, DOI 10.1016/S0006-2952(02)01031-6; McPartland JM, 2007, BRIT J PHARMACOL, V152, P583, DOI 10.1038/sj.bjp.0707399; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Moreira FA, 2009, REV BRAS PSIQUIATR, V31, P145, DOI 10.1590/S1516-44462009000200012; Moulin DE, 2014, PAIN RES MANAG, V19, P328; Naderi N, 2012, NEUROCHEM RES, V37, P279, DOI 10.1007/s11064-011-0607-y; Nguyen BM, 2014, AM SURGEON, V80, P979; Notcutt W, 2012, MULT SCLER J, V18, P219, DOI 10.1177/1352458511419700; Pertwee RG, 2006, INT J OBESITY, V30, pS13, DOI 10.1038/sj.ijo.0803272; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Pertwee RG, 2005, HANDB EXP PHARMACOL, V168, P1; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Picone RP, 2005, MOL PHARMACOL, V68, P1623, DOI 10.1124/mol.105.014407; Presley C.S., 2016, DATA BRIEF; Price TJ, 2004, BRIT J PHARMACOL, V142, P257, DOI 10.1038/sj.bjp.0705778; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; RinaldiCarmona M, 1996, J PHARMACOL EXP THER, V278, P871; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Ross RA, 2007, TRENDS PHARMACOL SCI, V28, P567, DOI 10.1016/j.tips.2007.10.006; Rouzer CA, 2002, CHEM PHYS LIPIDS, V119, P69, DOI 10.1016/S0009-3084(02)00068-3; Ryberg E, 2005, FEBS LETT, V579, P259, DOI 10.1016/j.febslet.2004.11.085; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Shen MX, 1998, BRAIN RES, V783, P77, DOI 10.1016/S0006-8993(97)01195-5; Shire D, 1996, BBA-GENE STRUCT EXPR, V1307, P132, DOI 10.1016/0167-4781(96)00047-4; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Shukla AK, 2014, TRENDS BIOCHEM SCI, V39, P594, DOI 10.1016/j.tibs.2014.10.001; Silvestri C, 2015, J HEPATOL, V62, P1382, DOI 10.1016/j.jhep.2015.01.001; Song ZH, 1999, MOL PHARMACOL, V56, P834; Song ZH, 1996, MOL PHARMACOL, V49, P891; Steffens M, 2005, BIOCHEM PHARMACOL, V69, P169, DOI 10.1016/j.bcp.2004.08.033; Steffens M, 2004, BRIT J PHARMACOL, V141, P1193, DOI 10.1038/sj.bjp.0705706; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Tao Q, 1998, J PHARMACOL EXP THER, V285, P651; Thomas BF, 1998, J PHARMACOL EXP THER, V285, P285; Valenzano KJ, 2005, NEUROPHARMACOLOGY, V48, P658, DOI 10.1016/j.neuropharm.2004.12.008; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Vasquez C, 2003, CAN J PHYSIOL PHARM, V81, P436, DOI 10.1139/Y03-055; Yates ML, 2009, MOL PHARMACOL, V76, P11, DOI 10.1124/mol.109.055251; Zhang HY, 2014, P NATL ACAD SCI USA, V111, pE5007, DOI 10.1073/pnas.1413210111	106	6	6	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	APR 1	2016	498						8	28		10.1016/j.ab.2015.12.019			21	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	DF6DE	WOS:000371445300002	26772161				2022-02-06	
J	Supnet, C; Crow, A; Stutzman, S; Olson, D				Supnet, Charlene; Crow, April; Stutzman, Sonja; Olson, DaiWai			Music as Medicine: The Therapeutic Potential of Music for Acute Stroke Patients	CRITICAL CARE NURSE			English	Article							MECHANICALLY-VENTILATED PATIENTS; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CARE-UNIT; INTRACEREBRAL HEMORRHAGE; BLOOD-PRESSURE; ANXIETY; STRESS; SEDATION; RELAXATION	Nurses caring for patients with acute stroke are likely to administer both music and medication with therapeutic intent. The administration of medication is based on accumulated scientific evidence and tailored to the needs of each patient. However, the therapeutic use of music is generally based on good intentions and anecdotal evidence. This review summarizes and examines the current literature regarding the effectiveness of music in the treatment of critically ill patients and the use of music in neurologically injured patients. The rationale for hypothesis-driven research to explore therapeutic music intervention in acute stroke is compelling.	[Supnet, Charlene] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Supnet, Charlene; Stutzman, Sonja; Olson, DaiWai] Univ Texas SW Med Ctr Dallas, Neurosci Nursing Res Ctr, Dallas, TX 75390 USA; [Crow, April] Zale Lipshy Univ Hosp, Inpatient Rehabil Unit, Dallas, TX USA		Olson, D (corresponding author), Univ Texas SW Med Ctr Dallas, 5323 Harry Hines Blvd,CS07-104, Dallas, TX 75390 USA.	daiwai.olson@utsouthwestern.edu	Olson, DaiWai/I-5932-2019	Olson, DaiWai/0000-0002-9280-078X; Supnet, Charlene/0000-0001-6917-770X			American Music Therapy Association, 2014, DEF QUOT MUS THER WH; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bae I, 2014, COMPLEMENT THER MED, V22, P251, DOI 10.1016/j.ctim.2014.02.002; Bardutzky J, 2004, INTENS CARE MED, V30, P151, DOI 10.1007/s00134-003-1988-4; Bardutzky J, 2004, J NEUROSURG, V100, P266, DOI 10.3171/jns.2004.100.2.0266; Beaulieu-Boire G, 2013, J CRIT CARE, V28, P442, DOI 10.1016/j.jcrc.2013.01.007; BRADT J, 2014, COCHRANE DB SYST REV, V12; Bradt J, 2013, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD006577.PUB3; Bradt J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub2; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; BURVILL PW, 1995, BRIT J PSYCHIAT, V166, P328, DOI 10.1192/bjp.166.3.328; Camara E, 2009, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.019.2008; Chang SC, 2005, RES NURS HEALTH, V28, P453, DOI 10.1002/nur.20102; Chemerinski E, 2006, MT SINAI J MED, V73, P1006; Chlan L, 1999, Crit Care Nurse, V19, P35; Chlan L L, 2000, AACN Clin Issues, V11, P128, DOI 10.1097/00044067-200002000-00014; Chlan L, 2009, ARCH PSYCHIAT NURS, V23, P177, DOI 10.1016/j.apnu.2008.12.005; Chlan LL, 2013, JAMA-J AM MED ASSOC, V309, P2335, DOI 10.1001/jama.2013.5670; Chlan LL, 2013, INTENS CRIT CARE NUR, V29, P121, DOI 10.1016/j.iccn.2012.11.001; Christensen MC, 2009, STROKE, V40, P1677, DOI 10.1161/STROKEAHA.108.538967; Comeaux Tressa, 2013, Medsurg Nurs, V22, P313; Davis T, 2012, DIMENS CRIT CARE NUR, V31, P159, DOI 10.1097/DCC.0b013e31824dffc6; Dennis CM, 2010, J NEUROSCI NURS, V42, P217, DOI 10.1097/JNN.0b013e3181e26c20; Douds GL, 2014, J STROKE CEREBROVASC, V23, P123, DOI 10.1016/j.jstrokecerebrovasdis.2012.10.018; DUNTON W R Jr, 1946, Occup Ther Rehabil, V25, P247; El Husseini N, 2012, STROKE, V43, P1609, DOI 10.1161/STROKEAHA.111.643130; Fachner J, 2013, BRAIN TOPOGR, V26, P338, DOI 10.1007/s10548-012-0254-x; Georgiadis D, 2002, INTENS CARE MED, V28, P1089, DOI 10.1007/s00134-002-1351-1; GOOD M, 1995, NURS RES, V44, P52; Gutgsell KJ, 2013, J PAIN SYMPTOM MANAG, V45, P822, DOI 10.1016/j.jpainsymman.2012.05.008; GUZZETTA CE, 1989, HEART LUNG, V18, P609; Han L, 2010, J CLIN NURS, V19, P978, DOI 10.1111/j.1365-2702.2009.02845.x; Hegde S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00034; Hermans H, 2013, INT J GERIATR PSYCH, V28, P691, DOI 10.1002/gps.3872; Hunter BC, 2010, J MUSIC THER, V47, P198, DOI 10.1093/jmt/47.3.198; Ikonomidou Eleni, 2004, AORN J, V80, P269, DOI 10.1016/S0001-2092(06)60564-4; Jaber S, 2007, ANN FR ANESTH, V26, P30, DOI 10.1016/j.annfar.2006.09.002; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Jolly K, 2006, INT J CARDIOL, V111, P343, DOI 10.1016/j.ijcard.2005.11.002; Jones AL, 2000, DISABIL REHABIL, V22, P490, DOI 10.1080/096382800413970; Korhan EA, 2011, J CLIN NURS, V20, P1026, DOI 10.1111/j.1365-2702.2010.03434.x; Magee WL, 2002, J MUSIC THER, V39, P20, DOI 10.1093/jmt/39.1.20; Meehan TC, 2012, J CLIN NURS, V21, P2905, DOI 10.1111/j.1365-2702.2012.04214.x; Mornhinweg G C, 1995, J Holist Nurs, V13, P248, DOI 10.1177/089801019501300306; Nightingale F, 1992, F NIGHTINGALES NOTES; Nilsson U, 2005, EUR J ANAESTH, V22, P96, DOI 10.1017/S0265021505000189; Nilsson U, 2001, ACTA ANAESTH SCAND, V45, P812, DOI 10.1034/j.1399-6576.2001.045007812.x; Nuyen J, 2008, STROKE, V39, P132, DOI 10.1161/STROKEAHA.107.490565; O'Connor SE, 1993, J CLIN NURS, V2, P29; Olson D M, 2001, Am J Crit Care, V10, P74; Olson DM, 2005, AACN ADV CRIT CARE, V16, P441, DOI 10.1097/00044067-200510000-00003; Olson Daiwai M, 2005, Crit Care Nurs Clin North Am, V17, P257, DOI 10.1016/j.ccell.2005.04.008; Olson DM, 2015, J HOLIST NURS; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; RAUSCHER FH, 1993, NATURE, V365, P611, DOI 10.1038/365611a0; Rodriguez-Fornells A, 2012, ANN NY ACAD SCI, V1252, P282, DOI 10.1111/j.1749-6632.2011.06425.x; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Sarkamo T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00245; Sarkamo T, 2012, ANN NY ACAD SCI, V1252, P266, DOI 10.1111/j.1749-6632.2011.06405.x; Seo W, 2009, WORLDV EVID-BASED NU, V6, P36, DOI 10.1111/j.1741-6787.2008.00139.x; Skrobik Y, 2010, ANESTH ANALG, V111, P451, DOI 10.1213/ANE.0b013e3181d7e1b8; Sousa Karen H, 2011, AACN Adv Crit Care, V22, P275, DOI 10.1097/NCI.0b013e3182209279; Su CP, 2013, J ADV NURS, V69, P1377, DOI 10.1111/j.1365-2648.2012.06130.x; Thaut MH, 2015, PROG BRAIN RES, V217, P143, DOI 10.1016/bs.pbr.2014.11.025; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Treggiari MM, 2009, CRIT CARE MED, V37, P2527, DOI 10.1097/CCM.0b013e3181a5689f; van Rijk MC, 2009, CRIT CARE MED, V37, P1831, DOI 10.1097/CCM.0b013e3181a096e8; Walworth D, 2008, J MUSIC THER, V45, P349, DOI 10.1093/jmt/45.3.349; White J M, 2000, Crit Care Nurs Clin North Am, V12, P219; Wuchner SS, 2012, J NEUROSCI NURS, V44, P177, DOI 10.1097/JNN.0b013e318252763f; Yang CY, 2012, BIOL RES NURS, V14, P197, DOI 10.1177/1099800411406258; Zatorre R, 2005, NATURE, V434, P312, DOI 10.1038/434312a; Zhang YH, 2008, J HYPERTENS, V26, P1446, DOI 10.1097/HJH.0b013e328300a24a	74	6	6	0	13	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	0279-5442	1940-8250		CRIT CARE NURSE	Crit. Care Nurse	APR	2016	36	2					E1	E7		10.4037/ccn2016413			7	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	DI4CQ	WOS:000373448300001	27037347	Bronze			2022-02-06	
J	Guerriero, EN; Smith, PM; Stergiou-Kita, M; Colantonio, A				Guerriero, E. Niki; Smith, Peter M.; Stergiou-Kita, Mary; Colantonio, Angela			Rehabilitation Utilization following a Work-Related Traumatic Brain Injury: A Sex-Based Examination of Workers' Compensation Claims in Victoria, Australia	PLOS ONE			English	Article							SERVICE UTILIZATION; HEALTH-CARE; GENDER-DIFFERENCES; MEDICAL-CARE; EPIDEMIOLOGY; DISABILITY; POPULATION; BEHAVIOR; OUTCOMES; TBI	Objectives To report on and examine differences in the use of four types of rehabilitation services (occupational therapy, physiotherapy, psychology, and speech therapy) by men and women following a work-related traumatic brain injury in Victoria, Australia; and to examine the importance of demographic, need, work-related and geographic factors in explaining these differences. Methods A retrospective cohort design was used to analyze 1786 work-related traumatic brain injury workers' compensation claims lodged between 2004 and 2012 in Victoria, Australia. ZINB regressions were conducted for each type of rehabilitation service to examine the relationship between sex and rehabilitation use. Covariates included demographic, need-related, work-related, and geographic factors. Results Out of all claims (63% male, 37% female), 13% used occupational therapy, 23% used physiotherapy, 9% used psychology, and 2% used speech therapy at least once during the first year of service utilization. After controlling for demographic, need-related, work-related, and geographic factors, women were more likely to use physiotherapy compared to men. Men and women were equally likely to use occupational therapy and psychology services. The number of visits in the first year for each type of service did not differ between male and female users. Conclusions Our findings support a sex-based approach to studying rehabilitation utilization in work-related populations. Future research is needed to examine other factors associated with rehabilitation utilization and to determine the implications of different rehabilitation utilization patterns on health and return-to-work outcomes.	[Guerriero, E. Niki; Stergiou-Kita, Mary; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Smith, Peter M.] Inst Work & Hlth, Toronto, ON, Canada; [Smith, Peter M.; Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Smith, Peter M.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Stergiou-Kita, Mary; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Stergiou-Kita, Mary; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada		Guerriero, EN (corresponding author), Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada.	eileennicolina@gmail.com	Smith, Peter/AAE-4293-2021	Smith, Peter/0000-0001-8286-4563; Colantonio, Angela/0000-0003-2094-4765	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [494372]; Research Chair in Gender, Work, & Health from the Canadian Institutes of Health Research [201210CGW]; Transport Accident Commission (TAC); WorkSafe Victoria (WSV); Monash UniversityMonash University	This study, including support for ENG and AC, was funded by the Canadian Institutes of Health Research (#494372). PMS is supported by a Research Chair in Gender, Work, & Health from the Canadian Institutes of Health Research (#201210CGW). The Canadian Institutes of Health Research had no involvement in the study design; collection, analysis, and interpretation of the data; writing of the manuscript; and decision to submit the paper for publication. For more information about the Canadian Institutes of Health Research, go to http://www.cihr-irsc.gc.ca. Data for the analysis conducted uses unit record data from the Compensation Research Database (CRD), which was initiated and funded by the Transport Accident Commission (TAC), WorkSafe Victoria (WSV), and Monash University, and is managed by the Institute for Safety, Compensation, and Recovery Research (ISCRR). The findings and views reported in this paper, however, are those of the authors and should not be attributed to TAC, WSV, or ISCRR. For more information about ISCRR, go to http://www.iscrr.com.au.; The authors would like to thank the staff at the Institute for Safety, Compensation, and Recovery Research for data extraction, and Amber Bielecky for her assistance with SAS programming. Peter M. Smith and Angela Colantonio are both supported by a Research Chair in Gender, Work & Health from the Canadian Institutes of Health Research.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Australian Bureau of Statistics, 2011, AUSTR STAT GEOGR STA, V5; Australian Bureau of Statistics, 2006, ANZSCO AUSTR NZ STAN; Australian Bureau of Statistics, 2005, ANZSCO AUSTR NZ STAN; Australian Bureau of Statistics, 2006, AUSTR NZ STAND IND C; Australian Bureau of Statistics (ABS), 2011, CENS POP HOUS SOC IN; Australian Safety and Compensation Council, 2008, TYP OCC CLASS SYST, V3rd; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Borkhoff CM, 2008, CAN MED ASSOC J, V178, P681, DOI 10.1503/cmaj.071168; Brasure M., 2012, AHRQ PUBLICATION, V12-EHC101-EF; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Chang VC, 2014, OCCUP ENVIRON MED, V71, P695, DOI 10.1136/oemed-2014-102097; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Collie A, 2013, INJURY, V44, P1514, DOI 10.1016/j.injury.2013.03.006; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Foster M, 2000, BRAIN INJURY, V14, P1035; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Keene J, 2005, J PUBLIC HEALTH-UK, V27, P74, DOI 10.1093/pubmed/fdh208; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim H, 2006, NEUROREHABILITATION, V21, P269; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS295, DOI 10.1016/j.apmr.2013.08.296; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Menard MR, 1996, J OCCUP ENVIRON MED, V38, P1161, DOI 10.1097/00043764-199611000-00017; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Ruseckaite R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002396; Siqueira FV, 2005, REV SAUDE PUBL, V39, P663, DOI 10.1590/S0034-89102005000400022; Victorian Neurotrauma Initiative, 2009, EC COST SPIN CORD IN; Willemse-van Son AHP, 2009, J REHABIL MED, V41, P59, DOI 10.2340/16501977-0294; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327	34	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151462	10.1371/journal.pone.0151462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	WOS:000372574900086	26982491	gold, Green Published, Green Submitted			2022-02-06	
J	Callaway, L; Tregloan, K; Williams, G; Clark, R				Callaway, Libby; Tregloan, Kate; Williams, Gavin; Clark, Ross			Evaluating Access and Mobility within a New Model of Supported Housing for People with Neurotrauma: A Pilot Study	BRAIN IMPAIRMENT			English	Article						Housing; design; independence; mobility	DEVICES SCALE PIADS; PSYCHOMETRIC EVALUATION; PSYCHOSOCIAL IMPACT; PARTICIPATION; HOME; INTERVENTION; TRANSLATION; TRIAL	Objectives: (1) Evaluate the features of purpose-built apartment living on access, environmental control, and home and community mobility of people living with neurotrauma and (2) Examine tenant perceptions of those features. Research design: Observational case series pilot study. Setting: Three apartments within a residential development in Melbourne, Australia. Participants: Three males (aged 30-55 years) with traumatic brain and/or spinal cord injury living in the three separate apartments. Method and procedures: Measures: Two-published measures of user experience of built and technology environments, coupled with customised interdisciplinary post-occupancy evaluation (POE) methods and GPS-enabled mobility tracking. Analysis: Measures completed per manual guidelines and data reported descriptively. Customised measured drawings produced to represent tenants' physical access and mobility. GPS community mobility data plotted on Google Earth. Results: Built design features which enabled access and mobility included linear paths of travel, well-located furnishings, and joinery design that allowed approach from either side using a wheelchair. Personal home furnishing choices posed barriers to physical access. Home automation technologies positively influenced participants' sense of control and independence, but posed learning challenges. Close proximity of housing to accessible public transport and services enabled community travel options. Conclusion: Findings from this pilot study indicate the combination of housing location, design and technologies used, together with availability of local community services, provides an acceptable level of environmental control, access, mobility and tenant experience. Further research is required to determine validity of the novel measures used, and deliver rigorous research design to evaluate those features most important in achieving optimal outcomes.	[Callaway, Libby] Monash Univ, Dept Occupat Therapy, POB 527, Frankston, Vic 3199, Australia; [Callaway, Libby] Summer Fdn Ltd, Blackburn, Lancs, England; [Tregloan, Kate] Monash Univ, Fac Art Design Architecture, Caulfield, Australia; [Williams, Gavin] Epworth Med Fdn, Physiotherapy Dept, Richmond, Vic, Australia; [Williams, Gavin] Univ Melbourne, Physiotherapy Dept, Melbourne, Vic, Australia; [Clark, Ross] Australian Natl Univ, Sch Exercise Sci, Melbourne, Vic, Australia		Callaway, L (corresponding author), Monash Univ, Dept Occupat Therapy, POB 527, Frankston, Vic 3199, Australia.	libby.callaway@monash.edu	Tregloan, Kate/AAJ-9483-2021; Clark, Ross/K-7613-2019; Clark, Ross A/R-5664-2018	Clark, Ross/0000-0002-7291-8553; Clark, Ross A/0000-0002-7291-8553; Williams, Gavin/0000-0003-2758-7473; Tregloan, Kate/0000-0003-2412-6225	TAC through the Institute for Safety, Compensation and Recovery Research (ISCRR) [C-M-13-064]	This project was funded by the TAC through the Institute for Safety, Compensation and Recovery Research (ISCRR), project number C-M-13-064.	Access Economics, 2009, EC COST COST SPIN CO; Aplin T, 2015, AUST OCCUP THER J, V62, P123, DOI 10.1111/1440-1630.12156; Bonyhady B., 2014, COMM HOUS FED AUSTR; Callaway L, 2013, MODELS SUPPORTED ACC; Clark RA, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-37; Commonwealth of Australia, 2015, SEN EC REF COMM OUT; Crews Douglas E, 2006, J Physiol Anthropol, V25, P113, DOI 10.2114/jpa2.25.113; Currin ML, 2012, AUSTRALAS J AGEING, V31, P90, DOI 10.1111/j.1741-6612.2011.00545.x; Demers L, 2002, QUAL LIFE RES, V11, P583, DOI 10.1023/A:1016397412708; Department of Social Services, 2010, NAT DIS STRAT 2010 2; Fange Agneta, 2005, Occup Ther Int, V12, P44, DOI 10.1002/oti.14; Fisher G., 2004, AOTA DEV DISABILITIE, V27, P1; Fisher G, 2012, OCCUP THER HEALTH CA, V26, P224, DOI 10.3109/07380577.2012.723152; Gitlin LN, 2006, J AM GERIATR SOC, V54, P809, DOI 10.1111/j.1532-5415.2006.00703.x; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Hsieh YJ, 2006, DISABIL REHABIL-ASSI, V1, P49, DOI 10.1080/09638280500167217; Johansson Karin, 2007, Scand J Occup Ther, V14, P44, DOI 10.1080/11038120601094997; Jones R., 2003, INT J PSYCHOSOCIAL R, V7, P67; Jutai J., 2002, TECHNOLOGY DISABILIT, V14, P107, DOI DOI 10.3233/TAD-2002-14305; Jutai J., 1996, CANADIAN J REHABILIT, V9, P159; Koskinen I., 2011, DESIGN RES PRACTICE; McLachlan R., 2013, DEEP PERSISTENT DISA; Ocepek J, 2013, COMP MATH MATH PHYS, V2013, P1; Parkinson S, 2011, RESIDENTIAL ENV IMPA; Rand D, 2009, STROKE, V40, P163, DOI 10.1161/STROKEAHA.108.523621; Sloan S, 2012, BRAIN IMPAIR, V13, P24, DOI 10.1017/BrImp.2012.5; Tanner B, 2008, J HOUS ELDER, V22, P195, DOI 10.1080/02763890802232048; Tregloan K., 2014, RIPL PROJECT ONE POS; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Verdonschot MML, 2009, J INTELL DISABIL RES, V53, P54, DOI 10.1111/j.1365-2788.2008.01128.x; Wheeler S., 2005, HUMAN DEV PERFORMANC, P264; Williams G, 2012, BRAIN INJURY, V26, P1065, DOI 10.3109/02699052.2012.667586; Williams G., 2013, BRAIN INJURY, V26, P1065; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; World Health Organization, 2007, INT CLASS FUNCT DIS; ZIMRING CM, 1980, ENVIRON BEHAV, V12, P429, DOI 10.1177/0013916580124002	37	6	6	0	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2016	17	1			SI		64	76		10.1017/BrImp.2016.7			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DK6FQ	WOS:000375018500007					2022-02-06	
J	Chen, DYT; Hsu, HL; Kuo, YS; Wu, CW; Chiu, WT; Yan, FX; Wang, WS; Chen, CJ; Tseng, YC				Chen, David Yen-Ting; Hsu, Hui-Ling; Kuo, Ying-Sheng; Wu, Changwei Wesley; Chiu, Wen-Ta; Yan, Feng-Xian; Wang, Wei-Shuan; Chen, Chi-Jen; Tseng, Ying-Chi			Effect of Age on Working Memory Performance and Cerebral Activation after Mild Traumatic Brain Injury: A Functional MR Imaging Study	RADIOLOGY			English	Article							COGNITIVE NEUROSCIENCE; OLDER-ADULTS; VERBAL MEMORY; HEAD-INJURY; ABNORMALITIES; EPIDEMIOLOGY; METAANALYSIS; RECRUITMENT; ATTENTION; SPAN	Purpose: To evaluate the age effect on working memory (WM) performance and functional activation after mild traumatic brain injury (MTBI). Materials and Methods: This study was approved by the local research ethics committee. All participants provided written informed consent. N-back WM cerebral activation was assessed with functional magnetic resonance (MR) imaging in 13 younger (mean age, 26.2 years +/- 2.9; range, 21-30 years) and 13 older (mean age, 57.8 years +/- 6.6; range, 51-68 years) patients with MTBI and 26 age- and sex-matched control subjects. Two functional MR images were obtained within 1 month after injury and 6 weeks after the initial study. Group comparison and regression analysis were performed among postconcussion symptoms, neuropsychologic tests, and WM activity in both groups. Results: In younger patients, initial hyperactivation was seen in the right precuneus and right inferior parietal gyrus (P = .047 and P = .025, respectively) in two-back greater than one-back conditions compared with younger control subjects, whereas in older patients, hypoactivation was seen in the right precuneus and right inferior frontal gyrus (P = .013 and P =. 019, respectively) compared with older control subjects. Increased WM activity was associated with increased postconcussion symptoms in the right precuneus (r = 0.57; P = .026) and right inferior frontal gyrus (r = 0.60; P = .019) and poor WM performance in the right precuneus (r = 20.55; P = .027) in younger patients at initial studies but not in older patients. At follow-up examinations, partial recovery of activation pattern and decreased postconcussion symptoms (P = .04) were observed in younger patients but not in older patients. Conclusion: The different manifestations of postconcussion symptoms at functional MR imaging between younger and older patients confirmed the important role of age in the activation, modulation, and allocation of WM processing resources after MTBI. These findings also supported that younger patients have better neural plasticity and clinical recovery than do older patients. (C) RSNA, 2015	[Chen, David Yen-Ting; Hsu, Hui-Ling; Kuo, Ying-Sheng; Yan, Feng-Xian; Wang, Wei-Shuan; Chen, Chi-Jen; Tseng, Ying-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, 291 Jhong Jheng Rd,235 Jhonghe Dist, New Taipei, Taiwan; [Chen, David Yen-Ting; Wu, Changwei Wesley; Tseng, Ying-Chi] Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, 291 Jhong Jheng Rd,235 Jhonghe Dist, New Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Shuang Ho Hosp, Grad Inst Injury Prevent & Control, 291 Jhong Jheng Rd,235 Jhonghe Dist, New Taipei, Taiwan; [Wu, Changwei Wesley] Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan; [Chen, Chi-Jen] Minist Hlth & Welf, Dept Radiol, Chia Yi Hosp, Chiayi, Taiwan		Tseng, YC (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, 291 Jhong Jheng Rd,235 Jhonghe Dist, New Taipei, Taiwan.; Tseng, YC (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, 291 Jhong Jheng Rd,235 Jhonghe Dist, New Taipei, Taiwan.	x2mickey@yahoo.com.tw		Wu, Changwei W./0000-0001-8968-9366	National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 101-2314-B-038-035-MY3]; Taipei Medical University, Taiwan [102TMU-SHH-20]	Supported by grants from the National Science Council, Taiwan (grant #NSC 101-2314-B-038-035-MY3), and from Taipei Medical University, Taiwan (grant #102TMU-SHH-20).	Baddeley A.D., 1986, WORKING MEMORY; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grady CL, 2005, NEUROPSYCHOLOGIA, V43, P1466, DOI 10.1016/j.neuropsychologia.2004.12.016; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McIntosh AR, 1999, CURR BIOL, V9, P1275, DOI 10.1016/S0960-9822(99)80512-0; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Park DC, 2003, J COGNITIVE NEUROSCI, V15, P1122, DOI 10.1162/089892903322598094; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Pascual-Leone A, 2011, BRAIN TOPOGR, V24, P302, DOI 10.1007/s10548-011-0196-8; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thermenos HW, 2005, SCHIZOPHR RES, V74, P179, DOI 10.1016/j.schres.2004.07.021; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	32	6	8	0	13	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	MAR	2016	278	3					854	862		10.1148/radiol.2015150612			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DO3TC	WOS:000377703400023	26439705	Bronze			2022-02-06	
J	Driver, S; Rachal, L; Swank, C; Dubiel, R				Driver, Simon; Rachal, Lauren; Swank, Chad; Dubiel, Randi			Objective Assessment of Activity in Inpatients with Traumatic Brain Injury: Initial Findings	BRAIN IMPAIRMENT			English	Article						Head injury; exercise; accelerometers; rehabilitation	RANDOMIZED CONTROLLED-TRIAL; PHYSICAL-ACTIVITY; REHABILITATION PROGRAM; UNITED-STATES; ADULTS; ACCELEROMETER; INDIVIDUALS; THERAPY; STROKE; INTENSITY	Purpose: Use accelerometers to examine the physical activity behaviours of individuals following TBI undergoing inpatient rehabilitation. Method: Twenty-one individuals with Traumatic brain injury (TBI) undergoing inpatient rehabilitation (9 females, 12 males; M age = 43.8 14.7 years; M GCS = 9.1 4.3; M time since injury = 40.8 +/- 22.1 days; M length of stay (LOS) = 30 +/- 14 days) wore accelerometers for an average of 8.4 +/- 2.0 consecutive days (1440 minutes/day). Activity counts (AC) were collected at 1 minute epochs and descriptive statistics were calculated to assess intensity of activity and time spent being active and sedentary. Results: During scheduled therapy, time individuals completed an average of 161.4 +/- 65.5 AC/minute, which decreased to 114.5 +/- 51.3 during non-therapy time and 22.2 +/- 10 when sleeping. Using population level cut points, individuals were on average considered inactive during therapy, inactive or sedentary during non-therapy time, and only one participant spent >1 minute in moderate intensity activity. The mean length of active and sedentary bouts was 9 minutes. Discussion: Findings indicate that the amount and intensity of activity completed is low amongst individuals completing inpatient rehabilitation after TBI, with the majority considered sedentary or inactive. While the sample is small, it is important to develop and implement safe and effective strategies to increase activity levels during rehabilitation.	[Driver, Simon; Rachal, Lauren; Swank, Chad; Dubiel, Randi] Baylor Inst Rehabil, Phys Med & Rehabil, Dallas, TX USA; [Swank, Chad] Texas Womans Univ, Sch Phys Therapy, Dallas, TX USA		Driver, S (corresponding author), 909 N Washington Ave,Suite 232, Dallas, TX 75246 USA.	simon.driver@baylorhealth.edu			Ginger Murchison Foundation TBI Research Fund; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0045-01-0]	The project was supported by the Ginger Murchison Foundation TBI Research Fund. The contents of this manuscript were also developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DP0045-01-0). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Amonette WE, 2013, J HEAD TRAUMA REHAB, V28, pE13, DOI 10.1097/HTR.0b013e31826463a1; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Banham-Hall N, 2013, PHYSIOTHERAPY, V99, P328, DOI 10.1016/j.physio.2012.12.009; Berlin AA, 2006, PSYCHOSOM MED, V68, P224, DOI 10.1097/01.psy.0000204628.73273.23; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Canning CG, 2003, CLIN REHABIL, V17, P355, DOI 10.1191/0269215503cr620oa; Cuddy JS, 2007, MED SCI SPORT EXER, V39, P1004, DOI 10.1249/mss.0b013e318040b2fb; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; DeJong G, 2011, PHYS THER, V91, P1826, DOI 10.2522/ptj.20100424; DRIVER S, 2009, J COGN REHABIL, V33, P4; Driver S, 2008, ADAPT PHYS ACT Q, V25, P289, DOI 10.1123/apaq.25.4.289; Driver S, 2012, BRAIN INJURY, V26, P1482, DOI 10.3109/02699052.2012.694568; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Galvin R, 2014, TOP STROKE REHABIL, V21, P63, DOI 10.1310/tsr2101-63; Galvin R, 2011, STROKE, V42, P681, DOI 10.1161/STROKEAHA.110.594689; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Hassett L, 2015, J HEAD TRAUMA REHAB, V30, pE55, DOI 10.1097/HTR.0000000000000047; Hassett LM, 2012, J PHYSIOTHER, V58, P105, DOI 10.1016/S1836-9553(12)70090-5; Jackson D, 2001, CLIN REHABIL, V15, P535, DOI 10.1191/026921501680425252; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Kuys S, 2006, PHYSIOTHER RES INT, V11, P219, DOI 10.1002/pri.344; MacKay-Lyons MJ, 2002, ARCH PHYS MED REHAB, V83, P1378, DOI 10.1053/apmr.2002.35089; Mang CS, 2014, J APPL PHYSIOL, V117, P1325, DOI 10.1152/japplphysiol.00498.2014; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Mattlage AE, 2015, J NEUROL PHYS THER, V39, P166, DOI 10.1097/NPT.0000000000000092; McDermott S., 2007, PRIM HEALTH CARE RES, V8, P36, DOI [DOI 10.1017/S1463423607000059, 10.1017/S1463423607000059]; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Mulder E, 2015, EUR J APPL PHYSIOL, V115, P727, DOI 10.1007/s00421-014-3045-0; National Health and Nutrition Examination Survey, 2014, EX LAB PROC MAN; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Self M, 2013, ADAPT PHYS ACT Q, V30, P20, DOI 10.1123/apaq.30.1.20; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Slade A, 2002, J REHABIL MED, V34, P260, DOI 10.1080/165019702760390347; Traumatic Brain Injury Model Systems, 2015, ID SUBJ; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; Tweedy SM, 2005, MED SCI SPORT EXER, V37, P1474, DOI 10.1249/01.mss.0000177584.43330.ae; Wilson DJ, 2006, AM J PHYS MED REHAB, V85, P68, DOI 10.1097/01.phm.0000193507.28759.37	45	6	6	0	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2016	17	1			SI		55	63		10.1017/BrImp.2015.20			9	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DK6FQ	WOS:000375018500006					2022-02-06	
J	Garcia-Baran, D; Johnson, TM; Wagner, J; Shen, J; Geers, M				Garcia-Baran, Dynela; Johnson, Thomas M.; Wagner, Joyce; Shen, Joann; Geers, Michelle			Therapeutic Approach of a High Functioning Individual With Traumatic Brain Injury and Subsequent Emotional Volatility With Features of Pathological Laughter and Crying With Dextromethorphan/Quinidine	MEDICINE			English	Article							PSEUDOBULBAR AFFECT; TRIAL	Pathological laughing and crying, or pseudobulbar affect (PBA), has been described in patients with neurological disorders such as multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, and traumatic brain injury (TBI) since the 19th century (Schiffer 2005). The syndrome is characterized by inappropriate episodes of laughing or crying after minor stimuli. It was first coined a disinhibition of cortical control by Kinnier Wilson in 1924. It was observed in brain disease and seen with mild TBI. It can impair social and occupational function and is largely underrecognized in clinical settings. PBA is usually treated with antidepressants and dopaminergic agents. In this case we treated a military recruit with TBI with Nuedexta-a dextromethorphan/Quinidine derivative with a subsequent decrease in his episodes.	[Garcia-Baran, Dynela] NHCL, Regimental Aid Stn, Paris, France; [Johnson, Thomas M.; Wagner, Joyce] NHCL, Intrepid Spine Concuss Recovery Ctr, Dept Neurol, Paris, France		Garcia-Baran, D (corresponding author), Marine Logist Grp, Camp Lejeune, NC USA.	dgdynela@gmail.com					Brooks BR, 2004, NEUROLOGY, V63, P1364; Panitch HS, 2006, ANN NEUROL, V59, P780, DOI 10.1002/ana.20828; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Pioro EP, 2010, ANN NEUROL, V68, P693, DOI 10.1002/ana.22093; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; Werling LL, 2007, NEUROLOGIST, V13, P272, DOI 10.1097/NRL.0b013e3180f60bd8; Wilson SAK, 1924, J NEUROL PSYCHOPATHO, V4, P299	7	6	6	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAR	2016	95	12							e2886	10.1097/MD.0000000000002886			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK9ND	WOS:000375256400003	27015166	Green Published, gold			2022-02-06	
J	Jokar, TO; Khalil, M; Rhee, P; Kulvatunyou, N; Pandit, V; O'Keeffe, T; Tang, A; Joseph, B				Jokar, Tahereh Orouji; Khalil, Mazhar; Rhee, Peter; Kulvatunyou, Narong; Pandit, Viraj; O'Keeffe, Terence; Tang, Andrew; Joseph, Bellal			Ratio-based Resuscitation in Trauma Patients with Traumatic Brain Injury: Is There a Similar Effect?	AMERICAN SURGEON			English	Article							DAMAGE CONTROL RESUSCITATION; TRANSFUSION; COAGULOPATHY; MORTALITY; PLASMA	The use of 1:1:1 (packed red blood cells: fresh frozen plasma: platelets) transfusion ratio has been shown to improve survival in severely injured trauma patients. The aim of this study was to assess the outcomes in patients with traumatic brain injury (TBI) receiving 1:1:1 ratio-based blood product transfusion (RBT). We hypothesized that RBT improves survival in patients with TBI as only major injury. We performed a 3-year retrospective analysis of all patients with TBI as only major injury presenting to our Level I trauma center. Patients receiving blood transfusion were included. Patients were stratified into two groups: those who received RBTand those who did not receive RBT (No-RBT). The outcome measure was inhospital mortality. Multivariate logistic regression analysis was performed. A total of 189 patients were included of which 29 per cent (n = 55) received RBT. The mean age was 48 +/- 24 years, median (range) Glasgow Coma Scale score was 12 (3-15), and median head abbreviated injury severity scale was 3 (3-5). The overall mortality rate was 28.5 per cent. Patients in the RBT group had a higher survival rate compared with the patients in the No-RBT group (83.6% vs 66.5%, P = 0.02). In conclusion, the survival benefit of RBT exists even in patients with TBI as major injury. Guidelines for the initial management of TBI patients should focus on the use of RBT. The beneficial effect of platelets in RBT among TBI patients requires further evaluation.	[Jokar, Tahereh Orouji; Khalil, Mazhar; Rhee, Peter; Kulvatunyou, Narong; Pandit, Viraj; O'Keeffe, Terence; Tang, Andrew; Joseph, Bellal] Univ Arizona, Dept Surg, Div Trauma Crit Care Burn & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care Burn & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu					Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brain Trauma Foundation, TRAUM BRAIN INJ GUID; Brasel KJ, 2011, J TRAUMA SUPPL 3, V71, pS343; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; CDC, GET STATS TRAUM BRAI; Duchesne JC, 2008, J TRAUMA, V65, P272, DOI 10.1097/TA.0b013e31817e5166; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Gunter OL, 2008, J TRAUMA, V65, P527, DOI 10.1097/TA.0b013e3181826ddf; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Kutcher ME, 2014, ANN SURG, V260, P1103, DOI 10.1097/SLA.0000000000000366; Letarte PB, 2008, J TRAUMA, V64, P627; Nascimento B, 2013, CAN MED ASSOC J, V185, pE583, DOI 10.1503/cmaj.121986; Nascimento B, 2011, J TRAUMA, V71, pS418, DOI 10.1097/TA.0b013e318232e591; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Spahn DR, 2005, BRIT J ANAESTH, V95, P130, DOI 10.1093/bja/aei169; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Watters JM, 2006, J TRAUMA, V61, P300, DOI 10.1097/01.ta.0000224211.36154.44	19	6	6	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	MAR	2016	82	3					271	277					7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DI1QG	WOS:000373270000022	27099065				2022-02-06	
J	Kosheleva, E; Spadoni, AD; Strigo, IA; Buchsbaum, MS; Simmons, AN				Kosheleva, Elena; Spadoni, Andrea D.; Strigo, Irina A.; Buchsbaum, Monte S.; Simmons, Alan N.			Faking Bad: The Neural Correlates of Feigning Memory Impairment	NEUROPSYCHOLOGY			English	Article						fMRI; test of memory malingering; anterior cingulate cortex; mild traumatic brain injury; feigning	ANTERIOR CINGULATE; TEST-PERFORMANCE; BRAIN; DECEPTION; FMRI; ACTIVATION; INJURY; LIE	Objective: The detection of malingering in cognitive performance is a challenge in clinical and legal environments. Neuroimaging may provide an objective method for delineation of malingering. Method: A heterogeneous with concern of gender and racial-ethnic identity of 22 healthy volunteers completed the Tombaugh Test of Memory Malingering during an fMRI scan. Subjects were either instructed to perform optimally (not feigning) or to perform "as if they had a mild traumatic brain injury with memory impairment" (feigning). Results: A voxel-based multiple regression analysis revealed that during correct responses there was greater activation in the superior and medial prefrontal cortex during the feigning versus the not-feigning responses. Conclusions: This finding suggests that falsified memory performance requires greater activation of cognitive control networks to determine a correct selection.	[Kosheleva, Elena; Spadoni, Andrea D.; Simmons, Alan N.] San Diego Vet Affairs Hlth Care Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Kosheleva, Elena; Spadoni, Andrea D.; Buchsbaum, Monte S.; Simmons, Alan N.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Strigo, Irina A.] San Francisco VA Med Ctr, San Francisco, CA USA; [Strigo, Irina A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Buchsbaum, Monte S.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA		Simmons, AN (corresponding author), San Diego VA, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ansimmons@ucsd.edu	strigo, irina A/L-9882-2016; Simmons, Alan N/A-9815-2008	strigo, irina A/0000-0002-8799-716X; Simmons, Alan N/0000-0003-3963-2112; Spadoni, Andrea/0000-0002-8367-6406	Department of Veterans AffairsUS Department of Veterans Affairs [I01-CX-000715-01, I01-CX-000816-01, 1 IK2 CX000864-01]; VA Center of Excellence in Stress and Mental Health; Veterans AffairsUS Department of Veterans Affairs [IK2CX000864] Funding Source: NIH RePORTER	This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research. Salary was supported by Department of Veterans Affairs via Merit Grant I01-CX-000715-01 to Alan N. Simmons; Grant I01-CX-000816-01 to Irina A. Strigo; Career Development Grant 1 IK2 CX000864-01 to Andrea D. Spadoni; and the VA Center of Excellence in Stress and Mental Health to Alan N. Simmons, Elena Kosheleva, and Andrea D. Spadoni.	Abe N, 2011, NEUROSCIENTIST, V17, P560, DOI 10.1177/1073858410393359; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Brandt J, 2007, CLIN NEUROPSYCHOL, V21, P553, DOI 10.1080/13854040600770800; Brickman AM, 2006, APPL NEUROPSYCHOL, V13, P91, DOI 10.1207/s15324826an1302_4; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Browndyke JN, 2008, BRAIN INJURY, V22, P481, DOI 10.1080/02699050802084894; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Ellenberg C, 2009, LAW PSYCHOL REV, V33, P139; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Ganis G, 2011, NEUROIMAGE, V55, P312, DOI 10.1016/j.neuroimage.2010.11.025; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Holley Benjamin, 2009, DEV MENTAL HEALTH L, V28, P1; Institute of Medicine, 2015, PSYCH TEST SERV ADM; Kozel F Andrew, 2009, Open Forensic Sci J, V2, P6; Kozel FA, 2005, BIOL PSYCHIAT, V58, P605, DOI 10.1016/j.biopsych.2005.07.040; Kozel FA, 2004, J NEUROPSYCH CLIN N, V16, P295, DOI 10.1176/appi.neuropsych.16.3.295; Kozel FA, 2004, BEHAV NEUROSCI, V118, P852, DOI 10.1037/0735-7044.118.4.852; Langleben DD, 2005, HUM BRAIN MAPP, V26, P262, DOI 10.1002/hbm.20191; Larsen JD, 2010, BRAIN INJURY, V24, P89, DOI 10.3109/02699050903508218; Lee TMC, 2005, NEUROIMAGE, V28, P305, DOI 10.1016/j.neuroimage.2005.06.051; Lee TMC, 2002, HUM BRAIN MAPP, V15, P157, DOI 10.1002/hbm.10020; Liang CY, 2012, BRAIN COGNITION, V79, P70, DOI 10.1016/j.bandc.2012.01.009; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; Mindt MR, 2010, CLIN NEUROPSYCHOL, V24, P429, DOI 10.1080/13854040903058960; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Muller SV, 2005, CLIN NEUROPHYSIOL, V116, P63, DOI 10.1016/j.clinph.2004.07.009; Pankratz L., 1997, CLIN ASSESSMENT MALI, P223; Poldrack RA, 2011, NEURON, V72, P692, DOI 10.1016/j.neuron.2011.11.001; Reynolds CR, 1998, CRIT ISS NE, P261; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Sherer M, 2015, CLIN NEUROPSYCHOL, V29, P522, DOI 10.1080/13854046.2015.1052763; Spadoni AD, 2015, PSYCHIAT RES-NEUROIM, V233, P367, DOI 10.1016/j.pscychresns.2015.06.007; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vitacco M. J., 2002, FORENSIC PSYCHOL CLA, P83; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Weinborn M, 2003, J CLIN EXP NEUROPSYC, V25, P979, DOI 10.1076/jcen.25.7.979.16481	46	6	6	1	12	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2016	30	3					377	384		10.1037/neu0000251			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DF0ZS	WOS:000371068800012	26765340	Bronze			2022-02-06	
J	Ren, SL; Xu, Y; Lv, DW; Zhang, L				Ren, Shanling; Xu, Yan; Lv, Dongwei; Zhang, Lei			Rosiglitazone ameliorates astrocyte over-activation and inflammatory cytokine release induced by global cerebral ischemia/reperfusion	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						rosiglitazone; global cerebral ischemia; inflammatory; astrocyte over-activation; glutamate transporter-1; rats	GAMMA AGONIST ROSIGLITAZONE; ISCHEMIC NEURONAL DEATH; TRAUMATIC BRAIN-INJURY; RAT MODEL; STROKE; NEUROTOXICITY; MECHANISMS; ADULT	Global cerebral ischemia (GCI) is a leading cause of mortality worldwide and remains the primary cause of long-term neurological disability. Astrocyte over-activation and extensive neuron loss in the ischemic brain are the characteristic pathological features of cerebral ischemia. Rosiglitazone (RSG) is a peroxisome-proliferating activating receptor-gamma agonist known for its anti-inflammatory activity. Previous studies have suggested that RSG is able to exert neuroprotection in numerous acute and chronic brain injury models. However, whether RSG treatment is involved in astrocyte over-activation and inflammatory reaction in the cortex remains unclear. The aim of the present study was to investigate whether RSG treatment improved functional impairment induced following GCI and protected against cortex neuron loss, and to elucidate the potential mechanisms underlying these functions. Rats were randomly divided into three groups: Sham-operated, GCI and RSG treatment groups. The RSG treatment group was treated with 2 mg/kg RSG immediately following GCI. The results demonstrated that RSG treatment significantly reduced infarct volume and neuron survival rates in addition to increasing function recovery. Furthermore, these results correlate with a reduction in astrocyte over-activation and inflammatory cytokines in the rat cortex. However, no significant changes in glutamate transporter-1 expression levels were observed following RSG treatment compared with the GCI rats. The results of this investigation provide in vivo evidence that RSG significantly protected rats against ischemia-reperfusion-induced brain injury. In addition, RSG may exert neuroprotective effects by inhibiting astrocyte over-activation, and thereby reducing the levels of inflammatory cytokines in the GCI-injured brain. All data revealed that RSG may be a potential neuroprotective agent for cerebral ischemia.	[Ren, Shanling; Xu, Yan; Lv, Dongwei; Zhang, Lei] Wuhan Univ, Zhongnan Hosp, Dept Neurol, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China		Ren, SL (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Neurol, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	shanlingren24k@163.com			Nature Science Foundation of Hubei ProvinceNatural Science Foundation of Hubei Province [2014CFB479]	The present study was supported by a grant from the Nature Science Foundation of Hubei Province (grant no. 2014CFB479).	Al Rouq F, 2014, EXP GERONTOL, V51, P1, DOI 10.1016/j.exger.2013.12.008; Anderson CM, 2000, GLIA, V32, P1; Azbill RD, 2000, BRAIN RES, V871, P175, DOI 10.1016/S0006-8993(00)02430-6; Barone FC, 2000, EXPERT OPIN INV DRUG, V9, P2281, DOI 10.1517/13543784.9.10.2281; Batti L, 2010, J NEUROIMMUNOL, V218, P21, DOI 10.1016/j.jneuroim.2009.11.002; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Cao YG, 2011, BRAIN RES BULL, V85, P396, DOI 10.1016/j.brainresbull.2011.05.002; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Harvey BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022135; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Liu Shimin, 2010, J Exp Stroke Transl Med, V3, P47; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Love S, 1999, BRAIN PATHOL, V9, P119; Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1111/j.1471-4159.2006.03758.x; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Shamloo M, 1999, NEUROSCIENCE, V93, P81, DOI 10.1016/S0306-4522(99)00137-2; Shimamura N, 2006, J NEUROSCI RES, V84, P1837, DOI 10.1002/jnr.21073; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Vexler ZS, 2006, CLIN NEUROSCI RES, V6, P293, DOI 10.1016/j.cnr.2006.09.008; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0; Willis CL, 2011, TOXICOL PATHOL, V39, P172, DOI 10.1177/0192623310385830; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zhang Q, 2010, NEUROL RES, V32, P852, DOI 10.1179/016164110X12556180206112	33	6	6	0	8	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAR	2016	11	3					1071	1076		10.3892/etm.2016.2975			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DC9PV	WOS:000369554400059	26998039	Green Published, gold			2022-02-06	
J	Saber, A; Tabatabaei, SM; Akasheh, G; Sehat, M; Zanjani, Z; Larijani, B				Saber, Ali; Tabatabaei, Seyed Mahmoud; Akasheh, Goodarz; Sehat, Mojtaba; Zanjani, Zahra; Larijani, Bagher			Cross-Cultural Adaptations of the MacArthur Competence Assessment Tool for Treatment in Iran	ARCHIVES OF TRAUMA RESEARCH			English	Article						Decision-Making Capacity; Competency; Assessment Tools for Treatment; Translation and Cross-Cultural Adaptation; Macarthur Assessment Tool	DECISION-MAKING CAPACITY; TRAUMATIC BRAIN-INJURY; MACCAT-T; CONSENT; TRANSLATION; INSTRUMENTS; SCHIZOPHRENIA; IMPAIRMENT; CLINICIAN; BIOETHICS	Objectives: Due to the lack of a standard tool for assessing patients' capacity to consent to medical treatment in Iran, the present study was carried out aiming to devise a Persian version of a cross-cultural adaptation of the MacArthur competence assessment tool. Patients and Methods: By reviewing different methods of cultural translation and adaptation for assessment tools, and due to the lack of consensus on its processes, we selected Wild's model as one of the most comprehensive methods in this regard. Wild's (2005) 10-stage model includes preparation, forward translation, reconciliation of the forward translation, back translation of reconciliation, back translation review, cognitive debriefing and cognitive review, and finalization, proofreading and final reporting. Using this model, we translated the MacArthur assessment tool and made it adaptable to Iranian patients. Results: The MacArthur assessment tool is not dependent on any specific culture and language. As a result, if translation and its scientific adaptation are done based on an integrated and detailed model, the tool can be used for every culture and language. In other words, this tool is not culture-specific; so, it is applicable in cases where a translation is needed, and it can be culturally adapted to suit different societies. Conclusions: In the present study, we are able to focus on and prove the efficacy and benefits of this measurement tool.	[Saber, Ali; Tabatabaei, Seyed Mahmoud; Larijani, Bagher] Univ Tehran Med Sci, Med Eth & Hist Med Res Ctr, Tehran, Iran; [Akasheh, Goodarz] Kashan Univ Med Sci, Dept Psychiat, Kashan, Iran; [Sehat, Mojtaba] Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran; [Zanjani, Zahra] Kashan Univ Med Sci, Dept Psychol, Kashan, Iran; [Larijani, Bagher] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran		Larijani, B (corresponding author), Univ Tehran Med Sci, Med Eth & Hist Med Res Ctr, Tehran, Iran.	larijanib@TUMS.ac.ir	zanjani, zahra/Q-7548-2017; larijani, Bagher/ABE-3315-2020; Saber, Ali/I-5091-2017	larijani, Bagher/0000-0001-5386-7597; 			AFRASIBAI A, 2006, J NURSING MIDWIFERY, V54, P58; Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bilanakis N, 2013, ANN GEN PSYCHIATR, V12, DOI 10.1186/1744-859X-12-10; Borsa Juliane Callegaro, 2012, Paidéia (Ribeirão Preto), V22, P423; Breden TM, 2004, HEALTH CARE ANAL, V12, P273, DOI 10.1007/s10728-004-6635-x; Dunn LB, 2006, AM J PSYCHIAT, V163, P1323, DOI 10.1176/appi.ajp.163.8.1323; Etchells E, 1996, CAN MED ASSOC J, V155, P387; Etchells E, 1996, CAN MED ASSOC J, V155, P177; Gjersing L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-13; GRAHAM C, 2014, J CLIN URO; Grisso T., 1998, MACARTHUR COMPETENCE; HASSANVAND S, 2014, FUT MED ED J, V4, P22; HEIN IM, 2014, ACCURACY ASSESSMENT, DOI DOI 10.1002/14651858.CD011099; Hein IM, 2015, BMC MED ETHICS, V16, DOI 10.1186/1472-6939-16-1; Hermann H, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14039; Robles PH, 2012, REV CALID ASSIST, V27, P85, DOI 10.1016/j.cali.2011.08.003; Jeste DV, 2009, SCHIZOPHRENIA BULL, V35, P719, DOI 10.1093/schbul/sbm148; Jones RC, 2004, CLEV CLIN J MED, V71, P971, DOI 10.3949/ccjm.71.12.971; KARLAWISH MJ, 2015, ASSESSMENT DECISION; Khosravi M., 2013, TEHRAN U MED J, V71, P53; Kim SYH, 2007, BRIT J PSYCHIAT, V191, P38, DOI 10.1192/bjp.bp.106.033324; Lamont S, 2013, J CLIN NURS, V22, P2387, DOI 10.1111/jocn.12215; Lui V W C, 2010, East Asian Arch Psychiatry, V20, P116; Malda M., 2008, PSYCHOL SCI Q, V50, P451, DOI DOI 10.1177/0022022109349172; MARKANI AK, 2012, J URMI NURS MID FAC, V10, P11; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; Moye J, 2006, CLIN PSYCHOL REV, V26, P1054, DOI 10.1016/j.cpr.2005.04.013; Palmer BW, 2002, AM J GERIAT PSYCHIAT, V10, P207, DOI 10.1176/appi.ajgp.10.2.207; Poduri A, 1998, J NATL MED ASSOC, V90, P531; POORKEMALI M, 2011, ASSESSMENT CAPACITY; Rosnah I, 2013, MED J MALAYSIA, V68, P425; ROTH MS, 1981, AM J PSYCHIAT, V138, P1170; Sturman ED, 2005, CLIN PSYCHOL REV, V25, P954, DOI 10.1016/j.cpr.2005.04.010; Triebel KL, 2012, NEUROLOGY, V78, P1472, DOI 10.1212/WNL.0b013e3182553c38; Triebel KL, 2014, ARCH PHYS MED REHAB, V95, P2296, DOI 10.1016/j.apmr.2014.07.413; van Widenfelt BM, 2005, CLIN CHILD FAM PSYCH, V8, P135, DOI 10.1007/s10567-005-4752-1; Weeks A, 2007, EVALUATION REV, V31, P153, DOI 10.1177/0193841X06294184; *WHO, 2011, WHO MAN SUBST AB PRO; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x	40	6	6	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	MAR	2016	5	1							e33464	10.5812/atr.33464			7	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	DY6KG	WOS:000385217300010	27148503	Green Published, Green Submitted			2022-02-06	
J	Strasberg, S; Johnson, EJ; Parry, T				Strasberg, Stephen; Johnson, Elizabeth J.; Parry, Thomas			"Stuttering" after minor head trauma	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							BRAIN-INJURY; APHASIA; DISCOURSE	Traumatic brain injury (TBI) is defined as impairment in brain function as a result ofmechanical force. It is classified based on clinical findings using the Glasgow Coma Scale (GCS). Mild TBI is defined as GCS 1415; moderate, 9-13; and severe, 3-8 [1-6]. Patients with the same TBI classification may have very different underlying pathology. In moderate to severe TBI, the primary pathology may include contusions, hemorrhage, diffuse axonal injury, direct cellular damage, "tearing and shearing of the tissues, loss of the blood-brain barrier, disruption of the neurochemical homeostasis and loss of the electrochemical function" [5]. Although the primary pathology associated with mild TBI may be milder versions of the same pathology associated with moderate and severe TBI, it is generally a metabolic injury [7-13]. However, it is reported that 15% of patients with mild TBI and a GCS score of 14 or 15 will have an intracranial lesion; less than 1% of these require neurosurgical intervention. Although patients with mild TBI may have intracranial lesions, it is rare that the presenting and only physical examination finding is an isolated neurologic finding [1-19]. Here we present a case of isolated head trauma with a single physical examination finding-expressive aphasia.	[Strasberg, Stephen; Johnson, Elizabeth J.; Parry, Thomas] Lincoln Med & Mental Hlth Ctr, Dept Emergency Med, Bronx, NY 10451 USA		Johnson, EJ (corresponding author), Lincoln Med & Mental Hlth Ctr, Dept Emergency Med, Bronx, NY 10451 USA.	johnson.elizabeth.jane@gmail.com					Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Chhiber SS, 2011, TURK NEUROSURG, V21, P418, DOI 10.5137/1019-5149.JTN.2913-10.0; Grochmal-Bach B, 2009, MED SCI MONITOR, V15, pCS67; Guo CJ, 2009, CHIN J TRAUMATOL, V12, P302, DOI 10.3760/cma.j.issn.1008-1275.2009.05.010; Ha JW, 2012, YONSEI MED J, V53, P486, DOI 10.3349/ymj.2012.53.3.486; Huff J, 2011, TINTINALLIS EMERGENC; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kavanagh DO, 2010, CASE REP MED, V2010; Meairs S, 2000, LANCET, V356, P40, DOI 10.1016/S0140-6736(00)02433-8; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Stables G, 2005, EMERG MED J, V22, P303; Stein M, 1999, J ORAL MAXIL SURG, V57, P745, DOI 10.1016/S0278-2391(99)90446-9; Tani T, 2011, J FLUENCY DISORD, V36, P1, DOI 10.1016/j.jfludis.2010.12.002; WONG PP, 1994, BRAIN INJURY, V8, P509, DOI 10.3109/02699059409151003; Wright DW, 2011, TINTINALLIS EMERGENC; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P283, DOI 10.1080/09084282.2010.525118	19	6	6	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAR	2016	34	3								10.1016/j.ajem.2015.07.056			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DI4TB	WOS:000373491100097	26371830				2022-02-06	
J	Lau, KM; Madden, E; Neylan, TC; Seal, KH; Maguen, S				Lau, Karen M.; Madden, Erin; Neylan, Thomas C.; Seal, Karen H.; Maguen, Shira			Assessing for mild TBI among Iraq and Afghanistan veterans: Outcomes of injury severity and neurological factors	BRAIN INJURY			English	Article						veterans; injury severity markers; nausea; neurologic symptoms; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; NEUROBEHAVIORAL SYMPTOM INVENTORY; POSTCONCUSSION SYNDROME; CLINICAL MANAGEMENT; HEAD-INJURY; MILITARY; DIAGNOSIS; MANIFESTATIONS; CLASSIFICATION; PERFORMANCE	Objective: To investigate injury severity markers and neurological symptoms associated with clinician-confirmed mild traumatic brain injury (TBI) among Iraq and Afghanistan veterans. Setting: Department of Veterans Affairs (VA) medical centre and five affiliated community-based outpatient clinics. Participants: Three hundred and fifty Iraq and Afghanistan veterans with positive initial VA TBI screens between 1 April 2007 and 1 June 2010 and clinician-confirmed TBI status by 1 December 2010. Methods: Retrospective-cohort study of medical record data. Main measures included clinician-confirmed TBI status, injury severity markers (e.g. loss of consciousness (LOC), post-traumatic amnesia (PTA) or confusion/disorientation) and neurological symptoms. Results: Among veterans who screened positive on the initial VA TBI and then received a clinician evaluation, 60% were confirmed to have a TBI diagnosis. Veterans reporting at least one LOC, confusion or PTA were almost 18-times more likely to receive a confirmed TBI diagnosis. Odds of clinician-confirmed TBI were 2.5-3-times greater among those who endorsed dizziness, poor coordination, headaches, nausea, vision problems and/or irritability, compared to those not endorsing these symptoms. Nausea had greatest utility for confirming a TBI. Conclusions: Identification of neurologic symptoms that most contribute to a clinician-confirmed diagnosis of TBI has potential for streamlining detection of TBI and symptoms needed for treatment.	[Lau, Karen M.; Madden, Erin; Neylan, Thomas C.; Seal, Karen H.; Maguen, Shira] San Francisco VA Med Ctr, 4150 Clement St 116-P, San Francisco, CA 94121 USA; [Neylan, Thomas C.; Seal, Karen H.; Maguen, Shira] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Seal, Karen H.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA		Lau, KM (corresponding author), San Francisco VA Med Ctr, 4150 Clement St 116-P, San Francisco, CA 94121 USA.	karen.lau2@va.gov			Department of Defense Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program; VA Health Sciences Research and Development (HSR&D) Career Development 475 Award	This research was supported by a Department of Defense Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program (Maguen) and VA Health Sciences Research and Development (HSR&D) Career Development 475 Award (Maguen). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Baldassarre M, 2015, PM&R, V7, P845, DOI 10.1016/j.pmrj.2015.03.003; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Department of Veterans Affairs, 2009, OEF OIF ROST RMTPRD; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; DVBIC  Defense and Veterans Brain Injury Center, 2015, DOD NUMB TRAUM BRAIN; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Maguen S, 2012, J REHABIL RES DEV, V49, P1115, DOI 10.1682/JRRD.2011.02.0015; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; National Center for Posttraumatic Stress Disorder (PTSD), 2010, VA CONS C PRACT REC; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; U. S. Government Accountability Office. VA Health Care, 2008, GAO08276 VA HLTH CAR; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374	37	6	6	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2016	30	3					287	294		10.3109/02699052.2015.1089601			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DG9QM	WOS:000372418900006	26910483				2022-02-06	
J	Zhu, L; Huang, G; Sheng, J; Fu, Q; Chen, A				Zhu, L.; Huang, G.; Sheng, J.; Fu, Q.; Chen, A.			HIGH-MOBILITY GROUP BOX 1 INDUCES NEURON AUTOPHAGY IN A RAT SPINAL ROOT AVULSION MODEL	NEUROSCIENCE			English	Article						spinal root avulsion; HMGB1; autophagy	SIGNAL-TRANSDUCTION PATHWAYS; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; CELL-DEATH; EXTRACELLULAR SIGNAL; MAMMALIAN AUTOPHAGY; CHROMATIN PROTEIN; HMGB1 RELEASE; UP-REGULATION; CORD-INJURY	Autophagy, a tightly regulated lysosomedependent catabolic pathway, is implicated in various pathological states in the nervous system. High-mobility group box 1 (HMGB1) is an inflammatory mediator known to be released into the local microenvironment from damaged cells. However, whether autophagy is induced and exogenous HMGB1 is involved in the process of spinal root avulsion remain unclear. Here, we investigated the induction effect of autophagy and the possible role of HMGB1 during spinal root avulsion. It was found that autophagy was activated in the anterior horn of the spinal cord as represented by the increased expression of the autophagic marker microtubule-associated protein light chain 3-II (LC3-II), degradation of sequestosome 1 (p62), and formation of autophagosomes, and that autophagy was inhibited after intraperitoneal injection of anti-HMGB1-neutralizing antibodies in the rat spinal root avulsion model. In addition, HMGB1induced autophagy and activated mitogen-activated protein kinases (MAPKs) in primary spinal neurons, including cJun N-terminal kinase (JNK), extracellular-signal-regulated kinase (ERK), and p38MAPK. Inhibition of JNK or ERK activity significantly blocked the effect of HMGB1-induced autophagy in primary spinal neurons. Finally, HMGB1-induced autophagy increased cell viability in primary spinal neurons under oxygen-glucose deprivation conditions. The above results suggest that HMGB1 is a critical regulator of autophagy and HMGB1-induced autophagy plays an important role in protecting spinal neurons against injury, which may provide new insights into the pathophysiological process of spinal root avulsion. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Zhu, L.; Fu, Q.; Chen, A.] Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Trauma Surg, Shanghai 200003, Peoples R China; [Huang, G.] Second Mil Med Univ, Dept Pathophysiol, Shanghai 200433, Peoples R China; [Sheng, J.] Changhai Hosp, Dept Burn Surg, Shanghai 200433, Peoples R China		Chen, A (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Trauma Surg, 415 Fengyang Rd, Shanghai 200003, Peoples R China.	hailangzhulei@126.com; gaoxiangsoar-ing@163.com; rei.sheng@163.com; 254134536@qq.com; aiminchen@aliyun.com			National Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC) [NSFC81171161, NSFC81272012, NSFC81571204]	The present study was supported by grants from the National Natural Scientific Foundation of China (No. NSFC81171161, No. NSFC81272012 and No. NSFC81571204).	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chen HC, 2012, SPINE, V37, P470, DOI 10.1097/BRS.0b013e318221e859; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Gurusamy N, 2009, METHODS MOL BIOL, V559, P95, DOI 10.1007/978-1-60327-017-5_7; He Y, 2008, J CEREBR BLOOD F MET, V28, P897, DOI 10.1038/sj.jcbfm.9600578; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Jiang X, 2014, ACTA NEUROCHIR, V156, P1599, DOI 10.1007/s00701-014-2114-9; Jiang XY, 2006, J NEUROSCI METH, V158, P13, DOI 10.1016/j.jneumeth.2006.05.014; Kanno H, 1976, SPINE, V36, pE1427; Kim SW, 2011, NEUROTOX RES, V20, P159, DOI 10.1007/s12640-010-9231-x; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Korenic A, 2015, NEUROSCI LETT, V595, P128, DOI 10.1016/j.neulet.2015.04.020; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang Y, 2015, MOL CELL BIOCHEM, V405, P63, DOI 10.1007/s11010-015-2396-0; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mantell LL, 2006, SHOCK, V25, P4, DOI 10.1097/01.shk.0000188710.04777.9e; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Penas C, 2011, J NEUROTRAUM, V28, P831, DOI 10.1089/neu.2010.1674; Qin ZH, 2004, ACTA PHARMACOL SIN, V25, P1243; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sekiguchi A, 2012, J NEUROTRAUM, V29, P946, DOI 10.1089/neu.2011.1919; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Suzuki C, 2008, BIOCHEM BIOPH RES CO, V368, P100, DOI 10.1016/j.bbrc.2008.01.059; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tang DL, 2007, J LEUKOCYTE BIOL, V81, P741, DOI 10.1189/jlb.0806540; Tang DL, 2005, SHOCK, V23, P434, DOI 10.1097/01.shk.0000159556.95285.df; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Torres-Espin A, 2013, NEUROTHERAPEUTICS, V10, P354, DOI 10.1007/s13311-013-0178-5; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wang L, 2014, BIOTECHNOL LETT, V36, P1631, DOI 10.1007/s10529-014-1525-2; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Zhang QY, 2015, ONCOL REP, V33, P1630, DOI 10.3892/or.2015.3782; Zou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087915	52	6	6	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 19	2016	315						286	295		10.1016/j.neuroscience.2015.12.020			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB2BG	WOS:000368312700022	26705737				2022-02-06	
J	Davidson, J				Davidson, Joyce			Plenary address - A year of living 'dangerously': Reflections on risk, trust, trauma and change	EMOTION SPACE AND SOCIETY			English	Article						Concussion; Medical technologies; Multiple pregnancy; Quantification; Quantified self	SELF; EXPERIENCES; CONTEXT	This paper examines the role of emotions in the construction and performance of mis/trustful relations; with medical professionals, their technologies, and ultimately, with oneself. Using personal experience of two common conditions as illustrative examples, it questions what it means and feels like to trust, and how, where and by whom such feelings can be enhanced or undermined. It explores some of the ways in which discourses of risk are mobilized and embodied to create a crisis of trust, asking; what kind of selves and emotionalities surface, and what are the health outcomes, when bodies are viewed as 'at risk'? Visualizing technologies that probe the interior for data play an increasingly prominent role in healthcare, and are typically considered more trustworthy sources of knowledge about the body than anything that might be produced by the tech-free sensing self. However, not all (even 'physical') trauma can be seen or quantified, and not all information is equal. The paper reflects on the emotional dissonance that ensues when one's own perceptions and representations are at odds with those of medical experts for whom one is supposed to perform trust. It examines the feeling rules that are broken when we fail to appreciate our treatment at their hands, and asks: What happens when we resist expert authority by telling different stories about our embodied selves, ones that make space for emotions in contexts where they are rarely seen to count, and where only what can be measured matters? (C) 2016 Elsevier Ltd. All rights reserved.	[Davidson, Joyce] Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada		Davidson, J (corresponding author), Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada.	joyce.davidson@queensu.ca					Abi- Rached Joelle M., 2013, NEURO NEW BRAIN SCI; Adams D., 1979, HITCHHIKERS GUIDE GA; Anderson NG, 2007, ULTRASOUND OBST GYN, V30, P173, DOI 10.1002/uog.4037; Benjamin J, 2013, SHADOW OTHER INTERSU; BIGNELL P, 2011, INDEPENDENT; Bondi L, 2005, T I BRIT GEOGR, V30, P433, DOI 10.1111/j.1475-5661.2005.00183.x; Bondi L, 2011, T I BRIT GEOGR, V36, P595, DOI 10.1111/j.1475-5661.2011.00460.x; Brownlie J, 2008, ROUT STUD HLTH SOC W, V1, P17; Bunn Geoff, 2014, HIST BRAIN; Chamorro-Premuzic T, 2015, GUARDIAN; Costea B, 2008, HUM RELAT, V61, P661, DOI 10.1177/0018726708091763; Damasio A., 1999, FEELING WHAT HAPPENS; Damasio Antonio, 2010, SELF COMES MIND; Davidson J, 2009, ENVIRON PLANN D, V27, P898, DOI 10.1068/d4308; Draper J, 2002, SOCIOL HEALTH ILL, V24, P771, DOI 10.1111/1467-9566.00318; Gaunt K, 2014, CHI 14 EXT HUM FACT, P263; Giddens Anthony, 1991, MODERNITY SELF IDENT; Haggerty K. D., 2006, NEW POLITICS SURVEIL, P3; Hand M., 2014, BIG DATA QUALITATIVE; Hanks Gentry, 2013, ASS AM GEOGR ANN C A; Harris G, 2004, MED ANTHROPOL Q, V18, P23, DOI 10.1525/maq.2004.18.1.23; HEIDEGGER M, 1993, BASIC WRITINGS, P311; Jenks C., 1995, VISUAL CULTURE; Jones Terry, 1983, THE MEANING OF LIFE; KEMBER S, 1998, VIRTUAL ANXIETY PHOT; LeDoux J. E., 2003, SYNAPTIC SELF OUR BR; Lucherini Mark, 2015, THESIS U GLASGOW; Lupton D, 2013, PALGRAVE PIVOT, P1, DOI 10.1057/9781137310729; Lupton D., 2012, SOCIOLOGICAL LIFE BL; LUPTON D, 2014, P 26 AUSTR COMP HUM; Lupton D, 2015, DIGITAL SOCIOLOGY; Lupton D, 2013, CRIT PUBLIC HEALTH, V23, P393, DOI 10.1080/09581596.2013.794931; Lupton Deborah., 2016, LIFELOGGING THEORETI; McClusky M., 2009, WIRED; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; Mechanic D, 2000, SOC SCI MED, V51, P657, DOI 10.1016/S0277-9536(00)00014-9; Mollering G, 2001, SOCIOLOGY, V35, P403, DOI 10.1177/S0038038501000190; NAFUS D, 2014, INT J COMMUNICATION, V0008, P00011; Orton-Johnson K., 2013, DIGITAL SOCIOLOGY CR; Parr H, 2008, ROUT STUD HLTH SOC W, V1, P33; Parry DC, 2006, QUAL INQ, V12, P459, DOI 10.1177/1077800406286225; Porter T.M., 1996, TRUST NUMBERS PURSUI; Shapin S, 1998, T I BRIT GEOGR, V23, P5, DOI 10.1111/j.0020-2754.1998.00005.x; Simmel G., 1990, PHILOS MONEY; Smith Niall D., 2013, THESIS U GALSGOW; Solbjor M, 2008, ROUT STUD HLTH SOC W, V1, P54; Solomon Robert C., 2000, HEIDEGGER COPING COG; Swan M, 2013, BIG DATA-US, V1, P85, DOI 10.1089/big.2012.0002; Swan M, 2012, J SENS ACTUAR NETW, V1, P217, DOI 10.3390/jsan1030217; Ventresca M., 2014, SPORT SOC TECHN SESS; WOLF G, 2010, NY TIMES; Woliver Laura R., 2002, POLITICAL GEOGRAPHIE; [No title captured]	53	6	6	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1755-4586	1878-0040		EMOT SPACE SOC	Emot. Space Soc.	FEB	2016	18						28	34		10.1016/j.emospa.2016.01.002			7	Geography; Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Geography; Social Sciences - Other Topics	DF2IC	WOS:000371164900005					2022-02-06	
J	Jang, SH; Lee, HD				Jang, Sung Ho; Lee, Han Do			Compensatory Neural Tract from Contralesional Fornical Body to Ipsilesional Medial Temporal Lobe in a Patient with Mild Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Fornix; Memory; Diffusion Tensor Imaging; Brain Plasticity; Mild Traumatic Brain Injury	DIFFUSION TENSOR TRACTOGRAPHY; CONNECTIVITY	The authors attempted to demonstrate the compensatory process for an injured fornical crus after mild traumatic brain injury, using follow-up diffusion tensor tractography. A 50-yr-old female patient had a mild traumatic brain injury resulting from a collision that occurred while driving a sedan that was hit from the side. The patient complained of memory impairment since the onset of head trauma and underwent neuropsychologic evaluation at 2 mos after onset with global memory: 77 (6%ile) on the Memory Assessment Scale. She underwent rehabilitation, including cognitive therapy and cholinergic drugs until 12mos after onset. At that time, she showed improvement of memory impairment with global memory: 90 (25%ile) on the Memory Assessment Scale. On 2-mo diffusion tensor tractography, a discontinuation was observed in the left fornical crus. By contrast, on 12-mo diffusion tensor tractography, the left discontinued fornical crus was shortened; instead, a neural tract from the right fornical body extended to the left medial temporal lobe via the splenium of the corpus callosumand the left fornical column was elongated to the left medial temporal lobe. The authors report on a patient who showed a compensatory neural tract from the contralesional fornical body to the ipsilesional medial temporal lobe via the corpus callosum after mild traumatic brain injury.	[Jang, Sung Ho; Lee, Han Do] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Namku 705717, Daegu, South Korea		Lee, HD (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Namku 705717, Daegu, South Korea.				National Research Foundation of Korea Grant - Korean Government (MSIP) [2015R1A2A2A01004073]	Supported by the National Research Foundation of Korea Grant funded by the Korean Government (MSIP) (2015R1A2A2A01004073). Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bach y Rita P., 1981, ARCH PHYS MED REHAB, V62, P413; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Jang SH, 2014, NEURAL REGEN RES, V9, P1434, DOI 10.4103/1673-5374.139459; Jang SH, 2014, NEUROSCI LETT, V559, P72, DOI 10.1016/j.neulet.2013.11.040; Jang SH, 2013, NEUROSCI LETT, V549, P116, DOI 10.1016/j.neulet.2013.06.017; Lee HD, 2014, BRAIN INJURY, V28, P1485, DOI 10.3109/02699052.2014.930178; TEASDALE G, 1974, LANCET, V2, P81; Williams JM., 1991, MAS MEMORY ASSESSMEN; Yamada K, 2009, P NATL ACAD SCI USA, V106, pE14, DOI 10.1073/pnas.0812352106; Yeo SS, 2013, J REHABIL MED, V45, P1078, DOI 10.2340/16501977-1232; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145	12	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	2016	95	2					E14	E17		10.1097/PHM.0000000000000390			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DB6MF	WOS:000368628400001	26390396				2022-02-06	
J	Kreinest, M; Gliwitzky, B; Goller, S; Munzberg, M				Kreinest, M.; Gliwitzky, B.; Goller, S.; Muenzberg, M.			Pre-clinical spinal immobilisation. Friend or foe of trauma patients?	NOTFALL & RETTUNGSMEDIZIN			German	Article						Spine; Immobilization; Trauma; Emergency; Accident	TISSUE-INTERFACE PRESSURES; CERVICAL-SPINE; CORD INJURY; PENETRATING TRAUMA; VACUUM MATTRESS; RIGID COLLAR; IMMOBILIZATION; RULE; RECOMMENDATIONS; BACKBOARD	The question about the need of spinal immobilization of trauma patients in general, and the various ways to do it in particular are nowadays increasingly discussed in scientific literature. Furthermore, daily practice of spinal immobilization routines also reflects a huge heterogeneity. The aim of this article is to give an overview about exemplarily selected literature on the subject of spinal immobilization of trauma patients. Thus, possible recommendations concerning spinal immobilization could be derived by the reader. The general lack of evidence towards spinal immobilization is well known. In the current scientific literature increasing hints can be found that the sole application of a cervical collar does not ensure a sufficient immobilization of the cervical spine. Thus, total spine immobilization, meaning fixation of the entire body of the trauma patient is recommended. However, total spine immobilization is also said to be associated with significant complications such as aggravated airway management or reduced lung function due to restrictions. Furthermore, the application of a cervical collar can lead to increased intracranial pressure. Thus, the indication for spinal immobilization should be sophisticated on behalf of immobilization decision tools such as the Canadian C-spine rule. In patients with acute life threatening conditions such as Hemorrhagic shock, it must be decided whether the immediate transport can be delayed by immobilization procedures. In the case of a trauma patient suffering from severe traumatic brain injury, one should consider whether the application of a cervical collar is mandatory or if alternative ways of immobilization could be carried out. Hence, the vacuum mattress offers better stability and greater comfort during total spinal immobilization compared to the spine board.	[Kreinest, M.; Goller, S.; Muenzberg, M.] BG Unfallklin Ludwigshafen, Klin Unfallchirurg & Orthopadie, Ludwig Guttmann Str 13, D-67071 Ludwigshafen, Germany; [Kreinest, M.; Gliwitzky, B.; Goller, S.; Muenzberg, M.] PHTLS Europe Res Grp, Offenbach Queich, Germany; [Kreinest, M.; Gliwitzky, B.; Goller, S.; Muenzberg, M.] PHTLS Deutschland, Offenbach Queich, Germany; [Gliwitzky, B.] MegaMed Notfallmanagement GbR, Annweiler, Germany		Kreinest, M (corresponding author), BG Unfallklin Ludwigshafen, Klin Unfallchirurg & Orthopadie, Ludwig Guttmann Str 13, D-67071 Ludwigshafen, Germany.; Kreinest, M (corresponding author), PHTLS Europe Res Grp, Offenbach Queich, Germany.; Kreinest, M (corresponding author), PHTLS Deutschland, Offenbach Queich, Germany.	michael.kreinest@bgu-ludwigshafen.de	Kreinest, Michael/ABI-7282-2020				Baez AA, 2006, ANN EMERG MED, V47, P110, DOI 10.1016/j.annemergmed.2005.09.008; BAUER D, 1988, ANN EMERG MED, V17, P915, DOI 10.1016/S0196-0644(88)80671-1; Ben-Galim P, 2010, J TRAUMA, V69, P447, DOI 10.1097/TA.0b013e3181be785a; Boissy P, 2011, CLIN J SPORT MED, V21, P80, DOI 10.1097/JSM.0b013e31820f8ad5; Braude Darren, 2002, BMJ, V325, P279; Butler J, 2001, EMERG MED J, V18, P275, DOI 10.1136/emj.18.4.275; CHANDLER DR, 1992, ANN EMERG MED, V21, P1185, DOI 10.1016/S0196-0644(05)81743-3; Clarke A, 2010, ACTA ORTHOP BELG, V76, P413; Cloward R B, 1980, Clin Symp, V32, P1; Connell RA, 2003, INJURY, V34, P912, DOI 10.1016/S0020-1383(03)00070-6; Connor D, 2013, EMERG MED J, V30, P1067, DOI 10.1136/emermed-2013-203207; Conrad Bryan P, 2012, Surg Neurol Int, V3, pS188, DOI 10.4103/2152-7806.98584; Conrad BP, 2012, J SPINAL CORD MED, V35, P53, DOI 10.1179/2045772311Y.0000000045; CORDELL WH, 1995, ANN EMERG MED, V26, P31, DOI 10.1016/S0196-0644(95)70234-2; CRAIG GR, 1991, INTENS CARE MED, V17, P504, DOI 10.1007/BF01690778; Cross D A, 2001, Prehosp Emerg Care, V5, P270, DOI 10.1080/10903120190939779; Deutsche Gesellschaft fur Unfallchirurgie (DGU), 2014, TRAUMAREGISTER DGU J; Garcia A, 2014, J TRAUMA ACUTE CARE, V76, P534, DOI 10.1097/TA.0b013e3182aafe50; Goutcher CM, 2005, BRIT J ANAESTH, V95, P344, DOI 10.1093/bja/aei190; Hamilton Robert S., 1996, Journal of Emergency Medicine, V14, P553, DOI 10.1016/S0736-4679(96)00170-9; Hauswald M, 1998, ACAD EMERG MED, V5, P214, DOI 10.1111/j.1553-2712.1998.tb02615.x; Haut ER, 2010, J TRAUMA, V68, P115, DOI 10.1097/TA.0b013e3181c9ee58; Helm M, 2013, ANAESTHESIST, V62, P973, DOI 10.1007/s00101-013-2255-x; Hemmes B, 2010, J TRAUMA, V68, P593, DOI 10.1097/TA.0b013e3181a5f304; Hindman BJ, 2014, ANESTHESIOLOGY, V121, P260, DOI 10.1097/ALN.0000000000000263; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Holla M, 2012, EMERG MED J, V29, P104, DOI 10.1136/emj.2010.092973; Horodyski M, 2011, J EMERG MED, V41, P513, DOI 10.1016/j.jemermed.2011.02.001; Hostler D, 2009, PREHOSP EMERG CARE, V13, P256, DOI 10.1080/10903120802706195; Johnson DR, 1996, AM J EMERG MED, V14, P369, DOI 10.1016/S0735-6757(96)90051-0; Keller BPJA, 2005, INJURY, V36, P946, DOI 10.1016/j.injury.2004.09.017; Kwan I, 2009, COCHRANE DB SYST REV; Luscombe MD, 2003, EMERG MED J, V20, P476, DOI 10.1136/emj.20.5.476; Mahshidfar B, 2013, PREHOSP DISASTER MED, V28, P462, DOI 10.1017/S1049023X13008637; MASINI M, 1994, PARAPLEGIA, V32, P93, DOI 10.1038/sc.1994.16; Michaleff ZA, 2012, CAN MED ASSOC J, V184, pE867, DOI 10.1503/cmaj.120675; Mobbs RJ, 2002, ANZ J SURG, V72, P389, DOI 10.1046/j.1445-2197.2002.02462.x; Papadopoulos MC, 1999, BRIT MED J, V319, P171, DOI 10.1136/bmj.319.7203.171; Perry SD, 1999, SPINE, V24, P1839, DOI 10.1097/00007632-199909010-00014; Schweigkofler U, 2013, CHIRURG, V84, P739, DOI 10.1007/s00104-013-2475-2; Stephan K, 2015, SPINE J, V15, P1994, DOI 10.1016/j.spinee.2015.04.041; Stiell IG, 2003, NEW ENGL J MED, V349, P2510, DOI 10.1056/NEJMoa031375; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Stuke LE, 2011, J TRAUMA, V71, P763, DOI 10.1097/TA.0b013e3182255cb9; Sundstrom T, 2014, J NEUROTRAUM, V31, P531, DOI 10.1089/neu.2013.3094; Theodore N, 2013, NEUROSURGERY, V72, P22, DOI 10.1227/NEU.0b013e318276edb1; TOSCANO J, 1988, PARAPLEGIA, V26, P143, DOI 10.1038/sc.1988.23; Totten V Y, 1999, Prehosp Emerg Care, V3, P347, DOI 10.1080/10903129908958967; Vaillancourt C, 2009, ANN EMERG MED, V54, P663, DOI 10.1016/j.annemergmed.2009.03.008; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f	50	6	6	1	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	FEB	2016	19	1					41	47		10.1007/s10049-015-0118-5			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DD6SB	WOS:000370053400009					2022-02-06	
J	Neumann, MV; Eley, R; Vallmuur, K; Schuetz, M				Neumann, Mirjam V.; Eley, Rob; Vallmuur, Kirsten; Schuetz, Michael			Current profile of cycling injuries: A retrospective analysis of a trauma centre level 1 in Queensland	EMERGENCY MEDICINE AUSTRALASIA			English	Article						cycling; emergency medicine; fracture; injury; trauma	BICYCLE SAFETY HELMETS; VICTORIA; CRASHES	ObjectivesOne out of 50 injury-related presentations to an ED is a transport-related cycling injury. Detailed information about the most frequent mechanism of cycling injuries, sustained injuries and patterns are under-reported. The objective of this research was to examine the pattern of injuries sustained by cyclists at a level 1 trauma centre. MethodsA retrospective review of data of injured cyclists admitted and treated at a level 1 trauma centre between 2011 and 2012 evaluated demographic data, mechanism of injury, injury pattern, economic costs and outcome. ResultsData of 261 patients (mean age of 39years) were reviewed, of which 88% was male patients with an average age of 38years. Non-collision cycling injuries were reported in 55% of cases followed by collisions with other motor vehicles in 25.6% of cases. The mean injury severity score (ISS) was 9, but an ISS12 was documented in 24%. Predominantly upper limb injuries (24.8%) were found, followed by injuries to the head and lower limb (each with 16.8%). Traumatic brain and chest injuries were equally seen in 8%. The overall length of stay was 4days, and survival rate was 98%. ConclusionThis current data review reveals that non-collision traffic crashes accounted for the majority of injuries in cyclists treated in this facility, and the upper limb has replaced the head as the most injured body part. With a growing number of cyclists, this information contributes to considerations to improve road safety and trauma management.	[Neumann, Mirjam V.] Univ Freiburg, Dept Orthopaed & Trauma Surg, Fahnenbergpl, D-79085 Freiburg, Germany; [Eley, Rob] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Eley, Rob] Princess Alexandra Hosp, Emergency Dept, Brisbane, Qld 4102, Australia; [Vallmuur, Kirsten] Queensland Univ Technol, Ctr Accid Res & Rd Safety Queensland, Brisbane, Qld 4001, Australia; [Schuetz, Michael] Princess Alexandra Hosp, Trauma Serv, Brisbane, Qld 4102, Australia; [Schuetz, Michael] Queensland Univ Technol, Traumatol, Brisbane, Qld 4001, Australia		Neumann, MV (corresponding author), Univ Freiburg, Dept Orthopaed & Trauma Surg, Fahnenbergpl, D-79085 Freiburg, Germany.	neumannmd@gmail.com	Eley, Rob/A-8121-2011; Vallmuur, Kirsten/AAL-9526-2021	Eley, Rob/0000-0003-0856-4313; Vallmuur, Kirsten/0000-0002-3760-0822			Australian Bureau of Statistics and Australian Institute for Health and Welfare, 2013, CAUS OF DEATH; Australian Government's Department of Infrastructure and Regional Development 'Fatal Road Crash Database, 2013, TMS WEBCRASH DAT; Austroads Ltd, AUSTR CYCL PART 2013; Boufous S, 2011, TRAFFIC INJ PREV, V12, P244, DOI 10.1080/15389588.2011.563333; de Rome L, 2014, TRAFFIC INJ PREV, V15, P81, DOI 10.1080/15389588.2013.781591; FRANK E, 1995, ACAD EMERG MED, V2, P200, DOI 10.1111/j.1553-2712.1995.tb03198.x; Haworth N, 2013, CARRS Q SUBMISSION Q; Heesch KC, 2011, ACCIDENT ANAL PREV, V43, P2085, DOI 10.1016/j.aap.2011.05.031; Hitchens PL, 2012, ACCIDENT ANAL PREV, V49, P449, DOI 10.1016/j.aap.2012.03.013; Hooten KG, 2014, J NEUROTRAUM, V31, P1329, DOI 10.1089/neu.2013.3253; Konkin DE, 2006, AM J SURG, V191, P615, DOI 10.1016/j.amjsurg.2006.02.012; Lindsay, 2013, INJURED CYCLIST PROF; Lusk AC, 2015, INJURY PREV, V21, P221, DOI 10.1136/injuryprev-2014-041317; MCDERMOTT FT, 1995, ANN ROY COLL SURG, V77, P38; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; Metro South Health, PRINC AL HOSP PROC M; Monea AG, 2014, J MECH BEHAV BIOMED, V33, P3, DOI 10.1016/j.jmbbm.2013.06.011; Olivier J, 2013, ACCIDENT ANAL PREV, V50, P1128, DOI 10.1016/j.aap.2012.09.003; RIVARA FP, 1994, PEDIATRICS, V93, P567; Silberman MR, 2013, CURR SPORT MED REP, V12, P337, DOI 10.1249/JSR.0b013e3182a4bab7; Strohm PC, 2005, UNFALLCHIRURG, V108, P1022, DOI 10.1007/s00113-005-0975-3; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1471, DOI 10.2105/AJPH.80.12.1471; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1974, DOI 10.1001/jama.276.24.1974; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Tin ST, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-655; Webman R, 2013, J TRAUMA ACUTE CARE, V75, P877, DOI 10.1097/TA.0b013e3182a85f97; Yilmaz P, 2013, INJURY, V44, P848, DOI 10.1016/j.injury.2013.03.007	27	6	6	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-6731	1742-6723		EMERG MED AUSTRALAS	Emerg. Med. Australas.	FEB	2016	28	1					90	95		10.1111/1742-6723.12495			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DD9SN	WOS:000370266000014	26607850				2022-02-06	
J	Zonfrillo, MR; Zaniletti, I; Hall, M; Fieldston, ES; Colvin, JD; Bettenhausen, JL; Macy, ML; Alpern, ER; Cutler, GJ; Raphael, JL; Morse, RB; Sills, MR; Shah, SS				Zonfrillo, Mark R.; Zaniletti, Isabella; Hall, Matthew; Fieldston, Evan S.; Colvin, Jeffrey D.; Bettenhausen, Jessica L.; Macy, Michelle L.; Alpern, Elizabeth R.; Cutler, Gretchen J.; Raphael, Jean L.; Morse, Rustin B.; Sills, Marion R.; Shah, Samir S.			Socioeconomic Status and Hospitalization Costs for Children with Brain and Spinal Cord Injury	JOURNAL OF PEDIATRICS			English	Article							RESOURCE UTILIZATION; INPATIENT REHABILITATION; UNITED-STATES; DISPARITIES; CARE; PATTERNS; DISABILITY; QUALITY	Objective To determine if household income is associated with hospitalization costs for severe traumatic brain injury (TBI) and spinal cord injury (SCI). Study design Retrospective cohort study of inpatient, nonrehabilitation hospitalizations at 43 freestanding children's hospitals for patients <19 years old with unintentional severe TBI and SCI from 2009-2012. Standardized cost of care for hospitalizations was modeled using mixed-effects methods, adjusting for age, sex, race/ethnicity, primary payer, presence of chronic medical condition, mechanism of injury, injury severity, distance from residence to hospital, and trauma center level. Main exposure was zip code level median annual household income. Results There were 1061 patients that met inclusion criteria, 833 with TBI only, 227 with SCI only, and 1 with TBI and SCI. Compared with those with the lowest-income zip codes, patients from the highest-income zip codes were more likely to be older, white (76.7% vs 50.4%), have private insurance (68.9% vs 27.9%), and live closer to the hospital (median distance 26.7 miles vs 81.2 miles). In adjusted models, there was no significant association between zip code level household income and hospitalization costs. Conclusions Children hospitalized with unintentional, severe TBI and SCI showed no difference in standardized hospital costs relative to a patient's home zip code level median annual household income. The association between household income and hospitalization costs may vary by primary diagnosis.	[Zonfrillo, Mark R.] Hasbro Childrens Hosp, Dept Emergency Med, 55 Claverick St,2nd Floor, Providence, RI 02903 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Injury Prevent Ctr, 55 Claverick St,2nd Floor, Providence, RI 02903 USA; [Zonfrillo, Mark R.; Fieldston, Evan S.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Zaniletti, Isabella] Univ Missouri, Dept Stat, Columbia, MO 65211 USA; [Hall, Matthew] Childrens Hosp Assoc, Overland Pk, KS USA; [Fieldston, Evan S.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Colvin, Jeffrey D.; Bettenhausen, Jessica L.] Univ Missouri, Sch Med, Childrens Mercy Hosp & Clin, Dept Pediat, Kansas City, MO 64108 USA; [Macy, Michelle L.] Univ Michigan, CS Mott Childrens Hosp, Dept Emergency Med, Child Hlth Evaluat & Res Unit,Div Gen Pediat,Med, Ann Arbor, MI 48109 USA; [Alpern, Elizabeth R.] Northwestern Univ, Dept Pediat, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Chicago, IL 60611 USA; [Cutler, Gretchen J.] Childrens Hosp & Clin Minnesota, Dept Pediat Emergency Med, Minneapolis, MN USA; [Raphael, Jean L.] Baylor Coll Med, Sect Acad Gen Pediat, Dept Pediat, Houston, TX 77030 USA; [Morse, Rustin B.] Childrens Hlth Syst Texas, Dallas, TX USA; [Sills, Marion R.] Childrens Hosp Colorado, Aurora, CO USA; [Shah, Samir S.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA		Zonfrillo, MR (corresponding author), Hasbro Childrens Hosp, Dept Emergency Med, 55 Claverick St,2nd Floor, Providence, RI 02903 USA.; Zonfrillo, MR (corresponding author), Hasbro Childrens Hosp, Injury Prevent Ctr, 55 Claverick St,2nd Floor, Providence, RI 02903 USA.	zonfrillo@brown.edu	Macy, Michelle/AAV-7528-2020; Colvin, Jeffrey/L-5492-2019; Zonfrillo, Mark R./H-9403-2017	Macy, Michelle/0000-0003-4401-7384; Zonfrillo, Mark R./0000-0002-0610-9563; Sills, Marion/0000-0003-1322-0822; Alpern, Elizabeth/0000-0001-7887-3563	Children's Hospital Association; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD073241]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD073241] Funding Source: NIH RePORTER	Supported by the Children's Hospital Association and Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08HD073241). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Children's Hospital Association or the National Institutes of Health. The authors declare no conflicts of interest.	AAAM International Injury Scaling Committee (IISC), ABBR INJ SCAL; Aboutanos MB, 2011, J TRAUMA, V71, P228, DOI 10.1097/TA.0b013e31821e0c86; Association for the Advancement of Automotive Medicine (AAAM), 2008, ABBR INJ SCAL AIS 20; Averill RF, 2007, ALL PATIENT REFINED; Berry JG, 2011, JAMA-J AM MED ASSOC, V305, P682, DOI 10.1001/jama.2011.122; Bierman AS, 2007, BMJ-BRIT MED J, V334, P1333, DOI 10.1136/bmj.39251.660127.AD; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Cassidy LD, 2013, J AM COLL SURGEONS, V217, P233, DOI 10.1016/j.jamcollsurg.2013.02.032; Chien AT, 2007, MED CARE RES REV, V64, p283S, DOI 10.1177/1077558707305426; Durbin D R, 2001, Inj Prev, V7, P96, DOI 10.1136/ip.7.2.96; Feudtner C, 2002, PEDIATRICS, V109, P656, DOI 10.1542/peds.109.4.656; Fieldston ES, 2013, PEDIATRICS, V132, pE1592, DOI 10.1542/peds.2013-0619; Fieldston ES, 2013, PEDIATRICS, V131, P1050, DOI 10.1542/peds.2012-2494; Geronimus AT, 1998, AM J EPIDEMIOL, V148, P475; Glance LG, 2013, HEALTH SERV RES, V48, P1684, DOI 10.1111/1475-6773.12064; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Hakmeh W, 2010, ACAD EMERG MED, V17, P809, DOI 10.1111/j.1553-2712.2010.00819.x; Jonas J, 2015, SHIFTING CARE PAYMEN; Keren R, 2012, ARCH PEDIAT ADOL MED, V166, P1155, DOI 10.1001/archpediatrics.2012.1266; Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson K, 2010, MATERN CHILD HLTH J, V14, P332, DOI 10.1007/s10995-009-0477-y; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Macy ML, 2012, J HOSP MED, V7, P287, DOI 10.1002/jhm.949; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Mongelluzzo J, 2008, JAMA-J AM MED ASSOC, V299, P2048, DOI 10.1001/jama.299.17.2048; Morse RB, 2011, JAMA-J AM MED ASSOC, V306, P1454, DOI 10.1001/jama.2011.1385; Peden M, 2008, WORLD REPORT CHILD I; Schaeffer AJ, 2014, J UROLOGY, V191, P1381, DOI 10.1016/j.juro.2013.11.054; Schermer CR, 2011, J TRAUMA, V71, P236; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Shah SS, 2009, CLIN INFECT DIS, V49, P1369, DOI 10.1086/606048; Simpson L, 2005, AMBUL PEDIATR, V5, P6, DOI 10.1367/A04-119R.1; Turney CM, 2011, STROKE, V42, P3219, DOI 10.1161/STROKEAHA.111.614917; US Department of Health and Human Services, 2010, FED REGISTER, V75; Wall S, 2014, J HOSP MED, V9, P261, DOI 10.1002/jhm.2162; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zonfrillo MR, 2014, J PEDIATR-US, V164, P130, DOI 10.1016/j.jpeds.2013.09.022; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418	40	6	6	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	FEB	2016	169						250	255		10.1016/j.jpeds.2015.10.043			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DB6AK	WOS:000368595300047	26563534	Green Accepted			2022-02-06	
J	Dhamapurkar, SK; Rose, A; Florschutz, G; Wilson, BA				Dhamapurkar, Samira Kashinath; Rose, Anita; Florschutz, Gerhard; Wilson, Barbara A.			The natural history of continuing improvement in an individual after a long period of impaired consciousness: The story of I.J	BRAIN INJURY			English	Article						long period of impaired consciousness; Vegetative state; hydrocephalus; continuing improvement; minimally conscious state; traumatic brain injury; cranioplasty	VEGETATIVE STATE; LATE RECOVERY; CRANIOPLASTY; AWARENESS; AROUSAL	Aim: Recovery of consciousness and recovery of function among patients with prolonged disorders of consciousness rarely occur. Those patients who do regain consciousness typically remain with severe disability. The aim of this retrospective study is to suggest that continuing improvement is possible in a survivor of catastrophic brain injury after being in a prolonged state of disordered consciousness. Case study: This retrospective single case study follows the progress of a 29 year old man, I.J, who sustained a severe traumatic brain injury following an assault in October 2011. He was in a vegetative state for 15 months and in a minimally conscious state for a further 4 months. This was followed by a slow and steady recovery of motor and cognitive functions. At 3 years post-injury I.J is considered to be moderately disabled. He is now living in the community with continuing outpatient support. On the disability rating scale his level of functioning is rated as mildly dependent. Conclusion: This study shows that continuing recovery to a level of moderate disability is possible, even after a prolonged disorder of consciousness. Intense multi-disciplinary long-term rehabilitation and cranioplasty may be contributing factors for such an unexpected recovery.	[Dhamapurkar, Samira Kashinath; Rose, Anita; Florschutz, Gerhard; Wilson, Barbara A.] Raphael Med Ctr, Coldharbour Lane, Tonbridge TN11 9LE, Kent, England; [Wilson, Barbara A.] Oliver Zangwill Ctr, Ely, Cambs, England		Dhamapurkar, SK (corresponding author), Raphael Med Ctr, Coldharbour Lane, Tonbridge TN11 9LE, Kent, England.	samaira_sagi@yahoo.co.in					Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; Elliott L, 2005, J NEUROL NEUROSUR PS, V76, P298, DOI 10.1136/jnnp.2004.047357; Erdogan E, 2003, NEUROL INDIA, V51, P479; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Faran S, 2006, J NEUROL NEUROSUR PS, V77, P998, DOI 10.1136/jnnp.2005.076554; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Padovan BAE, 1992, HEILP K LEB HEILP, P464; Pedretti LW, 2001, OCCUPATIONAL THERAPY, P316; Posner JB, 2008, PLUM POSNERS DIAGNOS, P3; Prolonged Disorders of Consciousness, 2013, PROL DIS CONSC; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Shiel A, 2000, WHIM WESSEX HEAD INJ; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Wilson BA, 2013, BRAIN IMPAIR, V14, P475, DOI 10.1017/BrImp.2013.34; Wittich W, 2010, J VISUAL IMPAIR BLIN, V104, P360, DOI 10.1177/0145482X1010400606; Wright J, 2000, DISABILITY RATING SC; Wright J., 2000, FUNCTIONAL ASSESSMEN; Zeman A, 1997, LANCET, V350, P795, DOI 10.1016/S0140-6736(97)06447-7	36	6	6	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2016	30	2					230	236		10.3109/02699052.2015.1094132			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DF3MM	WOS:000371248400015	26680113				2022-02-06	
J	Tsushima, WT; Geling, O; Arnold, M; Oshiro, R				Tsushima, William T.; Geling, Olga; Arnold, Monica; Oshiro, Ross			Effects of Two Concussions on the Neuropsychological Functioning and Symptom Reporting of High School Athletes	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						concussions; high school athletes; neuropsychology	FOOTBALL PLAYERS; PERFORMANCE; RECOVERY; HISTORY; SPORTS; IMPACT	To assess the effects of two sports-related concussions on neuropsychological functioning and symptom reporting, the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) was administered to 483 high school athletes. Three groups of athletes were determined based on the number of previous concussions: no concussion (n=409), 1 concussion (n=58), and 2 concussions (n=16). The results showed that the three groups did not differ in terms of their ImPACT composite scores (Verbal Memory, Visual Memory, Reaction Time, and Processing Speed) and the Total Symptom Score. As there are only a few studies that have reported the sequelae of 2 concussions in high school athletes, it is premature to declare that a repeated concussion does not have persistent neurocognitive effects on high school athletes.	[Tsushima, William T.] Straub Clin & Hosp, Psychiat & Psychol, 888 South King St, Honolulu, HI 96813 USA; [Geling, Olga] Univ Hawaii, Publ Hlth Sci, Honolulu, HI 96822 USA; [Arnold, Monica] NYU, Dept Math, New York, NY USA; [Oshiro, Ross] State Hawaii, Dept Educ, Honolulu, HI USA		Tsushima, WT (corresponding author), Straub Clin & Hosp, Psychiat & Psychol, 888 South King St, Honolulu, HI 96813 USA.	wtsushima@straub.net			Hawaii Pacific Health Conference Services in Honolulu, HI	This research was supported in part by a summer scholarship awarded to Monica Arnold by the Hawaii Pacific Health Conference Services in Honolulu, HI.	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Brown CN, 2007, J ATHL TRAINING, V42, P515; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Graham R, 2013, SPORTS RELATED CONCU; Henry L. C., 2011, HDB SPORT NEUROPSYCH, P155; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell M. R., 2012, CLIN INTERPRETATION; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moser R. S., 2011, HDB SPORTS NEUROPSYC, P187; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	27	6	6	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JAN 2	2016	5	1					9	13		10.1080/21622965.2014.902762			5	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DB7TH	WOS:000368718500002	25397997				2022-02-06	
J	Van Patten, R; Keith, C; Bertolin, M; Wright, JD				Van Patten, Ryan; Keith, Cierra; Bertolin, Madison; Wright, John D.			The effect of premorbid attention-deficit/ hyperactivity disorder on neuropsychological functioning in individuals with acute mild traumatic brain injuries	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; attention-deficit; hyperactivity disorder; neuropsychological functioning; neurocognitive performance; acute patient care	CLOSED-HEAD INJURY; DEFICIT/HYPERACTIVITY DISORDER; PSYCHIATRIC-DISORDERS; SUSTAINED ATTENTION; TEST-PERFORMANCE; CHILDREN; ADHD; ADOLESCENTS; RECOVERY; INHIBITION	Introduction. Mild traumatic brain injury (mTBI) is a frequent, yet undertreated condition that typically manifests with transient neurological and cognitive symptoms that resolve over the course of several weeks. In contrast, attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that presents initially in childhood but often persists into adulthood. mTBI and ADHD include overlapping symptomatology, making it difficult for clinicians to disentangle the sequelae of each condition when they co-occur in the same individual. We hypothesized that neuropsychological tests would be sensitive to preexisting ADHD in inpatients with acute mTBIs. Method. We retrospectively examined the medical charts of 100 inpatients, aged 18-40 years (96% Caucasian; 77% male) with mTBIs in an acute care setting, half of whom had self-reported the presence of premorbid ADHD, and half of whom were matched controls. We analyzed group differences across neuropsychological tests of attention, processing speed, and executive functions, examined the profile ratings of independent, blinded, board-certified neuropsychologists, and correlated cognitive performance with time from traumatic injury to testing. Results. Individuals with premorbid ADHD (a) performed significantly worse than their matched counterparts on several tests of attention, processing speed, and working memory, and (b) were significantly more likely to produce profiles later rated as impaired by independent, board-certified clinical neuropsychologists. In addition, time from traumatic injury to testing was found to be negatively correlated with neurocognitive performance. Conclusions. These findings (a) argue for the utility of a brief assessment of premorbid ADHD in the acute care of individuals with mTBIs and (b) provide clinicians with a barometer for gauging the relative contributions of premorbid ADHD to neuropsychological impairments in the neurocognitive profiles of individuals with mTBIs. Reported effect sizes will assist clinicians in accurately weighing the impact of premorbid ADHD when interpreting such profiles.	[Van Patten, Ryan; Keith, Cierra; Bertolin, Madison] St Louis Univ, Dept Psychol, St Louis, MO 63103 USA; [Van Patten, Ryan; Keith, Cierra; Wright, John D.] Mercy Hosp St Louis, Dept Neurosci, St Louis, MO 63141 USA		Wright, JD (corresponding author), Mercy Hosp St Louis, Neuropsychol Serv, 615 South New Ballas Rd, St Louis, MO 63141 USA.	john.wright@mercy.net	Van+Patten, Ryan/AAZ-6757-2021				ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Army Individual Test Battery, 1944, MAN DIR SCOR; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Brewer TL, 2002, RES NURS HEALTH, V25, P269, DOI 10.1002/nur.10045; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Byerley AK, 2013, REHABIL PSYCHOL, V58, P412, DOI 10.1037/a0034228; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CASSIDY JD, 2014, ARCH PHYS MED REHAB, V95, P132; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; de Zeeuw P, 2008, J AM ACAD CHILD PSY, V47, P808, DOI 10.1097/CHI.0b013e318172eee9; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; DuPaul GJ, 2013, J LEARN DISABIL-US, V46, P43, DOI 10.1177/0022219412464351; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Eme R, 2012, EXPERT REV NEUROTHER, V12, P475, DOI [10.1586/ERN.12.15, 10.1586/ern.12.15]; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fletcher J.M., 2007, LEARNING DISABILITIE; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; HANKS GW, 1995, EUR J CLIN PHARMACOL, V48, P455; Heaton RK, 1991, COMPREHENSIVE NORMS; Heyer EJ, 2000, J CLIN EXP NEUROPSYC, V22, P633; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Konrad K, 2003, COGNITIVE BRAIN RES, V16, P425, DOI 10.1016/S0926-6410(03)00057-0; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Kuntsi Jonna, 2012, Curr Top Behav Neurosci, V9, P67, DOI 10.1007/7854_2011_145; Lange RT, 2008, ARCH CLIN NEUROPSYCH, V23, P809, DOI 10.1016/j.acn.2008.07.004; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Libon DJ, 1996, CLIN NEUROPSYCHOL, V10, P237, DOI 10.1080/13854049608406686; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nicholls E, 2012, POSTGRAD MED, V124, P78, DOI 10.3810/pgm.2012.09.2596; Ornstein TJ, 2014, J INT NEUROPSYCH SOC, V20, P971, DOI 10.1017/S1355617714000903; Ornstein TJ, 2013, J NEUROPSYCHOL, V7, P1, DOI 10.1111/j.1748-6653.2012.02027.x; PLESS IB, 1995, PEDIATRICS, V95, P219; Plotts C. A., 2001, ADULT LEARNING, V12, P5; Reitan R, 1985, HALSTEAD REITAN NEUR; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Smith A., 1982, SYMBOL DIGIT MODALIT; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; TEASDALE G, 1974, LANCET, V2, P81; Thaler NS, 2010, J CLIN EXP NEUROPSYC, V32, P929, DOI 10.1080/13803391003596488; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; Woods SP, 2002, CLIN NEUROPSYCHOL, V16, P12, DOI 10.1076/clin.16.1.12.8336	54	6	6	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN 2	2016	38	1					12	22		10.1080/13803395.2015.1091064			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CX4JK	WOS:000365665900002	26588804				2022-02-06	
J	Adjorlolo, S				Adjorlolo, Samuel			Ecological validity of executive function tests in moderate traumatic brain injury in Ghana	CLINICAL NEUROPSYCHOLOGIST			English	Article						Ecological validity; executive function test; traumatic brain injury; cross-cultural neuropsychology; Africa; Ghana	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; COGNITIVE-ABILITY; IMPAIRMENT; CHILDREN; ACCULTURATION; SPECIFICITY; INDIVIDUALS; ASSOCIATION; SENSITIVITY; INFECTION	Objective: While executive functioning (EF) tests are frequently administered in several Sub-Saharan African countries, studies examining their predictive relationships with real-world behaviors (i.e. ecological validity) are nonexistent. The present study investigated the predictive relationship between the Stroop Test, Controlled Oral Word Association Test, and Trail Making Test (TMT), a general cognitive screening test, Revised Quick Cognitive Screening Test (RQCST), and measures of activities of daily living, quality of life, and cognitive failures in Ghana. Method: A total of 50 literate urban dwellers who were diagnosed with moderate traumatic brain injury (TBI) were administered the neuropsychological tests and the self-report measures stated above. The informant version of the Cognitive failure questionnaire (CFQ) was completed by 50 'significant other' who knew the patients very well. Results: There was no statistically significant difference between the self and informant versions of the CFQ. Some EF test scores, specifically the Stroop Test, TMT and EF composite scores, correlated significantly with the outcome measures, with correlations ranging from .29 to .55. The RQCST explained 40-49% variance in the outcome measures, while the addition of the EF composite score not only resulted in 57-62% variance accounted for but also added incremental validity to the RQCST in predicting the behavioral measures, with the exception of cognitive failures. Conclusion: This study has shown that although EF test scores, specifically the Stroop Test, TMT and EF composite scores, can be used to predict real-world behavior after moderate TBI in Ghana, such predictions are likely to be limited. The general implication for cross-cultural neuropsychology is that the (limited) ecological validity of EF tests may not necessarily be affected by whether the tests were administered in settings where they have not been standardized. This argument is, however, tenable granted that the test taker's backgrounds are similar to those on which the tests have been standardized.	[Adjorlolo, Samuel] City Univ Hong Kong, Dept Appl Social Sci, Kowloon, Hong Kong, Peoples R China		Adjorlolo, S (corresponding author), City Univ Hong Kong, Dept Appl Social Sci, Kowloon, Hong Kong, Peoples R China.	sadjorlol2-c@my.cityu.edu.hk	Adjorlolo, Samuel/AAL-1009-2020				Adjorlolo S., 2015, INT J PSYCHOL; Adjorlolo S., DIAGNOSTIC IN PRESS; Adjorlolo S., 2016, J FORENSIC PSYCHIATR, P1, DOI DOI 10.1080/14789949.2016.1141431; Adjorlolo S, 2015, APPL NEUROPSYCH-ADUL, V22, P388, DOI 10.1080/23279095.2014.949718; Agranovich AV, 2007, ARCH CLIN NEUROPSYCH, V22, P273, DOI 10.1016/j.acn.2007.01.003; Agranovich AV, 2011, J INT NEUROPSYCH SOC, V17, P692, DOI 10.1017/S1355617711000592; Akanji AO, 2015, MED PRACT REV, V6, P1; Akolo C, 2014, J NEUROVIROL, V20, P380, DOI 10.1007/s13365-014-0254-6; Amer Psychological Assoc, 2003, AM PSYCHOL, V58, P377, DOI 10.1037/0003-066X.58.5.377; American Psychological Association, 2017, ETH PRINC PSYCH COD; Anum A., 2014, CONT PSYCHOL READING, P71; Ardila A, 2005, NEUROPSYCHOL REV, V15, P185, DOI 10.1007/s11065-005-9180-y; Ardila A, 2001, J INT NEUROPSYCH SOC, V7, P510, DOI 10.1017/S1355617701004076; Boivin MJ, 2002, J DEV BEHAV PEDIATR, V23, P353, DOI 10.1097/00004703-200210000-00010; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Brickman AM, 2006, APPL NEUROPSYCHOL, V13, P91, DOI 10.1207/s15324826an1302_4; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess P, 1996, BEHAV ASSESSMENT DYS; Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Cole M., 1996, CULTURAL PSYCHOL ONC; Cuellar I, 1998, J PERS ASSESS, V70, P71, DOI 10.1207/s15327752jpa7001_5; European Asylum Support Office, LAT AS TRENDS 2015 O; Farias ST, 2003, ARCH CLIN NEUROPSYCH, V18, P655, DOI 10.1016/S0887-6177(02)00159-2; Field A., 2011, DISCOVERING STAT USI; Fillenbaum G. G., 1985, MULTIDIMENSIONAL FUN; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Gerstenbrand F, 2001, BRAIN INJURY, V15, P95; Ghana Statistical Service, 2012, 2010 POP HOUS CENS S; Golden CJ, 1978, STROOP COLOR WORD TE; Greenfield PM, 1997, AM PSYCHOL, V52, P1115, DOI 10.1037/0003-066X.52.10.1115; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; HELMS JE, 1992, AM PSYCHOL, V47, P1083, DOI 10.1037/0003-066X.47.9.1083; Hestad KA, 2012, J NERV MENT DIS, V200, P336, DOI 10.1097/NMD.0b013e31824cc225; Iverson G., 2011, ENCY CLIN NEUROPSYCH, P2459, DOI DOI 10.1007/978-0-387-79948-3_1254; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P207, DOI 10.1080/09084282.2011.643956; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kashala E, 2005, PEDIATR NEUROL, V33, P357, DOI 10.1016/j.pediatrneurol.2005.05.013; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kotik-Friedgut B, 2006, NEUROPSYCHOL REV, V16, P43, DOI 10.1007/s11065-006-9003-9; Kriegler S. M., 1996, PERSPECTIVES LEARNIN, P109; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Long, 1996, ECOLOGICAL VALIDITY, P15; Long C.J., 1995, ADV MED PSYCHOTHERAP, V8, P59; Lucas JA, 2005, CLIN NEUROPSYCHOL, V19, P243, DOI 10.1080/13854040590945337; Luria A.R., 1976, COGNITIVE DEV ITS CU; Manly JJ, 2005, CLIN NEUROPSYCHOL, V19, P270, DOI 10.1080/13854040590945346; Mate-Kole CC, 2009, ARCH PHYS MED REHAB, V90, P1469, DOI 10.1016/j.apmr.2009.02.007; Mindt MR, 2010, CLIN NEUROPSYCHOL, V24, P429, DOI 10.1080/13854040903058960; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Mosdell J, 2010, S AFR J PSYCHOL, V40, P250, DOI 10.1177/008124631004000304; Mulenga K, 2001, DEV NEUROPSYCHOL, V20, P375, DOI 10.1207/S15326942DN2001_4; National Road Safety Commission, 2013, REG MONTHL MON; Nell V., 2000, CROSS CULTURAL NEURO; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Ramlall S, 2014, SAJP-S AFR J PSYCHI, V20, P153, DOI [10.7196/sajp.558, 10.7196/SAJP.558]; Ramlall S, 2013, DEMENT GERIATR COGN, V36, P119, DOI 10.1159/000350768; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Roebuck-Spencer T, 2008, TXB CLIN NEUROPSYCHO, P411; Rosselli N, 2003, BRAIN COGNITION, V52, P326, DOI 10.1016/S0278-2626(03)00170-2; Sacktor N, 2013, J NEUROVIROL, V19, P48, DOI 10.1007/s13365-012-0139-5; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Snyder HR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00328; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; TEASDALE G, 1974, LANCET, V2, P81; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Wood RL, 2009, J HEAD TRAUMA REHAB, V24, P88, DOI 10.1097/HTR.0b013e31819b118a; Ylvisaker M, 2000, TOP LANG DISORD, V20, P29, DOI 10.1097/00011363-200020020-00005; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27	80	6	6	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2016	30			1			1517	1537		10.1080/13854046.2016.1172667			21	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	ED7EL	WOS:000389024800008	27071720				2022-02-06	
J	Agrawal, D; Saini, R; Singh, PK; Sinha, S; Gupta, DK; Satyarthee, GD; Misra, MC				Agrawal, Deepak; Saini, Renu; Singh, Pankaj Kumar; Sinha, Sumit; Gupta, Deepak Kumar; Satyarthee, Guru Dutta; Misra, Mahesh Chandra			Bedside computed tomography in traumatic brain injury: Experience of 10,000 consecutive cases in neurosurgery at a level 1 trauma center in India	NEUROLOGY INDIA			English	Article						Computed tomography; head injury; mobile CT; severe traumatic brain injury	INTENSIVE-CARE-UNIT; BURDEN	Introduction: Patients with traumatic brain injury (TBI) need frequent computed tomography (CT) of the head for assessment and management. In view of the associated polytrauma, hemodynamic instability, and various in-dwelling catheters and tubes, shifting of patients for CT scans may be difficult. Aims and Objectives: To assess the role of mobile CT (Ceretom (R); NeuroLogica Corporation, Boston, MA, USA) in a trauma center with respect to patient management. Materials and Methods: In this retrospective study over 67 months (June 2009 to January 2015), the number of CT scans done, the time taken for CT and downtime were evaluated. Also, for the first 1000 mobile CT scans, the clinical and radiological records of all patients with TBI who underwent imaging using the mobile CT scanner in the intensive care units (ICUs) were analyzed. Observations and Results: A total of 10,000 mobile CT scans were done on the mobile CT scanner till January 5, 2015. Of the first 1000 patients evaluated, 75.3% had severe TBI, 15.1% had moderate TBI, and 9.6% had mild TBI. 78.1% patients were on ventilator, with 80.2% requiring sedation and 8.4%, an inotropic support. An in situ intracranial pressure monitoring was present in 21.1% of patients. In all, 12.4% of patients had long-bone fractures requiring skeletal traction; and, the tube thoracostomy was in-situ in 7.4%. No adverse events related to line malfunction/pullout occurred. The mean time for the performance of imaging using the mobile CT scan was 11.6 minutes compared with 47.8 minutes when patients were shifted to a conventional CT scan suite. The machine was nonfunctional 94 times, with an average downtime of 4.2 hours (range 2-72 hours). The life-cycle cost per mobile CT scan was Rs. 1340. Conclusions: A mobile CT has considerably changed the management response time in the neurosurgical intensive care unit (ICU) setup and decreased patient transfer times and the associated complications. Inclusion of a mobile CT scanner in the armamentarium of a neurosurgeon as a "bedside tool" can dramatically change decision making and the response time. It should be considered as the standard of care in any large-volume emergency department or neurosurgical facility.	[Agrawal, Deepak; Saini, Renu; Singh, Pankaj Kumar; Sinha, Sumit; Gupta, Deepak Kumar; Satyarthee, Guru Dutta] All India Inst Med Sci, Dept Neurosurgery, New Delhi 110029, India; [Misra, Mahesh Chandra] All India Inst Med Sci, JPNA Trauma Ctr, Dept Neurosurg, New Delhi 110029, India		Agrawal, D (corresponding author), All India Inst Med Sci, JPNA Trauma Ctr, Dept Neurosurg, New Delhi 110029, India.	drdeepak@gmail.com	/AAG-3032-2021	/0000-0002-5499-0746			Agrawal D, 2011, NEUROL INDIA, V59, P91, DOI 10.4103/0028-3886.86551; [Anonymous], 2008, Health Devices, V37, P325; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Butler WE, 1998, NEUROSURGERY, V42, P1304, DOI 10.1097/00006123-199806000-00064; Dandona R, 2008, INJURY PREV, V14, P354, DOI 10.1136/ip.2008.019620; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gunnarsson T, 2000, J NEUROSURG, V93, P432, DOI 10.3171/jns.2000.93.3.0432; Gururaj G, 2008, NATL MED J INDIA, V21, P14; Masaryk Thomas, 2008, Radiol Manage, V30, P50; Mirvis SE, 1999, SURG CLIN N AM, V79, P1317, DOI 10.1016/S0039-6109(05)70080-3; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Rajendra Prasad B, 2009, J Emerg Trauma Shock, V2, P89, DOI 10.4103/0974-2700.50742; Stevens GC, 2009, J RADIOL PROT, V29, P483, DOI 10.1088/0952-4746/29/4/002	14	6	7	0	4	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	JAN-FEB	2016	64	1					62	65		10.4103/0028-3886.173649			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DD9XC	WOS:000370278000017	26754994				2022-02-06	
J	Andraweera, N; Seemann, R				Andraweera, Nalinda; Seemann, Richard			Acute rehospitalisation during the first 3 months of in-patient rehabilitation for traumatic brain injury	AUSTRALIAN HEALTH REVIEW			English	Article							SPINAL-CORD-INJURY; MULTICENTER ANALYSIS; HOSPITAL READMISSION; ETIOLOGY; ADULTS	Objective. Unplanned re-admission to acute care hospitals during in-patient rehabilitation causes disruption to the rehabilitation program and increases the cost of health care. The aims of the present study were to identify the frequency, reasons and duration of disruption to rehabilitation because of acute re-admissions during the first 3 months of in-patient rehabilitation for traumatic brain injury (TBI) and to investigate the correlation between the duration of acute rehospitalisation and the discharge functional independence measure (FIM) score. Methods. A retrospective study was conducted on patients admitted for in-patient rehabilitation following TBI to a rehabilitation hospital in Auckland, New Zealand, between January 2009 and August 2013. Data on duration and reasons for acute rehospitalisation, as well as admission and discharge FIM scores, were obtained from electronic patient records. Pearson correlation was used to evaluate the relationship between the duration of acute rehospitalisation and the discharge FIM score. Results. Of the 628 patients admitted for brain injury rehabilitation, 71 (11.3%) required acute rehospitalisation within the first 3 months. The main reasons for acute rehospitalisation were preventable medical causes (43.8%), including urinary tract infections, respiratory tract infections and coronary artery disease. Of the acute re-admissions, 76.6% were within the first month of admission to the rehabilitation centre and 46.6% needed in-patient treatment in the acute care hospital for >5 days. There was a moderately strong negative correlation between the duration of stay in the acute care hospital and the discharge FIM score (r = -0.412; P = 0.0005). Conclusion. A significant number of patients admitted for in-patient rehabilitation following TBI require acute rehospitalisation due to preventable medical causes. Because the duration of acute rehospitalisation has a negative impact on rehabilitation functional gain, preventive measures and surveillance need to be further investigated and optimised.	[Andraweera, Nalinda] Royal Adelaide Hosp, Hampstead Rehabil Ctr, Adelaide, SA 5085, Australia; [Andraweera, Nalinda; Seemann, Richard] ABI Rehabil, Rehabil Med, Auckland, New Zealand		Andraweera, N (corresponding author), Royal Adelaide Hosp, Hampstead Rehabil Ctr, Adelaide, SA 5085, Australia.; Andraweera, N (corresponding author), ABI Rehabil, Rehabil Med, Auckland, New Zealand.	Nalinda.Andraweera@health.sa.gov.au; richard.seemann@abi-rehab.co.nz					Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; DeJong G, 2013, ARCH PHYS MED REHAB, V94, pS87, DOI 10.1016/j.apmr.2012.10.037; Foy CML, 2013, NEUROREHABILITATION, V32, P671, DOI 10.3233/NRE-130890; Hammond FM, 2013, ARCH PHYS MED REHAB, V94, pS106, DOI 10.1016/j.apmr.2012.12.023; Hammond FM, 2013, ARCH PHYS MED REHAB, V94, pS98, DOI 10.1016/j.apmr.2012.11.051; Hoyer EH, 2013, ARCH PHYS MED REHAB, V94, P1951, DOI 10.1016/j.apmr.2013.05.028; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Ottenbacher KJ, 2012, J GERONTOL A-BIOL, V67, P875, DOI 10.1093/gerona/glr247; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ottenbacher KJ, 2000, AM J PUBLIC HEALTH, V90, P1920, DOI 10.2105/AJPH.90.12.1920; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631	13	6	6	0	3	CSIRO PUBLISHING	CLAYTON	UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA	0156-5788	1449-8944		AUST HEALTH REV	Aust. Health Rev.		2016	40	1					114	117		10.1071/AH15062			4	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	DC7WM	WOS:000369431400018	26164449				2022-02-06	
S	Bailey, ZS; Hubbard, WB; VandeVord, PJ		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Bailey, Zachary S.; Hubbard, W. Brad; VandeVord, Pamela J.			Cellular Mechanisms and Behavioral Outcomes in Blast-Induced Neurotrauma: Comparing Experimental Setups	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Blast; Neurotrauma; Traumatic brain injury; In vivo; Methodology; Preclinical models; Neuropathology; Shock wave; Shock tube	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; INTRACRANIAL-PRESSURE; MOUSE MODEL; RAT MODEL; EXPOSURE; OVERPRESSURE; INFLAMMATION; ACTIVATION; BARRIER	Blast-induced neurotrauma (BINT) has increased in incidence over the past decades and can result in cognitive issues that have debilitating consequences. The exact primary and secondary mechanisms of injury have not been elucidated and appearance of cellular injury can vary based on many factors, such as blast overpressure magnitude and duration. Many methodologies to study blast neurotrauma have been employed, ranging from open-field explosives to experimental shock tubes for producing free-field blast waves. While there are benefits to the various methods, certain specifications need to be accounted for in order to properly examine BINT. Primary cell injury mechanisms, occurring as a direct result of the blast wave, have been identified in several studies and include cerebral vascular damage, blood-brain barrier disruption, axonal injury, and cytoskeletal damage. Secondary cell injury mechanisms, triggered subsequent to the initial insult, result in the activation of several molecular cascades and can include, but are not limited to, neuroinflammation and oxidative stress. The collective result of these secondary injuries can lead to functional deficits. Behavioral measures examining motor function, anxiety traits, and cognition/memory problems have been utilized to determine the level of injury severity. While cellular injury mechanisms have been identified following blast exposure, the various experimental models present both concurrent and conflicting results. Furthermore, the temporal response and progression of pathology after blast exposure have yet to be detailed and remain unclear due to limited resemblance of methodologies. This chapter summarizes the current state of blast neuropathology and emphasizes the need for a standardized preclinical model of blast neurotrauma.	[Bailey, Zachary S.; Hubbard, W. Brad; VandeVord, Pamela J.] Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA		Bailey, ZS (corresponding author), Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.						Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; CELANDER H, 1955, ACTA PHYSIOL SCAND, V33, P6, DOI 10.1111/j.1748-1716.1955.tb01188.x; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chai JK, 2013, SHOCK, V40, P297, DOI 10.1097/SHK.0b013e3182837831; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; CLEMEDSON CJ, 1955, AM J PHYSIOL, V181, P471, DOI 10.1152/ajplegacy.1955.181.3.471; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Fitzpatrick MO, 1998, BRIT J NEUROSURG, V12, P313; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Hicks R, 2014, COMMON DATA ELEMENTS; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kinney G F, 1962, EXPLOSIVE SHOCKS AIR; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Muhl H, 2003, INT IMMUNOPHARMACOL, V3, P1247, DOI 10.1016/S1567-5769(03)00131-0; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; ROMBA J, 1961, PROPAGATION AIR SHOC; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sajja Venkata Siva Sai S, 2012, Biomed Sci Instrum, V48, P374; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Siva Sai Sujith Sajja Benkata, 2014, Biomed Sci Instrum, V50, P375; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	76	6	6	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						119	138		10.1007/978-1-4939-3816-2_8	10.1007/978-1-4939-3816-2		20	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500010	27604716				2022-02-06	
J	Balasundaram, AP; Athens, J; Schneiders, AG; McCrory, P; Sullivan, SJ				Balasundaram, Arun Prasad; Athens, Josie; Schneiders, Anthony G.; McCrory, Paul; Sullivan, S. John			Day-to-day variability of post-concussion-like symptoms reported over time by a non-concussed cohort	BRAIN INJURY			English	Article						Total symptom score; symptom severity score; Sport Concussion Assessment Tool 2; return-to-play	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; BASE-LINE VALUES; HIGH-SCHOOL; PERFORMANCE; STATEMENT; STRESS; RATES	Primary objective: To explore the change (trend) in post-concussion-like symptoms reported over time. Research design: Longitudinal study. Methods and procedures: University students aged 18-30 years self-reported their symptoms experienced on a daily basis. Each participant was contacted via a text message each day during one of three pre-defined time zones to complete the Sport Concussion Assessment Tool 2 (SCAT2) post-concussion symptom scale on 7 consecutive days. Main outcomes and results: One hundred and ten (26 males and 84 females) students completed the study on all 7 days. Only two meaningful clusters emerged and comprised of a total of 105 participants. The primary cluster included 85 participants who showed a relatively stable pattern in their symptoms reported over time. Meanwhile, a second cluster comprised of 20 participants who demonstrated a decreasing trend in the reported symptom scores. Conclusions: The data indicated that non-concussed participants exhibited considerable individual variability in the symptom scores reported over time. However, some participants showed a systematic decreasing trend in their symptom scores reported over the 7 days. Caution must be exercised in interpreting the serial symptom scores that are obtained following a concussion, given that this study was conducted in a non-concussed cohort.	[Balasundaram, Arun Prasad; Sullivan, S. John] Univ Otago, Sch Physiotherapy, Ctr Hlth Act & Rehabil Res, 325 Great King St, Dunedin 9054, New Zealand; [Athens, Josie] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; [Schneiders, Anthony G.] Cent Queensland Univ, Sch Human Hlth & Social Sci, Branyan, Australia; [McCrory, Paul] Univ Melbourne, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia		Balasundaram, AP (corresponding author), Univ Otago, Sch Physiotherapy, Ctr Hlth Act & Rehabil Res, 325 Great King St, Dunedin 9054, New Zealand.	bapganesha@gmail.com	McCrory, Paul/Q-8688-2019; Balasundaram, Arun Prasad/D-1270-2017	Balasundaram, Arun Prasad/0000-0001-8256-857X; McCrory, Paul/0000-0003-4850-0568	International Olympic Committee (IOC); Axon Sports (USA)CogState Limited; CogState IncCogState Limited	Paul McCrory is a co-investigator, collaborator or consultant on grants relating to mild TBI funded by several governmental organizations. He is Co-Chair of the Australian Centre for Research into Sports Injury and its Prevention (ACRISP), which is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee (IOC). He has a clinical and consulting practice in general and sports neurology. He receives book royalties from McGraw-Hill and was employed in an editorial capacity by the British Medical Journal Publishing Group from 2001-2008. He has been reimbursed by the government, professional scientific bodies and sporting bodies for presenting research relating to mild TBI and sports-related concussion at meetings, scientific conferences and symposiums. He received consultancy fees in 2010 from Axon Sports (USA) for the development of educational material (which was not renewed) and has received support since 2001 from CogState Inc for research costs and the development of educational material. He is a cofounder and shareholder in two biomedical companies (involved in eHealth and Compression garment technologies) but does not hold any individual shares in any company related to concussion or brain injury assessment or technology. The other authors report no conflicts of interest.	Alla S, 2011, BRIT J SPORT MED, V45, P132, DOI 10.1136/bjsm.2010.074088; Anthony CA, 2015, CLIN J SPORT MED, V25, P149, DOI 10.1097/JSM.0000000000000115; Balasundaram AP, 2016, ARCH CLIN NEUROPSYCH, V31, P197, DOI 10.1093/arclin/acw001; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brunswik E, 1943, PSYCHOL REV, V50, P255, DOI 10.1037/h0060889; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Christensen T.C., 2003, J HAPPINESS STUDIES, V4, P53, DOI [DOI 10.1023/A:1023609306024, 10.1023/A:1023609306024]; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; CRIDER DM, 1973, SOCIOL METHOD RES, V2, P3, DOI 10.1177/004912417300200101; Egon B, 1939, J UNIFIED SCI, V8, P36, DOI DOI 10.1007/BF00176018.; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; KIMBERLY JR, 1976, SOCIOL METHOD RES, V4, P321, DOI 10.1177/004912417600400303; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mehl M.R., 2011, HDB RES METHODS STUD; Pennebaker JW, 2000, SCIENCE OF SELF-REPORT, P299; Putukian M, 2013, BRIT J SPORT MED, V47, P285, DOI 10.1136/bjsports-2013-092158; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramanathan DM, 2012, J INT NEUROPSYCH SOC, V18, P101, DOI 10.1017/S1355617711001457; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; SNIJDERS TAB, 1993, J EDUC STAT, V18, P237, DOI 10.3102/10769986018003237; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9	43	6	6	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1599	1604		10.1080/02699052.2016.1199902			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800012	27625182				2022-02-06	
J	Bao, Z; Qiu, XJ; Wang, DL; Ban, N; Fan, SC; Chen, WJ; Sun, J; Xing, WK; Wang, YF; Cui, G				Bao, Zhen; Qiu, Xiaojun; Wang, Donglin; Ban, Na; Fan, Shaochen; Chen, Wenjuan; Sun, Jie; Xing, Weikang; Wang, Yunfeng; Cui, Gang			High expression of adenylate cyclase-associated protein 1 accelerates the proliferation, migration and invasion of neural glioma cells	PATHOLOGY RESEARCH AND PRACTICE			English	Article						Glioma; CAP1; Proliferation; Migration; Invasion	ACTIN CYTOSKELETON; MALIGNANT GLIOMAS; HEPATOCELLULAR-CARCINOMA; CAP1; REORGANIZATION; GENETICS; CTBP2	Adenylate cyclase-associated protein 1 (CAP1), a conserved member of cyclase-associated proteins was reported to be associated with the proliferation, migration or invasion of the tumors of pancreas, breast and liver, and was involved in astrocyte proliferation after acute Traumatic Brain Injury (TBI). In this study, we sought to investigate the character of CAP1 in the pathological process of human glioma by detecting human glioma specimens and cell lines. 43 of 100 specimens showed high expression of CAP1 via immunohistochemistry. With statistics analysis, we found out the expression level of CAP1 was correlated with the WHO grades of human glioma and was great positively related to Ki-67 (p < 0.01). In vitro, silencing CAP1 in U251 and U87MG, the glioma cell lines with the relatively higher expression of CAP1, induced the proliferation of the cells significantly retarded, migration and invasion as well. Obviously, our results indicated that CAP1 participated in the molecular pathological process of giloma indeed, and in a certain sense, CAP1 might be a potential and promising molecular target for glioma diagnosis and therapies in the future. (C) 2016 Elsevier GmbH. All rights reserved.	[Bao, Zhen; Xing, Weikang; Wang, Yunfeng; Cui, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China; [Qiu, Xiaojun] Nantong Univ, Affiliated Hosp, Dept Oncol, Nantong, Jiangsu, Peoples R China; [Wang, Donglin] Nantong Univ, Coll Med, Dept Pathol, Nantong, Jiangsu, Peoples R China; [Ban, Na; Fan, Shaochen; Chen, Wenjuan; Sun, Jie] Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong, Jiangsu, Peoples R China		Cui, G (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China.	cuigang120@sina.com	weikang, Xing/K-1246-2013	weikang, Xing/0000-0001-7121-8750	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372687, 81272789]	This work was supported by National Natural Science Foundation of China (81372687), National Natural Science Foundation of China (81272789).	Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Chang MS, 2000, BIOCHEM BIOPH RES CO, V279, P732, DOI 10.1006/bbrc.2000.3992; Deorah Sundeep, 2006, Neurosurg Focus, V20, pE1, DOI 10.3171/foc.2006.20.4.E1; Ding ZM, 2015, MOL CARCINOGEN, V54, P405, DOI 10.1002/mc.22114; Ferguson SD, 2011, DM-DIS MON, V57, P558, DOI 10.1016/j.disamonth.2011.08.020; Freeman NL, 1996, MOL CELL BIOL, V16, P548; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; Huang XD, 2014, DIGEST DIS SCI, V59, P795, DOI 10.1007/s10620-013-2969-2; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Kahlert UD, 2013, CANCER LETT, V331, P131, DOI 10.1016/j.canlet.2012.12.010; Konakahara S, 2012, FEBS LETT, V586, P2251, DOI 10.1016/j.febslet.2012.05.053; Liu XC, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0878-7; Liu YH, 2014, PATHOL RES PRACT, V210, P169, DOI 10.1016/j.prp.2013.11.011; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Papakonstanti EA, 2008, FEBS LETT, V582, P2120, DOI 10.1016/j.febslet.2008.02.064; Peche V, 2007, CELL MOL LIFE SCI, V64, P2702, DOI 10.1007/s00018-007-7316-3; Qi ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038842; Radner H, 2002, PATHOLOGE, V23, P260, DOI 10.1007/s00292-002-0530-8; Reardon DA, 2012, BRIT J CANCER, V107, P1481, DOI 10.1038/bjc.2012.415; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; SWISTON J, 1995, GENE, V165, P273, DOI 10.1016/0378-1119(95)00522-8; Wang Q, 2013, J NEURO-ONCOL, V112, P73, DOI 10.1007/s11060-013-1045-2; Wang YC, 2013, J BIOL CHEM, V288, P9028, DOI 10.1074/jbc.M112.432005; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yamazaki K, 2009, LAB INVEST, V89, P425, DOI 10.1038/labinvest.2009.5; Yu XF, 2014, EXP MOL PATHOL, V96, P188, DOI 10.1016/j.yexmp.2014.02.002; Zhang HT, 2013, J BIOL CHEM, V288, P20966, DOI 10.1074/jbc.M113.484535; Zhang HY, 2014, J MOL NEUROSCI, V54, P653, DOI 10.1007/s12031-014-0363-y; Zhou GL, 2014, CELL ADHES MIGR, V8, P55, DOI 10.4161/cam.27479; Zhuang WZ, 2009, ACTA BIOCH BIOPH SIN, V41, P341, DOI 10.1093/abbs/gmp028	31	6	6	0	6	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0344-0338			PATHOL RES PRACT	Pathol. Res. Pract.		2016	212	4					264	273		10.1016/j.prp.2015.12.017			10	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	DL2YE	WOS:000375500300005	26810579				2022-02-06	
J	Bergmann, KR; Flood, A; Kreykes, NS; Kharbanda, AB				Bergmann, Kelly R.; Flood, Andrew; Kreykes, Nathaniel S.; Kharbanda, Anupam B.			Concussion Among Youth Skiers and Snowboarders A Review of the National Trauma Data Bank From 2009 to 2010	PEDIATRIC EMERGENCY CARE			English	Article						concussion; traumatic brain injury; skiing; snowboarding; trauma	HEAD-INJURIES; HELMET USE; SAFETY HELMETS; CHILDREN; REDUCTION; ATTITUDES; FOOTBALL; WEAR	Objective There are limited data regarding concussion among youth skiers and snowboarders. The objective of this study was to examine the frequency of concussion among helmeted and unhelmeted youth skiers and snowboarders presenting to trauma centers. Methods Subjects 18 years or younger with a ski- or snowboard-related injury were studied using data from the National Trauma Data Bank from 2009 to 2010. We further selected those with head/neck injuries and stratified based on helmet status. Concussive injuries were identified from International Classification of Diseases, 9th Revision codes. Severity analysis was based on the Glasgow Coma Scale and Injury Severity Score. Results A total of 1001 subjects met inclusion criteria with 678 subjects having documented helmet status. Subjects 12 years or younger were more likely to use helmets compared to 13-18 year-olds (odds ratio, 2.21; 95% confidence interval [95% CI], 1.52-3.21). Skiers were more likely to use helmets compared to snowboarders (odds ratios, 1.60; 95% CI, 1.16-2.19). Snowboarders had a greater likelihood of concussion (estimated-, 2.1; 95% CI, 1.48-2.85) after adjusting for helmet status and age. There was no significant difference in the frequency of concussion among helmeted compared to unhelmeted subjects. Imputing missing values for helmets status had no effect on outcome for concussion. We found no difference in injury severity among helmeted compared to unhelmeted subjects. Conclusions Among youth skiers and snowboarders who present to trauma centers with a head injury, the likelihood of that injury involving a concussion was not associated with helmet use.	[Bergmann, Kelly R.; Kharbanda, Anupam B.] Childrens Hosp & Clin Minnesota, Dept Pediat Emergency Med, Minneapolis, MN 55404 USA; [Flood, Andrew] Childrens Hosp & Clin Minnesota, Dept Res & Sponsored Programs, Minneapolis, MN 55404 USA; [Kreykes, Nathaniel S.] Childrens Hosp & Clin Minnesota, Dept Surg, Minneapolis, MN 55404 USA		Bergmann, KR (corresponding author), Childrens Hosp & Clin Minnesota, Dept Pediat Emergency Med, 2525 Chicago Ave, Minneapolis, MN 55404 USA.	Kelly.Bergmann@childrensmn.org		Kharbanda, Anupam/0000-0001-5231-9855			Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; American College of Surgeons Committee on Trauma, NAT TRAUM DAT BANK U; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Brooks MA, 2010, INJURY PREV, V16, P119, DOI 10.1136/ip.2009.022608; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Cundy TP, 2010, J TRAUMA, V69, P1486, DOI 10.1097/TA.0b013e3181fee31c; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Graves JM, 2013, INJURY PREV, V19, P399, DOI 10.1136/injuryprev-2012-040727; Greve MW, 2009, WILD ENVIRON MED, V20, P234, DOI 10.1580/08-WEME-OR-244R1.1; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hayes JR, 2008, J PEDIATR SURG, V43, P928, DOI 10.1016/j.jpedsurg.2007.12.041; Lawrence L, 2008, PEDIATR EMERG CARE, V24, P219, DOI 10.1097/PEC.0b013e31816a9f0a; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meyers MC, 2007, SPORTS MED, V37, P485, DOI 10.2165/00007256-200737060-00003; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; National Ski Areas Association (NSSA), NSAA FACT SHEET; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ruedl G, 2010, BRIT J SPORT MED, V44, P204, DOI 10.1136/bjsm.2009.066779; Ruedl G, 2012, INJURY PREV, V18, P182, DOI 10.1136/injuryprev-2011-040042; Rughani AI, 2011, J NEUROSURG-PEDIATR, V7, P268, DOI 10.3171/2010.12.PEDS10415; Rust DA, 2013, AM J SPORT MED, V41, P652, DOI 10.1177/0363546512472045; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Scott MD, 2007, INJURY PREV, V13, P173, DOI 10.1136/ip.2006.014142; Shorter NA, 1999, AM J EMERG MED, V17, P261, DOI 10.1016/S0735-6757(99)90121-3; U.S. Consumer Product Safety Commission, SKIING HELM EV POT R; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Williams R, 2007, WILD ENVIRON MED, V18, P102, DOI 10.1580/06-WEME-OR-037R1.1	33	6	6	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2016	32	1					9	13		10.1097/PEC.0000000000000364			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	DA8AX	WOS:000368027800003	25834958				2022-02-06	
S	Berkner, J; Mannix, R; Qiu, JH		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Berkner, Justin; Mannix, Rebekah; Qiu, Jianhua			Clinical Traumatic Brain Injury in the Preclinical Setting	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury; Preclinical models; Controlled cortical impact; Closed head injury; Fluid percussion; Blast injury	CONTROLLED CORTICAL IMPACT; CLOSED-HEAD-INJURY; EXPERIMENTAL-MODEL; FLUID-PERCUSSION; AXONAL INJURY; BEHAVIORAL DEFICITS; COGNITIVE DEFICITS; MOUSE MODEL; CELL-DEATH; RAT MODEL	Traumatic brain injury (TBI) is the leading cause of death and disability for people under 45 years of age. Clinical TBI is often the result of disparate forces resulting in heterogeneous injuries. Preclinical modeling of TBI is a vital tool for studying the complex cascade of metabolic, cellular, and molecular post-TBI events collectively termed secondary injury. Preclinical models also provide an important platform for studying therapeutic interventions. However, modeling TBI in the preclinical setting is challenging, and most models replicate only certain aspects of clinical TBI. This chapter details the most widely used models of preclinical TBI, including the controlled cortical impact, fluid percussion, blast, and closed head models. Each of these models replicates particular critical aspects of clinical TBI. Prior to selecting a preclinical TBI model, it is important to address what aspect of human TBI is being sought to evaluate.	[Berkner, Justin; Mannix, Rebekah; Qiu, Jianhua] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Mannix, Rebekah; Qiu, Jianhua] Harvard Med Sch, Boston, MA USA		Berkner, J (corresponding author), Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA.		Mannix, Rebekah/AAD-8702-2020				Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Carey M E, 1990, Adv Neurol, V52, P301; CAREY ME, 1995, NEUROSURG CLIN N AM, V6, P629; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00209; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; CLEMEDSON CJ, 1956, ACTA PHYSIOL SCAND, V37, P202; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; Dapul HR, 2013, J NEUROTRAUM, V30, P382, DOI 10.1089/neu.2012.2536; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dohi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108034; Driscoll DM, 2012, COGN BEHAV NEUROL, V25, P160, DOI 10.1097/WNN.0b013e318280cf4e; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Elias PZ, 2012, J NEUROTRAUM, V29, P2086, DOI 10.1089/neu.2011.2181; Faden AI, 1999, AM J PHYSIOL-REG I, V277, pR1196, DOI 10.1152/ajpregu.1999.277.4.R1196; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FINNIE JW, 1993, J COMP PATHOL, V109, P253, DOI 10.1016/S0021-9975(08)80250-2; Fitch MT, 1999, J NEUROSCI, V19, P8182; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gajavelli S, 2015, J CEREBR BLOOD F MET, V35, P773, DOI 10.1038/jcbfm.2014.243; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Ghirnikar RS, 1996, J NEUROSCI RES, V46, P727; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Kawamata T, 1997, ACT NEUR S, V70, P191; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Krave U, 2011, J NEUROTRAUM, V28, P57, DOI 10.1089/neu.2010.1431; Kroppenstedt SN, 1999, J NEUROTRAUM, V16, P629, DOI 10.1089/neu.1999.16.629; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu XCM, 2015, J NEUROTRAUM, V32, P1621, DOI 10.1089/neu.2014.3766; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mahmood A, 2013, J NEUROSURG, V118, P381, DOI 10.3171/2012.11.JNS12753; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathew P, 1996, J NEUROSURG, V85, P860, DOI 10.3171/jns.1996.85.5.0860; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Risling M, 2004, RESTOR NEUROL NEUROS, V23, P141; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; SALAZAR AM, 1986, NEUROLOGY, V36, P459, DOI 10.1212/WNL.36.4.459; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sun D, 2000, J NEUROPATH EXP NEUR, V59, P1031, DOI 10.1093/jnen/59.12.1031; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Wang EY, 2012, J NEUROTRAUM, V29, P295, DOI 10.1089/neu.2011.2043; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; WHITE BC, 1993, ANN EMERG MED, V22, P970, DOI 10.1016/S0196-0644(05)82737-4; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828	88	6	6	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						11	28		10.1007/978-1-4939-3816-2_2	10.1007/978-1-4939-3816-2		18	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500004	27604710				2022-02-06	
J	Caudle, KL; Lu, XCM; Mountney, A; Shear, DA; Tortella, FC				Caudle, Krista L.; Lu, Xi-Chun M.; Mountney, Andrea; Shear, Deborah A.; Tortella, Frank C.			Neuroprotection and anti-seizure effects of levetiracetam in a rat model of penetrating ballistic-like brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; post-traumatic seizures; neuroprotection; motor; cognitive function; rat	ANTICONVULSANT DRUG LEVETIRACETAM; ACUTE NONCONVULSIVE SEIZURES; CEREBRAL-ARTERY OCCLUSION; CRITICALLY-ILL ADULTS; INTRAVENOUS LEVETIRACETAM; BARRIER PERMEABILITY; CONSENSUS STATEMENT; CONTINUOUS EEG; PROPHYLAXIS; PHENYTOIN	Purpose: We assessed the therapeutic efficacy of FDA-approved anti-epileptic drug Levetiracetam (LEV) to reduce post-traumatic nonconvulsive seizure (NCS) activity and promote neurobehavioral recovery following 10% frontal penetrating ballistic-like brain injury (PBBI) in male Sprague-Dawley rats. Methods: Experiment 1 anti-seizure study: 50 mg/kg LEV (25 mg/kg maintenance doses) was given twice daily for 3 days (LEV3D) following PBBI; outcome measures included seizures incidence, frequency, duration, and onset. Experiment 2 neuroprotection studies: 50 mg/kg LEV was given twice daily for either 3 (LEV3D) or 10 days (LEV10D) post-injury; outcome measures include motor (rotarod) and cognitive (water maze) functions. Results: LEV3D treatment attenuated seizure activity with significant reductions in NCS incidence (54%), frequency, duration, and delayed latency to seizure onset compared to vehicle treatment. LEV3D treatment failed to improve cognitive or motor performance; however extending the dosing regimen through 10 days post-injury afforded significant neuroprotective benefit. Animals treated with the extended LEV10D dosing regimen showed a twofold improvement in rotarod task latency to fall as well as significantly improved spatial learning performance (24%) in the MWM task. Conclusions: These findings support the dual anti-seizure and neuroprotective role of LEV, but more importantly identify the importance of an extended dosing protocol which was specific to the therapeutic targets studied.	[Caudle, Krista L.; Lu, Xi-Chun M.; Mountney, Andrea; Shear, Deborah A.; Tortella, Frank C.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Caudle, KL (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	krista.l.caudle.civ@mail.mil			United States ArmyUnited States Department of Defense [W81XWH-10-1-0623]	This work was supported by the United States Army [grant number W81XWH-10-1-0623].	Ahishali B, 2010, LIFE SCI, V87, P609, DOI 10.1016/j.lfs.2010.09.014; [Anonymous], 2014, INJURY PREVENTION CO; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Benge JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00195; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Centers for Disease Control and Prevention National Institutes of Health Department of Defense VA Leadership Panel, 2013, REP C TRAUM BRAIN IN; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Cuomo O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080852; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; de Groot M, 2013, NEURO-ONCOLOGY, V15, P216, DOI 10.1093/neuonc/nos288; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; DeWolfe JL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00121; Gurses C, 2009, BRAIN RES, V1281, P71, DOI 10.1016/j.brainres.2009.05.033; Haghikia A, 2008, J NEUROSCI RES, V86, P1781, DOI 10.1002/jnr.21639; Hanon E, 2001, SEIZURE-EUR J EPILEP, V10, P287, DOI 10.1053/seiz.2000.0511; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; Johnson W.D., 2015, NAT CAP AR TBI RES S; Kilicdag H, 2013, EARLY HUM DEV, V89, P355, DOI 10.1016/j.earlhumdev.2012.12.002; Kirmani BF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00170; Komur M, 2014, CHILD NERV SYST, V30, P1001, DOI 10.1007/s00381-014-2375-x; Lewis-Beck M. S., 2004, ENCY SOCIAL SCI RES; Lu XCM, 2013, LIFE SCI, V92, P1055, DOI 10.1016/j.lfs.2013.04.004; Lu XCM, 2013, J NEUROTRAUM, V30, P580, DOI 10.1089/neu.2012.2641; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Malykh AG, 2010, DRUGS, V70, P287, DOI 10.2165/11319230-000000000-00000; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mountney A, 2013, J NEUROTRAUM, V30, P1973, DOI 10.1089/neu.2013.3001; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Murphy-Human T, 2011, WORLD NEUROSURG, V75, P269, DOI 10.1016/j.wneu.2010.09.002; Pagni Carlo Alberto, 2006, Expert Rev Neurother, V6, P1223, DOI 10.1586/14737175.6.8.1223; Rowe AS, 2014, PHARMACOTHERAPY, V34, P396, DOI 10.1002/phar.1374; Shear D.A., 2014, J NEUROTRAUM, V31, DOI [10.1089/neu.2014.9935.abstracts, DOI 10.1089/NEU.2014.9935.ABSTRACTS]; Shear DA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00073; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shear DA, 2009, PHARMACOL BIOCHEM BE, V94, P56, DOI 10.1016/j.pbb.2009.07.006; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Stienen MN, 2011, BRIT J PHARMACOL, V162, P491, DOI 10.1111/j.1476-5381.2010.01038.x; Szaflarski JP, 2007, NEUROCRIT CARE, V7, P140, DOI 10.1007/s12028-007-0042-8; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Taylor S, 2011, NEUROCRIT CARE, V15, P80, DOI 10.1007/s12028-010-9341-6; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vezzani A, 1999, J NEUROSCI, V19, P5054; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Zou H., 2014, BRAIN INJURY, V25, P1; Zou HC, 2015, BRAIN INJURY, V29, P78, DOI 10.3109/02699052.2014.955528	55	6	8	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2016	34	2					257	270		10.3233/RNN-150580			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI3JG	WOS:000373394300009	26890099				2022-02-06	
J	Chen, C; Duan, J; Shen, AF; Wang, W; Song, H; Liu, YM; Lu, XJ; Wang, XB; You, ZQ; Han, ZC; Han, FB				Chen, Chao; Duan, Jing; Shen, Aifang; Wang, Wei; Song, Hao; Liu, Yanming; Lu, Xianjie; Wang, Xiaobing; You, Zhiqing; Han, Zhongchao; Han, Fabin			Transplantation of human umbilical cord blood-derived mononuclear cells induces recovery of motor dysfunction in a rat model of Parkinson's disease	JOURNAL OF NEURORESTORATOLOGY			English	Article						hUCB-MNCs; Parkinson's disease; transplantation; differentiation; dopamine neurons	MESENCHYMAL STEM-CELLS; STROMAL CELLS; IN-VITRO; 6-HYDROXYDOPAMINE NEUROTOXICITY; PROGENITOR CELLS; THERAPY; NEURONS; STROKE; BRAIN; ASYMMETRY	Human umbilical cord blood-derived mononuclear cells (hUCB-MNCs) were reported to have neurorestorative capacity for neurological disorders such as stroke and traumatic brain injury. This study was performed to explore if hUCB-MNC transplantation plays any therapeutic effects for Parkinson's disease (PD) in a 6-OHDA-lesioned rat model of PD. hUCB-MNCs were isolated from umbilical cord blood and administered to the striatum of the 6-OHDA-lesioned rats. The apomorphine-induced locomotive turning-overs were measured to evaluate the improvement of motor dysfunctions of the rats after administration of hUCB-MNCs. We observed that transplanted hUCB-MNCs significantly improve the motor deficits of the PD rats and that grafted hUCB-MNCs integrated to the host brains and differentiated to neurons and dopamine neurons in vivo after 16 weeks of transplantation. Our study provided evidence that transplanted hUCB-MNCs play therapeutic effects in a rat PD model by differentiating to neurons and dopamine neurons.	[Chen, Chao; Duan, Jing; Wang, Wei; Song, Hao; Liu, Yanming; Lu, Xianjie; You, Zhiqing; Han, Fabin] Taishan Med Univ, Affiliated Liaocheng Hosp, Liaocheng Peoples Hosp, Ctr Stem Cells & Regenerat Med, 67 Dongchang West Rd, Liaocheng 252000, Shandong, Peoples R China; [Shen, Aifang; Wang, Xiaobing] Taishan Med Univ, Affiliated Liaocheng Hosp, Liaocheng Peoples Hosp, Dept Gynecol & Obstet, Liaocheng, Shandong, Peoples R China; [Han, Zhongchao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Han, Zhongchao] Chinese Acad Med Sci, Peking Union Med Coll, Hosp Blood Dis, Tianjin, Peoples R China; [Han, Zhongchao] AmCellGene Co Ltd, TEDA, Natl Engn Res Ctr Cell Prod, Tianjin, Peoples R China		Han, FB (corresponding author), Taishan Med Univ, Affiliated Liaocheng Hosp, Liaocheng Peoples Hosp, Ctr Stem Cells & Regenerat Med, 67 Dongchang West Rd, Liaocheng 252000, Shandong, Peoples R China.	fhan2013@126.com			Science and Technology Department of Shandong Province, Shandong, People's Republic of China [2012GSF11808]	The authors thank all the participants in the study. Funding was provided through the Science and Technology Department of Shandong Province, Shandong, Peoples Republic of China (2012GSF11808).	Arien-Zakay H, 2009, EXP NEUROL, V216, P83, DOI 10.1016/j.expneurol.2008.11.006; Bachstetter AD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-22; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Blandini F, 2010, CELL TRANSPLANT, V19, P203, DOI 10.3727/096368909X479839; Boltze J, 2012, CELL TRANSPLANT, V21, P1199, DOI 10.3727/096368911X589609; Button RW, 2015, NEUROSCI BULL, V31, P382, DOI 10.1007/s12264-015-1528-y; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Danielyan L, 2011, REJUV RES, V14, P3, DOI 10.1089/rej.2010.1130; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Domanska-Janik K, 2008, INT J DEV BIOL, V52, P237, DOI 10.1387/ijdb.072315kd; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fan XT, 2014, MED RES REV, V34, P957, DOI 10.1002/med.21309; Han FB, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0039-8; Han FB, 2015, CYTOTHERAPY, V17, P665, DOI 10.1016/j.jcyt.2015.02.001; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; HOWS JM, 1992, BONE MARROW TRANSPL, V9, P105; Jaatinen Taina, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI [10.1002/9780470151808.sc02a02s1, 10.1002/9780470151808.sc02a01s1]; Jiang LX, 2010, STEM CELLS DEV, V19, P221, DOI 10.1089/scd.2009.0170; Karlupia N, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt434; Khoo MLM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019025; Laitinen A, 2011, METHODS MOL BIOL, V698, P63, DOI 10.1007/978-1-60761-999-4_6; Lee HJ, 2012, CELL TRANSPLANT, V21, P2487, DOI 10.3727/096368912X638964; Leonardo CC, 2010, J NEUROSCI RES, V88, P1213, DOI 10.1002/jnr.22306; Li H, 2015, CELL BIOL INT, V39, P84, DOI 10.1002/cbin.10355; Li SY, 2015, MOL MED REP, V12, P4320, DOI 10.3892/mmr.2015.3999; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128647; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; Liu TW, 2013, INT J BIOCHEM CELL B, V45, P1265, DOI 10.1016/j.biocel.2013.03.011; McGuckin CP, 2004, EXP CELL RES, V295, P350, DOI 10.1016/j.yexcr.2003.12.028; Meirelles LD, 2009, FRONT BIOSCI-LANDMRK, V14, P4281, DOI 10.2741/3528; Otsuru S, 2013, CYTOTHERAPY, V15, P146, DOI 10.1016/j.jcyt.2012.10.012; Rodrigues LP, 2012, BRAZ J MED BIOL RES, V45, P49, DOI 10.1590/S0100-879X2011007500162; Rosenkranz K, 2011, ANN ANAT, V193, P371, DOI 10.1016/j.aanat.2011.03.005; ROUSSEV RG, 1993, J REPROD IMMUNOL, V25, P15, DOI 10.1016/0165-0378(93)90039-K; Sanberg PR, 2011, CELL TRANSPLANT, V20, P85, DOI 10.3727/096368910X532855; Sheikh AM, 2011, NEUROBIOL DIS, V41, P717, DOI 10.1016/j.nbd.2010.12.009; Singh A, 2015, NEUROSCI BULL, V31, P705, DOI 10.1007/s12264-015-1559-z; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Vanneaux V, 2010, CELL TRANSPLANT, V19, P1143, DOI 10.3727/096368910X504487; Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006; Weise G, 2014, J CEREBR BLOOD F MET, V34, P182, DOI 10.1038/jcbfm.2013.185; Weiss ML, 2006, STEM CELL REV, V2, P155, DOI 10.1007/s12015-006-0022-y; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Yang WZ, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-75; Zangiacomi V, 2009, STEM CELLS DEV, V18, P1369, DOI 10.1089/scd.2008.0367; Zhu SY, 2015, NAT NEUROSCI, V18, P1084, DOI 10.1038/nn.4060	49	6	6	1	6	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	2324-2426			J NEURORESTORATOLOGY	J. NEURORESSTORATOLOGY		2016	4						23	33		10.2147/JN.S98835			11	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DV0DR	WOS:000382588700003		Green Submitted, gold			2022-02-06	
J	Choe, MC; Valino, H; Fischer, J; Zeiger, M; Breault, J; McArthur, DL; Leung, M; Madikians, A; Yudovin, S; Lerner, JT; Giza, CC				Choe, M. C.; Valino, H.; Fischer, J.; Zeiger, M.; Breault, J.; McArthur, D. L.; Leung, M.; Madikians, A.; Yudovin, S.; Lerner, J. T.; Giza, C. C.			Targeting the Epidemic: Interventions and Follow-up Are Necessary in the Pediatric Traumatic Brain Injury Clinic	JOURNAL OF CHILD NEUROLOGY			English	Article						traumatic brain injury clinic; postconcussive syndrome; traumatic brain injury management	HEAD-INJURY; INTERNATIONAL-CONFERENCE; POSTTRAUMATIC HEADACHES; CONSENSUS STATEMENT; SPORT HELD; CONCUSSION; CHILDREN; POPULATION; RECOVERY; SYMPTOMS	Traumatic brain injury is a major public health problem in the pediatric population. Previously, management was acute emergency department/primary care evaluation with follow-up by primary care. However, persistent symptoms after traumatic brain injury are common, and many do not have access to a specialized traumatic brain injury clinic to manage chronic issues. The goal of this study was to determine the factors related to outcomes, and identify the interventions provided in this subspecialty clinic. Data were extracted from medical records of 151 retrospective and 403 prospective patients. Relationships between sequelae, injury characteristics, and clinical interventions were analyzed. Most patients returning to clinic were not fully recovered from their injury. Headaches were more common after milder injuries, and seizures were more common after severe. The majority of patients received clinical intervention. The presence of persistent sequelae for traumatic brain injury patients can be evaluated and managed by a specialty concussion/traumatic brain injury clinic ensuring that medical needs are met.	[Choe, M. C.; McArthur, D. L.; Leung, M.; Yudovin, S.; Giza, C. C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA; [Choe, M. C.; Fischer, J.; Zeiger, M.; Yudovin, S.; Lerner, J. T.; Giza, C. C.] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Neurol, Los Angeles, CA 90095 USA; [Choe, M. C.; Fischer, J.; Zeiger, M.; Yudovin, S.; Lerner, J. T.; Giza, C. C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA 90095 USA; [Valino, H.] Univ Calif Davis, Sch Med, Los Angeles, CA USA; [Breault, J.] Ross Univ, Sch Med, Los Angeles, CA USA; [Madikians, A.] Div Pediat Crit Care, Los Angeles, CA USA		Choe, MC (corresponding author), Univ Calif Los Angeles, Mattel Childrens Hosp, Div Pediat Neurol, 22-474 MDCC,10833 LeConte Ave, Los Angeles, CA 90095 USA.	mchoe@mednet.ucla.edu			Morris A. Hazan Friends of Semel Fellowship; University of California Los Angeles Brain Injury Research Center; Child Neurology Society/Winokur Family Foundation; Thrasher Research Fund; Today's and Tomorrow's Children Fund; Joseph Drown Foundation; University of California Los Angeles Faculty Grants Program; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Child Neurology Foundation/Winokur Family Foundation; NCAA; Department of DefenseUnited States Department of Defense	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by the Morris A. Hazan Friends of Semel Fellowship, University of California Los Angeles Brain Injury Research Center, Child Neurology Society/Winokur Family Foundation, Thrasher Research Fund, Today's and Tomorrow's Children Fund, Joseph Drown Foundation and University of California Los Angeles Faculty Grants Program. Financial disclosures: CCG receives grant or research support from: NINDS, Thrasher Research Foundation, Child Neurology Foundation/Winokur Family Foundation, Today's and Tomorrow's Children Fund, University of California Los Angeles Faculty Grants Program, NCAA, Department of Defense, and Joseph Drown Foundation. He has been a consultant for Pearson TLC and Alcobra. He is on the speaker's bureau for the Medical Education Speakers Network and provides expert testimony for a few legal cases per year.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Faul M, 2010, TRAUMATIC BRAIN INJU; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477, DOI 10.1152/jn.1938.1.6.477; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Raj SP, 2014, J HEAD TRAUMA REHABI; Robertson Charlene M T, 2002, Pediatr Crit Care Med, V3, P345, DOI 10.1097/00130478-200210000-00003; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Theeler BJ, 2012, CEPHALALGIA, V32, P589, DOI 10.1177/0333102412445220; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	32	6	6	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2016	31	1			SI		109	115		10.1177/0883073815572685			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	CY8HW	WOS:000366650400011	25795464				2022-02-06	
J	Clark-Wilson, J; Giles, GM; Seymour, S; Tasker, R; Baxter, DM; Holloway, M				Clark-Wilson, Jo; Giles, Gordon Muir; Seymour, Stephanie; Tasker, Ross; Baxter, Doreen M.; Holloway, Mark			Factors influencing community case management and care hours for clients with traumatic brain injury living in the UK	BRAIN INJURY			English	Article						Traumatic brain injury; brain injury; case management; care needs; neurobehavioural disability; behaviour disorder; executive function	LONG-TERM-CARE; HEAD-INJURY; EXECUTIVE FUNCTIONS; AGGRESSIVE-BEHAVIOR; IMPAIRED AWARENESS; YOUNG-PEOPLE; REHABILITATION; ADULTS; MORTALITY; AGITATION	Objective: To investigate the relationship between deficits associated with traumatic brain injury (TBI) and case management (CM) and care/support (CS) in two UK community samples. Research design: Prospective descriptive study. Method: Case managers across the UK and from a single UK CM service contributed client profiles to two data sets (Groups 1 and 2, respectively). Data were entered on demographics, injury severity, functional skills, functional-cognition (including executive functions), behaviour and CM and CS hours. Relationships were explored between areas of disability and service provision. Results: Clients in Group 2 were more severely injured, longer post-injury and had less family support than clients in Group 1. There were few significant differences between Groups 1 and 2 on measures of Functional skill, Functional-cognition and Behaviour disorder. Deficits in Functional skills were associated with CS, but not CM. Deficits in measures of executive functions (impulsivity, predictability, response to direction) were related to CM, but not to CS. Insight was related to both CM and CS. Variables related to behaviour disorder were related to CM, but were less often correlated to CS. Conclusions: The need for community support is related not only to Functional skills (CS), but also to behaviour disorder, self-regulatory skills and impaired insight (CM).	[Clark-Wilson, Jo; Seymour, Stephanie; Tasker, Ross; Baxter, Doreen M.; Holloway, Mark] Head First, Cranbrook Rd, Hawkhurst TN18 4AS, Kent, England; [Giles, Gordon Muir] Samuel Merritt Univ, Oakland, CA USA; [Giles, Gordon Muir] Crestwood Treatment Ctr, Fremont, CA USA		Clark-Wilson, J (corresponding author), Head First, Cranbrook Rd, Hawkhurst TN18 4AS, Kent, England.	jo.clarkwilson@head-first.org		Holloway, Mark/0000-0003-3491-8242			[Anonymous], 2010, IBM SPSS STAT WIND V; Arnold Susan, 2013, Care Manag J, V14, P2; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; British Association of Brain Injury Case Management, WHAT IS BABICM; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Buchan A, 2014, PERSONAL INJURY PRAC; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Clark-Wilson J, 2015, NEUROREHABILITATION, V36, P289, DOI 10.3233/NRE-151217; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Davis JR, 2003, BRAIN INJURY, V17, P359, DOI 10.1080/0269905021000038429; DeBattista Charles, 2005, Expert Rev Neurother, V5, P79, DOI 10.1586/14737175.5.1.79; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Diwan S, 1999, GERONTOLOGIST, V39, P580, DOI 10.1093/geront/39.5.580; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Eslinger PJ, 2011, J NEUROPSYCH CLIN N, V23, P74, DOI 10.1176/appi.neuropsych.23.1.74; Feeney TJ, 2001, J HEAD TRAUMA REHABI, V16, P61; Foster ER, 2011, AM J OCCUP THER, V65, P306, DOI 10.5014/ajot.2011.000588; Giles GM, 2007, BRAIN INJURY, V21, P521, DOI 10.1080/02699050701311067; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; GREENWOOD RJ, 1994, BRIT MED J, V308, P1199, DOI 10.1136/bmj.308.6938.1199; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hunter D., 1988, BRIDGING GAP CASE MA, P17; Johansson SH, 2008, BRAIN INJURY, V22, P999, DOI 10.1080/02699050802530573; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kerr K, 2011, BRAIN INJURY, V25, P729, DOI 10.3109/02699052.2011.580315; Kim E, 2002, NEUROREHABILITATION, V17, P297; Lannin NA, 2014, NEUROREHABILITATION, V35, P635, DOI 10.3233/NRE-141161; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; MAHONEY F I, 1965, Md State Med J, V14, P61; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P2271, DOI 10.1016/j.apmr.2012.06.013; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; McAllister TW, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1034; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McMillan TM, 2013, NEUROREHABILITATION, V32, P791, DOI 10.3233/NRE-130903; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Norman D., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; O'Callaghan A, 2012, BRAIN INJURY, V26, P1599, DOI 10.3109/02699052.2012.698788; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pontius AA, 2003, AGGRESS VIOLENT BEH, V8, P245, DOI 10.1016/S1359-1789(01)00069-6; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Powell JM, 2007, AM J OCCUP THER, V61, P269, DOI 10.5014/ajot.61.3.269; Priestley N, 2013, J PERSONAL INJURY LA, V4, P240; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Raiff NR, 1993, ADV CASE MANAGEMENT; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Robson C., 1993, REAL WORLD RES RESOU; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sargent S, 1997, MED ASPECTS PERSONAL, P330; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Shimamura AP, 2000, CONSCIOUS COGN, V9, P313, DOI 10.1006/ccog.2000.0450; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TEASDALE G, 1974, LANCET, V2, P81; The NHS Scotland, 2009, TRAUM BRAIN INJ AD; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tranel D, 2007, J CLIN EXP NEUROPSYC, V29, P319, DOI 10.1080/13803390600701376; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 2012, CLIN REHABIL, V26, P264, DOI 10.1177/0269215511417467; Turner-Stokes L, 2012, CLIN REHABIL, V26, P256, DOI 10.1177/0269215511417469; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; World Health Organization, 2007, INT CLASS FUNCT DIS; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; [No title captured]	80	6	6	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	7					872	882		10.3109/02699052.2016.1146799			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DP2MI	WOS:000378322400006	27058173	Green Published, Green Accepted, hybrid			2022-02-06	
J	Davis, L; Hanson, B; Gilliam, S				Davis, Lauren; Hanson, Brenda; Gilliam, Sara			Pilot study of the effects of mixed light touch manual therapies on active duty soldiers with chronic post-traumatic stress disorder and injury to the head	JOURNAL OF BODYWORK AND MOVEMENT THERAPIES			English	Article						Traumatic brain injury; Head injury; Post-traumatic stress disorder; Headache; Anxiety; Pain Interference; Manual therapy; Craniosacral Therapy; Brain Curriculum; United States Soldiers	TRAUMATIC BRAIN-INJURY; PROTEIN-SYNTHESIS; DENDRITIC SPINES; PRIMARY-CARE; MIGRAINE; CHECKLIST; SYMPTOMS; PTSD; AFGHANISTAN; PREVALENCE	This pilot study was designed to examine the effects of mixed Light Touch Manual Therapies (LTMT) on headache, anxiety and other symptoms suffered by active duty United States service members experiencing chronic Post-Traumatic Stress Disorder (PTSD). Ten service members diagnosed with PTSD and having a self-reported injury to the head acquired at least two years prior, were provided with two hour-long sessions of mixed LTMT given a week apart. Data to assess the immediate and durable effects were gathered before and after the LTMT sessions. Results indicate that headache, anxiety, and pain interference were significantly reduced during the course of the pilot study. This suggests that mixed LTMT may be helpful in reducing some of the symptoms of PTSD and injury to the head. Further studies will be needed to determine if LTMT is an effective non-pharmacological treatment for headache, anxiety or other problems associated with PTSD or injury to the head. (C) 2015 Elsevier Ltd. All rights reserved.	[Davis, Lauren] Brain Plus Manual Therapy, El Paso, TX USA; [Hanson, Brenda; Gilliam, Sara] William Beaumont Army Med Ctr, El Paso, TX USA		Davis, L (corresponding author), 6329 Falling Star Way, El Paso, TX 79912 USA.	LaurenDavisMT@gmail.com		Davis, Lauren/0000-0003-4431-3124			Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Arnadottir TS, 2013, COMPLEMENT THER CLIN, V19, P11, DOI 10.1016/j.ctcp.2012.09.003; Bennett AV, 2012, VALUE HEALTH, V15, P466, DOI 10.1016/j.jval.2011.12.005; Berlant J, 2002, J CLIN PSYCHIAT, V63, P15, DOI 10.4088/JCP.v63n0104; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Cella D., 2012, 1 NAT QUAL FOR; Chaibi A, 2011, J HEADACHE PAIN, V12, P127, DOI 10.1007/s10194-011-0296-6; Chaitow L., 2005, CRANIAL MANIPULATION; Channell MK, 2009, J AM OSTEOPATH ASSOC, V109, P509; Chen CS, 1999, OSTEOARTHR CARTILAGE, V7, P81, DOI 10.1053/joca.1998.0164; Chikly B., 2004, BRAIN TISSUE NUCL FL; Chikly B., 2010, COMMUNICATION; Chikly B., 2007, BRAIN TISSUE NUCL FL; Cohen J., 2013, STAT POWER ANAL BEHA; CRICK F, 1982, TRENDS NEUROSCI, V5, P44, DOI 10.1016/0166-2236(82)90020-0; DAVIS L, 1992, J NEUROSCI, V12, P4867; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; Defense and Veterans Brain Injury Center (DVBIC), 2014, DOD NUMB TRAUM BRAIN; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkel AG, 2012, HEADACHE, V52, P957, DOI 10.1111/j.1526-4610.2012.02167.x; Fischer H., 2013, US MILITARY CASUALTY; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Gallagher RM, 2003, HEADACHE, V43, P36, DOI 10.1046/j.1526-4610.2003.03006.x; Gilliam S., 2011, COMMUNICATION; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; GREENMAN PE, 1991, S REH TRAUM BRAIN IN; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Hernandez-Reif M, 1998, INT J NEUROSCI, V96, P1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jackman R., 2007, UPLEDGER UPDATE SPRI; JENSEN OK, 1990, CEPHALALGIA, V10, P241, DOI 10.1046/j.1468-2982.1990.1005241.x; Keller SM, 2014, J CONSULT CLIN PSYCH, V82, P102, DOI 10.1037/a0035286; Kennedy A., 2011, AM MASSAGE THERAPY A; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kozminski M., 2009, AM ACAD OSTEOPAT J, V19, P23; Lai JS, 2009, J CLIN EPIDEMIOL, V62, P991, DOI 10.1016/j.jclinepi.2008.10.007; Lang AJ, 2012, GEN HOSP PSYCHIAT, V34, P332, DOI 10.1016/j.genhosppsych.2012.02.003; Lawler SP, 2006, ANN BEHAV MED, V32, P50, DOI 10.1207/s15324796abm3201_6; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; MELCHART D, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001218; Mills Roth Julie, 2003, Curr Pain Headache Rep, V7, P482, DOI 10.1007/s11916-003-0065-6; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Nestoriuc Y, 2008, APPL PSYCHOPHYS BIOF, V33, P125, DOI 10.1007/s10484-008-9060-3; Nishith P, 2002, J CONSULT CLIN PSYCH, V70, P880, DOI 10.1037/0022-006X.70.4.880; Oschman J.H.L., 2000, ENERGY MED SCI BASIS; Paterson C, 1996, BRIT MED J, V312, P1016; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Schwab KA, 2006, NEUROLOGY, V66, pA235; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; SIMONS DJ, 1946, PSYCHOSOM MED, V8, P227, DOI 10.1097/00006842-194607000-00001; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; STEWARD O, 1988, MOL NEUROBIOL, V2, P227, DOI 10.1007/BF02935634; Stewart WF, 2001, NEUROLOGY, V56, pS20, DOI 10.1212/WNL.56.suppl_1.S20; Swanson RL, 2013, J AM OSTEOPATH ASSOC, V113, P34, DOI 10.7556/jaoa.2013.113.1.34; Taylor FB, 2008, BIOL PSYCHIAT, V63, P629, DOI 10.1016/j.biopsych.2007.07.001; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Upledger J, 1996, CRANIOSACRAL THERAPY, P131; Vickers AJ, 2004, BRIT MED J, V328, P744, DOI 10.1136/bmj.38029.421863.EB; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Weathers F.W., 1993, 9 ANN C ISTSS; Zwart JA, 2003, NEUROLOGY, V61, P160, DOI 10.1212/01.WNL.0000069924.69078.8D	68	6	6	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1360-8592	1532-9283		J BODYW MOV THER	J. Bodyw. Mov. Ther.	JAN	2016	20	1					42	51		10.1016/j.jbmt.2015.03.006			10	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	DT7TA	WOS:000381689000007	26891636				2022-02-06	
J	Dickinson, P; Rempel, P				Dickinson, Philip; Rempel, Philip			Prohibiting Headgear for Safety in Amateur Boxing? Opinion of the Canadian Boxing Community: an Online Poll	SPORTS MEDICINE-OPEN			English	Article						Amateur boxing; Concussion; Safety; Head injury; Opinion poll; Headgear	CHRONIC TRAUMATIC ENCEPHALOPATHY; CONCUSSION; SPORTS; INJURY; RISK; EPIDEMIOLOGY; PERFORMANCE; STATEMENT; GENDER; IMPACT	Background: In 2013, the Amateur International Boxing Association (AIBA) introduced a rule banning headgear for male-senior open class boxers during competition. The AIBA has defended the rule change as motivated by safety and supported by internal unpublished studies. As a result, in 2018, the AIBA plans to universally prohibit headgear in competition: for all competitors (male and female), all ages and all levels. Within Canada, this ruling has generated controversy in the boxing community, yet there has been no overall measure of opinion. Methods: To address this, we instituted a voluntary, anonymous, online open-access poll to allow members of the boxing community to express their stance on headgear use in competition. Results: In total, 636 responses were received. A total of 71.5 % of Canadian respondents believed headgear should be mandatory at all levels. Only 5.8 % agreed that headgear should be prohibited, as planned for 2018. Estimating results on a representative breakdown of boxing membership in Canada, a similar pattern emerged, whereby 68.2 % concurred with mandatory headgear while only 4.95 % supported its prohibition. Parents of boxers were almost unanimously against banning headgear, stating they would change sports as a result. Similarly, only 1.7 % of women believed headgear should be prohibited. Conclusions: The consensus of the Canadian boxing community largely opposes the rule changes that the AIBA has implemented. The results highlight risks posed to the long-term viability of the sport, if significant grassroots safety concerns are disregarded.	[Dickinson, Philip; Rempel, Philip] Ctr Sportif Chat Bleu, 435 Rue Beaubien Ouest,4e, Montreal, PQ H2V 1C9, Canada		Dickinson, P (corresponding author), Ctr Sportif Chat Bleu, 435 Rue Beaubien Ouest,4e, Montreal, PQ H2V 1C9, Canada.	pdickinson@centrechatbleu.com					Agresti A., 2013, WILEY SERIES PROBABI, V792; AIBA, 2015, AIBA BOX HIST; AIBA, 2015, AIBA OP BOX AOB COMP; [Anonymous], 2014, CNN; [Anonymous], 2013, BRIT J SPORT MED, V47, P267; [Anonymous], 2014, CBC NEWS; [Anonymous], 2013, BBC NEWS; Associated Press, 2013, ASS PRESS; Bartsch AJ, 2012, J NEUROSURG, V116, P1070, DOI 10.3171/2011.12.JNS111478; Bianco M, 2013, BRIT J SPORT MED, V47, P452, DOI 10.1136/bjsports-2012-091771; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; CBC (Canadian Broadcasting Corporation), 2015, CBC NEWS; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dau N, 2006, ANN C AM SOC BIOM; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Eckel C.C., 2008, HDB EXPT EC RESULTS, V1, P1061, DOI DOI 10.1016/S1574-0722(07)00113-8; Falvey EC, 2015, BRIT J SPORT MED, V49, P1091, DOI 10.1136/bjsports-2015-095170; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Ganim S, 2014, CNN; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gillespie K., 2014, STAR; GOODMAN LA, 1965, TECHNOMETRICS, V7, P247, DOI 10.2307/1266673; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; HOLM S, 1979, SCAND J STAT, V6, P65; Hubbard A., 2015, INDEPENDENT; Jako P, 2002, BRIT J SPORT MED, V36, P394, DOI 10.1136/bjsm.36.6.394; Kelly JP, 1997, NEUROLOGY, V48, P581; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; Loosemore M, 2015, BRIT J SPORT MED, V49, P1100, DOI 10.1136/bjsports-2015-094755; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Makdissi Michael, 2015, Neurol Clin Pract, V5, P2, DOI 10.1212/CPJ.0000000000000061; May WL, 2000, J STAT SOFTW, V5, P1, DOI DOI 10.18637/JSS.V005.I06; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, BRIT J SPORT MED, V46, P459, DOI 10.1136/bjsports-2012-091276; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1113, DOI 10.1136/bjsports-2015-095093; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1108, DOI 10.1136/bjsports-2015-095094; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; Power M., 2014, USE HEADGEAR OPEN CL; Ringside World Championships, 2015, INT BOX OUTS US; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; SMITH M, 2014, HIST WOMENS BOXING; Special Correspondent, 2014, HINDU; Strauss B., 2014, NY TIMES; Wang SS., 2013, WALL STREET J; Whistler J., 2013, EXPRESS NEWS; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001; Zazryn TR, 2009, PHYS MED REH CLIN N, V20, P227, DOI 10.1016/j.pmr.2008.10.004; Zazryn TR, 2009, CLIN J SPORT MED, V19, P20, DOI 10.1097/JSM.0b013e31818f1582	53	6	6	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open		2016	2								19	10.1186/s40798-016-0043-2			11	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VI8CQ	WOS:000514829300004	26913220	Green Published, gold			2022-02-06	
J	Geurten, M; Catale, C; Geurten, C; Wansard, M; Meulemans, T				Geurten, Marie; Catale, Corinne; Geurten, Claire; Wansard, Murielle; Meulemans, Thierry			Studying self-awareness in children: validation of the Questionnaire of Executive Functioning (QEF)	CLINICAL NEUROPSYCHOLOGIST			English	Article						Self-awareness; executive functions; psychometric properties; children	TRAUMATIC BRAIN-INJURY; BEHAVIOR RATING INVENTORY; INTERNAL CONSISTENCY; DEFICITS; KNOWLEDGE; MEMORY; ANOSOGNOSIA; IMPAIRMENT; COGNITION; SCALE	Objective: People with accurate representations of their own cognitive functioning (i.e. cognitive self-awareness) tend to use appropriate strategies to regulate their behavior. Due to the lack of appropriate instruments, few studies have examined the development of this ability among children. Method: This study tested the measurement properties of the self-rating and other-rating forms of the Questionnaire of Executive Functioning (QEF), designed to tap children's knowledge of their executive functioning. Specifically, the construct, convergent, and discriminant validities were investigated and a self-other discrepancy score was computed to assess children's executive self-awareness. Participants were 317 children aged 7-14years old. Results: Confirmatory factor analyses carried out on the QEF confirmed the eight-factor structure of both versions. There were significant correlations between the QEF and the parent versions of the Behavior Rating Inventory of Executive Function, the Dysexecutive Questionnaire for Children, and the Childhood Executive Functioning Inventory. Both forms of the QEF were able to distinguish between children who had sustained a traumatic brain injury (TBI) and control participants. A statistical difference was observed between the TBI and control groups on this score, suggesting that TBI may trigger self-awareness impairments in children. Conclusion: The good psychometric properties of the two forms of the QEF were established. Furthermore, results of the analyses carried out on the different discrepancy scores seem to indicate that the QEF could help clinicians to detect patients with self-awareness deficits.	[Geurten, Marie; Catale, Corinne; Wansard, Murielle; Meulemans, Thierry] Univ Liege, Dept Psychol, Neuropsychol Unit, Liege, Belgium; [Geurten, Claire] Univ Liege, Dept Pediat, Fac Med, Liege, Belgium		Geurten, M (corresponding author), Univ Liege, Dept Psychol, Neuropsychol Unit, Liege, Belgium.	mgeurten@ulg.ac.be		Geurten, Marie/0000-0003-3743-5246			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Archibald SJ, 1999, CHILD NEUROPSYCHOL, V5, P115, DOI 10.1076/chin.5.2.115.3167; Baron I. S., 2007, CHILD NEUROPSYCHOL, V13, P539, DOI DOI 10.1080/09297040601112781; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Brown TA., 2015, CONFIRMATORY FACTOR, V2; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burmeister R, 2005, CHILD NEUROPSYCHOL, V11, P265, DOI 10.1080/092970490911324; Catale C, 2015, J ATTEN DISORD, V19, P489, DOI 10.1177/1087054712470971; Chau LT, 2007, NEUROPSYCHOL REHABIL, V17, P707, DOI 10.1080/09602010600923926; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Dunn TJ, 2014, BRIT J PSYCHOL, V105, P399, DOI 10.1111/bjop.12046; Flashman Laura A, 2002, Curr Psychiatry Rep, V4, P346, DOI 10.1007/s11920-002-0082-x; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming JM, 1996, BRAIN INJURY, V10, P1; Fritz K, 2010, METACOGN LEARN, V5, P207, DOI 10.1007/s11409-010-9058-0; Geurten M, 2017, CHILD NEUROPSYCHOL, V23, P67, DOI 10.1080/09297049.2015.1077945; Geurten M, 2016, APPL COGNITIVE PSYCH, V30, P70, DOI 10.1002/acp.3168; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Hernandez MT, 2002, NEUROPSYCHOLOGIA, V40, P384, DOI 10.1016/S0028-3932(01)00130-0; Hill T., 2007, STAT METHODS APPL; Hufford BJ, 2005, J CLIN EXP NEUROPSYC, V27, P255, DOI 10.1080/13803390490515478; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; KREUTZER MA, 1975, MONOGR SOC RES CHILD, V40, P1, DOI 10.2307/1165955; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; McDonald R, 1999, TEST THEORY UNIFIED; Morris RG, 2013, CORTEX, V49, P1553, DOI 10.1016/j.cortex.2012.09.006; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Muthun B.O., 2007, MPLUS STAT SOFTWARE; Naglieri J. A., 2012, COMPREHENSIVE EXECUT; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Pressley M, 1997, INTRO MEMORY DEV CHI; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; Schneider W, 2008, MIND BRAIN EDUC, V2, P114, DOI 10.1111/j.1751-228X.2008.00041.x; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Smith MM, 2010, J CLIN EXP NEUROPSYC, V32, P780, DOI 10.1080/13803390903540307; Sperling RA, 2002, CONTEMP EDUC PSYCHOL, V27, P51, DOI 10.1006/ceps.2001.1091; Stone LL, 2013, EUR J PSYCHOL ASSESS, V29, P44, DOI 10.1027/1015-5759/a000119; TEASDALE G, 1974, LANCET, V2, P81; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446	48	6	6	2	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2016	30	4					558	578		10.1080/13854046.2016.1178331			21	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DO6YO	WOS:000377929600006	27117835	Green Submitted			2022-02-06	
J	Glintborg, C; Hansen, TGB				Glintborg, Chalotte; Hansen, Tia G. B.			Bio-psycho-social effects of a coordinated neurorehabilitation programme: A naturalistic mixed methods study	NEUROREHABILITATION			English	Article						ABI; quality of life; psychological rehabilitation; bio-psycho-social outcome	TRAUMATIC BRAIN INJURY; QUALITY-OF-LIFE; DEPRESSION; INDIVIDUALS; STROKE	PURPOSE: Best practice guidelines for neurorehabilitation recommend coordinated rehabilitation programmes to ensure seamless service transitions and comprehensive rehabilitation practices. However, this recommendation for practice and the evidence informing its advancement is based on unexamined assumptions. Therefore, this study investigates bio-psycho-social outcomes and perceptions of a coordinated rehabilitation programme. METHOD: In a prospective, naturalistic mixed methods study, rehabilitation outcomes for 82 adults (18-66 years) with moderate to severe acquired brain injury were investigated. Clients who received the coordinated rehabilitation programme KORE (n = 27) were compared to clients from the same area who received standard rehabilitation prior to the implementation of the KORE programme (n = 37) and clients who received other coordinated efforts elsewhere (n = 18). The study employed quantitative data from standardized tests (Functional Independence Measure, Major Depression Inventory, Quality of life, and Impact on Participation and Autonomy Questionnaire, as well as information on return to work and qualitative interviews with clients (n = 82) and their relatives (n = 40). RESULTS: Outcomes did not improve from hospital discharge to two years later. Notably, physiological recovery had probably been achieved to the extent possible, but depression and reduced psychological well-being remained prevalent across groups. Qualitative interviews suggested several barriers to improvement, such as identity dilemmas and unmet needs for psychological support, while rehabilitation services focused on physical and practical training. CONCLUSION: Coordinated interventions do not guarantee comprehensive rehabilitation and better outcomes for clients with acquired brain injury. Psychological support seems to be important and largely unaddressed.	[Glintborg, Chalotte; Hansen, Tia G. B.] Aalborg Univ, Dept Commun & Psychol, Ctr Dev & Appl Psychol Sci CeDAPS, Kroghstr 3, DK-9220 Aalborg O, Denmark		Glintborg, C (corresponding author), Aalborg Univ, Dept Commun & Psychol, Ctr Dev & Appl Psychol Sci CeDAPS, Kroghstr 3, DK-9220 Aalborg O, Denmark.	cgl@hum.aau.dk	; Glintborg, Chalotte/G-6599-2017	Hansen, Tia Gitte Bondesen/0000-0002-8823-5183; Glintborg, Chalotte/0000-0001-6074-7219	Ministry of Health; Inge Lehmann's scholarship	This article is affiliated with the REKO-project (Rehabilitation Mediated by Coordinated Interventions), funded by the Ministry of Health though a grant to Aalborg Municipality and Aalborg University, Denmark. Furthermore, we would like to thank the Inge Lehmann's scholarship that supported this project.	American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT, VIV; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Bech P., 2005, BLA BOG RATING SCALE; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brenner LA, 2009, PSYCHIAT THEOR APPL, P189; Danish Board of Health (Sundhedsstyrelsen), 2011, FORL OBSPR REH VOKSN; Danish Board of Health (Sundhedsstyrelsen), 2011, HJERN MED TEKN; Ellervik C, 2014, NORD J PSYCHIAT, V68, P507, DOI 10.3109/08039488.2013.877074; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Ghaziani E, 2013, SCAND J OCCUP THER, V20, P190, DOI 10.3109/11038128.2012.737370; Glintborg C., 2014, EFFEKTER KOORDINERET; Glintborg C., WHAT MAY HE IN PRESS; Glintborg C., 2014, PSYKE LOGOS, V34; Glintborg C, 2015, NARRAT INQ, V25, P1, DOI 10.1075/ni.25.1.01gli; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hald S, 2012, MUSIC THERAPY ACQUIR; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Holm LV, 2013, ACTA ONCOL, V52, P410, DOI 10.3109/0284186X.2012.745014; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kennedy P., 2012, OXFORD HDB REHABILIT; Miles M.B., 2013, QUALITATIVE DATA ANA; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Norholm V, 2001, NORD J PSYCHIAT, V55, P229; Pallant J.F., 2007, SPSS SURVIVAL MANUAL; Plano Clark, 2018, DESIGNING CONDUCTING; Rivera PA, 2006, J CLIN PSYCHOL MED S, V13, P431, DOI 10.1007/s10880-006-9043-6; Schlossberg N., 1984, COUNSELING ADULTS TR; Teasdale TW, 2005, BRAIN INJURY, V19, P1049, DOI 10.1080/02699050500110421; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; WHO, 1996, WHOQOL BREF INTR ADM; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization (WHO), 2006, ICD 10 INT STAT CLAS	37	6	7	0	12	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	38	2					99	113		10.3233/NRE-161301			15	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DI3JO	WOS:000373395100001	26889730				2022-02-06	
J	Haran, FJ; Dretsch, MN; Bleiberg, J				Haran, F. Jay; Dretsch, Michael N.; Bleiberg, Joseph			Performance on the Defense Automated Neurobehavioral Assessment across controlled environmental conditions	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						DANA; military; NCAT; neurocognitive	NEUROCOGNITIVE ASSESSMENT-TOOL; SPORT-RELATED CONCUSSION; BASE-LINE; COGNITIVE PERFORMANCE; RELIABILITY; DEPLOYMENT; SYMPTOMS; BATTERY; STRAIN; INJURY	Neurocognitive assessment tools (NCAT) are commonly used to screen for changes in cognitive functioning following a mild traumatic brain injury and to assist with a return to duty decision. As such, it is critical to determine if performance on the Defense Automated Neurobehavioral Assessment (DANA) is adversely affected by operationally-relevant field environments. Differences in DANA performance between a thermoneutral environment and three simulated operationally-relevant field environments across the thermal stress continuum were calculated for 16 healthy U.S. Navy service members. Practice effects associated with brief test-retest intervals were calculated within each environmental condition. There were no significant differences between the simulated environmental conditions suggesting that performance on the DANA Brief is not impacted by thermal stress. Additionally, there were no significant differences in performance within each simulated environmental condition associated with repeated administrations.	[Haran, F. Jay] NSMRL, Box 900, Groton, CT 06349 USA; [Dretsch, Michael N.] US Army Aeromed Res Lab, Warfighter Hlth Div, Ft Rucker, AL USA; [Bleiberg, Joseph] WRNMMC, Bethesda, MD USA		Haran, FJ (corresponding author), NSMRL, Box 900, Groton, CT 06349 USA.	francis.j.haran.mil@mail.mil		Bleiberg, Joseph/0000-0003-0867-5494	Bureau of Medicine and Surgery (BUMED), Wounded, Ill and Injured Directorate [12 PR0056]	Funding is gratefully acknowledged from the Bureau of Medicine and Surgery (BUMED), Wounded, Ill and Injured Directorate (M9 Grant Number 12 PR0056).	Adam GE, 2008, PHYSIOL BEHAV, V93, P748, DOI 10.1016/j.physbeh.2007.11.028; Caldwell JN, 2012, EUR J APPL PHYSIOL, V112, P3597, DOI 10.1007/s00421-012-2340-x; Caldwell JN, 2011, MIL MED, V176, P488, DOI 10.7205/MILMED-D-10-00010; Castellani J. W., 2009, HYPOHYDRATION EFFECT; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Department of Defense, 2013, 649013 DODI US DEP D; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Dretsch M, 2015, APPL NEUROPSYCH-ADUL, V22, P304, DOI 10.1080/23279095.2014.926454; Dretsch MN, 2013, APPL NEUROPSYCH-ADUL, V20, P272, DOI 10.1080/09084282.2012.715110; Driskell J. E., 1992, ALTR1911009 AIR FORC; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Haran F. J., 2015, 1511 NEDU; Johnson R. F., 2002, MED ASPECTS HARSH EN, V1, P135; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Koziol L. F., 2009, SUBCORTICAL STRUCTUR; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Law R, 2012, ANXIETY STRESS COPIN, V25, P711, DOI 10.1080/10615806.2011.630070; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, V5; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Norris JN, 2014, BRAIN INJURY, V28, P1052, DOI 10.3109/02699052.2014.891761; Rahman-Filipiak AAM, 2013, NEUROPSYCHOL REV, V23, P314, DOI 10.1007/s11065-013-9241-6; Randolph C, 2005, J ATHL TRAINING, V40, P139; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Russo CR, 2015, APPL PSYCH MEAS, V39, P566, DOI 10.1177/0146621615577361; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Staal M.A., 2004, NASATM2004212824 AM; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Weber AF, 2013, J ATHL TRAINING, V48, P153, DOI 10.4085/1062-6050-48.1.07	37	6	6	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2016	23	6					411	417		10.1080/23279095.2016.1166111			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	DX6XV	WOS:000384530300004	27182844				2022-02-06	
J	Holmes, L; Tworig, J; Casini, J; Morgan, I; O'Brien, K; Oceanic, P; Dabney, K				Holmes, Laurens, Jr.; Tworig, Joshua; Casini, Joseph; Morgan, Isabel; O'Brien, Kathleen; Oceanic, Patricia; Dabney, Kirk			Implication of Socio-Demographics on Cognitive-Related Symptoms in Sports Concussion Among Children	SPORTS MEDICINE-OPEN			English	Article							TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; SEX-DIFFERENCES; UNITED-STATES; ADOLESCENTS; AMERICAN; OUTCOMES; GENDER	Background: Sports-related concussion remains a public health challenge due to its morbidity and mortality. One of the consequences of concussion is cognitive impairment (CI) and cognitive-related symptoms (CRS) which determine, to some extent, physical and behavioral functioning of children who sustain concussion. Despite the high prevalence of CI and CRS associated with concussion, the risk factors are not fully understood. We aimed to characterize CRS and to examine its relationship with race, ethnicity, age, insurance, and sex in a pediatric population. Methods: A retrospective cohort (case-only) design was used to assess CRS prevalence and its relationship with race and sex using a pediatric hospital's electronic medical records. A consecutive sample was used with 1429 cases between 2007 and 2014. Study characteristics were examined using chi-square and log binomial regression for hypothesis-specific testing. Results: Of the 1429 cases, 872 (61.0 %) were boys and 557 (39.0 %) were girls. The racial distribution indicated 1146 (80.2 %) Whites, 170 (11.9 %) Blacks/African Americans, and 113 (7.9 %) others. The prevalence of CRS was 78.0 %. Whereas boys had sustained more concussions, girls were more likely to present with CRS; prevalence risk ratio = 1.07, 95 % CI 1.01-1.13, p = 0.02. The crude analysis indicated no racial disparities in CRS prevalence, but the multivariable analysis did, comparing White to Black/African American children; adjusted prevalence risk ratio (aPRR) = 1.77, 99 % CI 1.02-3.08, p = 0.008. Conclusions: Racial disparities exist in CRS among children with sports-related concussion, and Black/African American children are more likely, relative to Whites, to suffer CRS. Due to uncertainty in causal inference, we caution the interpretation and application of these data in risk-adapted concussion prevention.	[Holmes, Laurens, Jr.; Morgan, Isabel; Oceanic, Patricia; Dabney, Kirk] Nemours Alfred I DuPont Hosp Children, Off Hlth Equ & Inclus, POB 269, Wilmington, DE 19803 USA; [Holmes, Laurens, Jr.; Tworig, Joshua] Univ Delaware, Newark, DE 19716 USA; [Casini, Joseph] Villanova Univ, Villanova, PA 19085 USA; [Morgan, Isabel] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [O'Brien, Kathleen; Dabney, Kirk] Nemours A I duPont Hosp Children, Orthoped Dept, Wilmington, DE 19803 USA		Holmes, L (corresponding author), Nemours Alfred I DuPont Hosp Children, Off Hlth Equ & Inclus, POB 269, Wilmington, DE 19803 USA.; Holmes, L (corresponding author), Univ Delaware, Newark, DE 19716 USA.	drholmesjr@gmail.com		Tworig, Joshua/0000-0001-7798-4480			[Anonymous], 2013, STATA DAT AN STAT SO; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Holmes L, 2007, PROSTATE CANCER P D, V10, P388, DOI 10.1038/sj.pcan.4500973; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, ISSUES ASS PRESCHOOL; McKinlay A., 2012, CHILDREN ADOLESCENTS; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	28	6	6	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open		2016	2								38	10.1186/s40798-016-0058-8			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VI8CQ	WOS:000514829300023	27747794	gold, Green Published			2022-02-06	
J	Ishida, Y; McLean, SF; Tyroch, AH				Ishida, Yuichi; McLean, Susan F.; Tyroch, Alan H.			Cecal bascule after spinal cord injury: A case series report	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Cecal bascule; Volvulus; Trauma Spinal cord injury; Case report	COLONIC VOLVULUS; UNITED-STATES; DIAGNOSIS	INTRODUCTION: Cecal bascule is a rare cause of intestinal obstruction associated with upward and anterior folding of the ascending colon. We report three patients who presented with spinal cord injury complicated with a cecal bascule. Diagnosis and management of cecal bascule is discussed. PRESENTATION OF CASES: Patient 1:59-year-old male sustained a traumatic brain injury and cervical spinal cord injury after a motorcycle crash. He had abdominal distension and the diagnosis of cecal bascule was made. Cecopexy was performed. Patient 2:51-year-old male sustained an unstable C7 vertebral fracture with a cord contusion and quadriplegia after a diving incident. After an unsuccessful medical management of the colonic distension, the patient was taken for a laparotomy and cecal bascule was found. A cecostomy and a cecopexy were performed. Patient 3:63-year-old male was transferred after a fall. He had diffuse degenerative changes in the thoracic and lumbar spine. He was found to have a perforated cecal bascule. He had a right hemicolectomy with an ileocolic anastomosis. DISCUSSION: We suggest the possibility of spinal cord injury being a risk factor for cecal bascule. Currently, right hemicolectomy is recommended for the treatment of cecal bascule. Cecopexy is also acceptable treatment option for a case in which the patient will be undergoing an operation with an insertion of hardware. CONCLUSION: The diagnosis of cecal bascule should be considered for trauma patients with cecal distention without delay in order to prevent disastrous complications. (C) 2016 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing Group Ltd.	[Ishida, Yuichi; McLean, Susan F.; Tyroch, Alan H.] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Surg, 4800 Alberta Ave, El Paso, TX 79905 USA		Ishida, Y (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Surg, 4800 Alberta Ave, El Paso, TX 79905 USA.	yuichi.ishida@ttuhsu.edu					Consorti ET, 2005, POSTGRAD MED J, V81, P772, DOI 10.1136/pgmj.2005.035311; Delabrousse E, 2007, EMERG RADIOL, V14, P411, DOI 10.1007/s10140-007-0647-4; Ebert E, 2012, J GASTROINTEST LIVER, V21, P75; Gagnier JJ, 2014, J CLIN EPIDEMIOL, V67, P46, DOI 10.1016/j.jclinepi.2013.08.003; Habre Jihad, 2008, Am J Surg, V196, pe48, DOI 10.1016/j.amjsurg.2007.11.029; Halabi WJ, 2014, ANN SURG, V259, P293, DOI 10.1097/SLA.0b013e31828c88ac; Harper SG, 1995, SURG COLON RECTUM AN, P657; HASKIN PH, 1981, JAMA-J AM MED ASSOC, V245, P2433, DOI 10.1001/jama.245.23.2433; Katoh T, 2009, WORLD J GASTROENTERO, V15, P2547, DOI 10.3748/wjg.15.2547; Lee SJ, 2013, J THORAC ONCOL, V8, P185, DOI 10.1097/JTO.0b013e3182773f21; Margolin DA, 2007, SEMIN COLON RECTAL S, V18, P79, DOI 10.1053/j.scrs.2006.12.013; Nwanguma OR, 2011, J TRAUMA, V71, P1082, DOI 10.1097/TA.0b013e318224da21; OGILVIE WH, 1987, DIS COLON RECTUM, V30, P984; Ramsingh J., 2014, J SURG CASE REP, V2014; Shah Nihar, 2015, N AM J MED SCI, V8, P143; SHOOP SA, 1993, SURG ENDOSC-ULTRAS, V7, P450, DOI 10.1007/BF00311742; Swenson BR, 2012, DIS COLON RECTUM, V55, P444, DOI 10.1097/DCR.0b013e3182404b3d; Vandendries C, 2010, BRIT J RADIOL, V83, P983, DOI 10.1259/bjr/35714052	18	6	6	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.		2016	22						94	97		10.1016/j.ijscr.2016.03.040			4	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	DK6IX	WOS:000375027600026	27077698	gold, Green Published			2022-02-06	
J	Jentzsch, T; Neuhaus, V; Seifert, B; Osterhoff, G; Simmen, HP; Werner, CML; Moos, R				Jentzsch, Thorsten; Neuhaus, Valentin; Seifert, Burkhardt; Osterhoff, Georg; Simmen, Hans-Peter; Werner, Clement M. L.; Moos, Rudolf			The impact of public versus private insurance on trauma patients	JOURNAL OF SURGICAL RESEARCH			English	Article						Level of health care insurance (public versus private extended); Epidemiology of injuries; Mortality; Surgeries; Trauma patients	HEALTH-CARE INSURANCE; INJURY; MORTALITY; OUTCOMES; DISPARITIES; RACE; PREDICTOR; EUROPE; STAY	Background: The socioeconomic status has been associated with disparities in the incidence and mortality of traumatic injuries. However, there is a lack of studies on the level of health insurance with regard to various epidemiologic data of traumatic injuries, which this study opted to clarify. Materials and methods: All consecutive 6595 patients admitted to a level one trauma center in 2012 and 2013 were included in this retrospective cohort study. Patients were grouped according to their health insurance status (public versus private extended health care insurance) and compared with regard to several epidemiologic variables, that is, the type of injuries, inhospital outcome, and surgical procedures. Results: Public insurance coverage was significantly more common than private insurance (75% versus 25%). Public insurance was associated with younger age, male sex, transfers to another hospital or mental institution, head concussions, head fractures, and increased mortality. Contrarily, patients with private insurance were more often associated with longer hospital stay, discharge to a rehabilitation clinic, fractures of the proximal humerus, and shoulder dislocations. However, there were no significant differences for the remaining majority of studied variables. Conclusions: In a trauma setting, the level of insurance does not seem to play a crucial role in most types of injuries and surgical procedures in a country with a high level of obligatory health care coverage. Nonetheless, it appears that publicly insured patients are more commonly younger, males, transferred to another hospital more often, more prone to head trauma, and subject to increased mortality, whereas privately insured patients show longer hospital stays, increased transfers to rehabilitation clinics, and more fractures of the proximal humerus. (C) 2016 Elsevier Inc. All rights reserved.	[Jentzsch, Thorsten; Neuhaus, Valentin; Osterhoff, Georg; Simmen, Hans-Peter; Werner, Clement M. L.] Univ Zurich, Dept Surg, Div Trauma Surg, Univ Zurich Hosp, Zurich, Switzerland; [Seifert, Burkhardt] Univ Zurich, Dept Biostat, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Moos, Rudolf] Univ Zurich Hosp, Off Med Directorate, CH-8091 Zurich, Switzerland		Jentzsch, T (corresponding author), Univ Zurich Hosp, Dept Surg, Div Trauma Surg, Ramistr 100, CH-8091 Zurich, Switzerland.	thorsten.jentzsch@usz.ch	Jentzsch, Thorsten/AAR-6135-2020	Jentzsch, Thorsten/0000-0002-6133-3314; Simmen, Hans-Peter/0000-0002-5201-4549; Osterhoff, Georg/0000-0001-5051-0998; Neuhaus, Valentin/0000-0003-4012-5628			ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; Agarwal E, 2013, CLIN NUTR, V32, P737, DOI 10.1016/j.clnu.2012.11.021; Alexandrescu R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-226; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bell TM, 2013, J TRAUMA ACUTE CARE, V75, P728, DOI 10.1097/TA.0b013e3182a53aaa; Greene WR, 2010, AM J SURG, V199, P554, DOI 10.1016/j.amjsurg.2009.11.005; Gundle KR, 2010, J BONE JOINT SURG AM, V92A, P2452, DOI 10.2106/JBJS.I.01369; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Hazlitt M, 2014, J SURG RES, V191, P6, DOI 10.1016/j.jss.2013.05.052; Hochfelder JP, 2014, J ORTHOP TRAUMA, V28, P422, DOI 10.1097/BOT.0000000000000037; Kelz RR, 2004, CANCER-AM CANCER SOC, V101, P2187, DOI 10.1002/cncr.20624; Lee J, 2014, J TRAUMA ACUTE CARE, V77, P298, DOI 10.1097/TA.0000000000000334; Lehmann H, 2004, J HEALTH ECON, V23, P997, DOI 10.1016/j.jhealeco.2003.12.007; Matusitz J, 2014, SOC WORK PUBLIC HLTH, V29, P444, DOI 10.1080/19371918.2013.865108; Maybury RS, 2010, SURGERY, V148, P202, DOI 10.1016/j.surg.2010.05.010; Nirula R, 2009, J TRAUMA, V66, P255, DOI 10.1097/TA.0b013e31815ede46; Rosen H, 2009, ARCH SURG-CHICAGO, V144, P1006, DOI 10.1001/archsurg.2009.195; Salim A, 2010, J TRAUMA, V68, P211, DOI 10.1097/TA.0b013e3181a0e659; Swiss Statistics, MORT CAUS DEATH DAT; Swiss Statistics, 14 SCHWEIZ OP CHOP; Swiss Statistics, 14 INT KLASS KRANKH; Thomson S, 2013, HEALTH POLICY, V109, P209, DOI 10.1016/j.healthpol.2013.01.005; World Health Organization, INT STAT CLASS DIS R; World Health Organization, INJ VIOL FACTS	26	6	6	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2016	200	1					236	241		10.1016/j.jss.2015.06.055			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	CZ1BM	WOS:000366840700034	26248479				2022-02-06	
J	Kerr, K; Wilkerson, C; Shepard, S; Choi, H; Kitagawa, R				Kerr, Keith; Wilkerson, Christopher; Shepard, Scott; Choi, HuiMahn; Kitagawa, Ryan			Use of anti-platelet agents after traumatic intracranial hemorrhage	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Neurotrauma; Traumatic intracranial hemorrhage; Blunt cerebral vascular injury; Antiplatelet therapy	BLUNT CEREBROVASCULAR INJURIES; OUTCOMES; MANAGEMENT; THERAPY	Objective: To evaluate the risk of hemorrhagic complications associated with starting anti-platelet therapy (APT) after acute traumatic intracranial hemorrhage (tICH) and to examine the frequency of thrombotic complications. Patients and methods: We retrospectively identified all patients admitted to our institution with tICH that received APT during their initial hospitalization over a three-year period. We reviewed their demographics, hospital course, clinical indication and timing for initiation of APT, and complications. Results: A total of 222 patients were identified. The median age and Injury Severity Score (ISS) was 61 and 21, respectively. Fifty (23%) patients required neurosurgical procedures. APTs were initiated due to a history of APT use in 91 patients (41%) and blunt cerebrovascular injury in 86 patients (38.6%). The median time from injury to starting APT was 4 days. Immediate complications including new or worsening hemorrhage occurred in 1 (<1%) patient. Delayed hemorrhagic complications occurred in 6 (4.7%) patients. Thrombotic events occurred in 21 (9.4%) patients prior to starting APT. Thirteen (5.8%) of these were potentially preventable. Conclusion: The risk of immediate and delayed intracranial hemorrhages from initiating APT after tICH must be weighed against the morbidity of delaying indicated thrombotic prophylaxis. Our initial data indicates that hemorrhagic complications are infrequent, and thrombotic complications can have significant clinical consequences. Our retrospective review provides the first rates of complications for this patient population. (C) 2015 Elsevier B.V. All rights reserved.	[Kerr, Keith; Shepard, Scott; Choi, HuiMahn; Kitagawa, Ryan] Univ Texas Hlth Sci Ctr Houston, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA; [Wilkerson, Christopher] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT 84112 USA		Kitagawa, R (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Med, Vivian L Smith Dept Neurosurg, 6400 Fannin 2800, Houston, TX 77030 USA.	Ryan.S.Kitagawa@uth.tmc.edu		Wilkerson, Christopher/0000-0002-5761-1377			Ajani UA, 2006, AM J PREV MED, V30, P74, DOI 10.1016/j.amepre.2005.08.042; Anderson JL, 2013, J AM COLL CARDIOL, V61, pE179, DOI 10.1016/j.jacc.2013.01.014; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Biffl WL, 2002, ANN SURG, V235, P699, DOI 10.1097/00000658-200205000-00012; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cothren CC, 2009, ARCH SURG-CHICAGO, V144, P685, DOI 10.1001/archsurg.2009.111; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Fabian TC, 2002, ANN SURG, V235, P706; Grines CL, 2007, J AM DENT ASSOC, V138, P652, DOI 10.14219/jada.archive.2007.0237; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Paulus EM, 2014, J TRAUMA ACUTE CARE, V76, P279, DOI 10.1097/TA.0000000000000101; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Son S, 2013, J KOREAN NEUROSURG S, V54, P211, DOI 10.3340/jkns.2013.54.3.211; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Wei CW, 2010, CAN J NEUROL SCI, V37, P574, DOI 10.1017/S0317167100010726	17	6	6	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JAN	2016	140						85	90		10.1016/j.clineuro.2015.11.012			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DD7HI	WOS:000370093900014	26688502				2022-02-06	
J	Kline, T				Kline, Tori			Art Therapy for Individuals With Traumatic Brain Injury: A Comprehensive Neurorehabilitation-Informed Approach to Treatment	ART THERAPY			English	Article							REHABILITATION; PLASTICITY	I describe an approach to art therapy treatment for survivors of traumatic brain injury developed at a rehabilitation facility for adults that serves inpatient, outpatient, and long-term residential clients. This approach is based on a review of the literature on traumatic brain injury, comprehensive neurorehabilitation, brain plasticity, and art therapy, as well as personal experiences working with clients. There is a paucity of recent art therapy literature on working with this population, and given the continually advancing knowledge of the brain and its plastic qualities, attention to a framework for treatment is needed. The comprehensive neurorehabilitation art therapy treatment approach presented is tailored to accommodate clients' individualized presentations while following the goals and core guidelines of brain injury rehabilitation.	[Kline, Tori] ReMed, Paoli, PA USA		Kline, T (corresponding author), ReMed, Paoli, PA USA.	tkline711@gmail.com					Brain Injury Association of America, 2007, ESS BRAIN INJ GUID; Brain Injury Association of America, 2014, BRAIN INJ FACT SHEET; Centers for Disease Control and Prevention, 2014, TRAUMATIC BRAIN INJU; Chapman L., 2014, NEUROBIOLOGICALLY IN; Chen H., 2010, PM&R, V2, P306, DOI [10.1016/j.prmrj.2010.10.006, DOI 10.1016/J.PRMRJ.2010.10.006]; CHEYNEKING SE, 1990, ART PSYCHOTHER, V17, P69, DOI 10.1016/0197-4556(90)90042-O; Constantinidou F, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P549, DOI 10.1201/9781439849828-c18; Conti GE, 2009, OCCUP THER INT, V16, P171, DOI 10.1002/oti.279; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Garner RL, 1996, AM J ART THER, V34, P107; GERVIN AP, 1991, MUSIC THERAPY PERSPE, V9, P87, DOI DOI 10.1093/MTP/9.1.87; Jang SH, 2007, NEUROREHABILITATION, V22, P117; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Koehler R, 2011, COGNITIVE REHABILITATION THERAPY FOR TRAUMATIC BRAIN INJURY: EVALUATING THE EVIDENCE, P1; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; Lazarus -Leff B., 2013, ART THERAPY J AM ART, V15, P120, DOI [10.1080/07421656.1989.10758723, DOI 10.1080/07421656.1989.10758723]; Lusebrink VB., 2004, ART THER, V21, P125, DOI [10.1080/07421656.2004.10129496, DOI 10.1080/07421656.2004.10129496]; Makuuchi M, 2003, COGNITIVE BRAIN RES, V16, P338, DOI 10.1016/S0926-6410(02)00302-6; Martin E., 2008, CREATIVE INTERVENTIO, P112; MCGRAW M, 1989, AM J ART THER, V28, P37; McGraw M., 1999, MED ART THERAPY ADUL, P25; Nayak S, 2000, REHABIL PSYCHOL, V45, P274, DOI 10.1037/0090-5550.45.3.274; Perna R., 2004, J COGNITIVE REHABILI, V22, P20; Perruzza N, 2010, BRIT J OCCUP THER, V73, P261, DOI 10.4276/030802210X12759925468943; Peters S., 2015, FAILURE ENGAGE CRITI; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Reynolds F, 2003, DISABIL REHABIL, V25, P785, DOI 10.1080/0963828031000093486; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Sell M., 2006, ALTERN THER HEALTH M, P29; Stepankova H, 2014, DEV PSYCHOL, V50, P1049, DOI 10.1037/a0034913; Symons J, 2011, BRIT J OCCUP THER, V74, P44, DOI 10.4276/030802211X12947686093729; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Wald J., 1989, ADV ART THERAPY; Wald J., 1999, MED ART THERAPY ADUL, P25; Weinberg D.J, 1985, ART THERAPY J AM ART, V3, P66, DOI [10.1080/07421656.1985.10758788, DOI 10.1080/07421656.1985.10758788]; Westlake KP, 2013, J HAND THER, V26, P87, DOI 10.1016/j.jht.2012.12.009	36	6	6	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0742-1656	2159-9394		ART THER	Art Ther.		2016	33	2					67	73		10.1080/07421656.2016.1164002			7	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	DN4JY	WOS:000377033300003					2022-02-06	
J	Kolomeyer, AM; Kodat, S				Kolomeyer, Anton M.; Kodat, Shyam			Lamotrigine-induced tubulointerstitial nephritis and uveitis-atypical Cogan syndrome	EUROPEAN JOURNAL OF OPHTHALMOLOGY			English	Article						Atypical Cogan syndrome; Lamotrigine; TINU; Tubulointerstitial nephritis and uveitis		Purpose: To report a case of lamotrigine-induced tubulointerstitial nephritis and uveitis (TINU)-atypical Cogan syndrome. Methods: Case report. Results: A 16-year-old boy with traumatic brain injury and seizures presented to the emergency department with facial swelling, rash, and back pain several days after increasing lamotrigine dose secondary to a breakthrough seizure. Creatinine, urine beta 2 microglobulin, and eosinophils were elevated. Antinuclear antibodies, antineutrophil cytoplasmic antibodies, angiotensin-converting enzyme, and complement were normal. Renal biopsy showed acute granulomatous tubulointerstitial nephritis. Lamotrigine was discontinued, intravenous steroids were initiated, and the patient was discharged on Ativan and prednisone. Subsequently, he was diagnosed with bilateral anterior uveitis (vision 20/30 bilaterally) and started on prednisolone and cyclopentolate. Two months later, he developed a branch retinal artery occlusion in the right eye (vision 20/70) and bilateral ocular hypertension for which timolol-brimonidine and dorzolamide were added. Neuroimaging and hypercoagulability workup was unremarkable. Vision and intraocular pressure improved, while uveitis remained recalcitrant. Several months later, the patient developed central serous retinopathy in the right eye (vision 20/30). Prednisone was stopped but restarted due to methotrexate intolerance. A month later, he reported dizziness and was diagnosed with severe bilateral sensorineural hearing loss. Brain magnetic resonance imaging showed foci of perivascular, subcortical, and cochlear enhancement. Transtympanic Decadron injections and infliximab infusions were initiated. At the final visit, vision remained at 20/30 with trace anterior chamber reaction bilaterally while on timolol-brimonidine, dorzolamide, and prednisolone. Conclusions: An idiosyncratic drug reaction should be considered in the differential diagnosis of TINU-atypical Cogan syndrome.	[Kolomeyer, Anton M.; Kodat, Shyam] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15213 USA		Kodat, S (corresponding author), Univ Pittsburgh Med Ctr, Eye & Ear Inst, 203 Lothrop St, Pittsburgh, PA 15213 USA.	kodatism2@upmc.edu					Blaszczyk B, 2015, PHARMACOL REP, V67, P426, DOI 10.1016/j.pharep.2014.11.009; Brogan K, 2012, RHEUMATOLOGY, V51, P950, DOI 10.1093/rheumatology/ker443; Espinoza GM, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0499-y; Fervenza FC, 2000, AM J KIDNEY DIS, V36, P1034; Grasland A, 2004, RHEUMATOLOGY, V43, P1007, DOI 10.1093/rheumatology/keh228; Mandeville JTH, 2001, SURV OPHTHALMOL, V46, P195, DOI 10.1016/S0039-6257(01)00261-2; Navarro JF, 1997, NEPHROL DIAL TRANSPL, V12, P781, DOI 10.1093/ndt/12.4.781	7	6	6	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1120-6721	1724-6016		EUR J OPHTHALMOL	Eur. J. Ophthalmol.	JAN-FEB	2016	26	1					E14	E16		10.5301/ejo.5000674			3	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	DG7IQ	WOS:000372258400025	26350991				2022-02-06	
J	Kuczawski, M; Stevenson, M; Goodacre, S; Teare, MD; Ramlakhan, S; Morris, F; Mason, S				Kuczawski, Maxine; Stevenson, Matt; Goodacre, Steve; Teare, M. Dawn; Ramlakhan, Shammi; Morris, Francis; Mason, Suzanne			Should all anticoagulated patients with head injury receive a CT scan? Decision-analysis modelling of an observational cohort	BMJ OPEN			English	Article							DIAGNOSTIC MANAGEMENT STRATEGIES; TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; COST-EFFECTIVENESS; WARFARIN; RULE; PHARMACOGENETICS; ADULTS	Objectives: It is not currently clear whether all anticoagulated patients with a head injury should receive CT scanning or only those with evidence of traumatic brain injury (eg, loss of consciousness or amnesia). We aimed to determine the cost-effectiveness of CT for all compared with selective CT use for anticoagulated patients with a head injury. Design: Decision-analysis modelling of data from a multicentre observational study. Setting: 33 emergency departments in England and Scotland. Participants: 3566 adults (aged >= 16 years) who had suffered blunt head injury, were taking warfarin and underwent selective CT scanning. Main outcome measures: Estimated expected benefits in terms of quality-adjusted life years (QALYs) were the entire cohort to receive a CT scan; estimated increased costs of CT and also the potential cost implications associated with patient survival and improved health. These values were used to estimate the cost per QALY of implementing a strategy of CT for all patients compared with observed practice based on guidelines recommending selective CT use. Results: Of the 1420 of 3534 patients (40%) who did not receive a CT scan, 7 (0.5%) suffered a potentially avoidable head injury-related adverse outcome. If CT scanning had been performed in all patients, appropriate treatment could have gained 3.41 additional QALYs but would have incurred 193 pound 149 additional treatment costs and 130 pound 683 additional CT costs. The incremental cost-effectiveness ratio of 94 pound 895/QALY gained for unselective compared with selective CT use is markedly above the threshold of 20-30 pound 000/QALY used by the UK National Institute for Care Excellence to determine cost-effectiveness. Conclusions: CT scanning for all anticoagulated patients with head injury is not cost-effective compared with selective use of CT scanning based on guidelines recommending scanning only for those with evidence of traumatic brain injury.	[Kuczawski, Maxine; Stevenson, Matt; Goodacre, Steve; Teare, M. Dawn; Mason, Suzanne] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Ramlakhan, Shammi; Morris, Francis] Northern Gen Hosp, Emergency Dept, Sheffield, S Yorkshire, England		Mason, S (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.	s.mason@sheffield.ac.uk	Ramlakhan, Shammi/ABD-5794-2020	Ramlakhan, Shammi/0000-0003-1792-0842; Teare, Marion Dawn/0000-0003-3994-0051; Kuczawski, Maxine/0000-0002-0774-8113; Mason, Suzanne/0000-0002-1701-0577	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) ProgrammeNational Institute for Health Research (NIHR) [PB-PG-0808-17148]; Sheffield Teaching Hospitals NHS Foundation Trust [STH15705]	This paper presents independent research commissioned by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme grant reference number PB-PG-0808-17148. This work is sponsored by Sheffield Teaching Hospitals NHS Foundation Trust, reference number STH15705.	Ara R, 2010, VALUE HEALTH, V13, P509, DOI 10.1111/j.1524-4733.2010.00700.x; Curtis L., 2015, UNIT COSTS HLTH SOCI; Department of Health, 2015, NAT SCHED REF COSTS; Ferrera PC, 1999, AM J EMERG MED, V17, P154, DOI 10.1016/S0735-6757(99)90050-5; HART RG, 1995, STROKE, V26, P1471, DOI 10.1161/01.STR.26.8.1471; Holmes MW, 2012, INJURY, V43, P1423, DOI 10.1016/j.injury.2011.07.017; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kamali F, 2006, BRIT J CLIN PHARMACO, V61, P746, DOI 10.1111/j.1365-2125.2006.02679.x; Leiblich A, 2011, EMERG MED J, V28, P115, DOI 10.1136/emj.2009.079442; Li J, 2012, ANN EMERG MED, V59, P457, DOI 10.1016/j.annemergmed.2012.01.010; MATHIESEN T, 1995, ACTA NEUROL SCAND, V91, P208; Melnick ER, 2015, JT COMM J QUAL PATIE, V41, P313, DOI 10.1016/S1553-7250(15)41041-4; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence, 2007, HEAD INJ TRIAG ASS I; National Institute for Health and Care Excellence, 2014, HEAD INJ TRIAG ASS I; Office for National Statistics, 2014, NAT LIF TABL 2010 20; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Volans AP, 1998, J ACCID EMERG MED, V15, P159; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wadelius M, 2007, PHARMACOGENOMICS J, V7, P99, DOI 10.1038/sj.tpj.6500417; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	26	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	12							e013742	10.1136/bmjopen-2016-013742			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG8JS	WOS:000391303600079	27974370	Green Accepted, gold, Green Published			2022-02-06	
J	Martinez, S; Davalos, D				Martinez, Sarah; Davalos, Deana			Investigating metacognition, cognition, and behavioral deficits of college students with acute traumatic brain injuries	JOURNAL OF AMERICAN COLLEGE HEALTH			English	Article						Academic success; cognitive health; college students; concussions; traumatic brain injuries	SELF-AWARENESS; EXECUTIVE FUNCTION; SYMPTOMS; ATTENTION; RECOVERY; CHILDREN	Objective: Executive dysfunction in college students who have had an acute traumatic brain injury (TBI) was investigated. The cognitive, behavioral, and metacognitive effects on college students who endorsed experiencing a brain injury were specifically explored. Participants: Participants were 121 college students who endorsed a mild TBI, and 121 college students with no history of a TBI were matched on sex and ethnicity to examine potential differences between groups. Methods: Participants completed the Dysexecutive Questionnaire (DEX). Results: A Rasch analysis indicated that the TBI group had significantly higher total scores on the DEX than the control group. Moreover, when compared with the control group, the students with a TBI had higher scores on all 3 subcomponents of the DEX. Conclusion: These findings suggest that students who endorse brain injuries may experience more difficulty with specific facets of college. Thus, the importance of academic and personal resources available for students with a TBI is discussed.	[Martinez, Sarah; Davalos, Deana] Colorado State Univ, Dept Psychol, 1876 Campus Delivery, Ft Collins, CO 80523 USA		Davalos, D (corresponding author), Colorado State Univ, Dept Psychol, 1876 Campus Delivery, Ft Collins, CO 80523 USA.	Deana.Davalos@ColoState.Edu	Davalos, Deana/ABB-6630-2021				Amieva H, 2003, BRAIN COGNITION, V53, P129, DOI 10.1016/S0278-2626(03)00094-0; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Ardila A., 2013, J NEUROLOGICAL DISOR, V1, P114, DOI [10.4172/2329-6895.1000114, DOI 10.4172/2329-6895.1000114]; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Dunlosky J., 2005, COGNITIVE TECHNOLOGY, V10, P4; Gerstorf D, 2008, AGING NEUROPSYCHOL C, V15, P424, DOI 10.1080/13825580701640374; Getzel E, 2006, GOING COLL, P139; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Hanna-Pladdy B, 2007, J Neurol Phys Ther, V31, P119; Hollingworth R. W., 2001, Australian Journal of Educational Technology, V17, P50; Hux K, 2010, BRAIN INJURY, V24, P13, DOI 10.3109/02699050903446823; Johnson JK, 2007, J GERONTOL A-BIOL, V62, P1134, DOI 10.1093/gerona/62.10.1134; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Mack J, 2013, J NEUROPSYCH CLIN N, V25, P141, DOI 10.1176/appi.neuropsych.12030076; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; MOWBRAY CT, 1993, PSYCHOSOC REHABIL, V17, P129, DOI DOI 10.1037/H0095619; Pa J, 2009, ANN NEUROL, V65, P414, DOI 10.1002/ana.21591; Pangilinan PH, CLASSIFICATION COMPL; Roy A, 2015, J CLIN EXP NEUROPSYC, V37, P956, DOI 10.1080/13803395.2015.1072138; Schmitter-Edgecombe M, 2012, J CLIN EXP NEUROPSYC, V34, P256, DOI 10.1080/13803395.2011.633497; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Struss D., 2011, NEUROLOGY, V24, P548; Tavano A, 2014, BRAIN INJURY, V28, P900, DOI 10.3109/02699052.2014.890742; Wagner M., 2005, HIGH SCH 1 LOOK POST, V2; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; YEATES G, 2008, NEUROPSYCHOANALYSIS, V10, P43; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	33	6	8	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0744-8481	1940-3208		J AM COLL HEALTH	J. Am. Coll. Health		2016	64	5					390	396		10.1080/07448481.2016.1167057			7	Education & Educational Research; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Education & Educational Research; Public, Environmental & Occupational Health	DT3FT	WOS:000381367000005	27007810				2022-02-06	
J	Mazlan, M; Ghani, SZSA; Tan, KF; Subramanian, P				Mazlan, Mazlina; Ghani, Sharifah Zarina Syed Abd; Tan, King-Fang; Subramanian, Pathmawathi			Life satisfaction and strain among informal caregivers of patients with traumatic brain injury in Malaysia	DISABILITY AND REHABILITATION			English	Article						Burden; caregivers; life satisfaction; rehabilitation; strain; traumatic brain injury	FAMILY CAREGIVERS; MENTAL-HEALTH; SOCIAL SUPPORT; BURDEN; INDIVIDUALS; PREDICTORS; OUTCOMES; CARERS; STRESS; STROKE	Purpose: This study aims to determine the life satisfaction and strain on informal caregivers when caring for traumatic brain injury (TBI) patients and to examine the factors predicting the level of strain among the informal caregivers. Method: A cross-sectional survey on a purposive sampling was performed in a single centre in Malaysia recruiting caregivers of patients with TBI. Life Satisfaction Questionnaire-9 and Caregiver Strain Index questionnaires were used to ascertain the life satisfaction and strain of caregivers respectively. Relationship between life satisfaction and strain was analysed, together with factors significantly associated with strain. Results: A total of 141 caregivers (77.3% women, average age of 46.1 years +/- 12.8 and mean duration of caregiving of 24.8 months +/- 14.3) were included in the analysis. Most caregivers (75%) were satisfied with their lives but more than half claimed to have strain (57%). There was a significant relationship between life satisfaction and strain among the caregivers (p < 0.001). From a multiple linear regression analysis, a caregiver's monthly income of less than RM3000 (OR 6.48, 95% CI 1.48-28.40, p = 0.04), presence of patient's neurobehavioural disturbances (OR 4.48, 95% CI 1.60-12.55, p = 0.004) and cognitive dysfunctions (OR 31.72, 95% CI 10.27-97.96, p < 0.001) were significant predictors of caregiver's strain. Conclusion: Caregivers with lower monthly income and caring for TBI patients with cognitive and neurobehavioural disturbances are at higher risk of developing strain. Rehabilitation interventions post-discharge should aim at supporting the caregivers at risk. IMPLICATIONS FOR REHABILITATION Informal caregivers of patients with traumatic brain injury who are not satisfied with their lives are most likely experiencing strain. Caregivers in Malaysia who are at high risk of experiencing strain are those with lower monthly income and care for patients with significant cognitive and neurobehavioural disturbances. Efforts to reduce strain in caregivers at risk should be included in the post-discharge rehabilitation programme in Malaysia.	[Mazlan, Mazlina] Univ Malaya, Dept Rehabil Med, Fac Med, Kuala Lumpur, Malaysia; [Ghani, Sharifah Zarina Syed Abd; Subramanian, Pathmawathi] Univ Malaya, Dept Nursing Sci, Fac Med, Kuala Lumpur, Malaysia; [Tan, King-Fang] Kolej Sains Kesihatan Bersekutu Sultan Azlan Shah, Ulu Kinta, Perak, Malaysia; [Tan, King-Fang] Univ Sci, Biostat & Res Methodol Unit, Fac Med Sci, George Town, Malaysia		Mazlan, M (corresponding author), Univ Malaya, Dept Rehabil Med, Med Ctr, Fac Med, 12th Floor,Menara Selatan, Kuala Lumpur 50603, Malaysia.	drmazlina@gmail.com	Tan, Fang/AAD-7039-2020; Mazlan, Mazlina/A-1015-2011; MAZLAN, MAZLINA/Y-9327-2019	Mazlan, Mazlina/0000-0002-4012-1873; 	University of MalayaUniversiti Malaya [P0033 2013A]	This study was supported in part by the postgraduate research fund from University of Malaya awarded to one of the authors, MM (No. P0033 2013A). The investigators had full access to the data, and the final responsibility for the decision to submit the manuscript for publication, statistical support and data analysis.	Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Boonstra AM, 2012, INT J REHABIL RES, V35, P153, DOI 10.1097/MRR.0b013e328352ab28; BRODATY H, 1990, AUST NZ J PSYCHIAT, V24, P351, DOI 10.3109/00048679009077702; Canadian Caregiver Coalition, 2008, FRAM CAN CAR STRAT; Choi H, 2011, ASIA PAC J SOC WORK, V21, P5, DOI 10.1080/21650993.2011.9756103; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Department of Social Welfare Malaysia, 2013, FIN ASS SCHEM PWDS; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Economic Planning Unit, 2013, 11 MAL PLAN 2016 202; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Family Caregiver Alliance, 2012, FCA FAM CAR ALL NAT; Geurtsen GJ, 2011, BRAIN INJURY, V25, P691, DOI 10.3109/02699052.2011.574675; Harding R, 2015, J PAIN SYMPTOM MANAG; Hejazi SMA, 2015, SINGAP MED J, V56, P116, DOI 10.11622/smedj.2015025; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Leibach GG, 2014, NEUROREHABILITATION, V34, P167, DOI 10.3233/NRE-131013; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Merican M I, 2004, Med J Malaysia, V59, P84; Mitnick S, 2010, J GEN INTERN MED, V25, P255, DOI 10.1007/s11606-009-1206-3; Paget A, 2016, DISABIL REHABIL, V38, P223, DOI 10.3109/09638288.2015.1035458; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rehabilitation Measures Database, 2013, REH MEAS LIF SAT QUE; Rehabilitation Measures Database, 2013, REH MEAS CAR STRAIN; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Samartkit N, 2010, PAC RIM INT J NURS R, V14, P297; Stevens LF, 2013, AM J PHYS MED REHAB, V92, P959, DOI 10.1097/PHM.0b013e31828cd549; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; van Exel NJA, 2004, CLIN REHABIL, V18, P203, DOI 10.1191/0269215504cr723oa; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Visser-Meily A, 2008, PATIENT EDUC COUNS, V73, P153, DOI 10.1016/j.pec.2008.03.011; Watanabe Y, 2001, DISABIL REHABIL, V23, P370	41	6	6	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2016	38	22					2198	2205		10.3109/09638288.2015.1123307			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DU1AI	WOS:000381936700005	26731553				2022-02-06	
J	Mohseni, S; Bellander, BM; Riddez, L; Talving, P; Thelin, EP				Mohseni, Shahin; Bellander, Bo-Michael; Riddez, Louis; Talving, Peep; Thelin, Eric P.			Positive blood alcohol level in severe traumatic brain injury is associated with better long-term functional outcome	BRAIN INJURY			English	Article						Traumatic brain injury; beta-blockade; functional outcome	GLASGOW COMA SCALE; HEAD-INJURY; ETHANOL; INTOXICATION; CONSUMPTION; MORTALITY; SCORE; CLASSIFICATION; DYSFUNCTION; TOMOGRAPHY	Objective: To investigate the association between positive blood alcohol level (BAL) and functional outcome in patients suffering severe traumatic brain injury.Study design: The brain trauma registry of an academic trauma centre was queried for patients admitted between January 2007 and December 2011. All patients ( 18 years) with a neurosurgical intensive care length of stay beyond 2 days were included. Patient demographics, clinical characteristics, injury profile, laboratory test and outcomes were abstracted for analysis. Primary outcome was unfavourable functional outcome defined as Glasgow Outcome Score (GOS) 3. Multivariable regression models were used for analysis.Results: Of the 352 patients, 39% were BAL (+) at admission. Patients with (+) BAL were significantly younger with less co-morbidities. The cohorts exhibited no significant difference in the severity of the intra-cranial injury and the use of intra-cranial monitoring or surgical interventions. Further, the groups presented no difference in in-hospital mortality (p = 0.1) or 1-year mortality (p = 0.5). There was a worse long-term functional outcome in (-) BAL patients compared to their BAL (+) counterparts after adjustment for confounders (GOS 3: AOR = 2.0, 95% CI = 1.1-3.5, p = 0.02).Conclusion: Positive BAL on admission is associated with a better long-term functional outcome in patients suffering severe traumatic brain injury.	[Mohseni, Shahin; Riddez, Louis] Karolinska Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, Stockholm, Sweden; [Mohseni, Shahin] Orebro Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, Orebro, Sweden; [Bellander, Bo-Michael; Thelin, Eric P.] Karolinska Inst, Neurosurg Sect, Dept Clin Neurosci, Stockholm, Sweden; [Talving, Peep] Tartu Univ Hosp, Dept Surg, Tartu, Estonia		Mohseni, S (corresponding author), Orebro Univ Hosp, Dept Surg, S-70185 Orebro, Sweden.; Mohseni, S (corresponding author), Univ Orebro, S-70185 Orebro, Sweden.	mohsenishahin@yahoo.com	Thelin, Eric Peter/K-2144-2012	Thelin, Eric Peter/0000-0002-2338-4364			Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; Cebere A, 2003, NEUROCHEM RES, V28, P1193, DOI 10.1023/A:1024228412198; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coons SJ, 2000, PHARMACOECONOMICS, V17, P13, DOI 10.2165/00019053-200017010-00002; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; GULYA K, 1991, BRAIN RES, V547, P129; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hadjibashi AA, 2012, J SURG RES, V173, P212, DOI 10.1016/j.jss.2011.05.029; Hsieh CH, 2013, AM SURGEON, V79, P1289; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Kanbak G, 2013, GENE, V512, P492, DOI 10.1016/j.gene.2012.10.012; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kelm MK, 2011, BRAIN RES REV, V65, P113, DOI 10.1016/j.brainresrev.2010.09.003; KIM K, 1995, ACCIDENT ANAL PREV, V27, P469, DOI 10.1016/0001-4575(95)00001-G; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Pouw ME, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5913; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Vaagenes IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120356; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275	44	6	6	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1256	1260		10.1080/02699052.2016.1183823			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300014	27389876				2022-02-06	
J	Mollayeva, T; Mollayeva, S; Lewko, J; Colantonio, A				Mollayeva, Tatyana; Mollayeva, Shirin; Lewko, John; Colantonio, Angela			Sex differences in work-related traumatic brain injury due to assault	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Traumatic brain injury; workplace; assault; occupation; epidemiology	WORKPLACE-VIOLENCE; HEALTH; CONSEQUENCES; EPIDEMIOLOGY; ACCIDENT; RISK	OBJECTIVES: To examine the etiology, prevalence and severity of assault-precipitated work-related traumatic brain injury (wrTBI) in Ontario, Canada through a sex lens. METHODS: Cross-sectional study using data abstracted from the Ontario Workplace Safety and Insurance Board (WSIB) claims files in 2004. Descriptive analyses were conducted to determine the distribution of worker/employment/incident characteristics. RESULTS: Workplace physical violence that resulted in a TBI accounted for 6.6% percent of all TBI injury claims. Female workers, primarily in the health care/social services sector, accounted for over half of all TBIs. Most workers were assaulted by consumers/clients. Forty five percent of injuries occurred among workers with less than 3 years of employment. CONCLUSIONS: This paper identifies profiles of workers and workplaces for targeted preventive efforts. Future studies are needed to further address risk factors by sex and outcomes, such as length of disability and health care cost.	[Mollayeva, Tatyana] Univ Toronto, Fac Med, Rehabil Sci Inst, Toronto, ON M5S 1A1, Canada; [Mollayeva, Tatyana] Univ Toronto, Collaborat Program Neurosci, Toronto, ON M5S 1A1, Canada; [Mollayeva, Tatyana] Toronto Rehab Univ Hlth Network, Toronto, ON, Canada; [Mollayeva, Shirin] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada; [Mollayeva, Shirin; Colantonio, Angela] Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON M5S 1A1, Canada; [Lewko, John] Laurentian Univ, Ctr Res Human Dev Humanities & Social Sci, Sudbury, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5S 1A1, Canada		Mollayeva, T (corresponding author), Toronto Rehabil Inst, 550 Univ Ave,Rm 11207, Toronto, ON M5G 2A2, Canada.	tatyana.mollayeva@utoronto.ca	, Mollayeva/A-4522-2018	Colantonio, Angela/0000-0003-2094-4765; Mollayeva, Shirin/0000-0001-9612-8655	Toronto Rehabilitation Institute Scholarship; Ontario Graduate ScholarshipOntario Graduate Scholarship; Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Ontario Work Study Program; Ontario Neurotrauma Foundation; CIHR Canadian Traumatic Brain Injury and Violence Research TeamCanadian Institutes of Health Research (CIHR); Saunderson Family Chair in Acquired Brain Injury Research; Canadian Institutes for Health Research Grant-Institute for Gender and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]	The first author was supported by the 2012/2013 Toronto Rehabilitation Institute Scholarship, the Ontario Graduate Scholarship 2012/2013 and the 2013/2015 Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health Research. Support was also provided through the Ontario Work Study Program, the Ontario Neurotrauma Foundation, and the CIHR Canadian Traumatic Brain Injury and Violence Research Team. Dr. Colantonio was supported by the Saunderson Family Chair in Acquired Brain Injury Research and the Canadian Institutes for Health Research Grant-Institute for Gender and Health (#CGW-126580).	Anderson Cheryl, 2002, Issues Ment Health Nurs, V23, P351, DOI 10.1080/01612840290052569; [Anonymous], STAT CAN EMPL AG SEX; [Anonymous], WORKPL VIOL PROT SAM; Barling JA, 2011, J OCCUP HEALTH PSYCH, V6, P255; Bowie V., 2002, WORKPLACE VIOLENCE; Bowman C., 2005, BEHAV HLTH MANAGEMEN, V25, P38; Breslin C., 2003, OCCUP ENVIRON MED, V60, P1; Breslin FC, 2005, AM J IND MED, V48, P50, DOI 10.1002/ajim.20185; Canton Allison N, 2009, Home Healthc Nurse, V27, P364, DOI 10.1097/01.NHH.0000356828.27090.bd; Caskey C R, 2001, Clin Lab Sci, V14, P95; Colantonio A, 2012, WORK, V43, P195, DOI 10.3233/WOR-2012-1377; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Downing A, 2003, EMERG MED J, V20, P434, DOI 10.1136/emj.20.5.434; ELOVIC E, 1996, MED REHABILITATION T, P1; Gallant-Roman MA, 2008, AAOHN J, V56, P449, DOI 10.3928/08910162-20081101-04; Gerberich SG, 2004, OCCUP ENVIRON MED, V61, P495, DOI 10.1136/oem.2003.007294; Gielen A, 2001, INTEGRATING BEHAV SO, P203; Hartley D, 2012, WORK, V42, P125, DOI 10.3233/WOR-2012-1328; Hodgson MJ, 2004, J OCCUP ENVIRON MED, V46, P1158, DOI 10.1097/01.jom.0000141658.91805.47; Islam SS, 2003, AM J PREV MED, V25, P31, DOI 10.1016/S0749-3797(03)00095-3; Ito S, 2014, WORK, V49, P225, DOI 10.3233/WOR-131656; Kim H, 2006, NEUROREHABILITATION, V21, P269; Kim H, 2008, J TRAUMA, V65, P1287, DOI 10.1097/TA.0b013e31817196f5; LEATHER P, 1999, WORKRELATED VIOLENCE; Lehmann LS, 1999, PSYCHIATR SERV, V50, P384, DOI 10.1176/ps.50.3.384; Leino T, 2011, IND HEALTH, V49, P143, DOI 10.2486/indhealth.MS1208; Lindquist CH, 2013, J INTERPERS VIOLENCE, V28, P2437, DOI 10.1177/0886260513479032; Macdonald G, 2005, INT SOC WORK, V48, P772, DOI 10.1177/0020872805057087; Mar J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-46; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McAlister TW, 2011, TXB TRAUMATIC BRAIN; McCall BP, 2004, J OCCUP ENVIRON MED, V46, P357, DOI 10.1097/01.jom.0000121131.34757.ed; Myers Douglas, 2005, AAOHN J, V53, P489; Nachreiner NM, 2012, WORK, V42, P39, DOI 10.3233/WOR-2012-1331; Neuman JH, 1998, J MANAGE, V24, P391, DOI 10.1177/014920639802400305; Peek-Asa C, 1999, J OCCUP ENVIRON MED, V41, P647, DOI 10.1097/00043764-199908000-00006; Piquero NL, 2013, AGGRESS VIOLENT BEH, V18, P383, DOI 10.1016/j.avb.2013.03.001; Rona RJ, 2012, BRIT J PSYCHIAT, V201, P172, DOI 10.1192/bjp.bp.112.111492; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shepherd JP, 1998, J ACCID EMERG MED, V15, P39; Short D, 1999, JEMS, V24, P68; Short D, 1999, JEMS, V24, P72; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Swaen GMH, 2003, OCCUP ENVIRON MED, V60, P88; Taeed G, 2014, NEUROPSYCHOL REHABIL, P1; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; Vidal-Marti C, 2014, TESTOR CP PATIENT AS; Wei Chia, 2012, Minn Med, V95, P55; Williams M F, 1996, AAOHN J, V44, P73; Workplace Safety and Insurance Board of Ontario, 2012, MILD TRAUM BRAIN INJ; Workplace Safety and Insurance Boards (WSIB), 2005, 2005 ANN REP; Wright J, 1997, J ROY SOC MED, V90, P322, DOI 10.1177/014107689709000608; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008	56	6	6	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2016	54	2					415	423		10.3233/WOR-162339			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DS9RM	WOS:000381121000016	27315416				2022-02-06	
J	Naylor, JC; Kilts, JD; Strauss, JL; Szabo, ST; Dunn, CE; Wagner, HR; Hamer, RM; Shampine, LJ; Zanga, JR; Marx, CE				Naylor, Jennifer C.; Kilts, Jason D.; Strauss, Jennifer L.; Szabo, Steven T.; Dunn, Charlotte E.; Wagner, H. Ryan; Hamer, Robert M.; Shampine, Lawrence J.; Zanga, Joseph R.; Marx, Christine E.		Dept Vet Affairs Midatlantic Menta	An exploratory pilot investigation of neurosteroids and self-reported pain in female Iraq/Afghanistan-era Veterans	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						Afghanistan; back; biomarker; dehydroepiandrosterone; dehydroepiandrosterone sulfate; DHEA; DHEAS; female; Iraq; low back pain; neurosteroid; novel; pain; therapeutic; Veteran	TRAUMATIC BRAIN-INJURY; DEHYDROEPIANDROSTERONE-SULFATE; SEX-DIFFERENCES; TEMPOROMANDIBULAR DISORDERS; DEPRESSIVE SYMPTOMS; HIPPOCAMPAL-NEURONS; DHEA-SULFATE; IN-VITRO; WOMEN; MEN	Female Veterans are the most rapidly growing segment of new users of the Veterans Health Administration (VHA), and a significant proportion of female Veterans receiving treatment from VHA primary care providers report persistent pain symptoms. Currently, available data characterizing the neurobiological underpinnings of pain disorders are limited. Preclinical data suggest that neurosteroids may be involved in the modulation of pain symptoms, potentially via actions at gamma-aminobutyric acid (GABA) and N-methyl-D-aspartate (NMDA) receptors. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) are neurosteroids that modulate inhibitory GABA receptors and excitatory NMDA receptors, producing complex neuronal effects. Emerging evidence from male Iraq/Afghanistan-era Veterans suggests that reductions in neurosteroid levels are associated with increased pain symptoms and that neurosteroids may be promising biomarker candidates. The current exploratory study thus examined associations between self-reported pain symptoms in 403 female Iraq/Afghanistan-era Veterans and serum DHEAS and DHEA levels. Serum DHEAS levels were inversely correlated with low back pain in female Veterans (Spearman r = -0.103; p = 0.04). Nonparametric analyses indicate that female Veterans reporting moderate/extreme low back pain demonstrated significantly lower DHEAS levels than those reporting no/little low back pain (vertical bar Z vertical bar = 2.60; p = 0.009). These preliminary findings support a role for DHEAS in pain physiology of low back pain and the rationale for neurosteroid therapeutics in pain analgesia.	[Naylor, Jennifer C.; Kilts, Jason D.; Strauss, Jennifer L.; Szabo, Steven T.; Dunn, Charlotte E.; Wagner, H. Ryan; Shampine, Lawrence J.; Marx, Christine E.] Durham Dept Vet Affairs Med Ctr VAMC, Res & Dev Mental Hlth Serv, Durham, NC USA; [Naylor, Jennifer C.; Kilts, Jason D.; Strauss, Jennifer L.; Szabo, Steven T.; Dunn, Charlotte E.; Wagner, H. Ryan; Shampine, Lawrence J.; Marx, Christine E.] Durham VAMC, Vet Integrated Serv Network 6, Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Naylor, Jennifer C.; Kilts, Jason D.; Strauss, Jennifer L.; Szabo, Steven T.; Wagner, H. Ryan; Shampine, Lawrence J.; Marx, Christine E.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Hamer, Robert M.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Hamer, Robert M.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Zanga, Joseph R.] Durham VAMC, Ambulatory Care Serv Line, Durham, NC USA; [Zanga, Joseph R.] Durham VAMC, Mental Hlth Care Serv Line, Durham, NC USA		Marx, CE (corresponding author), Durham VA Med Ctr, 508 Fulton St, Durham, NC 27705 USA.	christine.marx@va.gov	Stevens, David/F-4683-2015		VA Career Development Transition Award; VA Merit Review AwardsUS Department of Veterans Affairs; VA MIRECC; VA Rehabilitation Research and Development Career Development Award [11K2RX000908]; Veterans AffairsUS Department of Veterans Affairs [IK2RX000908] Funding Source: NIH RePORTER	This material was based on work supported by a VA Career Development Transition Award (Dr. Marx), VA Merit Review Awards (Dr. Marx), and the VA MIRECC (Dr. Fairbank). Dr. Naylor is funded by a VA Rehabilitation Research and Development Career Development Award (11K2RX000908).	Aloisi AM, 2011, PSYCHONEUROENDOCRINO, V36, P1032, DOI 10.1016/j.psyneuen.2010.12.017; Altman R, 2008, VASC PHARMACOL, V48, P76, DOI 10.1016/j.vph.2007.12.002; Barrett-Connor E, 1999, J AM GERIATR SOC, V47, P685, DOI 10.1111/j.1532-5415.1999.tb01590.x; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Bergeron R, 1996, J NEUROSCI, V16, P1193; Bilmes L., 2007, P ALL SOC SCI ASS M; Brewer GJ, 2001, J NEUROSCI METH, V107, P15, DOI 10.1016/S0165-0270(01)00342-9; Cepeda MS, 2003, ANESTH ANALG, V97, P1464, DOI 10.1213/01.ANE.0000080153.36643.83; Choe MA, 2009, J KOREAN ACAD NURS, V39, P632, DOI 10.4040/jkan.2009.39.5.632; CORPECHOT C, 1981, P NATL ACAD SCI-BIOL, V78, P4704, DOI 10.1073/pnas.78.8.4704; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; CROOK J, 1984, PAIN, V18, P299, DOI 10.1016/0304-3959(84)90824-8; Daniell HW, 2006, J PAIN, V7, P901, DOI 10.1016/j.jpain.2006.04.011; Freitas RPD, 2012, J BACK MUSCULOSKELET, V25, P245, DOI 10.3233/BMR-2012-0331; Derogatis LR, 1994, SCL 90 R SYMPTOM CHE; Du CG, 2001, J IMMUNOL, V167, P7094, DOI 10.4049/jimmunol.167.12.7094; Edinger KL, 2004, BEHAV NEUROSCI, V118, P1352, DOI 10.1037/0735-7044.118.6.1352; Fillingim R B, 2000, Curr Rev Pain, V4, P24; Finset A, 2004, PSYCHONEUROENDOCRINO, V29, P49, DOI 10.1016/S0306-4530(02)00134-8; Fiore C, 2004, J NEUROSCI RES, V75, P391, DOI 10.1002/jnr.10821; Frye CA, 2001, COGN AFFECT BEHAV NE, V1, P371, DOI 10.3758/CABN.1.4.371; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Gasinska E, 2012, PHARMACOL REP, V64, P965; Genazzani A R, 2004, Aging Male, V7, P133; Genud R, 2009, NEUROPSYCHOPHARMACOL, V34, P577, DOI 10.1038/npp.2008.46; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Harding G, 2006, CYTOKINE, V36, P57, DOI 10.1016/j.cyto.2006.10.012; Haskell SG, 2012, CLIN J PAIN, V28, P163, DOI 10.1097/AJP.0b013e318223d951; Haskell SG, 2009, PAIN MED, V10, P1167, DOI 10.1111/j.1526-4637.2009.00714.x; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hoffman SW, 2003, J NEUROTRAUM, V20, P859, DOI 10.1089/089771503322385791; Juhasz-Vedres G, 2006, ENDOCRINOLOGY, V147, P683, DOI 10.1210/en.2005-0693; Karishma KK, 2002, EUR J NEUROSCI, V16, P445, DOI 10.1046/j.1460-9568.2002.02099.x; Kaur S, 2007, J GEN INTERN MED, V22, P228, DOI 10.1007/s11606-006-0048-5; Kibaly C, 2008, FASEB J, V22, P93, DOI 10.1096/fj.07-8930com; Kilts JD, 2010, PAIN MED, V11, P1469, DOI 10.1111/j.1526-4637.2010.00927.x; Kimonides VG, 1998, P NATL ACAD SCI USA, V95, P1852, DOI 10.1073/pnas.95.4.1852; Kurata K, 2004, J PHARMACOL EXP THER, V311, P237, DOI 10.1124/jpet.104.067629; LeResche L, 1997, CRIT REV ORAL BIOL M, V8, P291, DOI 10.1177/10454411970080030401; Li Z, 2009, J CEREBR BLOOD F MET, V29, P287, DOI 10.1038/jcbfm.2008.118; Lipton RB, 1998, CLIN NEUROSCI, V5, P2; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; Lur G, 2006, CELL MOL NEUROBIOL, V26, P1505, DOI 10.1007/s10571-006-9073-5; Marx CE, 2000, BRAIN RES, V871, P104, DOI 10.1016/S0006-8993(00)02452-5; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Morsink LFJ, 2007, PSYCHONEUROENDOCRINO, V32, P874, DOI 10.1016/j.psyneuen.2007.06.009; Paller CJ, 2009, PAIN MED, V10, P289, DOI 10.1111/j.1526-4637.2008.00558.x; Park-Chung M, 1999, BRAIN RES, V830, P72, DOI 10.1016/S0006-8993(99)01381-5; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Racine M, 2012, PAIN, V153, P619, DOI 10.1016/j.pain.2011.11.026; Rahmani A, 2013, ADV PHARMACOL SCI, V2013, DOI 10.1155/2013/506191; Rauhala K, 2000, CRANIO, V18, P40, DOI 10.1080/08869634.2000.11746112; REGELSON W, 1994, ANN NY ACAD SCI, V719, P553; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Ruau D, 2012, J PAIN, V13, P228, DOI 10.1016/j.jpain.2011.11.002; Schmidt PJ, 2005, ARCH GEN PSYCHIAT, V62, P154, DOI 10.1001/archpsyc.62.2.154; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Sinha Nupur, 2005, Indian Journal of Experimental Biology, V43, P420; Sripada RK, 2014, HUM BRAIN MAPP, V35, P3249, DOI 10.1002/hbm.22399; Sripada RK, 2013, NEUROPSYCHOPHARMACOL, V38, P1798, DOI 10.1038/npp.2013.79; Stavropoulos Franci, 2007, Oral Maxillofac Surg Clin North Am, V19, P245, DOI 10.1016/j.coms.2007.01.010; Straub RH, 1998, J CLIN ENDOCR METAB, V83, P2012, DOI 10.1210/jc.83.6.2012; Strous RD, 2003, ARCH GEN PSYCHIAT, V60, P133, DOI 10.1001/archpsyc.60.2.133; Tabuchi K, 2003, HEARING RES, V180, P51, DOI 10.1016/S0378-5955(03)00078-9; Tan XD, 2009, J NEUROIMMUNOL, V207, P39, DOI 10.1016/j.jneuroim.2008.11.011; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; VA Palo Alto Health Care System Women's Health Evaluation Initiative; U.S. Women Veterans Health Strategic Health Care Group, 2010, SOURC WOM VET VET HL, V1; Weimer MB, 2013, PAIN MED, V14, P1839, DOI 10.1111/pme.12177; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; Wong SYS, 2011, ASIAN J ANDROL, V13, P898, DOI 10.1038/aja.2011.116; Yamamotova A, 2012, NEUROENDOCRINOL LETT, V33, P401; Yoon SY, 2009, BRIT J PHARMACOL, V157, P666, DOI 10.1111/j.1476-5381.2009.00197.x; Zhao ZY, 2003, STEROIDS, V68, P133, DOI 10.1016/S0039-128X(02)00167-8	74	6	6	0	1	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	4					499	509		10.1682/JRRD.2014.11.0294			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DS7YY	WOS:000381000600009	27533747	gold			2022-02-06	
J	Pacurar, EE; Sethi, SK; Habib, C; Laze, MO; Martis-Laze, R; Haacke, EM				Pacurar, Emil E.; Sethi, Sean K.; Habib, Charbel; Laze, Marius O.; Martis-Laze, Rachel; Haacke, E. Mark			Database integration of protocol-specific neurological imaging datasets	NEUROIMAGE			English	Article							INTERNAL JUGULAR VEINS; CEREBROSPINAL VENOUS INSUFFICIENCY; MULTIPLE-SCLEROSIS PATIENTS; TRAUMATIC BRAIN-INJURY	For many years now, Magnetic Resonance Innovations (MR Innovations), a magnetic resonance imaging (MRI) software development, technology, and research company, has been aggregating a multitude of MRI data from different scanning sites through its collaborations and research contracts. The majority of the data has adhered to neuroimaging protocols developed by our group which has helped ensure its quality and consistency. The protocols involved include the study of: traumatic brain injury, extracranial venous imaging for multiple sclerosis and Parkinson's disease, and stroke. The database has proven invaluable in helping to establish disease bio-markers, validate findings across multiple data sets, develop and refine signal processing algorithms, and establish both public and private research collaborations. Myriad Masters and PhD dissertations have been possible thanks to the availability of this database. As an example of a project that cuts across diseases, we have used the data and specialized software to develop new guidelines for detecting cerebral microbleeds. Ultimately, the database has been vital in our ability to provide tools and information for researchers and radiologists in diagnosing their patients, and we encourage collaborations and welcome sharing of similar data in this database. (C) 2015 Elsevier Inc. All rights reserved.	[Pacurar, Emil E.; Sethi, Sean K.; Habib, Charbel; Laze, Marius O.; Martis-Laze, Rachel; Haacke, E. Mark] Magnet Resonance Innovat Inc, Detroit, MI 48202 USA; [Pacurar, Emil E.; Sethi, Sean K.; Martis-Laze, Rachel; Haacke, E. Mark] MRI Inst Biomed Res, Detroit, MI USA; [Habib, Charbel; Martis-Laze, Rachel; Haacke, E. Mark] Wayne State Univ, Dept Radiol, Detroit, MI USA		Sethi, SK (corresponding author), Magnet Resonance Innovat Inc, 440 East Ferry St, Detroit, MI 48202 USA.	sethisea@gmail.com		Martis-Laze, Rachel/0000-0001-8600-6240; Haacke, Mark/0000-0003-4965-7954; Habib, Charbel/0000-0002-5587-6320	National Heart, Lung, and Blood Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R42HL112580]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R42HL112580] Funding Source: NIH RePORTER	The research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number R42HL112580. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Dake MD, 2011, FUNCT NEUROL, V26, P181; DCoE Clinical Recommendation, 2013, NEUR FOLL MILD TRAUM; Feng W, 2012, NEUROL RES, V34, P802, DOI 10.1179/1743132812Y.0000000079; Feng W, 2012, REV RECENT CLIN TRIA, V7, P117, DOI 10.2174/157488712800100206; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Haacke E.M., 2015, AM SOC NEUR C; Haacke EM, 2012, REV RECENT CLIN TRIA, V7, P100, DOI 10.2174/157488712800100305; Haacke EM, 2012, J VASC INTERV RADIOL, V23, P60, DOI 10.1016/j.jvir.2011.09.027; Haacke EM, 2011, EXPERT REV NEUROTHER, V11, P5, DOI [10.1586/ern.10.174, 10.1586/ERN.10.174]; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Liu MJ, 2015, J VASC SURG, V61, P1511, DOI 10.1016/j.jvs.2014.02.021; Poldrack RA, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00012; Poline JB, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00009; Rahman MT, 2013, MAGN RESON IMAGING, V31, P1668, DOI 10.1016/j.mri.2013.05.012; Sethi SK, 2014, J NEUROIMAGING; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Utriainen D, 2012, NEUROL RES, V34, P780, DOI 10.1179/1743132812Y.0000000078; Utriainen D, 2012, TECH VASC INTERV RAD, V15, P101, DOI 10.1053/j.tvir.2012.02.003; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164	19	6	6	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JAN 1	2016	124		B		SI		1220	1224		10.1016/j.neuroimage.2015.04.066			5	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CY1FB	WOS:000366151000027	25959660	Green Accepted			2022-02-06	
J	Raman, S; Ray, S; Peters, MJ				Raman, Sainath; Ray, Samiran; Peters, Mark J.			Survey of Oxygen Delivery Practices in UK Paediatric Intensive Care Units	CRITICAL CARE RESEARCH AND PRACTICE			English	Article							CRITICALLY-ILL; VENTILATED PATIENTS; HYPEROXIA; MULTICENTER; TARGETS	Purpose. Administration of supplemental oxygen is common in paediatric intensive care. We explored the current practice of oxygen administration using a case vignette in paediatric intensive care units (PICU) in the united kingdom. Methods. We conducted an online survey of Paediatric Intensive Care Society members in the UK. The survey outlined a clinical scenario followed by questions on oxygenation targets for 5 common diagnoses seen in critically ill children. Results. Fifty-three paediatric intensive care unit members from 10 institutions completed the survey. In a child with moderate ventilatory requirements, 21 respondents (42%) did not follow arterial partial pressure of oxygen (PaO2) targets. In acute respiratory distress syndrome, cardiac arrest, and sepsis, there was a trend to aim for lower PaO2 as the fraction of inspired oxygen (FiO(2)) increased. Conversely, in traumatic brain injury and pulmonary hypertension, respondents aimed for normal PaO2 even as the FiO(2) increased. Conclusions. In this sample of clinicians PaO2 targets were not commonly used. Clinicians target lower PaO2 as FiO(2) increases in acute respiratory distress syndrome, cardiac arrest, and sepsis whilst targeting normal range irrespective of FiO(2) in traumatic brain injury and pulmonary hypertension.	[Raman, Sainath] UCL, Inst Child Hlth, Resp Crit Care & Anaesthesia Grp, Infect Immun Inflammat & Physiol Med Programme, Great Ormond St, London WC1N 3JH, England; Great Ormond St Hosp Sick Children, Great Ormond St, London WC1N 3JH, England		Raman, S (corresponding author), UCL, Inst Child Hlth, Resp Crit Care & Anaesthesia Grp, Infect Immun Inflammat & Physiol Med Programme, Great Ormond St, London WC1N 3JH, England.	sainath.raman@ucl.ac.uk	Peters, Mark/AAD-7518-2019; Ray, Samiran/AAZ-4916-2020	Peters, Mark/0000-0003-3653-4808; Ray, Samiran/0000-0002-3738-4672; Raman, Sainath/0000-0002-0152-9980	HCA fellowship; Great Ormond Street Hospital Childrens Charity [V0417, V2216] Funding Source: researchfish	Dr. Raman is a holder of HCA fellowship.	Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; de Graaff AE, 2011, INTENS CARE MED, V37, P46, DOI 10.1007/s00134-010-2025-z; Eastwood GM, 2011, ANAESTH INTENS CARE, V39, P122, DOI 10.1177/0310057X1103900120; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0996-4; Leteurtre S, 2010, CAN MED ASSOC J, V182, P1181, DOI 10.1503/cmaj.081715; Magder S, 2006, CRIT CARE, V10, DOI 10.1186/cc3992; Network PICA, 2013, PICANET ANN REP 2013; Panwar R, 2016, AM J RESP CRIT CARE, V193, P43, DOI 10.1164/rccm.201505-1019OC; Santschi M, 2013, PEDIATR CRIT CARE ME, V14, pE332, DOI 10.1097/PCC.0b013e31828a89a2; Treacher DF, 1998, BRIT MED J, V317, P1302, DOI 10.1136/bmj.317.7168.1302; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Young P, 2014, RESUSCITATION, V85, P1686, DOI 10.1016/j.resuscitation.2014.09.011; Young PJ, 2015, CRIT CARE RESUSC, V17, P202	13	6	6	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-1305	2090-1313		CRIT CARE RES PRACT	Crit. Care Res. Pract.		2016	2016								UNSP 6312970	10.1155/2016/6312970			4	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	DS3XH	WOS:000380715500001	27516901	Green Published, gold, Green Submitted			2022-02-06	
S	Ratai, EM; Gonzalez, RG		Masdeu, JC; Gonzalez, RG		Ratai, Eva-Maria; Gonzalez, R. Gilberto			Clinical magnetic resonance spectroscopy of the central nervous system	NEUROIMAGING, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							PROTON MR SPECTROSCOPY; APPEARING WHITE-MATTER; TRAUMATIC BRAIN-INJURY; AUTOMATED SPECTRAL-ANALYSIS; TEMPORAL-LOBE EPILEPSY; IN-VIVO DETECTION; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; APPARENT DIFFUSION-COEFFICIENT; GAMMA-AMINOBUTYRIC-ACID; AIDS DEMENTIA COMPLEX	Proton magnetic resonance spectroscopy (1H MRS) is a noninvasive imaging technique that can easily be added to the conventional magnetic resonance (MR) imaging sequences. Using MRS one can directly compare spectra from pathologic or abnormal tissue and normal tissue. Metabolic changes arising from pathology that can be visualized by MRS may not be apparent from anatomy that can be visualized by conventional MR imaging. In addition, metabolic changes may precede anatomic changes. Thus, MRS is used for diagnostics, to observe disease progression, monitor therapeutic treatments, and to understand the pathogenesis of diseases. MRS may have an important impact on patient management. The purpose of this chapter is to provide practical guidance in the clinical application of MRS of the brain. This chapter provides an overview of MRS-detectable metabolites and their significance. In addition some specific current clinical applications of MRS will be discussed, including brain tumors, inborn errors of metabolism, leukodystrophies, ischemia, epilepsy, and neurodegenerative diseases. The chapter concludes with technical considerations and challenges of clinical MRS.	[Ratai, Eva-Maria] Massachusetts Gen Hosp, Dept Radiol, Div Neuroradiol, Boston, MA USA; [Ratai, Eva-Maria] Harvard Med Sch, Boston, MA USA; [Ratai, Eva-Maria] Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA		Ratai, EM (corresponding author), Bldg 149,13th St,Room 2301, Charlestown, MA 02129 USA.	ratai@nmr.mgh.harvard.edu					Achten E, 1997, AM J NEURORADIOL, V18, P1131; Achten E, 1998, AM J NEURORADIOL, V19, P1; Adalsteinsson E, 2000, LANCET, V355, P1696, DOI 10.1016/S0140-6736(00)02246-7; ALGER JR, 1993, J COMPUT ASSIST TOMO, V17, P191, DOI 10.1097/00004728-199303000-00006; Andronesi OC, 2012, RADIOLOGY, V262, P647, DOI 10.1148/radiol.11110277; Andronesi OC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002693; Andronesi OC, 2010, MAGN RESON MED, V64, P1542, DOI 10.1002/mrm.22535; ARNOLD DL, 1990, MAGNET RESON MED, V14, P154, DOI 10.1002/mrm.1910140115; ARNOLD DL, 1994, ANN NEUROL, V36, P76, DOI 10.1002/ana.410360115; ARNOLD DL, 1992, ANN NEUROL, V31, P235, DOI 10.1002/ana.410310302; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; BARKER PB, 1995, RADIOLOGY, V195, P58, DOI 10.1148/radiology.195.1.7892496; BARKER PB, 1993, NMR BIOMED, V6, P89, DOI 10.1002/nbm.1940060114; Barkovich AJ, 2001, AM J NEURORADIOL, V22, P1786; Bendszus M, 2000, AM J NEURORADIOL, V21, P375; Bertolino A, 2001, BIOL PSYCHIAT, V49, P39, DOI 10.1016/S0006-3223(00)00997-5; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; BLUSZTAJN JK, 1983, SCIENCE, V221, P614, DOI 10.1126/science.6867732; Boichot C, 2006, RADIOLOGY, V239, P839, DOI 10.1148/radiol.2393050027; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Braus DF, 2001, PHARMACOPSYCHIATRY, V34, P251, DOI 10.1055/s-2001-18037; BREITER SN, 1994, AM J NEURORADIOL, V15, P373; BRENNER RE, 1993, MAGNET RESON MED, V29, P737, DOI 10.1002/mrm.1910290605; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; BRUHN H, 1989, MAGNET RESON MED, V9, P126, DOI 10.1002/mrm.1910090115; Brulatout S, 1996, J NEUROCHEM, V66, P2491; Caruso PA, 2013, NEUROIMAG CLIN N AM, V23, P407, DOI 10.1016/j.nic.2012.12.012; Castillo M, 2000, AM J NEURORADIOL, V21, P1645; CASTILLO M, 1995, AM J NEURORADIOL, V16, P233; Cecil KM, 2006, NEUROIMAG CLIN N AM, V16, P87, DOI 10.1016/j.nic.2005.10.004; Cendes F, 1997, NEUROLOGY, V49, P1525, DOI 10.1212/WNL.49.6.1525; Cendes F, 1997, ANN NEUROL, V41, P74, DOI 10.1002/ana.410410113; CENDES F, 1993, NEUROLOGY, V43, P719, DOI 10.1212/WNL.43.4.719; CHAMULEAU RAFM, 1991, NMR BIOMED, V4, P103, DOI 10.1002/nbm.1940040213; Chang L, 2002, NEUROIMAGE, V17, P1638, DOI 10.1006/nimg.2002.1254; Chang L, 1999, NEUROLOGY, V53, P782, DOI 10.1212/WNL.53.4.782; Chang L, 2003, J CLIN PSYCHIAT, V64, P7; CHANG L, 1995, J NEUROIMAGING, V5, P157, DOI 10.1111/jon199553157; Cheng LL, 1997, P NATL ACAD SCI USA, V94, P6408, DOI 10.1073/pnas.94.12.6408; Cheng LL, 2002, MAGN RESON IMAGING, V20, P527, DOI 10.1016/S0730-725X(02)00512-X; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; CHONG WK, 1993, RADIOLOGY, V188, P119, DOI 10.1148/radiology.188.1.8099750; CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P107, DOI 10.1016/0730-725X(93)90418-D; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Cohen-Gadol AA, 2004, J NEUROSURG, V101, P613, DOI 10.3171/jns.2004.101.4.0613; Collins J G, 1990, Vital Health Stat 10, P1; CROSS JH, 1993, J INHERIT METAB DIS, V16, P800, DOI 10.1007/BF00711912; DAVIE CA, 1995, ANN NEUROL, V37, P204, DOI 10.1002/ana.410370211; DAVIE CA, 1994, BRAIN, V117, P49, DOI 10.1093/brain/117.1.49; Davies NP, 2010, NMR BIOMED, V23, P80, DOI 10.1002/nbm.1432; De Stefano N, 1998, BRAIN, V121, P1469, DOI 10.1093/brain/121.8.1469; De Stefano N, 2007, J NEUROIMAGING, V17, p31S, DOI 10.1111/j.1552-6569.2007.00134.x; Demougeot C, 2004, J NEUROCHEM, V90, P776, DOI 10.1111/j.1471-4159.2004.02583.x; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Eichler FS, 2002, NEUROLOGY, V58, P901, DOI 10.1212/WNL.58.6.901; Einstein DB, 2012, INT J RADIAT ONCOL, V84, P668, DOI 10.1016/j.ijrobp.2012.01.020; Ernst T, 2004, AIDS, V18, pS61, DOI 10.1097/00002030-200401001-00009; Federico F, 1997, J NEUROL NEUROSUR PS, V62, P239, DOI 10.1136/jnnp.62.3.239; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; da Silva LFG, 2006, PEDIATR NEUROL, V34, P360, DOI 10.1016/j.pediatrneurol.2005.10.011; Firbank MJ, 2002, DEMENT GERIATR COGN, V14, P64, DOI 10.1159/000064927; FISCHER M, 1995, MAGN RESON IMAGING, V13, P781, DOI 10.1016/0730-725X(95)00030-K; FRAHM J, 1989, MAGNET RESON MED, V11, P47, DOI 10.1002/mrm.1910110105; Fu L, 1998, BRAIN, V121, P103, DOI 10.1093/brain/121.1.103; Gabis L, 2001, J NEUROIMAGING, V11, P209, DOI 10.1111/j.1552-6569.2001.tb00036.x; Garcia-Gomez JM, 2009, MAGN RESON MATER PHY, V22, P5, DOI 10.1007/s10334-008-0146-y; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; GARWOOD M, 1989, MAGNET RESON MED, V9, P25, DOI 10.1002/mrm.1910090105; Gerstner ER, 2010, J CLIN ONCOL, V28, pE91, DOI 10.1200/JCO.2009.25.0233; GILL SS, 1990, J COMPUT ASSIST TOMO, V14, P497, DOI 10.1097/00004728-199007000-00001; Gillard JH, 1996, AM J NEURORADIOL, V17, P873; Glodzik-Sobanska L, 2006, PSYCHIAT RES-NEUROIM, V148, P111, DOI 10.1016/j.pscychresns.2006.08.004; Gonzalez-Toledo E, 2006, NEUROL RES, V28, P280, DOI 10.1179/016164106X98161; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; GRAHAM GD, 1993, STROKE, V24, P1891, DOI 10.1161/01.STR.24.12.1891; GRAHAM GD, 1992, STROKE, V23, P333, DOI 10.1161/01.STR.23.3.333; Gredal O, 1997, NEUROLOGY, V48, P878, DOI 10.1212/WNL.48.4.878; Griffith HR, 2008, ALZHEIMERS DEMENT, V4, P421, DOI 10.1016/j.jalz.2008.04.008; GRODD W, 1991, RADIOLOGY, V181, P173, DOI 10.1148/radiology.181.1.1887030; Groenendaal F, 2001, BIOL NEONATE, V79, P254; Gruetter R, 2000, MAGNET RESON MED, V43, P319, DOI 10.1002/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1; GUILFOYLE DN, 1989, MAGNET RESON MED, V10, P282, DOI 10.1002/mrm.1910100213; Hardy DL, 1998, J MAGN RESON, V133, P70, DOI 10.1006/jmre.1998.1433; Harms L, 1997, J NEUROL NEUROSUR PS, V62, P27, DOI 10.1136/jnnp.62.1.27; Hartmann M, 2003, NEUROSCI LETT, V338, P119, DOI 10.1016/S0304-3940(02)01367-8; Hattingen E, 2009, MAGN RESON MATER PHY, V22, P33, DOI 10.1007/s10334-008-0145-z; HEINDEL W, 1995, PEDIATR RADIOL, V25, P296, DOI 10.1007/BF02011106; HEINDEL W, 1993, AM J NEURORADIOL, V14, P629; HENNIG J, 1992, NMR BIOMED, V5, P193, DOI 10.1002/nbm.1940050406; HENRIKSEN O, 1992, JMRI-J MAGN RESON IM, V2, P511, DOI 10.1002/jmri.1880020508; Hess AT, 2011, MAGN RESON MED, V66, P314, DOI 10.1002/mrm.22805; HETHERINGTON H, 1995, ANN NEUROL, V38, P396, DOI 10.1002/ana.410380309; Hetherington HP, 2006, MAGN RESON MED, V56, P26, DOI 10.1002/mrm.20941; Higuchi T, 1997, MAGNET RESON MED, V37, P851, DOI 10.1002/mrm.1910370608; HILL A, 1991, PEDIATR NEUROL, V7, P317, DOI 10.1016/0887-8994(91)90060-X; Hoang TQ, 1998, NEUROLOGY, V50, P1033, DOI 10.1212/WNL.50.4.1033; Hollingworth W, 2006, AM J NEURORADIOL, V27, P1404; Holmes E, 1997, J PHARMACEUT BIOMED, V15, P1647, DOI 10.1016/S0731-7085(97)00066-6; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Howe FA, 2003, MAGNET RESON MED, V49, P223, DOI 10.1002/mrm.10367; Huisman TAGM, 2002, EUR RADIOL, V12, P858, DOI 10.1007/s003300101073; Hunter JV, 2005, AM J NEURORADIOL, V26, P482; HUSTED CA, 1994, ANN NEUROL, V36, P157, DOI 10.1002/ana.410360207; Inglese M, 2004, NEUROIMAGE, V21, P1825, DOI 10.1016/j.neuroimage.2003.12.008; Ishimaru H, 2001, EUR RADIOL, V11, P1784, DOI 10.1007/s003300000814; Jacobs MA, 2001, MAGNET RESON MED, V46, P699, DOI 10.1002/mrm.1248; JARVIK JG, 1993, RADIOLOGY, V186, P739, DOI 10.1148/radiology.186.3.8430182; Jayakumar PN, 2004, NEURORADIOLOGY, V46, P72, DOI 10.1007/s00234-003-1108-8; JENKINS BG, 1993, NEUROLOGY, V43, P2689, DOI 10.1212/WNL.43.12.2689; JONES AP, 1995, J NEUROL SCI, V129, P85, DOI 10.1016/0022-510X(95)00072-A; Julia-Sape M, 2012, NMR BIOMED, V25, P661, DOI 10.1002/nbm.1782; JUNGLING FD, 1993, MAGNET RESON MED, V30, P155, DOI 10.1002/mrm.1910300203; Kadri Munaf, 2003, J Perinatol, V23, P181, DOI 10.1038/sj.jp.7210913; Kamada Kyousuke, 1997, Neurologia Medico-Chirurgica, V37, P250, DOI 10.2176/nmc.37.250; Kanayama S, 1996, MAGNET RESON MED, V36, P637, DOI 10.1002/mrm.1910360421; Kano H, 2006, NEUROSURG REV, V29, P88, DOI 10.1007/s10143-005-0408-3; Kantarci K, 2000, NEUROLOGY, V55, P210, DOI 10.1212/WNL.55.2.210; Kantarci K, 2007, BRIT J RADIOL, V80, pS146, DOI 10.1259/bjr/60346217; Kantarci K, 2009, NEUROLOGY, V72, P1519, DOI 10.1212/WNL.0b013e3181a2e864; Kantarci K, 2008, RADIOLOGY, V248, P210, DOI 10.1148/radiol.2481071590; Keating B, 2010, MAGN RESON MED, V64, P672, DOI 10.1002/mrm.22448; Keil B, 2011, MAGN RESON MED, V66, P1777, DOI 10.1002/mrm.22961; Keltner JR, 1997, MAGNET RESON MED, V37, P366, DOI 10.1002/mrm.1910370312; Keltner JR, 1998, MAGNET RESON MED, V39, P651, DOI 10.1002/mrm.1910390420; Keshavan MS, 2000, BIOL PSYCHIAT, V48, P369, DOI 10.1016/S0006-3223(00)00940-9; Khong PL, 2004, J CHILD NEUROL, V19, P872, DOI 10.1177/08830738040190110501; Kim H, 2011, CANCER RES, V71, P3745, DOI 10.1158/0008-5472.CAN-10-2991; Kim SH, 1997, RADIOLOGY, V204, P239, DOI 10.1148/radiology.204.1.9205254; Kinoshita K, 1997, AM J NEURORADIOL, V18, P1753; Kovanlikaya A, 2005, RADIOLOGY, V236, P1020, DOI 10.1148/radiol.2363040856; Kreis R, 2004, NMR BIOMED, V17, P361, DOI 10.1002/nbm.891; Kreis R, 1996, J CLIN INVEST, V97, P1142, DOI 10.1172/JCI118528; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Krep H, 2003, RESUSCITATION, V58, P337, DOI 10.1016/S0300-9572(03)00151-5; KRUSE B, 1994, DEV MED CHILD NEUROL, V36, P839; Kuesel AC, 1996, ANTICANCER RES, V16, P1485; KUESEL AC, 1994, NMR BIOMED, V7, P172, DOI 10.1002/nbm.1940070404; Kuhn B, 1996, MAGNET RESON MED, V35, P457, DOI 10.1002/mrm.1910350403; Kuzniecky R, 2004, NEUROIMAG CLIN N AM, V14, P507, DOI 10.1016/j.nic.2004.04.010; Lange T, 2006, AM J NEURORADIOL, V27, P895; Law M, 2003, AM J NEURORADIOL, V24, P1989; Law M, 2005, CLIN MAGNETIC RESONA; Lee JH, 1999, AM J GASTROENTEROL, V94, P2206; Leuzzi V, 2000, J INHERIT METAB DIS, V23, P563, DOI 10.1023/A:1005621727560; Leuzzi V, 2007, J INHERIT METAB DIS, V30, P209, DOI 10.1007/s10545-006-0399-4; Lin A, 1999, J NEURO-ONCOL, V45, P69, DOI 10.1023/A:1006387703127; Llumiguano C, 2008, PARKINSONISM RELAT D, V14, P229, DOI 10.1016/j.parkreldis.2007.08.009; Mainero C, 2009, NEUROLOGY, V73, P941, DOI 10.1212/WNL.0b013e3181b64bf7; Majos C, 2004, AM J NEURORADIOL, V25, P1696; MANSFIELD P, 1984, MAGNET RESON MED, V1, P370, DOI 10.1002/mrm.1910010308; MATTHEWS PM, 1990, NEUROLOGY, V40, P985, DOI 10.1212/WNL.40.6.985; MATTHEWS PM, 1991, NEUROLOGY, V41, P1251, DOI 10.1212/WNL.41.8.1251; MATTHEWS PM, 1993, NEUROLOGY, V43, P2484, DOI 10.1212/WNL.43.12.2484; MAUDSLEY AA, 1994, MAGN RESON MED, V31, P645, DOI 10.1002/mrm.1910310610; MENON DK, 1992, J COMPUT ASSIST TOMO, V16, P538, DOI 10.1097/00004728-199207000-00007; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Meyerand ME, 1999, AM J NEURORADIOL, V20, P117; MEYERHOFF DJ, 1993, NEUROLOGY, V43, P509, DOI 10.1212/WNL.43.3_Part_1.509; Meyerhoff DJ, 1999, NEUROLOGY, V52, P995, DOI 10.1212/WNL.52.5.995; MICHAELIS T, 1993, RADIOLOGY, V187, P219, DOI 10.1148/radiology.187.1.8451417; MILLER BL, 1993, RADIOLOGY, V187, P433, DOI 10.1148/radiology.187.2.8475286; Miller BL, 1996, LIFE SCI, V58, P1929, DOI 10.1016/0024-3205(96)00182-8; Miller DH, 2003, J NEUROL, V250, P1407, DOI 10.1007/s00415-003-0243-9; MILLER DH, 1991, LANCET, V337, P58, DOI 10.1016/0140-6736(91)93383-K; MIYAKE M, 1981, J NEUROCHEM, V36, P804, DOI 10.1111/j.1471-4159.1981.tb01665.x; MOFFETT JR, 1991, NEUROREPORT, V2, P131, DOI 10.1097/00001756-199103000-00005; Moller-Hartmann W, 2002, NEURORADIOLOGY, V44, P371, DOI 10.1007/s00234-001-0760-0; Moser H, 2001, X LINKED ADRENO LEUK; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Murphy M, 2002, BRIT J NEUROSURG, V16, P329, DOI 10.1080/0268869021000007687; Nakabayashi M, 2007, J NEUROSURG, V106, P370, DOI 10.3171/jns.2007.106.3.370; Narayana PA, 2005, J NEUROIMAGING, V15, p46S, DOI 10.1177/1051228405284200; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Nasrallah F, 2010, PEDIATR NEUROL, V42, P163, DOI 10.1016/j.pediatrneurol.2009.07.015; Oz G, 2011, MAGN RESON MED, V65, P901, DOI 10.1002/mrm.22708; Opstad KS, 2007, NMR BIOMED, V20, P763, DOI 10.1002/nbm.1147; Opstad KS, 2003, MAGNET RESON MED, V49, P632, DOI 10.1002/mrm.10416; Outteryck O, 2010, J NEUROL, V257, P1759, DOI 10.1007/s00415-010-5598-0; Oz G, 2005, NEUROLOGY, V64, P434, DOI 10.1212/01.WNL.0000150906.52208.E7; Oz G, 2014, RADIOLOGY, V270, P658, DOI 10.1148/radiol.13130531; Pan JW, 1996, MAGNET RESON MED, V36, P7, DOI 10.1002/mrm.1910360103; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PIORO EP, 1994, NEUROLOGY, V44, P1933, DOI 10.1212/WNL.44.10.1933; Pivawer G, 2007, MAGN RESON IMAGING, V25, P238, DOI 10.1016/j.mri.2006.09.028; POSSE S, 1995, MAGN RESON MED, V33, P34, DOI 10.1002/mrm.1910330106; Preul MC, 1998, CAN J NEUROL SCI, V25, P13, DOI 10.1017/S0317167100033436; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Puts NAJ, 2012, PROG NUCL MAG RES SP, V60, P29, DOI 10.1016/j.pnmrs.2011.06.001; Rabinov JD, 2002, RADIOLOGY, V225, P871, DOI 10.1148/radio1.225301-997; Ratai EM, 2009, MAGNETIC RESONANCE I, V2; Ratai EM, 2012, NEUROIMAGING CLIN AP; Ratai E, 2008, ARCH NEUROL-CHICAGO, V65, P1488, DOI 10.1001/archneur.65.11.1488; Ratai EM, 2013, NEURO-ONCOLOGY, V15, P936, DOI 10.1093/neuonc/not044; Ratai EM, 2011, MAGN RESON MED, V66, P625, DOI 10.1002/mrm.22821; Reese TG, 1995, JMRI-J MAGN RESON IM, V5, P739, DOI 10.1002/jmri.1880050621; Ross BD, 1998, NEUROIMAG CLIN N AM, V8, P809; ROSS BD, 1991, NMR BIOMED, V4, P59, DOI 10.1002/nbm.1940040205; ROTHMAN DL, 1993, P NATL ACAD SCI USA, V90, P5662, DOI 10.1073/pnas.90.12.5662; ROTHMAN DL, 1984, P NATL ACAD SCI-BIOL, V81, P6330, DOI 10.1073/pnas.81.20.6330; Rowland L.M., 2012, SCHIZOPHR B, V39, P1096, DOI DOI 10.1093/SCHBUL/SBS092.-; RUTHERFORD MA, 1995, NEUROPEDIATRICS, V26, P183, DOI 10.1055/s-2007-979751; Sacktor N, 2005, J MAGN RESON IMAGING, V21, P325, DOI 10.1002/jmri.20272; Saunders DE, 2000, BRIT MED BULL, V56, P334, DOI 10.1258/0007142001903256; Saunders DE, 1999, JMRI-J MAGN RESON IM, V9, P711, DOI 10.1002/(SICI)1522-2586(199905)9:5<711::AID-JMRI14>3.0.CO;2-3; SCHNEIDER E, 1991, MAGNET RESON MED, V18, P335, DOI 10.1002/mrm.1910180208; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Shiino A, 2012, J CEREBR BLOOD F MET, V32, P805, DOI 10.1038/jcbfm.2012.9; SHONK TK, 1995, RADIOLOGY, V195, P65, DOI 10.1148/radiology.195.1.7892497; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; Simpson HB, 2012, NEUROPSYCHOPHARMACOL, V37, P2684, DOI 10.1038/npp.2012.132; Slotboom J, 1998, MAGNET RESON MED, V39, P899, DOI 10.1002/mrm.1910390607; Soher BJ, 1996, MAGNET RESON MED, V35, P356, DOI 10.1002/mrm.1910350313; Soher BJ, 1998, MAGNET RESON MED, V40, P822, DOI 10.1002/mrm.1910400607; Stanley JA, 2000, BIOL PSYCHIAT, V48, P357, DOI 10.1016/S0006-3223(00)00949-5; STANLEY JA, 1995, MAGNET RESON MED, V34, P17, DOI 10.1002/mrm.1910340105; Steenweg ME, 2010, BRAIN, V133, P2971, DOI 10.1093/brain/awq257; Suzuki Yasuhiro, 2001, No To Hattatsu, V33, P422; Tartaglia Maria Carmela, 2006, Adv Neurol, V98, P185; Taylor JS, 1996, INT J RADIAT ONCOL, V36, P1251, DOI 10.1016/S0360-3016(96)00376-8; Tedeschi G, 1997, BRAIN, V120, P1541, DOI 10.1093/brain/120.9.1541; Thayyil S, 2010, PEDIATRICS, V125, pE382, DOI 10.1542/peds.2009-1046; Thomas MA, 2001, MAGNET RESON MED, V46, P58, DOI 10.1002/mrm.1160; Tkac I, 2001, MAGNET RESON MED, V46, P451, DOI 10.1002/mrm.1213; Tofts P S, 1988, NMR Biomed, V1, P1, DOI 10.1002/nbm.1940010103; Tracey I, 1996, NEUROLOGY, V46, P783, DOI 10.1212/WNL.46.3.783; Tran TKC, 2000, MAGN RESON MED, V43, P23, DOI 10.1002/(SICI)1522-2594(200001)43:1<23::AID-MRM4>3.0.CO;2-E; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; TSAI GC, 1995, PROG NEUROBIOL, V46, P531, DOI 10.1016/0301-0082(95)00014-M; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Wartenberg KE, 2004, J NEUROIMAGING, V14, P180, DOI 10.1177/1051228403259514; WEBB P, 1989, MAGNET RESON MED, V12, P306, DOI 10.1002/mrm.1910120303; WEBB P, 1991, MAGNET RESON MED, V20, P113, DOI 10.1002/mrm.1910200112; WELCH KMA, 1992, NEUROL CLIN, V10, P1; WESTERGAARD N, 1995, DEV NEUROSCI-BASEL, V17, P203, DOI 10.1159/000111288; WILMAN AH, 1995, J MAGN RESON SER B, V109, P202, DOI 10.1006/jmrb.1995.0010; WILMAN AH, 1995, J MAGN RESON SER B, V107, P25, DOI 10.1006/jmrb.1995.1054; Wolf NI, 2005, NEUROLOGY, V64, P1461, DOI 10.1212/01.WNL.0000158615.56071.E3; Young K, 1998, MAGNET RESON MED, V40, P812, DOI 10.1002/mrm.1910400605; Young K, 1998, MAGNET RESON MED, V40, P816, DOI 10.1002/mrm.1910400606; Zarifi MK, 2002, RADIOLOGY, V225, P859, DOI 10.1148/radiol.2253011797; Zhu WZ, 2008, TRANSL RES, V152, P225, DOI 10.1016/j.trsl.2008.09.004	247	6	7	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-7020-4537-0; 978-0-444-53485-9	HAND CLINIC			2016	135						93	116					24	Clinical Neurology; Neuroimaging	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BH8WG	WOS:000403702900007	27432661				2022-02-06	
J	Rose, SC; Fischer, AN; Heyer, GL				Rose, Sean C.; Fischer, Anastasia N.; Heyer, Geoffrey L.			Physicians' Management Practices and Perceived Health Risks When Postconcussion Symptoms Persist	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; postconcussion syndrome; mild traumatic brain injury; management; survey	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; REPETITIVE HEAD-INJURY; 2ND IMPACT SYNDROME; PATHOPHYSIOLOGY; REST	Background: Concussion guidelines recommend physical and cognitive rest until all postconcussion symptoms resolve, in part because of potential health risks, including catastrophic injury related to a second impact. However, when postconcussion symptoms persist for weeks or months, these risks are poorly characterized. Hypothesis: Physicians' perceived health risks and management strategies for patients with persistent postconcussion symptoms will vary. Study Design: Cross-sectional study. Level of Evidence: Level 3. Methods: A survey of the physician members of the American College of Sports Medicine assessed the perceived health risks related to advancing activity, the indications for neuroimaging, and the referral patterns for patients with persistent postconcussion symptoms. Results: A total of 572 physicians completed the survey (response rate, 27.2%). The majority of physicians recommended physical rest (97.4%) and cognitive rest (93.8%) within the first week of injury. Perceived health risks related to advancing activity in the symptomatic patient differed at 2 weeks versus 3 months after injury (P < 0.001 for all comparisons). Respondents from the United States were more likely to list second impact syndrome as a potential health risk at 2 weeks compared with respondents from other countries (P = 0.04). The majority (56%) responded that the risk of second impact syndrome remains until all symptoms resolve. When post concussion symptoms persist beyond 1 month, 61.9% of physicians responded that neuroimaging is indicated. Approximately 60% of respondents had access to a multidisciplinary concussion clinic within 60 miles of their practice. Conclusion: When postconcussion symptoms persist, the perceived health risks, management practices, and access to multidisciplinary care vary among physicians.	[Rose, Sean C.; Heyer, Geoffrey L.] Ohio State Univ, Nationwide Childrens Hosp, Div Pediat Neurol, 700 Childrens Dr, Columbus, OH 43205 USA; [Rose, Sean C.; Heyer, Geoffrey L.] Ohio State Univ, Dept Neurol, 700 Childrens Dr, Columbus, OH 43205 USA; [Fischer, Anastasia N.] Ohio State Univ, Nationwide Childrens Hosp, Div Sports Med, Columbus, OH 43210 USA; [Fischer, Anastasia N.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA		Heyer, GL (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Div Pediat Neurol, 700 Childrens Dr, Columbus, OH 43205 USA.; Heyer, GL (corresponding author), Ohio State Univ, Dept Neurol, 700 Childrens Dr, Columbus, OH 43205 USA.	geoffrey.heyer@nationwidechildrens.org		Heyer, Geoffrey/0000-0001-9334-3739; Rose, Sean/0000-0001-5177-7715			Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020	21	6	6	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2016	8	1					37	42		10.1177/1941738115591948			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DH1EI	WOS:000372526800004	26733591	Green Published			2022-02-06	
S	Rostami, E		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Rostami, Elham			Traumatic Brain Injury Models in Animals	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury models; Experimental animal models; Fluid percussion; Controlled cortical impact; Blast brain injury	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; CONTROLLED CORTICAL IMPACT; RAT-BRAIN; MISSILE INJURY; BLAST INJURY; PRESSURE; EXPOSURE; MODERATE; COMA	Traumatic brain injury (TBI) is the leading cause of death in young adults in industrialized nations and in the developing world the WHO considers TBI a silent epidemic caused by an increasing number of traffic accidents. Despite the major improvement of TBI outcome in the acute setting in the past 20 years, the assessment, therapeutic interventions, and prevention of long-term complications remain a challenge. In order to get a deeper insight into the pathology of TBI and advancement of medical understanding and clinical progress experimental animal models are an essential requirement. This chapter provides an overview of most commonly used experimental animal TBI models and the pathobiological findings based on current data. In addition, limitations and advantages of each TBI model are mentioned. This will hopefully give an insight into the possibilities of each model and be of value in choosing one when designing a study.	[Rostami, Elham] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden; [Rostami, Elham] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Rostami, Elham] NIAAA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA		Rostami, E (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden.; Rostami, E (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.; Rostami, E (corresponding author), NIAAA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.						ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1989, SCOT MED J, V34, P399, DOI 10.1177/003693308903400106; Adams JH, 1992, GREENFIELDS NEUROPAT, P106; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Budinich CS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/378307; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; CLEMEDSON C.-J., 1957, ACTA PATHOL ET MICROBIOL SCAND, V40, P89; CLEMEDSON CARL-JOHAN, 1955, JOUR AVIATION MED, V26, P373; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FINNIE JW, 1993, J COMP PATHOL, V108, P93, DOI 10.1016/S0021-9975(08)80231-9; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Garner JP, 2009, WORLD J SURG, V33, P2194, DOI 10.1007/s00268-009-0105-4; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Holbourn AHS, 1943, LANCET, V2, P438; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; KANDA R, 1981, Neurologia Medico-Chirurgica, V21, P645; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maruichi K, 2009, NEUROPATHOLOGY, V29, P132, DOI 10.1111/j.1440-1789.2008.00956.x; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; Ono K., 1980, P 24 STAPP CAR CRASH; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Richmond DR, 1967, 1854 DASA LOV FDN ME, P1; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Tan YH, 1998, J ORAL MAXIL SURG, V56, P345, DOI 10.1016/S0278-2391(98)90113-6; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; White C. S., 1965, CEX REPORTS, P1; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313	65	6	6	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						47	59		10.1007/978-1-4939-3816-2_4	10.1007/978-1-4939-3816-2		13	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500006	27604712				2022-02-06	
J	Sabesan, V; Steffes, Z; Lombardo, DJ; Petersen-Fitts, GR; Jildeh, TR				Sabesan, Vani; Steffes, Zachary; Lombardo, Daniel J.; Petersen-Fitts, Graysen R.; Jildeh, Toufic R.			Epidemiology and location of rugby injuries treated in US emergency departments from 2004 to 2013	OPEN ACCESS JOURNAL OF SPORTS MEDICINE			English	Article						rugby; injury pattern; epidemiology	LEAGUE PLAYERS; PROTECTIVE EQUIPMENT; PREVENTION PROGRAM; CONTACT INJURY; UNION FOOTBALL; UNITED-STATES; RISK-FACTORS; CONCUSSION; HEADGEAR; COHORT	Rugby participation in the US is increasing, and with its inclusion in the 2016 Summer Olympics, the increased participation rates are expected to continue. Naturally, as participation increases, so too do rugby-related injuries. The difference in injury patterns with regard to age and gender illustrates differences in how the game is being played. Understanding what accounts for these emerging injury patterns will help guide future injury prevention efforts. This study provides an update on injury rates for the growing population of rugby players in the US, especially young players. Our results focus on the variation of injury types and the injury rates of various levels of rugby players, including youth, collegiate, and recreational. Using injury data from the National Electronic Injury Surveillance System, we analyzed data in rugby patients for age, gender, body region, type of injury, and severity. We employed statistical weights to calculate national injury estimates. During the 10 years studied, the trend in the number of rugby injuries among all age groups showed a statistically significant increase (R=0.804, P=0.005). The average age of injury was 21.5 +/- 6.3 years with facial and head injuries constituting >33% of all injuries, representing a proportional increase of >10%. Men were most frequently injured in the face (18.2%) and head (15.9%); women were most frequently injured in the head (23%) and shoulder (12.3%). There were 9,059 concussions, constituting 7% of all injuries.	[Sabesan, Vani; Lombardo, Daniel J.; Petersen-Fitts, Graysen R.] Dept Orthopaed Surg, Detroit, MI USA; [Steffes, Zachary; Jildeh, Toufic R.] Wayne State Univ, Sch Med, Detroit, MI USA		Sabesan, V (corresponding author), Wayne State Univ, Sch Med, Dept Orthopaed Surg, 10000 Telegraph Rd, Taylor, MI 48120 USA.	sabes001@gmail.com			Exactech, Inc.; Tornier; Arthrex, Inc.	Vani Sabesan discloses the following conflicts of interest. She has worked as a paid consultant in Arthrex, Inc., has received research support from Exactech, Inc. and Tornier, and was a board or committee member of Michigan Orthopaedic Society. The other authors report no conflicts of interest in this work.	[Anonymous], 2009, ASS PRESS; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Bleakley C, 2011, J ATHL TRAINING, V46, P555; Brown JC, 2016, SCAND J MED SCI SPOR, V26, P221, DOI 10.1111/sms.12414; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Dietzen C J, 1999, Phys Med Rehabil Clin N Am, V10, P159; EDGAR M, 1995, LANCET, V345, P1452, DOI 10.1016/S0140-6736(95)91031-X; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Gabbett TJ, 2012, J SCI MED SPORT, V15, P496, DOI 10.1016/j.jsams.2012.03.017; Gabbett TJ, 2012, J SPORT SCI, V30, P1421, DOI 10.1080/02640414.2012.710760; Gabbett TJ, 2004, SPORTS MED, V34, P849, DOI 10.2165/00007256-200434120-00004; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Garraway WM, 2000, BRIT J SPORT MED, V34, P348, DOI 10.1136/bjsm.34.5.348; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; International Rugby Board, 2009, INT RUGB YEAR REV 20; International Rugby Board, 2012, INT RUGB YEAR REV 20; International Rugby Board, 2013, INT RUGB BOARD YEAR; Jones SJ, 2004, BRIT J SPORT MED, V38, P159, DOI 10.1136/bjsm.2002.002584; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Kahanov Leamor, 2005, Res Sports Med, V13, P77, DOI 10.1080/15438620590956025; Kaplan KM, 2008, BULL HOSP JT DIS, V66, P86; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; Marshall SW, 2002, INT J EPIDEMIOL, V31, P587, DOI 10.1093/ije/31.3.587; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; Micheli L J, 1974, J Sports Med, V2, P93; Mills A, 2004, HAZARD SCREENING REP; Mueller F. O., 2013, CATASTROPHIC SPORTS; Palmer-Green DS, 2015, AM J SPORT MED, V43, P475, DOI 10.1177/0363546514560337; Patricios JS, 2014, CURR SPORT MED REP, V13, P326, DOI 10.1249/JSR.0000000000000086; Patricios JS, 2014, BRIT J SPORT MED, V48, P76, DOI 10.1136/bjsports-2013-093031; Peck KY, 2013, SPORTS HEALTH, V5, P327, DOI 10.1177/1941738113487165; Quarrie KL, 2005, BRIT J SPORT MED, V39, P650, DOI 10.1136/bjsm.2004.016022; The Outdoor Foundation, 2013, OUTD PART REP; US Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; Wilson BD, 1998, SPORTS MED, V25, P333, DOI 10.2165/00007256-199825050-00005; Yard EE, 2006, J ATHL TRAINING, V41, P325	41	6	6	0	6	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1543			OPEN ACCESS J SPORTS	Open Access J. Sports Med.		2016	7						135	142		10.2147/OAJSM.S114019			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	ET0EH	WOS:000399934200002	27822128	Green Published, Green Submitted, gold			2022-02-06	
S	Samaddar, S		Essa, MM; Akbar, M; Guillemin, G		Samaddar, Sreyashi			Effect of Docosahexaenoic Acid (DHA) on Spinal Cord Injury	BENEFITS OF NATURAL PRODUCTS FOR NEURODEGENERATIVE DISEASES	Advances in Neurobiology		English	Article; Book Chapter						Spinal cord injury; DHA; Neurodegeneration; Neurotrauma; Treatment	FUNCTIONAL RECOVERY; STEM-CELLS; MICE; RAT; OMEGA-3-FATTY-ACIDS; NEUROPROTECTION; PROTECTION; APOPTOSIS; RILUZOLE; BLOCKERS	Spinal cord injury (SCI) has become one of the most leading concerns in the past decade. Preclinical and research studies are now ongoing trying to understand the molecular mechanisms and develop treatment strategies for this neurodegenerative condition. In the last decade, researchers have deciphered few of the leading players that play a major role in worsening the condition. But till date none of these have been applied to the clinical treatment of patients with SCI. Here in this chapter I discuss about one of the dietary requirements that could ameliorate the condition of these patients.	[Samaddar, Sreyashi] CUNY, Res Fdn, Dept Neurosci Biol, Staten Isl, NY 10314 USA		Samaddar, S (corresponding author), CUNY, Res Fdn, Dept Neurosci Biol, Staten Isl, NY 10314 USA.	sreyashi.samaddar@gmail.com					Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Cheriyan T, 2014, SPINAL CORD, V52, P588, DOI 10.1038/sc.2014.91; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Ephraim Y, 2002, NUTR NEUROSCI, V5, P149; Figueroa JD, 2013, J NEUROTRAUM, V30, P853, DOI 10.1089/neu.2012.2718; Figueroa JD, 2012, J NEUROTRAUM, V29, P551, DOI 10.1089/neu.2011.2141; Furutani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132472; Hall JCE, 2012, J NEUROCHEM, V121, P738, DOI 10.1111/j.1471-4159.2012.07726.x; Horrocks LA, 1999, PHARMACOL RES, V40, P211, DOI 10.1006/phrs.1999.0495; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Joseph MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041288; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Langston TH, 2012, J NEUROSURG-SPINE, V17, P134; Lim SN, 2013, NEUROBIOL DIS, V51, P104, DOI 10.1016/j.nbd.2012.10.021; Lim SJ, 2012, ONCOL REP, V27, P2023, DOI 10.3892/or.2012.1706; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; McAdoo DJ, 2005, BRAIN RES, V1038, P92, DOI 10.1016/j.brainres.2005.01.024; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Mu XJ, 2000, J NEUROTRAUM, V17, P773, DOI 10.1089/neu.2000.17.773; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Nakamura M, 2013, CELL RES, V23, P70, DOI 10.1038/cr.2012.171; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Satkunendrarajah K, 2013, EXP NEUROL, V249, P104, DOI 10.1016/j.expneurol.2013.08.008; Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245; Tator CH., 2000, CONT MANAGEMENT SPIN, V2nd ed; Vreugdenhil M, 1996, P NATL ACAD SCI USA, V93, P12559, DOI 10.1073/pnas.93.22.12559; Ward RE, 2010, J NEUROTRAUM, V27, P1769, DOI 10.1089/neu.2010.1348; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]; Zhu ZR, 2015, NUTRITION, V31, P1025, DOI 10.1016/j.nut.2015.02.012	30	6	6	0	1	SPRINGER INT PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2190-5215		978-3-319-28383-8; 978-3-319-28381-4	ADV NEUROBIOL	Adv. Neurobiol.		2016	12						27	39		10.1007/978-3-319-28383-8_2	10.1007/978-3-319-28383-8		13	Integrative & Complementary Medicine; Neurosciences	Book Citation Index – Science (BKCI-S)	Integrative & Complementary Medicine; Neurosciences & Neurology	BH2GH	WOS:000398929300003	27651246				2022-02-06	
S	Simon, DW; Vagni, VM; Kochanek, PM; Clark, RSB		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Simon, Dennis W.; Vagni, Vincent M.; Kochanek, Patrick M.; Clark, Robert S. B.			Combined Neurotrauma Models: Experimental Models Combining Traumatic Brain Injury and Secondary Insults	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury; Secondary brain injury; Combined injury model; Controlled cortical impact; Hemorrhagic shock; Hypoxia	CEREBRAL-BLOOD-FLOW; LARGE ANIMAL-MODEL; HEMORRHAGIC-SHOCK; FLUID RESUSCITATION; HEAD-INJURY; INTRACRANIAL-PRESSURE; RATS; HYPOXIA; MICE; DAMAGE	Patients with severe traumatic brain injury (TBI) frequently present with concomitant injuries that may cause secondary brain injury and impact outcomes. Animal models have been developed that combine contemporary models of TBI with a secondary neurologic insult such as hypoxia, shock, long bone fracture, and radiation exposure. Combined injury models may be particularly useful when modeling treatment strategies and in efforts to map basic research to a heterogeneous patient population. Here, we review these models and their collective contribution to the literature on TBI. In addition, we provide protocols and notes for two well-characterized models of TBI plus hemorrhagic shock.	[Simon, Dennis W.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, UPMC, Dept Crit Care Med,Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; [Simon, Dennis W.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, UPMC, Dept Pediat,Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; [Simon, Dennis W.; Vagni, Vincent M.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15261 USA; [Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA		Simon, DW (corresponding author), Univ Pittsburgh, Sch Med, UPMC, Dept Crit Care Med,Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA.; Simon, DW (corresponding author), Univ Pittsburgh, Sch Med, UPMC, Dept Pediat,Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA.; Simon, DW (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER		Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Aji AA, 2009, CHILD NERV SYST, V25, P1325; Allen AR, 2014, INT J RADIAT BIOL, V90, P214, DOI 10.3109/09553002.2014.859761; Allen AR, 2013, RADIAT RES, V180, P78, DOI 10.1667/RR3344.1; Blasiole B, 2013, ANESTHESIOLOGY, V118, P649, DOI 10.1097/ALN.0b013e318280a42d; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; Carrillo P, 1998, J TRAUMA, V45, P239, DOI 10.1097/00005373-199808000-00007; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Glass TF, 2001, J NEUROTRAUM, V18, P57, DOI 10.1089/089771501750055776; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Leung LY, 2013, J NEUROTRAUM, V30, P1288, DOI 10.1089/neu.2012.2715; Mahoney EJ, 2003, J TRAUMA, V55, P1065, DOI 10.1097/01.TA.0000100381.89107.93; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; Mikrogianakis A, 2007, J NEUROTRAUM, V24, P338, DOI 10.1089/neu.2006.003615; Mirzayan MJ, 2012, EXP TOXICOL PATHOL, V64, P133, DOI 10.1016/j.etp.2010.07.007; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Ramaiah VK, 2013, CHILD NERV SYST, V29, P629, DOI 10.1007/s00381-012-1984-5; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; White NJ, 2013, SHOCK, V39, P210, DOI 10.1097/SHK.0b013e31827fd62b; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408	49	6	6	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						393	411		10.1007/978-1-4939-3816-2_22	10.1007/978-1-4939-3816-2		19	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500024	27604730				2022-02-06	
B	Sohrabji, F; Welsh, CJ; Reddy, DS		Shansky, RM		Sohrabji, Farida; Welsh, C. Jane; Reddy, Doodipala Samba			Sex Differences in Neurological Diseases	SEX DIFFERENCES IN THE CENTRAL NERVOUS SYSTEM			English	Article; Book Chapter							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CEREBRAL-ARTERY OCCLUSION; ESTROGEN-RECEPTOR-ALPHA; HIPPOCAMPUS KINDLING MODEL; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; GENDER-DIFFERENCES; THEILERS VIRUS; NEUROSTEROID WITHDRAWAL; ANTICONVULSANT ACTIVITY		[Sohrabji, Farida; Reddy, Doodipala Samba] TAMHSC Coll Med, Dept Neurosci & Expt Therapeut, Bryan, TX 77807 USA; [Welsh, C. Jane] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA		Sohrabji, F (corresponding author), TAMHSC Coll Med, Dept Neurosci & Expt Therapeut, Bryan, TX 77807 USA.			Sohrabji, Farida/0000-0002-6960-3411; Reddy, Samba/0000-0003-2735-9550			ABRAMSKY O, 1994, ANN NEUROL, V36, pS38, DOI 10.1002/ana.410360712; Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Allen CL, 2008, INT J STROKE, V3, P105, DOI 10.1111/j.1747-4949.2008.00187.x; Alley J, 2003, EXP NEUROL, V180, P14, DOI 10.1016/S0014-4886(02)00054-7; Alonso A, 2005, ARCH NEUROL-CHICAGO, V62, P1362, DOI 10.1001/archneur.62.9.1362; ANDERSON DW, 1992, ANN NEUROL, V31, P333, DOI 10.1002/ana.410310317; Arnold AP, 2009, FRONT NEUROENDOCRIN, V30, P1, DOI 10.1016/j.yfrne.2008.11.001; BACKSTROM T, 1976, ACTA NEUROL SCAND, V54, P321; BACKSTROM T, 1984, ACTA NEUROL SCAND, V69, P240; Bake S, 2004, ENDOCRINOLOGY, V145, P5471, DOI 10.1210/en.2004-0984; Banerjee PN, 1997, EPILEPSY COMPREHENSI, P47, DOI 10.1007/978-88-470-2903-3_81; Bazan ACB, 2005, ARQ NEURO-PSIQUIAT, V63, P751, DOI 10.1590/S0004-282X2005000500006; Bebo BF, 1999, J NEUROSCI RES, V55, P432, DOI 10.1002/(SICI)1097-4547(19990215)55:4<432::AID-JNR4>3.0.CO;2-2; Bebo BF, 1996, J NEUROSCI RES, V45, P680, DOI 10.1002/(SICI)1097-4547(19960915)45:6<680::AID-JNR4>3.0.CO;2-4; Bebo BF, 1998, J NEUROSCI RES, V52, P420, DOI 10.1002/(SICI)1097-4547(19980515)52:4<420::AID-JNR5>3.3.CO;2-4; Bebo BF, 2001, J IMMUNOL, V166, P2080, DOI 10.4049/jimmunol.166.3.2080; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BONUCCELLI U, 1989, EPILEPSY RES, V3, P100, DOI 10.1016/0920-1211(89)90037-5; Brann D, 2012, J NEUROENDOCRINOL, V24, P34, DOI 10.1111/j.1365-2826.2011.02185.x; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Bushnell CD, 2008, NEUROL CLIN, V26, P1161, DOI 10.1016/j.ncl.2008.05.009; Carver CM, 2013, PSYCHOPHARMACOLOGY, V230, P151, DOI 10.1007/s00213-013-3276-5; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Chesik D, 2010, NEUROSCI LETT, V468, P178, DOI 10.1016/j.neulet.2009.10.051; Choi YC, 2004, FUND CLIN PHARMACOL, V18, P547, DOI 10.1111/j.1472-8206.2004.00284.x; Christensen J, 2005, EPILEPSIA, V46, P956, DOI 10.1111/j.1528-1167.2005.51204.x; Cipolla MJ, 2009, MICROCIRCULATION, V16, P685, DOI 10.3109/10739680903164131; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Coomber B, 2010, BRAIN RES, V1361, P124, DOI 10.1016/j.brainres.2010.09.037; Cottrell DA, 1999, BRAIN, V122, P625, DOI 10.1093/brain/122.4.625; CRAIG CR, 1966, J PHARMACOL EXP THER, V153, P337; Crawford DK, 2010, BRAIN, V133, P2999, DOI 10.1093/brain/awq237; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; De Butte-Smith M, 2007, BRAIN RES, V1153, P214, DOI 10.1016/j.brainres.2007.03.082; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, ENDOCRINOLOGY, V142, P43, DOI 10.1210/en.142.1.43; El-Khayat HA, 2008, EPILEPSIA, V49, P1619, DOI 10.1111/j.1528-1167.2008.01622.x; El-Sayed YY, 1998, EPILEPSIA, V39, pS17, DOI 10.1111/j.1528-1157.1998.tb02603.x; Espinosa-Garcia C, 2013, NEUROSCI LETT, V550, P98, DOI 10.1016/j.neulet.2013.06.023; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Fuller A, 2007, J NEUROSCI RES, V85, P871, DOI 10.1002/jnr.21184; Galea E, 2002, NEUROREPORT, V13, P1469, DOI 10.1097/00001756-200208070-00024; Gangisetty O, 2010, NEUROSCIENCE, V170, P865, DOI 10.1016/j.neuroscience.2010.07.037; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Gilad R, 2008, SEIZURE-EUR J EPILEP, V17, P531, DOI 10.1016/j.seizure.2008.02.001; Giraud SN, 2010, P NATL ACAD SCI USA, V107, P8416, DOI 10.1073/pnas.0910627107; Glendenning ML, 2008, NEUROSCI LETT, V445, P188, DOI 10.1016/j.neulet.2008.09.006; Gold SM, 2009, PROG BRAIN RES, V175, P239, DOI 10.1016/S0079-6123(09)17516-7; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Harden CL, 2009, EPILEPSIA, V50, P1247, DOI 10.1111/j.1528-1167.2009.02130.x; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; Hawk T, 1998, BRAIN RES, V796, P296, DOI 10.1016/S0006-8993(98)00327-8; Herzog AG, 2012, NEUROLOGY, V78, P1959, DOI 10.1212/WNL.0b013e318259e1f9; Herzog AG, 2004, ANN NEUROL, V56, P431, DOI 10.1002/ana.20214; Herzog AG, 1997, EPILEPSIA, V38, P1082, DOI 10.1111/j.1528-1157.1997.tb01197.x; Herzog AG, 2001, EPILEPSY BEHAV, V2, P367, DOI 10.1006/ebeh.2001.0232; Herzog AG, 2009, NEUROTHERAPEUTICS, V6, P383, DOI 10.1016/j.nurt.2009.01.009; Hesdorffer DC, 2013, CURR OPIN NEUROL, V26, P168, DOI 10.1097/WCO.0b013e32835ef2c7; Hill KE, 1998, J NEUROIMMUNOL, V85, P44, DOI 10.1016/S0165-5728(97)00263-4; Hosie AM, 2007, PHARMACOL THERAPEUT, V116, P7, DOI 10.1016/j.pharmthera.2007.03.011; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Jacobs MP, 2009, EPILEPSY BEHAV, V14, P438, DOI 10.1016/j.yebeh.2009.02.036; JACONO JJ, 1987, EPILEPSIA, V28, P571, DOI 10.1111/j.1528-1157.1987.tb03690.x; Jezierski MK, 2000, MOL BRAIN RES, V85, P77, DOI 10.1016/S0169-328X(00)00244-8; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Johnson AB, 2005, NEUROBIOL AGING, V26, P1365, DOI 10.1016/j.neurobiolaging.2004.12.006; Jover-Mengual T, 2010, BRAIN RES, V1321, P1, DOI 10.1016/j.brainres.2010.01.046; Kantarci OH, 2005, NEUROL CLIN, V23, P17, DOI 10.1016/j.ncl.2004.10.002; Kaplan PW, 2007, EPILEPSY BEHAV, V11, P283, DOI 10.1016/j.yebeh.2007.08.012; Kapral MK, 2005, STROKE, V36, P809, DOI 10.1161/01.STR.0000157662.09551.e5; Kipp M, 2012, FRONT NEUROENDOCRIN, V33, P1, DOI 10.1016/j.yfrne.2012.01.001; Kipp M, 2009, FRONT NEUROENDOCRIN, V30, P188, DOI 10.1016/j.yfrne.2009.04.004; Kirkman NJ, 2010, EPILEPSIA, V51, P454, DOI 10.1111/j.1528-1167.2009.02390.x; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Kurth F, 2014, NEUROIMAGE-CLIN, V4, P454, DOI 10.1016/j.nicl.2014.03.001; Lai Sue-Min, 1800, Prev Chronic Dis, V2, pA13; LANDGREN S, 1978, J NEUROL SCI, V36, P119, DOI 10.1016/0022-510X(78)90166-1; Lelu K, 2011, J IMMUNOL, V187, P2386, DOI 10.4049/jimmunol.1101578; Leon RL, 2012, ENDOCRINOLOGY, V153, P3386, DOI 10.1210/en.2011-1859; Liao SL, 2001, NEUROSCI LETT, V297, P159, DOI 10.1016/S0304-3940(00)01704-3; LIPTON HL, 1975, INFECT IMMUN, V11, P1147, DOI 10.1128/IAI.11.5.1147-1155.1975; Liu FD, 2009, J CEREBR BLOOD F MET, V29, P792, DOI 10.1038/jcbfm.2009.5; Liu R, 2005, BRAIN RES, V1060, P55, DOI 10.1016/j.brainres.2005.08.048; Liu R, 2007, NEUROSCI LETT, V415, P237, DOI 10.1016/j.neulet.2007.01.074; LOGOTHETIS J, 1959, NEUROLOGY, V9, P352, DOI 10.1212/WNL.9.5.352; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Magnoni M, 2010, CIRCULATION, V121, pE1, DOI 10.1161/CIRCULATIONAHA.109.878314; Manwani B, 2015, J CEREBR BLOOD F MET, V35, P221, DOI 10.1038/jcbfm.2014.186; Manwani B, 2013, EXP NEUROL, V249, P120, DOI 10.1016/j.expneurol.2013.08.011; Manwani B, 2011, BRAIN BEHAV IMMUN, V25, P1689, DOI 10.1016/j.bbi.2011.06.015; Marriott LK, 2002, BEHAV NEUROSCI, V116, P902, DOI 10.1037//0735-7044.116.5.902; McClain MA, 2007, J IMMUNOL, V179, P8146, DOI 10.4049/jimmunol.179.12.8146; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; Morales LBJ, 2006, J NEUROSCI, V26, P6823, DOI 10.1523/JNEUROSCI.0453-06.2006; Morali G, 2011, RESTOR NEUROL NEUROS, V29, P1, DOI 10.3233/RNN-2011-0571; Morrell MJ, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s4.2.x; Nicot A, 2009, FRONT BIOSCI-LANDMRK, V14, P4477, DOI 10.2741/3543; Noonan CW, 2002, NEUROLOGY, V58, P136, DOI 10.1212/WNL.58.1.136; Nordell VL, 2003, NEUROBIOL AGING, V24, P733, DOI 10.1016/S0197-4580(02)00193-8; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Offner H, 2006, ANN NY ACAD SCI, V1089, P343, DOI 10.1196/annals.1386.021; Okuda Y, 2002, IMMUNOL LETT, V81, P25, DOI 10.1016/S0165-2478(01)00339-X; Olsen TS, 2010, GENDER MED, V7, P284, DOI 10.1016/j.genm.2010.08.001; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Ozacmak VH, 2009, PHYSIOL RES, V58, P909, DOI 10.33549/physiolres.931647; Palaszynski KM, 2004, J NEUROIMMUNOL, V149, P84, DOI 10.1016/j.jneuroim.2003.12.015; Palaszynski KM, 2004, J NEUROIMMUNOL, V146, P144, DOI 10.1016/j.jneuroim.2003.11.004; Papenfuss TL, 2004, J NEUROIMMUNOL, V150, P59, DOI 10.1016/j.jneuroim.2004.01.018; Park SK, 2008, J CLIN NEUROSCI, V15, P389, DOI 10.1016/j.jocn.2007.04.007; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Polanczyk MJ, 2005, J NEUROIMMUNOL, V170, P85, DOI 10.1016/j.jneuroim.2005.08.023; Quigg M, 2009, NEUROLOGY, V73, P223, DOI 10.1212/WNL.0b013e3181ae7adf; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; Reddy DS, 2009, ENCYCLOPEDIA OF BASIC EPILEPSY RESEARCH, VOLS 1-3, P526; Reddy DS, 2007, FASEB J, V21, pA1179; Reddy DS, 2009, NEUROTHERAPEUTICS, V6, P392, DOI 10.1016/j.nurt.2009.01.006; Reddy DS, 2014, NEUROBIOL DIS, V72, P198, DOI 10.1016/j.nbd.2014.06.010; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; Reddy DS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00115; Reddy DS, 2013, HORM BEHAV, V63, P254, DOI 10.1016/j.yhbeh.2012.04.016; Reddy DS, 2012, EPILEPSY BEHAV, V25, P92, DOI 10.1016/j.yebeh.2012.05.024; Reddy DS, 2012, J PHARMACOL EXP THER, V341, P784, DOI 10.1124/jpet.112.192377; Reddy DS, 2011, J NEUROSCI, V31, P650, DOI 10.1523/JNEUROSCI.4488-10.2011; Reddy DS, 2010, PROG BRAIN RES, V186, P113, DOI 10.1016/B978-0-444-53630-3.00008-7; Reddy Doodipala Samba, 2010, Expert Rev Clin Pharmacol, V3, P183, DOI 10.1586/ecp.10.3; Reddy DS, 2010, NEUROPHARMACOLOGY, V59, P573, DOI 10.1016/j.neuropharm.2010.08.017; Reddy DS, 2010, J PHARMACOL EXP THER, V334, P1031, DOI 10.1124/jpet.110.169854; Reddy DS, 2009, EPILEPSY RES, V85, P1, DOI 10.1016/j.eplepsyres.2009.02.017; Reddy DS, 2000, J PHARMACOL EXP THER, V295, P1241; Reddy DS, 2001, EPILEPSIA, V42, P328, DOI 10.1046/j.1528-1157.2001.10100.x; Reddy DS, 2000, J PHARMACOL EXP THER, V294, P909; Reddy DS, 2004, NEUROSCIENCE, V129, P195, DOI 10.1016/j.neuroscience.2004.08.002; Reddy DS, 2004, NEUROREPORT, V15, P515, DOI 10.1097/00001756-200403010-00026; Reddy DS, 2004, J PHARMACOL EXP THER, V310, P230, DOI 10.1124/jpet.104.065268; Rinta S, 2010, ACTA NEUROL SCAND, V122, P168, DOI 10.1111/j.1600-0404.2009.01301.x; Rogawski M.A., 2001, EPILEPSIA, V42, P303; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rojas A, 2014, EPILEPSIA, V55, P17, DOI 10.1111/epi.12461; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Sakata A, 2011, J AM SOC HYPERTENS, V5, P7, DOI 10.1016/j.jash.2010.12.003; Seifert HA, 2012, J NEUROIMMUNE PHARM, V7, P1017, DOI 10.1007/s11481-012-9406-8; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Selvamani A, 2010, NEUROBIOL AGING, V31, P1618, DOI 10.1016/j.neurobiolaging.2008.08.014; Shao B, 2012, CURR DRUG TARGETS, V13, P188, DOI 10.2174/138945012799201702; Sicotte NL, 2002, ANN NEUROL, V52, P421, DOI 10.1002/ana.10301; Sieve AN, 2004, J NEUROIMMUNOL, V155, P103, DOI 10.1016/j.jneuroim.2004.06.006; Silva GS, 2010, CEREBROVASC DIS, V30, P470, DOI 10.1159/000317088; Simpkins JW, 2010, BBA-GEN SUBJECTS, V1800, P1113, DOI 10.1016/j.bbagen.2009.11.013; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Singh M, 2013, BRAIN RES, V1514, P98, DOI 10.1016/j.brainres.2013.01.027; SMITH R, 1992, J ROY SOC MED, V85, P612; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; Sohrabji F, 2006, ENDOCRINE, V29, P191, DOI 10.1385/ENDO:29:2:191; Soldan SS, 2003, J IMMUNOL, V171, P6267, DOI 10.4049/jimmunol.171.11.6267; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Soucy G, 2005, J IMMUNOL, V174, P6391, DOI 10.4049/jimmunol.174.10.6391; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Spence RD, 2012, FRONT NEUROENDOCRIN, V33, P105, DOI 10.1016/j.yfrne.2011.12.001; Spence RD, 2011, P NATL ACAD SCI USA, V108, P8867, DOI 10.1073/pnas.1103833108; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stuart M, 2011, J MIDWIFERY WOM HEAL, V56, P41, DOI 10.1111/j.1542-2011.2010.00008.x; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Suuronen T, 2005, INFLAMM RES, V54, P194, DOI 10.1007/s00011-005-1343-z; Theiler M, 1934, SCIENCE, V80, P122, DOI 10.1126/science.80.2066.122-a; Thompson C, 2004, CURR OPIN PHARMACOL, V4, P408, DOI 10.1016/j.coph.2004.05.001; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Tiwari-Woodruff S, 2009, J NEUROL SCI, V286, P81, DOI 10.1016/j.jns.2009.04.023; Toung TK, 2000, STROKE, V31, P2701, DOI 10.1161/01.STR.31.11.2701; Towfighi A, 2007, NEUROLOGY, V69, P1898, DOI 10.1212/01.wnl.0000268491.89956.c2; Tuveri A, 2008, EPILEPSIA, V49, P1221, DOI 10.1111/j.1528-1167.2008.01555.x; Valor L, 2011, EUR J CLIN INVEST, V41, P357, DOI 10.1111/j.1365-2362.2010.02414.x; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; Verrotti A, 2007, J ENDOCRINOL INVEST, V30, P797, DOI 10.1007/BF03350821; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Voskuhl RR, 1996, ANN NEUROL, V39, P724, DOI 10.1002/ana.410390608; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; WEINSHENKER BG, 1994, ANN NEUROL, V36, pS6, DOI 10.1002/ana.410360704; WELSH CJR, 1990, AUTOIMMUNITY, V6, P105, DOI 10.3109/08916939008993375; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wingerchuk DM, 2001, LAB INVEST, V81, P263, DOI 10.1038/labinvest.3780235; Wu X, 2013, J PHARMACOL EXP THER, V346, P146, DOI 10.1124/jpet.113.203653; Yang SH, 2003, ANN NY ACAD SCI, V1007, P101, DOI 10.1196/annals.1286.010; Yates MA, 2010, J NEUROIMMUNOL, V220, P136, DOI 10.1016/j.jneuroim.2010.01.013; Young EE, 2010, J NEUROIMMUNOL, V220, P79, DOI 10.1016/j.jneuroim.2010.01.015; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339; Zhang Z, 2010, NEUROPHARMACOLOGY, V58, P930, DOI 10.1016/j.neuropharm.2010.01.002	192	6	6	0	0	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			978-0-12-802198-9; 978-0-12-802114-9				2016							297	323		10.1016/B978-0-12-802114-9.00012-3	10.1016/C2014-0-01274-9		27	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BM3IM	WOS:000462134000012					2022-02-06	
J	Sumritpradit, P; Setthalikhit, T; Chumnanvej, S				Sumritpradit, Preeda; Setthalikhit, Thitipong; Chumnanvej, Sorayouth			Assessment and Predicting Factors of Repeated Brain Computed Tomography in Traumatic Brain Injury Patients for Risk-Stratified Care Management: A 5-Year Retrospective Study	NEUROLOGY RESEARCH INTERNATIONAL			English	Article							MINIMAL HEAD-INJURY; INTRACRANIAL HEMORRHAGE; CT; UTILITY; SCANS	Background and Objective. To determine the value of repeated brain CT in TBI cases for risk-stratified care management (RSCM) and to identify predicting factors which will change the neurosurgical management after repeated brain CTs. Methods. A 5-year retrospective study from January 2009 to August 2013 was conducted. The primary outcome was the value of repeated brain CT in TBI cases. The secondary outcome is to identify predicting factors which will change the neurosurgical management after repeated brain CTs. Results. There were 145 consecutive patients with TBI and repeated brain CT after initial abnormal brain CT. Forty-two percent of all cases (N = 61) revealed the progression of intracranial hemorrhage after repeated brain CT. In all 145 consecutive patients, 67.6% of cases (N = 98) were categorized as mild TBI. For mild head injury, 8.2% of cases (N = 8) had undergone neurosurgical management after repeated brain CT. Only 1 from 74 mild TBI patients with repeated brain CT had neurosurgical intervention. Clopidogrel and midline shift more than 2mm on initial brain CT were significant predicting factors to indicate the neurosurgicalmanagement inmild TBI cases. Conclusion. Routine repeated brain CT for RSCM had no clinical benefit in mild TBI cases.	[Sumritpradit, Preeda; Setthalikhit, Thitipong] Mahidol Univ, Ramathibodi Hosp, Dept Surg, Acute Care Unit,Fac Med, Bangkok, Thailand; [Chumnanvej, Sorayouth] Mahidol Univ, Ramathibodi Hosp, Neurosurg Div, Dept Surg,Fac Med, Bangkok, Thailand		Chumnanvej, S (corresponding author), Mahidol Univ, Ramathibodi Hosp, Neurosurg Div, Dept Surg,Fac Med, Bangkok, Thailand.	sorayouth.chu@mahidol.ac.th					AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Park HK, 2009, BRIT J NEUROSURG, V23, P617, DOI 10.3109/02688690902999302; Roka Y B, 2008, Nepal Med Coll J, V10, P225; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Sifri ZC, 2011, J TRAUMA, V71, P1605, DOI 10.1097/TA.0b013e31822b3728; Stearley H E, 1998, Am J Crit Care, V7, P282; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	18	6	6	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-1852	2090-1860		NEUROL RES INT	Neurol. Res. Int.		2016	2016								UNSP 2737028	10.1155/2016/2737028			7	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DX1DX	WOS:000384107100001	27703812	gold, Green Submitted, Green Published			2022-02-06	
J	Tazopoulou, E; Miljkovitch, R; Truelle, JL; Schnitzler, A; Onillon, M; Zucco, T; Hawthorne, G; Montreuil, M				Tazopoulou, Eva; Miljkovitch, Raphaele; Truelle, Jean-Luc; Schnitzler, Alexis; Onillon, Michel; Zucco, Thierry; Hawthorne, Graeme; Montreuil, Michele			Rehabilitation following cerebral anoxia: An assessment of 27 patients	BRAIN INJURY			English	Article						Anoxia; disability; psychotherapy; quality-of-life; rehabilitation; social re-integration	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CARDIAC-ARREST; ALEXITHYMIA; SURVIVAL; VALIDITY; OUTCOMES; SCALE	Objectives: (1) To evaluate cognitive and emotional impairments, disability and quality-of-life for adults with cerebral anoxia institutionalized in residential care facilities. (2) To evaluate the efficacy of medication, psychotherapy, support group and therapeutic activities. Methods: Twenty-seven persons with cerebral anoxia were recruited, on average 8 years post-injury. Only 20 went through the whole study. Over three consecutive 2-month periods, they were assessed four times to evaluate: baseline observations (T1-T2), adjustment of their medication (T2-T3); and the effect of psychotherapy, support group and therapeutic activities such as physical and artistic or cultural activities usually proposed in the facilities involved (T3-T4). Examined variables at all time points were cognitive status, anxiety and depression, anosognosia, alexithymia, disability and quality-of-life. Results: All participants exhibited cognitive and emotional impairments comparable to those reported in the literature. Statistical analyses revealed good baseline stability of their condition and no significant effects of changes in medication (between T2 and T3). Conversely, following implementation of psychotherapy, support group and therapeutic activities (between T3 and T4), quality-of-life and social participation were significantly improved. Conclusion: Social participation and quality-of-life for persons instutionalized several years after cerebral anoxia were improved by psychotherapeutic and therapeutic activities.	[Tazopoulou, Eva; Montreuil, Michele] Univ Paris 08, Lab Psychopathol & Neuropsychol, 2 Rue Liberte, F-93526 St Denis, France; [Tazopoulou, Eva; Truelle, Jean-Luc; Schnitzler, Alexis; Onillon, Michel; Zucco, Thierry] Univ Paris 08, Lab Paragraphe, 2 Rue Liberte, F-93526 St Denis, France; [Miljkovitch, Raphaele] Facil Persons Acquired Brain Injury, Ivry, France; [Truelle, Jean-Luc; Schnitzler, Alexis] Univ Hosp, Dept Neurorehabil, Garches, France; [Onillon, Michel] French Natl Union Families Persons Acquired Brain, Paris, France; [Hawthorne, Graeme] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia		Montreuil, M (corresponding author), Univ Paris 08, Lab Psychopathol & Neuropsychol, EA 2027, 2 Rue Liberte, F-93526 St Denis, France.	michele.montreuil@univ-paris8.fr			Parlementary Fund from French National Assembly	We thank Mr. Dominique Bourgine, general manager of ADEF-residences, Mr. Michel Onillon, who got a fund for this study from a Parlementary Fund from the French National Assembly, the managers of the five facilities involved, psychologists, physicians, employees and persons with cerebral anoxia who participated in the study.	Allen JS, 2006, J CLIN EXP NEUROPSYC, V28, P457, DOI 10.1080/13803390590949287; Armengol CG, 2000, BRAIN INJURY, V14, P237, DOI 10.1080/026990500120718; Ben-Yishay Y, 2000, REHABIL PSYCHOL, V45, P112, DOI 10.1037/0090-5550.45.2.112; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Borras L, 2009, REV MED INTERNE, V30, P43, DOI 10.1016/j.revmed.2008.04.014; Cowan MJ, 2001, NURS RES, V50, P68, DOI 10.1097/00006199-200103000-00002; Deye N, 2009, REANIMATION, V18, P223; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garcia-Molina A, 2006, BRAIN INJURY, V20, P1139, DOI 10.1080/02699050600983248; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Middelkamp W, 2007, CLIN REHABIL, V21, P425, DOI 10.1177/0269215507075307; Miller WR, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-25; Mimura K, 1999, Seishin Shinkeigaku Zasshi, V101, P592; Mimura K, 2005, J NEUROIMAGING, V15, P144; Peskine A, 2010, BRAIN INJURY, V24, P755, DOI 10.3109/02699051003709581; Prigatano GP, 2013, BRAIN INJURY, V27, P1435, DOI 10.3109/02699052.2013.823665; Prigatano GP, 1986, CLIN NEUROPSYCHOLOGY, P135; Pusswald G, 2000, RESUSCITATION, V47, P241, DOI 10.1016/S0300-9572(00)00240-9; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Tazopoulou E, 2010, EDITIONS U EUROPEENN, V1, P1; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Vijayaraghavan L, 2008, NEUROPSYCHOLOGY, V22, P412, DOI 10.1037/0894-4105.22.3.412; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Wachelder M, 2007, RESUSCITATION, V80, P517; Williams G, 2012, BRAIN INJURY, V26, P1065, DOI 10.3109/02699052.2012.667586; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	6	6	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	1					95	103		10.3109/02699052.2015.1113563			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DJ8YT	WOS:000374501200014	26735867				2022-02-06	
J	Vakil, E; Hoofien, D				Vakil, Eli; Hoofien, Dan			Clinical neuropsychology in Israel: history, training, practice and future challenges	CLINICAL NEUROPSYCHOLOGIST			English	Article						Clinical neuropsychology; history; Israel	DIFFERENT MEMORY MEASURES; TRAUMATIC BRAIN-INJURY; DEVELOPMENTAL NORMS; REY AVLT; SENSITIVITY; AGE	Objective: This is an invited paper for a special issue on international perspectives on training and practice in clinical neuropsychology. We provide a review of the status of clinical neuropsychology in Israel, including the history of neuropsychological, educational, and accreditation requirements to become a clinical neuropsychologist and to practice clinical neuropsychology. Method: The information is based primarily on the personal knowledge of the authors who have been practicing clinical neuropsychology for over three decades and hold various administrative and academic positions in this field. Second, we conducted three ad hoc surveys among clinical and rehabilitation psychologists; heads of academic programs for rehabilitation and neuropsychology; and heads of accredited service providers. Third, we present a literature review of publications by clinical neuropsychologists in Israel. Results: Most of the clinical neuropsychologists are graduates of either rehabilitation or clinical training programs. The vast majority of neuropsychologists are affiliated with rehabilitation psychology. The training programs (2-3years of graduate school) provide solid therapeutic and diagnostic skills to the students. Seventy-five percent of the participants in this survey are employed at least part-time by public or state-funded institutions. Israeli neuropsychologists are heavily involved in case management, including vocational counseling, and rehabilitation psychotherapy. Conclusions and future goals: Although clinical neuropsychologists in Israel are well educated and valued by all health professionals, there are still several challenges that must be addressed in order to further advance the field and the profession. These included the need for Hebrew-language standardized and normalized neuropsychological tests and the application of evidence-based interventions in neuropsychological rehabilitation.	[Vakil, Eli] Bar Ilan Univ, Dept Psychol, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; [Hoofien, Dan] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel		Vakil, E (corresponding author), Bar Ilan Univ, Dept Psychol, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel.	vakile@mail.biu.ac.il					Ben-Yishay Y., 1978, MONOGRAPH, P1; Gross Y., 1991, MONOGRAPH, V50, P23; Gross Y., 1986, CLIN NEUROPSYCHOLOGY, P179, DOI DOI 10.1007/978-1-4613-2291-7; Hegedish O, 2013, EUR J PSYCHOL ASSESS, V29, P253, DOI 10.1027/1015-5759/a000154; Heled E, 2012, J CLIN EXP NEUROPSYC, V34, P151, DOI 10.1080/13803395.2011.625351; Hoofien D., 1991, MONOGRAPH, V50, P41; Hoofien D., 2012, J INT NEUROPSYCH SOC, V18, P140; Hoofien D., 1987, COGNITIVE REHABILITA, P259; Hoofien D, 2006, ISR J PSYCHIATR REL, V43, P296; Katz S., 1991, MONOGRAPH, V50, P9; Kave G, 2005, J CLIN EXP NEUROPSYC, V27, P690, DOI 10.1080/13803390490918499; Stern M. J., 1991, MONOGRAPH, V50, P23; VAKIL E, 1994, NEUROPSYCHOL REV, V4, P271, DOI 10.1007/BF01876078; Vakil E, 1998, CHILD NEUROPSYCHOL, V4, P161, DOI 10.1076/chin.4.3.161.3173; Vakil E, 1997, CLIN NEUROPSYCHOL, V11, P356, DOI 10.1080/13854049708400464; Vakil E., 1990, REHABILITATION BRAIN, P125	16	6	7	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2016	30	8					1267	1277		10.1080/13854046.2016.1175667			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EA8NR	WOS:000386893100009	27090578				2022-02-06	
J	Villarreal, IM; Mendez, D; Silva, JMD; del Alamo, PO				Villarreal, I. M.; Mendez, D.; Duque Silva, J. M.; Ortega del Alamo, P.			Contralateral Cochlear Labyrinthine Concussion without Temporal Bone Fracture: Unusual Posttraumatic Consequence	CASE REPORTS IN OTOLARYNGOLOGY			English	Article							SENSORINEURAL HEARING-LOSS; HEAD-INJURY	Introduction. Labyrinthine concussion is a term used to describe a rare cause of sensorineural hearing loss with or without vestibular symptoms occurring after head trauma. Isolated damage to the inner ear without involving the vestibular organ would be designated as a cochlear labyrinthine concussion. Hearing loss is not a rare finding in head trauma that involves petrous bone fractures. Nevertheless it generally occurs ipsilateral to the side of the head injury and extraordinarily in the contralateral side and moreover without the presence of a fracture. Case Report. The present case describes a 37-year-old patient with sensorineural hearing loss and tinnitus in his right ear after a blunt head trauma of the left-sided temporal bone (contralateral). Otoscopy and radiological images showed no fractures or any abnormalities. A severe sensorineural hearing loss was found in his right ear with a normal hearing of the left side. Conclusion. The temporal bone trauma requires a complete diagnostic battery which includes a neurotologic examination and a high resolution computed tomography scan in the first place. Hearing loss after a head injury extraordinarily occurs in the contralateral side of the trauma as what happened in our case. In addition, the absence of fractures makes this phenomenon even more unusual.	[Villarreal, I. M.; Mendez, D.; Duque Silva, J. M.; Ortega del Alamo, P.] Mostoles Univ Hosp, Dept Otorhinolaryngol, Madrid, Spain		Villarreal, IM (corresponding author), Mostoles Univ Hosp, Dept Otorhinolaryngol, Madrid, Spain.	imvillarrealp@gmail.com		Villarreal, Ithzel Maria/0000-0002-3886-7094			Brusis T, 2011, LARYNGO RHINO OTOL, V90, P73, DOI 10.1055/s-0030-1267938; Chiaramonte R, 2013, NEURORADIOL J, V26, P52, DOI 10.1177/197140091302600109; Daud MKM, 2009, ANN ACAD MED SINGAP, V38, P1017; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Juliano AF, 2015, RADIOLOGY, V276, P654, DOI 10.1148/radiol.2015140800; Kelly K, 1994, NEUROTOLOGY, P1127; Kennedy TA, 2014, NEUROIMAG CLIN N AM, V24, P467, DOI 10.1016/j.nic.2014.03.003; Lawrence R, 2015, CLIN OTOLARYNGOL, V40, P176, DOI 10.1111/coa.12363; Singh G, 2013, INDIAN J OTOLARYNGOL, V65, pS498, DOI 10.1007/s12070-011-0404-6; Toh A, 2010, AM J OTOLARYNG, V31, P54, DOI 10.1016/j.amjoto.2008.08.010; Ulug T, 2006, J OTOLARYNGOL, V35, P380, DOI 10.2310/7070.2006.0069	12	6	6	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-6765	2090-6773		CASE REP OTOLARYNGOL	Case Rep. Otolaryngol.		2016	2016								UNSP 2123182	10.1155/2016/2123182			4	Otorhinolaryngology	Emerging Sources Citation Index (ESCI)	Otorhinolaryngology	DY5FJ	WOS:000385124300001	27738540	Green Published, Green Submitted, gold			2022-02-06	
J	Williams, CS; Spitz, MC; Foley, JF; Weaver, LK; Lindblad, AS; Wierzbicki, MR				Williams, Christopher S.; Spitz, Mark C.; Foley, John F.; Weaver, Lindell K.; Lindblad, Anne S.; Wierzbicki, Michael R.			Baseline EEG abnormalities in mild traumatic brain injury from the BIMA study	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						mild traumatic brain injury; EEG; slowing	CONCUSSION	The Brain Injury and Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (BIMA), sponsored by the Department of Defense, is a randomized, double-blind, sham controlled trial of hyperbaric oxygen (HBO2) in service members with persistent post-concussive symptoms following mild TBI, undergoing comprehensive assessments. The clinical EEG was assessed by neurologists for slow wave activity, ictal/interictal epileptiform abnormalities, and background periodic discharges. There is scant literature about EEG findings in this population, so we report baseline clinical EEG results and explore associations with other evaluations, including demographics, medication, neurological assessments, and clinical MRI outcomes. Seventy-one participants were enrolled: median age 32 years, 99% male, 49% comorbid PTSD, 28% with mTBI in the previous year, 32% blast injuries only, and 73% multiple injuries. All participants reported medication use (mean medications = 8, SD = 5). Slowing was present in 39%: generalized 37%, localized 8%, both 6%. No other abnormalities were identified. Slowing was not significantly associated with demographics, medication or neurological evaluation. Participants without EEG abnormalities paradoxically had significantly higher number of white matter hyperintensities as identified on MRI (p = 0.003). EEG slowing is present in more than one-third of participants in this study without evidence of associations with demographics, medications or neurological findings.	[Williams, Christopher S.; Spitz, Mark C.; Foley, John F.] Lovelace Biomed Res, Albuquerque, NM USA; [Williams, Christopher S.] Univ Colorado, CHMG Neurosci, Colorado Springs, CO 80907 USA; [Spitz, Mark C.] Univ Colorado, Hlth Sci Ctr, Aurora, CO USA; [Spitz, Mark C.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Foley, John F.] Intermt LDS Hosp, Rocky Mt Neurol Associates, Salt Lake City, UT USA; [Weaver, Lindell K.] Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA; [Weaver, Lindell K.] Intermt LDS Hosp, Salt Lake City, UT 84143 USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA; [Lindblad, Anne S.; Wierzbicki, Michael R.] Emmes Corp, Rockville, MD USA		Weaver, LK (corresponding author), Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA.; Weaver, LK (corresponding author), Intermt LDS Hosp, Salt Lake City, UT 84143 USA.; Weaver, LK (corresponding author), Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA.	lindell.weaver@imail.org			U.S. Army Medical Materiel Development Activity	This work was supported by the U.S. Army Medical Materiel Development Activity. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the U.S. Army or its subordinate activities. Because the BIMA study is still ongoing, clinical trial data summarized in this publication has not yet been locked and is therefore subject to change.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BERG K, 1989, Physiotherapy Canada, V41, P304; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COOPER KH, 1968, J AMER MED ASSOC, V203, P201, DOI 10.1001/jama.203.3.201; Defense and Veterans Brain Injury Center, UND TRAUM BRAIN INJ; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; First M. B., 2012, STRUCTURED CLIN INTE; Frieden T., 2013, REPORT C TRAUMATIC B; GLOOR P, 1968, BRAIN, V91, P779, DOI 10.1093/brain/91.4.779; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LORENZON.E, 1970, ELECTROEN CLIN NEURO, V28, P216; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Temkin N, 2013, EPILEPISA S10, V44, P18; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; Warren M, 2008, TRAUMATIC BRAIN INJU; Williams CS, 2016, UNDERSEA HYPERBAR M, V43, P511	25	6	6	0	4	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.		2016	43	5			SI		521	530					10	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	EA8EE	WOS:000386867300004	28768071				2022-02-06	
J	Williams, G; Schache, AG				Williams, Gavin; Schache, Anthony G.			The distribution of positive work and power generation amongst the lower-limb joints during walking normalises following recovery from traumatic brain injury	GAIT & POSTURE			English	Article						Brain injuries; Quantitative gait analysis; Mobility limitation; Inverse dynamics	NEUROLOGIC REHABILITATION; STROKE; ANKLE; GAIT; ENERGETICS; STRENGTH; LEVEL; SPEED; HIP; POSTSTROKE	Objective: To determine whether better walking performance following recovery from traumatic brain injury (TBI) is attributable to an accentuation of compensatory strategies or an improvement in the way positive work is done and power is generated by the lower-limb joints. Setting: A large metropolitan rehabilitation hospital. Participants: Thirty-five ambulant people with extremely-severe TBI who were attending physiotherapy for mobility limitations, and a comparative sample of 25 healthy controls (HC). Design: Cross-sectional cohort study with six month follow-up. Main Measures: Positive work done and average power (i.e. over time) generation by the hip, knee and ankle during stance as well as self-selected gait velocity. Results: In comparison to HCs, TBI participants walked at baseline with a significantly (p<.01) reduced contribution from the ankle to total lower-limb average power generation (and positive work done) during stance, and a significantly (p=.03) greater contribution from the hip. However, this compensatory strategy resolved over time such that at six month follow-up no significant differences in the relative contributions from the ankle and hip were identified for the TBI participants when compared to HCs. Conclusion: Better walking performance following recovery from TBI is attributable to an improvement in the way positive work is done and power is generated by the lower-limb joints rather than an accentuation of compensatory strategies. (C) 2015 Elsevier B.V. All rights reserved.	[Williams, Gavin] Epworth Med Fdn, Melbourne, Vic, Australia; [Williams, Gavin] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic, Australia; [Schache, Anthony G.] Univ Melbourne, Dept Mech Engn, Melbourne, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	Schache, Anthony G/F-4482-2016	Schache, Anthony G/0000-0002-1041-5213; Williams, Gavin/0000-0003-2758-7473	Victorian Neurotrauma Initiative	This manuscript was funded in part by a post-doctoral scholarship obtained by Gavin Williams from the Victorian Neurotrauma Initiative.	Ada L, 2006, AUST J PHYSIOTHER, V52, P241, DOI 10.1016/S0004-9514(06)70003-4; Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Cronin NJ, 2013, J BIOMECH, V46, P1383, DOI 10.1016/j.jbiomech.2013.02.023; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; Farris DJ, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0012-x; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Morris SL, 2004, CLIN REHABIL, V18, P27, DOI 10.1191/0269215504cr699oa; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; OLNEY SJ, 1996, GAIT POSTURE, V4, P136, DOI 10.1016/0966-6362(96)01063-6; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pak S, 2008, TOP STROKE REHABIL, V15, P177, DOI 10.1310/tsr1503-177; Sawicki GS, 2009, EXERC SPORT SCI REV, V37, P130, DOI 10.1097/JES.0b013e31819c2df6; Schache A.G., 2014, J NETW SYST MANAG, P1; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; Schache AG, 2015, J EXP BIOL, V218, P2472, DOI 10.1242/jeb.119156; van de Port IGL, 2007, AM J PHYS MED REHAB, V86, P935, DOI 10.1097/PHM.0b013e31802ee464; Williams G, 2014, AM J PHYS MED REHAB, V93, P828, DOI 10.1097/PHM.0000000000000139; Williams G, 2014, AM J PHYS MED REHAB, V93, P511, DOI 10.1097/PHM.0000000000000058; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2013, J HEAD TRAUMA REHAB, V28, P371, DOI 10.1097/HTR.0b013e31824a1d40; Williams GP, 2010, J HEAD TRAUMA REHAB, V25, P164, DOI 10.1097/HTR.0b013e3181dc120b; Winter D. A., 2009, BIOMECHANICS MOTOR C, DOI 10.1002/9780470549148; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147; WINTER DA, 1983, J MOTOR BEHAV, V15, P302	29	6	6	0	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	JAN	2016	43						265	269		10.1016/j.gaitpost.2015.10.009			5	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	CY1HW	WOS:000366158300046	26531767				2022-02-06	
J	Wolf, H; Krall, C; Pajenda, G; Hajdu, S; Widhalm, H; Leitgeb, J; Sarahrudi, K				Wolf, H.; Krall, C.; Pajenda, G.; Hajdu, S.; Widhalm, H.; Leitgeb, J.; Sarahrudi, K.			Preliminary findings on biomarker levels from extracerebral sources in patients undergoing trauma surgery: Potential implications for TBI outcome studies	BRAIN INJURY			English	Article						Clinical trials; head injury; outcome; surgery; traumatic brain injury; trauma	NEURON-SPECIFIC-ENOLASE; FIBRILLARY ACIDIC PROTEIN; BILATERAL FEMUR FRACTURE; NSE SERUM MEASUREMENTS; BRAIN-INJURY; S100B LEVELS; SERIAL S100B; HEAD-INJURY; S-100B; LESIONS	Background: Despite several experimental studies on the role of S100B and NSE in fractures, no studies on the influence of surgery on the biomarker serum levels have been performed yet.Methods: The serum levels of S100B and NSE were analysed in patients with fractures that were located in the spine (group 1, n = 35) or in the lower extremity (group 2, n = 32) pre- and post-operatively.Results: The mean S100B serum level showed a significant increase (p = 0.04) post-surgery in the patients of group 1. In patients undergoing acute surgery (< 24 hours) the mean S100B serum level was 0.23 0.22 g L-1 pre-operatively and 1.24 +/- 1.38 g L-1 post-operatively. Likewise, the mean S100B serum level significantly increased in group 2 after surgery (p < 0.0001). In this group patients undergoing acute surgery showed a mean S100B serum level of 0.23 +/- 0.14 g L-1 and 1.11 +/- 0.73 g L-1 pre- and post-operatively.Conclusion: This study demonstrates significant alterations of the biomarker S100B serum levels in patients undergoing surgery. Higher S100B serum levels were found within 24 hours and might be related to the acute fracture. The NSE serum levels were unchanged and this biomarker may offer the probability to serve as a future outcome predictor in studies with patients with traumatic brain injury and additional extracerebral injuries.	[Wolf, H.; Pajenda, G.; Hajdu, S.; Widhalm, H.; Leitgeb, J.; Sarahrudi, K.] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Wolf, H.; Krall, C.] Univ Trnava, Fac Hlth Care & Social Work, Dept Publ Hlth, Trnava, Slovakia; [Wolf, H.] INRO, Vienna, Austria; [Krall, C.] Med Univ Vienna, Dept Med Stat, Vienna, Austria		Wolf, H (corresponding author), Vienna Gen Hosp, Dept Trauma Surg, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	harald.wolf@meduniwien.ac.at		Widhalm, Harald/0000-0001-9739-6176			AEBI M, 1987, ORTHOPADE, V16, P27; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Benneker LM, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-13; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Lee SJ, 2010, EMERG MED J, V27, P209, DOI 10.1136/emj.2008.063743; Lesko MM, 2014, BRAIN INJURY, V28, P987, DOI 10.3109/02699052.2014.890743; Marquardt G, 2009, ACTA NEUROCHIR, V151, P1439, DOI 10.1007/s00701-009-0408-0; Marquardt G, 2011, NEUROL RES, V33, P421, DOI 10.1179/1743132810Y.0000000005; Marquardt G, 2009, NEUROL RES, V31, P265, DOI 10.1179/174313209X382287; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pelinka LE, 2004, SHOCK, V22, P88, DOI 10.1097/01.shk.0000130157.34382.3f; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Takala RS, 2015, WORLD NEUROSURG; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Wolf H, 2014, SPINE J, V14, P2918, DOI 10.1016/j.spinee.2014.04.027; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181	26	6	6	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1220	1225		10.3109/02699052.2016.1170883			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300008	27295302				2022-02-06	
J	Zakzanis, KK; Grimes, KM; Uzzaman, S; Schmuckler, MA				Zakzanis, Konstantine K.; Grimes, Kyrsten M.; Uzzaman, Sarah; Schmuckler, Mark A.			Prospection and its relationship to instrumental activities of daily living in patients with mild traumatic brain injury with cognitive impairment	BRAIN INJURY			English	Article						Traumatic brain injury; prospection; executive functioning; activities of daily living; neuropsychology	ECOLOGICAL VALIDITY; NEUROPSYCHOLOGICAL ASSESSMENT; CLINICAL NEUROPSYCHOLOGY; POSTCONCUSSION SYMPTOMS; EXECUTIVE DYSFUNCTION; EMERGENCY-DEPARTMENT; POSTTRAUMATIC-STRESS; VERBAL FLUENCY; BASE RATES; PERFORMANCE	Objective: Prospection is the ability to plan ahead by creating a series of intentions and sequential steps to achieve a particular goal. The current study examined whether prospection was compromised in patients who had sustained a mild traumatic brain injury (mTBI) and who claimed to be disabled because of their chronic cognitive impairment, as operationalized by an inability to achieve goals (e.g. return to work) well after their expected recovery.Method: This study employed the Tower of London (TOL) to measure prospection and compared two groups of patients who sustained a mTBI who both presented with cognitive impairment, but were or were not disabled in terms of their real world functioning (as defined by their instrumental activities of daily living, IADLs).Results: The results revealed that the TOL could reliably discriminate between these two groups. In subsequent structural equation modelling, TOL scores were used to create a prospection model that was able to predict IADLs functioning.Conclusions: This study demonstrates that prospection is a critical component of one's ability to function independently following the onset of a mTBI when chronic cognitive impairment is evident and that clinicians should routinely investigate prospection in this context.	[Zakzanis, Konstantine K.; Grimes, Kyrsten M.; Uzzaman, Sarah; Schmuckler, Mark A.] Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada		Zakzanis, KK (corresponding author), Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	zakzanis@utsc.utoronto.ca	Schmuckler, Mark/ABE-7557-2020; Schmuckler, Mark/O-9491-2015	Schmuckler, Mark/0000-0002-9945-6141; Schmuckler, Mark/0000-0002-9945-6141			Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Arenth PM, 2012, J CLIN EXP NEUROPSYC, V34, P333, DOI 10.1080/13803395.2011.633896; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Campbell Z, 2009, APPL NEUROPSYCHOL, V16, P295, DOI 10.1080/09084280903297891; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Cohen J., 2013, STAT POWER ANAL BEHA; Culbertson W C, 2005, TOWER LONDON DREXEL; Davies SR, 2011, J CLIN EXP NEUROPSYC, V33, P820, DOI 10.1080/13803395.2011.574608; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Goldstein, 1996, ECOLOGICAL VALIDITY, P75; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Grant I., 2010, NEUROPSYCHOLOGY EVER, P93; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Heaton, 2010, NEUROPSYCHOLOGY EVER, P5; Howieson D. B., 2002, NEUROPSYCHOLOGICAL E; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Koehler M, 2011, DEMENT GERIATR COGN, V31, P81, DOI 10.1159/000323315; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kumar S, 2013, CLIN NEUROL NEUROSUR, V115, P1326, DOI 10.1016/j.clineuro.2012.12.038; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MAHURIN RK, 1991, J GERONTOL, V46, pP58, DOI 10.1093/geronj/46.2.P58; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Pontifex MB, 2012, RES Q EXERCISE SPORT, V83, P553; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Schmuckler MA, 2001, INFANCY, V2, P419, DOI 10.1207/S15327078IN0204_02; Schnabel R, 2012, CLIN NEUROPSYCHOL, V26, P769, DOI 10.1080/13854046.2012.693541; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stroop JR, 1935, J EXP PSYCHOL, V18, P420; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Torralva T, 2012, BIPOLAR DISORD, V14, P118, DOI 10.1111/j.1399-5618.2012.00987.x; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Wechsler D., 2011, WECHSLER ABBREVIATED; Zakzanis KK, 1998, J CLIN EXP NEUROPSYC, V20, P419, DOI 10.1076/jcen.20.3.419.821; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zakzanis KK, 2004, HELLENIC J PSYCHOL, V1, P326; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496	65	6	6	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	8					986	992		10.3109/02699052.2016.1147077			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DS6OP	WOS:000380901800006	27110863				2022-02-06	
J	Brown, AW; Moessner, AM; Bergquist, TF; Kendall, KS; Diehl, NN; Mandrekar, J				Brown, Allen W.; Moessner, Anne M.; Bergquist, Thomas F.; Kendall, Kathryn S.; Diehl, Nancy N.; Mandrekar, Jay			A randomized practical behavioural trial of curriculum- based advocacy training for individuals with traumatic brain injury and their families	BRAIN INJURY			English	Article							COMMUNITY-BASED ADVOCACY; LONG-TERM SURVIVAL; INTERVENTION PROGRAM; ABUSIVE PARTNERS; CLINICAL-TRIALS; CHINESE WOMEN; HEALTH; DISABILITIES; SPECTRUM; VIOLENCE		[Brown, Allen W.; Moessner, Anne M.; Kendall, Kathryn S.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; [Bergquist, Thomas F.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Diehl, Nancy N.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Mandrekar, Jay] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Mandrekar, Jay] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA		Brown, AW (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 100 First St SW, Rochester, MN 55905 USA.	brown.allen@mayo.edu		Brown, Allen W./0000-0001-7228-3351	Department of Education, National Institute on Disability and Rehabilitation Research, Mayo Clinic TBI Model System Center [H133A070013]	No competing financial interests exist for any author. This study was funded by the Department of Education, National Institute on Disability and Rehabilitation Research, Mayo Clinic TBI Model System Center Grant H133A070013.	BALCAZAR FE, 1990, AM J COMMUN PSYCHOL, V18, P281, DOI 10.1007/BF00931305; Balcazar FE, 1996, MENT RETARD, V34, P341; Brass EP, 2010, CLIN PHARMACOL THER, V87, P351, DOI 10.1038/clpt.2009.218; Brown AW, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318280d3e6; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Davis C, 2001, EUR J CANCER CARE, V10, P82, DOI 10.1046/j.1365-2354.2001.00250.x; Finkelstein E., 2006, INCIDENCE EC BURDEN; Glasgow RE, 2006, ANN BEHAV MED, V31, P5, DOI 10.1207/s15324796abm3101_3; Goodkind JR, 2005, AM J COMMUN PSYCHOL, V36, P387, DOI 10.1007/s10464-005-8633-z; Hermoso J, 2006, J GERONTOL SOC WORK, V48, P179, DOI 10.1300/J083v48n01_12; Kelly JA, 1997, PSYCHIATR SERV, V48, P1283; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; LOZANO P, 1994, PEDIATRICS, V94, P532; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; McKirnan DJ, 2010, J CONSULT CLIN PSYCH, V78, P952, DOI 10.1037/a0020759; MDHS, 1994, VIS FUT TBI TOWN M 1; Paterniti DA, 2006, ACAD MED, V81, P347, DOI 10.1097/00001888-200604000-00008; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Roessler RT, 1998, J POSTSECONDARY ED D, V13, P18; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; SIEVERT AL, 1988, J APPL BEHAV ANAL, V21, P299, DOI 10.1901/jaba.1988.21-299; SULLIVAN CM, 1994, AM J COMMUN PSYCHOL, V22, P101, DOI 10.1007/BF02506819; SULLIVAN CM, 1992, AM J COMMUN PSYCHOL, V20, P309, DOI 10.1007/BF00937912; Sullivan CM, 1999, J CONSULT CLIN PSYCH, V67, P43, DOI 10.1037/0022-006X.67.1.43; Thorpe KE, 2009, CAN MED ASSOC J, V180, pE47, DOI 10.1503/cmaj.090523; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tiwari A, 2012, INT J NURS STUD, V49, P645, DOI 10.1016/j.ijnurstu.2011.12.005; Tiwari A, 2010, JAMA-J AM MED ASSOC, V304, P536, DOI 10.1001/jama.2010.1052; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Winkleby MA, 2004, ARCH PEDIAT ADOL MED, V158, P269, DOI 10.1001/archpedi.158.3.269; ZIRPOLI TJ, 1994, MENT RETARD, V32, P422	36	6	6	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1530	1538		10.3109/02699052.2015.1075173			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800002	26488141				2022-02-06	
J	Hill-Jarrett, TG; Gravano, JT; Sozda, CN; Perlstein, WM				Hill-Jarrett, Tanisha G.; Gravano, Jason T.; Sozda, Christopher N.; Perlstein, William M.			Visuospatial attention after traumatic brain injury: The role of hemispheric specialization	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; STIMULUS-DRIVEN ATTENTION; FIELD-OF-VIEW; VISUAL-ATTENTION; NETWORK TEST; REACTION-TIME; MILD; DEFICITS; INDEPENDENCE; PERFORMANCE		[Hill-Jarrett, Tanisha G.; Gravano, Jason T.; Perlstein, William M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA; [Sozda, Christopher N.] VA Northern Calif Hlth Care Syst, Martinez, CA USA; [Perlstein, William M.] Malcom Randall VA, VA RR&D Brain Rehabil & Res Ctr Excellence, Gainesville, FL USA		Perlstein, WM (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.	wmp@phhp.ufl.edu		Hill-Jarrett, Tanisha/0000-0002-6924-0702	American Psychological Association (APA) Dissertation Research Award	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This work was supported by a 2011 American Psychological Association (APA) Dissertation Research Award awarded to CNS.	Arrington CM, 2000, J COGNITIVE NEUROSCI, V12, P106, DOI 10.1162/089892900563975; Asanowicz D, 2012, BRAIN COGNITION, V79, P117, DOI 10.1016/j.bandc.2012.02.014; Asplund CL, 2010, NAT NEUROSCI, V13, P507, DOI 10.1038/nn.2509; Audet T, 2000, BRAIN COGNITION, V43, P17; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; Barlow-Ogden K, 2012, J REHABIL RES DEV, V49, P1101, DOI 10.1682/JRRD.2010.09.0188; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Calleja A, 2005, EXPT BRAIN RES, V167, P2737; Callejas A, 2004, BRAIN COGNITION, V54, P225, DOI 10.1016/j.bandc.2004.02.012; Chen P, 2014, NEUROLOGY S, V82, p[289, 7]; Chica AB, 2014, NEUROSCI BIOBEHAV R, V40, P35, DOI 10.1016/j.neubiorev.2014.01.002; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CREMONAMETEYARD SL, 1992, NEUROPSYCHOLOGIA, V30, P123, DOI 10.1016/0028-3932(92)90022-E; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J., 2008, TOPICS INTEGRATIVE N, P31, DOI DOI 10.1017/CBO9780511541681.005; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Goode KT, 1998, J CLIN PSYCHOL MED S, V5, P425, DOI 10.1023/A:1026206927686; Grandori F., 1990, AUDITORY EVOKED MAGN, V6, P40; Greene DJ, 2008, BRAIN COGNITION, V66, P21, DOI 10.1016/j.bandc.2007.05.003; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Han YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100454; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; MacLeod JW, 2010, NEUROPSYCHOLOGY, V24, P637, DOI 10.1037/a0019803; McGinley JJ, 2000, ALCOHOLISM TREATMENT, V19, P33; Neuhaus AH, 2010, INT J PSYCHOPHYSIOL, V76, P72, DOI 10.1016/j.ijpsycho.2010.02.005; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Pavlovskaya M, 2007, BRAIN COGNITION, V64, P21, DOI 10.1016/j.bandc.2006.10.003; Pavlovskaya M, 2007, BRAIN INJURY, V21, P489, DOI 10.1080/02699050701311117; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011; Poynter W, 2010, BRAIN COGNITION, V72, P355, DOI 10.1016/j.bandc.2009.10.014; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Redick TS, 2006, APPL COGNITIVE PSYCH, V20, P713, DOI 10.1002/acp.1224; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Urbanek C, 2010, MULT SCLER J, V16, P93, DOI 10.1177/1352458509350308; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; Whyte J., 2004, REHABILITATION MED P, P1677; Wood JM, 2012, OPTOMETRY VISION SCI, V89, P373, DOI 10.1097/OPX.0b013e31824c17ee; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924	55	6	6	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1617	1629		10.3109/02699052.2015.1075155			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800012	26451899				2022-02-06	
J	Pang, EW				Pang, Elizabeth W.			Different Neural Mechanisms Underlie Deficits in Mental Flexibility in Post-traumatic stress Disorder compared to Mild traumatic Brain injury	FRONTIERS IN PSYCHIATRY			English	Article						mental flexibility; executive function; set-shifting; post-traumatic stress disorder; traumatic brain injury; concussion; magnetoencephalography; functional connectivity	CARD SORTING TEST; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; FRONTAL LOBES; FUNCTIONAL CONNECTIVITY; COGNITIVE SEQUELAE; VIETNAM VETERANS; IMAGING APPROACH; WORKING-MEMORY; MEG	Mental flexibility is a core executive function that underlies the ability to adapt to changing situations and respond to new information. Individuals with post-traumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI) complain of a number of executive function difficulties, one of which is mental inflexibility or an inability to switch between concepts. While the behavioral presentation of mental inflexibility is similar in those with PTSD or mTBI, we hypothesized that the differences in their etiology would manifest as differences in their underlying brain processing. The neural substrates of mental flexibility have been examined with a number of neuroimaging modalities. Functional magnetic resonance imaging has elucidated the brain regions involved, whereas electroencephalography has been applied to understand the timing of the brain activations. Magnetoencephalography, with its high temporal and spatial resolution, has more recently been used to delineate the spatiotemporal progression of brain processes involved in mental flexibility and has been applied to the study of clinical populations. In a number of separate studies, our group has compared the source localization and brain connectivity during a mental flexibility set-shifting task in a group of soldiers with PTSD and civilians with an acute mTBI. In this article, we review the results from these studies and integrate the data between groups to compare and contrast differences in behavioral, neural, and connectivity findings. We show that the different etiologies of PTSD and mTBI are expressed as distinct neural profiles for mental flexibility that differentiate the groups despite their similar clinical presentations.	[Pang, Elizabeth W.] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Pang, Elizabeth W.] Sick Kids Res Inst, Neurosci & Mental Hlth, Toronto, ON, Canada; [Pang, Elizabeth W.] Univ Toronto, Fac Med, Toronto, ON, Canada		Pang, EW (corresponding author), Hosp Sick Children, Div Neurol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	elizabeth.pang@sickkids.ca					Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Dunkley BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123541; GURVITS TV, 1993, J NEUROPSYCH CLIN N, V5, P183; Hari R, 2012, NEUROIMAGE, V61, P386, DOI 10.1016/j.neuroimage.2011.11.074; Henaff MA, 2010, CLIN NEUROPHYSIOL, V121, P508, DOI 10.1016/j.clinph.2009.11.082; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI [10.1586/ern.10.198, 10.1586/ERN.10.198]; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Konishi S, 2002, P NATL ACAD SCI USA, V99, P7803, DOI 10.1073/pnas.122644899; Konishi S, 1999, CEREB CORTEX, V9, P745, DOI 10.1093/cercor/9.7.745; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.2005.10.031; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Milner B, 1963, ARCH NEUROL-CHICAGO, V9, P100, DOI DOI 10.1001/ARCHNEUR.1963.00460070100010; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Nagahama Y, 2001, CEREB CORTEX, V11, P85, DOI 10.1093/cercor/11.1.85; Nagahama Y, 1998, NEUROREPORT, V9, P2633, DOI 10.1097/00001756-199808030-00038; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oh A, 2014, BRAIN COGNITION, V86, P90, DOI 10.1016/j.bandc.2014.02.006; Pang EW, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.63; Perianez JA, 2004, NEUROIMAGE, V21, P687, DOI 10.1016/j.neuroimage.2003.10.008; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rogers RD, 2000, J COGNITIVE NEUROSCI, V12, P142, DOI 10.1162/089892900561931; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Simmons A, 2009, PSYCHOSOM MED, V71, P373, DOI 10.1097/PSY.0b013e3181a56ed8; Simmons AN, 2012, NEUROREPORT, V23, P234, DOI 10.1097/WNR.0b013e3283503275; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Taylor MJ, 2012, NEUROPHYSIOL CLIN, V42, P19, DOI 10.1016/j.neucli.2011.08.002; Taylor MJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00453; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Wang LH, 2001, COGNITIVE BRAIN RES, V12, P19, DOI 10.1016/S0926-6410(01)00022-2	54	6	6	0	14	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	DEC 3	2015	6								170	10.3389/fpsyt.2015.00170			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	CZ2LW	WOS:000366937700001	26696907	gold, Green Published			2022-02-06	
J	Birnbaum, FA; Hackley, SA; Johnson, LN				Birnbaum, Faith A.; Hackley, Steven A.; Johnson, Lenworth N.			Enhancing visual performance in individuals with cortical visual impairment (homonymous hemianopsia): Tapping into blindsight	JOURNAL OF MEDICAL HYPOTHESES AND IDEAS			English	Article						Blindsight; Cortical blindness; Homonymous hemianopsia; Augmented virtual reality; Vision restoration therapy		Homonymous hemianopsia is a type of cortical blindness in which vision is lost completely or partially in the left half or the right half of the field of vision. It is prevalent in approximately 12% of traumatic brain injury and 35% of strokes. Patients often experience difficulty with activities such as ambulating, eating, reading, and driving. Due to the high prevalence of homonymous hemianopsia and its associated difficulties, it is imperative to find methods for visual rehabilitation in this condition. Traditional methods such as prism glasses can cause visual confusion and result in patient noncompliance. There is a large unmet medical need for improving this condition. In this article, we propose that modifying visual stimuli to activate non-cortical areas of visual processing, such as lateral geniculate nucleus and superior colliculus, may result in increased visual awareness. Presenting high contrast and low spatial frequency visual stimuli can increase visual detection in patients with cortical blindness, a phenomenon known as blindsight. Augmented virtual reality goggles have the potential to alter real-time visual input to high contrast and low spatial frequency images, possibly improving visual detection in the blind hemifield and providing an alternative therapy for homonymous hemianopsia. (C) 2016 Tehran University of Medical Sciences. Published by Elsevier Ltd.	[Birnbaum, Faith A.; Johnson, Lenworth N.] Brown Univ, Dept Ophthalmol, Warren Alpert Med Sch, Neuro Ophthalmol Unit,Lifespan,Rhode Isl Hosp, Providence, RI 02912 USA; [Hackley, Steven A.] Univ Missouri Columbia, Dept Psychol Sci, Columbia, MO USA		Johnson, LN (corresponding author), Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Neuro Ophthalmol Unit,Dept Ophthalmol, 1 Hoppin St,Suite 200, Providence, RI 02903 USA.	LJohnson12@Lifespan.org					Ajina S, 2015, ELIFE, V4, DOI 10.7554/eLife.08935; Ali M, 2013, NEUROREHAB NEURAL RE, V27, P133, DOI 10.1177/1545968312454683; Balasubramanian V, 2009, J PHYSIOL-LONDON, V587, P2753, DOI 10.1113/jphysiol.2009.170704; Baylis G, 2002, NEUROPSYCHOLOGIA, V40, P1027, DOI 10.1016/S0028-3932(01)00144-0; Bruce BB, 2006, J NEUROL NEUROSUR PS, V77, P986, DOI 10.1136/jnnp.2006.088799; Cate A, 2002, NEUROPSYCHOLOGIA, V40, P2206, DOI 10.1016/S0028-3932(02)00128-8; Cowey A, 1998, CONSCIOUS COGN, V7, P312, DOI 10.1006/ccog.1998.0359; Das A, 2014, J NEUROSCI, V34, P11652, DOI 10.1523/JNEUROSCI.1076-14.2014; de Haan B, 2012, NEUROPSYCHOLOGIA, V50, P1045, DOI 10.1016/j.neuropsychologia.2012.02.015; de Haan GA, 2015, J NEURO-OPHTHALMOL, V35, P259, DOI 10.1097/WNO.0000000000000244; Grunda T, 2013, ACTA NEUROBIOL EXP, V73, P237; Johnson LN, 1996, ARCH OPHTHALMOL-CHIC, V114, P171, DOI 10.1001/archopht.1996.01100130165009; Kleiser R, 2001, NEUROIMAGE, V13, P654, DOI 10.1006/nimg.2000.0720; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; MEIENBERG O, 1986, J NEUROL, V233, P97, DOI 10.1007/BF00313854; Miesner N., 2004, TOP GERIATR REHABIL, V20, P212, DOI DOI 10.1097/00013614-200407000-00009; Perez C., 2014, FRONTIERS INTEGRATIV, V8, P1; RAFAL R, 1990, SCIENCE, V250, P118, DOI 10.1126/science.2218503; Rorden C, 1997, NEUROPSYCHOLOGIA, V35, P421, DOI 10.1016/S0028-3932(96)00093-0; Sahraie A, 2003, EUR J NEUROSCI, V18, P1189, DOI 10.1046/j.1460-9568.2003.02853.x; Sahraie A, 2008, NEUROPSYCHOLOGIA, V46, P879, DOI 10.1016/j.neuropsychologia.2007.11.008; Sahraie A, 2010, P NATL ACAD SCI USA, V107, P21217, DOI 10.1073/pnas.1015652107; Schmid MC, 2010, NATURE, V466, P373, DOI 10.1038/nature09179; Seifert D, 2010, CONSCIOUS COGN, V19, P144, DOI 10.1016/j.concog.2010.01.005; Sinha P, 2013, SCI AM, V309, P48, DOI 10.1038/scientificamerican0713-48; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25	26	6	6	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2251-7294			J MED HYPOTHESES IDE	J. Med. Hypotheses Ideas	DEC	2015	9	2		S			S8	S13		10.1016/j.jmhi.2015.12.001			6	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	V4D7T	WOS:000218839600003		hybrid			2022-02-06	
J	Bleton, H; Sejdic, E				Bleton, Heloise; Sejdic, Ervin			A cerebral blood flow evaluation during cognitive tasks following a cervical spinal cord injury: a case study using transcranial Doppler recordings	COGNITIVE NEURODYNAMICS			English	Article						Transcranial Doppler; Spinal cord injury; Cognitive tasks; Cerebral blood flow velocity; Signal processing	LEMPEL-ZIV COMPLEXITY; VELOCITY CHANGES; LANGUAGE LATERALIZATION; BRAIN LATERALIZATION; CARBON-DIOXIDE; ARTERY; PERFORMANCE; ULTRASOUND; SONOGRAPHY; SIGNALS	A spinal cord injury (SCI) is one of the most common neurological disorders. In this paper, we examined the consequences of upper SCI in a male participant on the cerebral blood flow velocity. In particular, transcranial Doppler was used to study these effects through middle cerebral arteries (MCA) during resting-state periods and during cognitive challenges (non-verbal word-generation tasks and geometric-rotation tasks). Signal characteristics were analyzed from raw signals and envelope signals (maximum velocity) in the time domain, the frequency domain and the time-frequency domain. The frequency features highlighted an increase of the peak frequency in L-MCA and R-MCA raw signals, which revealed stronger cerebral blood flow during geometric/verbal processes respectively. This underlined a slight dominance of the right hemisphere during word-generation periods and a slight dominance of the left hemisphere during geometric processes. This finding was confirmed by cross-correlation in the time domain and by the entropy rate in information-theoretic domain. A comparison of our results to other neurological disorders (Alzheimer's disease, Parkinson's disease, autism, epilepsy, traumatic brain injury) showed that the SCI had similar effects such as general decreased cerebral blood flow and similar regular hemispheric dominance in a few cases.	[Bleton, Heloise; Sejdic, Ervin] Univ Pittsburgh, Dept Elect & Comp Engn, Pittsburgh, PA 15261 USA		Sejdic, E (corresponding author), Univ Pittsburgh, Dept Elect & Comp Engn, Pittsburgh, PA 15261 USA.	esejdic@ieee.org			NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024827] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG024827] Funding Source: Medline		AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Abasolo D, 2006, MED ENG PHYS, V28, P315, DOI 10.1016/j.medengphy.2005.07.004; Aboy M, 2006, IEEE T BIO-MED ENG, V53, P2282, DOI 10.1109/TBME.2006.883696; Adcock JE, 2003, NEUROIMAGE, V18, P423, DOI 10.1016/S1053-8119(02)00013-7; Ahmed SU, 2011, INT J NEURAL SYST, V21, P427, DOI 10.1142/S0129065711002936; Alexandrov AV, 2007, J NEUROIMAGING, V17, P11, DOI 10.1111/j.1552-6569.2006.00088.x; Allen JJB, 2004, BIOL PSYCHOL, V67, P183, DOI 10.1016/j.biopsycho.2004.03.007; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; BODE H, 1992, EUR J PEDIATR, V151, P706, DOI 10.1007/BF01957579; BRASS LM, 1988, STROKE, V19, P1466, DOI 10.1161/01.STR.19.12.1466; Bridge PD, 1999, J CLIN EPIDEMIOL, V52, P229, DOI 10.1016/S0895-4356(98)00168-1; BullaHellwig M, 1996, NEUROPSYCHOLOGIA, V34, P987, DOI 10.1016/0028-3932(96)00021-8; Burgin WS, 2000, STROKE, V31, P1128, DOI 10.1161/01.STR.31.5.1128; Burroni L, 2008, NUCL MED COMMUN, V29, P150, DOI 10.1097/MNM.0b013e3282f1bb8e; Catz A, 2007, AM J PHYS MED REHAB, V86, P875, DOI 10.1097/PHM.0b013e3181583caf; Cirak B, 2004, J PEDIATR SURG, V39, P607, DOI 10.1016/j.jpedsurg.2003.12.011; Claassen JAHR, 2009, J ALZHEIMERS DIS, V17, P621, DOI 10.3233/JAD-2009-1079; COMPTON JS, 1987, J NEUROL NEUROSUR PS, V50, P1499, DOI 10.1136/jnnp.50.11.1499; Costa M, 1998, PSYCHOPHYSIOLOGY, V35, P737; Cupini LM, 1996, BRAIN, V119, P1249, DOI 10.1093/brain/119.4.1249; Curt A, 2004, J NEUROTRAUM, V19, P43; Davidoff G, 1990, Arch Clin Neuropsychol, V5, P77, DOI 10.1016/0887-6177(90)90009-E; DAWSON G, 1982, BRAIN LANG, V15, P353, DOI 10.1016/0093-934X(82)90065-7; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Deppe M, 2004, NEUROIMAGE, V21, P1124, DOI 10.1016/j.neuroimage.2003.10.016; Deppe M, 1997, J NEUROSCI METH, V75, P147, DOI 10.1016/S0165-0270(97)00067-8; DePuy V., 2005, ENCY STAT BEHAV SCI; Derejko M, 2006, NUCL MED COMMUN, V27, P945, DOI 10.1097/01.mnm.0000243370.18883.62; Diehl B, 1997, STROKE, V28, P2457, DOI 10.1161/01.STR.28.12.2457; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; DROSTE DW, 1989, NEUROPSYCHOLOGIA, V27, P1221, DOI 10.1016/0028-3932(89)90034-1; DROSTE DW, 1989, STROKE, V20, P1005, DOI 10.1161/01.STR.20.8.1005; Duschek S, 2004, PSYCHOPHYSIOLOGY, V41, P905, DOI 10.1111/j.1469-8986.2004.00249.x; Duschek S, 2003, CLIN AUTON RES, V13, P427, DOI 10.1007/s10286-003-0124-4; Escalante-Mead PR, 2003, J AUTISM DEV DISORD, V33, P539, DOI 10.1023/A:1025887713788; Everts R, 2010, EPILEPSIA, V51, P627, DOI 10.1111/j.1528-1167.2009.02406.x; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Gao JB, 2011, COGN NEURODYNAMICS, V5, P171, DOI 10.1007/s11571-011-9151-3; GEORGE MS, 1992, J NERV MENT DIS, V180, P413, DOI 10.1097/00005053-199207000-00002; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; GONZALEZ F, 1991, PARAPLEGIA, V29, P1, DOI 10.1038/sc.1991.1; Han CX, 2013, COGN NEURODYNAMICS, V7, P351, DOI 10.1007/s11571-013-9247-z; HARTJE W, 1994, NEUROPSYCHOLOGIA, V32, P1443, DOI 10.1016/0028-3932(94)90116-3; Hayman G, 1970, AM MATH SOC; Hilton ML, 1997, IEEE T BIO-MED ENG, V44, P394, DOI 10.1109/10.568915; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; HOSKING JRM, 1990, J ROY STAT SOC B MET, V52, P105; Houtman S, 2001, J APPL PHYSIOL, V91, P2199, DOI 10.1152/jappl.2001.91.5.2199; Hu J, 2006, IEEE T BIO-MED ENG, V53, P2606, DOI 10.1109/TBME.2006.883825; Joo EY, 2008, J NEUROL, V255, P520, DOI 10.1007/s00415-008-0727-8; KELLEY RE, 1992, STROKE, V23, P9, DOI 10.1161/01.STR.23.1.9; Knake S, 2003, NEUROIMAGE, V19, P1228, DOI 10.1016/S1053-8119(03)00174-5; Knecht S, 1998, STROKE, V29, P82, DOI 10.1161/01.STR.29.1.82; Krassioukov A, 2009, RESP PHYSIOL NEUROBI, V169, P157, DOI 10.1016/j.resp.2009.08.003; Krejza J, 1999, AM J ROENTGENOL, V172, P213, DOI 10.2214/ajr.172.1.9888770; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; Lee J, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-7; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Li M, 2014, NEUROSCI RES, V84, P19, DOI 10.1016/j.neures.2014.02.009; LINDEGAARD KF, 1987, STROKE, V18, P1025, DOI 10.1161/01.STR.18.6.1025; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Morris J, 1986, J HEAD TRAUMA REHAB, V1, P31; Morris MC, 2002, NEUROEPIDEMIOLOGY, V21, P123, DOI 10.1159/000054809; Nanda R N, 1974, Paraplegia, V12, P212; Nishida H, 2014, COGN NEURODYNAMICS, V8, P363, DOI 10.1007/s11571-014-9289-x; Oja H, 1990, STAT PROBABIL LETT, V1, P327; Papoulis A., 1991, PROBABILITY RANDOM V; Phillips AA, 2013, J NEUROTRAUM, V30, P1551, DOI 10.1089/neu.2013.2972; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Porta A, 1998, BIOL CYBERN, V78, P71, DOI 10.1007/s004220050414; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Rasmussen T, 1977, Ann N Y Acad Sci, V299, P355, DOI 10.1111/j.1749-6632.1977.tb41921.x; REID JM, 1972, SCIENCE, V176, P1235, DOI 10.1126/science.176.4040.1235; Ringelstein EB, 1998, STROKE, V29, P725; Rombouts SARB, 2005, NEUROIMAGE, V26, P1078, DOI 10.1016/j.neuroimage.2005.03.022; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; Sadowsky C, 2002, DISABIL REHABIL, V24, P680, DOI 10.1080/09638280110110640; Schmidt P, 1999, STROKE, V30, P939, DOI 10.1161/01.STR.30.5.939; SCHNEIDER PA, 1988, STROKE, V19, P589, DOI 10.1161/01.STR.19.5.589; Scott JM, 2011, SPINAL CORD, V49, P4, DOI 10.1038/sc.2010.53; Sejdic E, 2013, PLOS ONE, V8; Sejdic E, 2009, DIGIT SIGNAL PROCESS, V19, P153, DOI 10.1016/j.dsp.2007.12.004; Shih WJ, 1999, CLIN NUCL MED, V24, P773, DOI 10.1097/00003072-199910000-00008; Silvestrini M, 2006, STROKE, V37, P1010, DOI 10.1161/01.STR.0000206439.62025.97; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Standring S., 2008, GRAYS ANATOMY ANATOM, V40th; Szirmai I, 2010, J NEUROSURG, VJ Neurosurg 112, P37; Tachibana H, 1993, DEMENT GERIATR COGN; TIAO GC, 1981, J AM STAT ASSOC, V76, P802, DOI 10.2307/2287575; Tzeng YC, 2010, J APPL PHYSIOL, V108, P1162, DOI 10.1152/japplphysiol.01390.2009; Vergara L, 2004, SIGNAL PROCESS, V84, P2315, DOI 10.1016/j.sigpro.2004.07.025; Vingerhoets G, 1999, STROKE, V30, P2152, DOI 10.1161/01.STR.30.10.2152; Wecht JM, 2012, CLIN AUTON RES, V22, P25, DOI 10.1007/s10286-011-0139-1; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; Whitehouse AJO, 2008, BRAIN, V131, P3193, DOI 10.1093/brain/awn266; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; ZANETTE EM, 1989, STROKE, V20, P899, DOI 10.1161/01.STR.20.7.899; Zoubir AM, 1998, IEEE SIGNAL PROC MAG, V15, P56, DOI 10.1109/79.647043	102	6	8	1	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1871-4080	1871-4099		COGN NEURODYNAMICS	Cogn. Neurodynamics	DEC	2015	9	6					615	626		10.1007/s11571-015-9355-z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB5DP	WOS:000368534600006	26557931	Green Published			2022-02-06	
J	Chase, RP; McMahon, SA; Winch, PJ				Chase, Rachel P.; McMahon, Shannon A.; Winch, Peter J.			Injury careers after blast exposure among combat veterans deployed to Iraq or Afghanistan	SOCIAL SCIENCE & MEDICINE			English	Article						Military personnel; Veterans; Invisible injuries; Blast injuries; Traumatic brain injury; Mental health; Combat injuries; Health careseeking behavior	TRAUMATIC BRAIN-INJURY; FATIGUE; PEOPLE	During the Iraq and Afghanistan wars, blasts were the most common cause of combat injuries, including traumatic brain injury (TBI). Prior to 2007, service members were not systematically screened for TBI, and estimates suggest that tens of thousands of mild TBIs went undiagnosed. This study sought to understand post-acute "injury careers," documenting the life- and health-related narratives of veterans who were at high risk of undocumented TBI due to being blast-exposed before 2007. Researchers conducted 38 in-depth interviews between May 2013 and August 2014 with Army veterans who served in combatintense settings (n = 16) and their family members (n = 10). Respondents detailed a series of experiences in the months and years following blast exposure. We present this series as a model that draws upon the vernacular of participants who described veterans "downplaying" their injuries and later "detaching" themselves from friends, family, and communities, and "denying" or being "oblivious" to their circumstances until a "wake-up call" pushed them to "get help." Looking to the future, veterans grapple with uncertainties related to personal identity and professional or social expectations. This model is presented within a member-checked metaphor of an individual being hurled into - and emerging from - a canyon. Policies and programs addressing veteran health, particularly among those exposed to multiple blasts prior to systematic TBI documentation, must consider the personal, social, and health system challenges faced by veterans and their families throughout their injury careers. (C) 2015 Elsevier Ltd. All rights reserved.	[Chase, Rachel P.; McMahon, Shannon A.; Winch, Peter J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [McMahon, Shannon A.] Heidelberg Univ, Inst Publ Hlth, D-69120 Heidelberg, Germany		Chase, RP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	rachel.chase@jhu.edu; shannon.mcmahon@jhu.edu; pwinch@jhu.edu		Chase, Rachel/0000-0002-1503-4954; McMahon, Shannon/0000-0002-8634-9283	National Institute of Mental Health of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [F31MH095653]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [F31MH095653] Funding Source: NIH RePORTER	The National Institute of Mental Health of the National Institutes of Health supported Shannon A. McMahon via an Individual Pre-doctoral Fellowship (Parent F31) the "Ruth L. Kirschstein National Research Service Award (NRSA)" (Award F31MH095653). The content is the responsibility of the authors and does not necessarily represent the National Institutes of Health or the United States Government. The authors wish to acknowledge Dr. Mary Cwik, Dr. Namrita Singh, Paul Horn, and the veterans and family members who participated in this study.	BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cemak I., 2010, J CEREB BLOOD FLOW M, V30, P255; Charmaz, 1991, GOOD DAYS BAD DAYS S; Chase R. P., 2015, MILITARY ME IN PRESS; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Defense and Veterans Brain Injury Center, 2014, WHAT AR RISKS COSTS; Fisher B. J, 1987, QUALITATIVE SOCIOLOG, V10, P132, DOI DOI 10.1007/BF00988525; Foley G, 2014, SOC SCI MED, V101, P113, DOI 10.1016/j.socscimed.2013.11.003; Glaser B.G., 1968, A TIME FOR DYING; Goffman E., 1961, ASYLUMS; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jeste DV, 2007, ARCH GEN PSYCHIAT, V64, P966, DOI 10.1001/archpsyc.64.8.966; Kendall E, 2008, SOC SCI MED, V67, P1217, DOI 10.1016/j.socscimed.2008.05.033; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; KUBLERROSS E, 1997, DEATH DYING; Lazarus RS, 1987, EUR J PERSONAL, V1, P141, DOI [10.1002/per.2410010304, DOI 10.1002/PER.2410010304]; McCrickerd J, 2000, J MED ETHICS, V26, P340, DOI 10.1136/jme.26.5.340; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pescosolido B.A., 2010, HDB SOCIOLOGY HLTH I; Pescosolido BA, 1998, SOC SCI MED, V46, P275, DOI 10.1016/S0277-9536(97)00160-3; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; RIDLEY B, 1989, SOC SCI MED, V29, P555, DOI 10.1016/0277-9536(89)90201-3; Rosenfeld D., 2006, SOCIAL THEORY HLTH, V4, P64; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Stockl A, 2007, SOC SCI MED, V65, P1549, DOI 10.1016/j.socscimed.2007.05.016; Taber KH, 2014, J HEAD TRAUMA REHABI; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	34	6	7	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	DEC	2015	147						309	316		10.1016/j.socscimed.2015.11.015			8	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	DA2PA	WOS:000367637100037	26618495				2022-02-06	
J	Damkliang, J; Considine, J; Kent, B; Street, M				Damkliang, Jintana; Considine, Julie; Kent, Bridie; Street, Maryann			Using an evidence-based care bundle to improve initial emergency nursing management of patients with severe traumatic brain injury	JOURNAL OF CLINICAL NURSING			English	Article						brain injury; care bundle; emergency nursing; evidence-based practice; neurotrauma; Thailand; trauma		Aims and objectives. To test the feasibility of an evidence-based care bundle in a Thai emergency department. The specific objective of this study was to examine the impact of the implementation of the care bundle on the initial emergency nursing management of patients with severe traumatic brain injury. Background. A care bundle approach is one strategy used to improve the consistency, quality and safety of emergency care for different patients groups, however, has not been tested in patients with severe traumatic brain injury. Design. A pretest/post-test design was used. The study intervention was an evidence-based care bundle for initial emergency nursing management of patients with severe traumatic brain injury. Methods. Nonparticipant observations were conducted between October 2012-June 2013 at an emergency department of a 640 bed regional hospital in Southern Thailand. The initial emergency nursing care was observed in 45 patients with severe traumatic brain injury: 20 patients in the pretest period and 25 patients in the post-test period. Results. There were significant improvements in clinical care of patients with severe traumatic brain injury after implementation of the care bundle: (1) use of end-tidal carbon dioxide monitoring, (2) frequency of respiratory rate assessment, (3) frequency of pulse rate and blood pressure assessment, and (4) patient positioning. Conclusion. This study demonstrated that implementation of an evidence-based care bundle improved specific elements of emergency nurses' clinical management of patients with severe traumatic brain injury. Relevance to clinical practice. The study suggests that a care bundle approach can be used as a strategy to improve emergency nursing care of patients with severe traumatic brain injury.	[Damkliang, Jintana] Deakin Univ, Sch Nursing & Midwifery, Burwood, Vic, Australia; [Damkliang, Jintana] Prince Songkla Univ, Fac Nursing, Hat Yai, Thailand; [Considine, Julie] Deakin Univ, Nursing & Midwifery Res Ctr, Eastern Hlth, Nursing, Burwood, Vic, Australia; [Considine, Julie; Street, Maryann] Deakin Univ, Ctr Qual & Patient Safety Res, Sch Nursing & Midwifery, Burwood, Vic, Australia; [Kent, Bridie] Univ Plymouth, Sch Nursing & Midwifery, Leadership Nursing, Plymouth PL4 8AA, Devon, England; [Street, Maryann] Deakin Univ, Eastern Hlth, Nursing & Midwifery Res Ctr, Burwood, Vic, Australia		Damkliang, J (corresponding author), Prince Songkla Univ, Fac Nursing, 15 Kanchanavanit Rd, Hat Yai, Songkhla, Thailand.	jintana.d@psu.ac.th	Street, Maryann/A-2709-2010	Street, Maryann/0000-0002-5615-141X; Considine, Julie/0000-0003-3801-2456; Kent, Bridie/0000-0001-9550-1913	Faculty of Nursing, Prince of Songkla University, Thailand	This study is an unfunded PhD study. Ms Damkliang is supported by a scholarship from Faculty of Nursing, Prince of Songkla University, Thailand.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; Brain Trauma Foundation (BTF), 2007, GUID PREH MAN TRAUM; Bureau of Epidemiology Ministry of Public Health Thailand, 2007, SEV INJ DUE TRANSP A; Bureau of Policy and Strategy (BOPS) Ministry of Public Health Thailand, 2011, HLTH STAT INF; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; Damkliang J, 2014, AUSTRALAS EMERG NURS, V17, P152, DOI 10.1016/j.aenj.2014.05.005; Damkliang J, 2013, AUSTRALAS EMERG NURS, V16, P127, DOI 10.1016/j.aenj.2013.09.001; Faul M, 2010, TRAUMATIC BRAIN INJU; Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Gravetter F. J., 2011, ESSENTIALS STAT BEHA; Helps Y., 2008, HOSP SEPARATIONS DUE; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; McCarthy C, 2013, INT J CHRONIC OBSTR, V8, P605, DOI 10.2147/COPD.S52883; McCreanor JE, 2012, THORAX, V67, pA183, DOI 10.1136/thoraxjnl-2012-202678.363; McNett M, 2010, AM J CRIT CARE, V19, P250, DOI 10.4037/ajcc2009293; McQuillan K, 2009, TRAUMA NURSING RESUS, P448; Mittal R, 2009, EMERG MED J, V26, P513, DOI 10.1136/emj.2009.072041; Morris AC, 2011, CRIT CARE MED, V39, P2218, DOI 10.1097/CCM.0b013e3182227d52; New Zealand Guidelines Group (NZGG), 2007, TRAUM BRAIN INJ DIAG; Nguyen HB, 2011, CRIT CARE, V15, DOI 10.1186/cc10469; NICE, 2007, HEAD INJ TRIAG ASS I; O'Phelan K, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P3; Price Ann M, 2003, Nurs Crit Care, V8, P126, DOI 10.1046/j.1478-5153.2003.00019.x; Ratanalert S, 2007, EMERG MED J, V24, P25, DOI 10.1136/emj.2006.039974; Reed D, 2011, ADULT TRAUMA CLIN PR; Resar R, 2012, IHI INNOVATION SERIE; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Sedwick Mary Beth, 2012, Crit Care Nurse, V32, P41, DOI 10.4037/ccn2012964; SIGN, 2009, EARL MAN PAT HEAD IN; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Waltz CF, 2010, MEASUREMENT NURSING, V4th; Weeraratne JI, 2010, MED J AUSTRALIA, V193, P381, DOI 10.5694/j.1326-5377.2010.tb03962.x; Winter CD, 2005, SURG-J R COLL SURG E, V3, P329, DOI 10.1016/S1479-666X(05)80112-X; Wong F W, 2000, Crit Care Nurse, V20, P18	36	6	7	3	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	DEC	2015	24	23-24					3365	3373		10.1111/jocn.12923			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DB1OM	WOS:000368277900004	26299272				2022-02-06	
J	Drummond, M; Douglas, J; Olver, J				Drummond, Melanie; Douglas, Jacinta; Olver, John			The Invisible Problem: The Incidence of Olfactory Impairment following Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; smell; olfaction; rehabilitation	OF-PENNSYLVANIA SMELL; TASTE DISORDERS; CONSEQUENCES; DYSFUNCTION; QUALITY; ANOSMIA	Background and aims: As many as 50-60% of patients with traumatic brain injury (TBI) admitted to rehabilitation facilities may have olfactory impairment (OI). These incidence estimates are derived from studies conducted internationally and there is no comparable data available in the Australian context. The primary aim of this study was to identify the incidence of OI following TBI in a consecutive sample of adults admitted to the Epworth Hospital Brain Injury Rehabilitation Program in Victoria, Australia. A secondary aim was to investigate whether age, duration of posttraumatic amnesia (PTA) and presence of facial fractures made a significant contribution to the prediction of severity of OI. Method: The sample comprised 134 adults (mean age 39.09 years, SD 18.36), the majority of whom had sustained moderate to severe injury (PTA mean 21.57 days, SD 18.78). OI was measured using the Pocket Smell Test (PST) and the University of Pennsylvania Smell Identification Test (UPSIT). Results: Seventy-three participants (54.48%) demonstrated OI on the PST whereas 89 (66.42%) demonstrated OI on the UPSIT. Age, PTA duration, and presence of facial fractures predicted 10.3% of the variance in severity of OI. Conclusion: A substantial proportion of adults admitted for rehabilitation following TBI has OI. Accurate assessment and appropriate management of post-traumatic OI must be incorporated into rehabilitation programs.	[Drummond, Melanie; Douglas, Jacinta] La Trobe Univ, Coll Sci Hlth & Engn, Bundoora, Vic 3086, Australia; [Drummond, Melanie; Olver, John] Epworth Monash Rehabil Med Unit, Melbourne, Vic, Australia; [Drummond, Melanie; Olver, John] Epworth Hlth Care, Epworth Rehabil, Melbourne, Vic, Australia; [Douglas, Jacinta] NHMRC Clin Ctr Res Excellence Brain Recovery, Melbourne, Vic, Australia; [Douglas, Jacinta] Summer Fdn, Melbourne, Vic, Australia		Drummond, M (corresponding author), Epworth Rehabil Execut Team, 25 Burwood Rd, Hawthorn, Vic 3122, Australia.	melanie.drummond@epworth.org.au		Olver, John/0000-0001-7069-1191; Douglas, Jacinta/0000-0003-0940-6624	Victorian Brain Injury Recovery Association; Epworth Health Care Scholarship Program; Epworth Monash Rehabilitation Medicine Unit; Latrobe University Post Graduate Support Grant; Health Sciences Post Graduate Program	Financial assistance was received from the Victorian Brain Injury Recovery Association; Epworth Health Care Scholarship Program; Epworth Monash Rehabilitation Medicine Unit; and the Latrobe University Post Graduate Support Grant and Health Sciences Post Graduate Program.	Access Economics, 2008, EC COST SPIN CORD IN; AIHW, 2007, AIHW B, V55; Blomqvist EH, 2004, RHINOLOGY, V42, P189; Bromley SM, 2000, AM FAM PHYSICIAN, V61, P427; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; DAVIDSON TM, 1995, POSTGRAD MED, V98, P107, DOI 10.1080/00325481.1995.11946020; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Doty RL, 2014, FRONT PSYCHOL, V5, P20, DOI DOI 10.3389/FPSYG.2014.00020; Drummond M., 2007, BRAIN IMPAIR, V8, P31; Drummond M, 2013, BRAIN INJURY, V27, P332, DOI 10.3109/02699052.2012.750743; Eslinger P J, 1982, Brain Cogn, V1, P259, DOI 10.1016/0278-2626(82)90028-8; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Jennett B, 1981, CONT NEUROLOGY SERIE; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; Menco B. P., 2003, HDB OLFACTION GUSTAT, V2nd, P17; Mueller Christian A, 2009, J Med Case Rep, V3, P9283, DOI 10.4076/1752-1947-3-9283; Pink B.N., 2006, AUSTR NZ STANDARD CL; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Renzi G, 2002, ANN PLAS SURG, V48, P355, DOI 10.1097/00000637-200204000-00003; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Sensonics Inc., 1995, POCK SMELL TEST; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	32	6	6	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2015	16	3					196	204		10.1017/BrImp.2015.27			9	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DD4KV	WOS:000369892700004					2022-02-06	
J	Graham, MR; Pates, J; Davies, B; Cooper, SM; Bhattacharya, K; Evans, PJ; Baker, JS				Graham, M. R.; Pates, J.; Davies, B.; Cooper, S. M.; Bhattacharya, K.; Evans, P. J.; Baker, J. S.			Should an increase in cerebral neurochemicals following head kicks in full contact karate influence return to play?	INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY			English	Article						concussion; NSE; S100-B; sport; TBI	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; SPORT-RELATED CONCUSSION; SERUM BIOMARKERS; PROTEIN S-100B; MANAGEMENT; BLOOD; CHILDREN; MARKERS; DAMAGE	Background: Cerebral neurochemicals are markers of traumatic brain injury (TBI). Objectives: The aim of the study was to determine whether kicks to the head (KTH) in full contact karate significantly increased serum concentrations of protein S-100B, and neurone specific enolase (NSE). Kicks to the body (KTB) were also quantified to asses muscle tissue injury. Muscle damage was assessed by analysis of serum total creatine kinase (CK). Methods: Twenty-four full contact karate practitioners were observed and filmed during actual competition and divided into two main groups post event: (1) Kicks to the head and body group (KTH): n = 12; mean +/- SD; age, 30.4 +/- 6.7 years; height, 1.74 +/- 0.1 m; weight, 79.1 +/- 2.1 kg; and (2): Kicks to the body group (KTB): n = 12; mean +/- SD; age, 28.2 +/- 6.5 years; height, 1.75 +/- 0.1 m; weight, 79.2 +/- 1.7 kg. The KTH group received direct kicks to the head, while group KTB received kicks and punches to the body. Blood samples were taken before and immediately post-combat for analysis of serum S-100B, NSE, CK and cardiac troponin. Results: Significant increases in serum concentrations of S-100B (0.12 +/- 0.17 vs. 0.37 +/- 0.26, mu g.L-1) and NSE (11.8 +/- 4.1 vs. 20.2 +/- 9.1 ng.mL(-1)) were encountered after combat in the KTH group and CK (123 +/- 53 vs. 184 +/- 103 U.L-1) in the KTB group (all P <0.05). Conclusions: Head kicks in full contact karate cause elevation of neurochemical markers associated with damaged brain tissue. The severity of injury is related to the early post-traumatic release of protein S-100B and NSE. The early kinetics and appearance post injury can reflect intracranial pathology, and suggest S-100B and NSE are extremely sensitive prognostic markers of TBI.	[Graham, M. R.; Pates, J.] Llantarnam Res Acad, Llantarnam, Cwmbran, Wales; [Davies, B.] Univ South Wales, Hlth & Exercise Sci Dept, Cardiff, S Glam, Wales; [Cooper, S. M.] Cardiff Metropolitan Univ, Cardiff Sch Sport, Cardiff, S Glam, Wales; [Bhattacharya, K.] Royal Infirm Edinburgh NHS Trust, Dept Cardiovasc Surg, Edinburgh, Midlothian, Scotland; [Evans, P. J.] Royal Gwent Hosp, Dept Endocrinol, Newport NPT 2VB, Gwent, Wales; [Baker, J. S.] Univ West Scotland, Sch Sci & Sport, Inst Clin Exercise & Hlth Sci, Appl Physiol Res Lab, Hamilton ML3 OJB, Lanark, Scotland		Baker, JS (corresponding author), Univ West Scotland, Sch Sci & Sport, Inst Clin Exercise & Hlth Sci, Appl Physiol Res Lab, Hamilton ML3 OJB, Lanark, Scotland.	jsbaker@uws.ac.uk					BBC, 2014, 8 SPORTS COMP INCL 2; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bouvier D, 2013, ANN BIOL CLIN-PARIS, V71, P145, DOI 10.1684/abc.2013.0812; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chern JJ, 2014, J NEUROSURG-PEDIATR, V14, P306, DOI 10.3171/2014.6.PEDS13682; Cohen J., 1988, STAT POWER ANAL; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Gorji MAH, 2014, SAUDI J ANAESTH, V8, P193, DOI 10.4103/1658-354X.130708; Graham MR, 2011, INT J IMMUNOPATH PH, V24, P119, DOI 10.1177/039463201102400114; Graham MR, 2007, J SPORT SCI MED, V6, P62; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Nagahiro S, 2014, NEUROL MED-CHIR, V54, P878, DOI 10.2176/nmc.ra.2014-0224; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Opara J A, 2014, J Med Life, V7, P124; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shinozaki K, 2009, RESUSCITATION, V80, P870, DOI 10.1016/j.resuscitation.2009.05.005; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Springborg Jtiaocnob Bertram, 2009, Ugeskr Laeger, V171, P978; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wainwright P., 2009, HDB NEUROPSYCHIATRIC, P13; Zazryn TR, 2009, PHYS MED REH CLIN N, V20, P227, DOI 10.1016/j.pmr.2008.10.004	37	6	6	0	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0394-6320			INT J IMMUNOPATH PH	Int. J. Immunopathol. Pharmacol.	DEC	2015	28	4					539	546		10.1177/0394632015577045			8	Immunology; Pathology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pathology; Pharmacology & Pharmacy	CV6YM	WOS:000364418300010	25816397	Green Accepted, Bronze			2022-02-06	
J	Parveen, Y; Dhandapani, M; Dhandapani, S; Gupta, SK				Parveen, Yadav; Dhandapani, Manju; Dhandapani, Sivashanmugam; Gupta, Sunil K.			A Randomized Controlled Trial to Assess the Efficacy of Auditory Stimulation on Selected Parameters of Comatose Patients with Traumatic Brain Injury	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; coma; auditory stimulation; communication; consciousness		Problem Considered Prevention of sensory deprivation and early sensory stimulation are essential to enhance optimal recovery in patients with traumatic brain injury (TBI). This was an RCT to assess the efficacy of auditory stimulation on various physiologic parameters and level of consciousness in comatose patients of TBI. Methods A total of 80 comatose patients with TBI were enrolled and 40 were assigned using computer-generated random table in each intervention and control group. In intervention group, auditory stimulation was provided by a family member talking to the patient for 10 minutes, twice daily for 2 weeks. Physiologic parameters such as heart rate, respiratory rate, blood pressure, SpO(2), and level of consciousness were recorded before, during and after each intervention. Parameters in the control group were recorded on days 1, 7, and 14. Results Baseline characteristics in both the groups were comparable. On day 7, GCS was significantly higher (7.26 +/- 2.39) in intervention group as compared with (5.54 +/- 1.75) control group. On day 14, GCS was again significantly higher (8.17 +/- 2.06) in intervention group as compared with (6.34 +/- 2.36) control group. There was significant increase in PR and SpO2 during and after intervention. Conclusion Auditory stimulation by family members appears to be effective in improving level of consciousness in comatose patients with TBI.	[Parveen, Yadav; Dhandapani, Manju] Natl Inst Nursing Educ, Post Grad Inst Med Educ & Res, Neuronursing Div, Chandigarh, Punjab, India; [Dhandapani, Sivashanmugam; Gupta, Sunil K.] Post Grad Inst Med Educ & Res, Dept Neurosurg, Chandigarh, Punjab, India		Dhandapani, M (corresponding author), Natl Inst Nursing Educ, Post Grad Inst Med Educ & Res, Chandigarh, Punjab, India.	manjuseban@gmail.com	Dhandapani, Sivashanmugam/I-2395-2013	Dhandapani, Sivashanmugam/0000-0002-3497-4255; Dhandapani, Manju/0000-0003-3351-3841			Abbasi M, 2009, JPN J NURS SCI, V6, P21, DOI 10.1111/j.1742-7924.2009.00117.x; [Anonymous], 1998, NIH Consens Statement, V16, P1; [Anonymous], COM GUID CAR DEL HLT; Bassampour S, 2007, J HAYAT, V13, P89; Bos S, 1997, ONLINE J KNOWL SYN N, V4, pU3, DOI 10.1111/j.1524-475X.1997.00001.x; Cheng LJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-27; Davis Alice E, 2003, J Neurosci Nurs, V35, P202; Dhandapani M, 2014, J CLIN NURS, V23, P1114, DOI 10.1111/jocn.12396; Dhandapani SS, 2010, INDIAN J NEUROTRAUM, V7, P23, DOI 10.1016/S0973-0508(10)80007-3; Dhandapani S S, 2012, Asian J Neurosurg, V7, P17, DOI 10.4103/1793-5482.95690; Dhandapani SS, 2007, INDIAN J NEUROTRAUM, V4, P35, DOI 10.1016/S0973-0508(07)80009-8; Dhandapani S, 2015, WORLD NEUROSURG, V84, P1244, DOI 10.1016/j.wneu.2015.05.058; Dhandapani S, 2014, J CLIN NEUROSCI, V21, P745, DOI 10.1016/j.jocn.2013.07.038; Puggina ACG, 2011, J NEUROSCI NURS, V43, pE8, DOI 10.1097/JNN.0b013e3182029778; Gorji MAH, 2014, SAUDI J ANAESTH, V8, P69, DOI 10.4103/1658-354X.125940; Government of India Ministry of Home Affairs, 2010, NAT CRIM REC BUR 201; JONES R, 1994, ARCH PHYS MED REHAB, V75, P164; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Ludlow CL, 2008, J SPEECH LANG HEAR R, V51, pS240, DOI 10.1044/1092-4388(2008/019); Machado C, 2007, CLIN EEG NEUROSCI, V38, P124, DOI 10.1177/155005940703800306; Maleki M, 2012, HORIZON MED SCI, V18, P66; Mandeep, 2013, INDIAN J NEUROTRAUM, V10, P13, DOI 10.1016/j.ijnt.2013.05.004; Orem DE, 1991, NURSING CONCEPTS PRA, V4th; Pape TLB, 2012, J REHABIL RES DEV, V49, P1137, DOI 10.1682/JRRD.2011.08.0154; SISSON R, 1990, HEART LUNG, V19, P373; Sosnowski C, 1994, J Neurosci Nurs, V26, P336; Tanaka YL, 2012, INT J NURS PRACT, V18, P38, DOI 10.1111/j.1440-172X.2012.02027.x; TEASDALE G, 1974, LANCET, V2, P81; Urbenjaphol P, 2009, J NEUROSCI NURS, V41, P10; Walker J S, 1998, J Trauma Nurs, V5, P41	30	6	6	0	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2015	12	2					128	134		10.1055/s-0035-1569470			7	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M8G	WOS:000218398900007					2022-02-06	
J	Sikoglu, EM; Navarro, AAL; Czerniak, SM; McCafferty, J; Eisenstock, J; Stevenson, JH; King, JA; Moore, CM				Sikoglu, Elif M.; Navarro, Ana A. Liso; Czerniak, Suzanne M.; McCafferty, Joseph; Eisenstock, Jordan; Stevenson, J. Herbert; King, Jean A.; Moore, Constance M.			Effects of Recent Concussion on Brain Bioenergetics: A Phosphorus-31 Magnetic Resonance Spectroscopy Study	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article							HIGH-SCHOOL; INJURY; PATHOPHYSIOLOGY; ACCUMULATION; CALCIUM; LACTATE; SPORTS; STATE		[Sikoglu, Elif M.; Navarro, Ana A. Liso; Czerniak, Suzanne M.; McCafferty, Joseph; Eisenstock, Jordan; King, Jean A.; Moore, Constance M.] Univ Massachusetts, Sch Med, Ctr Comparat NeuroImaging, Worcester, MA USA; [Sikoglu, Elif M.; Navarro, Ana A. Liso; King, Jean A.; Moore, Constance M.] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Eisenstock, Jordan] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Stevenson, J. Herbert] Univ Massachusetts, Sch Med, Dept Sports Med, Worcester, MA USA; [King, Jean A.; Moore, Constance M.] Univ Massachusetts, Sch Med, Dept Radiol, Worcester, MA USA; [Navarro, Ana A. Liso] Univ Geneva, Sch Med, Off Med Pedagog, Dept Psychiat, CH-1211 Geneva, Switzerland		Moore, CM (corresponding author), Ctr Comparat Neuroimaging, 303 Belmont St, Worcester, MA 01604 USA.	constance.moore@umassmed.edu			US National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH073998]; University of Massachusetts Medical School; Department of Radiology at the University of Massachusetts Medical School; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [PBGEP3-134252]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073998] Funding Source: NIH RePORTER	Supported in part by US National Institute of Mental Health Grant MH073998 (C.M.M.), start-up funds from the University of Massachusetts Medical School (C.M.M.), an award from the Department of Radiology at the University of Massachusetts Medical School for pilot MRI scan time (C.M.M.), and Swiss National Science Foundation Grant PBGEP3-134252 (A.A.L.N.).	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Barker P. B., 2010, CLIN MR SPECTROSCOPY; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Delis DC., 2001, DELIS KAPLAN EXECUTI; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Faul M, 2010, TRAUMATIC BRAIN INJU; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldstein G, 2009, J INT NEUROPSYCH SOC, V15, P671, DOI 10.1017/S1355617709990233; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Ji S, 2014, J NEUROTRAUM, V32, P441; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Pedersen A, 2012, BRAIN COGNITION, V79, P245, DOI 10.1016/j.bandc.2012.03.007; Pettegrew JW, 2002, BIPOLAR DISORD, V4, P61, DOI 10.1034/j.1399-5618.2002.01180.x; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rae C, 2003, DEV NEUROSCI-BASEL, V25, P324, DOI 10.1159/000073509; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Sikoglu EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054536; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thompson A, 1998, AM J CLIN NUTR, V67, P39, DOI 10.1093/ajcn/67.1.39; Tortora G.J., 1987, PRINCIPLES ANATOMY P; Tsushima WT, 2013, APPL NEUROPSYCH-CHIL, V2, P13, DOI 10.1080/09084282.2011.643967; VanDenThillart G, 1996, PHYSIOL REV, V76, P799, DOI 10.1152/physrev.1996.76.3.799; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Yildiz A, 2005, PSYCHIAT RES-NEUROIM, V138, P51, DOI 10.1016/j.pscychresns.2003.10.005; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	42	6	6	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	DEC	2015	28	4					181	187					7	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	CZ5HW	WOS:000367134400001	26705264				2022-02-06	
J	Liu, GX; Ni, J; Mao, L; Yan, M; Pang, T; Liao, H				Liu, Gaoxiang; Ni, Jie; Mao, Lei; Yan, Ming; Pang, Tao; Liao, Hong			Expression of Nogo receptor 1 in microglia during development and following traumatic brain injury	BRAIN RESEARCH			English	Article						NgR1; Microglia; Expression; Development; Traumatic brain injury	OUTGROWTH INHIBITOR; FAMILY-MEMBER; MYELIN; ADHESION; NEUROGENESIS; GLYCOPROTEIN; MIGRATION; CELLS; DEGENERATION; CORECEPTOR	As the receptor of myelin associated inhibitory factors Nogo receptor 1 (NgR1) plays an important role in central nervous system (CNS) injury and regeneration. It is found that NgR1 complex acts in neurons to transduce the signals intracelluarly including induction of growth cone collapse, inhibition of axonal regeneration and regulation of nerve inflammation. In recent studies, NgR1 has also been found to be expressed in the microglia. However, NgR1 expressed in microglia in the developing nervous systems and following CNS injury have not been widely investigated. In this study, we detected the expression and cellular localization of NgR1 in microglia during development and following traumatic brain injury (TBI) in mice. The results showed that NgR1 was mainly expressed in microglia during embryonic and postnatal periods. The expression levels peaked at P4 and decreased thereafter into adulthood, while increased significantly with aging representatively at 17 mo. On the other hand, there was no significant difference in the number of double positive NgR1(+)Iba1(+) cells between normal and TBI group. In summary, we first detected the expression of NgR1 in microglia during development and found that NgR1 protein expression increased significantly in microglia with aging. These findings will contribute to make a foundation for subsequent study about the role of NgR1 expressed in microglia on the CNS disorders. (C) 2015 Elsevier B.V. All rights reserved.	[Liu, Gaoxiang; Ni, Jie; Yan, Ming; Pang, Tao; Liao, Hong] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing 210009, Jiangsu, Peoples R China; [Mao, Lei] Jinling Hosp, Dept Neurosurg, Nanjing 210000, Jiangsu, Peoples R China		Liao, H (corresponding author), China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China.	hliao@cpu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070967, 81271338]; Specialized Research Fund for the Doctoral Program of Higher Education of ChinaSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20130096110011]; Initial Fund of China Pharmaceutical University [211047]	We gratefully acknowledge the support from the National Natural Science Foundation of China (81070967 and 81271338), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20130096110011), and Initial Fund of China Pharmaceutical University (211047).	Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Liao H, 2004, J NEUROCHEM, V90, P1156, DOI 10.1111/j.1471-4159.2004.02573.x; Mathis C, 2010, CEREB CORTEX, V20, P2380, DOI 10.1093/cercor/bhp307; McDonald CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-113; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mingorance A, 2004, MOL CELL NEUROSCI, V26, P34, DOI 10.1016/j.mcn.2004.01.001; O'Neill P, 2004, DEV DYNAM, V231, P109, DOI 10.1002/dvdy.20116; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Perry VH, 2010, ASN NEURO, V2, P281, DOI 10.1042/AN20100024; Pool M, 2009, EXP NEUROL, V217, P371, DOI 10.1016/j.expneurol.2009.03.014; Raposo C, 2014, GLIA, V62, P1895, DOI 10.1002/glia.22676; Rymo SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015846; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Streit WJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00138; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Wang J, 2010, BRAIN RES, V1306, P8, DOI 10.1016/j.brainres.2009.10.018; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2002, J NEUROSCI, V22, P5505; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Yan J, 2012, J NEUROCHEM, V120, P721, DOI 10.1111/j.1471-4159.2011.07619.x; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	40	6	6	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 19	2015	1627						41	51		10.1016/j.brainres.2015.09.006			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CY2HC	WOS:000366228400005	26367446				2022-02-06	
J	Armistead-Jehle, P; Green, P; Gervais, RO; Hungerford, LD				Armistead-Jehle, Patrick; Green, Paul; Gervais, Roger O.; Hungerford, Lars D.			An Examination of the Word Memory Test as a Measure of Memory	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						California Verbal Learning Test; memory testing; Word Memory Test	TEST-PERFORMANCE; IMPAIRMENT	This study examined the utility of the Word Memory Test (WMT) as a measure of verbal episodic memory by comparing select WMT subtests to the California Verbal Learning Test (CVLT) First and Second Editions (CVLT-II) across two samples. Correlations between the WMT and CVLT/CVLT-II subtests were statistically significant in the expected direction. Effect sizes were examined to assess the degree to which the WMT memory subtests and the CVLT First Edition subtests discriminated between groups of people who would be expected to differ from each other in verbal memory abilities. Comparison groups included cases of mild, moderate, and severe traumatic brain injury, mixed neurological patients, healthy adult controls, and patients with possible early dementia. Once invalid data were removed by studying only those who passed performance validity testing, it was found that the effect sizes between these groups were comparable. The WMT, CVLT, and CVLT-II were found to discriminate to about the same degree between people differing from each other in age, intelligence levels, and gender. Based on these data from a total sample of more than 3,000 cases, it is concluded that select WMT subtests are commensurate with the CVLT subtests as measures of memory within primarily disability-seeking samples.	[Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Dept Behav Hlth, Ft Leavenworth, KS 66027 USA; [Gervais, Roger O.] Neurobehav Associates, Edmonton, AB, Canada; [Gervais, Roger O.] Univ Alberta, Dept Educ Psychol, Edmonton, AB T6G 2E1, Canada		Armistead-Jehle, P (corresponding author), Munson Army Hlth Ctr, Dept Behav Hlth, 550 Pope Ave, Ft Leavenworth, KS 66027 USA.	patrick.j.armistead-jehle.civ@mail.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432			Bauer R. M., 2003, CLIN NEUROPSYCHOLOGY, P495; Davachi L, 2008, CURR DIR PSYCHOL SCI, V17, P112, DOI 10.1111/j.1467-8721.2008.00559.x; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Donders J, 2013, J CLIN EXP NEUROPSYC, V35, P827, DOI 10.1080/13803395.2013.824557; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P., 2003, GREENS WORD MEMORY T; Green P, 2008, TEST MANUAL NONVERBA; Green P, 2004, GREENS MED SYMPTOM V; Green P., 2003, DETECTION RESPONSE B, P91; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Jackson D.N., 1998, MULTIDIMENSIONAL APT; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Rienstra A, 2013, J CLIN EXP NEUROPSYC, V35, P59, DOI 10.1080/13803395.2012.751361; Schneider W., 2011, HUMAN DEV EARLY CHIL, P63; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Tombaugh T.N., 1996, TEST MEMORY MALINGER; [No title captured]	20	6	6	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 2	2015	22	6					415	426		10.1080/23279095.2014.953678			12	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	CS6VM	WOS:000362221000004	25874848				2022-02-06	
J	Ren, LH; Baumgartner, D; Yang, JK; Davidsson, J; Willinger, R				Ren, Lihai; Baumgartner, Daniel; Yang, Jikuang; Davidsson, Johan; Willinger, Remy			Investigation of diffuse axonal injury induced by rotational acceleration via numerical reconstructions of in vivo rat head impact experiments	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						traumatic brain injury; diffuse axonal injury; animal experiments; finite element simulation	TRAUMATIC BRAIN-INJURY; MECHANICAL CHARACTERIZATION; TISSUE; MODEL; THRESHOLD; CONTUSION; SIMON; SHEAR	The purpose of this study is to investigate the brain-strain-based thresholds for better prediction of the diffuse axonal injury (DAI) induced by a rotational acceleration on the rat brain. A previously developed and validated rat head finite element model was used to reconstruct 26 in vivo rat head impact experiments. DAI was produced via the high rotational acceleration applied to the rat head on the sagittal plane. Intracranial strain and strain-based injury indexes were calculated, including the maximum principal strain (MPS), the product of strain and strain rate, and the cumulative strain damage measure (CSDM). The region-specific conservative thresholds for DAI were estimated in terms of strain and strain-based injury indexes in the frontal, middle, and occipital regions of the corpus callosum. The axonal injuries observed in the experiments were used to formulate the injury risk functions, and the DAI risks were analysed via binary logistic regressions in terms of the calculated injury indexes. The logistic regression analysis demonstrated that the MPS, the product of strain and strain rate, as well as the CSDM were significantly correlated with DAI in the frontal corpus callosum. For the 50% probability of DAI in the frontal corpus callosum, it is suggested that the strain-based threshold is 0.12 for the MPS, 110 s(-1) for the product of strain and strain rate, and 17% for the CSDM.	[Ren, Lihai; Yang, Jikuang] Hunan Univ, Res Ctr Vehicle Traff Safety, State Key Lab Adv Design & Mfg Vehicle Body, Changsha 410082, Hunan, Peoples R China; [Ren, Lihai; Baumgartner, Daniel; Willinger, Remy] Univ Strasbourg, Strasbourg, France; [Yang, Jikuang; Davidsson, Johan] Chalmers Univ Technol, Dept Appl Mech, S-41296 Gothenburg, Sweden		Yang, JK (corresponding author), Hunan Univ, Res Ctr Vehicle Traff Safety, State Key Lab Adv Design & Mfg Vehicle Body, Changsha 410082, Hunan, Peoples R China.	jikuang.yang@chalmers.se	Yang, Jikuang/Y-2391-2018; Davidsson, Johan/A-3229-2016	Yang, Jikuang/0000-0003-4737-511X; Davidsson, Johan/0000-0002-1717-1514; ren, lihai/0000-0003-0477-8699			Adams, 1987, SAE TECHNICAL PAPER; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Anderson R. W. G., 1997, P IRCOBI C BRON; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F. A, 1994, SAE TECHNICAL PAPER; Baumgartner D., 2009, P IRCOBI C YORK; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Brands D W, 2000, Stapp Car Crash J, V44, P249; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Coronado VG, 2011, SURVEILLANCE TRAUMAT; Davidsson J, 2011, FRONTIERS NEUROTRAUM, V2, P1; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Jacobo A-M, 2014, INT J AUTOMOTIVE ENG, V5, P31; King AI, 2003, P IRCOBI C LISB; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lamy M., 2013, P IRCOBI C GOTH; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Ommaya A. k., 1967, SAE TECHNICAL PAPERS; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Puvanachandra P, 2009, PAK J NEUROL SCI, V4, P27; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Ren L., 2014, P IRCOBI C BERL; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Takhounts EG, 2003, SAE TECHNICAL PAPER; Takhounts EG, 2008, STAPP CAR C, V52, P1; Viano D. C., 1999, J CRASH PREVENTION I, V1, P35; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zakaria N, 2012, BRAIN RES, V1467, P81, DOI 10.1016/j.brainres.2012.05.046; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	56	6	6	1	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness	NOV 2	2015	20	6					602	612		10.1080/13588265.2015.1073132			11	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	CT5VF	WOS:000362878500007					2022-02-06	
J	Dhakar, MB; Sivakumar, S; Bhattacharya, P; Shah, A; Basha, MM				Dhakar, Monica B.; Sivakumar, Sanjeev; Bhattacharya, Pratik; Shah, Aashit; Basha, Maysaa M.			A retrospective cross-sectional study of the prevalence of generalized convulsive status epilepticus in traumatic brain injury: United States 2002-2010	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Traumatic brain injury; Status epilepticus; Outcome; Mortality	POPULATION-BASED COHORT; INTRACEREBRAL HEMORRHAGE; ONSET SEIZURES; TERM MORTALITY; EPILEPSY; PREDICTORS; RISK; DISABILITY; CHILDREN; EPISODE	Purpose: To determine the incidence, predictors, and outcomes of generalized convulsive status epilepticus (GCSE) in traumatic brain injury (TBI) patients. Methods: We conducted a retrospective cross-sectional study of adult patients with acute TBI using the 2002-2010 Nationwide Inpatient Sample (NIS) database of USA. We used multivariable logistic regression analyses to identify independent predictors of GCSE in patients with TBI and to determine the impact of GCSE on outcomes (in-hospital mortality, length of stay, total hospital charges, and discharge disposition). Results: Among 1,457,869 patients hospitalized with TBI, 2315 (0.16%) had GCSE. In-hospital mortality was significantly higher in patients with GCSE (32.5% vs. 9.6%; unadjusted OR 4.54, 95% CI 4.16-4.96; p<0.001; adjusted OR 3.41; 95% CI 3.09-3.76 p<0.001). Patients with GCSE had longer length of stay (17.3 +/- 21.9 vs. 6.8 +/- 11.1 days; p<0.001), higher total hospital charges ($147,415 +/- 162,319 vs. $54,041 +/- 90,524; p<0.001), and were less likely to be discharged home (19.8% vs. 52.7%; p<0.001). Using multivariable logistic regression analysis, age >35 years (OR 2.15; 95% CI 1.87-2.47), CNS infections (OR 4.86; 95% CI 3.70-6.38), anoxic brain injury (OR 9.54; 95% CI 8.10-11.22), and acute ischemic stroke (OR 4.09; 95% CI 3.41-4.87) were independent predictors of GCSE in TBI patients. Epilepsy was an independent negative predictor of GCSE (OR 0.74; 95% CI 0.55-0.99). Conclusion: Despite its low incidence, GCSE in TBI patients was associated with worse outcomes with threefold higher in-hospital mortality, prolonged hospitalization, higher hospital charges, and worse discharge disposition. Surprisingly, epilepsy is a negative predictor of GCSE in this population. (C) 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Dhakar, Monica B.; Sivakumar, Sanjeev; Bhattacharya, Pratik; Shah, Aashit; Basha, Maysaa M.] Wayne State Univ, Dept Neurol, Detroit Med Ctr, Detroit, MI 48202 USA		Dhakar, MB (corresponding author), Wayne State Univ, Dept Neurol, Detroit Med Ctr, 4201 St Antoine St,8C UHC, Detroit, MI 48202 USA.	monicadhakar@gmail.com		Shah, Aashit/0000-0001-7370-3004; Sivakumar, Sanjeev/0000-0002-4846-4301	Department of Neurology	Funding was provided by Department of Neurology.	AMINOFF MJ, 1980, AM J MED, V69, P657, DOI 10.1016/0002-9343(80)90415-5; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BARRY E, 1993, NEUROLOGY, V43, P1473, DOI 10.1212/WNL.43.8.1473; Bateman BT, 2007, NEUROCRIT CARE, V7, P187, DOI 10.1007/s12028-007-0056-2; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Canoui-Poitrine F, 2011, EPILEPSIA, V52, P1849, DOI 10.1111/j.1528-1167.2011.03168.x; Cardenas VM, 2014, EPILEPSIA, V55, P1347, DOI 10.1111/epi.12719; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Claassen J, 2002, NEUROLOGY, V58, P139, DOI 10.1212/WNL.58.1.139; Claassen J, 2007, NEUROSURGERY, V61, P4; Claassen J, 2007, NEUROSURGERY, V61, P60, DOI 10.1227/01.neu.0000279724.05898.e7; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Delanty N, 2001, SEIZURE-EUR J EPILEP, V10, P116, DOI 10.1053/seiz.2000.0482; DeLorenzo RJ, 1999, EPILEPSIA, V40, P164, DOI 10.1111/j.1528-1157.1999.tb02070.x; DELORENZO RJ, 1992, EPILEPSIA, V33, pS15; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Falcone GJ, 2013, JAMA NEUROL, V70, P988, DOI 10.1001/jamaneurol.2013.98; Fields MC, 2013, JAMA NEUROL, V70, P360, DOI 10.1001/2013.jamaneurol.337; Fountain NB, 2000, EPILEPSIA, V41, pS23, DOI 10.1111/j.1528-1157.2000.tb01521.x; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Jette N, 2010, EPILEPSIA, V51, P62, DOI 10.1111/j.1528-1167.2009.02201.x; Koubeissi M, 2007, NEUROLOGY, V69, P886, DOI 10.1212/01.wnl.0000269791.96189.70; Logroscino G, 2002, NEUROLOGY, V58, P537, DOI 10.1212/WNL.58.4.537; Logroscino G, 1997, EPILEPSIA, V38, P1344, DOI 10.1111/j.1528-1157.1997.tb00073.x; Lu J, 2005, ACT NEUR S, V95, P281; Maas MB, 2013, NEUROCRIT CARE, V18, P166, DOI 10.1007/s12028-012-9814-x; NG SKC, 1988, NEW ENGL J MED, V319, P666; Penberthy LT, 2005, SEIZURE-EUR J EPILEP, V14, P46, DOI 10.1016/j.seizure.2004.06.001; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Rossetti AO, 2006, J NEUROL NEUROSUR PS, V77, P611, DOI 10.1136/jnnp.2005.080887; SCHOLTES FB, 1994, EPILEPSIA, V35, P1104, DOI 10.1111/j.1528-1157.1994.tb02562.x; Shneker BF, 2003, NEUROLOGY, V61, P1066, DOI 10.1212/01.WNL.0000082653.40257.0B; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Wu YW, 2002, NEUROLOGY, V58, P1070, DOI 10.1212/WNL.58.7.1070; Young GB, 1996, NEUROLOGY, V47, P83	43	6	6	0	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	NOV	2015	32						16	22		10.1016/j.seizure.2015.08.005			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX0BT	WOS:000365362600004	26552556	Bronze			2022-02-06	
J	Di Paola, M; Phillips, O; Costa, A; Ciurli, P; Bivona, U; Catani, S; Formisano, R; Caltagirone, C; Carlesimo, GA				Di Paola, Margherita; Phillips, Owen; Costa, Alberto; Ciurli, Paola; Bivona, Umberto; Catani, Sheila; Formisano, Rita; Caltagirone, Carlo; Carlesimo, Giovanni Augusto			Selective Cognitive Dysfunction Is Related to a Specific Pattern of Cerebral Damage in Persons With Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						executive function; frontal lobe; hippocampus; memory function; structural MRI; TBI	WHITE-MATTER; MEMORY IMPAIRMENT; HYPOXIC AMNESIA; NORMATIVE DATA; AXONAL INJURY; FRONTAL LOBES; HIPPOCAMPUS; MORPHOLOGY; SURVIVORS; ATROPHY	Objective: Cognitive dysfunction is a common sequela of traumatic brain injury (TBI); indeed, patients show a heterogeneous pattern of cognitive deficits. This study was aimed at investigating whether patients who show selective cognitive dysfunction after TBI present a selective pattern of cerebral damage. Setting: Post-Coma Unit, IRCCS Santa Lucia Foundation, Rome, Italy. Participants: We collected data from 8 TBI patients with episodic memory disorder and without executive deficits, 7 patients with executive function impairment and preserved episodic memory capacities, and 16 healthy controls. Design: We used 2 complementary analyses: (1) an exploratory and qualitative approach in which we investigated the distribution of lesions in the TBI groups, and (2) a hypothesisdriven and quantitative approach in which we calculated the volume of hippocampi of individuals in the TBI and control groups. Main Measures: Neuropsychological scores and hippocampal volumes. Results: We found that patients with TBI and executive functions impairment presented focal lesions involving the frontal lobes, whereas patients with TBI and episodic memory disorders showed atrophic changes of the mesial temporal structure (hippocampus). Conclusion: The complexity of TBI is due to several heterogeneous factors. Indeed, studying patients with TBI and selective cognitive dysfunction should lead to a better understanding of correlations with specific brain impairment and damage, better follow-up of long-term outcome scenarios, and better planning of selective and focused rehabilitation programs.	[Di Paola, Margherita; Phillips, Owen; Costa, Alberto; Caltagirone, Carlo; Carlesimo, Giovanni Augusto] IRCCS Santa Lucia Fdn, Clin & Behav Neurol Dept, I-00179 Rome, Italy; [Bivona, Umberto; Catani, Sheila; Formisano, Rita] IRCCS Santa Lucia Fdn, Post Coma Unit, I-00179 Rome, Italy; [Ciurli, Paola] IRCCS Santa Lucia Fdn, Neuropsychol Diag & Rehabil Unit, I-00179 Rome, Italy; [Di Paola, Margherita] Univ Aquila, MeSVA Dept, I-67100 Laquila, Italy; [Caltagirone, Carlo; Carlesimo, Giovanni Augusto] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy		Di Paola, M (corresponding author), IRCCS Santa Lucia Fdn, Via Ardeatina 306, I-00179 Rome, Italy.	m.dipaola@hsantalucia.it	Costa, Alberto/AAA-7038-2019; phillips, owen/J-3651-2017	phillips, owen/0000-0002-5391-707X; COSTA, Alberto/0000-0002-4784-5524			Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; CARLESIMO A, 2002, NUOVA RIV NEUROLOGIA, V12, P1; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Chang MC, 2010, NEUROREHABILITATION, V26, P347, DOI 10.3233/NRE-2010-0572; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Di Paola M, 2008, HIPPOCAMPUS, V18, P719, DOI 10.1002/hipo.20432; Di Paola M, 2011, NEUROCASE, V17, P46, DOI 10.1080/13554794.2010.497155; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Monaco M, 2013, NEUROL SCI, V34, P749, DOI 10.1007/s10072-012-1130-x; Nocentini U, 2002, NEUROLOGIA, V12, P15; Orsini A., 2003, B PSICOL APPL, V239, P73; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; PENFIELD W, 1958, ARCH NEURO PSYCHIATR, V79, P475, DOI 10.1001/archneurpsyc.1958.02340050003001; Raven J. C, 1947, PROGR MATRICES SETS; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rieger M, 2002, NEUROPSYCHOLOGIA, V40, P76, DOI 10.1016/S0028-3932(01)00068-9; Spinnler M., 1987, ITAL J NEUROL SCI, V6, P1; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; TEASDALE G, 1974, LANCET, V2, P81; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; Tulving E., 2000, OXFORD HDB MEMORY; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	39	6	6	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2015	30	6					402	410		10.1097/HTR.0000000000000063			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JN	WOS:000369606300012	24901328				2022-02-06	
J	Fuller, HR; Slade, R; Jovanov-Milosevic, N; Babic, M; Sedmak, G; Simic, G; Fuszard, MA; Shirran, SL; Botting, CH; Gates, MA				Fuller, Heidi R.; Slade, Robert; Jovanov-Milosevic, Natasa; Babic, Mirjana; Sedmak, Goran; Simic, Goran; Fuszard, Matthew A.; Shirran, Sally L.; Botting, Catherine H.; Gates, Monte A.			Stathmin is enriched in the developing corticospinal tract	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Corticospinal tract; Spinal cord; Development; Proteomics; Microtubule dynamics; Stathmin	ZAGREB COLLECTION; MICE LACKING; GUIDANCE; AXONS; GROWTH; PHOSPHORYLATION; EXPRESSION; RECEPTORS; NETRIN-1; TARGET	Understanding the intra- and extracellular proteins involved in the development of the corticospinal tract (CST) may offer insights into how the pathway could be regenerated following traumatic spinal cord injury. Currently, however, little is known about the proteome of the developing corticospinal system. The present study, therefore, has used quantitative proteomics and bioinformatics to detail the protein profile of the rat CST during its formation in the spinal cord. This analysis identified increased expression of 65 proteins during the early ingrowth of corticospinal axons into the spinal cord, and 36 proteins at the period of heightened CST growth. A majority of these proteins were involved in cellular assembly and organization, with annotations being most highly associated with cytoskeletal organization, microtubule dynamics, neurite outgrowth, and the formation, polymerization and quantity of microtubules. In addition, 22 proteins were more highly expressed within the developing CST in comparison to other developing white matter tracts of the spinal cord of age-matched animals. Of these differentially expressed proteins, only one, stathmin 1 (a protein known to be involved in microtubule dynamics), was both highly enriched in the developing CST and relatively sparse in other developing descending and ascending spinal tracts. Immunohistochemical analyses of the developing rat spinal cord and fetal human brain stem confirmed the enriched pattern of stathmin expression along the developing CST, and in vitro growth assays of rat corticospinal neurons showed a reduced length of neurite processes in response to pharmacological perturbation of stathmin activity. Combined, these findings suggest that stathmin activity may modulate axonal growth during development of the corticospinal projection, and reinforces the notion that microtubule dynamics could play an important role in the generation and regeneration of the CST. (C) 2015 Elsevier Inc. All rights reserved.	[Fuller, Heidi R.] Robert Jones & Agnes Hunt Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry SY10 7AG, Shrops, England; [Fuller, Heidi R.; Slade, Robert; Gates, Monte A.] Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England; [Fuller, Heidi R.; Slade, Robert] Keele Univ, Postgrad Med, Keele ST5 5BG, Staffs, England; [Jovanov-Milosevic, Natasa; Babic, Mirjana; Sedmak, Goran; Simic, Goran] Croatian Inst Brain Res, Zagreb 10000, Croatia; [Fuszard, Matthew A.; Shirran, Sally L.; Botting, Catherine H.] Univ St Andrews, BSRC Mass Spectrometry & Proteom Facil, St Andrews KY16 9ST, Fife, Scotland		Gates, MA (corresponding author), Keele Univ, Dept Life Sci, Keele ST5 5BG, Staffs, England.	m.a.gates@keele.ac.uk	Milosevic, Natasa Jovanov/N-3622-2019; Babic Leko, Mirjana/ABG-3331-2021; Leko, Mirjana Babic/C-3514-2018; Sedmak, Goran/AAK-3342-2021; Simic, Goran/A-9262-2013; Sedmak, Goran/AAB-3436-2019	Milosevic, Natasa Jovanov/0000-0001-7897-6212; Babic Leko, Mirjana/0000-0003-4223-4190; Sedmak, Goran/0000-0002-9049-2461; Simic, Goran/0000-0002-6339-9261; Sedmak, Goran/0000-0002-9049-2461; Shirran, Sally/0000-0003-3516-3507; Fuller, Heidi/0000-0002-2858-869X	Henry Smith Charity [20114975]; Wellcome TrustWellcome TrustEuropean Commission [094476/Z/10/Z]; Croatian Science Foundation [09/16]	This study was generously supported by a grant (20114975) from The Henry Smith Charity. We acknowledge the Wellcome Trust for funding the BSRC Mass Spectrometry and Proteomics Facility at the University of St. Andrews and in particular for grant 094476/Z/10/Z to CHB which funded the mass spectrometer this work was carried out on and supported MAF. The work with human tissue by GSi. NJ-M, GSe and MB was supported by the Croatian Science Foundation Grant No. 09/16. The authors would like to thank Professor Glenn Morris (Wolfson Centre for Inherited Neuromuscular Disease, RJAH Orthopedic Hospital) for providing some laboratory supplies and access to equipment.	Bagnard D, 1998, DEVELOPMENT, V125, P5043; Baquero MT, 2012, CANCER-AM CANCER SOC, V118, P4660, DOI 10.1002/cncr.27453; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Dobson CB, 2001, BRAIN, V124, P2393, DOI 10.1093/brain/124.12.2393; DONATELLE JM, 1977, J COMP NEUROL, V175, P207, DOI 10.1002/cne.901750205; DOYE V, 1990, J BIOL CHEM, V265, P11650; Duncan JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068324; Finger JH, 2002, J NEUROSCI, V22, P10346; Gardner MK, 2013, CURR OPIN CELL BIOL, V25, P14, DOI 10.1016/j.ceb.2012.09.006; Gavet O, 2002, J NEUROSCI RES, V68, P535, DOI 10.1002/jnr.10234; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; JOOSTEN EAJ, 1989, NEUROSCIENCE, V31, P439, DOI 10.1016/0306-4522(89)90386-2; Judas M, 2011, ANN NY ACAD SCI, V1225, pE105, DOI 10.1111/j.1749-6632.2011.05993.x; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kruslin B, 2014, TRANSL NEUROSCI, V5, P293, DOI 10.2478/s13380-014-0231-9; Kurup N, 2013, CURR OPIN NEUROBIOL, V23, P1011, DOI 10.1016/j.conb.2013.06.009; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Liedtke W, 2002, AM J PATHOL, V160, P469, DOI 10.1016/S0002-9440(10)64866-3; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Metin C, 1997, DEVELOPMENT, V124, P5063; MILLER MW, 1987, EXP BRAIN RES, V67, P339; Mizumura K, 2006, J CELL PHYSIOL, V206, P363, DOI 10.1002/jcp.20465; NAGASHIMA M, 1994, NEUROSCI RES, V19, P81, DOI 10.1016/0168-0102(94)90011-6; Richards LJ, 1997, J NEUROSCI, V17, P2445; ROOS G, 1993, LEUKEMIA, V7, P1538; Sakai N, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00059; SCHREYER DJ, 1982, NEUROSCIENCE, V7, P1837, DOI 10.1016/0306-4522(82)90001-X; SCHREYER DJ, 1988, DEV BRAIN RES, V38, P103, DOI 10.1016/0165-3806(88)90089-2; Schubart UK, 1996, J BIOL CHEM, V271, P14062, DOI 10.1074/jbc.271.24.14062; STANFIELD BB, 1992, PROG NEUROBIOL, V38, P169, DOI 10.1016/0301-0082(92)90039-H; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stone MC, 2012, CELL REP, V2, P1340, DOI 10.1016/j.celrep.2012.09.032; ten Donkelaar HJ, 2004, J NEUROL, V251, P1429, DOI 10.1007/s00415-004-0653-3; Tortoriello G, 2014, EMBO J, V33, P668, DOI 10.1002/embj.201386035; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110; Yamada K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008596; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9	42	6	7	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	NOV	2015	69						12	21		10.1016/j.mcn.2015.09.003			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DD2TD	WOS:000369774200002	26370173	Green Accepted			2022-02-06	
J	Lajiness-O'Neill, R; Hoodin, F; Kentor, R; Heinrich, K; Colbert, A; Connelly, JA				Lajiness-O'Neill, R.; Hoodin, F.; Kentor, R.; Heinrich, K.; Colbert, A.; Connelly, J. A.			Alterations in Memory and Impact on Academic Outcomes in Children Following Allogeneic Hematopoietic Cell Transplantation	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Allogeneic hematopoietic cell transplantation; HCT; Late effects; Cognition; Memory; Processing speed	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; PROCESSING SPEED; PREDICTORS; SURVIVORS; MALIGNANCIES; DISORDERS; LEUKEMIA; THERAPY; SCT	The prevalence of late effects following allogeneic hematopoietic cell transplantation (HCT), a curative treatment for pediatric leukemia, is high: 79% of HCT recipients experience chronic medical conditions. The few extant studies of cognitive late effects have focused on intelligence and are equivocal about HCT neurotoxicity. In an archival study of 30 children (mean transplant age = 6 years), we characterize neuropsychological predictors of academic outcomes. Mean intellectual and academic abilities were average, but evidenced extreme variability, particularly on measures of attention and memory: similar to 25% of the sample exhibited borderline performance or lower. Medical predictors of outcome revealed paradoxically better memory associated with more severe acute graft-versus-host disease(GVHD) and associated with steroid treatment. Processing speed and memory accounted for 69% and 61% of variance in mathematics and reading outcomes, respectively. Thus, our findings revealed neurocognitive areas of vulnerability in processing speed and memory following HCT that contribute to subsequent academic difficulties.	[Lajiness-O'Neill, R.; Hoodin, F.; Kentor, R.; Colbert, A.] Eastern Michigan Univ, Dept Psychol, Ypsilanti, MI 48197 USA; [Lajiness-O'Neill, R.] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Hoodin, F.; Heinrich, K.] Univ Michigan Hlth Syst, Dept Psychiat, Ann Arbor, MI USA; [Connelly, J. A.] Univ Michigan Hlth Syst, Dept Pediat Hematol Oncol, Ann Arbor, MI USA		Lajiness-O'Neill, R (corresponding author), Eastern Michigan Univ, Dept Psychol, Sci Complex, Ypsilanti, MI 48197 USA.	rlajines@emich.edu					Abou-Mourad YR, 2010, BONE MARROW TRANSPL, V45, P295, DOI 10.1038/bmt.2009.128; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Armenian SH, 2011, BLOOD, V118, P1413, DOI 10.1182/blood-2011-01-331835; Armstrong D. F., 2001, FRONTIERS BIOSCIENCE, V6, pG6; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barrera M, 2008, BONE MARROW TRANSPL, V42, P15, DOI 10.1038/bmt.2008.84; Bejanyan N, 2015, BIOL BLOOD MARROW TR, V21, P454, DOI 10.1016/j.bbmt.2014.11.007; Belsley DA., 1980, REGRESSION DIAGNOSTI, DOI 10.1002/0471725153; Bowerman B.L., 1990, LINEAR STAT MODELS A, V2nd ed.; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Collins DW, 2003, J CLIN EXP NEUROPSYC, V25, P1011, DOI 10.1076/jcen.25.7.1011.16487; Conners C. K., 2000, CONNERS CONTINUOUS P; Delis DC., 1994, CALIFORNIA VERBAL LE; Ferry C, 2007, BONE MARROW TRANSPL, V40, P219, DOI 10.1038/sj.bmt.1705710; Hayes, 2018, INTRO MEDIATION MODE; Kodituwakku PW, 2007, NEUROSCI BIOBEHAV R, V31, P192, DOI 10.1016/j.neubiorev.2006.06.020; Kramer JH, 1997, BONE MARROW TRANSPL, V19, P607, DOI 10.1038/sj.bmt.1700699; Kupst MJ, 2002, BONE MARROW TRANSPL, V30, P609, DOI 10.1038/sj.bmt.1703683; Levy JMM, 2013, PEDIATR BLOOD CANCER, V60, P700, DOI 10.1002/pbc.24252; MENARD S, 1995, SAGE U PAPER SERIES; Moscovitch M., 2007, COGNITION BRAIN CONS; Murray AL, 2014, NEUROPSYCHOLOGY, V28, P552, DOI 10.1037/neu0000071; Pasquini Marcelo, 2013, Clin Transpl, P187; Perkins JL, 2007, PEDIATR BLOOD CANCER, V49, P958, DOI 10.1002/pbc.21207; Peterson CC, 2008, PEDIATR BLOOD CANCER, V51, P99, DOI 10.1002/pbc.21544; Phipps S, 2008, J CLIN ONCOL, V26, P2027, DOI 10.1200/JCO.2007.13.6135; Pingali SR, 2015, BONE MARROW TRANSPL, V50, P1157, DOI 10.1038/bmt.2015.61; Rasche L, 2014, BONE MARROW TRANSPL, V49, P163, DOI 10.1038/bmt.2013.96; Schatz J, 2000, NEUROPSYCHOLOGY, V14, P189, DOI 10.1037//0894-4105.14.2.189; Shah AJ, 2008, J PEDIAT HEMATOL ONC, V30, P411, DOI 10.1097/MPH.0b013e318168e750; Simms S, 2002, J PEDIAT HEMATOL ONC, V24, P115, DOI 10.1097/00043426-200202000-00011; Sun CL, 2010, BLOOD, V116, P3129, DOI 10.1182/blood-2009-06-229369; WABER DP, 1986, J CLIN EXP NEUROPSYC, V8, P563, DOI 10.1080/01688638608405176; Wechsler D, 2003, WECHSLER INTELLIGENC; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; Woodcock R.W., 2007, WOODCOCK JOHNSON TES; Worel N, 2002, BONE MARROW TRANSPL, V30, P619, DOI 10.1038/sj.bmt.1703677	39	6	6	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2015	30	7					657	669		10.1093/arclin/acv053			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CY4GQ	WOS:000366367000007	26319492				2022-02-06	
J	Sweis, RT; Ouyang, BC; Lopez, GA; Bleck, TP; Busl, KM				Sweis, Rochelle T.; Ouyang, Bichun; Lopez, George A.; Bleck, Thomas P.; Busl, Katharina M.			FALCINE AND TENTORIAL SUBDURAL HEMATOMAS MAY NOT ROUTINELY REQUIRE TRANSFER TO A TERTIARY CARE CENTER	JOURNAL OF EMERGENCY MEDICINE			English	Article						subdural hematoma; falcine and tentorial subdural hematoma; triage; transfer; neurocritical care; tertiary care center	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; NEUROSURGICAL CONSULTATION; UTILITY	Background: Patients with subdural hematomas (SDH) are frequently transferred to tertiary care centers. Although many prognostic factors, treatment strategies, and outcomes for convexity SDH have been reported, little is known about falcine and tentorial SDH. Objectives: To describe features and outcomes of isolated falcine and tentorial SDH. Methods: We reviewed clinical/radiographic findings, treatment, length of stay (LOS), and outcome of adult patients transferred to a tertiary care center for acute SDH. Characteristics of patients with isolated falcine/tentorial SDH and outcomes (favorable [discharge to home/ acute rehabilitation] vs. unfavorable [death/hospice/skilled nursing facility/long term care]) were assessed with univariate analyses. Results: Of 210 patients with SDH, mean age was 69.5 years; 117 were male; 98 (47%) underwent surgical SDH evacuation. Twenty-seven patients had isolated falcine or tentorial SDH, with known traumatic etiology in 23. None of the falcine/tentorial SDH patients required surgery or intubation. Compared with convexity SDH, patients with falcine/tentorial SDH were younger (59.7 vs. 70.9 years, p = 0.01), had higher admission Glasgow Coma Scale scores at the referring (p = 0.01) and receiving facility (p = 0.004), and shorter median intensive care unit LOS (1 vs. 3, p < 0.0001). All patients (100%) with falcine/tentorial SDH had favorable outcome vs. 68% with convexity SDH (p = 0.0005). Conclusion: Isolated tentorial/falcine SDH without associated neurological deficits represent a benign entity among acute SDH, with no need for surgical intervention, short LOS, and favorable outcome. Our data indicate that for these patients, in the absence of complicating factors, transfer to a tertiary care center may not be routinely indicated. (C) 2015 Elsevier Inc.	[Sweis, Rochelle T.; Ouyang, Bichun] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Lopez, George A.; Busl, Katharina M.] Rush Univ, Med Ctr, Dept Neurol Sci, Sect Neurocrit Care, Chicago, IL 60612 USA; [Bleck, Thomas P.] Rush Med Coll, Dept Neurol Sci, Chicago, IL 60612 USA; [Bleck, Thomas P.] Rush Med Coll, Dept Neurosurg, Chicago, IL 60612 USA; [Bleck, Thomas P.] Rush Med Coll, Dept Internal Med, Chicago, IL 60612 USA; [Bleck, Thomas P.] Rush Med Coll, Dept Anesthesiol, Chicago, IL 60612 USA; [Bleck, Thomas P.] Rush Univ, Med Ctr, Crit Care, Chicago, IL 60612 USA		Busl, KM (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Sect Neurocrit Care, 1725 West Harrison St,POB Suite 1121, Chicago, IL 60612 USA.		lopez, george/W-4435-2019; Bleck, Thomas/D-3772-2009; Bleck, Thomas/R-2286-2019	Bleck, Thomas/0000-0002-8267-9787			Barker DE, 2006, AM SURGEON, V72, P1166; BARTELS RHMA, 1995, NEUROSURGERY, V36, P1210, DOI 10.1227/00006123-199506000-00026; BORZONE M, 1995, ZBL NEUROCHIR, V56, P51; Bullock MR, 2006, NEUROSURGERY S, V58; Busl KM, 2013, J NEUROSURG, V119, P1296, DOI 10.3171/2013.4.JNS122236; Byrne RW, 2008, NEUROSURGERY, V62, P709, DOI 10.1227/01.neu.0000317320.79106.7e; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gerard C, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0275-0; Holland CM, 2015, NEUROSURGERY, V77, P200, DOI 10.1227/NEU.0000000000000752; Huynh T, 2006, AM SURGEON, V72, P1162; Krishnaney AA, 2004, AM J NEURORADIOL, V25, P1006; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Marion DW, 2006, NEUROSURGERY, V58, P655; Takeuchi S, 2012, TURK NEUROSURG, V22, P305, DOI 10.5137/1019-5149.JTN.5178-11.2; Wang YH, 2014, TURK NEUROSURG, V24, P228, DOI 10.5137/1019-5149.JTN.8377-13.0	16	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	NOV	2015	49	5					679	685		10.1016/j.jemermed.2015.06.055			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CX0SN	WOS:000365407100023	26279513				2022-02-06	
J	Van Beek, L; Ghesquiere, P; De Smedt, B; Lagae, L				Van Beek, Leen; Ghesquiere, Pol; De Smedt, Bert; Lagae, Lieven			Arithmetic difficulties in children with mild traumatic brain injury at the subacute stage of recovery	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							SINGLE-DIGIT MULTIPLICATION; NEUROPHYSIOLOGICAL ASSESSMENT; SHORT-TERM; CONCUSSION; COMPONENT	AimArithmetic difficulties have been reported in children with mild traumatic brain injury (mTBI), but the electrophysiological abnormalities underlying these impairments remain unknown. We therefore used event-related potentials (ERPs) to investigate brain functioning during arithmetic in children in the subacute phase after mTBI. MethodThe participants comprised 16 children with mTBI at the subacute phase of recovery (10 males, mean age 10y 8mo; six females, mean age 10y 8mo) and 16 well-matched comparison children (11 males, mean age 10y 11mo; five females, mean age 10y 6mo). All children were asked to solve single-digit addition problems of small (sum 10) and large problem size (sum >10) and ERPs were simultaneously recorded. ResultsChildren with mTBI performed significantly less accurately (mean 81%) than comparison children (mean 91%) on the large (p=0.026) but not on the small problems (p=0.171). We observed no group differences in the early ERP components P1, N1, P2, and N2 (all p values 0.241), yet significant group differences (p=0.019) emerged for the late positivity component (LPC), which showed smaller mean amplitudes (mean 8.35V) in mTBI patients than comparison children (mean 12.95V). InterpretationImmediately after the injury, arithmetic difficulties in children with mTBI are particularly pronounced on more complex arithmetical problems that are less automated. This is reflected in the ERP pattern, with decreased LPC but normal N2 and early ERP components.	[Van Beek, Leen; Ghesquiere, Pol; De Smedt, Bert] Univ Leuven, Fac Psychol & Educ Sci, Parenting & Special Educ, Leuven, Belgium; [Lagae, Lieven] Univ Leuven, Biomed Sci Grp, Dept Dev & Regenerat, Leuven, Belgium		De Smedt, B (corresponding author), Parenting & Special Educ Res Unit, Leopold Vanderkelenstr 32,Box 3765, B-3000 Leuven, Belgium.	Bert.DeSmedt@ppw.kuleuven.be	Ghesquiere, Pol/B-9226-2009; De Smedt, Bert/U-6124-2019; De Smedt, Bert/Q-7020-2019; De Smedt, Bert/G-4729-2010	Ghesquiere, Pol/0000-0001-9056-7550; De Smedt, Bert/0000-0002-3313-3278; De Smedt, Bert/0000-0002-3313-3278	Research Foundation Flanders (FWO)FWO [G.A113.11N]	This study was supported by grant G.A113.11N from the Research Foundation Flanders (FWO). We thank the children and their families for their time and contribution to this study. We also thank Ivan Myatchin and Jan Vervisch for their technical assistance with the ERP design and data analysis. The authors have stated that they had no interests that could be perceived as posing a conflict or bias.	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Campbell J.I.D., 2005, HDB MATH COGNITION, P347, DOI DOI 10.4324/9780203998045; De Smedt B, 2009, CORTEX, V45, P177, DOI 10.1016/j.cortex.2007.06.003; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dudal P., 2000, LEERLINGVOLGSYSTEEM; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Hubber PJ, 2014, Q J EXP PSYCHOL, V67, P936, DOI 10.1080/17470218.2013.838590; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kort W., 2005, WISC 3 NL WECHSLER I; LeFevre JA, 1996, J EXP PSYCHOL GEN, V125, P284, DOI 10.1037/0096-3445.125.3.284; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Mennes M, 2010, PSYCHOPHYSIOLOGY, V47, P1142, DOI 10.1111/j.1469-8986.2010.01015.x; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Prieto-Corona B, 2010, NEUROSCI LETT, V468, P220, DOI 10.1016/j.neulet.2009.10.094; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Slater E.J., 1989, J ADOLESCENT RES, V4, P371; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Van Beek L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00756; Xuan D, 2007, CHILD NEUROPSYCHOL, V13, P1, DOI 10.1080/09297040600760465; Zbrodoff W., 2005, HDB MATH COGNITION, P331; Zhou XL, 2006, NEUROPSYCHOLOGIA, V44, P2500, DOI 10.1016/j.neuropsychologia.2006.04.003; Zhou XL, 2011, DEV NEUROPSYCHOL, V36, P338, DOI 10.1080/87565641.2010.549873	27	6	6	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	NOV	2015	57	11					1042	1048		10.1111/dmcn.12858			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	CT3YG	WOS:000362742200014	26268837	Green Accepted			2022-02-06	
J	Wielenga-Boiten, JE; Heijenbrok-Kal, MH; Ribbers, GM				Wielenga-Boiten, Janet E.; Heijenbrok-Kal, Majanka H.; Ribbers, Gerard M.			The Relationship of Health Locus of Control and Health-Related Quality of Life in the Chronic Phase After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; locus of control; quality of life; rehabilitation	FUNCTIONAL ASSESSMENT MEASURE; SICKNESS IMPACT PROFILE; SHORT GENERIC VERSION; INTERRATER RELIABILITY; SOCIAL SUPPORT; FOLLOW-UP; REHABILITATION; INTERVENTION; DISABILITY; BELIEFS	Objective: To study health locus of control (HLC) after moderate to severe traumatic brain injury (TBI) compared with norm values and in relation to health-related quality of life (HR-QoL) over time. Setting: Three level-1 trauma centers. Participants: Individuals with moderate to severe TBI (N = 85). Design: Prospective cohort study. Main Measures: Multidimensional health locus of control scales including internal control (Internal-HLC), control attributed to physicians (Physician-HLC) or to chance (Chance-HLC) and sickness impact profile-68 including physical and psychosocial HR-QoL. Results: One to 3 years after TBI, Internal-HLC, and Chance-HLC significantly declined, whereas Physician-HLC remained stable. Total and psychosocial HR-QoL did not change over time, but physical HR-QoL improved. Three years after TBI, Internal-HLC (P <.001), and Physician-HLC (P <.001) were significantly lower and Chance-HLC (P <.001) significantly higher than norm values. Chance-HLC was independently related to total (beta =.321, P <.001) and psychosocial HR-QoL (beta =.258, P <.001), adjusted for baseline characteristics, functional, and cognitive outcome. Conclusions: After TBI, HLC may change over time and may be different from healthy adults. The external Chance-HLC orientation has a negative relationship with HR-QoL. Future research focused on the effect of rehabilitation programs for improving the balance in internal and external locus of control is needed.	Univ Med Ctr Rotterdam, Rijndam Rehabil Ctr, Erasmus MC, Rotterdam, Netherlands; Univ Med Ctr Rotterdam, Dept Rehabil Med, Erasmus MC, Rotterdam, Netherlands; [Heijenbrok-Kal, Majanka H.] Erasmus MC, NL-3015 LJ Rotterdam, Netherlands		Heijenbrok-Kal, MH (corresponding author), Rijndam Rehabil Ctr, Rotterdam Neurorehabil Res RoNeRes, Westersingel 300, NL-3015 LJ Rotterdam, Netherlands.	mheijenbrok@rijndam.nl	Ribbers, Gerard/N-3623-2019; Ribbers, Gerard M/C-1454-2014	Ribbers, Gerard M/0000-0002-6114-349X; Heijenbrok-Kal, Majanka H./0000-0002-2982-4404	Netherlands Organization for Health Research and DevelopmentNetherlands Organization for Health Research and Development [1435.0020]	This study was financially supported by the Netherlands Organization for Health Research and Development (project no. 1435.0020).	Aalto AM, 1997, PATIENT EDUC COUNS, V30, P215, DOI 10.1016/S0738-3991(96)00963-9; Allen L L, 2000, Clin Excell Nurse Pract, V4, P41; Amir M, 1999, EPILEPSIA, V40, P216, DOI 10.1111/j.1528-1157.1999.tb02078.x; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; de Boer MJ, 2014, EUR J PAIN, V18, P1440, DOI 10.1002/ejp.509; DEBRUIN AF, 1994, J CLIN EPIDEMIOL, V47, P863, DOI 10.1016/0895-4356(94)90189-9; DEBRUIN AF, 1994, J CLIN EPIDEMIOL, V47, P407, DOI 10.1016/0895-4356(94)90162-7; DeValck C, 1996, PATIENT EDUC COUNS, V28, P179, DOI 10.1016/0738-3991(96)00897-X; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Fleming JM, 1997, J HEAD TRAUMA REHAB, V12, P27, DOI 10.1097/00001199-199706000-00004; Goldstein LH, 2003, AMYOTROPH LATERAL SC, V4, P27, DOI 10.1080/14660820310006698; Gruber-Baldini AL, 2009, PARKINSONISM RELAT D, V15, P665, DOI 10.1016/j.parkreldis.2009.03.005; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Izaute M, 2008, BRAIN INJURY, V22, P758, DOI 10.1080/02699050802366002; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Keers JC, 2006, PATIENT EDUC COUNS, V60, P16, DOI 10.1016/j.pec.2004.10.013; Lefcourt H, 1981, ROYAL COMMISSION NEW, V1, P1; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; McPherson KM, 1996, DISABIL REHABIL, V18, P341, DOI 10.3109/09638289609165892; MILLER WR, 1975, J ABNORM PSYCHOL, V84, P228, DOI 10.1037/h0076720; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Petersen C, 2005, PROG BRAIN RES, V150, P545, DOI 10.1016/S0079-6123(05)50038-4; Preau M, 2005, J PSYCHOSOM RES, V59, P407, DOI 10.1016/j.jpsychores.2005.06.005; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Rybarczyk B, 2001, BEHAV MED, V27, P15, DOI 10.1080/08964280109595768; Sengul Y, 2010, TURK NEUROSURG, V20, P180, DOI 10.5137/1019-5149.JTN.2616-09.1; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; vanBalen HGG, 1996, DISABIL REHABIL, V18, P181, DOI 10.3109/09638289609166298; WALLSTON KA, 1994, J PERS ASSESS, V63, P534, DOI 10.1207/s15327752jpa6303_10; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; Wallston KA, 1981, RES LOCUS CONTROL CO, V1, P189, DOI DOI 10.1016/B978-0-12-443201-7.50010-5; Willemse-van Son AHP, 2009, J REHABIL MED, V41, P59, DOI 10.2340/16501977-0294	48	6	7	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2015	30	6					424	431		10.1097/HTR.0000000000000128			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JN	WOS:000369606300014	25699627				2022-02-06	
J	Zhang, J; Liu, L; Mu, JA; Yang, TT; Zheng, N; Dong, HM				Zhang, Ji; Liu, Liang; Mu, Jiao; Yang, Tiantong; Zheng, Na; Dong, Hongmei			Chemical Analysis in the Corpus Callosum Following Traumatic Axonal Injury using Fourier Transform Infrared Microspectroscopy: A Pilot Study	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; forensic pathology; traumatic axonal injury; traumatic brain injury; Fourier transform infrared microspectroscopy; animal study	FT-IR SPECTROSCOPY; DIFFUSE BRAIN INJURY; TISSUE; PROTEINS; DAMAGE; MODEL; IDENTIFICATION; DIAGNOSIS; SPECTRA; DISEASE	Evaluating traumatic axonal injury remains challenging in clinical and forensic sciences as its identification is difficult using routine diagnostic methods. This study used Fourier transform infrared microspectroscopy to detect TAI within the corpus callosum in an animal model. Protein conformational analysis revealed significantly increased beta-sheet and beta-turn contents paralleled by a decrease in alpha-helix content at 24 h postinjury, while the antiparallel V-sheet content was decreased at 12 h postinjury. Compared with the control group, the lipid/protein ratio was significantly reduced in all of the injured groups. At 24 h postinjury, there were increases in the olefinic=CH and CH3 group of lipids accompanied by the decreased CH2 group, but the results at 12 and 72 h were contrary to that at 24 h. Our study showed that FTIRM could differentiate injured from normal white matter at different time points following TBI via examination of these infrared spectral parameters.	[Zhang, Ji] Xi An Jiao Tong Univ, Dept Forens Med, Xian 710049, Shanxi, Peoples R China; [Liu, Liang; Mu, Jiao; Dong, Hongmei] Huazhong Univ Sci & Technol, Dept Forens Med, Wuhan 430074, Hubei, Peoples R China; [Yang, Tiantong] China Univ Polit Sci & Law, Key Lab Evidence Sci, Collaborat Innovat Ctr Judicial Civilizat, Beijing, Peoples R China; [Zheng, Na] Shenzhen Univ, Dept Pathophysiol, Shenzhen, Peoples R China		Dong, HM (corresponding author), Huazhong Univ Sci & Technol, Dept Forens Med, 13 Hangkong Rd, Wuhan 430074, Hubei, Peoples R China.	shanrenziyoumiao@126.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81102298]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2014TS139]	Funded by the National Nature Science Foundation of China (No. 81102298) and the Fundamental Research Funds for the Central Universities (No. 2014TS139).	Agrawal SK, 1996, J NEUROSCI, V16, P545; Ali K, 2008, INT J MOL MED, V21, P297; Archer RP, 2009, FORENSIC SCI INT, V185, P10, DOI 10.1016/j.forsciint.2008.11.013; Beekes M, 2007, VET MICROBIOL, V123, P305, DOI 10.1016/j.vetmic.2007.04.010; Bennett M, 1994, IRAN MED J, V88, P59; Bennett M, 1994, IRAN MED J, V88; Bennett M, 1994, IRAN MED J, V88, P60; Bozkurt O, 2010, ANALYST, V135, P3110, DOI 10.1039/c0an00542h; Bright NJ, 2013, FORENSIC SCI INT, V230, P81, DOI 10.1016/j.forsciint.2013.03.047; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2006, ACTA NEUROCHIR WIEN, V148, P93; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cakmak G, 2006, AQUAT TOXICOL, V77, P53, DOI 10.1016/j.aquatox.2005.10.015; Cakmak G, 2012, ARCH BIOCHEM BIOPHYS, V520, P67, DOI 10.1016/j.abb.2012.02.012; CHOO LP, 1995, BIOSPECTROSCOPY, V1, P141, DOI 10.1002/bspy.350010208; Cox RJ, 2000, FORENSIC SCI INT, V108, P107, DOI 10.1016/S0379-0738(99)00203-0; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gasper R, 2009, BBA-BIOMEMBRANES, V1788, P1263, DOI 10.1016/j.bbamem.2009.02.016; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; HARIS PI, 1986, BIOCHIM BIOPHYS ACTA, V874, P255, DOI 10.1016/0167-4838(86)90024-5; Kneipp J, 2000, BBA-MOL BASIS DIS, V1501, P189, DOI 10.1016/S0925-4439(00)00021-1; Kretlow A, 2008, BBA-MOL BASIS DIS, V1782, P559, DOI 10.1016/j.bbadis.2008.06.004; Kretlow A, 2006, BBA-BIOMEMBRANES, V1758, P948, DOI 10.1016/j.bbamem.2006.05.026; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liu KZ, 2002, VIB SPECTROSC, V28, P131, DOI 10.1016/S0924-2031(01)00163-1; MANTSCH H, 1995, J MOL STRUCT, V347, P187, DOI 10.1016/0022-2860(95)08545-7; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Ohler B, 2004, BBA-MOL BASIS DIS, V1688, P10, DOI 10.1016/j.bbadis.2003.10.001; Ozek NS, 2010, ANALYST, V135, P3094, DOI 10.1039/c0an00543f; Petibois C, 2006, TRENDS BIOTECHNOL, V24, P455, DOI 10.1016/j.tibtech.2006.08.005; Richter T, 2002, VIB SPECTROSC, V28, P103, DOI 10.1016/S0924-2031(01)00149-7; Severcan F, 2005, ANAL BIOCHEM, V339, P36, DOI 10.1016/j.ab.2005.01.011; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shinitzky M, 1979, INT REV CYTOL, V60, P12; Szczerbowska-Boruchowska M, 2007, ARCH BIOCHEM BIOPHYS, V459, P241, DOI 10.1016/j.abb.2006.12.027; Thomas M, 2009, REHABIL NURS, V34, P179, DOI 10.1002/j.2048-7940.2009.tb00276.x; Toyran N, 2004, EUR BIOPHYS J BIOPHY, V33, P549, DOI 10.1007/s00249-004-0396-1; Wang XF, 2014, FORENSIC SCI INT, V236, P99, DOI 10.1016/j.forsciint.2013.12.034; Whiteman S C, 2008, Ther Adv Respir Dis, V2, P23, DOI 10.1177/1753465807087972; Yang TAT, 2011, FORENSIC SCI INT, V207, pE34, DOI 10.1016/j.forsciint.2010.12.005	44	6	7	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	NOV	2015	60	6					1488	1494		10.1111/1556-4029.12871			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	DA3CA	WOS:000367672300012	26272718				2022-02-06	
J	Barry, NC; Tomes, JL				Barry, Nicole C.; Tomes, Jennifer L.			Remembering your past: The effects of concussion on autobiographical memory recall	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Memory; Episodic memory; Concussion; Autobiographical memory	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL PLAYERS; MILD HEAD-INJURY; INTERNATIONAL-CONFERENCE; FUNCTIONAL NEUROANATOMY; COGNITIVE PERFORMANCE; EPISODIC MEMORY; SELF; SPORTS; INDIVIDUALS	To date, research focusing on long-term memory functioning post concussion is limited. The purpose of the current study was to investigate the effects of concussion on long-term episodic autobiographical memory, once acute postconcussive symptoms have abated. Individuals with and without a history of concussion were asked to recall autobiographical memories from different life periods. The details, self-reported vividness, ease of recall, and completeness of these memories were assessed. Results indicated that although both control and previously concussed participants were equally able to recall autobiographical memories from all life periods, the transcribed memories of previously concussed participants were less detailed, were less complex, and revealed less active involvement in recollection. Specifically, memories of control participants contained more words and a higher proportion of pronouns, personal pronouns, cognitive process words, perceptual process words, and past-tense words. Deficits were found regardless of the frequency or recency of concussion. Concussion information, limitations, and implications of the current findings are discussed.	[Barry, Nicole C.] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada; [Tomes, Jennifer L.] Mt Allison Univ, Dept Psychol, Sackville, NB E4L 1M3, Canada		Tomes, JL (corresponding author), Mt Allison Univ, Dept Psychol, Sackville, NB E4L 1M3, Canada.	jtomes@mta.ca					Baker JM, 2014, BRAIN INJURY, V28, P51, DOI 10.3109/02699052.2013.857787; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bergouignan L, 2008, BEHAV RES THER, V46, P322, DOI 10.1016/j.brat.2007.12.007; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2003, CORTEX, V39, P667, DOI 10.1016/S0010-9452(08)70859-1; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Finkelstein E., 2006, INCIDENCE EC BURDEN; Giza CC, 2001, J ATHL TRAINING, V36, P228; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hart R.P., 2001, THEORY METHOD PRACTI, P43; Herlitz A, 2008, CURR DIR PSYCHOL SCI, V17, P52, DOI 10.1111/j.1467-8721.2008.00547.x; Hirshhorn M, 2012, NEUROPSYCHOLOGIA, V50, P3094, DOI 10.1016/j.neuropsychologia.2012.08.008; Iverson G. L., 2009, BLACK BOOK NEUROPSYC; Jackson D.N., 1998, MULTIDIMENSIONAL APT; Kasai M, 2006, PSYCHIAT CLIN NEUROS, V60, P139, DOI 10.1111/j.1440-1819.2006.01478.x; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kit KA, 2007, REHABIL PSYCHOL, V52, P25, DOI 10.1037/0090-5550.52.1.25; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levine B, 2004, BRAIN COGNITION, V55, P54, DOI 10.1016/s0278-2626(03)00280-x; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Pennebaker J.W., 2007, LINGUISTIC INQUIRY W; Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041; Piefke M, 2005, HUM BRAIN MAPP, V24, P313, DOI 10.1002/hbm.20092; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schmitter-Edgecombe M, 2007, NEUROPSYCHOLOGY, V21, P224, DOI 10.1037/0894-4105.21.2.224; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Tulving E., 1983, ELEMENTS EPISODIC ME; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; VERNON PA, 1986, INTELLIGENCE, V10, P315, DOI 10.1016/0160-2896(86)90002-4; von Stumm S, 2013, PSYCHOL AGING, V28, P680, DOI 10.1037/a0033924; Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551	53	6	6	3	63	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT 21	2015	37	9					994	1003		10.1080/13803395.2015.1038981			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CQ5LZ	WOS:000360647100009	26300529				2022-02-06	
J	Tian, RF; Han, L; Hou, ZG; Hao, SY; Mao, X; Zhu, ZD; Tao, XG; Zhang, Q; Liu, BY				Tian, Runfa; Han, Li; Hou, Zonggang; Hao, Shuyu; Mao, Xiang; Zhu, Zhendan; Tao, Xiaogang; Zhang, Qi; Liu, Baiyun			Neuroprotective efficacy of decompressive craniectomy after controlled cortical impact injury in rats: An MRI study	BRAIN RESEARCH			English	Article						Brain trauma; Controlled cortical impact; Decompressive craniectomy; Magnetic resonance imaging; Proton magnetic resonance; spectroscopy	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; METABOLIC-CHANGES; TIME-COURSE; DIFFUSION; BIOMARKERS; MANAGEMENT; MODELS; DTI	Decompressive craniectomy (DC) is one of the therapeutic options for severe traumatic brain injury (TBI), and it has long been used for the treatment of patients with malignant post-traumatic brain edema. However, a lack of definitive evidence prevents physicians from drawing any conclusions about the efficacy of DC for the treatment of TBI. Magnetic resonance imaging (MRI) is widely used to evaluate the effects of TBI in both experimental and clinical studies. Therefore, the aim of the present study was to investigate the MRI assessment of DC post-TBI in rats to provide experimental animal data and radiological evidence to support the clinical application of DC. We used both in vivo MRI and proton magnetic resonance spectroscopy (H-1-MRS) to evaluate the therapeutic effect of DC on lateral controlled cortical impact (CCI) rat models at 3 h, 1 d, 2 d, 3 d and 7 d after TBI. Our data suggest that DC can reduce brain edema; decrease the apparent diffusion coefficient value, contusion volume and lactate (Lac)/creatine (Cr) ratio; and increase the N-acetylaspartate (NAA)/Cr and choline (Cho)/Cr ratios after TBI. The present results suggest that DC can indeed reduce brain edema formation and exhibits good neuroprotective efficacy after CCI injury in rats. (C) 2015 Elsevier B.V. All rights reserved.	[Tian, Runfa; Hou, Zonggang; Hao, Shuyu; Tao, Xiaogang; Liu, Baiyun] Capital Med Univ, Dept Neurosurg, Beijing Tian Tan Hosp, Beijing 100050, Peoples R China; [Han, Li; Zhang, Qi] Huazhong Univ Sci & Technol, Liyuan Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430000, Peoples R China; [Mao, Xiang] Anhui Med Univ, Dept Neurosurg, Affiliated Hosp 1, Hefei 230000, Peoples R China; [Liu, Baiyun] Capital Med Univ, Neurotrauma Lab, Beijing Neurosurg Inst, Beijing 100050, Peoples R China; [Zhu, Zhendan; Liu, Baiyun] Gen Hosp Armed Police Forces, Dept Neurotrauma, Beijing 100039, Peoples R China; [Tian, Runfa; Hou, Zonggang; Hao, Shuyu; Tao, Xiaogang; Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing 100050, Peoples R China; [Tian, Runfa; Hou, Zonggang; Hao, Shuyu; Tao, Xiaogang; Liu, Baiyun] Beijing Key Lab Cent Nervous Syst Injury, Beijing 100050, Peoples R China		Hou, ZG (corresponding author), Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, Tiantan Xili 6, Beijing 100050, Peoples R China.	houzg2006@163.com; liubaiyun1212@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171144, 81471238]; Beijing Nova programBeijing Municipal Science & Technology Commission [XX2012033]; National Key Technology Research and Development Program of the Ministry of Science and Technology of ChinaNational Key Technology R&D Program [2013BAI09B03]; Beijing Institute for Brain Disorders [BIBD-PXM2013_014226_07_000084]	We would like to acknowledge the assistance of Shaowu Li, Zhenlan Li, Sijia Wang, Feifan Xu, Xuetao Chen and Weichuan Wu for their support of this study. This study was supported by National Natural Science Foundation of China (nos. 81171144 and 81471238), Beijing Nova program (no. XX2012033), National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAI09B03) and Beijing Institute for Brain Disorders (BIBD-PXM2013_014226_07_000084).	Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Bohman L, 2013, CURR NEUROL NEUROSCI, V13, P1; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dapul HR, 2013, J NEUROTRAUM, V30, P382, DOI 10.1089/neu.2012.2536; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gasparovic C, 2001, J NEUROTRAUM, V18, P241, DOI 10.1089/08977150151070856; Gupta M, 2013, NMR BIOMED, V26, P1733, DOI 10.1002/nbm.3010; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Lin Y, 2012, J CEREBR BLOOD F MET, V32, P1484, DOI 10.1038/jcbfm.2012.33; Marchadour C, 2012, J CEREBR BLOOD F MET, V32, P2153, DOI 10.1038/jcbfm.2012.119; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Price WS, 1996, J MAGN RESON SER B, V112, P190, DOI 10.1006/jmrb.1996.0129; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Shimoda K., 2014, WORLD NEUROSURG; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083; Zweckberger K, 2011, NEUROL RES, V33, P875, DOI 10.1179/1743132811Y.0000000017	42	6	6	1	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 5	2015	1622						339	349		10.1016/j.brainres.2015.06.039			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS4OC	WOS:000362054100032	26168891				2022-02-06	
J	Chouliara, N; Lincoln, NB				Chouliara, Niki; Lincoln, Nadina B.			Developing a questionnaire to assess the outcome of memory rehabilitation for people with neurological disabilities	INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION			English	Article						Memory rehabilitation; Outcome measure; Neurological disabilities; Meta-memory	MULTIPLE-SCLEROSIS; BRAIN-INJURY; TESTS	Aims: To develop an outcome questionnaire, the Adaptation to Memory Difficulties Outcome Questionnaire, on the effectiveness of memory rehabilitation. Methods: An initial pool of items was identified through observations and qualitative interviews with participants receiving memory rehabilitation. A 45-item version of the questionnaire was posted to people with traumatic brain injury and multiple sclerosis. A second copy was posted to those who agreed to be reassessed 2 weeks later. Results: The questionnaire was returned by 141 people. Some items were removed due to poor response distributions. Principal component analysis indicated that the questionnaire comprised five subscales: i) memory knowledge; ii) control; iii) emotional adjustment; iv) internal memory aids; v) external memory aids. Internal consistency was satisfactory (Cronbach's alpha=0.74-0.84). Test-retest reliability was assessed on 50 participants completing a second questionnaire within a 4-week interval and was shown to be satisfactory (Cronbach's alpha= 0.67-0.86). There was no significant association between subscale scores and age, gender, diagnosis or time since onset. Conclusions: The questionnaire may be used as a measure of the effect of memory problems, tailored to the aims of memory rehabilitation. Responsiveness to change needs to be assessed.	[Chouliara, Niki] Univ Nottingham, NIHR Collaborat Leadership Appl Hlth Res & Care C, Nottingham NG7 2RD, England; [Lincoln, Nadina B.] Univ Nottingham, Clin Psychol, Nottingham NG7 2RD, England		Chouliara, N (corresponding author), Univ Nottingham, NIHR Collaborat Leadership Appl Hlth Res & Care C, Nottingham NG7 2RD, England.	niki.chouliara@nottingham.ac.uk					Aldridge A, 2001, SURVEYING SOCIAL WOR; Anderson ND, 2010, HDB CLIN NEUROPSYCHO; Bowling A, 2009, RES METHODS HLTH; Braun V, 2003, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, DOI 10.1191/1478088706QP0630A]; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Calabrese P, 2006, J NEUROL, V253, P10, DOI 10.1007/s00415-006-1103-1; Chouliara N., 2013, THESIS; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; das Nair R, 2013, NEUROPSYCHOL REHABIL, V23, P528, DOI 10.1080/09602011.2013.792290; das Nair R, 2012, CLIN REHABIL, V26, P894, DOI 10.1177/0269215511435424; DAWSON DR, 2008, COGNITIVE NEUROREHAB, P232; Evans J, 1992, CLIN REHABIL, V6, P75, DOI DOI 10.1177/026921559200600110; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Ferguson E, 1993, INT J SELECT ASSESS, V1, P84, DOI DOI 10.1111/J.1468-2389.1993.TB00092.X; FERKETICH S, 1991, RES NURS HEALTH, V14, P165, DOI 10.1002/nur.4770140211; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Hannay JH, 2004, NEUROPSYCHOLOGICAL A, P157; Hobart JC, 2004, HEALTH TECHNOL ASSES, V8, P1; Lincoln NB, 2008, COGNITIVE NEUROREHAB, P91; Lucas SE, 2005, AUSTR OCCUPATIONAL T, V52, P160, DOI DOI 10.1111/J.1440-1630.2005.00485.X; Madureira S, 2001, EUR J NEUROL, V8, P621, DOI 10.1046/j.1468-1331.2001.00332.x; Prigatano G., 2008, COGNITIVE NEUROREHAB, P218; Quemada JI, 2003, J HEAD TRAUMA REHAB, V18, P532, DOI 10.1097/00001199-200311000-00007; Streiner DL, 2014, HLTH MEASUREMENT SCA, V4th; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Tabachnick BG., 2012, USING MULTIVARIATE S; Tam SF, 2004, BRAIN INJURY, V18, P461, DOI 10.1080/02699050310001646099; Wilson BA, 2008, COGNITIVE NEUROREHAB, P522	28	6	6	0	1	MARK ALLEN GROUP	LONDON	ST JUDES CHURCH, DULWICH RD, LONDON, SE24 0PB, ENGLAND	1741-1645	1759-779X		INT J THER REHABIL	Int. J. Ther. Rehabil.	OCT	2015	22	10					470	477		10.12968/ijtr.2015.22.10.470			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	CX4DF	WOS:000365648000004		Bronze			2022-02-06	
J	Hoopes, MJ; Dankovchik, J; Weiser, T; Cheng, T; Bigback, K; Knaster, ES; Sugerman, DE				Hoopes, Megan J.; Dankovchik, Jenine; Weiser, Thomas; Cheng, Tabitha; Bigback, Kristyn; Knaster, Elizabeth S.; Sugerman, David E.			Uncovering a missing demographic in trauma registries: epidemiology of trauma among American Indians and Alaska Natives in Washington State	INJURY PREVENTION			English	Article							UNITED-STATES; RACIAL MISCLASSIFICATION; MORTALITY; SURVEILLANCE; INJURIES; CHILDREN; TRENDS	Background The objectives of this study were to evaluate racial misclassification in a statewide trauma registry and to describe the epidemiology of trauma among the Washington American Indian and Alaska Native (AI/AN) population. Methods We performed probabilistic record linkage between the Washington Trauma Registry (2005-2009) and Northwest Tribal Registry, a dataset of known AI/AN. AI/AN patients were compared with caucasians on demographic, injury and clinical outcome factors. A multivariable model estimated odds of mortality. Results Record linkage increased ascertainment of AI/AN cases in the trauma registry 71%, from 1777 to 3039 cases. Compared with caucasians, AI/AN trauma patients were younger (mean age=36 vs 47 years, p<0.001) and more commonly male (66.5% vs 61.2%, p<0.001). AI/AN experienced more intentional injuries (suicide or homicide: 20.1% vs 6.7%, p<0.001), a higher proportion of severe traumatic brain injury (20.7% vs 16.8%, p=0.004) and were less likely than caucasians to use safety equipment such as seat belts/airbags (53.9% vs 76.7%, p<0.001). ISSs were similar (ISS > 15: 21.4% vs 20.5%, p=0.63), and no difference was observed in mortality after adjustment for covariates (p=0.58). Conclusions Linkage to a state trauma registry improved data quality by correcting racial misclassification, allowing for a comprehensive description of injury patterns for the AI/AN population. AI/AN sustained more severe injuries with similar postinjury outcomes to caucasians. Future efforts should focus on primary prevention for this population, including increased use of seat belts and child safety seats and reduction of interpersonal violence and suicide.	[Hoopes, Megan J.; Dankovchik, Jenine; Weiser, Thomas; Bigback, Kristyn] Northwest Portland Area Indian Hlth Board, Northwest Tribal Epidemiol Ctr, Portland, OR 97201 USA; [Weiser, Thomas] Northwest Portland Area Indian Hlth Board, Portland Area Indian Hlth Serv, Portland, OR 97201 USA; [Cheng, Tabitha] Ctr Dis Control & Prevent, Div Sci Educ & Profess Dev, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Knaster, Elizabeth S.] Seattle Indian Hlth Board, Urban Indian Hlth Inst, Seattle, WA USA; [Sugerman, David E.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA		Dankovchik, J (corresponding author), Northwest Portland Area Indian Hlth Board, Northwest Tribal Epidemiol Ctr, 2121 SW Broadway,Suite 300, Portland, OR 97201 USA.	jdankovchik@npaihb.org			Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS019972]; Office of Minority HealthUnited States Department of Health & Human Services [AIAMP120012]; CDC Foundation External Medical Affairs, Pfizer; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS019972] Funding Source: NIH RePORTER	Supported by the grant #R01HS019972 from the Agency for Healthcare Research and Quality Grant #AIAMP120012 from the Office of Minority Health. The CDC Experience is a 1-year fellowship in applied epidemiology at CDC made possible by a public/private partnership supported by a grant to the CDC Foundation from External Medical Affairs, Pfizer.	[Anonymous], 2014, RAC ETH DAT IMPR TOO; Arias Elizabeth, 2008, Vital Health Stat 2, P1; Becker TM, 2002, AM J PUBLIC HEALTH, V92, P1469, DOI 10.2105/AJPH.92.9.1469; Bernard Stephanie J., 2007, Morbidity and Mortality Weekly Report, V56, P1; Bertolli J, 2007, PUBLIC HEALTH REP, V122, P382, DOI 10.1177/003335490712200312; Boehmer U, 2002, AM J PUBLIC HEALTH, V92, P1471, DOI 10.2105/AJPH.92.9.1471; Borse Nagesh N., 2012, Morbidity and Mortality Weekly Report, V61, P830; Centers for Disease Control and Prevention, INJ PREV CONTR DAT S; Centers for Disease Control and Prevention, TOOLS CLASS ICD COD; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P303; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dankovchik J, 2012, NW AM INDIAN ALASKA; Espey DK, 2008, CANCER-AM CANCER SOC, V113, P1120, DOI 10.1002/cncr.23724; Espey DK, 2014, AM J PUBLIC HEALTH, V104, pS286, DOI 10.2105/AJPH.2013.301716; Haas B, 2010, J AM COLL SURGEONS, V211, P804, DOI 10.1016/j.jamcollsurg.2010.08.014; Hicks KR, 2007, IHS PRIM CARE PROVID, V32, P274; Hoopes M, 2012, NW TRIBAL REGISTRY 9; Hoopes M, 2012, LEADING CAUSES DEATH; Horn A, 2003, INJURY PREV, V9, P231, DOI 10.1136/ip.9.3.231; Hu GQ, 2009, AM J PREV MED, V37, P188, DOI 10.1016/j.amepre.2009.04.023; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Jim MA, 2014, AM J PUBLIC HEALTH, V104, pS295, DOI 10.2105/AJPH.2014.301933; Johnson S J, 1999, Inj Prev, V5, P119; Kunitz SJ, 2014, AM J PUBLIC HEALTH, V104, pS268, DOI 10.2105/AJPH.2013.301684; Lapidus JA, 2013, AM J PUBLIC HEALTH, V103, P355, DOI 10.2105/AJPH.2012.300834; Letourneau R, 2009, IHS PRIM CARE PROVID, V35, P212; Murphy T, 2014, AM J PUBLIC HEALTH, V104, pS470, DOI 10.2105/AJPH.2013.301854; Partin MR, 1999, AM J PUBLIC HEALTH, V89, P1673, DOI 10.2105/AJPH.89.11.1673; Reede C, 2007, IHS PRIM CARE PROVID, V32, P209; Satter D. E., 2010, HLTH AM INDIAN ALASK; Stehr-Green P, 2002, AM J PUBLIC HEALTH, V92, P443, DOI 10.2105/AJPH.92.3.443; SUGARMAN JR, 1993, AM J PUBLIC HEALTH, V83, P681, DOI 10.2105/AJPH.83.5.681; SUGARMAN JR, 1992, IHS PROVIDER, V17, P113; Tribal Epidemiology Centers, BEST PRACT AM IND AL; U. S. Department of Health and Human Services, 2009, IND HLTH SERV TRENDS; U.S. Department of Health and Human Services (HHS), 2007, GAPS STRAT IMPR AI A; US Census Bureau, 2011, AM FACTFINDER SEL PO; Washington State Department of Health, WASH STAT TRAUM REG	38	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	OCT	2015	21	5					335	343		10.1136/injuryprev-2014-041419			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CT4MC	WOS:000362779600009	25924945	Green Accepted			2022-02-06	
J	Rymarczuk, GN; Davidson, L; Severson, MA; Armonda, RA				Rymarczuk, George N.; Davidson, Laurence; Severson, Meryl A.; Armonda, Rocco A.			Use of a Minimally Invasive Retractor System for Retrieval of Intracranial Fragments in Wartime Trauma	WORLD NEUROSURGERY			English	Article						Minimally invasive; Penetrating brain injury; Shrapnel; Tubular retractor system; War trauma	PENETRATING CRANIOCEREBRAL INJURIES; BONE FRAGMENTS; MISSILE WOUNDS; TECHNICAL NOTE; BRAIN-LESIONS; BLOOD-FLOW; RAT; INFECTIONS; MANAGEMENT; RESECTION	OBJECTIVE: Wartime penetrating brain injury can result in deep-seated parenchymal and intraventicular shrapnel, bullets, and bone. Large fragments pose a risk of secondary injury from migration, infection, and metal toxicity. It has been recommended that aggressive removal of fragments be avoided. The goal of this study is to report our technique of minimally invasive removal of select deep-seated fragments using a tubular retractor system. METHODS: A retrospective review of our database of service members presenting with penetrating traumatic brain injuries incurred during Operations Iraqi Freedom and Enduring Freedom and treated at the Walter Reed Army Medical Center and the National Naval Medical Center was performed. Six individuals were identified in which the Vycor ViewSite retractor system (Vycor Medical, Boca Raton, Florida, USA) was used to remove a ventricular or deep intraparenchymal fragment. All patients were male and ranged in age from 21 to 29 years. Fragment location included the foramen of Monro; the atrium of the right lateral ventricle; parasagittally within the right occipital lobe; the occipital horn of the right lateral ventricle; the deep white matter of the dominant temporal lobe; and within the posterior right temporal lobe deep to the junction of the transverse and sigmoid dural venous sinuses. Fragments included in-driven bone, shrapnel from improvised explosive devices, and bullets. RESULTS: In all cases the fragment was successfully removed. No patient had worsening of their neurologic condition following surgery. CONCLUSION: Deep parenchymal and intraventricular fragments can be safely removed using a tubular retractor system.	[Rymarczuk, George N.; Davidson, Laurence; Severson, Meryl A.; Armonda, Rocco A.] Walter Reed Natl Mil Med Ctr, Div Neurosurg, Bethesda, MD 20894 USA		Rymarczuk, GN (corresponding author), Walter Reed Natl Mil Med Ctr, Div Neurosurg, Bethesda, MD 20894 USA.	george.n.rymarczuk.mil@mail.mil					Aarabi B, 1998, NEUROSURGERY, V42, P500, DOI 10.1097/00006123-199803000-00014; Almenawer SA, 2013, NEUROSURG REV, V36, P321, DOI 10.1007/s10143-012-0442-x; Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; Cushing H, 1918, Br Med J, V1, P221; de Madureira PR, 2009, SAO PAULO MED J, V127, P52, DOI 10.1590/S1516-31802009000100011; DILLMAN RO, 1979, AM J MED, V66, P509, DOI 10.1016/0002-9343(79)91083-0; DIMAIO VJM, 1983, AM J FOREN MED PATH, V4, P165; Dougherty PJ, 2009, J BONE JOINT SURG AM, V91A, P2002, DOI 10.2106/JBJS.H.01077; Eward William C, 2011, J Surg Orthop Adv, V20, P241; Fahim DK, 2009, J NEUROSURG-PEDIATR, V3, P101, DOI 10.3171/2008.11.PEDS08280; GJEDDE A, 1980, ACTA PHYSIOL SCAND, V108, P321, DOI 10.1111/j.1748-1716.1980.tb06540.x; Grant GA, 2012, WORLD NEUROSURG, V77, P479, DOI 10.1016/j.wneu.2011.08.005; Greenfield JP, 2008, NEUROSURGERY, V63, P334, DOI [10.1227/01.NEU.0000334741.61745.72, 10.1227/01.neu.0000334741.61745.72]; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; Herrera Sebastian R, 2010, Surg Technol Int, V19, P47; KELLY PJ, 1987, APPL NEUROPHYSIOL, V50, P107; Kocak A, 2004, AM J FOREN MED PATH, V25, P246, DOI 10.1097/01.paf.0000127403.97576.0b; LINDEN MA, 1982, ANN SURG, V195, P305, DOI 10.1097/00000658-198203000-00010; MAGOS L, 1994, HUM EXP TOXICOL, V13, P735, DOI 10.1177/096032719401301101; MARTIN J, 1946, J NEUROSURG, V3, P58, DOI 10.3171/jns.1946.3.1.0058; MEIROWSKY AM, 1982, J NEUROSURG, V57, P617, DOI 10.3171/jns.1982.57.5.0617; Ogura K, 2006, ACTA NEUROCHIR, V148, P779, DOI 10.1007/s00701-006-0768-7; PITLYK PJ, 1970, J NEUROSURG, V33, P19, DOI 10.3171/jns.1970.33.1.0019; Rammo RA, 2012, WORLD NEUROSURG, V77, DOI 10.1016/j.wneu.2011.06.015; Recinos PF, 2011, J NEUROSURG-PEDIATR, V7, P516, DOI 10.3171/2011.2.PEDS10515; RISH BL, 1981, NEUROSURGERY, V9, P535, DOI 10.1227/00006123-198111000-00008; ROSENORN J, 1985, J NEUROSURG, V63, P608, DOI 10.3171/jns.1985.63.4.0608; ROSENORN J, 1982, J NEUROSURG, V56, P826, DOI 10.3171/jns.1982.56.6.0826; Schick U, 2003, ACTA NEUROCHIR, V145, P79, DOI 10.1007/s00701-002-1034-2; WANNAMAKER GT, 1958, J NEUROSURG, V15, P512, DOI 10.3171/jns.1958.15.5.0512; Yadav YR, 2011, NEUROL INDIA, V59, P74, DOI 10.4103/0028-3886.76870	33	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2015	84	4					1055	1061		10.1016/j.wneu.2015.05.067			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CV0EI	WOS:000363920900033	26092532				2022-02-06	
J	Yoon, KJ; Lee, YT; Chung, PW; Lee, YK; Kim, DY; Chun, MH				Yoon, Kyung Jae; Lee, Yong-Taek; Chung, Pil-Wook; Lee, Yun Kyung; Kim, Dae Yul; Chun, Min Ho			Effects of Repetitive Transcranial Magnetic Stimulation on Behavioral Recovery during Early Stage of Traumatic Brain Injury in Rats	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Transcranial Magnetic Stimulation; Brain Injury; Apoptosis; Recovery; Bcl-2; BAX; TBI; rTMS	PRIMARY MOTOR CORTEX; TRANSGENIC MICE; CEREBRAL-ISCHEMIA; ANTI-APOPTOSIS; BLOOD-FLOW; IN-VITRO; BCL-2; STROKE; RTMS; OVEREXPRESSION	Repetitive transcranial magnetic stimulation (rTMS) is a promising technique that modulates neural networks. However, there were few studies evaluating the effects of rTMS in traumatic brain injury (TBI). Herein, we assessed the effectiveness of rTMS on behavioral recovery and metabolic changes using brain magnetic resonance spectroscopy (MRS) in a rat model of TBI. We also evaluated the safety of rTMS by measuring brain swelling with brain magnetic resonance imaging (MRI). Twenty male Sprague-Dawley rats underwent lateral fluid percussion and were randomly assigned to the sham (n = 10) or the rTMS (n = 10) group. rTMS was applied on the fourth day after TBI and consisted of 10 daily sessions for 2 weeks with 10 Hz frequency (total pulses = 3,000). Although the rTMS group showed an anti-apoptotic effect around the peri-lesional area, functional improvements were not significantly different between the two groups. Additionally, rTMS did not modulate brain metabolites in MRS, nor was there any change of brain lesion or edema after magnetic stimulation. These data suggest that rTMS did not have beneficial effects on motor recovery during early stages of TBI, although an anti-apoptosis was observed in the peri-lesional area.	[Yoon, Kyung Jae; Lee, Yong-Taek] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Phys Med & Rehabil, Seoul, South Korea; [Chung, Pil-Wook] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Neurol, Seoul, South Korea; [Yoon, Kyung Jae; Lee, Yong-Taek] Kangbuk Samsung Hosp, Regenerat & Neurosci Lab, Med Res Inst, Seoul, South Korea; [Lee, Yun Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Kim, Dae Yul; Chun, Min Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, Seoul 05505, South Korea		Chun, MH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.	mhchun@amc.seoul.kr	Yoon, Kyung Jae/ABB-3785-2021	Chun, Min Ho/0000-0001-8666-7225	Samsung Biomedical Research Institute grantSamsung [SMX1132351]	This work was supported by Samsung Biomedical Research Institute grant (2012, #SMX1132351).	Antonsson B, 2001, CELL TISSUE RES, V306, P347, DOI 10.1007/s00441-001-0472-0; Arnold DL, 1996, MR SPECTROSCOPY CLIN, P139; CharriautMarlangue C, 1996, J CEREBR BLOOD F MET, V16, P186, DOI 10.1097/00004647-199603000-00002; Chouinard PA, 2003, J NEUROPHYSIOL, V90, P1071, DOI 10.1152/jn.01105.2002; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clemens JA, 1997, STROKE, V28, P1073, DOI 10.1161/01.STR.28.5.1073; Clemens JA, 1997, STROKE, V28, P80; Fitzgerald PB, 2002, CLIN NEUROPHYSIOL, V113, P1136, DOI 10.1016/S1388-2457(02)00145-1; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Gao F, 2010, EUR J NUCL MED MOL I, V37, P954, DOI 10.1007/s00259-009-1342-3; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Humm JL, 1999, EXP NEUROL, V157, P349, DOI 10.1006/exnr.1999.7061; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; KLINE RA, 1990, MAGNET RESON MED, V13, P319, DOI 10.1002/mrm.1910130215; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Kornienko VN, 2009, DIAGNOSTIC NEURORADI, P18; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Minambres E, 2008, J NEUROTRAUM, V25, P581; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Ogiue-Ikeda M, 2003, BRAIN RES, V993, P222, DOI 10.1016/j.brainres.2003.09.009; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Risedal A, 1999, J CEREBR BLOOD F MET, V19, P997, DOI 10.1097/00004647-199909000-00007; Siebner HR, 2000, NEUROLOGY, V54, P956, DOI 10.1212/WNL.54.4.956; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Strafella AP, 2001, J NEUROPHYSIOL, V85, P2624, DOI 10.1152/jn.2001.85.6.2624; Takeuchi N, 2005, STROKE, V36, P2681, DOI 10.1161/01.STR.0000189658.51972.34; Tehranian R, 2006, BRAIN RES, V1101, P126, DOI 10.1016/j.brainres.2006.05.049; Verma A, 2000, J HEAD TRAUMA REHAB, V15, P1149, DOI 10.1097/00001199-200010000-00008; Vexler ZS, 1997, J CLIN INVEST, V99, P1453, DOI 10.1172/JCI119304; Yoon KJ, 2011, EXP BRAIN RES, V214, P549, DOI 10.1007/s00221-011-2853-2	38	6	7	2	10	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	OCT	2015	30	10					1496	1502		10.3346/jkms.2015.30.10.1496			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV4BE	WOS:000364209600018	26425049	Green Published, gold, Green Submitted			2022-02-06	
J	Lintern, TO; Gamage, NTP; Bloomfield, FH; Kelly, P; Finch, MC; Taberner, AJ; Nash, MP; Nielsen, PMF				Lintern, T. O.; Gamage, N. T. Puhulwelle; Bloomfield, F. H.; Kelly, P.; Finch, M. C.; Taberner, A. J.; Nash, M. P.; Nielsen, P. M. F.			Head kinematics during shaking associated with abusive head trauma	JOURNAL OF BIOMECHANICS			English	Article						Abusive head trauma; Rigid-body computational modelling; Head kinematics	SHAKEN-BABY SYNDROME; OPERATIONAL CASE-DEFINITION; OPEN-SOURCE SOFTWARE; CERVICAL-SPINE; MECHANICAL-PROPERTIES; CEREBRAL CONCUSSION; INJURY; CHILDREN; BRAIN; MODEL	Abusive head trauma (AHT) is a potentially fatal result of child abuse but the mechanisms of injury are controversial. To address the hypothesis that shaking alone is sufficient to elicit the injuries observed, effective computational and experimental models are necessary. This paper investigates the use of a coupled rigid-body computational modelling framework to reproduce in vivo shaking kinematics in AHT. A sagittal plane OpenSim computational model of a lamb was developed and used to interpret biomechanical data from in vivo shaking experiments. The acceleration of the head during shaking was used to provide in vivo validation of the associated computational model. Results of this study demonstrated that peak accelerations occurred when the head impacted the torso and produced acceleration magnitudes exceeding 200 m s(-2). The computational model demonstrated good agreement with the experimental measurements and was shown to be able to reproduce the high accelerations that occur during impact. The biomechanical results obtained with the computational model demonstrate the utility of using a coupled rigid-body modelling framework to describe infant head kinematics in AHT. (C) 2015 Elsevier Ltd. All rights reserved.	[Lintern, T. O.; Gamage, N. T. Puhulwelle; Finch, M. C.; Taberner, A. J.; Nash, M. P.; Nielsen, P. M. F.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Bloomfield, F. H.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Kelly, P.] Starship Childrens Hosp, Te Puaruruhau Child Protect Team, Auckland, New Zealand; [Taberner, A. J.; Nash, M. P.; Nielsen, P. M. F.] Univ Auckland, Dept Engn Sci, Auckland 1, New Zealand		Nielsen, PMF (corresponding author), Auckland Bioengn Inst, Level 6,70 Symonds St, Auckland 1142, New Zealand.	p.nielsen@auckland.ac.nz	Nash, Martyn P/F-6982-2012	Nash, Martyn P/0000-0002-6466-4936; Kelly, Patrick/0000-0002-8813-8877; Taberner, Andrew/0000-0002-0452-0308	CureKids [9491]; Health Research Council of New Zealand Maori Health Doctoral Scholarship [10/738]	The authors would like to acknowledge the support of CureKids (grant number 9491), the Health Research Council of New Zealand Maori Health Doctoral Scholarship (T.O.L) (grant number 10/738), and medical imaging support provided by Ascot Radiology (http://www.ascotrad.co.nz/) and the Centre for Advanced MRI (http://www.mri.auckland.ac.nz/). Additional technical support was provided by Mr. Mark Finch from IMeasureU Ltd (http://imeasureu.com/).	Coleman T.F., 1994, MATH PROGRAM, V67, P189, DOI DOI 10.1007/BF01582221; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; Cory CZ, 2003, MED SCI LAW, V43, P317, DOI 10.1258/rsmmsl.43.4.317; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Dibb AT, 2014, TRAFFIC INJ PREV, V15, P386, DOI 10.1080/15389588.2013.824568; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Finch M. C., 2011, 2011 Fifth International Conference on Sensing Technology (ICST 2011), P607, DOI 10.1109/ICSensT.2011.6137053; Finnie JW, 2012, AUST VET J, V90, P301, DOI 10.1111/j.1751-0813.2012.00955.x; Finnie JW, 2012, J CLIN NEUROSCI, V19, P1159, DOI 10.1016/j.jocn.2011.12.019; Finnie JW, 2010, J CLIN NEUROSCI, V17, P237, DOI 10.1016/j.jocn.2009.07.001; Gamage TPB, 2011, INT J NUMER METH BIO, V27, P391, DOI 10.1002/cnm.1429; Geddes J F, 2004, Pediatr Rehabil, V7, P261, DOI 10.1080/13638490412331280435; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Harding B, 2004, BMJ-BRIT MED J, V328, P720, DOI 10.1136/bmj.328.7442.720; HUNT KH, 1975, J APPL MECH-T ASME, V42, P440, DOI 10.1115/1.3423596; Jun OY, 2005, SPINE, V30, pE716, DOI 10.1097/01.brs.0000192280.53831.70; Lanir Y, 1996, J BIOMECH ENG-T ASME, V118, P41, DOI 10.1115/1.2795944; Luck IF., 2012, THESIS DUKE U US; Luck JF, 2013, SPINE, V38, pE1, DOI 10.1097/BRS.0b013e3182793873; Luck JF, 2008, STAPP CAR C, V52, P107; NATHANSON MH, 1985, AM J PHYSIOL, V248, pR378, DOI 10.1152/ajpregu.1985.248.3.R378; Nuckley DJ, 2006, J BIOMECH, V39, P3045, DOI 10.1016/j.jbiomech.2005.10.014; Nuckley DJ, 2005, J BIOMECH, V38, P2266, DOI 10.1016/j.jbiomech.2004.09.021; Ommaya A.K., 1968, JAMA-J AM MED ASSOC, V204, P75; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parks S, 2012, INJURY PREV, V18, P392, DOI 10.1136/injuryprev-2011-040234; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Sandoz B., 2012, COMPUT METHODS BI S1, V15, pS293; Squier W, 2008, DEV MED CHILD NEUROL, V50, P10, DOI 10.1111/j.1469-8749.2007.02004.x; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Wolfson DR, 2005, P I MECH ENG H, V219, P63, DOI 10.1243/095441105X9237	38	6	6	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	SEP 18	2015	48	12					3123	3127		10.1016/j.jbiomech.2015.07.016			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CT8ME	WOS:000363069900026	26256822				2022-02-06	
J	Seruca, T; Silva, CF				Seruca, Tania; Silva, Carlos F.			Recidivist criminal behaviour and executive functions: a comparative study	JOURNAL OF FORENSIC PSYCHIATRY & PSYCHOLOGY			English	Article						criminal recidivism; executive functions; neuropsychological assessment; mental flexibility; planning	TRAUMATIC BRAIN-INJURY; ANTISOCIAL-BEHAVIOR; SELECTIVE ATTENTION; NEURAL PLASTICITY; PREFRONTAL CORTEX; DYSFUNCTION; AGGRESSION; DISORDERS; OFFENDERS; FREQUENCY	This study sought to analyse the relation between executive functions and criminal recidivism. We assessed a set of cognitive abilities associated with executive functioning in a group of recidivist offenders (n=19), primary offenders (n=25) and non-offenders (n=30). Our results, tested with nonparametric statistics and Monte Carlo method, revealed that there were no executive differences between both groups of offenders but, when compared with non-offenders, the recidivists showed a worse performance in Trail Making Test part B, and the primary offenders presented a significant lower score on Porteus Maze Test Age score. This study suggests that there can be a different pattern of executive functioning deficits associated with the offenders' criminal record: recidivism may be more related to mental flexibility impairments and primary offenders' antisocial behaviour may be aggravated by planning deficits.	[Seruca, Tania] Inst Univ, ISPA, Lisbon, Portugal; [Seruca, Tania] Univ Aveiro, P-3800 Aveiro, Portugal; [Silva, Carlos F.] Univ Aveiro, Dept Educ, P-3800 Aveiro, Portugal; [Silva, Carlos F.] Univ Porto, R&D Ctr, CINTESIS, P-4100 Oporto, Portugal		Seruca, T (corresponding author), Inst Univ, ISPA, Lisbon, Portugal.	taniaseruca@iol.pt	Silva, Carlos F/K-5584-2013	Silva, Carlos F/0000-0002-1399-6674; Seruca, Tania/0000-0001-9674-2225	Fundacao Para a Ciencia e TecnologiaPortuguese Foundation for Science and TechnologyEuropean Commission [SFRH/BD/27450/2006]	This work was supported by the Fundacao Para a Ciencia e Tecnologia [grant number SFRH/BD/27450/2006].	Alink LRA, 2013, AGGRESSIVE BEHAV, V39, P131, DOI 10.1002/ab.21464; Anckarsater H, 2006, BRAIN RES BULL, V69, P259, DOI 10.1016/j.brainresbull.2006.01.008; Alcazar-Corcoles MA, 2010, REV NEUROLOGIA, V50, P291, DOI 10.33588/rn.5005.2009316; Barker ED, 2007, ARCH GEN PSYCHIAT, V64, P592, DOI 10.1001/archpsyc.64.5.592; Brill M, 1937, PSYCHOL REV, V28, P481; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Cacioppo JT, 2007, PERSPECT PSYCHOL SCI, V2, P99, DOI 10.1111/j.1745-6916.2007.00032.x; De Bellis MD, 2005, CHILD MALTREATMENT, V10, P150, DOI 10.1177/1077559505275116; Dein K., 2010, ADV PSYCHIAT TREATME, V16, P37, DOI DOI 10.1192/APT.BP.107.005082; DOCTER RF, 1954, J CONSULT PSYCHOL, V18, P71, DOI DOI 10.1037/H0054124; Farrington D. P., 2004, CROSS NATL STUDIES C, P1; Fernandes S., 2009, THESIS U SALAMANCA S; Fonseca A. C., 2004, COMPORTAMENTO ANTISO, P1; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Giancola PR, 1998, J ABNORM PSYCHOL, V107, P629, DOI 10.1037/0021-843X.107.4.629; Giancola PR, 1995, AGGRESSIVE BEHAV, V21, P431, DOI 10.1002/1098-2337(1995)21:6<431::AID-AB2480210604>3.0.CO;2-Q; Goldberg E., 2001, EXECUTIVE BRAIN FRON; Golden CJ, 1978, STROOP COLOR WORD TE; Gunter TD, 2008, J AM ACAD PSYCHIATRY, V36, P27; Hancock M, 2010, AGGRESSIVE BEHAV, V36, P338, DOI 10.1002/ab.20353; Hiatt KD, 2004, NEUROPSYCHOLOGY, V18, P50, DOI 10.1037/0894-4105.18.1.50; Hoaken PNS, 2003, AGGRESSIVE BEHAV, V29, P15, DOI 10.1002/ab.10023; Hodgins S., 2009, NEUROBIOLOGICAL BASI, P167; Joseph R, 1999, CHILD PSYCHIAT HUM D, V29, P189, DOI 10.1023/A:1022660923605; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kagan J, 2004, COMPORTAMENTO ANTISO, P1; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Krikorian R, 1998, CLIN NEUROPSYCHOL, V12, P305, DOI 10.1076/clin.12.3.305.1984; Lahey B. B., 2004, COMPORTAMENTO ANTISO, P161; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; MACK JL, 1995, NEUROPSYCHOLOGY, V9, P556, DOI 10.1037/0894-4105.9.4.556; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Meijers J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00043; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Murphy D., 2010, ADV PSYCHIAT TREATME, V16, P44, DOI [DOI 10.1192/APT.BP.109.006775, 10.1192/apt.bp.109.006775]; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; Pham TH, 2003, AGGRESSIVE BEHAV, V29, P393, DOI 10.1002/ab.10051; Porteus S. D., 1965, MANUEL TEST LABYRINT; Poythress NG, 2010, J ABNORM PSYCHOL, V119, P389, DOI 10.1037/a0018611; Raine A, 2002, J ABNORM CHILD PSYCH, V30, P311, DOI 10.1023/A:1015754122318; Raine A, 2005, J ABNORM PSYCHOL, V114, P38, DOI 10.1037/0021-843X.114.1.38; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Raine A, 2008, CURR DIR PSYCHOL SCI, V17, P323, DOI 10.1111/j.1467-8721.2008.00599.x; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; RIDDLE M, 1977, PSYCHOL BULL, V84, P417, DOI 10.1037/0033-2909.84.3.417; Ross EH, 2011, CAN J CRIMINOL CRIM, V53, P377, DOI 10.3138/cjccj.53.4.377; Barbosa MFS, 2008, SPAN J PSYCHOL, V11, P259, DOI 10.1017/S1138741600004297; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Soloff PH, 2003, PSYCHIAT RES-NEUROIM, V123, P153, DOI 10.1016/S0925-4927(03)00064-7; Stiles J, 2000, DEV NEUROPSYCHOL, V18, P237, DOI 10.1207/S15326942DN1802_5; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Tuominen T, 2014, CRIM BEHAV MENT HEAL, V24, P36, DOI 10.1002/cbm.1879; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Yang YL, 2005, BIOL PSYCHIAT, V57, P1103, DOI 10.1016/j.biopsych.2005.01.021; Young S, 2011, WORLD J BIOL PSYCHIA, V12, P124, DOI 10.3109/15622975.2011.600319; [No title captured]	65	6	7	0	54	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-9949	1478-9957		J FORENSIC PSYCHI PS	J. Forensic Psychiatry Psychol.	SEP 3	2015	26	5					699	717		10.1080/14789949.2015.1054856			19	Criminology & Penology; Psychiatry	Social Science Citation Index (SSCI)	Criminology & Penology; Psychiatry	CR7JK	WOS:000361525500009		Green Submitted			2022-02-06	
J	Caron, JG; Bloom, GA; Bennie, A				Caron, Jeffrey G.; Bloom, Gordon A.; Bennie, Andrew			Canadian High School Coaches' Experiences, Insights, and Perceived Roles With Sport-Related Concussions	INTERNATIONAL SPORT COACHING JOURNAL			English	Article						coaching science; brain concussion; qualitative research; concussion education; concussion-reporting		There is a need to improve concussion education and prevention efforts for youth athletes and those responsible for their care. The purpose of this study was to understand Canadian high school coaches' insights and perceptions of concussions. Using a case study design, eight high school coaches were interviewed and the data were analysed using a hierarchical content analysis. Findings indicated that participants primarily acquired information about concussions through their own experiences as athletes and parents, and from reports in the sports media. The coaches' felt their role with concussions was to teach athletes safety techniques during practices and competitions and to encourage them to accurately report their concussion symptoms. In addition, participants forwarded a number of recommendations to improve the dissemination of information to coaches. Results from this study will add to a limited body of concussion research with youth sport coaches. Participants' insights provide researchers and clinicians with information about coaches' perceived role with sport-related concussions.	[Caron, Jeffrey G.] McGill Univ, Sport & Exercise Psychol, Montreal, PQ, Canada; [Bloom, Gordon A.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Bloom, Gordon A.] McGill Univ, Dept Kinesiol & Phys Educ, Sport Psychol Res Lab, Montreal, PQ, Canada; [Bennie, Andrew] Western Sydney Univ, Hlth & Phys Educ Program, Sydney, NSW, Australia		Caron, JG (corresponding author), McGill Univ, Sport & Exercise Psychol, Montreal, PQ, Canada.	jeffrey.caron@mail.mcgill.ca	Bennie, Andrew/V-2369-2019	Bennie, Andrew/0000-0001-9151-4821			Albuquerque A., 2014, POSITIVE HUMAN FUNCT, V3, P107; Bennie A, 2011, YOUTH SPORT IN AUSTRALIA, P211; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Bramley H, 2012, CLIN PEDIATR, V51, P283, DOI 10.1177/0009922811422434; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Caron JG, 2015, NEUROETHICS-NETH, V8, P5, DOI 10.1007/s12152-014-9210-7; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Carroll Linda, 2012, CONCUSSION CRISIS AN; Cassidy T, 2013, ROUTLEDGE HDB SPORTS, P172; Coaching Association of Canada, 2015, COACH CONC AW; COTE J, 1993, SPORT PSYCHOL, V7, P127, DOI 10.1123/tsp.7.2.127; Cote J, 2009, INT J SPORTS SCI COA, V4, P307, DOI 10.1260/174795409789623892; Creswell J. W., 2016, QUAL INQ; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Dessy A. M, 2014, NEUROSURGERY Q; Falcao WR, 2012, J APPL SPORT PSYCHOL, V24, P429, DOI 10.1080/10413200.2012.692452; Galgano M, 2014, CUREUS, DOI [10.7759/cureus.234, DOI 10.7759/CUREUS.234]; Gearity BT, 2011, PSYCHOL SPORT EXERC, V12, P213, DOI 10.1016/j.psychsport.2010.11.004; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Greenwood D, 2014, J SPORT SCI, V32, P328, DOI 10.1080/02640414.2013.824599; HEADS UP to Youth Sport Coaches, 2015, CONCUSSION INFORM CO; International Council for Coaching Excellence, 2013, INT SPORT COACH FRAM; International Q. S. R, 2014, NVIVO QUAL DAT AN SO; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; National Council for Youth Sports, 2015, CONC INF AM YOUTH SP; Podlog L, 2014, PHYS MED REH CLIN N, V25, P915, DOI 10.1016/j.pmr.2014.06.011; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; SMITH RE, 1995, J APPL DEV PSYCHOL, V16, P125, DOI 10.1016/0193-3973(95)90020-9; Sparkes AC., 2014, QUALITATIVE RES METH; Stake R.E., 2005, SAGE HDB QUALITATIVE, V3rd ed., P443; Straus SE, 2013, KNOWLEDGE TRANSLATION IN HEALTH CARE: MOVING FROM EVIDENCE TO PRACTICE, 2ND EDITION, P1, DOI 10.1002/9781118413555; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; White RL, 2015, INT J SPORTS SCI COA, V10, P379, DOI 10.1260/1747-9541.10.2-3.379	42	6	6	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2328-918X	2328-9198		INT SPORT COACH J	Int. Sport Coach J.	SEP	2015	2	3					285	297		10.1123/iscj.2015-0022			13	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	VF3CU	WOS:000442553800004		Green Submitted			2022-02-06	
J	Hasler, RM; Baschera, D; Taugwalder, D; Exadaktylos, AK; Raabe, A				Hasler, Rebecca M.; Baschera, Dominik; Taugwalder, David; Exadaktylos, Aristomenis K.; Raabe, Andreas			Cohort Study on the Association Between Helmet Use and Traumatic Brain Injury in Snowboarders From a Swiss Tertiary Trauma Center	WORLD NEUROSURGERY			English	Article						Helmet; Snowboarding; TBI; Traumatic brain injury	HEAD-INJURIES; PRACTICAL SCALE; SAFETY HELMETS; ALPINE SKIERS; RISK; NIIGATA; SLOPES; JAPAN	BACKGROUND: Since the introduction of helmets in winter sports there is on-going debate on whether they decrease traumatic brain injuries (TBI). METHODS: This cohort study included 117 adult (>= 16 years) snowboarders with TBI admitted to a level I alpine trauma center in Switzerland between 2000/2001 and 2010/2011. The primary objective was to examine the association between helmet use and moderate-to-severe TBI. Secondary objectives were to describe the epidemiology of TBI during the past decade in relation to increased helmet use. RESULTS: Of 691 injured snowboarders evaluated, 117 (17%) suffered TBI. Sixty-six percent were men (median age, 23 years). Two percent of accidents were fatal. Ninety-two percent of patients sustained minor, 1% moderate, and 7% severe TBI according to the Glasgow coma scale. Pathologic computed tomography findings were present in 16% of patients, 26% of which required surgery. Eighty-three percent of TBIs occurred while riding on-slope. There was no trend in the TBI rate during the studied period, although helmet use increased from 10% to 69%. Comparing patients with and without a helmet showed no significant difference in odds ratios for the severity of TBI. However, of the 5 patients requiring surgery only 1 was wearing a helmet. Off-piste compared with on-slope snowboarders showed an odds ratio of 26.5 (P = 0.003) for sustaining a moderate-to-severe TBI. CONCLUSIONS: Despite increased helmet use we found no decrease in TBI among snowboarders. The possibility of TBI despite helmet use and the dangers of riding off-piste should be a focus of future prevention programs.	[Hasler, Rebecca M.; Taugwalder, David; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland; [Baschera, Dominik; Raabe, Andreas] Univ Hosp Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland		Hasler, RM (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland.	rebecca.hasler@gmail.com	Dominik, Baschera/AAI-1953-2021	Dominik, Baschera/0000-0002-9634-9922; Taugwalder, David/0000-0002-1619-4917			Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; [Anonymous], 2013, BFU ERH US PROT EQ A; [Anonymous], 2013, STANDARD PROTECTIVE; [Anonymous], F20402 ASTM; [Anonymous], 2007, 1077 CSN EN; Byrd D, 2013, NSAA HELMET FACT SHE; Cusimano MD, 2010, JAMA-J AM MED ASSOC, V303, P661, DOI 10.1001/jama.2010.147; Ehrnthaller C, 2014, UNFALLCHIRURG, V117, P7, DOI 10.1007/s00113-013-2467-1; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Hasler Rebecca M, 2011, J Trauma Manag Outcomes, V5, P5, DOI 10.1186/1752-2897-5-5; Hasler RM, 2010, BRIT J SPORT MED, V44, P816, DOI 10.1136/bjsm.2010.071357; JENNETT B, 1975, LANCET, V1, P480; Kim S, 2012, AM J SPORT MED, V40, P770, DOI 10.1177/0363546511433279; Kommission fur die Statistik der Unfallversicherung, 2012, INJ STAT 2012; Koyama S, 2011, AM J SPORT MED, V39, P2656, DOI 10.1177/0363546511422331; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; Niemann S, 2013, TRANSPORT; R Core Team, 2012, LANG ENV STAT COMP; Ruedl G, 2015, SCAND J MED SCI SPOR, V25, P125, DOI 10.1111/sms.12139; Ruedl G, 2013, WILD ENVIRON MED, V24, P118, DOI 10.1016/j.wem.2012.11.021; Ruedl G, 2011, WILD ENVIRON MED, V22, P326, DOI 10.1016/j.wem.2011.06.008; Rughani AI, 2011, J NEUROSURG-PEDIATR, V7, P268, DOI 10.3171/2010.12.PEDS10415; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Sakamoto Y, 2008, AM J SPORT MED, V36, P943, DOI 10.1177/0363546507313573; Scott MD, 2007, INJURY PREV, V13, P173, DOI 10.1136/ip.2006.014142; Siu TLT, 2004, J CLIN NEUROSCI, V11, P236, DOI 10.1016/j.jocn.2003.08.003; Sommer H, 2007, EC COSTS NONOCCUPATI; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Taugwalder D, 2014, THESIS U BERN BERN; TEASDALE G, 1974, LANCET, V2, P81; Vanat L, ANN REPORT SKIER DAY; Wasden CC, 2009, J TRAUMA, V67, P1022, DOI 10.1097/TA.0b013e3181b0d559	36	6	6	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2015	84	3								10.1016/j.wneu.2015.05.016			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CR0LR	WOS:000361010700040	26004699				2022-02-06	
J	Jin, Y; Bouyer, J; Haas, C; Fischer, I				Jin, Ying; Bouyer, Julien; Haas, Christopher; Fischer, Itzhak			Evaluation of the anatomical and functional consequences of repetitive mild cervical contusion using a model of spinal concussion	EXPERIMENTAL NEUROLOGY			English	Article						Repetitive spinal cord contusion; Vulnerability; Behavioral consequences; Morphological changes; Spinal cord concussion model	QUANTITATIVE GAIT ANALYSIS; CORD CONTUSION; HEAD-INJURY; OVERGROUND LOCOMOTION; ALZHEIMERS-DISEASE; RAT; RECOVERY; NEURAPRAXIA; RETURN; RISK	Spinal cord concussion is characterized by a transient loss of motor and sensory function that generally resolves without permanent deficits. Spinal cord concussions usually occur during vehicular accidents, falls, and sport activity, but unlike brain concussions, have received much less attention despite the potential for repeated injury leading to permanent neurological sequelae. Consequently, there is no consensus regarding decisions related to return to play following an episode of spinal concussion, nor an understanding of the short- and long-term consequences of repeated injury. Importantly, there are no models of spinal concussion to study the anatomical and functional sequelae of single or repeated injury. We have developed a new model of spinal cord concussion focusing on the anatomical and behavioral outcomes of single and repeated injury. Rats received a very mild (50 kdyn, IH impactor) spinal contusion at C5 and were separated into two groups three weeks after the initial injury - C1, which received a second, sham surgery, and C2, which received a second contusion at the same site. To track motor function and recovery, animals received weekly behavioral tests - BBB, CatWalk (TM), cylinder, and Von Frey. Analysis of locomotor activity by BBB demonstrated that rats rapidly recovered, regaining near-normal function by one week after the first and second injury, which was confirmed using the more detailed CatWalk (TM) analysis. The cylinder test showed that a single contusion did not induce significant deficits of the affected limb, but that repeated injury resulted in significant alteration in paw preference, with animals favoring the unaffected limb. Intriguingly, Von Frey analysis demonstrated an increased sensitivity in the contralateral hindlimb in the C2 group vs. the Cl group. Anatomical analyses revealed that while the lesion volume of both groups was minimal, the area of spared white matter in the C2 group was significantly reduced I and 2 mm rostral to the lesion epicenter. Reactive astrocytes were present in both groups, with the majority found at the lesion epicenter in the Cl group, whereas the C2 group demonstrated increased reactive astrocytes extending 1 mm caudal to the lesion epicenter. Macrophages accumulated within the injured, dorsal and ipsilateral spinal cord, with significant increases at 2 and 3 mm rostral to the epicenter in the C2 group. Our model is designed to represent the clinical presentation of spinal cord concussion, and highlight the susceptibility and functional sequelae of repeated injury. Future experiments will examine the temporal and spatial windows of vulnerability for repeated injuries. (C) 2015 Elsevier Inc All rights reserved.	[Jin, Ying; Bouyer, Julien; Haas, Christopher; Fischer, Itzhak] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA		Fischer, I (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane, Philadelphia, PA 19129 USA.	ifischer@drexelmed.edu	Fischer, Itzhak/D-1080-2012	Fischer, Itzhak/0000-0003-3187-8740	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [PO1 NS055976]; Jekall Endowment Grant, Drexel University College of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS055976] Funding Source: NIH RePORTER	We thank Theresa Connors for technical support. This work was supported by NIH grant (PO1 NS055976) and Jekall Endowment Grant, Drexel University College of Medicine.	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bailes JE, 2005, J NEUROSURG-SPINE, V2, P11, DOI 10.3171/spi.2005.2.1.0011; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Brigham CD, 2013, SPINE, V38, P315, DOI 10.1097/BRS.0b013e31827973f6; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Cantu RC, 2007, NEW ENGL J MED, V356, P1787; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Cantu Robert V, 2005, Curr Sports Med Rep, V4, P27; CODERRE TJ, 1988, PAIN, V33, P81, DOI 10.1016/0304-3959(88)90208-4; DELBIGIO MR, 1989, SPINE, V14, P37, DOI 10.1097/00007632-198901000-00007; Detloff MR, 2013, J NEUROTRAUM, V30, P884, DOI 10.1089/neu.2012.2632; Detloff MR, 2012, JOVE-J VIS EXP, DOI 10.3791/3247; Detloff MR, 2010, EXP NEUROL, V225, P366, DOI 10.1016/j.expneurol.2010.07.009; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; GRONWALL D, 1974, LANCET, V2, P605; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Jin Y, 2014, EXP NEUROL, V257, P57, DOI 10.1016/j.expneurol.2014.04.016; Liu Y, 1999, J NEUROSCI, V19, P4370; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Maroon JC, 2007, J NEUROSURG-SPINE, V6, P356, DOI 10.3171/spi.2007.6.4.13; Martin JH, 2005, NEUROSCIENTIST, V11, P161, DOI 10.1177/1073858404270843; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Medhurst SJ, 2002, PAIN, V96, P129, DOI 10.1016/S0304-3959(01)00437-7; Muir GD, 2000, EUR J NEUROSCI, V12, P1113, DOI 10.1046/j.1460-9568.2000.00987.x; PARKINSON D, 1983, SURG NEUROL, V20, P456, DOI 10.1016/0090-3019(83)90027-7; PARKINSON D, 1981, SURG NEUROL, V16, P347, DOI 10.1016/0090-3019(81)90272-X; Pearse DD, 2005, J NEUROTRAUM, V22, P680, DOI 10.1089/neu.2005.22.680; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; RATHBONE D, 1992, J PEDIATR ORTHOPED, V12, P616; SCHER AT, 1991, AM J SPORT MED, V19, P485, DOI 10.1177/036354659101900511; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Shumsky JS, 2003, EXP NEUROL, V184, P114, DOI 10.1016/S0014-4886(03)00398-4; Soblosky JS, 2001, BEHAV BRAIN RES, V119, P1, DOI 10.1016/S0166-4328(00)00328-4; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tabo E, 1998, J NEUROSCI METH, V81, P139, DOI 10.1016/S0165-0270(98)00018-1; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Torg JS, 1997, J NEUROSURG, V87, P843, DOI 10.3171/jns.1997.87.6.0843; Torreman M, 1996, J NEUROSURG, V84, P663, DOI 10.3171/jns.1996.84.4.0663; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; WHISHAW IQ, 1992, BEHAV BRAIN RES, V47, P59, DOI 10.1016/S0166-4328(05)80252-9; Whishaw IQ, 1996, BEHAV BRAIN RES, V74, P79, DOI 10.1016/0166-4328(95)00161-1; Winder MJ, 2011, J NEUROSURG-SPINE, V14, P677, DOI 10.3171/2011.1.SPINE10345; ZWIMPFER TJ, 1990, J NEUROSURG, V72, P894, DOI 10.3171/jns.1990.72.6.0894	49	6	7	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2015	271						175	188		10.1016/j.expneurol.2015.06.001			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT2JG	WOS:000362627200019	26070306	Green Accepted			2022-02-06	
J	Kane, I; Ong, A; Radcliff, KE; Austin, LS; Maltenfort, M; Tjoumakaris, F				Kane, Ian; Ong, Alvin; Radcliff, Kris E.; Austin, Luke S.; Maltenfort, Mitchell; Tjoumakaris, Fotios			Epidemiology of Aquatic and Recreational Water Sport Injuries: A Case-Control Analysis	ORTHOPEDICS			English	Article							SPINAL-CORD-INJURY; CERVICAL-SPINE; RETROSPECTIVE ANALYSIS; RISK-FACTORS; PREVENTION; ACCIDENTS; FRACTURES; WORLDWIDE	The purposes of the current investigation are to evaluate the epidemiology of water sport injuries at a coastal tertiary trauma center and to determine the association of these activities with spinal column injury and to determine whether aquatic trauma injuries differ significantly from those that occur terrestrially. A retrospective review of a consecutive series of 105 patients with aquatic-based mechanisms of injury admitted to a Level II trauma center over a 3-year period, as well as a matched control cohort with terrestrial-based mechanisms of injury, was conducted. Patients were treated at a Level II trauma center from January 1, 2008, to December 31, 2010. All patients received a full trauma work-up on arrival. Patients were identified retrospectively from a prospectively collected database (N=5298). Eligible patients were identified from billing/coding data as having mechanisms of injury related to an aquatic setting. Patients were evaluated using standard trauma protocols. Spinal column and cord injury occurrence and differences between groups were reviewed. Personal watercrafts accounted for the majority of injuries (n=39). Cervical (33.3%), closed-head (25.7%), and thoracolumbar (21.9%) injuries accounted for the majority of injury types. The cervical spinal column and the spinal cord were at an increased risk of injury in the aquatic injury cohort (P<.0001). The current data show the high incidence of spinal column and cord injuries in this patient population relative to controls. Practitioners who care for trauma patients near an aquatic environment should be aware of the high prevalence of these injuries, with proper spinal cord preservation protocols in place to optimize outcome.	[Kane, Ian] New York Med Coll, Valhalla, NY 10595 USA; [Ong, Alvin; Radcliff, Kris E.; Austin, Luke S.; Maltenfort, Mitchell; Tjoumakaris, Fotios] Jefferson Univ Hosp, Rothman Inst Orthoped, Philadelphia, PA USA		Tjoumakaris, F (corresponding author), Rothman Inst, 2500 English Creek Ave,Bldg 1300, Egg Harbor Township, NJ 08234 USA.	Fotios.Tjoumakaris@rothmaninstitute.com	Tjoumakaris, Fotios/N-7039-2019	Tjoumakaris, Fotios/0000-0002-1013-7735	Smith Nephew; Stryker; Globus; MedtronicMedtronic; DePuy; Tornier	Mr Kane, Dr Maltenfort, and Dr Tjoumakaris have no relevant financial relationships to disclose. Dr Ong is a paid consultant for Smith & Nephew and Stryker. Dr Radcliff is a paid consultant for Globus, Medtronic, and DePuy. Dr Austin receives personal fees from Tornier.	Boran S, 2011, IRISH J MED SCI, V180, P859, DOI 10.1007/s11845-011-0730-4; BRANCHE CM, 1991, ACCIDENT ANAL PREV, V23, P13, DOI 10.1016/0001-4575(91)90030-9; Breitmeier Dirk, 2010, Archiv fuer Kriminologie, V226, P107; Chalmers DJ, 2003, SPORTS MED, V33, P745, DOI 10.2165/00007256-200333100-00003; de Jonge MC, 2014, SEMIN MUSCULOSKEL R, V18, P246, DOI 10.1055/s-0034-1375568; Drabova M, 2010, MED SCI MONITOR, V16, pSC13; Franklin RC, 2012, MED SPORT SCI, V58, P98, DOI 10.1159/000338698; Giustini Marco, 2003, Ann Ist Super Sanita, V39, P69; Hadley Mark N, 2002, Clin Neurosurg, V49, P407; Hooten KG, 2014, J NEUROTRAUM, V31, P1329, DOI 10.1089/neu.2013.3253; HUMMEL G, 1982, AM J SPORT MED, V10, P215, DOI 10.1177/036354658201000405; Ivancic PC, 2014, ORTHOP TRAUMATOL-SUR, V100, P127, DOI 10.1016/j.otsr.2013.10.015; Jazayeri SB, 2015, EUR SPINE J, V24, P905, DOI 10.1007/s00586-014-3424-6; Jecmenica D S, 2010, Acta Chir Iugosl, V57, P135; Jones CS, 2000, ACCIDENT ANAL PREV, V32, P373, DOI 10.1016/S0001-4575(99)00091-3; Kaufman RP, 2013, ACCIDENT ANAL PREV, V59, P153, DOI 10.1016/j.aap.2013.05.023; Kim CW, 2003, J ORTHOP TRAUMA, V17, P571, DOI 10.1097/00005131-200309000-00005; Lignitz Eberhard, 2014, Arch Kriminol, V233, P20; Manen O, 2014, AVIAT SPACE ENVIR MD, V85, P66, DOI 10.3357/ASEM.3639.2014; Merriman D, 2008, J TRAUMA, V65, P487, DOI 10.1097/TA.0b013e31817daca5; Nijendijk JHB, 2014, SPINAL CORD, V52, P258, DOI 10.1038/sc.2013.180; Rahimi-Movaghar V, 2013, NEUROEPIDEMIOLOGY, V41, P65, DOI 10.1159/000350710; Robles LA, 2006, NEUROSURGERY, V58, P920, DOI 10.1227/01.NEU.0000209941.18102.35; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Selvarajah S, 2014, J NEUROTRAUM, V31, P1548, DOI 10.1089/neu.2014.3332; TATOR CH, 1979, CAN J SURG, V22, P575; TORG JS, 1985, MED SCI SPORT EXER, V17, P295; Wang HW, 2013, J SPINAL DISORD TECH, V26, pE306, DOI 10.1097/BSD.0b013e3182886db9; Yang R, 2014, INT J NANOMED, V9, P1, DOI 10.2147/IJN.S67210	29	6	6	1	9	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0147-7447	1938-2367		ORTHOPEDICS	Orthopedics	SEP	2015	38	9					E813	E818		10.3928/01477447-20150902-60			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	CX0NL	WOS:000365393600011	26375540				2022-02-06	
J	Langford, MA; Cheung, K; Li, ZY				Langford, Matthew A.; Cheung, Kevin; Li, Zhongyu			Percutaneous Distraction Pinning for Metacarpophalangeal Joint Stabilization After Blast or Crush Injuries of the Hand	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							PROXIMAL INTERPHALANGEAL JOINT; INTRAARTICULAR PHALANGEAL FRACTURES; EXTERNAL FIXATION; METACARPAL; PLATE; DISLOCATIONS; SYSTEM	Background Unstable, severely comminuted fractures of the metacarpophalangeal (MCP) joint are difficult to treat. Closed treatment and casting of these fractures often fail to maintain proper alignment and impede wound care where concomitant open injuries such as gunshot wounds are present. Conventional pinning or plating techniques are not feasible if extensive bone loss and comminution are present. A distraction pinning technique represents a potential alternative, but results with this approach, to our knowledge, have not been reported. Questions/purposes The purposes of this study were (1) to evaluate the effectiveness (defined as osseous union and joint stability) of distraction pinning for comminuted fractures involving MCP joints after gunshot or crush injuries; (2) to report the short-term results in terms of pain and function in a small group of patients who underwent MCP distraction pinning; and (3) to evaluate complications and return to work status of these patients in the short term. Methods We reviewed 10 patients with comminuted pilon-type fractures of the base of the proximal phalanx or metacarpal head treated with wire distraction fixation from 2005 and 2014. During that period, we used this technique to treat all patients whose fractures were deemed too comminuted for plating or pinning, and during that period, no other techniques (such as simple external fixation) were used for patients meeting those indications. The minimum followup was 6 months; eight of the 10 patients were accounted at a median of 10 months (range, 6-89 months). The median age was 47 years (range, 28-57 years), and seven of the eight were male. Kirschner wire fixation frames were removed 3.5 to 6 weeks after the index surgery when fracture consolidation was confirmed on radiography by the treating surgeon. Stability and range of motion of the MCP joint were assessed using physical examination, radiographs, and goniometer by the treating surgeon. Patients completed the Quick Disabilities of the Arm, Shoulder and Hand score at latest followup or by telephone, and complications were assessed by chart review. Results All fractures were healed with stable MCP joints. Eight patients reported having no pain or minimal pain of their injuries to the hand. The median finger and thumb MCP arc of motion were 80 degrees (range, 70 degrees-105 degrees) and 30 degrees (range, 0 degrees-60 degrees), respectively. The median Quick Disabilities of the Arm, Shoulder and Hand score was 3 (range, 0-41). One patient underwent a second surgical procedure for bone grafting and soft tissue coverage. Three patients developed pin site irritations and were treated with oral antibiotics. Six patients returned to their original job. Conclusions The distraction pinning technique provides reliable osseous union and joint stability of comminuted pilon-type fractures of the base of the proximal phalanx or metacarpal head, even with associated open wounds. Future studies will need to evaluate these patients at longer term followup and compare this approach with other available techniques, because arthrosis, stiffness, and progressive loss of function seem likely to occur given the severity of these injuries.	[Langford, Matthew A.; Cheung, Kevin; Li, Zhongyu] Wake Forest Univ, Sch Med, Wake Forest Baptist Med Ctr, Dept Orthopaed Surg, Winston Salem, NC 27157 USA		Li, ZY (corresponding author), Wake Forest Univ, Sch Med, Wake Forest Baptist Med Ctr, Dept Orthopaed Surg, 1 Med Ctr Blvd, Winston Salem, NC 27157 USA.	zli@wfubmc.edu					Badia A, 2005, J HAND SURG-AM, V30A, P154, DOI 10.1016/j.jhsa.2004.07.019; Cardoso Roy, 2011, Tech Hand Up Extrem Surg, V15, P162, DOI 10.1097/BTH.0b013e31820a02aa; Deal DN, 2011, J RECONSTR MICROSURG, V27, P133, DOI 10.1055/s-0030-1268852; Drenth DJ, 1998, J BONE JOINT SURG BR, V80B, P227, DOI 10.1302/0301-620X.80B2.8131; Ebinger T, 1999, J HAND SURG-AM, V24A, P1254; FAHMY NRM, 1990, J HAND SURG-BRIT EUR, V15B, P303, DOI 10.1016/0266-7681(90)90009-S; Johnson D, 2004, J HAND SURG-BRIT EUR, V29B, P76, DOI 10.1016/j.jhsb.2003.08.009; Klein DM, 2000, CLIN ORTHOP RELAT R, P116; Li ZY, 2010, J HAND SURG-EUR VOL, V35E, P508, DOI 10.1177/1753193409362644; Margic K, 2006, J HAND SURG-BRIT EUR, V31B, P30, DOI 10.1016/j.jhsb.2005.09.013; Omokawa S, 2008, J HAND SURG-AM, V33A, P857, DOI 10.1016/j.jhsa.2008.01.040; Ouellette EA, 1996, CLIN ORTHOP RELAT R, P38; PUN WK, 1991, J HAND SURG-AM, V16A, P113, DOI 10.1016/S0363-5023(10)80023-1; Ruland RT, 2008, J HAND SURG-AM, V33A, P19, DOI 10.1016/j.jhsa.2007.07.018; SHEHADI SI, 1991, J HAND SURG-AM, V16A, P544, DOI 10.1016/0363-5023(91)90030-F; STERN PJ, 1991, J HAND SURG-AM, V16A, P844, DOI 10.1016/S0363-5023(10)80147-9; Turker T, 2013, J HAND SURG-AM, V38A, P1641, DOI 10.1016/j.jhsa.2013.02.011	17	6	6	1	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	SEP	2015	473	9					2785	2789		10.1007/s11999-015-4233-x			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	CO1TA	WOS:000358936900011	25754757	Green Published			2022-02-06	
J	Roy, D; McCann, U; Han, DF; Rao, V				Roy, Durga; McCann, Una; Han, Dingfen; Rao, Vani			Pathological Laughter and Crying and Psychiatric Comorbidity After Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							STROKE; EMOTIONALISM; ASSOCIATION; DEPRESSION	There are limited data regarding the incidence of pathological laughter and crying (PLC) after traumatic brain injury (TBI). This study aimed to identify the occurrence of PLC in the first year after TBI and to determine whether there is a relationship between PLC and other clinical features or demographics. Subjects who sustained a first-time TBI were recruited from acute trauma units and were assessed at 3, 6, and 12 months after TBI. Rates of PLC at 3, 6, and 12 months after TBI were 21.4%, 17.5%, and 15.5%, respectively. Patients with PLC had higher percentages of psychiatric diagnoses, including personality changes, depressive disorders, and mood disorders secondary to a general medical condition, as well as higher rates of posttraumatic stress disorder. Univariate logistic and linear regression analyses indicated a significant association between PLC and scores on the Clinical Anxiety Scale 3 months after TBI and on the Hamilton Depression Rating Scale 12 months after TBI. Individuals who have PLC during the first year after TBI are more likely to have any psychiatric diagnosis as well as higher rates of mood and anxiety symptoms. In addition, PLC in the early TBI period may serve as a predictor of depression and anxiety symptoms at 12 months after TBI.	[Roy, Durga; McCann, Una; Han, Dingfen; Rao, Vani] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Roy, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.	droy4@jhmi.edu			NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23 MH 066894]; Department of DefenseUnited States Department of Defense [W81XWH-13-1-0469]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH066894] Funding Source: NIH RePORTER	This study was supported by NIMH grant K23 MH 066894. This literature review was supported in part by Department of Defense grant W81XWH-13-1-0469.	Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Calvert T, 1998, J NEUROL NEUROSUR PS, V65, P928, DOI 10.1136/jnnp.65.6.928; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kim JS, 2000, NEUROLOGY, V54, P1805, DOI 10.1212/WNL.54.9.1805; McCullagh S, 1999, J NEUROL SCI, V169, P43, DOI 10.1016/S0022-510X(99)00214-2; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P601, DOI 10.3109/00048679309075822; Parvizi J, 2009, J NEUROPSYCH CLIN N, V21, P75, DOI 10.1176/appi.neuropsych.21.1.75; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160	15	6	7	0	6	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2015	27	4					299	303		10.1176/appi.neuropsych.15030045			5	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	DM0ON	WOS:000376045400007	26258492				2022-02-06	
J	Rueckriegel, SM; Baron, M; Domschke, K; Neuderth, S; Kunze, E; Kessler, AF; Nickl, R; Westermaier, T; Ernestus, RI				Rueckriegel, Stefan Mark; Baron, Marianne; Domschke, Katharina; Neuderth, Silke; Kunze, Ekkehard; Kessler, Almuth Friederike; Nickl, Robert; Westermaier, Thomas; Ernestus, Ralf-Ingo			Trauma- and distress-associated mental illness symptoms in close relatives of patients with severe traumatic brain injury and high-grade subarachnoid hemorrhage	ACTA NEUROCHIRURGICA			English	Article						Subarachnoid hemorrhage; Traumatic brain injury; Post-traumatic stress disorder; Anxiety symptoms; Depression symptoms; Intensive care unit	POSTTRAUMATIC-STRESS-DISORDER; INTENSIVE-CARE-UNIT; QUALITY-OF-LIFE; FAMILY-MEMBERS; EVENT SCALE; PSYCHOMETRIC PROPERTIES; CLINICAL ARTICLE; DEPRESSION SCALE; HOSPITAL ANXIETY; COPING STYLE	Background Close relatives (CR) of patients with severe traumatic brain injury (TBI) and high-grade subarachnoid hemorrhage (SAH) suffer extraordinary distress during the treatment: Distressmay lead to persisting mental illness symptoms within the spectrum of post-traumatic stress disorder (PTSD), anxiety disorders, and depression. The primary goal of this study was to determine the prevalence and severity of these symptoms in CR. The secondary goal was identification of associated factors. Method Standardized interviews were conducted with 53 CR (mean age of 57.7 +/- 11.4 years) of patients with TBI degrees III (n=27) and high-grade SAH H& H degrees III-V (n=26) between 5 and 15 months after the event. The interviews contained a battery of surveys to quantify symptoms of PTSD, anxiety disorders, and depression, i.e., Impact of Event Scale (IES-R), 36-item Short-Form General Health Survey (SF-36), and Hospital Anxiety and Depression Scale (HADS). Fixed and modifiable possibly influencing factors were correlated. Results Twenty-eight CR (53 %) showed IES-R scores indicating a probable diagnosis of PTSD. Twenty-five CR (47 %) showed an increased anxiety score and 18 (34%) an increased depression score using HADS. Mean physical component summary of SF-36 was not abnormal (49.1 +/- 9.1), whereas mean mental component summary was under average (41.0 +/- 13.2), indicating a decreased quality of life caused by mental effects. Perception of the interaction quality with the medical staff and involvement into medical decisions correlated negatively with severity of mental illness symptoms. Evasive coping strategies were highly significantly associated with symptoms. Conclusions This study quantifies an extraordinarily high prevalence of mental illness symptoms in CR of patients with critical acquired brain injury due to SAH and TBI. Modifiable factors were associated with severity of mental illness symptoms. Prospective studies testing efficiency of early psychotherapeutic interventions are needed.	[Rueckriegel, Stefan Mark; Baron, Marianne; Kunze, Ekkehard; Kessler, Almuth Friederike; Nickl, Robert; Westermaier, Thomas; Ernestus, Ralf-Ingo] Univ Hosp Wuerzburg, Dept Neurosurg, D-97080 Wurzburg, Germany; [Domschke, Katharina] Univ Hosp Wuerzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97080 Wurzburg, Germany; [Neuderth, Silke] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97080 Wurzburg, Germany		Rueckriegel, SM (corresponding author), Univ Hosp Wuerzburg, Dept Neurosurg, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	rueckriege_s@ukw.de	Kunze, Ekkehard/AAE-6926-2019; Westermaier, Thomas/AAE-2701-2019; Rueckriegel, Stefan M./AAE-4002-2019; Kessler, Almuth F./AAE-5618-2019; Nickl, Robert/AAE-6948-2019	Rueckriegel, Stefan/0000-0001-9886-6512			Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay E, 2001, AM J RESP CRIT CARE, V163, P135, DOI 10.1164/ajrccm.163.1.2005117; Azoulay E, 2003, INTENS CARE MED, V29, P1498, DOI 10.1007/s00134-003-1904-y; Azoulay E, 2004, CRIT CARE MED, V32, P1832, DOI 10.1097/01.CCM.0000139693.88931.59; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Bieber C, 2009, PATIENT EDUC COUNS, V77, P48, DOI 10.1016/j.pec.2009.03.019; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boerboom W, 2014, J REHABIL MED, V46, P321, DOI 10.2340/16501977-1273; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Buchanan KM, 2000, NEUROSURGERY, V46, P831, DOI 10.1097/00006123-200004000-00012; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Covey J, 2013, J NEUROSURG, V119, P948, DOI 10.3171/2013.5.JNS121688; Curtis JR, 2001, CRIT CARE MED, V29, pN26, DOI 10.1097/00003246-200102001-00006; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Dennis M, 1998, STROKE, V29, P1867, DOI 10.1161/01.STR.29.9.1867; GJERRIS A, 1983, J AFFECT DISORDERS, V5, P163, DOI 10.1016/0165-0327(83)90009-5; Gries CJ, 2010, CHEST, V137, P280, DOI 10.1378/chest.09-1291; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Harris IA, 2008, ANZ J SURG, V78, P583, DOI 10.1111/j.1445-2197.2008.04578.x; Hinz A, 2001, PSYCHOTHER PSYCH MED, V51, P193, DOI 10.1055/s-2001-13279; Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798; Hop JW, 2001, J NEUROSURG, V95, P957, DOI 10.3171/jns.2001.95.6.0957; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Noble AJ, 2008, J NEUROSURG, V109, P1027, DOI 10.3171/JNS.2008.109.12.1027; Paparrigopoulos T, 2014, INT J PSYCHIAT CLIN, V18, P25, DOI 10.3109/13651501.2013.855793; Pryzby Barbara J, 2005, Intensive Crit Care Nurs, V21, P16, DOI 10.1016/j.iccn.2004.06.008; Rothen HU, 2010, CURR OPIN CRIT CARE, V16, P623, DOI 10.1097/MCC.0b013e32833e9718; Rusinova K, 2009, CRIT CARE MED, V37, pS140, DOI [10.1097/CCM.0b013e31819207e7, 10.1097/CCM.0b013e3181b6e145]; Smith LN, 2004, CEREBROVASC DIS, V18, P145, DOI 10.1159/000079268; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Thompson HJ, 2009, J NEUROSCI NURS, V41, P148, DOI 10.1097/JNN.0b013e3181a23eda; Visser-Meily A, 2005, CEREBROVASC DIS, V20, P443, DOI 10.1159/000088983; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Zatzick DF, 2002, ARCH SURG-CHICAGO, V137, P200, DOI 10.1001/archsurg.137.2.200; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313; Zirke N, 2007, PSYCHOSOC MED, V4	37	6	6	0	12	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2015	157	8					1329	1336		10.1007/s00701-015-2470-0			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	CM9JR	WOS:000358025200009	26105760				2022-02-06	
J	Schroeter, ML; Mueller, K; Arelin, K; Sacher, J; Holiga, S; Kratzsch, J; Luck, T; Riedel-Heller, S; Villringer, A				Schroeter, Matthias L.; Mueller, Karsten; Arelin, Katrin; Sacher, Julia; Holiga, Stefan; Kratzsch, Juergen; Luck, Tobias; Riedel-Heller, Steffi; Villringer, Arno			Serum Neuron-Specific Enolase Is Related to Cerebellar Connectivity: A Resting-State Functional Magnetic Resonance Imaging Pilot Study	JOURNAL OF NEUROTRAUMA			English	Article						neuropsychiatric disorders; resting-state fMRI; neuron-specific enolase; neurons; connectivity	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; MOOD DISORDERS; BIOMARKERS; NETWORKS; MARKERS; SYSTEMS; DISEASE; S100B	Neuron-specific enolase (NSE) has been suggested as a prognostic biomarker for neuronal alterations resulting from conditions such as traumatic brain injury (TBI), neurodegenerative disease, or cardiac arrest. To validate serum NSE (sNSE) as a brain-specific biomarker, we related it to functional brain imaging data in 38 healthy adults to create a physiological framework for future studies in neuropsychiatric diseases. sNSE was measured by monoclonal two-site immunoluminometric assays, and functional connectivity was investigated with resting-state functional magnetic resonance imaging (rfMRI). To identify neural hubs most essentially related to sNSE, we applied graph theory approaches, namely, the new data-driven and parameter-free approach, eigenvector centrality mapping. sNSE and eigenvector centrality were negatively correlated in the female cerebellum, without any effects in male subjects. In cerebellar cortex, NSE expression was significantly higher than whole-brain expression as investigated in the whole brain and whole genome-wide atlas of the Allen Institute for Brain Sciences (Seattle, WA). Our study shows a specific linkage between the neuronal marker protein, sNSE, and cerebellar connectivity as measured with rfMRI in the female human brain, although this finding shall be proven in future studies including more subjects. Results suggest that the inclusion of sNSE in the analysis of imaging data is a useful approach to obtain more-specific information on the neuronal mechanisms that underlie functional connectivity at rest. Establishing such a baseline resting-state pattern that is tied to a neuronal serum marker opens new perspectives in the characterization of neuropsychiatric disorders as disconnective syndromes or nexopathies, in particular, resulting from TBI, neurodegenerative disease, or cardiac arrest, in the future.	[Schroeter, Matthias L.; Mueller, Karsten; Arelin, Katrin; Sacher, Julia; Holiga, Stefan; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany; [Sacher, Julia] Univ Leipzig, Clin Cognit Neurol, D-04109 Leipzig, Germany; [Arelin, Katrin; Holiga, Stefan; Luck, Tobias; Riedel-Heller, Steffi; Villringer, Arno] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Schroeter, Matthias L.] German Consortium Frontotemporal Lobar Degenerat, Ulm, Germany; [Kratzsch, Juergen] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04109 Leipzig, Germany; [Luck, Tobias; Riedel-Heller, Steffi] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany		Schroeter, ML (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Stephanstr 1A, D-04103 Leipzig, Germany.	schroet@cbs.mpg.de	Riedel-Heller, Steffi/ABG-1537-2021; Sacher, Julia/M-7060-2016	Sacher, Julia/0000-0003-0944-0558; Luck, Tobias/0000-0001-7551-4397; Villringer, Arno/0000-0003-2604-2404	LIFE (Leipzig Research Center for Civilization Diseases at the University of Leipzig) - European Union, European Regional Development Fund (ERDF); Free State of Saxony within the framework of the excellence initiative; German Consortium for Frontotemporal Lobar Degeneration - German Federal Ministry of Education and Research; Parkinson's Disease Foundation [PDF-IRG-1307]; Alexander von Humboldt FoundationAlexander von Humboldt Foundation; Society in Science (Branco Weiss fellowship)	This study has been supported by LIFE (Leipzig Research Center for Civilization Diseases at the University of Leipzig), funded by the European Union, European Regional Development Fund (ERDF), and by means of the Free State of Saxony within the framework of the excellence initiative (M.L.S., K.A., S.H., T.L., S.R.H., and A.V.), by the German Consortium for Frontotemporal Lobar Degeneration, funded by the German Federal Ministry of Education and Research (M.L.S. and S.H.), by the Parkinson's Disease Foundation (grant no.: PDF-IRG-1307; to M.L.S., S.H., and K.M.), and by research and salary support of the Alexander von Humboldt Foundation and the Society in Science (Branco Weiss fellowship; to J.S.).	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Casmiro M, 2005, EUR J NEUROL, V12, P369, DOI 10.1111/j.1468-1331.2004.01021.x; Cronberg T, 2011, NEUROLOGY, V77, P623, DOI 10.1212/WNL.0b013e31822a276d; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Herculano-Houzel S, 2011, BRAIN BEHAV EVOLUT, V78, P22, DOI 10.1159/000327318; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Mueller K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.121; Mueller K, 2013, NEW ENGL J MED, V368, P482, DOI 10.1056/NEJMc1214078; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Schroeter ML, 2009, MOL PSYCHIATR, V14, P235, DOI 10.1038/mp.2008.85; Schroeter ML, 2013, CURR DRUG TARGETS, V14, P1237; Schroeter ML, 2009, PSYCHIAT RES, V167, P66, DOI 10.1016/j.psychres.2008.01.002; Schroeter ML, 2008, J AFFECT DISORDERS, V111, P271, DOI 10.1016/j.jad.2008.03.005; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Warren JD, 2012, NEURON, V73, P1060, DOI 10.1016/j.neuron.2012.03.006; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	21	6	9	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2015	32	17					1380	1384		10.1089/neu.2013.3163			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CP0KP	WOS:000359564500011	24844267				2022-02-06	
J	Verma, SK; Kan, EM; Lu, J; Ng, KC; Ling, EA; Seramani, S; Kn, BP; Wong, YC; Tan, MH; Velan, SS				Verma, Sanjay Kumar; Kan, Enci Mary; Lu, Jia; Ng, Kian Chye; Ling, Eng Ang; Seramani, Sankar; Kn, Bhanu Prakash; Wong, Yong Chiat; Tan, Mui Hong; Velan, S. Sendhil			Multi-echo susceptibility-weighted imaging and histology of open-field blast-induced traumatic brain injury in a rat model	NMR IN BIOMEDICINE			English	Article						traumatic brain injury; blast injury; susceptibility-weighted imaging; immunohistochemistry; cerebral blood flow	AMYLOID PRECURSOR PROTEIN; IN-VIVO MEASUREMENT; OXYGEN-SATURATION; CEREBRAL VASOSPASM; BLOOD-FLOW; EXPRESSION; MILD; ISCHEMIA; PEPTIDE; LESIONS	Blast-induced traumatic brain injury is on the rise, predominantly as a result of the use of improvised explosive devices, resulting in undesirable neuropsychological dysfunctions, as demonstrated in both animals and humans. This study investigated the effect of open-field blast injury on the rat brain using multi-echo, susceptibility-weighted imaging (SWI). Multi-echo SWI provided phase maps with better signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR), making it a sensitive technique for brain injury. Male Sprague-Dawley rats were subjected to a survivable blast of 180 kPa. The visibility of blood vessels of varying sizes improved with multi-echo SWI. Reduced signal intensity from major vessels post-blast indicates increased deoxyhaemoglobin. Relative cerebral blood flow was computed from filtered phase SWI images using inferred changes in oxygen saturation from major blood vessels. Cerebral blood flow decreased significantly at day 3 and day 5 post-blast compared with that pre-blast. This was substantiated by the upregulation of -amyloid precursor protein (-APP), a marker of ischaemia, in the neuronal perikaya of the cerebral cortex, as observed by immunofluorescence, and in the cortical tissue by western blot analysis. Our findings indicate the presence of brain ischaemia in post-blast acute phase of injury with possible recovery subsequently. Our results from cerebrovascular imaging, histology and staining provide an insight into the ischaemic state of the brain post-blast and may be useful for prognosis and outcome. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Verma, Sanjay Kumar; Seramani, Sankar; Kn, Bhanu Prakash; Velan, S. Sendhil] Singapore Bioimaging Consortium, Lab Mol Imaging, Singapore 138667, Singapore; [Kan, Enci Mary; Lu, Jia; Ng, Kian Chye; Wong, Yong Chiat; Tan, Mui Hong] DSO Natl Labs, Def Med & Environm Res Inst, Singapore 117560, Singapore; [Kan, Enci Mary; Lu, Jia; Ling, Eng Ang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Velan, S. Sendhil] Agcy Sci Technol & Res, Clin Imaging Res Ctr, Singapore, Singapore		Velan, SS (corresponding author), Singapore Bioimaging Consortium, Lab Mol Imaging, 11 Biopolis Way,02-02 Helios, Singapore 138667, Singapore.	ljia@dso.org.sg; sendhil_velan@sbic.a-star.edu.sg	Velan, S. Sendhil/B-6374-2017; Verma, Sanjay Kumar/AAU-1481-2021; KN, Bhanu Prakash/AAI-7884-2020	Velan, S. Sendhil/0000-0002-4096-0722; Verma, Sanjay Kumar/0000-0002-1111-1836; KN, Bhanu Prakash/0000-0002-7555-7431	Agency for Science, Technology and Research (A*STAR), SingaporeAgency for Science Technology & Research (ASTAR) [10/1/83/19/668]; Ministry of Defence (MINDEF), Singapore	Part of this work was supported by grant 10/1/83/19/668 from the Agency for Science, Technology and Research (A*STAR), Singapore and the Ministry of Defence (MINDEF), Singapore. The authors thank Zou Ying-Ying and Bian Ligong from Kunming Medical University China for technical assistance.	ABE K, 1991, NEUROSCI LETT, V125, P172, DOI 10.1016/0304-3940(91)90020-T; Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Denk C, 2010, J MAGN RESON IMAGING, V31, P185, DOI 10.1002/jmri.21995; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haacke EM, 1997, HUM BRAIN MAPP, V5, P341, DOI 10.1002/(SICI)1097-0193(1997)5:5<341::AID-HBM2>3.0.CO;2-3; HAACKE EM, 1999, MAGNETIC RESONANCE I, P741; Hald ES, 2014, TRANSL STROKE RES, V5, P385, DOI 10.1007/s12975-013-0300-3; Hammeke TA, 2003, NEUROPSYCHIATRY; Harrington D, 2000, J Clin Forensic Med, V7, P19, DOI 10.1054/jcfm.2000.0359; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Humphrey JD, 2007, ANN BIOMED ENG, V35, P1485, DOI 10.1007/s10439-007-9321-y; KALARIA RN, 1993, NEUROREPORT, V4, P211, DOI 10.1097/00001756-199302000-00025; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Lee Bruce, 2005, NeuroRx, V2, P372; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lin BW, 2001, BRAIN RES, V888, P107, DOI 10.1016/S0006-8993(00)03023-7; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Meyer FB, 1989, CEREBRAL ISCHEMIA CA, P429; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nihashi T, 2001, ACTA NEUROCHIR, V143, P287, DOI 10.1007/s007010170109; Park SH, 2008, MAGN RESON MED, V59, P855, DOI 10.1002/mrm.21573; Popa-Wagner A, 1998, STROKE, V29, P2196, DOI 10.1161/01.STR.29.10.2196; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Rasband W.S, 1997, IMAGEJ US; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Roy B, 2011, J MAGN RESON IMAGING, V34, P1060, DOI 10.1002/jmri.22744; Santos SF, 2009, J NEUROSCI, V29, P4708, DOI 10.1523/JNEUROSCI.4917-08.2009; Sedlacik J, 2007, MAGN RESON MED, V58, P1035, DOI 10.1002/mrm.21283; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tang H, 2011, P 19 ANN M ISMRM MON, P2376; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Verma SK, 2013, P 21 ANN M ISMRM SAL, P1072; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	53	6	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	SEP	2015	28	9					1069	1077		10.1002/nbm.3351			9	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	CP3VD	WOS:000359809800001	26152641				2022-02-06	
J	Braun, T; Kunz, U; Schulz, C; Lieber, A; Willy, C				Braun, T.; Kunz, U.; Schulz, C.; Lieber, A.; Willy, C.			Near-infrared spectroscopy for the detection of traumatic intracranial hemorrhage. Feasibility study in a German army field hospital in Afghanistan	UNFALLCHIRURG			German	Article						Traumatic brain injury; Emergency and disaster surgery; Military surgery; Infrascanne	HEMATOMAS; INJURY; DEVICE	Traumatic brain injury (TBI) is one of the most common causes of death in ordinary accidents, natural disasters, or warfare. The gold standard for diagnosis of TBI is the CT scan; a delay of diagnostics or medical care is the strongest independent predictor of mortality of TBI patients-particularly in the case of a surgically treatable intracranial hematoma. The proper classification of these patients is of major importance in situations where a CT is not accessible. A portable screening device that uses near-infrared spectroscopy (NIRS) technology allows a preliminary estimate of an intracranial hematoma. This study assessing practicability shows that the use of the device in a military medical rescue center (Kunduz, Afghanistan) is easy to learn and can be repeatedly used even under emergency room conditions. The technique can be applied in penetrating and blunt TBIs in the absence of an immediately available CT scan in rural areas, preclinically, under mass casualty conditions (e.g., in disaster situations) as well as in humanitarian crises or war zones. Nevertheless, further studies to assess the validity of this device are necessary.	[Braun, T.] Univ Giessen Klinikum, Klin Unfall Hand & Wiederherstellungschirurg, Giessen, Germany; [Kunz, U.; Schulz, C.] Bundeswehrkrankenhaus Ulm, Klin Neurochirurg, D-10115 Berlin, Germany; [Lieber, A.] Bundeswehrkrankenhaus Berlin, Sekt Gefass & Thoraxchirurg, D-10115 Berlin, Germany; [Willy, C.] Bundeswehrkrankenhaus Berlin, Septisch Plast Chirurg, Abt Unfallchirurg & Orthopadie, D-10115 Berlin, Germany		Willy, C (corresponding author), Bundeswehrkrankenhaus Berlin, Septisch Plast Chirurg, Abt Unfallchirurg & Orthopadie, Scharnhorststr 13, D-10115 Berlin, Germany.	christianwilly@bundeswehr.org	Willy, Christian/AAJ-3174-2021				A Arbeitsmedizin BfAu, 2011, GES UNF UNF 2009 DEU; [Anonymous], 2011, POL SCHW BEH; [Anonymous], 2011, GEK B ARZTREPORT 201; Bardenheuer M, 2000, UNFALLCHIRURG, V103, P355, DOI 10.1007/s001130050550; Burgess Paula, 2010, J Emerg Trauma Shock, V3, P164, DOI 10.4103/0974-2700.62120; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; Demmer KW, 2001, DTSCH ARZTEBL, V98, pA2256; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Jennett B, 1991, J NEUROTRAUMA S1, V8, P15; Keenan HT, 2004, AM J PREV MED, V26, P189, DOI 10.1016/j.amepre.2003.10.023; Lechner R, 2010, UNFALLCHIRURG, V113, P106, DOI 10.1007/s00113-009-1732-9; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Naghii MR, 2005, REV PANAM SALUD PUBL, V18, P216, DOI 10.1590/S1020-49892005000800013; Nast-Kolb D, 2007, CHIRURG, V78, P885, DOI 10.1007/s00104-007-1405-6; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P591, DOI 10.1089/neu.1995.12.591; Schulz C., 2004, Intensivmedizin und Notfallmedizin, V41, P417; Schulz C, 2005, AKTUEL NEUROL, V32, P28, DOI 10.1055/s-2004-834545; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Siebers C, 2008, ROFO-FORTSCHR RONTG, V180, P733, DOI 10.1055/s-2008-1027561; VICK K, 2004, LASTING WOUNDS WAR R; Willy C, 2008, CHIRURG, V79, P66, DOI 10.1007/s00104-007-1403-8; Willy C, 2011, LANGENBECK ARCH SURG, V396, P507, DOI 10.1007/s00423-011-0760-4	23	6	6	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	AUG	2015	118	8					693	700		10.1007/s00113-013-2549-0			8	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	CP1OQ	WOS:000359645500007	24435101				2022-02-06	
J	Goede, A; Dressler, J; Sommer, G; Schober, K; Franke, H; Ondruschka, B				Goede, A.; Dressler, J.; Sommer, G.; Schober, K.; Franke, H.; Ondruschka, B.			Wound age diagnostics after fatal traumatic brain injury. Expression of neuron-specific enolase and glial fibrillary acidic protein in brain tissue	RECHTSMEDIZIN			German	Article						Biomarker; Neurons; Astrocytes; Western blotting; Forensic pathology	ASTROCYTES; APOPTOSIS; MARKER; S100B; NSE	The diagnosis of traumatic brain injury (TBI) is of exceptional importance in forensic medicine due to its statistical frequency in autopsies; however, no single reliable method has yet been established to determine a precise aging of TBI. The aim of this study was to determine the quantity and evaluate the time-related protein expression of the biomarkers neuron-specific enolase (NSE) and glial fibrillary acidic protein (GFAP) at defined locations in human brain tissue following fatal TBI. Tissue samples of the cerebrum and cerebellum were collected from 42 brains during forensic autopsies following fatal TBI with survival periods ranging from a few minutes to 37 days. Brain tissue samples from 13 cases of cardiovascular death were used as the control group. Western blotting was used to determine the protein expression of NSE and GFAP. The NSE concentration was highest in the cerebellum and GFAP expression was highest in the hippocampal region up to 4 days after TBI. With the exception of the pericontusional zone, NSE expression increased in all areas after a posttraumatic survival period of more than 2 h. A similar increase in GFAP was observed after 4 days survival. The results show that NSE and GFAP using Western blotting analysis may have an additional value as a supplement to autopsy and histological findings in the diagnostic process of wound aging in TBI.	[Goede, A.; Dressler, J.; Ondruschka, B.] Univ Leipzig, Inst Rechtsmed, Fak Med, D-04103 Leipzig, Germany; [Sommer, G.] Univ Klinikum Leipzig, Klin & Poliklin Orthopadie Unfallchirurg & Plast, Leipzig, Germany; [Schober, K.] Zentrum Luft & Raumfahrtmed Luftwaffe, Furstenfeldbruck, Germany; [Franke, H.] Univ Leipzig, Rudolf Boehm Inst Pharmakol & Toxikol, D-04103 Leipzig, Germany		Ondruschka, B (corresponding author), Univ Leipzig, Inst Rechtsmed, Fak Med, Johannisallee 28, D-04103 Leipzig, Germany.	benjamin.ondruschka@medizin.uni-leipzig.de					Bratzke H, 2011, RECHTSMEDIZIN, V21, P258, DOI 10.1007/s00194-011-0760-2; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; DEARMOND SJ, 1983, BRAIN RES, V262, P275, DOI 10.1016/0006-8993(83)91018-1; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; FLETCHER L, 1976, BIOCHIM BIOPHYS ACTA, V452, P245, DOI 10.1016/0005-2744(76)90077-2; Franke H, 2013, PURINERG SIGNAL, V9, P451, DOI 10.1007/s11302-013-9366-3; Franke H, 2012, PURINERG SIGNAL, V8, P629, DOI 10.1007/s11302-012-9300-0; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Hausmann R, 2007, INT J LEGAL MED, V121, P175, DOI 10.1007/s00414-006-0122-x; Hausmann R, 2004, INT J LEGAL MED, V118, P32, DOI 10.1007/s00414-003-0413-4; Herculano-Houzel S, 2011, BRAIN BEHAV EVOLUT, V78, P22, DOI 10.1159/000327318; Kleine TO, 2003, BRAIN RES BULL, V61, P265, DOI 10.1016/S0361-9230(03)00090-X; Kokjohn TA, 2013, J NEUROTRAUM, V30, P981, DOI 10.1089/neu.2012.2699; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Maxeiner H, 2011, RECHTSMEDIZIN, V21, P197, DOI 10.1007/s00194-011-0753-1; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Petzold A, 2015, BRAIN RES, V1600, P17, DOI 10.1016/j.brainres.2014.12.027; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rickels E, 2011, UNFALLCHIRURG, V114, P417, DOI 10.1007/s00113-010-1872-y; SCHMECHEL D, 1978, NATURE, V276, P834, DOI 10.1038/276834a0; Schober K, 2015, INT J LEGAL MED, V129, P701, DOI 10.1007/s00414-014-1129-3; Schroeter ML, 2015, J NEUROTRAUM, V32, P1380, DOI 10.1089/neu.2013.3163; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	31	6	6	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9819	1434-5196		RECHTSMEDIZIN	Rechtsmedizin	AUG	2015	25	4					261	267		10.1007/s00194-015-0040-7			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	CN8DC	WOS:000358667100002					2022-02-06	
J	Kempema, J; Trust, MD; Ali, S; Cabanas, JG; Hinchey, PR; Brown, LH; Brown, CVR				Kempema, James; Trust, Marc D.; Ali, Sadia; Cabanas, Jose G.; Hinchey, Paul R.; Brown, Lawrence H.; Brown, Carlos V. R.			Prehospital endotracheal intubation vs extraglottic airway device in blunt trauma	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							RAPID-SEQUENCE INTUBATION; HOSPITAL CARDIAC-ARREST; BRAIN-INJURY; SUPRAGLOTTIC AIRWAY; SUCCESS RATES; HYPERVENTILATION; METAANALYSIS; MORTALITY; HYPOXIA; TIME	Objective: The objective of the study is to compare outcomes in blunt trauma patients managed with prehospital insertion of an extraglottic airway device (EGD) vs endotracheal intubation (ETI). The null hypothesis was that there would be no difference in mortality for the 2 groups. Methods: This is a retrospective study of blunt trauma patients with Glasgow Coma Scale score less than or equal to 8 transported by ground emergency medical services directly from the scene of injury to a single urban level 1 trauma center. Patients managed with only noninvasive airway techniques were excluded, leaving patients undergoing either EGD placement or ETI. Outcomes included in-emergency department (ED) traumatic arrest and hospital mortality. Multivariable logistic regression was used to control for the potential confounding effects of demographic and clinical variables. For all analyses, P<.05 was used to establish statistical significance. Results: In bivariate analysis, patients managed with EGD were more likely than those managed with ETI to have an in-ED traumatic arrest (36.5% vs 17.1%; P=.005), but eventual hospital mortality did not significantly differ between the 2 groups (75.7% vs 67.1%; P=.228). After controlling for demographic and clinical characteristics, patients managed with EGD were no more likely than patients managed with ETI to experience traumatic arrest in the ED (adjusted odds ratio, 1.67; 95% confidence interval, 0.72-3.89), and there was also no difference in overall hospital mortality (adjusted odds ratio, 0.912; 95% confidence interval, 0.36-2.30). Conclusion: In this preliminary, retrospective analysis, we found no difference in overall survival among trauma patients managed with prehospital EGD and those managed with prehospital ETI. (C) 2015 Elsevier Inc. All rights reserved.	[Kempema, James; Brown, Lawrence H.] Univ Texas Austin, Emergency Med Residency Program, Austin, TX 78701 USA; [Kempema, James; Trust, Marc D.; Ali, Sadia; Brown, Lawrence H.; Brown, Carlos V. R.] Univ Med Ctr Brackenridge, Austin, TX 78701 USA; [Trust, Marc D.; Ali, Sadia; Brown, Carlos V. R.] Univ Texas Austin, Dept Surg, Austin, TX 78701 USA; [Cabanas, Jose G.; Hinchey, Paul R.] Austin Travis Cty Off Med Director, Austin, TX 78741 USA; [Brown, Lawrence H.] James Cook Univ, Mt Isa Ctr Rural & Remote Hlth, Townsville, Qld 4811, Australia		Brown, LH (corresponding author), Univ Texas Austin Emergency Med, 1400 N IH 35,Suite C2-230, Austin, TX 78701 USA.	Lawrence.Brown@my.jcu.edu.au		Brown, Lawrence/0000-0002-5940-1840			[Anonymous], 2012, AIRWAY MANAGEMENT AD, V9th, P30; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Brown Lawrence H, 2011, Air Med J, V30, P140, DOI 10.1016/j.amj.2010.11.010; Cady CE, 2009, PREHOSP EMERG CARE, V13, P495, DOI 10.1080/10903120903144874; Cudnik MT, 2008, PREHOSP EMERG CARE, V12, P459, DOI 10.1080/10903120802290745; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Hanif MA, 2010, ACAD EMERG MED, V17, P926, DOI 10.1111/j.1553-2712.2010.00829.x; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P515, DOI 10.3109/10903127.2010.497903; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; Johnston BD, 2006, ACAD EMERG MED, V13, P1051, DOI 10.1197/j.aem.2006.06.031; Jones JH, 2004, ACAD EMERG MED, V11, P707, DOI 10.1197/j.aem.2003.12.026; Kajino K, 2011, CRIT CARE, V15, DOI 10.1186/cc10483; Lerner EB, 2003, ACAD EMERG MED, V10, P949, DOI 10.1197/S1069-6563(03)00313-0; Ochs M, 2000, Prehosp Emerg Care, V4, P333, DOI 10.1080/10903120090941065; Segal N, 2012, RESUSCITATION, V83, P1025, DOI 10.1016/j.resuscitation.2012.03.025; Studnek JR, 2010, ACAD EMERG MED, V17, P918, DOI 10.1111/j.1553-2712.2010.00827.x; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2012, RESUSCITATION, V83, P1061, DOI 10.1016/j.resuscitation.2012.05.018; Wang HE, 2010, ACAD EMERG MED, V17, P987, DOI 10.1111/j.1553-2712.2010.00864.x; Wang HE, 2010, ANN EMERG MED, V55, P527, DOI 10.1016/j.annemergmed.2009.12.020; Wirtz DD, 2007, PREHOSP EMERG CARE, V11, P213, DOI 10.1080/10903120701205935	28	6	6	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	AUG	2015	33	8					1080	1083		10.1016/j.ajem.2015.04.046			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CL0BR	WOS:000356604000018	25963681				2022-02-06	
J	Kim, WH; Lim, DJ; Kim, SH; Ha, SK; Choi, JI; Kim, SD				Kim, Won-Hyung; Lim, Dong-Jun; Kim, Se-Hoon; Ha, Sung-Kon; Choi, Jong-Il; Kim, Sang-Dae			Is Routine Repeated Head CT Necessary for All Pediatric Traumatic Brain Injury?	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Computed tomography; Cranial epidural hemorrhage; Glasgow Coma Scale; Traumatic brain injury	REPEATED COMPUTED-TOMOGRAPHY; NEUROLOGIC EXAMINATION; BENEFIT PATIENTS; MILD; MANAGEMENT; UTILITY; CRANIOTOMY; HEMORRHAGE; MODERATE; ABSENCE	Objective : Repeated computed tomography (CT) follow up for traumatic brain injury (TBI) patients is often performed. But there is debate the indication for repeated CT scans, especially in pediatric patients. Purpose of our study is to find risk factors of progression on repeated CT and delayed surgical intervention based on the repeated head CT. Methods : Between March, 2007 and December, 2013, 269 pediatric patients (age 0-18 years) had admitted to our hospital for head trauma. Patients were classified into 8 subgroups according to mechanisms of injury. Types, amount of hemorrhage and amount changes on repeated CT were analyzed as well as initial Glasgow Coma Scale (GCS) scores. Results : Within our cohort of 269 patients, 174 patients received repeat CT. There were progression in the amount of hemorrhage in 48 (27.6%) patients. Among various hemorrhage types, epidural hemorrhage (EDH) more than 10 cc measured in initial CT was found to be at risk of delayed surgical intervention significantly after routine repeated CT with or without neurological deterioration than other types of hemorrhage. Based on initial GCS, severe head trauma group (GCS 3-8) was at risk of delayed surgical intervention after routine repeated CT without change of clinical neurologic status. Conclusion : We suggest that the patients with EDH more than 10 cc or GCS below 9 should receive repeated head CT even though absence of significant clinical deterioration.	[Kim, Won-Hyung; Lim, Dong-Jun; Kim, Se-Hoon; Ha, Sung-Kon; Choi, Jong-Il; Kim, Sang-Dae] Korea Univ, Coll Med, Korea Univ Ansan Hosp, Dept Neurosurg, 123 Jeokgeum Ro, Ansan 15355, South Korea		Kim, SD (corresponding author), Korea Univ, Coll Med, Korea Univ Ansan Hosp, Dept Neurosurg, 123 Jeokgeum Ro, Ansan 15355, South Korea.	neuron19@korea.ac.kr		Kim, Se-Hoon/0000-0002-1716-1375			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Bata SC, 2014, ANZ J SURG, V84, P438, DOI 10.1111/ans.12582; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY, V58, pS1; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Howe J, 2014, J TRAUMA ACUTE CARE, V76, P292, DOI 10.1097/TA.0000000000000119; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; Salim A, 2013, J TRAUMA ACUTE CARE, V74, P973; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Shackford SR, 2004, J TRAUMA, V56, P480; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Sing RF, 2006, J TRAUMA, V60, P499; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Thorson CM, 2013, J TRAUMA ACUTE CARE, V74, P967, DOI 10.1097/TA.0b013e3182877fed; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	28	6	6	0	2	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	AUG	2015	58	2					125	130		10.3340/jkns.2015.58.2.125			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CX1ZT	WOS:000365495300006	26361528	gold, Green Submitted, Green Published			2022-02-06	
J	Subirats, L; Lopez-Blazquez, R; Ceccaroni, L; Gifre, M; Miralles, F; Garcia-Rudolph, A; Tormos, JM				Subirats, Laia; Lopez-Blazquez, Raquel; Ceccaroni, Luigi; Gifre, Mariona; Miralles, Felip; Garcia-Rudolph, Alejandro; Maria Tormos, Jose			Monitoring and Prognosis System Based on the ICF for People with Traumatic Brain Injury	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						international classification of functioning; disability and health; medical records; information systems; brain injuries; prognosis; public health	INTERNATIONAL CLASSIFICATION; HEALTH-STATUS; DISABILITY	The objective of this research is to provide a standardized platform to monitor and predict indicators of people with traumatic brain injury using the International Classification of Functioning, Disability and Health, and analyze its potential benefits for people with disabilities, health centers and administrations. We developed a platform that allows automatic standardization and automatic graphical representations of indicators of the status of individuals and populations. We used data from 730 people with acquired brain injury performing periodic comprehensive evaluations in the years 2006-2013. Health professionals noted that the use of color-coded graphical representation is useful for quickly diagnose failures, limitations or restrictions in rehabilitation. The prognosis system achieves 41% of accuracy and sensitivity in the prediction of emotional functions, and 48% of accuracy and sensitivity in the prediction of executive functions. This monitoring and prognosis system has the potential to: (1) save costs and time, (2) provide more information to make decisions, (3) promote interoperability, (4) facilitate joint decision-making, and (5) improve policies of socioeconomic evaluation of the burden of disease. Professionals found the monitoring system useful because it generates a more comprehensive understanding of health oriented to the profile of the patients, instead of their diseases and injuries.	[Subirats, Laia; Miralles, Felip] Eurecat, eHlth Dept, Barcelona 08018, Spain; [Subirats, Laia] Univ Autonoma Barcelona, Bellaterra 08193, Spain; [Lopez-Blazquez, Raquel; Gifre, Mariona; Garcia-Rudolph, Alejandro; Maria Tormos, Jose] UAB, Inst Univ Neurorehabil Adscrit, Inst Guttmann, Badalona 08916, Spain; [Ceccaroni, Luigi] 1000001 Labs, Barcelona 08024, Spain		Subirats, L (corresponding author), Eurecat, eHlth Dept, Barcelona 08018, Spain.	laia.subirats@eurecat.org; rlopez@guttmann.com; luigi@1000001labs.org; mgifre@guttmann.com; felip.miralles@eurecat.org; agarciar@guttmann.com; jmtormos@guttmann.com	Subirats, Laia/C-3642-2018	Subirats, Laia/0000-0001-8646-5463; Ceccaroni, Luigi/0000-0002-3116-0811; Tormos Munoz, Jose Maria/0000-0002-8764-2289; Miralles, Felip/0000-0002-6917-6691; Gifre, Mariona/0000-0001-5214-8806	CDTI under Avanza Ciudadania Digital [TSI-040200-2009-73]; Spanish research project called Rehabilita (Disruptive technologies for the rehabilitation of the future) - CDTI under CENIT program of the Spanish government's INGENIO initiative [CEN-2009-1043]; Catalonia Competitiveness Agency (ACC1O)	The authors thank all volunteers from Institut Guttmann that have participated in this study for their cooperation. The research described in this paper arises from a Spanish research project called Circles of Health TSI-040200-2009-73 funded by CDTI under Avanza Ciudadania Digital. This work is also partially supported by a Spanish research project called Rehabilita (Disruptive technologies for the rehabilitation of the future) CEN-2009-1043, which is funded by CDTI, under the CENIT program, in the framework of the Spanish government's INGENIO 2010 initiative. It is also partly supported by the Catalonia Competitiveness Agency (ACC1O).	Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bickenbach J, 2012, ICF CORE SETS MANUAL; Calvo M, 2013, INT J ENV RES PUB HE, V10, P5266, DOI 10.3390/ijerph10115266; Ceccaroni L., 2012, INT J APPL COMPUT MA, V11, P303; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; College of American Pathologists and National Health Service, 2011, SYST NOM MED CLIN TE; Comin MC, 2011, GAC SANIT, V25, P39, DOI 10.1016/j.gaceta.2011.09.004; Dijkers M, COMMUNITY INTEGRATIO; Espallargues Mireia, 2011, Gac Sanit, V25 Suppl 1, P40, DOI 10.1016/S0213-9111(11)70007-3; Garcia-Rudolph A, 2014, EXPERT SYST APPL, V41, P5238, DOI 10.1016/j.eswa.2014.03.001; Institut Guttmann Qvidlab, 2009, TECHNICAL REPORT; Kolakowsky-Hayner S, PATIENT COMPETENCY R; Laxe S, 2012, CLIN NEUROL NEUROSUR, V114, P645, DOI 10.1016/j.clineuro.2011.12.038; MAHONEY F I, 1965, Md State Med J, V14, P61; Miralles F., 2015, Patent Application, Patent No. [PCT/ EP2011/ 074267, 2011074267]; Miralles F., 2015, Patent Application, Patent No. [WO/ 2013/ 097905, 2013097905]; Mpofu E., 2010, REHABILITATION HLTH; RECTOR AL, 1991, METHOD INFORM MED, V30, P179; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Sander A, LEVEL COGNITIVE FUNC; Sander A., EXTENDED GLASGOW OUT; Sassi F, 2006, HEALTH POLICY PLANN, V21, P402, DOI 10.1093/heapol/czl018; Serra J., 2013, P ADV COGN TECHN APP; Subirats L., 2013, MANAGEMENT INTELLIGE, P51; Subirats L, 2013, J BIOMED INFORM, V46, P1006, DOI 10.1016/j.jbi.2013.09.001; Subirats L, 2012, FUTURE INTERNET, V4, P762, DOI 10.3390/fi4030762; Traffic Service of the Interior Department of the Goverment of Catalonia, 2002, ACC DIS SOM FIGS; Vargiu E., 2014, COMPUTATIONAL INTELL; WHO, 2001, INT CLASS FUNCT DIS; World Health Organization, 2008, INT CLASS DIS ICD 10; Wright J, 2000, DISABILITY RATING SC	32	6	6	0	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	AUG	2015	12	8					9832	9847		10.3390/ijerph120809832			16	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CQ4PT	WOS:000360587800078	26295252	Green Published, Green Submitted, gold			2022-02-06	
J	Wei, L; Xue, R; Zhang, PP; Wu, YJ; Li, XJ; Pei, FK				Wei, Lai; Xue, Rong; Zhang, Panpan; Wu, Yijie; Li, Xiaojing; Pei, Fengkui			H-1 NMR-Based Metabolomics and Neurotoxicity Study of Cerebrum and Cerebellum in Rats Treated with Cinnabar, a Traditional Chinese Medicine	OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; MERCURIC-CHLORIDE; N-ACETYLASPARTYLGLUTAMATE; GLUTAMATE TRANSPORT; ASTROCYTE CULTURES; OXIDATIVE STRESS; GRANULE CELLS; DISEASES	Cinnabar, an important traditional Chinese mineral medicine, has been widely used as a Chinese patent medicine ingredient for sedative therapy. Nevertheless, the neurotoxic effects of cinnabar have also been noted. In this study, H-1 NMR-based metabolomics, combined with multivariate pattern recognition, were applied to investigate the neurotoxic effects of cinnabar after intragastrical administration (dosed at 2 and 5 g/kg body weight) on male Wistar rats. The metabolite variations induced by cinnabar were characterized by increased levels of glutamate, glutamine, myo-inositol, and choline, as well as decreased levels of GABA, taurine, NAA, and NAAG in tissue extracts of the cerebellum and cerebrum. These findings suggested that cinnabar induced glutamate excitotoxicity, neuronal cell loss, osmotic state changes, membrane fluidity disruption, and oxidative injury in the brain. We also show here that there is a dose- and time-dependent neurotoxicity of cinnabar, and that cerebellum was more sensitive to cinnabar induction than cerebrum. This work illustrates the utility and reliability of H-1 NMR-based metabolomics approach for examining the potential neurotoxic effects of cinnabar and other traditional Chinese medicines.	[Wei, Lai; Xue, Rong; Zhang, Panpan; Wu, Yijie; Li, Xiaojing; Pei, Fengkui] Chinese Acad Sci, Changchun Inst Appl Chem, Changchun 130022, Peoples R China		Xue, R (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, 5625 Renmin St, Changchun 130022, Peoples R China.	xuerong@ciac.ac.cn; xjli@ciac.ac.cn			National Basic Research Program of ChinaNational Basic Research Program of China [20972057, 21305134]; Open Project of State Key Laboratory of Supramolecular Structure and Materials of Jilin UniversityJilin University [sklssm201427]	This work is funded by the National Basic Research Program of China (Project numbers 20972057 and 21305134) and Open Project of State Key Laboratory of Supramolecular Structure and Materials of Jilin University (Grant Number sklssm201427).	ALBRECHT J, 1994, NEUROTOXICOLOGY, V15, P897; Albrecht J, 1996, METAB BRAIN DIS, V11, P175, DOI 10.1007/BF02069504; Altmaier E, 2011, EUR J EPIDEMIOL, V26, P145, DOI 10.1007/s10654-010-9524-7; Aschner M, 2007, BRAZ J MED BIOL RES, V40, P285, DOI 10.1590/S0100-879X2007000300001; Aschner M, 1996, NEUROTOXICOLOGY, V17, P663; Beckwith-Hall BM, 2002, CHEM RES TOXICOL, V15, P1136, DOI 10.1021/tx020020+; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bondia-Pons I, 2013, OMICS, V17, P611, DOI 10.1089/omi.2013.0027; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; BROOKES N, 1988, J NEUROCHEM, V50, P1117, DOI 10.1111/j.1471-4159.1988.tb10581.x; BROOKES N, 1992, TOXICOLOGY, V76, P245, DOI 10.1016/0300-483X(92)90193-I; CHANG LW, 1977, ENVIRON RES, V14, P329, DOI 10.1016/0013-9351(77)90044-5; Cheng JP, 2005, J ENVIRON SCI-CHINA, V17, P469; Cheng LL, 2002, MAGN RESON IMAGING, V20, P527, DOI 10.1016/S0730-725X(02)00512-X; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Chun JJ, 2001, N-S ARCH PHARMACOL, V364, P249, DOI 10.1007/s002100000279; Chuu JJ, 2007, TOXICOL LETT, V169, P109, DOI 10.1016/j.toxlet.2006.12.006; CLARKSON TW, 1972, ANNU REV PHARMACOLOG, V12, P375, DOI 10.1146/annurev.pa.12.040172.002111; Counter SA, 2004, TOXICOL APPL PHARM, V198, P209, DOI 10.1016/j.taap.2003.11.032; COUSIN MA, 1995, J NEUROCHEM, V64, P2097; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; Ekman DR, 2006, METABOLOMICS, V2, P63, DOI 10.1007/s11306-006-0020-8; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Fitsanakis VA, 2005, TOXICOL APPL PHARM, V204, P343, DOI 10.1016/j.taap.2004.11.013; Fonfria E, 2005, J NEUROSCI RES, V79, P545, DOI 10.1002/jnr.20375; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gehl LM, 2004, J NEUROCHEM, V90, P989, DOI 10.1111/j.1471-4159.2004.02578.x; GRAHAM GD, 1992, STROKE, V23, P333, DOI 10.1161/01.STR.23.3.333; Hardy AD, 1995, J ETHNOPHARMACOL, V49, P17, DOI 10.1016/0378-8741(95)01296-6; Hindmarsh JP, 2012, J SCI FOOD AGR, V92, P2013, DOI 10.1002/jsfa.5636; Hoang TQ, 1998, NEUROLOGY, V50, P1033, DOI 10.1212/WNL.50.4.1033; Holmes Elaine, 2006, NeuroRx, V3, P358, DOI 10.1016/j.nurx.2006.05.004; Howe FA, 2003, MAGNET RESON MED, V49, P223, DOI 10.1002/mrm.10367; Huang CF, 2008, NEUROTOXICOLOGY, V29, P386, DOI 10.1016/j.neuro.2008.01.005; Huang CF, 2007, TOXICOL APPL PHARM, V224, P192, DOI 10.1016/j.taap.2007.07.003; HUGG JW, 1993, ANN NEUROL, V34, P788, DOI 10.1002/ana.410340606; Hussain S, 1997, J ENVIRON SCI HEAL B, V32, P395, DOI 10.1080/03601239709373094; ISAACKS RE, 1994, NEUROCHEM RES, V19, P331, DOI 10.1007/BF00971582; Jenkins BG, 1998, NEUROLOGY, V50, P1357, DOI 10.1212/WNL.50.5.1357; Ji CL, 2015, ENVIRON TOXICOL PHAR, V39, P545, DOI 10.1016/j.etap.2015.01.004; Kang YS, 2006, ADV EXP MED BIOL, V583, P291; KANGYUM E, 1992, VET HUM TOXICOL, V34, P235; Kim Paul, 1995, Yonsei Medical Journal, V36, P299; LEBEL CP, 1991, NEUROTOXICOL TERATOL, V13, P341, DOI 10.1016/0892-0362(91)90081-7; Liang Ai-hua, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1809; Lindon JC, 1999, ANNU REP NMR SPECTRO, V38, P1, DOI 10.1016/S0066-4103(08)60035-6; Liu J, 2008, EXP BIOL MED, V233, P810, DOI 10.3181/0712-MR-336; Lucetti C, 2001, NEUROL SCI, V22, P69, DOI 10.1007/s100720170051; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; Mason GF, 2006, NMR BIOMED, V19, P690, DOI 10.1002/nbm.1080; Moffett JR, 2006, ADV EXP MED BIOL, V576, P7; Moreno A, 2001, J NEUROCHEM, V77, P347, DOI 10.1046/j.1471-4159.2001.00282.x; Mutkus L, 2006, BIOL TRACE ELEM RES, V109, P267, DOI 10.1385/BTER:109:3:267; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; NICHOLSON JK, 1989, PROG NUCL MAG RES SP, V21, P449, DOI 10.1016/0079-6565(89)80008-1; OLNEY JW, 1973, NEW ENGL J MED, V289, P1374; PATERSON RA, 1971, LIFE SCI 2-BIOCH GEN, V10, P121, DOI 10.1016/0024-3205(71)90024-5; Pfefferbaum A, 1999, ARCH GEN PSYCHIAT, V56, P185, DOI 10.1001/archpsyc.56.2.185; Pinto J, 2015, J PROTEOME RES, V14, P2696, DOI 10.1021/acs.jproteome.5b00260; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; Rooney JPK, 2007, TOXICOLOGY, V234, P145, DOI 10.1016/j.tox.2007.02.016; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; SCHOUSBOE A, 1993, DEV NEUROSCI-BASEL, V15, P359, DOI 10.1159/000111356; Seppi K, 2005, CURR OPIN NEUROL, V18, P370, DOI 10.1097/01.wco.0000173141.74137.63; Trifonova O, 2013, OMICS, V17, P550, DOI 10.1089/omi.2012.0121; van der Sar SA, 2015, ANAL BIOANAL CHEM, V407, P4835, DOI 10.1007/s00216-015-8663-9; Wei L, 2008, TOXICOL APPL PHARM, V227, P417, DOI 10.1016/j.taap.2007.11.015; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; Wu QF, 2010, J PHARMACEUT BIOMED, V51, P698, DOI 10.1016/j.jpba.2009.09.042; YEOH TS, 1986, TOXICOLOGY, V41, P107, DOI 10.1016/0300-483X(86)90108-3; Young YH, 2002, TOXICOL SCI, V67, P256, DOI 10.1093/toxsci/67.2.256; ZEISEL SH, 1981, ANNU REV NUTR, V1, P95, DOI 10.1146/annurev.nu.01.070181.000523; Zheng W, 2003, TOXICOL APPL PHARM, V192, P1, DOI 10.1016/S0041-008X(03)00251-5; Zivkovic AM, 2009, CURR OPIN CLIN NUTR, V12, P501, DOI 10.1097/MCO.0b013e32832f1916	75	6	11	3	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1536-2310	1557-8100		OMICS	OMICS	AUG 1	2015	19	8					490	498		10.1089/omi.2015.0042			9	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	CO9ZH	WOS:000359535100007	26110755				2022-02-06	
J	Micci, MA; Boone, DR; Parsley, MA; Wei, JN; Patrikeev, I; Motamedi, M; Hellmich, HL				Micci, Maria-Adelaide; Boone, Debbie R.; Parsley, Margaret A.; Wei, Jingna; Patrikeev, Igor; Motamedi, Massoud; Hellmich, Helen L.			Development of a novel imaging system for cell therapy in the brain	STEM CELL RESEARCH & THERAPY			English	Article							SODIUM-IODIDE SYMPORTER; NEURAL STEM-CELLS; REPORTER GENE; RADIOIODINE THERAPY; ANIMAL-MODELS; IN-VIVO; TRANSPLANTATION; TOMOGRAPHY; DELIVERY; FEASIBILITY	Introduction: Stem cells have been evaluated as a potential therapeutic approach for several neurological disorders of the central and peripheral nervous system as well as for traumatic brain and spinal cord injury. Currently, the lack of a reliable and safe method to accurately and non-invasively locate the site of implantation and track the migration of stem cells in vivo hampers the development of stem cell therapy and its clinical application. In this report, we present data that demonstrate the feasibility of using the human sodium iodide symporter (hNIS) as a reporter gene for tracking neural stem cells (NSCs) after transplantation in the brain by using single-photon emission tomography/computed tomography (SPECT/CT) imaging. Methods: NSCs were isolated from the hippocampus of adult rats (Hipp-NSCs) and transduced with a lentiviral vector containing the hNIS gene. Hipp-NSCs expressing the hNIS (NIS-Hipp-NSCs) were characterized in vitro and in vivo after transplantation in the rat brain and imaged by using technetium-99m (99mTc) and a small rodent SPECT/CT apparatus. Comparisons were made between Hipp-NSCs and NIS-Hipp-NSCs, and statistical analysis was performed by using two-tailed Student's t test. Results: Our results show that the expression of the hNIS allows the repeated visualization of NSCs in vivo in the brain by using SPECT/CT imaging and does not affect the ability of Hipp-NSCs to generate neuronal and glial cells in vitro and in vivo. Conclusions: These data support the use of the hNIS as a reporter gene for non-invasive imaging of NSCs in the brain. The repeated, non-invasive tracking of implanted cells will accelerate the development of effective stem cell therapies for traumatic brain injury and other types of central nervous system injury.	[Micci, Maria-Adelaide; Boone, Debbie R.; Parsley, Margaret A.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Wei, Jingna; Patrikeev, Igor; Motamedi, Massoud] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA		Micci, MA (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.	mmicci@utmb.edu	Patrikeev, Igor/F-5660-2016		National Center for Research Resources, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1UL1RR029876-01]; Moody Project for Translational Traumatic Brain Injury Research; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR029876] Funding Source: NIH RePORTER	This study was supported by grant 1UL1RR029876-01 from the National Center for Research Resources, National Institutes of Health and by the Moody Project for Translational Traumatic Brain Injury Research. We thank Sissy M. Jhiang for providing the full-length hNIS cDNA, Lori Follis for preparing <SUP>99m</SUP>Tc, Elizabeth Bishop for helping with the cell culture of Hipp-NSCs, Donald J. Deyo for providing valuable expertise and assistance with the intraventricular injection procedure, and Christine Courteau-Butler for editorial support.	Baghbaderani BA, 2011, CURR STEM CELL RES T, V6, P229; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; Barton KN, 2011, MOL THER, V19, P1353, DOI 10.1038/mt.2011.89; BEASLEY TM, 1966, HEALTH PHYS, V12, P1425, DOI 10.1097/00004032-196610000-00004; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; Brader P, 2013, J NUCL MED, V54, P167, DOI 10.2967/jnumed.111.099788; Cho JY, 2002, GENE THER, V9, P1139, DOI 10.1038/sj.gt.3301787; Conti L, 2006, BRAIN PATHOL, V16, P143, DOI 10.1111/j.1750-3639.2006.00009.x; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Higuchi T, 2009, J NUCL MED, V50, P1881, DOI 10.2967/jnumed.109.067801; Hwang DW, 2008, EUR J NUCL MED MOL I, V35, P135, DOI 10.1007/s00259-007-0561-8; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Jain KK, 2009, MOL BIOTECHNOL, V42, P367, DOI 10.1007/s12033-009-9166-8; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Miyagawa M, 2005, CARDIOVASC RES, V65, P195, DOI 10.1016/j.cardiores.2004.10.001; Okuyama S, 1997, LIFE SCI, V60, P1881, DOI 10.1016/S0024-3205(97)00149-5; Olivier JC, 2002, PHARMACEUT RES, V19, P1137, DOI 10.1023/A:1019842024814; Ourednik J, 2004, CELL TRANSPLANT, V13, P307, DOI 10.3727/000000004783983963; Ourednik V, 2005, ANN NY ACAD SCI, V1049, P172, DOI 10.1196/annals.1334.016; Penheiter AR, 2012, CURR GENE THER, V12, P33; Pluchino S, 2005, BRAIN RES REV, V48, P211, DOI 10.1016/j.brainresrev.2004.12.011; Portulano C, 2014, ENDOCR REV, V35, P106, DOI 10.1210/er.2012-1036; Schaller B, 2004, NEUROBIOL DIS, V15, P437, DOI 10.1016/j.nbd.2003.11.023; Seo JH, 2010, J NUCL MED, V51, P1637, DOI 10.2967/jnumed.110.077891; Shin JH, 2004, EUR J NUCL MED MOL I, V31, P425, DOI 10.1007/s00259-003-1394-8; Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004; Spiriev T, 2013, METHODS MOL BIOL, V1052, P195, DOI 10.1007/7651_2013_27; Templin C, 2012, CIRCULATION, V126, P430, DOI 10.1161/CIRCULATIONAHA.111.087684; Terrovitis J, 2008, J AM COLL CARDIOL, V52, P1652, DOI 10.1016/j.jacc.2008.06.051; Varma NRS, 2013, WORLD J CLIN ONCOL, V4, P91, DOI 10.5306/wjco.v4.i4.91; Zhao C, 2010, OPEN NUCL MED J, V2, P171, DOI DOI 10.2174/1876388X01002010171	32	6	8	0	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-6512			STEM CELL RES THER	Stem Cell Res. Ther.	JUL 21	2015	6								31	10.1186/s13287-015-0129-7			16	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	CO7RC	WOS:000359357600001	26194790	Green Published, gold			2022-02-06	
J	Bogner, J; French, LM; Lange, RT; Corrigan, JD				Bogner, Jennifer; French, Louis M.; Lange, Rael T.; Corrigan, John D.			Pilot study of traumatic brain injury and alcohol misuse among service members	BRAIN INJURY			English	Article						Alcohol-related disorders; craniocerebral trauma; military personnel; substance-related disorders	POSTTRAUMATIC-STRESS-DISORDER; OPERATIONS ENDURING FREEDOM; SICKNESS IMPACT PROFILE; SUBSTANCE USE; MILITARY PERSONNEL; CONSTRUCT-VALIDITY; INVENTORY-II; HEAD-INJURY; RISK; SYMPTOMS	Objective: Explore relationships among traumatic brain injury (TBI), substance misuse and other mental health disorders in US service members and to identify risk factors for substance misuse. Participants: Service members (n=93 in final sample) injured while deployed to Operation Enduring Freedom or Operation Iraqi Freedom. Methods and materials: Longitudinal survey at 6 and 12 months post-intake. The following measures were used: problem substance use, Alcohol Expectancies Questionnaire-HI, MINI International Neuropsychiatric Interview Substance Abuse Modules, Ohio State University TBI Identification Method, Neurobehavioural Symptom Inventory, Rivermead Post-Concussion Symptoms Questionnaire, Buss-Perry Aggression Questionnaire, Post-Traumatic Stress Disorder Checklist-Civilian Version, Beck Depression Inventory-II, Beck Anxiety Inventory. Results: More severe TBI and post-traumatic stress disorder (PTSD) symptoms at 6 months post-enrolment were associated with decreased odds of substance misuse 12 months after study enrolment. Alcohol expectancies and incurring a TBI at a younger age increased the odds of substance misuse. Conclusions: While the ability to generalize the current findings to a larger population is limited, the results provide direction for future studies on the prevention and treatment of substance misuse following TBI. The unexpected protective effect of more severe TBI may result from prospective attention to the injury and its consequences. Greater preventive benefit may result from identifying more service members with elevated risk. Lifetime history of TBI and alcohol expectancies may be candidate indicators for greater attention.	[Bogner, Jennifer; Corrigan, John D.] Ohio State Univ, Columbus, OH 43210 USA; [French, Louis M.; Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [French, Louis M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada		Bogner, J (corresponding author), Dept Phys Med & Rehabil, Res & Acad Affairs, 480 Med Ctr Dr, Columbus, OH 43210 USA.	bogner.1@osu.edu	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	Defense and Veterans Brain Injury Injury Center	This study was funded by a grant from the Defense and Veterans Brain Injury Injury Center administered by the Henry M. Jackson Foundation to The Ohio State University. The Henry M. Jackson Foundation was not involved in article preparation. Drs French and Lange are affiliated with the Defense and Veterans Brain Injury Injury Center, Walter Reed National Military Medical Center. The opinions expressed here are those of the authors and do not necessarily reflect the opinion of the United States Department of Defense or the United States Government.	Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Baker MS, 2012, MIL MED, V177, P430, DOI 10.7205/MILMED-D-11-00312; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bickel WK, 2012, PHARMACOL THERAPEUT, V134, P287, DOI 10.1016/j.pharmthera.2012.02.004; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bowen A, 1999, BRAIN INJURY, V13, P547; Bray RM, 2013, SUBST USE MISUSE, V48, P799, DOI 10.3109/10826084.2013.796990; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carlson SR, 2012, ADDICT BEHAV, V37, P556, DOI 10.1016/j.addbeh.2011.12.007; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Chan RCK, 2005, BRAIN INJURY, V19, P1117, DOI 10.1080/026990500150088; Cicerone KD, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P246; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan J.D., 2003, TECHNICAL REPORT PRO; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, AM J PSYCHIAT, V170, P351, DOI 10.1176/appi.ajp.2012.12121602; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Dennhardt AA, 2013, ADDICT BEHAV, V38, P2607, DOI 10.1016/j.addbeh.2013.06.006; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gallaway MS, 2012, AGGRESSIVE BEHAV, V38, P357, DOI 10.1002/ab.21436; GEORGE WH, 1995, J STUD ALCOHOL, V56, P177, DOI 10.15288/jsa.1995.56.177; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Harris JA, 1997, BEHAV RES THER, V35, P1047, DOI 10.1016/S0005-7967(97)00064-8; Helmick K, 2012, MIL MED, V177, P86, DOI 10.7205/MILMED-D-12-00174; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; JURKOVICH G, 1995, J TRAUMA, V39, P625, DOI 10.1097/00005373-199510000-00001; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lanska DJ, 2009, ANN NEUROL, V66, P444, DOI 10.1002/ana.21822; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3; Nicolai J, 2012, DRUG ALCOHOL DEPEN, V126, P347, DOI 10.1016/j.drugalcdep.2012.05.040; Ouimette P, 2003, J CONSULT CLIN PSYCH, V71, P410, DOI 10.1037/0022-006X.71.2.410; Pabst A, 2010, J STUD ALCOHOL DRUGS, V71, P46, DOI 10.15288/jsad.2010.71.46; Parks CL, 2013, ANESTHESIOLOGY, V118, P1019, DOI 10.1097/ALN.0b013e318286d0e2; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Viera AJ, 2008, SOUTH MED J, V101, P730, DOI 10.1097/SMJ.0b013e31817a7ee4; Wallace CA, 2000, BRAIN INJURY, V14, P549; Weathers F.W., 1993, P ANN M INT SOC TRAU; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	69	6	6	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					905	914		10.3109/02699052.2015.1005136			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800016	25950266				2022-02-06	
J	Faux, SG; Kohler, F; Mozer, R; Klein, LA; Courtenay, S; D'Amours, SK; Chapman, J; Estell, J				Faux, S. G.; Kohler, F.; Mozer, R.; Klein, L. A.; Courtenay, S.; D'Amours, S. K.; Chapman, J.; Estell, J.			The ROARI project - Road Accident Acute Rehabilitation Initiative: a randomised clinical trial of two targeted early interventions for road-related trauma	CLINICAL REHABILITATION			English	Article						Road crash accident; trauma; rehabilitation; Injury Severity Scoring	POSTTRAUMATIC-STRESS-DISORDER; MUSCULOSKELETAL PAIN QUESTIONNAIRE; MOTOR-VEHICLE CRASHES; LOW-BACK-PAIN; BRAIN-INJURY; CAGE QUESTIONNAIRE; ORTHOPEDIC TRAUMA; PERSISTENT PAIN; GENERAL HEALTH; PRIMARY-CARE	Objectives: To determine the effectiveness of an Early Rehabilitation Intervention (ERI ) versus a Brief Education Intervention (BEI) following road trauma. Primary objective: return to work or usual activities at 12 weeks (for minor/moderate injury) and 24 weeks for major injury. Secondary objectives: Reduction in pain, anxiety, depression, disability and incidence of Post Traumatic Stress Disorder and improved quality of life. Design: A multi-site single-blinded stratified randomized clinical trial (RCT). Methods: 184 patients (92 in each arm) were recruited over 18 months and followed for 12 weeks (minor/moderate injury) and 24 weeks (major injury). Screening questionnaires at 2-4 weeks and follow-up interviews by phone for all outcome measures were undertaken. For those in the ERI group with a positive screen for high risk of persistent symptoms, an early assessment and intervention by a Rehabilitation Physician was offered. Those in the BEI group were sent written information and advised to see their GP. Results: 89.4% of injuries were mild in this cohort. At 12 weeks 73.8% and 69.1% of patients in the ERI and the BEI groups respectively had returned to work or usual activities. There were no significant differences between the two intervention groups with respect to the primary or any secondary outcome measures. Conclusion: This is the first RCT of an ERI following road trauma in Australia. A targeted ERI is as effective as a BEI in assisting those with mild/moderate trauma to return to work or usual activities.	[Faux, S. G.; Kohler, F.; D'Amours, S. K.; Estell, J.] Univ New S Wales, Sydney, NSW 2010, Australia; [Faux, S. G.; Mozer, R.; Courtenay, S.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Kohler, F.; D'Amours, S. K.; Chapman, J.] Liverpool Hosp, Liverpool, NSW, Australia; [Klein, L. A.] Univ Sydney, Sydney, NSW 2006, Australia; [Chapman, J.] Westmead Hosp, Westmead, NSW, Australia		Faux, SG (corresponding author), Univ New S Wales, St Vincents Hosp, Dept Rehabil & Pain Med, 170 Darlinghurst Rd, Sydney, NSW 2010, Australia.	sfaux@stvincents.com.au	Klein, Linda/AAW-3659-2021; Faux, Steven/Y-3409-2019	Klein, Linda/0000-0002-2063-1518; Faux, Steven/0000-0001-8846-216X	Motor Accidents Authority of New South Wales	This study was funded by the Motor Accidents Authority of New South Wales.	Australasian Faculty of Pain Medicine and the Royal Australasian College of Physicians, 2011, STAND PROV INP REH M; Australian Bureau of Statistics (ABS), 2001, NATIONAL HEALTH SURV; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Berry JG, 2008, INJCAT 113, V42; Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866; Brooke KJ, 2014, J REHABIL MED, V46, P335, DOI 10.2340/16501977-1275; Bugg A, 2009, BEHAV RES THER, V47, P6, DOI 10.1016/j.brat.2008.10.006; Centre for Road Safety Transport for NSW Road Traffic Crashes in New South Wales, 2012, STAT STAT YEAR END 3; Clay FJ, 2010, J PAIN, V11, P420, DOI 10.1016/j.jpain.2009.12.002; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Connelly LB, 2006, ACCIDENT ANAL PREV, V38, P1087, DOI 10.1016/j.aap.2006.04.015; Ellul J, 1998, AGE AGEING, V27, P115, DOI 10.1093/ageing/27.2.115; Faux SG, 2009, J AUSTRALAS COLL ROA, V20, P30; Fort E, 2011, J REHABIL MED, V43, P283, DOI 10.2340/16501977-0670; *GRAPHPAD SOFTW, 2012, QUICKCALCS; Groah SL, 2009, PM&R, V1, P941, DOI 10.1016/j.pmrj.2009.06.001; Harris IA, 2008, J ORTHOP TRAUMA, V22, P216, DOI 10.1097/BOT.0b013e31815c11dc; Hockings RL, 2008, SPINE, V33, pE494, DOI 10.1097/BRS.0b013e31817ba3bb; Hours M, 2010, ACCIDENT ANAL PREV, V42, P412, DOI 10.1016/j.aap.2009.09.002; Johnsen LG, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-148; Karjalainen K, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002193; Keefe FJ, 2004, J PAIN, V5, P195, DOI 10.1016/j.jpain.2004.02.576; Khan F, 2012, BRIT J SURG, V99, P88, DOI 10.1002/bjs.7776; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Koren D, 1999, AM J PSYCHIAT, V156, P367; Linton SJ, 2003, CLIN J PAIN, V19, P80, DOI 10.1097/00002508-200303000-00002; LISKOW B, 1995, J STUD ALCOHOL, V56, P277, DOI 10.15288/jsa.1995.56.277; Macintyre PE, 2009, ACUTE PAIN MANAGEMENT, P204, DOI 10.1017/CBO9780511576706.016; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Motor Accident Authority of NSW, 2003, GUID MAN ANX FOLL MO, V1876958, P170; O'Donnell ML, 2012, J TRAUMA STRESS, V25, P125, DOI 10.1002/jts.21677; Ouimette P, 2008, J ANXIETY DISORD, V22, P337, DOI 10.1016/j.janxdis.2007.02.010; Paniak C, 2000, BRAIN INJURY, V14, P219; Pinto-Meza A, 2005, J GEN INTERN MED, V20, P738, DOI 10.1111/j.1525-1497.2005.0144.x; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Read KM, 2004, J TRAUMA, V57, P815, DOI 10.1097/01.TA.0000136289.15303.44; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sullivan MJL, 2006, PHYS THER, V86, P8, DOI 10.1093/ptj/86.1.8; Teasell R, 2012, MANAGING STROKE REHA; Urquhart DM, 2006, ANZ J SURG, V76, P600, DOI 10.1111/j.1445-2197.2006.03785.x; Wand BM, 2004, SPINE, V29, P2350, DOI 10.1097/01.brs.0000143619.34308.b4; Wessely S, 2008, PSYCHIATRY, V71, P287, DOI 10.1521/psyc.2008.71.4.287; Williamson OD, 2009, J ORTHOP TRAUMA, V23, P139, DOI 10.1097/BOT.0b013e3181962e29	47	6	6	0	13	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JUL	2015	29	7					639	652		10.1177/0269215514552083			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CM6KM	WOS:000357797400003	25413170				2022-02-06	
J	Figueroa, XA; Wright, JK				Figueroa, Xavier A.; Wright, James K.			Clinical results in brain injury trials using HBO2 therapy: Another perspective	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						traumatic brain injury; hyperbaric oxygen; cognitive function; TBI; HBO; HBO2	HYPERBARIC-OXYGEN THERAPY; ACUTE ISCHEMIC-STROKE; POSTTRAUMATIC-STRESS-DISORDER; PROGENITOR-CELL MOBILIZATION; HYDROGEN-SULFIDE PROTECTS; FOCAL CEREBRAL-ISCHEMIA; 3RD GASEOUS TRANSMITTER; WHITE-MATTER INJURY; RAT MODEL; MITOCHONDRIAL-FUNCTION	The current debate surrounding the use of hyperbaric oxygen (HBO2) for neurological indications, specifically mild to moderate chronic traumatic brain injury (mTBI) and post-concussion syndrome (PCS), is mired in confusion due to the use of non-validated controls and an unfamiliarity by many practitioners of HBO2 therapy with the experimental literature. In the past 40 years, the use of an air sham (21% oxygen, 1.14-1.5 atmospheres absolute/atm abs) in clinical and animal studies, instead of observational or crossover controls, has led to false acceptance of the null hypothesis (declaring no effect when one is present), due to the biological activity of these "sham" controls. The recent Department of Defense/Veterans Administration (DoD/VA) sponsored trials, previous published reports on the use of HBO2 therapy on stroke and mTBI and preliminary reports from the HOPPS Army trial, have helped to highlight the biological activity of pressurized air, validate the development of a convincing control for future studies and demonstrate the effectiveness of a hyperbaric intervention for mTBI/PCS. Approval of HBO2 for neurological indications, especially for mTBI/PCS, should be granted at the federal, state and certifying body levels as a safe and viable treatment for recovery in the post-acute phase.	[Figueroa, Xavier A.] Brain Hlth & Healing Fdn, Seattle, WA USA; [Wright, James K.] Swedish Med Ctr Edmonds, Wound Healing & Hyperbar, Edmonds, WA USA		Figueroa, XA (corresponding author), Brain Hlth & Healing Fdn, Seattle, WA USA.	bhif.figueroa@gmail.com					ACEVEDO AD, 1993, J CELL PHYSIOL, V157, P603, DOI 10.1002/jcp.1041570321; Acker T, 2004, J EXP BIOL, V207, P3171, DOI 10.1242/Jeb.01075; ANDERSON DC, 1991, STROKE, V22, P1137, DOI 10.1161/01.STR.22.9.1137; Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Atochin DN, 2000, UNDERSEA HYPERBAR M, V27, P185; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; Baumgart K, 2009, CURR OPIN ANESTHESIO, V22, P168, DOI 10.1097/ACO.0b013e328328d22f; Benedetti S, 2004, CLIN BIOCHEM, V37, P312, DOI 10.1016/j.clinbiochem.2003.12.001; Bensing JM, 2010, PATIENT EDUC COUNS, V80, P293, DOI 10.1016/j.pec.2010.05.033; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Blackstone E, 2007, SHOCK, V27, P370, DOI 10.1097/SHK.0b013e31802e27a0; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Brown Richard B., 1995, Comprehensive Therapy, V21, P663; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Buras JA, 2000, AM J PHYSIOL-CELL PH, V278, pC292, DOI 10.1152/ajpcell.2000.278.2.C292; Busija DW, 2014, J VASC RES, V51, P175, DOI 10.1159/000360765; Chandel NS, 2000, J APPL PHYSIOL, V88, P1880, DOI 10.1152/jappl.2000.88.5.1880; Chen CQ, 2007, ACTA PHARMACOL SIN, V28, P1709, DOI 10.1111/j.1745-7254.2007.00629.x; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Cimsit M, 2009, EXPERT REV ANTI-INFE, V7, P1015, DOI [10.1586/eri.09.76, 10.1586/ERI.09.76]; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Dennog C, 1996, MUTAGENESIS, V11, P605, DOI 10.1093/mutage/11.6.605; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Enck P, 2011, PHILOS T R SOC B, V366, P1889, DOI 10.1098/rstb.2010.0384; Eovaldi B, 2010, NEUROPSYCH DIS TREAT, V6, P785, DOI 10.2147/NDT.S16071; Eto K, 2002, J NEUROSCI, V22, P3386; Flock E., 2013, MED REPORTS VETERANS; Freiberger JJ, 2006, BRAIN RES, V1075, P213, DOI 10.1016/j.brainres.2005.12.088; Galea Sandro, 2014, TREATMENT POSTTRAUMA; Game FL, 2012, DIABETES-METAB RES, V28, P119, DOI 10.1002/dmrr.2246; Garcia-Lechuz J, 2009, EXPERT OPIN PHARMACO, V10, P35, DOI [10.1517/14656560802611766 , 10.1517/14656560802611766]; Gesell L.B., 2008, HYPERBARIC OXYGEN TH; Gilles-Gonzalez MA, 2001, IUBMB LIFE, V51, P165, DOI 10.1080/152165401753544232; Godman CA, 2010, CELL STRESS CHAPERON, V15, P431, DOI 10.1007/s12192-009-0159-0; Goldstein LJ, 2006, STEM CELLS, V24, P2309, DOI 10.1634/stemcells.2006-0010; Goldstein LJ, 2013, DERMATOL THER, V26, P207, DOI 10.1111/dth.12053; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Gu GJ, 2008, J APPL PHYSIOL, V104, P1185, DOI 10.1152/japplphysiol.00323.2007; Gu N, 2012, EUR J PAIN, V16, P1094, DOI 10.1002/j.1532-2149.2012.00113.x; Gutsaeva DR, 2006, NEUROSCIENCE, V137, P493, DOI 10.1016/j.neuroscience.2005.07.061; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; HOLBACH KH, 1977, SURG NEUROL, V7, P325; Ito U, 2003, ACTA NEUROCHIR SUPPL, V86, P131; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Kaludercic N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00285; Kemp J, 2012, SUICIDE DATA REPORT; Kendall AC, 2013, WOUND REPAIR REGEN, V21, P860, DOI 10.1111/wrr.12108; Khiabani KT, 2004, PLAST RECONSTR SURG, V114, P1846, DOI 10.1097/01.PRS.0000143580.45631.DD; Kimura H, 2012, ANTIOXID REDOX SIGNA; Klosterhalfen S, 2005, PSYCHOTHER PSYCH MED, V55, P433, DOI 10.1055/s-2005-866915; Kraitsy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097750; KRAMER MR, 1994, ANN INTERN MED, V121, P658, DOI 10.7326/0003-4819-121-9-199411010-00005; Kramer MR, 1998, CHEST, V113, P571, DOI 10.1378/chest.113.3.571; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuffler DP, 2011, P R HEALTH SCI J, V30, P35; Larson JL, 2000, PLAST RECONSTR SURG, V105, P1375, DOI 10.1097/00006534-200004040-00017; Leask A, 2013, ADV WOUND CARE, V2, P160, DOI 10.1089/wound.2012.0365; Lee EAD, 2012, PERSPECT PSYCHIATR C, V48, P108, DOI 10.1111/j.1744-6163.2011.00312.x; Lee YS, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/512978; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; Li FH, 2011, ANESTH ANALG, V113, P626, DOI 10.1213/ANE.0b013e31821f9544; Li Y, 2011, J CARDIOTHOR VASC AN, V25, P908, DOI 10.1053/j.jvca.2011.06.017; Li Z, 2008, BRAIN RES, V1196, P151, DOI 10.1016/j.brainres.2007.12.039; Lim SW, 2013, J SURG RES; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu Zhan, 2006, Chin J Traumatol, V9, P168; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Livnat A, 2010, J NEUROSCI METH, V188, P76, DOI 10.1016/j.jneumeth.2010.01.022; Lou M, 2006, BRAIN RES BULL, V69, P109, DOI 10.1016/j.brainresbull.2005.11.009; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Matchett GA, 2009, NEUROL RES, V31, P114, DOI 10.1179/174313209X389857; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mikami Y, 2011, J BIOL CHEM, V286, P39379, DOI 10.1074/jbc.M111.298208; Miljkovic-Lolic M, 2003, BRAIN RES, V971, P90, DOI 10.1016/S0006-8993(03)02364-3; Miller S., 2013, PRIMARY OUTCOMES RAN, P15; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Morbelli S, 2013, ACTA PHYSL OXF; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mychaskiw G, 2012, UNDERSEA HYPERBAR M, V39, P795; Neubauer R.A., 1990, LANCET, V335, P1217; NEUBAUER RA, 1992, CLIN NUCL MED, V17, P477, DOI 10.1097/00003072-199206000-00010; Neubauer RA, 1998, NEUROL RES, V20, pS33; Neubauer RA, 1990, LANCET, V335, P542; Nierenberg AA, 2010, CNS SPECTRUMS, V15, P348; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; Niklas A, 2004, J NEUROL SCI, V219, P77, DOI 10.1016/j.jns.2003.12.013; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Pun PBL, 2010, MITOCHONDRION, V10, P83, DOI 10.1016/j.mito.2009.12.142; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Quaegebeur A, 2010, CURR TOP MICROBIOL, V345, P71, DOI 10.1007/82_2010_83; Quock LP, 2011, BRAIN RES, V1368, P102, DOI 10.1016/j.brainres.2010.10.079; Rapp PE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00177; Reno J., 2014, INT BUSINESS TIMES; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; ROSSI GF, 1987, ITAL J NEUROL SCI, V8, P465, DOI 10.1007/BF02334603; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rusyniak DE, 2003, STROKE, V34, P571, DOI 10.1161/01.STR.0000050644.48393.D0; Sahni T, 2012, BRIT J NEUROSURG, V26, P202, DOI 10.3109/02688697.2011.626879; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Schmeisser S, 2013, MOL METAB, V2, P92, DOI 10.1016/j.molmet.2013.02.002; Shin SS, 2014, PROG NEUROL SURG, V28, P86, DOI 10.1159/000358767; Shin SS, 2011, NEUROSCI LETT, V496, P168, DOI 10.1016/j.neulet.2011.04.009; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith EG, 2011, J CLIN PSYCHIAT, V72, P622, DOI 10.4088/JCP.09m05608blu; Soejima Y, 2013, EXP NEUROL, V247, P737, DOI 10.1016/j.expneurol.2013.03.019; Soustiel JF, 2008, NEUROPATH APPL NEURO, V34, P412, DOI 10.1111/j.1365-2990.2007.00906.x; Stetler RA, 2013, J CEREBR BLOOD F MET, V33, P22, DOI 10.1038/jcbfm.2012.158; Stetler RA, 2014, PROG NEUROBIOL; Stoller KP, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-17; Straus JL, 1996, PSYCHOSOMATICS, V37, P315, DOI 10.1016/S0033-3182(96)71544-X; Tay AS, 2010, NEUROSCIENCE, V167, P277, DOI 10.1016/j.neuroscience.2010.02.006; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; Thom SR, 2013, J BIOL CHEM, V288, P4810, DOI 10.1074/jbc.M112.426353; Thom SR, 2011, WOUND REPAIR REGEN, V19, P149, DOI 10.1111/j.1524-475X.2010.00660.x; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tobinick E, 2010, EXPERT REV NEUROTHER, V10, P985, DOI 10.1586/ERN.10.52; TOKUNAGA O, 1987, IN VITRO CELL DEV B, V23, P528, DOI 10.1007/BF02620969; TOKUNAGA O, 1989, ACTA PATHOL JAPON, V39, P356; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Velazquez OC, 2007, J VASC SURG, V45, p39A, DOI 10.1016/j.jvs.2007.02.068; Villa RF, 2013, NEUROCHEM INT, V63, P765, DOI 10.1016/j.neuint.2013.10.004; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wada K, 2000, ACT NEUR S, V76, P285; Wagner F, 2009, CRIT CARE, V13, DOI 10.1186/cc7700; Walker WC, 2013, NEUROREHABIL NEURAL; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasserman S, 2012, SAMJ S AFR MED J, V102, P541, DOI 10.7196/SAMJ.5403; Waypa GB, 2002, CIRC RES, V91, P719, DOI 10.1161/01.RES.0000036751.04896.F1; Wilkinson PR, 1997, QUAL HEALTH CARE, V6, P125, DOI 10.1136/qshc.6.3.125; Wilson HD, 2007, J PAIN, V8, P924, DOI 10.1016/j.jpain.2007.06.005; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Wolin MS, 2005, AM J PHYSIOL-LUNG C, V289, pL159, DOI 10.1152/ajplung.00060.2005; Wright JK, 2009, UNDERSEA HYPERBAR M, V36, P391; Yogaratnam JZ, 2008, J SURG RES, V149, P155, DOI 10.1016/j.jss.2007.09.003; Yogaratnam JZ, 2011, UNDERSEA HYPERBAR M, V38, P175; Yogaratnam JZ, 2010, CARDIOVASC REVASCULA, V11, P8, DOI 10.1016/j.carrev.2009.03.004; Yong QC, 2010, NEUROCHEM INT, V56, P508, DOI 10.1016/j.neuint.2009.12.011; Zeng Y, 2012, BRAIN RES, V1452, P140, DOI 10.1016/j.brainres.2012.02.063; Zhang K, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00005; Zhang YM, 2014, NEUROCHEM RES, V39, P950, DOI 10.1007/s11064-014-1292-4; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687; Zoroya G., 2013, US TODAY	162	6	7	0	8	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	JUL-AUG	2015	42	4					333	351					19	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	DB5RM	WOS:000368571300005	26403018				2022-02-06	
J	Gill, JM; Lee, H; Baxter, T; Reddy, SY; Barr, T; Kim, HS; Wang, D; Mysliwiec, V				Gill, Jessica M.; Lee, Hyunhwa; Baxter, Tristin; Reddy, Swarnalatha Y.; Barr, Taura; Kim, Hyung-suk; Wang, Dan; Mysliwiec, Vincent			A Diagnosis of Insomnia Is Associated With Differential Expression of Sleep-Regulating Genes in Military Personnel	BIOLOGICAL RESEARCH FOR NURSING			English	Article						insomnia; military; gene expression; urotensin	SUDDEN UNEXPLAINED DEATH; TRAUMATIC BRAIN-INJURY; EYE-MOVEMENT SLEEP; NARCOLEPSY; DISORDER; DURATION; HYPERTENSION; DEPRESSION; DROSOPHILA; SOLDIERS	Sleep disturbance is a common and disturbing symptom in military personnel, with many individuals progressing to the development of insomnia, which is characterized by increased arousals, wakefulness after sleep onset, and distorted sleep architecture. The molecular mechanisms underlying insomnia remain elusive, limiting future therapeutic development to address this critical issue. We examined whole gene expression profiles associated with insomnia. We compared subjects with insomnia (n = 25) to controls (n = 13) without insomnia using microarray gene expression profiles obtained from peripheral samples of whole blood obtained from military personnel. Compared to controls, participants with insomnia had differential expression of 44 transcripts from 43 identified genes. Among the identified genes, urotensin 2 was downregulated by more than 6 times in insomnia participants, and the fold-change remained significant after controlling for depression, posttraumatic stress disorder, and medication use. Urotensin 2 is involved in regulation of orexin A and B activity and rapid eye movement during sleep. These findings suggest that differential expression of these sleep-regulating genes contributes to symptoms of insomnia and, specifically, that switching between rapid eye movement and nonrapid eye movement sleep stages underlies insomnia symptoms. Future work to identify therapeutic agents that are able to regulate these pathways may provide novel treatments for insomnia.	[Gill, Jessica M.; Kim, Hyung-suk; Wang, Dan] NINR, NIH, Bethesda, MD 20892 USA; [Lee, Hyunhwa] Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA; [Baxter, Tristin; Mysliwiec, Vincent] Madigan Army Med Ctr, Tacoma, WA 98431 USA; [Reddy, Swarnalatha Y.] NINR, Bethesda, MD 20892 USA; [Barr, Taura] W Virginia Univ, Morgantown, WV 26506 USA		Gill, JM (corresponding author), NINR, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.	gillj@mail.nih.gov	Gill, Gill M/Q-2020-2017; Reddy, Swarna/G-5349-2013	Lee, Hyunhwa/0000-0002-5625-3141	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000027, ZIANR000015] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded, in part, by the Center for Neuroscience and Regenerative Medicine (grant #60855) and by the by the intramural research program of the National Institute of Nursing Research. Additionally, Taura Barr is a 2012 Robert Wood Johnson Foundation Nurse Faculty Scholar.	*AM AC SLEEP MED, 2001, INT CLASS SLEEP DIS; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; Cavaliere S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023898; Chadha PS, 2012, HYPERTENSION, V59, P877, DOI 10.1161/HYPERTENSIONAHA.111.187427; Fernandez-Mendoza J, 2012, HYPERTENSION, V60, P929, DOI 10.1161/HYPERTENSIONAHA.112.193268; Fitzpatrick K, 2012, SLEEP, V35, P949, DOI 10.5665/sleep.1958; Furutani N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062391; Grandner M. A., 2013, J NATURE SCI SLEEP, V5, P93, DOI [10.2147/nss.s31063, DOI 10.2147/NSS.S31063]; Han F, 2012, SLEEP MED, V13, P269, DOI 10.1016/j.sleep.2011.06.020; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huitron-Resendiz S, 2005, J NEUROSCI, V25, P5465, DOI 10.1523/JNEUROSCI.4501-04.2005; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Miller NL, 2010, SLEEP, V33, P1623, DOI 10.1093/sleep/33.12.1623; Minkel J, 2013, SLEEP MED CLIN, V8, P333, DOI 10.1016/j.jsmc.2013.06.002; Mitchell MD, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-40; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Miyagawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053707; Miyagawa T, 2011, SLEEP, V34, P349, DOI 10.1093/sleep/34.3.349; Mysliwiec V, 2014, J CLIN SLEEP MED, V10, P1143, DOI 10.5664/jcsm.4120; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Ono T, 2008, NEUROSCI LETT, V440, P275, DOI 10.1016/j.neulet.2008.05.096; Pfeffer M, 2012, NEUROBIOL AGING, V33, P393, DOI 10.1016/j.neurobiolaging.2010.02.019; Pfeiffenberger C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003003; Porkka-Heiskanen T, 2013, ACTA PHYSIOL, V208, P311, DOI 10.1111/apha.12134; Ramaligam V, 2013, SLEEP MED, V14, P707, DOI 10.1016/j.sleep.2013.03.017; Ribeiro JD, 2012, J AFFECT DISORDERS, V136, P743, DOI 10.1016/j.jad.2011.09.049; Saper Clifford B, 2013, Continuum (Minneap Minn), V19, P19, DOI 10.1212/01.CON.0000427215.07715.73; Saus E, 2010, HUM MOL GENET, V19, P4017, DOI 10.1093/hmg/ddq316; Seugnet L, 2009, J NEUROSCI, V29, P7148, DOI 10.1523/JNEUROSCI.5629-08.2009; Shahly V, 2012, ARCH GEN PSYCHIAT, V69, P1054, DOI 10.1001/archgenpsychiatry.2011.2188; Sims RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053814; Stavropoulos N, 2011, NEURON, V72, P964, DOI 10.1016/j.neuron.2011.12.003; Stenfors CUD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060637; Tester DJ, 2007, J AM COLL CARDIOL, V49, P240, DOI 10.1016/j.jacc.2006.10.010; Tester DJ, 2012, MAYO CLIN PROC, V87, P524, DOI 10.1016/j.mayocp.2012.02.017; Tian C, 2013, MOL NEUROBIOL, V48, P36, DOI 10.1007/s12035-013-8426-6; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Tylee DS, 2013, AM J MED GENET B, V162, P595, DOI 10.1002/ajmg.b.32150; Vgontzas AN, 2013, SLEEP MED REV, V17, P241, DOI 10.1016/j.smrv.2012.09.005; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x	43	6	6	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	JUL	2015	17	4			SI		384	392		10.1177/1099800415575343			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED)	Nursing	CK7TU	WOS:000356437200005	25767060				2022-02-06	
J	Kelley, AM; Ranes, BM; Estrada, A; Grandizio, CM				Kelley, Amanda M.; Ranes, Bethany M.; Estrada, Art; Grandizio, Catherine M.			Evaluation of the Military Functional Assessment Program: Preliminary Assessment of the Construct Validity Using an Archived Database of Clinical Data	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY	Background: Several important factors must be considered when deciding to return a soldier to duty after a traumatic brain injury (TBI). Premature return increases risk for not only second-impact syndrome during the acute phase but also permanent changes from repetitive concussions. Thus, there is a critical need for return-to-duty (RTD) assessment criteria that encompass the spectrum of injury and disease experienced by US soldiers, particularly TBI. Objectives: To provide evidence-based standards to eventually serve as criteria for operational competence and performance of a soldier after injury. Specifically, the relationships between clinical assessments and novel military-specific tasks were evaluated. Method: Exploratory analyses (including nonparametric tests and Spearman rank correlations) of an archived database. Participants: A total of 79 patients with TBI who participated in an RTD assessment program at a US Army rehabilitation and recovery center. Main Measures: Military Functional Assessment Program (to determine a soldier's operational competence and performance after TBI) tasks; Dizziness Handicap Inventory; Dynamic Visual Acuity (vestibular function); Sensory Organization Test (postural control); Repeatable Battery for the Assessment of Neuropsychological Status (neuropsychological screening test); Beck Depression Inventory-II; Beck Anxiety Inventory; Comprehensive Trail Making Test (visual search and sequencing); posttraumatic stress disorder checklist military version; Alcohol Use Disorders Identification Test; Epworth Sleepiness Scale; Patient Health Questionnaire; and Military Acute Concussion Evaluation. Results: Selected military operational assessment tasks correlated significantly with clinical measures of vestibular function, psychological well-being, and cognitive function. Differences on occupational therapy assessments, a concussion screening tool, and a self-report health questionnaire were seen between those who passed and those who failed the RTD assessment. Specifically, those who passed the RTD assessment scored more favorably on these clinical assessments. Conclusions: This study demonstrated convergent validity between Military Functional Assessment Program tasks and clinical assessment scores. The Military Functional Assessment Program shows promise for augmenting decision making related to RTD and soldier skills. Additional research is needed to determine the effectiveness of this program in predicting RTD success.	[Kelley, Amanda M.; Estrada, Art; Grandizio, Catherine M.] US Army Aeromed Res Lab, Warfighter Hlth Div, Ft Rucker, AL USA; [Ranes, Bethany M.] Oak Ridge Inst, Sci & Educ, Oak Ridge, TN USA; [Kelley, Amanda M.] Natl Highway Traff Safety Adm US, Dept Transportat, Washington, DC 20590 USA; [Grandizio, Catherine M.] Embry Riddle Aeronaut Univ, Daytona Beach, FL USA		Kelley, AM (corresponding author), Natl Highway Traff Safety Adm US, Dept Transportat, 1200 New Jersey Ave SE, Washington, DC 20590 USA.	amanda.kelley@dot.gov			US Army Medical Research and Materiel Command's (USAMRMC's) Military Operational Medicine Research Program; US Department of EnergyUnited States Department of Energy (DOE); USAMRMCU.S. Army Medical Research & Materiel Command (USAMRMC)	This study was funded by the US Army Medical Research and Materiel Command's (USAMRMC's) Military Operational Medicine Research Program. This research was supported in part by an appointment to the Postgraduate Research Participation Program at the US Army Aeromedical Research Laboratory administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and USAMRMC.	Babor T.F., 2001, AUDIT THE ALCOHOL US; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beck AT, 1993, BECK ANXIETY INVENTO; Blacker D, 2009, KAPLAN SADOCKS COMPR, P1042; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Department of the Army, 2012, SOLD MAN COMM TASKS, V1; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Fetzner S, 2004, ARCH CLIN NEUROPSYCH, V19, P918; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Goebel JA, 2009, BALLENGERS OTORHINOL, V17th, P131; Helmick K, 2012, FORT CAMPBELL MAKES; Iverson GL, 2006, BRAIN INJURY MED PRI, P373; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lachapelle J, 2005, INVEST OPHTH VIS SCI, V46, pe3603; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McKay C, 2008, INT J CLIN NEUROPSYC, V22, P1; Nicholson K, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P335, DOI 10.1007/0-387-25610-5_18; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Zeitzer MB, 2008, AAOHN J, V56, P347, DOI 10.3928/08910162-20080801-03	23	6	6	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2015	30	4					E11	E20		10.1097/HTR.0000000000000060			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CM8JB	WOS:000357944800002	24922040				2022-02-06	
J	Lavon, O; Eisenkraft, A; Blanca, M; Raveh, L; Ramaty, E; Krivoy, A; Atsmon, J; Grauer, E; Brandeis, R				Lavon, Ophir; Eisenkraft, Arik; Blanca, Merav; Raveh, Lily; Ramaty, Erez; Krivoy, Amir; Atsmon, Jacob; Grauer, Ettie; Brandeis, Rachel			Is rivastigmine safe as pretreatment against nerve agents poisoning? A pharmacological, physiological and cognitive assessment in healthy young adult volunteers	NEUROTOXICOLOGY			English	Article						Rivastigmine; Cholinesterase inhibitors; Psychometric evaluation; Nerve agents; Organophosphates	ANTICHOLINESTERASE DFP TOXICITY; CLOSED-HEAD INJURY; SDZ ENA 713; ALZHEIMERS-DISEASE; ACETYLCHOLINESTERASE INHIBITOR; CHOLINESTERASE INHIBITOR; TRANSDERMAL SCOPOLAMINE; PARKINSONS-DISEASE; LEWY BODIES; SARIN VAPOR	Rivastigmine, a reversible cholinesterase inhibitor, approved as a remedy in Alzheimer's disease, was suggested as pretreatment against nerve agents poisoning. We evaluated the pharmacokinetic, pharmacodynamic, physiologic, cognitive and emotional effects of repeated rivastigmine in young healthy male adults, in a double blind, placebo controlled crossover trial. Three groups completed 3 treatment periods: 0, 1.5 and 3 mg twice a day, for a total of 5 intakes. Parameters monitored were: vital signs, ECG, laboratory tests, sialometry, visual accommodation, inspiratory peak flow, and cognitive function tests. Adverse reactions were mild. Peak blood levels and peak cholinesterase inhibition increased with repeated intakes, and high variability and non-linear pharmacokinetics were demonstrated. In addition, two cognitive functions were affected (perceptual speed and dynamic tracking). The complicated pharmacological profile and the high inter-personal variability limit the potential use of rivastigmine as pretreatment for war fighters and first responders. (C) 2015 Elsevier Inc. All rights reserved.	[Lavon, Ophir; Eisenkraft, Arik; Ramaty, Erez; Krivoy, Amir] Israel Def Forces, Med Corps, Ramat Gan, Israel; [Lavon, Ophir] Carmel Hosp, Clin Pharmacol & Toxicol Unit, IL-34642 Haifa, Israel; [Lavon, Ophir] Technion Israel Inst Technol, Rappaport Family Fac Med, Haifa, Israel; [Eisenkraft, Arik] Israel Minist Def, Tel Aviv, Israel; [Eisenkraft, Arik] Hebrew Univ Jerusalem, Inst Res Mil Med, Fac Med, Jerusalem, Israel; [Blanca, Merav; Raveh, Lily; Grauer, Ettie; Brandeis, Rachel] Israel Inst Biol Res, IL-70450 Ness Ziona, Israel; [Krivoy, Amir] Geha Mental Hlth Ctr, Petah Tiqwa, Israel; [Atsmon, Jacob] Tel Aviv Med Ctr & Sch Med, Clin Res Ctr, Tel Aviv, Israel		Lavon, O (corresponding author), Carmel Hosp, Clin Pharmacol & Toxicol Unit, 7 Michal St, IL-34642 Haifa, Israel.	ophir.lavon@clalit.org.il			Israel Ministry of Defense	This study was funded by the Israel Ministry of Defense. The authors wish to thank the expert technical support of Shlomi Baraness, Inbal Egoz, and Miryam Magen.	Albuquerquet EX, 2006, P NATL ACAD SCI USA, V103, P13220, DOI 10.1073/pnas.0605370103; Alexandrova EA, 2014, NEUROTOXICOLOGY, V44, P270, DOI 10.1016/j.neuro.2014.07.005; Allon N, 2011, TOXICOL APPL PHARM, V253, P31, DOI 10.1016/j.taap.2011.03.007; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Corey-Bloom J, 1998, INT J GERIATR PSYCHO, V1, P55; Cummings JL, 2000, LANCET, V356, P2024, DOI 10.1016/S0140-6736(00)03393-6; Cutler NR, 1998, ACTA NEUROL SCAND, V97, P244; Darreh-Shori T, 2002, NEUROLOGY, V59, P563, DOI 10.1212/WNL.59.4.563; Emre M, 2004, NEW ENGL J MED, V351, P2509, DOI 10.1056/NEJMoa041470; ENZ A, 1991, ANN NY ACAD SCI, V640, P272; Finkel SI, 2004, CLIN THER, V26, P980, DOI 10.1016/S0149-2918(04)90172-5; Giladi N, 2003, ACTA NEUROL SCAND, V108, P368, DOI 10.1034/j.1600-0404.2003.00211.x; Grauer E, 2008, TOXICOL APPL PHARM, V227, P265, DOI 10.1016/j.taap.2007.11.006; Gron G, 2005, PSYCHOPHARMACOLOGY, V182, P170, DOI 10.1007/s00213-005-0043-2; GRUNWALD J, 1994, LIFE SCI, V54, P991, DOI 10.1016/0024-3205(94)00501-X; HARRIS LW, 1991, DRUG CHEM TOXICOL, V14, P265, DOI 10.3109/01480549109002189; Haug KH, 2007, TOXICOL APPL PHARM, V220, P156, DOI 10.1016/j.taap.2006.12.023; HOLSBOERTRACHSLER E, 1993, NEUROPSYCHOPHARMACOL, V8, P87, DOI 10.1038/npp.1993.10; Hugo FN, 2008, GERODONTOLOGY, V25, P18, DOI 10.1111/j.1741-2358.2007.00188.x; Janowsky DS, 2005, PHARMACOL BIOCHEM BE, V81, P917, DOI 10.1016/j.pbb.2005.06.017; Janowsky DS, 2004, PHARMACOL BIOCHEM BE, V77, P337, DOI 10.1016/j.pbb.2003.11.012; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; Kaasinen V, 2002, J CLIN PSYCHOPHARM, V22, P615, DOI 10.1097/00004714-200212000-00012; Kennedy JS, 1999, J CLIN PSYCHOPHARM, V19, P513, DOI 10.1097/00004714-199912000-00005; Khosravani N, 2009, EUR J ORAL SCI, V117, P209, DOI 10.1111/j.1600-0722.2009.00632.x; Lallement G, 2001, DRUG CHEM TOXICOL, V24, P165, DOI 10.1081/DCT-100102608; Levy A, 1996, P MED DEF BIOSC REV, P505; Marino MT, 1998, J CLIN PHARMACOL, V38, P227, DOI 10.1002/j.1552-4604.1998.tb04420.x; Markel G, 2008, ISR MED ASSOC J, V10, P761; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; McNair D., 1981, MANUAL PROFILE MOOD; Moretti R, 2001, EUR J NEUROL, V8, P361, DOI 10.1046/j.1468-1331.2001.00224.x; MUNRO NB, 1994, ENVIRON HEALTH PERSP, V102, P18, DOI 10.1289/ehp.9410218; PARROTT AC, 1987, NEUROPSYCHOBIOLOGY, V17, P53, DOI 10.1159/000118371; PARROTT AC, 1989, AVIAT SPACE ENVIR MD, V60, P1; Philippens LHCHM, 2000, PHARMACOL BIOCHEM BE, V65, P175, DOI 10.1016/S0091-3057(99)00171-9; Ribeiz SRI, 2010, CNS DRUGS, V24, P303, DOI 10.2165/11530260-000000000-00000; Rosler M, 1999, BMJ-BRIT MED J, V318, P633, DOI 10.1136/bmj.318.7184.633; Rosler M, 1998, BEHAV NEUROL, V11, P211; Rosman Y, 2014, ANN INTERN MED, V160, P644, DOI 10.7326/M13-2799; Schredl M, 2000, EXP GERONTOL, V35, P243, DOI 10.1016/S0531-5565(00)00077-2; Seng KY, 2009, J PHARM PHARMACOL, V61, P1187, DOI 10.1211/jpp/61.09.0008; SEPPALA T, 1983, MIL MED, V148, P673; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Sofuoglu M, 2010, ADDICTION, V105, P38, DOI 10.1111/j.1360-0443.2009.02791.x; Sramek JJ, 1996, LIFE SCI, V58, P1201, DOI 10.1016/0024-3205(96)00081-1; TANAKA K, 1995, NEUROCHEM RES, V20, P663, DOI 10.1007/BF01705533; Theunissen EL, 2015, PSYCHOPHARMACOLOGY, V232, P343, DOI 10.1007/s00213-014-3667-2; Tourinsky, 2008, TXB MILITARY MED MED, P155; TSUJIMOTO S, 1993, ACTA NEUROCHIR, V124, P127, DOI 10.1007/BF01401134; Weinstock M, 1999, CNS DRUGS, V12, P307, DOI 10.2165/00023210-199912040-00005; WESNES K, 1987, MED SCI RES-BIOCHEM, V15, P1063; Wesnes KA, 2002, DEMENT GERIATR COGN, V13, P183, DOI 10.1159/000048651	54	6	6	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	JUL	2015	49						36	44		10.1016/j.neuro.2015.05.003			9	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	CO5DQ	WOS:000359180200005	26001567	Bronze			2022-02-06	
J	Pastore, V; Colombo, K; Maestroni, D; Galbiati, S; Villa, F; Recla, M; Locatelli, F; Strazzer, S				Pastore, Valentina; Colombo, Katia; Maestroni, Deborah; Galbiati, Susanna; Villa, Federica; Recla, Monica; Locatelli, Federica; Strazzer, Sandra			Psychological problems, self-esteem and body dissatisfaction in a sample of adolescents with brain lesions: A comparison with a control group	BRAIN INJURY			English	Article						Adolescent; brain injuries; body image disorders; psychological adjustment; self-esteem	QUALITY-OF-LIFE; PROBLEM-SOLVING SKILLS; ADJUSTMENT PROBLEMS; SEVERE TBI; INJURY; CHILDREN; DISORDERS; CHILDHOOD; SEQUELAE; OUTCOMES	Primary objectives: This study aims to describe psychological problems, self-esteem difficulties and body dissatisfaction in a sample of adolescents with acquired brain lesions and to compare them with an age- and gender-matched control group. Research design: In an experimental design, the psychological profile of 26 adolescents with brain lesions of traumatic or vascular aetiology, aged 12-18 years, was compared with that of 18 typically-developing subjects. Moreover, within the clinical group, patients with TBI were compared with patients with vascular lesions. Methods and procedures: The psychological and adaptive profile of the adolescents was assessed by a specific protocol, including CBCL, VABS, RSES, EDI-2 and BES. Main outcome and results: Adolescents with brain lesions showed more marked psychological problems than their healthy peers; they also presented with a greater impairment of adaptive skills and a lower self-esteem. No significant differences were found between patients with traumatic lesions and patients with vascular lesions. Conclusions: Adolescents with acquired brain lesions were at higher risk to develop psychological and behavioural difficulties. Furthermore, in the clinical sample, some variables such as the long hospitalization and isolation from family and peers were associated to a greater psychological burden than the aetiology of the brain damage.	[Pastore, Valentina; Colombo, Katia; Maestroni, Deborah; Galbiati, Susanna; Villa, Federica; Recla, Monica; Locatelli, Federica; Strazzer, Sandra] IRCCS Eugenio Medea, Assoc La Nostra Famiglia, I-23842 Bosisio Parini, Lecco, Italy		Pastore, V (corresponding author), IRCCS Eugenio Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini, Lecco, Italy.	valentina.pastore@bp.lnf.it	Colombo, Katia/ABE-5754-2020; Strazzer, Sandra/AAH-5712-2019; FEDERICA, LOCATELLI/AAA-5601-2020; Recla, Monica/ABG-1905-2020; Pastore, Valentina/AAH-6831-2019; Galbiati, Susanna/AAH-6883-2019	Colombo, Katia/0000-0002-5390-106X; Strazzer, Sandra/0000-0001-8414-6565; FEDERICA, LOCATELLI/0000-0002-8243-5483; Recla, Monica/0000-0002-3001-8872; Pastore, Valentina/0000-0002-3170-3070; Galbiati, Susanna/0000-0001-7209-4251			Achenbach T. M., 1983, CHILD BEHAV CHECKLIS; Almeida S, 2012, J PAEDIATR CHILD H, V48, pE165, DOI 10.1111/j.1440-1754.2012.02576.x; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; [Anonymous], 2014, J CHILD NEUROL, V34, P45; Barbero P, 2003, REV NEUROLOGIA, V36, P143; Bardoni A, 2013, BRAIN INJURY, V27, P1395, DOI 10.3109/02699052.2013.823652; Baumeister R. F, 1993, SELF ESTEEM PUZZLE L; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Daseking M, 2008, FORTSCHR NEUROL PSYC, V76, P662, DOI 10.1055/s-2008-1038262; FRANZOI SL, 1984, J PERS ASSESS, V48, P173, DOI 10.1207/s15327752jpa4802_12; FRANZOI SL, 1986, J PERS ASSESS, V50, P24, DOI 10.1207/s15327752jpa5001_4; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Garner D.M., 1984, EATING DISORDER INVE; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; GrayLittle B, 1997, PERS SOC PSYCHOL B, V23, P443, DOI 10.1177/0146167297235001; Green L, 2013, BRAIN INJURY, V27, P872, DOI 10.3109/02699052.2013.775506; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Hawley CA, 2012, NEUROREHABILITATION, V30, P173, DOI 10.3233/NRE-2012-0742; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Larouche Sandie S, 2006, J Pediatr Oncol Nurs, V23, P200, DOI 10.1177/1043454206289756; Long B, 2011, DEV NEUROPSYCHOL, V36, P971, DOI 10.1080/87565641.2011.581537; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McLean SA, 2013, BODY IMAGE, V10, P282, DOI 10.1016/j.bodyim.2013.01.009; Pastore V, 2014, J CHILD NEUROL, V29, P1664, DOI 10.1177/0883073813513329; Pastore V, 2013, BRAIN INJURY, V27, P677, DOI 10.3109/02699052.2013.775482; Pastore V, 2011, DISABIL REHABIL, V33, P675, DOI 10.3109/09638288.2010.506239; Petroski EL, 2012, CIENC SAUDE COLETIVA, V17, P1071, DOI 10.1590/S1413-81232012000400028; Pinquart M, 2013, BODY IMAGE, V10, P141, DOI 10.1016/j.bodyim.2012.10.008; Poggi G, 2009, DISABIL REHABIL, V31, P1066, DOI 10.1080/09638280802509546; Recla M, 2013, BRAIN INJURY, V27, P862, DOI 10.3109/02699052.2013.775499; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Ross KA, 2011, BRAIN INJURY, V25, P1206, DOI 10.3109/02699052.2011.609519; Rumsey Nichola, 2007, Dev Neurorehabil, V10, P113, DOI 10.1080/13638490701217396; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Schneider S, 2013, EUR J PEDIATR, V172, P373, DOI 10.1007/s00431-012-1897-z; Steinlin M, 2013, HAND CLINIC, V112, P1053, DOI 10.1016/B978-0-444-52910-7.00023-4; Stevens C, 1998, J GENET PSYCHOL, V159, P94, DOI 10.1080/00221329809596137; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tomori M, 2000, J ADOLESCENT HEALTH, V26, P361, DOI 10.1016/S1054-139X(98)00042-1; van Tuijl LA, 2014, J BEHAV THER EXP PSY, V45, P113, DOI 10.1016/j.jbtep.2013.09.007; VARNI JW, 1995, J BEHAV MED, V18, P261, DOI 10.1007/BF01857873; Wallander JL, 1998, J CHILD PSYCHOL PSYC, V39, P29, DOI 10.1017/S0021963097001741; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Wingeier K, 2011, CHILD NERV SYST, V27, P923, DOI 10.1007/s00381-010-1357-x; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	58	6	7	1	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					937	945		10.3109/02699052.2015.1008045			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800020	25950267				2022-02-06	
J	Nokkari, A; Mouhieddine, TH; Itani, MM; Abou-Kheir, W; Daoud, G; Zhu, R; Meshref, Y; Soueid, J; Al Hariri, M; Mondello, S; Jaffa, AA; Kobeissy, F				Nokkari, Amaly; Mouhieddine, Tarek H.; Itani, Muhieddine M.; Abou-Kheir, Wassim; Daoud, Georges; Zhu, Rui; Meshref, Yehia; Soueid, Jihane; Al Hariri, Moustafa; Mondello, Stefania; Jaffa, Ayad A.; Kobeissy, Firas			Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; BRADYKININ B-2 RECEPTOR; PC12 CELLS; PROTEOMIC ANALYSIS; INDUCED APOPTOSIS; PHOSPHOLIPASE-D; CALCIUM; BIOMARKERS; BIOLOGY; DEATH	Traumatic Brain Injury (TBI) is the result of a mechanical impact on the brain provoking mild, moderate or severe symptoms. It is acknowledged that TBI leads to apoptotic and necrotic cell death; however, the exact mechanism by which brain trauma leads to neural injury is not fully elucidated. Some studies have highlighted the pivotal role of the Kallikrein-Kinin System (KKS) in brain trauma but the results are still controversial and inconclusive. In this study, we investigated both the expression and the role of Bradykinin 1 and 2 receptors (B1R and B2R), in mediating neuronal injury under chemical neurotoxicity paradigm in PC12 cell lines. The neuronal cell line PC12 was treated with the apoptotic drug Staurosporine (STS) to induce cell death. Intracellular calcium release was evaluated by Fluo 4-AM staining and showed that inhibition of the B2R prevented calcium release following STS treatment. Differential analyses utilizing immunofluorescence, Western blot and Real-time Polymerase Chain Reaction revealed an upregulation of both bradykinin receptors occurring at 3h and 12h post-STS treatment, but with a higher induction of B2R compared to B1R. This implies that STS-mediated apoptosis in PC12 cells is mainly conducted through B2R and partly via B1R. Finally, a neuroproteomics approach was conducted to find relevant proteins associated to STS and KKS in PC12 cells. Neuroproteomics results confirmed the presence of an inflammatory response leading to cell death during apoptosis-mediated STS treatment; however, a "survival" capacity was shown following inhibition of B2R coupled with STS treatment. Our data suggest that B2R is a key player in the inflammatory pathway following STS-mediated apoptosis in PC12 cells and its inhibition may represent a potential therapeutic tool in TBI.	[Nokkari, Amaly; Soueid, Jihane; Al Hariri, Moustafa; Kobeissy, Firas] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon; [Mouhieddine, Tarek H.] Amer Univ Beirut, Fac Med, Med Ctr, Beirut, Lebanon; [Itani, Muhieddine M.] St George Univ London, Fac Med, Nicosia, Cyprus; [Abou-Kheir, Wassim; Daoud, Georges] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol, Beirut, Lebanon; [Zhu, Rui; Meshref, Yehia] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy		Nokkari, A (corresponding author), Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon.	amalyn.breizh@gmail.com; wa12@aub.edu.lb; firasko@gmail.com	Mondello, Stefania/A-1813-2012; Itani, Muhieddine/R-3826-2019; Kobeissy, Firas/E-7042-2017; Abou-Kheir, Wassim/AAP-2587-2020	Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944; Abou-Kheir, Wassim/0000-0001-9719-9324; Daoud, Georges/0000-0001-8043-3882; Mouhieddine, Tarek/0000-0002-1190-5978	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL077192, HL087986]; Medical Practice Grant faculty of Medicine; CNRSCentre National de la Recherche Scientifique (CNRS)European Commission [10267]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL087986, R01HL077192] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health grants HL077192 and HL087986, Medical Practice Grant faculty of Medicine, CNRS Award Number 10267 (AAJ). Grant recipient: Dr. Ayad Jaffa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Bal-Price A, 2006, NITRIC OXIDE-BIOL CH, V14, P238, DOI 10.1016/j.niox.2005.10.002; Ballesteros MA, 2007, INTENS CARE MED, V33, P58, DOI 10.1007/s00134-006-0361-9; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Boutte AM, 2012, ELECTROPHORESIS, V33, P3693, DOI 10.1002/elps.201200196; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Fischer H., 2014, GUIDE US MILITARY CA; Furuno T, 2006, NEUROSCI LETT, V392, P240, DOI 10.1016/j.neulet.2005.09.031; Guevara-Lora I, 2012, NEUROCHEM INT, V61, P72, DOI 10.1016/j.neuint.2012.04.013; Guingab-Cagmat JD, 2012, ELECTROPHORESIS, V33, P3786, DOI 10.1002/elps.201200326; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; Hillmeister P, 2012, ACTA PHYSIOL, V206, P215, DOI 10.1111/apha.12007; HORWITZ J, 1991, J NEUROCHEM, V56, P509, DOI 10.1111/j.1471-4159.1991.tb08179.x; HORWITZ J, 1992, J NEUROCHEM, V59, P1474, DOI 10.1111/j.1471-4159.1992.tb08463.x; Jaffa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044714; Jiang CY, 2014, BIOL TRACE ELEM RES, V158, P249, DOI 10.1007/s12011-014-9918-6; Jiang H, 2014, INT J MOL MED, V33, P1298, DOI 10.3892/ijmm.2014.1684; KLYSZCZNASKO H, 1993, ARCH BIOCHEM BIOPHYS, V306, P383, DOI 10.1006/abbi.1993.1527; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kobeissy FH, 2010, METHODS MOL BIOL, V662, P303, DOI 10.1007/978-1-60761-800-3_15; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar S, 2015, LEUKEMIA LYMPHOMA, V56, P1846, DOI 10.3109/10428194.2014.974042; Liu Bo, 2003, V237, P99; Liu J, 2013, BIOL CHEM, V394, P319, DOI 10.1515/hsz-2012-0316; Malekinejad H, 2014, IRAN J PHARM RES, V13, P191; Marks J, 2003, J BIOL CHEM, V278, P34158, DOI 10.1074/jbc.M304543200; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; NEUHAUS R, 1991, J NEUROSCI, V11, P3984; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Cunha MP, 2014, ASN NEURO, V6, DOI 10.1177/1759091414554945; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Shen S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-11; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tang SCW, 2011, CONTRIB NEPHROL, V170, P145, DOI 10.1159/000325650; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128601	10.1371/journal.pone.0128601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	WOS:000355652200082	26047500	Green Published, gold			2022-02-06	
J	Ahmed, N; Soroush, A; Kuo, YH; Davis, JM				Ahmed, N.; Soroush, A.; Kuo, Y. -H.; Davis, J. M.			Risk associated with traumatic intracranial bleed and outcome in patients following a fall from a standing position	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Fall from a standing position; Trauma; Intracranial bleeding; Risk factors	BRAIN-INJURY; MORTALITY; AGE	A fall from a standing position (FFS) is a low impact injury; however, in certain patient populations it can result in serious, complex injuries associated with significant morbidity and mortality. The purpose of the study was to identify the patient population, risk factors and outcomes of intracranial bleed (ICB) after a fall from a standing position. Data of all patients from the trauma database at State designated Trauma Center were analyzed who FFS. Patient's demography, clinical information was obtained. An ICB seen on computed tomography (CT) scan was considered positive. From January 2001 through December 2008, 163 patients admitted to the trauma center after FFS. Ninety-one out of 163 patients (56 %) had positive CT scan. There was no significant difference between the groups with a positive or negative CT regarding age (P = 0.07), gender (P = 0.58), race (P = 0.15), Glasgow Coma Scale (P = 0.27), aspirin use (P = 0.06), Plavix (P = 0.92), combination of aspirin and Plavix (P = 0.86) or use of Coumadin (P = 0.82). Patients with ICB had significantly higher injury severity score (ISS) than patients without ICB (P < 0.0001). However, the overall mortality between the groups was not significant (P = 0.66). From a multiple logistic regression model, age a parts per thousand yen70 years was the only predictor for the ICB. A high proportion of our patients had positive ICB due to falls from a standing position. No significant differences were seen between the groups in terms of mortality. Age a parts per thousand yen70 years was the only factor for positive ICB. Prognostic study investigating the effect of a patient characteristic on the outcome of the disease, level III.	[Ahmed, N.; Kuo, Y. -H.; Davis, J. M.] Jersey Shore Univ, Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, Neptune, NJ 07754 USA; [Ahmed, N.; Kuo, Y. -H.; Davis, J. M.] Jersey Shore Univ, Med Ctr, Dept Res, Neptune, NJ 07754 USA; [Soroush, A.] Georgetown Univ, Washington, DC 20057 USA		Ahmed, N (corresponding author), Jersey Shore Univ, Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, 1945 State Route 33, Neptune, NJ 07754 USA.	nahmed@meridianhealth.com; ali.soroush.2012@gmail.com; yenkuo@gmail.com; jmdavis@meridianhealth.com	Soroush, Ali/ABG-5994-2021	Soroush, Ali/0000-0001-6900-5596			Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; Ajani UA, 2006, AM J PREV MED, V30, P74, DOI 10.1016/j.amepre.2005.08.042; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Howard JL, 2009, J TRAUMA, V66, P1518, DOI 10.1097/TA.0b013e3181a59728; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MILLER J D, 1989, Neurosurgical Review, V12, P441; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; ROZYCKI GS, 1991, ARCH EMERG MED, V8, P245; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Velmahos GC, 2001, J AM COLL SURGEONS, V192, P147, DOI 10.1016/S1072-7515(00)00790-0	15	6	6	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	JUN	2015	41	3					307	311		10.1007/s00068-014-0432-5			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CJ7OY	WOS:000355687600013	26037978				2022-02-06	
J	Blake, ML; Ott, S; Villanyi, E; Kazhuro, K; Schatz, P				Blake, Margaret Lehman; Ott, Summer; Villanyi, Elizabeth; Kazhuro, Katia; Schatz, Philip			Influence of Language of Administration on ImPACT Performance by Bilingual Spanish-English College Students	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Cross-cultural; Norms/normative studies	INTERFERENCE; TRANSLATION; CHILDREN	Previous research has suggested that there are performance differences on the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) battery related to language of administration, such that scores are higher with the English than the Spanish version of the battery. This study extended those findings in a within-subjects design, evaluating neurocognitive performance of 58 bilingual English-Spanish-speaking individuals who completed ImPACT in both languages. Results revealed a significant multivariate effect of language of test administration, p < .01; partial eta(2) = 0.23, with significantly better English language performance on Verbal Memory and Visual Motor Speed composite scores, but not Visual Memory, Reaction Time, or Total Symptom score. Results are discussed in relation to potential linguistic biases of the ImPACT and functional language dominance that may contribute to the lower scores. These results extend previous findings and suggest a need for separate normative data for Spanish-speaking individuals completing the ImPACT battery if baseline data are not present.	[Blake, Margaret Lehman; Kazhuro, Katia] Univ Houston, Dept Commun Sci & Disorders, Houston, TX 77204 USA; [Ott, Summer] Univ Texas Med Sch Houston, Houston, TX USA; [Villanyi, Elizabeth; Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA		Blake, ML (corresponding author), Univ Houston, Dept Commun Sci & Disorders, Houston, TX 77204 USA.	mtblake@uh.edu					Adesope OO, 2010, REV EDUC RES, V80, P207, DOI 10.3102/0034654310368803; [Anonymous], 2000, IMM POSTC ASS COGN T; Ardila A, 2000, Appl Neuropsychol, V7, P3, DOI 10.1207/S15324826AN0701_2; Costa A, 2000, J EXP PSYCHOL LEARN, V26, P1283, DOI 10.1037//0278-7393.26.5.1283; Ellis N. C., 1992, ADV PSYCHOL COGNITIV, V83, P137; Festman J, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-5; Fortuny LAI, 2005, J CLIN EXP NEUROPSYC, V27, P555, DOI 10.1080/13803390490918282; Gasquoine PG, 2012, ARCH CLIN NEUROPSYCH, V27, P268, DOI 10.1093/arclin/acs004; Gold BT, 2013, J NEUROSCI, V33, P387, DOI 10.1523/JNEUROSCI.3837-12.2013; Jahn DR, 2013, J CLIN EXP NEUROPSYC, V35, P835, DOI 10.1080/13803395.2013.825234; Jones NS, 2014, CLIN J SPORT MED, V24, P284, DOI 10.1097/JSM.0000000000000031; Kisser JE, 2012, ARCH CLIN NEUROPSYCH, V27, P749, DOI 10.1093/arclin/acs082; Kranzler JH, 2010, SCHOOL PSYCHOL REV, V39, P431; KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008; Mindt MR, 2008, NEUROPSYCHOL REV, V18, P255, DOI 10.1007/s11065-008-9069-7; Mungas D, 2005, NEUROPSYCHOLOGY, V19, P466, DOI 10.1037/0894-4105.19.4.466; Naglieri JA, 2004, PSYCHOL ASSESSMENT, V16, P81, DOI 10.1037/1040-3590.16.1.81; Ott S, 2014, ARCH CLIN NEUROPSYCH, V29, P152, DOI 10.1093/arclin/act091; Ryan C, 2013, LANGUAGE USE US 2011; Zgonc E., 2010, NCAA STUDENT ATHLETE	20	6	6	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2015	30	4					302	309		10.1093/arclin/acv021			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CJ6VF	WOS:000355632300002	25870148	Bronze			2022-02-06	
J	Brooks, JC; Shavelle, RM; Strauss, DJ; Hammond, FM; Harrison-Felix, CL				Brooks, Jordan C.; Shavelle, Robert M.; Strauss, David J.; Hammond, Flora M.; Harrison-Felix, Cynthia L.			Long-Term Survival After Traumatic Brain Injury Part I: External Validity of Prognostic Models	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Mortality; Survival; Prognosis; Rehabilitation; Validation studies	SPINAL-CORD-INJURY; LIFE EXPECTANCY; CEREBRAL-PALSY; MORTALITY; REHABILITATION; CHILDREN	Objectives: To develop prognostic models for long-term survival in adults with traumatic brain injury (TBI) and to assess their external validity in 2 independent populations. Design: Survival analysis. Setting: Post-discharge from rehabilitation units and long-term follow-up at regional centers. Participants: Two cohorts of long-term survivors of TBI (N=12,481): the Traumatic Brain Injury Model Systems (TBIMS) cohort comprised 7365 persons who were admitted. to a TBIMS facility and were assessed at >= 1 years postinjury, and the California Department of Developmental Services (CDDS) cohort comprised 5116 persons who sustained a TBI and received long-term services from the CDDS. Interventions: Not applicable. Main Outcome Measures: Survival/mortality. Results: Older age, male sex, and severity of disability in walking and feeding were significant predictors of increased long-term mortality rates (all P<.05, both databases). The CDDS model predicted 623 deaths for persons in the TBIMS cohort, with an observed-to-expected ratio of .94 (95% confidence interval [CI], 0.87-1.02). The TBIMS model predicted a total of 525 deaths for persons in the CDDS cohort, with an observed-to-expected ratio of 1.08 (95% CI, 0.99-1.17). Regression calibration statistics were satisfactory, and both models ranked survival times well from shortest to longest (TBIMS: C index, .78; 95% CI, .76.80; CDDS: C index, .80; 95% CI, .78.82). Conclusions: Long-term survival prognosis in TBI is related to age, sex, and severity of disability. When compared on the basis of these factors, the survival estimates derived from the TBIMS and CDDS cohorts are found to be similar. The close agreement between model predictions and actual mortality rates confirm the external validity of the prognostic models presented herein. (C) 2015 by the American Congress of Rehabilitation Medicine	[Brooks, Jordan C.; Shavelle, Robert M.; Strauss, David J.] Life Expectancy Project, San Francisco, CA 94122 USA; [Hammond, Flora M.] Indiana Univ, Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Harrison-Felix, Cynthia L.] Craig Hosp, Englewood, CO USA; [Harrison-Felix, Cynthia L.] Univ Colorado, Dept Phys Med & Rehabil, Denver, CO 80202 USA		Brooks, JC (corresponding author), Life Expectancy Project, 1439 17th Ave, San Francisco, CA 94122 USA.	Brooks@LifeExpectancy.org			National Institute on Disability and Rehabilitation Research (NIDRR) of the U.S. Department of Education	Supported by the National Institute on Disability and Rehabilitation Research (NIDRR) of the U.S. Department of Education. However, the contents do not necessarily reflect the opinions or views of the Traumatic Brain Injury Model Systems centers, NIDRR, or the U.S. Department of Education.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; [Anonymous], 1992, INT STAT CLASS DIS I; Arias M, 1983, PACIFIC STATE ARCH, P28; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brooks JC, 2012, DEV MED CHILD NEUROL, V54, P383, DOI 10.1111/j.1469-8749.2012.04236.x; California Department of Developmental Services, 1986, CLIENT DEV EV REP CD; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; DeVivo MJ, 1995, SPINAL CORD INJURY; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638; Harrell FE Jr, 2017, REGRESSION MODELING; Harris C, 1983, INTERRATER RELIABILI; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; Harrison-Felix CL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P319; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Middleton JW, 2012, SPINAL CORD, V50, P803, DOI 10.1038/sc.2012.55; Preston DL, 2005, ENCY BIOSTATISTICS, P1; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Shavelle R, 2000, J Insur Med, V32, P163; Shavelle RM, 2001, DEV MED CHILD NEUROL, V43, P574, DOI 10.1017/S0012162201211049; Shavelle RM, 2007, BRAIN INJURY MED PRI, P247; Strauss D, 2004, NEUROREHABILITATION, V19, P257; Strauss D, 1999, J INSUR MED, V31, P104; Strauss D, 2008, DEV MED CHILD NEUROL, V50, P487, DOI 10.1111/j.1469-8749.2008.03000.x; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; UB Foundation Activities Inc, 2002, IRF PAI TRAIN MAN	31	6	6	2	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2015	96	6					994	999		10.1016/j.apmr.2015.02.003			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CK7FM	WOS:000356398200004	26043194				2022-02-06	
J	Dhawan, V; Robeson, W; Bjelke, D; Chaly, T; Graf, K; Hellman, M; Zhuo, LM; Mackay, M; Eidelberg, D				Dhawan, Vijay; Robeson, William; Bjelke, David; Chaly, Thomas; Graf, Kristin; Hellman, Matthew; Zhuo, Limei; Mackay, Meggan; Eidelberg, David			Human Radiation Dosimetry for the N-Methyl-D-Aspartate Receptor Radioligand C-11-CNS5161	JOURNAL OF NUCLEAR MEDICINE			English	Article						C-11-CNS5161; dosimetry; PET	POSITRON-EMISSION-TOMOGRAPHY; NMDA RECEPTORS; PARKINSONS-DISEASE; PET TRACER; BIODISTRIBUTION; LIGAND; BRAIN	C-11-CNS5161 (N-(2-chloro-5-methylthiophenyl)-N'-(3-methylthiophenyl)-N'-C-11-methylguanidine) has been successfully used in PET imaging of N-methyl-D-aspartate (NMDA) receptors. However, no human dosimetry data have been published. We are planning to use this radiotracer for investigating NMDA receptor function in systemic lupus erythematosus, traumatic brain injury, and Parkinson disease. We have therefore undertaken C-11-CNS5161 PET imaging to measure the whole-body distribution of this radionuclide and to estimate radiation dose to various organs. Methods: Dynamic PET studies of the whole body were performed on 5 healthy adults. Regions of interest were drawn over the visualized structures. Resultant time-activity curves were generated and used to determine residence times for dosimetry calculations. S factors were implemented within the OLINDA/EXM software for each structure or organ. Results: For C-11-CNS5161, organ doses ranged from 0.0002 to 0.0393 mGy/MBq (0.0006-0.1455 rad/mCi). The critical organ for radiation burden was the lungs, with a dose of 0.0393 mGy/MBq (0.1455 rad/mCi). Radiation doses to the reproductive and blood-forming organs were 0.0023, 0.0002, and 0.0020 mGy/MBq (0.0086, 0.0006, and 0.0074 rad/mCi) for the ovaries, testes, and red marrow, respectively. The effective dose equivalent was 0.0106 mSv/MBq (0.0392 rem/mCi). Conclusion: The radiation dosimetry for C-11-CNS5161 for a standard single injection of 555 MBq (15 mCi) will result in an effective dose equivalent of 5.9 mSv (0.59 rem) and a lung dose of 21.8 mGy (2.18 rad) in young, healthy subjects.	[Dhawan, Vijay; Bjelke, David; Chaly, Thomas; Graf, Kristin; Hellman, Matthew; Zhuo, Limei; Eidelberg, David] Feinstein Inst Med Res, Ctr Neurosci, Manhasset, NY 11030 USA; [Robeson, William] North Shore LIJ Hlth Syst, Dept Radiol, Manhasset, NY USA; [Mackay, Meggan] Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA		Dhawan, V (corresponding author), Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA.	dhawan@nshs.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1P01AI073693-05]; Lupus Foundation of America [113121]; NIH (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NIH (NIDCD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD); NIH (NIAID)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P01AI073693] Funding Source: NIH RePORTER	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This research was supported by the National Institutes of Health (grant 1P01AI073693-05) and the Lupus Foundation of America (grant 113121). David Eidelberg serves on the scientific advisory board and has received honoraria from the Michael J. Fox Foundation for Parkinson's Research; is listed as coinventor of patents regarding markers for use in screening patients for nervous system dysfunction and a method and apparatus for using the same (without financial gain); and has received research support from the NIH (NINDS, NIDCD, and NIAID) and the Dana Foundation. No other potential conflict of interest relevant to this article was reported.	Ahmed I, 2011, BRAIN, V134, P979, DOI 10.1093/brain/awr028; Benarroch EE, 2011, NEUROLOGY, V76, P1750, DOI 10.1212/WNL.0b013e31821b7cc9; Biegon A, 2007, SYNAPSE, V61, P577, DOI 10.1002/syn.20400; BROOKS DJ, 1992, ANN NEUROL, V31, P184, DOI 10.1002/ana.410310209; Dhawan V, 1996, J NUCL MED, V37, P1850; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Kumlien E, 1999, EPILEPSIA, V40, P30, DOI 10.1111/j.1528-1157.1999.tb01985.x; McGinnity CJ, 2014, J NUCL MED, V55, P423, DOI 10.2967/jnumed.113.130641; Robeson W, 2003, J NUCL MED, V44, P961; Scheinin NM, 2007, J NUCL MED, V48, P128; Schiffer WK, 2005, J CEREB BLOOD FLOW S, V25, pS595; Slifstein M, 2006, J NUCL MED, V47, P313; Stabin MG, 2005, J NUCL MED, V46, P1023; van der Aart J, 2012, NUCL MED BIOL, V39, P305, DOI 10.1016/j.nucmedbio.2011.08.005; Zhao YJ, 2006, J LABELLED COMPD RAD, V49, P163, DOI 10.1002/jlcr.1033	16	6	6	0	1	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	JUN 1	2015	56	6					869	872		10.2967/jnumed.114.152447			4	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	CJ5YO	WOS:000355570300014	25931480	Bronze, Green Accepted			2022-02-06	
J	Rivera-Barrios, AE; Brown, S; Reid, CM; Hassanein, AH; Coimbra, R; Dobke, M; Herrera, FA				Rivera-Barrios, Angel E.; Brown, Satara; Reid, Christopher M.; Hassanein, Aladdin H.; Coimbra, Raul; Dobke, Marek; Herrera, Fernando A., Jr.			Craniofacial Fracture Patterns in All Terrain Vehicle Injuries	ANNALS OF PLASTIC SURGERY			English	Article; Proceedings Paper	57th Annual Meeting of the South6eastern-Society-of-Plastic-and-Reconstructive-Surgeons	JUN 08-12, 2014	Nassau, BAHAMAS	SE Soc Plast & Reconstruct Surg			ACCIDENTS; CHILDREN	Background A multicenter, retrospective study was conducted to determine the frequency and distribution of craniofacial fractures sustained from all terrain vehicle (ATV) accidents. Methods Medical records of all patients presenting to 2 trauma centers with ATV-related craniofacial trauma from 2001 to 2013 were reviewed. Patient notes and radiographic images were analyzed for detailed craniofacial injury data. The identified fractures were classified as: frontal/skullbase, naso-orbital, maxilla/zygoma, and mandible. In addition, patient demographic information, length of stay, airway status, intensive care unit stay, Glasgow coma scale, use of safety equipment, associated traumatic brain injury, and surgical intervention were compiled. Results One hundred fifty-six patients with craniofacial fractures secondary to ATV accidents presented from 2001 to 2013. The incidence of craniofacial fractures found in patients with ATV injuries was 12.2%. Sixty-one patients (39.1%) suffered frontal/skullbase fractures, 98 (62.8%) naso-orbital fractures, 62 (39.7%) maxillary/zygoma fractures, and 35 (22.4%) mandibular fractures. Forty-one patients (26.3%) required surgical intervention to correct their craniofacial injuries. Conclusions The most common craniofacial fractures experienced in ATV injuries are naso-orbital fractures. The correlation of nonuse of safety equipment and associated traumatic brain injuries displays the importance of using helmets when operating ATVs. Future studies can be conducted examining ATV-related upper extremity injuries, among others.	[Rivera-Barrios, Angel E.; Brown, Satara; Reid, Christopher M.; Hassanein, Aladdin H.; Coimbra, Raul; Dobke, Marek; Herrera, Fernando A., Jr.] Med Univ S Carolina, Ralph Johnson VA Med Ctr, Charleston, SC 29425 USA; [Rivera-Barrios, Angel E.; Brown, Satara; Reid, Christopher M.; Hassanein, Aladdin H.; Coimbra, Raul; Dobke, Marek; Herrera, Fernando A., Jr.] Univ Calif San Diego, San Diego, CA 92103 USA		Herrera, FA (corresponding author), Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA.	herreraf@musc.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851; Reid, Christopher/0000-0001-9173-3944; Herrera, Fernando/0000-0001-6957-0413			[Anonymous], 2012, INT J SURG CASE REP, V3, P222; [Anonymous], 2013, 2011 ANN REP ATV REL; Holmes PJ, 2004, J ORAL MAXIL SURG, V62, P697, DOI 10.1016/j.joms.2003.12.011; Jennissen CA, 2014, ANN FAM MED, V12, P310, DOI 10.1370/afm.1663; Kellum E, 2008, J PEDIATR ORTHOPED, V28, P854, DOI 10.1097/BPO.0b013e31818e198f; Kirkpatrick R, 2007, J PEDIATR ORTHOPED, V27, P725, DOI 10.1097/BPO.0b013e3181558856; Rodgers GB, 2001, AM J EPIDEMIOL, V153, P1112, DOI 10.1093/aje/153.11.1112; Testerman George M, 2009, Tenn Med, V102, P45; Wang BS, 2007, OTOLARYNG HEAD NECK, V137, P201, DOI 10.1016/j.otohns.2007.01.033; White LC, 2013, INT J PEDIATR OTORHI, V77, P414, DOI 10.1016/j.ijporl.2012.11.043	10	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	JUN	2015	74			4			S229	S230		10.1097/SAP.0000000000000445			2	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	CQ4IC	WOS:000360567200011	25695451				2022-02-06	
J	Taylor, O; Barrett, RD; McLellan, T; McKinlay, A				Taylor, Olivia; Barrett, Robert D.; McLellan, Tracey; McKinlay, Audrey			Traumatic brain injury and adverse life events: Group differences in young adults injured as children	BRAIN INJURY			English	Article						Adverse life events; brain injury; outcomes; young adults	QUALITY-OF-LIFE; OUTCOMES; CHILDHOOD; ADOLESCENTS; PREDICTORS; DEPRESSION; BEHAVIOR	Objectives: To investigate whether individuals with a history of traumatic brain injury (TBI) experience a greater number of adverse life events (ALE) compared to controls, to identify significant predictors of experiencing ALE and whether the severity of childhood TBI negatively influences adult life outcomes. Design: A total of 167 individuals, injured prior to age 18, 5 or more years post-injury and 18 or more years of age, were recruited in the Canterbury region of New Zealand, with 124 having sustained childhood TBI (62 mild, 62 moderate/severe) and 43 orthopaedic injury controls. Participants were asked about ALE they had experienced and other adult life outcomes. Results: Individuals with a history of TBI experienced more ALE compared to controls. The number of ALE experienced by an individual was associated with more visits to the doctor, lower education level and lower satisfaction with material standard of living. Conclusions: Childhood TBI is associated with an increased number of ALE and adult negative life outcomes. Understanding factors that contribute to negative outcomes following childhood TBI will provide an avenue for rehabilitation and support to reduce any problems in adulthood.	[Taylor, Olivia; Barrett, Robert D.; McLellan, Tracey; McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia		McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P267, DOI 10.1111/j.2044-8260.1989.tb01376.x; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; King JE, 2007, ANN M SW ED RES ASS; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lima-Costa Maria Fernanda, 2003, Rev Panam Salud Publica, V13, P387, DOI 10.1590/S1020-49892003000500007; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Ou SR, 2007, SOC SERV REV, V81, P85, DOI 10.1086/510783; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	30	6	6	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2015	29	6					709	714		10.3109/02699052.2015.1004739			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CL8RL	WOS:000357241700005	25789938				2022-02-06	
J	Hill, BD; Womble, MN; Rohling, ML				Hill, Benjamin David; Womble, Melissa N.; Rohling, Martin L.			Logistic Regression Function for Detection of Suspicious Performance During Baseline Evaluations Using Concussion Vital Signs	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						baseline testing; sports concussion; computerized assessment; performance validity	VERBAL-LEARNING TEST; TEST-SCORES; VALIDITY; INJURY; ISSUES	This study utilized logistic regression to determine whether performance patterns on Concussion Vital Signs (CVS) could differentiate known groups with either genuine or feigned performance. For the embedded measure development group (n=174), clinical patients and undergraduate students categorized as feigning obtained significantly lower scores on the overall test battery mean for the CVS, Shipley-2 composite score, and California Verbal Learning Test-Second Edition subtests than did genuinely performing individuals. The final full model of 3 predictor variables (Verbal Memory immediate hits, Verbal Memory immediate correct passes, and Stroop Test complex reaction time correct) was significant and correctly classified individuals in their known group 83% of the time (sensitivity=.65; specificity=.97) in a mixed sample of young-adult clinical cases and simulators. The CVS logistic regression function was applied to a separate undergraduate college group (n=378) that was asked to perform genuinely and identified 5% as having possibly feigned performance indicating a low false-positive rate. The failure rate was 11% and 16% at baseline cognitive testing in samples of high school and college athletes, respectively. These findings have particular relevance given the increasing use of computerized test batteries for baseline cognitive testing and return-to-play decisions after concussion.	[Hill, Benjamin David; Womble, Melissa N.; Rohling, Martin L.] Univ S Alabama, Dept Psychol, Mobile, AL 36688 USA		Hill, BD (corresponding author), Univ S Alabama, Dept Psychol, UCOM 1000, Mobile, AL 36688 USA.	bdhill@southalabama.edu		Hill, Benjamin/0000-0002-5797-5082			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barth Jeffrey T, 2010, HDB SPORT NEUROPSYCH, P75; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Crouse Karen, 2013, NY TIMES; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Goodyear B., 1998, FORENSIC EXAMINER, V7, P32; Green P, 2001, CLIN NEUROPSYCHOL, V15, P492, DOI 10.1076/clin.15.4.492.1887; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2005, WORD MEMORY TEST WIN; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Schatz P., 2011, HDB SPORT NEUROPSYCH, P173; Schatz P, 2010, ARCH CLIN NEUROPSYCH, V25, P285, DOI 10.1093/arclin/acq022; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shipley WC, 2009, SHIPLEY 2 MANUAL; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	33	6	6	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAY 4	2015	22	3					233	240		10.1080/23279095.2014.910215			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CG6MZ	WOS:000353417000010	25371976				2022-02-06	
J	Chin, KH; Bell, MJ; Wisniewski, SR; Balasubramani, GK; Kochanek, PM; Beers, SR; Brown, SD; Adelson, PD				Chin, Katherine H.; Bell, Michael J.; Wisniewski, Stephen R.; Balasubramani, Goundappa K.; Kochanek, Patrick M.; Beers, Sue R.; Brown, S. Danielle; Adelson, P. David		Pediat Traumatic Brain Injury; Hypothermia Investigators	Effect of Administration of Neuromuscular Blocking Agents in Children With Severe Traumatic Brain Injury on Acute Complication Rates and Outcomes: A Secondary Analysis From a Randomized, Controlled Trial of Therapeutic Hypothermia	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						guidelines; intracranial hypertension; neuromuscular blockade; pediatric neurocritical care; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; HEAD-INJURY; GUIDELINES; BLOCKADE; VALIDITY; SCALE	Objective: To evaluate the association between neuromuscular blocking agents and outcome, intracranial pressure, and medical complications in children with severe traumatic brain injury. Design: A secondary analysis of a randomized, controlled trial of therapeutic hypothermia. Setting: Seventeen hospitals in the United States, Australia, and New Zealand. Patients: Children (< 18 yr) with severe traumatic brain injury. Interventions: None for this secondary analysis. Measurements and Main Results: Children received neuromuscular blocking agent on the majority of days of the study (69.6%), and the modified Pediatric Intensity Level of Therapy scores (modified by removing neuromuscular blocking agent administration from the score) were increased on days when neuromuscular blocking agents were used (9.67 +/- 0.21 vs 5.48 +/- 0.26; p < 0.001). Children were stratified into groups based on exposure to neuromuscular blocking agents (group 1 received neuromuscular blocking agents each study day; group 2 did not). Group 1 had increased number of daily intracranial pressure readings more than 20 mm Hg (4.4 +/- 1.1 vs 2.4 +/- 0.5; p = 0.015) and longer ICU and hospital length of stay (p = 0.003 and 0.07, respectively, Kaplan-Meier). The Glasgow Outcome Score-Extended for Pediatrics at hospital discharge and 3, 6, and 12 months after traumatic brain injury and medical complications observed during the acute hospitalization were similar between groups. Conclusions: Administration of neuromuscular blocking agents was ubiquitous and daily administration of neuromuscular blocking agents was associated with intracranial hypertension but not outcomes-likely indicating that increased injury severity prompted their use. Despite this, neuromuscular blocking agent use was not associated with complications. A different study design-perhaps using randomization or methodologies-of a larger cohort will be required to determine if neuromuscular blocking agent use is helpful after severe traumatic brain injury in children.	[Chin, Katherine H.; Bell, Michael J.; Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Chin, Katherine H.; Bell, Michael J.; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bell, Michael J.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Wisniewski, Stephen R.; Balasubramani, Goundappa K.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Beers, Sue R.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Brown, S. Danielle; Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA		Bell, MJ (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu	Adelson, David/W-2083-2019	Kochanek, Patrick/0000-0002-2627-913X; Wisniewski, Stephen/0000-0002-3877-9860; Goundappa K, Balasubramani/0000-0001-7221-1825	Office of the Dean of the University of Pittsburgh School of Medicine; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS052478]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [HD0499893, HD08003, NS072308, NS081041, NS069247, NS070324, MH56612, MH085722]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS081041, NIH NS070324]; U.S. ArmyUnited States Department of Defense; Laerdal Foundation; Codman; Baxter; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD008003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R10MH056612, R01MH056612, R01MH085722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS052478, R01NS072308, R01NS069247, U01NS081041, U44NS070324] Funding Source: NIH RePORTER	Supported, in part, by the Office of the Dean of the University of Pittsburgh School of Medicine. Pediatric Traumatic Brain Injury Consortium: Hypothermia was funded by the National Institute of Neurological Disorders and Stroke (NINDS) (NS052478).; Dr. Bell was supported by federal grants from the NINDS (HD0499893, HD08003, NS072308, and NS081041). Dr. Wisniewski was supported by federal grants from the NINDS (NS069247 and NS081041). Dr. Kochanek was supported by federal grants from the NINDS (NS070324 and NS081041). Dr. Beers was supported by federal grants from the NINDS (MH56612, MH085722, and NS081041). Dr. Adelson was supported by federal grants from the NINDS (NS081041).; Dr. Bell received support for article research from the National Institutes of Health (NIH). His institution received grant support from the NINDS. Dr. Chin received grant support from the NIH. Her institution received grant support from the NIMH and NIDDK and is employed by the University of Pittsburgh School of Medicine. Dr. Wisniewski received support for article research from the NIH. His institution received grant support from the NIH. Dr. Goundappa is employed by the University of Pittsburgh. His institution received grant support from the NIMH and NIDDK. Dr. Kochanek is a co-provisional patent holder on 3 patents, received royalties (Textbook of Critical Care Medicine and Pediatric Critical Care Medicine journal editor), and received support for article research from the NIH. His institution received grant support from the NIH (NIH NS070324 and NS081041), the U.S. Army, and the Laerdal Foundation (Dr. Kochanek has numerous grants under consideration from these entities, including grants for trainee). Dr. Beers received royalties, consulted for GlaxoSmithKline, is employed by the University of Pittsburgh School of Medicine, and received support for article research from the NIH. Her institution received grant support from the NINDS and the NIH and provided expert testimony for various law firms (paid to University of Pittsburgh Physicians, Inc).; Dr. Brown received support for article research from the NIH. Her institution received grant support, support for travel, and support for participation in review activities from the NINDS. Dr. Adelson consulted for Tramatec, is employed by Phoenix Children's Hospital, provided expert testimony for various medical legal cases, and received royalties from Thieme Publishing. His institution received grant support from the NIH, Codman, and Baxter.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS34; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Empey PE, 2013, CRIT CARE MED, V41, P2379, DOI 10.1097/CCM.0b013e318292316c; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fayon MJ, 1997, AM J RESP CRIT CARE, V155, P162, DOI 10.1164/ajrccm.155.1.9001306; Greenberg SB, 2013, CRIT CARE MED, V41, P1332, DOI 10.1097/CCM.0b013e31828ce07c; Hanson SJ, 2010, J TRAUMA, V68, P52, DOI 10.1097/TA.0b013e3181a74652; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Martin Lynn D., 2001, Pediatr Crit Care Med, V2, P205, DOI 10.1097/00130478-200107000-00003; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Playfor S, 2007, PEDIATR ANESTH, V17, P881, DOI 10.1111/j.1460-9592.2007.02313.x; Schramm WM, 1997, ACTA ANAESTH SCAND, V41, P1319, DOI 10.1111/j.1399-6576.1997.tb04651.x; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Vernon DD, 2000, CRIT CARE MED, V28, P1569, DOI 10.1097/00003246-200005000-00051	21	6	6	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2015	16	4					352	358		10.1097/PCC.0000000000000344			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	CH5QC	WOS:000354089400010	25599147	Green Accepted			2022-02-06	
J	Krauss, H; Maier, D; Buhren, V; Hogel, F				Krauss, H.; Maier, D.; Buehren, V.; Hoegel, F.			Development of heterotopic ossifications, blood markers and outcome after radiation therapy in spinal cord injured patients	SPINAL CORD			English	Article							SERUM ALKALINE-PHOSPHATASE; DEEP-VENOUS THROMBOSIS; BONE-FORMATION; RISK-FACTORS; PARAPLEGIA; PREVENTION; APPEARANCE; HIP	Study Design: Retrospective study. Objectives: This study was implemented to detect risk factors for the developing of heterotopic ossifications (HOs) in spinal cord injury (SCI) patients. Setting: This study was conducted in Murnau, Germany. Methods: All patients from 2008-2012 with acute SCI were routinely examined by ultrasound of the hips every 2 weeks. The sub group of SCI patients suffering of HO of the hips were extracted and the incidence of developing an HO was calculated. Parameters like age, level of injury, ASIA Impairment Scale (AIS), duration time of accident until diagnosis of HO, Brooker stage, localization of HO (magnetic resonance imaging (MRI)) and symptoms like thrombosis, emboli, decrease of range of motion (ROM), dermal symptoms, swelling, increase in D-Dimere level, were evaluated. Also accompanying injuries of the brain, lung and extremities were recorded. Results: From January 2008 until January 2012, 575 patients with an acute and traumatic SCI were treated in our Department. During this period 32 HOs were detected in the muscles surrounding the hip. In 10 cases a single side and in 22 cases both sides were affected. A total of 26 patients were detected showing up a Brooker 0, two patients Brooker 1, and five patients a Brooker stage >2. The adductor muscles showed an edema in 19 cases and the quadriceps muscles were affected in 15 cases. 26% of all SCI patients showed AIS A status, but in patients who developed HO, 64% have had an AIS A status. 19% of patients with a HO were AIS B and 9.5% showed an AIS C and D. Regarding the level of injury the distribution of patients suffering of HO was comparable to the distribution of SCI patients without HO. In mean HO were detected 9 weeks after SCI and no new HO were found after the 22nd (n=1) week of injury. Clinical symptoms such as swelling, pain, redness or decrease in ROM or increase in D-Dimere levels were seen in 24 cases. Accompanying injuries like brain injury and lung contusions were found in 83% of patients developing HO. The incidence of thrombosis was comparable to SCI patients without HO. One patient with no accompanying injuries or clinical symptoms was detected by routinely performed ultrasound. Conclusions: The risk of developing HO in patients with traumatic SCI is 5.5% but increases when accompanying injuries of the brain and lung occur. Patients with a neurological status of AIS A must also be quoted as risk patients. When considering the described risk factors and clinical symptoms, 96% of all HO can be detected.	[Krauss, H.; Maier, D.; Buehren, V.; Hoegel, F.] BG Trauma Ctr, Dept Spinal Cord Injury, Murnau, Germany		Hogel, F (corresponding author), PD PMU Salzburg, Dept Spinal Cord Injury, BG Trauma Ctr Murnau, Prof Kuntscher Str 8, D-82418 Murnau, Germany.	florian.hoegel@bgu-murnau.de					ABRAMSON AS, 1948, J BONE JOINT SURG AM, V30-A, P982, DOI 10.2106/00004623-194830040-00020; Banovac K, 2004, SPINAL CORD, V42, P707, DOI 10.1038/sj.sc.3101628; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; BRAVOPAYNO P, 1992, PARAPLEGIA, V30, P740, DOI 10.1038/sc.1992.142; CATZ A, 1992, PARAPLEGIA, V30, P361, DOI 10.1038/sc.1992.83; CHANTRAINE A, 1995, PARAPLEGIA, V33, P398, DOI 10.1038/sc.1995.89; Citak M, 2012, SPINE, V37, P1953, DOI 10.1097/BRS.0b013e31825ee81b; COLACHIS SC, 1993, PARAPLEGIA, V31, P507, DOI 10.1038/sc.1993.82; DAMANSKI M, 1961, J BONE JOINT SURG BR, V43, P286, DOI 10.1302/0301-620X.43B2.286; FINERMAN GAM, 1981, METAB BONE DIS RELAT, V3, P337, DOI 10.1016/0221-8747(81)90050-3; Freehafer A A, 1966, Med Serv J Can, V22, P471; FURMAN R, 1970, J BONE JOINT SURG AM, VA 52, P1131, DOI 10.2106/00004623-197052060-00005; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; HARDY AG, 1963, J BONE JOINT SURG BR, V45, P76, DOI 10.1302/0301-620X.45B1.76; HASELKORN JK, 1991, ARCH PHYS MED REHAB, V72, P227; HASSARD GH, 1975, ARCH PHYS MED REHAB, V56, P355; HEILBRUN N, 1947, RADIOLOGY, V48, P579, DOI 10.1148/48.6.579; KIM SW, 1992, PARAPLEGIA, V30, P803, DOI 10.1038/sc.1992.155; KIM SW, 1990, PARAPLEGIA, V28, P441, DOI 10.1038/sc.1990.59; KNUDSEN L, 1982, SCAND J RHEUMATOL, V11, P27, DOI 10.3109/03009748209098110; LIBERSON M, 1953, JAMA-J AM MED ASSOC, V152, P1010, DOI 10.1001/jama.1953.03690110024008; LODGE T, 1956, ACTA RADIOL, V46, P435; Lotta S, 2001, SPINAL CORD, V39, P595, DOI 10.1038/sj.sc.3101134; Mahay PR, 1988, CLIN ORTHOP RELAT R, V237, P236; Maier D, 2005, ORTHOPADE, V34, P120, DOI 10.1007/s00132-004-0754-9; PERKASH A, 1993, PARAPLEGIA, V31, P653, DOI 10.1038/sc.1993.105; SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120; Silver J R, 1969, Paraplegia, V7, P220; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; STOVER SL, 1975, ARCH PHYS MED REHAB, V56, P199; Taly AB, 1999, SPINAL CORD, V37, P47, DOI 10.1038/sj.sc.3100751; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; VENIER L H, 1971, Archives of Physical Medicine and Rehabilitation, V52, P475; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215, DOI 10.1302/0301-620X.74B2.1544955	36	6	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	MAY	2015	53	5					345	348		10.1038/sc.2014.186			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	CH6HU	WOS:000354138000004	25420497	Bronze			2022-02-06	
J	Manzanares, W; Aramendi, I; Langlois, PL; Biestro, A				Manzanares, W.; Aramendi, I.; Langlois, P. L.; Biestro, A.			Hyponatremia in the neurocritical care patient: An approach based on current evidence	MEDICINA INTENSIVA			Spanish	Article						Hyponatremia; Neurocritically ill patient; Cerebral salt wasting; Syndrome of inappropriate antidiuretic secretion; Hypertonic saline solution	ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE; POSTOPERATIVE HYPONATREMIA; HYPERTONIC SALINE; VASOPRESSIN; VOLUME; MANAGEMENT; THERAPY; SODIUM	In the neurocritical care setting, hyponatremia is the commonest electrolyte disorder, which is associated with significant morbimortality. Cerebral salt wasting and syndrome of inappropriate antidiuretic hormone have been classically described as the 2 most frequent entities responsible of hyponatremia in neurocritical care patients. Nevertheless, to distinguish between both syndromes is usually difficult and useless as volume status is difficult to be determined, underlying pathophysiological mechanisms are still not fully understood, fluid restriction is usually contraindicated in these patients, and the first option in the therapeutic strategy is always the same: 3% hypertonic saline solution. Therefore, we definitively agree with the current concept of "cerebral salt wasting", which means that whatever is the etiology of hyponatrennia, initially in neurocritical care patients the treatment will be the same: hypertonic saline solution. (C) 2014 Elsevier Espana, S.L.U. and SEMICYUC. All rights reserved.	[Manzanares, W.; Aramendi, I.; Biestro, A.] Univ Repabl UdeLaR, Hosp Clin, Fac Med, Ctr Tratamiento Intens,Catedra Med Intens, Montevideo, Uruguay; [Langlois, P. L.] Univ Sherbrooke, Hop Fleurimont, Ctr Hosp, Fac Med & Sci Sante,Dept Anesthesie Reanimat, Sherbrooke, PQ J1K 2R1, Canada		Manzanares, W (corresponding author), Univ Repabl UdeLaR, Hosp Clin, Fac Med, Ctr Tratamiento Intens,Catedra Med Intens, Montevideo, Uruguay.	wmanzanares@adinet.com.uy					Aditya Suruchi, 2012, Int J Appl Basic Med Res, V2, P77, DOI 10.4103/2229-516X.106347; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Ayus JC, 2008, AM J PHYSIOL-RENAL, V295, pF619, DOI 10.1152/ajprenal.00502.2007; Bagshaw SM, 2009, CAN J ANAESTH, V56, P151, DOI 10.1007/s12630-008-9017-2; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Brimioulle S, 2008, INTENS CARE MED, V34, P125, DOI 10.1007/s00134-007-0905-7; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; Diringer MN, 2013, CURR OPIN CRIT CARE, V19, P77, DOI 10.1097/MCC.0b013e32835eba30; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Feigin VL, 2005, COCHRANE DB SYST REV, V20, P3; Friedman B, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.06.001; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Funk GC, 2010, INTENS CARE MED, V36, P304, DOI 10.1007/s00134-009-1692-0; Galton C, 2011, NEUROCRIT CARE, V14, P354, DOI 10.1007/s12028-011-9525-8; Gritti P, 2014, J ANESTH, V28, P687, DOI 10.1007/s00540-014-1814-x; Hannon MJ, 2014, J CLIN ENDOCR METAB, V99, P291, DOI 10.1210/jc.2013-3032; Hardesty DA, 2012, NEUROCRIT CARE, V17, P382, DOI 10.1007/s12028-011-9618-4; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Huang WY, 2012, CEREBROVASC DIS, V34, P55, DOI 10.1159/000338906; Human T, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.03.003; Hussain NS, 2013, J NEUROSURG, V119, P1453, DOI 10.3171/2013.8.JNS13411; Hwang JJ, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0271-4; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Jahangiri A, 2013, J NEUROSURG, V119, P1478, DOI 10.3171/2013.7.JNS13273; Kao L, 2009, PITUITARY, V12, P347, DOI 10.1007/s11102-009-0188-9; Katayama Y, 2007, STROKE, V38, P2373, DOI 10.1161/STROKEAHA.106.480038; Kirkman MA, 2014, MINERVA ENDOCRINOL, V39, P13; Kirkman MA, 2013, NEUROCRIT CARE, V18, P406, DOI 10.1007/s12028-012-9805-y; LIBERT N, 2010, REANIMATION, V19, P163; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Lopez-Dominguez A, 2007, MOL CELL BIOCHEM, V306, P95, DOI 10.1007/s11010-007-9558-7; Maesaka JK, 2009, KIDNEY INT, V76, P934, DOI 10.1038/ki.2009.263; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Murphy T, 2009, NEUROCRIT CARE, V11, P14, DOI 10.1007/s12028-008-9179-3; Nakagawa I, 2013, CEREBROVASC DIS, V35, P131, DOI 10.1159/000346586; Nakagawa I, 2010, ACTA NEUROCHIR, V152, P2147, DOI 10.1007/s00701-010-0735-1; Ochagavia A, 2014, MED INTENSIVA, V38, P154, DOI 10.1016/j.medin.2013.10.006; Pasantes-Morales H, 2010, NEUROSCIENCE, V168, P871, DOI 10.1016/j.neuroscience.2009.11.074; Rodrigues B, 2014, J STROKE CEREBROVASC, V23, P850, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.011; Roivainen R, 2013, EUR J NEUROL, V20, P1247, DOI 10.1111/ene.12157; Sabatier C, 2012, MED INTENSIVA, V36, P45, DOI 10.1016/j.medin.2011.04.005; Saramma PP, 2013, J NEUROSCI RURAL PRA, V4, P24, DOI 10.4103/0976-3147.105605; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819; Spasovski G, 2014, INTENS CARE MED, V40, P320, DOI 10.1007/s00134-014-3210-2; Steele A, 1997, ANN INTERN MED, V126, P20, DOI 10.7326/0003-4819-126-1-199701010-00003; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Sterns RH, 2008, J AM SOC NEPHROL, V19, P194, DOI 10.1681/ASN.2007101118; Sterns RH, 2010, AM J KIDNEY DIS, V56, P774, DOI 10.1053/j.ajkd.2010.04.020; Sterns RH, 2009, SEMIN NEPHROL, V29, P282, DOI 10.1016/j.semnephrol.2009.03.002; Sturdik I, 2014, EUR J INTERN MED, V25, P379, DOI 10.1016/j.ejim.2014.02.002; Thongrong C, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.02.027; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Verbalis JG, 2014, J CLIN ENDOCR METAB, V99, P59, DOI 10.1210/jc.2013-4289; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Verbalis JG, 2011, EUR J ENDOCRINOL, V164, P725, DOI 10.1530/EJE-10-1078; Wang GQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/702871; Wright WL, 2009, NEUROCRIT CARE, V11, P6, DOI 10.1007/s12028-008-9152-1; Yee AH, 2010, NEUROSURG CLIN N AM, V21, P339, DOI 10.1016/j.nec.2009.10.011	60	6	7	0	5	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	MAY	2015	39	4					234	243		10.1016/j.medin.2014.11.004			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH7QK	WOS:000354231500005	25593019				2022-02-06	
J	Fraga-Maia, HMS; Werneck, G; Dourado, I; Fernandes, RDP; Brito, LL				Silveira Fraga-Maia, Helena Maria; Werneck, Guilherme; Dourado, Ines; Pereira Fernandes, Rita de Cassia; Brito, Luciara Leite			Translation, adaptation and validation of "Community Integration Questionnaire"	CIENCIA & SAUDE COLETIVA			English	Article						Traumatic brain injury; Community integration; Questionnaires; Validity	TRAUMATIC BRAIN-INJURY; OUTCOMES; REHABILITATION; GUIDELINES; FAMILY; MODEL	Objective: To translate, adapt, and validate the "Community Integration Questionnaire (CIQ)," a tool that evaluates community integration after traumatic brain injury (TBI). Methods: A study of 61 TBI survivors was carried out. The appraisal of the measurement equivalence was based on a reliability assessment by estimating inter-rater agreement, item-scale correlation and internal consistency of CIQ scales, concurrent validity, and construct validity. Results: Inter-rater agreement ranged from substantial to almost perfect. The item-scale correlations were generally higher between the items and their respective domains, whereas the intra-class correlation coefficients were high for both the overall scale and the CIQ domains. The correlation between the CIQ and Disability Rating Scale (DRS), the Extended Glasgow Outcome Scale (GOSE), and the Rancho Los Amigos Level of Cognitive Functioning Scale (RLA) reached values considered satisfactory. However, the factor analysis generated four factors (dimensions) that did not correspond with the dimensional structure of the original tool. Conclusion: The resulting tool herein may be useful in globally assessing community integration after TBI in the Brazilian context, at least until new CIQ psychometric assessment studies are developed with larger samples.	[Silveira Fraga-Maia, Helena Maria] Univ Estado Bahia, Dept Ciencias Vida, BR-41150000 Salvador, BA, Brazil; [Werneck, Guilherme] Univ Estado Rio de Janeiro, Fac Ciencias Med, Inst Social Med, Rio De Janeiro, Brazil; [Dourado, Ines] Univ Fed Bahia, Inst Saude Coletiva, BR-41170290 Salvador, BA, Brazil; [Pereira Fernandes, Rita de Cassia] Univ Fed Bahia UFBA, Fac Med Bahia, Salvador, BA, Brazil; [Brito, Luciara Leite] Univ Fed Bahia, Fac Nutr, Salvador, BA, Brazil		Fraga-Maia, HMS (corresponding author), Univ Estado Bahia, Dept Ciencias Vida, Av Silveira Martins 2555, BR-41150000 Salvador, BA, Brazil.	helenafragamaia@gmail.com	Werneck, Guilherme/A-2841-2013; Dourado, Ines/Q-6535-2016; Fraga-Maia, Helena MS/H-3682-2014	Werneck, Guilherme/0000-0003-1169-1436; Dourado, Ines/0000-0003-1675-2146; Fraga-Maia, Helena MS/0000-0002-2782-4910	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); CITECS	The research was funded by the Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) and CITECS. The authors also thank the professionals at the Hospital Geral do Estado (HGE) for their collaboration in the production of hospital data and the Instituto de Saude Coletiva da Universidade Federal da Bahia for logistical support to obtain household data.	Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Backhouse M, 1999, AUST OCCUP THER J, V46, P99, DOI DOI 10.1046/J.1440-1630.1999.00183.X; Brasil. Ministerio da Saude (MS), 2005, PLAN NAC RED MORB AC; Brasil. Ministerio da Saude (MS), 2005, IMPACTO VIOLENCIA SA; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Fraga-Maia H., 2006, THESIS I SAUDE COLET; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Herdman M, 1998, QUAL LIFE RES, V7, P323, DOI 10.1023/A:1008846618880; HORN LJ, 1996, MED REHABILITATION T; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Manly BFJ, 1994, MULTIVARIATE STAT ME, P93; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Rintala DH, 2002, REHABIL PSYCHOL, V47, P144, DOI 10.1037//0090-5550.47.2.144; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Streiner D. L., 2004, HLTH MEASUREMENT SCA; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 1993, INT CLASS IMP DIS HA	31	6	6	0	3	ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA	RIO DE JANEIRO	AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36, BRAZIL	1413-8123	1678-4561		CIENC SAUDE COLETIVA	Cienc. Saude Coletiva	MAY	2015	20	5					1340	1351		10.1590/1413-81232015205.08312014			12	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CM0ZB	WOS:000357408200004	26017937	gold, Green Submitted			2022-02-06	
J	Slocum, CS; Goldstein, R; DiVita, MA; Mix, J; Niewczyk, P; Gerrard, P; Sheridan, R; Kowalske, KJ; Zafonte, R; Ryan, CM; Schneider, JC				Slocum, Chloe S.; Goldstein, Richard; DiVita, Margaret A.; Mix, Jacqueline; Niewczyk, Paulette; Gerrard, Paul; Sheridan, Robert; Kowalske, Karen J.; Zafonte, Ross; Ryan, Colleen M.; Schneider, Jeffrey C.			Assessing the Ability of Comorbidity Indexes to Capture Comorbid Disease in the Inpatient Rehabilitation Burn Injury Population	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Burns; Comorbidities; Inpatient Rehabilitation; Comorbidity Indexes	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; RISK-FACTORS; ACUTE-CARE; STROKE REHABILITATION; CANCER-PATIENTS; ADULT PATIENTS; OUTCOMES; MORTALITY; PREDICTORS	Objective: Burn patients exhibit comorbidities that influence outcomes. This study examines whether existing comorbidity measures capture comorbidities in the burn inpatient rehabilitation population. Design: Data were obtained from the Uniform Data System for Medical Rehabilitation from 2002 to 2011 for adults with burn injury. International Classification of Diseases, 9th Revision, codes were used to assess three comorbidity measures (Charlson Comorbidity Index, Elixhauser Comorbidity Index, Centers for Medicare and Medicaid Services Comorbidity Tiers). The number of subjects and unique comorbidity codes (>1% of frequency) captured by each comorbidity measure was calculated. Results: The study included 5347 patients with a median total body surface area burn decile of 20%-29%, mean age of 51.6 yrs, and mean number of comorbidities of 7.6. There were 2809 unique International Classification of Diseases, 9th Revision, comorbidity codes. The Charlson Comorbidity Index, Elixhauser Comorbidity Index, and Centers for Medicare and Medicaid Services Comorbidity Tiers did not capture 67%, 27%, and 58% of the subjects, respectively. There were 107 unique comorbidities that occurred with a frequency of greater than 1%. Of these, 67% were not captured in all three comorbidity measures. Conclusions: Commonly used comorbidity indexes do not reflect the extent of comorbid disease in the burn rehabilitation population. Future work is needed to assess the need for comorbidity indexes specific to the inpatient rehabilitation setting.	[Slocum, Chloe S.; Goldstein, Richard; Gerrard, Paul; Zafonte, Ross; Schneider, Jeffrey C.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [DiVita, Margaret A.; Mix, Jacqueline; Niewczyk, Paulette] Uniform Data Syst Med Rehabil, Amherst, NY USA; [Niewczyk, Paulette] Daemen Coll, Hlth Care Studies Dept, Amherst, NY USA; [Sheridan, Robert; Ryan, Colleen M.] Shriners Hosp Children, Dept Surg, Boston, MA USA; [Sheridan, Robert; Ryan, Colleen M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Surg Serv,Sumner Redstone Burn Ctr, Boston, MA USA; [Kowalske, Karen J.] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA		Schneider, JC (corresponding author), Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 1st Ave, Charlestown, MA 02129 USA.		Schneider, Jeffrey/AAO-2126-2020	DiVita, Margaret/0000-0002-4878-2959; Ryan, Colleen/0000-0002-6455-936X	Department of Education, NIDRR [H133A120034]	Funded by grants from the Department of Education, NIDRR grant number H133A120034. However, these contents do not necessarily represent the policy of the Department of Education, and endorsement by the Federal Government should not be assumed. Presented at the 46th Annual Meeting of the American Burn Association, Boston, Massachusetts, March 25-28, 2014, in Correlative Session V, Session Title: Rehabilitation. Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.	Alam E, 2008, ARCH PHYS MED REHAB, V89, P1284, DOI 10.1016/j.apmr.2008.01.014; American Burn Association, NAT BURN REP 2012 VE; Badgwell B, 2013, J SURG ONCOL, V108, P182, DOI 10.1002/jso.23369; Banta JE, 2012, CRIT CARE MED, V40, P2960, DOI 10.1097/CCM.0b013e31825bc92f; Bhavnani SP, 2013, ANN NONINVAS ELECTRO, V18, P379, DOI 10.1111/anec.12045; Bombaro KM, 2003, BURNS, V29, P299, DOI 10.1016/S0305-4179(03)00067-6; CARTER GM, 2002, EXECUTIVE SUMMARY AN; Carter GM, 2002, ANAL INITIAL IMPLEME, P99; Carter GM, 2002, ANAL INITIAL IMPLEME; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CMS, 2001, FED REGISTER, V66, P41316; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Dehal A, 2013, BREAST CANCER RES TR, V139, P469, DOI 10.1007/s10549-013-2543-9; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dyster-Aas J, 2008, J TRAUMA, V64, P1349, DOI 10.1097/TA.0b013e318047e005; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Godleski M, 2013, J BURN CARE RES, V34, P420, DOI 10.1097/BCR.0b013e3182700178; Gomez M, 2008, J BURN CARE RES, V29, P130, DOI [1097/BCR.0b013e31815f6efd, 10.1097/BCR.0b013e31815f6efd]; Groll DL, 2006, AM J PHYS MED REHAB, V85, P574, DOI 10.1097/01.phm.0000223220.91914.61; Guo Y, 2008, AM J PHYS MED REHAB, V87, P647, DOI 10.1097/PHM.0b013e31817fb94e; Hoyer EH, 2013, ARCH PHYS MED REHAB, V94, P1951, DOI 10.1016/j.apmr.2013.05.028; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Liu JN, 2010, KIDNEY INT, V77, P141, DOI 10.1038/ki.2009.413; NORRISBAKER C, 1981, ARCH PHYS MED REHAB, V62, P602; Post MWM, 1998, ARCH PHYS MED REHAB, V79, P395, DOI 10.1016/S0003-9993(98)90139-3; Roth EJ, 2001, STROKE, V32, P523, DOI 10.1161/01.STR.32.2.523; Rumbach AF, 2012, J BURN CARE RES, V33, P336, DOI 10.1097/BCR.0b013e3182356143; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Schneider J, 2010, AM J PHYS MED REHABI, V89, pS36; Schneider JC, 2013, PM&R, V5, P114, DOI 10.1016/j.pmrj.2012.07.014; Schneider JC, 2012, J TRAUMA ACUTE CARE, V73, P1596, DOI 10.1097/TA.0b013e318270d73d; Silverberg R, 2000, J BURN CARE REHABIL, V21, P259, DOI 10.1097/00004630-200021030-00014; Sliwa JA, 2005, ARCH PHYS MED REHAB, V86, P1920, DOI 10.1016/j.apmr.2005.04.024; Spires MC, 2005, J BURN CARE REHABIL, V26, P532, DOI 10.1097/01.bcr.0000185397.39029.0a; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P712, DOI 10.1016/S0003-9993(03)04850-5; Tan WH, 2012, J BURN CARE RES, V33, P110, DOI 10.1097/BCR.0b013e318234d91a; Tessier A, 2008, ARCH PHYS MED REHAB, V89, P1276, DOI 10.1016/j.apmr.2007.11.049; Thombs BD, 2007, ANN SURG, V245, P629, DOI 10.1097/01.sla.0000250422.36168.67; UB Foundation Activities Inc, 2004, UN DAT SYST MED REH; VITALE M, 1991, Journal of Burn Care and Rehabilitation, V12, P330, DOI 10.1097/00004630-199107000-00008	41	6	6	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY	2015	94	5					373	384		10.1097/PHM.0000000000000180			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CG3BN	WOS:000353151700008	25171665				2022-02-06	
J	Stoknes, M; Lien, E; Andersen, GL; Bao, YD; Blackman, JA; Lie, RT; Vik, T				Stoknes, Magne; Lien, Espen; Andersen, Guro L.; Bao, Yongde; Blackman, James A.; Lie, Rob Terje; Vik, Torstein			Child apolipoprotein E gene variants and risk of cerebral palsy: Estimation from case-parent triads	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Cerebral palsy; Apolipoprotein E; Genetics; Case-parent triads	TRAUMATIC BRAIN-INJURY; GROSS MOTOR FUNCTION; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; ALLELE; POLYMORPHISMS; METAANALYSIS; DECREASES; SEVERITY; GENOTYPE	Objective: To use case parent triad data to investigate if cerebral palsy (CP) is associated with variants of the APOE gene, the rs59007384 SNP of the TOMM40 gene or combined haplotypes of the two genes. Study design: DNA was analyzed in buccal swabs from 235 children with CP, their parents and a sibling. The relative risks (RR) with 95% confidence intervals (CI) that the children would have a distribution of APOE genotypes, rs59007384 variants or combined haplotypes deviating from Mendelian inheritance were estimated. Results: Children with CP were more likely than expected to carry the APOE epsilon 3 allele (RR 7.5; CI: 0.99-53.7 for heterozygotes and 10.3; CI: 1.4-79.6 for homozygotes), and to have the haplotype of APOE epsilon 3 and rs59007384 G (RR 2.4; CI: 1-5.7 for heterozygotes, RR 3.7; CI: 1.4 -9.5 for homozygotes) whereas the distribution was as expected for rs59007384 alone. In the subgroup analyses the findings were confined to children born preterm. Among siblings the distribution of these genes was as expected according to Mendelian inheritance. Conclusion: We speculate that children with APOE epsilon 2/APOE epsilon 4 alleles are more likely to die following cerebral injury in utero, resulting in a higher than expected proportion of children with CP carrying the APOE epsilon 3 allele. (C) 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Stoknes, Magne; Lien, Espen; Andersen, Guro L.; Vik, Torstein] Norwegian Univ Sci & Technol, Fac Med, Dept Lab Med Childrens & Womens Hlth, N-7491 Trondheim, Norway; [Stoknes, Magne; Lien, Espen; Vik, Torstein] Univ Trondheim Hosp, St Olavs Hosp, Dept Pediat, Trondheim, Norway; [Andersen, Guro L.] Cerebral Palsy Register Norway, Vestfold Hosp Trust, Tonsberg, Norway; [Bao, Yongde] Univ Virginia, Sch Med, DNA Sci Core, Charlottesville, VA 22908 USA; [Blackman, James A.] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Blackman, James A.] Cerebral Palsy Int Res Fdn, New York, NY USA; [Lie, Rob Terje] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway		Stoknes, M (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Lab Med Childrens & Womens Hlth, PB 8905, N-7491 Trondheim, Norway.	magne.stoknes@grnail.com			Central Norway Regional Health Authority (RHA) [4230/2010]; Norwegian University of Science and Technology (NTNU); Liaison Committee [4230/2010]	Liaison Committee (ID: 4230/2010) between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU).	Andersen GL, 2008, EUR J PAEDIATR NEURO, V12, P4, DOI 10.1016/j.ejpn.2007.05.001; Beckung E, 2002, DEV MED CHILD NEUROL, V44, P309; Bekris LM, 2008, J ALZHEIMERS DIS, V13, P255; Blackman JA, 2009, J PEDIATR REHAB MED, V2, P67, DOI 10.3233/PRM-2009-0063; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cotten CM, 2014, PEDIATR RES, V75, P424, DOI 10.1038/pr.2013.235; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Gale SC, 2014, J ALLERGY CLIN IMMUN, V134, P127, DOI 10.1016/j.jaci.2014.01.032; Gjessing HK, 2006, ANN HUM GENET, V70, P382, DOI 10.1111/j.1469-1809.2005.00218.x; Guo L, 2004, J MOL NEUROSCI, V23, P205, DOI 10.1385/JMN:23:3:205; Himpens E, 2010, EUR J PEDIATR, V169, P305, DOI 10.1007/s00431-009-1026-9; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kuroda MM, 2007, PEDIATRICS, V119, P306, DOI 10.1542/peds.2006-1083; Li J, 2014, J ASSIST REPROD GEN, V31, P139, DOI 10.1007/s10815-013-0128-5; Lien E, 2014, EUR J PAEDIATR NEURO, V18, P591, DOI 10.1016/j.ejpn.2014.04.003; Lien E, 2013, DEV MED CHILD NEUROL, V55, P372, DOI 10.1111/dmcn.12086; Mulder M, 1998, ALZ DIS ASSOC DIS, V12, P198, DOI 10.1097/00002093-199809000-00012; O'Callaghan ME, 2009, HUM GENET, V126, P149, DOI 10.1007/s00439-009-0638-5; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Palisano RJ, 2008, DEV MED CHILD NEUROL, V50, P744, DOI 10.1111/j.1469-8749.2008.03089.x; Rosner B., 2000, FUNDAMENTALS BIOSTAT, P792; Schiefermeier M, 2000, STROKE, V31, P2068, DOI 10.1161/01.STR.31.9.2068; Stoknes M, 2012, EUR J PAEDIATR NEURO, V16, P56, DOI 10.1016/j.ejpn.2011.10.004; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yu CE, 2007, GENOMICS, V89, P655, DOI 10.1016/j.ygeno.2007.02.002; Zeng S, 2014, GENET TEST MOL BIOMA, V18, P202, DOI 10.1089/gtmb.2013.0421; Zhang W, 2010, CLIN DEV IMMUNOL, DOI [10.1155/2010/459143, 10.1155/2010/186813]; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	30	6	8	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	MAY	2015	19	3					286	291		10.1016/j.ejpn.2014.12.017			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	CG9CM	WOS:000353612000005	25596901				2022-02-06	
J	Wood, H; Cupitt, C; Lavender, T				Wood, Helen; Cupitt, Caroline; Lavender, Tony			The Experience of Cognitive Impairment in People with Psychosis	CLINICAL PSYCHOLOGY & PSYCHOTHERAPY			English	Article						Psychosis; Schizophrenia; Cognitive Functioning; Cognitive Impairment; Interpretative Phenomenological Analysis; Qualitative	TRAUMATIC BRAIN-INJURY; QUALITATIVE RESEARCH; EXECUTIVE FUNCTION; LEARNING-DISABILITIES; SOCIAL FUNCTION; WORKING-MEMORY; WAIS-R; SCHIZOPHRENIA; DEFICITS; NEUROCOGNITION	Cognitive impairment has been widely studied in people with psychosis. However, research is lacking into the subjective experience of cognitive impairment, its impact and ways in which individuals cope. This study aimed to provide an account of the experience of cognitive impairment in people with a diagnosis of schizophrenia, including what difficulties people experience, how these difficulties are understood, how people respond to these difficulties and how they perceive others' views of these difficulties. A semi-structured interview was carried out with eight participants with a diagnosis of schizophrenia focusing on participants' experiences of difficulties with cognitive functioning. Interpretative phenomenological analysis was used to analyse interview transcripts. Experience of cognitive impairment was understood in terms of six master themes: impaired controlled thinking, physical sensations and impaired movement, explanations for the impairment and comparisons to the past, managing the impairment, how others see the impairment and anticipating the future. This study is the first rigorous qualitative study of the subjective experience of cognitive impairment in people with psychosis, and it provides greater context for empirical findings. The results have significant implications for clinical psychology, including education about cognitive difficulties and the importance of cognitive functioning to formulation. New areas for research include coping strategies in relation to functioning and future perspectives, ascertaining staff understanding of cognitive impairment, and reflective conversation style as an intervention for metacognitive difficulties. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Wood, Helen; Lavender, Tony] Canterbury Christ Church Univ, Appl Psychol, Tunbridge Wells, Kent, England; [Cupitt, Caroline] Oxleas NHS Fdn, Bexley Assert Outreach Team, Erith, Kent, England		Wood, H (corresponding author), Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, Adult Mood & Anxiety Disorder Serv, Pittsburgh, PA 15260 USA.	wood.helenj@gmail.com					AJZEN I, 1987, ADV EXP SOC PSYCHOL, V20, P1, DOI 10.1016/S0065-2601(08)60411-6; Ali A, 2008, BRIT J PSYCHIAT, V193, P410, DOI 10.1192/bjp.bp.107.045823; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Army Individual Test Battery, 1944, MAN DIR SCOR; Atkinson R. C., 1968, PSYCHOL LEARN MOTIV, V2, P89, DOI [10.1016/S0079-7421(08)60422-3., DOI 10.1016/S0079-7421(08)60422-3]; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barga NK, 1996, J LEARN DISABIL, V29, P413, DOI 10.1177/002221949602900409; Bell MD, 2001, SCHIZOPHRENIA BULL, V27, P269, DOI 10.1093/oxfordjournals.schbul.a006873; Bentall R. P., 2003, MADNESS EXPLAINED PS; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Bleuler E, 1950, DEMENTIA PRAECOX GRO; Bleuler E., 1976, TXB PSYCHIAT; BOLTON S, 1981, J ORTHOMOL MED, V10, P202; Bora E, 2010, SCHIZOPHRENIA BULL, V36, P36, DOI 10.1093/schbul/sbp094; Bora E, 2009, SCHIZOPHR RES, V109, P1, DOI 10.1016/j.schres.2008.12.020; Bowie CR, 2006, MT SINAI J MED, V73, P993; Boykoff N, 2009, J CANCER SURVIV, V3, P223, DOI 10.1007/s11764-009-0098-x; Bromley E, 2005, SCHIZOPHRENIA BULL, V31, P954, DOI 10.1093/schbul/sbi059; Bromley E, 2007, SCHIZOPHRENIA BULL, V33, P648, DOI 10.1093/schbul/sbm024; Burgess P.W., 1997, HAYLING BRIXTON TEST; Carroll A, 1999, SCHIZOPHR RES, V35, P247, DOI 10.1016/S0920-9964(98)00142-X; Christensen TO, 2007, INT J PSYCHIAT CLIN, V11, P89, DOI 10.1080/13651500600969061; Clark C, 2000, J ABNORM CHILD PSYCH, V28, P403, DOI 10.1023/A:1005176320912; Cohen AS, 2006, SCHIZOPHR RES, V81, P227, DOI 10.1016/j.schres.2005.09.007; Couture SM, 2011, SCHIZOPHR RES, V125, P152, DOI 10.1016/j.schres.2010.09.020; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; D'Argembeau A, 2008, J ABNORM PSYCHOL, V117, P247, DOI 10.1037/0021-843X.117.1.247; Davies HD, 2010, INT PSYCHOGERIATR, V22, P618, DOI 10.1017/S1041610210000177; DESROSIERS G, 1987, INT J CLIN NEUROPSYC, V9, P162; Destoop M, 2010, ACTA NEUROL BELG, V110, P128; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Dodgson G, 2009, BEHAV COGN PSYCHOTH, V37, P325, DOI 10.1017/S1352465809005244; Doody GA, 1998, PSYCHOL MED, V28, P397, DOI 10.1017/S003329179700648X; Doughty O J, 2009, Cogn Neuropsychiatry, V14, P473, DOI 10.1080/13546800903073291; Eack SM, 2008, PSYCHIAT SERV, V59, P256, DOI 10.1176/appi.ps.59.3.256; Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782; Fagerlund B, 2010, SCHIZOPHR RES, V117, P211, DOI 10.1016/j.schres.2010.02.294; Fischbein M., 1975, BELIEF ATTITUDE INTE; Fischer CT, 2009, PSYCHOTHER RES, V19, P583, DOI 10.1080/10503300902798375; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Forbes NF, 2009, PSYCHOL MED, V39, P889, DOI 10.1017/S0033291708004558; FREEDMAN B, 1973, J ABNORM PSYCHOL, V82, P46, DOI 10.1037/h0034952; FRITH CD, 1979, BRIT J PSYCHIAT, V134, P225, DOI 10.1192/bjp.134.3.225; Gauffin H, 2011, EPILEPSY BEHAV, V22, P750, DOI 10.1016/j.yebeh.2011.09.007; Gioia D, 2009, PSYCHIATRY, V72, P94, DOI 10.1521/psyc.2009.72.1.94; Gipps R. G. T, 2010, THESIS CCANTERBURY C; Givon S, 2010, INT J QUAL STUD EDUC, V23, P283, DOI 10.1080/09518390903352343; Green B, 2004, DRUG ALCOHOL REV, V23, P445, DOI 10.1080/09595230412331324563; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Hamsher K., 1989, MULTILINGUAL APHASIA; Hayward P., 1997, J MENT HLTH, V6, DOI 10.1080/09638239718671; Heerey EA, 2011, J ABNORM PSYCHOL, V120, P483, DOI 10.1037/a0021810; Heilbronner R L, 1991, Arch Clin Neuropsychol, V6, P251, DOI 10.1016/0887-6177(91)90002-Q; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hemsey DR, 2005, NEUROSCI BIOBEHAV R, V29, P977, DOI 10.1016/j.neubiorev.2004.12.008; Hemsley DR, 1998, BRIT J MED PSYCHOL, V71, P115, DOI 10.1111/j.2044-8341.1998.tb01373.x; Hoff AL, 2005, SCHIZOPHR RES, V78, P27, DOI 10.1016/j.schres.2005.05.010; Holthausen EAE, 2007, PSYCHIAT RES, V149, P71, DOI 10.1016/j.psychres.2005.07.037; Hughes JR, 1998, PSYCHIATR SERV, V49, P1415, DOI 10.1176/ps.49.11.1415; Iqbal Z, 2000, BRIT J PSYCHIAT, V177, P522, DOI 10.1192/bjp.177.6.522; Izaute M, 2010, TRENDS AND PROSPECTS IN METACOGNITION RESEARCH, P127, DOI 10.1007/978-1-4419-6546-2_7; JOHNSTONE EC, 1992, PSYCHOL MED, V22, P331, DOI 10.1017/S0033291700030270; Joshua N, 2009, SCHIZOPHR RES, V114, P84, DOI 10.1016/j.schres.2009.05.029; Kaneda Y, 2009, PSYCHIAT RES, V169, P178, DOI 10.1016/j.psychres.2008.08.003; Karande Sunil, 2009, Indian J Med Sci, V63, P382, DOI 10.4103/0019-5359.56109; Keefe Richard S E, 2012, Handb Exp Pharmacol, P11, DOI 10.1007/978-3-642-25758-2_2; Knight M.T., 2003, J MENT HEALTH, V12, P209, DOI [10.1080/0963823031000118203, DOI 10.1080/0963823031000118203]; Knudson B., 2002, EXISTENTIAL ANAL, V13, P117, DOI DOI 10.1111/j.1099-0860.2007.00108.x; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Kraeplin E., 1899, PSYCHIAT TXB STUDENT; Kremen WS, 2000, J ABNORM PSYCHOL, V109, P743, DOI 10.1037/0021-843X.109.4.743; Laing R. D., 1990, DIVIDED EXISTENTIAL; Lapornik R, 1996, FORENSIC SCI INT, V82, P121, DOI 10.1016/0379-0738(96)01985-8; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levack W. M. M., 2010, NZ J PHYSIOTHERAPY, V38, P71; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lincoln TM, 2007, SCHIZOPHR RES, V96, P232, DOI 10.1016/j.schres.2007.07.022; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Lysaker PH, 2010, ACTA PSYCHIAT SCAND, V122, P405, DOI 10.1111/j.1600-0447.2010.01554.x; MacDonald E., 2005, J MENTAL HLTH, V14, P129, DOI DOI 10.1080/09638230500060052; Marczewski P., 2001, COGNITIVE NEUROPSYCH, V6, P175, DOI DOI 10.1080/13546800042000115; MATARAZZO JD, 1984, J CLIN NEUROPSYCHOL, V6, P351, DOI 10.1080/01688638408401227; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McEvoy JP, 1999, AM J PSYCHIAT, V156, P1120; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; MCGHIE A, 1964, Proc R Soc Med, V57, P419; MCGLASHAN TH, 1975, ARCH GEN PSYCHIAT, V32, P1269; MCGLASHAN TH, 1987, J NERV MENT DIS, V175, P681, DOI 10.1097/00005053-198711000-00006; McGurk SR, 2000, SCHIZOPHR RES, V45, P175, DOI 10.1016/S0920-9964(99)00198-X; McGurk SR, 2007, AM J PSYCHIAT, V164, P1791, DOI 10.1176/appi.ajp.2007.07060906; Medalia A, 2010, SCHIZOPHR RES, V117, P143, DOI 10.1016/j.schres.2010.02.123; Merleau-Ponty M., 2012, PHENOMENOLOGY PERCEP; Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708; Mishara AL, 2004, BIOL PSYCHIAT, V55, P1013, DOI 10.1016/j.biopsych.2004.01.027; Moritz S, 2007, CURR OPIN PSYCHIATR, V20, P619, DOI 10.1097/YCO.0b013e3282f0b8ed; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Munir F, 2011, CANCER NURS, V34, P385, DOI 10.1097/NCC.0b013e31820254f3; Myers Jamie S, 2012, Oncol Nurs Forum, V39, pE31, DOI 10.1188/12.ONF.E31-E40; Newton E, 2007, PSYCHOL PSYCHOTHER-T, V80, P127, DOI 10.1348/147608306X110148; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; Pearce A., 2002, DEMENTIA, V1, P173, DOI [10.1177/147130120200100205, DOI 10.1177/147130120200100205]; Penn DL, 2001, SCHIZOPHRENIA BULL, V27, P197, DOI 10.1093/oxfordjournals.schbul.a006866; Perlick DA, 2008, SCHIZOPHR RES, V99, P192, DOI 10.1016/j.schres.2007.08.009; Perry B.M., 2007, J MENT HLTH, V16, P781, DOI DOI 10.1080/09638230701496360; Pineda DA, 2003, INT J NEUROSCI, V113, P397, DOI 10.1080/00207450390162164; Polgar P, 2010, SCHIZOPHR RES, V122, P85, DOI 10.1016/j.schres.2010.06.007; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Prouteau A, 2004, SCHIZOPHR RES, V69, P85, DOI 10.1016/j.schres.2003.08.011; *PSYCH CORP, 1997, WECHSL MEM SCAL; Qazi A, 2010, J AFFECT DISORDERS, V125, P295, DOI 10.1016/j.jad.2009.12.015; Reeder C, 2004, SCHIZOPHRENIA BULL, V30, P87, DOI 10.1093/oxfordjournals.schbul.a007070; Revheim Nadine, 2004, J Psychiatr Pract, V10, P73, DOI 10.1097/00131746-200401000-00009; Rhodes JE, 2000, BRIT J MED PSYCHOL, V73, P211, DOI 10.1348/000711200160435; Roscigno CI, 2008, J NEUROSCI NURS, V40, P212, DOI 10.1097/01376517-200808000-00005; Royan J, 2004, ARCH CLIN NEUROPSYCH, V19, P131, DOI 10.1016/S0887-6177(02)00216-0; Shevil E, 2006, DISABIL REHABIL, V28, P779, DOI 10.1080/09638280500387013; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Smith J.A., 2009, INTERPRETATIVE PHENO; SNOW WG, 1989, J CLIN EXP NEUROPSYC, V11, P423, DOI 10.1080/01688638908400903; Soeker MS, 2011, J OCCUP SCI, V18, P81, DOI 10.1080/14427591.2011.554155; Spencer C, 2002, SCHIZOPHRENIA BULL, V28, P233, DOI 10.1093/oxfordjournals.schbul.a006934; Spreen O., 1969, NEUROSENSORY CTR COM; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Stip E, 2006, ENCEPHALE, V32, P341; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; STRAUSS JS, 1989, SCHIZOPHRENIA BULL, V15, P179, DOI 10.1093/schbul/15.2.179; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; Tarrier N, 2002, CASEBOOK COGNITIVE T, P79; Thornhill Hermione, 2004, Anthropol Med, V11, P181, DOI 10.1080/13648470410001678677; Toulopoulou T, 2003, SCHIZOPHR RES, V63, P261, DOI 10.1016/S0920-9964(02)00324-9; Tracy JI, 2001, SCHIZOPHR RES, V50, P199, DOI 10.1016/S0920-9964(01)00241-9; Turpin G., 1997, CLIN PSYCHOL FORUM, V108, P3; Vauth R, 2005, SCHIZOPHRENIA BULL, V31, P55, DOI 10.1093/schbul/sbi013; *WHO, 2005, INT CLASS DIS HLTH R; Wykes T, 2005, COGNITIVE REMEDIATIO; Wykes T, 2011, AM J PSYCHIAT, V168, P472, DOI 10.1176/appi.ajp.2010.10060855; Yager JA, 2006, PSYCHIATRY, V69, P47, DOI 10.1521/psyc.2006.69.1.47; Yamauchi K, 2008, PSYCHIAT CLIN NEUROS, V62, P404, DOI 10.1111/j.1440-1819.2008.01818.x; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y	143	6	6	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1063-3995	1099-0879		CLIN PSYCHOL PSYCHOT	Clin. Psychol. Psychother.	MAY-JUN	2015	22	3					193	207		10.1002/cpp.1878			15	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	CK1PG	WOS:000355978700001	24281753				2022-02-06	
J	Bennett, RE; Brody, DL				Bennett, Rachel E.; Brody, David L.			Array tomography for the detection of non-dilated, injured axons in traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Array tomography; Axonal injury; Traumatic brain injury; Neurofilament; Tubulin; Electron microscopy	AMYLOID PRECURSOR PROTEIN; EARLY ALZHEIMERS-DISEASE; MILD HEAD-INJURY; MOUSE MODEL; CORPUS-CALLOSUM; COGNITIVE IMPAIRMENT; RTGTAUEC MODEL; MICE; BETA; DEFICITS	Background: Axonal injury is a key feature of several types of brain trauma and neurological disease. However, in mice and humans, many axons are less than 500 nm in diameter which is at or below the resolution of most conventional light microscopic imaging methods. In moderate to severe forms of axon injury, damaged axons become dilated and therefore readily detectible by light microscopy. However, in more subtle forms of injury, the damaged axons may remain undilated and therefore difficult to detect. New method: Here we present a method for adapting array tomography for the identification and quantification of injured axons. In this technique, ultrathin (similar to 70 nm) plastic sections of tissue are prepared, labeled with axon injury-relevant antibodies and imaged using conventional epifluorescence. Results: To demonstrate the use of array-tomography-based methods, we determined that mice that received two closed-skull concussive traumatic brain injury impacts had significantly increased numbers of non-dilated axons that were immunoreactive for non-phosphorylated neurofilament (SMI-32; a marker of axonal injury), compared to sham mice (1682 +/- 628 versus 339 +/- 52 per mm(2), p = 0.004, one-tailed Mann Whitney U test). Tubulin loss was not evident (p = 0.2063, one-tailed Mann Whitney U test). Furthermore, mice that were subjected to more severe injury had a loss of tubulin in addition to both dilated and non-dilated SMI-32 immunoreactive axons indicating that this technique is suitable for the analysis of various injury conditions. Comparison with existing method: With array tomography we could detect similar overall numbers of axons as electron microscopy, but accurate diameter measurements were limited to those with diameters >200 nm. Importantly, array tomography had greater sensitivity for detecting small non-dilated injured axons compared with conventional immunohistochemistry. Conclusion: Imaging of individual axons and quantification of subtle axonal injury is possible using this array tomography method. This method may be most useful for the assessment of concussive injuries and other pathologies in which injured axons are not typically dilated. The ability to process moderately large volumes of tissue, label multiple proteins of interest, and automate analysis support array tomography as a useful alternative to electron microscopy. (C) 2015 Elsevier B.V. All rights reserved.	[Bennett, Rachel E.; Brody, David L.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA		Brody, DL (corresponding author), Washington Univ, Dept Neurol, 660 S Euclid Ave, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu	Bennett, Rachel/AAU-6949-2020	Bennett, Rachel/0000-0001-9640-0575	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS065069, R01-NS065069, F31-NS076047, F31 NS076047] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065069, F31NS076047] Funding Source: NIH RePORTER		ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Bennett RE, 2014, J NEUROTRAUM, V31, P1647, DOI 10.1089/neu.2013.3320; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Franklin K.B.J., 2004, MOUSE BRAIN STEREOTA; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kay KR, 2013, NAT PROTOC, V8, P1366, DOI 10.1038/nprot.2013.078; Kim JHY, 1996, BRAIN RES, V740, P47, DOI 10.1016/S0006-8993(96)00637-3; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kopeikina KJ, 2013, J COMP NEUROL, V521, P1334, DOI 10.1002/cne.23234; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Olivares R, 2001, BRAIN BEHAV EVOLUT, V57, P98, DOI 10.1159/000047229; Polydoro M, 2013, J NEUROSCI, V33, P13300, DOI 10.1523/JNEUROSCI.0881-13.2013; Pooler AM, 2013, J COMP NEUROL, V521, P4236, DOI 10.1002/cne.23411; Saatchi S, 2012, J HISTOCHEM CYTOCHEM, V60, P97, DOI 10.1369/0022155411433066; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	37	6	6	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	APR 30	2015	245						25	36		10.1016/j.jneumeth.2015.02.005			12	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CG8XN	WOS:000353599100003	25687633	Green Accepted			2022-02-06	
J	Yu, Y; Jian, MY; Wang, YZ; Han, RQ				Yu, Yun; Jian, Min-Yu; Wang, Yun-Zhen; Han, Ru-Quan			Propofol Ameliorates Calpain-induced Collapsin Response Mediator Protein-2 Proteolysis in Traumatic Brain Injury in Rats	CHINESE MEDICAL JOURNAL			English	Article						Collapsin Response Mediator Protein-2; Lipid Peroxidation; Neuroprotection; Propofol; Traumatic Brain Injury	CONTROLLED CORTICAL IMPACT; ISCHEMIA-REPERFUSION; CEREBRAL-ISCHEMIA; CYTOSKELETAL DEGRADATION; OXIDATIVE STRESS; CELL-DEATH; ACTIVATION; NEURODEGENERATION; NEUROPROTECTION; INHIBITION	Background: Collapsin response mediator protein-2 (CRMP2), a multifunctional cytosolic protein highly expressed in the brain, is degraded by calpain following traumatic brain injury (TBI), possibly inhibiting posttraumatic neurite regeneration. Lipid peroxidation (LP) is involved in triggering postinjury CRMP2 proteolysis. We examined the hypothesis that propofol could attenuate LP, calpain-induced CRMP2 degradation, and brain injury after TBI. Methods: A unilateral moderate controlled cortical impact injury was induced in adult male Sprague-Dawley rats. The animals were randomly divided into seven groups: Sham control group, TBI group, TBI + propofol groups (including propofol 1 h, 2 h, and 4 h groups), TBI + U83836E group and TBI + fat emulsion group. The LP inhibitor U83836E was used as a control to identify that antioxidation partially accounts for the potential neuroprotective effects of propofol. The solvent of propofol, fat emulsion, was used as the vehicle control. Ipsilateral cortex tissues were harvested at 24 h post-TBI. Immunofluorescent staining, Western blot analysis, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling were used to evaluate LP, calpain activity, CRMP2 proteolysis and programmed cell death. The data were statistically analyzed using one-way analysis of variance and a paired t-test. Results: Propofol and U83836E significantly ameliorated the CRMP2 proteolysis. In addition, both propofol and U83836E significantly decreased the ratio of 145-kDa aII-spectrin breakdown products to intact 270-kDa spectrin, the 4-hydroxynonenal expression and programmed cell death in the pericontusional cortex at 24 h after TBI. There was no difference between the TBI group and the fat emulsion group. Conclusions: These results demonstrate that propofol postconditioning alleviates calpain-mediated CRMP2 proteolysis and provides neuroprotective effects following moderate TBI potentially by counteracting LP and reducing calpain activation.	[Yu, Yun; Jian, Min-Yu; Wang, Yun-Zhen; Han, Ru-Quan] Capital Med Univ, Beijing Tian Tan Hosp, Dept Anesthesiol, Beijing 100050, Peoples R China		Han, RQ (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Anesthesiol, Beijing 100050, Peoples R China.	ruquan.han@gmail.com	Han, Ruquan/K-2433-2019		Beijing Nova ProgramBeijing Municipal Science & Technology Commission [2007B074]; Beijing Municipal Health System "215" High-level Medical Personnel Culturing Project [2009-3-19]; Youth Foundation of Beijing Tian Tan Hospital [KY2011-03]	This study was supported by grants from the Beijing Nova Program (No. 2007B074), the Beijing Municipal Health System "215" High-level Medical Personnel Culturing Project (No. 2009-3-19) and the Youth Foundation of Beijing Tian Tan Hospital (No. KY2011-03).	Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Bu XN, 2011, J NEUROCHEM, V117, P346, DOI 10.1111/j.1471-4159.2011.07209.x; Chen RM, 2013, SURGERY, V154, P58, DOI 10.1016/j.surg.2013.02.003; Cui DR, 2013, NEUROSCIENCE, V246, P117, DOI 10.1016/j.neuroscience.2013.04.054; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Gu JW, 2014, J CRIT CARE, V29, P287, DOI 10.1016/j.jcrc.2013.10.021; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Harman F, 2012, CHILD NERV SYST, V28, P1055, DOI 10.1007/s00381-012-1782-0; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Holownia A, 2009, J PHYSIOL PHARMACOL, V60, P63; Hou ST, 2009, J NEUROCHEM, V111, P870, DOI 10.1111/j.1471-4159.2009.06375.x; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kalimeris K, 2013, J CARDIOTHOR VASC AN, V27, P1246, DOI 10.1053/j.jvca.2012.12.009; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kawasaki H, 1996, MOL MEMBR BIOL, V13, P217, DOI 10.3109/09687689609160599; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Li J, 2010, BRAIN RES, V1356, P11, DOI 10.1016/j.brainres.2010.08.012; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Stefanis L, 2005, NEUROSCIENTIST, V11, P50, DOI 10.1177/1073858404271087; Taghian K, 2012, J NEUROTRAUM, V29, P1728, DOI 10.1089/neu.2011.2063; Tawfeeq NA, 2009, INJURY, V40, pS75, DOI 10.1016/j.injury.2009.10.040; Thal SC, 2014, CRIT CARE MED, V42, P129, DOI 10.1097/CCM.0b013e3182a639fd; Vasileiou I, 2009, EUR J PHARMACOL, V605, P1, DOI 10.1016/j.ejphar.2009.01.007; Xi HJ, 2011, BRAIN RES, V1410, P24, DOI 10.1016/j.brainres.2011.06.060; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078	33	6	7	0	2	CHINESE MEDICAL ASSOC	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	APR 5	2015	128	7					919	927		10.4103/0366-6999.154298			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF4PW	WOS:000352533500012	25836613	gold, Green Published			2022-02-06	
J	Farsi, L; Afshari, K; Keshavarz, M; NaghibZadeh, M; Memari, F; Norouzi-Javidan, A				Farsi, Leila; Afshari, Khashayar; Keshavarz, Mansoor; NaghibZadeh, Maryam; Memari, Fereidoon; Norouzi-Javidan, Abbas			Postinjury treatment with magnesium sulfate attenuates neuropathic pains following spinal cord injury in male rats	BEHAVIOURAL PHARMACOLOGY			English	Article						hyperalgesia; magnesium sulfate; neuropathic pain; rat; spinal cord injury; tail flick	TRAUMATIC BRAIN-INJURY; ORAL MAGNESIUM; LIPID-PEROXIDATION; DOUBLE-BLIND; HYPERALGESIA; PREVENTION; EFFICACY; 5-LIPOXYGENASE; PROPHYLAXIS; MECHANISMS	Spinal cord injury (SCI) has a number of severe and disabling consequences including chronic pain. Approximately 40% of patients experience neuropathic pain, which appears to be persistent. Previous studies have demonstrated the neuroprotective effects of magnesium sulfate (MgSO4). We aimed to investigate the effect of MgSO4 on neuropathic pains following SCI in male rats. Thirty-two adult male rats (weight 300-350 g) were used. After laminectomy, a complete SCI was induced by compression of the spinal cord for 1 min with an aneurysm clip. A single dose of 300 or 600 mg/kg MgSO4 was injected intraperitoneally. Tail-flick latency and acetone drop test scores were evaluated before surgery and once a week for 4 weeks after surgery. Rats in groups SCI + Mg300 and SCI + Mg600 showed significantly higher mean tail-flick latencies and lower mean scores in the acetone test compared with those in the SCI + veh group 4 weeks after surgery (P < 0.05). These findings revealed that systemic single-dose administration of MgSO4 can attenuate thermal hyperalgesia and cold allodynia induced by SCI in rats. Behavioural Pharmacology 26:315-320 Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Farsi, Leila; Norouzi-Javidan, Abbas] Univ Tehran Med Sci, Brain & Spinal Cord Injury Res Ctr, Tehran 1456833581, Iran; [Farsi, Leila; Afshari, Khashayar; Keshavarz, Mansoor; NaghibZadeh, Maryam] Univ Tehran Med Sci, Neurosci Inst, Electrophysiol Res Ctr, Tehran 1456833581, Iran; [Keshavarz, Mansoor] Univ Tehran Med Sci, Sch Med, Dept Physiol, Tehran 1456833581, Iran; [Memari, Fereidoon] Univ Tehran Med Sci, Imam Khomeini Hosp, Canc Inst, Tehran 1456833581, Iran		Keshavarz, M (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Physiol, Poursina St, Tehran 1456833581, Iran.	mkeshavarz@sina.tums.ac.ir	Afshari, Khashayar/I-6373-2019	Afshari, Khashayar/0000-0001-9099-7948; norouzi javidan, abbas/0000-0002-6611-3919	Tehran University of Medical SciencesTehran University of Medical Sciences [91-03-139-18681]; Brain and Spinal Cord Injury Research Center	The authors thank Dr Dehpour and Dr Javadi-paydar for their collaborations. This study was financially supported by Tehran University of Medical Sciences (proposal code of 91-03-139-18681), in collaboration with the Brain and Spinal Cord Injury Research Center.	Arai YCP, 2013, J ANESTH, V27, P960, DOI 10.1007/s00540-013-1641-5; Baastrup C, 2008, CNS DRUGS, V22, P455, DOI 10.2165/00023210-200822060-00002; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Bonnefont-Rousselot Dominique, 2004, Treat Endocrinol, V3, P41; Crosby V, 2000, J PAIN SYMPTOM MANAG, V19, P35, DOI 10.1016/S0885-3924(99)00135-9; Crowther CA, 2004, OBSTET GYNECOL SURV, V59, P330; Cuzzocrea S, 2005, LAB INVEST, V85, P808, DOI 10.1038/labinvest.3700276; DICKENS BF, 1992, FEBS LETT, V311, P187, DOI 10.1016/0014-5793(92)81098-7; Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283; Doyle LW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004661.pub3; Dubray C, 1997, NEUROREPORT, V8, P1383, DOI 10.1097/00001756-199704140-00013; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; Finnerup NB, 2012, CURR PAIN HEADACHE R, V16, P207, DOI 10.1007/s11916-012-0259-x; Genovese T, 2005, J NEUROIMMUNOL, V166, P55, DOI 10.1016/j.jneuroim.2005.05.009; Gok B, 2007, CHINESE J PHYSIOL, V50, P93; Gowda RM, 2004, INT J CARDIOL, V96, P467, DOI 10.1016/j.ijcard.2003.04.067; HARDING JJ, 1992, DRUG AGING, V2, P287, DOI 10.2165/00002512-199202040-00003; HARLAN JM, 1987, SEMIN THROMB HEMOST, V13, P434, DOI 10.1055/s-2007-1003520; Hasanein P, 2006, DIABETES RES CLIN PR, V73, P17, DOI 10.1016/j.diabres.2005.12.004; Kaptanoglu E, 2003, NEUROSURG REV, V26, P283, DOI 10.1007/s10143-003-0272-y; Kaptanoglu E, 2003, J CLIN NEUROSCI, V10, P329, DOI 10.1016/S0967-5868(03)00031-6; Kauppila T, 2000, EXP NEUROL, V161, P740, DOI 10.1006/exnr.1999.7287; Kohno H, 2007, ANN VASC SURG, V21, P352, DOI 10.1016/j.avsg.2007.01.010; Lampl Y, 2001, CLIN NEUROPHARMACOL, V24, P11, DOI 10.1097/00002826-200101000-00003; Lang-Lazdunski L, 2000, J VASC SURG, V32, P179, DOI 10.1067/mva.2000.105960; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; LEMKE M, 1990, MOL CHEM NEUROPATHOL, V12, P147, DOI 10.1007/BF03159941; Lindsey AE, 2000, NEUROREHAB NEURAL RE, V14, P287, DOI 10.1177/154596830001400405; Marret S, 2008, GYNECOL OBSTET FERTI, V36, P278, DOI 10.1016/j.gyobfe.2008.01.012; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCLEAN RM, 1994, AM J MED, V96, P63, DOI 10.1016/0002-9343(94)90117-1; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Mert T, 2009, N-S ARCH PHARMACOL, V380, P415, DOI 10.1007/s00210-009-0447-3; Miles AN, 2001, NEUROSURGERY, V49, P1443, DOI 10.1097/00006123-200112000-00025; MUIR KW, 1995, STROKE, V26, P1183, DOI 10.1161/01.STR.26.7.1183; Peker S, 2004, LIFE SCI, V75, P1523, DOI 10.1016/j.lfs.2004.05.003; Pickering G, 2011, MAGNESIUM RES, V24, P28, DOI 10.1684/mrh.2011.0282; Piotrowski AA, 2004, PHARMACOTHERAPY, V24, P879, DOI 10.1592/phco.24.9.879.36092; Regan RF, 1998, J NEUROCHEM, V70, P77; Rondon LJ, 2010, J PHYSIOL-LONDON, V588, P4205, DOI 10.1113/jphysiol.2010.197004; Rouse DJ, 2008, NEW ENGL J MED, V359, P895, DOI 10.1056/NEJMoa0801187; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; Sakurai M, 2009, PAIN, V147, P165, DOI 10.1016/j.pain.2009.09.003; Sibai BM, 2005, CLIN OBSTET GYNECOL, V48, P478, DOI 10.1097/01.grf.0000160314.59736.d2; SIMPSON JI, 1994, ANESTHESIOLOGY, V81, P1493, DOI 10.1097/00000542-199412000-00025; Soltani N, 2005, LIFE SCI, V76, P1455, DOI 10.1016/j.lfs.2004.07.027; Soltani N, 2005, CLIN EXP PHARMACOL P, V32, P604, DOI 10.1111/j.0305-1870.2005.04238.x; Soltani N, 2007, EUR J PHARMACOL, V560, P201, DOI 10.1016/j.ejphar.2006.12.020; Song JW, 2011, ANESTH ANALG, V113, P390, DOI 10.1213/ANE.0b013e31821d72bc; Suzer T, 1999, SPINAL CORD, V37, P480, DOI 10.1038/sj.sc.3100874; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Ulugol A, 2002, BRAIN RES, V943, P101, DOI 10.1016/S0006-8993(02)02618-5; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; Weissberg N, 1991, Magnes Res, V4, P49; Wiseman DB, 2009, J NEUROSURG-SPINE, V10, P308, DOI 10.3171/spi.2009.10.4.308; WOLF G, 1991, NEUROSCIENCE, V43, P31, DOI 10.1016/0306-4522(91)90413-I; XU J, 1990, J NEUROCHEM, V55, P907, DOI 10.1111/j.1471-4159.1990.tb04577.x; XU XJ, 1994, PAIN, V56, P271, DOI 10.1016/0304-3959(94)90165-1; YAGIHASHI S, 1995, DIABETES METAB REV, V11, P193, DOI 10.1002/dmr.5610110304; Yezierski RP, 2013, BEHAV PHARMACOL, V24, P598, DOI 10.1097/FBP.0b013e3283656d9b	61	6	6	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0955-8810	1473-5849		BEHAV PHARMACOL	Behav. Pharmacol.	APR	2015	26	3					315	320		10.1097/FBP.0000000000000103			6	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	CD0MU	WOS:000350769200008	25369748				2022-02-06	
J	Hong, YY; Nie, H; Wei, XB; Fu, S; Ying, WH				Hong, Yunyi; Nie, Hui; Wei, Xunbin; Fu, Shen; Ying, Weihai			NAD(+) Treatment Can Prevent Rotenone-Induced Increases in DNA Damage, Bax Levels and Nuclear Translocation of Apoptosis-Inducing Factor in Differentiated PC12 Cells	NEUROCHEMICAL RESEARCH			English	Article						Apoptosis; Apoptosis-inducing factor; DNA double-strand breaks; Mitochondrial permeability transition; NAD(+); Necrosis	DEATH; PARKINSONS; MARKER; DEPLETION; MODEL	Nicotinamide adenine dinucleotide (NAD(+)) plays critical roles in energy metabolism, mitochondrial functions, calcium homeostasis and immunological functions. Our previous studies have found that NAD(+) administration can profoundly decrease ischemic brain injury and traumatic brain injury. Our recent study has also provided first direct evidence indicating that NAD(+) treatment can decrease cellular apoptosis, while the mechanisms underlying this protective effect remain unclear. In our current study, we determined the effects of NAD(+) treatment on several major factors in apoptosis and necrosis, including levels of Bax and nuclear translocation of apoptosis-inducing factor (AIF), as well as levels of DNA double-strand breaks (DSBs) and intracellular ATP in rotenone-treated differentiated PC12 cells. We found that NAD(+) treatment can markedly attenuate the rotenone-induced increases in the levels of Bax and nuclear translocation of AIF in the cells. We further found that NAD(+) treatment can significantly attenuate the rotenone-induced increase in the levels of DSBs and decrease in the intracellular ATP levels. Collectively, our study has suggested mechanisms underlying the preventive effects of NAD(+) on apoptosis, which has highlighted the therapeutic potential of NAD(+) for decreasing apoptotic changes in multiple major diseases.	[Hong, Yunyi; Nie, Hui; Wei, Xunbin; Ying, Weihai] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China; [Hong, Yunyi; Nie, Hui; Wei, Xunbin; Ying, Weihai] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Fu, Shen] Shanghai Proton & Heavy Ion Ctr, Dept Radiat Oncol, Shanghai 201321, Peoples R China; [Ying, Weihai] Shanghai Jiao Tong Univ, Ruijin Hosp, Inst Neurol, Sch Med, Shanghai 200030, Peoples R China		Ying, WH (corresponding author), Shanghai Jiao Tong Univ, Med X Res Inst, 1954 Huashan Rd, Shanghai 200030, Peoples R China.	weihaiy@sjtu.edu.cn		Hong, Yunyi/0000-0002-2921-6417	Chinese National Science FoundationNational Natural Science Foundation of China (NSFC) [81171098, 81271305]; Shanghai Jiao Tong University Grants for Interdisciplinary Research on Medicine and Engineering	This study was supported by Chinese National Science Foundation Grants #81171098 and #81271305 (to W. Y.), and two Shanghai Jiao Tong University Grants for Interdisciplinary Research on Medicine and Engineering (to W. Y.).	Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Chung DH, 1998, VIRCHOWS ARCH, V433, P113, DOI 10.1007/s004280050225; Chung YFA, 1998, BRIT J SURG, V85, P1255; Eguchi Y, 1997, CANCER RES, V57, P1835; Esposito E, 2010, CURR MED CHEM, V17, P2764, DOI 10.2174/092986710791859324; Greenamyre JT, 2003, PARKINSONISM RELAT D, V9, pS59, DOI 10.1016/S1353-8020(03)00023-3; Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085; Hong YY, 2014, NEUROSCI LETT, V560, P46, DOI 10.1016/j.neulet.2013.11.039; Jang SJ, 2003, FEMS MICROBIOL LETT, V224, P191, DOI 10.1016/S0378-1097(03)00422-1; Kristal BS, 2004, J BIOENERG BIOMEMBR, V36, P309, DOI 10.1023/B:JOBB.0000041759.35731.70; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; Sheng Caibin, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P1; Stryer L., 1995, BIOCHEMISTRY-US; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Won SJ, 2012, J NEUROTRAUM, V29, P1401, DOI 10.1089/neu.2011.2228; Yamada Y, 2005, ANN NY ACAD SCI, V1049, P9, DOI 10.1196/annals.1334.002; Ying W, 2006, FRONT BIOSCI, V12, P2728; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Zheng CB, 2012, NEUROSCI LETT, V512, P67, DOI 10.1016/j.neulet.2012.01.007	23	6	6	0	16	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	APR	2015	40	4					837	842		10.1007/s11064-015-1534-0			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CE5HE	WOS:000351861100021	25813492				2022-02-06	
J	Josse, F; Helm, M; Kulla, M; Ladehof, K; Hossfeld, B				Josse, F.; Helm, M.; Kulla, M.; Ladehof, K.; Hossfeld, B.			Prehospital Measures to Stop Bleeding: The Tourniquet	NOTARZT			German	Article						critical bleeding; trauma care; bleeding control; tourniquet	COMBAT CASUALTY CARE; TREATMENT OPTIONS; TRAUMA	Beside the traumatic brain injury the bleeding is the leading cause of death in trauma. Relevant bleeding results not only in reduction of oxygen transport capacity by loss of erythrocyts, but further more in coagulopathy by loss of thrombocyts and coagulation factors, which again can worsen the bleeding. To stop the bleeding as early as possible in the prehospital setting is an important and often neglected factor in EMS. To improve the awareness of physicians and EMS-personnel on this problem the classical ABCDE-algorithm of trauma care was extended by a frontal < C > meaning, critical bleeding". An easy to use, fast and safe device to control bleeding in extremities is the tourniquet, which was frowned long time and now after successful use in military missions returns to civilian use. The following article is to explain indications and correct use of the tourniquet in the prehospital setting.	[Josse, F.; Helm, M.; Kulla, M.] Klin Anasthesiol & Intensivmed, Sekt Notfallmed, Bundeswehrkrankenhaus, D-89081 Ulm, Germany; [Josse, F.; Helm, M.; Hossfeld, B.] Deutsch Gesell Anasthesiol & Intensivmed, Arbeitsgrp Takt Med Arbeitskreises Notfallmellmed, Berlin, Germany; [Ladehof, K.] Tact Rescue & Emergency Med Assoc TREMA eV, Lubeck, Germany		Josse, F (corresponding author), Klin Anasthesiol & Intensivmed, Sekt Notfallmed, Bundeswehrkrankenhaus, Oberer Eselsberg 40, D-89081 Ulm, Germany.	florentjosse@bundeswehr.org	Kulla, Martin/AAA-7718-2020	Kulla, Martin/0000-0001-7454-0876			BELLAMY RF, 1984, MIL MED, V149, P55; Bohnen R., 2012, TAKTISCHE MED, P323, DOI [10.1007/978-3-642-20697-9_23, DOI 10.1007/978-3-642-20697-9_23]; Butler FK, 1996, MIL MED, V161, P3, DOI 10.1093/milmed/161.suppl_1.3; Dorlac WC, 2005, J TRAUMA, V59, P217, DOI 10.1097/01.TA.0000173699.71652.BA; Doyle GS, 2008, PREHOSP EMERG CARE, V12, P241, DOI 10.1080/10903120801907570; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Fludger Stuart, 2009, Air Med J, V28, P291, DOI 10.1016/j.amj.2009.06.002; Hauschild SW, 2013, NOTFALL RETTUNGSMED, V16, P1; Josse F, 2014, NOTFALLMED UP2DATE, V9, P7, DOI DOI 10.1055/s-0033-1357878; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kleber C, 2013, WORLD J SURG, V37, P1154, DOI 10.1007/s00268-013-1964-2; Kragh John F Jr, 2013, J Spec Oper Med, V13, P5; Kragh JF, 2009, ANN SURG, V249, P1, DOI 10.1097/SLA.0b013e31818842ba; Kulla M, 2015, NOTARZT, V31, P47, DOI 10.1055/s-0034-1399823; Kulla M, 2014, NOTFALL RETTUNGSMED, V17, P575, DOI 10.1007/s10049-014-1864-5; TREMA ed. TREMA e.V., 2013, GUID TCCC TACT RESC; Walter P, 1981, Unfallchirurgie, V7, P90, DOI 10.1007/BF02589638	17	6	6	1	5	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0177-2309	1438-8693		NOTARZT	Notarzt	APR	2015	31	2					103	107		10.1055/s-0035-1550274			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CG4AX	WOS:000353223600014					2022-02-06	
J	Keiski, MA; Shore, DL; Hamilton, JM; Malec, JF				Keiski, Michelle A.; Shore, Douglas L.; Hamilton, Joanna M.; Malec, James F.			Simulation of Traumatic Brain Injury Symptoms on the Personality Assessment Inventory: An Analogue Study	ASSESSMENT			English	Article						traumatic brain injury; malingering; simulation; Personality Assessment Inventory; validity scales; operating characteristics	FAKE-BAD SCALE; MALINGERED NEUROCOGNITIVE DYSFUNCTION; MMPI-2 VALIDITY SCALES; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; HEAD-INJURY; CLINICAL-SAMPLE; POOR EFFORT; DIGIT SPAN; PAI; EXAGGERATION	The purpose of this study was to characterize the operating characteristics of the Personality Assessment Inventory (PAI) validity scales in distinguishing simulators feigning symptoms of traumatic brain injury (TBI) while completing the PAI (n = 84) from a clinical sample of patients with TBI who achieved adequate scores on performance validity tests (n = 112). The simulators were divided into two groups: (a) Specific Simulators feigning cognitive and somatic symptoms only or (b) Global Simulators feigning cognitive, somatic, and psychiatric symptoms. The PAI overreporting scales were indeed sensitive to the simulation of TBI symptoms in this analogue design. However, these scales were less sensitive to the feigning of somatic and cognitive TBI symptoms than the feigning of a broad range of cognitive, somatic, and emotional symptoms often associated with TBI. The relationships of TBI simulation to consistency and underreporting scales are also explored.	[Keiski, Michelle A.; Malec, James F.] Indiana Univ, Indianapolis, IN 46204 USA; [Shore, Douglas L.] Univ Windsor, Windsor, ON N9B 3P4, Canada; [Hamilton, Joanna M.] Independent Practice, Peterborough, ON, Canada		Keiski, MA (corresponding author), IU Ctr Neuroimaging, 355 W 16th St,Suite 4100 Room 4072, Indianapolis, IN 46202 USA.	mkeiski@iupui.edu					Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P101, DOI 10.1093/arclin/acr081; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; Berry DTR, 1998, CRIT ISS NE, P209; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Dearth CS, 2005, ARCH CLIN NEUROPSYCH, V20, P95, DOI 10.1016/j.acn.2004.03.004; Delis D.C., 2000, CALIFORNIA VERBAL LE; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Haggerty KA, 2007, CLIN NEUROPSYCHOL, V21, P917, DOI 10.1080/13854040600899724; Hawes SW, 2009, PSYCHOL ASSESSMENT, V21, P112, DOI 10.1037/a0015036; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hoffman R. G., 1999, J FORENSIC NEUROPSYC, V1, P3, DOI DOI 10.1300/J151V01N02_02; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martin-Cannici C, 1995, ASSESSMENT, V2, P333, DOI [10.1177/1073191195002004004, DOI 10.1177/1073191195002004004]; McCaffrey R.J., 2003, J FORENSIC NEUROPSYC, V3, P45, DOI [https://doi.org/10.1300/J151v03n03_03, DOI 10.1300/J151V03N03_03]; Mild Traumatic Brain Injury Committee American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morey, 1991, PERSONALITY ASSESSME; Morey L. C., 1996, INTERPRETIVE GUIDE P; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; Rogers R, 1998, LAW HUMAN BEHAV, V22, P273, DOI 10.1023/A:1025702405865; Rogers R, 1998, ASSESSMENT, V5, P399, DOI 10.1177/107319119800500409; ROGERS R, 1993, J PERS ASSESS, V60, P554, DOI 10.1207/s15327752jpa6003_12; Rogers R, 1996, J PERS ASSESS, V67, P629, DOI 10.1207/s15327752jpa6703_15; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Sumanti M, 2006, CLIN NEUROPSYCHOL, V20, P754, DOI 10.1080/13854040500428467; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Till C, 2009, BRAIN INJURY, V23, P655, DOI 10.1080/02699050902970794; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Velikonja D, 2010, J CLIN EXP NEUROPSYC, V32, P610, DOI 10.1080/13803390903401302; Whiteside DM, 2012, J CLIN EXP NEUROPSYC, V34, P172, DOI 10.1080/13803395.2011.630648; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	52	6	8	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	APR	2015	22	2					233	247		10.1177/1073191114539380			15	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	CC3LR	WOS:000350251000010	24965838				2022-02-06	
J	Partridge, B; Hall, W				Partridge, Brad; Hall, Wayne			Repeated Head Injuries in Australia's Collision Sports Highlight Ethical and Evidential Gaps in Concussion Management Policies	NEUROETHICS			English	Article						Concussion; Chronic traumatic encephalopathy; Traumatic brain injury; Rugby league; Australian Rules football; Rugby union	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RECURRENT CONCUSSION; RISK-FACTOR; ENCEPHALOPATHY; EPIDEMIOLOGY; ASSOCIATION; IMPAIRMENT; MEDICINE	Head injuries (including concussion) are an inherent risk of participating in the major collision sports played in Australia (rugby league, rugby union and Australian Rules football). Protocols introduced by the governing bodies of these sports are ostensibly designed to improve player safety but do not prevent players suffering from repeated concussions. There is evidence that repeated traumatic brain injuries increase the risk of developing a number of long term problems but scientific and popular debates have largely focused on whether there is a causal link between concussion and chronic traumatic encephalopathy (CTE). We argue that the governing bodies of collision sports played in Australia have used uncertainty about CTE to justify a "wait and see" approach instead of attempting to prevent repeated head injuries. This stance is difficult to defend when these governing bodies claim to give a high priority to protecting player welfare.	[Partridge, Brad; Hall, Wayne] Univ Queensland, UQCCR, Herston, Qld 4029, Australia		Partridge, B (corresponding author), Univ Queensland, UQCCR, Herston, Qld 4029, Australia.	b.partridge@uq.edu.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096	National Health and Medical Research Council Postdoctoral FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	Thanks to Dr Lynley Anderson and Dr Andrew Gardner for providing useful insights, feedback and suggestions on this paper. Brad Partridge is supported by a National Health and Medical Research Council Postdoctoral Fellowship (2011-2014).	ABC, HARD KNOCKS 2012; Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Carlisle W., 2014, CONCUSSION GAMES ABC; Crawley Paul, 2014, DAILY TELEGRAPH; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guskiewicz K.M., 2007, NEUROLOGY, V39, P903; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kaye AH, 2012, MED J AUSTRALIA, V196, P547, DOI 10.5694/mja12.10539; Lane S, 2012, SYDNEY MORNING HERAL; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McNamee M, 2013, AM J BIOETHICS, V13, P15, DOI 10.1080/15265161.2013.828123; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; NRL, NRL MAILB PLAYER SAF; NRL, MAN CONC RUGB LEAG; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Partridge B, 2014, NEUROETHICS-NETH, V7, P63, DOI 10.1007/s12152-013-9182-z; Raftery M, 2014, BRIT J SPORT MED, V48, P79, DOI 10.1136/bjsports-2013-093051; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Walter B., 2013, BRAINS TRUST DEBATES; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785	36	6	6	0	37	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1874-5490	1874-5504		NEUROETHICS-NETH	Neuroethics	APR	2015	8	1					39	45		10.1007/s12152-014-9217-0			7	Ethics; Medical Ethics; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Biomedical Social Sciences	CH2UZ	WOS:000353881500005					2022-02-06	
J	Putnam, JB; Untaroiu, CD; Littell, J; Annett, M				Putnam, Jacob B.; Untaroiu, Costin D.; Littell, Justin; Annett, Martin			Finite Element Model of the THOR-NT Dummy under Vertical Impact Loading for Aerospace Injury Prediction: Model Evaluation and Sensitivity Analysis	JOURNAL OF THE AMERICAN HELICOPTER SOCIETY			English	Article								Anthropometric test devices, commonly referred to as crash test dummies, are effective tools used to conduct aerospace safety evaluations. In this study, the latest finite element (FE) model of the Test Device for Human Occupant Restraint (THOR) dummy was simulated under vertical impact conditions based on data recorded in a series of drop tests conducted at the NASA Langley Research Center. The purpose of this study was threefold. The first was to improve and then evaluate this FE model for use in a vertical loading environment through kinematic and kinetic response comparisons. The second was to evaluate dummy injury criteria under variable impact conditions. The last was to determine the response sensitivity of the FE model with respect to its preimpact postural position. Results demonstrate that the updated FE model performs well under vertical loading and predicts injury criteria values close to those recorded in testing. In the postural sensitivity study, the head injury criteria response and peak lumbar load show to be primarily sensitive to the preimpact head angle and thorax angle, respectively. The promising results shown by the dummy model recommends its use in impact simulations with vertical deceleration pulses close to those used in this study. In addition, it is believed that assigning accurate viscoelastic material properties to the deformable parts of the model may further increase the model fidelity for a larger range of impacts.	[Putnam, Jacob B.; Untaroiu, Costin D.] Virginia Tech, Blacksburg, VA USA; [Littell, Justin; Annett, Martin] NASA, Langley Res Ctr, Hampton, VA 23665 USA		Untaroiu, CD (corresponding author), Virginia Tech, Blacksburg, VA USA.	costin@vt.edu	Untaroiu, Costin/D-4106-2009	Untaroiu, Costin/0000-0002-1813-669X			[Anonymous], 2007, J2111 SAE; Barbat S., 2013, P 23 INT TECHN C ENH; Bass CR, 2006, INT IRCOBI C BIOM IM; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Eekhout M, 2008, CARDBOARD ARCHITECTU; EWING CL, 1968, 12 STAPP CAR CRASH C; Gehre C., 2009, ESV C STUTTG GERM JU; GESAC, 2005, GESAC0504; Hovenga P. E., 2004, 10 INT MADYMO US M A; Jackson KE, 2009, J AEROSPACE ENG, V22, P229, DOI 10.1061/(ASCE)0893-1321(2009)22:3(229); JACOB C, 2000, INT J CRASHWORTHINES, V5, P417; Kleinberger M., 1998, DEV IMPR INJ CRIT AS; Littell J., 2013, AM HEL SOC 69 ANN FO; Manoogian SJ, 2006, AVIAT SPACE ENVIR MD, V77, P509; Pellettiere JA, 2012, ADV HUM FACT ERG SER, P307; Polanco M. A., 2011, AM HEL SOC 67 ANN FO; Putnam JB, 2014, TRAFFIC INJ PREV, V15, P844, DOI 10.1080/15389588.2014.880886; Salzar RS, 2009, AVIAT SPACE ENVIR MD, V80, P621, DOI 10.3357/ASEM.2472.2009; Sarin H., 2008, P ASME INT DES ENG T, V1, P1275; Shaw G., 2000, IRCOBI C P MONTP FRA; Somers J. T., 2014, FRONTIERS BIOENGINEE, V2; Thunert, 2012, CORA RELEASE 3 6 USE; Untaroiu C., 2011, SAE 2011 WORLD C EXH; Untaroiu C., 2009, 21 ESV C STUTTG GERM; Untaroiu CD, 2013, INT J AUTO TECH-KOR, V14, P395, DOI 10.1007/s12239-013-0043-x; Untaroiu CD, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/460413; Untaroiu CD, 2013, J MECH BEHAV BIOMED, V26, P11, DOI 10.1016/j.jmbbm.2013.05.013; Untaroiu CD, 2009, INT J IMPACT ENG, V36, P210, DOI 10.1016/j.ijimpeng.2008.01.012; Versace J, 1971, REV SEVERITY INDEX; Yu H, 2004, INT J CRASHWORTHINES, V9, P175, DOI 10.1533/ijcr.2004.0276; Zhan Z., 2011, SAE 2011 WORLD C DET	31	6	6	1	7	AMER HELICOPTER SOC INC	ALEXANDRIA	217 N WASHINGTON ST, ALEXANDRIA, VA 22314 USA	0002-8711	2161-6027		J AM HELICOPTER SOC	J. Am. Helicopter Soc.	APR	2015	60	2							022004	10.4050/JAHS.60.022004			10	Engineering, Aerospace	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	DE1LD	WOS:000370387600004					2022-02-06	
J	Wooten, NR				Wooten, Nikki R.			Military Social Work: Opportunities and Challenges for Social Work Education	JOURNAL OF SOCIAL WORK EDUCATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; COMBAT-RELATED PTSD; OPERATIONS ENDURING FREEDOM; FAMILY-CENTERED PREVENTION; TRAUMATIC BRAIN-INJURY; SERVICE MEMBERS; US MILITARY; PSYCHOLOGICAL-RESILIENCE; HOME TELEHEALTH	Military social work is a specialized field of practice spanning the micro-macro continuum and requiring advanced social work knowledge and skills. The complex behavioral health problems and service needs of Iraq and Afghanistan veterans highlight the need for highly trained social work professionals who can provide militarily relevant and culturally responsive evidence-informed services. Responding to the military behavioral health workforce and service needs of recently returned veterans presents both opportunities and challenges for military social work education. This article discusses the rationale for a military social work specialization, the need for military social work education, and opportunities and challenges for social work education. An integrated model of intellectual capital is proposed to guide strategic planning for future military social work education.	[Wooten, Nikki R.] Univ S Carolina, Columbia, SC 29208 USA; [Wooten, Nikki R.] Dist Columbia Army Natl Guard, Washington, DC USA		Wooten, NR (corresponding author), Univ S Carolina, Coll Social Work, DeSaussure Coll, Columbia, SC 29208 USA.	nwooten@sc.edu	Wooten, Nikki/R-7071-2019	Wooten, Nikki/0000-0002-6319-8224	National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K01DA037412]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K01DA037412] Funding Source: NIH RePORTER	Dr. Wooten acknowledges the support of National Institute on Drug Abuse K01DA037412.	Adler AB, 2013, MILITARY BEHAV HLTH, V1, P41, DOI DOI 10.1080/21635781.2012.721063; Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1097/00000374-199706000-00008; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P2; Beardslee W, 2011, PREV SCI, V12, P339, DOI 10.1007/s11121-011-0234-5; Beardslee WR, 2013, CLIN CHILD FAM PSYCH, V16, P394, DOI 10.1007/s10567-013-0154-y; Ben-Zeev D, 2012, J MENT HEALTH, V21, P264, DOI 10.3109/09638237.2011.621468; Benish SG, 2008, CLIN PSYCHOL REV, V28, P746, DOI 10.1016/j.cpr.2007.10.005; Besterman-Dahan K, 2012, MIL MED, V177, P1028, DOI 10.7205/MILMED-D-12-00071; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Blount TH, 2014, COGN BEHAV PRACT, V21, P89, DOI 10.1016/j.cbpra.2013.05.004; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Bowles SV, 2010, MIL MED, V175, P382, DOI 10.7205/MILMED-D-10-00099; Boyko EJ, 2013, DIABETES CARE, V36, P3154, DOI 10.2337/DC13-0042; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; Cardona S. E. A., 2000, PROQUEST INFORM LEAR; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Casey GW, 2011, AM PSYCHOL, V66, P1, DOI 10.1037/a0021930; Chaison A. D., 2010, CLIN CASE STUD, V9, P191, DOI [10.1177/1534650110372252, DOI 10.1177/1534650110372252]; Coll JE, 2011, SOC WORK HEALTH CARE, V50, P487, DOI 10.1080/00981389.2010.528727; Compton PA, 2008, J PAIN SYMPTOM MANAG, V36, P383, DOI 10.1016/j.jpainsymman.2007.11.006; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Council on Social Work Education, 2010, ADV SOC WORK PRACT M; Cukor J, 2009, CLIN PSYCHOL REV, V29, P715, DOI 10.1016/j.cpr.2009.09.001; Darkins A, 2008, TELEMED J E-HEALTH, V14, P1118, DOI 10.1089/tmj.2008.0021; Davis J. G., 2013, HDB MILITARY SOCIAL, P51; DeVoe ER, 2012, MIL MED, V177, P184, DOI 10.7205/MILMED-D-11-00292; Dickstein BD, 2010, MIL PSYCHOL, V22, P224, DOI 10.1080/08995600903417399; Engel CC, 2008, MIL MED, V173, P935, DOI 10.7205/MILMED.173.10.935; Esposito-Smythers C, 2011, J FAM PSYCHOL, V25, P497, DOI 10.1037/a0024534; Foa EB, 1997, ANNU REV PSYCHOL, V48, P449, DOI 10.1146/annurev.psych.48.1.449; Gibbs DA, 2011, MIL PSYCHOL, V23, P97, DOI 10.1080/08995605.2011.534418; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Granado NS, 2009, HYPERTENSION, V54, P966, DOI 10.1161/HYPERTENSIONAHA.109.132555; Greene RR., 2004, J HUM BEHAV SOC ENVI, V8, P75, DOI [10.1300/J137v08n04_05, DOI 10.1300/J137V08N04_05]; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Harb GC, 2012, J TRAUMA STRESS, V25, P511, DOI 10.1002/jts.21748; Harris J., 2000, SOCIAL WORK MILITARY, P3; Hartman RT, 2004, MIL MED, V169, P1; Hawkins Judge Michael Daly, 2009, OHIO STATE J CRIMINA, V7, P563; Hogan TP, 2011, J GEN INTERN MED, V26, pS628, DOI 10.1007/s11606-011-1765-y; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoge CW, 2005, AM J PSYCHIAT, V162, P585, DOI 10.1176/appi.ajp.162.3.585; Hoge MA, 2005, ADM POLICY MENT HLTH, V32, P509, DOI 10.1007/s10488-005-3263-1; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Hudak RP, 2009, MIL MED, V174, P566, DOI 10.7205/MILMED-D-04-0408; Huebner AJ, 2009, FAM RELAT, V58, P216, DOI 10.1111/j.1741-3729.2008.00548.x; Institute of Medicine, 2012, SUBST US DIS US ARME; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Khalique M., 2011, INT J CURRENT RES, V3, P343; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Larson MJ, 2012, J SOC WORK PRACT ADD, V12, P6, DOI 10.1080/1533256X.2012.647586; Larson MJ, 2014, AM J PUBLIC HEALTH, V104, P1402, DOI 10.2105/AJPH.2014.301901; LeardMann CA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1273; Lester P, 2011, MIL MED, V176, P19, DOI 10.7205/MILMED-D-10-00122; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; Marrelli AF, 2005, ADM POLICY MENT HLTH, V32, P533, DOI 10.1007/s10488-005-3264-0; Matthews-Juarez P, 2013, J HUM BEHAV SOC ENVI, V23, P769, DOI 10.1080/10911359.2013.795073; Meredith L, 2011, PROMOTING PSYCHOL RE; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Monson C. M., 2011, CARING VETERANS DEPL, P151; Moore B. A., 2011, TREATING PTSD MILITA; Morasco BJ, 2008, GEN HOSP PSYCHIAT, V30, P93, DOI 10.1016/j.genhosppsych.2007.12.004; Murphy RA, 2013, CLIN CHILD FAM PSYCH, V16, P348, DOI 10.1007/s10567-013-0149-8; National Association of Social Workers, 2012, NASW STAND SOC WORK; National Association of State Alcohol and Drug Abuse Directors, 2009, ADDR SUBST US DIS SE; Newby JH, 2005, MIL MED, V170, P643, DOI 10.7205/MILMED.170.8.643; Olatunji BO, 2014, PSYCHOL TRAUMA-US, V6, P50, DOI 10.1037/a0029682; Paley B, 2013, CLIN CHILD FAM PSYCH, V16, P245, DOI 10.1007/s10567-013-0138-y; Peterson AL, 2011, J CLIN PSYCHOL MED S, V18, P164, DOI 10.1007/s10880-011-9238-3; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P745, DOI 10.1002/da.20558; Ramsberger P. F., 2012, HIST RES METHODS SEL; Reisinger HS, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110116; Rentz ED, 2007, AM J EPIDEMIOL, V165, P1199, DOI 10.1093/aje/kwm008; Rubin A., 2013, HDB MILITARY SOCIAL; Rubin A, 2012, SOC WORK, V57, P293, DOI 10.1093/sw/sws048; Sanders D. K. A., 1994, PROQUEST INFORM LEAR; Savitsky L, 2009, SOC WORK, V54, P327, DOI 10.1093/sw/54.4.327; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Stander VA, 2014, CLIN PSYCHOL REV, V34, P87, DOI 10.1016/j.cpr.2013.12.002; Tanielian T., 2008, INVISIBLE WOUNDS WAR; U. S. Department of the Army, 2009, WARR TRANS UN CONS G; U. S. Department of Veterans Affairs & U. S. Department of Defense, 2010, MAN POSTTR STRESS DI; U. S. Department of Veterans Affairs & U. S. Department of Defense, 2013, VA DOD CLIN PRACT GU; U. S. Department of Veterans Affairs & U. S. Department of Defense, 2009, MAN SUBST US DIS SUD; U. S. Government Accountability Office, 2006, POSTTR STRESS DIS DO; U. S. Government Accountability Office, 2006, EFF PROV SEAML TRANS; US Government Accountability Office, 2012, GAO12718T; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Waynick Thomas, 2006, MILITARY LIFE PSYCHO, V2, P173; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Williams A.M., 2011, TREATING PTSD MILITA, P59; Wooten N. R., 2014, SAGE RES MEYHODS CAS; Wooten NR, 2013, J HUM BEHAV SOC ENVI, V23, P699, DOI 10.1080/10911359.2013.795049; Wooten NR, 2013, J SUBST ABUSE TREAT, V45, P257, DOI 10.1016/j.jsat.2013.04.001; Wooten NR, 2012, SOC WORK HEALTH CARE, V51, P828, DOI 10.1080/00981389.2012.692353; Wooten NR, 2011, NEW HORIZ MANAG, P71; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	104	6	6	2	29	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1043-7797	2163-5811		J SOC WORK EDUC	J. Soc. Work Educ.	APR 1	2015	51			1	SI		S6	S25		10.1080/10437797.2015.1001274			20	Education & Educational Research; Social Work	Social Science Citation Index (SSCI)	Education & Educational Research; Social Work	CG7RA	WOS:000353500900002	26089628				2022-02-06	
J	Awai, L; Curt, A				Awai, Lea; Curt, Armin			Preserved Sensory-Motor Function Despite Large-Scale Morphological Alterations in a Series of Patients with Holocord Syringomyelia	JOURNAL OF NEUROTRAUMA			English	Article						holocord; plasticity; spinal cord; syringomyelia	SPINAL-CORD-INJURY; SOMATOSENSORY-EVOKED-POTENTIALS; UPPER-LIMB; RECOVERY; DEFICITS; BRAIN; PROPRIOCEPTION; RELIABILITY; CONDUCTION; VALIDITY	Although the central nervous system has a limited capacity for regeneration after acute brain and spinal cord injuries, it can reveal extensive morphological changes. Occasionally, the formation of an extensive syrinx in the spinal cord can be observed that causes no or only limited signs of functional impairment. This condition creates a unique opportunity to evaluate the mismatch between substantial morphological changes and functional outcomes. We identified seven patients with holocord syringomyelia affecting the cervical cord following chronic traumatic thoracic/lumbar spinal cord injury (19-34 years after injury) or holocord syringomyelia of non-traumatic origin, and anatomical syrinx dimensions (length, cross-sectional area) were determined using sagittal and axial magnetic resonance imaging scans. Motor- and sensory-pathway integrity were evaluated using electrophysiological assessments (i.e., motor, dermatomal sensory, and dermatomal contact-heat [dCHEP] evoked potentials, as well as nerve conduction studies). These were specifically compared to clinical measures of upper-limb strength and grasping performance, including three-dimensional motion analysis. Despite extensive anatomical changes of the cervical cord (on average 26% reduction of residual spinal cord area and intrusion of almost the entire cervical spinal cord), a clinically relevant impairment of upper-limb motor function was absent while only subtle sensory deficits could be detected. dCHEPs revealed the highest sensitivity by disclosing impairments of spinothalamic pathways. Comparable to that of the brain, extensive anatomical changes of the spinal cord can occur with only subtle functional impairment. The time scale of slowly-emerging morphological alterations is essential to permit an enormous capacity for plasticity of the spinal cord.	[Awai, Lea; Curt, Armin] Univ Zurich, Spinal Cord Injury Ctr, Balgrist Univ Hosp, CH-8006 Zurich, Switzerland		Awai, L (corresponding author), Balgrist Univ Hosp, Spinal Cord Injury Ctr, Forchstr 340, CH-8008 Zurich, Switzerland.	lawai@paralab.balgrist.ch		Awai, Lea/0000-0002-9542-1152	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [CP-IP 258654]; Wolf Foundation, Switzerland; Clinical Research Priority Program CRPP Neurorehab UZH	This work was supported by the European Commission's Seventh Framework Program [CP-IP 258654, NEUWalk]; the Wolf Foundation, Switzerland; the Clinical Research Priority Program CRPP Neurorehab UZH.	Buurke JH, 2008, NEUROREHAB NEURAL RE, V22, P676, DOI 10.1177/1545968308317972; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Chamberlain MC, 2011, CURR NEUROL NEUROSCI, V11, P320, DOI 10.1007/s11910-011-0190-2; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Curt A, 2012, Handb Clin Neurol, V109, P63, DOI 10.1016/B978-0-444-52137-8.00004-8; Curt A, 1999, SPINAL CORD, V37, P157, DOI 10.1038/sj.sc.3100809; Curt A, 1996, ARCH PHYS MED REHAB, V77, P48, DOI 10.1016/S0003-9993(96)90219-1; Curt A, 1997, ARCH PHYS MED REHAB, V78, P39, DOI 10.1016/S0003-9993(97)90007-1; Curt A, 1996, NEUROREHABILITATION, V7, P165, DOI 10.3233/NRE-1996-7302; Desmurget M, 2007, BRAIN, V130, P898, DOI 10.1093/brain/awl300; Ditunno JF, 2000, SPINAL CORD, V38, P234, DOI 10.1038/sj.sc.3100993; Emery E, 1998, NEUROPHYSIOL CLIN, V28, P56, DOI 10.1016/S0987-7053(97)89578-0; Feuillet L, 2007, LANCET, V370, P262, DOI 10.1016/S0140-6736(07)61127-1; Gezen F, 2000, SPINE, V25, P727, DOI 10.1097/00007632-200003150-00013; GORDON J, 1995, J NEUROPHYSIOL, V73, P347, DOI 10.1152/jn.1995.73.1.347; GRANT R, 1987, J NEUROL NEUROSUR PS, V50, P1008, DOI 10.1136/jnnp.50.8.1008; Grasso R, 2004, BRAIN, V127, P1019, DOI 10.1093/brain/awh115; Haefeli J, 2014, NEUROREHAB NEURAL RE, V28, P494, DOI 10.1177/1545968313517755; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Hubli M, 2012, NEUROREHAB NEURAL RE, V26, P188, DOI 10.1177/1545968311420844; Itzkovich M, 2007, DISABIL REHABIL, V29, P1926, DOI 10.1080/09638280601046302; Ivanenko YP, 2003, J NEUROPHYSIOL, V90, P3555, DOI 10.1152/jn.00223.2003; JABBARI B, 1990, ELECTROEN CLIN NEURO, V77, P277, DOI 10.1016/0168-5597(90)90066-M; Kalsi-Ryan S, 2012, J NEUROSURG-SPINE, V17, P65, DOI 10.3171/2012.6.AOSPINE1258; Kamper DG, 2002, ARCH PHYS MED REHAB, V83, P702, DOI 10.1053/apmr.2002.32446; Kato T, 2000, GLIA, V30, P209, DOI 10.1002/(SICI)1098-1136(200005)30:3<209::AID-GLIA1>3.0.CO;2-8; Kramer JK, 2010, NEUROREHAB NEURAL RE, V24, P309, DOI 10.1177/1545968309348312; Kramer JLK, 2012, J CLIN NEUROPHYSIOL, V29, P70, DOI 10.1097/WNP.0b013e318246ada2; Kuhn F, 2012, J NEUROTRAUM, V29, P1829, DOI 10.1089/neu.2011.2277; MASUR H, 1992, ELECTROEN CLIN NEURO, V85, P321, DOI 10.1016/0168-5597(92)90108-N; MCILROY WJ, 1965, CAN MED ASSOC J, V93, P731; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Milhorat TH, 2003, NEUROSURGERY, V53, P1220, DOI 10.1227/01.NEU.0000088809.14965.00; Muhn Narry, 2002, J Clin Neuromuscul Dis, V3, P133, DOI 10.1097/00131402-200203000-00006; Onizuka M, 2001, NEUROL MED-CHIR, V41, P431, DOI 10.2176/nmc.41.431; ROTH EJ, 1990, ARCH PHYS MED REHAB, V71, P18; SAINBURG RL, 1993, J NEUROPHYSIOL, V70, P2136, DOI 10.1152/jn.1993.70.5.2136; Schurch B, 1996, J NEUROL NEUROSUR PS, V60, P61, DOI 10.1136/jnnp.60.1.61; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Ulrich A, 2013, NEUROLOGY, V80, P1393, DOI 10.1212/WNL.0b013e31828c2ed1; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; VERNON JD, 1982, PARAPLEGIA, V20, P339, DOI 10.1038/sc.1982.64; WINTER DA, 1992, PHYS THER, V72, P45, DOI 10.1093/ptj/72.1.45; ZAGER EL, 1990, J NEUROSURG, V72, P133, DOI 10.3171/jns.1990.72.1.0133; Zimmerli L, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-6	45	6	6	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 15	2015	32	6					403	410		10.1089/neu.2014.3536			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CC9DQ	WOS:000350668400005	25219978	Green Accepted			2022-02-06	
J	Mack, J; Herrberg, M; Hetzel, A; Wallesch, CW; Bengel, J; Schulz, M; Rohde, N; Schonberger, M				Mack, Julian; Herrberg, Marlene; Hetzel, Andreas; Wallesch, Claus Werner; Bengel, Juergen; Schulz, Moritz; Rohde, Nathalie; Schoenberger, Michael			The factorial and discriminant validity of the German version of the Post-traumatic Growth Inventory in stroke patients	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Post-traumatic Growth Inventory; Factor analysis; Stroke; Post-traumatic growth; Validity; Depression	CONFIRMATORY FACTOR-ANALYSIS; ACQUIRED BRAIN-INJURY; CANCER SURVIVORS; FIT INDEXES; MODELS; SAMPLE; VALIDATION; STUDENTS; PEOPLE; TRAUMA	Post-traumatic growth (PTG) is the experience of positive changes that can follow a traumatic event. The current study examined the factorial as well as the discriminant validity of the German version of the Post-traumatic Growth Inventory (PTGI-G) in stroke patients. A total of 188 adult stroke patients (63.3% male; median age 69 years) completed the PTGI-G and the German version of the Hospital Anxiety and Depression Scale (HADS-D) at the end of their inpatient rehabilitation. Confirmatory factor analyses indicate an acceptable model fit of both the original five-factor solution as well as a second-order factor model of the PTGI-G (CFI > .95; RMSEA < .01). Small and non-significant correlations between the PTGI-G subscales and the depression scale of the HADS-D support the discriminant validity of the PTGI-G. The PTGI-G appears to be a valid tool in the context of stroke research.	[Mack, Julian; Herrberg, Marlene; Bengel, Juergen; Schulz, Moritz; Rohde, Nathalie; Schoenberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, D-79085 Freiburg, Germany; [Hetzel, Andreas] Pk Klinikum Bad Krozingen, Schwarzwald Klin Neurol, Bad Krozingen, Germany; [Wallesch, Claus Werner] BDH Klin Elzach, Elzach, Germany; [Schoenberger, Michael] Monash Univ Melbourne, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Schonberger, M (corresponding author), Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, Engelberger Str 41, D-79085 Freiburg, Germany.	michael.schoenberger@psychologie.uni-freiburg.de					Asparouhov T., 2010, MULTIPLE IMPUTATION; BENTLER PM, 1990, MULTIVAR BEHAV RES, V25, P163, DOI 10.1207/s15327906mbr2502_3; Browne MW, 1993, TESTING STRUCTURAL E, V154, P136, DOI DOI 10.1177/0049124192021002005; Brunet J, 2010, PSYCHO-ONCOLOGY, V19, P830, DOI 10.1002/pon.1640; Byrne B.M., 2012, STRUCTURAL EQUATION; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.534487, 10.1161/STROKEAHA.108.535088]; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gangstad B, 2009, REHABIL PSYCHOL, V54, P69, DOI 10.1037/a0014639; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; Hair JF., 2014, MULTIVARIATE DATA AN, V7; Hancock G. R., 2001, STRUCTURAL EQUATION, P195; Herrmann-Lingen C, 2011, HOSP ANXIETY DEPRESS; Ho SMY, 2004, PSYCHO-ONCOLOGY, V13, P377, DOI 10.1002/pon.758; Hooper LM, 2009, J MENT HEALTH, V18, P335, DOI 10.1080/09638230802522502; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699; JOSEPH S, 2010, ADV SCI PROMOTING UN, V0021, P00001; Joseph S, 2012, CLIN PSYCHOL PSYCHOT, V19, P316, DOI 10.1002/cpp.1798; Lee JA, 2010, J CLIN PSYCHOL, V66, P813, DOI 10.1002/jclp.20692; Linley PA, 2007, J LOSS TRAUMA, V12, P321, DOI 10.1080/15325020601162823; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Maercker A, 2001, DIAGNOSTICA, V47, P153, DOI 10.1026//0012-1924.47.3.153; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Morris BA, 2005, J TRAUMA STRESS, V18, P575, DOI 10.1002/jts.20067; Muthen B., 1997, ROBUST INFERENCE USI; Muthen L. K., 1998, MPLUS USERS GUIDE ST; Pahlman U, 2012, J STROKE CEREBROVASC, V21, P652, DOI 10.1016/j.jstrokecerebrovasdis.2011.02.012; Palmer GA, 2012, J LOSS TRAUMA, V17, P545, DOI 10.1080/15325024.2012.678779; Powell S, 2003, J CLIN PSYCHOL, V59, P71, DOI 10.1002/jclp.10117; Rogan C, 2013, NEUROPSYCHOL REHABIL, V23, P639, DOI 10.1080/09602011.2013.799076; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Sheikh AI, 2005, MEAS EVAL COUNS DEV, V38, P66, DOI 10.1080/07481756.2005.11909769; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Steiger J., 1980, ANN M PSYCH SOC IOW, V758; Stockton H, 2011, J TRAUMA STRESS, V24, P85, DOI 10.1002/jts.20606; Taku K, 2008, J TRAUMA STRESS, V21, P158, DOI 10.1002/jts.20305; Taku K, 2007, ANXIETY STRESS COPIN, V20, P353, DOI 10.1080/10615800701295007; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tedeschi RG, 2007, APPL PSYCHOL-INT REV, V56, P396, DOI 10.1111/j.1464-0597.2007.00299.x; THOMPSON SC, 1991, BASIC APPL SOC PSYCH, V12, P81, DOI 10.1207/s15324834basp1201_6; Weiss T, 2006, RES SOCIAL WORK PRAC, V16, P191, DOI 10.1177/1049731505281374	43	6	6	1	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 4	2015	25	2					216	232		10.1080/09602011.2014.918885			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	AZ6BY	WOS:000348304600003	24885533				2022-02-06	
J	Charier, D; Beauchet, O; Bell, M; Brugg, B; Bartha, R; Annweiler, C				Charier, David; Beauchet, Olivier; Bell, Morgane; Brugg, Bernard; Bartha, Robert; Annweiler, Cedric			Memantine Plus Vitamin D Prevents Axonal Degeneration Caused by Lysed Blood	ACS CHEMICAL NEUROSCIENCE			English	Article						Intracranial hemorrhage; blood; memantine; vitamin D; neuroprotection	HIPPOCAMPAL-NEURONS; ALZHEIMER-DISEASE; AMYLOID-BETA; NEUROTOXICITY; GLUTAMATE; INJURY; RAT; COMBINATION; HEMORRHAGE; COGNITION	Intracranial hemorrhage, whether due to traumatic brain injury or ruptured cerebral aneurysm, is characterized by major neurological damage and a high mortality rate. Apart from cerebral vasospasm and mass effect, brain injury results from the release of unclotted blood that contacts neurons causing calcic stress. The combination of memantine with vitamin D, a neurosteroid hormone, may prevent blood neurotoxicity. Our purpose was to examine the potential protective effects of memantine + vitamin D against lysed or clotted blood in cortical neuronal cultures. We provide the first evidence that cortical axons in contact with lysed blood degenerate less after exposure to lysed blood in microfluidic neuronal cultures enriched with both memantine and vitamin D compared to control medium and cultures enriched with only memantine or only vitamin D. The reported synergistic neuroprotective effect of memantine + vitamin D, the combination originating an effect stronger than the sum, strongly encourages using both drugs following intracranial hemorrhage.	[Charier, David] Univ Hosp, Dept Anesthesiol & Intens Care, F-42055 St Etienne 2, France; [Beauchet, Olivier; Annweiler, Cedric] Angers Univ Hosp, Div Geriatr Med, Dept Neurosci, F-49933 Angers 9, France; [Beauchet, Olivier; Annweiler, Cedric] Univ Memory Clin, F-49933 Angers 9, France; [Beauchet, Olivier; Annweiler, Cedric] Univ Angers, UNAM, UPRES EA 4638, F-49000 Angers, France; [Bell, Morgane; Brugg, Bernard] CNRS, UMR 8256, Biol Adaptat & Ageing, Paris, France; [Bell, Morgane; Brugg, Bernard] Univ Paris 06, Sorbonne Univ, UMR7102, F-75006 Paris, France; [Bartha, Robert; Annweiler, Cedric] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, London, ON N6A 3K7, Canada		Annweiler, C (corresponding author), Angers Univ Hosp, Div Geriatr Med, Dept Neurosci, F-49933 Angers 9, France.	CeAnnweiler@chu-angers.fr	Beauchet, Olivier/AAP-8108-2020; Bartha, Robert/K-3611-2013	Bartha, Robert/0000-0002-7118-9096; Annweiler, Cedric/0000-0002-7199-8109	Aging Balance and Cognition (ABC) research group, Angers, France	This study was supported by a grant from Aging Balance and Cognition (ABC) research group, Angers, France.	Annweiler C, 2015, J INTERN MED, V277, P45, DOI 10.1111/joim.12279; Annweiler C, 2014, NEUROBIOL AGING, V35, P331, DOI 10.1016/j.neurobiolaging.2013.07.029; Annweiler C, 2013, J ALZHEIMERS DIS, V37, P147, DOI 10.3233/JAD-130452; Annweiler C, 2012, COGN BEHAV NEUROL, V25, P121, DOI 10.1097/WNN.0b013e31826df647; Annweiler C, 2012, DRUG AGING, V29, P81, DOI 10.2165/11597550-000000000-00000; Annweiler C, 2010, NEUROPSYCHOBIOLOGY, V62, P139, DOI 10.1159/000318570; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Brown J, 2003, NEUROSCI LETT, V343, P139, DOI 10.1016/S0304-3940(03)00303-3; Bullock MR, 1999, ANN NY ACAD SCI, V890, P51, DOI 10.1111/j.1749-6632.1999.tb07980.x; Chipana C, 2008, NEUROTOXICOLOGY, V29, P179, DOI 10.1016/j.neuro.2007.09.005; Dursun E, 2013, J ALZHEIMERS DIS, V36, P459, DOI 10.3233/JAD-130416; Gezen-Ak D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017553; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Ibi M, 2001, NEUROPHARMACOLOGY, V40, P761, DOI 10.1016/S0028-3908(01)00009-0; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; Jaremko KM, 2010, J NEUROCHEM, V114, P1063, DOI 10.1111/j.1471-4159.2010.06826.x; Kalueff AV, 2007, CURR OPIN CLIN NUTR, V10, P12, DOI 10.1097/MCO.0b013e328010ca18; Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8; Littlejohns TJ, 2014, NEUROLOGY, V83, P920, DOI 10.1212/WNL.0000000000000755; Moore ME, 2005, BIOCHEM SOC T, V33, P573, DOI 10.1042/BST0330573; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; Shalak L, 2004, EARLY HUM DEV, V80, P125, DOI 10.1016/j.earlhumdev.2004.06.003; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Wong MSK, 2010, AM J PHYSIOL-HEART C, V299, pH1226, DOI 10.1152/ajpheart.00288.2010	25	6	6	0	9	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	MAR	2015	6	3					393	397		10.1021/cn500303k			5	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	CD9LN	WOS:000351419900007	25587803				2022-02-06	
J	Kennedy, JN; Bebarta, VS; Varney, SM; Zarzabal, LA; Ganem, VJ				Kennedy, Jennifer N.; Bebarta, Vikhyat S.; Varney, Shawn M.; Zarzabal, Lee Ann; Ganem, Victoria J.			Prescription Stimulant Misuse in a Military Population	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Systems Research Symposium (MHSRS)	AUG 13-16, 2012	Fort Lauderdale, FL				MEDICATIONS; PERSONNEL; ALCOHOL; DRUGS	Background: Increased prescription drug misuse has been reported in veterans, yet there has not been a focused look at stimulant misuse in the military community or correlation with deployment injuries and illnesses. Our objective was to identify rates of stimulant misuse and any correlation with deployment in the military population. Methods: A prospective, anonymous institutional review board-approved survey in the emergency department waiting room of a military tertiary care hospital using a 12-item questionnaire created with fixed response and multiple-choice questions. Stimulant misuse was defined as taking more than prescribed, obtaining stimulants from others, and taking it for a nonprescribed reason. Proportions were assessed by Chi-square test and Fisher's exact test. Results: 26/ 498 (5%) of respondents reported misusing stimulants in the last 5 years. Misusers were more likely to have a mental health diagnosis, and they suffered either a deployment-related injury or another injury, as compared to those who used stimulants properly (p < 0.05). The stimulant misuse did not correlate with age, gender, active duty status, education, location of deployment, number of times deployed, traumatic brain injury diagnosis, or enlistment status. Conclusion: Stimulant drug misuse in the military community is associated with mental health conditions, deployment-related injuries, or new physical injuries.	[Kennedy, Jennifer N.; Bebarta, Vikhyat S.; Varney, Shawn M.; Zarzabal, Lee Ann; Ganem, Victoria J.] San Antonio Mil Med Ctr, Dept Emergency Med, San Antonio, TX 78234 USA		Kennedy, JN (corresponding author), San Antonio Mil Med Ctr, Dept Emergency Med, 3851 Roger Brooke Dr, San Antonio, TX 78234 USA.		Bebarta, Vikhyat S/L-9537-2015; Bebarta, Vikhyat S/M-1513-2015		U.S. Air Force Office of the Surgeon General [FWH20110172E]	The study was funded by the U.S. Air Force Office of the Surgeon General (FWH20110172E).	Bossaer JB, 2013, ACAD MED, V88, P967, DOI 10.1097/ACM.0b013e318294fc7b; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; James LM, 2013, MIL MED, V178, P159, DOI 10.7205/MILMED-D-12-00282; Jeffery DD, 2013, MIL MED, V178, P180, DOI 10.7205/MILMED-D-12-00192; Kaplan J., 2006, Morbidity and Mortality Weekly Report, V55, P1293; Levine M, 2013, CLIN TOXICOL, V51, P147, DOI 10.3109/15563650.2013.772623; McCabe SE, 2006, J AM COLL HEALTH, V54, P269, DOI 10.3200/JACH.54.5.269-278; McCabe SE, 2011, ARCH PEDIAT ADOL MED, V165, P729, DOI 10.1001/archpediatrics.2011.114; Setlik J, 2009, PEDIATRICS, V124, P875, DOI 10.1542/peds.2008-0931; Stein MT, 2012, J DEV BEHAV PEDIATR, V33, P589, DOI 10.1097/DBP.0b013e31826745ad	10	6	6	0	7	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2015	180	3		S			191	194		10.7205/MILMED-D-14-00375			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CD3OQ	WOS:000350988500033	25747652	Bronze			2022-02-06	
J	Loftus, K; Tilley, T; Hoffman, J; Bradburn, E; Harvey, E				Loftus, Kelli; Tilley, Terry; Hoffman, Jason; Bradburn, Eric; Harvey, Ellen			Use of Six Sigma Strategies to Pull the Line on Central Line-Associated Bloodstream Infections in a Neurotrauma Intensive Care Unit	JOURNAL OF TRAUMA NURSING			English	Article						Central venous catheter; DMAIC; Infection; Neurotrauma; Quality	PREVENTION	The creation of a consistent culture of safety and quality in an intensive care unit is challenging. We applied the Six Sigma Define-Measure-Analyze-Improve-Control (DMAIC) model for quality improvement (QI) to develop a long-term solution to improve outcomes in a high-risk neurotrauma intensive care unit. We sought to reduce central line utilization as a cornerstone in preventing central line-associated bloodstream infections (CLABSIs). This study describes the successful application of the DMAIC model in the creation and implementation of evidence-based quality improvement designed to reduce CLABSIs to below national benchmarks.	[Loftus, Kelli; Bradburn, Eric; Harvey, Ellen] Carillon Roanoke Mem Hosp, Roanoke, VA 24014 USA; [Tilley, Terry] Carillon New River Valley Med Ctr, Christiansburg, VA USA; [Hoffman, Jason] Carillon Med Ctr, Roanoke, VA USA		Harvey, E (corresponding author), Carillon Roanoke Mem Hosp, 1906 Belleview Ave, Roanoke, VA 24014 USA.	emharvey@carilionclinic.org					Adams K., 2003, PRIORITY AREAS NATL; Amin AN, 2009, JT COMM J QUAL PATIE, V35, P558, DOI 10.1016/S1553-7250(09)35076-X; [Anonymous], 2012, AN REP; Benedetto AR, 2002, RADIOL MANAGE, V25, P40; Centers for Disease Control and Prevention, DIRECT MED COSTS HEA; Centers for Medicare & Medicaid Services, HOSP ACQ COND HOSP ACQ COND; Clancy CM, 2012, J NURS CARE QUAL, V27, P191, DOI 10.1097/NCQ.0b013e31825733d1; Dixon JM, 2010, AM J INFECT CONTROL, V38, P817, DOI 10.1016/j.ajic.2010.06.005; Edgeworth J, 2009, J HOSP INFECT, V73, P323, DOI 10.1016/j.jhin.2009.05.008; Eggimann P, 2007, CURR OPIN INFECT DIS, V20, P353, DOI 10.1097/QCO.0b013e32819382d1; Exline MC, 2013, CRIT CARE, V17, DOI 10.1186/cc12551; Grima P, 2014, TOTAL QUAL MANAG BUS, V25, P198, DOI 10.1080/14783363.2013.825101; Institute for Healthcare Improvement, PREV CENTR LIN INF; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552; Joint Commission, NAT PAT SAF GOALS HO; Kaye J, 2000, AM J INFECT CONTROL, V28, P197, DOI 10.1016/S0196-6553(00)90028-2; Marschall J, 2008, INFECT CONT HOSP EP, V29, pS22, DOI 10.1086/591059; Marsteller JA, 2012, CRIT CARE MED, V40, P2933, DOI 10.1097/CCM.0b013e31825fd4d8; Mathur Purva, 2014, J Lab Physicians, V6, P22, DOI 10.4103/0974-2727.129086; McDonald Angelic P, 2013, Radiol Manage, V35, P38; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; Mirtallo J, 2004, JPEN-PARENTER ENTER, V28, pS39, DOI 10.1177/0148607104028006S39; National Quality Forum, 2004, NAT VOLUNT CONS STAN; O'Grady NP, 2011, CLIN INFECT DIS, V52, pe1; Ong A, 2011, ARCH SURG-CHICAGO, V146, P302, DOI 10.1001/archsurg.2011.9; Pronovost PJ, 2006, HEALTH SERV RES, V41, P1599, DOI 10.1111/j.1475-6773.2006.00567.x; Rutherford Pat, 2009, Am J Nurs, V109, P5, DOI 10.1097/01.NAJ.0000362010.68589.27; Sawyer M, 2010, CRIT CARE MED, V38, pS292, DOI 10.1097/CCM.0b013e3181e6a165; Smith JW, 2011, AM SURGEON, V77, P1038; Toledo AH, 2013, PROG TRANSPLANT, V23, P350, DOI 10.7182/pit2013226; Walley Susan Chu, 2013, Hosp Pediatr, V3, P108; Weber DJ, 2011, INFECT DIS CLIN N AM, V25, P77, DOI 10.1016/j.idc.2010.11.012	32	6	8	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	MAR-APR	2015	22	2					78	86		10.1097/JTN.0000000000000111			9	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	CD3SR	WOS:000351001500006	25768963				2022-02-06	
J	Schweigkofler, U; Reimertz, C; Lefering, R; Hoffmann, R				Schweigkofler, U.; Reimertz, C.; Lefering, R.; Hoffmann, R.		TraumaRegister DGU	Importance of air ambulances for the care of the severely injured	UNFALLCHIRURG			German	Article						TraumaRegister DGU (R); TraumaNetzwerk (R); Emergency Helicopters; Traumatic brain injury; Injury Severity Score	MEDICAL-SERVICE; POLYTRAUMATIZED PATIENTS; TRAUMA REGISTRY; GERMAN SOCIETY; HELICOPTER; MORTALITY; IMPACT; NIGHT	In the late 1960s, helicopter emergency medical services (HEMS) were established because of the increasing number of severely injured in road traffic accidents. It was initially thought to bring the doctor to the patient quickly. Today, the rescue helicopter covers the entire field of emergency medicine. By analyzing the databases of the TraumaRegister DGUA (R) (2005-2011), the importance of the HEMS for the treatment of the severely injured was examined. The results showed that around 30 % of severely injured are allocated to hospitals by HEMS. In addition to regional differences, the level of the hospital also plays a particularly important role. The combination of the transfer by HEMS and treatment in a level I trauma center has a significantly positive effect on the survival rate of the patient, especially in patients with traumatic brain injury (TBI).	[Schweigkofler, U.] Berufsgenossenschaftliche Unfallklin Frankfurt Ma, Notfall & Rettungszentrum, D-60389 Frankfurt, Germany; [Reimertz, C.; Hoffmann, R.] Berufsgenossenschaftliche Unfallklin Frankfurt Ma, Unfallchirurg & Orthopad Chirurg, D-60389 Frankfurt, Germany; [Lefering, R.] Univ Witten Herdecke, IFOM, Cologne, Germany		Schweigkofler, U (corresponding author), Berufsgenossenschaftliche Unfallklin Frankfurt Ma, Notfall & Rettungszentrum, Friedberger Landstr 430, D-60389 Frankfurt, Germany.	uwe.schweigkofler@bgu-frankfurt.de					Andruszkow H, 2013, CRIT CARE, V17, DOI 10.1186/cc12796; Beck A, 2002, NOTFALL RETTUNGSMED, V5, P57; Biewener A, 2005, UNFALLCHIRURG, V108, P370, DOI 10.1007/s00113-005-0928-x; Biewener A, 2004, J TRAUMA, V56, P94, DOI 10.1097/01.TA.0000061883.92194.50; Bouillon B, 1997, J TRAUMA, V42, P652, DOI 10.1097/00005373-199704000-00012; DGU, 2012, ORTHOP UNFALL MIT S1, P1; Frink M, 2007, UNFALLCHIRURG, V110, P334, DOI 10.1007/s00113-006-1222-2; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Gries A, 2008, ANAESTHESIST, V57, P562, DOI 10.1007/s00101-008-1373-3; Institut fur Notfallmedizinmanagement (INM), 2009, KLIN U MUNCH BED; Kleber C, 2013, WORLD J SURG, V37, P1154, DOI 10.1007/s00268-013-1964-2; Kleber C, 2012, UNFALLCHIRURG, V115, P700; Kuhne CA, 2013, UNFALLCHIRURG, V116, P39, DOI 10.1007/s00113-011-2042-6; Lefering R, 2012, UNFALLCHIRURG, V115, P30, DOI 10.1007/s00113-011-2141-4; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; MESSELKEN M, 2003, NOTFALL RETTUNGSMED, V6, P189; Mommsen P, 2012, TECHNOL HEALTH CARE, V20, P49, DOI 10.3233/THC-2011-0655; Nast-Kolb D, 1999, UNFALLCHIRURG, V102, P338, DOI 10.1007/s001130050415; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Ruchholtz S, 2000, UNFALLCHIRURG, V103, P30, DOI 10.1007/s001130050005; Schlechtriemen T, 2001, NOTFALL RETTUNGSMED, V4; Schlechtriemen T., 2005, NOTF RETT, V8, P96, DOI DOI 10.1007/S10049-005-0718-6; TSCHERNE H, 1987, CHIRURG, V58, P631; Wiss Gries A, 62012 IESE; Wurm S, 2012, Z ORTHOP UNFALLCHIR, V150, P296, DOI 10.1055/s-0031-1280415; Zimmermann M, 2008, NOTFALL RETTUNGSMED, V11, P37, DOI 10.1007/s10049-007-0967-7; Zimmermann M, 2008, NOTFALL RETTUNGSMED, V11, P117, DOI 10.1007/s10049-007-0968-6	27	6	6	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	MAR	2015	118	3					240	244		10.1007/s00113-014-2566-7			5	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	CD9ZR	WOS:000351461400012	24687696				2022-02-06	
J	Shavelle, RM; Paculdo, DR; Tran, LM; Strauss, DJ; Brooks, JC; DeVivo, MJ				Shavelle, Robert M.; Paculdo, David R.; Tran, Linh M.; Strauss, David J.; Brooks, Jordan C.; DeVivo, Michael J.			Mobility, Continence, and Life Expectancy in Persons with ASIA Impairment Scale Grade D Spinal Cord Injuries	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Mortality; Life Expectancy; Urinary Bladder; Neurogenic; Walking	LONG-TERM SURVIVAL; URINARY-TRACT DYSFUNCTION; TRAUMATIC BRAIN-INJURY; NEUROGENIC BLADDER; FOLLOW-UP; MORTALITY; RECOVERY; STROKE; POPULATION; PREDICTORS	Objective Previous research on the life expectancy of persons with American Spinal Injury Association (ASIA) Impairment Scale Grade D spinal cord injury has considered them as a large homogenous group, making no functional or medical distinctions. This study sought to (1) determine how survival in this group depends on ambulatory function and the extent of bowel or bladder dysfunction, (2) compute life expectancies for various subgroups, and (3) examine whether survival has improved over time. Design Data were from 8,206 adults with ASIA Impairment Scale Grade D spinal cord injury in the Spinal Cord Injury Model Systems database who were not ventilator dependent and who survived more than 1 yr after injury. There were a total of 114,739 person-years of follow-up and 1,730 deaths during the 1970-2011 study period. Empirical age- and sex-specific mortality rates were computed. Regression analysis of survival data with time-dependent covariates was used to determine the effect of risk factors, to test for a time trend, and to estimate mortality rates for subgroups. Life expectancies were obtained from life tables constructed for each subgroup. Results The ability to walk, whether independently or with an assistive device, was associated with longer survival than wheelchair dependence. The need for an indwelling catheter, and to a lesser extent intermittent catheterization, was associated with increased mortality risk. Persons who walked unaided and who did not require catheterization had life expectancies roughly 90% of normal. Those who required a wheelchair for locomotion had life expectancies comparable with that in paraplegia, less than 75% of normal. No time trend in survival was found. Conclusions Life expectancy of persons with ASIA Impairment Scale D spinal cord injury depends strongly on the ability to walk and the need for catheterization.	[Shavelle, Robert M.; Paculdo, David R.; Tran, Linh M.; Strauss, David J.; Brooks, Jordan C.] Life Expectancy Project, San Francisco, CA 94122 USA; [DeVivo, Michael J.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA		Shavelle, RM (corresponding author), Life Expectancy Project, 1439 17th Ave, San Francisco, CA 94122 USA.			Paculdo, David/0000-0002-2184-4603	National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, United States Department of Education, Washington, DC [H133A060039]	Disclosures: Funded in part by grant H133A060039 from the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, United States Department of Education, Washington, DC. Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.	American Spinal Injury Association, 2000, INT STAND NEUR CLASS; Arias, 2012, NATL VITAL STAT REPO, V61; Benevento BT, 2002, PHYS THER, V82, P601, DOI 10.1093/ptj/82.6.601; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Collett D., 1994, MODELLING SURVIVAL D; DeVivo MJ, 2007, SPINAL CORD, V45, P713, DOI 10.1038/sj.sc.3102026; Devivo Michael J., 1995, P289; DeVivo Michael J, 2002, J Spinal Cord Med, V25, P335; DeVivo MJ, 2004, BRAIN INJURY, V18, P1155, DOI 10.1080/02699050410001672323; Dvorak MF, 2005, SPINE, V30, P2303, DOI 10.1097/01.brs.0000182304.35949.11; Feifer A, 2008, NEUROUROL URODYNAM, V27, P475, DOI 10.1002/nau.20569; Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638; Gormley EA, 2010, UROL CLIN N AM, V37, P601, DOI 10.1016/j.ucl.2010.07.002; Han DS, 2008, J REHABIL MED, V40, P844, DOI 10.2340/16501977-0275; Jeong SL, 2010, UROL CLIN N AM, V37, P537, DOI 10.1016/j.ucl.2010.06.005; Kirshblum SC, 1998, ARCH PHYS MED REHAB, V79, P1456, DOI 10.1016/S0003-9993(98)90244-1; Krause JS, 2008, ARCH PHYS MED REHAB, V89, P1482, DOI 10.1016/j.apmr.2007.11.062; Lin SH, 2010, AM J EPIDEMIOL, V171, P917, DOI 10.1093/aje/kwq003; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; Moore KN, 2007, COCHRANE DB SYST REV, V4; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Rotar M, 2011, NEUROUROL URODYNAM, V30, P1315, DOI 10.1002/nau.21013; SAS Institute Inc, 2008, SAS STAT VERS 9 2 WI; Shavelle RM, 2007, BRAIN INJURY MED PRI, P247; Shavelle RM, 2007, J SPINAL CORD MED, V30, pS48, DOI 10.1080/10790268.2007.11753969; Shavelle RM, 2006, J SPINAL CORD MED, V29, P511, DOI 10.1080/10790268.2006.11753901; Stohrer M, 2009, EUR UROL, V56, P81, DOI 10.1016/j.eururo.2009.04.028; Strauss D, 2000, J Insur Med, V32, P217; Strauss D, 2008, DEV MED CHILD NEUROL, V50, P487, DOI 10.1111/j.1469-8749.2008.03000.x; Strauss DJ, 2006, ARCH PHYS MED REHAB, V87, P1079, DOI 10.1016/j.apmr.2006.04.022; Strauss DJ, 2000, J INSURANCE MED, V32, P11; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P67; Yeo JD, 1998, SPINAL CORD, V36, P329, DOI 10.1038/sj.sc.3100628	33	6	6	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2015	94	3					180	191		10.1097/PHM.0000000000000140			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CC2VT	WOS:000350203500002	24919073				2022-02-06	
J	Juratli, TA; Stephan, SE; Stephan, AE; Sobottka, SB				Juratli, T. A.; Stephan, S. E.; Stephan, A. E.; Sobottka, S. B.			Acute treatment of patients with severe traumatic brain injury	ANAESTHESIST			German	Article						Prehospital emergency care; Intracranial pressure; Intubation; Brain damage; Coagulopathy	GLASGOW COMA SCALE; RAPID-SEQUENCE INTUBATION; INTRACRANIAL-PRESSURE; AIRWAY MANAGEMENT; COAGULATION DISORDERS; HYPERTONIC SALINE; VENTILATION; HYPOTENSION; ANESTHESIA; IMPACT	Traumatic brain injury (TBI) is a leading cause of death and permanent disability and a common and important global problem. The contribution of secondary posttraumatic brain damage to overall disability in TBI is significant, underlining the importance of prompt and comprehensive treatment for affected patients. This article focuses on current concepts of prehospital and emergency room management of patients with severe TBI to prevent secondary brain injuries. Preclinical prevention and treatment of hypoxia, hypotension and hypercarbia are essential, as they affect the long-term outcome in TBI patients. Prehospital intubation should be critically weighed and in the context of an individual decision. In general, prehospital intubation is more difficult than in the clinical setting. The combination of ketamine and benzodiazepines are commonly used to induce anesthesia before intubation in hemodynamic instable patients. The choice of a muscle relaxant for anesthesia induction is either a non-depolarizing neuromuscular blocking agent or succinylcholine. Administration of mannitol or hypertonic saline is effective to rapidly decrease intracranial pressure. Whenever possible the final destination for transport of TBI patients should be a level I center with round the clock neurosurgical expertise. Trauma-induced coagulopathy should be recognized and immediately treated using a point-of-care testing. Hypoxia, hypotension and hypercarbia should strictly be avoided to improve survival and neurological outcome in patients with severe TBI. The prehospital decision to intubate must be made on a case by case basis at the accident site. A level I trauma center should be the destination for this patient group.	[Juratli, T. A.; Sobottka, S. B.] Tech Univ Dresden, Carl Gustav Carus Univ Klinikum, Klin & Poliklin Neurochirurg, D-01307 Dresden, Germany; [Stephan, S. E.] Freiberuflicher Notarzt, Cologne, Germany; [Stephan, A. E.] Univ Klinikum Heidelberg, Klin Anasthesiol, Heidelberg, Germany		Juratli, TA (corresponding author), Tech Univ Dresden, Carl Gustav Carus Univ Klinikum, Klin & Poliklin Neurochirurg, Fetscherstr 74, D-01307 Dresden, Germany.	tareq.juratli@uniklinikum-dresden.de	Juratli, Tareq/J-6832-2014	Juratli, Tareq/0000-0003-2236-6719			Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; Bernhard M, 2011, ANAESTHESIST, V60, P1027, DOI 10.1007/s00101-011-1957-1; Bock W, 2006, SCHADEL HIRN VERLETZ; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Byhahn C, 2007, NOTFALL RETTUNGSMED, V10, P482, DOI 10.1007/s10049-007-0957-9; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chieregato A, 2010, ACTA ANAESTH SCAND, V54, P696, DOI 10.1111/j.1399-6576.2010.02234.x; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Colton K, 2014, J TRAUMA ACUTE CARE, V77, P47, DOI 10.1097/TA.0000000000000270; Combes X, 2006, ACAD EMERG MED, V13, P828, DOI 10.1197/j.aem.2006.02.016; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; DGAI, 2011, INN AK PAT SCHAD HIR; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dubick M. A., 1997, Annals Academy of Medicine Singapore, V26, P64; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; ElGanzouri AR, 1996, ANESTH ANALG, V82, P1197, DOI 10.1097/00000539-199606000-00017; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Firsching R, 2007, SCHADEL HIRN TRAUMA; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Gries A, 2014, ANAESTHESIST, V63, P555, DOI 10.1007/s00101-014-2340-9; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Hilbert P, 2011, ANAESTHESIST, V60, P819, DOI 10.1007/s00101-011-1881-4; Hudetz JA, 2010, J CARDIOTHOR VASC AN, V24, P131, DOI 10.1053/j.jvca.2009.05.008; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Joosse P, 2012, J TRAUMA ACUTE CARE, V72, P487, DOI 10.1097/TA.0b013e318226ed59; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Juul N, 2000, ACT NEUR S, V76, P467; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; LASSEN NA, 1976, BRIT J ANAESTH, V48, P719, DOI 10.1093/bja/48.8.719; Mann V, 2013, ANAESTHESIST, V62, P285, DOI 10.1007/s00101-013-2154-1; Marquez J, 2008, CRIT CARE MED, V36, P3001, DOI 10.1097/CCM.0b013e31818b31f0; Mobbs RJ, 2002, ANZ J SURG, V72, P389, DOI 10.1046/j.1445-2197.2002.02462.x; Morris C, 2009, ANAESTHESIA, V64, P532, DOI 10.1111/j.1365-2044.2008.05835.x; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murphy GS, 2001, CRIT CARE CLIN, V17, P925, DOI 10.1016/S0749-0704(05)70187-1; Paal P, 2010, RESUSCITATION, V81, P148, DOI 10.1016/j.resuscitation.2009.10.023; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; Raslan Ahmed, 2007, Neurosurg Focus, V22, pE12; RAVUSSIN P, 1988, J NEUROSURG, V69, P869, DOI 10.3171/jns.1988.69.6.0869; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Roewer, 2012, ANASTHESIE COMPACT; Russo SG, 2010, ANAESTHESIST, V59, P929, DOI 10.1007/s00101-010-1782-y; Schaller B, 2005, J TRAUMA, V59, P1521, DOI 10.1097/01.ta.0000197402.20180.6b; SCHNEIDER GH, 1993, ACTA NEUROCHIR, P107; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schochl H, 2009, J TRAUMA, V67, P125, DOI 10.1097/TA.0b013e31818b2483; Scholz J, 2013, NOTFALLMEDIZIN; Smorenberg A, 2013, PERIOPER MED, V2, DOI 10.1186/2047-0525-2-17; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; STRANDGAARD S, 1984, STROKE, V15, P413, DOI 10.1161/01.STR.15.3.413; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Sturmer KM, 2011, S3 LEITLINIE POLYTRA; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tawfeeq NA, 2009, INJURY, V40, pS75, DOI 10.1016/j.injury.2009.10.040; TEASDALE G, 1974, LANCET, V2, P81; Timmermann A, 2012, ANAESTHESIST, V61, P148, DOI 10.1007/s00101-011-1977-x; Timmermann A, 2011, ANAESTHESIA, V66, P45, DOI 10.1111/j.1365-2044.2011.06934.x; Timmermann A, 2006, RESUSCITATION, V70, P179, DOI 10.1016/j.resuscitation.2006.01.010; von Goedecke A, 2006, ANAESTHESIST, V55, P70, DOI 10.1007/s00101-005-0927-x; von Goedecke A, 2007, ANESTH ANALG, V104, P481, DOI 10.1213/01.ane.0000255964.86086.63; Wan WH, 2008, J CLIN NEUROSCI, V15, P223, DOI 10.1016/j.jocn.2007.05.025; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Warner KJ, 2009, J TRAUMA, V67, P45, DOI 10.1097/TA.0b013e3181a92a70; Wissenschaftlicher Arbeitskreis Neuroanasthesie der DGAI, 2009, ANASTH INTENSIVMED, V50, P489	77	6	6	0	14	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	FEB	2015	64	2					159	172		10.1007/s00101-014-2337-4			14	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	CB9MD	WOS:000349954800010	25608499				2022-02-06	
J	Koskinen, LOD; Eklund, A; Sundstrom, N; Olivecrona, M				Koskinen, Lars-Owe D.; Eklund, Anders; Sundstrom, Nina; Olivecrona, Magnus			Prostacyclin Influences the Pressure Reactivity in Patients with Severe Traumatic Brain Injury Treated with an ICP-Targeted Therapy	NEUROCRITICAL CARE			English	Article						ICP; Pressure reactivity; Traumatic brain injury; Prostacyclin; Outcome	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; PLATELET-AGGREGATION; HEAD-INJURY; AUTOREGULATION; MICRODIALYSIS; METABOLISM; PRINCIPLES; VASOSPASM; TISSUE	This prospective consecutive double-blinded randomized study investigated the effect of prostacyclin on pressure reactivity (PR) in severe traumatic brain injured patients. Other aims were to describe PR over time and its relation to outcome. Blunt head trauma patients, Glasgow coma scale a parts per thousand currency sign8, age 15-70 years were included and randomized to prostacyclin treatment (n = 23) or placebo (n = 25). Outcome was assessed using the extended Glasgow outcome scale (GOSE) at 3 months. PR was calculated as the regression coefficient between the hourly mean values of ICP versus MAP. Pressure active/stable was defined as PR a parts per thousand currency sign0. Mean PR over 96 h (PRtot) was 0.077 +/- A 0.168, in the prostacyclin group 0.030 +/- A 0.153 and in the placebo group 0.120 +/- A 0.173 (p < 0.02). There was a larger portion of pressure-active/stable patients in the prostacyclin group than in the placebo group (p < 0.05). Intra-individual changes over time were common. PRtot correlated negatively with GOSE score (p < 0.04). PRtot was 0.117 +/- A 0.182 in the unfavorable (GOSE 1-4) and 0.029 +/- A 0.140 in the favorable outcome group (GOSE 5-8). Area under the curve for prediction of death (ROC) was 0.742 and for favorable outcome 0.628. Prostacyclin influenced the PR in a direction of increased pressure stability and a lower PRtot was associated with improved outcome. The individual PR varied substantially over time. The predictive value of PRtot for outcome was not solid enough to be used in the clinical situation.	[Koskinen, Lars-Owe D.; Olivecrona, Magnus] Umea Univ, Dept Neurosurg, Div Pharmacol & Clin Neurosci, S-90185 Umea, Sweden; [Eklund, Anders; Sundstrom, Nina] Umea Univ, Dept Radiat Sci Biomed Engn, S-90185 Umea, Sweden; [Eklund, Anders; Sundstrom, Nina] Umea Univ, Ctr Biomed Engn & Phys, S-90185 Umea, Sweden		Koskinen, LOD (corresponding author), Umea Univ, Dept Neurosurg, Div Pharmacol & Clin Neurosci, S-90185 Umea, Sweden.	lars-owe.koskinen@neuro.umu.se; anders.eklund@vll.se; nina.sundstrom@vll.se; magnus.olivecrona@neuro.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502; Eklund, Anders/0000-0002-2031-722X; Olivecrona, Magnus/0000-0001-8457-4711	Department of Clinical Neuroscience University Hospital Research Found; Tore Nilsson Found; Kempe Found; Capio Research Found; Umea University	The Department of Clinical Neuroscience University Hospital Research Found, Tore Nilsson Found, Kempe Found, Capio Research Found and Umea University financially supported this study.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BRANDT L, 1981, J NEUROSURG, V55, P877, DOI 10.3171/jns.1981.55.6.0877; BRANDT L, 1983, GEN PHARMACOL-VASC S, V14, P141, DOI 10.1016/0306-3623(83)90085-X; Cold G E, 1990, Acta Neurochir Suppl (Wien), V49, P1; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1997, NEUROSURGERY, V41, P17; de Souza MDC, 2013, MICROVASC RES, V90, P121, DOI 10.1016/j.mvr.2013.08.001; FITZGERALD GA, 1979, LIFE SCI, V25, P665, DOI 10.1016/0024-3205(79)90507-1; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Kirkness C J, 2001, Biol Res Nurs, V2, P175, DOI 10.1177/109980040100200303; Koskinen LOD, 2009, ACTA NEUROCHIR, V151, P595, DOI 10.1007/s00701-009-0295-4; KURIHARA J, 1990, BRIT J PHARMACOL, V99, P91, DOI 10.1111/j.1476-5381.1990.tb14659.x; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; Lundblad C, 2008, J CEREBR BLOOD F MET, V28, P367, DOI 10.1038/sj.jcbfm.9600533; MONCADA S, 1979, FED PROC, V38, P66; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; MONCADA S, 1984, ANN CLIN RES, V16, P241; MONCADA S, 1977, LANCET, V1, P18; MONCADA S, 1979, NEW ENGL J MED, V300, P1142, DOI 10.1056/NEJM197905173002006; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; PICKARD JD, 1981, J CEREBR BLOOD F MET, V1, P361, DOI 10.1038/jcbfm.1981.41; RIPPE B, 1994, PHYSIOL REV, V74, P163, DOI 10.1152/physrev.1994.74.1.163; Rosenkranz AC, 2011, MOL PHARMACOL, V80, P337, DOI 10.1124/mol.111.072850; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; Shahsavari S, 2011, IEEE T BIO-MED ENG, V58, P2072, DOI 10.1109/TBME.2011.2142415; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steiner LA, 2009, NEUROCRIT CARE, V10, P122, DOI 10.1007/s12028-008-9140-5; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Wahlstrom MR, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-98; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	38	6	6	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2015	22	1					26	33		10.1007/s12028-014-0030-8			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CA3FH	WOS:000348791300005	25052160				2022-02-06	
J	Krause, M; Byom, L; Meulenbroek, P; Richards, S; O'Brien, K				Krause, Miriam; Byom, Lindsey; Meulenbroek, Peter; Richards, Stephanie; O'Brien, Katy			Supporting the Literacy Skills of Adolescents with Traumatic Brain Injury	SEMINARS IN SPEECH AND LANGUAGE			English	Article						Traumatic brain injury; reading; writing; adolescents	CLOSED-HEAD INJURY; WORKING-MEMORY; COLLEGE-STUDENTS; INDIVIDUAL-DIFFERENCES; LEARNING-DISABILITIES; READING-COMPREHENSION; EXECUTIVE FUNCTIONS; INHIBITORY CONTROL; EXPOSITORY TEXT; CHILDREN	Traumatic brain injury (TBI) can affect developmental trajectories as well as language, attention, memory, executive functions, and other cognitive skills related to literacy. Literacy demands change through adolescence and into young adulthood, with academic literacy demands increasing and vocational literacy demands being introduced. Speech-language pathology services must evolve with the literacy needs of each client. This article discusses assessment and treatment approaches designed for adolescents with TBI and recommendations for adapting literacy interventions from the learning disabilities literature. Through proper assessment and intervention, speech-language pathologists can have a meaningful impact on the academic and vocational literacy needs of adolescents with TBI.	[Krause, Miriam; O'Brien, Katy] Univ Minnesota Twin Cities, Dept Speech Language Hearing Sci, Minneapolis, MN 55455 USA; [Byom, Lindsey] Walter Reed Natl Mil Med Ctr, Audiol & Speech Ctr, Bethesda, MD USA; [Meulenbroek, Peter] Northwestern Univ, Rehabil Inst Chicago, Chicago, IL 60611 USA; [Richards, Stephanie] Cent Michigan Univ, Dept Commun Disorders, Mt Pleasant, MI 48859 USA		Krause, M (corresponding author), Univ Minnesota Twin Cities, Dept Speech Language Hearing Sci, 164 Pillsbury Dr SE, Minneapolis, MN 55455 USA.	krau0067@umn.edu	Krause, Miriam/AAD-1197-2022; Byom, Lindsey/AAC-5095-2019	Krause, Miriam/0000-0002-6798-3991; Byom, Lindsey/0000-0002-2457-1735; Meulenbroek, Peter/0000-0003-4233-9910	U.S. Army Public Health Command (USAPHC); Dr. Muelenbroek's Advanced Rehabilitation Research Training Award: Interventions for Neurologic Communication Disorders from the National Institute on Disability and Rehabilitation Research (NIDRR) within the Department of Health and Human Services [H133P120013]	This work was supported in part by Dr. Byron's appointment to the Postgraduate Research Participation Program at the U.S. Army Public Health Command (USAPHC) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and USAPHC. It was also supported in part by Dr. Muelenbroek's Advanced Rehabilitation Research Training Award: Interventions for Neurologic Communication Disorders #H133P120013 from the National Institute on Disability and Rehabilitation Research (NIDRR) within the Department of Health and Human Services.	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Apel K, 1999, LANG SPEECH HEAR SER, V30, P231, DOI 10.1044/0161-1461.3003.231; Baker L, 2000, HDB READING RES, P353; Belfiore M, 2004, READING WORK LITERAC; Berkeley S, 2010, REM SPEC EDUC, V31, P423, DOI 10.1177/0741932509355988; Berninger VW, 2008, J SCHOOL PSYCHOL, V46, P1, DOI 10.1016/j.jsp.2006.11.008; Berninger VW, 2011, J LEARN DISABIL-US, V44, P167, DOI 10.1177/0022219410391189; Boudreau D, 2011, LANG SPEECH HEAR SER, V42, P152, DOI 10.1044/0161-1461(2010/09-0088); Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Centers for disease control and prevention, 2014, INJ PREV CONTR TRAUM; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Ciccia Angel H., 2002, ADV SPEECH LANGUAGE, V4, P1, DOI DOI 10.1080/14417040210001669181; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Downing JA, 2005, INTERV SCH CLIN, V40, P243; Eastin MS, 2006, ADV MANAG INFORM SYS, V7, P28; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferretti RP, 2007, READ WRIT Q, V23, P267, DOI DOI 10.1080/10573560701277740; Ferstl EC, 2002, NEUROPSYCHOLOGY, V16, P292, DOI 10.1037//0894-4105.16.3.292; Goldman SR, 2012, FUTURE CHILD, V22, P89, DOI 10.1353/foc.2012.0011; Graesser, 1996, MODELS UNDERSTANDING, P73; Griffiths G, 2012, PERSPECT NEUROPHYSIO, V22, P47; Griffiths GG, 2013, THESIS U OREGON EUGE; GUYER BP, 1989, J LEARN DISABIL, V22, P430, DOI 10.1177/002221948902200707; Hasbrouck J, 2006, READ TEACH, V59, P636, DOI 10.1598/RT.59.7.3; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); JOHNSON KR, 1992, AM PSYCHOL, V47, P1475, DOI 10.1037/0003-066X.47.11.1475; JOHNSTON CL, 1984, J LEARN DISABIL, V17, P386, DOI 10.1177/002221948401700701; Jury MA, 2001, NEW ZEAL MED J, V114, P286; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; KAPLAN JA, 1990, BRAIN LANG, V38, P315, DOI 10.1016/0093-934X(90)90117-Y; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kennedy MR, 2012, PERSPECTIVES NEUROPH, V22, P143, DOI DOI 10.1044/NNSLD22.4.143; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Konrad KN, 2000, BRAIN INJURY, V14, P859; Le K., 2011, ASHA LEADER; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Linderholm T, 2002, J EDUC PSYCHOL, V94, P778, DOI 10.1037/0022-0663.94.4.778; MacLennan DL, 2008, NEUROREHABILITATION, V23, P521; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Manasse NJ, 2000, BRAIN INJURY, V14, P1015; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Meulenbroek P, J VOCAT REHAB; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Moran CA, 2006, BRAIN INJURY, V20, P417, DOI 10.1080/02699050500488223; Moran C, 2012, LANG SPEECH HEAR SER, V43, P264, DOI 10.1044/0161-1461(2011/10-0114); Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ochoa T., 2005, AMERICAN SECONDARY E, V33, P6; PARIS SG, 1981, J READING BEHAV, V13, P5, DOI 10.1080/10862968109547390; Penn C, 2000, NEUROGENIC COMMUNICA, P103; Rapp DN, 2007, SCI STUD READ, V11, P289, DOI 10.1080/10888430701530417; Rath KA, 2002, EDUC PSYCHOL REV, V14, P353, DOI 10.1023/A:1020694510935; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Robinson F., 1978, EFFECTIVE STUDY; Salmen D. J., 2004, THESIS U UTAH SALT L; Santangelo T, 2008, REM SPEC EDUC, V29, P78, DOI 10.1177/0741932507311636; Schmitter-Edgecombe M, 2005, BRAIN LANG, V94, P331, DOI 10.1016/j.bandl.2005.01.007; Snow P, 1997, BRAIN INJURY, V11, P409; Sohlberg MM, 2014, AM J SPEECH-LANG PAT, V23, P160, DOI 10.1044/2013_AJSLP-12-0005; Stangl W, 1970, EFFECTIVE STUDY; Steinberg L, 2001, ANNU REV PSYCHOL, V52, P83, DOI 10.1146/annurev.psych.52.1.83; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; SUH SY, 1993, J MEM LANG, V32, P279, DOI 10.1006/jmla.1993.1015; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; Tsai MC, 2014, J PEDIAT, V164, P136; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Turkstra LS, 2010, ASHA LEADER; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Vaughn S, 2000, EXCEPT CHILDREN, V67, P99, DOI 10.1177/001440290006700107; WILSON C, 1992, NEUROPSYCHOL REHABIL, V2, P193; YOST DS, 1994, J LEARN DISABIL, V27, P631; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162	87	6	6	1	33	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	FEB	2015	36	1					60	73		10.1055/s-0034-1396447			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	CA3HR	WOS:000348797800008	25633145				2022-02-06	
J	Shim, J; Smith, DH; Van Lunen, BL				Shim, Jaebin; Smith, Deanna H.; Van Lunen, Bonnie L.			On-Field Signs and Symptoms Associated With Recovery Duration After Concussion in High School and College Athletes: A Critically Appraised Topic	JOURNAL OF SPORT REHABILITATION			English	Article						adolescent; return to play; head injury	SPORT; STATEMENT	Clinical Scenario: Over the past decade, sport-related concussions have received increased attention due to their frequency and severity over a wide range of athletics. Clinicians have developed return-to-play protocols to better manage concussions in young athletes; however, a standardized process projecting the length of recovery time after concussion has remained an elusive piece of the puzzle. The recovery times associated with such an injury once diagnosed can last anywhere from 1 wk to several months. Risk factors that could lead to protracted recovery times include a history of 1 or multiple concussions and a greater number, severity, and duration of symptoms after the injury. Examining the possible relationship between on-field or sideline signs and symptoms and recovery times would give clinicians the confident ability to properly treat and manage an athlete's recovery process in a more systematic manner. Furthermore, identifying factors after a head injury that may be predictive of protracted recovery times would be useful for athletes, parents, and coaches alike. Focused Clinical Question: Which on-field and sideline signs and symptoms affect length of recovery after concussion in high school and college athletes?	[Shim, Jaebin; Smith, Deanna H.; Van Lunen, Bonnie L.] Old Dominion Univ, Sch Phys Therapy & Athlet Training, Norfolk, VA 23529 USA		Van Lunen, BL (corresponding author), Old Dominion Univ, Sch Phys Therapy & Athlet Training, Norfolk, VA 23529 USA.	bvanlune@odu.edu					Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313	6	6	6	0	18	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	FEB	2015	24	1					72	76		10.1123/jsr.2013-0058			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CA0UP	WOS:000348632100011	24589692	Green Published			2022-02-06	
J	Simmel, S; Buhren, V				Simmel, S.; Buehren, V.			Rehabilitation in the German statutory accident insurance. Guide to the new outpatient and inpatient structures	UNFALLCHIRURG			German	Article						Employer's mutual insurance association; Extended inpatient treatment; Extended outpatient physiotherapy; Work-related musculoskeletal rehabilitation; Complex inpatient rehabilitation	PREVALENCE; RETURN; WORK; PAIN	The German statutory accident insurance (DGUV) has the statutory mandate to eliminate or to prevent an aggravation of the consequences of accidents by all appropriate means and is based on the principle of rehabilitation before pension. For this, special methods have been developed in recent decades, such as employer's mutual insurance inpatient further treatment (BGSW, Berufsgenossenschaftliche Stationare Weiterbehandlung) and extended outpatient physiotherapy (EAP, Erweiterte Ambulante Physiotherapie). In 2012 the workplace-related musculoskeletal rehabilitation (ABMR, Arbeitsplatz-bezogene muskuloskelettale Rehabilitation) was added to these complex treatments. For complex injuries and delayed healing these methods approach their limits. The accident clinics of the Association of Clinics in Statutory Accident Insurance (KUV, Klinikverbund der gesetzlichen Unfallversicherung) provide a number of specialized rehabilitation measures in order to ensure an optimal seamless rehabilitation of the severely injured. In addition to complex inpatient rehabilitation (KSR, Komplexe Stationare Rehabilitation) integrated special rehabilitation procedures, such as neurorehabilitation for severely traumatic brain injured patients and rehabilitation after spinal cord injury and other special rehabilitation methods, such as occupation-oriented rehabilitation (TOR, Tatigkeitsorientierte Rehabilitation) and pain rehabilitation, ensure that the German Society for Trauma Surgery (DGU) phase model of trauma rehabilitation is implemented. This provides an early start in the context of acute treatment as so-called early rehabilitation. After a specialized post-acute rehabilitation, additional therapeutic options are often required. An appropriate treatment of severely injured patients is important, for example through rehabilitation managers, which must not end with discharge from the rehabilitation hospital. The aim of all efforts is the reintegration into the working and social environment in addition to the best possible quality of life.	[Simmel, S.; Buehren, V.] BG Unfallklin Murnau, Abt BG Rehabil, D-82418 Murnau, Germany		Simmel, S (corresponding author), BG Unfallklin Murnau, Abt BG Rehabil, Prof Kntscher Str 8, D-82418 Murnau, Germany.	stefan.simmel@bgu-murnau.de					[Anonymous], 2008, HANDL VER DURCHF QUA; Deutsche Rentenversicherung, MED VOR AHB 09 05; DGUV-Statistiken fur die Praxis, 2012, AKT ZAHL ZEITR DTSCH; Gross T, 2011, SURGERY, V150, P985, DOI 10.1016/j.surg.2011.04.003; Leistner K, 2005, PHYS MED REHAB KUROR, V15, P157, DOI 10.1055/s-2004-834762; Lohstrater A, 2007, THESIS ERNST MORITZ; Neugebauer EAM, 2012, DTSCH ARZTEBL INT, V109, P102, DOI 10.3238/arztebl.2012.0102; Post RB, 2006, DISABIL REHABIL, V28, P1399, DOI 10.1080/09638280600641392; Rybak C, 2008, ORTHOPADIE UNFALLCHI, V3, P345; Simmel S, 2014, TRAUMA BERUFSKRANKH, V16, P197, DOI 10.1007/s10039-014-2138-7; Simmel S, 2010, TRAUMA BERUFSKRANKH, V12, P194, DOI 10.1007/s10039-010-1612-0; Simmel S, 2013, CHIRURG, V84, P771, DOI 10.1007/s00104-013-2479-y; Simmel S, 2009, UNFALLCHIRURG, V112, P965, DOI 10.1007/s00113-009-1686-y; Tiling T, 2007, TRAUMA BERUFSKRAN S3, V9, P370; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F	15	6	6	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	FEB	2015	118	2					112	121		10.1007/s00113-014-2615-2			10	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	CB1DD	WOS:000349366000003	25578397				2022-02-06	
J	Abogunrin, S; Hortobagyi, L; Remak, E; Dinet, J; Gabriel, S; Bakheit, AMO				Abogunrin, Seye; Hortobagyi, Linda; Remak, Edit; Dinet, Jerome; Gabriel, Sylvie; Bakheit, Abdel Magid O.			Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom	CLINICOECONOMICS AND OUTCOMES RESEARCH			English	Article						stroke; cerebral palsy; multiple sclerosis; traumatic brain injury		Background: Botulinum toxin A (BoNT-A) is an effective treatment for patients with upper limb spasticity (ULS), which is a debilitating feature of upper motor neuron lesions. BoNT-A preparations available in the UK are associated with different costs. Methods: We developed a budget impact model to assess the effect of changing market shares of different BoNT-A formulations - abobotulinumtoxinA, onabotulinumtoxinA, and incobotulinumtoxinA - and best supportive care, from the UK payer perspective, over a 5-year time horizon. Epidemiological and resource use data were derived from published literature and clinical expert opinion. One-way sensitivity analyses were performed to determine parameters most influential on budget impact. Results: Base-case assumptions showed that an increased uptake of abobotulinumtoxinA resulted in a 5-year savings of 6,283,829 pound. Treatment with BoNT-A costs less than best supportive care per patient per year, although treating a patient with onabotulinumtoxinA (20,861) pound and incobotulinumtoxinA (20,717) pound cost more per patient annually than with abobotulinumtoxinA (19,800) pound. Sensitivity analyses showed that the most influential parameters on budget were percentage of cerebral palsy and stroke patients developing ULS, and the prevalence of stroke. Conclusion: Study findings suggest that increased use of abobotulinumtoxinA for ULS in the UK could potentially reduce total ULS cost for the health system and society.	[Abogunrin, Seye] Evidera, Meta Res, Metro Bldg,6th Floor,1 Butterwick, London W6 8DL, England; [Hortobagyi, Linda] Evidera, Hlth Econ, London, England; [Remak, Edit] Evidera, Hlth Econ, Budapest, Hungary; [Dinet, Jerome] Ipsen Pharma, Hlth Econ & Outcomes Res Global, Boulogne, France; [Gabriel, Sylvie] Ipsen Pharma, Global Market Access & Pricing, Boulogne, France; [Bakheit, Abdel Magid O.] Moseley Hall Hosp, Neurol Rehabil, Birmingham, W Midlands, England		Abogunrin, S (corresponding author), Evidera, Meta Res, Metro Bldg,6th Floor,1 Butterwick, London W6 8DL, England.	seye.abogunrin@evidera.com			Ipsen PharmaIpsen; Allergan IncAbbVieAllergan; Merz Pharmaceutical	Seye Abogunrin, Linda Hortobagyi, and Edit Remak are employees of Evidera Inc., which received consulting fees from Ipsen Pharma to conduct the research. Jerome Dinet and Sylvie Gabriel are full-time employees of Ipsen Pharma. Professor Bakheit has received research and educational grants and consultancy fees from Ipsen Pharma, Allergan Inc., and Merz Pharmaceutical.	[Anonymous], 2012, DYSP 300 UN DYSP 500; [Anonymous], 2013, BOT 100 UN SUMM PROD; [Anonymous], 2012, XEOM 100 UN SUMM PRO; Bakheit AMO, 2000, STROKE, V31, P2402, DOI 10.1161/01.STR.31.10.2402; Bandi S, 2010, INT ENCY REHABILITAT; Beecham J, 2009, BRAIN INJURY, V23, P30, DOI 10.1080/02699050802590338; Bhakta BB, 1996, J NEUROL NEUROSUR PS, V61, P30, DOI 10.1136/jnnp.61.1.30; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Buchanan RJ, 2009, NEUROREHABILITATION, V25, P271, DOI 10.3233/NRE-2009-0525; Buxton MJ, 1997, HEALTH ECON, V6, P217, DOI 10.1002/(SICI)1099-1050(199705)6:3<217::AID-HEC267>3.3.CO;2-N; Caty GD, 2009, STROKE, V40, P2589, DOI 10.1161/STROKEAHA.108.544346; Dinet J, 2014, VALUE HEALTH, V17, pA377, DOI 10.1016/j.jval.2014.08.2596; Doan QV, 2013, EUR J NEUROL, V20, P773, DOI 10.1111/ene.12062; Doan QV, 2012, PM&R, V4, P4, DOI 10.1016/j.pmrj.2011.10.001; Esquenazi A., 2011, J CLIN OUTCOMES MANA, V18, P607; Francis HP, 2004, J NEUROL NEUROSUR PS, V75, P1547, DOI 10.1136/jnnp.2003.025551; Hesse S, 1998, CLIN REHABIL, V12, P381, DOI 10.1191/026921598668275996; Ivanhoe CB, 2004, AM J PHYS MED REHAB, V83, pS3, DOI 10.1097/01.PHM.0000141125.28611.3E; Lawrenson R, 2001, NEUROEPIDEMIOLOGY, V20, P138, DOI 10.1159/000054774; Lukban MB, 2009, J NEURAL TRANSM, V116, P319, DOI 10.1007/s00702-008-0175-8; Lundstrom E, 2010, STROKE, V41, P319, DOI 10.1161/STROKEAHA.109.558619; National Institute for Health and Care Excellence, 2012, SPAST CHILDR YOUNG P; Ozcakir S, 2007, CLIN MED RES, V5, P132, DOI 10.3121/cmr.2007.716; Royal College of Physicians British Society of Rehabilitation Medicine Chartered Society of Physiotherapy, 2009, SPAST AD MAN US BOT; Shaw L, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14260; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Timothy W, 2006, ISPOR CONNECTIONS, V12, P7; Turner-Stokes L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002771; Ward A, 2005, J REHABIL MED, V37, P252, DOI 10.1080/16501970510027312; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa; WHO, 2008, ATL MULT SCLER RES W; Yeargin-Allsopp M, 2008, PEDIATRICS, V121, P547, DOI 10.1542/peds.2007-1270	32	6	6	0	3	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-6981			CLINICOECONOMIC OUTC	CLINICOECONOMICS OUTCOMES RES.		2015	7						185	193		10.2147/CEOR.S76141			9	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	V06XJ	WOS:000213972600020	25878510	Green Published, gold, Green Submitted			2022-02-06	
S	Buki, A; Kovacs, N; Czeiter, E; Schmid, K; Berger, RP; Kobeissy, F; Italiano, D; Hayes, RL; Tortella, FC; Mezosi, E; Schwarcz, A; Toth, A; Nemes, O; Mondello, S		Schramm, J		Buki, Andras; Kovacs, Noemi; Czeiter, Endre; Schmid, Kara; Berger, Rachel P.; Kobeissy, Firas; Italiano, Domenico; Hayes, Ronald L.; Tortella, Frank C.; Mezosi, Emese; Schwarcz, Attila; Toth, Arnold; Nemes, Orsolya; Mondello, Stefania			Minor and Repetitive Head Injury	ADVANCES AND TECHNICAL STANDARDS IN NEUROSURGERY, VOL 42	Advances and Technical Standards in Neurosurgery		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; POST-CONCUSSION SYMPTOMS; FIBRILLARY ACIDIC PROTEIN; SPORT-RELATED CONCUSSION; OPERATION-IRAQI-FREEDOM; C-TERMINAL HYDROLASE; SERUM-LEVELS; COMPUTED-TOMOGRAPHY; PITUITARY DYSFUNCTION		[Buki, Andras; Czeiter, Endre; Schwarcz, Attila] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Buki, Andras; Kovacs, Noemi; Czeiter, Endre; Schwarcz, Attila] Univ Pecs, Sch Med, Dept Neurosurg, Pecs, Hungary; [Czeiter, Endre] Univ Pecs, Sch Med, Dept Anat, Pecs, Hungary; [Czeiter, Endre] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Schmid, Kara; Tortella, Frank C.] Walter Reed Army Inst Res, Dept Appl Neurobiol, Div Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Berger, Rachel P.] UPMC, Safar Ctr Resuscitat Res, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Kobeissy, Firas] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Italiano, Domenico] Univ Messina, Dept Clin & Expt Med & Pharmacol, I-98125 Messina, Italy; [Hayes, Ronald L.] Banyan Biomarkers Inc, Dept Clin Programs, Alachua, FL 32615 USA; [Mezosi, Emese; Nemes, Orsolya] Univ Pecs, Sch Med, Dept Med 1, Div Endocrinol, Pecs, Hungary; [Toth, Arnold] Univ Pecs, Sch Med, Dept Neurol, Pecs, Hungary; [Mondello, Stefania] Univ Messina, Dept Neurosci, I-98125 Messina, Italy		Buki, A (corresponding author), MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary.	2saturn@gmail.com	Mondello, Stefania/A-1813-2012; Kobeissy, Firas/E-7042-2017; Czeiter, Endre/B-1404-2009	Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944; 			Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Arienta C, 1997, SURG NEUROL, V48, P213, DOI 10.1016/S0090-3019(97)00019-0; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Berger R, 2009, PEDIATR CRIT CARE ME, V10, P260, DOI 10.1097/PCC.0b013e31819a376d; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Dubourg J, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11182; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Falimirski ME, 2003, J TRAUMA, V55, P1, DOI 10.1097/01.TA.0000071295.67263.A2; Faul M, 2010, TRAUMATIC BRAIN INJU; Filippidis AS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10185; Floret D, 2006, ARCH PEDIATRIE, V13, P528, DOI 10.1016/j.arcped.2006.03.017; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; GOUDIE RB, 1962, J PATHOL BACTERIOL, V83, P584, DOI 10.1002/path.1700830241; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hallen M, 2010, J TRAUMA, V69, P284, DOI 10.1097/TA.0b013e3181ca060b; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; Homnick A, 2012, INJURY, V43, P2122, DOI 10.1016/j.injury.2012.04.013; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; JENKINS A, 1986, LANCET, V2, P445; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kushner DS, 2001, AM FAM PHYSICIAN, V64, P1007; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Lincoln S, 1999, NEUROREPORT, V10, P427, DOI 10.1097/00001756-199902050-00040; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayers L, 2008, ARCH NEUROL-CHICAGO, V65, P1158, DOI 10.1001/archneur.65.9.1158; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Missler U, 1999, CLIN CHEM, V45, P138; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Morris MW, 2000, PEDIATRICS, V105, P549, DOI 10.1542/peds.105.3.549; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Ott MM, 2010, J TRAUMA, V68, P560, DOI 10.1097/TA.0b013e3181ad6600; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Romualdi E, 2009, THROMB HAEMOSTASIS, V101, P290, DOI 10.1160/TH08-07-0474; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Rudehill S, 2006, ACTA NEUROCHIR, V148, P199, DOI 10.1007/s00701-005-0673-5; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Schmidt IL, 2003, J CLIN ENDOCR METAB, V88, P4193, DOI 10.1210/jc.2002-021897; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; SHARPLES PM, 1990, BRIT MED J, V301, P1193, DOI 10.1136/bmj.301.6762.1193; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Sturmi JE, 1998, SPORTS MED, V25, P351, DOI 10.2165/00007256-199825060-00001; Tanielian T, 2014, MG7201CCF RAND CORP; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Zee CS, 1998, NEUROIMAG CLIN N AM, V8, P525	162	6	7	1	7	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0095-4829		978-3-319-09066-5; 978-3-319-09065-8	ADV TECH STAND NEURO			2015	42						147	192		10.1007/978-3-319-09066-5_8	10.1007/978-3-319-09066-5		46	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BD0YM	WOS:000357856300008	25411149				2022-02-06	
J	Caron, AM; Stephenson, R				Caron, Aimee M.; Stephenson, Richard			Sleep deprivation does not affect neuronal susceptibility to mild traumatic brain injury in the rat	NATURE AND SCIENCE OF SLEEP			English	Article						sleep deprivation; concussion; traumatic brain injury; dark neuron; neurodegeneration; rat cortex	LIGHT MICROSCOPIC RESPONSE; FOCAL CEREBRAL-ISCHEMIA; DARK COMPACTED NEURONS; CONCUSSIVE HEAD-INJURY; RESTRICTION; RECOVERY; APOPTOSIS; MODEL; PATHOPHYSIOLOGY; ENVIRONMENT	Mild and moderate traumatic brain injuries (TBIs) (and concussion) occur frequently as a result of falls, automobile accidents, and sporting activities, and are a major cause of acute and chronic disability. Fatigue and excessive sleepiness are associated with increased risk of accidents, but it is unknown whether prior sleep debt also affects the pathophysiological outcome of concussive injury. Using the "dark neuron" (DN) as a marker of reversible neuronal damage, we tested the hypothesis that acute (48 hours) total sleep deprivation (TSD) and chronic sleep restriction (CSR; 10 days, 6-hour sleep/day) affect DN formation following mild TBI in the rat. TSD and CSR were administered using a walking wheel apparatus. Mild TBI was administered under anesthesia using a weight-drop impact model, and the acute neuronal response was observed without recovery. DNs were detected using standard bright-field microscopy with toluidine blue stain following appropriate tissue fixation. DN density was low under home cage and sleep deprivation control conditions (respective median DN densities, 0.14% and 0.22% of neurons), and this was unaffected by TSD alone (0.1%). Mild TBI caused significantly higher DN densities (0.76%), and this was unchanged by preexisting acute or chronic sleep debt (TSD, 0.23%; CSR, 0.7%). Thus, although sleep debt may be predicted to increase the incidence of concussive injury, the present data suggest that sleep debt does not exacerbate the resulting neuronal damage.	[Caron, Aimee M.; Stephenson, Richard] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada		Stephenson, R (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Ramsay Wright Labs, 25 Harbord St, Toronto, ON M5S 3G5, Canada.	richard.stephenson@utoronto.ca			Natural Sciences and Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Postgraduate Scholarship	This study was funded by the Natural Sciences and Research Council of Canada (NSERC) through a Discovery Grant to RS and Postgraduate Scholarship to AMC. NSERC had no involvement in the design, conduct, or interpretation of this study.	Barlow KM, 2014, J CHILD NEUROL, V29, P1; Biswas S, 2006, NEUROSCIENCE, V142, P315, DOI 10.1016/j.neuroscience.2006.06.026; CAMMERMEYER J, 1978, HISTOCHEMISTRY, V56, P97, DOI 10.1007/BF00508437; CAMMERMEYER J, 1960, EXP NEUROL, V2, P379, DOI 10.1016/0014-4886(60)90022-4; CAMMERMEYER JAN, 1961, ACTA NEUROPATHOL, V1, P245; Caron AM, 2010, SLEEP, V33, P1226, DOI 10.1093/sleep/33.9.1226; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Cirelli C, 1999, BRAIN RES, V840, P184, DOI 10.1016/S0006-8993(99)01768-0; Crile GW, 1921, ARCH SURG-CHICAGO, V2, P196, DOI 10.1001/archsurg.1921.01110050014002; Csordas A, 2003, ACTA NEUROPATHOL, V106, P37, DOI 10.1007/s00401-003-0694-1; CZURKO A, 1993, NEUROSCI LETT, V162, P71, DOI 10.1016/0304-3940(93)90562-Y; Deurveilher S, 2015, SLEEP, V38, P515, DOI 10.5665/sleep.4562; Eiland MM, 2002, BRAIN RES, V945, P1, DOI 10.1016/S0006-8993(02)02448-4; EVERSON CA, 1989, SLEEP, V12, P60; Everson CA, 2014, SLEEP, V37, P1929, DOI 10.5665/sleep.4244; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Gallyas F, 2008, BIOTECH HISTOCHEM, V83, P221, DOI 10.1080/10520290802538543; GALLYAS F, 1990, ACTA NEUROPATHOL, V79, P620, DOI 10.1007/BF00294239; GALLYAS F, 1992, ACTA NEUROPATHOL, V83, P394, DOI 10.1007/BF00713531; GALLYAS F, 1992, ACTA NEUROPATHOL, V83, P386, DOI 10.1007/BF00713530; Gallyas F, 2009, BRAIN RES, V1270, P152, DOI 10.1016/j.brainres.2009.03.020; Gao B, 2010, SLEEP, V33, P879, DOI 10.1093/sleep/33.7.879; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hipolide DC, 2002, INT J NEUROSCI, V112, P155, DOI 10.1080/00207450212022; Hsu JC, 2003, BRAIN RES, V984, P170, DOI 10.1016/S0006-8993(03)03128-7; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jinno S, 2001, BRAIN RES, V900, P195, DOI 10.1016/S0006-8993(01)02292-2; Jortner BS, 2006, NEUROTOXICOLOGY, V27, P628, DOI 10.1016/j.neuro.2006.03.002; Kherani ZS, 2008, ACTA NEUROPATHOL, V116, P447, DOI 10.1007/s00401-008-0386-y; Kiernan JA, 2005, BIOTECH HISTOCHEM, V80, P44; Kim Y, 2007, P NATL ACAD SCI USA, V104, P10697, DOI 10.1073/pnas.0610351104; Kovesdi E, 2007, BRAIN RES, V1147, P272, DOI 10.1016/j.brainres.2007.02.011; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martinez-Vargas M, 2012, NEUROSCI LETT, V529, P118, DOI 10.1016/j.neulet.2012.09.037; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCoy JG, 2013, NEUROREPORT, V24, P91, DOI 10.1097/WNR.0b013e32835cd97a; McCoy JG, 2011, NEUROBIOL LEARN MEM, V96, P564, DOI 10.1016/j.nlm.2011.07.004; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Moldovan M, 2010, EXP NEUROL, V222, P135, DOI 10.1016/j.expneurol.2009.12.023; Morrissey MJ, 2004, MED HYPOTHESES, V62, P876, DOI 10.1016/j.mehy.2004.01.014; Novati A, 2012, J SLEEP RES, V21, P3, DOI 10.1111/j.1365-2869.2011.00932.x; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rechtschaffen A, 2002, SLEEP, V25, P18, DOI 10.1093/sleep/25.1.18; Rechtschaffen A, 1999, SLEEP, V22, P11, DOI 10.1093/sleep/22.1.11; Ribeiro S, 2012, PFLUG ARCH EUR J PHY, V463, P111, DOI 10.1007/s00424-011-1031-5; Stephenson R, 2015, SLEEP, V38, P685, DOI 10.5665/sleep.4656; Strohl KP, 2013, AM J RESP CRIT CARE, V187, P1259, DOI 10.1164/rccm.201304-0726ST; Uehli K, 2014, SLEEP MED REV, V18, P61, DOI 10.1016/j.smrv.2013.01.004; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Weil ZM, 2009, EXP NEUROL, V218, P129, DOI 10.1016/j.expneurol.2009.04.018; Zager A, 2007, AM J PHYSIOL-REG I, V293, pR504, DOI 10.1152/ajpregu.00105.2007; Zsombok A, 2005, J NEUROSCI METH, V142, P145, DOI 10.1016/j.jneumeth.2004.08.005	57	6	6	0	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1608			NAT SCI SLEEP	NAT. SCI. SLEEP		2015	7						63	72		10.2147/NSS.S82888			10	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V05PN	WOS:000213884600007	26124685	Green Published, Green Submitted, gold			2022-02-06	
J	Carrick, FR; Pagnacco, G; McLellan, K; Solis, R; Shores, J; Fredieu, A; Brock, JB; Randall, C; Wright, C; Oggero, E				Carrick, Frederick Robert; Pagnacco, Guido; McLellan, Kate; Solis, Ross; Shores, Jacob; Fredieu, Andre; Brock, Joel Brandon; Randall, Cagan; Wright, Cameron; Oggero, Elena			Short- and long-term effectiveness of a subject's specific novel brain and vestibular rehabilitation treatment modality in combat veterans suffering from PTSD	FRONTIERS IN PUBLIC HEALTH			English	Article						PTSD; vestibular rehabilitation; brain rehabilitation; off vertical axis rotation; DSM-IV CAPS		Introduction: Treatment for post-traumatic stress disorder (PTSD) in combat veterans that have a long-term positive clinical effect has the potential to modify the treatment of PTSD. This outcome may result in changed and saved lives of our service personnel and their families. In a previous before-after-intervention study, we demonstrated high statistical and substantively significant short-term changes in the Clinician Administered DSM-IV PTSD Scale (CAPS) scores after a 2-week trial of a subject's particular novel brain and vestibular rehabilitation (VR) program. The long-term maintenance of PTSD severity reduction was the subject of this study. Material and methods: We studied the short- and long-term effectiveness of a subject's particular novel brain and VR treatment of PTSD in subjects who had suffered combatrelated traumatic brain injuries in terms of PTSD symptom reduction. The trial was registered as ClinicalTrials.gov Identifier: NCT02003352. We analyzed the difference in the CAPS scores pre- and post-treatment (1 week and 3 months) using our subjects as their matched controls. Results: The generalized least squares (GLS) technique demonstrated that with our 26 subjects in the 3 timed groups the R2 within groups was 0.000, R2 between groups was 0.000, and overall the R2 was 0.000. The GLS regression was strongly statistically significant z = 21.29, p < 0.001, 95% CI [58.7, 70.63]. The linear predictive margins over time demonstrated strong statistical and substantive significance of decreasing PTSD severity scores for all timed CAPS tests. Discussion: Our investigation has the promise of the development of superior outcomes of treatments in this area that will benefit a global society. The length of the treatment intervention involved (2 weeks) is less that other currently available treatments and has profound implications for cost, duration of disability, and outcomes in the treatment of PTSD in combat veterans.	[Carrick, Frederick Robert; Pagnacco, Guido; McLellan, Kate; Wright, Cameron; Oggero, Elena] Carrick Inst, Cape Canaveral, FL USA; [Carrick, Frederick Robert] Harvard Med Sch, Global Clin Scholars Res Training Program, Boston, MA 02115 USA; [Carrick, Frederick Robert; McLellan, Kate; Solis, Ross; Shores, Jacob; Fredieu, Andre; Brock, Joel Brandon; Randall, Cagan] Carrick Brain Ctr, Neurol, Dallas, TX USA; [Pagnacco, Guido; Wright, Cameron; Oggero, Elena] Univ Wyoming, Elect & Comp Engn, Laramie, WY 82071 USA		Carrick, FR (corresponding author), 8941 Lake Dr 203, Cape Canaveral, FL 32920 USA.	drfrcarrick@post.harvard.edu	Brock, Joel/AAZ-3439-2020	Carrick, Frederick/0000-0002-2818-6551			Aligene K, 2013, NEUROREHABILITATION, V32, P543, DOI 10.3233/NRE-130876; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Association A.P, 2013, DIAGN STAT MAN MENT; Auxemery Y, 2012, ENCEPHALE, V38, P329, DOI 10.1016/j.encep.2011.07.003; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Carrick FR, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00015; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen J., 1998, STAT POWER ANAL BEHA, V2nd; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Hedges L.V., 1985, STAT METHODS META AN; Herdman SJ, 2013, CURR OPIN NEUROL, V26, P96, DOI 10.1097/WCO.0b013e32835c5ec4; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Honaker Julie A, 2012, Int Tinnitus J, V17, P124, DOI 10.5935/0946-5448.20120023; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; King PR, 2012, J CLIN PSYCHOL MED S, V19, P376, DOI 10.1007/s10880-012-9345-9; Leon AC, 2009, J TRAUMA STRESS, V22, P603, DOI 10.1002/jts.20466; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; National Clinical Practice Guideline Number 26, 2005, MANAGEMENT PTSD ADUL; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ryan PB, 2011, BRAIN INJURY, V25, P1019, DOI 10.3109/02699052.2011.597044; Seidler GH, 2006, PSYCHOL MED, V36, P1515, DOI 10.1017/S0033291706007963; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Van Etten ML, 1998, CLIN PSYCHOL PSYCHOT, V5, P126, DOI 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.0.CO;2-H; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	29	6	6	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-2565		FRONT PUBLIC HEALTH	Front. Public Health		2015	3								151	10.3389/fpubh.2015.00151			11	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	VI6BA	WOS:000498912900093	26082920	Green Published, gold			2022-02-06	
J	Cote, KA; Milner, CE; Speth, TA				Cote, Kimberly A.; Milner, Catherine E.; Speth, Tamara A.			Altered Sleep Mechanisms following Traumatic Brain Injury and Relation to Waking Function	AIMS NEUROSCIENCE			English	Article						traumatic brain injury (TBI); sleep; sleep regulation; electroencephalography (EEG); k-complexes; sleep spindles		Sleep difficulties are commonly reported following traumatic brain injury (TBI), but few studies have systematically examined the neurophysiological characteristics of sleep. Sleep EEG was quantified over multiple nights to examine mechanisms underlying sleep disruption in individuals who had sustained a TBI and to explore the relationship between sleep disruption and waking function. Sleep was recorded from 20 individuals with a TBI (18-64 years) and 20 age-matched controls over two uninterrupted nights, as well as during a night where auditory stimuli were delivered. All participants underwent neuropsychological testing and waking performance assessment. Compared to controls, the TBI group had subjective complaints of falling asleep, delayed sleep onset on polysomnography (PSG), less Slow Wave (< 1 Hz) and delta (1-4 Hz) EEG power in non-REM sleep, fewer spontaneous and evoked k-complexes, reduced periodicity of spontaneous k-complexes, and lower amplitude of evoked k-complexes. While for controls, the density, duration and periodicity of sleep spindles diminished with deepening of non-REM as typically observed, this pattern was disrupted in the TBI group with peak spindle presentation occurring in Stage 3 sleep. Night-to-night-stability of Stage 2 spindles was high for controls but absent for the TBI group. Greater injury severity was related to fewer evoked k-complexes and lower spindle density. Greater spindle production predicted better waking function in the TBI group. Taken together, these data demonstrate impairment in sleep regulatory and inhibitory mechanisms as factors underlying sleep complaints following a TBI. Spindle generation may be adaptive or a marker of resiliency following TBI.	[Cote, Kimberly A.; Milner, Catherine E.; Speth, Tamara A.] Brock Univ, Dept Psychol, St Catharines, ON, Canada		Cote, KA (corresponding author), Brock Univ, Dept Psychol, St Catharines, ON, Canada.	kcote@brocku.ca			Natural Science and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation (CFI)Canada Foundation for Innovation; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); Ontario Neurotrauma Foundation (ONF) Fellowship	The Sleep Research Laboratory at Brock University is funded by the Natural Science and Engineering Research Council of Canada (NSERC) and Canadian Foundation for Innovation (CFI). C. Milner was the recipient of an NSERC pre-doctoral scholarship and an Ontario Neurotrauma Foundation (ONF) Fellowship.	Amzica F, 2000, ACTA NEUROBIOL EXP, V60, P229; Arbour C, 2015, SLEEP MED, V16, P534, DOI 10.1016/j.sleep.2014.12.002; Armitage R, 2007, ACTA PSYCHIAT SCAND, V115, P104, DOI 10.1111/j.1600-0447.2007.00968.x; BADDELEY AD, 1993, SPEED CAPACITY LANGU; BASTEIN C, 1994, J SLEEP RES, V3, P65, DOI 10.1111/j.1365-2869.1994.tb00109.x; BASTIEN C, 1992, SLEEP, V15, P236, DOI 10.1093/sleep/15.3.236; Bastien CH, 2009, J PSYCHOSOM RES, V67, P117, DOI 10.1016/j.jpsychores.2009.01.014; Bastien CH, 2009, J PSYCHOSOM RES, V66, P59, DOI 10.1016/j.jpsychores.2008.05.013; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benson D.F., 1986, FRONTAL LOBES; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; Cote KA, 2000, J SLEEP RES, V9, P19, DOI 10.1046/j.1365-2869.2000.00188.x; Cote KA, 1999, J SLEEP RES, V8, P263, DOI 10.1046/j.1365-2869.1999.00164.x; De Gennaro L, 2000, NEUROSCI LETT, V291, P41, DOI 10.1016/S0304-3940(00)01366-5; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dement WC, 2011, PRINCIPLES PRACTICE, P54; Dien J, 2005, EVENT RELATED POTENT, P57; DIJK DJ, 1993, BRAIN RES, V626, P190, DOI 10.1016/0006-8993(93)90579-C; Fogel SM, 2007, BEHAV NEUROSCI, V121, P1, DOI 10.1037/0735-7044.121.1.1; Fogel SM, 2007, BEHAV BRAIN RES, V180, P48, DOI 10.1016/j.bbr.2007.02.037; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; GROSSMAN C, 1949, ELECTROEN CLIN NEURO, V1, P487, DOI 10.1016/0013-4694(49)90222-9; Hammill D.D., 1996, COMPREHENSIVE TEST N; Harada M, 1976, Kumamoto Med J, V29, P110; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; HOWELL DC, 1992, STAT METHODS PSYCHOL; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LIOTTI M, 1992, BRAIN COGNITION, V18, P138, DOI 10.1016/0278-2626(92)90075-W; Lu W, 2015, BRAIN INJURY, V19, P1; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mantua J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00328; Molle M, 2011, SLEEP, V34, P1411, DOI 10.5665/SLEEP.1290; Moldofsky H, 2001, SLEEP MED REV, V5, P387, DOI 10.1053/smrv.2001.0179; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Parsons LC, 1976, J NEUROTRAUM, V14, P549; PIVIK RT, 1993, PSYCHOPHYSIOLOGY, V30, P547, DOI 10.1111/j.1469-8986.1993.tb02081.x; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Ramsawh H, 2011, PRINCIPLES PRACTICE, P1473; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Wiseman-Hakes C., 2009, CRIT REV PHYS REHABI, V21, P317, DOI [10.1615/CritRevPhysRehabilMed.v21.i3-4.70, DOI 10.1615/CRITREVPHYSREHABILMED.V21.I3-4.70]; YOSHITAKE H, 1978, ERGONOMICS, V21, P231, DOI 10.1080/00140137808931718	61	6	7	0	0	AMER INST MATHEMATICAL SCIENCES-AIMS	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	2373-8006	2373-7972		AIMS NEUROSCI	AIMS Neurosci.		2015	2	4					203	228		10.3934/Neuroscience.2015.4.203			26	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V25NZ	WOS:000215232600002		Green Submitted, gold			2022-02-06	
J	Haller, CS				Haller, Chiara S.			Mindful Creativity Scale (MCS): Validation of a German version of the Langer Mindfulness Scale with patients with severe TBI and controls	BRAIN INJURY			English	Article						Creativity; mindfulness; severe traumatic brain injury; short-form; validation	TRAUMATIC BRAIN-INJURY; NEUROBEHAVIORAL RATING-SCALE; STRESS REDUCTION; HEAD-INJURY; ACCEPTANCE; VALIDITY; INTERVENTION; MINDLESSNESS; RELIABILITY; PREVALENCE	Background: Mindfulness may have an impact on the recovery process in patients who have suffered severe traumatic brain injury (TBI). In order to make an instrument for measuring mindfulness within the German speaking clinical community available, a short, easily usable scale and a cross-cultural adaptation is needed. Objectives: To validate the Langer Mindfulness Scale (LMS) with German-speaking patients with severe TBI and their relatives (healthy controls). Research design: In a prospective cohort study of patients with severe TBI, test-re-test interviews were carried out at 6-month intervals. Sample: A total of 225 participants responded to the first survey and 230 completed the second survey. Measures: LMS, self-report questions on personality, openness and attention, as well as health and clinical evaluations (including cognitive and behavioural assessments). Results: On the basis of factor analysis, principal component analysis and item response analysis, the initial 21-items were reduced to six items. The resulting unidimensional scale showed high internal consistency (alpha = 0.82) and good test-re-test reliability (intra-class correlation for total score = 0.46). External validity was confirmed for the entire sample. Conclusion: It was concluded that the German short form of the original LMS (MCS) is a valid and reliable measure of mindful creativity.	[Haller, Chiara S.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Haller, Chiara S.] Harvard Univ, Sch Med, Boston, MA USA; [Haller, Chiara S.] Massachusetts Mental Hlth Ctr, Div Publ Psychiat, Boston, MA 02115 USA; [Haller, Chiara S.] Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA 02215 USA		Haller, CS (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	haller@fas.harvard.edu					Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Baer RA, 2004, ASSESSMENT, V11, P191, DOI 10.1177/1073191104268029; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bodner T., 2001, INDIVIDUAL DIFFERENC; Borkenau P., 1993, NEOFUNF FAKTOREN INV; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Bylsma LM, 2008, CLIN PSYCHOL REV, V28, P676, DOI 10.1016/j.cpr.2007.10.001; Cardaciotto L, 2008, ASSESSMENT, V15, P204, DOI 10.1177/1073191107311467; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Chadwick P, 2008, BRIT J CLIN PSYCHOL, V47, P451, DOI 10.1348/014466508X314891; Costa PT, 1992, REVISED NEOPERSONALI; de Bruin EI, 2012, ASSESSMENT, V19, P187, DOI 10.1177/1073191112446654; Feldman G, 2007, J PSYCHOPATHOL BEHAV, V29, P177, DOI 10.1007/s10862-006-9035-8; Feldner MT, 2006, J BEHAV THER EXP PSY, V37, P146, DOI 10.1016/j.jbtep.2005.03.002; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Haigh EAP, 2011, ASSESSMENT, V18, P11, DOI 10.1177/1073191110386342; Haller CS, 2011, CREATIVITY RES J, V23, P99, DOI 10.1080/10400419.2011.571182; Haller CS, 2010, PSYCHOL AESTHET CREA, V4, P149, DOI 10.1037/a0017084; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Ie A, 2012, COMPUT HUM BEHAV, V28, P1526, DOI 10.1016/j.chb.2012.03.022; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; KABATZINN J, 1985, J BEHAV MED, V8, P163, DOI 10.1007/BF00845519; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Lama Das S., 1998, AWAKENING BUDDHA 8 S; LANGER E, 1992, COMMUN MONOGR, V59, P324, DOI 10.1080/03637759209376274; Langer E.J., 1978, NEW DIRECTIONS ATTRI, VVol. 2, P35, DOI 10.4324/9780203780978-3; Langer EJ, 2000, J SOC ISSUES, V56, P1, DOI 10.1111/0022-4537.00148; Langer EJ, 2000, CURR DIR PSYCHOL SCI, V9, P220, DOI 10.1111/1467-8721.00099; LANGER EJ, 1992, CONSCIOUS COGN, V1, P289, DOI 10.1016/1053-8100(92)90066-J; Langer EJ, 2009, COUNTER CLOCKWISE MI; Langer EJ., 1989, MINDFULNESS; Langer EJ., 1989, CREATIVITY RES J, V2, P139, DOI [DOI 10.1080/10400418909534311, 10.1080/10400418909534311]; Langer Ellen J., 2006, BECOMING ARTIST REIN; Lau MA, 2006, J CLIN PSYCHOL, V62, P1445, DOI 10.1002/jclp.20326; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lundqvist A, 2012, BRAIN INJURY, V26, P1574, DOI 10.3109/02699052.2012.698363; MacKillop J, 2007, J PSYCHOPATHOL BEHAV, V29, P289, DOI 10.1007/s10862-007-9045-1; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Olson-Madden JH, 2012, REHABILITATION RES P, V2012, P6; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825; Suzuki DT, 1994, INTRO ZEN BUDDHISM; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; Walach H, 2006, PERS INDIV DIFFER, V40, P1543, DOI 10.1016/j.paid.2005.11.025; Whittingham K., 2010, MINDFULNESS, V1, P177, DOI [10.1007/s12671-010-0023-4, DOI 10.1007/S12671-010-0023-4]; Williams KA, 2001, AM J HEALTH PROMOT, V15, P422, DOI 10.4278/0890-1171-15.6.422; Zvolensky MJ, 2005, SER ANXIETY, P325	56	6	6	0	24	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	4					517	526		10.3109/02699052.2014.989906			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF8JE	WOS:000352803300014	25536391				2022-02-06	
J	Hua, Y; Akula, P; Kelso, M; Gu, LX				Hua, Yi; Akula, Praveen; Kelso, Matthew; Gu, Linxia			Characterization of Closed Head Impact Injury in Rat	BIOMED RESEARCH INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; AXONAL INJURY; MODEL; VULNERABILITY; RECOVERY	The closed head impact (CHI) rat models are commonly used for studying the traumatic brain injury. The impact parameters vary considerably among different laboratories, making the comparison of research findings difficult. In this work, numerical CHI experiments were conducted to investigate the sensitivities of intracranial responses to various impact parameters (e.g., impact depth, velocity, and position; impactor diameter, material, and shape). A three-dimensional finite element rat head model with anatomical details was subjected to impact loadings. Results revealed that impact depth and impactor shape were the two leading factors affecting intracranial responses. The influence of impactor diameter was region-specific and an increase in impactor diameter could substantially increase tissue strains in the region which located directly beneath the impactor. The lateral impact could induce higher strains in the brain than the central impact. An indentation depth instead of impact depth would be appropriate to characterize the influence of a large deformed rubber impactor. The experimentally observed velocity-dependent injury severity could be attributed to the "overshoot" phenomenon. This work could be used to better design or compare CHI experiments.	[Hua, Yi; Akula, Praveen; Gu, Linxia] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA; [Kelso, Matthew] Univ Nebraska Med Ctr, Dept Pharm Practice, Omaha, NE 68198 USA		Gu, LX (corresponding author), Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA.	lgu@unl.edu	gu, linxia/A-5645-2013	gu, linxia/0000-0003-2637-0299			Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Finan JD, 2012, ANN BIOMED ENG, V40, P982, DOI 10.1007/s10439-012-0537-0; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gurkoff GG, 2013, J NEUROTRAUM, V30, P292, DOI 10.1089/neu.2012.2463; Hua Y., COMPUTATION IN PRESS; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mao HJ, 2011, J MECH MED BIOL, V11, P1199, DOI 10.1142/S021951941100423X; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Maruichi K, 2009, NEUROPATHOLOGY, V29, P132, DOI 10.1111/j.1440-1789.2008.00956.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f	24	6	6	0	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015	2015								272976	10.1155/2015/272976			9	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CS3UH	WOS:000362000000001	26451365	gold, Green Published			2022-02-06	
J	Jackson, K; Rubin, R; Van Hoeck, N; Hauert, T; Lana, V; Wang, H				Jackson, Kevin; Rubin, Rachael; Van Hoeck, Nicole; Hauert, Tommy; Lana, Valentina; Wang, Huan			THE EFFECT OF SELECTIVE HEAD-NECK COOLING ON PHYSIOLOGICAL AND COGNITIVE FUNCTIONS IN HEALTHY VOLUNTEERS	TRANSLATIONAL NEUROSCIENCE			English	Article						Athletics; Brain; Concussion; Feasibility; Intervention	TRAUMATIC BRAIN-INJURY; LONG-TERM; SPORTS CONCUSSION; FOOTBALL PLAYERS; UNITED-STATES; ACUTE STROKE; HYPOTHERMIA; IMPACT; SYSTEM; HYPERTHERMIA	In general, brain temperatures are elevated during physical sporting activities; therefore, reducing brain temperature shortly after a sports-related concussion (SRC) could be a promising intervention technique. The main objective of this study was to examine the effects of head and neck cooling on physiological and cognitive function in normal healthy volunteers. Twelve healthy volunteers underwent two different sessions of combined head and neck cooling, one session with a cold pack and one session with a room temperature pack. Physiological measurements included: systolic/diastolic blood pressure, pulse oximetry, heart rate, and sublingual and tympanic temperature. Cognitive assessment included: processing speed, executive function, and working memory tasks. Physiological measurements were taken pre-, mid- and post-cooling, while cognitive assessments were done before and after cooling. The order of the sessions was randomized. There was a significant decrease in tympanic temperature across both sessions; however more cooling occurred when the cold pack was in the device. There was no significant decrease in sublingual temperature across either session. The observed heart rates, pulse oximetry, systolic and diastolic blood pressure during the sessions were all within range of a normal healthy adult. Cognitive assessment remained stable across each session for both pre- and post-cooling. We propose that optimizing brain temperature management after brain injury using head and neck cooling technology may represent a sensible, practical, and effective strategy to potentially enhance recovery and perhaps minimize the subsequent short and long term consequences from SRC.	[Jackson, Kevin; Rubin, Rachael; Hauert, Tommy; Lana, Valentina; Wang, Huan] Univ Illinois, Beckman Inst, Thermal Neurosci, Urbana, IL 61801 USA; [Rubin, Rachael; Wang, Huan] Carle Fdn Hosp, Urbana, IL 61801 USA; [Van Hoeck, Nicole] Vrije Univ Brussel, Psychol & Educ Sci, Brussels, Belgium		Jackson, K (corresponding author), Univ Illinois, Beckman Inst, Thermal Neurosci, Urbana, IL 61801 USA.	huanwang@illinois.org		Jackson, kevin/0000-0001-9917-3312			Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Covaciu L, 2011, INTENS CARE MED, V37, P1277, DOI 10.1007/s00134-011-2264-7; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2013, BEHAV BRAIN RES, V253, P152, DOI 10.1016/j.bbr.2013.07.002; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Georgiadis D, 2001, STROKE, V32, P2550, DOI 10.1161/hs1101.097382; Godek SF, 2005, AM J SPORT MED, V33, P843, DOI 10.1177/0363546504270999; Godek SF, 2005, BRIT J SPORT MED, V39, P205, DOI 10.1136/bjsm.2004.011767; Hemmen TM, 2007, STROKE, V38, P794, DOI 10.1161/01.STR.0000247920.15708.fa; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kallmunzer B, 2011, CEREBROVASC DIS, V32, P207, DOI 10.1159/000329376; Kammersgaard LP, 2000, STROKE, V31, P2251, DOI 10.1161/01.STR.31.9.2251; Kochanek PM, 2015, EXP NEUROL, V267, P13, DOI 10.1016/j.expneurol.2015.02.019; Koehn J, 2012, STROKE, V43, P2142, DOI 10.1161/STROKEAHA.112.652248; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JKW, 2014, EUR J APPL PHYSIOL, V114, P375, DOI 10.1007/s00421-013-2774-9; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Miyauchi T, 2014, J NEUROTRAUM, V31, P773, DOI 10.1089/neu.2013.3181; Nybo L, 2002, J APPL PHYSIOL, V93, P58, DOI 10.1152/japplphysiol.00049.2002; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Ozgunen KT, 2010, SCAND J MED SCI SPOR, V20, P140, DOI 10.1111/j.1600-0838.2010.01219.x; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Wang H, 2015, TRANSL NEUROSCI, V6, P20, DOI 10.1515/tnsci-2015-0004; Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003	46	6	6	0	11	SCIENDO	WARSAW	DE GRUYTER POLAND SP Z O O, BOGUMILA ZUGA 32A STR, 01-811 WARSAW, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	JAN	2015	6	1					131	138		10.1515/tnsci-2015-0012			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ6GJ	WOS:000360702200005	28123796	gold, Green Published			2022-02-06	
J	Kearns, WD; Fozard, JL; Schonfeld, L; Scott, S; Marshall, K				Kearns, William D.; Fozard, James L.; Schonfeld, Lawrence; Scott, Steven; Marshall, Katharine			Elevated Movement Path Tortuosity in Voluntary Outdoor Ambulation in Community-Dwelling Veterans With a History of Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						global positioning systems; (GPS); movement path tortuosity; outdoor ambulation; traumatic brain injury; veterans	REHABILITATION; IMPAIRMENT; GAIT; VARIABILITY; PATTERNS; OUTCOMES; PROFILE; WALKING	Objective: In comparison to veterans without a history of traumatic brain injury (TBI), we hypothesized that veterans with past TBI would have slower walking speed and more path tortuosity, TBI symptoms, problems with spatial orientation, and poorer executive function. Setting: Community nonclinical. Participants: Seventeen males (mean age of 37.2 years) reporting prior TBI and 20 non-TBI (mean age of 42.9 years). The number of years separating date of discharge and testing was 10.8 and 15.4 for the TBI and non-TBI groups, respectively. Design: Small 2 groups without random assignment. Main Measures: Brief Traumatic Brain Injury Screen, Trail Making Test-B, Clock Drawing Test, walking speed, and distance and path tortuosity in 30 minutes of voluntary outdoor walking wearing a small Global Positioning Systems recorder. Results: Those with TBI reported 4 Brief Traumatic Brain Injury Screen symptoms versus 0.4 for controls (F = 49.1; df = 1,35; P < .001) but did not differ on Trail Making Test-B or the Clock Drawing Test. Veterans with TBI walked shorter distances, 2.33 km versus 2.84 km (F = 4.8; df = 1,35; P < .05), and had greater path tortuosity (fractal D of 1.22 vs 1.15; F = 3.5; df = 1,35; P < .05) but did not differ on travel speed or time spent walking. Conclusions: Traumatic brain injury has persistent symptomatic effects and significantly affects ambulation and spatial orientation years after the event. These findings corroborate and extend observations linking cognitive impairment and ambulation.	[Kearns, William D.; Marshall, Katharine] Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL 33612 USA; [Fozard, James L.] Univ S Florida, Sch Aging Studies, Tampa, FL 33612 USA; [Schonfeld, Lawrence] Univ S Florida, Florida Mental Hlth Inst, Tampa, FL 33612 USA; [Scott, Steven] James A Haley Vet Adm Hosp, Phys Med & Rehabil Serv, US Dept Vet Affairs, Tampa, FL USA		Kearns, WD (corresponding author), Univ S Florida, Coll Behav & Community Sci, Dept Rehabil & Mental Hlth Counseling, 13301 B Downs Blvd,MHC1601 Tampa, Tampa, FL 33612 USA.	Kearns@usf.edu	Kearns, William D/F-9810-2015	Kearns, William D/0000-0002-0241-814X	US Department of DefenseUnited States Department of Defense [W81XWH-11-1-0634]	This research was supported by the US Department of Defense under award number W81XWH-11-1-0634 to Dr Paul Sanberg "Battlefield-Related Injury Translational Research, Post-Traumatic Disease, and Disability Veterans Re-Integration." The authors also acknowledge Mr Charles Dion for his assistance with the statistical analysis.	Attum O, 2011, EUR J WILDLIFE RES, V57, P251, DOI 10.1007/s10344-010-0419-4; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Craighead JD, 2011, J INTELL ROBOT SYST, V64, P97, DOI 10.1007/s10846-010-9530-8; Delgado MD, 2009, ARDEA, V97, P7, DOI 10.5253/078.097.0102; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hillier SL, 1997, BRAIN INJURY, V11, P661; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jasiewicz J, 2011, J REHABIL RES DEV, V48, pVII, DOI 10.1682/JRRD.2011.07.0129; Kearns William D., 2011, Gerontechnology, V10, P90, DOI 10.4017/gt.2011.10.2.004.00; Kearns WD, 2010, METHOD INFORM MED, V49, P592, DOI 10.3414/ME09-01-0079; Kearns WD, 2012, J AM MED DIR ASSOC, V13; Luis CA, 2007, EVIDENCE BASED PROTO, P65; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Nams VO, 2006, ANIM BEHAV, V72, P1197, DOI 10.1016/j.anbehav.2006.04.005; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Royall DR, 1999, J GERONTOL B-PSYCHOL, V54, pP328, DOI 10.1093/geronb/54B.5.P328; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Terrier P, 2003, EUR J APPL PHYSIOL, V90, P554, DOI 10.1007/s00421-003-0906-3; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wagner PJ, 2011, J NEUROPSYCH CLIN N, V23, P449, DOI 10.1176/jnp.23.4.jnp449; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; WATSON YI, 1993, J AM GERIATR SOC, V41, P1235, DOI 10.1111/j.1532-5415.1993.tb07308.x; Webb SL, 2009, J MAMMAL, V90, P1210, DOI 10.1644/08-MAMM-A-278.1; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D	28	6	6	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2015	30	1					E8	E14		10.1097/HTR.0000000000000021			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AY8BW	WOS:000347780400002	24590148				2022-02-06	
J	Lewis, FD; Horn, GJ				Lewis, Frank D.; Horn, Gordon J.			Neurologic continuum of care: Evidence-based model of a post-hospital system of care	NEUROREHABILITATION			English	Article						Brain injury; continuum of care; neurologic outcomes; predictors; post-hospital rehabilitation	TRAUMATIC BRAIN-INJURY; REHABILITATION	BACKGROUND: There is increasing need for a well-organized continuum of post-hospital rehabilitative care to reduce long term disability resulting from acquired brain injury. OBJECTIVE: This study examined the effectiveness of four levels of post-hospital care (active neurorehabilitation, neurobehavioral intensive, day treatment, and supported living) and the functional variables most important to their success. METHODS: Participants were 1276 adults with acquired brain injury who were being treated in one of the four program levels. A Repeated Measures MANOVA was used to evaluate change from admission to discharge on the Mayo Portland Adaptability Inventory-4 T-scores. Regression analyses were used to identify predictors of outcome. RESULTS: Statistical improvement on the MPAI-4 was observed at each program level. Self-care and Initiation were the strongest predictors of outcome. CONCLUSION: The results support the effectiveness of a continuum of care for acquired brain injury individuals beyond hospitalization and acute in-hospital rehabilitation. It is particularly noteworthy that reduction in disability was achieved for all levels of programming even with participants whose onset to admission exceeded 7 years post-injury.	[Lewis, Frank D.] Georgia Regents Univ, Med Coll Georgia, NeuroRestorat Natl Clin Outcomes, Augusta, GA 30909 USA; [Horn, Gordon J.] Florida State Univ, Coll Med, NeuroRestorat Natl Clin Outcomes, Tallahassee, FL 32306 USA		Lewis, FD (corresponding author), Georgia Regents Univ, 1227 Augusta West Pkwy, Augusta, GA 30909 USA.	Frank.Lewis@neurorestorative.com					Cohen J., 1975, APPL MULTIPLE REGRES; Cope N. D., 1991, BRAIN INJURY, V5, P111; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; Hayden M. E., 2013, AM ACAD PHYS MED REH, P319; Horn G. J., 2014, J NURSE LIFE CARE PL, V14, P681; Horn G, 2013, J HEAD TRAUMA REHAB, V28, pE53; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewis F. D., 2014, ARCH PHYS M IN PRESS; Lewis Frank D, 2013, J Spec Oper Med, V13, P56; Malec J. F., 2008, CHILD ADOLESCENCE MA, P1; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; Selby M. J., 2000, NEUROPSYCHOLOGICAL A, P48; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	17	6	6	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	3					243	251		10.3233/NRE-151213			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CM8WS	WOS:000357984000003	26409328				2022-02-06	
J	Libin, AV; Scholten, J; Schladen, MM; Danford, E; Shara, N; Penk, W; Grafman, J; Resnik, L; Bruner, D; Cichon, S; Philmon, M; Tsai, B; Blackman, M; Dromerick, A				Libin, Alexander V.; Scholten, Joel; Schladen, Manon Maitland; Danford, Ellen; Shara, Nawar; Penk, Walter; Grafman, Jordan; Resnik, Linda; Bruner, Dwan; Cichon, Samantha; Philmon, Miriam; Tsai, Brenda; Blackman, Marc; Dromerick, Alexander			Executive functioning in TBI from rehabilitation to social reintegration: COMPASS(goal), a randomized controlled trial (grant: 1I01RX000637-01A3 by the VA ORD RR&D, 2013-2016)	MILITARY MEDICAL RESEARCH			English	Article						Executive function; Traumatic brain injury; Goal-setting; Community re-integration; Veterans; Randomized controlled trial; Manualized psychosocial intervention	TRAUMATIC BRAIN-INJURY; NEUROPSYCHIATRIC INTERVIEW MINI; PRIMARY-CARE PATIENTS; PARKINSONS-DISEASE; COMMUNITY REINTEGRATION; COMBAT VETERANS; JOB PLACEMENT; STRATEGY USE; RELIABILITY; VALIDITY	Background: Traumatic brain injury is a major health problem that frequently leads to deficits in executive function. Self-regulation processes, such as goal-setting, may become disordered after traumatic brain injury, particularly when the frontal regions of the brain and their connections are involved. Such impairments reduce injured veterans' ability to return to work or school and to regain satisfactory personal lives. Understanding the neurologically disabling effects of brain injury on executive function is necessary for both the accurate diagnosis of impairment and the individual tailoring of rehabilitation processes to help returning service members recover independent function. Methods/design: The COMPASSgoal (Community Participation through Self-Efficacy Skills Development) program develops and tests a novel patient-centered intervention framework for community re-integration psychosocial research in veterans with mild traumatic brain injury. COMPASSgoal integrates the principles and best practices of goal self-management. Goal setting is a core skill in self-management training by which persons with chronic health conditions learn to improve their status and decrease symptom effects. Over a three-year period, COMPASSgoal will recruit 110 participants with residual executive dysfunction three months or more post-injury. Inclusion criteria combine both clinical diagnosis and standardized scores that are > 1 SD from the normative score on the Frontal Systems Rating Scale. Participants are randomized into two groups: goal-management (intervention) and supported discharge (control). The intervention is administered in eight consecutive, weekly sessions. Assessments occur at enrollment, post-intervention/supported discharge, and three months post-treatment follow-up. Discussion: Goal management is part of the "natural language" of rehabilitation. However, collaborative goal-setting between clinicians/case managers and clients can be hindered by the cognitive deficits that follow brain injury. Re-training returning veterans with brain injury in goal management, with appropriate help and support, would essentially treat deficits in executive function. A structured approach to goal self-management may foster greater independence and self-efficacy, help veterans gain insight into goals that are realistic for them at a given time, and help clinicians and veterans to work more effectively as true collaborators.	[Libin, Alexander V.] Washington DC VA Med Ctr, Mental Hlth Serv, 50 Irving St, Washington, DC 20422 USA; [Libin, Alexander V.; Schladen, Manon Maitland; Philmon, Miriam; Tsai, Brenda; Dromerick, Alexander] MedStar Natl Rehabil Hosp, Washington, DC 20010 USA; [Scholten, Joel; Bruner, Dwan] Washington DC VA Med Ctr, Phys Med & Rehabil Serv, Washington, DC 20422 USA; [Schladen, Manon Maitland; Danford, Ellen; Shara, Nawar; Cichon, Samantha; Blackman, Marc; Dromerick, Alexander] Washington DC VA Med Ctr, Res Serv, Washington, DC 20422 USA; [Libin, Alexander V.; Schladen, Manon Maitland; Shara, Nawar] MedStar Hlth Res Inst, Hyattsville, MD 20782 USA; [Penk, Walter] Texas A&M Coll Med, Bryan, TX 77807 USA; [Grafman, Jordan] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Resnik, Linda] VA Med Ctr, Res Serv, Providence, RI 02908 USA		Libin, AV (corresponding author), Washington DC VA Med Ctr, Mental Hlth Serv, 50 Irving St, Washington, DC 20422 USA.	Alexander.Libin2@VA.gov	Libin, Alexander V./W-8641-2019; Libin, Alexander V/G-3208-2015; Blackman, Marc/AAT-5771-2021	Libin, Alexander V./0000-0001-7847-3463; Libin, Alexander V/0000-0001-7847-3463; 	United States Department of Veterans Affairs Rehabilitation Research and Development Service Program [I 01 RX000637-01A3]; National Center for Research Resources, a component of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U54 RR026076-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000101] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031975] Funding Source: NIH RePORTER	This work is supported by Merit Review Award # I 01 RX000637-01A3 from the United States Department of Veterans Affairs Rehabilitation Research and Development Service Program. Partial logistical support for the preparatory phase of the project was provided through the MedStar Health Research Institute, a component of the Georgetown-Howard Universities Center for Clinical and Translational Science, and supported by Grant U54 RR026076-01 from the National Center for Research Resources, a component of the National Institutes of Health. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the views of the United States Government, the Department of Veterans Affairs, the National Center for Research Resources, the National Institutes of Health, or MedStar Health.	Amorim P, 1998, EUR PSYCHIAT, V13, P26, DOI 10.1016/S0924-9338(97)86748-X; Anderson V, 2008, STUDIES NEUROPSYCHOL; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Arzaga Deborah, 2003, SCI Nurs, V20, P86; Baddeley A.D., 2007, COMMUNICATION 0913; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Baum CM, 2013, EXECUTIVE FUNCTIONIN; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bernstein NA., 1967, COORDINATION REGULAT; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2009, POTENTIAL RISK FACTO; CHRISTENSEN AL, 1984, LURIAS NEUROPSYCHOLO; Cicerone K. D., 2005, REHABILITATION TRAUM, P71; Department of Defense, 2010, DEF CAS UPD; Department of Veterans Affairs, 2010, VHA HDB; Department of Veterans Affairs, 2013, VHA HDB; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Dickstein BD, 2015, ASSESSMENT, V22, P289, DOI 10.1177/1073191114548683; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diggle P., 2002, ANAL LONGITUDINAL DA; Donovan JJ, 2003, J APPL PSYCHOL, V88, P379, DOI 10.1037/0021-9010.88.3.379; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Elnitsky CA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-498; FALSSTEWART W, 1992, PERCEPT MOTOR SKILL, V74, P39, DOI 10.2466/PMS.74.1.39-42; FISHER AG, 1993, AM J OCCUP THER, V47, P319, DOI 10.5014/ajot.47.4.319; GIBB WRG, 1992, NEUROL CLIN, V10, P361, DOI 10.1016/S0733-8619(18)30215-9; Goldberg E., 2001, EXECUTIVE BRAIN FRON; GOLDBERG E, 1990, CONT NEUROPSYCHOLOGY; Government Accountability Office, 2008, VA HLTH CAR MILD TRA; Grace J, 2001, FRSBE FRONTAL SYSTEM; Grafman J, 2000, CEREBRAL REORGANIZAT; Grafman J., 1995, STRUCTURE FUNCTIONS; Grafman J., 2007, NEUROERGONOMICS BRAI; Hamsher K., 1989, MULTILINGUAL APHASIA; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; HARRINGTON DL, 1991, NEUROPSYCHOLOGIA, V29, P147, DOI 10.1016/0028-3932(91)90017-3; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Heitger M, 2005, 6 WORLD C BRAIN INJ; Hoerster KD, 2015, TELEMED E-HEALTH, V21, P42, DOI 10.1089/tmj.2013.0337; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; IBM Corp, 2012, IMB SPSS STAT WIND V; ICH, 1994, CLIN SAF DAT MAN DEF; Institute of Medicine (IOM), 2013, RET HOM IR AFGH READ; Institute of Medicine (IOM), 2010, RET HOM IR AFGH PREL; International Committee of Medical Journal Editors, 2010, UN REQ MAN SUBM BIOM; JASON GW, 1985, NEUROPSYCHOLOGIA, V23, P483, DOI 10.1016/0028-3932(85)90003-X; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Laine M, 2009, SCAND J PSYCHOL, V50, P33, DOI 10.1111/j.1467-9450.2008.00682.x; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Leland A., 2009, AM WAR MILITARY OPER; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Libin A., 1994, GEOMETRICAL FORM PRE; Libin A., 2008, DIFFERENTIAL PSYCHOL; Libin A., 2008, PSYCHOL J RUSSIAN AC, V29, P10; Libin A, 2008, GEOMETRICAL FORM PRE; Libin E., 2008, COPING INTELLIGENCE; Luria, 1996, HIGHER CORTICAL FUNC; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Marx B., 2010, DEV VALIDATION PTSD; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Meyers A W, 1996, Prog Behav Modif, V30, P137; Mohr DC, 2012, JAMA-J AM MED ASSOC, V307, P2278, DOI 10.1001/jama.2012.5588; NCSS, 2008, STAT SOFTW; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Nich C, 2002, DRUG ALCOHOL DEPEN, V68, P121, DOI 10.1016/S0376-8716(02)00111-4; Niogi SN, 2007, NEUROIMAGE, V35, P166, DOI 10.1016/j.neuroimage.2006.10.040; Oettingen G, 2001, J PERS SOC PSYCHOL, V80, P736, DOI 10.1037//0022-3514.80.5.736; Penk W, 2009, PSYCHIATR REHABIL J, V33, P297, DOI 10.2975/33.4.2010.297.307; Plotnik M, 2009, J NEUROL NEUROSUR PS, V80, P347, DOI 10.1136/jnnp.2008.157362; Rabbitt P, 1998, METHODOLOGY FRONTAL; RAND Center for Military Health Policy Research, 2015, INV WOUNDS WAR PROJ; RASKIN SA, 1992, J CLIN EXP NEUROPSYC, V14, P801, DOI 10.1080/01688639208402864; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; RIEDERER P, 1976, J NEURAL TRANSM, V38, P277, DOI 10.1007/BF01249445; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P153, DOI 10.1016/S0887-6177(01)00192-5; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Scott SG, 2008, ESSENTIALS PHYS MED; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; VA Informatics and Computer Infrastructure-VINCI Central, 2014, VINCI DESCR IRBS; WEI LJ, 1988, CONTROL CLIN TRIALS, V9, P345, DOI 10.1016/0197-2456(88)90048-7; World Health Organization, 2007, INT CLASS FUNCT DIS; Zeitzer MB, 2008, AAOHN J, V56, P347, DOI 10.3928/08910162-20080801-03; Ziv I, 1999, ACTA NEUROL SCAND, V99, P106, DOI 10.1111/j.1600-0404.1999.tb00666.x	103	6	6	4	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2095-7467	2054-9369		MILITARY MED RES	MILITARY MED. RES.		2015	2								32	10.1186/s40779-015-0061-2			20	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V33AG	WOS:000215737700032	26664736	Green Published, gold			2022-02-06	
J	Luoto, TM; Iverson, GL; Losoi, H; Waljas, M; Tenovuo, O; Kataja, A; Brander, A; Ohman, J				Luoto, Teemu M.; Iverson, Grant L.; Losoi, Heidi; Waljas, Minna; Tenovuo, Olli; Kataja, Anneli; Brander, Antti; Ohman, Juha			Clinical correlates of retrograde amnesia in mild traumatic brain injury	BRAIN INJURY			English	Article						Concussion; head injury; post-concussion syndrome; retrograde amnesia; return to work; traumatic brain injury	CLOSED-HEAD-INJURY; POST-CONCUSSION SYMPTOMS; POSTTRAUMATIC AMNESIA; TEMPORAL-LOBE; SCANDINAVIAN GUIDELINES; INITIAL MANAGEMENT; PRACTICAL SCALE; MEMORY; IMPAIRMENT; PREDICTORS	Primary objective: The purpose of this study was to examine the clinical significance of retrograde amnesia (RA) in patients with acute mild traumatic brain injuries (MTBI). Methods and procedures: An emergency department sample of patients (n = 75), aged 18-60 years, with no pre-morbid medical or psychiatric conditions, who met the WHO criteria for MTBI were enrolled in this prospective, descriptive, follow-up study. This study examined the presence and duration of RA in relation to socio-demographics, MTBI severity markers including neuroimaging (CT, MRI) and clinical outcomes (Rivermead post-concussion symptoms questionnaire, post-concussion syndrome (PCS) diagnosis and return to work (RTW) status) at 2 weeks, 1 month and 6 months post-injury. Main outcomes and results: GCS scores and duration of post-traumatic amnesia (PTA) were related to RA. Those with GCS scores of 14 vs. 15 were more likely to have RA (chi(2) (1) = 13.70, p<0.0001) and a longer duration (Mann-Whitney U = 56.0, p<0.0001, d = 1.15) of RA. The duration of RA and PTA correlated positively (Spearman rho(75) = 0.42, p<0.0001) and those with RA had longer durations of PTA (Mann-Whitney U = 228.5, p = 0.001, d = 1.21). During the follow-up, the presence and duration of RA were not significantly associated with PCS diagnosis or time to RTW. Conclusions: In this study, the presence and duration of RA was not associated with outcome.	[Luoto, Teemu M.; Losoi, Heidi; Waljas, Minna; Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, FI-33521 Tampere, Finland; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Tenovuo, Olli] Univ Turku, Dept Rehabil & Brain Trauma, Turku, Finland; [Tenovuo, Olli] Univ Turku, Cent Hosp, FIN-20520 Turku, Finland; [Kataja, Anneli; Brander, Antti] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, FI-33521 Tampere, Finland		Luoto, TM (corresponding author), Tampere Univ Hosp, P Box 2000, FI-33521 Tampere, Finland.	teemu.luoto@pshp.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Iverson, Grant/0000-0001-7348-9570; Ohman, Juha/0000-0002-6592-1367	Medical Research Fund of Tampere University Hospital	The authors thank research assistants Anne Simi and Marika Suopanki-Ervasti for their contribution in data collection. This study was done as part of the first author's PhD thesis research program. A portion of this study was presented at the 9th World Congress on Brain Injury in Edinburgh, Scotland, in March 2012. This study has been supported by the Medical Research Fund of Tampere University Hospital.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; [Anonymous], 2014, BMJ CLIN RES ED, V348, pg409; Anstey K, 2000, GERONTOLOGY, V46, P163, DOI 10.1159/000022153; Ashley J, 1990, Health Trends, V22, P135; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BENSON DF, 1967, J NEUROL NEUROSUR PS, V30, P539, DOI 10.1136/jnnp.30.6.539; BLOMERT DM, 1974, CAN PSYCHIAT ASSOC J, V19, P185, DOI 10.1177/070674377401900215; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Dawson KS, 2007, BRAIN INJURY, V21, P943, DOI 10.1080/02699050701553171; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; Hurlemann R, 2007, PSYCHOPHARMACOLOGY, V194, P261, DOI 10.1007/s00213-007-0836-6; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jenkins KG, 2009, CURR OPIN NEUROL, V22, P601, DOI 10.1097/WCO.0b013e32833299bb; Kapur N, 2002, CORTEX, V38, P660, DOI 10.1016/S0010-9452(08)70032-7; KAPUR N, 1992, BRAIN, V115, P73, DOI 10.1093/brain/115.1.73; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kopelman MD, 2000, COGNITIVE NEUROPSYCH, V17, P585, DOI 10.1080/026432900750002172; Kopelman MD, 2002, BRAIN, V125, P2152, DOI 10.1093/brain/awf229; Kopelman MD, 1999, NEUROPSYCHOLOGIA, V37, P939, DOI 10.1016/S0028-3932(98)00143-2; KOPELMAN MD, 1987, BRIT J PSYCHIAT, V150, P428, DOI 10.1192/bjp.150.4.428; Kopelman Michael D, 2008, Handb Clin Neurol, V88, P185, DOI 10.1016/S0072-9752(07)88008-0; Kopelman MD, 2007, NEUROPSYCHOLOGIA, V45, P1232, DOI 10.1016/j.neuropsychologia.2006.10.005; Lee S, 2003, AM J EPIDEMIOL, V157, P712, DOI 10.1093/aje/kwg042; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Markowitsch HJ, 2012, LANCET, V380, P1429, DOI 10.1016/S0140-6736(11)61304-4; Markowitsch HJ, 2003, NEUROIMAGE, V20, pS132, DOI 10.1016/j.neuroimage.2003.09.010; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Nash RA, 2011, MEMORY, V19, P566, DOI 10.1080/09658211.2011.590508; National Institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I, V56; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; O'Boyle C A, 1988, Psychopharmacol Ser, V6, P146; Ouellet J, 2008, BEHAV NEUROL, V20, P27, DOI [10.1155/2008/520328, 10.3233/BEN-2008-0213]; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SIGN, 2009, EARL MAN PAT HEAD IN; Staniloiu A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00403; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Vik PW, 2004, PSYCHIAT CLIN N AM, V27, P97, DOI 10.1016/S0193-953X(03)00110-2; Walker DJ, 1998, PSYCHOPHARMACOLOGY, V140, P191, DOI 10.1007/s002130050757; Whiting MD, 2008, BRAIN RES, V1213, P69, DOI 10.1016/j.brainres.2008.01.107; WILLIAMS M, 1952, J NEUROL NEUROSUR PS, V15, P54, DOI 10.1136/jnnp.15.1.54	56	6	6	0	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	5					565	572		10.3109/02699052.2014.1002421			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH3GL	WOS:000353917000004	25789824				2022-02-06	
J	Maegele, M; Braun, M; Wafaisade, A; Schafer, N; Lippert-Gruener, M; Kreipke, C; Rafols, J; Schafer, U; Angelov, DN; Stuermer, EK				Maegele, M.; Braun, M.; Wafaisade, A.; Schaefer, N.; Lippert-Gruener, M.; Kreipke, C.; Rafols, J.; Schaefer, U.; Angelov, D. N.; Stuermer, E. K.			Long-Term Effects of Enriched Environment on Neurofunctional Outcome and CNS Lesion Volume After Traumatic Brain Injury in Rats	PHYSIOLOGICAL RESEARCH			English	Article						Traumatic brain injury; Enriched environment; Controlled cortical impact; Neurobehavioral; Functional recovery	FLUID PERCUSSION INJURY; MEDIATED FUNCTIONAL IMPROVEMENT; NEURON-SPECIFIC ENOLASE; EARLY-ONSET STIMULATION; FACTOR MESSENGER-RNA; DENTATE GYRUS; COGNITIVE RECOVERY; MOTOR DEFICITS; VISUAL-CORTEX; STEREOLOGICAL METHODS	To determine whether the exposure to long term enriched environment (EE) would result in a continuous improvement of neurological recovery and ameliorate the loss of brain tissue after traumatic brain injury (TBI) vs. standard housing (SH). Male Sprague-Dawley rats (300-350 g, n=28) underwent lateral fluid percussion brain injury or SHAM operation. One TBI group was held under complex EE for 90 days, the other under SH. Neuromotor and sensorimotor dysfunction and recovery were assessed after injury and at days 7, 15, and 90 via Composite Neuroscore (NS), RotaRod test, and Barnes Circular Maze (BCM). Cortical tissue loss was assessed using serial brain sections. After day 7 EE animals showed similar latencies and errors as SHAM in the BCM. SH animals performed notably worse with differences still significant on day 90 (p<0.001). RotaRod test and NS revealed superior results for EE animals after day 7. The mean cortical volume was significantly higher in EE vs. SH animals (p=0.003). In summary, EE animals after lateral fluid percussion (LFP) brain injury performed significantly better than SH animals after 90 days of recovery. The window of opportunity may be wide and also lends further credibility to the importance of long term interventions in patients suffering from TBI.	[Maegele, M.; Braun, M.; Wafaisade, A.; Schaefer, N.; Stuermer, E. K.] Univ Witten Herdecke, Inst Res Operat Med IFOM, Campus Cologne Merheim, Cologne, Germany; [Maegele, M.; Wafaisade, A.] Univ Witten Herdecke, Cologne Merheim Med Ctr, Dept Traumatol & Orthoped Surg, Cologne, Germany; [Lippert-Gruener, M.] Univ Cologne Med Ctr, Dept Neurosurg, Cologne, Germany; [Kreipke, C.; Rafols, J.] Wayne State Univ, Sch Med, Dept Anat, Detroit, MI USA; [Schaefer, U.] Med Univ Graz, Univ Hosp Neurosurg, Expt Neurotraumatol, Graz, Austria; [Angelov, D. N.] Univ Cologne, Inst Anat, D-50931 Cologne, Germany		Maegele, M (corresponding author), Univ Witten Herdecke, Inst Res Operat Med IFOM, Campus Cologne Merheim, Cologne, Germany.						Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; ANGELOV DN, 1994, J NEUROCYTOL, V23, P218, DOI 10.1007/BF01275526; Angelov DN, 2007, NEUROBIOL DIS, V26, P229, DOI 10.1016/j.nbd.2006.12.016; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; Bennett JC, 2006, NEUROBIOL LEARN MEM, V85, P139, DOI 10.1016/j.nlm.2005.09.003; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brook GA, 1998, ACTA NEUROPATHOL, V95, P378, DOI 10.1007/s004010050814; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chapillon P, 1999, BEHAV GENET, V29, P41, DOI 10.1023/A:1021437905913; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; CONNOR JR, 1982, EXP NEUROL, V78, P466, DOI 10.1016/0014-4886(82)90064-4; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; DIAMOND MC, 1972, J NEUROBIOL, V3, P47, DOI 10.1002/neu.480030105; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; DIAMOND MC, 1976, J NEUROBIOL, V7, P75, DOI 10.1002/neu.480070108; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DOBBING J, 1970, DEV NEUROBIOL, P253; DUNHAM NW, 1957, J AM PHARM ASSOC, V46, P208, DOI 10.1002/jps.3030460322; Emery DL, 2000, J COMP NEUROL, V424, P521; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Friske JE, 2005, PHYSIOL BEHAV, V85, P187, DOI 10.1016/j.physbeh.2005.03.022; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; GREENOUGH WT, 1985, P NATL ACAD SCI USA, V82, P4549, DOI 10.1073/pnas.82.13.4549; GREENOUGH WT, 1973, EXP NEUROL, V41, P371, DOI 10.1016/0014-4886(73)90278-1; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Grow JL, 2003, DEV NEUROSCI-BASEL, V25, P394, DOI 10.1159/000075665; Gruner ML, 2000, BRAIN INJURY, V14, P585; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; GUNTINAS-LICHIUS O, 1996, ACTA STEREOL, V15, P31; GUNTINASLICHIUS O, 1994, EUR ARCH OTO-RHINO-L, V251, P410; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hebb, 1947, AM PSYCHOL, V2, P306, DOI DOI 10.1037/H0028720; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hicks RR, 2002, J NEUROTRAUM, V19, P705, DOI 10.1089/08977150260139093; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; INGLIS FM, 1995, NEUROSCIENCE, V66, P81, DOI 10.1016/0306-4522(94)00578-S; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; JONES BJ, 1968, N-S ARCH PHARMAKOL, V259, P211, DOI 10.1007/BF00537801; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Kolb B, 1991, CEREB CORTEX, V1, P189, DOI 10.1093/cercor/1.2.189; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kozlowski DA, 2004, J NEUROTRAUM, V21, P513, DOI 10.1089/089771504774129856; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Lee EHY, 2003, EUR J NEUROSCI, V18, P2842, DOI 10.1111/j.1460-9568.2003.03032.x; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; LIPPERT-GRUENER M, 2006, PHYS MED REHAB KUROR, V16, P1; Lippert-Gruener M, 2007, EXP NEUROL, V203, P82, DOI 10.1016/j.expneurol.2006.07.025; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Lippert-Gruner M, 2002, ACT NEUR S, V79, P21; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Lozada A, 2005, NEUROPATH APPL NEURO, V31, P150, DOI 10.1111/j.1365-2990.2004.00622.x; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Maegele M, 2005, SHOCK, V23, P476, DOI 10.1097/01.shk.0000159929.87737.5c; MAEGELE M, 2002, LANGENBECK ARCH SURG, V387, P266; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; MAYHEW TM, 1991, EXP PHYSIOL, V76, P639, DOI 10.1113/expphysiol.1991.sp003533; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Moser MB, 1997, J COMP NEUROL, V380, P373, DOI 10.1002/(SICI)1096-9861(19970414)380:3<373::AID-CNE6>3.0.CO;2-#; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; MYSLIVECEK J, 1987, ONTOGENESIS BRAIN, P117; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; NEISS WF, 1992, ANN ANAT, V174, P419, DOI 10.1016/S0940-9602(11)80266-9; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; RINK A, 1995, AM J PATHOL, V147, P1575; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Schrijver NCA, 2002, PHARMACOL BIOCHEM BE, V73, P209, DOI 10.1016/S0091-3057(02)00790-6; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; SCHWARTZ S, 1964, J COMP PHYSIOL PSYCH, V57, P72, DOI 10.1037/h0045518; SINSON G, 1995, J NEUROCHEM, V65, P2209; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; SOSIN DM, 1991, BRAIN INJURY, V10, P47, DOI DOI 10.1080/026990596124719; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; vanRijzingen IMS, 1997, NEUROBIOL LEARN MEM, V67, P21, DOI 10.1006/nlme.1996.3735; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; WHISHAW IQ, 1984, BEHAV NEURAL BIOL, V42, P183, DOI 10.1016/S0163-1047(84)91046-X; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WILL BE, 1976, PHYSIOL BEHAV, V16, P603, DOI 10.1016/0031-9384(76)90221-3	149	6	6	0	9	ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY	PRAGUE 4	VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC	0862-8408	1802-9973		PHYSIOL RES	Physiol. Res.		2015	64	1					129	145		10.33549/physiolres.932664			17	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	CD3WP	WOS:000351014800013	25194132	gold			2022-02-06	
J	Man, D; Yip, C; Lee, G; Fleming, J; Shum, D				Man, David; Yip, Calvin; Lee, Grace; Fleming, Jennifer; Shum, David			Self-report prospective memory problems in people with stroke	BRAIN INJURY			English	Article						ADL; age; functional; IADL; prospective memory; stroke	TRAUMATIC BRAIN-INJURY; YOUNG-ADULTS; INSTRUMENTAL ACTIVITIES; ISCHEMIC-STROKE; TIME; AGE; REHABILITATION; INVOLVEMENT; PERFORMANCE; PREDICTORS	Background and purpose: Prospective memory (PM) is a common problem which can limit performance of basic and instrumental activities of daily living in patients with stroke. This study compared self-report PM failures between older and younger people with stroke, examined differences in perceptions of PM failures between people with stroke and relatives, relationships between these PM failures and functional performance. Methods: A total of 105 patients with stroke, 65 relatives and 112 healthy controls were recruited. Both the patients with stroke and controls were further divided into an older (age>55 years) and a younger (age <= 55 years) group. Data for patients with stroke and relatives were obtained via the Brief Assessment of Prospective Memory (BAPM), Basic Activity of Daily Living (BADL) related Modified Barthel Index (MBI) and Lawton Instrumental Activities of Daily Living (Lawton IADL) Scale. Healthy controls' data were also collected. Results: The older stroke group had significantly higher BAPM total scores and BADL and IADL sub-scale scores than the younger group. Difference in perceptions of the patients' self-report of PM failures and their relatives' report was significant for the IADL sub-scale. Self-report of PM failure was significantly related to functional BADL and IADL measures. Conclusions: Results highlight the impact of PM failures in patients with stroke and their assessment, management and rehabilitation of these patients.	[Man, David; Yip, Calvin] City Polytech Hong Kong, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; [Yip, Calvin] Kwai Chung Hosp, Occupat Therapy Dept, Hong Kong, Hong Kong, Peoples R China; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; [Fleming, Jennifer] Queensland Hlth, Metro South Hlth Serv Dist, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Shum, David] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; [Shum, David] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia		Man, D (corresponding author), City Polytech Hong Kong, Dept Rehabil Sci, Yuk Choi Rd, Kowloon, Hong Kong, Peoples R China.	david.man@polyu.edu.hk	Fleming, Jennifer/AAH-5108-2020; Shum, David/A-3914-2008	Shum, David/0000-0002-4810-9262; YIP, Chi Kong/0000-0002-5393-6609	Griffith University, AustraliaGriffith University [H-ZG66]; Hong Kong Polytechnic UniversityHong Kong Polytechnic University [G-YK42]	This research was partly supported by a collaborative research fund (H-ZG66) given by The Griffith University, Australia and The Departmental Research Grant (DRG) of The Hong Kong Polytechnic University (G-YK42). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Banks P., 2004, SEXUAL RELATIONSHIP, V19, P413, DOI DOI 10.1080/14681990412331298009; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Cheng HD, 2010, BEHAV NEUROSCI, V124, P152, DOI 10.1037/a0018306; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.534487, 10.1161/STROKEAHA.108.535088]; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Feigin VL, 2005, LANCET, V365, P2160, DOI 10.1016/S0140-6736(05)66755-4; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Gao JL, 2013, AGING NEUROPSYCHOL C, V20, P80, DOI 10.1080/13825585.2012.672948; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; HART RG, 1983, STROKE, V14, P110, DOI 10.1161/01.STR.14.1.110; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Hong Kong Stroke Society, 2014, KNOW AC STROK; IBM Corp Released, 2011, IBM SPSS STAT WIND V; Kim HJ, 2009, J NEUROL SCI, V283, P319, DOI 10.1016/j.jns.2009.02.299; Kim HJ, 2009, NEUROCASE, V15, P145, DOI 10.1080/13554790802709039; Kvavilashvili L, 2009, MEMORY, V17, P180, DOI 10.1080/09658210802194366; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Mackay J, 2014, ALTAS HEART DIS STRO; Man DWK, 2011, NEUROPSYCHOL REHABIL, V21, P884, DOI 10.1080/09602011.2011.627270; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; Maylor EA, 1998, AGING NEUROPSYCHOL C, V5, P107, DOI 10.1076/anec.5.2.107.599; McDowell I, 1996, MEASURING HLTH GUIDE, P56; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; Morris R, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/534812; Putaala J, 2009, STROKE, V40, P2698, DOI 10.1161/STROKEAHA.109.554998; RADHAKRISHNAN K, 1986, ACTA NEUROL SCAND, V73, P434, DOI 10.1111/j.1600-0404.1986.tb03301.x; Ritch JL, 2003, SCHIZOPHR RES, V60, P180, DOI 10.1016/S0920-9964(03)81071-X; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Roding J, 2009, DISABIL REHABIL, V31, P1092, DOI 10.1080/09638280802510965; Rutten-Jacobs LCA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-109; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Smith RE, 2012, AGING NEUROPSYCHOL C, V19, P495, DOI 10.1080/13825585.2011.633161; Spíndola Lívia, 2011, Dement. neuropsychol., V5, P64, DOI 10.1590/S1980-57642011DN05020002; Teasell RW, 2000, ARCH PHYS MED REHAB, V81, P205; Tong AYC, 2002, OTJR-OCCUP PART HEAL, V22, P132, DOI 10.1177/153944920202200402; Twamley EW, 2008, SCHIZOPHR RES, V106, P42, DOI 10.1016/j.schres.2007.10.030; Ungvari GS, 2008, ARCH CLIN NEUROPSYCH, V23, P613, DOI 10.1016/j.acn.2008.06.005; Varona JF, 2004, J NEUROL, V251, P1507, DOI 10.1007/s00415-004-0583-0; West R, 2002, NEUROSCI BIOBEHAV R, V26, P827, DOI 10.1016/S0149-7634(02)00069-6; Woods SP, 2012, J INT NEUROPSYCH SOC, V18, P134, DOI 10.1017/S1355617711001263	42	6	6	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					329	335		10.3109/02699052.2014.974672			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000007	25356927	Green Accepted			2022-02-06	
J	Moreno, JA; das Nair, R				Moreno, Jhon Alexander; das Nair, Roshan			Translating knowledge into practice: content analysis of online resources about sexual difficulties for individuals with traumatic brain injury	SEXUAL AND RELATIONSHIP THERAPY			English	Article						online resources; traumatic brain injury; sexuality; sexual rehabilitation; Internet	GENDER-DIFFERENCES; MULTICENTER; PREDICTORS; PERCEPTIONS; ADOLESCENTS; INFORMATION; PREVALENCE; DISABILITY; EDUCATION; INTERNET	For many individuals with traumatic brain injury (TBI), the Internet is the only available source of information regarding their sexual problems following TBI. This study aimed to evaluate the content and the quality of patient or carer information that is readily available on the Internet about specific aspects of sexuality after TBI. A purposive (non-exhaustive) sample of eight leaflets available on the Internet related to sexuality following TBI was analysed using content analysis. Decreased desire was reported as the main sexual difficulty following TBI (87.5%), followed by inappropriate sexual behaviour (62.5%). Among the strategies to overcome these difficulties, all leaflets recommended seeking help from healthcare professionals; 42.8% were centred on the carer or the family, and only 28.5% was directly addressed to the individual with TBI. The information available overemphasises disinhibition, underscores other aspects of sexuality (e.g. sexual risk and inability to fantasise), and is conceived mainly for carers and families. A bias assuming that most individuals with TBI are involved in a romantic relationship was also present. Adolescents, women, older people, single people, and non-heterosexual individuals were not adequately represented. There is a need for Internet resources to provide specific recommendations for these groups.	[Moreno, Jhon Alexander] Ctr Readapat Lucie Bruneau, Ctr Interdisciplinary Res Rehabil CRIR, Montreal, PQ, Canada; [Moreno, Jhon Alexander] Univ Montreal, Dept Psychol, Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ H3C 3J7, Canada; [das Nair, Roshan] Univ Nottingham, Div Rehabil & Ageing, Nottingham NG7 2RD, England; [das Nair, Roshan] Nottingham Univ Hosp NHS Trust, Dept Clin Psychol & Neuropsychol, Nottingham, England		Moreno, JA (corresponding author), Ctr Readapat Lucie Bruneau, Ctr Interdisciplinary Res Rehabil CRIR, Montreal, PQ, Canada.	jhon.alexander.moreno@umontreal.ca		das Nair, Roshan/0000-0001-8143-7893			Anderson P, 2000, SOC SCI MED, V51, P1163, DOI 10.1016/S0277-9536(00)00019-8; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P268, DOI 10.1097/HTR.0000000000000053; Buhi ER, 2009, J AM COLL HEALTH, V58, P101, DOI 10.1080/07448480903221236; CARLEY K, 1993, SOCIOL METHODOL, V23, P75, DOI 10.2307/271007; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Cooper ML, 2002, J STUD ALCOHOL, P101, DOI 10.15288/jsas.2002.s14.101; das Nair R., 2007, J INT NEUROPSYCH SOC, V13, P91; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Dyer K, 2014, DISABIL REHABIL, V36, P1431, DOI 10.3109/09638288.2013.859747; Dyer K, 2013, J SEX MED, V10, P2658, DOI 10.1111/j.1743-6109.2012.02856.x; Esmail S, 2010, DISABIL REHABIL, V32, P1148, DOI 10.3109/09638280903419277; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Goldin Y, 2014, J HEAD TRAUMA REHAB, V29, P418, DOI 10.1097/HTR.0b013e31829cf76d; Griffith ER, 1993, SEXUALITY PERSON TRA; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Mapou R. L., 1990, J HEAD TRAUMA REHAB, V5, P67, DOI DOI 10.1097/00001199-199005020-00011; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Moreno A., 2014, S 91 AM C REH MED TR; Moreno A., 2014, 28 INT C APPL PSYCH; Moreno A., 2014, BRAIN INJURY, V28, P35; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Roebuck-Spencer T., 2014, HDB NEUROPSYCHOLOGY, P3; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Simon L, 2013, INT J SEX HEALTH, V25, P305, DOI 10.1080/19317611.2013.823899; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; Smith M, 2000, HEALTH EDUC BEHAV, V27, P684, DOI 10.1177/109019810002700603; Stelter L, 2001, J Assoc Healthc Philanthr, P10; Struchen MA, 2014, HDB NEUROPSYCHOLOGY, P213, DOI DOI 10.1007/978; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; Zasler N., 2007, BRAIN INJURY MED PRI	40	6	6	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1468-1994	1468-1749		SEX RELATSH THER	Sex. Relatsh. Ther.		2015	30	4					448	461		10.1080/14681994.2015.1039937			14	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DD3UA	WOS:000369847300005		Green Accepted, Green Submitted			2022-02-06	
J	Phillips, J; Tierney, R				Phillips, Jacqueline; Tierney, Ryan			Effect of Target Type on Near Point of Convergence in a Healthy, Active, Young Adult Population	JOURNAL OF EYE MOVEMENT RESEARCH			English	Article						Near point of convergence; target type; concussion	PROFESSIONAL FOOTBALL PLAYERS; RECURRENT CONCUSSION; NCAA CONCUSSION; BRAIN-FUNCTION; ACCOMMODATION; NEARPOINT; ASSOCIATION; DEPRESSION; MANAGEMENT; VERGENCE	Purpose: Measuring near point of convergence (NPC) has recently emerged as a concussion assessment tool. Differences in administration of the test can be seen within the literature, which may affect results and normative values. There has been little investigation examining if clinically accessible target types affects NPC and no examination of NPC in a healthy, active young adult population. Methods: NPC was measured in 39 subjects using 5 different targets two times each with an accommodative ruler. Results: NPC ranged from 1.5-10cm in this population with an overall mean of 5.9 +/- 1.6 cm. There were significant differences between the middle sized font and the line (p = .024) and pen (p = .047), and also between the largest sized font and the line (p = .026). Conclusion: For physically active young adults, the measurement of NPC is affected by target type.	[Phillips, Jacqueline; Tierney, Ryan] Temple Univ, Philadelphia, PA 19122 USA		Phillips, J (corresponding author), Temple Univ, Philadelphia, PA 19122 USA.						Adler PM, 2007, OPHTHAL PHYSL OPT, V27, P22, DOI 10.1111/j.1475-1313.2006.00418.x; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; BRUCE AS, 1995, INVEST OPHTH VIS SCI, V36, P406; CAPOBIANCO N M, 1952, Am Orthopt J, V2, P40; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ., 1974, OPT J REV OPTOM, V111, P9; Cohen A H, 1983, J Am Optom Assoc, V54, P979; DAVIES CE, 1946, CAN MED ASSOC J, V55, P47; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; EAMES TH, 1961, AM J OPHTHALMOL, V51, P1255, DOI 10.1016/0002-9394(61)92467-9; Flames D. E., 2006, FUNDAMENTAL NEUROSCI; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hayes GJ, 1998, OPTOMETRY VISION SCI, V75, P506, DOI 10.1097/00006324-199807000-00019; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; HELVESTON EM, 1985, AM J OPHTHALMOL, V99, P346, DOI 10.1016/0002-9394(85)90368-X; HOFFMAN LG, 1980, J AM OPTOM ASSOC, V51, P119; Horwood AM, 2010, OPHTHAL PHYSL OPT, V30, P152, DOI 10.1111/j.1475-1313.2009.00706.x; Lavrich JB, 2010, CURR OPIN OPHTHALMOL, V21, P356, DOI 10.1097/ICU.0b013e32833cf03a; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mohindra I, 1980, OPTOM MONTHLY, V71, P155; Mucha A, 2014, AM J SPORTS MED; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; PICKWELL LD, 1981, OPHTHAL PHYSL OPT, V1, P13, DOI 10.1111/j.1475-1313.1981.tb00143.x; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Siderov J, 2001, OPHTHAL PHYSL OPT, V21, P356, DOI 10.1046/j.1475-1313.2001.00609.x; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; WOLD RM, 1967, AMER J OPT ARCH AM A, V44, P642	34	6	6	1	3	INT GROUP EYE MOVEMENT RESEARCH	IFFWIL	C/O RUDOLF GRONER, AL NASEEM ARABIAN STUD, IFFWIL, CH-3305, SWITZERLAND	1995-8692			J EYE MOVEMENT RES	J. Eye Mov. Res.		2015	8	3							1				6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	DD0HO	WOS:000369601200005					2022-02-06	
J	van Velzen, JM; van Bennekom, CAM; Sluiter, JK; Frings-Dresen, MHW				van Velzen, Judith; van Bennekom, Coen; Sluiter, Judith; Frings-Dresen, Monique			Early vocational rehabilitation after acquired brain injury: A structured and interdisciplinary approach	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Acquired brain injury; traumatic brain injury; stroke; return to work; vocational rehabilitation		BACKGROUND: There are indications that specialist vocational rehabilitation is beneficial when trying to return to work after acquired brain injury (ABI). OBJECTIVE: To give a description of the Early Vocational Rehabilitation (EVR) protocol and its development in order to make it available for implementation in rehabilitation institutes to strengthen the appearance of these institutes as relevant partners and supporters during the process of (sustaining) return to work of people with ABI. METHODS: The Early Vocational Rehabilitation (EVR) protocol is a process guideline to facilitate the interdisciplinary rehabilitation team to systematically focus on return to work during an early stage of (inpatient or outpatient) rehabilitation of people with ABI. The development was expert based. RESULTS: The EVR protocol consists of four stages: 1) orientation of the rehabilitation team towards the patient's work; 2) investigating the gap between the patient's abilities and work; 3) work training; and 4) finalizing EVR. Cooperation among all relevant partners from inside or outside the rehabilitation institute is important for maximally adapting the EVR treatment to the individual (work) situation of the person with ABI. CONCLUSION: TheEVRprotocol is available for implementation in other rehabilitation institutes. Performing a context analysis for each new context in which it is implemented is recommended.	[van Velzen, Judith; van Bennekom, Coen] Heliomare Rehabil Ctr, Dept Res & Dev, Wijk Aan Zee, Netherlands; [van Velzen, Judith; van Bennekom, Coen] Heliomare Rehabil Ctr, Inst Vocat Assessment & Educ, Wijk Aan Zee, Netherlands; [van Velzen, Judith; van Bennekom, Coen; Sluiter, Judith; Frings-Dresen, Monique] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, Amsterdam, Netherlands		van Velzen, JM (corresponding author), Heliomare Res & Dev, Relweg 51, NL-1949 EC Wijk Aan Zee, Netherlands.	j.van.velzen@heliomare.nl			Netherlands Organization for Health Research and DevelopmentNetherlands Organization for Health Research and Development [60-62300-98-028]	The adaptation of the EVR protocol, in cooperation with colleagues of other rehabilitation centers and other relevant partners, was supported by the Netherlands Organization for Health Research and Development (grant number 60-62300-98-028).	Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Spanjer J., 2012, THESIS, P139; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; Van Velzen J., 2011, EARLY VOCATIONAL REH; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Van Velzen J. M., 2012, J OCCUPATIONAL INSUR, V5, P209; Wehman P, 2012, J VOCAT REHABIL, V37, P139, DOI 10.3233/JVR-2012-0607	8	6	6	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2015	42	1					31	40		10.3233/JVR-140725			10	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V72JH	WOS:000211637600003					2022-02-06	
J	Waldron-Perrine, B; Tree, HA; Spencer, RJ; Suhr, J; Bieliauskas, L				Waldron-Perrine, Brigid; Tree, Heather A.; Spencer, Robert J.; Suhr, Julie; Bieliauskas, Linas			Informational literature influences symptom expression following mild head injury: An analog study	BRAIN INJURY			English	Article						Concussion; head injury; mild brain injury	TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL PREVENTION; GOOD OLD DAYS; POSTCONCUSSION SYNDROME; DIAGNOSIS THREAT; PERFORMANCE; VETERANS; EXPECTATION	Primary objective: Many Veterans involved in recent OEF/OIF conflicts return with reports of having experienced an mTBI. The Veteran's Affairs (VA) and Department of Defense (DoD) have gone to great lengths to provide information to Veterans regarding possible effects of TBI. Although well intended, this information may possibly have an iatrogenic effect. Conversely, setting positive expectations for recovery from mTBI has been shown to result in decreased symptomatology. Research design: One-way ANOVA and Tukey post-hoc analyses were used to determine whether there were significant differences on reported severity and number of PCS symptoms (NSI) among the three experimental groups (recovery focused information; expectation for persistent symptoms; and no information given). Methods and procedures: Undergraduate students, who were told to imagine they had experienced a military-related TBI, reported varying levels of expected symptoms when given either positive or negative information about symptom expectation. Main outcomes and results: The results indicate that presenting recovery-oriented literature resulted in the lowest report of expected symptoms, whereas presenting no information resulted in the highest report of expected symptoms. Conclusions: Providing Veterans with information regarding a likely positive trajectory of recovery may result in less symptom persistence during rehabilitation.	[Waldron-Perrine, Brigid; Tree, Heather A.; Spencer, Robert J.; Bieliauskas, Linas] VA Ann Arbor Healthcare Syst, Dept Psychiat, Neuropsychol Sect, Ann Arbor, MI 48105 USA; [Suhr, Julie] Ohio Univ, Dept Psychol, Athens, OH 45701 USA		Bieliauskas, L (corresponding author), VA Ann Arbor Healthcare Syst, 2215 Fuller Rd,Mental Hlth Serv 116B, Ann Arbor, MI 48105 USA.	linas@umich.edu					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Blaine H, 2013, J NEUROTRAUM, V30, P1405, DOI 10.1089/neu.2013.2865; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kay T., J HEAD TRAUMA REHABI, V8, P86; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; McCrea M., 2008, MILD TRAUMATIC BRAIN; McHugh T, 2006, BRAIN COGNITION, V60, P209; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mittenberg W, 1998, RECOVERY, V9, P27; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Spencer RJ, 2013, J REHABIL RES DEV, V50, P1, DOI 10.1682/JRRD.2012.01.0018; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282	25	6	6	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	9					1051	1055		10.3109/02699052.2015.1004742			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR1UG	WOS:000361110000005	26182232				2022-02-06	
J	Wiechman, SA; Carrougher, GJ; Esselman, PC; Klein, MB; Martinez, EM; Engrav, LH; Gibran, NS				Wiechman, Shelley A.; Carrougher, Gretchen J.; Esselman, Peter C.; Klein, Matthew B.; Martinez, Erin M.; Engrav, Loren H.; Gibran, Nicole S.			An Expanded Delivery Model for Outpatient Burn Rehabilitation	JOURNAL OF BURN CARE & RESEARCH			English	Article							POSTTRAUMATIC STRESS SYMPTOMS; TRAUMATIC BRAIN-INJURY; CLINICAL-RESEARCH; RANDOMIZED-TRIAL; DISTRESS; CARE; DEPRESSION; MANAGEMENT; PROGRAM	Despite the numerous multidisciplinary services burn centers provide, a number of challenges to obtaining optimal outcomes exist. The goal of this study was to overcome the barriers to effective burn rehabilitation by utilizing an expanded care coordinator (ECC) to supplement the existing outpatient services. In this between-group, single-blind, randomized, controlled trial, the control group (n = 41) received standard outpatient care and the experimental group (n = 40) received additional services provided by the ECC, including telephone calls at set intervals (24 hours postdischarge, 2, 4, 8, 12 weeks postdischarge and 5, 7, 9 months postdischarge). The ECC was trained in motivational interviewing, crisis intervention, and solution-focused counseling. He assisted patients before and after each clinic visit, coordinated outpatient services in their geographic area (physical and occupational therapy, counseling, primary care provider referrals, etc.), and helped develop problem-solving approaches to accomplish individualized goals. Outcome measures included patient identified goals utilizing the goal attainment scale, the urn-specific health scale-brief, the Short Form 12, a patient satisfaction survey, and a return to work survey. The average subject age was 43 years (SD = 16.9) with a mean TBSA of 19% (SD = 18.8). The average length of hospitalization was 36 days (SD = 42.9). The patient and injury characteristics were similar between the study groups. For the experimental group, 33% completed seven calls, with 23% completing all the eight calls. All were assessed using general linear models and were adjusted for sex, age, length of hospitalization, urban vs rural area of residence, % TBSA burn, and ethnicity. There was no difference between the control and experimental groups for any of the outcome measures at either 6 or 12 months postburn. No differences in outcomes between the groups were found. All participants appreciated the individualized goal setting process that was used as an outcome measure and this may have accounted for the similar outcomes in both the groups. (The measure may have been more of an intervention, thus contributing to the strength of the control group.) Although most patients with burn injuries may not need an intervention that is this intensive, a subset of patients at higher risk or with more severe injuries may benefit from more intensive and personalized services. Future research should examine the benefits of individual goal setting processes for all the patients and also attempt to identify those patients most at risk for poorer outcomes and therefore, likely to benefit of more intensive personalized services.	[Wiechman, Shelley A.; Esselman, Peter C.; Engrav, Loren H.] Univ Washington, Sch Med, Harborview Med Ctr, Dept Rehabil Med, Seattle, WA 98104 USA; [Carrougher, Gretchen J.; Klein, Matthew B.; Gibran, Nicole S.] Univ Washington, Sch Med, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA; [Martinez, Erin M.] Univ Colorado, Hlth Sci Ctr, Dept Biostat & Informat, Denver, CO USA		Wiechman, SA (corresponding author), Univ Washington, Sch Med, Harborview Med Ctr, 325 Ninth Ave,Box 359612, Seattle, WA 98104 USA.				National Institute on Disability and Rehabilitation Research in the Office of Special Education and Rehabilitative Services in the U.S. Department of Education [H133A070047]	This work was supported by funds from the National Institute on Disability and Rehabilitation Research in the Office of Special Education and Rehabilitative Services in the U.S. Department of Education (H133A070047).	Askay SW, 2009, J BURN CARE RES, V30, P83, DOI 10.1097/BCR.0b013e3181921f42; Bandura A, 1986, SOCIAL FDN THOUGHT A; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bell KR, 2004, J HEAD TRAUMA REHAB, V19, P502, DOI 10.1097/00001199-200411000-00007; Boeve S. A., 2002, Journal of Burn Care & Rehabilitation, V23, P32, DOI 10.1097/00004630-200201000-00007; Bombaro KM, 2003, BURNS, V29, P299, DOI 10.1016/S0305-4179(03)00067-6; Bostrom J, 1996, APPL NURS RES, V9, P47, DOI 10.1016/S0897-1897(96)80402-2; Britt E, 2004, PATIENT EDUC COUNS, V53, P147, DOI 10.1016/S0738-3991(03)00141-1; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; Cleary PD, 1997, JAMA-J AM MED ASSOC, V278, P1608, DOI 10.1001/jama.278.19.1608; Cox RM, 2002, ELECTRON BUS, V28, P10; Donnelly Catherine, 2002, Can J Occup Ther, V69, P84; Dunn C, 2001, ADDICTION, V96, P1725, DOI 10.1046/j.1360-0443.2001.961217253.x; Ehde DM, 1999, BURNS, V25, P587, DOI 10.1016/S0305-4179(99)00050-9; Ehde DM, 2000, J BURN CARE REHABIL, V21, P105, DOI 10.1097/00004630-200021020-00005; Esselman PC, 2006, AM J PHYS MED REHAB, V85, P383, DOI 10.1097/01.phm.0000202095.51037.a3; Esselman PC, 2007, ARCH PHYS MED REHAB, V88, pS50, DOI 10.1016/j.apmr.2007.09.009; Fauerbach JA, 1999, J BEHAV MED, V22, P359, DOI 10.1023/A:1018726103302; Finfgeld-Connett D, 2005, QUAL HEALTH RES, V15, P19, DOI 10.1177/1049732304269852; Fisher K, 2002, CLIN REHABIL, V16, P871, DOI 10.1191/0269215502cr554oa; Gordon JE, 1999, AGE AGEING, V28, P275, DOI 10.1093/ageing/28.3.275; HEAVLIN WD, 1982, COMMUNITY MENT HLT J, V18, P230, DOI 10.1007/BF00754339; Katon W, 2001, ARCH GEN PSYCHIAT, V58, P241, DOI 10.1001/archpsyc.58.3.241; Kildal M, 2001, J TRAUMA, V51, P740, DOI 10.1097/00005373-200110000-00020; Lawrence JW, 1998, J BURN CARE REHABIL, V19, P480, DOI 10.1097/00004630-199811000-00005; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Patterson DR, 2000, J BURN CARE REHABIL, V21, P490, DOI 10.1097/00004630-200021060-00004; PATTERSON DR, 1993, PSYCHOL BULL, V113, P362, DOI 10.1037/0033-2909.113.2.362; Richard R, 2000, J BURN CARE REHABIL, V21, P506, DOI 10.1097/00004630-200021060-00006; Roessler RT, 1994, J APPL REHABILITATIO, V25, P16; STOLEE P, 1992, J AM GERIATR SOC, V40, P574, DOI 10.1111/j.1532-5415.1992.tb02105.x; Tsionos I, 2004, J BONE JOINT SURG BR, V86B, P396, DOI 10.1302/0301-620X.86B3.14480; Van Loey NEE, 2003, AM J CLIN DERMATOL, V4, P245, DOI 10.2165/00128071-200304040-00004; Wiechman SA, 2001, J BURN CARE REHABIL, V22, P417, DOI 10.1097/00004630-200111000-00012	34	6	7	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1559-047X	1559-0488		J BURN CARE RES	J. Burn Care Res.	JAN-FEB	2015	36	1					14	22		10.1097/BCR.0000000000000153			9	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Dermatology; Surgery	AY3AG	WOS:000347456400006	25198101	Bronze			2022-02-06	
J	Zasler, ND				Zasler, Nathan D.			Validity assessment and the neurological physical examination	NEUROREHABILITATION			English	Article						Neurological exam; validity assessment; effort; functional neurologic disorder; malingering; symptom exaggeration	TRAUMATIC BRAIN-INJURY; GRIP STRENGTH; FUNCTIONAL WEAKNESS; SYMPTOMS; DIAGNOSIS; PARESIS; DISORDERS; MOTOR; SIGN; GAIT	BACKGROUND: The assessment of any patient or examinee with neurological impairment, whether acquired or congenital, provides a key set of data points in the context of developing accurate diagnostic impressions and implementing an appropriate neurorehabilitation program. As part of that assessment, the neurological physical exam is an extremely important component of the overall neurological assessment. PURPOSE: In the aforementioned context, clinicians often are confounded by unusual, atypical or unexplainable physical exam findings that bring into question the organicity, veracity, and/or underlying cause of the observed clinical presentation. The purpose of this review is to provide readers with general directions and specific caveats regarding validity assessment in the context of the neurological physical exam. CONCLUSIONS: It is of utmost importance for health care practitioners to be aware of assessment methodologies that may assist in determining the validity of the neurological physical exam and differentiating organic from non-organic/functional impairments. Maybe more importantly, the limitations of many commonly used strategies for assessment of non-organicity should be recognized and consider prior to labeling observed physical findings on neurological exam as non-organic or functional.	[Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA 23233 USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.] VCU Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Zasler, Nathan D.] Univ Virginia, Brain Injury & Sports Concuss Inst, Charlottesville, VA USA; [Zasler, Nathan D.] Touro Coll, Sch Hlth Sci, Hlth Sci, New York, NY USA		Zasler, ND (corresponding author), Concuss Care Ctr Virginia Ltd, 3721 Westerre Pkwy,Suite B, Richmond, VA 23233 USA.	nzasler@cccv-ltd.com					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Apartis E, 2014, NEUROPHYSIOL CLIN, V44, P417, DOI 10.1016/j.neucli.2013.08.014; Babinski J., 1897, B MEM SOC MED HOP P, V14, P1098; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Black D., 2014, NEUROLOGY, V82; Bruce BB, 2010, NEUROL CLIN, V28, P789, DOI 10.1016/j.ncl.2010.03.012; Busse J., 2014, OCCUP ENVIRON MED, V71, pA83; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Campbell WW, 2012, DEJONGS NEUROLOGIC E; Coelho DH, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P769; DELLON AL, 1993, J HAND SURG-AM, V18A, P756, DOI 10.1016/0363-5023(93)90333-X; Enslin J. M. N., 2013, CONTINUING MED ED, V31, P80; Fahn S, 1988, Adv Neurol, V50, P431; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Gould R., 1988, J NERV MENT DIS, V174, P593; Greer S, 2005, J FAM PRACTICE, V54, P719; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); Hoover CF, 1908, J AMER MED ASSOC, V51, P746; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P434; Jones E, 1908, REV NEUROL-FRANCE, V16, P193; Kapoor N., 2012, NEUROTRAUMALETTER; Keizer D, 2007, EUR J ANAESTH, V24, P658, DOI 10.1017/S0265021507000221; Kemp S, 2008, J PSYCHOSOM RES, V65, P319, DOI 10.1016/j.jpsychores.2008.02.010; Lanska DJ, 2006, SEMIN NEUROL, V26, P297, DOI 10.1055/s-2006-945516; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lees AJ, 2002, J NEUROL NEUROSUR PS, V72, pI17; LEMPERT T, 1991, J NEUROL, V238, P140, DOI 10.1007/BF00319680; Lin J, 2006, SEMIN NEUROL, V26, P321, DOI 10.1055/s-2006-945518; Martelli M. F., 2002, FUNCTIONAL DISORDERS, V16, P1; Martelli MF, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1415; McBain VA, 2007, GRAEF ARCH CLIN EXP, V245, P502, DOI 10.1007/s00417-006-0431-2; Mehta A K, 2000, Med J Armed Forces India, V56, P79, DOI 10.1016/S0377-1237(17)30105-3; Merten T, 2013, J EXP PSYCHOPATHOL, V4, P20, DOI 10.5127/jep.023711; Nichols LL, 2012, NEUROREHABILITATION, V31, P95, DOI 10.3233/NRE-2012-0778; Okun MS, 2007, NEUROLOGIST, V13, P87, DOI 10.1097/01.nrl.0000256358.52613.cc; Phillips HJ, 2011, J ORTHOP SPORT PHYS, V41, P149, DOI 10.2519/jospt.2011.3328; Reuber M, 2005, J NEUROL NEUROSUR PS, V76, P307, DOI 10.1136/jnnp.2004.048280; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Robinson ME, 2004, CLIN J PAIN, V20, P392, DOI 10.1097/00002508-200411000-00003; ROLAK LA, 1988, J NERV MENT DIS, V176, P686, DOI 10.1097/00005053-198811000-00007; Sanders Richard D, 2010, Psychiatry (Edgmont), V7, P17; Shaibani A, 1998, AM FAM PHYSICIAN, V57, P2485; Shepard NT, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P779; Shill H, 2006, MOVEMENT DISORD, V21, P1163, DOI 10.1002/mds.20921; Smith HE, 2007, J SPINAL CORD MED, V30, P509, DOI 10.1080/10790268.2007.11754585; Sonoo M, 2004, J NEUROL NEUROSUR PS, V75, P121; Stone J, 2005, J NEUROL NEUROSUR PS, V76, pI2, DOI 10.1136/jnnp.2004.061655; Stone J, 2002, J NEUROL NEUROSUR PS, V73, P241, DOI 10.1136/jnnp.73.3.241; Stone J, 2002, J NEUROL NEUROSUR PS, V73, P578, DOI 10.1136/jnnp.73.5.578; Stone J, 2008, J PSYCHOSOM RES, V65, P327, DOI 10.1016/j.jpsychores.2008.05.004; Taylor C, 2000, J Hand Ther, V13, P195; Westbrook AP, 2002, J HAND SURG-AM, V27A, P329, DOI 10.1053/jhsu.2002.30910; Ziv I, 1998, J NEUROL, V245, P797, DOI 10.1007/s004150050289	54	6	6	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	4					401	413		10.3233/NRE-151229			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CN8YP	WOS:000358732300003	26409489				2022-02-06	
J	Adams, S; Condrey, JA; Tsai, HW; Svetlov, SI; Davenport, PW				Adams, Sherry; Condrey, Jillian A.; Tsai, Hsiu-Wen; Svetlov, Stanislav I.; Davenport, Paul W.			Respiratory responses following blast-induced traumatic brain injury in rats	RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY			English	Article						Overpressurization blast; Traumatic brain injury; Respiration; Electromyographic recording	MODEL; VULNERABILITY; MICE	Blast overpressure (OB) injury in rodents has been employed for modeling the traumatic brain injury (TBI) induced by an improvised explosive device (IED) in military service personnel. IED's can cause respiratory arrest if directed at the thorax due to the fluid-tissue interface of the lungs but it is unclear what respiratory changes occur in a head-directed OB injury. The diaphragm is the primary muscle of inspiration and electromyographic (EMG) recordings from this muscle are used for recording breathing in anesthetized and conscious rats. The breathing pattern of the rodents will be recorded during the OB injury. Our results indicate that a dorsal directed closed-head OB injury results in a neurally mediated apnea followed by respiratory timing changes. (C) 2014 Elsevier B.V. All rights reserved.	[Adams, Sherry; Condrey, Jillian A.; Tsai, Hsiu-Wen; Davenport, Paul W.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32611 USA; [Svetlov, Stanislav I.] Banyan Biomarkers, Alachua, FL USA; [Svetlov, Stanislav I.] Univ Florida, Dept Med & Psychiat, Gainesville, FL USA		Davenport, PW (corresponding author), Univ Florida, Dept Physiol Sci, Gainesville, FL 32611 USA.	pdavenpo@ufl.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HL109025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL109025] Funding Source: NIH RePORTER	Training support to SLA was provied by NIH R01HL109025.	Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Faul M, 2010, TRAUMATIC BRAIN INJU; Guy R J, 1998, J R Nav Med Serv, V84, P79; Guy RJ, 1998, J TRAUMA, V45, P983, DOI 10.1097/00005373-199812000-00001; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885	13	6	7	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1569-9048	1878-1519		RESP PHYSIOL NEUROBI	Respir. Physiol. Neuro.	DEC 1	2014	204				SI		112	119		10.1016/j.resp.2014.08.015			8	Physiology; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Respiratory System	AW7PT	WOS:000346457900016	25242461	Green Accepted			2022-02-06	
J	Chen, JQ; Zhang, CC; Lu, H; Wang, W				Chen, Jian-Qiang; Zhang, Cheng-Cheng; Lu, Hong; Wang, Wei			Assessment of traumatic brain injury degree in animal model	ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE			English	Article						CCI; Traumatic brain injury; MRI	CONTROLLED CORTICAL IMPACT; HEAD-INJURY; RATS; TOMOGRAPHY	Objective: To establish stable and controllable brain injury with accurate degree and good repeatability in rat model. Methods: Controlled cortical impact (CCI) device was used to prepare for the rat brain injury model by the impact head of different model (Group A No. 4, Group B No. 5, Group C No. 6) and the impact depth (Group A: 1.5-2.0 mm, Group B: 2.5-3.0 mm, Group C: 3.5-4.0 mm) with impact time of 0.1 s and impact velocity of 2.5 m/s. Twelve rats with three months of age were used in each group (the impact depth of every two rats was added 1 nun respectively). After modeling for 1 h, magnetic resonance imaging (MRI) was received and brain histopathology was observed to assess degree of injury by model parameters of three groups. Results: After modeling of Group A, MRI showed that the cortex structure was damaged with a small amount of bleeding in center and mild edema around, and the total volume of injury was (28.69 +/- 4.94) mm(3). Pathology revealed the injury was confined to the superficial cortical with mild edema of nerve cell, which was assessed as mild cerebral contusion. While after modeling, MRI of Croup B showed that the structure of cortex and medulla were damaged simultaneously and extended to cerebral nuclei zone, with 4 cases of hematoma in the center and larger edema range around, and the total volume of injury was (78.38 +/- 9.28) mm(3). Pathology revealed the injury range was reached nuclei zone, with swell of nerve cell and mitochondria, which was assessed to moderate cerebral contusion. After modeling of Group C, MRI showed that extensive tissue injury was appeared in cortex and medulla and deep nuclei, with 9 cases of hematoma and large edema signal of surrounding tissue T2WI, while in 5 cases, lateral nucleus of injury signal was increased, and the total volume of injury was (135.89 +/- 24.80) mm(3). Pathology revealed the deep cerebral nuclei was damaged, with the disappearance of neuronal structure and vacuolization of mitochondria, which was assessed as severe cerebral contusion. MRI changes were consistent with pathological changes in three groups of model, and the injury range was significantly different (P<0.01). Conclusions: Application of CCI can make stable quantitative traumatic brain injury model, which overcomes the randomness in previous injury model and possesses highly unity in iconography and pathology changes. This can provide quantitative modeling reference for clinical research.	[Chen, Jian-Qiang; Zhang, Cheng-Cheng; Lu, Hong] Cent S Univ, Xiangya Sch Med, Haikou Hosp, Dept Radiol, Haikou 570208, Peoples R China; [Chen, Jian-Qiang; Wang, Wei] Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha 410013, Hunan, Peoples R China		Lu, H (corresponding author), Cent S Univ, Xiangya Sch Med, Haikou Hosp, Dept Radiol, Haikou 570208, Peoples R China.	471739847@qq.com; cjr.wangwei@vip.163.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81160181]; major project of Haikou City [2014-079]	Foundation project: It is supported by funding project of Natural Science Foundation of China (Grant No. 81160181) and major project of Haikou City (Grant No. 2014-079).	Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Ding GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061241; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Furlow B, 2013, RADIOL TECHNOL, V84, p291CT; Furlow Bryant, 2013, Radiol Technol, V84, p273CT; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; ICHISE M, 1994, J NUCL MED, V35, P217; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lu H, 2013, CHINESE MED J-PEKING, V126, P4316, DOI 10.3760/cma.j.issn.0366-6999.20131139; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Patricia M, 2012, J NEUROTRAUM, V29, P2283; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Takuji I, 2007, EXP NEUROL, V203, P258; Watson W.D., 2014, FRONT NEUROENERGETIC, V5, P12; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	19	6	9	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1995-7645			ASIAN PAC J TROP MED	Asian Pac. J. Trop. Med.	DEC	2014	7	12					991	995		10.1016/S1995-7645(14)60174-7			5	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	AT3JB	WOS:000344830300011	25479629	gold			2022-02-06	
J	Chen, LH; Chang, YP				Chen, Lung Hung; Chang, Yen-Ping			Cross-Lagged Associations between Gratitude and Adolescent Athlete Burnout	CURRENT PSYCHOLOGY			English	Article						Positive psychology; Time lagged design; Well-being	TRAUMATIC BRAIN-INJURY; PERSONALITY-CHANGE; SOCIAL SUPPORT; GRATEFUL; STRESS; CONCEPTUALIZATION; SATISFACTION; MATERIALISM; ACHIEVEMENT; PERSPECTIVE	The current study aims to investigate the cross-lagged relationship between gratitude and adolescent athlete burnout through the corresponsive perspective of personality. Adolescent athletes completed surveys at two time points with a three-month interval. Current study used structural equation modeling to examine hypothesis. Contrary to previous studies, the results revealed that after controlling for the gender, age, and athlete burnout at time 1, gratitude at time 1 did not predict athlete burnout at time 2. However, this study found a reverse relationship by showing athlete burnout at time 1 negatively related to gratitude at time 2. The findings indicate that athletes' experience of burnout might decrease dispositional gratitude. The mechanisms and the implications for measuring gratitude were discussed.	[Chen, Lung Hung] Natl Taiwan Sport Univ, Dept Recreat & Leisure Ind Management, Kueishan, Taoyuan County, Taiwan; [Chang, Yen-Ping] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA		Chen, LH (corresponding author), Natl Taiwan Sport Univ, Dept Recreat & Leisure Ind Management, 250 Wen Hua 1st Rd, Kueishan, Taoyuan County, Taiwan.	fjudragon@gmail.com	, 陳龍弘/AAP-3685-2020	, 陳龍弘/0000-0001-5217-1117			Algoe SB, 2010, PERS RELATIONSHIP, V17, P217, DOI 10.1111/j.1475-6811.2010.01273.x; Appleton PR, 2009, PSYCHOL SPORT EXERC, V10, P457, DOI 10.1016/j.psychsport.2008.12.006; Arnett JJ, 1999, AM PSYCHOL, V54, P317, DOI 10.1037/0003-066X.54.5.317; Awa WL, 2010, PATIENT EDUC COUNS, V78, P184, DOI 10.1016/j.pec.2009.04.008; Baumeister RF., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, 10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Brown M.W., 1993, SOCIOL METHOD RES, P136; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Chan D, 1998, ORGAN RES METHODS, V1, P421, DOI 10.1177/109442819814004; Chang YP, 2012, J HAPPINESS STUD, V13, P761, DOI 10.1007/s10902-011-9289-z; Chen LH, 2008, SOC INDIC RES, V89, P361, DOI 10.1007/s11205-008-9237-4; Chen LH, 2008, PERCEPT MOTOR SKILL, V106, P693, DOI 10.2466/PMS.106.3.693-698; Chen LH, 2013, SOC INDIC RES, V114, P273, DOI 10.1007/s11205-012-0145-2; Chen LH, 2012, INT J PSYCHOL, V47, P381, DOI 10.1080/00207594.2011.632009; Chen LH, 2009, J HAPPINESS STUD, V10, P655, DOI 10.1007/s10902-008-9112-7; Cheng WNK, 2009, PSYCHOL SPORT EXERC, V10, P271, DOI 10.1016/j.psychsport.2008.08.001; Cho, 2006, PHYS ED J, V39, P83, DOI 10.6222/pej.3903.200609.1107; Clark LA, 2009, CURR DIR PSYCHOL SCI, V18, P27, DOI 10.1111/j.1467-8721.2009.01600.x; COAKLEY J, 1992, SOCIOL SPORT J, V9, P271, DOI 10.1123/ssj.9.3.271; Cole DA, 2003, J ABNORM PSYCHOL, V112, P558, DOI 10.1037/0021-843X.112.4.558; Conroy DE, 2001, QUEST, V53, P165, DOI 10.1080/00336297.2001.10491736; Cresswell SL, 2007, SPORT PSYCHOL, V21, P1, DOI 10.1123/tsp.21.1.1; Cresswell SL, 2006, J APPL SPORT PSYCHOL, V18, P219, DOI 10.1080/10413200600830299; Cresswell SL, 2005, MED SCI SPORT EXER, V37, P1957, DOI 10.1249/01.mss.0000176304.14675.32; Cresswell SL, 2003, AUST J PSYCHOL, V55, P173; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Duckworth AL, 2010, SOC PSYCHOL PERS SCI, V1, P311, DOI 10.1177/1948550609359707; FINKEL SE, 1995, CAUSAL ANAL PANEL DA; Fredrickson, 2000, PREVENTION TREATMENT, V3; Fredrickson B. L., 2004, PSYCHOL GRATITUDE PP, P145, DOI DOI 10.1093/ACPROF:OSO/9780195150100.003.0008; Fredrickson B.L., 1998, REV GEN PSYCHOL, V2, P300, DOI [DOI 10.1037/1089-2680.2.3.300, 10.1037/1089-2680.2.3.300]; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; FREUDENBERGER HJ, 1975, PSYCHOTHER-THEOR RES, V12, P73, DOI 10.1037/h0086411; Froh JJ, 2011, J HAPPINESS STUD, V12, P289, DOI 10.1007/s10902-010-9195-9; Froh JJ, 2010, MOTIV EMOTION, V34, P144, DOI 10.1007/s11031-010-9163-z; Garland EL, 2010, CLIN PSYCHOL REV, V30, P849, DOI 10.1016/j.cpr.2010.03.002; GOLEMBIEWSKI RT, 1976, J APPL BEHAV SCI, V12, P133, DOI 10.1177/002188637601200201; Gould D, 1997, SPORT PSYCHOL, V11, P257, DOI 10.1123/tsp.11.3.257; Gustafsson H, 2008, PSYCHOL SPORT EXERC, V9, P800, DOI 10.1016/j.psychsport.2007.11.004; Gustafsson H, 2010, J SPORT SCI, V28, P1495, DOI 10.1080/02640414.2010.521943; Hagger MS, 2009, PSYCHOL SPORT EXERC, V10, P511, DOI 10.1016/j.psychsport.2009.01.004; Hancock G. R., 2001, STRUCTURAL EQUATION, P195; Hill PL, 2011, J POSIT PSYCHOL, V6, P397, DOI 10.1080/17439760.2011.602099; Hoyle R.H, 1995, STRUCTURAL EQUATION; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jowett S, 2005, PSYCHOLOGIST, V18, P412; Jowett S, 2003, PSYCHOL SPORT EXERC, V4, P313, DOI 10.1016/S1469-0292(02)00011-0; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Lambert NM, 2009, PSYCHOL RELIG SPIRIT, V1, P139, DOI 10.1037/a0016731; Lambert NM, 2009, J POSIT PSYCHOL, V4, P461, DOI 10.1080/17439760903157182; Lambert NM, 2009, J POSIT PSYCHOL, V4, P32, DOI 10.1080/17439760802216311; Lemyre PN, 2008, SCAND J MED SCI SPOR, V18, P221, DOI 10.1111/j.1600-0838.2007.00671.x; Lewis C., 1990, INSIDE TRACK MY PROF; Lewis M, 2001, PSYCHOL INQ, V12, P67, DOI 10.1207/S15327965PLI1202_02; Lonsdale C, 2011, MED SCI SPORT EXER, V43, P913, DOI 10.1249/MSS.0b013e3181ff56c6; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 2001, PSYCHOL HEALTH, V16, P607, DOI 10.1080/08870440108405530; Maslach C., 1976, HUM BEHAV, V5, P16; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McCullough ME, 2001, PSYCHOL BULL, V127, P249, DOI 10.1037//0033-2909.127.2.249; McCullough ME, 2002, J PERS SOC PSYCHOL, V82, P112, DOI 10.1037//0022-3514.82.1.112; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Moneta GB, 2011, PERS INDIV DIFFER, V50, P274, DOI 10.1016/j.paid.2010.10.002; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Pitariu AH, 2010, J MANAGE, V36, P405, DOI 10.1177/0149206308331096; Ployhart RE, 2010, J MANAGE, V36, P94, DOI 10.1177/0149206309352110; Pompili M, 2006, ARCH PSYCHIAT NURS, V20, P135, DOI 10.1016/j.apnu.2005.12.002; Purvanova RK, 2010, J VOCAT BEHAV, V77, P168, DOI 10.1016/j.jvb.2010.04.006; Quattrin R, 2006, ONCOL NURS FORUM, V33, P815, DOI 10.1188/06.ONF.815-820; Raedeke TD, 2004, J SPORT EXERCISE PSY, V26, P525, DOI 10.1123/jsep.26.4.525; Raedeke TD, 2001, J SPORT EXERCISE PSY, V23, P281, DOI 10.1123/jsep.23.4.281; Raykov T, 2008, STRUCT EQU MODELING, V15, P449, DOI 10.1080/10705510802154315; Reinboth M, 2006, PSYCHOL SPORT EXERC, V7, P269, DOI 10.1016/j.psychsport.2005.06.002; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Rosmarin DH, 2011, J POSIT PSYCHOL, V6, P389, DOI 10.1080/17439760.2011.596557; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Schaufeli WB, 2011, J OCCUP ORGAN PSYCH, V84, P248, DOI 10.1111/j.2044-8325.2010.02013.x; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; Steinhardt MA, 2011, STRESS HEALTH, V27, P420, DOI 10.1002/smi.1394; Swider BW, 2010, J VOCAT BEHAV, V76, P487, DOI 10.1016/j.jvb.2010.01.003; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Wood AM, 2008, J RES PERS, V42, P854, DOI 10.1016/j.jrp.2007.11.003; Wood AM, 2008, PERS INDIV DIFFER, V45, P49, DOI 10.1016/j.paid.2008.02.019; Wood AM, 2010, CLIN PSYCHOL REV, V30, P890, DOI 10.1016/j.cpr.2010.03.005; Wood AM, 2009, PERS INDIV DIFFER, V46, P443, DOI 10.1016/j.paid.2008.11.012	86	6	6	2	29	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1046-1310	1936-4733		CURR PSYCHOL	Curr. Psychol.	DEC	2014	33	4					460	478		10.1007/s12144-014-9223-8			19	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	AT2BJ	WOS:000344735600003					2022-02-06	
J	Chio, CC; Chang, CP; Lin, MT; Su, FC; Yang, CZ; Tseng, HY; Liu, ZM; Huang, HS				Chio, Chung-Ching; Chang, Ching-Ping; Lin, Mao-Tsun; Su, Fang-Cheng; Yang, Chung-Zhing; Tseng, Hong-Yu; Liu, Zi-Miao; Huang, Huei-Sheng			Involvement of TG-interacting factor in microglial activation during experimental traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						microglial activation; TG-interacting factor; traumatic brain injury	HOMEODOMAIN PROTEIN TGIF; PEPTIDE INHIBITOR; UBIQUITIN LIGASE; GENE-EXPRESSION; INFLAMMATION; CELLS; MODEL; JNK; ANGIOGENESIS; SUPERFAMILY	Traumatic brain injury (TBI) is a complex injury involving several physiological alterations, potentially leading to neurological impairment. Previous mouse studies using high-density oligonucleotide array analysis have confirmed the upregulation of transforming growth-interacting factor (TGIF) mRNA in TBI. TGIF is a transcriptional corepressor of transforming growth factor beta (TGF-) signaling which plays a protective role in TBI. However, the functional roles of TGIF in TBI are not well understood. In this study, we used confocal microscopy after immunofluorescence staining to demonstrate the increase of TGIF levels in the activated microglia of the pericontusional cortex of rats with TBI. Intracerebral knockdown of TGIF in the pericontusional cortex significantly downregulated TGIF expression, attenuated microglial activation, reduced the volume of damaged brain tissue, and facilitated recovery of limb motor function. Collectively, our results indicate that TGIF is involved in TBI-induced microglial activation, resulting in secondary brain injury and motor dysfunction.	[Chio, Chung-Ching] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; [Chang, Ching-Ping] Southern Taiwan Univ, Dept Biotechnol, Tainan, Taiwan; [Lin, Mao-Tsun] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Su, Fang-Cheng; Tseng, Hong-Yu; Liu, Zi-Miao; Huang, Huei-Sheng] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Yang, Chung-Zhing] Taipei Med Univ, Program Canc Biol & Drug Discovery CBDD, Taipei, Taiwan		Huang, HS (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan.	huanghs@mail.ncku.edu.tw	Huang, Huei-Sheng/F-9945-2011; Tseng, Hongyu/Z-2669-2019	Chang, Ching-Ping/0000-0003-0890-9414	National Science Council (Taipei, Taiwan)Ministry of Science and Technology, Taiwan [NSC102-2320-B-006-017-]; Chi Met Medical Center (Tainan, Taiwan) [CMNCKU9911, CMNCKU10011]	This work was supported in part by grants from the National Science Council (Taipei, Taiwan; NSC102-2320-B-006-017-), and the Chi Met Medical Center (Tainan, Taiwan; CMNCKU9911, CMNCKU10011). The authors have no conflicts of interest to declare,	Bartholin L, 2006, MOL CELL BIOL, V26, P990, DOI 10.1128/MCB.26.3.990-1001.2006; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Buckwalter MS, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-10; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; Chen SH, 2009, CRIT CARE MED, V37, P3097, DOI 10.1097/CCM.0b013e3181bc7986; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; DeGeorge ML, 2011, BRAIN RES, V1403, P45, DOI 10.1016/j.brainres.2011.05.058; Demange C, 2009, MOL CELL, V36, P1073, DOI 10.1016/j.molcel.2009.12.009; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Pietro V, 2010, J NEUROTRAUM, V27, P349, DOI 10.1089/neu.2009.1095; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fee DB, 2004, BRAIN RES, V1012, P52, DOI 10.1016/j.brainres.2004.03.028; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; Guan QH, 2006, NEUROSCIENCE, V139, P609, DOI 10.1016/j.neuroscience.2005.11.067; Hailer NP, 2005, EUR J NEUROSCI, V21, P2347, DOI 10.1111/j.1460-9568.2005.04067.x; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Herpin A, 2004, DEV COMP IMMUNOL, V28, P461, DOI 10.1016/j.dci.2003.09.007; Hneino M, 2012, J BIOL CHEM, V287, P38913, DOI 10.1074/jbc.M112.388389; Huang HS, 2006, J BIOMED SCI, V13, P113, DOI 10.1007/s11373-005-9040-z; Huang HS, 2010, TOXICOL APPL PHARM, V244, P234, DOI 10.1016/j.taap.2009.12.037; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Knepper JL, 2006, DEV DYNAM, V235, P1482, DOI 10.1002/dvdy.20725; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu ZM, 2008, J BIOMED SCI, V15, P333, DOI 10.1007/s11373-007-9232-9; Liu ZM, 2008, TOXICOL APPL PHARM, V233, P297, DOI 10.1016/j.taap.2008.08.015; Liu ZM, 2006, CELL SIGNAL, V18, P244, DOI 10.1016/j.cellsig.2005.04.006; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; Mannick EE, 2004, CLIN IMMUNOL, V112, P247, DOI 10.1016/j.clim.2004.03.014; Mar L, 2006, MOL CELL BIOL, V26, P4302, DOI 10.1128/MCB.02156-05; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Pessah M, 2001, P NATL ACAD SCI USA, V98, P6198, DOI 10.1073/pnas.101579798; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rimaniol AC, 1995, NEUROREPORT, V7, P133, DOI 10.1097/00001756-199512290-00032; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Seo SR, 2006, MOL CELL, V23, P547, DOI 10.1016/j.molcel.2006.06.018; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Wallis DE, 1999, MOL GENET METAB, V68, P126, DOI 10.1006/mgme.1999.2895; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wotton D, 2001, CELL GROWTH DIFFER, V12, P457; Yang Y, 2000, J BIOL CHEM, V275, P20734, DOI 10.1074/jbc.M908382199	55	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2014	131	6					816	824		10.1111/jnc.12971			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AW2ZX	WOS:000346156200011	25319900				2022-02-06	
J	Curtis, K; Chan, DL; Lam, MK; Mitchell, R; King, K; Leonard, L; D'Amours, S; Black, D				Curtis, Kate; Chan, Daniel Leonard; Lam, Mary Kit; Mitchell, Rebecca; King, Kate; Leonard, Liz; D'Amours, Scott; Black, Deborah			The injury profile and acute treatment costs of major trauma in older people in New South Wales	AUSTRALASIAN JOURNAL ON AGEING			English	Article						cost; injury; older people; patient outcomes; trauma	GERIATRIC TRAUMA; MORTALITY	AimsTo Describe injury profile and costs of older person trauma in New South Wales; quantify variations with peer group costs; and identify predictors of higher costs. MethodsNine level 1 New South Wales trauma centres provided data on major traumas (aged 55 years) during 2008-2009 financial year. Trauma register and financial data of each institution were linked. Treatment costs were compared with peer group Australian Refined Diagnostic Related Groups costs, on which hospital funding is based. Variables examined through multivariate analyses. ResultsSix thousand two hundred and eighty-nine patients were admitted for trauma. Most common injury mechanism was falls (74.8%) then road trauma (14.9%). Median patient cost was $7044 (Q1-3: $3405-13 930) and total treatment costs $76 694 252. Treatment costs were $5 813 975 above peer group average. Intensive care unit admission, age, injury severity score, length of stay and traumatic brain injury were independent predictors of increased costs. ConclusionOlder person trauma attracts greater costs and length of stay. Cost increases with age and injury severity. Hospital financial information and trauma registry data provides accurate cost information that may inform future funding.	[Curtis, Kate; Leonard, Liz] Univ Sydney, Sydney Nursing Sch, Sydney, NSW 2006, Australia; [Curtis, Kate; Chan, Daniel Leonard] St George Hosp, Dept Surg, Sydney, NSW, Australia; [Curtis, Kate] George Inst Global Hlth, Sydney, NSW, Australia; [Curtis, Kate; Chan, Daniel Leonard] Univ New S Wales, Fac Med, St George Clin Sch, Sydney, NSW, Australia; [Lam, Mary Kit; Black, Deborah] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Mitchell, Rebecca] Univ New S Wales, Sydney, NSW, Australia; [King, Kate] John Hunter Hosp, Trauma Serv, Newcastle, NSW, Australia; [King, Kate] Univ Newcastle, Newcastle, NSW 2300, Australia; [D'Amours, Scott] Liverpool Hosp, Dept Trauma, Sydney, NSW, Australia		Chan, DL (corresponding author), St George Publ Hosp, Trauma Serv, Kogarah, NSW, Australia.	daniel.l.chan@unsw.edu.au	Chan, Daniel Leonard/I-6179-2019; black, deborah/C-2829-2017; Mitchell, Rebecca/Z-5476-2019	Chan, Daniel Leonard/0000-0001-9488-4094; black, deborah/0000-0001-9174-1565; Mitchell, Rebecca/0000-0003-1939-1761			Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; *AUSTR BUR STAT, 2006, AUSTR CENS POP HOUS; Australian Institute of Health and Welfare (AIHW), 2010, HLTH SYST EXP DIS IN, V36; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Curtis K, 2012, INJURY IN PRESS, DOI [10.1016/j.injury.2012.10.002, DOI 10.1016/J.INJURY.2012.10.002]; Curtis Kate, 2012, J Trauma Nurs, V19, P214, DOI 10.1097/JTN.0b013e3182759a7d; Curtis K, 2011, HEALTH INF MANAG J, V40, P7, DOI 10.1177/183335831104000102; Curtis K, 2009, AUST HEALTH REV, V33, P84, DOI 10.1071/AH090084; Frydenberg EM, 2012, J AUSTRALAS COLL ROA, V23, P21; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Grotz M, 2004, UNFALLCHIRURG, V107, P68, DOI 10.1007/s00113-003-0715-5; Holbrook TL, 2001, J TRAUMA, V50, P91, DOI 10.1097/00005373-200101000-00016; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Lyons RA, 2010, INT J INJ CONTROL SA, V17, P145, DOI 10.1080/17457300903453104; Mangram AJ, 2012, J TRAUMA ACUTE CARE, V72, P119, DOI 10.1097/TA.0b013e318241f0ba; Mitchell Rebecca, 2006, Aust New Zealand Health Policy, V3, P11, DOI 10.1186/1743-8462-3-11; NSW Health Department, 2006, 2006 2007 NSW PROGR; NSW Health Department, 2003, MAN POL RED FALL INJ; NSW Health Inter-Governement and Funding Strategies, 2008, EP FUND POL 2008 09; NSW Institute of Trauma and Injury Management, 2007, NSW TRAUM REG PROF S; Pape HC, 2009, EUR J TRAUMA EMERG S, V35, P61, DOI 10.1007/s00068-008-8013-0; Potter-Forbes M, 2003, INJURY COSTS VALUATI; Psoinos CM, 2012, J TRAUMA ACUTE CARE, V73, P469, DOI 10.1097/TA.0b013e318258437c; Reserve Bank of Australia, 2012, INFL CALC; Rowell D, 2011, J TRAUMA, V70, P1086, DOI 10.1097/TA.0b013e3181ed4d29; Santana MJ, 2012, J TRAUMA ACUTE CARE, V72, P1298, DOI 10.1097/TA.0b013e318246584c; Soles GLS, 2011, J ORTHOP TRAUMA, V25, pS61, DOI 10.1097/BOT.0b013e31821b8a3b; Watson W., 1997, COST INJURY VICTORIA; Willenberg L, 2011, COST MAJOR TRAUMA SY; Willenberg L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-267	31	6	6	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-6381	1741-6612		AUSTRALAS J AGEING	Australas. Ageing	DEC	2014	33	4					264	270		10.1111/ajag.12059			7	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	AW0LO	WOS:000345984000018	24520942				2022-02-06	
J	Gawlikowski, T; Golasik, M; Gomolka, E; Piekoszewski, W				Gawlikowski, Tomasz; Golasik, Magdalena; Gomolka, Ewa; Piekoszewski, Wojciech			Proteins as biomarkers of carbon monoxide neurotoxicity	INHALATION TOXICOLOGY			English	Article						CO poisoning; neurological biomarkers; serum; S100B protein; Tau protein	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; SERUM S100B PROTEIN; TAU-PROTEIN; ALZHEIMERS-DISEASE; AXONAL DAMAGE; MARKER; INTOXICATION; DIAGNOSIS	Context: Carbon monoxide (CO) poisoning is the most common form of accidental lethal poisoning and is associated with a risk of brain damage in survivors. Objective: The goal of this study was to examine whether Tau protein or S100B protein may be used as a biomarker for acute brain dysfunction. Materials and methods: The determination of Tau and S100B proteins was performed in serum samples collected from 27 CO-poisoned patients and 12 healthy volunteers. Results: The level of Tau protein in the serum of patients (444 +/- 227 ng L-1) differed significantly compared with those in the healthy controls (240 +/- 61 ng L-1) and correlated with the level of carboxyhemoglobin. A higher concentration of Tau protein was found in patients who had lost consciousness during CO exposure. The concentration of S100B in the serum of CO-poisoned subjects (0.08 +/- 0.03 mg L-1) was not statistically different from values obtained for the controls (0.07 +/- 0.02 mg L-1). Conclusion: CO poisoning appears to be associated with an elevated level of Tau and S100B proteins in the serum of patients who had suffered a loss of consciousness. The study has shown that Tau protein is a more sensitive biomarker than S100B protein for the earlier stage of neurotoxic effects of CO intoxication.	[Gawlikowski, Tomasz] Jagiellonian Univ, Sch Med, Dept Clin Toxicol, PL-30060 Krakow, Poland; [Golasik, Magdalena; Piekoszewski, Wojciech] Jagiellonian Univ, Fac Chem, Dept Analyt Chem, PL-30060 Krakow, Poland; [Gomolka, Ewa] Jagiellonian Univ, Sch Med, Lab Analyt Toxicol & Therapeut Drug Monitoring, PL-30060 Krakow, Poland		Piekoszewski, W (corresponding author), Jagiellonian Univ, Fac Chem, Dept Analyt Chem, Ingardena 3, PL-30060 Krakow, Poland.	wpiekosz@tlen.pl	Piekoszewski, Wojciech/AAV-5051-2020; Gomolka, Ewa/D-1367-2014	Piekoszewski, Wojciech/0000-0001-5718-9797			Annane D, 2001, INTENS CARE MED, V27, P1776, DOI 10.1007/s00134-001-1127-z; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bitsch A, 2002, EUR NEUROL, V47, P45, DOI 10.1159/000047946; Brvar M, 2004, RESUSCITATION, V61, P357, DOI 10.1016/j.resuscitation.2004.01.009; Cakir Z, 2010, AM J EMERG MED, V28, P61, DOI 10.1016/j.ajem.2008.10.032; Chu K, 2004, EUR NEUROL, V51, P98, DOI 10.1159/000076536; Cronje FJ, 2004, FREE RADICAL BIO MED, V37, P1802, DOI 10.1016/j.freeradbiomed.2004.08.022; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Foerch C, 2005, ARCH NEUROL-CHICAGO, V62, P1130, DOI 10.1001/archneur.62.7.1130; Gawlikowski T, 2013, BASIC CLIN PHARMACOL, V112, P352, DOI 10.1111/bcpt.12042; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Gorman D, 2003, TOXICOLOGY, V187, P25, DOI 10.1016/S0300-483X(03)00005-2; Henry CR, 2006, JAMA-J AM MED ASSOC, V295, P398, DOI 10.1001/jama.295.4.398; Hu HT, 2012, CLIN BIOCHEM, V45, P1320, DOI 10.1016/j.clinbiochem.2012.06.003; Hu HJ, 2011, AM J EMERG MED, V29, P261, DOI 10.1016/j.ajem.2009.09.030; Ide T, 2012, AM J EMERG MED, V30, P222, DOI 10.1016/j.ajem.2010.11.025; Iqbal S, 2012, AM J EMERG MED, V30, P657, DOI 10.1016/j.ajem.2011.03.003; Kilicaslan I, 2012, CLIN TOXICOL, V50, P497, DOI 10.3109/15563650.2012.698742; Kim JH, 2003, AM J NEURORADIOL, V24, P1592; Li XY, 2011, EMBO J, V30, P4825, DOI 10.1038/emboj.2011.376; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Lippi G, 2012, CLIN BIOCHEM, V45, P1278, DOI 10.1016/j.clinbiochem.2012.06.004; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Moon JM, 2011, HUM EXP TOXICOL, V30, P836, DOI 10.1177/0960327110384527; Omaye ST, 2002, TOXICOLOGY, V180, P139, DOI 10.1016/S0300-483X(02)00387-6; Park E, 2012, CLIN TOXICOL, V50, P183, DOI 10.3109/15563650.2012.658918; Parkinson RB, 2002, NEUROLOGY, V58, P1525, DOI 10.1212/WNL.58.10.1525; Rasmussen LS, 2004, ACTA ANAESTH SCAND, V48, P469, DOI 10.1111/j.1399-6576.2004.00362.x; Sakatani S, 2008, J NEUROSCI, V28, P10928, DOI 10.1523/JNEUROSCI.3693-08.2008; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Shakeril M, 2013, ARCH TRAUMA RES, V2, P76, DOI 10.5812/atr.8549; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Souter S, 2009, J CELL BIOCHEM, V108, P555, DOI 10.1002/jcb.22287; Sparks D Larry, 2012, Am J Neurodegener Dis, V1, P99; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Thom SR, 2006, AM J RESP CRIT CARE, V174, P1239, DOI 10.1164/rccm.200604-557OC; Thom SR, 2006, TOXICOL APPL PHARM, V213, P152, DOI 10.1016/j.taap.2005.10.006; Trojanowski JQ, 2002, MED CLIN N AM, V86, P615, DOI 10.1016/S0025-7125(02)00002-0; Wang K, 2013, TUMOR BIOL, V34, P33, DOI 10.1007/s13277-012-0507-z; Wang Q, 2013, PATHOL ONCOL RES, V19, P429, DOI 10.1007/s12253-012-9598-5; Wojtczak-Soska K, 2010, CARDIOL J, V17, P532; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Yardan T, 2009, AM J EMERG MED, V27, P838, DOI 10.1016/j.ajem.2008.04.016; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163	47	6	7	0	11	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0895-8378	1091-7691		INHAL TOXICOL	Inhal. Toxicol.	DEC	2014	26	14					885	890		10.3109/08958378.2014.970786			6	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	AW0KI	WOS:000345980700008	25357234				2022-02-06	
J	Oudman, E; Wijnia, JW				Oudman, Erik; Wijnia, Jan W.			Evolution of quality of life in patients with Korsakoff's syndrome in a long-term care facility	INTERNATIONAL PSYCHOGERIATRICS			English	Article						quality of life (QoL); longitudinal studies; long-term care; traumatic brain injury (TBI)	DEMENTIA; INSTRUMENT; ALCOHOL; RELIABILITY; SCALABILITY; SETTINGS; PEOPLE	Background: Korsakoff's syndrome (KS) is a neuropsychiatric disorder characterized by severe amnesia. Quality of life (QoL) is becoming an increasingly used outcome measure in clinical practice but little is known about QoL in KS and how it may change over time. The purpose of this study was therefore to assess the QoL in patients with KS at baseline and with a 20-month follow-up. Methods: The current study is a longitudinal study on the QoL in patients with KS living in two long-term care facilities for KS patients in the Netherlands. QoL was scored with the proxy-based QUALIDEM scale with a 20-month follow-up. Results: Of the 72 KS patients included at baseline, 57 KS patients had a follow-up QoL score (79.2%). On the subscales "Feeling at home," "Positive affect," and "Care relationship" of the QUALIDEM, there was a better QoL in the follow-up, although effects were relatively small. Other subscales indicated a stable QoL over time. There were inter-relations between changes in subscales. Conclusions: The main finding of this study is that patients with KS on average do show a relatively stable moderate to good QoL despite the severity of the syndrome. On specific subscales, there is a small increase in QoL over time. Results do suggest that prolonged stay in a long-term care facility for KS patients does have a neutral to a positive effect on QoL in KS.	[Oudman, Erik] Univ Utrecht, Helmholtz Res Inst, Dept Expt Psychol, NL-3584 CS Utrecht, Netherlands; [Oudman, Erik; Wijnia, Jan W.] Slingedael Korsakoff Ctr, Rotterdam, Netherlands		Oudman, E (corresponding author), Univ Utrecht, Helmholtz Res Inst, Dept Expt Psychol, Heidelberglaan 1, NL-3584 CS Utrecht, Netherlands.	e.oudman@leliezorggroep.nl		Oudman, Erik/0000-0002-4441-0365			Beerens HC, 2013, INT J NURS STUD, V50, P1259, DOI 10.1016/j.ijnurstu.2013.02.005; BLANSJAAR BA, 1992, ACTA PSYCHIAT SCAND, V86, P240, DOI 10.1111/j.1600-0447.1992.tb03260.x; Bouman AIE, 2011, INT J GERIATR PSYCH, V26, P711, DOI 10.1002/gps.2585; Brod M, 1999, GERONTOLOGIST, V39, P25, DOI 10.1093/geront/39.1.25; de Lange J., 2001, CARE PROGRAM KORSAKO; Egger JIM, 2002, ACTA NEUROPSYCHIATR, V14, P231, DOI 10.1034/j.1601-5215.2002.140506.x; Ettema T. P., 2005, MANUAL QUALIDEM; Ettema TP, 2007, INT J GERIATR PSYCH, V22, P549, DOI 10.1002/gps.1713; Ettema TP, 2007, INT J GERIATR PSYCH, V22, P424, DOI 10.1002/gps.1692; Ettema TP, 2005, QUAL LIFE RES, V14, P675, DOI 10.1007/s11136-004-1258-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujiwara E, 2008, J CLIN EXP NEUROPSYC, V30, P576, DOI 10.1080/13803390701557271; Funaki Yuuka, 2005, Scand J Occup Ther, V12, P4, DOI 10.1080/11038120510031725; Gerridzen IJ, 2014, INT PSYCHOGERIATR, V26, P115, DOI 10.1017/S1041610213001543; Hoe J, 2009, ALZ DIS ASSOC DIS, V23, P285, DOI 10.1097/WAD.0b013e318194fc1e; Kok R. M., 2004, TIJDSCHR PSYCHIAT, V46, P665; KOPELMAN MD, 1995, BRIT J PSYCHIAT, V166, P154, DOI 10.1192/bjp.166.2.154; Kopelman MD, 2009, ALCOHOL ALCOHOLISM, V44, P148, DOI 10.1093/alcalc/agn118; Kril JJ, 2012, NEUROPSYCHOL REV, V22, P72, DOI 10.1007/s11065-012-9195-0; Lyketsos CG, 2003, INT J GERIATR PSYCH, V18, P275, DOI 10.1002/gps.796; Missotten P, 2007, INT J GERIATR PSYCH, V22, P1201, DOI 10.1002/gps.1814; Mulder JL, 2006, WORD FLUENCY TEST; Oudman E, 2012, J AM MED DIR ASSOC, V13, P778, DOI 10.1016/j.jamda.2012.08.003; Popoola A, 2008, IRISH J MED SCI, V177, P141, DOI 10.1007/s11845-008-0135-1; Sechi G, 2007, LANCET NEUROL, V6, P442, DOI 10.1016/S1474-4422(07)70104-7; Selwood A, 2005, INT J GERIATR PSYCH, V20, P232, DOI 10.1002/gps.1271; Verhage F., 1964, INTELLIGENCE AGE; Vogel A, 2012, INT PSYCHOGERIATR, V24, P82, DOI 10.1017/S1041610211001128; Zahr NM, 2011, NAT REV NEUROL, V7, P284, DOI 10.1038/nrneurol.2011.42	29	6	6	0	5	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1041-6102	1741-203X		INT PSYCHOGERIATR	Int. Psychogeriatr.	DEC	2014	26	12			SI		2073	2079		10.1017/S1041610214001719			7	Psychology, Clinical; Geriatrics & Gerontology; Gerontology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Geriatrics & Gerontology; Psychiatry	AT4YG	WOS:000344948000017	25119794				2022-02-06	
J	Post, A; Oeur, A; Hoshizaki, TB; Gilchrist, MD				Post, Andrew; Oeur, Anna; Hoshizaki, Thomas B.; Gilchrist, Michael D.			Differences in region-specific brain tissue stress and strain due to impact velocity for simulated American football impacts	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						American football; concussion; impact biomechanics; football standards; impact reconstruction; football helmet	HEAD IMPACTS; INJURY; CONCUSSION; MODEL; ACCELERATION; LANGUAGE; CRITERIA; HELMETS; MOTION	Concussion has become a prevalent injury in the sport of American football, and its severity can be influenced by the mass of the impactor, velocity, compliance, and direction of impact. As a result, it is important to characterize how American football helmets perform against these impact characteristics. The purpose of this research is to examine how an American football helmet performs across velocities and impact angles which can occur in the sport of American football. The methods used a combination of Hybrid III headform impacts combined with a finite element modeling approach to find the brain deformation variables known to be associated with concussion. At the 9.5 m/s impacts, the brain deformation metrics showed an increase in risk of concussion. Also, the region of the brain with the largest magnitude deformation shifted with differing velocities when analyzed using maximum principal strain but not von Mises stress. The results indicate that impact conditions (location and velocity) can influence the regional brain strains.	[Post, Andrew; Oeur, Anna; Hoshizaki, Thomas B.] Univ Ottawa, Dept Human Kinet, Ottawa, ON K1N 6N5, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland		Post, A (corresponding author), Univ Ottawa, Dept Human Kinet, 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca		Post, Andrew/0000-0002-5960-5552			Augustine G., 2001, NEUROSCIENCE; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BOTTINI G, 1994, BRAIN, V117, P1241, DOI 10.1093/brain/117.6.1241; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Gilchrist MD, 2001, INT J CRASHWORTHINES, V6, P253, DOI 10.1533/cras.2001.0176; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hu H, 1998, 5 INT LS DYNA US C S; Hunt T, 2010, CLIN SPORT MED, V29, P5, DOI 10.1016/j.csm.2009.09.002; Kang HS, 1997, P STAPP CAR CRASH J, V41, P329; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Karton C, J ASTM INT IN PRESS; Karton C, 2012, THESIS U OTTAWA OTTA; Kendall M, 2012, P IRCOBI C DUBL 12 1; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2002, P IRCOBI, P161; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Miller R.T., 1998, STAPP CAR CRASH J, P155; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nahum AM, 1977, P 21 STAPP CAR CRASH; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Post A, 2012, J ASTM INT, V9, P5; Post A, 2011, COMPUT METHOD BIOMEC, V16, P511; Post A, 2013, ROUTLEDGE HDB ERGONO, P399; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P159, DOI 10.1243/17543371JSET36; Ruan J. S., 1994, THESIS WAYNE STATE U; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	52	6	6	1	27	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	DEC	2014	228	4					276	286		10.1177/1754337114527742			11	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	AU0UY	WOS:000345341400007					2022-02-06	
J	Raukar, NP; Zonfrillo, MR; Kane, K; Davenport, M; Espinoza, TR; Weiland, J; Franco, V; Vaca, FE				Raukar, Neha P.; Zonfrillo, Mark R.; Kane, Kathleen; Davenport, Moira; Espinoza, Tamara R.; Weiland, Jessica; Franco, Vanessa; Vaca, Federico E.			Gender- and Sex-specific Sports-related Injury Research in Emergency Medicine: A Consensus on Future Research Direction and Focused Application	ACADEMIC EMERGENCY MEDICINE			English	Article							CARDIAC TROPONIN INCREASES; TRAUMATIC BRAIN-INJURY; ATHLETES HEART; BLOOD-FLOW; CLINICAL-SIGNIFICANCE; ENDURANCE EXERCISE; MENSTRUAL-CYCLE; RISK-FACTORS; CONCUSSION; RUNNERS	Title IX, the commercialization of sports, the social change in sports participation, and the response to the obesity epidemic have contributed to the rapid proliferation of participation in both competitive organized sports and nontraditional athletic events. As a consequence, emergency physicians are regularly involved in the acute diagnosis, management, disposition, and counseling of a broad range of sports-related pathology. Three important and highly publicized mechanisms of injury in sports relevant to emergency medicine (EM) include concussion, heat illness, and sudden cardiac death. In conjunction with the 2014 Academic Emergency Medicine consensus conference Gender-specific Research in Emergency Care: Investigate, Understand, and Translate How Gender Affects Patient Outcomes, a consensus group consisting of experts in EM, emergency neurology, sports medicine, and public health convened to deliberate and develop research questions that could ultimately advance the field of sports medicine and allow for meaningful application in the emergency department (ED) clinical setting. Sex differences in injury risk, diagnosis, ED treatment, and counseling are identified in each of these themes. This article presents the consensus-based priority research agenda.	[Raukar, Neha P.] Brown Univ, Dept Emergency Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Davenport, Moira] Allegheny Gen Hosp, Dept Emergency Med, Pittsburgh, PA 15212 USA; [Espinoza, Tamara R.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Franco, Vanessa] Univ Calif Los Angeles, Dept Emergency Med, Los Angeles, CA USA; [Vaca, Federico E.] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT USA; [Zonfrillo, Mark R.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Kane, Kathleen; Weiland, Jessica] Lehigh Valley Hosp, USF Morsani Coll Med, Dept Emergency Med, Allentown, PA USA		Raukar, NP (corresponding author), Brown Univ, Dept Emergency Med, Warren Alpert Med Sch, Providence, RI 02912 USA.	Neha_Raukar@Brown.edu	Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R13NS087861-01]; Office of Research on Women's Health at the National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R13NS087861] Funding Source: NIH RePORTER	The consensus conference was supported by grant 1R13NS087861-01 from the National Institute of Neurological Disorders and Stroke and the Office of Research on Women's Health at the National Institutes of Health. Additional funding was provided by several organizational, institutional, and individual donors. Non-CME events were supported by Janssen Pharmaceuticals and Besins Critical Care/BH Pharma. See the executive summary elsewhere in this issue for full funding information.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Amit D, 2012, AVIAT SPACE ENVIR MD, V83, P58, DOI 10.3357/ASEM.3130.2012; Armstrong LE, 2007, MED SCI SPORT EXER, V39, P556, DOI 10.1249/MSS.0b013e31802fa199; Asif I, 2014, BRIT J SPORT MED, V48, P562; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bar-Or O, 1998, INT J SPORTS MED, V19, pS106, DOI 10.1055/s-2007-971970; Battle CE, 2013, INJURY, V44, P56, DOI 10.1016/j.injury.2011.12.012; Bergeron MF, 2013, PEDIATR REV, V34, P270, DOI 10.1542/pir.34-6-270; Bertinchant JP, 2000, J TRAUMA, V48, P924, DOI 10.1097/00005373-200005000-00018; Bianco M, 2001, EUR HEART J, V22, P504, DOI 10.1053/euhj.2000.2247; BJORNSTAD H, 1994, CARDIOLOGY, V84, P51, DOI 10.1159/000176328; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruning RS, 2013, MED SCI SPORT EXER, V45, P674, DOI 10.1249/MSS.0b013e31827981dc; Casa Douglas J, 2005, Curr Sports Med Rep, V4, P309; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P465; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Comstock RD, 2013, 4 ANN YOUTH SPORTS S; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Council Sports Med, 2011, PEDIATRICS, V128, pE741, DOI 10.1542/peds.2011-1664; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; D'Ascenzi F, 2014, CIRC-CARDIOVASC IMAG, V7, P222, DOI 10.1161/CIRCIMAGING.113.001345; Deaner RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049168; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Filippidis AS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10185; Fortescue EB, 2007, ANN EMERG MED, V49, P137, DOI 10.1016/j.annemergmed.2006.09.024; Frassl W, 2008, CLIN LAB, V54, P81; FRYE AJ, 1982, EUR J APPL PHYSIOL O, V48, P279, DOI 10.1007/BF00422988; Gagnon D, 2013, J APPL PHYSIOL, V114, P394, DOI 10.1152/japplphysiol.00877.2012; Gagnon D, 2012, J PHYSIOL-LONDON, V590, P5963, DOI 10.1113/jphysiol.2012.240739; Gatson J, 2014, JAMA NEUROL, V71, P677, DOI 10.1001/jamaneurol.2014.443; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gilchrist I., 2010, Morbidity and Mortality Weekly Report, V59, P1009; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P977; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Glickman-Weiss EL, 2000, UNDERSEA HYPERBAR M, V27, P75; Hubble KM, 2009, MED J AUSTRALIA, V190, P91, DOI 10.5694/j.1326-5377.2009.tb02286.x; Inbar O, 2004, EXP PHYSIOL, V89, P691, DOI 10.1113/expphysiol.2004.027979; Inoue Y, 2005, EUR J APPL PHYSIOL, V94, P323, DOI 10.1007/s00421-004-1303-2; Institute of Medicine, 2014, SPORTS REL CONC YOUT; International Olympic Committee: Factsheet, FACTSH WOM OL MOV; Kaciuba-Uscilko H, 2001, CURR OPIN CLIN NUTR, V4, P533, DOI 10.1097/00075197-200111000-00012; Kim JH, 2012, NEW ENGL J MED, V366, P130, DOI 10.1056/NEJMoa1106468; Kitamura T, 2010, EUR HEART J, V31, P1365, DOI 10.1093/eurheartj/ehq059; Kravchenko J, 2013, AM J PREV MED, V44, P274, DOI 10.1016/j.amepre.2012.11.015; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Leers MPG, 2006, CLIN CHEM LAB MED, V44, P999, DOI 10.1515/CCLM.2006.179; Lemire BB, 2009, MED SCI SPORT EXER, V41, P1633, DOI 10.1249/MSS.0b013e31819e010c; Lengyel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018751; Link MS, 2012, CIRC-ARRHYTHMIA ELEC, V5, P425, DOI 10.1161/CIRCEP.111.962712; Macchi Claudio, 2001, Italian Journal of Anatomy and Embryology, V106, P221; Marijon E, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1185, DOI 10.1161/CIRCEP.113.000651; Maron BJ, 2014, J AM COLL CARDIOL, V63, P1636, DOI 10.1016/j.jacc.2014.01.041; Maron BJ, 2013, HEART RHYTHM, V10, P219, DOI 10.1016/j.hrthm.2012.10.034; Maron BJ, 2010, NEW ENGL J MED, V362, P917, DOI 10.1056/NEJMra0910111; Maron BJ, 2003, J AM COLL CARDIOL, V41, P974, DOI 10.1016/S0735-1097(02)02976-5; Maron BJ, 2002, AM J CARDIOL, V89, P210, DOI 10.1016/S0002-9149(01)02202-0; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Minns AB, 2011, AM J EMERG MED, V29, P1182, DOI 10.1016/j.ajem.2010.06.035; Mosen H, 2014, SCAND CARDIOVASC J, V48, P20, DOI 10.3109/14017431.2013.860234; Mousavi N, 2009, AM J CARDIOL, V103, P1467, DOI 10.1016/j.amjcard.2009.01.294; Nelson NG, 2011, AM J PREV MED, V40, P54, DOI 10.1016/j.amepre.2010.09.031; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; O'Connor FG, 2010, CURR SPORT MED REP, V9, P314, DOI 10.1249/JSR.0b013e3181f1d183; O'Hanlon R, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-38; Pagourelias ED, 2013, J AM SOC ECHOCARDIOG, V26, P1344, DOI 10.1016/j.echo.2013.07.019; Pelliccia A, 2000, CIRCULATION, V102, P278; Pelliccia A, 1996, JAMA-J AM MED ASSOC, V276, P211, DOI 10.1001/jama.276.3.211; Pillai SK, 2014, J COMMUN HEALTH, V39, P90, DOI 10.1007/s10900-013-9743-4; Prior DL, 2012, HEART, V98, P947, DOI 10.1136/heartjnl-2011-301329; Raukar NP, 2014, AM AC NEUR SPORTS CO; Rawlins J, 2010, CIRCULATION, V121, P1078, DOI 10.1161/CIRCULATIONAHA.109.917211; Rivera-Brown AM, 2006, INT J SPORTS MED, V27, P943, DOI 10.1055/s-2006-923863; Rowland T, 2007, INT J SPORTS MED, V28, P26, DOI 10.1055/s-2006-924142; Rowland T, 2008, J APPL PHYSIOL, V105, P718, DOI 10.1152/japplphysiol.01196.2007; Safdar B, 2014, ACAD EMERG MED, V21, P1307, DOI 10.1111/acem.12530; Salim A, 2001, J TRAUMA, V50, P237, DOI 10.1097/00005373-200102000-00008; Scharhag J, 2002, J AM COLL CARDIOL, V40, P1856, DOI 10.1016/S0735-1097(02)02478-6; Sedlak T, 2013, ANN NONINVAS ELECTRO, V18, P389, DOI 10.1111/anec.12050; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; SHAPIRO Y, 1981, ERGONOMICS, V24, P375, DOI 10.1080/00140138108924859; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith JE, 2005, BRIT J SPORT MED, V39, P503, DOI 10.1136/bjsm.2004.013466; Stamatakis E, 2008, BRIT J SPORT MED, V42, P901, DOI 10.1136/bjsm.2008.048082; The White House Office of the Press Secretary, FACTSH PRES OB APPL; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Trivax JE, 2010, J APPL PHYSIOL, V108, P1148, DOI 10.1152/japplphysiol.01151.2009; United States Department of Justice, EQ ACC ED 40 YEARS T; Weeks KL, 2011, PHYSIOLOGY, V26, P97, DOI 10.1152/physiol.00043.2010; Wilcox B, 2013, HEAD IMPACT EXPOSURE; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Wu C J, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P343; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	98	6	6	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	DEC	2014	21	12					1370	1379		10.1111/acem.12535			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AW9KS	WOS:000346576700011	25420669	Bronze			2022-02-06	
J	Triebel, KL; Martin, RC; Novack, TA; Dreer, LE; Turner, C; Kennedy, R; Marson, DC				Triebel, Kristen L.; Martin, Roy C.; Novack, Thomas A.; Dreer, Laura E.; Turner, Crystal; Kennedy, Richard; Marson, Daniel C.			Recovery Over 6 Months of Medical Decision-Making Capacity After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Decision making; Ethics; medical; Informed consent; Rehabilitation	HEAD-INJURY; MILD; CONSENT; IMPAIRMENT; COMPETENCE; CONCUSSION	Objective: To investigate recovery of medical decision-making capacity (MDC) over 6 months in persons with traumatic brain injury (TBI) stratified by injury severity. Design: Longitudinal study comparing controls and patients with TBI 1 month after injury (t1) and 6 months after injury (t2). Setting: Inpatient TBI rehabilitation unit and outpatient neurology department. Participants: Participants (N=151) consisted of control subjects (n=60) and patients with TBI (n=91) stratified by injury severity: mild TBI (mTBI; n=27), complicated mild TBI (cmTBI; n=20), and moderate/severe TBI (msevTBI; n=44). Interventions: Not applicable. Main Outcome Measures: We used the Capacity to Consent to Treatment Instrument to evaluate MDC performance on 5 consent standards (expressing choice, reasonable choice, appreciation, reasoning, and understanding). We also assigned capacity impairment ratings on the consent standards to each participant with TBI using cut scores referenced to control performance. Results: Control performance was stable across time on the consent standards. Patients with mTBI and cmTBI performed below controls on the understanding standard at t1 but not t2. Patients with msevTBI performed below controls on appreciation, reasoning, and understanding at t1, and on appreciation and understanding at t2, but showed substantial improvement over time. Conclusions: Regardless of injury severity, all groups with TBI demonstrated baseline impairment of MDC with subsequent partial or full recovery of MDC over a 6-month period. However, a sizeable proportion of individual patients with TBI in each group continued to demonstrate capacity compromise at 6 months postinjury. Clinically, this finding suggests that individuals with TBI, regardless of injury severity, need continued monitoring regarding MDC for at least 6 months after injury. (C) 2014 by the American Congress of Rehabilitation Medicine	[Triebel, Kristen L.; Martin, Roy C.; Turner, Crystal; Marson, Daniel C.] Univ Alabama Birmingham, Dept Neurol, Div Neuropsychol, Birmingham, AL 35294 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Kennedy, Richard] Univ Alabama Birmingham, Dept Med, Div Gerontol Geriatr & Palliat Care, Birmingham, AL 35294 USA		Marson, DC (corresponding author), Univ Alabama Birmingham, Dept Neurol, Sparks Ctr 650,1720 7th Ave South, Birmingham, AL 35294 USA.	dmarson@uab.edu	triebel, kristen/A-6569-2019; Kennedy, Richard/K-1525-2018	triebel, kristen/0000-0001-9161-7847; Kennedy, Richard/0000-0003-4638-126X; Martin, Roy/0000-0001-9328-0846	National Institutes of Health/National Institute on Child Health and Human Development [IR01HD053074]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074] Funding Source: NIH RePORTER	Support by the National Institutes of Health/National Institute on Child Health and Human Development (grant no. IR01HD053074).	APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Bushnik T, 2008, ARCH PHYS MED REHAB, V89, P894, DOI 10.1016/j.apmr.2008.03.001; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dymek MP, 1999, J FORENSIC NEUROPSYC, V1, P27, DOI DOI 10.1300/J151V01N01_; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; GRISSO T, 1986, EVALUATING COMPETENC; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; MCKINLAY W, 1999, REHABILITATION ADULT, P74; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Pentland B, 1999, REHABILITATION ADULT, P42; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; TEPPER AM, 1984, LAW HUMAN BEHAV, V8, P205, DOI 10.1007/BF01044693; Triebel KL, 2012, NEUROLOGY, V78, P1472, DOI 10.1212/WNL.0b013e3182553c38; Triebel KL, 2009, NEUROLOGY, V73, P2086, DOI 10.1212/WNL.0b013e3181c67bce; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	31	6	6	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2014	95	12					2296	2303		10.1016/j.apmr.2014.07.413			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AW0AY	WOS:000345954000009	25152169	Green Accepted			2022-02-06	
J	Zhang, HY; Liu, YH; Li, Y; Zhou, Y; Chen, DJ; Shen, JH; Yan, YH; Yan, S; Wu, XM; Li, AH; Guo, AS; Cheng, C				Zhang, Haiyan; Liu, Yonghua; Li, Yao; Zhou, Ying; Chen, Dongjian; Shen, Jianhong; Yan, Yaohua; Yan, Song; Wu, Xinmin; Li, Aihong; Guo, Aisong; Cheng, Chun			The Expression of CAP1 After Traumatic Brain Injury and Its Role in Astrocyte Proliferation	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; CAP1; Astrocyte proliferation	CELL-CYCLE; SPINAL-CORD; REACTIVE ASTROCYTES; NEURITE OUTGROWTH; SCAR FORMATION; INHIBITION; ASTROGLIOSIS; MECHANISMS; MIGRATION; RESPONSES	Adenylate cyclase-associated protein 1 (CAP1), a member of cyclase-associated proteins involved in the regulation of actin filaments, was recently reported to play a role in the pathology of sciatic nerves injury. However, the distribution and function of CAP1 in the central nervous system (CNS) remain unclear. To investigate whether CAP1 is involved in CNS injury and repair, we used an acute traumatic brain injury (TBI) model in adult rats. Western blot analysis and immunohistochemistry showed a significant upregulation of CAP1 in ipsilateral peritrauma cortex compared with the contralateral and sham-operated ones. Double immunofluorescence staining showed that CAP1 was co-expressed with glial fibrillary acidic protein (GFAP). In addition, we detected that Ki-67 had colocalization with GFAP and CAP1 after TBI. In vitro, during the process of lipopolysaccharide (LPS)-induced primary astrocyte proliferation, we observed enhanced expression of CAP1. Specially, CAP1-specific siRNA-transfected primary astrocytes show significantly decreased ability for proliferation. Together, all these data indicated that the change of CAP1 protein expression was associated with astrocyte proliferation after the trauma of the central nervous system (CNS).	[Zhang, Haiyan; Li, Yao; Zhou, Ying; Cheng, Chun] Nantong Univ, Coll Med, Dept Immunol, Nantong 226001, Jiangsu, Peoples R China; [Zhang, Haiyan; Liu, Yonghua; Yan, Song; Cheng, Chun] Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Jiangsu, Peoples R China; [Liu, Yonghua] Nantong Univ, Coll Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China; [Chen, Dongjian; Shen, Jianhong; Yan, Yaohua] Nantong Univ, Dept Neurosurg, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China; [Yan, Song; Wu, Xinmin; Li, Aihong; Guo, Aisong] Nantong Univ, Dept Neurol, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China; [Cheng, Chun] Nantong Univ, Nantong 226001, Jiangsu, Peoples R China		Cheng, C (corresponding author), Nantong Univ, 19 Qi Xiu Rd, Nantong 226001, Jiangsu, Peoples R China.	chengchun0514@sohu.com			National Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81373223, 81172879, 81200828, 31300902]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20131206]; Colleges and Universities in Natural Science Research Project of Jiangsu Province [13KJB310009]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Scientific Foundation of China grant (No. 81373223, No. 81172879, No. 81200828, No. 31300902), the Natural Science Foundation of Jiangsu Province (No. BK20131206), the Colleges and Universities in Natural Science Research Project of Jiangsu Province (13KJB310009), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Charvet C, 2006, J IMMUNOL, V177, P5024, DOI 10.4049/jimmunol.177.8.5024; Chen X, 2012, J MOL NEUROSCI, V47, P158, DOI 10.1007/s12031-011-9704-2; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; Freeman NL, 1996, MOL CELL BIOL, V16, P548; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Hubberstey A, 1996, J CELL BIOCHEM, V61, P459, DOI 10.1002/(SICI)1097-4644(19960601)61:3<459::AID-JCB13>3.3.CO;2-#; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Konakahara S, 2012, FEBS LETT, V586, P2251, DOI 10.1016/j.febslet.2012.05.053; Konakahara S, 2011, FEBS LETT, V585, P2377, DOI 10.1016/j.febslet.2011.06.011; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Lepelletier Y, 2006, EUR J IMMUNOL, V36, P1782, DOI 10.1002/eji.200535601; LOGAN A, 1992, J NEUROSCI, V12, P3828; Ma JF, 2010, J HUAZHONG U SCI-MED, V30, P201, DOI 10.1007/s11596-010-0214-1; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Nieto-Sampedro M, 1999, ADV EXP MED BIOL, V468, P207; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Papakonstanti EA, 2008, FEBS LETT, V582, P2120, DOI 10.1016/j.febslet.2008.02.064; Peche V, 2007, CELL MOL LIFE SCI, V64, P2702, DOI 10.1007/s00018-007-7316-3; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; RUDGE JS, 1990, J NEUROSCI, V10, P3594; SWISTON J, 1995, GENE, V165, P273, DOI 10.1016/0378-1119(95)00522-8; Tawfik VL, 2006, GLIA, V54, P193, DOI 10.1002/glia.20365; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; White RE, 2008, RESTOR NEUROL NEUROS, V26, P197; YU G, 1994, J CELL SCI, V107, P1671; Yu XF, 2014, EXP MOL PATHOL, V96, P188, DOI 10.1016/j.yexmp.2014.02.002; Yue JP, 2011, J VIROL, V85, P8477, DOI 10.1128/JVI.02561-10	44	6	9	1	10	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	DEC	2014	54	4					653	663		10.1007/s12031-014-0363-y			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AW0PP	WOS:000345995700007	25060335				2022-02-06	
J	Clausen, F; Lindh, T; Salimi, S; Erlandsson, A				Clausen, Fredrik; Lindh, Tone; Salimi, Shabnam; Erlandsson, Anna			Combination of growth factor treatment and scaffold deposition following traumatic brain injury has only a temporary effect on regeneration	BRAIN RESEARCH			English	Article						Traumatic brain injury; Neural stem cells; Regeneration; Epidermal growth factor; Vascular endothelial factor; Scaffold	CONTROLLED CORTICAL IMPACT; NEURAL STEM-CELLS; CONTUSION INJURY; SPATIAL MEMORY; IN-VIVO; RATS; NEUROGENESIS; LESION; LAMININ; PROLIFERATION	The recovery after traumatic brain injury (TBI) is hampered by the poor regenerative capacity of the brain. Today there is no treatment available that effectively restores lost brain tissue, but much research is focused on the stimulation of endogenous neural stem cells to viably and functionally repopulate the injured parenchyma. It is crucial that the therapies have a proven long-term effect on both regeneration and functional recovery to be clinically interesting. Here we have studied the induction of stem cell activation in rats at three weeks and six weeks after inducing TBI using controlled cortical impact model at a severe setting. We combined intracerebroventricular growth factor and scaffold treatment in order to accomplish an optimal effect on the stem cell regeneration. Immediately after TBI epidermal growth factor infusion with osmotic minipumps was started and continued for seven days. The pumps were removed and an extracellular matrix scaffold containing vascular endothelial growth factor was deposited into the cortical cavity. Three weeks after injury there was a positive effect of the treatment with a significant increase inneuronal and astrocytic regeneration. However, after six weeks there was no difference in the number of newly generated neurons and astrocytes in treated or untreated rats. Evaluation of tissue loss and spatial learning in the Morris water maze corroborated that the treatment had no effect at the later time point. Our results highlight the importance of long-term studies to ensure that a promising effect on tissue regeneration and functional outcome is not only temporary. (C) 2014 Elsevier B.V. All rights reserved.	[Clausen, Fredrik; Lindh, Tone; Salimi, Shabnam; Erlandsson, Anna] Uppsala Univ, Dept Neurosci, Uppsala, Sweden		Erlandsson, A (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	anna.erlandsson@pubcare.uu.se	Salimi, Shabnam/ABD-9552-2020	Salimi, Shabnam/0000-0002-5522-0305; Clausen, Fredrik/0000-0003-3592-4417	Tore Nilssons Foundation; Jeanssons Foundation; Lars Hierta Memorial Foundation; Swedish Society of Medicine [SLS-332271]; Medical Faculty Foundation for Psychological and Neurological Research, Uppsala University	This study was supported by grants from Tore Nilssons Foundation, Jeanssons Foundation, Lars Hierta Memorial Foundation, the Swedish Society of Medicine (Grant number SLS-332271) and the Medical Faculty Foundation for Psychological and Neurological Research, Uppsala University.	Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; Craig CG, 1996, J NEUROSCI, V16, P2649; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Elias P.Z., 2012, J TISSUE ENG REGEN M; Erlandsson A, 2006, CURR OPIN MOL THER, V8, P331; Gibson RM, 2005, MOL CELL NEUROSCI, V28, P588, DOI 10.1016/j.mcn.2004.11.004; Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001; Hall PE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-71; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahmood A, 2011, J NEUROTRAUM, V28, P1199, DOI 10.1089/neu.2010.1694; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Siddiq I., 2012, J NEUROTRAUMA; SINSON G, 1995, J NEUROCHEM, V65, P2209; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223; Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Yao J, 2012, PROTEIN CELL, V3, P251, DOI 10.1007/s13238-012-2033-6; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040	36	6	6	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 7	2014	1588						37	46		10.1016/j.brainres.2014.08.043			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU2SX	WOS:000345468900004	25157904				2022-02-06	
J	Chang, WTW; Badjatia, N				Chang, Wan-Tsu W.; Badjatia, Neeraj			Neurotrauma	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Neurotrauma; Traumatic brain injury; Traumatic spinal cord injury; Neuroprotection; Neurocritical care	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SPINAL-CORD-INJURY; ELEVATED INTRACRANIAL-PRESSURE; SEVERE HEAD-INJURY; LENGTH-OF-STAY; HYPERTONIC SALINE; DECOMPRESSIVE CRANIECTOMY; PERFUSION-PRESSURE; MODERATE HYPOTHERMIA	Neurotrauma continues to be a significant cause of morbidity and mortality. Prevention of primary neurologic injury is a critical public health concern. Early and thorough assessment of the patient with neurotrauma with high index of suspicion of traumatic spinal cord injuries and traumatic vascular injuries requires a multidisciplinary approach involving prehospital providers, emergency physicians, neurosurgeons, and neurointensivists. Critical care management of the patient with neurotrauma is focused on the prevention of secondary injuries. Much research is still needed for potential neuroprotection therapies.	[Chang, Wan-Tsu W.] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA; [Badjatia, Neeraj] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Badjatia, Neeraj] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Badjatia, Neeraj] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA		Badjatia, N (corresponding author), Univ Maryland, Sch Med, Dept Neurol, 22 South Greene St G718, Baltimore, MD 21201 USA.	nbadjatia@som.umaryland.edu	Badjatia, Neeraj/AAS-4855-2021	Badjatia, Neeraj/0000-0003-1509-9034			Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; Al-Tamimi YZ, 2009, NEUROSURGERY, V64, P94, DOI 10.1227/01.NEU.0000328392.98602.5A; Ali B, 2002, EMERG MED J, V19, P552, DOI 10.1136/emj.19.6.552; BERING EA, 1961, AM J PHYSIOL, V200, P417; Bochicchio GV, 2008, AM SURGEON, V74, P267; Bochicchio GV, 2006, JPEN-PARENTER ENTER, V30, P503, DOI 10.1177/0148607106030006503; Bohman LE, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0392-x; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bracken MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001046.pub2; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Center N. S. C. I. S., 2013, SPIN CORD INJ FACTS; Centers for Disease Control and Prevention NC for IP and C, 2013, TRAUM BRAIN INJ STAT; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Dietrich WD, 2011, NEUROTHERAPEUTICS, V8, P229, DOI 10.1007/s13311-011-0035-3; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; Faul M, 2010, TRAUMATIC BRAIN INJU; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; FRESHMAN SP, 1993, J TRAUMA, V35, P344, DOI 10.1097/00005373-199309000-00003; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; Hadley MN, 2013, NEUROSURGERY, V72, P5, DOI 10.1227/NEU.0b013e3182773549; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; HARTL R, 1995, SHOCK, V3, P274; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Hutchinson PJ, 2011, CRIT CARE, V15, pP312, DOI 10.1186/cc9732; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Inoue T, 2014, J NEUROTRAUM, V31, P284, DOI 10.1089/neu.2013.3061; Jalan R, 2004, GASTROENTEROLOGY, V127, P1338, DOI 10.1053/j.gastro.2004.08.005; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; KASSELL NF, 1982, STROKE, V13, P59, DOI 10.1161/01.STR.13.1.59; Kim JT, 2007, ANAESTH INTENS CARE, V35, P20, DOI 10.1177/0310057X0703500102; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1983, J NEUROSURG, V58, P566, DOI 10.3171/jns.1983.58.4.0566; MAXWELL RE, 1971, J NEUROSURG, V34, P477, DOI 10.3171/jns.1971.34.4.0477; McCarthy PJ, 2010, NEUROCRIT CARE, V12, P220, DOI 10.1007/s12028-009-9284-y; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McManus ML, 1998, ANESTHESIOLOGY, V88, P1586, DOI 10.1097/00000542-199806000-00023; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Myburgh J, 2007, NEW ENGL J MED, V357, P874; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Palma L, 2006, J Neurosurg Sci, V50, P63; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Piepmeier J M, 1985, Cent Nerv Syst Trauma, V2, P153; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; Ratilal BO, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004884, 10.1002/14651858.CD004884.pub3]; Rincon F, 2013, J INTENSIVE CARE MED; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robinson N, 2001, EMERG MED J, V18, P453, DOI 10.1136/emj.18.6.453; ROSNER MJ, 1987, NEUROSURGERY, V21, P147, DOI 10.1227/00006123-198708000-00003; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Scalfani MT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.008; Schatzmann C, 1998, ACT NEUR S, V71, P31; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Seder DB, 2012, NEUROCRIT CARE, V17, P4, DOI 10.1007/s12028-012-9753-6; Servadei F, 2002, ACT NEUR S, V81, P81; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Sonabend AM, 2011, NEUROSURGERY, V68, P996, DOI 10.1227/NEU.0b013e3182096d84; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; SYDENHAM E, 2009, COCHRANE DATABASE SY; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Thenuwara K, 2002, ANESTHESIOLOGY, V96, P416, DOI 10.1097/00000542-200202000-00029; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wang LC, 2013, ANESTHESIOLOGY, V118, P903, DOI 10.1097/ALN.0b013e31828156ff; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Zabramski JM, 2003, J NEUROSURG, V98, P725, DOI 10.3171/jns.2003.98.4.0725	99	6	6	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	NOV	2014	32	4					889	+		10.1016/j.emc.2014.07.008			18	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AT3EY	WOS:000344820000012	25441041				2022-02-06	
J	Jin, XL; Wang, FF; Liu, XJ; Liang, B; Chen, ZQ; He, JF; Zhang, H; Zhang, JN				Jin, Xuelong; Wang, Feifei; Liu, Xingju; Liang, Bin; Chen, Zequn; He, Junfeng; Zhang, Hong; Zhang, Jianning			Negative Correlation of CD34(+) Cells with Blood-Brain Barrier Permeability following Traumatic Brain Injury in a Rat Model	MICROCIRCULATION			English	Article						CD34(+) cells; endothelial barrier antigen; blood-brain barrier; traumatic brain injury	ENDOTHELIAL PROGENITOR CELLS; UMBILICAL-CORD BLOOD; GROWTH-FACTOR; QUANTITATIVE-ANALYSIS; NEUROVASCULAR INJURY; CEREBRAL-ISCHEMIA; ANGIOGENESIS; EXPRESSION; BREAKDOWN; ANTIGEN	ObjectiveTBI causes localized cerebral ischemia that, in turn, is accompanied by both changes in BBB permeability and recruitment of CD34(+) cells to the injured tissue. However, it remains unknown whether CD34(+) cell recruitment is linked to BBB permeability. This study is a preliminary investigation into possible correlations between CD34(+) cell recruitment and BBB permeability following TBI in a rat model. MethodsMale SD rats were subjected to mild fluid percussion injury. BBB permeability was assessed by measuring extrinsic EB dye extravasation and endogenous EBA expression at days 1, 3, 5, 7, and 12 post injury. The number of CD34(+) cells in the damaged tissue was analyzed by immunohistochemistry at each time point. ResultsEB dye extravasation reached a peak at day 3 following TBI, while EBA expression displayed the reverse profile. Accumulation of CD34(+) cells in injured brain tissue was evident at five days post injury. It revealed a negative linear correlation between CD34(+) cell and BBB permeability. ConclusionsThe negative linear correlation between CD34(+) cell recruitment and BBB permeability following TBI provides a support for further study of CD34(+) cell transplantation for BBB repair after TBI.	[Jin, Xuelong; Wang, Feifei; Liu, Xingju; Liang, Bin; Chen, Zequn] Tianjin Med Univ, Dept Physiol, Tianjin 300070, Peoples R China; [He, Junfeng] Hunan Univ Chinese Med, Affiliated Hosp, Liuyang Hosp Tradit Chinese Med, Liuyang, Peoples R China; [Zhang, Hong] Tianjin Chest Hosp, Dept Radiol, Tianjin, Peoples R China; [Zhang, Jianning] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China		Jin, XL (corresponding author), Tianjin Med Univ, Dept Physiol, Tianjin 300070, Peoples R China.	econversation@163.com			International Science & Technology Cooperation Program of China, Ministry of Science and Technology of the People's Republic of China [2011DFA30550]	This research was supported by International Science & Technology Cooperation Program of China, Ministry of Science and Technology of the People's Republic of China (No. 2011DFA30550). The authors thank Neurological Institute of Tianjin Medical University for equipment assistance.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Chen SH, 2014, CELL TRANSPLANT, V23, P959, DOI 10.3727/096368913X667006; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Fei-Fei W, 2013, J TIANJIN MED U, V19, P13; Ghabriel MN, 2002, BRAIN RES, V934, P140, DOI 10.1016/S0006-8993(02)02416-2; Gong D, 2011, J TRAUMA, V70, P1480, DOI 10.1097/TA.0b013e31821ac9e1; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Kaya M, 2004, BRAIN RES, V1019, P105, DOI 10.1016/j.brainres.2004.05.102; Lamping K, 2007, CIRC RES, V100, P1243, DOI 10.1161/01.RES.0000268193.46418.d1; Lee SW, 2009, INT J MOL MED, V23, P279, DOI 10.3892/ijmm_00000128; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Liu HY, 2006, CHINESE MED J-PEKING, V119, P1744, DOI 10.1097/00029330-200610020-00013; Lu AG, 2008, EXP NEUROL, V210, P549, DOI 10.1016/j.expneurol.2007.12.003; Maolood N, 2009, J CHEM NEUROANAT, V37, P182, DOI 10.1016/j.jchemneu.2008.12.007; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Norsted E, 2008, J CHEM NEUROANAT, V36, P107, DOI 10.1016/j.jchemneu.2008.06.002; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Omura K, 2004, BRAIN RES, V1001, P13, DOI 10.1016/j.brainres.2003.10.067; Ou YL, 2010, BRAIN RES, V1366, P217, DOI 10.1016/j.brainres.2010.09.098; Pelz J, 2013, EUR J HISTOCHEM, V57, P255, DOI 10.4081/ejh.2013.e38; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Saubamea B, 2012, J CEREBR BLOOD F MET, V32, P81, DOI 10.1038/jcbfm.2011.109; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; STERNBERGER NH, 1987, P NATL ACAD SCI USA, V84, P8169, DOI 10.1073/pnas.84.22.8169; Suofu Y, 2010, J NEUROCHEM, V115, P1266, DOI 10.1111/j.1471-4159.2010.07026.x; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Taguchi A, 2011, PSYCHOGERIATRICS, V11, P113, DOI 10.1111/j.1479-8301.2010.00343.x; Tei K, 2008, STEM CELLS, V26, P819, DOI 10.1634/stemcells.2007-0671; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035	36	6	6	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1073-9688	1549-8719		MICROCIRCULATION	Microcirculation	NOV	2014	21	8					696	702		10.1111/micc.12150			7	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	AT2TQ	WOS:000344789400003	24894113				2022-02-06	
J	Kim, BC; Lee, JI; Cho, WH; Nam, KH				Kim, Byung Chul; Lee, Jae Il; Cho, Won Ho; Nam, Kyoung Hyup			Fatal Traumatic Subarachnoid Hemorrhage due to Acute Rebleeding of a Pseudoaneurysm Arising from the Distal Basilar Artery	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Traumatic brain injury; Subarachnoid hemorrhage; Basilar artery; Pseudoaneurysm	ANEURYSM; FISTULA	Isolated traumatic pseudoaneurysms of the basilar artery are extremely rare but often fatal resulting in a mortality rate as high as 50%. A 51-year-old man presented with craniofacial injury after blunt trauma. A brain computed tomography (CT) scan showed thick basal subarachnoid hemorrhage associated with multiple craniofacial fractures, while CT angiography revealed contrast extravasation at the distal basilar artery with pseudoaneurysm formation. After this primary survey, the condition of the patient suddenly deteriorated. Conventional angiography confirmed the contrast extravasation resulted from pseudoaneurysm formation, which was successfully treated with endovascular coil embolization. Decompressive craniectomy and coma therapy with propofol were also performed. However, the patient died on the 7th hospital day because of the poor initial clinical condition. The current case is the first report of acute pseudoaneurysm rupture arising from the basilar artery within the first day after trauma. Our findings suggest the possibility that pseudoaneurysm rupture should be considered if brain CT shows thick traumatic subarachnoid hemorrhage on the basal cistern with a basal skull fracture.	[Kim, Byung Chul; Lee, Jae Il; Cho, Won Ho; Nam, Kyoung Hyup] Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Neurosurg,Med Res Inst, Pusan 602739, South Korea		Nam, KH (corresponding author), Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Neurosurg,Med Res Inst, 179 Gudeok Ro, Pusan 602739, South Korea.	namdark@daum.net			Pusan National University HospitalPusan National University	This study was supported by clinical research grant (2013), Pusan National University Hospital.	BANK WO, 1978, AM J ROENTGENOL, V130, P975, DOI 10.2214/ajr.130.5.975; Connor SEJ, 2001, NEURORADIOLOGY, V43, P249, DOI 10.1007/s002340000466; FELDGES A, 1989, INTENS CARE MED, V15, P400; Ko JK, 2011, J KOREAN NEUROSURG S, V50, P48, DOI 10.3340/jkns.2011.50.1.48; Loevner LA, 1998, AM J NEURORADIOL, V19, P386; McElroy KM, 2008, AM J PHYS MED REHAB, V87, P690, DOI 10.1097/PHM.0b013e31817fbaea; Ong CK, 2010, J CLIN NEUROSCI, V17, P515, DOI 10.1016/j.jocn.2009.06.041; Quintana F, 1996, AM J NEURORADIOL, V17, P283; Teitelbaum GP, 1998, NEUROSURGERY, V42, P1394, DOI 10.1097/00006123-199806000-00134	9	6	6	0	4	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2014	56	5					428	430		10.3340/jkns.2014.56.5.428			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AW9AQ	WOS:000346550600011	25535522	gold, Green Submitted, Green Published			2022-02-06	
J	Malish, RG; Arnett, AD; Place, RJ				Malish, Richard G.; Arnett, Anthony D.; Place, Ronald J.			Returning to Duty from Temporary Disability in the US Army: Observational Data and Commentary for Commanders, Providers, and Soldiers	MILITARY MEDICINE			English	Article							RISK-FACTORS; U.S. ARMY	Before 2011, Army commanders were unable to achieve complete visibility of soldiers possessing temporary medical limitations. The creation of time-limited definitions and technical categorization of this group, now known as the medically not ready (MNR) population, eventually allowed its quantification. With heightened visibility of the group, leaders in the Fort Stewart community facilitated its management through soldier medical readiness councils. In this commentary, we introduce a project that identified and tracked a cohort of 2,490 MNR soldiers for a 1-year period until they either recovered or entered the medical separation process. We identified that musculoskeletal injuries accounted for a heretofore unrecognized 87.4% majority of the MNR population. Prognosis of the MNR population was generally good. Fifty percent of the population returned to duty within 90 days of illness/injury. Seventy-seven percent returned to duty during the follow-up period. Although low back and knee/leg injuries were the largest contributors to the MNR population, low back issues were more likely to result in medical separation. Traumatic brain injury and post-traumatic stress disorder did not contribute significantly to the MNR population. This article seeks to describe the natural history of the MNR category of temporary disability for commanders, providers, and soldiers alike.	[Malish, Richard G.; Arnett, Anthony D.; Place, Ronald J.] Winn Army Community Hosp, Ft Stewart, GA 31314 USA		Malish, RG (corresponding author), Winn Army Community Hosp, 1061 Harmon Ave, Ft Stewart, GA 31314 USA.						Amoroso P J, 1999, Mil Med, V164, P1; Bell NS, 2008, DISABIL HEALTH J, V1, P14, DOI 10.1016/j.dhjo.2007.11.007; Gubata ME, 2013, MIL MED, V178, P708, DOI 10.7205/MILMED-D-12-00542; Lincoln Andrew E, 2002, Work, V18, P99; Malish RG, 2013, MIL MED, V178, P715, DOI 10.7205/MILMED-D-13-00003; Niebuhr DW, 2011, MIL MED, V176, P170, DOI 10.7205/MILMED-D-10-00114; Sikorski C, 2012, MIL MED, V177, P128, DOI 10.7205/MILMED-D-11-00250	7	6	6	0	4	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV	2014	179	11					1190	1197		10.7205/MILMED-D-14-00131			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7LK	WOS:000349098600009	25373040	Bronze			2022-02-06	
J	Mo, J; Marshall, B; Covar, J; Zhang, NY; Smith, SB; Atherton, SS; Zhang, M				Mo, Juan; Marshall, Brendan; Covar, Jason; Zhang, Nancy Y.; Smith, Sylvia B.; Atherton, Sally S.; Zhang, Ming			Role of Bax in Death of Uninfected Retinal Cells During Murine Cytomegalovirus Retinitis	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						murine cytomegalovirus; retinitis; apoptosis; Bax	APOPTOSIS-INDUCING FACTOR; NECROSIS-FACTOR-ALPHA; MITOCHONDRIAL OUTER-MEMBRANE; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; BCL-2 FAMILY PROTEINS; FACTOR AIF; POLY(ADP-RIBOSE) POLYMERASE-1; NATURAL-HISTORY; RIP1 KINASE	PURPOSE. Extensive death of uninfected bystander neuronal cells is an important component of the pathogenesis of cytomegalovirus retinitis. Our previous results have shown that caspase 3-dependent and -independent pathways are involved in death of uninfected bystander cells during murine cytomegalovirus (MCMV) retinitis and also that Bcl-2, an important inhibitor of apoptosis via the Bax-mediated mitochondrial pathway, is downregulated during this process. The purpose of this study was to determine whether Bax-mediated mitochondrial damage has a significant role in the death of uninfected retinal cells. METHODS. BALB/c mice, Bax(-)/(-) mice, or Bax(+/+) mice were immunosuppressed with methylprednisolone and infected with 5 x 10(3) plaque-forming units (PFU) of the K181 strain of MCMV via the supraciliary route. Injected eyes were analyzed by plaque assay, electron microscopy, hematoxylin and eosin (H&E) staining, TUNEL assay, Western blot (for caspase 3, caspase 12, Bax, receptor interacting protein-1 [RIP1] and receptor interacting protein-3 [RIP3]), as well as immunohistochemical staining for MCMV early antigen and cleaved caspase 3. RESULTS. Significantly more Bax was detected in mitochondrial fractions of MCMV-infected eyes than in mitochondrial fractions of mock-infected control eyes. Furthermore, the level of cleaved caspase 3 was significantly lower in MCMV-infected Bax(-)/(-) eyes than in MCMV-infected Bax(+/+) eyes. However, more caspase 3-independent cell death of uninfected bystander retinal cells and more cleaved RIP1 were observed in Bax(-)/(-) than in Bax(+/+) eyes. CONCLUSIONS. During MCMV retinitis, Bax is activated and has an important role in death of uninfected bystander retinal cells by caspase 3-dependent apoptosis. Although the exact mechanism remains to be deciphered, active Bax might also prevent death of some types of uninfected retinal cells by a caspase 3-independent pathway.	[Mo, Juan; Marshall, Brendan; Covar, Jason; Zhang, Nancy Y.; Smith, Sylvia B.; Atherton, Sally S.; Zhang, Ming] Georgia Regents Univ, Dept Cellular Biol & Anat, Med Coll Georgia, Augusta, GA 30912 USA; [Smith, Sylvia B.] Georgia Regents Univ, Dept Ophthalmol, Med Coll Georgia, Augusta, GA 30912 USA; [Smith, Sylvia B.; Atherton, Sally S.; Zhang, Ming] Georgia Regents Univ, James & Jean Culver Vis Discovery Inst, Med Coll Georgia, Augusta, GA 30912 USA		Zhang, M (corresponding author), Georgia Regents Univ, Dept Cellular Biol & Anat, R&E Bldg,Room CB2815, Augusta, GA 30912 USA.	mzhang@gru.edu		Zhang, Ming/0000-0002-4012-3932; Mo, Juan/0000-0002-7655-7521	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY009169]; Retinal Research Foundation; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY009169] Funding Source: NIH RePORTER	Supported by National Institutes of Health Grant EY009169 and the Retinal Research Foundation.	Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; Arnoult D, 2008, APOPTOSIS, V13, P1100, DOI 10.1007/s10495-008-0245-2; ATHERTON SS, 1992, INVEST OPHTH VIS SCI, V33, P3353; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bigger JE, 2000, INVEST OPHTH VIS SCI, V41, P2248; Braithwaite RS, 2008, ANN INTERN MED, V148, P178, DOI 10.7326/0003-4819-148-3-200802050-00004; Brooks C, 2007, CELL CYCLE, V6, P3043, DOI 10.4161/cc.6.24.5115; Buggage RR, 2000, CURR EYE RES, V21, P721, DOI 10.1076/0271-3683(200009)21:3;1-R;FT721; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Chien H, 2012, J VIROL, V86, P10961, DOI 10.1128/JVI.01275-12; Chiou SH, 2002, OPHTHALMIC RES, V34, P77, DOI 10.1159/000048332; Chiou SH, 2001, J IMMUNOL, V167, P4098, DOI 10.4049/jimmunol.167.7.4098; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; COHEN J, 1995, SCIENCE, V268, P368, DOI 10.1126/science.7716538; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Dix RD, 2004, CURR EYE RES, V29, P173, DOI 10.1080/02713680490504876; DREW WL, 1992, CLIN INFECT DIS, V14, P608, DOI 10.1093/clinids/14.2.608-a; DUAN YP, 1994, INVEST OPHTH VIS SCI, V35, P1124; DUERKSENHUGHES PJ, 1991, J VIROL, V65, P1236, DOI 10.1128/JVI.65.3.1236-1244.1991; Ebermann L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003062; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Galluzzi L, 2014, SEMIN CELL DEV BIOL, V35, P24, DOI 10.1016/j.semcdb.2014.02.006; Gillies LA, 2014, J CELL BIOCHEM, V115, P632, DOI 10.1002/jcb.24709; Hagberg H, 2004, J NEUROCHEM, V90, P1068, DOI 10.1111/j.1471-4159.2004.02547.x; Handke W, 2012, MED MICROBIOL IMMUN, V201, P475, DOI 10.1007/s00430-012-0264-z; Hisatomi T, 2008, J CLIN INVEST, V118, P2025, DOI 10.1172/JCI34267; Holtzer CD, 1998, AIDS, V12, P1931; ISTAS AS, 1995, CLIN INFECT DIS, V20, P665, DOI 10.1093/clinids/20.3.665; Jabs D A, 1995, Trans Am Ophthalmol Soc, V93, P623; Jabs DA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1143, DOI 10.1001/archopht.126.8.1143; Jabs DA, 2007, OPHTHALMOLOGY, V114, P780, DOI 10.1016/j.ophtha.2006.11.008; Jacobson MA, 2000, CLIN INFECT DIS, V30, P231, DOI 10.1086/313612; Jurak I, 2008, J VIROL, V82, P4812, DOI 10.1128/JVI.02570-07; Li XL, 2010, J NEUROCHEM, V113, P1012, DOI 10.1111/j.1471-4159.2010.06667.x; Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2; Mandir AS, 2000, J NEUROSCI, V20, P8005; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Manzur M, 2009, CELL DEATH DIFFER, V16, P312, DOI 10.1038/cdd.2008.152; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Norris KL, 2008, J VIROL, V82, P6232, DOI 10.1128/JVI.02710-07; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Osato K, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.63; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Renault TT, 2013, INT J BIOCHEM CELL B, V45, P64, DOI 10.1016/j.biocel.2012.09.022; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Sarnaik AA, 2010, J NEUROTRAUM, V27, P465, DOI 10.1089/neu.2009.1171; Shouse R. L., 2009, Morbidity and Mortality Weekly Report, V58, P661; Su F, 1997, P NATL ACAD SCI USA, V94, P8744, DOI 10.1073/pnas.94.16.8744; Thal SE, 2011, NEUROSCI LETT, V499, P1, DOI 10.1016/j.neulet.2011.05.016; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Wang YF, 2009, J NEUROCHEM, V110, P687, DOI 10.1111/j.1471-4159.2009.06167.x; Wei Q, 2007, KIDNEY INT, V72, P53, DOI 10.1038/sj.ki.5002256; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200; Zhang M, 2005, INVEST OPHTH VIS SCI, V46, P2047, DOI 10.1167/iovs.05-0005; Zhang M, 2002, J CLIN VIROL, V25, pS137; Zhang M, 2008, INVEST OPHTH VIS SCI, V49, P295, DOI 10.1167/iovs.07-0612; Zhang M, 2007, INVEST OPHTH VIS SCI, V48, P285, DOI 10.1167/iovs.06-0792; Zhang M, 2011, INVEST OPHTH VIS SCI, V52, P1800, DOI 10.1167/iovs.10-6904; Zhou CJ, 2012, J CELL PHYSIOL, V227, P3778, DOI 10.1002/jcp.24086; Zhou J, 2007, INVEST OPHTH VIS SCI, V48, P1691, DOI 10.1167/iovs.06-1040; Zhu C, 2007, CELL DEATH DIFFER, V14, P775, DOI 10.1038/sj.cdd.4402053; Zhu CL, 2003, J NEUROCHEM, V86, P306, DOI 10.1046/j.1471-4159.2003.01832.x	69	6	7	0	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	NOV	2014	55	11					7137	7146		10.1167/iovs.14-15404			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	AX9IR	WOS:000347217300014	25298417	Green Published			2022-02-06	
J	Shokouhi, G; Haghjoo, AG; Sattarnezhad, N; Asghari, M; Sattarnezhad, A; Asghari, A; Pezeshki, A				Shokouhi, Ghaffar; Haghjoo, Amir Ghorbani; Sattarnezhad, Neda; Asghari, Mohammad; Sattarnezhad, Aida; Asghari, Ali; Pezeshki, Arastoo			Effects of citicoline on level of consciousness, serum level of fetuin-A and matrix Gla-protein (MGP) in trauma patients with diffuse axonal injury (DAI) and GCS <= 8	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Citicoline; GCS; fetuin-A; level of consciousness; matrix Gla protein; traumatic brain injury	C-REACTIVE PROTEIN; BRAIN-INJURY; ENDOTHELIAL-CELLS; CALCIFICATION; ANGIOGENESIS; STROKE; EXPRESSION; MORTALITY; INFARCTION; MANAGEMENT	BACKGROUND: Citicoline, a neuroprotective drug, has been suggested to improve level of consciousness, mitigating secondary to brain damage and ectopic vascular calcification, following post-traumatic neurogenesis and angiogenesis, inducing calcification modulators, like fetuin-A and matrix Gla-protein (MGP). This study aimed to investigate effects of citicoline on levels of consciousness, serum levels of fetuin-A and MGP in patients with severe traumatic brain injury. METHODS: This double blind randomized controlled trial (RCT) was conducted on patients with diagnosis of diffuse axonal injury (DAI) and GCS <= 8. The cases were treated with citicoline (500 mg every 6 hours) intravenously for fifteen days. Daily GCS assessment and intermittent blood sampling were done for both cases and controls. RESULTS: Fifty-eight patients were included in the study and during the study period, mean GCS levels improved in both groups; however, the difference was inconsiderable (p > 0.05). Serum levels of fetuin-A, a negative phase reactant, increased in the group treated with citicoline (p = 0.012), while these changes were insignificant for the controls (p = 0.455). Serum levels of MGP, a calcification inhibitor, increased in the cases (p = 0.046). The alterations were inconsequential in the control group (p = 0.405). CONCLUSION: The findings of this study suggest neutral effects of citicoline on level of consciousness and GCS. Through increasing levels of fetuin-A and MGP, citicoline may have protective effects against inflammatory damage and vascular calcification secondary to head trauma.	[Shokouhi, Ghaffar; Sattarnezhad, Neda; Asghari, Mohammad; Asghari, Ali; Pezeshki, Arastoo] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz 51664, Iran; [Haghjoo, Amir Ghorbani] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz 51664, Iran; [Sattarnezhad, Aida] Eastern Mediterranean Univ, Dept Pharm, Gazimagusa, Cyprus		Sattarnezhad, N (corresponding author), Tabriz Univ Med Sci, Neurosci Res Ctr, Golgasht St,Daneshgah St, Tabriz 51664, Iran.	n.sattarnejad@gmail.com	Oskouei, Neda Sattarnezhad/U-6133-2019; Jafarabadi, Mohammmad Asghari/A-7478-2017; Tabrizi, Ghaffar Shokouhi/L-6326-2017	Jafarabadi, Mohammmad Asghari/0000-0003-3284-9749; Tabrizi, Ghaffar Shokouhi/0000-0001-5081-9928	Iran's National Elites Foundation; Neuroscience Research Center, Tabriz University of Medical Sciences, Tabriz, Iran	This research project was funded by Iran's National Elites Foundation and supported by Neuroscience Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.	Aghakhani N, 2013, IRAN RED CRESCENT ME, V15, P173, DOI 10.5812/ircmj.2090; Aniruddha TJ, 2009, INDIAN J NEUROTRAUM, V6, P49; Bajracharya A, 2010, J NEUROSCI RURAL PRA, V1, P2, DOI 10.4103/0976-3147.63092; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Boraldi F, 2013, BBA-MOL BASIS DIS, V1832, P2077, DOI 10.1016/j.bbadis.2013.07.017; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Cassidy-Bushrow AE, 2013, ARTERIOSCL THROM VAS, V33, P645, DOI 10.1161/ATVBAHA.112.300491; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Chopp M, 2008, ACTA NEUROCHIR SUPPL, V105, P79; Clark WM, 2009, EXPERT OPIN PHARMACO, V10, P839, DOI [10.1517/14656560902765652, 10.1517/17460440902835475 ]; Clark WM, 1997, NEUROLOGY, V49, P671, DOI 10.1212/WNL.49.3.671; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Clauss RP, 2000, S AFR MED J, V90, P68; Cola C, 2004, BIOCHEM BIOPH RES CO, V320, P424, DOI 10.1016/j.bbrc.2004.05.181; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; Cranenburg ECM, 2008, J VASC RES, V45, P427, DOI 10.1159/000124863; Davalos A, 2011, STROKE, V42, pS36, DOI 10.1161/STROKEAHA.110.605568; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Dempsey RJ, 2003, J NEUROSURG, V98, P867, DOI 10.3171/jns.2003.98.4.0867; Endang W, 2004, FOLIA MED INDONESIAN, V40, P43; Firooz S, 2012, J INJURY VIOLENCE S1, V4; Garcia-Cobos R, 2010, J NEUROL SCI, V299, P188, DOI 10.1016/j.jns.2010.08.027; Goldstein LB, 2012, STROKE, V43, P3433, DOI 10.1161/STROKEAHA.112.669200; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Hurtado O, 2005, NEUROBIOL DIS, V18, P336, DOI 10.1016/j.nbd.2004.10.006; Hurtado O, 2011, STROKE, V42, pS33, DOI 10.1161/STROKEAHA.110.597435; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje; Ketteler M, 2002, BLOOD PURIFICAT, V20, P473, DOI 10.1159/000063554; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Khavandgar Z, 2014, J BONE MINER RES, V29, P327, DOI 10.1002/jbmr.2039; Krupinski J, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-20; Lazowski T, 2003, CRITICAL CARE, V7, P1; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lim P, 2013, AM J CARDIOL, V111, P31, DOI 10.1016/j.amjcard.2012.08.042; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Majidi S, 2013, AM J EMERG MED, V31, P1215, DOI 10.1016/j.ajem.2013.05.026; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Martynov M.Y., 2013, NEUROSCIENCE BEHAV P, V43, P706, DOI 10.1007/s11055-013-9797-x; Mendelow AD, 2005, HEAD INJURY PATHOPHY, P73; Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006; Oncu K, 2013, DIGEST DIS SCI, V58, P3212, DOI 10.1007/s10620-013-2814-7; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Rocamonde B, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/521939; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schurgers LJ, 2008, THROMB HAEMOSTASIS, V100, P593, DOI 10.1160/TH08-02-0087; Segun TD, 2011, MEDSCAPE REFERENCE D; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Shin V, 2004, J VASC RES, V41, P193, DOI 10.1159/000077394; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Tanriverdi MH, 2014, NEUROL SCI, V35, P271, DOI 10.1007/s10072-013-1504-8; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xie Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054507; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yang H, 2002, J ENDOTOXIN RES, V8, P469, DOI 10.1179/096805102125001091; Yucel N, 2006, NEUROCHEM RES, V31, P767, DOI 10.1007/s11064-006-9075-1; Zargar Moosa, 2004, Indian J Med Sci, V58, P109; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	63	6	7	0	4	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	NOV	2014	20	6					410	416		10.5505/tjtes.2014.05769			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AW2OS	WOS:000346128500003	25541919	Bronze			2022-02-06	
J	Wen, L; Xu, J; Zhan, TX; Wang, H; Huang, X; Liu, WC; Yang, XF; Zhan, RY				Wen, Liang; Xu, Jun; Zhan, Tianxiang; Wang, Hao; Huang, Xin; Liu, Wenchao; Yang, Xiaofeng; Zhan, Renya			The occurrence of diffuse axonal injury in the brain: associated with the accumulation and clearance of myelin debris	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; neurodegeneration; diffuse axonal injury; myelin debris; neuroinflammation; traumatic brain injury; head trauma; central nervous system; inflammation; axon; prognosis; NSFC grants; neural regeneration	INFLAMMATORY RESPONSE; WALLERIAN DEGENERATION; MULTIPLE-SCLEROSIS; HEAD-INJURY; MODEL	The accumulation of myelin debris may be a major contributor to the inflammatory response after diffuse axonal injury. In this study, we examined the accumulation and clearance of myelin debris in a rat model of diffuse axonal injury. Oil Red O staining was performed on sections from the cerebral cortex, hippocampus and brain stem to identify the myelin debris. Seven days after diffuse axonal injury, many Oil Red O-stained particles were observed in the cerebral cortex, hippocampus and brain stem. In the cerebral cortex and hippocampus, the amount of myelin debris peaked at 14 days after injury, and decreased significantly at 28 days. In the brain stem, the amount of myelin debris peaked at 7 days after injury, and decreased significantly at 14 and 28 days. In the cortex and hippocampus, some myelin debris could still be observed at 28 days after diffuse axonal injury. Our findings suggest that myelin debris may persist in the rat central nervous system after diffuse axonal injury, which would hinder recovery.	[Wen, Liang; Xu, Jun; Zhan, Tianxiang; Wang, Hao; Huang, Xin; Liu, Wenchao; Yang, Xiaofeng; Zhan, Renya] Zhejiang Univ, Affiliated Hosp 1, Dept Neurosurg, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Neurosurg, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	jediwen@163.com; zhanry1960@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81200955, 81271357]	This work was supported by the National Natural Science Foundation of China, No. 81200955, 81271357.	Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; David Samuel, 2012, Handb Clin Neurol, V109, P485, DOI 10.1016/B978-0-444-52137-8.00030-9; Dubovy P, 2013, INT REV NEUROBIOL, V108, P173, DOI 10.1016/B978-0-12-410499-0.00007-1; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Jiang J, 2006, ZHONGHUA SHENJING WA, V22, P645; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kwon HG, 2012, NEURAL REGEN RES, V7, P475, DOI 10.3969/j.issn.1673-5374.2012.06.012; Langham J, 2000, COCHRANE DB SYST REV; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Ma MH, 2002, J NEUROSCI RES, V68, P691, DOI 10.1002/jnr.10269; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pillai SV, 2003, NEUROL INDIA, V51, P361; Plemel JR, 2013, GLIA, V61, P1471, DOI 10.1002/glia.22535; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Rawji KS, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/948976; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Vallieres N, 2006, GLIA, V53, P103, DOI 10.1002/glia.20266; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	32	6	6	2	19	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	NOV	2014	9	21					1902	1906		10.4103/1673-5374.145358			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AW5OT	WOS:000346324900011	25558240	gold, Green Submitted, Green Published			2022-02-06	
J	Wu, H; Yang, SF; Qiu, YM; Dai, J; Li, SQ; Zhang, XH; Miao, YF				Wu, Hui; Yang, Shao-Feng; Qiu, Yong-Ming; Dai, Jiong; Li, Shan-Quan; Zhang, Xiao-Hua; Miao, Yi-Feng			The Diagnosis and Surgical Treatment of Central Brain Herniations Caused by Traumatic Bifrontal Contusions	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Traumatic brain injury; central brain herniation; traumatic bifrontal contusions; decompressive craniectomy	INJURY; SECONDARY	The objective of this study was to investigate the diagnosis and surgical treatment of central brain herniations caused by traumatic bifrontal contusions. A total of 63 patients (45 men and 18 women; mean age of 43 years with a range from 20 to 72 years) who suffered from traumatic bifrontal contusions between January 2007 and December 2012 were inspected. The clinical and imaging results were studied for all patients, and we found that swelling of the mesencephalon and a downward shift of the bilateral red nucleus were significant signs of central brain herniation in the image of magnetic resonance imaging. All patients were given a simultaneous bilateral craniotomy for balanced decompressive surgery. The Glasgow Outcome Scale was used to monitor the patients during the follow-up period, which lasted from 6 to 52 months with a mean of 22 months. At the termination of the follow-up period, the following Glasgow Outcome Scale scores were obtained: 14 patients scored 5 points, 22 patients scored 4 points, 7 patients scored 3 points, 13 patients scored 2 points, and 7 patients scored 1 point. Therefore, our study suggested that an early magnetic resonance imaging scan could result in a more timely diagnosis of central brain herniation, and simultaneous bilateral craniotomy was found to be one of the best treatments for central brain herniation to improve patient outcomes.	[Wu, Hui; Yang, Shao-Feng; Qiu, Yong-Ming; Dai, Jiong; Li, Shan-Quan; Zhang, Xiao-Hua; Miao, Yi-Feng] Shanghai Jiao Tong Univ, Dept Neurosurg, Ren Ji Hosp, Sch Med, Shanghai 201112, Peoples R China		Zhang, XH (corresponding author), Shanghai Jiao Tong Univ, Dept Neurosurg, Ren Ji Hosp, Sch Med, Shanghai 201112, Peoples R China.	zxh1969@aliyun.com; yifengmwx@hotmail.com			National Nature Science FoundationNational Natural Science Foundation of China (NSFC) [81000498]	Supported by the National Nature Science Foundation (no. 81000498).	HANNA JP, 1995, NEUROLOGY, V45, P985, DOI 10.1212/WNL.45.5.985; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; King AP, 2009, NEUROIMAGE, V47, P872, DOI 10.1016/j.neuroimage.2009.05.088; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; Morey RA, 2009, J PSYCHIATR RES, V43, P809, DOI 10.1016/j.jpsychires.2008.10.014; Motohashi O, 2000, No To Shinkei, V52, P833; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Ratnaike TE, 2011, BRIT J NEUROSURG, V25, P410, DOI 10.3109/02688697.2010.548879; Rehman Tausif, 2008, Cases J, V1, P203, DOI 10.1186/1757-1626-1-203; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Sekula RF, 2006, J NEUROSURG, V105, P472, DOI 10.3171/jns.2006.105.3.472; Shrier DA, 1999, AM J NEURORADIOL, V20, P1885; Siddqui AA, 2001, SURG NEUROL, V56, P42, DOI 10.1016/S0090-3019(01)00505-5; Strowitzki M, 2001, PEDIATR NEUROSURG, V35, P1, DOI 10.1159/000050377; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; Yamahata H, 2011, J CRANIO MAXILL SURG, V39, P624, DOI 10.1016/j.jcms.2010.11.014	18	6	6	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	NOV	2014	25	6					2105	2108		10.1097/SCS.0000000000001050			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AT5XB	WOS:000345012000070	25304144				2022-02-06	
J	Lin, J; German, M; Wong, B				Lin, Jonathan; German, Michael; Wong, Brian			Use of Copolymer Polylactic and Polyglycolic Acid Resorbable Plates in Repair of Orbital Floor Fractures	FACIAL PLASTIC SURGERY			English	Article						implant; orbital; PLLA/PGA; LactoSorb; resorbable	BLOW-OUT FRACTURE; MESH PLATE; RECONSTRUCTION; SURGERY; COMPLICATIONS; MANAGEMENT; LACTOSORB; FIXATION	The fractures of the orbital floor are common after craniofacial trauma. Repair with resorbable plates is a viable reconstructive option; however, there are few reports in the literature. This study describes our experience using copolymer polylactic and polyglycolic acid (PLLA/PGA) orbital reconstruction plates (LactoSorb, Lorenz Surgical, Jacksonville, FL) in 29 cases of the orbital floor fracture repair. We conducted a retrospective review of 29 orbital floor fractures at a single institution repaired through transconjunctival, preseptal dissection using PLLA/PGA plates fashioned to repair the orbital floor defect. Associated fractures included zygomaticomaxillary, LeFort, and nasoethmoid fractures. There were six patients with complications. Four patients had transient diplopia with complete resolution of symptoms within 1 year. One patient had diplopia postoperatively, but was later lost to follow-up. Two patients have had persistent enophthalmos since 1 year. In each of these cases, the floor fracture was coincident with significant panfacial or neurotrauma. We did not encounter any adverse inflammatory reactions to the implant material itself. The study concluded that orbital floor fracture repair with resorbable plates is safe, relatively easy to perform, and in the majority of cases was effective without complications. In the presence of severe orbital trauma, more rigid implant materials may be appropriate.	[Lin, Jonathan; Wong, Brian] Univ Calif Irvine, Irvine Sch Med, Dept Otolaryngol Head & Neck Surg, Irvine, CA 92617 USA; [German, Michael] Cent Coast Head & Neck Surg, Dept Otolaryngol Head & Neck Surg, St Monterey, CA USA; [Wong, Brian] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Dept Otolaryngol Head & Neck Surg, Irvine, CA 92617 USA		Wong, B (corresponding author), Univ Calif Irvine, Beckman Laser Inst & Med Clin, 1002 Hlth Sci Rd E, Irvine, CA 92617 USA.	bjwong@uci.edu					Alinasab B, 2014, INJURY, V45, P197, DOI 10.1016/j.injury.2012.09.009; [Anonymous], OPHTHALMOLOGY; [Anonymous], J ORAL MAXILLOFAC SU; Baser NT, 2011, ULUS TRAVMA ACIL CER, V17, P545, DOI 10.5505/tjtes.2011.47135; Brucoli M, 2011, J CRANIOFAC SURG, V22, P1387, DOI 10.1097/SCS.0b013e31821cc317; Burnstine MA, 2002, OPHTHALMOLOGY, V109, P1207, DOI 10.1016/S0161-6420(02)01057-6; Burnstine MA, OPHTHALMOLOGY, P1212; Celikoz B, 1997, J ORAL MAXIL SURG, V55, P240; Chowdhury K, 1998, ARCH OTOLARYNGOL, V124, P1398, DOI 10.1001/archotol.124.12.1398; Clodius LB, 2002, LEATHERBARROW OCULOP, P156; Enislidis G, 1997, J CRANIO MAXILL SURG, V25, P316, DOI 10.1016/S1010-5182(97)80033-9; Eppley BL, 2004, PLAST RECONSTR SURG, V114, P850, DOI 10.1097/01.PRS.0000132856.69391.43; Gunarajah DR, 2013, J ORAL MAXIL SURG, V71, P550, DOI 10.1016/j.joms.2012.10.029; HAWES MJ, 1983, OPHTHALMOLOGY, V90, P1066; Hollier LH, 2001, J CRANIOFAC SURG, V12, P242, DOI 10.1097/00001665-200105000-00009; Krishnan V, 1997, J ORAL MAXIL SURG, V55, P327, DOI 10.1016/S0278-2391(97)90117-8; Kuhn F, 2002, OCULAR TRAUMA PRINCI, P385; Motamedi MHK, 2003, J ORAL MAXIL SURG, V61, P61, DOI 10.1053/joms.2003.50049; Ng JD, 2004, OPHTHAL PLAST RECONS, V20, P85, DOI 10.1097/01.IOP.0000105514.08654.13; Persons BL, 2002, J CRANIOFAC SURG, V13, P483, DOI 10.1097/00001665-200205000-00022; Persons BL, J CRANIOFAC SURG, P488; Rosado P, 2012, OR SURG OR MED OR PA, V113, P168, DOI 10.1016/j.tripleo.2011.01.035; Shere JL, 2004, OTOLARYNG HEAD NECK, V130, P164, DOI 10.1016/j.otohns.2003.09.018; Suga H, 2004, J CRANIOFAC SURG, V15, P454, DOI 10.1097/00001665-200405000-00022; Tong L, 2001, PLAST RECONSTR SURG, V108, P612, DOI 10.1097/00006534-200109010-00003; Tuncer S, 2007, J CRANIOFAC SURG, V18, P598, DOI 10.1097/01.scs.0000246735.92095.ef; Uygur S, 2009, J CRANIOFAC SURG, V20, P71, DOI 10.1097/SCS.0b013e318190dee0; Wiltfang J, 1999, J CRANIO MAXILL SURG, V27, P207, DOI 10.1016/S1010-5182(99)80030-4	28	6	8	0	9	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0736-6825	1098-8793		FACIAL PLAST SURG	Facial Plast. Surg.	OCT	2014	30	5					581	586		10.1055/s-0034-1393697			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AT5IZ	WOS:000344978300012	25397715				2022-02-06	
J	Roessler, M; Bode, K; Bauer, M				Roessler, M.; Bode, K.; Bauer, M.			Fluid resuscitation in hemorrhage	ANAESTHESIST			German	Article						Perfusion; Oxygen; Colloids; Crystalloids; Hemodynamics	HYDROXYETHYL STARCH 130/0.4; SYSTOLIC BLOOD-PRESSURE; TRAUMATIC BRAIN-INJURY; GOAL-DIRECTED THERAPY; ENDOTHELIAL GLYCOCALYX; HYPOVOLEMIC SHOCK; OXYGEN DELIVERY; INTENSIVE-CARE; SEVERE SEPSIS; HYPERCHLOREMIC ACIDOSIS	How fluid resuscitation has to be performed for acute hemorrhage situations is still controversially discussed. Although the forced administration of crystalloids and colloids has been and still is practiced, nowadays there are good arguments that a cautious infusion of crystalloids may be initially sufficient. Saline should no longer be used for fluid resuscitation. The main argument for cautious fluid resuscitation is that no large prospective randomized clinical trials exist which have provided evidence of improved survival when fluid resuscitation is applied in an aggressive manner. The explanation that no positive effect has so far been observed is that fluid resuscitation is thought to boost bleeding by increasing blood pressure and dilutional coagulopathy. Nevertheless, national and international guidelines recommend that fluid resuscitation should be applied at the latest when hemorrhage causes hemodynamic instability. Consideration should be given to the fact that damage control resuscitation per se will neither improve already reduced tissue perfusion nor hemostasis. In acute and possibly rapidly progressing hypovolemic shock, colloids can be used. The third and fourth generations of hydroxyethyl starch (HES) are safe and effective if used correctly and within prescribed limits. If fluid resuscitation is applied with ongoing re-evaluation of the parameters which determine oxygen supply, it should be possible to keep fluid resuscitation restricted without causing undesirable side effects and also to administer a sufficient quantity so that survival of patients is ensured.	[Roessler, M.; Bode, K.; Bauer, M.] Univ Gottingen, Zentrum Anasthesiol Rettungs & Intens Med, Univ Med Gottingen, D-37075 Gottingen, Germany		Roessler, M (corresponding author), Univ Gottingen, Zentrum Anasthesiol Rettungs & Intens Med, Univ Med Gottingen, Robert Koch Str 40, D-37075 Gottingen, Germany.	m.roessler@med.uni-goettingen.de	Roessler, Markus Soeren/I-7834-2013				Adams HA, 2005, ANASTH INTENSIVMED, V4, P111; Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Appelman MH, 2011, PERFUSION-UK, V26, P175, DOI 10.1177/0267659110394711; Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; BARRIOT P, 1987, INTENS CARE MED, V13, P203; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Biffl WL, 2001, AM J SURG, V182, P645, DOI 10.1016/S0002-9610(01)00814-5; BISHOP MH, 1995, J TRAUMA, V38, P780, DOI 10.1097/00005373-199505000-00018; BOEREMA I, 1965, AM HEART J, V69, P289, DOI 10.1016/0002-8703(65)90267-X; Boerema I, 1959, J CARDIOVASC SURG, V13, P133; Bolliger D, 2010, ANESTHESIOLOGY, V113, P1205, DOI 10.1097/ALN.0b013e3181f22b5a; Brasel KJ, 2007, J TRAUMA, V62, P812, DOI 10.1097/TA.0b013e31803245a1; Brunkhorst FM, 2010, INTERNIST, V51, P925, DOI 10.1007/s00108-010-2663-9; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bunn F, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002045.PUB2; Bunn F, 2011, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001319.PUB3; Campagna JA, 2003, ANESTHESIOLOGY, V98, P1250; Carl M, 2010, Ger Med Sci, V8, pDoc12, DOI 10.3205/000101; Chappell D, 2008, ANAESTHESIST, V57, P959, DOI 10.1007/s00101-008-1445-4; Chappell D, 2008, ANESTHESIOLOGY, V109, P723, DOI 10.1097/ALN.0b013e3181863117; Chappell D, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-61; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2009, J TRAUMA, V67, P389, DOI 10.1097/TA.0b013e3181a8b26f; DALRYMPLEHAY M, 1992, CLIN LAB HAEMATOL, V14, P209; DAMON L, 1987, NEW ENGL J MED, V317, P964; de Jonge E, 1998, THROMB HAEMOSTASIS, V79, P286; de Jonge E, 2001, CRIT CARE MED, V29, P1261, DOI 10.1097/00003246-200106000-00038; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Demetriades D, 1998, J TRAUMA, V45, P534, DOI 10.1097/00005373-199809000-00020; Deusch E, 2004, ANESTH ANALG, V99, P665, DOI 10.1213/01.ANE.0000130349.99727.58; Deutsche Gesellschaft fur Unfallchirurgie, 2011, S 3 LEITL POL SCHWE; Donati A, 2007, CHEST, V132, P1817, DOI 10.1378/chest.07-0621; Dorje P, 2000, ANESTHESIOLOGY, V92, P625, DOI 10.1097/00000542-200002000-00055; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Entholzner EK, 2000, ACTA ANAESTH SCAND, V44, P1116, DOI 10.1034/j.1399-6576.2000.440914.x; Falk JL, 1988, J CARDIAC THORAC ANA, V2, P33; Finfer S, 2004, NEW ENGL J MED, V350, P2247; FISHMAN AP, 1973, CIRCULATION, V47, P921, DOI 10.1161/01.CIR.47.5.921; Fries D, 2010, ANASTH INTENSIV NOTF, V45, P552, DOI 10.1055/s-0030-1265746; Fuller G, 2014, INJURY, V45, P612, DOI 10.1016/j.injury.2013.09.008; Futier E, 2010, CRIT CARE, V14, DOI 10.1186/cc9251; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Gutierrez G, 2004, CRIT CARE, V8, P373, DOI 10.1186/cc2851; HamiltonDavies C, 1997, INTENS CARE MED, V23, P276, DOI 10.1007/s001340050328; Hampton DA, 2013, J TRAUMA ACUTE CARE, V75, pS9, DOI 10.1097/TA.0b013e318290cd52; Hartog CS, 2011, ANESTH ANALG, V112, P156, DOI 10.1213/ANE.0b013e3181eaff91; Hasler RM, 2011, RESUSCITATION, V82, P1202, DOI 10.1016/j.resuscitation.2011.04.021; Helm M, 2013, UNFALLCHIRURG, V116, P326, DOI 10.1007/s00113-011-2096-5; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Hussmann B, 2011, UNFALLCHIRURG, V114, P705, DOI 10.1007/s00113-010-1842-4; Innerhofer P, 2002, ANESTH ANALG, V95, P858, DOI 10.1097/00000539-200210000-00012; Jacob M, 2003, ANAESTHESIST, V52, P896, DOI 10.1007/s00101-003-0557-0; Jacob M, 2009, ANASTH INTENSIVMED, V50, P358; Jacob M, 2007, LANCET, V369, P1984, DOI 10.1016/S0140-6736(07)60926-X; Jacob M, 2007, CARDIOVASC RES, V73, P575, DOI 10.1016/j.cardiores.2006.11.021; Jacob M, 2006, ANESTHESIOLOGY, V104, P1223, DOI 10.1097/00000542-200606000-00018; Jacob M, 2009, BEST PRACT RES-CLIN, V23, P145, DOI 10.1016/j.bpa.2009.05.001; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Khan S, 2014, J TRAUMA ACUTE CARE, V76, P561, DOI 10.1097/TA.0000000000000146; Kozek-Langenecker SA, 2008, ANESTH ANALG, V107, P382, DOI 10.1213/ane.0b013e31817e6eac; Krappweis J, 2013, BFARM B ARZNEIMITTEL, V1, P3; Kwan I, 2009, COCHRANE DB SYST REV, V3; LAMKE L-O, 1976, Resuscitation, V5, P93, DOI 10.1016/0300-9572(76)90029-0; Laubenthal H, 1997, ANAESTHESIST, V46, P253; LAXENAIRE MC, 1994, ANN FR ANESTH, V13, P301, DOI 10.1016/S0750-7658(94)80038-3; Levi M, 2007, SEMIN THROMB HEMOST, V33, P810, DOI 10.1055/s-2007-1000370; Ley EJ, 2009, J TRAUMA, V67, P1051, DOI 10.1097/TA.0b013e3181bba222; Lieberman JA, 2000, ANESTHESIOLOGY, V92, P407, DOI 10.1097/00000542-200002000-00022; Lier H, 2009, ANAESTHESIST, V58, P1010, DOI 10.1007/s00101-009-1595-z; LITTLE RA, 1995, J ACCID EMERG MED, V12, P1; Lobo DN, 2010, CRIT CARE MED, V38, P464, DOI 10.1097/CCM.0b013e3181bc80f1; Lobo SMA, 2000, CRIT CARE MED, V28, P3396, DOI 10.1097/00003246-200010000-00003; MACKEY DC, 1989, ANESTHESIOLOGY, V70, P866, DOI 10.1097/00000542-198905000-00026; Mahmood A, 2007, BRIT J SURG, V94, P427, DOI 10.1002/bjs.5726; Maier S, 2009, J TRAUMA, V66, P337, DOI 10.1097/TA.0b013e31817dac66; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Mardel SN, 1998, BRIT J ANAESTH, V80, P204, DOI 10.1093/bja/80.2.204; Mittermayr M, 2008, BRIT J ANAESTH, V100, P307, DOI 10.1093/bja/aem363; Mittermayr M, 2007, ANESTH ANALG, V105, P905, DOI 10.1213/01.ane.0000280481.18570.27; Morrison LJ, 2011, J CRIT CARE, V26, P363, DOI 10.1016/j.jcrc.2010.08.021; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Neff TA, 2003, ANESTH ANALG, V96, P1453, DOI 10.1213/01.ANE.0000061582.09963.FD; Ogilvie MP, 2010, J AM COLL SURGEONS, V210, P870, DOI 10.1016/j.jamcollsurg.2010.01.010; Perel P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub4; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Pinsky MR, 2007, CHEST, V132, P2020, DOI 10.1378/chest.07-0073; PRICE HL, 1966, CIRC RES, V18, P469, DOI 10.1161/01.RES.18.5.469; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Raghunathan K, 2013, NEW ENGL J MED, V368, P774, DOI 10.1056/NEJMc1215977; Raum MR, 2009, NOTFALL RETTUNGSMED, V12, P188, DOI 10.1007/s10049-009-1168-3; Rehm M, 2004, ANESTHESIOLOGY, V100, P1211, DOI 10.1097/00000542-200405000-00025; Rehm M, 2001, ANAESTHESIST, V50, P569, DOI 10.1007/s001010100165; Rehm M, 2001, ANAESTHESIST, V50, P580, DOI 10.1007/s001010100176; Rehm M, 2000, ANESTHESIOLOGY, V92, P657, DOI 10.1097/00000542-200003000-00008; Rehm M, 1998, INFUSIONSTHERAPIE, V25, P222; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Reid F, 2003, CLIN SCI, V104, P17, DOI 10.1042/cs1040017; Rhee P, 2000, CRIT CARE MED, V28, P74, DOI 10.1097/00003246-200001000-00012; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Riddez L, 1998, J TRAUMA, V44, P433, DOI 10.1097/00005373-199803000-00001; Riddez L, 1997, CRIT CARE MED, V25, P635, DOI 10.1097/00003246-199704000-00013; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; SANDERJENSEN K, 1986, BMJ-BRIT MED J, V292, P364, DOI 10.1136/bmj.292.6517.364; SANDERJENSEN K, 1990, ANGIOLOGY, V41, P687, DOI 10.1177/000331979004100903; Schabinski F, 2009, INTENS CARE MED, V35, P1539, DOI 10.1007/s00134-009-1509-1; Scheingraber S, 1999, ANESTHESIOLOGY, V90, P1265, DOI 10.1097/00000542-199905000-00007; Schochl H, 2010, WIEN KLIN MAG, V13, P12; Schortgen F, 2008, INTENS CARE MED, V34, P2157, DOI 10.1007/s00134-008-1225-2; SECHER NH, 1984, CIRC SHOCK, V14, P267; SHOEMAKER WC, 1973, ARCH SURG-CHICAGO, V106, P630; Sossdorf M, 2009, CRIT CARE, V13, DOI 10.1186/cc8223; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; SWAN HJC, 1970, NEW ENGL J MED, V283, P447, DOI 10.1056/NEJM197008272830902; Traumaregister der Deutschen Gesellschaft fur Unfallchirurgie, JAHR 2013 ZEITR BIS; Van Der Linden P, 2013, ANESTH ANALG, V116, P35, DOI 10.1213/ANE.0b013e31827175da; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; Velmahos GC, 2000, ANN SURG, V232, P409, DOI 10.1097/00000658-200009000-00013; Victorino GP, 2003, J AM COLL SURGEONS, V196, P679, DOI 10.1016/S1072-7515(03)00128-5; WAKIM KG, 1970, J AMER MED ASSOC, V214, P1710, DOI 10.1001/jama.1970.03180090074027; Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V279, P217, DOI 10.1001/jama.279.3.217; WISNER DH, 1986, INJURY, V17, P295, DOI 10.1016/0020-1383(86)90149-X; Wohlauer MV, 2012, J SURG RES, V173, P26, DOI 10.1016/j.jss.2011.04.047; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zander R, 2009, ANASTH INTENSIVMED, V50, P348; Zander R, 2010, WIEN KLIN WOCHENSCHR, V122, pS6	135	6	6	0	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	OCT	2014	63	10					730	744		10.1007/s00101-014-2377-9			15	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	AR7IK	WOS:000343752700002	25205551				2022-02-06	
J	von Holst, H; Li, XG				von Holst, Hans; Li, Xiaogai			Decompressive craniectomy (DC) at the non-injured side of the brain has the potential to improve patient outcome as measured with computational simulation	ACTA NEUROCHIRURGICA			English	Article						Decompressive craniectomy; Finite element modeling; Axonal stretching	MODEL; DEFORMATION; TISSUE; SHIFT	Decompressive craniectomy (DC) is efficient in reducing the intracranial pressure in several complicated disorders such as traumatic brain injury (TBI) and stroke. The neurosurgical procedure has indeed reduced the number of deaths. However, parallel with the reduced fatal cases, the number of vegetative patients has increased significantly. Mechanical stretching in axonal fibers has been suggested to contribute to the unfavorable outcome. Thus, there is a need for improving treatment procedures that allow both reduced fatal and vegetative outcomes. The hypothesis is that by performing the DC at the non-injured side of the head, stretching of axonal fibers at the injured brain tissue can be reduced, thereby having the potential to improve patient outcome. Six patients, one with TBI and five with stroke, were treated with DC and where each patient's pre- and postoperative computerized tomography (CT) were analyzed and transferred to a finite element (FE) model of the human head and brain to simulate DC both at the injured and non-injured sides of the head. Poroelastic material was used to simulate brain tissue. The computational simulation showed slightly to substantially increased axonal strain levels over 40 % on the injured side where the actual DC had been performed in the six patients. However, when the simulation DC was performed on the opposite, non-injured side, there was a substantial reduction in axonal strain levels at the injured side of brain tissue. Also, at the opposite, non-injured side, the axonal strain level was substantially lower in the brain tissue. The reduced axonal strain level could be verified by analyzing a number of coronal sections in each patient. Further analysis of axial slices showed that falx may tentatively explain part of the different axonal strain levels between the DC performances at injured and opposite, non-injured sides of the head. By using a FE method it is possible to optimize the DC procedure to a non-injured area of the head thereby having the potential to reduce axonal stretching at the injured brain tissue. The postoperative DC stretching of axonal fibers may be influenced by different anatomical structures including falx. It is suggested that including computational FE simulation images may offer guidance to reduce axonal strain level tailoring the anatomical location of DC performance in each patient.	[von Holst, Hans; Li, Xiaogai] Royal Inst Technol KTH, Sch Technol & Hlth, Div Neuron Engn, Stockholm, Sweden; [von Holst, Hans] Karolinska Inst, Div Clin Neurosci, Neurosurg Sect, Stockholm, Sweden		von Holst, H (corresponding author), Karolinska Inst, Div Clin Neurosci, Neurosurg Sect, Stockholm, Sweden.	hans.vonholst@karolinska.se		Li, Xiaogai/0000-0001-8522-4705	research foundation at Karolinska University Hospital, Stockholm County; research foundation at division of Neuronic engineering at KTH, Sweden	The present study was supported by the research foundations at Karolinska University Hospital, Stockholm County, and division of Neuronic engineering at KTH, Sweden	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bohman L, 2013, CURR NEUROL NEUROSCI, V13, P1; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DeLorenzo C, 2012, IEEE T MED IMAGING, V31, P1607, DOI 10.1109/TMI.2012.2197407; Dumpuri P, 2007, MED IMAGE ANAL, V11, P128, DOI 10.1016/j.media.2006.11.002; Dumpuri P, 2010, IEEE T BIO-MED ENG, V57, P1285, DOI 10.1109/TBME.2009.2039643; Elkhodary, 2013, NONLINEAR FINITE ELE; Feigin V. L., 2007, HDB CLIN NEUROEPIDEM, P197; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2012, J MED ETHICS, V38, P657, DOI 10.1136/medethics-2012-100672; Hu JW, 2007, J NEUROSURG, V106, P164, DOI 10.3171/jns.2007.106.1.164; Kleiven S, 2002, THESIS KTH STOCKHOLM; Li XG, 2013, J CLIN NEUROSCI, V20, P509, DOI 10.1016/j.jocn.2012.04.019; Li XG, 2011, ACTA NEUROCHIR, V153, P2057, DOI 10.1007/s00701-011-1078-2; Marechal L, 2009, PROCEEDINGS OF THE 18TH INTERNATIONAL MESHING ROUNDTABLE, P65, DOI 10.1007/978-3-642-04319-2_5; Miga MI, 2000, IEEE T BIO-MED ENG, V47, P266, DOI 10.1109/10.821778; Miga MI, 1999, LECT NOTES COMPUT SC, V1679, P900; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pieper S, 2004, IEEE INT S BIOMED IM, V1, P632, DOI DOI 10.1109/ISBI.2004.1398617; Schneider GH, 2002, ACT NEUR S, V81, P77; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; von Holst H, 2013, J NEUROTRAUM, V30, P1192, DOI 10.1089/neu.2012.2730; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Wittek A, 2010, PROG BIOPHYS MOL BIO, V103, P292, DOI 10.1016/j.pbiomolbio.2010.09.001; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009	26	6	6	0	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2014	156	10					1961	1967		10.1007/s00701-014-2195-5			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AP6SX	WOS:000342209100021	25100152				2022-02-06	
J	Spratt, NJ; Tomkins, AJ; Pepperall, D; McLeod, DD; Calford, MB				Spratt, Neil J.; Tomkins, Amelia J.; Pepperall, Debbie; McLeod, Damian D.; Calford, Mike B.			Allopregnanolone and Its Precursor Progesterone Do Not Reduce Injury after Experimental Stroke in Hypertensive Rats - Role of Postoperative Temperature Regulation?	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; ACUTE ISCHEMIC-STROKE; CELL-DEATH; NEUROPROTECTIVE PROPERTIES; OCCLUSION; HYPOTHERMIA; RECOMMENDATIONS; METAANALYSIS; METABOLITE	Allopregnanolone is a neurosteroid synthesized from progesterone in brain. It increases inhibition through modulation of the gamma-aminobutyric acid type A (GABA-A) receptor. Both agents are putative neuroprotectants after ischemic stroke. We sought to confirm their effectiveness in a hypertensive rat stroke model, with intra-and post-operative temperature regulation. The primary study compared allopregnanolone, progesterone or vehicle control treatments, administered 105 minutes after induction of temporary middle cerebral artery occlusion in spontaneously hypertensive rats. Temperature was controlled intraoperatively and a heat mat used in the 6 hours postoperatively to permit animal temperature self-regulation. The primary outcome was infarct volume and secondary outcomes were tests of sensory and motor function. There was no significant effect of treatment on any outcome measure. Given prior reports of GABA-A receptor agonists causing hypothermia, follow-up experiments were conducted to examine postoperative temperature regulation. These did not reveal a difference in postoperative temperature in neurosteroid-treated animals compared to control. However, in all rats maintained postoperatively in ambient temperature, moderate hypothermia was observed. This was in contrast to rats maintained over a heat mat. The lowest mean postoperative temperature was between 34.4-34.9 degrees C in all 3 groups. These data do not support a neuroprotective effect of allopregnanolone or progesterone in ischemic stroke in hypertensives in the setting of normothermia. Given previous evidence of synergy between neuroprotective agents and hypothermia, demonstration of neuroprotective effect of these agents in the absence of postoperative hypothermia would be prudent before consideration of these agents for further clinical investigation.	[Spratt, Neil J.; Tomkins, Amelia J.; Pepperall, Debbie; McLeod, Damian D.; Calford, Mike B.] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2300, Australia; [Spratt, Neil J.; Tomkins, Amelia J.; Pepperall, Debbie; McLeod, Damian D.; Calford, Mike B.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Spratt, Neil J.] Hunter New England Local Hlth Dist, Newcastle, NSW, Australia; [Calford, Mike B.] Univ Tasmania, Sch Med, Hobart, Tas, Australia		Spratt, NJ (corresponding author), Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2300, Australia.	neil.spratt@newcastle.edu.au	Spratt, Neil J/K-4208-2012; MCLEOD, DAMIAN/G-7704-2013	Spratt, Neil J/0000-0002-9023-6177; MCLEOD, DAMIAN/0000-0002-1297-8984; Calford, Mike/0000-0002-5727-0234	Greater Building Society/Hunter Medical Research Institute; Sylvia and Charles Viertel charitable foundation; Royal Australian College of Physicans / High Blood Pressure Foundation; NHMRCNational Health and Medical Research Council of Australia [454417, APP1035465]	This work was supported by grants from the Greater Building Society/Hunter Medical Research Institute, the Sylvia and Charles Viertel charitable foundation, the Royal Australian College of Physicans / High Blood Pressure Foundation and by the NHMRC (program grant 454417). Dr. Spratt was supported by a NHMRC Career Development Fellowship, APP1035465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Armstrong SR, 2005, J VET EMERG CRIT CAR, V15, P32, DOI 10.1111/j.1476-4431.2005.04033.x; Aronowski J, 1996, J CEREBR BLOOD F MET, V16, P705, DOI 10.1097/00004647-199607000-00022; Azcoitia I, 1999, J NEUROCYTOL, V28, P699, DOI 10.1023/A:1007025219044; Berger C, 2004, EXP NEUROL, V185, P305, DOI 10.1016/j.expneurol.2003.10.008; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Campbell K, 2008, BRAIN RES B; Chaulk D, 2003, EXP NEUROL, V182, P476, DOI 10.1016/S0014-4886(03)00121-3; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Lust WD, 2002, METAB BRAIN DIS, V17, P113, DOI 10.1023/A:1015420222334; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Macleod MM, 2008, GOOD LAB PRACTICE PR; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Parker SM, 2005, J CEREB BLOOD FLOW M, V25, pS21; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Saalmann YB, 2007, J NEUROENDOCRINOL, V19, P272, DOI 10.1111/j.1365-2826.2006.01527.x; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Spratt NJ, 2006, J NEUROSCI METH, V155, P285, DOI 10.1016/j.jneumeth.2006.01.020; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; VanLandingham JW, 2006, NEUROPHARMACOLOGY, V51, P1078, DOI 10.1016/j.neuropharm.2006.07.015; Wong R, 2013, J CEREBR BLOOD F MET, V33, P1362, DOI 10.1038/jcbfm.2013.120; Zivin JA, 2008, STROKE, V39, P2697, DOI 10.1161/STROKEAHA.108.519488	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e107752	10.1371/journal.pone.0107752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	WOS:000342351800034	25248155	Green Published, gold			2022-02-06	
J	Lipp, LL				Lipp, Laura L.			Brain Perfusion and Oxygenation	CRITICAL CARE NURSING CLINICS OF NORTH AMERICA			English	Article						Brain perfusion and oxygenation; Oxygen consumption; Cerebral metabolic rate of oxygen; Cerebral blood flow; Neuromonitoring	BLOOD-FLOW; PRESSURE; MICRODIALYSIS; INJURY; CARE	Maintenance of brain perfusion and oxygenation is of paramount importance to patient outcome with various types of brain injuries (traumatic, ischemic, and hemorrhagic). Historically, monitoring of intracranial pressure and cerebral perfusion pressure has been the mainstay of neuromonitoring techniques used at the critical care bedside to monitor brain perfusion and oxygenation. This article describes the bedside neuromonitoring techniques that have emerged for use with these patients in the critical care area. To give the reader an understanding of the functionality of these neuromonitoring techniques, the article first summarizes the physiology of brain perfusion and oxygenation.	Houston Methodist Hosp, Nurse Practitioner Serv, Houston, TX 77030 USA		Lipp, LL (corresponding author), Houston Methodist Hosp, Nurse Practitioner Serv, 6565 Fannin St, Houston, TX 77030 USA.	llipp@houstonmethodist.org					Aiyagari V, 2005, PRINCIPLES CRITICAL; Barrett KE, 2012, GANONGS REV MED PHYS, V24th; Bor-Seng-Shu E, 2012, ARQ NEURO-PSIQUIAT, V70, P357, DOI 10.1590/S0004-282X2012000500010; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Cryer PE, 2012, HARRISONS PRINCIPLES; Dillon WP, 2012, HARRISONS PRINCIPLES; Diringer MN, 2007, CURR OPIN CRIT CARE, V13, P156, DOI 10.1097/MCC.0b013e32807f2aa5; Ekbal NJ, 2013, CHEST, V143, P1799, DOI 10.1378/chest.12-1849; Feyen BFE, 2012, MINERVA ANESTESIOL, V78, P949; Frank JI, 2005, PRINCIPLES CRITICAL; Frost EA, 2012, ANESTHESIOLOGY NEWS; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hemphill III JC, 2012, HARRISONS PRINCIPLES; Jan BV, 2010, SCHWARTZS PRINCIPLES; Mackey DC, 2013, MORGAN MIKHAILS CLIN, V5th; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; National Institutes of Health Health & Human Services, BRAIN TISS OX MON TR; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Ropper A, 2013, ADAMS VICTORS PRINCI; Ropper AH, 2009, ADAMS VICTORS PRINCI; Rose JC, 2006, CURR OPIN CRIT CARE, V12, P97, DOI 10.1097/01.ccx.0000216574.26686.e9; Shannon RJ, 2013, J PHARMACOKINET PHAR, V40, P343, DOI 10.1007/s10928-013-9306-4; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stover JF, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13245; Taussky P, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.12.FOCUS11280; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Waxman SG., 2013, CLIN NEUROANATOMY; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Zapadka ME, 2011, BASIC RADIOLOGY; Zuckerbraun BS, 2010, SCHWARTZS PRINCIPLES; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	36	6	6	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0899-5885	1558-3481		CRIT CARE NURS CLIN	Crit. Care Nurs. Clin. N. Am.	SEP	2014	26	3					389	+		10.1016/j.ccell.2014.04.008			11	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	AO4JU	WOS:000341304400009	25169691				2022-02-06	
J	Mihaljcic, T; Haines, TP; Ponsford, JL; Stolwyk, RJ				Mihaljcic, Tijana; Haines, Terry P.; Ponsford, Jennie L.; Stolwyk, Renerus J.			Development of a new self-awareness of falls risk measure (SAFRM)	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Awareness; Insight; Falls; Falls risk; Scale	STAGE ALZHEIMERS-DISEASE; TRAUMATIC BRAIN-INJURY; IMPAIRED AWARENESS; DEFICITS; SCALE; REHABILITATION; PREVENTION; ADHERENCE; GO; INTERVENTIONS	Research suggests that some older individuals may lack awareness of personal falls risk; however, there is no validated scale to measure self-awareness (SA) of falls risk in this population. Therefore, the objective of this study is to describe the development and psychometric evaluation of a new three part (intellectual, emergent, and anticipatory) SAFRM to be used in the older population undergoing inpatient rehabilitation. The SAFRM underwent a comprehensive scale development process. Ninety-one participants aged over 60 years were recruited from rehabilitation wards with their treating physiotherapist and occupational therapist. The results indicated a three factor structure of the scale corresponding to the theoretically developed intellectual, emergent and anticipatory SA sections which explained 50.26% of variance. The SAFRM demonstrated good internal consistency (Cronbach's alpha = .86-.92), inter-rater reliability between clinicians (ICC = .61-.87), and convergent validity with an SA interview (r(s) = .31-.50). The SAFRM scores were significantly correlated with clinician-rated SA (r(s) = -.40 to -.63) providing evidence of ecological validity. The present study provides initial empirical support of the reliability and validity of the SAFRM for assessment of SA of falls risk in the older inpatient population. The availability of this measure will allow further investigation into the causes and consequences of reduced SA in the older population. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Mihaljcic, Tijana; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Haines, Terry P.] Monash Univ, Dept Physiotherapy, Frankston, Vic 3199, Australia; [Haines, Terry P.] Monash Hlth, Allied Hlth Res Unit, Cheltenham, Vic 3192, Australia; [Ponsford, Jennie L.] Monash Epworth Rehabil Res Ctr, Richmond, Vic 3121, Australia		Stolwyk, RJ (corresponding author), Monash Univ, Sch Psychol Sci, Melbourne, Vic 3800, Australia.	Tijana.Mihaljcic@monash.edu; Rene.Stolwyk@monash.edu	Haines, Terrence/E-9372-2015	Haines, Terrence/0000-0003-3150-6154	Monash University Strategic Grant SchemeMonash University [ECD013]	This work was supported by the Monash University Strategic Grant Scheme (ECD013). The study sponsors were not involved in any aspect of the study design, data collection, data analysis, interpretation, or writing and submission of the manuscript.	Aizen E, 2007, ARCH GERONTOL GERIAT, V44, P1, DOI 10.1016/j.archger.2006.01.005; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Bunn F, 2008, AGEING SOC, V28, P449, DOI 10.1017/S0144686X07006861; Butler AA, 2011, J GERONTOL A-BIOL, V66, P896, DOI 10.1093/gerona/glr071; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Clare L, 2005, AGING MENT HEALTH, V9, P394, DOI 10.1080/13607860500142903; Clare L, 2004, BRIT J CLIN PSYCHOL, V43, P155, DOI 10.1348/014466504323088033; Clare L, 2004, J CLIN EXP NEUROPSYC, V26, P215, DOI 10.1076/jcen.26.2.215.28088; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Cohen J., 2013, STAT POWER ANAL BEHA; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; de Winter JCF, 2009, MULTIVAR BEHAV RES, V44, P147, DOI 10.1080/00273170902794206; DeVellis RF., 2012, SCALE DEV THEORY APP, V34; Ecklund-Johnson E, 2005, NEUROPSYCHOL REV, V15, P147, DOI 10.1007/s11065-005-9026-7; Farrer C, 2008, CEREB CORTEX, V18, P254, DOI 10.1093/cercor/bhm050; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Haines T. P., 2012, HLTH EXPECTATIONS; Haines T, 2009, MED CARE, V47, P448, DOI 10.1097/MLR.0b013e318190ccc0; Haines TP, 2007, J GERONTOL A-BIOL, V62, P664, DOI 10.1093/gerona/62.6.664; Haines TP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-135; Ham T. E., 2013, BRAIN; Hinkin TR, 1998, ORGAN RES METHODS, V1, P104, DOI 10.1177/109442819800100106; Kamata N, 2007, CLIN REHABIL, V21, P357, DOI 10.1177/0269215507073346; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kristensen MT, 2007, PHYS THER, V87, P24, DOI 10.2522/ptj.20050271; Lafargue G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051218; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Matsunaga M, 2010, INT J PSYCHOL RES, V3, P97, DOI 10.21500/20112084.854; McPhate L, 2013, J PHYSIOTHER, V59, P81, DOI 10.1016/S1836-9553(13)70160-7; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; NYBERG L, 1995, STROKE, V26, P838, DOI 10.1161/01.STR.26.5.838; O'Connell M. E., 2014, J AGING RES; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Pallant J.F., 2007, SPSS SURVIVAL MANUAL; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pondal Margarita, 2008, J Geriatr Phys Ther, V31, P57; Robertsson B., 2007, DEMENTIA, V6, P45; Robinovitch SN, 1999, J GERONTOL A-BIOL, V54, pB124, DOI 10.1093/gerona/54.3.B124; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Rymer S, 2002, ALZ DIS ASSOC DIS, V16, P248, DOI 10.1097/00002093-200210000-00006; Sakurai R, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-44; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Simek EM, 2012, PREV MED, V55, P262, DOI 10.1016/j.ypmed.2012.07.007; Simms LJ, 2008, SOC PERSONAL PSYCHOL, V2, P414, DOI 10.1111/j.1751-9004.2007.00044.x; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; Snow AL, 2004, ALZ DIS ASSOC DIS, V18, P22, DOI 10.1097/00002093-200401000-00005; Stalenhoef' PA, 1999, PATIENT EDUC COUNS, V36, P23, DOI 10.1016/S0738-3991(98)00071-8; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Yardley L, 2006, GERONTOLOGIST, V46, P650, DOI 10.1093/geront/46.5.650; Zamboni G, 2013, CORTEX, V49, P668, DOI 10.1016/j.cortex.2012.04.011	63	6	6	0	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	SEP-OCT	2014	59	2					249	256		10.1016/j.archger.2014.06.001			8	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	AO0RE	WOS:000341018300007	24997096				2022-02-06	
J	Morrissey, D; Raukar, NP; Andrade-Koziol, J; Mello, M				Morrissey, Dina; Raukar, Neha P.; Andrade-Koziol, Jennifer; Mello, Michael			Statewide assessment of the Rhode Island School and Youth Programs Concussion Act	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Injury; injury prevention; concussion; youth sports	SPORTS	BACKGROUND: Sport-related concussion among youth athletes has become an area of increasing concern. Rhode Island passed the School and Youth Programs Concussion Act (SYPCA) in July 2010. The law contains both mandatory and recommended provisions outlining management of youth with a suspected concussion. Only Rhode Island Interscholastic League (RIIL) member schools are bound by this legislation. The purpose of this study was to assess compliance with the law. METHODS: We designed a 29-question survey to assess compliance with the SYPCA. The survey was e-mailed to athletic directors of all RIIL member high schools, nonmember high schools, and selected community sports organizations. RESULTS: Surveys were e-mailed to 65 athletic directors. Seven were returned as undeliverable. Forty-two individuals (71%) responded, and 38 (65%) submitted a completed survey. Among the RIIL schools that completed the survey, 100% stated that they require students and parents to sign preseason concussion information sheets. All reported that athletes with a suspected concussion are immediately removed from play, and 93% (29 of 31) stated that athletes must receive written clearance from a licensed physician before being able to return to play. All require annual concussion training for coaches, and 29 (93%) require annual training for volunteers. Only six RIIL schools require all student athletes to complete preseason neurocognitive testing. Approximately half of the RIIL respondents (17 of 31) stated that their school has a written return-to-play protocol. Compliance with all provisions of the law was lower among the non-RIIL schools and organizations. CONCLUSION: Compliance with mandated elements of the SYPCA is close to universal; however, compliance with recommended elements is limited. To best protect Rhode Island youth athletes, all recommendations in the law should be mandatory, and non-RIIL schools and organizations should be required to comply. (Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Morrissey, Dina; Mello, Michael] Rhode Isl Hosp, Injury Prevent Ctr, Providence, RI 02903 USA; [Raukar, Neha P.] Brown Univ, Warren Alpert Med Sch, Div Sports Med, Providence, RI 02912 USA; [Morrissey, Dina; Mello, Michael] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Raukar, Neha P.] CAQ Primary Care Sports Med, Providence, RI USA; [Andrade-Koziol, Jennifer] Rhode Isl Dept Hlth, Providence, RI 02908 USA		Morrissey, D (corresponding author), Rhode Isl Hosp, Injury Prevent Ctr, 55 Claverick St, Providence, RI 02903 USA.	dmorrissey@lifespan.org					Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Langthorn L, 2012, J SAFETY RES, V43, P311, DOI 10.1016/j.jsr.2012.08.013	4	6	6	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2014	77			1			S8	S11		10.1097/TA.0000000000000331			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AO2BK	WOS:000341120300003	25153057				2022-02-06	
J	Nnadi, MON; Bankole, OB; Fente, BG				Nnadi, M. O. N.; Bankole, O. B.; Fente, B. G.			Epidemiology and treatment outcome of head injury in children: A prospective study	JOURNAL OF PEDIATRIC NEUROSCIENCES			English	Article						Children; epidemiology; head injury; outcome		Head injury in children is a major concern all over the world. The increasing level of poverty in the world is exposing more children to trauma situations. The future consequences of trauma in these children are enormous, hence prevention they say, is better than cure. Aim of the Study: The study was designed to determine the etiological pattern, age group affectation and treatment outcome in children managed for head injury in our center. Methods: It was a prospective, descriptive and cross-sectional study of children with head injuries managed in our center from July 2010 to December 2013. Data were collected using structured proforma that was part of our prospective Data Bank approved by our hospital Research and Ethics Committee. Data were collected in accident and emergency unit, Intensive Care Unit, wards and out-patient clinic. The data was analyzed using Epi Info 7 software. Results: Total of 76 children managed by the unit and followed-up to a minimum of 3 months qualified for the study. There were 42 males. The age ranged from 7 months to 18 years with a mean of 8.66 years. There were 30 adolescent/teenagers. Road traffic accident formed 63.15%. Pedestrian accident was more among preschool and school children. Thirty-seven patients had mild head injury. Sixty-six patients were managed conservatively. The commonest posttraumatic effect was seizure (15.79%). Good functional outcome (>= 4) was seen in 92.1%. Mode of accident and severity of injury affected the outcome. Conclusions: The etiologies of traumatic brain injury, from our study, were age dependent with falls commonest in toddlers and pedestrian accident commonest in pre-school and school ages. The outcome of treatment was related to severity of injury.	[Nnadi, M. O. N.] Univ Calabar, Teaching Hosp, Dept Surg, Div Neurosurg, Calabar, Cross River Sta, Nigeria; [Bankole, O. B.] Lagos Univ, Teaching Hosp, Dept Surg, Neurosurg Unit, Lagos, Nigeria; [Fente, B. G.] Niger Delta Univ, Teaching Hosp, Dept Surg, Gen Surg Unit, Okolobri, Bayelsa State, Nigeria		Nnadi, MON (corresponding author), Univ Calabar, Teaching Hosp, Dept Surg, Div Neurosurg, Calabar, Cross River Sta, Nigeria.	nnadimon@yahoo.com					Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Adesunkanmi ARK, 1998, J TRAUMA, V44, P506, DOI 10.1097/00005373-199803000-00015; Agrawal A, 2008, Afr J Paediatr Surg, V5, P15, DOI 10.4103/0189-6725.41630; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; [Anonymous], 2005, HARV MENT HLTH LETT, V22, P1; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bener A, 1998, EUR J EPIDEMIOL, V14, P175, DOI 10.1023/A:1007444109260; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bruce DA, 1996, NEUROSURGERY, P2709; Chabok SY, 2012, ARCH TRAUMA RES, V1, P19, DOI 10.5812/atr.5289; Chinda J Y, 2013, Afr J Paediatr Surg, V10, P358, DOI 10.4103/0189-6725.125448; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Csepregi Gyula, 2007, Orvosi Hetilap, V148, P771, DOI 10.1556/OH.2007.27879; Emejulu JKC, 2010, NIGER J CLIN PRACT, V13, P276; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Glasgow JF, 1997, CURR PEDIAT, V7, P187; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hymel KP, 2010, PEDIATRICS, V125, P712, DOI 10.1542/peds.2009-2133; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; INSEL TR, 1990, NEUROSCIENCE, V35, P31, DOI 10.1016/0306-4522(90)90117-M; JENNETT B, 1975, LANCET, V1, P480; Johnstone AJ, 1996, J ACCID EMERG MED, V13, P386; Jones PA, 2003, BRIT J NEUROSURG, V17, P29, DOI 10.1080/0268869031000093708; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; MILLER LP, 1990, NEUROSCIENCE, V35, P45, DOI 10.1016/0306-4522(90)90118-N; Myhre MC, 2007, ACTA PAEDIATR, V96, P1159, DOI 10.1111/j.1651-2227.2007.00356.x; National Center for Health Statistics, 1987, ADV REP FIN MORT STA; Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Shokunbi T, 1994, West Afr J Med, V13, P38; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; Vaghani Gaurang, 2013, J Pediatr Neurosci, V8, P104, DOI 10.4103/1817-1745.117836; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380	38	6	6	0	2	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1817-1745	1998-3948		J PEDIATR NEUROSCI	J. Pediatr. Neurosci.	SEP-DEC	2014	9	3					237	241	PMID 25624926	10.4103/1817-1745.147577			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V4R1M	WOS:000219187300006	25624926	Green Published			2022-02-06	
J	Russell, K; Meeuwisse, W; Nettel-Aguirre, A; Emery, CA; Wishart, J; Romanow, NTR; Rowe, BH; Goulet, C; Hagel, BE				Russell, Kelly; Meeuwisse, Willem; Nettel-Aguirre, Alberto; Emery, Carolyn A.; Wishart, Jillian; Romanow, Nicole T. R.; Rowe, Brian H.; Goulet, Claude; Hagel, Brent E.			Comparing the characteristics of snowboarders injured in a terrain park who present to the ski patrol, the emergency department or both	INTERNATIONAL JOURNAL OF INJURY CONTROL AND SAFETY PROMOTION			English	Article						snowboard; data quality; injury	RISK-FACTORS; INTERVAL ESTIMATION; CONCUSSION; EPIDEMIOLOGY; WRIST	Ski patrol report forms are a common data source in ski/snowboard research, but it is unclear if those who only present to the emergency department (ED) are systematically different from those who see the ski patrol. To determine the proportion and characteristics of injured snowboarders who bypass the ski patrol before presenting to the ED, three groups of injured snowboarders were compared: presented to the ED only, ski patrol only and ski patrol and ED. Data were collected from ski patrol Accident Report Forms (ARFs), ED medical records and telephone interviews. There were 333 injured snowboarders (ED only: 34, ski patrol only: 107, both: 192). Ability, time of day, snow conditions or drugs/alcohol predicted ED only presentation. Concussions (RRR: 4.66; 95% CI: 1.83, 11.90), sprains/strains (RRR: 4.22; 95% CI: 1.87, 9.49), head/neck (RRR: 2.90; 95% CI: 1.48, 5.78), trunk (RRR: 4.17; 95% CI: 1.92, 9.09) or lower extremity (RRR: 3.65; 95% CI: 1.32, 10.07) injuries were significantly more likely to present to ski patrol only versus ski patrol and ED. In conclusion, snowboarders who presented to the ED only had similar injuries as those who presented to both.	[Russell, Kelly] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3E 3P4, Canada; [Meeuwisse, Willem; Emery, Carolyn A.] Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Meeuwisse, Willem; Emery, Carolyn A.] Fac Kinesiol, Calgary, AB T2N 1N4, Canada; [Nettel-Aguirre, Alberto; Hagel, Brent E.] Univ Calgary, Alberta Childrens Hosp, Dept Paediat, Calgary, AB T3B 6A8, Canada; [Nettel-Aguirre, Alberto; Hagel, Brent E.] Univ Calgary, Alberta Childrens Hosp, Dept Community Hlth Sci, Calgary, AB T3B 6A8, Canada; [Wishart, Jillian; Romanow, Nicole T. R.] Univ Calgary, Dept Paediat, Calgary, AB T3B 6A8, Canada; [Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Edmonton, AB T6G 2B7, Canada; [Rowe, Brian H.] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 2B7, Canada; [Goulet, Claude] Univ Laval, Dept Phys Educ, Quebec City, PQ G1V 0A6, Canada		Russell, K (corresponding author), Univ Manitoba, Dept Pediat & Child Hlth, 656-715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada.	krussell@mich.ca	Nettel-Aguirre, Alberto/ABB-9412-2021; Emery, Carolyn/AAI-2761-2020; Hagel, Brent/AAK-3319-2020	Nettel-Aguirre, Alberto/0000-0001-6604-0652; Russell, Kelly/0000-0002-9159-9201	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR-104028] Funding Source: Medline		Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Boldrino C, 1999, AM SOC TEST MATER, V1345, P166, DOI 10.1520/STP12367S; Bridges EJ, 2003, BRIT J SPORT MED, V37, P511, DOI 10.1136/bjsm.37.6.511; Brooks MA, 2010, INJURY PREV, V16, P119, DOI 10.1136/ip.2009.022608; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Davidson TM, 1996, WESTERN J MED, V164, P231; Davidson TM, 1996, WESTERN J MED, V164, P310; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; EKELAND A, 2004, KNEE SURG SPORT TR A, V12, P169; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Goulet C, 2007, CAN J PUBLIC HEALTH, V98, P402, DOI 10.1007/BF03405428; Greenwald RM, 2000, AM SOC TEST MATER, V1397, P119, DOI 10.1520/STP12869S; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hagel BE, 2004, INJURY PREV, V10, P275, DOI 10.1136/ip.2004.005546; Hagel BE, 2004, EPIDEMIOLOGY, V15, P279, DOI 10.1097/01.ede.0000120044.62029.b4; Hagel BE, 1999, CLIN J SPORT MED, V9, P9, DOI 10.1097/00042752-199901000-00003; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hasler RM, 2010, BRIT J SPORT MED, V44, P816, DOI 10.1136/bjsm.2010.071357; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Lamont M. K., 1995, SKIING TRAUMA SAFETY, P82; Langran M, 2004, AM J SPORT MED, V32, P96, DOI 10.1177/0095399703258684; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; Made C, 2004, SCAND J MED SCI SPOR, V14, P128, DOI 10.1111/j.1600-0838.2003.00342.x; Matsumoto K, 2002, CLIN J SPORT MED, V12, P354, DOI 10.1097/00042752-200211000-00006; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Moffat C, 2009, WEST J EMERG MED, V10, P257; PELLETIER RL, 1991, CAN J SPORT SCI, V16, P99; PICKARD MA, 1988, SCOT MED J, V33, P296, DOI 10.1177/003693308803300405; Pigozzi F, 1997, ORTHOPEDICS, V20, P505; Ronning R, 2001, AM J SPORT MED, V29, P581, DOI 10.1177/03635465010290051001; Russell K., 2011, THESIS U CALGARY CAN; Russell K, 2007, CLIN J SPORT MED, V17, P145, DOI 10.1097/JSM.0b013e31803f901b; Russell K, 2013, CLIN J SPORT MED, V23, P172, DOI 10.1097/JSM.0b013e31827bd918; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Shealy JE, 1997, AM SOC TEST MATER, V1289, P49, DOI 10.1520/STP18288S; Shealy JE, 1989, SKIING TRAUMA SAFETY, P75; Torjussen J, 2006, BRIT J SPORT MED, V40, P230, DOI 10.1136/bjsm.2005.021329	39	6	6	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1745-7300	1745-7319		INT J INJ CONTROL SA	Int. J. Inj. Control Saf. Promot.	SEP	2014	21	3					244	251		10.1080/17457300.2013.812665			8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AN2CC	WOS:000340390000007	23802582	Green Published			2022-02-06	
J	Ungureanu, D; Iencean, SM; Dimitriu, C; Iencean, AS; Tascu, A				Ungureanu, Didona; Iencean, Stefan Mircea; Dimitriu, Cristina; Iencean, Andrei Stefan; Tascu, Alexandru			Determination of the phosphorylated neurofilament subunit NF-H (pNF-H) in cerebro-spinal fluid as biomarker in acute traumatic spinal cord injuries	REVISTA ROMANA DE MEDICINA DE LABORATOR			English	Article						biomarker; cerebro-spinal fluid; phosphorylated neurofilament subunit NF-H; spinal cord injury	NEURON-SPECIFIC ENOLASE; BRAIN-INJURY; S-100-BETA PROTEIN; CLINICAL-TRIALS; AXONAL INJURY; REPAIR; DEGENERATION; PROGNOSIS; SEVERITY; MARKERS	Study objective. The objective of this study was to measure the phosphorylated neurofilament subunit NF-H (pNF-H) in cerebro-spinal fluid of patients with spinal cord injury and to determine the correlation between the pNF-H levels and the severity of the injury. Materials and methods. The study included 15 subjects with acute traumatic spinal cord injury: eight patients with complete spinal cord injury (SCI) and seven patients with incomplete SCI. All patients were classified according to the American Spinal Injury Association impairment scale (ASIA) and all patients underwent surgery during the first 24 hours (decompression, stabilization). We measured daily the heavy phosphorylated neurofilament subunit (pNF-H) concentration by sandwich ELISA test in CSF in all patients and we correlated the values of pNF-H with the clinical evolution. Results. For all patients with SCI pNF-H was detectable in CSF samples and the values were different in the cases of complete SCI toward the cases of incomplete SCI and the cerebro-spinal pNF-H level was more elevated in cases of complete SCI. The level of CSF pNF-H was ten to a hundred times higher in complete SCI than the level of CSF pNF-H in cases with incomplete SCI, where the level of this biomarker was close to normal. The patients with a favorable neurological evolution after treatment had a specific pattern of daily values of pNF-H: a sudden increase up to a maximum value then a progressive decrease until normal. The maximum values were different in each case, from 10 times up to 170 times higher than the normal. Conclusion. The phosphorylated form of the high-molecular-weight neurofilament subunit NF-H (pNF-H) in cerebro-spinal fluid can be a specific biomarker for spinal cord injury and it can distinguish the severity of SCI. pNF-H is a predictive biomarker because of its values pattern can show the reducing or stopping of the secondary lesion and the favorable result.	[Ungureanu, Didona; Dimitriu, Cristina] Gr T Popa Univ Med & Pharm, Dept Biochem, Iasi, Romania; [Iencean, Stefan Mircea] Gr T Popa Univ Med & Pharm, Dept Neurosurg, Iasi, Romania; [Iencean, Andrei Stefan] Prof Dr N Oblu Emergency Clin Hosp Iasi, Dept Neurosurg, Iasi, Romania; [Tascu, Alexandru] Carol Davila Univ Med & Pharm Bucharest, Dept Neurosurg, Bucharest, Romania		Iencean, SM (corresponding author), Gr T Popa Univ Med & Pharm, Iasi, Romania.	mirceasteffan@yahoo.com	Dimitriu, Daniela Cristina/AAW-7204-2020	Iencean, Stefan Mircea/0000-0002-6230-8540	grant: ''Immediate neuroprotective therapy in acute traumatic spinal cord injury'' [PN-II-IDPCE-2011-3-0569]; CNCS-UEFISCDI Romania	This work is part of the grant: "Immediate neuroprotective therapy in acute traumatic spinal cord injury", grant number: PN-II-IDPCE-2011-3-0569, and was funded by the CNCS-UEFISCDI Romania.	Boylan KB, 2013, J NEUROL NEUROSUR PS, V84, P467, DOI 10.1136/jnnp-2012-303768; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Ferreira VMD, 2012, SPINAL CORD, V50, P28, DOI 10.1038/sc.2011.95; DiLeonardi AM, 2012, J NEUROPATH EXP NEUR, V71, P959, DOI 10.1097/NEN.0b013e31826f5876; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Guez M, 2003, J NEUROTRAUM, V20, P853, DOI 10.1089/089771503322385782; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Houle JD, 2003, EXP NEUROL, V182, P247, DOI 10.1016/S0014-4886(03)00029-3; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Lammertse D, 2007, J SPINAL CORD MED, V30, P205, DOI 10.1080/10790268.2007.11753928; Lee JY, 2011, J KOREAN MED SCI, V26, P814, DOI 10.3346/jkms.2011.26.6.814; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Maas MB, 2009, BIOMARK MED, V3, P363, DOI 10.2217/BMM.09.30; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2007, J IMMUNOL METHODS, V319, P34, DOI 10.1016/j.jim.2006.09.021; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Ramer LM, 2005, SPINAL CORD, V43, P134, DOI 10.1038/sj.sc.3101715; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shen S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-11; Shiiya N, 2004, ANN THORAC SURG, V77, P2034, DOI 10.1016/j.athoracsur.2003.12.057; Shinozaki K, 2009, CRIT CARE, V13, DOI 10.1186/cc7973; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Ueno T, 2011, SPINAL CORD, V49, P333, DOI 10.1038/sc.2010.116; Yagi M, 2010, J NEUROSURG-SPINE, V12, P59, DOI 10.3171/2009.5.SPINE08940	30	6	6	0	11	UNIV PRESS	TIRES MURES	UNIV MED FARMACIE TIRGU MURES, DISCIPLINA BIOCHIMIE CLIN, STR GHEORGHE MARINESCU, NR 38, TIRES MURES, 00000, ROMANIA	1841-6624	2284-5623		REV ROMANA MED LAB	Rev. Romana Med. Lab.	SEP	2014	22	3					377	386		10.2478/rrlm-2014-0029			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AU0HB	WOS:000345303100009		gold			2022-02-06	
J	Verma, A; Kole, T				Verma, Ankur; Kole, Tamorish			International normalized ratio as a predictor of mortality in trauma patients in India	WORLD JOURNAL OF EMERGENCY MEDICINE			English	Article						Hemorrhage; Trauma; International normalized ratio; Mortality		BACKGROUND: Hemorrhage is the second leading cause of death in trauma patients preceded only by traumatic brain injury. But hemorrhagic shock is the most common cause of preventable death within 6 hours of admission. Traumatic coagulopathy is a hypocoagulable state that occurs in the most severely injured. International normalized ratio (INR) and its relationship with trauma mortality have not been studied specifically. This study aimed to establish a predictive value of INR for trauma-related mortality. METHODS: A total of 99 trauma patients aged 18-70 years were included in the study. Their INR was determined and patient progression was followed up till death/discharge. According to previous retrospective studies, the cutoff value for INR in our study was kept at 1.5. RESULTS: The total mortality rate of the patients was 16.16% (16/99). The mean INR was 1.45 with a SD of 1.35. INR was deranged in a total of 14 patients (14.14%). Of these patients, 11 died (78.57%) and 3 survived. INR was deranged in 11 (68.75%) of the 16 patients who died, but 5 deaths (31.25%) had normal INR values. The sensitivity of INR was 69% (95%C141%-88%) and the specificity 96% (95%C/90%-99%). The diagnostic accuracy of INR was 92% (95%C/85%-96%). Positive predictive value and negative predictive value were 79% (95%C/49%-95%) and 94% (95%C/87%-98%), respectively. CONCLUSION: Our results showed that INR is a good predictor of mortality in trauma patients.	[Verma, Ankur] King Hamad Univ Hosp, Dept Emergency Med, Busaiteen, India; [Kole, Tamorish] Max Hosp, Dept Emergency Med, New Delhi 110017, India		Verma, A (corresponding author), King Hamad Univ Hosp, Dept Emergency Med, Busaiteen, India.	anksv25@gmail.com		Verma, Ankur/0000-0001-9524-9164			Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2009, J R Army Med Corps, V155, P320; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; ESPOSITO TJ, 1995, J TRAUMA, V39, P955, DOI 10.1097/00005373-199511000-00022; Hess JR, 2009, TRANSFUSION, V49, P34, DOI 10.1111/j.1537-2995.2008.01944.x; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; INNES D, 1964, J CLIN PATHOL, V17, P1, DOI 10.1136/jcp.17.1.1; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2011, DTSCH ARZTEBL INT, V108, P827, DOI [10.3238/arztebl.2011.0827, 10.3238/arztebl.2011.0836a]; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; Ragaller Max, 2010, J Emerg Trauma Shock, V3, P1, DOI 10.4103/0974-2700.58649; Roberts I, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub3; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1	17	6	8	0	1	ZHEJIANG UNIV SCH MEDICINE	HANGZHOU	SECOND AFFILIATED HOSPITAL, 88 JIEFANG RD, HANGZHOU, 310009, PEOPLES R CHINA	1920-8642			WORLD J EMERG MED	World J. Emerg. Med.	SEP	2014	5	3					192	195		10.5847/wjem.j.issn.1920-8642.2014.03.006			4	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V4Z2F	WOS:000219397200006	25225583	Green Published			2022-02-06	
J	Wright, JM; Islas, AA				Wright, Justin M.; Islas, Arthur A.			Concussion Management in the Wilderness	WILDERNESS & ENVIRONMENTAL MEDICINE			English	Article						concussion; head injury; wilderness	SOCIETY PRACTICE GUIDELINES; RECREATIONAL INJURIES; MOUNTAIN; PATHOPHYSIOLOGY; PREVENTION; ILLNESS; SPORT	Head trauma accounts for a significant number of injuries in the wilderness setting. Concussions are possible sequelae of falls or encounters with unforeseen obstacles. Although not immediately life-threatening, concussions can be a source of significant short- and long-term morbidity. Diagnosis of a concussion in the wilderness may be challenging as symptoms can often be confused with other conditions, such as altitude illness and hyponatremia. Successful management depends on accurate diagnosis and determination of the severity of symptoms so that appropriate decisions regarding treatment and need for evacuation can be made.	[Wright, Justin M.; Islas, Arthur A.] Texas Tech Univ, Hlth Sci Ctr, Dept Family & Community Med, Paul L Foster Sch Med, El Paso, TX 79924 USA		Wright, JM (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Family & Community Med, Paul L Foster Sch Med, 9849 Kenworthy St, El Paso, TX 79924 USA.	justin.wright@ttuhsc.edu		Wright, Justin/0000-0002-3261-1688			Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bennett BL, 2013, WILD ENVIRON MED, V24, P228, DOI 10.1016/j.wem.2013.01.011; Bergman DA, 1999, PEDIATRICS, V104, P1407; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Ela GK, 2004, WILD ENVIRON MED, V15, P11, DOI 10.1580/1080-6032(2004)015[0011:EOWSAR]2.0.CO;2; Flores AH, 2008, WILD ENVIRON MED, V19, P91, DOI 10.1580/07-WEME-OR-152.1; Forrester JD, 2009, WILD ENVIRON MED, V20, P318, DOI 10.1580/1080-6032-020.004.0318; GENTILE DA, 1992, ANN EMERG MED, V21, P853, DOI 10.1016/S0196-0644(05)81034-0; Imray C, 2010, PROG CARDIOVASC DIS, V52, P467, DOI 10.1016/j.pcad.2010.02.003; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Johnson RM, 2007, WILD ENVIRON MED, V18, P186, DOI 10.1580/06-WEME-OR-046R1.1; Lareau SA, 2011, WILD ENVIRON MED, V22, P222, DOI 10.1016/j.wem.2011.04.004; Leemon D, 2003, WILD ENVIRON MED, V14, P174, DOI 10.1580/1080-6032(2003)14[174:WIIAEN]2.0.CO;2; Luks AM, 2010, WILD ENVIRON MED, V21, P146, DOI 10.1016/j.wem.2010.03.002; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh SE, 2007, WILD ENVIRON MED, V18, P298, DOI 10.1580/07-WEME-OR-093R1.1; Montalvo R, 1998, WESTERN J MED, V168, P248; Mort A, 2011, CLIN J SPORT MED, V21, P530, DOI 10.1097/JSM.0b013e318234be97; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Quinn R, 2013, WILD ENVIRON MED, V24, P241, DOI 10.1016/j.wem.2013.03.004; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Rogers IR, 2009, WILD ENVIRON MED, V20, P139, DOI 10.1580/08-WEME-CON-231R2.1; Schoene RB, 2008, CHEST, V134, P402, DOI 10.1378/chest.07-0561; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Stephens BD, 2005, WILD ENVIRON MED, V16, P192, DOI 10.1580/1080-6032(2005)16[192:RIIWSN]2.0.CO;2	26	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1080-6032	1545-1534		WILD ENVIRON MED	Wildern. Environ. Med.	FAL	2014	25	3					319	324		10.1016/j.wem.2014.01.004			6	Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Sport Sciences	AO4DJ	WOS:000341286100009	24656906	Bronze			2022-02-06	
J	Schorl, M; Valerius-Kukula, SJ; Kemmer, TP				Schorl, Martin; Valerius-Kukula, Seung-Ja; Kemmer, Thomas P.			Median-evoked somatosensory potentials in severe brain injury: Does initial loss of cortical potentials exclude recovery?	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Brain injury; Prognosis; Evoked potentials; Outcome; Rehabilitation	BILATERAL ABSENT N20; ANOXIC-ISCHEMIC COMA; CRITICAL-CARE PATIENTS; SEVERE HEAD-INJURY; CARDIAC-ARREST; PREDICTIVE-VALUE; THERAPEUTIC HYPOTHERMIA; PROGNOSTIC VALUE; POSTANOXIC COMA; CARDIOPULMONARY-RESUSCITATION	Objective: In patients with severe brain injury (SBI) median-evoked somatosensory potentials (M-SSEP) serve as a prognostic tool. Bilateral loss of cortical responses (BLCR) is usually thought to be a reliable marker of poor prognosis. Prognostic accuracy to predict a poor outcome depends on the cause of coma and is best in hypoxic-ischemic encephalopathy (HIE) reaching almost 100% which is in contrast to patients with other etiologies of coma, especially traumatic brain injury (TBI). Only little evidence exists on the possibility of electrophysiological recovery of BLCR in repeated or serial SSEP-examinations and detailed functional outcome in these cases. Methods: 28 patients (78.6% male, 21.4% female, mean age 43.1 +/- 18.6 years) from our in-patient early (post-acute) neurorehabilitation center with BLCR in their first M-SSEP were re-examined after a mean interval of 66 +/- 55.8 days. SBI was caused by different etiologies. We retrospectively analyzed (a) the recovery rate from BLCR in consecutive M-SSEP and (b) the detailed functional outcome of those patients with recovered cortical responses. Results: 14/28(50%) patients with primarily BLCR showed re-occurrence of cortical potentials, either uni- or bilaterally. Of the 14 patients, one died due to a non-neurological cause. Of the remaining 13 patients 6 - most of them suffering from traumatic brain injury (TBI) - could be transferred to further continuing neurorehabilitation and achieved good functional long-term outcome. BLCR in HIE still had a poor prognosis with none of our patients achieving an outcome better than vegetative state. Conclusions: Electrophysiological recovery from primarily BLCR seems possible and is accompanied by good functional outcome in a relevant number of patients. Thus caution is warranted in predicting a poor prognosis based predominantly on SSEP, especially in patients with TBI. Focusing SSEP-examination on the early days after severe brain injury and performing only one examination in the case of BLCR may lead to systematic underestimation of the possibility of recovery. (C) 2014 Elsevier B.V. All rights reserved.	[Schorl, Martin; Valerius-Kukula, Seung-Ja; Kemmer, Thomas P.] SRH Fachkrankenhaus Neresheim, D-73450 Neresheim, Germany; [Schorl, Martin] Asklepios Schlossberg Klin, D-64732 Bad Konig, Hessen, Germany		Schorl, M (corresponding author), Asklepios Schlossberg Klin, Frankfurter St 33, D-64732 Bad Konig, Hessen, Germany.	mschorl@hotmail.com		Schorl, Martin/0000-0001-5075-1636			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Al Thenayan E, 2008, NEUROLOGY, V71, P1535, DOI 10.1212/01.wnl.0000334205.81148.31; Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; BARELLI A, 1991, CRIT CARE MED, V19, P1374, DOI 10.1097/00003246-199111000-00013; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Bender A, 2012, J NEUROL, V259, P2481, DOI 10.1007/s00415-012-6573-8; Bolay H, 2002, STROKE, V33, P1369, DOI 10.1161/01.STR.0000013708.54623.DE; Bouwes A, 2012, ANN NEUROL, V71, P206, DOI 10.1002/ana.22632; BRUNKO E, 1987, ELECTROEN CLIN NEURO, V66, P15, DOI 10.1016/0013-4694(87)90133-7; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; Christophis P, 2004, ZBL NEUROCHIR, V65, P25, DOI 10.1055/s-2004-44885; Claassen J, 2001, CRIT CARE MED, V29, P494, DOI 10.1097/00003246-200103000-00005; Cronberg T, 2013, RESUSCITATION, V84, P867, DOI 10.1016/j.resuscitation.2013.01.019; CURIO G, 1994, ELECTROEN CLIN NEURO, V91, P483, DOI 10.1016/0013-4694(94)90169-4; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; FERBERT A, 1990, BRAIN, V113, P49, DOI 10.1093/brain/113.1.49; Fischer C, 2005, NEUROPSYCHOL REHABIL, V15, P372, DOI 10.1080/09602010443000434; Fisher M, 2004, CEREBROVASC DIS, V17, P1, DOI 10.1159/000074790; Geocadin RG, 2006, NEUROLOGY, V67, P105, DOI 10.1212/01.wnl.0000223335.86166.b4; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; Hakimi K, 2009, NEUROCRIT CARE, V11, P353, DOI 10.1007/s12028-009-9251-7; Hashimoto I, 1996, EVOKED POTENTIAL, V100, P189, DOI 10.1016/0168-5597(95)00244-8; Haupt WF, 2006, J CLIN NEUROPHYSIOL, V23, P389, DOI 10.1097/01.wnp.0000223454.04161.cf; Haupt WF, 2000, J CLIN NEUROPHYSIOL, V17, P326, DOI 10.1097/00004691-200005000-00010; Howell K, 2013, RESUSCITATION, V84, P1409, DOI 10.1016/j.resuscitation.2013.05.015; HUTCHINSON DO, 1991, ELECTROEN CLIN NEURO, V78, P228, DOI 10.1016/0013-4694(91)90037-5; Ikeda H, 2005, CLIN NEUROPHYSIOL, V116, P827, DOI 10.1016/j.clinph.2004.10.010; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; Leithner C, 2012, AKTUEL NEUROL, V39, P145, DOI 10.1055/s-0032-1308995; Leithner C, 2010, NEUROLOGY, V75, P575; Leithner C, 2010, NEUROLOGY, V74, P965, DOI 10.1212/WNL.0b013e3181d5a631; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; Lule D, 2009, PROG BRAIN RES, V177, P339, DOI 10.1016/S0079-6123(09)17723-3; MAHONEY F I, 1965, Md State Med J, V14, P61; Morgalla MH, 2006, ANAESTHESIST, V55, P760, DOI 10.1007/s00101-006-1036-1; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Neugebauer H, 2014, NEUROCRIT CARE, V21, P27, DOI 10.1007/s12028-014-9956-0; Oddo M, 2011, CURR OPIN CRIT CARE, V17, P254, DOI 10.1097/MCC.0b013e328344f2ae; PohlmannEden B, 1997, INTENS CARE MED, V23, P301, DOI 10.1007/s001340050332; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Robinson Lawrence R, 2004, Phys Med Rehabil Clin N Am, V15, P43, DOI 10.1016/S1047-9651(03)00102-5; Robinson LR, 2010, NEUROCRIT CARE, V12, P69, DOI 10.1007/s12028-009-9191-2; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Rothstein T, 2010, NEUROLOGY, V75, P575, DOI 10.1212/WNL.0b013e3181ec6819; Rothstein TL, 2012, NEUROCRIT CARE, V17, P146, DOI 10.1007/s12028-012-9696-y; Rothstein TL, 2000, J CLIN NEUROPHYSIOL, V17, P486, DOI 10.1097/00004691-200009000-00007; RUMPL E, 1988, J CLIN NEUROPHYSIOL, V5, P237, DOI 10.1097/00004691-198807000-00002; Samaniego EA, 2011, CURR NEUROL NEUROSCI, V11, P111, DOI 10.1007/s11910-010-0148-9; Schonle P W, 1995, Rehabilitation (Stuttg), V34, P69; Schwarz S, 1999, CRIT CARE MED, V27, P182, DOI 10.1097/00003246-199901000-00049; Sherman AL, 2000, NEUROLOGY, V54, P889, DOI 10.1212/WNL.54.4.889; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; Steffen IG, 2010, CRIT CARE, V14, DOI 10.1186/cc8975; Tiainen M, 2005, CRIT CARE MED, V33, P1736, DOI 10.1097/01.CCM.0000171536.63641.D9; van Putten MJAM, 2012, CLIN NEUROPHYSIOL, V123, P1460, DOI 10.1016/j.clinph.2011.10.049; Wang JT, 2004, CAN J NEUROL SCI, V31, P438, DOI 10.1017/S0317167100003619; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wohlrab G, 2001, NEUROPEDIATRICS, V32, P271, DOI 10.1055/s-2001-19123; Young GB, 2009, NEW ENGL J MED, V361, P605, DOI 10.1056/NEJMcp0903466; Young GB, 2005, NEUROCRIT CARE, V2, P159, DOI 10.1385/NCC:2:2:159; Zandbergen EGJ, 2006, NEUROLOGY, V67, P583, DOI 10.1212/01.wnl.0000230162.35249.7f; Zandbergen EGJ, 2006, CLIN NEUROPHYSIOL, V117, P1529, DOI 10.1016/j.clinph.2006.03.018; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	72	6	6	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2014	123						25	33		10.1016/j.clineuro.2014.05.004			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AM6QG	WOS:000339989100006	25012007				2022-02-06	
J	Galbraith, KL; Keck, AS; Little, C				Galbraith, Kyle L.; Keck, Anna-Sigrid; Little, Charletta			SINGLE-SITE COMMUNITY CONSULTATION FOR EMERGENCY RESEARCH IN A COMMUNITY HOSPITAL SETTING	PREHOSPITAL EMERGENCY CARE			English	Article						exception from informed consent; community consultation; social media; institutional review board (IRB); research ethics	INFORMED-CONSENT; PUBLIC DISCLOSURE; EXCEPTION; WAIVER	Objectives. The purpose of this study was to evaluate community member feedback from community consultation and public disclosure activities performed for a clinical investigation involving a device designed to treat traumatic brain injury in prehospital contexts. The clinical investigation of that device was to be performed under the federal regulations providing an exception from prospective informed consent requirements in emergency settings. Secondarily, we sought to assess the community consultation process by measuring the levels of outreach provided by the different communication methods used in these activities, with special attention to the effectiveness of social media for community outreach. Methods and setting. The medical device investigation consists of a single-site pilot study based at a 345-bed community hospital in east central Illinois, which also serves as the area's only level I trauma center. Investigators, in collaboration with the local institutional review board, fulfilled community consultation and public disclosure requirements through four public town hall meetings, seven targeted focus groups, targeted mailings to 884 community leaders and researchers, a press conference and press release, internal and external websites, and multiple postings to the hospital's Facebook and Twitter accounts. Community members provided feedback by completing paper or electronic comment cards. Results. A total of 428 community members attended the four town hall meetings and seven focus group sessions. Attendance at each meeting ranged from 4 to 20 attendees for the town hall meetings and 8 to 140 attendees for the focus groups. The investigation's external website received 626 unique visitors and the intranet website received 528 unique visits. Social media postings on Facebook and Twitter received six comments and eight "likes" to indicate that an individual read the posting. In total, attendees completed 175 comment cards to provide their feedback. Community member attitudes regarding the research were very positive, with 173 (98.8%) comment card respondents viewing the research as beneficial and 162 (92.6%) indicating that they would allow themselves or their family members to participate in the research. Conclusions. The internal and external websites provided the most effective means for sharing research-related information to community members. While cost-effective, social media outreach was very limited and did not foster communication with community members.	[Galbraith, Kyle L.; Keck, Anna-Sigrid; Little, Charletta] Carle Fdn Hosp, Urbana, IL 61801 USA		Keck, AS (corresponding author), Carle Fdn Hosp, Urbana, IL 61801 USA.	kyle.galbraith@carle.com		Keck, Anna-Sigrid/0000-0003-1664-8699			Biros MH, 1999, ACAD EMERG MED, V6, P1272, DOI 10.1111/j.1553-2712.1999.tb00144.x; Contant C, 2006, CRIT CARE MED, V34, P2049, DOI 10.1097/01.CCM.0000227649.72651.F1; Department of health and human Services/Food and Drug Administration/office of Secretary, 1996, FED REGISTER, V61, P51497; Department of Health and Human Services/ U. S. Food and Drug Administration, 2011, GUID I REV BOARDS CL; Ernst AA, 2005, ACAD EMERG MED, V12, P1050, DOI 10.1197/j.aem.2005.06.015; Faul M, 2010, TRAUMATIC BRAIN INJU; Govindarajan P, 2013, ACAD EMERG MED, V20, P98, DOI 10.1111/acem.12039; Ramsey CA, 2011, ACAD EMERG MED, V18, P733, DOI 10.1111/j.1553-2712.2011.01102.x; Shah AN, 2003, ANN EMERG MED, V41, P72, DOI 10.1067/mem.2003.14; Silbergleit R, 2012, ACAD EMERG MED, V19, P448, DOI 10.1111/j.1553-2712.2012.01328.x; Stephens SW, 2013, CIRCULATION, V128, P267, DOI 10.1161/CIRCULATIONAHA.113.002390; Thaker SI, 2011, ANN INTERN MED, V154, P707, DOI 10.7326/0003-4819-154-10-201105170-00021; Tisherman SA, 2008, CIRCULATION, V118, P1585, DOI 10.1161/CIRCULATIONAHA.107.764084; Zickuhr K., 2012, DIGITAL DIFFERENCES	14	6	6	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JUL-SEP	2014	18	3					328	334		10.3109/10903127.2014.882998			7	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	AJ7UH	WOS:000337903300002	24669874				2022-02-06	
J	Tinney, G; Gerlock, AA				Tinney, Glenna; Gerlock, April A.			INTIMATE PARTNER VIOLENCE, MILITARY PERSONNEL, VETERANS, AND THEIR FAMILIES	FAMILY COURT REVIEW			English	Article						Co-Occurring Conditions; Family Court Personnel; Intimate Partner Violence; Military Personnel; Posttraumatic Stress Disorder; and Veterans	POSTTRAUMATIC-STRESS-DISORDER; RISK-FACTORS; DOMESTIC VIOLENCE; ABUSE; AFGHANISTAN; IRAQ; AGGRESSION; TRAUMA; WAR	Communities throughout the country are grappling with the aftermath of the protracted wars in Iraq (Operation Iraqi Freedom) and Afghanistan (Operation Enduring Freedom) and how to serve military personnel, veterans, and their families effectively with sensitivity to the experiences they have had and the issues they face. This article begins with a discussion of bringing a contextual analysis to the understanding of intimate partner violence (IPV) and how IPV may or may not overlap with potential co-occurring combat-related conditions such as posttraumatic stress disorder, traumatic brain injury, substance use disorder, and depression. Elements of risk and danger, especially in relationship to IPV, these co-occurring conditions, and suicide are also addressed. Implications for family court personnel start with effective methods for screening and assessment within the framework of the larger contextual analysis. The article provides tips for family court personnel by addressing the larger context, applying effective screening/assessment strategies, and utilizing resources available within the military, Veterans' Health Administration, and community settings.	[Tinney, Glenna] Mil Advocacy Program, Sydney, NSW, Australia; [Tinney, Glenna] Battered Womens Justice Project, Minneapolis, MN USA; [Gerlock, April A.] Univ Washington, Sch Nursing, Psychosocial & Community Hlth Nursing, Seattle, WA 98195 USA		Tinney, G (corresponding author), Mil Advocacy Program, Sydney, NSW, Australia.	gtinney@bwjp.org; gerlockaprila@comcast.net			Office on Violence Against Women, U.S. Department of Justice [2011-TA-AX-K110]	This project was supported by Grant No. 2011-TA-AX-K110 awarded by the Office on Violence Against Women, U.S. Department of Justice. The opinions, findings, conclusions, and recommendations expressed in this publication/program/exhibition are those of the authors and do not necessarily reflect the views of the Department of Justice, Office on Violence Against Women.	American Psychiatric Association, 2013, DIAG STAT MAN MENT D; Bachynski KE, 2012, INJURY PREV, V18, P405, DOI 10.1136/injuryprev-2011-040112; Bell KM, 2009, JAMA-J AM MED ASSOC, V302, P562, DOI 10.1001/jama.2009.1126; Bell NS, 2006, ALCOHOL CLIN EXP RES, V30, P1721, DOI 10.1111/j.1530-0277.2006.00214.x; Campbell J., 1995, ASSESSING DANGEROUSN; Campbell J. C., 2003, NATL I JUSTICE J, V250; Campbell J.C., 1992, FEMICIDE POLITICS WO, P99; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Catalano S., 2012, INTIMATE PARTNER VIO; Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury and the Defense andVeterans Brain Injury Center, 2010, MILD TRAUM BRAIN INJ; Dutton D., 2000, TRAUMA VIOLENCE ABUS, V1, P171, DOI DOI 10.1177/1524838000001002004; Dutton MA, 2005, SEX ROLES, V52, P743, DOI 10.1007/s11199-005-4196-6; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Elbogen Eric B, 2012, J Clin Psychiatry, V73, pe767, DOI 10.4088/JCP.11m07593; Gerlock A A, 1999, Issues Ment Health Nurs, V20, P373, DOI 10.1080/016128499248547; Gerlock AA, 2004, MIL MED, V169, P470, DOI 10.7205/MILMED.169.6.470; Gerlock AA, 2014, J MARITAL FAM THER, V40, P344, DOI 10.1111/jmft.12017; Goodman LA, 2000, J INTERPERS VIOLENCE, V15, P63, DOI 10.1177/088626000015001005; Heckert DA, 2004, J INTERPERS VIOLENCE, V19, P778, DOI 10.1177/0886260504265619; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hotaling G T, 1986, Violence Vict, V1, P101; Institute of Medicine of the National Academies, 2008, GULF WAR HLTH PHYS P, V6; Johnson MP, 2011, AGGRESS VIOLENT BEH, V16, P289, DOI 10.1016/j.avb.2011.04.006; Johnson MP., 2008, TYPOLOGY DOMESTIC VI; Karch D. L., 2011, SURVEILLANCE VIOLENT; Kropp PR, 2008, VIOLENCE VICTIMS, V23, P202, DOI 10.1891/0886-6708.23.2.202; Kropp PR, 2000, LAW HUMAN BEHAV, V24, P101, DOI 10.1023/A:1005430904495; Kulka R. A., 1988, CNTRACTUAL REPORT FI; Luxton D.D., 2012, DEP DEFENSE SUICIDE; Marshall AD, 2005, CLIN PSYCHOL REV, V25, P862, DOI 10.1016/j.cpr.2005.05.009; McCarroll James E, 2004, Violence Vict, V19, P453, DOI 10.1891/088667004780927882; McLeland KC, 2008, PSYCHOL REP, V103, P836, DOI 10.2466/PR0.103.3.836-844; National Center for PTSD, 2013, PTSD SCREEN INSTR; National Domestic Violence Fatality Review Initiative, 2012, REPORTS; Office of Applied Studies, 2008, MAJ DEPR EP TREATM D; Orcutt HK, 2003, J TRAUMA STRESS, V16, P381, DOI 10.1023/A:1024470103325; Pence E., 1998, DULUTH SAFETY ACCOUN; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Roehl J, 2000, JUSTICE SYST J, V21, P171, DOI 10.1080/23277556.2000.10871281; Savarese VW, 2001, J TRAUMA STRESS, V14, P717, DOI 10.1023/A:1013038021175; Sayers SL, 2009, J CLIN PSYCHIAT, V8, pe1; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sitterle, 2006, MEASURING INTIMATE P; Sonkin D., 1997, DOMESTIC VIOLENCE PE; Straus M. A., 1992, CHILDREN VIOLENCE RE; Suicide Risk Management & Surveillance Office, 2008, ARM SUIC REP CAL YEA; Taber KH, 2010, PTSD RES Q, V21, P1; Taft CT, 2007, J TRAUMA STRESS, V20, P135, DOI 10.1002/jts.20197; Taft CT, 2011, J CONSULT CLIN PSYCH, V79, P22, DOI 10.1037/a0022196; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teten AL, 2009, J TRAUMA STRESS, V22, P307, DOI 10.1002/jts.20422; U. S. Department of Veterans Affairs, 2013, POL TBI SYST CAR UND; Weisz AN, 2000, J INTERPERS VIOLENCE, V15, P75, DOI 10.1177/088626000015001006	54	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1531-2445	1744-1617		FAM COURT REV	Fam. Court Rev.	JUL	2014	52	3			SI		400	416		10.1111/fcre.12100			17	Family Studies; Law	Emerging Sources Citation Index (ESCI)	Family Studies; Government & Law	V81GK	WOS:000212238500007					2022-02-06	
J	Xerri, C; Zennou-Azogui, Y				Xerri, Christian; Zennou-Azogui, Yoh'i			Early and Moderate Sensory Stimulation Exerts a Protective Effect on Perilesion Representations of Somatosensory Cortex after Focal Ischemic Damage	PLOS ONE			English	Article							INDUCED MOVEMENT THERAPY; TRAUMATIC BRAIN-INJURY; INDUCED CORTICAL INFARCTS; NEUROTROPHIC FACTOR; ENVIRONMENTAL ENRICHMENT; SENSORIMOTOR CORTEX; RECEPTIVE-FIELDS; FOREPAW REPRESENTATION; CEREBRAL INFARCTION; MOTOR RECOVERY	Previous studies have shown that intensive training within an early critical time window after focal cortical ischemia increases the area of damaged tissue and is detrimental to behavioral recovery. We postulated that moderate stimulation initiated soon after the lesion could have protective effects on peri-infarct cortical somatotopic representations. Therefore, we have assessed the effects of mild cutaneous stimulation delivered in an attention-demanding behavioral context on the functional organization of the perilesion somatosensory cortex using high-density electrophysiological mapping. We compared the effects of 6-day training initiated on the 3rd day postlesion (early training; ET) to those of same-duration training started on the 8th day (delayed training; DT). Our findings confirm previous work showing that the absence of training aggravates representational loss in the perilesion zone. In addition, ET was found to be sufficient to limit expansion of the ischemic lesion and reduce tissue loss, and substantially maintain the neuronal responsiveness to tactile stimulation, thereby preserving somatotopic map arrangement in the peri-infarct cortical territories. By contrast, DT did not prevent tissue loss and only partially reinstated lost representations in a use-dependent manner within the spared peri-infarct cortical area. This study differentiates the effects of early versus delayed training on perilesion tissue and cortical map reorganization, and underscores the neuroprotective influence of mild rehabilitative stimulation on neuronal response properties in the peri-infarct cortex during an early critical period.	[Xerri, Christian; Zennou-Azogui, Yoh'i] Aix Marseille Univ, CNRS, Unite Mixte Rech 7260, Federat Rech Comportement Cerveau Cognit 3512, Marseille, France		Xerri, C (corresponding author), Aix Marseille Univ, CNRS, Unite Mixte Rech 7260, Federat Rech Comportement Cerveau Cognit 3512, Marseille, France.	christian.xerri@univ-amu.fr			Ministere de l'Enseignement Superieur et de la RechercheEstonian Research CouncilEuropean Commission; CNRSCentre National de la Recherche Scientifique (CNRS)European Commission	This work was supported by grants from Ministere de l'Enseignement Superieur et de la Recherche and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ADACHI H, 1995, INT J HYPERTHER, V11, P587, DOI 10.3109/02656739509022492; Back T, 2004, J NEUROL, V251, P388, DOI 10.1007/s00415-004-0399-y; Barbay S, 2006, EXP BRAIN RES, V169, P106, DOI 10.1007/s00221-005-0129-4; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; BROWN AG, 1989, J PHYSIOL-LONDON, V413, P119, DOI 10.1113/jphysiol.1989.sp017645; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; Burnett MG, 2006, STROKE, V37, P1327, DOI 10.1161/01.STR.0000217305.82123.d8; Burnett MG, 2005, BRAIN RES, V1047, P112, DOI 10.1016/j.brainres.2005.04.024; Carmichael ST, 2012, ARCH NEUROL-CHICAGO, V69, P161, DOI 10.1001/archneurol.2011.1175; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Chu CJ, 2000, EXP NEUROL, V166, P403, DOI 10.1006/exnr.2000.7509; Clarkson AN, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/708428; Clarkson AN, 2011, J NEUROSCI, V31, P3766, DOI 10.1523/JNEUROSCI.5780-10.2011; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Coq JO, 1998, EXP BRAIN RES, V121, P191, DOI 10.1007/s002210050452; Coq JO, 1999, EUR J NEUROSCI, V11, P2597, DOI 10.1046/j.1460-9568.1999.00673.x; Dalkara T, 2012, J CEREBR BLOOD F MET, V32, P2091, DOI 10.1038/jcbfm.2012.139; Davis MF, 2011, STROKE, V42, P792, DOI 10.1161/STROKEAHA.110.607135; DeBow SB, 2004, CAN J PHYSIOL PHARM, V82, P231, DOI 10.1139/Y04-013; DOETSCH GS, 1990, EXP NEUROL, V108, P162, DOI 10.1016/0014-4886(90)90024-M; DOMANN R, 1993, NEUROSCI LETT, V155, P69, DOI 10.1016/0304-3940(93)90675-B; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; DYKES RW, 1984, J NEUROPHYSIOL, V52, P1066, DOI 10.1152/jn.1984.52.6.1066; Enright LE, 2007, J CEREBR BLOOD F MET, V27, P1185, DOI 10.1038/sj.jcbfm.9600428; Eysel UT, 1997, ADV NEUROL, V73, P195; EYSEL UT, 1991, NEUROSCI LETT, V131, P45, DOI 10.1016/0304-3940(91)90333-O; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Friel KM, 1998, SOMATOSENS MOT RES, V15, P173, DOI 10.1080/08990229870745; Frostig RD, 2013, NEUROSCIENTIST, V19, P313, DOI 10.1177/1073858412462607; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Glazner GW, 2000, EXP NEUROL, V161, P442, DOI 10.1006/exnr.1999.7242; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Gottmann K, 2009, EXP BRAIN RES, V199, P203, DOI 10.1007/s00221-009-1994-z; Goubard V, 2011, J PHYSIOL-LONDON, V589, P2301, DOI 10.1113/jphysiol.2010.203125; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; Green AR, 2003, TRENDS PHARMACOL SCI, V24, P402, DOI 10.1016/S0165-6147(03)00192-5; Hata R, 2000, J CEREBR BLOOD F MET, V20, P306, DOI 10.1097/00004647-200002000-00012; HICKS TP, 1983, BRAIN RES, V274, P160, DOI 10.1016/0006-8993(83)90533-4; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jenkins WM, 1987, PROG BRAIN RES <D>, V71, P249; Johansson BB, 1996, EXP NEUROL, V139, P322, DOI 10.1006/exnr.1996.0106; Joo HW, 2012, EUR J NEUROSCI, V36, P3691, DOI 10.1111/ejn.12014; Perez-Alvarez MJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-157; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kesslak JP, 1998, BEHAV NEUROSCI, V112, P1012, DOI 10.1037/0735-7044.112.4.1012; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kundrotiene J, 2002, J NEUROTRAUM, V19, P69, DOI 10.1089/089771502753460259; LASKIN SE, 1979, J NEUROPHYSIOL, V42, P1061, DOI 10.1152/jn.1979.42.4.1061; Lay CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011270; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Lippert-Gruener M, 2007, EXP NEUROL, V203, P82, DOI 10.1016/j.expneurol.2006.07.025; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Mansoori BK, 2014, EXP NEUROL, V254, P18, DOI 10.1016/j.expneurol.2014.01.010; Martinez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016726; MITTMANN T, 1994, NEUROSCIENCE, V60, P891, DOI 10.1016/0306-4522(94)90270-4; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Neumann-Haefelin T, 1998, NEUROSCIENCE, V87, P871, DOI 10.1016/S0306-4522(98)00124-9; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Ohmoto Y, 1996, INT J HYPERTHER, V12, P321, DOI 10.3109/02656739609022521; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; PETERSON BE, 1995, J NEUROSCI METH, V57, P133, DOI 10.1016/0165-0270(94)00103-N; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Que M, 1999, NEUROSCIENCE, V93, P1233, DOI 10.1016/S0306-4522(99)00197-9; Risedal A, 1999, J CEREBR BLOOD F MET, V19, P997, DOI 10.1097/00004647-199909000-00007; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Sigler A, 2009, P NATL ACAD SCI USA, V106, P11759, DOI 10.1073/pnas.0812695106; Tang AC, 2002, BEHAV BRAIN RES, V131, P1, DOI 10.1016/S0166-4328(01)00330-8; Taub E, 1999, J REHABIL RES DEV, V36, P237; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; WATERS RS, 1995, EXP BRAIN RES, V103, P183; Winship IR, 2009, NEUROSCIENTIST, V15, P507, DOI 10.1177/1073858409333076; Xerri C, 2004, ARCH ITAL BIOL, V142, P217; Xerri C, 2003, NEUROSCIENCE, V118, P161, DOI 10.1016/S0306-4522(02)00911-9; Xerri C, 1999, CEREB CORTEX, V9, P264, DOI 10.1093/cercor/9.3.264; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119; Xerri C, 2010, BRAIN MAPPING NEURAL, P111; Zepeda A, 2004, J NEUROSCI, V24, P1812, DOI 10.1523/JNEUROSCI.3213-03.2004; Zepeda A, 2003, J CEREBR BLOOD F MET, V23, P811, DOI 10.1097/01.WCB.0000075010.31477.1E; Zhang F, 2007, NEUROSCIENCE, V150, P938, DOI 10.1016/j.neuroscience.2007.09.070	87	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99767	10.1371/journal.pone.0099767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	WOS:000340947700130	24914807	Green Published, gold, Green Submitted			2022-02-06	
J	Chen, TJ; Fu, QY; Wu, WQ				Chen, Tie-Jiang; Fu, Qing-Yang; Wu, Wu-Quan			Plasma levels of adrenomedullin in patients with traumatic brain injury: Potential contribution to prognosis	PEPTIDES			English	Article						Adrenomedullin; Traumatic brain injury; Mortality; Functional outcome	ISCHEMIC NEUROLOGICAL DEFICITS; CEREBROSPINAL-FLUID; SUBARACHNOID HEMORRHAGE; THERAPEUTIC APPLICATION; HEAD-INJURY; EXPRESSION; STROKE; HYPERTENSION; MECHANISMS; MORTALITY	High plasma levels of adrenomedullin have been associated with stroke severity and clinical outcomes. This study aimed to analyze plasma levels of adrenomedullin in traumatic brain injury and their association with prognosis. One hundred and forty-eight acute severe traumatic brain injury and 148 sex-and age-matched healthy controls were recruited in this study. Plasma adrenomedullin concentration was measured by enzyme-linked immunosorbent assay. Unfavorable outcome was defined as Glasgow Outcome Scale score of 1-3. Compared to controls, the patients had significantly higher plasma concentrations of adrenomedullin, which were also highly associated negatively with Glasgow Coma Scale score. Plasma adrenomedullin level was proved to be an independent predictor for 6-month mortality and unfavorable outcome of patients in a multivariate analysis. A receiver operating characteristic curve was configured to show that a baseline plasma adrenomedullin level predicted 6-month mortality and unfavorable outcome of patients with high area under curve. The predictive performance of the plasma adrenomedullin concentration was also similar to that of Glasgow Coma Scale score for the prediction of 6-month mortality and unfavorable outcome of patients. In a combined logistic-regression model, adrenomedullin improved the area under curve of Glasgow Coma Scale score for the prediction of 6-month mortality and unfavorable outcome of patients, but the differences did not appear to be statistically significant. Thus, high plasma levels of adrenomedullin are associated with head trauma severity, and may independently predict long-term clinical outcomes of traumatic brain injury. (c) 2014 Elsevier Inc. All rights reserved.	[Chen, Tie-Jiang; Fu, Qing-Yang; Wu, Wu-Quan] Yiwu Cent Hosp, Dept Emergency Surg, Yiwu 322000, Zhejiang, Peoples R China		Chen, TJ (corresponding author), Yiwu Cent Hosp, Dept Emergency Surg, 699 Jiangdong Rd, Yiwu 322000, Zhejiang, Peoples R China.	hzhzzhoufeng@163.com					Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Ashizuka S, 2013, CURR PROTEIN PEPT SC, V14, P246, DOI 10.2174/13892037113149990044; Baliga RS, 2013, HANDB EXP PHARMACOL, V218, P477, DOI 10.1007/978-3-642-38664-0_19; Fern a ndez AP, 2008, P NATL ACAD SCI USA, V105, P12581; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Ishimitsu T, 2006, PHARM THER; Jahnke GD, 2001, J NEUROSCI RES, V66, P464, DOI 10.1002/jnr.1237; JENNETT B, 1975, LANCET, V1, P480; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kataoka Y, 2010, J CARDIOVASC PHARM, V56, P413, DOI 10.1097/FJC.0b013e3181f15b45; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kubo Y, 2008, CEREBROVASC DIS, V25, P164, DOI 10.1159/000113734; Kubo Y, 2013, NEUROL RES, V35, P713, DOI 10.1179/1743132813Y.0000000222; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Liu J, 2014, INT J NEUROSCI, V124, P271, DOI 10.3109/00207454.2013.837462; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Miyamoto N, 2009, J CEREBR BLOOD F MET, V29, P1769, DOI 10.1038/jcbfm.2009.92; Miyashita K, 2006, ENDOCRINOLOGY, V147, P1642, DOI 10.1210/en.2005-1038; Nishikimi T, 2013, CURR PROTEIN PEPT SC, V14, P256, DOI 10.2174/13892037113149990045; Robertson CL, 2000, ACT NEUR S, V76, P419; Robertson CL, 2001, J NEUROTRAUM, V18, P861, DOI 10.1089/089771501750451785; Serrano J, 2002, NEUROSCIENCE, V109, P717, DOI 10.1016/S0306-4522(01)00532-2; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Wang CL, 2014, PEPTIDES, V54, P27, DOI 10.1016/j.peptides.2014.01.005; Xia CF, 2006, EXP NEUROL, V197, P521, DOI 10.1016/j.expneurol.2005.10.027; Zhang H, 2014, PEPTIDES, V52, P44, DOI 10.1016/j.peptides.2013.11.025	29	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JUN	2014	56						146	150		10.1016/j.peptides.2014.04.005			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	AI0FL	WOS:000336521500019	24747282				2022-02-06	
J	Ehrmann, BJ; Selewski, DT; Troost, JP; Hieber, SM; Gipson, DS				Ehrmann, Brett J.; Selewski, David T.; Troost, Jonathan P.; Hieber, Susan M.; Gipson, Debbie S.			Hypertension and Health Outcomes in the PICU	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						acute kidney injury; hypertension; length of stay; mortality; pediatric intensive care unit; pediatrics	PEDIATRIC INTENSIVE-CARE; ACUTE KIDNEY INJURY; BLOOD-PRESSURE; CHILDREN; RISK; ADOLESCENTS; TRENDS; TERM; UNIT	Objectives: Reports of the burden of hypertension in hospitalized children are emerging, but the prevalence and significance of this condition within the PICU are not well understood. The aims of this study were to validate a definition of hypertension in the PICU and assess the associations between hypertension and acute kidney injury, PICU length of stay, and mortality. Design and Setting: Single-center retrospective study using a database of PICU discharges between July 2011 and February 2013. Patients: All children discharged from the PICU with length of stay more than 6 hours, aged 1 month through 17 years. Exclusions were traumatic brain injury, incident renal transplant, or hypotension. Interventions: None. Measurements and Main Results: Potential definitions of hypertension utilizing combinations of standardized cutoff percentiles, durations, initiation or dose escalation of antihypertensives, and/ or billing diagnosis codes for hypertension were compared using receiver operator characteristic curves against a manual medical record review. Multivariable logistic and linear regression analyses were conducted using the selected definition of hypertension to assess its independent association with acute kidney injury and PICU length of stay, respectively. A definition requiring three systolic and/ or diastolic readings above standardized 99th percentiles plus 5 mm Hg over 1 day was selected (area under the curve, 0.91; sensitivity, 94%; specificity, 87%). Among the 1,215 patients in this analysis, the prevalence of hypertension was 25%. Hypertension was independently associated with acute kidney injury (odds ratio, 2.89; 95% CI, 1.64- 5.09; p < 0.01) and increased PICU length of stay (1.50 d; 95% CI, 0.94- 2.05; p < 0.01) in multivariable analyses. Deaths were rare-0 in the normotension group and 3 (1%) in the hypertension group-but were statistically different (p = 0.02). Conclusions: Hypertension is common in the PICU and is associated with worse clinical outcomes. Future studies are needed to confirm these results.	[Ehrmann, Brett J.; Selewski, David T.; Troost, Jonathan P.; Hieber, Susan M.; Gipson, Debbie S.] Univ Michigan Hlth Syst, CS Mott Childrens Hosp, Dept Pediat, Div Pediat Nephrol, Ann Arbor, MI 48109 USA; CS Mott Childrens Hosp, Ann Arbor, MI USA		Ehrmann, BJ (corresponding author), Univ Michigan Hlth Syst, CS Mott Childrens Hosp, Dept Pediat, Div Pediat Nephrol, Ann Arbor, MI 48109 USA.	behrmann@med.umich.edu		Troost, Jonathan/0000-0002-1183-8330; Gipson, Debbie/0000-0003-4473-9045	Renal Research Institute and Clinical and Translational Science - National Center for Advancing Translational Studies and the National Institutes of Health. [2TL1TR000435-06]; predoctoral Master's degree program including didactics and conduction of a clinical research project; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Renal Research Institute; National Center for Advancing Translational Studies; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000435] Funding Source: NIH RePORTER	Supported, in part, by a grant from the Renal Research Institute and Clinical and Translational Science Award 2TL1TR000435-06 from the National Center for Advancing Translational Studies and the National Institutes of Health.; Dr. Ehrmann and his institution received grant support. This work was supported by Clinical and Translational Science Award 2TL1TR000435-06, from the National Center for Advancing Translational Studies and the National Institutes of Health ( NIH). This funding was awarded as a stipend for full-time participation in a predoctoral Master's degree program including didactics and conduction of a clinical research project (this manuscript being one of the end products). Dr. Ehrmann received support for article research from the NIH. Dr. Selewski's institution received grant support from the Renal Research Institute (Support database manager. No faculty support). Dr. Troost received support for article research from the NIH. His institution received grant support from the National Center for Advancing Translational Studies. Dr. Gipson consulted for GSK. Her institution received grant support from the NIH, PCORI, Renal Research Institute, UK British Council (RRI grant role is as mentor to junior faculty PI. Grant paid for a portion of the data management activity to establish an electronic medical record extract of all children admitted to the ICU. This data base, but not the funding, was subsequently used for this project. No other grants are related to AKI). Dr. Hieber disclosed that she does not have any potential conflicts of interest.	[Anonymous], 2011, HCUP CHRON COND IND; Askenazi DJ, 2006, KIDNEY INT, V69, P184, DOI 10.1038/sj.ki.5000032; Boer DP, 2010, PEDIATR NEPHROL, V25, P2107, DOI 10.1007/s00467-010-1533-y; Buck CJ, 2013, ICD 9 CM, V2; Buck CJ, 2013, ICD 9 CM, V3; Buck CJ, 2013, ICD 9 CM, V1; Chiolero A, 2007, J HYPERTENS, V25, P2209, DOI 10.1097/HJH.0b013e3282ef48b2; Derrico D J, 1993, Dimens Crit Care Nurs, V12, P31, DOI 10.1097/00003465-199301000-00013; Din-Dzietham R, 2007, CIRCULATION, V116, P1488, DOI 10.1161/CIRCULATIONAHA.106.683243; Dosa NP, 2001, PEDIATRICS, V107, P499, DOI 10.1542/peds.107.3.499; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Hansen ML, 2007, JAMA-J AM MED ASSOC, V298, P874, DOI 10.1001/jama.298.8.874; Holt TR, 2011, PEDIATR CRIT CARE ME, V12, pE391, DOI 10.1097/PCC.0b013e3182230f43; HORAN M J, 1987, Pediatrics, V79, P1; Lo JC, 2013, PEDIATRICS, V131, pE415, DOI 10.1542/peds.2012-1292; Mammen C, 2012, AM J KIDNEY DIS, V59, P523, DOI 10.1053/j.ajkd.2011.10.048; McNiece KL, 2007, HYPERTENSION, V50, P392, DOI 10.1161/HYPERTENSIONAHA.107.092197; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Merkel S I, 1997, Pediatr Nurs, V23, P293; Mitchell P, 2007, HYPERTENSION, V49, P1156, DOI 10.1161/HYPERTENSIONAHA.106.085910; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; PERRIN EC, 1993, PEDIATRICS, V91, P787; POLLACK MM, 1994, JAMA-J AM MED ASSOC, V272, P941, DOI 10.1001/jama.272.12.941; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Ruttimann UE, 1998, J PEDIATR-US, V133, P79, DOI 10.1016/S0022-3476(98)70182-9; Selewski DT, 2013, J PEDIATR-US, V162, P725, DOI 10.1016/j.jpeds.2012.10.002; Sharfuddin A, 2011, BRENNER RECTORS KIDN, P1044; Sleeper EJ, 2009, J PEDIATR-US, V154, P213, DOI 10.1016/j.jpeds.2008.08.009; Sorof JM, 2003, PEDIATR NEPHROL, V18, P1020, DOI 10.1007/s00467-003-1187-0; Tan G. H., 1998, Annals Academy of Medicine Singapore, V27, P813; Tran CL, 2012, HYPERTENSION, V60, P296, DOI 10.1161/HYPERTENSIONAHA.111.188813; Trasande L, 2009, HEALTH AFFAIR, V28, pW751, DOI 10.1377/hlthaff.28.4.w751; Turkel S, 2007, PSYCHIAT CLIN N AM, V30, P819, DOI 10.1016/j.psc.2007.07.009; Volakli EA, 2012, PEDIATR INT, V54, P248, DOI 10.1111/j.1442-200X.2011.03545.x	36	6	6	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUN	2014	15	5					417	427		10.1097/PCC.0000000000000126			11	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	AJ0TJ	WOS:000337368600009	24717906	Green Accepted			2022-02-06	
J	Schaadt, AK; Schmidt, L; Reinhart, S; Adams, M; Garbacenkaite, R; Leonhardt, E; Kuhn, C; Kerkhoff, G				Schaadt, Anna-Katharina; Schmidt, Lena; Reinhart, Stefan; Adams, Michaela; Garbacenkaite, Ruta; Leonhardt, Eva; Kuhn, Caroline; Kerkhoff, Georg			Perceptual Relearning of Binocular Fusion and Stereoacuity After Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						binocular vision; stereoacuity; vision rehabilitation; reading; diplopia; stroke rehabilitation; traumatic brain injury	VISUAL EXPLORATION; DEPTH-PERCEPTION; ISCHEMIC-STROKE; REHABILITATION; STEREOPSIS; VISION; PATHOPHYSIOLOGY; ORIENTATION; DISORDERS; LESIONS	Background. Brain lesions may disturb binocular fusion and stereopsis, leading to blurred vision, diplopia, and reduced binocular depth perception for which no evaluated treatment is currently available. Objective. The study evaluated the effects of a novel binocular vision treatment designed to improve convergent fusional amplitude and stereoacuity in patients with stroke or traumatic brain injury (TBI). Methods. Patients (20 in all: 11 with stroke, 9 with TBI) were tested in fusional convergence, stereoacuity, near/far visual acuity, accommodation, and subjective binocular reading time until diplopia emerged at 6 different time points. All participants were treated in a single subject baseline design, with 3 baseline assessments before treatment (pretherapy), an assessment immediately after a 6-week treatment period (posttherapy), and 2 follow-up tests 3 and 6 months after treatment. Patients received a novel fusion and dichoptic training using 3 different devices to slowly increase fusional and disparity angles. Results. At pretherapy, the stroke and TBI groups showed severe impairments in convergent fusional range, stereoacuity, subjective reading duration, and partially in accommodation (only TBI group). After treatment, both groups showed considerable improvements in all these variables as well as slightly increased near visual acuity. No significant changes were observed during the pretherapy and follow-up periods, ruling out spontaneous recovery and demonstrating long-term stability of binocular treatment effects. Conclusions. This proof-of-principle study indicates a substantial treatment-induced plasticity of the lesioned brain in the relearning of binocular fusion and stereovision, thus providing new, effective rehabilitation strategies to treat binocular vision deficits resulting from permanent visual cortical damage.	[Schaadt, Anna-Katharina; Schmidt, Lena; Reinhart, Stefan; Adams, Michaela; Garbacenkaite, Ruta; Leonhardt, Eva; Kuhn, Caroline; Kerkhoff, Georg] Univ Saarland, D-66123 Saarbrucken, Germany; [Schaadt, Anna-Katharina; Schmidt, Lena; Kerkhoff, Georg] Int Res Training Grp 1457 Adapt Minds, Saarbrucken, Germany		Schaadt, AK (corresponding author), Univ Saarland, Clin Neuropsychol Unit, Bldg A-1-3, D-66123 Saarbrucken, Germany.	annakatharina.schaadt@uni-saarland.de		Muller, Ruta/0000-0003-4184-1570	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Georg Kerkhoff receives funding from the Deutsche Forschungsgemeinschaft (DFG), International Research Training Group IRTG 1457 Adaptive Minds.	Alkan Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025866; Arking Robert, 1998, BIOL AGING OBSERVATI; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; BENTON AL, 1970, NEUROLOGY, V20, P1084, DOI 10.1212/WNL.20.11.1084; Cashell GTW, 1989, GRUNDRISS ORTHOPTIK; chieber F., 2006, HDB PSYCHOL AGING, P129, DOI DOI 10.1016/B978-012101264-9/50010-0; DANTA G, 1978, BRAIN, V101, P569, DOI 10.1093/brain/101.4.569; Duane A, 1922, Trans Am Ophthalmol Soc, V20, P132; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; FEENEY DM, 1985, BRAIN RES, V342, P352, DOI 10.1016/0006-8993(85)91135-7; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Funk J, 2013, NEUROREHAB NEURAL RE, V27, P142, DOI 10.1177/1545968312457826; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Garnham L, 2006, BRIT J OPHTHALMOL, V90, P91, DOI 10.1136/bjo.2005.077719; HAMSHER KDS, 1978, NEUROPSYCHOLOGIA, V16, P453; Harmsen P, 2009, STROKE, V40, P2691, DOI 10.1161/STROKEAHA.109.550814; HART CT, 1969, P ROY SOC MED, V62, P704, DOI 10.1177/003591576906200731; Huxlin KR, 2009, J NEUROSCI, V29, P3981, DOI 10.1523/JNEUROSCI.4882-08.2009; KELLER HH, 1984, KLIN MONATSBL AUGENH, V184, P62, DOI 10.1055/s-2008-1054413; KERKHOFF G, 1993, NEUROPSYCHOLOGIA, V31, P261, DOI 10.1016/0028-3932(93)90090-M; Kerkhoff G, 2000, J NEUROL NEUROSUR PS, V68, P691, DOI 10.1136/jnnp.68.6.691; Koh SB, 2008, EUR NEUROL, V60, P174, DOI 10.1159/000148244; Kraft A, 2014, CORTEX, V56, P38, DOI 10.1016/j.cortex.2012.10.004; Kruger KE, 1982, PHYSL METHODISCHE GR; Kuhn C, 2010, NEUROPSYCHOLOGIA, V48, P3205, DOI 10.1016/j.neuropsychologia.2010.06.035; Lane AR, 2010, BRAIN, V133, P1717, DOI 10.1093/brain/awq088; Lee, 1998, Strabismus, V6, P175, DOI 10.1076/stra.6.4.175.621; Miller LJ, 1999, ARCH CLIN NEUROPSYCH, V14, P537; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; Orban GA, 2008, PHYSIOL REV, V88, P59, DOI 10.1152/physrev.00008.2007; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; PRATTJOHNSON JA, 1973, BRIT J OPHTHALMOL, V57, P347, DOI 10.1136/bjo.57.5.347; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; PTITO A, 1991, BRAIN, V114, P1323, DOI 10.1093/brain/114.3.1323; PTITO A, 1988, NEUROPSYCHOLOGIA, V26, P547, DOI 10.1016/0028-3932(88)90111-X; Reinhart S, 2011, NEUROPSYCHOLOGIA, V49, P2728, DOI 10.1016/j.neuropsychologia.2011.05.022; Richter HO, 2000, EUR J NEUROSCI, V12, P311, DOI 10.1046/j.1460-9568.2000.00962.x; Rizzo M., 1989, HDB NEUROPSYCHOLOGY, P415; ROSENBLUM WI, 1981, NEUROSURGERY, V9, P613, DOI 10.1227/00006123-198112000-00001; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; SALMASO D, 1985, CORTEX, V21, P533, DOI 10.1016/S0010-9452(58)80003-9; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Schuett S, 2012, BRAIN, V135, P912, DOI 10.1093/brain/awr356; SERVOS P, 1992, VISION RES, V32, P1513, DOI 10.1016/0042-6989(92)90207-Y; SKELTON BJ, 1991, VISION RES, V31, P1573, DOI 10.1016/0042-6989(91)90134-Q; Spiegel DP, 2013, NEUROTHERAPEUTICS, V10, P831, DOI 10.1007/s13311-013-0200-y; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Yoonessi A, 2011, J VISION, V11, DOI 10.1167/11.9.13	51	6	6	0	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUN	2014	28	5					462	471		10.1177/1545968313516870			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	AN6SQ	WOS:000340727700008	24376065				2022-02-06	
J	Bohman, K; Stigson, H; Krafft, M				Bohman, Katarina; Stigson, Helena; Krafft, Maria			Long-Term Medical Consequences for Child Occupants 0 to 12 Years Injured in Car Crashes	TRAFFIC INJURY PREVENTION			English	Article						child injury; head injury; neck injury; WAD; disability; permanent medical impairment	TRAUMATIC BRAIN-INJURY; POSITIONING BOOSTER SEATS; ROAD TRAFFIC ACCIDENTS; QUALITY-OF-LIFE; SAFETY SEATS; PULMONARY CONTUSION; CAUSATION SCENARIOS; RISK; MORTALITY; OUTCOMES	Objective: There is limited knowledge of the long-term medical consequences for children injured in car crashes. Thus, in the event of injury, the aim of the study was to specify patterns and risks of injuries resulting in permanent medical impairment of children (0-12years) for different body regions and injury severity levels, according to Abbreviated Injury Scale (AIS). The aim was also to compare the impairment outcome with adults. Methods: Data were obtained from the Folksam insurance company, including reported car crashes from 1998 to 2010 with at least one injured child 0-12years of age. In all, 2619 injured children with 3704 reported medical diagnoses were identified. All injuries were classified according to the AIS 2005 revision. If the child had not recovered within 1 year postinjury an assessment of permanent medical impairment (PMI) was made by one or several medical specialists. Results: In all, 55 children sustained 59 injuries resulting in PMI of which 75 percent were at AIS 1 or AIS 2. The head and cervical spine were the body regions sustaining the most injuries resulting in PMI. Sixty-eight percent of all injuries resulting in PMI were AIS 1 injuries to the cervical spine, with the majority occurring in frontal or rear impacts. Given an injury to the cervical spine, the risk of injuries resulting in PMI was 3 percent, and older children (6years) had a significantly higher risk (3% versus 1%) than younger children. The head was the second most commonly injured body region with injuries resulting in PMI (12/59), which were predominantly AIS 2+. In addition, mild traumatic brain injuries at AIS 1 were found to lead to PMI. Whereas for children the injuries leading to PMI were primarily limited to the head and cervical spine, adults sustained injuries that led to PMI from a more diverse distribution of body regions. Conclusion: The pattern of injuries resulting in permanent medical impairment is different for children and adults; therefore, safety priorities for children need to be based on child data. The majority of those injuries leading to PMI were at lower AIS levels. Furthermore, AIS 1 cervical spine and AIS 1+ head injuries should be given priority concerning mitigation of long-term consequences for children.	[Bohman, Katarina] Autoliv Res, SE-44783 Vargarda, Sweden; [Bohman, Katarina; Stigson, Helena] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Stigson, Helena; Krafft, Maria] Folksam Res, Stockholm, Sweden; [Krafft, Maria] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden		Bohman, K (corresponding author), Autoliv Res, Wallentinsvagen 22, SE-44783 Vargarda, Sweden.	katarina.bohman@autoliv.com	Stigson, Helena/AAZ-6786-2020	Stigson, Helena/0000-0002-2409-1379	"Fordonsstrategisk Forskning och Innovation" (FFI)	The authors acknowledge the "Fordonsstrategisk Forskning och Innovation" (FFI) for partially funding the project.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; AGRAN PF, 1987, J TRAUMA, V27, P58, DOI 10.1097/00005373-198701000-00011; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Amital A, 2009, ISR MED ASSOC J, V11, P673; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Arbogast K. B., 2005, INT RES C BIOM IMP I; Arbogast KB, 2004, ACCIDENT ANAL PREV, V36, P585, DOI 10.1016/S0001-4575(03)00065-4; Arbogast KB, 2004, INT RES C BIOM IMP I; Arbogast KB, 2004, 49 ANN M ASS ADV AUT; Arbogast Kristy B, 2012, Ann Adv Automot Med, V56, P213; Arbogast KB, 2010, J TRAUMA, V69, P913, DOI 10.1097/TA.0b013e3181e883f9; Arbogast KB, 2009, PEDIATRICS, V124, P1281, DOI 10.1542/peds.2009-0908; Association for the Advancement of Automotive Medicine, 2005, ABBR INJ SCAL 2005; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bilston LE, 2010, ACCIDENT ANAL PREV, V42, P1974, DOI 10.1016/j.aap.2010.06.002; Bohman K, 2000, Stapp Car Crash J, V44, P103; Bohman K, 2011, TRAFFIC INJ PREV, V12, P62, DOI 10.1080/15389588.2010.526159; Boyd R, 2002, EMERG MED J, V19, P311, DOI 10.1136/emj.19.4.311; Bradford M, 1994, 38 ANN M ASS ADV AUT; Coons SJ, 2000, PHARMACOECONOMICS, V17, P13, DOI 10.2165/00019053-200017010-00002; *CTR INJ RES PREV, 2008, PARTN CHILD PASS SAF; Durbin DR, 2003, JAMA-J AM MED ASSOC, V289, P2835, DOI 10.1001/jama.289.21.2835; Elliott MR, 2006, ARCH PEDIAT ADOL MED, V160, P617, DOI 10.1001/archpedi.160.6.617; Esfahani ES, 2009, 2009 SAE WORLD C EXH; Gaines BA, 2002, CRIT CARE MED, V30, pS416, DOI 10.1097/00003246-200211001-00006; Galasko CS, 1986, 59 TRANSP RES LAB; GALASKO CSB, 1993, INJURY, V24, P155, DOI 10.1016/0020-1383(93)90279-F; Garcia-Espana JF, 2008, ACCIDENT ANAL PREV, V40, P2024, DOI 10.1016/j.aap.2008.08.018; Gustafsson H, 1985, 10 INT TECHN C ENH S; Hadfield JM, 1998, J ACCID EMERG MED, V15, P388; Haxhija EQ, 2004, PEDIATR SURG INT, V20, P412, DOI 10.1007/s00383-004-1165-z; Henary B, 2007, INJURY PREV, V13, P398, DOI 10.1136/ip.2006.015115; Howard A, 2004, J TRAUMA, V56, P1276, DOI 10.1097/01.TA.0000078883.74947.EB; Jonsson B, 2011, INT RES C BIOM IMP I; Kallan MJ, 2008, PEDIATRICS, V121, pE1342, DOI 10.1542/peds.2007-1512; Kent R, 2007, 20 ENH SAF VEH C JUN; KISHIKAWA M, 1991, J TRAUMA, V31, P1203, DOI 10.1097/00005373-199109000-00002; Krafft M, 1997, J TRAFFIC MED, V25, P89; Kullgren A, 2000, Stapp Car Crash J, V44, P117; Kuppa S., 2005, 19 INT TECHN C ENH S; Landolt MA, 2009, AUST NZ J PSYCHIAT, V43, P746, DOI 10.1080/00048670903001919; Larsson J, 2011, BALTESANVANDNINGEN S; Locey Caitlin M, 2012, Ann Adv Automot Med, V56, P299; Loftis Kathryn L, 2011, Ann Adv Automot Med, V55, P81; Loftis Kathryn L, 2011, Biomed Sci Instrum, V47, P94; MacKenzie EJ, 1996, J TRAUMA, V41, P799, DOI 10.1097/00005373-199611000-00006; Malm Sigrun, 2008, Ann Adv Automot Med, V52, P93; Maltese MR, 2007, STAPP CAR CRASH JO, V51, P299; Meridith M., 2012, JEMS, V4, P52; Nygren A., 1984, AKTA OTOLARYNGOL S, V395, P81; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Platzer P, 2007, J TRAUMA, V62, P389, DOI 10.1097/01.ta.0000221802.83549.46; Scheidler MG, 2000, J TRAUMA, V49, P864, DOI 10.1097/00005373-200011000-00012; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; SPITZER WO, 1995, SPINE, V20, pS1; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Sveriges Forsakringsforbund, 2004, GRAD MED IMP DEGR 20; Swanson J, 2003, 18 INT TECHN C ENH S; Swedish Road Administration, 2008, SWED ROAD ADM PUBL, V2008, P31; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Thompson EC, 2003, ARCH SURG-CHICAGO, V138, P142, DOI 10.1001/archsurg.138.2.142; Tingvall C, 1987, Acta Paediatr Scand Suppl, V339, P1; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	63	6	6	1	38	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	MAY 19	2014	15	4					370	378		10.1080/15389588.2013.826799			9	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	297OI	WOS:000330264400007	24471361				2022-02-06	
J	Paul, S; Khanapur, S; Boersma, W; Sijbesma, JW; Ishiwata, K; Elsinga, PH; Meerlo, P; Doorduin, J; Dierckx, RA; van Waarde, A				Paul, Soumen; Khanapur, Shivashankar; Boersma, Wytske; Sijbesma, Jurgen W.; Ishiwata, Kiichi; Elsinga, Philip H.; Meerlo, Peter; Doorduin, Janine; Dierckx, Rudi A.; van Waarde, Aren			Cerebral adenosine A(1) receptors are upregulated in rodent encephalitis	NEUROIMAGE			English	Article						Herpes simplex virus-1; MicroPET; Neuroinflammation; Rats; Adenosine; A1 receptors; Kinetic modeling	HERPES-SIMPLEX-VIRUS; POSITRON-EMISSION-TOMOGRAPHY; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ATTENUATES NEUROINFLAMMATION; PARKINSONS-DISEASE; HUMAN BRAIN; RAT-BRAIN; PET; CAFFEINE	Adenosine A(1) receptors (A(1) Rs) are implied in the modulation of neuroinflammation. Activation of cerebral A(1) Rs acts as a brake on the microglial response after traumatic brain injury and has neuroprotective properties in animal models of Parkinson's disease and multiple sclerosis. Neuroinflammatory processes in turn may affect the expression of A1Rs, but the available data is limited and inconsistent. Here, we applied an animal model of encephalitis to assess how neuroinflammation affects the expression of A1 Rs. Two groups of animals were studied: Infected rats (n=7) were intranasally inoculated with herpes simplex virus-1 (HSV-1, 1 x 10(7) plaque forming units), sham-infected rats (n=6) received only phosphate-buffered saline. Six or seven days later, microPET scans (60 min with arterial blood sampling) were made using the tracer 8-dicyclopropyl-1-C-11-methy1-3-propyl-xanthine (C-11-MPDX). Tracer clearance from plasma and partition coefficient (K-1/k(2) estimated from a 2-tissue compartment model fit) were not significantly altered after virus infection. PET tracer distribution volume calculated from a Logan plot was significantly increased in the hippocampus (+37%) and medulla (+27%) of virug infected rats. Tracer binding potential (k(3)/k(4) estimated from the model fit) was significantly increased in the cerebellum (+87%) and the medulla (+148%) which may indicate increased A1R expression. This was confirmed by immunohistochemical analysis showing a strong increase of A1R immunoreactivity in the cerebellum of HSV-1-infected rats. Both the quantitative PET data and immunohistochemical analysis indicate that A1Rs are upregulated in brain areas where active virus is present. (C) 2014 Elsevier Inc. All rights reserved.	[Paul, Soumen; Khanapur, Shivashankar; Sijbesma, Jurgen W.; Elsinga, Philip H.; Doorduin, Janine; Dierckx, Rudi A.; van Waarde, Aren] Univ Groningen, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands; [Boersma, Wytske] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, NL-9713 GZ Groningen, Netherlands; [Ishiwata, Kiichi] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Itabashi Ku, Tokyo 1730015, Japan; [Meerlo, Peter] Univ Groningen, Ctr Behav & Neurosci, NL-9747 AG Groningen, Netherlands		van Waarde, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	a.van.waarde@umcg.nl	Paul, Soumen/S-2333-2018	Sijbesma, JWA/0000-0002-8878-2355; van Waarde, Aren/0000-0003-1183-1603; Meerlo, Peter/0000-0002-8330-6050; Doorduin, Janine/0000-0003-2925-9959; Khanapur, Shivashankar/0000-0002-2755-1887; Paul, Soumen/0000-0001-6706-6205			Ando Y, 2008, MICROBES INFECT, V10, P1514, DOI 10.1016/j.micinf.2008.09.005; Antunes IF, 2012, J NUCL MED, V53, P451, DOI 10.2967/jnumed.111.096388; BEERS DR, 1993, J NEUROPATH EXP NEUR, V52, P241, DOI 10.1097/00005072-199305000-00008; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Boeck CR, 2005, NEUROPHARMACOLOGY, V49, P17, DOI 10.1016/j.neuropharm.2005.01.024; Brothers HM, 2010, NEUROSCI LETT, V480, P97, DOI 10.1016/j.neulet.2010.06.013; Buursma AR, 2005, J VIROL, V79, P7721, DOI 10.1128/JVI.79.12.7721-7727.2005; Cao CH, 2012, J ALZHEIMERS DIS, V30, P559, DOI 10.3233/JAD-2012-111781; Chen GQ, 2010, BRAIN RES, V1309, P116, DOI 10.1016/j.brainres.2009.10.054; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Doorduin J, 2010, NUCL MED BIOL, V37, P9, DOI 10.1016/j.nucmedbio.2009.09.002; Doorduin J, 2009, MOL IMAGING BIOL, V11, P386, DOI 10.1007/s11307-009-0211-6; Fujii S, 1999, VIROLOGY, V256, P203, DOI 10.1006/viro.1999.9610; Fukumitsu N, 2005, J NUCL MED, V46, P32; Fukumitsu N, 2003, ANN NUCL MED, V17, P511, DOI 10.1007/BF03006445; Fukumitsu N, 2008, ANN NUCL MED, V22, P841, DOI 10.1007/s12149-008-0185-5; GebickeHaerter PJ, 1996, NEUROCHEM INT, V29, P37, DOI 10.1016/0197-0186(95)00137-9; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Jhaveri KA, 2007, NEUROSCIENCE, V146, P415, DOI 10.1016/j.neuroscience.2006.12.035; Johnston JB, 2001, ANN NEUROL, V49, P650, DOI 10.1002/ana.1007.abs; Liu HQ, 2006, BRIT J PHARMACOL, V148, P314, DOI 10.1038/sj.bjp.0706732; Logan J, 2000, NUCL MED BIOL, V27, P661, DOI 10.1016/S0969-8051(00)00137-2; Mayne M, 1999, ANN NEUROL, V45, P633, DOI 10.1002/1531-8249(199905)45:5<633::AID-ANA12>3.0.CO;2-X; MERKEL KHH, 1984, HISTOCHEM J, V16, P467, DOI 10.1007/BF01002882; Nariai T, 2003, J NUCL MED, V44, P1839; Ochiishi T, 1999, J COMP NEUROL, V411, P301; Palacios N, 2012, MOVEMENT DISORD, V27, P1276, DOI 10.1002/mds.25076; Paul S, 2011, CURR MED CHEM, V18, P4820, DOI 10.2174/092986711797535335; Paul S, 2011, J NUCL MED, V52, P1293, DOI 10.2967/jnumed.111.088005; POLI A, 1991, J NEUROCHEM, V57, P298, DOI 10.1111/j.1471-4159.1991.tb02128.x; Sachse KT, 2008, J CEREBR BLOOD F MET, V28, P395, DOI 10.1038/sj.jcbfm.9600539; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Shimada Y, 2002, NUCL MED BIOL, V29, P29, DOI 10.1016/S0969-8051(01)00265-7; STROOP WG, 1984, LAB INVEST, V51, P27; Takaki J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-275; Tsutsui S, 2004, J NEUROSCI, V24, P1521, DOI 10.1523/JNEUROSCI.4271-03.2004	36	6	6	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAY 15	2014	92						83	89		10.1016/j.neuroimage.2014.01.054			7	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AG9BG	WOS:000335713000010	24513151				2022-02-06	
J	Kalinich, JF; Kasper, CE				Kalinich, John F.; Kasper, Christine E.			Do metals that translocate to the brain exacerbate traumatic brain injury?	MEDICAL HYPOTHESES			English	Article							DEPLETED URANIUM PELLETS; OXIDATIVE STRESS; NEUROLOGICAL DISEASES; BARRIER PERMEABILITY; DIETARY-SUPPLEMENTS; MICROGLIA; RATS; NEURODEGENERATION; INVOLVEMENT; DYSFUNCTION	Metal translocation to the brain is strictly controlled and often prevented by the blood-brain barrier. For the most part, only those metals required to maintain normal function are transported into the brain where they are under tight metabolic control. From the literature, there are reports that traumatic brain injury disrupts the blood-brain barrier. This could allow the influx of metals that would normally have been excluded from the brain. We also have preliminary data showing that metal pellets, surgically-implanted into the leg muscle of a rat to simulate a shrapnel wound, solubilize and the metals comprising the pellet can enter the brain. Surprisingly, rats implanted with a military-grade tungsten alloy composed of tungsten, nickel, and cobalt also showed significantly elevated uranium levels in their brains as early as 1 month after pellet implantation. The only source of uranium was low levels that are naturally found in food and water. Conversely, rats implanted with depleted uranium pellets demonstrated elevated uranium levels in brain resulting from degradation of the implanted pellets. However, when cobalt levels were measured, there were no significant increases in the brain until the rats had reached old age. The only source of cobalt for these rats was the low levels found in their food and water. These data suggest that some metals or metal mixtures (i.e., tungsten alloy), when embedded into muscle, can enhance the translocation of other, endogenous metals (e.g., uranium) across the blood-brain barrier. For other embedded metals (i.e., depleted uranium), this effect is not observed until the animal is of advanced age. This raises the possibility that metal body-burdens can affect blood-brain barrier permeability in a metal-specific and age-dependent manner. This possibility is disconcerting when traumatic brain injury is considered. Traumatic brain injury has been called the "signature" wound of the conflicts in Iraq and Afghanistan, often, an embedded metal fragment wound occurs simultaneously. Since the blood-brain barrier can be disrupted by traumatic brain injury, this raises the possibility of free access to the brain for any metals found in the body. Therefore, we hypothesize that this influx of metals overwhelms normal brain homeostasis, depletes the brain's antioxidant defense systems, and activates microglial cells resulting in the release of inflammatory mediators that can potentially exacerbate the adverse effects of traumatic brain injury. Published by Elsevier Ltd.	[Kalinich, John F.] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Internal Contaminat & Met Tox Program, Bethesda, MD 20814 USA; [Kasper, Christine E.] Uniformed Serv Univ Hlth Sci, Dept Vet Affairs, Off Nursing Serv, Bethesda, MD 20814 USA; [Kasper, Christine E.] Uniformed Serv Univ Hlth Sci, Grad Sch Nursing, Bethesda, MD 20814 USA		Kalinich, JF (corresponding author), Armed Forces Radiobiol Res Inst, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.	john.kalinich@usuhs.edu	Kasper, Christine/AAF-2347-2021	Kasper, Christine/0000-0002-7784-2519	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD17-01-1-0821];  [VA B5044R]	The views expressed do not necessarily represent the Armed Forces Radiobiology Research Institute, the Graduate School of Nursing, the Uniformed Services University of the Health Sciences, or the United States Departments of Defense and Veterans Affairs. This work was supported in part by VA B5044R to C.E. Kasper and U.S. Army Medical Research and Materiel Command grant DAMD17-01-1-0821 to J.F. Kalinich.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Barton AL, 2013, ANN CLIN BIOCHEM, V50, P496, DOI 10.1177/0004563212473276; Berry JP, 1997, MICROSC RES TECHNIQ, V36, P313, DOI 10.1002/(SICI)1097-0029(19970215)36:4<313::AID-JEMT9>3.0.CO;2-M; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bressler JP, 2007, HUM EXP TOXICOL, V26, P221, DOI 10.1177/0960327107070573; Catalani S, 2012, HUM EXP TOXICOL, V31, P421, DOI 10.1177/0960327111414280; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cope EC, 2012, NUTR REV, V70, P410, DOI 10.1111/j.1753-4887.2012.00486.x; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Fitsanakis VA, 2006, BIOL TRACE ELEM RES, V111, P185, DOI 10.1385/BTER:111:1:185; Flynn JM, 2013, FREE RADICAL BIO MED, V62, P4, DOI 10.1016/j.freeradbiomed.2013.05.027; Freeman LR, 2012, BBA-MOL BASIS DIS, V1822, P822, DOI 10.1016/j.bbadis.2011.12.009; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hamilton MM, 1997, J CHEM SOC PERK T 2, P2491, DOI 10.1039/a702509b; Jiang GCT, 2006, BIOL TRACE ELEM RES, V110, P1, DOI 10.1385/BTER:110:1:1; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Kalinich JF, 2005, ENVIRON HEALTH PERSP, V113, P729, DOI 10.1289/ehp.7791; Kalinich JF, 2002, TOXICOLOGY, V179, P105, DOI 10.1016/S0300-483X(02)00318-9; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Leal SS, 2012, COORDIN CHEM REV, V256, P2253, DOI 10.1016/j.ccr.2012.04.004; Lemercier V, 2003, RADIAT PROT DOSIM, V105, P243, DOI 10.1093/oxfordjournals.rpd.a006232; Li Y, 2010, BRAIN RES, V1330, P131, DOI 10.1016/j.brainres.2010.03.034; Liu Y, 2013, TOXICOL SCI, V132, P298, DOI 10.1093/toxsci/kfs344; Lockman JA, 2012, NEUROCHEM RES, V37, P134, DOI 10.1007/s11064-011-0591-2; Mates JM, 2010, FREE RADICAL BIO MED, V49, P1328, DOI 10.1016/j.freeradbiomed.2010.07.028; Mou YH, 2012, INT IMMUNOPHARMACOL, V13, P120, DOI 10.1016/j.intimp.2012.03.017; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151; Pellmar TC, 1999, TOXICOL SCI, V49, P29, DOI 10.1093/toxsci/49.1.29; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Radcliffe PM, 2009, NEUROTOXICOLOGY, V30, P445, DOI 10.1016/j.neuro.2009.02.004; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Suchenski M, 2010, ARTHROSCOPY, V26, P821, DOI 10.1016/j.arthro.2009.12.026; Tjalve H, 1999, NEUROTOXICOLOGY, V20, P181; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; van der Voet GB, 2008, BIOL TRACE ELEM RES, V125, P1, DOI 10.1007/s12011-008-8157-0; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; ZALESKA MM, 1985, NEUROCHEM RES, V10, P397, DOI 10.1007/BF00964608; Zheng W, 2003, TOXICOL APPL PHARM, V192, P1, DOI 10.1016/S0041-008X(03)00251-5	44	6	7	0	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	MAY	2014	82	5					558	562		10.1016/j.mehy.2014.02.011			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AG0KT	WOS:000335105100010	24613092				2022-02-06	
J	Hamilton, BH; Sheth, A; McCormack, RT; McCormack, RP				Hamilton, Baker H.; Sheth, Amish; McCormack, Ross T.; McCormack, Ryan P.			IMAGING OF FREQUENT EMERGENCY DEPARTMENT USERS WITH ALCOHOL USE DISORDERS	JOURNAL OF EMERGENCY MEDICINE			English	Article						imaging; alcohol use disorders; frequent users; trauma; overcrowding	CT HEAD RULE; INTRACRANIAL INJURY; COMPUTED-TOMOGRAPHY; INTOXICATION; RADIATION; EXPOSURE; CRITERIA; RISK	Background: Patients with altered level of consciousness secondary to alcohol use disorders (AUDs) often undergo imaging in the emergency department (ED), although the frequency and yield of this practice over time are unknown. Study Objectives: We describe the use of imaging, the associated ionizing radiation exposure, cumulative costs, and identified acute and chronic injuries and abnormalities among frequent users of the ED with AUDs. Methods: This is a retrospective case series of individuals identified through an administrative database having 10 or more annual ED visits in 2 consecutive years who were prospectively followed for a third year. International Classification of Diseases, 9th Revision, Clinical Modification and Current Procedural Terminology codes were used to select individuals with alcohol-related diagnoses, track imaging procedures, and calculate cost. Diagnoses, imaging results, and radiation exposure per computed tomography (CT) study were abstracted from the medical record. Results: Fifty-one individuals met inclusion criteria and had a total of 1648 imaging studies over the 3-year period. Subjects had a median of 5 (interquartile range [IQR] 2-10) CT scans, 20 (IQR 10-33) radiographs, 28.3 mSv (IQR 8.97-61.71) ionizing radiation, 0.2% (IQR 0.07-0.4) attributable risk of cancer, and $2979 (IQR 1560-5440) in charges using a national rate. The incidence of acute fracture or intracranial head injury was 55%, and 39% of the cohort had a history of moderate or severe traumatic brain injury. Conclusion: The remarkable use of imaging and occurrence of injury among these highly vulnerable and frequently encountered individuals compels further study to refine clinical practices through the development of evidence-based, effective interventions. (C) 2014 Elsevier Inc.	[Hamilton, Baker H.; McCormack, Ryan P.] NYU, Bellevue Hosp Ctr, Langone Med Ctr, Dept Emergency Med, New York, NY 10016 USA; [Sheth, Amish; McCormack, Ross T.] NYU, Sch Med, New York, NY USA		Hamilton, BH (corresponding author), Bellevue Hosp, Dept Emergency Med, 462 First Ave,OBV A345, New York, NY 10016 USA.			McCormack, Ryan/0000-0002-7210-4736	NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R25 DA022461] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R25DA022461] Funding Source: NIH RePORTER		[Anonymous], 2006, FRONT MATT HLTH RISK; Bracken ME, 2007, ANN EMERG MED, V49, P45, DOI 10.1016/j.annemergmed.2006.04.013; Christner JA, 2010, AM J ROENTGENOL, V194, P881, DOI 10.2214/AJR.09.3462; Doupe MB, 2012, ANN EMERG MED, V60, P24, DOI 10.1016/j.annemergmed.2011.11.036; Easter JS, 2013, ACAD EMERG MED, V20, P753, DOI 10.1111/acem.12184; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; Godbout BJ, 2011, EMERG RADIOL, V18, P381, DOI 10.1007/s10140-011-0966-3; Grover CA, 2010, WEST J EMERG MED, V11, P336; Holmes JF, 1997, ACAD EMERG MED, V4, P788, DOI 10.1111/j.1553-2712.1997.tb03786.x; McCormack RP, 2013, AM J PUBLIC HEALTH, V103, pS221, DOI 10.2105/AJPH.2013.301373; McCormack RP, 2013, LANCET, V382, P995, DOI 10.1016/S0140-6736(12)62206-5; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Shrimpton P, 2004, EUR GUID MULT COMP T; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	18	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	APR	2014	46	4					582	587		10.1016/j.jemermed.2013.08.129			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AD7QK	WOS:000333459200035	24412058	Green Accepted			2022-02-06	
J	Nichols, JL; Kosciulek, J				Nichols, Jane L.; Kosciulek, John			Social Interactions of Individuals with Traumatic Brain Injury	JOURNAL OF REHABILITATION			English	Article							UNITED-STATES; SELF; PEOPLE	The purpose of this qualitative study was to understand better the social interactions of individuals with Traumatic Brain Injury (TBI) by exploring how individuals with TBI describe their social interaction experiences. The concepts and themes which emerged from the data suggest a process of refocusing values and re-establishing a view of the self as able and valuable following injury. On the intrapersonal level, the importance of understanding what it meant to live with TBI was a crucial factor in developing core relationships. The development of positive and negative images of "self' emerged at this level along with questions about social competency. Among the broad spectrum of factors that impact social interactions, a combination of social interaction context, communication partner and individual attitudes were significant indicators of a successful social interaction experience.	[Nichols, Jane L.] Southern Illinois Univ Carbondale, Carbondale, IL USA; [Kosciulek, John] Michigan State Univ, E Lansing, MI 48824 USA		Nichols, JL (corresponding author), So Illinois Univ, Inst Rehabil, 329A Rehn Hall,Lincoln Dr, Carbondale, IL 62901 USA.	jlnichols@siu.edu					Antonak RF, 2000, DISABIL REHABIL, V22, P211; Argyle M., 2008, SOCIAL INTERACTION; Ashby C, 2011, DISABILITY STUDIES Q, V31; BLATT B, 1981, J PSYCHIAT TREAT EV, V3, P183; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Butler EA, 2003, EMOTION, V3, P48, DOI 10.1037/1528-3542.3.1.48; Callaway L., 2005, AUSTR OCCUPATIONAL T, V52, P257, DOI [10.1111/j.1440-1630.2005.00492, DOI 10.1111/J.1440-1630.2005.00492]; Carlsson E, 2007, QUAL HEALTH RES, V17, P1361, DOI 10.1177/1049732307306926; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Charmaz KC., 2000, HDB QUALITATIVE RES, V2nd edn, P509, DOI DOI 10.1177/0891241609342193; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; De Jaegher H, 2010, TRENDS COGN SCI, V14, P441, DOI 10.1016/j.tics.2010.06.009; Denzin N. K, 2005, SAGE HDB QUALITATIVE, V3rd; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; KOSCIULEK JF, 1994, REHABIL PSYCHOL, V39, P215, DOI 10.1037/h0080325; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Oliver M., 1999, QUATER CENTURY NORMA, P98; Patton M. Q., 1980, QUALITATIVE EVALUATI; Polit D., 2004, NURSING RES METHODS; RIGGIO RE, 1986, J PERS SOC PSYCHOL, V51, P649, DOI 10.1037/0022-3514.51.3.649; Ritchie J., 2003, QUALITATIVE RES PRAC; Rossman G. B., 1998, LEARNING FIELD INTRO; Rubin IS, 2012, QUALITATIVE INTERVIE; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Segrin C., 2001, INTERPERSONAL PROCES; Sherif M., 2006, SOCIAL INTERACTION P; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thorne S, 2003, QUAL HEALTH RES, V13, P1337, DOI 10.1177/1049732303258039; Wiley M. G., 1986, SELF IDENTITY PSYCHO; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Ylvisaker M., 2006, SENSE SELF PERSONAL; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	38	6	6	0	14	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	APR-JUN	2014	80	2					21	29					9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	AU8ZJ	WOS:000345881500003					2022-02-06	
J	Schonberger, M; Ponsford, J; McKay, A; Wong, D; Spitz, G; Harrington, H; Mealings, M				Schoenberger, Michael; Ponsford, Jennie; McKay, Adam; Wong, Dana; Spitz, Gershon; Harrington, Helen; Mealings, Margaret			Development and predictors of psychological adjustment during the course of community-based rehabilitation of traumatic brain injury: A preliminary study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Psychological adjustment; Depression; Awareness; Community-based rehabilitation; Longitudinal study	IMPAIRED SELF-AWARENESS; EMOTIONAL ADJUSTMENT; POSTTRAUMATIC GROWTH; DISCREPANCY THEORY; HOSPITAL ANXIETY; HEAD-INJURY; DEPRESSION; RECOVERY; ADULTS; INTERVIEW	The aim of the study was to describe the development and predictors of psychological adjustment during community-based traumatic brain injury (TBI) rehabilitation. Forty-two adolescent and adult individuals with TBI (mean age 32 years, 88% male, median post-traumatic amnesia 11 days) participated in a single-group, longitudinal design study. The main measures used were the Reactions to Impairment and Disability Inventory, Adjustment subscale; Sydney Psychosocial Reintegration Scale; Hospital Anxiety and Depression Scale; and Self-awareness of Deficits Interview. At rehabilitation start, individuals differed significantly from each other with respect to their level of psychological adjustment. Individual trajectories of psychological adjustment were highly variable. However, for the sample as a whole, psychological adjustment did not change during the course of rehabilitation (multilevel regression models; p > .05). Good psychological adjustment was related to low levels of emotional distress and a small discrepancy between current and aspired functional status. Poor functional status had a more minor impact on psychological adjustment in individuals with poor self-awareness than in individuals with high levels of self-awareness. The results confirm parts of theoretical models of psychological adjustment to acquired brain injury, especially the importance of goal refinement. However, the results need to be treated cautiously, given the limited sample size.	[Schoenberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, D-79106 Freiburg, Germany; [Schoenberger, Michael; Ponsford, Jennie; McKay, Adam; Wong, Dana; Spitz, Gershon] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Schoenberger, Michael; Ponsford, Jennie; Spitz, Gershon] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Harrington, Helen; Mealings, Margaret] Epworth Healthcare, Melbourne, Vic, Australia		Schonberger, M (corresponding author), Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, Engelberger Str 41, D-79106 Freiburg, Germany.	Michael.schoenberger@psychologie.uni-freiburg.de	Spitz, Gershon/H-7755-2014; Wong, Dana/AAD-3410-2020; McKay, Adam JD/M-6003-2017	Spitz, Gershon/0000-0002-7810-1480; McKay, Adam JD/0000-0002-0479-7681; Wong, Dana/0000-0001-9619-1929	Victorian Neurotrauma Initiative	This work was carried out at the Monash-Epworth Rehabilitation Research Centre, Epworth Healthcare, Melbourne, Australia and supported by the Victorian Neurotrauma Initiative.	Brands IMH, 2012, CLIN REHABIL, V26, P840, DOI 10.1177/0269215511432018; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Carver C.S., 1998, SELF REGULATION BEHA; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Doering BK, 2011, NEUROPSYCHOL REHABIL, V21, P515, DOI 10.1080/09602011.2011.583500; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; HIGGINS ET, 1985, SOC COGNITION, V3, P51, DOI 10.1521/soco.1985.3.1.51; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Livneh H, 1990, J APPLIED REHABILITA, V21, P13; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; McBrinn J, 2008, BRAIN INJURY, V22, P765, DOI 10.1080/02699050802372208; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; Singer J. D., 2003, APPL LONGITUDINAD DA; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2010, COMPENDIUM TESTS SCA; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x	35	6	6	0	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR	2014	24	2					202	219		10.1080/09602011.2013.878252			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AI9BG	WOS:000337220800003	24533829				2022-02-06	
J	de Vries, MJ; Sival, DA; van Doormaal-Stremmelaar, EF; ter Horst, HJ				de Vries, Maaike J.; Sival, Deborah A.; van Doormaal-Stremmelaar, Elisabeth F.; ter Horst, Hendrik J.			Traumatic Perforation of the Lamina Cribrosa During Nasal Intubation of a Preterm Infant	PEDIATRICS			English	Article						brain injury; complication; endotracheal intubation; lamina cribrosa; preterm	NASOTRACHEAL INTUBATION; COMPLICATIONS; CHILDREN	Traumatic perforation of the lamina cribrosa and penetration of the brain occurred during nasotracheal intubation of a preterm infant requiring resuscitation. This rare complication is specifically associated with the nasal route of intubation. The complication resulted in significant morbidity. The infant developed an extensive intracranial hemorrhage and posthemorrhagic hydrocephalus that required ventricular drainage. We recommend that nasotracheal intubation be performed with utmost care. We confirm Cameron and Lupton's recommendation of using a small feeding tube over which to slide the endotracheal tube. Despite extensive iatrogenic damage, the patient's neurodevelopmental follow-up at 2 years 9 months appeared relatively mild.	[de Vries, Maaike J.; Sival, Deborah A.; van Doormaal-Stremmelaar, Elisabeth F.; ter Horst, Hendrik J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, NL-9700 RB Groningen, Netherlands		ter Horst, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, POB 30001, NL-9700 RB Groningen, Netherlands.	h.j.ter.horst@umcg.nl					ANGELOS G M, 1989, Pediatric Dentistry, V11, P133; BLACK AE, 1990, BRIT J ANAESTH, V65, P461, DOI 10.1093/bja/65.4.461; Bos AF, 2011, DEV MED CHILD NEUROL, V53, P35, DOI 10.1111/j.1469-8749.2011.04062.x; CAMERON D, 1993, ARCH DIS CHILD-FETAL, V69, P79, DOI 10.1136/adc.69.1_Spec_No.79; FLETCHER SA, 1987, J TRAUMA, V27, P948, DOI 10.1097/00005373-198708000-00017; HEY E, 1971, J OBSTET GYN BR COMM, V78, P1137; HORELLOU MF, 1978, ANAESTHESIA, V33, P73, DOI 10.1111/j.1365-2044.1978.tb08301.x; RIVERA R, 1992, CRIT CARE MED, V20, P193, DOI 10.1097/00003246-199202000-00008; Spence K, 2000, COCHRANE DB SYST REV, V1999; UPTON CJ, 1991, ARCH DIS CHILD-FETAL, V66, P39, DOI 10.1136/adc.66.1_Spec_No.39; VANDENANKER JN, 1992, PEDIATR RADIOL, V22, P545, DOI 10.1007/BF02013011	11	6	6	0	1	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	MAR	2014	133	3					E762	E765		10.1542/peds.2012-3802			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AG3PB	WOS:000335330700062	24534399				2022-02-06	
J	Henry, GK; Heilbronner, RL; Mittenberg, W; Hellemann, G; Myers, A				Henry, George K.; Heilbronner, Robert L.; Mittenberg, Wiley; Hellemann, Gerhard; Myers, Allison			Development of the MMPI-2 cognitive complaints scale as an embedded measure of symptom validity	BRAIN INJURY			English	Article						Cognitive complaints scale; cognitive performance validity; symptom validity	FAKE BAD SCALE; MALINGERED NEUROCOGNITIVE DYSFUNCTION; PERSONAL-INJURY LITIGANTS; EMPIRICAL DERIVATION; PERFORMANCE; VALIDATION; INDICATORS	Objective: To empirically-derive a new MMPI-2 sub-scale, the 13-item Cognitive Complaints Scale (CCS), as an embedded measure of symptom validity. This study hypothesized that mild traumatic brain injured subjects with financial incentives who failed performance validity tests (PVTs) would score significantly higher on the CCS compared to mild traumatic brain injured subjects with financial incentives who passed PVTs. Mild traumatic brain injured controls with no financial incentives were predicted to score lowest on the CCS. Research design: A known groups design was utilized as this design allows for the accurate classification of criterion groups. Methods: One hundred and fifty mild head-injured adults were assigned to one of three groups: the Failed Performance Validity (FPV) group, the Passed Performance Validity (PPV) group or a control group. Results: An ANOVA revealed that the FPV group scored significantly higher on the CCS compared to the PPV group. Controls with no financial incentives scored lowest. A CCS cut-score of >= 12 discriminated between the FPV and PPV groups at a high level of specificity (94%). Conclusions: A dissociation between 'performance validity' and 'symptom validity' supports recommendations for the differential application of these descriptive terms. The CCS may be helpful to assess credibility of clinical presentation in situations where PVTs are absent.	[Henry, George K.] Los Angeles Neuropsychol Grp, Los Angeles, CA 90025 USA; [Heilbronner, Robert L.] Chicago Neuropsychol Grp, Chicago, IL USA; [Mittenberg, Wiley] Nova SE Univ, Ctr Psychol Studies, Ft Lauderdale, FL 33314 USA; [Hellemann, Gerhard] Univ Calif Los Angeles, Semel Inst, Los Angeles, CA USA; [Myers, Allison] Henry Ford Hosp, Detroit, MI 48202 USA		Henry, GK (corresponding author), Los Angeles Neuropsychol Grp, 1950 Sawtelle Blvd,Suite 342, Los Angeles, CA 90025 USA.	ghenry0249@aol.com					Bianchini KJ, 2008, ASSESSMENT, V15, P435, DOI 10.1177/1073191108317341; Boone K.B., 2007, ASSESSMENT FEIGNED C; Efron B., 1993, INTRO BOOTSTRAP; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2009, CLIN NEUROPSYCHOL, V23, P996, DOI 10.1080/13854040902748249; Green P, 1996, WORD MEMORY TEST; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Haggerty KA, 2007, CLIN NEUROPSYCHOL, V21, P917, DOI 10.1080/13854040600899724; Heilbronner RL, 2013, MILD TRAUMATIC BRAIN; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P158, DOI 10.1080/13825580601025916; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Henry GK, 2011, APPL NEUROPSYCHOL, V18, P47, DOI 10.1080/09084282.2010.523385; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MOKKEN RJ, 1982, APPL PSYCH MEAS, V6, P417, DOI 10.1177/014662168200600404; Nelson NW, 2007, J CLIN EXP NEUROPSYC, V29, P67, DOI 10.1080/13803390500488546; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; Neter J., 1996, APPL LINEAR REGRESSI, V3rd ed; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Tellegen, 2008, MINNESOTA MULTIPHASI; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Victor T, 2006, INT NEUR SOC 34 ANN	33	6	6	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2014	28	3					357	363		10.3109/02699052.2013.865272			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AC0RI	WOS:000332202100014	24354495				2022-02-06	
J	Kent, RW; Lievers, WB; Riley, PO; Frimenko, RE; Crandall, JR				Kent, Richard W.; Lievers, W. Brent; Riley, Patrick O.; Frimenko, Rebecca E.; Crandall, Jeff R.			Etiology and Biomechanics of Tarsometatarsal Injuries in Professional Football Players	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						Lisfranc injury; tarsometatarsal dislocation; biomechanics; video analysis; professional football	LISFRANC FRACTURE-DISLOCATION; CRUCIATE LIGAMENT INJURY; VIDEO ANALYSIS; INCIDENT ANALYSIS; MECHANISMS; CONCUSSION; MANAGEMENT	Background: Tarsometatarsal (TMT) dislocations are uncommon yet debilitating athletic injuries, particularly in American football. To date, the mechanisms of athletic TMT dislocation have been described only anecdotally. This lack of information confounds the development of preventative countermeasures. Purpose: To use video analysis to provide direct, independent identification of the etiologic and mechanistic variables responsible for TMT dislocations in professional football players. Study Design: Case series; Level of evidence, 4. Methods: Sixteen professional National Football League players who sustained publicly reported TMT dislocations were identified. Publicly broadcast game footage of the plays in which injury occurred was reviewed by a panel of 5 biomechanists. Consensus was reached regarding the details surrounding injury, and a weighting was assigned to each detail based on the panel's confidence. Results: Roughly 90% of injuries occurred while the injured player was engaged with or by another player, a detail that has heretofore been undocumented. Few injuries resulted from direct loading of either the foot or the ipsilateral limb; however, the injured foot was frequently subjected to axial loading from ground engagement with the foot in plantar flexion and the toes dorsiflexed. Injurious loading was often due to external rotation of the midfoot (86%). Fifteen of 16 injuries were season ending. Conclusion: TMT dislocations are frequently associated with engagement by or with a second player but infrequently caused by a direct blow to the foot. Axial loading of the foot, external rotation, and pronation/supination are the most common conditions during injurious loading.	[Kent, Richard W.; Riley, Patrick O.; Frimenko, Rebecca E.; Crandall, Jeff R.] Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA; [Lievers, W. Brent] Laurentian Univ, Bharti Sch Engn, Sudbury, ON, Canada		Kent, RW (corresponding author), Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	rwk3c@eservices.virginia.edu	Lievers, W. Brent/H-1924-2012	Lievers, W. Brent/0000-0002-1458-5375	National Football League; Biomechanics Consulting and Research (BioCore) LLC	One or more of the authors declared the following potential conflicts of interest or source of funding: The National Football League provided funding for this study. Financial support for the study was also provided by Biomechanics Consulting and Research (BioCore) LLC; this sponsorship covered a portion of the salary of the study authors. R.W.K. and J.R.C. are principals of BioCore LLC.	Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Andersen TE, 2004, BRIT J SPORT MED, V38, P626, DOI 10.1136/bjsm.2003.007955; Andersen TE, 2003, BRIT J SPORT MED, V37, P226, DOI 10.1136/bjsm.37.3.226; Andersen TE, 2004, AM J SPORT MED, V32, p69S, DOI 10.1177/0363546503262023; Appleby B, 2002, J SCI MED SPORT, V5, P129, DOI 10.1016/S1440-2440(02)80034-2; Arnason A, 2004, AM J SPORT MED, V32, P1459, DOI 10.1177/0363546504262973; Bere T, 2011, AM J SPORT MED, V39, P1421, DOI 10.1177/0363546511405147; Berg JH, 1998, J ORTHOP TRAUMA, V12, P366, DOI 10.1097/00005131-199806000-00015; Bloome D. M., 2002, TECH FOOT ANKLE SURG, V1, P94, DOI DOI 10.1097/00132587-200212000-00003; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; COHEN G, 1995, APPL COGNITIVE PSYCH, V9, P273, DOI 10.1002/acp.2350090402; CURTIS MJ, 1993, AM J SPORT MED, V21, P497, DOI 10.1177/036354659302100403; Gonsalves B, 2002, NEUROSCIENTIST, V8, P391, DOI 10.1177/107385802236964; Harwood MI, 2003, J AM BOARD FAM PRACT, V16, P69, DOI 10.3122/jabfm.16.1.69; Hummel CH, 2011, ATHL TRAIN SPORTS HL, V3, P95, DOI [10.3928/19425864-20100831-02, DOI 10.3928/19425864-20100831-02]; Kadel N, 2004, J DANCE MED SCI, V8, P56; Kaplan Lee D, 2011, Am J Orthop (Belle Mead NJ), V40, P40; Knox CL, 2006, BRIT J SPORT MED, V40, P268, DOI 10.1136/bjsm.2005.022855; Koh JO, 2004, BRAIN INJURY, V18, P1287, DOI 10.1080/02699050410001719907; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Lattermann C, 2007, CLIN J SPORT MED, V17, P311, DOI 10.1097/JSM.0b013e31811ed0ba; Lievers W Brent, 2012, Foot (Edinb), V22, P117, DOI 10.1016/j.foot.2012.03.003; Mannan JB, 2003, SEIZURE-EUR J EPILEP, V12, P444, DOI 10.1016/S1059-1311(03)00052-9; MEYER SA, 1994, AM J SPORT MED, V22, P392, DOI 10.1177/036354659402200316; Myerson MS, 2008, J BONE JOINT SURG AM, V90A, P2522; O'Regan D J, 1969, J Med Soc N J, V66, P575; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rajapakse B, 2006, INJURY, V37, P914, DOI 10.1016/j.injury.2005.12.003; Sauers R J, 1992, J Athl Train, V27, P24; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; WILEY J J, 1971, Journal of Bone and Joint Surgery British Volume, V53, P474	32	6	7	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAR	2014	2	3							2325967114525347	10.1177/2325967114525347			7	Orthopedics; Sport Sciences	Emerging Sources Citation Index (ESCI)	Orthopedics; Sport Sciences	V0R2L	WOS:000216485800002	26535306	Green Published, gold			2022-02-06	
J	Lancioni, GE; Singh, NN; O'Reilly, MF; Sigafoos, J; D'Amico, F; Addante, LM; Ferlisi, G; Zullo, V; Oliva, D; Megna, M				Lancioni, Giulio E.; Singh, Nirbhay N.; O'Reilly, Mark F.; Sigafoos, Jeff; D'Amico, Fiora; Addante, Luigi M.; Ferlisi, Gabriele; Zullo, Valeria; Oliva, Doretta; Megna, Marisa			Technology to help persons with extensive neuro-motor impairment and lack of speech with their leisure occupation and communication	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						Amyotrophic lateral sclerosis; Stroke; Neuro-motor impairment; Leisure occupation; Communication; Technology	AMYOTROPHIC-LATERAL-SCLEROSIS; POST-COMA PERSONS; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; ASSISTIVE TECHNOLOGY; MULTIPLE DISABILITIES; COGNITIVE REHABILITATION; ENVIRONMENTAL STIMULI; SOCIAL VALIDATION; STROKE PATIENTS	These two studies were aimed at extending the assessment of technology-aided programs to enhance leisure occupation or communication with persons with extensive neuromotor impairment and lack of speech. Specifically, Study I implemented the program for leisure occupation with two post-stroke patients. Study II implemented the program for communication with two persons affected by amyotrophic lateral sclerosis (ALS). In Study I, a computer system presented the participants with a variety of stimuli. The participants could select/access those stimuli by microswitch activation or could bypass them by abstaining from microswitch responses. In Study II, the participants used a computer-aided telephone system that allowed them to choose via microswitch activation the persons to call. On the computer screen, they also had words and phrases that they could activate during the calls to influence the conversation with the persons called. Data from both studies were largely positive. The post-stroke patients showed high levels of stimulus selection (access) and extended engagement. The patients with ALS were able to make phone calls and to select the words/phrases to influence the conversations. The relevance of technology-aided programs for leisure occupation and communication of persons with extensive multiple disabilities was discussed. (c) 2014 Elsevier Ltd. All rights reserved.	[Lancioni, Giulio E.; Megna, Marisa] Univ Bari, I-70121 Bari, Italy; [Singh, Nirbhay N.] Georgia Regents Univ, Med Coll Georgia, Augusta, GA USA; [O'Reilly, Mark F.] Univ Texas Austin, Austin, TX 78712 USA; [Sigafoos, Jeff] Victoria Univ Wellington, Wellington, New Zealand; [D'Amico, Fiora; Addante, Luigi M.] S Raffaele Med Care Ctr, Alberobello Modugno, Italy; [Ferlisi, Gabriele; Zullo, Valeria; Oliva, Doretta] Lega F DOro Res Ctr, Osimo, Italy		Lancioni, GE (corresponding author), Univ Bari, Dept Neurosci & Sense Organs, Via Quintino Sella 268, I-70100 Bari, Italy.	giulio.lancioni@uniba.it	D'Amico, Fiora/AAB-8309-2019; Megna, Marisa/ABE-8907-2020; Singh, Nouratan/N-9377-2017	Singh, Nouratan/0000-0002-8063-8375; Megna, Marisa/0000-0002-8486-103X; Lancioni, Giulio/0000-0002-6515-5690			Aoun S, 2010, J PALLIAT MED, V13, P653, DOI 10.1089/jpm.2009.0318; Barlow DH., 2009, SINGLE CASE EXPT DES, V3; Bauer S, 2012, DISABIL REHABIL-ASSI, V7, P350, DOI 10.3109/17483107.2011.653000; Bauer SM, 2011, DISABIL REHABIL-ASSI, V6, P243, DOI 10.3109/17483107.2010.529631; Baumann M, 2013, DISABIL REHABIL, V35, P244, DOI 10.3109/09638288.2012.694574; Borg J, 2011, DISABIL SOC, V26, P151, DOI 10.1080/09687599.2011.543862; Brauer SG, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-71; Brownlee A, 2012, TOP LANG DISORD, V32, P168, DOI 10.1097/TLD.0b013e31825616ef; Caligari M, 2013, AMYOTROPH LAT SCL FR, V14, P546, DOI 10.3109/21678421.2013.803576; Callahan K, 2008, J AUTISM DEV DISORD, V38, P678, DOI 10.1007/s10803-007-0434-9; Cameron JI, 2013, DISABIL REHABIL, V35, P315, DOI 10.3109/09638288.2012.691937; Casey KS, 2011, NEUROREHABILITATION, V28, P281, DOI 10.3233/NRE-2011-0656; Catania A.C., 2007, LEARNING; de Diego C, 2013, RESTOR NEUROL NEUROS, V31, P361, DOI 10.3233/RNN-120250; de Joode EA, 2012, BRAIN INJURY, V26, P1257, DOI 10.3109/02699052.2012.667590; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Eriksson G, 2012, TOP STROKE REHABIL, V19, P244, DOI 10.1310/tsr1903-244; Fischer T, 2008, J COGNITIVE NEUROSCI, V20, P1443, DOI 10.1162/jocn.2008.20101; Foley G, 2012, AM J HOSP PALLIAT ME, V29, P362, DOI 10.1177/1049909111423774; Franhoff DJ, 2011, TOP STROKE REHABIL, V18, P112, DOI 10.1310/tsr1802-112; Freyer F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00144; Geytenbeek JJM, 2010, AUGMENT ALTERN COMM, V26, P97, DOI 10.3109/07434618.2010.482445; Gibson BE, 2012, DISABIL REHABIL, V34, P1894, DOI 10.3109/09638288.2012.670040; Gruis KL, 2011, MUSCLE NERVE, V43, P643, DOI 10.1002/mus.21951; Gupta A, 2008, ANN INDIAN ACAD NEUR, V11, P225, DOI 10.4103/0972-2327.44557; Jumisko E, 2009, J CLIN NURS, V18, P2273, DOI 10.1111/j.1365-2702.2008.02738.x; Kattenstroth JC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00244; Kazdin A. E., 2001, BEHAV MODIFICATION A; Kennedy CH., 2005, SINGLE CASE DESIGNS; Lancioni GE, 2014, AUT CHILD PSYCHO, P1, DOI 10.1007/978-1-4899-8029-8; Lancioni GE, 2014, DISABIL REHABIL-ASSI, V9, P260, DOI 10.3109/17483107.2013.785037; Lancioni GE, 2013, DEV NEUROREHABIL, V16, P315, DOI 10.3109/17518423.2012.731086; Lancioni GE, 2013, RES DEV DISABIL, V34, P2959, DOI 10.1016/j.ridd.2013.06.006; Lancioni GE, 2013, RES DEV DISABIL, V34, P1749, DOI 10.1016/j.ridd.2013.02.019; Lancioni GE, 2012, RES DEV DISABIL, V33, P670, DOI 10.1016/j.ridd.2011.11.007; Lancioni GE, 2011, RES DEV DISABIL, V32, P2602, DOI 10.1016/j.ridd.2011.06.015; Lancioni GE, 2011, DISABIL REHABIL-ASSI, V6, P412, DOI 10.3109/17483107.2011.580899; Lancioni GE, 2011, J DEV PHYS DISABIL, V23, P173, DOI 10.1007/s10882-010-9212-2; Lancioni GE, 2010, RES DEV DISABIL, V31, P777, DOI 10.1016/j.ridd.2010.02.001; Lancioni GE, 2006, J DEV PHYS DISABIL, V18, P383, DOI 10.1007/s10882-006-9024-6; Lenker JA, 2013, DISABIL REHABIL-ASSI, V8, P373, DOI 10.3109/17483107.2012.749429; Lindqvist E, 2012, DISABIL REHABIL-ASSI, V7, P364, DOI 10.3109/17483107.2011.638036; Loureiro RCV, 2011, MED BIOL ENG COMPUT, V49, P1103, DOI 10.1007/s11517-011-0797-0; Moghimi S, 2013, ASSIST TECHNOL, V25, P99, DOI 10.1080/10400435.2012.723298; Posatskiy AO, 2012, MED ENG PHYS, V34, P1184, DOI 10.1016/j.medengphy.2011.12.007; Ripat J, 2011, DISABIL REHABIL-ASSI, V6, P87, DOI 10.3109/17483107.2010.507859; Sarkamo T., 2012, ANN NY ACAD SCI, V81, P1252; Scherer M. J., 2012, ASSISTIVE TECHNOLOGI; Scherer MJ, 2011, DISABIL REHABIL, V33, P811, DOI 10.3109/09638288.2010.511418; Silvoni S, 2013, AMYOTROPH LA SCL FR, V14, P390, DOI 10.3109/21678421.2013.770029; Sunderland N, 2009, DISABIL SOC, V24, P703, DOI 10.1080/09687590903160175; Trojano L, 2009, J REHABIL MED, V41, P393, DOI 10.2340/16501977-0344; Wallace J, 2011, NEUROREHABILITATION, V28, P295, DOI 10.3233/NRE-2011-0657; Wallace T, 2011, NEUROREHABILITATION, V28, P199, DOI 10.3233/NRE-2011-0649; Winkler SLH, 2010, MED CARE, V48, P558, DOI 10.1097/MLR.0b013e3181bd4a11	55	6	6	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	MAR	2014	35	3					611	618		10.1016/j.ridd.2014.01.002			8	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	AB8OR	WOS:000332050400005	24472502				2022-02-06	
J	Vestergaard, V; Astrand, R; Romner, B				Vestergaard, V.; Astrand, R.; Romner, B.			A survey of the management of paediatric minor head injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						children; clinical decision rules; guidelines; management; minor head injury	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; CHILDREN; MILD; CONSCIOUSNESS; METAANALYSIS; POPULATION; PREDICTION; HOSPITALS	ObjectivesTo investigate present established routines and standards in managing minor head-injured children in Danish hospitals, a survey of present management practice was conducted. Materials and MethodsA cross-sectional mail survey, detailing clinical and radiological examinations, in-hospital observation, discharge criteria and follow-up, was performed on all 46 hospitals treating children with minor head injury in Denmark. ResultsOf the 46 hospitals, 33% report having established written criteria for the referral and management of children with minor head injury. Ten (22%) of the 46 hospitals are so-called injury clinics, where only nurses are employed. All state that they use the Glasgow Coma Scale (GCS) and/or the paediatric GCS to assess the level of consciousness; 15% use the paediatric GCS exclusively. None perform routine radiological examinations. Criteria for early discharge are established in 98% of the hospitals. All hospitals provide written instructions for observations at home before discharge. ConclusionThe management of children with minor head injury varies between hospitals in Denmark. Local management guidelines are either lacking or mainly based on those of adults. Hence, there is a need for the development of minor head injury guidelines specifically designed for the management of children.	[Vestergaard, V.; Astrand, R.; Romner, B.] Rigshosp, Dept Neurosurg, DK-2100 Copenhagen, Denmark		Vestergaard, V (corresponding author), Holger Danskes Vej 87,4,9, DK-2000 Copenhagen, Denmark.	veronique.vestergaard@spray.se		Vestergaard, Veronique Alexandra/0000-0001-6845-5384			af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; af Geijerstam JL, 2004, EMERG MED J, V21, P54, DOI 10.1136/emj.2003.003178; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Astrand R, 2006, ACTA NEUROL SCAND, V113, P262, DOI 10.1111/j.1600-0404.2005.00573.x; Astrand R, 2010, PEDIATR NEUROSURG, V46, P101, DOI 10.1159/000319006; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Batchelor J, 2002, EMERG MED J, V19, P515, DOI 10.1136/emj.19.6.515; Bellner J, 1999, ACTA NEUROL SCAND, V100, P355; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; HALL P, 2005, LAKARTIDNINGEN, V102; HALL P, 2005, LAKARTIDNINGEN, V102, P20; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Ingebrigtsen T, 1997, ACTA NEUROL SCAND, V95, P51, DOI 10.1111/j.1600-0404.1997.tb00068.x; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Lyttle MD, 2012, EMERG MED J, DOI 10.1136/emermed-2012-201887.; McLeod TCV, 2005, J ATHL TRAINING, V40, P123; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Tavarez MM, 2012, CURR OPIN PEDIATR, V24, P307, DOI 10.1097/MOP.0b013e3283531ce6; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	28	6	6	0	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	MAR	2014	129	3					168	172		10.1111/ane.12158			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	297OU	WOS:000330265600005	23763509				2022-02-06	
J	Wang, YH; Wang, CL; Cai, S; Dong, JR; Yang, LK; Chen, L; Maas, AIR				Wang, Yuhai; Wang, Chunli; Cai, Sang; Dong, Jirong; Yang, Likun; Chen, Lei; Maas, Andrew I. R.			Surgical Management of Traumatic Interhemispheric Subdural Hematoma	TURKISH NEUROSURGERY			English	Article						Traumatic interhemispheric subdural hematoma; Surgery; Outcome; Prognosis; Traumatic brain injury		AIM: To review our experience in the surgical treatment of TISH, and to analyze prognostic factors. MATERIAL and METHODS: Clinical and imaging data, surgical modalities, and outcomes of 21 patients with TISH who were treated with microsurgery were analyzed retrospectively. Prognostic factors for outcome were analyzed by univariate analysis. RESULTS: Long-term follow up with outcome assessment according to the Glasgow Outcome Scale (GOS) showed good recovery in 16 cases, moderate disability in two cases, severe disability in one case, and death in two cases. During surgery the origin of bleeding could be identified in all 21 cases. A rupture of the distal anterior cerebral artery or veins in the interhemispheric fissure was seen more frequently in patients with whole interhemispheric fissure hematoma, while hemorrhage from brain tissue laceration was seen more frequently in patients with more localized hematomas. The outcome in patients with an identified rupture of a vessel was better than in those with cortical laceration. Preoperative GCS score and thickness of the interhemispheric hematoma were correlated with outcome (P=0.001 and P=0.004, respectively). CONCLUSION: Outcome after surgical treatment for TISH can be good, and careful surgical planning and microsurgical techniques to preserve venous drainage are essential.	[Wang, Yuhai; Wang, Chunli; Cai, Sang; Dong, Jirong; Yang, Likun; Chen, Lei] Chinese Peoples Liberat Army, Hosp 101, Dept Neurosurg, Wu Xi, Jiangsu, Peoples R China; [Maas, Andrew I. R.] Univ Antwerp Hosp, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Dept Neurosurg, B-2020 Antwerp, Belgium		Wang, YH (corresponding author), Chinese Peoples Liberat Army, Hosp 101, Dept Neurosurg, Wu Xi, Jiangsu, Peoples R China.	yuhaitwang@163.com					BARTELS RHMA, 1995, NEUROSURGERY, V36, P1210, DOI 10.1227/00006123-199506000-00026; BORZONE M, 1995, ZBL NEUROCHIR, V56, P51; CLEIN LJ, 1969, J NEUROL NEUROSUR PS, V32, P389, DOI 10.1136/jnnp.32.5.389; ELSNER H, 1990, J NEUROSURG, V72, P813, DOI 10.3171/jns.1990.72.5.0813; GARTMAN J J JR, 1989, Journal of Emergency Medicine, V7, P603, DOI 10.1016/0736-4679(89)90005-X; Houtteville J P, 1988, Br J Neurosurg, V2, P357, DOI 10.3109/02688698809001007; POZZATI E, 1982, J TRAUMA, V22, P241; Psaltis A, 2004, J CLIN NEUROSCI, V11, P546, DOI 10.1016/j.jocn.2003.09.013; Takeuchi S, 2010, J CLIN NEUROSCI, V17, P1527, DOI 10.1016/j.jocn.2010.03.055; TOFFOL G J, 1986, Journal of Emergency Medicine, V4, P103, DOI 10.1016/0736-4679(86)90072-7	10	6	6	0	3	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAR	2014	24	2					228	233		10.5137/1019-5149.JTN.8377-13.0			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AF2RX	WOS:000334560800013	24831365	Bronze			2022-02-06	
J	Wilson, MJ; Harkrider, AW; King, KA				Wilson, Matthew J.; Harkrider, Ashley W.; King, Kristin A.			The Effects of Visual Distracter Complexity on Auditory Evoked P3b in Contact Sports Athletes	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; EVENT-RELATED POTENTIALS; UNITED-STATES; HEAD-INJURY; HIGH-SCHOOL; P300; ATTENTION; CONCUSSION; TASK; DEFICITS	"Classic" P3b auditory oddball paradigms are insensitive to subtle deficits. An auditory oddball paradigm paired with visual distracters was used to compare football players with history of concussion, football players without history of concussion, and non-contact sport athletes. As hypothesized, increasing complexity of, and attention to, visual distracters reduced P3b amplitude. P3b amplitudes from non-contact athletes were larger than those from football players; however, players with and without a history of concussion were not significantly different. An auditory oddball paradigm with simple visual distracter improves sensitivity to cognitive deficits. Subconcussive impacts may contribute to brain damage frequently attributed to concussions.	[Wilson, Matthew J.] No Illinois Univ, Sch Allied Hlth & Commun Disorders, De Kalb, IL 60115 USA; [Harkrider, Ashley W.; King, Kristin A.] Univ Tennessee, Hlth Sci Ctr, Dept Audiol & Speech Pathol, Knoxville, TN USA		Wilson, MJ (corresponding author), No Illinois Univ, Sch Allied Hlth & Commun Disorders, 323 Wirtz Hall, De Kalb, IL 60115 USA.	mwilson@niu.edu					Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Burton CL, 2002, CLIN NEUROPSYCHOL, V16, P264, DOI 10.1076/clin.16.3.264.13854; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Crawcour S, 2009, NEUROPSYCHOLOGIA, V47, P2558, DOI 10.1016/j.neuropsychologia.2009.05.001; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; DUNCANJOHNSON CC, 1981, PSYCHOPHYSIOLOGY, V18, P207; DUNCANJOHNSON CC, 1982, BIOL PSYCHOL, V14, P1, DOI 10.1016/0301-0511(82)90016-3; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Faul M, 2010, TRAUMATIC BRAIN INJU; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; JASPER HH, 1958, J ELECTROENCEPHALOGR, V10, P371; Jocoy EL, 1998, INT J PSYCHOPHYSIOL, V30, P319, DOI 10.1016/S0167-8760(98)00029-4; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Kota S, 2013, NEUROREPORT, V24, P437, DOI 10.1097/WNR.0b013e3283616512; Lachapelle J, 2004, VISION RES, V44, P2835, DOI 10.1016/j.visres.2004.06.007; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lawler KA, 1996, J HEAD TRAUMA REHAB, V11, P18, DOI 10.1097/00001199-199612000-00005; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meinhardt J, 2003, COGNITION EMOTION, V17, P477, DOI 10.1080/02699930244000039; Muller-Gass A, 2007, BRAIN RES, V1136, P169, DOI 10.1016/j.brainres.2006.12.020; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Oray S, 2002, INT J PSYCHOPHYSIOL, V43, P213, DOI 10.1016/S0167-8760(01)00174-X; Polich J, 1997, BRAIN TOPOGR, V9, P275, DOI 10.1007/BF01464482; Polich J, 1996, INT J PSYCHOPHYSIOL, V23, P55, DOI 10.1016/0167-8760(96)00028-1; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Posner M. I., 2004, ATTENTION ORGAN SYST; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sivak S, 2008, BRAIN INJURY, V22, P193, DOI 10.1080/02699050801895431; Talavage TM, 2010, J NEUROTRAUMA; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Vohn R, 2007, HUM BRAIN MAPP, V28, P1267, DOI 10.1002/hbm.20350; Wilson MJ, 2012, EAR HEARING, V33, P480, DOI 10.1097/AUD.0b013e3182446a42; Yurgil K. A., 2013, PSYCHOPHYSIOLOGY, DOI 10.1111/psyp.12140	62	6	7	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	FEB 17	2014	39	2					113	130		10.1080/87565641.2013.870177			18	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AB6VU	WOS:000331928400004	24571930				2022-02-06	
J	Banks, SJ; Obuchowski, N; Shin, WY; Lowe, M; Phillips, M; Modic, M; Bernick, C				Banks, Sarah J.; Obuchowski, Nancy; Shin, Wanyong; Lowe, Mark; Phillips, Michael; Modic, Michael; Bernick, Charles			The Protective Effect of Education on Cognition in Professional Fighters	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Boxing; Mixed martial arts; Chronic traumatic encephalopathy; Thalamus; Hippocampus	TRAUMATIC BRAIN-INJURY; RESERVE; SIZE	Education has a protective effect against cognitive deficits following various forms of brain insult. Professional fighting (boxing and mixed martial arts) provides a model for assessing the impact of cumulative brain injuries on cognition and brain health. In the current cross-sectional observational study, we explore whether education would be protective against cognitive loss in fighters. We tested 141 professional fighters using a computerized neurocognitive battery, in addition to structural MRI. We used automated segmentation software to compute the volumes of various brain structures. We found fighters with high school education or less to show more associations between fight exposure and cognitive test scores. The relationship between brain structure volume and exposure did not differ based on education. These results are interpreted as putatively showing a protective effect of education on functional integrity in fighters, although longitudinal data and a larger sample size are required to further understand this relationship.	[Banks, Sarah J.; Bernick, Charles] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Cleveland, OH 44106 USA; [Shin, Wanyong; Lowe, Mark; Phillips, Michael; Modic, Michael] Cleveland Clin, Dept Radiol, Cleveland, OH 44106 USA; [Obuchowski, Nancy] Cleveland Clin, Cleveland, OH 44106 USA		Banks, SJ (corresponding author), Cleveland Clin, Lou Ruvo Ctr Brain Hlth, 888 W Bonneville Ave, Las Vegas, NV 89135 USA.	bankss2@ccf.org		Banks, Sarah/0000-0001-7536-2370	Lincy Foundation Triny Cooper; Isaac Santa Ana; Michelle Sholar	We gratefully acknowledge funding support from Lincy Foundation Triny Cooper, Isaac Santa Ana, Michelle Sholar were all instrumental in this work.	Alexander GE, 1997, AM J PSYCHIAT, V154, P165; Bernick C., 2012, AM AC NEUR NEW ORL; Bernick C., THRESHOLD EFFE UNPUB; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; BROOKS N, 1987, J NEUROL NEUROSUR PS, V50, P997, DOI 10.1136/jnnp.50.8.997; Coffey CE, 1999, NEUROLOGY, V53, P189, DOI 10.1212/WNL.53.1.189; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Maroof DA, 2011, J CLIN EXP NEUROPSYC, V33, P901, DOI 10.1080/13803395.2011.574606; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Stern RA, 1996, ARCH NEUROL-CHICAGO, V53, P148, DOI 10.1001/archneur.1996.00550020052015; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; STERN Y, 1992, ANN NEUROL, V32, P371, DOI 10.1002/ana.410320311; Stern Y, 2003, J CLIN EXP NEUROPSYC, V25, P691, DOI 10.1076/jcen.25.5.691.14573; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248	24	6	6	0	23	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2014	29	1					54	59		10.1093/arclin/act079			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AA1CA	WOS:000330832700007	24191967	Bronze			2022-02-06	
J	Vinas-Rios, JM; Sanchez-Aguilar, M; Sanchez-Rodriguez, JJ; Gonzalez-Aguirre, D; Heinen, C; Meyer, F; Kretschmer, T				Vinas-Rios, Juan Manuel; Sanchez-Aguilar, Martin; Sanchez-Rodriguez, Jose Juan; Gonzalez-Aguirre, Daniel; Heinen, Christian; Meyer, Frerk; Kretschmer, Thomas			Hypocalcaemia as a prognostic factor of early mortality in moderate and severe traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Hypocalcaemia; Predictive mortality factor; Traumatic brain injury	MAGNESIUM	Objectives: Our main objective was to evaluate whether serum hypocalcaemia on the third day [ defined as, 2.1 mmol/l (8.5 mg/dl)] is a prognostic factor for early mortality after moderate and severe traumatic brain injury (TBI). Methods: We developed an ambispective comparative case control study. We evaluated clinical profiles from included patients from January 2005 to July 2009 and we prospectively recruited additional patients from August 2009 to July 2011. Patients were between 1 and 89 years old and had a Glasgow Coma Scale of 3-12 points following TBI. Results: We calculated an Odds Ratio of 5.2 (Confidence Intervals 95%: 4.48 to 6.032) for hypocalcaemia on day three, which was associated with death. Retrospectively (January 2005 to July 2009) we compiled data from 81 patients. Prospectively (August 2009 to July 2011) we recruited 41 patients. The adjusted variables in the logistic regression final model were: serum calcium on day three (Odds Ratio 3.5, Confidence Intervals 95%: 1.12 to 13.61, P, 0.028) and anisocoria (Odds Ratio 8.24, Confidence Intervals 95%: 1.3 to 67.35, P, 0.019) obtaining an adjusted R2 of 0.22 (P, 0.005). Discussion: The serum levels of calcium on day three could be useful for the prediction of mortality in patients with moderate and severe TBI.	[Vinas-Rios, Juan Manuel; Heinen, Christian; Meyer, Frerk; Kretschmer, Thomas] Evangel Krankenhaus, Oldenburg, Germany; [Sanchez-Aguilar, Martin; Sanchez-Rodriguez, Jose Juan; Gonzalez-Aguirre, Daniel] Univ Autonoma San Luis Potosi, Fac Med, Dept Epidemiol & Publ Hlth, Mexico City, DF, Mexico		Sanchez-Aguilar, M (corresponding author), Univ Autonoma San Luis Potosi, Fac Med, Dept Epidemiol & Publ Hlth, Expt Surg Lab, Mexico City, DF, Mexico.	fa_chula@hotmail.com	Kretschmer, Thomas/AAW-1331-2020; Rios-Martin, Juan Jose/C-2724-2015	Kretschmer, Thomas/0000-0002-0419-6720; Rios-Martin, Juan Jose/0000-0001-6346-0061			Balbino M, 2010, J TRAUMA, V68, P859, DOI 10.1097/TA.0b013e3181af69d3; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Cook NL, 2009, MAGNESIUM RES, V22, P225, DOI 10.1684/mrh.2009.0189; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Dickerson RN, 2007, JPEN-PARENTER ENTER, V31, P228, DOI 10.1177/0148607107031003228; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; JMP, 1989, JMP VERS 7; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Mudo G, 2009, BRAIN RES, V1298, P24, DOI 10.1016/j.brainres.2009.08.074; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Nariai T, 2001, J NEUROTRAUM, V18, P1323, DOI 10.1089/08977150152725623; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Shahlaie K, 2010, J NEUROTRAUM, V27, P175, DOI 10.1089/neu.2009.1003; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Timofeev I, 2013, J CEREBR BLOOD F MET, V33, P422, DOI 10.1038/jcbfm.2012.186; Zauner A, 1997, BRAIN METABOLISM CER, P89; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y; Zivin JR, 2001, AM J KIDNEY DIS, V37, P689, DOI 10.1016/S0272-6386(01)80116-5	20	6	6	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	FEB	2014	36	2					102	106		10.1179/1743132813Y.0000000272			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI7VK	WOS:000337108700002	24139087				2022-02-06	
J	Aadal, L; Kirkevold, M; Borg, T				Aadal, Lena; Kirkevold, Marit; Borg, Tove			Neurorehabilitation analysed through 'situated learning' theory	SCANDINAVIAN JOURNAL OF DISABILITY RESEARCH			English	Article						traumatic brain injury; inpatient neurorehabilitation; situated learning; patient participation; everyday life skills		This paper proposes a perspective of learning in the context of neurorehabilitation. Central concepts from Lave and Wenger's theory of situated learning are presented as a promising theoretical perspective to grasp the problems typically encountered by professionals and a strategy to analyse the effectiveness of rehabilitation strategies aimed at everyday activities. Empirical data from field studies and focus group interviews describing rehabilitating efforts were analysed and discussed using central concepts from the 'theory of situated learning'. We found that professionals are challenged when including patients with severe brain injury as 'participants' in the 'rehabilitation practice community'. Systematic use of the proposed learning concepts may support rehabilitation professionals to facilitate and challenge patient participation and learning during rehabilitation. Two interrelated levels of pedagogical challenges exist: (1) supporting the gain of the patient or compensation for changed learning abilities and (2) supporting the patient in learning or compensating for lost abilities.	[Aadal, Lena; Borg, Tove] Univ Aarhus, Hammel Neurorehabil & Resarch Ctr, Hammel, Denmark; [Kirkevold, Marit] Univ Aarhus, Dept Nursing Sci, Aarhus, Denmark; [Kirkevold, Marit] Univ Oslo, Inst Hlth & Soc, Oslo, Norway		Aadal, L (corresponding author), Univ Aarhus, Hammel Neurorehabil & Resarch Ctr, Hammel, Denmark.	lena.aadal@hammel.rm.dk	aadal, lena/U-9172-2017	aadal, lena/0000-0001-7365-3916			Antelius E, 2009, HEALTH, V13, P361, DOI 10.1177/1363459308101808; Bazeleley P, 2007, QUALITATIVE DATA ANA; Benner P., 1997, NOVICE EKSPERT MESTE; Borg T., 2003, THESIS; Carey L. M., 2012, STROKE REHABILITATIO, P11, DOI [10.1093/med/9780199797882.003.0002, DOI 10.1093/MED/9780199797882.003.0002]; Carlson PM, 2006, BRAIN INJURY, V20, P1111, DOI 10.1080/02699050600955337; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Coyle Mary K, 2007, J Neurosci Nurs, V39, P274; Debesay J, 2008, NURS INQ, V15, P57, DOI 10.1111/j.1440-1800.2008.00390.x; Emerson F., 1995, WRITING ETHNOGRAPHIC; Freeman T, 2006, J ADV NURS, V56, P491, DOI 10.1111/j.1365-2648.2006.04043.x; Gadamer H. G., 2004, SANDHED METODE WAHRH; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Hammersley M, 2004, GRUNNLAGET FELTARBEI; Hansen H. P., 1994, FELTARBEJDE EGEN KUL, V15, P1; Hart T, 2011, J HEAD TRAUMA REHAB, V26, P179, DOI 10.1097/HTR.0b013e318218dd51; Hastrup K., 2003, IND VERDEN GRUNDBOG; Hastrup K., 1988, FELTARBEJDE OPLEVELS, P11; Hastrup K., 1990, ETNOGRAFISK GRUNDBOG; Jenkins M., 1995, BRIT J OCCUPATIONAL, V58, P332; Kolb B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00204; Kvale S., 2008, COMMUNICATION; Kvale S, 2003, INTERVIEW INTRO KVAL; Lave J., 1991, SITUATED LEARNING, DOI [10.1017/CBO9780511815355, DOI 10.1017/CBO9780511815355]; LAVE J, 1997, NORDISK PEDAGOGIK, V17, P140; Lave J., 2005, SITUERET LAERING; Lave J, 2008, UNDERSTANDING PRACTI, P3; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Li LC, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-27; Manly T, 2003, STUD NEUROPSYCHOL DE, P23; MATTINGLY C, 1994, SOC SCI MED, V38, P811, DOI 10.1016/0277-9536(94)90153-8; MATTINGLY C, 1994, CLIN REASONING FORMS, P178; Mattingly C, 2006, NEW LITERARY HIST, V37, P563, DOI 10.1353/nlh.2006.0050; McLafferty I, 2004, J ADV NURS, V48, P187, DOI 10.1111/j.1365-2648.2004.03186.x; *NO NURS FED, 2003, ETH GUID NURS RES NO; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Pryor J, 2009, J CLIN NURS, V18, P1766, DOI 10.1111/j.1365-2702.2008.02322.x; SCHWANDT TA, 2004, EVALUATING HOLISTIC; Spradley J.P., 1979, ETHNOGRAPHIC INTERVI; Spradley J. P., 1989, PARTICIPANT OBSERVAT; STANDAL OF, 2007, SOBAMA J S1, V12, P125; Standal OF, 2008, ADAPT PHYS ACT Q, V25, P208, DOI 10.1123/apaq.25.3.208; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Toombs K. S., 2001, HDB PHENOMENOLOGY ME, P229; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Vanetzian E, 1997, J ADV NURS, V26, P589, DOI 10.1046/j.1365-2648.1997.t01-20-00999.x; Wenger E., 2009, COMMUNITIES PRACTICE; WENGER E, 2008, COMMUNITIES PRACTICE; Whitehead L, 2004, J ADV NURS, V45, P512, DOI 10.1046/j.1365-2648.2003.02934.x; WHO, 2003, ICF INT KLASS FUNKT; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D	52	6	6	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1501-7419	1745-3011		SCAND J DISABIL RES	Scand. J. Disabil. Res.		2014	16	4					348	363		10.1080/15017419.2013.781956			16	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V85IE	WOS:000212513500004		gold			2022-02-06	
J	Allen, DN; Stolberg, PC; Thaler, NS; Sutton, G; Mayfield, J				Allen, Daniel N.; Stolberg, Paul C.; Thaler, Nicholas S.; Sutton, Griffin; Mayfield, Joan			Validity of the RIAS for Assessing Children With Traumatic Brain Injury: Sensitivity to TBI and Comparability to the WISC-III and WISC-IV	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						children; intelligence; RIAS; traumatic brain injury; WISC-III; WISC-IV	INTELLECTUAL-ASSESSMENT-SCALES; WECHSLER INTELLIGENCE SCALE; COLLEGE-STUDENTS; HEAD-INJURY; IQ GAINS; PROFILES; INDEX; PERFORMANCE; COMA	Intelligence tests are commonly administered to children following moderate-to-severe traumatic brain injury (TBI). The Reynolds Intellectual Assessment Scales (RIAS) is a recently developed measure of intellectual ability that has a number of appealing features for assessing individuals with brain damage, but as yet has little validity information when applied to children with TBI or other forms of brain injury. It is therefore unclear whether RIAS scores are sensitive to brain injury and how they compare to older more well-established tests such as the Wechsler scales. The current article reports two studies that examine these matters in youth with TBI. The first study examined sensitivity of the RIAS to TBI in 110 children. Results indicated the TBI sample performed significantly worse compared with the standardization sample on all RIAS index scores. The second study included 102 children who were administered either the RIAS, Wechsler Intelligence Scale for Children-Third Edition (WISC-III), or WISC-Fourth Edition (WISC-IV; 34 children in each group). Comparisons among the RIAS, WISC-III, and WISC-IV groups indicated no significant differences among the measures on verbal, nonverbal, and Composite Index/Full-Scale IQs. Results provide support for the sensitivity of the RIAS to TBI in children and also suggest that IQs produced by the RIAS, WISC-III, and WISC-IV do not significantly vary from one test to the other, which is particularly true of the verbal and Composite Index/Full-Scale IQs.	[Allen, Daniel N.; Stolberg, Paul C.; Thaler, Nicholas S.; Sutton, Griffin] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Neuropsychol, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Calhoun SL, 2005, PSYCHOL SCHOOLS, V42, P333, DOI 10.1002/pits.20067; Dombrowski SC, 2009, J PSYCHOEDUC ASSESS, V27, P494, DOI 10.1177/0734282909333179; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 1997, ASSESSMENT, V4, P107, DOI 10.1177/107319119700400114; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Edwards OW, 2007, J PSYCHOEDUC ASSESS, V25, P334, DOI 10.1177/0734282907300453; Flynn JR, 1999, AM PSYCHOL, V54, P5, DOI 10.1037/0003-066X.54.1.5; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; FLYNN JR, 1984, PSYCHOL BULL, V95, P29, DOI 10.1037/0033-2909.95.1.29; Goldstein S., 1999, HDB NEURODEVELOPMENT; Hiscock Merrill, 2002, Appl Neuropsychol, V9, P129, DOI 10.1207/S15324826AN0903_1; HORN JL, 1966, J EDUC PSYCHOL, V57, P253, DOI 10.1037/h0023816; JENNETT B, 1977, LANCET, V1, P878; Jennett B, 1981, MANAGEMENT HEAD INJU; Kamphaus, 2003, REYNOLDS INTELLECTUA; Kanaya T, 2003, J SCHOOL PSYCHOL, V41, P453, DOI 10.1016/j.jsp.2003.08.003; Kavale KA, 2000, J LEARN DISABIL-US, V33, P239, DOI 10.1177/002221940003300303; Kay JB, 1999, J CLIN EXP NEUROPSYC, V21, P186, DOI 10.1076/jcen.21.2.186.927; Morgan AW, 1997, J LEARN DISABIL, V30, P560, DOI 10.1177/002221949703000512; NAGLIERI JA, 2005, ANN CONV NAT ASS SCH; Nelson JM, 2007, J SCHOOL PSYCHOL, V45, P439, DOI 10.1016/j.jsp.2007.03.003; Ofiesh NS, 2000, J LEARN DISABIL, V33, P14, DOI 10.1177/002221940003300105; Rackley C, 2012, CHILD NEUROPSYCHOL, V18, P512, DOI 10.1080/09297049.2011.628308; Reschly D.J., 2002, MENTAL RETARDATION D; REYNOLDS CR, 1997, HDB CLIN CHILD NEURO; Schrank F. A., 2004, SCH PSYCHOL, V58, P96; Scruggs TE, 2002, LEARN DISABILITY Q, V25, P155, DOI 10.2307/1511299; Smith BL, 2009, PERCEPT MOTOR SKILL, V109, P30, DOI 10.2466/PMS.109.1.30-40; TEASDALE G, 1974, LANCET, V2, P81; Thaler NS, 2010, ARCH CLIN NEUROPSYCH, V25, P781, DOI 10.1093/arclin/acq073; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; Umphress TB, 2008, INTELLECT DEV DISAB, V46, P229, DOI 10.1352/2008.46:229-233; Wechsler D., 2003, WISC 4 TECHNICAL INT; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; Weiss LG, 2010, J PSYCHOEDUC ASSESS, V28, P482, DOI 10.1177/0734282910373572; Zimmerman IL, 1997, PERCEPT MOTOR SKILL, V85, P531; [No title captured]; [No title captured]	41	6	6	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2014	3	2					83	93		10.1080/21622965.2012.700531			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AF8DR	WOS:000334946200001	24716867				2022-02-06	
J	Biszak, AM; Babbage, DR				Biszak, Angela M.; Babbage, Duncan R.			Facial affect recognition difficulties in traumatic brain injury rehabilitation services	BRAIN INJURY			English	Article						Affect recognition; emotion recognition; facial affect; social functioning; traumatic brain injury	EMOTION RECOGNITION; SOCIAL COMMUNICATION; QUESTIONNAIRE EBIQ; DEFICITS; EXPRESSION; PERCEPTION; INDIVIDUALS; IMPAIRMENTS; INTEGRATION; COMPETENCE	Primary objective: The occurrence of facial affect recognition difficulties in a sample of people accessing traumatic brain injury (TBI) rehabilitation services was examined. It was hypothesized that between 13-39% of participants would demonstrate clinically significant impairment in facial affect recognition. Research design: Cross-sectional sample of eligible participants who were current clients of eight brain injury services were invited to participate. Methods and procedures: Forty-five participants with mild-to-severe TBI were assessed for facial affect recognition difficulties using the facial affect discrimination, naming, selection and matching sub-tests of the Florida Affect Battery. Main outcomes and results: Fifty-one per cent of participants had at least moderate difficulties with facial affect recognition. Conclusions: The current sample was not a random selection from the population of people with TBI, so the results do not establish a formal estimate of prevalence. Nonetheless, the data indicate that when assessing typical clients with severe brain injuries presenting to neurorehabilitation services, there is likely to be a high frequency of occurrence of facial affect recognition difficulties. Rehabilitation outcomes may be improved by screening for and treating facial affect recognition difficulties following TBI. Further examination and development of treatment options is warranted.	[Biszak, Angela M.] Massey Univ, Sch Psychol, Wellington, New Zealand; [Babbage, Duncan R.] Auckland Univ Technol, Person Centred Res Ctr, Auckland 1142, New Zealand		Babbage, DR (corresponding author), Auckland Univ Technol, Person Centred Res Ctr A11, Private Bag 92006, Auckland 1142, New Zealand.	duncan.babbage@aut.ac.nz		Babbage, Duncan/0000-0002-9259-9246			Allerdings MD, 2006, BRAIN COGNITION, V60, P193, DOI 10.1016/j.bandc.2004.09.018; Babbage DR, 2008, J INT NEUROPSYCHO S1, V14, P69; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bateman A, 2009, NEUROPSYCHOL REHABIL, V19, P941, DOI 10.1080/09602010903021170; Borgaro SR, 2004, BRAIN INJURY, V18, P33, DOI 10.1080/0269905031000110562; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Braun C M, 1989, Brain Inj, V3, P5, DOI 10.3109/02699058909008068; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Heilman KM, 1999, FLORIDA AFFECT BATTE; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Hynes CA, 2011, SOC NEUROSCI-UK, V6, P599, DOI 10.1080/17470919.2011.584447; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Jackson H, 1987, CORTEX J DEVOTED STU; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S, 2013, NEUROPSYCHOL REHABIL, V23, P267, DOI 10.1080/09602011.2012.751340; McDonald S, 2009, NEUROPSYCHOL REHABIL, V19, P321, DOI 10.1080/09602010802193989; Middleton JA, 2001, ADV PSYCHIAT TREAT, V7, P257, DOI DOI 10.1192/APT.7.4.257; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; New Zealand Guidelines Group, 2006, TRAUM BRIAN INJ DIAG, P240; Prigatano GP, 2005, ACT NEUR S, V93, P39; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Zupan B, 2009, J COMMUN DISORD, V42, P1, DOI 10.1016/j.jcomdis.2008.06.001	41	6	6	0	19	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2014	28	1					97	104		10.3109/02699052.2013.856475			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	274CC	WOS:000328581700012	24328805				2022-02-06	
S	Chamard, E; Lassonde, M; Theoret, H		Niranjan, A; Lunsford, LD		Chamard, Emilie; Lassonde, Maryse; Theoret, Hugo			Neurometabolic, Electrophysiological, and Imaging Abnormalities	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							SPORTS-RELATED CONCUSSION; LONG-TERM; PLAYERS; BRAINS	Sport-related concussions affect millions of athletes every year, but they generally present no anatomic alterations when examined using conventional magnetic resonance imaging or a computed tomography scan. Because the damage occurring after a head injury seems to be more functional than structural, these techniques are unable to detect subtle alterations. The absence of detectable structural alterations using traditional neuroimaging methods, the presence of persistent symptoms in some athletes, and the risk of developing neurodegenerative diseases emphasize the importance of assessing the impacts of a head injury with alternative neuroimaging techniques. Electrophysiological methods, magnetic resonance spectroscopy, and diffusion tensor imaging are useful techniques that are sensitive to the effects of a brain trauma, which provide complementary information to allow a more complete understanding of the multiple pathophysiological processes involved in concussive events. This report summarizes recent data using neurophysiological and neuroimaging techniques to better understand the acute and chronic effects of sport-related concussions. (C) 2014 S. Karger AG, Basel	[Chamard, Emilie; Lassonde, Maryse; Theoret, Hugo] Univ Montreal, Dept Psychol, Ctr Rech Neuropsychol & Cognit, Montreal, PQ H3C 3J7, Canada; [Lassonde, Maryse; Theoret, Hugo] CHU St Justine, Ctr Rech, Montreal, PQ, Canada		Theoret, H (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca		Theoret, Hugo/0000-0002-7458-8797			Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Cimatti M, 2006, J Neurosurg Sci, V50, P83; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lin A. P., 2010, 96 SCI ASS ANN M RAD; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	26	6	6	0	2	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						75	85		10.1159/000358766	10.1159/isbn.978-3-318-02649-8		11	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000008	24923394				2022-02-06	
J	de Guise, E; LeBlanc, J; Dagher, J; Tinawi, S; Lamoureux, J; Marcoux, J; Maleki, M; Feyz, M				de Guise, Elaine; LeBlanc, Joanne; Dagher, Jehane; Tinawi, Simon; Lamoureux, Julie; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra			Characteristics of patients with acute traumatic brain injury discharged against medical advice in a Level 1 urban trauma centre	BRAIN INJURY			English	Article						Discharge against medical advice; Level 1 trauma centre; outcome; traumatic brain injury	LEAVE; AMA; REHABILITATION; READMISSION; MORTALITY; HOMELESS; OUTCOMES; SERVICE; IMPACT; RISK	Primary objective: To predict which characteristics are associated with patients at risk of discharge against medical advice (AMA). Research design: Data were retrospectively collected on individuals (n = 5642) admitted to the Traumatic Brain Injury Program of the MUHC-MGH. Methods and procedures: Outcome measures used were length of stay (LOS), the Extended Glasgow Outcome Scale (GOSE) as well as the Functional Independence Measure (FIM (R)). Main outcomes: The overall rate of patients leaving AMA was 1.9% (n = 108). Age was negatively associated with AMA discharge (95% CI OR = [0.966;0.991]). Patients with a history of substance abuse were similar to 2-times more likely to leave AMA than those not using substances before injury (95% CI OR = [1.172;3.314]) and the homeless were similar to 3-times more likely to leave AMA compared to those who were not homeless (95% CI OR = [1.260;7.138]). Length of stay (LOS) was shorter for patients leaving AMA (p<0.001) and they showed better outcome (GOSE: p<0.001; FIM (R) : p = 0.032). Conclusions: Knowing the profile of patients with TBI leaving AMA hospitalized in an urban Level 1 Trauma centre will help in the development of effective strategies based on patient needs, values and pre-injury psychosocial situation to encourage them to complete their treatment course in hospital.	[de Guise, Elaine; Marcoux, Judith; Maleki, Mohammed] McGill Univ, Ctr Hlth, Dept Neurol & Neurosurg, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [LeBlanc, Joanne; Dagher, Jehane; Tinawi, Simon; Feyz, Mitra] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada; [Dagher, Jehane; Tinawi, Simon] McGill Univ, Ctr Hlth, Phys Med & Rehabil Serv, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada		de Guise, E (corresponding author), McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp Site,Room D13-124, Montreal, PQ H3G 1A4, Canada.	elaine.de.guise@umontreal.ca					Anis AH, 2002, CAN MED ASSOC J, V167, P633; Baptist AP, 2007, J ALLERGY CLIN IMMUN, V119, P924, DOI 10.1016/j.jaci.2006.11.695; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Brook M, 2006, PSYCHIAT SERV, V57, P1192, DOI 10.1176/appi.ps.57.8.1192; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Canadian Institute for Health Information (CIHI), 2006, HOSP DUE TRAUM BRAIN; CATON CLM, 1995, PSYCHIATR SERV, V46, P1139; Chan ACH, 2004, JAIDS-J ACQ IMM DEF, V35, P56, DOI 10.1097/00126334-200401010-00008; Choi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024459; Corrigan J, PROBLEMATIC SUBSTANC; Crilly J, 2012, ADV EMERG NURS J, V34, P357, DOI 10.1097/TME.0b013e3182705efb; Duno R, 2003, GEN HOSP PSYCHIAT, V25, P46, DOI 10.1016/S0163-8343(02)00253-0; Fiscella K, 2007, AM J MED, V120, P1047, DOI 10.1016/j.amjmed.2007.08.024; Glasgow JM, 2010, J GEN INTERN MED, V25, P926, DOI 10.1007/s11606-010-1371-4; Granger C.W.J., 1990, ADV ECONOM, V8, P71; Green P, 2004, AM J DRUG ALCOHOL AB, V30, P489, DOI 10.1081/ADA-120037390; Hayat AA, 2013, JCPSP-J COLL PHYSICI, V23, P342, DOI 05.2013/JCPSP.342346; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Ibrahim SA, 2007, AM J PUBLIC HEALTH, V97, P2204, DOI 10.2105/AJPH.2006.100164; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jerrard DA, 2011, J EMERG MED, V41, P412, DOI 10.1016/j.jemermed.2009.10.022; Kim H, 2013, BRAIN INJURY, V27, P325, DOI 10.3109/02699052.2012.750741; Kim H, 2011, J TRAUMA, V71, P1219, DOI 10.1097/TA.0b013e3182190fa6; Lauber C, 2006, EUR ARCH PSY CLIN N, V256, P138, DOI 10.1007/s00406-005-0616-4; Monico Edward P, 2009, J Healthc Risk Manag, V29, P6, DOI 10.1002/jhrm.20009; Myers RP, 2009, CLIN GASTROENTEROL H, V7, P786, DOI 10.1016/j.cgh.2009.03.020; OCHITILL HN, 1985, J CHRON DIS, V38, P79, DOI 10.1016/0021-9681(85)90010-4; Onukwugha E, 2009, NEUROREHABILITATION, V24, P67, DOI 10.3233/NRE-2009-0455; Onukwugha E, 2012, BMJ OPEN, V2, P900; Satz R., 2002, CANADIAN MED ASS J, V167, P647; Southern WN, 2012, AM J MED, V125, P594, DOI 10.1016/j.amjmed.2011.12.017	31	6	6	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	10					1288	1294		10.3109/02699052.2014.916820			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AN2ZZ	WOS:000340455900009	24884582				2022-02-06	
S	Fakhran, S; Alhilali, L		Niranjan, A; Lunsford, LD		Fakhran, Saeed; Alhilali, Lea			Neurodegenerative Changes after Mild Traumatic Brain Injury	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; HEAD-INJURY; RISK; DEMENTIA	A link between mild traumatic brain injury (mTBI) and neurodegenerative diseases, specifically Alzheimer's disease and chronic traumatic encephalopathy (CTE), has long been suspected. Shared clinical symptomology - most notably the prominent role of central auditory dysfunction and sleep-wake disturbances in both disease states - and similar findings on postmortem pathological examination has further reinforced suspected commonality between these seemingly disparate entities. However, conventional imaging techniques, including computed tomography and anatomic magnetic resonance, are unable to detect the symptomatic injuries in mTBI patients and therefore detection of neurodegenerative changes in vivo has previously not been reported. Recent research using diffusion tensor imaging, a novel imaging technique, and focused on patient-reported symptoms has for the first time demonstrated imaging findings in mTBI patients in vivo that are strikingly similar to Alzheimer's dementia and CTE. Moving forward, research will focus on identifying what renders certain patients with mTBI susceptible to developing full-fledged Alzheimer's disease and CTE later in life. (C) 2014 S. Karger AG, Basel	[Fakhran, Saeed; Alhilali, Lea] Univ Pittsburgh, Sch Med, Div Neuroradiol, Dept Radiol, Pittsburgh, PA 15213 USA		Fakhran, S (corresponding author), Univ Pittsburgh, Sch Med, Div Neuroradiol, Dept Radiol, 200 Lothrop St,Presby South Tower,8th Floor, Pittsburgh, PA 15213 USA.	fakhrans@upmc.edu					Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Covell GES, 2012, NEUROLOGIST, V18, P426, DOI 10.1097/NRL.0b013e318272f7ef; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Ginestroni A, 2009, J NEUROL, V256, P925, DOI 10.1007/s00415-009-5044-3; Golob EJ, 2007, BRAIN, V130, P740, DOI 10.1093/brain/awl375; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P51, DOI 10.1001/archneurol.2011.235; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Idrizbegovic E, 2011, AGE AGEING, V40, P249, DOI 10.1093/ageing/afq168; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Romito-DiGiacomo RR, 2007, J NEUROSCI, V27, P8496, DOI 10.1523/JNEUROSCI.1008-07.2007; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tranah GJ, 2011, ANN NEUROL, V70, P722, DOI 10.1002/ana.22468; Viswanathan A, 2006, STROKE, V37, P2690, DOI 10.1161/01.STR.0000245091.28429.6a; Yoshiura T, 2006, ACAD RADIOL, V13, P1460, DOI 10.1016/j.acra.2006.09.042	26	6	6	0	2	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						234	242		10.1159/000358787	10.1159/isbn.978-3-318-02649-8		9	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000021	24923407				2022-02-06	
J	Fleming, J; Liddle, J; Nalder, E; Weir, N; Cornwell, P				Fleming, Jennifer; Liddle, Jacki; Nalder, Emily; Weir, Nicole; Cornwell, Petrea			Return to driving in the first 6 months of community integration after acquired brain injury	NEUROREHABILITATION			English	Article						Community integration; rehabilitation; longitudinal studies; brain injuries; traumatic; automobile driving	SENTINEL EVENTS; TRANSITION; HEALTH; HOME; INDIVIDUALS; PARTICIPATION; EXPERIENCES; DEPRESSION; RECOVERY; VALIDITY	BACKGROUND: Return to driving is a goal and milestone in the recovery process following acquired brain injury (ABI). Knowledge of whether and when a person is likely to return to driving is important to people with ABI, family members and clinicians. OBJECTIVE: To determine the rates, timing, correlates, and predictors of return to driving in the first 6 months after discharge from hospital following ABI. METHODS: Survey of 212 participants with ABI and 121 family members at discharge and 3 and 6 months later. Participants with ABI were grouped according to driving status (not driving, returned within 3 months, returned within 6 months). Groups were compared on demographics, injury severity, quality of life, functioning, psychosocial integration, depression, and carer well-being. RESULTS: By 6 months post-discharge 62.3% had resumed driving. Between group differences existed on measures of injury severity, and psychosocial integration at 6 months, and carer depression and strain at discharge and 6 months. Whether and when someone returned to driving could be predicted by length of hospital stay, and level of community integration, and pain at discharge. CONCLUSIONS: Educating clients about their likelihood and timing of return to driving, and supporting non-drivers and their carers may improve psychosocial outcomes.	[Fleming, Jennifer; Liddle, Jacki; Nalder, Emily] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Fleming, Jennifer; Weir, Nicole] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; [Fleming, Jennifer] Metro South Hosp & Hlth Serv, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Cornwell, Petrea] Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia; [Cornwell, Petrea] Griffith Univ, Brisbane, Qld 4111, Australia; [Nalder, Emily] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada		Fleming, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	j.fleming@uq.edu.au	Cornwell, Petrea/AAE-5547-2019; Liddle, Jacki/F-6872-2010	Liddle, Jacki/0000-0002-6336-9898	Australian Research Council Linkage GrantAustralian Research Council [LP0776294]; Queensland Government Department of Communities (Disability Services); Acquired Brain Injury Outreach Service	The authors wish to acknowledge the funding support provided by an Australian Research Council Linkage Grant (LP0776294) and from partner organisations Queensland Government Department of Communities (Disability Services) and the Acquired Brain Injury Outreach Service. Our thanks are extended to Professor Linda Worrall, Dr Terry Haines, Dr Tamara Ownsworth, Dr Melissa Kendall and Prof Lesley Chenoweth for their contribution to the design and development of this project, to Ms Cassandra Shields for assistance with data collection, and to the study participants.	Alguren B, 2012, NEUROREHAB NEURAL RE, V26, P266, DOI 10.1177/1545968311414204; [Anonymous], 2007, STAT STAT SOFTW REL; Austroads, 2012, ASS FITN DRIV COMM P; Austroads, 2003, ASS FITN DRIV; BRAZIER J, 1993, QUAL LIFE RES, V2, P169, DOI 10.1007/BF00435221; Brooks N, 2005, BRAIN INJURY, V19, P165, DOI 10.1080/02699050410001720004; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Conneeley AL, 2012, BRAIN IMPAIR, V13, P72, DOI 10.1017/BrImp.2012.3; Dickerson AE, 2011, AM J OCCUP THER, V65, P64, DOI 10.5014/ajot.2011.09052; Evans L., 1985, HUMAN BEHAV TRAFFIC, P485; Fisk GD, 1997, ARCH PHYS MED REHAB, V78, P1338, DOI 10.1016/S0003-9993(97)90307-5; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; LANG TA, 2006, REPORT STAT MED; Liddle J., 2003, BRIT J OCCUPATIONAL, V66, P125, DOI DOI 10.1177/030802260306600307; Liddle J, 2012, AUST OCCUP THER J, V59, P79, DOI 10.1111/j.1440-1630.2011.00978.x; Liddle J, 2011, DISABIL REHABIL, V33, P2574, DOI 10.3109/09638288.2011.582922; Liddle J, 2009, BRAIN IMPAIR, V10, P271, DOI 10.1375/brim.10.3.271; Lister R, 1999, BRIT J OCCUPATIONAL, V62, P514; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Malec J. F., 2003, MANUAL MAYO PORTLAND; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Nalder E, 2012, J REHABIL MED, V44, P837, DOI 10.2340/16501977-1033; Nalder E, 2012, BRAIN INJURY, V26, P1381, DOI 10.3109/02699052.2012.676225; Nalder E, 2012, BRAIN IMPAIR, V13, P108, DOI 10.1017/BrImp.2012.4; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; Novack TA, 2000, BRAIN INJURY, V14, P987; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Pevalin D, 2009, STATA SURVIVAL MANUA; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; TEASDALE G, 1974, LANCET, V2, P81; Townend W, 2001, J NEUROL NEUROSUR PS, V70, P267; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; White JH, 2012, DISABIL REHABIL, V34, P831, DOI 10.3109/09638288.2011.623754; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	48	6	6	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	1					157	166		10.3233/NRE-131012			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AA4JN	WOS:000331062000017	24284461	Green Submitted			2022-02-06	
J	Forslund, MV; Arango-Lasprilla, JC; Roe, C; Perrin, PB; Andelic, N				Forslund, Marit V.; Arango-Lasprilla, Juan C.; Roe, Cecilie; Perrin, Paul B.; Andelic, Nada			Multilevel modeling of partnered relationship trajectories and relationship stability at 1, 2, and 5 years after traumatic brain injury in Norway	NEUROREHABILITATION			English	Article							QUALITY-OF-LIFE; MARITAL RELATIONSHIPS; INDIVIDUALS; CAREGIVERS	OBJECTIVES: The aims of this study were to examine (a) predictors of partnered relationship probability trajectories and relationship stability across 1, 2, and 5 years after traumatic brain injury, and (b) influences on the slopes of these trajectories. MATERIALS AND METHODS: Individuals (n = 105) from Norway with acute TBI were assessed during admission to an urban trauma center and again at 1, 2 and 5 years after injury. The outcome measures were partnered relationship status (partnered vs. single) at 1, 2 and 5 years post-injury investigated through multilevel modelling, and relationship stability (stable, unstable, and single) investigated through multinomial logistic regression. Independent variables were sex, age at injury, partnered relationship at injury, having dependent children, education, employment and occupation status at time of injury, acute Glasgow Coma Scale score, posttraumatic amnesia, and length of stay in hospital. RESULTS: Partnered relationship status at injury and the interaction of relationship status at injury by time, employment at injury and the interaction of TBI severity by time were significant predictors of participants' relationship trajectories. Having dependent children at the time of injury, higher education, and being in a blue collar occupation at time of injury were significant predictors of relationship stability. CONCLUSIONS: The identification of these influences on partnered relationship probability trajectories and stability could help clinicians and researchers develop and refine early interventions to reduce relationship dissolution in the first several years after brain injury.	[Forslund, Marit V.; Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Forslund, Marit V.; Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway; [Andelic, Nada] Univ Oslo, Fac Med, CHARM Res Ctr Habilitat & Rehabil Models & Serv, Inst Hlth & Soc, Oslo, Norway; [Arango-Lasprilla, Juan C.] Univ Deusto, Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Perrin, Paul B.] Virginia Commonwealth Univ, Richmond, VA USA		Andelic, N (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Postboks 4950 Nydalen, N-0424 Oslo, Norway.	nandelic@online.no	; Perrin, Paul/L-5373-2015	Andelic, Nada/0000-0002-3719-4406; Perrin, Paul/0000-0003-2070-215X			Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gosling J, 1999, BRAIN INJURY, V13, P785; Harkonen J, 2006, EUR SOCIOL REV, V22, P501, DOI 10.1093/esr/jcl011; Kieffer-Kristensen R, 2011, NEUROREHABILITATION, V28, P321, DOI 10.3233/NRE-2011-0660; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lyngstad Torkild H, 2004, DEMOGR RES, V10, P121, DOI DOI 10.4054/DEMRES.2004.10.5; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Rosand GMB, 2014, SOC PSYCH PSYCH EPID, V49, P109, DOI 10.1007/s00127-013-0681-3; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	22	6	6	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	4					781	788		10.3233/NRE-141084			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AK5CY	WOS:000338443100018	24820168				2022-02-06	
S	Gennarelli, TA		Niranjan, A; Lunsford, LD		Gennarelli, Thomas A.			Future Directions in Brain Injury Research	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							DIFFUSE AXONAL INJURY; HEAD-INJURY; CEREBRAL CONCUSSION	This paper reviews the potential future directions that are important for brain injury research, especially with regard to concussion. The avenues of proposed research are categorized according to current concepts of concussion, types of concussion, and a global schema for globally reducing the burden of concussion. (C) 2014 S. Karger AG, Basel	[Gennarelli, Thomas A.] Med Coll Wisconsin, Neurosurg, Milwaukee, WI 53226 USA; [Gennarelli, Thomas A.] George Washington Univ, Neurosurg, Washington, DC USA		Gennarelli, TA (corresponding author), 822 Grist Mill Lane, W Chester, PA 19380 USA.	tgennarelli@att.net					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Holbourn AHS, 1943, LANCET, V2, P438; Mohan D, 2003, INJURY PREVENTION CO; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; SYMONDS C, 1962, LANCET, V1, P1; Symonds CP, 1935, LANCET, V1, P486; WARD AA, 1966, CLIN NEUROSURG, V12, P95; World Health Organization, 2002, WORLD HLTH REP 2002, P7	14	6	6	0	2	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						243	250		10.1159/000358788	10.1159/isbn.978-3-318-02649-8		8	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000022	24923408				2022-02-06	
J	Griffin, ES; Lippmann, SJ; Travers, DA; Woodard, EK				Griffin, Elizabeth Stone; Lippmann, Steven J.; Travers, Debbie A.; Woodard, Elizabeth K.			A MATCHED-COHORT STUDY OF PEDIATRIC HEAD INJURIES: COLLECTING DATA TO INFORM AN EVIDENCE-BASED TRIAGE ASSESSMENT	JOURNAL OF EMERGENCY NURSING			English	Article						Pediatric; Head injury; Head trauma; Triage; Assessment	DECISION RULE; CHILDREN; PREDICTION; VALIDATION	Introduction: Triage nurses are the "first stop" for patients who present to the emergency department for care. The assessment of pediatric head injuries is especially challenging because signs and symptoms of head trauma in children do not correlate well with the risk of closed head injury (CHI). Methods: A retrospective matched cohort study was conducted to compare 2 groups of patients who presented to a pediatric emergency department for evaluation of a head injury: a CHI-positive cohort and a CHI-negative cohort as identified by computed tomography scan. The purpose of the chart review was to collect specific information from both cohorts which could be used to inform a nurse-driven pediatric head injury assessment tool. Results: The younger the child, the more likely they were to be asymptomatic. Scalp hematomas in infants <3 months were associated with CHI even if the infants were otherwise asymptomatic. Injuries to the temporal-parietal region were associated with CHI at every age. Frequency of caregiver report of loss of consciousness (LOC) was almost identical in both cohorts. Children in every age category sustained CHIs as the result of minor falls based on standard age-related fall criteria. Discussion: The infants and children at highest risk for CHI are often the most difficult to assess. The results of this study reinforce the need for a nurse-driven, evidence-based risk scoring system that could be used to aid with early identification of infants and children who are at high risk for CHI.	[Griffin, Elizabeth Stone; Woodard, Elizabeth K.] WakeMed Hlth & Hosp, Raleigh, NC 27610 USA; [Griffin, Elizabeth Stone] Univ N Carolina, Sch Nursing, Chapel Hill, NC USA; [Lippmann, Steven J.] Univ N Carolina, Sch Med, Dept Emergency Med, Carolina Ctr Hlth Informat, Chapel Hill, NC USA; [Travers, Debbie A.] Nursing & Emergency Med Univ North Carolina, Chapel Hill, NC USA; [Woodard, Elizabeth K.] Nursing Res & Evidence Based Practice WakeMed Hlt, Raleigh, NC USA		Griffin, ES (corresponding author), WakeMed Hlth & Hosp, Childrens Emergency Dept, 3000 New Bern Ave, Raleigh, NC 27610 USA.	esgriffi@email.unc.edu					Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; Bin SS, 2010, PEDIATR EMERG CARE, V26, P633, DOI 10.1097/PEC.0b013e3181ef0440; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Fabbri A, 2011, J TRAUMA, V70, pE79, DOI 10.1097/TA.0b013e3181d4885a; Gausche-Hill M, 2007, PEDIATRICS, V120, P1229, DOI 10.1542/peds.2006-3780; Gilboy N, 2012, AHRQ PUBLICATION; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Griffin E, 2011, J EMERG NURS, V37, P258, DOI 10.1016/j.jen.2011.02.015; Hauda WE, 2011, TINTINALLIS EMERGENC; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kuppermann N, 2008, PEDIATR RADIOL, V38, pS670, DOI 10.1007/s00247-008-0996-5; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Schaber B, 2002, AM J FOREN MED PATH, V23, P101, DOI 10.1097/00000433-200203000-00022; Schachar JL, 2011, PEDIATR RADIOL, V41, P971, DOI 10.1007/s00247-011-2032-4; Wang MY, 2001, J PEDIATR SURG, V36, P1528, DOI 10.1053/jpsu.2001.27037; Xiao B, 2013, EMERG MED J, V30, DOI 10.1136/emermed-2011-200525	19	6	6	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0099-1767	1527-2966		J EMERG NURS	J. Emerg. Nurs.	JAN	2014	40	1					98	104		10.1016/j.jen.2013.07.001			7	Emergency Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Nursing	281TS	WOS:000329124500031	24029043				2022-02-06	
J	Hirsch, MA; Williams, K; Norton, HJ; Hammond, F				Hirsch, Mark A.; Williams, Kathryn; Norton, H. James; Hammond, Flora			Reliability of the timed 10-metre walk test during inpatient rehabilitation in ambulatory adults with traumatic brain injury	BRAIN INJURY			English	Article						Gait; inpatient rehabilitation; reliability; timed 10-metre walk test; traumatic brain injury	FUNCTIONAL INDEPENDENCE MEASURE; PHYSICAL PERFORMANCE-MEASURES; SPINAL-CORD-INJURY; VALIDITY; GAIT; SPEED; MOBILITY; INDIVIDUALS; RECOVERY; DEFICITS	Objective: To determine the test-re-test reliability of the timed 10-metre walk test (10MWT) among adults with traumatic brain injury (TBI) enrolled in inpatient rehabilitation. Design: Prospective reliability study using a correlational design. Setting: Inpatient rehabilitation unit of a rehabilitation hospital. Participants: Twenty-three consecutive adults with acute TBI, mean age = 35.87, SD = 14.2 years (range = 18-64 years). This study tested 22 males and one female, who were 15.6 (SD = 9.1) days in inpatient rehabilitation at time of gait testing. Method: Repeated, timed 10-metre gait test within a 1-hour testing period with six trials at self-selected pace (SSP) and six trials at fastest pace (FP), recorded to the nearest 1/10 second with a hand-held stopwatch. Result: Gait speed measurements for SSP and FP were shown to have excellent test-re-test reliability (Intra Class Correlation coefficient = 0.964 and 0.961, respectively). Conclusions: These results add to the literature that the timed 10MWT is a reliable measure of gait velocity in adults with acute TBI for both FP and SSP.	[Hirsch, Mark A.] Carolinas Med Ctr, Charlotte, NC 28203 USA; [Williams, Kathryn] Carolinas Med Ctr, Dept Therapies, Charlotte, NC 28203 USA; [Norton, H. James] Carolinas Med Ctr, Dept Biostat, Charlotte, NC 28203 USA; [Hammond, Flora] Indiana Univ Sch Med, Indianapolis, IN 46202 USA		Hirsch, MA (corresponding author), Carolinas Rehabil Phys Med & Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.	mark.hirsch@carolinashealthcare.org	Hirsch, Mark A./D-2798-2016	Hirsch, Mark A./0000-0002-8997-7971			Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chow JW, 2010, BRAIN INJURY, V24, P1575, DOI 10.3109/02699052.2010.523053; Cohen JJ, 1987, TOP GERIATR REHABIL, V3, P71; Collen F M, 1990, Int Disabil Stud, V12, P6; Eng JJ, 2002, STROKE, V33, P756, DOI 10.1161/hs0302.104195; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Fritz NE, 2013, J NEUROL PHYS THER, V37, P37, DOI 10.1097/NPT.0b013e318282a20d; Fritz SL, 2012, TOP GERIATR REHABIL, V28, P91, DOI 10.1097/TGR.0b013e31823d9c22; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Langlois JA, 1997, AM J PUBLIC HEALTH, V87, P393, DOI 10.2105/AJPH.87.3.393; LERNERFRANKIEL MB, 1986, CLIN MANAG PHYS THER, V6, P12; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Peters DM, 2013, J GERIATR PHYS THER, V36, P24, DOI 10.1519/JPT.0b013e318248e20d; Poncumhak P, 2013, SPINAL CORD, V51, P214, DOI 10.1038/sc.2012.126; Quinn L, 2013, PHYS THER, V93, P942, DOI 10.2522/ptj.20130032; ROBINETT CS, 1988, PHYS THER, V68, P1371, DOI 10.1093/ptj/68.9.1371; Rossier P, 2001, ARCH PHYS MED REHAB, V82, P9, DOI 10.1053/apmr.2001.9396; SAS Institute Inc, 2008, SAS SYST WIND V9 3; Schenkman M, 1997, PHYS THER, V77, P19, DOI 10.1093/ptj/77.1.19; Scivoletto G, 2011, SPINAL CORD, V49, P736, DOI 10.1038/sc.2010.180; SWAINE BR, 1994, BRAIN INJURY, V8, P323, DOI 10.3109/02699059409150983; van Hedel HJ, 2005, ARCH PHYS MED REHAB, V86, P190, DOI 10.1016/j.apmr.2004.02.010; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; WADE DT, 1987, SCAND J REHABIL MED, V19, P25; Watson MJ, 2003, PHYSIOTHERAPY, V88, P386; Williams G, 2012, BRAIN INJURY, V26, P1065, DOI 10.3109/02699052.2012.667586; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013	32	6	6	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1115	1120		10.3109/02699052.2014.910701			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200014	24892222				2022-02-06	
J	Karton, C; Rousseau, P; Vassilyadi, M; Hoshizaki, TB				Karton, Clara; Rousseau, Philippe; Vassilyadi, Michael; Hoshizaki, Thomas Blaine			The evaluation of speed skating helmet performance through peak linear and rotational accelerations	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Concussion; Biomechanics; Head injuries; Injury Prevention; Sporting injuries	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; HEAD IMPACTS; CONCUSSION; SPORT; PROTECTION	Objective Like many sports involving high speeds and body contact, head injuries are a concern for short track speed skating athletes and coaches. While the mandatory use of helmets has managed to nearly eliminate catastrophic head injuries such as skull fractures and cerebral haemorrhages, they may not be as effective at reducing the risk of a concussion. The purpose of this study was to evaluate the performance characteristics of speed skating helmets with respect to managing peak linear and peak rotational acceleration, and to compare their performance against other types of helmets commonly worn within the speed skating sport. Materials and methods Commercially available speed skating, bicycle and ice hockey helmets were evaluated using a three-impact condition test protocol at an impact velocity of 4m/s. Results and discussion Two speed skating helmet models yielded mean peak linear accelerations at a low-estimated probability range for sustaining a concussion for all three impact conditions. Conversely, the resulting mean peak rotational acceleration values were all found close to the high end of a probability range for sustaining a concussion. A similar tendency was observed for the bicycle and ice hockey helmets under the same impact conditions. Conclusion Speed skating helmets may not be as effective at managing rotational acceleration and therefore may not successfully protect the user against risks associated with concussion injuries.	[Karton, Clara; Rousseau, Philippe; Hoshizaki, Thomas Blaine] Univ Ottawa, Neurotrauma Impact Sci Lab, Sch Human Kinet, Ottawa, ON K1S 5S9, Canada; [Vassilyadi, Michael] CHEO, Div Neurosurg, Ottawa, ON, Canada		Karton, C (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, Sch Human Kinet, A106-200 Lees Ave, Ottawa, ON K1S 5S9, Canada.	ckart020@uottawa.ca			ThinkFirst; Cheryl Marinsky; Gloucester Concordes	We would like to thank ThinkFirst, Cheryl Marinsky and the Gloucester Concordes for funding this research.	[Anonymous], 2009, CANCSAZ2621M90; [Anonymous], 2007, F184907 ASTM INT; Barth JT, 2001, J ATHL TRAINING, V36, P253; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; DENG YC, 1989, ACCIDENT ANAL PREV, V21, P85, DOI 10.1016/0001-4575(89)90051-1; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Engebretsen L, 2010, BRIT J SPORT MED, V44, P772, DOI 10.1136/bjsm.2010.076992; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Forero Rueda MA, 2010, COMPUT METHOD BIOMEC, V1, P1; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gimbel GM, 2008, EUR J SPORT SCI, V8, P341, DOI 10.1080/17461390802438763; Hodgson VR, 1983, P 27 STAPP CAR CRASH, P225; Holbourn AHS, 1943, LANCET, V2, P438; Hoshizaki B, 2012, J NEUROSURG-PEDIATR, V9, P133, DOI 10.3171/2011.11.PEDS11299; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Hubbard R, 1974, P 18 STAPP CAR CRASH; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; MERTZ HJ, 1985, BIOMECHANICS TRAUMA, P31; Newman J, 2002, P IRCOBI C MONTP FRA, P11; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Ommaya A. K., 1967, P 11 STAPP CAR CRASH, V670906; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Padagaonkar A. J., 1975, J APPL MECH, V42, P552; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Post A., 2011, COMPUT METHOD BIOMEC, P1; Post A, 2012, P I MECH ENG P-J SPO, V226, P200, DOI 10.1177/1754337112449420; Quinn A, 2003, AM J SPORT MED, V31, P507, DOI 10.1177/03635465030310040501; Regina Speed Skating Club, EQ BAS; Rousseau P, 2009, J ASTM INT, V6, P11; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Seemann M. R., 1986, P 30 STAPP CAR CRASH, V30, P291; Snell Memorial Foundation, 2000, 1995 STAND PROT EQU; Society of Automotive Engineers International (SAE), 2007, J2111 SAE; Speed Skate PEI, ALL SPEEDSK EUIPM; Speed Skating Canada, SPEED SKAT; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Zhang L., 2003, IRCOBI C LISB PORT S, P27; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	43	6	7	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2014	48	1					46	+		10.1136/bjsports-2012-091583			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	272YX	WOS:000328500500010	23314891				2022-02-06	
J	Kegel, J; Dux, M; Macko, R				Kegel, Jessica; Dux, Moira; Macko, Richard			Executive function and coping in stroke survivors	NEUROREHABILITATION			English	Article						Stroke; executive function; coping	COGNITIVE IMPAIRMENT; RECOVERY; FITNESS	BACKGROUND: Stroke is a leading cause of disability and sequelae may include physical, emotional, and cognitive impairments. The methods employed to cope with distress, both emotional and cognitive, have not been evaluated in individuals post-stroke. However, research in traumatic brain injury (TBI) suggests that executive function is positively correlated with adaptive coping and negatively correlated with maladaptive coping strategies (Krpan et al., 2007). Examination of these constructs post-stroke may assist with enriching our understanding of cognitive and emotional symptomatology and optimize rehabilitation strategies. OBJECTIVE: The present study aimed to assess the association between executive function and coping strategies in a sample of chronic stroke survivors. The researchers hypothesized that executive function would be positively correlated with adaptive coping strategies and negatively correlated with maladaptive coping strategies. METHODS: Fifteen stroke survivors were administered a battery of cognitive tests assessing executive function and also completed the Ways of Coping Questionnaire (WAYS), a self-report coping measure. RESULTS: Analyses indicated that executive function deficits were related to increased avoidant coping. Contrary to expectations, executive function was not significantly related to active coping. In addition, post hoc analyses revealed that executive function was a significant predictor of avoidant coping after controlling for demographics. CONCLUSIONS: Our data, in accordance with prior work in TBI, suggests that executive function and aspects of coping are associated. Rehabilitation strategies that improve executive function may also lead to utilization of adaptive coping strategies. Research has shown that aerobic exercise increases activation in the frontal lobe and improves executive function (Colcombe & Kramer, 2003; Colcombe et al., 2004). Future studies should examine whether aerobic exercise positively affects executive function and coping in stroke survivors.	[Kegel, Jessica; Dux, Moira; Macko, Richard] Baltimore Vet Affairs Med Hlth Ctr, Baltimore, MD USA; [Kegel, Jessica; Dux, Moira; Macko, Richard] VA Maryland Exercise & Robot Ctr Excellence MERCE, Baltimore, MD USA		Macko, R (corresponding author), VA Maryland Hlth Care Syst, 10 North Greene St,Mail Stop BT GR 18, Baltimore, MD 21201 USA.	rmacko@grecc.umaryland.edu	Kegel, Jessica/AAE-9381-2021		Veterans Affairs (VA)US Department of Veterans Affairs; Department of VA and VA Medical Center; Geriatric Research, Education and Clinical Center (GRECC); National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Older Americans Independence Center [P30-AG028747]; Department of VA, VA RR & D Exercise & Robotics Center of Excellence	This study was supported by a Veterans Affairs (VA) RR& DCDA-1 Award (Dr. Dux), Department of VA and VA Medical Center, Geriatric Research, Education and Clinical Center (GRECC), The National Institute on Aging (NIA) Claude D. Pepper Older Americans Independence Center (P30-AG028747), and the Department of VA, VA RR & D Exercise & Robotics Center of Excellence.	Brain Injury Association of America, 2011, BRAIN INJ; Ch'ng AM, 2008, J HEALTH PSYCHOL, V13, P1136, DOI 10.1177/1359105308095967; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Delis DC., 2001, DELIS KAPLAN EXECUTI; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Folkman S., 1988, WAYS COPING QUESTION; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Haring HP, 2002, CURR OPIN NEUROL, V15, P79, DOI 10.1097/00019052-200202000-00012; Knopman DS, 2009, ARCH NEUROL-CHICAGO, V66, P614, DOI 10.1001/archneurol.2009.30; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Lesniak M, 2008, DEMENT GERIATR COGN, V26, P356, DOI 10.1159/000162262; Lynch EB, 2008, J REHABIL MED, V40, P518, DOI 10.2340/16501977-0203; Mackay J., 2004, ATLAS HEART DIS STRO; National Institute of Neurological Disorders and Stroke, 2011, STROK HOP RES; National Institute of Neurological Disorders and Stroke, 2011, TRAUM BRAIN INJ HOP; Partington JE, 1949, PSYCHOL SERV CTR B, V1, P9; Psychological Corporation, 1997, WAIS 3 WMS 3 TECHNIC; Rabbitt P., 2005, METHODOLOGY FRONTAL; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Spreen O., 1969, NEUROSENSORY CTR COM	22	6	7	1	16	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	1					55	63		10.3233/NRE-131010			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AA4JN	WOS:000331062000008	24284457				2022-02-06	
J	Kesikburun, S; Alaca, R; Aras, B; Tugcu, I; Tan, AK				Kesikburun, Serdar; Alaca, Ridvan; Aras, Berke; Tugcu, Ilknur; Tan, Arif Kenan			Botulinum toxin injection for bruxism associated with brain injury: Case report	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						botulinum toxin; bruxism; bruxism treatment; case report; complication; masseter muscle; temporalis muscle; tooth clenching; tooth grinding; traumatic brain injury	NOCTURNAL BRUXISM	Bruxism is involuntary grinding of the teeth and can occur as a complication of brain injury. If untreated, bruxism can lead to severe occlusal trauma. Herein, we present a patient with traumatic brain injury and nocturnal bruxism that was treated with botulinum toxin injection. A 21 yr old male patient with traumatic brain injury from a car accident was admitted to our inpatient rehabilitation unit. He had a history of coma for 2 wk in the intensive care unit. The initial cranial computed tomography scan indicated a superior thalamic hemorrhage. On admission to our department 3 mo postinjury, his mental status was good and he was able to walk without assistance, but he had mild ataxia. He complained about severe teeth grinding at night, which began 2 mo postinjury. Botulinum toxin-A was injected into the masseter muscles (20 U in each muscle) and temporalis muscles (15 U in each muscle) bilaterally. A decrease in bruxism was reported within 3 d. Clinical improvement persisted at assessment 4 mo posttreatment. Botulinum toxin injection can be used as an effective treatment for bruxism associated with brain injury.	[Kesikburun, Serdar; Alaca, Ridvan; Aras, Berke; Tugcu, Ilknur; Tan, Arif Kenan] Turkish Armed Forces Rehabil Ctr, Gulhane Mil Med Acad, Dept Phys Med & Rehabil, Ankara, Turkey		Kesikburun, S (corresponding author), TSK Rehabil Merkezi, TR-06530 Bilkent, Turkey.	serdarkb@gmail.com	kesikburun, serdar/AAO-1445-2020	kesikburun, serdar/0000-0001-9400-4683			Dolly O, 2000, MOVEMENT DISORD, V15; Gormley ME, 1997, EUR J NEUROL, V4, pS27; Ivanhoe CB, 1997, ARCH PHYS MED REHAB, V78, P1272, DOI 10.1016/S0003-9993(97)90343-9; Koyano K, 2008, J ORAL REHABIL, V35, P495, DOI 10.1111/j.1365-2842.2008.01880.x; Lee SJ, 2010, AM J PHYS MED REHAB, V89, P16, DOI 10.1097/PHM.0b013e3181bc0c78; Lobbezoo F, 2006, J ORAL REHABIL, V33, P293, DOI 10.1111/j.1365-2842.2006.01609.x; Macedo CR, 2006, COCHRANE DB SYST REV; OKESON JP, 1987, J AM DENT ASSOC, V114, P788, DOI 10.14219/jada.archive.1987.0165; QUINN JH, 1995, CRANIO, V13, P30, DOI 10.1080/08869634.1995.11678039; REDING GR, 1966, J DENT RES, V45, P1198, DOI 10.1177/00220345660450042701; Santamato A, 2010, J CHIROPR MED, V9, P132, DOI 10.1016/j.jcm.2010.04.004; See SJ, 2003, ACTA NEUROL SCAND, V107, P161, DOI 10.1034/j.1600-0404.2003.02086.x	12	6	7	0	6	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	4					661	663		10.1682/JRRD.2013.10.0218			3	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AN8ZR	WOS:000340895400015	25144179	Bronze			2022-02-06	
J	Li, J; Wang, BG; Wang, SY; Mu, F				Li, Jiao; Wang, Baoguo; Wang, Shuangyan; Mu, Feng			Effects of hypertonic saline - hydroxyethyl starch and mannitol on serum osmolality, dural tension and hemodynamics in patients undergoing elective neurosurgical procedures	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Hypertonic saline; hydroxyethyl starch; mannitol; dural tension; neurosurgery anesthesia	TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; CEREBROSPINAL-FLUID DYNAMICS; CARDIOPULMONARY BYPASS; 20-PERCENT MANNITOL; DEXTRAN SOLUTION; HEAD-INJURY; PRESSURE; 7.5-PERCENT; RELAXATION	Objective: To investigate effect of equal volumes (250 ml) of 7.2% hypertonic saline - 6% hydroxyethyl starch (HS-HES) and 20% mannitol (M) on dural tension, serum osmolality and hemodynamics in patients during elective neurosurgical procedures. Material and methods: Forty ASA I-II patients scheduled for elective neurosurgical supratentorial procedures were randomly assigned to two groups. About 30 min before skull opening, patients received either HS-HES or M at infusion rate 750 ml/h. Dural tension score was used to evaluate the dural tension by neurosurgeons. Serum osmolality was tested at following time points: before, 125 ml infused, 250 ml infused, 30 min and 60 min after infusion. Hemodynamic variables were measured by FloTrac. Results: Patients who received HS-HES had a significant decrease in dural tension scores (P < 0.05) and obtained more satisfactory brain relaxation for neurosurgeon (95% vs. 75%). In HS-HES group, the peak of serum osmolality occurred earlier and hyper-osmolality lasted for longer time. Transient decrease in mean arterial pressure was observed in M group at 10 min after the start infusion (P < 0.01). Heart rate significantly decreased after HS-HES infusion, whereas no significant changes were observed in M group. In HS-HES group, stroke volume variation significantly decreased from 9.7 +/- 3.5 at the initiation of infusion to 6.7 +/- 2.4 at 30 min after the infusion and remained decreased more than 60 min while it decreased from 6.8 +/- 3.1 to 5.3 +/- 1.5 in M group. Moreover, urine output in HS-HES group from initiation to 60 min after the infusion was significantly less than those in M group. Conclusion: HS-HES might be an alternative to mannitol in treatment of intracranial hypertension.	[Li, Jiao; Wang, Baoguo; Wang, Shuangyan; Mu, Feng] Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Anesthesiol, Beijing, Peoples R China		Wang, BG (corresponding author), Beijing Sanbo Brain Hosp, Dept Anesthesiol, 50 Xiang Shan Yi Ke Song, Beijing 100093, Peoples R China.	wang-baoguo_00@163.com					Angle N, 2000, SHOCK, V14, P503, DOI 10.1097/00024382-200014050-00002; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BOLDT J, 1991, ANN THORAC SURG, V51, P610, DOI 10.1016/0003-4975(91)90320-P; Bressack M, 2012, PEDIATR CRIT CARE ME, V13, P496, DOI 10.1097/PCC.0b013e3182517c03; Bueno R, 2004, ANN THORAC SURG, V77, P604, DOI 10.1016/S0003-4975(03)01486-3; DONATO T, 1994, ANESTH ANALG, V78, P58; FOXWORTHY JC, 1990, J NEUROSURG ANESTH, V2, P256, DOI 10.1097/00008506-199012000-00002; FRESHMAN SP, 1993, J TRAUMA, V35, P344, DOI 10.1097/00005373-199309000-00003; Gemma M, 1997, J NEUROSURG ANESTH, V9, P329, DOI 10.1097/00008506-199710000-00007; Hartl R, 1997, ZBL CHIR, V122, P181; Hartl R, 1997, ACT NEUR S, V70, P126; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kyes J, 2011, COMPEND CONTIN ED VE, V33, pE9; Kyes Jennifer, 2011, Compend Contin Educ Vet, V33, pE1; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; OLIVEIRA SA, 1995, SHOCK, V3, P391; Pantaleon LG, 2010, COMPEND CONTIN ED VE, V32, pE7; Pantaleon Lucas G, 2010, Compend Contin Educ Vet, V32, pE1; Petersen KD, 2003, ANESTHESIOLOGY, V98, P329, DOI 10.1097/00000542-200302000-00010; Rasmussen M, 2004, J NEUROSURG, V101, P621, DOI 10.3171/jns.2004.101.4.0621; Rozet I, 2007, ANESTHESIOLOGY, V107, P697, DOI 10.1097/01.anes.0000286980.92759.94; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Sapsford W, 2003, J R Army Med Corps, V149, P110; Shao LJZ, 2013, CLINICS, V68, P323, DOI 10.6061/clinics/2013(03)OA07; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Takagi H, 1984, No To Shinkei, V36, P1095; Thompson R, 2006, J R Army Med Corps, V152, P6; Thongrong C, 2013, WORLD NEUROSURG; Toung TJK, 2002, CRIT CARE MED, V30, P644, DOI 10.1097/00003246-200203000-00025; Urbano J, 2012, RESUSCITATION, V83, P1159, DOI 10.1016/j.resuscitation.2012.02.003; Boas WWV, 2011, REV BRAS ANESTESIOL, V61, P456, DOI 10.1016/S0034-7094(11)70053-8; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Weed LH, 1919, AM J PHYSIOL, V48, P512, DOI 10.1152/ajplegacy.1919.48.4.512; Wu CT, 2010, ANESTH ANALG, V110, P903, DOI 10.1213/ANE.0b013e3181cb3f8b; Yu GF, 2012, PULM PHARMACOL THER, V25, P27, DOI 10.1016/j.pupt.2011.10.003	38	6	6	0	2	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2014	7	8					2266	2272					7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AO3SZ	WOS:000341257500048	25232419				2022-02-06	
J	Malouf, T; Langdon, R; Taylor, A				Malouf, Tania; Langdon, Robyn; Taylor, Alan			The Insight Interview: A new tool for measuring deficits in awareness after traumatic brain injury	BRAIN INJURY			English	Article						Assessment; psychometric assessment; self-awareness; traumatic brain injury	CLOSED-HEAD-INJURY; SELF-AWARENESS; IMPAIRED AWARENESS; PERCEPTION; ADULTS; UNAWARENESS; BEHAVIOR; EMOTION; PATIENT	Objective: Awareness deficits are common after traumatic brain injury (TBI); however, relatively little is known of awareness deficits in the early stages post-injury. This study outlines the development of a new tool, 'The Insight Interview', designed to measure awareness across different domains (awareness of change, severity of deficits, current and future functional consequences) from 3 months post-TBI. Methods: Forty-three patients with at least a severe TBI, their nominated family member and treating clinician were all administered different versions of the Insight Interview during the patient's inpatient stay. Awareness was measured; (1) by calculating a discrepancy score between the patient's and their family informant's and/or clinician's ratings of the patient's abilities and (2) using interviewer-based ratings of the patients' responses to interview questions. Results: Awareness differed depending upon the domain being assessed, with patients demonstrating greatest awareness in the current functional consequences domain. Evidence for a distinction between awareness of current and future functional consequences of impairments was also seen. Discrepancy scores and interviewer-based ratings showed good concordance. Adequate reliability and validity was demonstrated. Conclusion: The Insight Interview is a useful and valid tool for measuring awareness in the acute stages following TBI and highlights that awareness depends on domain assessed.	[Malouf, Tania] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Brisbane, Qld, Australia; [Malouf, Tania] Univ Queensland, Mater Childrens Hosp, Dept Psychol, Brisbane, Qld 4101, Australia; [Langdon, Robyn] Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia; [Taylor, Alan] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia		Malouf, T (corresponding author), Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Level 2,Coles Bldg,Herston Rd, Herston, Qld 4029, Australia.	tania_malouf@health.qld.gov.au		Taylor, Alan/0000-0003-1137-0691; Langdon, Robyn/0000-0002-1044-7194			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Anton H, 2003, CONT LINEAR ALGEBRA; Beitman BD, 2005, SELF AWARENESS PSYCH, P1; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Cannon BJ, 2000, ARCH CLIN NEUROPSYCH, V15, P327; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; DeHope E, 1999, NEUROREHABILITATION, V13, P3; FEINBERG TE, 1995, BRAIN, V118, P789, DOI 10.1093/brain/118.3.789; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming J., 1995, BRIT J OCCUPATIONAL, V58, P55, DOI [https://doi.org/10.1177/030802269505800204, DOI 10.1177/030802269505800204]; Fleming Jennifer M, 2006, Can J Occup Ther, V73, P44; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Fleming JM, 2002, J COGNITIVE REHABILI, V20, P28; Fordyce DJ, 1989, REHABIL PSYCHOL, V31, P217; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; Gwet K. L., 2012, HDB INTERRATER RELIA; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; Howorth P, 2003, AGING MENT HEALTH, V7, P113, DOI 10.1080/1360786031000072286; Landa-Gonzalez BELKIS, 2001, Occup Ther Int, V8, P49, DOI 10.1002/oti.131; Markova IS, 2006, NEUROPSYCHOL REHABIL, V16, P439, DOI 10.1080/09602010500373396; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; Mattson AJ, 2000, CORTEX, V36, P125, DOI 10.1016/S0010-9452(08)70841-4; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Peugh JL, 2005, EDUC PSYCHOL MEAS, V65, P717, DOI DOI 10.1177/0013164405278558; Prigatano, 2010, STUDY ANOSOGNOSIA, P229; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P359, DOI 10.1097/00001199-200507000-00007; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; STARKSTEIN SE, 1992, STROKE, V23, P1446, DOI 10.1161/01.STR.23.10.1446; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Visser-Keizer AC, 2002, J CLIN EXP NEUROPSYC, V24, P1032, DOI 10.1076/jcen.24.8.1032.8383; YOUNG AW, 1990, BRAIN COGNITION, V14, P1, DOI 10.1016/0278-2626(90)90056-T; YOUNG AW, 1993, BRAIN, V116, P941, DOI 10.1093/brain/116.4.941; [No title captured], DOI DOI 10.1097/00001199-199412000-00004	54	6	6	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	12					1523	1541		10.3109/02699052.2014.922700			19	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AR6UD	WOS:000343717700004	24926905				2022-02-06	
J	Mauritz, W; Brazinova, A; Majdan, M; Rehorcikova, V; Leitgeb, J				Mauritz, Walter; Brazinova, Alexandra; Majdan, Marek; Rehorcikova, Veronika; Leitgeb, Johannes			Deaths due to traumatic brain injury in Austria between 1980 and 2012	BRAIN INJURY			English	Article						Age; epidemiology; mortality rate; sex; traumatic brain injury deaths	SURVEILLANCE; TRENDS	Background: To investigate changes in TBI mortality in Austria during 1980-2012 and to identify causes for these changes. Methods: Statistik Austria provided data (from death certificates) on all TBI deaths from January 1980-December 2012. Data included year/month of death, age, sex, residency of the cases and mechanism of accident. Data regarding the size of the age groups was obtained from Statistik Austria. Mortality rates (MR; deaths/10(5) population/year) were calculated for male vs. female patients and for different age groups. Changes in mechanisms of TBI were evaluated. Results: The MR decreased from 28.1 to 11.8 deaths/10(5) population/year. Traffic-related TBI deaths decreased from 62% to 9%. This caused a significant decrease in TBI deaths in younger age groups. Fall-related TBI deaths (mostly geriatric cases) remained unchanged. Falls became the leading cause; its rate increased from 22% to 64% of all TBI deaths. Thus, the mean age of fatal TBI cases increased by 20 years and the rate of cases aged <60 years decreased from 71% to 28%. Another important cause was suicide by firearms; its rate increased from 10% to 23% of all TBI deaths. Conclusions: These findings warrant better prevention of falls in the elderly and of suicides.	[Mauritz, Walter] Trauma Hosp Lorenz Boehler, A-1200 Vienna, Austria; [Mauritz, Walter; Brazinova, Alexandra; Majdan, Marek; Rehorcikova, Veronika] INRO, Vienna, Austria; [Brazinova, Alexandra; Majdan, Marek; Rehorcikova, Veronika] Trnava Univ, Fac Hlth & Social Serv, Dept Publ Hlth, Trnava, Slovakia; [Leitgeb, Johannes] Univ Vienna, Dept Traumatol, Vienna, Austria		Mauritz, W (corresponding author), Trauma Hosp Lorenz Boehler, Donaueschingestr 13, A-1200 Vienna, Austria.	walter.mauritz@auva.at	Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012	Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X	Austrian Worker's Compensation Board (AUVA) [FK 09/13]	We are very grateful to the following experts: Dr Erika Baldaszti and Mag Barbara Leitner (both from Statistik Austria) who provided data on deaths (which included all deaths due to TBI). This work was supported by a grant from the Austrian Worker's Compensation Board (AUVA; FK 09/13). The International Neurotrauma Research Organization (INRO) is supported by an annual grant from Mrs Ala Auersperg-Isham and Mr Ralph Isham and by small donations from various sources.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Rodriguez SR, 2006, PUBLIC HEALTH REP, V121, P282, DOI 10.1177/003335490612100310; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Sundstrom Terje, 2005, Tidsskr Nor Laegeforen, V125, P1310	10	6	6	0	7	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1096	1101		10.3109/02699052.2014.904522			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200011	24734881				2022-02-06	
J	Meyers, JE; Miller, RM; Haws, NA; Murphy-Tafiti, JL; Curtis, TD; Rupp, ZW; Smart, TA; Thompson, LM				Meyers, John E.; Miller, Ronald M.; Haws, Nathan A.; Murphy-Tafiti, Jason L.; Curtis, Thomas D.; Rupp, Zachary W.; Smart, Taylor A.; Thompson, Lisa M.			An Adaptation of the MMPI-2 Meyers Index for the MMPI-2-RF	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						index; malingering; MMPI-2-RF; Symptom Validity Test	MALINGERED NEUROCOGNITIVE DYSFUNCTION; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; SYMPTOM VALIDITY TESTS; TRAUMATIC BRAIN-INJURY; RESPONSE BIAS; SCALES; VALIDATION; INDICATORS; BATTERY; SCORES	Using an overall sample of 278 individuals who had taken the Minnesota Multiphasic Personality Inventory-Second Edition (MMPI-2) and who had clear diagnostic information available in their medical records, the Meyers Index (MI) for the MMPI-2 (Meyers, Millis, & Volkert, 2002) was calculated for each individual, and a new version of the MI created for the MMPI-2 Restructured Form (MMPI-2-RF) was calculated. The MI is a method of combining multiple MMPI-2 validity scales into a single weighted index to assess exaggerated self-report on the MMPI-2. The new index is intended to provide the same type of global assessment of validity but for the MMPI-2-RF (MI-r). The MI and the MI-r were compared at both individual and group levels and were found to correlate well (r = .87). Diagnostic groups of litigants and nonlitigants of traumatic brain injury, chronic pain, and posttraumatic stress disorder were also examined; and the performance of the MI and the MI-r were similar. Similarly, the pass and fail agreement rate for the two scales was 93%. The results indicate that the MI and MI-r perform very similarly and are good methods of assessing overall validity of MMPI-2 and MMPI-2-RF test performance.	[Meyers, John E.] Meyers Neuropsychol Serv, Mililani, HI 96789 USA; [Miller, Ronald M.; Haws, Nathan A.; Murphy-Tafiti, Jason L.; Curtis, Thomas D.; Rupp, Zachary W.; Smart, Taylor A.; Thompson, Lisa M.] Brigham Young Univ Hawaii, Dept Psychol, Laie, HI USA		Meyers, JE (corresponding author), Meyers Neuropsychol Serv, 94-553 Alapoai St 162, Mililani, HI 96789 USA.	jmeyersneuro@yahoo.com					Aguerrevere LE, 2008, ARCH CLIN NEUROPSYCH, V23, P831, DOI 10.1016/j.acn.2008.06.008; Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Archer EM, 2012, ASSESSMENT, V19, P14, DOI 10.1177/1073191110397469; Barron F., 1956, J CONSULT PSYCHOL, V17, P327; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Bianchini KJ, 2008, ASSESSMENT, V15, P435, DOI 10.1177/1073191108317341; BRANDT J, 1985, ANN NY ACAD SCI, V444, P502, DOI 10.1111/j.1749-6632.1985.tb37625.x; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cohen J., 2013, STAT POWER ANAL BEHA; Gough HG, 1957, CALIFORNIA PSYCHOL I; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Hathaway SR, 1989, MMPI 2 MANUAL ADM SC; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hilbe, 2011, NEGATIVE BINOMIAL RE; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Klecka G.R., 1980, DISCRIMINANT ANAL; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Meyers J E, 1999, Appl Neuropsychol, V6, P208, DOI 10.1207/s15324826an0604_3; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Meyers J, 2011, CLIN NEUROPSYCHOL, V25, P477, DOI 10.1080/13854046.2011.554442; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; Scott Long J., 1997, REGRESSION MODELS CA, V7; Sellbom M., 2008, CLIN ASSESSMENT MALI, V3rd ed., P182; Sellbom M, 2006, ASSESSMENT, V13, P430, DOI 10.1177/1073191106293349; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; StatSoft Inc, 2012, STAT VERS 11 COMP SO; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Van Der Heijden PT, 2010, J PERS ASSESS, V92, P254, DOI 10.1080/00223891003670208; Vilar-Lopez R, 2011, ARCH CLIN NEUROPSYCH, V26, P133, DOI 10.1093/arclin/acq099; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wygant DB, 2011, PSYCHOL INJ LAW, V4, P13, DOI 10.1007/s12207-011-9098-z; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042	40	6	6	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2014	21	2					148	154		10.1080/09084282.2013.780173			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AM9VL	WOS:000340229000010	24826509				2022-02-06	
J	Petkus, V; Preiksaitis, A; Krakauskaite, S; Chomskis, R; Rocka, S; Kalasauskiene, A; Kalvaitis, E; Ragauskas, A				Petkus, V.; Preiksaitis, A.; Krakauskaite, S.; Chomskis, R.; Rocka, S.; Kalasauskiene, A.; Kalvaitis, E.; Ragauskas, A.			Novel Method and Device for Fully Non-Invasive Cerebrovascular Autoregulation Monitoring	ELEKTRONIKA IR ELEKTROTECHNIKA			English	Article						Cerebrovascular autoregulation; intracranial pressure waves; medical diagnosis; patient non-invasive monitoring	DYNAMIC CEREBRAL AUTOREGULATION; PRESSURE	The novel method and the device for non invasive cerebrovascular autoregulation (CA) status monitoring without using the arterial blood pressure (ABP) measurement channel are presented. This fully non-invasive CA monitor is based on the ultrasonic time-of-flight measurement of cerebral blood volume pulsations within the brain parenchyma, extraction of informative and reference slow and respiratory volumetric waves and calculation of CA estimating indexes without using any additional ABP measurements. For demonstrating the applicability of the proposed method, the CA status was monitored on 11 traumatic brain injury patients simultaneously by using the novel fully non-invasive monitor and compared to the CA status representing indexes calculated from the invasively measured intracranial pressure (ICP) and ABP slow waves. The total monitoring time was about 22 hrs. The correlation factor between the invasively and non-invasively obtained CA data showed significant agreement (r=0.751) between the two methods. The proposed innovative CA real-time monitoring method gives us new possibilities to perform estimation of the CA status from the intracranial waves only as well as to exclude the ABP line's errors and artifacts from the measurement results.	[Petkus, V.; Krakauskaite, S.; Chomskis, R.; Kalvaitis, E.; Ragauskas, A.] Kaunas Univ Technol, Hlth Telemat Sci Ctr, LT-51368 Kaunas, Lithuania; [Preiksaitis, A.; Rocka, S.] Vilnius Univ, Fac Med, Ctr Neuroangiosurg Clin Neurol & Neurosurg, LT-04130 Vilnius, Lithuania; [Kalasauskiene, A.] Hosp Lithuanian Univ, Hlth Sci Kaunas Clin, LT-50009 Kaunas, Lithuania		Petkus, V (corresponding author), Kaunas Univ Technol, Hlth Telemat Sci Ctr, Studentu St 50-450A, LT-51368 Kaunas, Lithuania.	vytautas.petkus@ktu.lt	Ragauskas, Art/J-7486-2016	Ragauskas, Art/0000-0002-3536-554X	Research Council of LithuaniaResearch Council of Lithuania (LMTLT) [MIP-118/2012]; European Commission under the 7th Framework Programme project DynICP [286610]	This research was funded by a grant MIP-118/2012 from the Research Council of Lithuania and supported in part by the European Commission under the 7th Framework Programme project DynICP (grant agreement No 286610).	Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Blaber AP, 1997, STROKE, V28, P1686, DOI 10.1161/01.STR.28.9.1686; Brain Trauma Foundation American Association of Neurological Surgeons, 2007, J NEUROTRAUM, V24, P59; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M., ACTA NEUROCHIRUR S, V81, P117; Czosnyka M, 2007, NEUROL RES, V29, P672, DOI 10.1179/016164107X240053; Czosnyka M, 2012, NEUROL RES, V34, P17, DOI 10.1179/1743132811Y.0000000040; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Kasprowicz M, 2010, PHYSIOL MEAS, V31, P1217, DOI 10.1088/0967-3334/31/9/011; Kirkness C J, 2001, Biol Res Nurs, V2, P175, DOI 10.1177/109980040100200303; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; Lewis Philip M, 1800, Acta Neurochir Suppl, V114, P141, DOI 10.1007/978-3-7091-0956-4_26; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Petkus V., 2013, CEREBROVASC DIS, V35, P44; Petkus V, 2012, MEDICINA-LITHUANIA, V48, P39; Ragauskas A, 2008, ELEKTRON ELEKTROTECH, P93; Ragauskas A, 2005, ACTA NEUROCHIR SUPPL, V95, P367; Ragauskas A, 2011, ELEKTRON ELEKTROTECH, P16; Ragauskas A, 2003, MED ENG PHYS, V25, P667, DOI 10.1016/S1350-4533(03)00082-1; Ragauskas A., 2014, P 2 INT C HEART BRAI, P190; Ragauskas A., 2011, European Patent, Patent No. [2111787 B1, 2111787B1]; Ragauskas A., 2009, Patent No. [European US Patent 20090270734, 20090270734]; Ragauskas A., 2010, Japanese Patent No, Patent No. 4607967; Reinhard M., STROKE, P2138; Schondorf R, 2001, J APPL PHYSIOL, V91, P2493, DOI 10.1152/jappl.2001.91.6.2493; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Sviri G.E., 2010, J OPEN NEUROSURGERY, V3, P6; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320	30	6	6	1	4	KAUNAS UNIV TECHNOLOGY	KAUNAS	KAUNAS UNIV TECHNOL, DEPT ELECTRONICS ENGINEERING, STUDENTU STR 50, KAUNAS, LT-51368, LITHUANIA	1392-1215			ELEKTRON ELEKTROTECH	Elektron. Elektrotech.		2014	20	8					24	29		10.5755/j01.eee.20.8.5464			6	Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	AS4GM	WOS:000344231600005		gold, Green Submitted			2022-02-06	
J	Sabatello, M				Sabatello, Maya			"If you can't do it now, you're out the door:" Employees with traumatic brain injury - A case study	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Traumatic brain injury; prejudice and discrimination; accommodation; vocational rehabilitation; Convention on the Rights of Persons with Disabilities	DISABILITY; EMPLOYMENT; VALIDITY; ABI	This study considers the employment of persons with traumatic brain injury (TBI) from a disability-rights perspective. This approach calls for a shift from a focus on one's (in) capacity towards one's capability, incorporating both factors of impairment and of appropriate accommodation and supports to create inclusion. To give a voice to persons with TBI, the discussion is based on interviews with Tracey (pseudonym), a woman who incurred the injury at a young age and carried its implications as she entered the workforce. It illustrates the discrimination and prejudice encountered by such individuals in procuring employment and gaining acceptance in workplaces and the accommodation-related challenges. The case study discusses the complexities involved as a way for developing a better understanding what must be considered, from a disability-rights perspective, regarding employment and workplace of persons with TBI. The 2006 Convention on the Rights of Persons with Disabilities (CRPD) provides a legal reference for the discussion.	Columbia Univ, Dept Psychiat, New York, NY 10027 USA		Sabatello, M (corresponding author), Columbia Univ, Dept Psychiat, 722 West 168th St,Room R720E, New York, NY 10027 USA.	ms4075@columbia.edu					Alderman N, 2011, BRAIN INJURY, V25, P83, DOI 10.3109/02699052.2010.532849; Allen S, 2006, BRAIN INJURY, V20, P1119; Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P801, DOI 10.3109/02699052.2012.655368; Bach M., 2010, NEW PARADIGM PROTECT; Barnes C., 1991, DISABLED PEOPLE BRIT; Bruyere S.M, 2010, INT J DISABILITY MAN, V5, P48, DOI DOI 10.1375/JDMR.5.2.48; Burton LA, 2003, APPL NEUROPSYCHOL, V10, P145, DOI 10.1207/S15324826AN1003_03; Chaves C, 2012, BRAIN INJURY, V26, P882, DOI 10.3109/02699052.2012.666373; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gallagher P, 2012, GUARDIAN; Gamble D, 2003, J VOCATIONAL REHABIL, V19, P19; Gupta J, 2012, DISABILITY STUDIES Q, V32; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; ILO, 2011, 6 ILO; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Malec JF, 2006, BRAIN INJURY, V20, P227, DOI 10.1080/02699050500488124; Marks D, 1997, DISABIL REHABIL, V19, P85, DOI 10.3109/09638289709166831; Murphy L, BRAIN INJURY, V20, P1119; O'Brien L, 2007, BRAIN INJURY, V21, P465, DOI 10.1080/02699050701315134; Oliver M., 1990, POLITICS DISABLEMENT; Ouellette-Kuntz H., 2016, J POLICY PRACT INTEL, V3, P114, DOI [DOI 10.1111/J.1741-1130.2006.00062.X, 10.1111/j.1741-1130.2006.00062.x]; Palmer G, 2012, DISABLED PEOPLE POVE; Possl O, 2001, BRAIN INJURY, V15, P15; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Ptyushkin P, 2010, BRAIN INJURY, V24, P1519, DOI 10.3109/02699052.2010.523054; Quinn G, 2002, HUMAN RIGHTS DISABIL; Randolph DS, 2004, DISABIL SOC, V19, P403, DOI 10.1080/09687590410001689494; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Roggero P, 2006, DISABIL SOC, V21, P645, DOI 10.1080/09687590600918370; Roulstone A, 2009, DISABLING BARRIERS E, P195; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Shakespeare T, 2009, DISABILITY EC CREATI; Shakespeare Tom, 2006, DISABILITY RIGHTS WR; Somavia Juan, 2001, GLOBAL CHALLENGE DEC; Stergiou-Kita M, 2010, BRAIN INJURY, V24, P948, DOI 10.3109/02699052.2010.491495; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WEBER MARK C., 2007, DISABILITY HARASSMEN; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977	42	6	6	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2014	48	3					373	379		10.3233/WOR-131792			7	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AN0UJ	WOS:000340299200010	24284686				2022-02-06	
J	Stahnisch, FW				Stahnisch, Frank W.			From War Neurology to Psychotherapy - Kurt Goldstein (1878-1965) and the Early Approaches in Group Analysis	GRUPPENPSYCHOTHERAPIE UND GRUPPENDYNAMIK			German	Article						Kurt Goldstein; war neurology; psychotherapy; Siegfried Heinrich Fuchs (Foulkes); history of group analysis		In the context of academic discussions about foundational problems of theory and practice in group analysis, the name of German-American neurologist and psychiatrist Kurt Goldstein has so far only been marginally mentioned. This is however all the more astonishing, since during his time in Frankfurt 1916 to 1930, as the Director of the Institute for Research into the Long-Term Effects of Brain Injuries, Goldstein had kept very close training and research ties to the Frankfurt Institute for Psychoanalysis, which was headed by psychiatrist and psychoanalyst Karl Landauer (1887-1945). Furthermore, one of Goldstein's academic pupils, the German-British psychiatrist S. H. Foulkes, who was himself a highly influential founding figure in the field of group analysis, repeatedly emphasized the strong influence of Goldstein on his own psychoanalytic and group-analytic thinking.	Univ Calgary, Fac Med, Calgary, AB T2N 4Z6, Canada		Stahnisch, FW (corresponding author), Univ Calgary, Fac Med, TRW Bldg,Room 3E41,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	fwstahni@ucalgary.ca	Stahnisch, Frank W./J-5318-2019				Be lz W., 2006, KONKRETEN ZUM ABSTRA, P11; Benzenhafer U., 1997, SCHRIFTENREIHE DTSCH, V3, P31; Bion W.R., 1961, EXPERIENCES GROUPS; Brocher T., 1979, GRUPPENDYNAMIK ERWAC; Crouthamel J., 2001, INVISIBLE TRAUMAS PS; Danzer G, 2006, KONKRETEN ZUM ABSTRA; Daring P., 2011, ANGST, P91; Foulkes SH, 2008, GRUPPENPSYCHOTHER GR, V44, P222; Foulkes S. H., 1936, IMAGO, V22, P210; Foulkes S.H., 1948, INTRO GROUP ANAL PSY; Foulkes S. H., 1990, SELECTED PAPERS SH F, P25; Frommelt P., 1999, NEUROREHABILITATION; Geroulanos S., 2013, EXPT INDIVIDUUM K GO; Goldstein K., 1971, SELECTED PAPERS, P1; Goldstein K., 1937, COMMUNICATION   0309; Goldstein K., 1903, ZUSAMMENSETZUNG HINT; Goldstein K., 1934, ENTWURF VORWORT  JUL; Goldstein K., 1937, COMMUNICATION   0930; Goldstein K., 1958, COMMUNICATION; Goldstein K, 1954, ACTA PSYCHOL, V10, P175, DOI 10.1016/0001-6918(54)90011-6; Harrington A., 2002, SUCHE NACH GANZHEIT; Harrington A., 1998, GREATER SUM ITS PART, P25; Heigl-Evers A., 1972, LEWIN FOLGEN SOZIALP; Hoffmann T., 2013, WILLE ENTWICKLUNG PR; Karenberg A, 2007, 100 JAHRE DTSCH GESE, P20; Kiitemeyer M., 1984, NICHT MISSHANDELN KR, P133; Kreft G., 2005, THESIS JOHANN WOLFGA; Laier M., 1994, FRANKFURTER PSYCHOAN; Laier M., 1996, PSYCHOANALYSE FRANKF, P41; LEMCHE E, 1993, GRUPPENPSYCHOTHER GR, V29, P70; Lobb M. S., 2003, CREATIVE LICENSE ART; MITCHELL SA, 1990, CONTEMP PSYCHOANAL, V26, P616; Neumarker KJ, 2003, HIST PSYCHIATR, V14, P411, DOI 10.1177/0957154X03144001; Nitzgen D, 2010, GROUP ANAL, V43, P354; Osenberg D., 2005, HDB WEITERENTWICKLUN, P749; Perls FS, 1948, AM J PSYCHOTHER, V2, P565, DOI 10.1176/appi.psychotherapy.1948.2.4.565; Peters U., 1992, PSYCHIAT EXIL EMIGRA; Pow S, 2014, J NEUROL, V261, P1049, DOI 10.1007/s00415-013-7020-1; Pross C., 1984, KRANKENHAUS MOABIT 1; Sandner D., 2013, GRUPPE UNBEWUSSTE, P33; Schroter M., 2008, Z GESCH PSYCHOANALYS, V42, P49; Schultz-Venrath U, 2008, GRUPPENPSYCHOTHER GR, V44, P215, DOI 10.13109/grup.2008.44.3.215; Siegel D. J., 2001, INTERPERSONAL MIND R; Simmel M. L., 1968, REACH MIND ESSAYS ME, P2; Simmer H.H., 2000, BERLINER PATHOLOGE L; Stahnisch E W, 2010, PSYCHIAT ZEITGEIST G, P76; Stahnisch F., 2010, WAS BEWEGT UNS MENSC, P283; Stahnisch F.W., 2009, TRAUMA WISSENSCHAFT, P29; Stahnisch F. W, 2014, J NEUROL, V261, P3, DOI [10.1007/s00415-013-7020-1, DOI 10.1007/S00415-013-7020-1]; Stahnisch FW, 2008, J NEUROL, V255, P147, DOI 10.1007/s00415-008-0793-y; STERN K, 1951, PILLAR FIRE; Tan S.Y., 2011, COUNSELING PSYCHOTHE; Teuber H.-L., 1966, SELECTED PAPERS, P299; Ulrich R., 1968, SELECTED PAPERS, P13; Vidal F, 2002, CRIT INQUIRY, V28, P930, DOI 10.1086/341240; Vogelsanger P., 2008, PSYCHIAT ZEITGEIST G, P256; Weingarten M., 2006, LEBEN GESCH ANTHR ET, P171; [No title captured]	58	6	6	0	4	VANDENHOECK & RUPRECHT GMBH & CO KG	GOTTINGEN	VIENNA UNIV PRESS, ROBERT BOSCH BREITE 6, D-37079 GOTTINGEN, GERMANY	0017-4947	2196-7989		GRUPPENPSYCHOTHER GR	Gruppenpsychother. Gruppendyn.		2014	50	2					146	165		10.13109/grup.2014.50.2.146			20	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	AK1JO	WOS:000338171600004					2022-02-06	
J	Sulejczak, D; Andrychowski, J; Kowalczyk, T; Nakielski, P; Frontczak-Baniewicz, M; Kowalewski, T				Sulejczak, Dorota; Andrychowski, Jarostaw; Kowalczyk, Tomasz; Nakielski, Pawet; Frontczak-Baniewicz, Malgorzata; Kowalewski, Tomasz			Electrospun nanofiber mat as a protector against the consequences of brain injury	FOLIA NEUROPATHOLOGICA			English	Article						brain injury; L-lactide-caprolactone copolymer nanofiber net; glial scar; neurodegeneration	GLIAL SCAR; OLIGOCARBONATE DIOLS; CYCLIC CARBONATES; POLYMERIZATION; PREVENTION; MONOMERS	Traumatic/surgical brain injury can initiate a cascade of pathological changes that result, in the long run, in severe damage of brain parenchyma and encephalopathy. Excessive scarring can also interfere with brain function and the glial scar formed may hamper the restoration of damaged brain neural pathways. In this preliminary study we aimed to investigate the effect of dressing with an L-lactide-caprolactone copolymer nanofiber net on brain wound healing and the fate of the formed glial scar Our rat model of surgical brain injury (SBI) of the fronto-temporal region of the sensorimotor cortex imitates well the respective human neurosurgery situation. Brains derived from SBI rats with net-undressed wound showed massive neurodegeneration, entry of systemic inflammatory cells into the brain parenchyma and the astrogliosis due to massive glial scar formation. Dressing of the wound with the nanofiber net delayed and reduced the destructive phenomena. We observed also a reduction in the scar thickness. The observed modification of local inflammation and cicatrization suggest that nanofiber nets could be useful in human neurosurgery.	[Sulejczak, Dorota] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Expt Pharmacol, PL-02106 Warsaw, Poland; [Andrychowski, Jarostaw] Med Univ Warsaw, Bielanski Hosp, Dept Neurosurg, Warsaw, Poland; [Andrychowski, Jarostaw] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurosurg, PL-02106 Warsaw, Poland; [Kowalczyk, Tomasz; Nakielski, Pawet; Kowalewski, Tomasz] Polish Acad Sci, Inst Fundamental Technol Res, PL-02106 Warsaw, Poland; [Frontczak-Baniewicz, Malgorzata] Polish Acad Sci, Mossakowski Med Res Ctr, PL-02106 Warsaw, Poland		Sulejczak, D (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Dept Expt Pharmacol, 5 Pawinskiego Str, PL-02106 Warsaw, Poland.	dsulejczak@imdik.pan.pl	Kowalczyk, Tomasz/H-3872-2012; Kowalewski, Tomasz A/F-2055-2011; Nakielski, Pawel/A-2077-2013	Kowalczyk, Tomasz/0000-0003-2381-4122; Kowalewski, Tomasz A/0000-0002-3664-9659; Nakielski, Pawel/0000-0001-6194-701X; Sulejczak, Dorota/0000-0002-1697-8164	National Centre for Research and Development Project [NR13-0081-10-2010]	This study was supported by the National Centre for Research and Development Project #NR13-0081-10-2010.	Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; Bretcanu O, 2009, MATER CHEM PHYS, V118, P420, DOI 10.1016/j.matchemphys.2009.08.011; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Frontczak-Baniewicz M, 2003, ACTA NEUROBIOL EXP, V63, P65; Frontczak-Baniewicz M, 2006, J PHYSIOL PHARMACOL, V57, P97; Frontczak-Baniewicz M, 2013, FOLIA NEUROPATHOL, V51, P324, DOI 10.5114/fn.2013.39723; Frontczak-Baniewicz M, 2011, FOLIA NEUROPATHOL, V49, P204; Fryczkowski R, 2009, SYNTHETIC MET, V159, P2266, DOI 10.1016/j.synthmet.2009.09.008; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Hillier SL, 1997, BRAIN INJURY, V11, P649; Jablonska A, 2011, ACTA NEUROBIOL EXP, V71, P74; Kamel H, 2012, ARCH NEUROL-CHICAGO, V69, P576, DOI 10.1001/archneurol.2011.3590; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kowalczyk T, 2008, BIOMACROMOLECULES, V9, P2087, DOI 10.1021/bm800421s; Kowalewski TA, 2009, IUTAM BOOKSER, V13, P279, DOI 10.1007/978-1-4020-9557-3_29; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Lee JB, 2011, TISSUE ENG PT A, V17, P2695, DOI [10.1089/ten.tea.2010.0709, 10.1089/ten.TEA.2010.0709]; Li HF, 2011, NEUROSCI LETT, V497, P172, DOI 10.1016/j.neulet.2011.02.042; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Reneker DH, 2007, ADV APPL MECH, V41, P43, DOI 10.1016/S0065-2156(07)41002-X; Rokicki G, 2000, POLYMER, V41, P9013, DOI 10.1016/S0032-3861(00)00273-1; Rokicki G, 2000, POLYM J, V32, P381, DOI 10.1295/polymj.32.381; Rokicki G, 2001, POLIMERY-W, V46, P483, DOI 10.14314/polimery.2001.483; Rokicki G, 1998, POLIMERY-W, V43, P407, DOI 10.14314/polimery.1998.407; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Shively S, 2012, ARCH NEUROL-CHICAGO, V9, P1; Sulejczak D, 2008, FOLIA NEUROPATHOL, V46, P213; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; Willmore LJ, 2012, EPILEPSY CURR, V12, P87, DOI 10.5698/1535-7511-12.3.87; Ziemka-Nalecz M, 2012, ACTA NEUROBIOL EXP, V72, P309	35	6	6	1	16	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1641-4640	1509-572X		FOLIA NEUROPATHOL	Folia Neuropathol.		2014	52	1					56	69		10.5114/fn.2014.41744			14	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	AF2VH	WOS:000334570100006	24729343	gold			2022-02-06	
J	Tavano, A; Galbiati, S; Recla, M; Bardoni, A; Dominici, C; Pastore, V; Strazzer, S				Tavano, Alessandro; Galbiati, Susanna; Recla, Monica; Bardoni, Alessandra; Dominici, Chiara; Pastore, Valentina; Strazzer, Sandra			Cognitive recovery after severe traumatic brain injury in children/adolescents and adults: Similar positive outcome but different underlying pathways?	BRAIN INJURY			English	Article						Age; coma duration; glasgow outcome scale; neuropsychological recovery; reserve capacity effect	SEVERE HEAD-INJURY; SELF-AWARENESS; CHILDREN; PLASTICITY; DEFICITS; IMPAIRMENT; CHILDHOOD; PREDICTOR; MODERATE; NETWORK	Primary objective: Does younger age at the time of severe traumatic brain injury (STBI) protect from cognitive symptoms? To answer this question, the authors compared the neuropsychological profile of late school-age children/adolescents and young adult patients at mid-and long-term recovery periods (6 and 12 months post-STBI). Methods and procedures: Twenty-eight children/adolescents and 26 clinically matched adults were tested on measures of general intelligence, attention, executive functions, visuoperceptual, visuospatial and visuoconstructive abilities. Coma duration and the post-acute Glasgow Outcome Scale (GOS) score were used as predictor variables in a series of regression analyses. Main outcomes and results: Children/adolescents and adults similarly improved on most measures, except for visuospatial and visuoconstructive skills, which worsened in time for children/adolescents. Coma duration significantly predicted performance IQ and visuoperceptual scores in children/adolescents. The GOS score significantly predicted performance and verbal IQ, sustained attention, visuoconstructive and long-term memory skills. Coma duration predicted executive function skills in both age groups. Conclusions: (1) No evidence was found for a neuroprotective effect of younger age at STBI; and (2) Coma duration and GOS score predicted neuropsychological recovery in children/adolescents and adults, respectively. This suggests the existence of underlying age-specific recovery processes after STBI.	[Tavano, Alessandro; Galbiati, Susanna; Recla, Monica; Bardoni, Alessandra; Dominici, Chiara; Pastore, Valentina; Strazzer, Sandra] Eugenio Medea Sci Inst, Acquired Brain Injury Rehabil Unit, Bosisio Parini, LC, Italy		Tavano, A (corresponding author), E Medea Sci Inst, Acquired Brain Injury Rehabil Unit, 20 V Don Luigi Monza, I-23842 Bosisio Parini, Lecco, Italy.	tavano@uni-leipzig.de	Galbiati, Susanna/AAH-6883-2019; Pastore, Valentina/AAH-6831-2019; BARDONI, ALESSANDRA/AAH-7233-2019; Strazzer, Sandra/AAH-5712-2019; Recla, Monica/ABG-1905-2020	Galbiati, Susanna/0000-0001-7209-4251; Pastore, Valentina/0000-0002-3170-3070; BARDONI, ALESSANDRA/0000-0001-8404-3857; Strazzer, Sandra/0000-0001-8414-6565; Recla, Monica/0000-0002-3001-8872; Tavano, Alessandro/0000-0002-2096-5542			Akshoomoff NA, 2002, NEUROPSYCHOLOGIA, V40, P539, DOI 10.1016/S0028-3932(01)00129-4; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; BENTON AL, 1983, CONTRIBUTIONS NEUROP, P44; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Conners CK, 2000, MHS STAFF CONNERS CO; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2012, INJURY, V43, P2141, DOI 10.1016/j.injury.2012.07.195; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Griffiths R., 1954, ABILITIES BABIES; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kolb B., 2000, FUNDAMENTALS HUMAN N; Kraus JF., 1995, TRAUMATIC HEAD INJUR, P117; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Liscio M, 2008, DISABIL REHABIL, V30, P275, DOI 10.1080/09638280701257023; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; May A, 2011, TRENDS COGN SCI, V15, P475, DOI 10.1016/j.tics.2011.08.002; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; Orsini A, 1987, ITALIAN J NEUROLOGIC, V210, P35; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Recla M, 2013, BRAIN INJURY, V27, P862, DOI 10.3109/02699052.2013.775499; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Snook L, 2005, NEUROIMAGE, V26, P1164, DOI 10.1016/j.neuroimage.2005.03.016; Spady DW, 2004, PEDIATRICS, V113, P522, DOI 10.1542/peds.113.3.522; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; WABER DP, 1985, J CLIN EXP NEUROPSYC, V7, P264, DOI 10.1080/01688638508401259; Wechsler D ., 1986, WECHSLER INTELLIGENC; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	54	6	6	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	7					900	905		10.3109/02699052.2014.890742			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9XL	WOS:000336498600003	24655151				2022-02-06	
J	Tomaszewski, W; Bulinski, L; Mirski, A; Rasmus, A; Kowalczyk, J; Bazan, M; Pachalska, M				Tomaszewski, Wieslaw; Bulinski, Leszek; Mirski, Andrzej; Rasmus, Anna; Kowalczyk, Jakub; Bazan, Maria; Pachalska, Maria			An evaluation of anti-social behaviour in children after traumatic brain injury - prospects for improving the quality of life in rehabilitation	ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE			English	Article						brain damage; anti-social behaviour; cognitive functions; microgenetic theory	SEVERE TBI; PATIENT; NEUROTHERAPY	Introduction and objective. The aim of the article is to present the consequences of traumatic brain injury in children, associated with general cognition and behavioural disorders, mainly of the anti-social type. Materials and method. A total of 20 school-age children took part in the study -6 girls and 14 boys; average age of the children - 13.35 years (standard deviation SD = 1.95). The research instruments included an analysis of documentation, a structured clinical interview, MMSE and Frontal Behavioral Inventory (FBInv) with an additional set of 5 supplementary questions directed at the detection of anti-social behaviour. Results. The functioning of the children with traumatic brain injury is severely disrupted because of the presence of cognitive impairment; however, dementia was not manifested. In a significant number of the children with traumatic brain injury, not only frontal syndrome was found, but also the occurrence of anti-social behaviour. The most commonly reported behavioural problems were: disorganization, commonly referred to as laziness, hypersensitivity, and anxiety. The most common types of anti-social behaviours were: impulsivity, physical and verbal aggression, as well as outbursts of anger. Conclusions. The children with traumatic brain injury suffer from cognitive disorders and behavioural problems, especially impulsivity, physical and verbal aggression, increased anxiety, and disorganization. The occurrence of frontal syndrome is related to the development of anti-social behaviour.	[Tomaszewski, Wieslaw] Coll Physiotherapy, Wroclaw, Poland; [Bulinski, Leszek] Ateneum Univ, Gdansk, Poland; [Mirski, Andrzej; Bazan, Maria; Pachalska, Maria] Andrzej Frycz Modrzewski Krakow Univ, Krakow, Poland; [Rasmus, Anna] Kazimierz Wielki Univ, Inst Psychol, Bydgoszcz, Poland; [Kowalczyk, Jakub] Polish Neuropsychol Soc, Reintegrat Training Ctr, Krakow, Poland; [Pachalska, Maria] Ctr Cognit & Commun, New York, NY USA		Pachalska, M (corresponding author), Andrzej Frycz Modrzewski Krakow Univ, Chair Neuropsychol, Krakow, Poland.	neuropsychologia23@o2.pl		Rasmus, Anna/0000-0001-5125-3081			Ashley M. J., 2004, TRAUMATIC BRAIN INJU, V2nd; Bilikiewicz A, 2002, PSYCHIATRIA, VII; Blachnio A, 2009, ACTA NEUROPSYCHOL, V7, P73; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glowacki J, 2000, URAZY CZASZKI MOZGU; Granacher Jr RP, 2007, TRAUMATIC BRAIN INJU; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Kaczmarek B. L. J., 1987, FRONTAL LOBES REVISI, P225; Kertesz A, 1997, CAN J NEUROL SCI, V24, P29, DOI 10.1017/S0317167100021053; Kolb B, 2003, FUNDAMENTALS HUMAN N; MacQueen B. D., 2003, NEUROPSYCHOLOGICZNE, P101; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Pachalska M., 2007, 1 2 PROCESY POZNAWCZ; Pachalska M., 2008, REHABILITACJA NEUROP; Pachalska M, 2013, ACTA NEUROPSYCHOL, V11, P435; Pachalska M, 2012, ACTA NEUROPSYCHOL, V10, P399, DOI 10.5604/17307503.1023689; Pachalska M, 2012, MED SCI MONITOR, V18, pCR432; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Tomaszewski W, 2013, ANN AGR ENV MED, V20, P361	23	6	6	0	20	INST AGRICULTURAL MEDICINE	LUBLIN	JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND	1232-1966	1898-2263		ANN AGR ENV MED	Ann. Agr. Env. Med.		2014	21	3					649	653		10.5604/12321966.1120620			5	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	AP6LH	WOS:000342188800039	25292146	gold			2022-02-06	
J	Turck, CJ; Frazee, E; Kram, B; Daley, MJ; Day, SA; Horner, D; Lesch, C; Mercer, JM; Plewa, AM; Herout, P				Turck, Charles J.; Frazee, Erin; Kram, Bridgette; Daley, Mitchell J.; Day, Sarah A.; Horner, Deanna; Lesch, Christine; Mercer, Jessica M.; Plewa, Angela M.; Herout, Peter		Critical Care Pharmacotherapy	Major publications in the critical care pharmacotherapy literature: February 2012 through February 2013	AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INTENSIVE INSULIN THERAPY; VENTILATOR-ASSOCIATED PNEUMONIA; CLINICAL-PRACTICE GUIDELINES; PROTON PUMP INHIBITORS; STRESS-ULCER PROPHYLAXIS; TRAUMATIC BRAIN-INJURY; TIGHT GLUCOSE CONTROL; ILL PATIENTS; MECHANICAL VENTILATION	Purpose. Recent impactful additions to the professional literature on the role of pharmacotherapy in treating the critically ill are summarized. Summary. An unusually large number of updated practice guidelines and other publications with broad critical care pharmacotherapy ramifications appeared in the primary biomedical literature during the designated review period (February 2012 February 2013). Hundreds of relevant articles were evaluated by the Critical Care Pharmacotherapy Literature Update group (CCPLU), a national group of pharmacists who routinely monitor 25 peer-reviewed journals for emerging evidence that pertains to rational medication use in the intensive care unit (ICU) setting. From among those articles, 64 were summarized for dissemination to CCPLU members; the 8 publications deemed to have the greatest utility for critical care practitioners, as determined by CCPLU through a voting process, were selected for inclusion in this review, with preference given to evidence, meeting high standards of methodological quality. The summaries presented here include (1) important new recommendations on management of pain, agitation, and delirium in critically ill patients; (2) a comprehensive update of a practice guideline issued in 2008 by the Surviving Sepsis Campaign, (3) novel strategies for the prevention and/or treatment of hyperglycemia in critical care, and (4) reports on clinical trials of promising alternative methods of sedation for use in weaning patients from mechanical ventilation. Conclusion. This review provides synopses of practice guidelines and other recent additions to the professional literature pertaining to rational medication use in the ICU practice setting.	[Turck, Charles J.] ScientiaCME LLC, Mission Viejo, CA USA; [Frazee, Erin] Mayo Clin, Rochester, MN USA; [Kram, Bridgette] Duke Univ Hosp, Durham, NC USA; [Daley, Mitchell J.] Seton Hlth Care Family, Crit Care, Austin, TX USA; [Day, Sarah A.] OhioHlth, Crit Care, Doctors Hosp, Columbus, OH USA; [Horner, Deanna] Vanguard Hlth Chicago, Chicago, IL USA; [Lesch, Christine] NewYork Presbyterian Hosp, Neurol ICU, Columbia Med Ctr, New York, NY USA; [Mercer, Jessica M.] Roper St Francis Hlth Care, Charleston, SC USA; [Plewa, Angela M.] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA; [Herout, Peter] Cardinal Hlth, Westmont, IL USA		Turck, CJ (corresponding author), ScientiaCME LLC, Mission Viejo, CA USA.	cturck@scientiacme.org	Turck, Charles J/AAK-6114-2021	Turck, Charles J/0000-0002-7547-322X	Optimer Pharmaceuticals; Astellas PharmaceuticalsAstellas Pharmaceuticals; Cumberland Pharmaceuticals	Dr. Frazee reports having received a research grant from Optimer Pharmaceuticals. Dr. Lesch reports having received research grants from Astellas Pharmaceuticals and Cumberland Pharmaceuticals. The other authors have declared no potential conflicts of interest.	Alhazzani W, 2013, CRIT CARE MED, V41, P693, DOI 10.1097/CCM.0b013e3182758734; Alhazzani W, 2012, POL ARCH MED WEWN, V122, P107, DOI 10.20452/pamw.1173; Andolfatto G, 2012, ANN EMERG MED, V59, P504, DOI 10.1016/j.annemergmed.2012.01.017; Annane D, 2007, LANCET, V370, P676, DOI 10.1016/S0140-6736(07)61344-0; Arnold HM, 2013, ANN PHARMACOTHER, V47, P170, DOI 10.1345/aph.1R523; Arrich J, 2012, RESUSCITATION, V83, P333, DOI 10.1016/j.resuscitation.2011.10.027; Asehnoune K, 2012, INTENS CARE MED, V38, P1673, DOI 10.1007/s00134-012-2619-8; Baggs JH, 2012, ANN PHARMACOTHER, V46, P51, DOI 10.1345/aph.1Q588; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Barr J, 2013, AM J HEALTH-SYST PH, V70, P53, DOI 10.1093/ajhp/70.1.53; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Brunkhorst FM, 2012, JAMA-J AM MED ASSOC, V307, P2390, DOI 10.1001/jama.2012.5833; Carson SS, 2006, CRIT CARE MED, V34, P1326, DOI 10.1097/01.CCM.0000215513.63207.7F; Chan JD, 2012, CRIT CARE MED, V40, P1437, DOI 10.1097/CCM.0b013e318243168e; Chiang YH, 2012, J NEUROTRAUM, V29, P75, DOI 10.1089/neu.2011.1801; Chytra I, 2012, CRIT CARE, V16, DOI 10.1186/cc11405; Cook AM, 2012, NEUROCRIT CARE, V17, P24, DOI 10.1007/s12028-012-9711-3; Cook D, 2011, NEW ENGL J MED, V364, P1305, DOI 10.1056/NEJMoa1014475; Dalfino L, 2012, CLIN INFECT DIS, V54, P1720, DOI 10.1093/cid/cis286; De Backer D, 2012, CRIT CARE MED, V40, P725, DOI 10.1097/CCM.0b013e31823778ee; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI [10.1007/s00134-007-0934-2, 10.1097/01.CCM.0000298158.12101.41]; Dellinger RP, 2012, CRIT CARE, V16, DOI 10.1186/cc11215; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Devlin JW, 2010, CRIT CARE MED, V38, P419, DOI 10.1097/CCM.0b013e3181b9e302; Dickerson RN, 2013, JPEN-PARENTER ENTER, V37, P342, DOI 10.1177/0148607112466894; Douketis JD, 2012, CHEST, V141, pE326S, DOI 10.1378/chest.11-2298; Drenger B, 2012, CIRCULATION, V126, P261, DOI 10.1161/CIRCULATIONAHA.111.059527; Dulhunty JM, 2013, CLIN INFECT DIS, V56, P236, DOI 10.1093/cid/cis856; Erstad BL, 2005, PHARMACOTHERAPY, V25, P585, DOI 10.1592/phco.25.4.585.61024; Erstad BL, 2002, PHARMACOTHERAPY, V22, P1594, DOI 10.1592/phco.22.17.1594.34122; Erstad BL, 2009, PHARMACOTHERAPY, V29, P1228, DOI 10.1592/phco.29.10.1228; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Florescu DF, 2012, CLIN INFECT DIS, V54, P670, DOI 10.1093/cid/cir934; Freestone PP, 2012, CHEST, V142, P1200, DOI 10.1378/chest.11-2614; Giglio M, 2012, CRIT CARE, V16, DOI 10.1186/cc11300; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Gordon AC, 2012, CHEST, V142, P593, DOI 10.1378/chest.11-2604; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2012, CHEST, V141, p53S, DOI 10.1378/chest.11-2288; Hamilton LA, 2012, J TRAUMA ACUTE CARE, V72, P1478, DOI 10.1097/TA.0b013e318250911b; Heenen S, 2012, CRIT CARE MED, V40, P1404, DOI 10.1097/CCM.0b013e3182416ecf; Hirsh J, 2008, CHEST, V133, p71S, DOI 10.1378/chest.08-0693; Inzucchi SE, 2009, NEW ENGL J MED, V360, P1346, DOI 10.1056/NEJMe0901507; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Jacobi J, 2012, CRIT CARE MED, V40, P3251, DOI 10.1097/CCM.0b013e3182653269; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Janda S, 2012, CHEST, V142, P401, DOI 10.1378/chest.11-3071; Kahn Susan R, 2012, Chest, V141, pe195S, DOI 10.1378/chest.11-2296; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Krinsley JS, 2008, CRIT CARE, V12, DOI 10.1186/cc6889; Kullar R, 2012, PHARMACOTHERAPY, V32, P195, DOI 10.1002/j.1875-9114.2011.01017.x; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Lamberts M, 2012, CIRCULATION, V126, P1185, DOI 10.1161/CIRCULATIONAHA.112.114967; Layios N, 2012, CRIT CARE MED, V40, P2304, DOI 10.1097/CCM.0b013e318251517a; Lee BH, 2012, CRIT CARE, V16, DOI 10.1186/cc11211; Lin PC, 2010, CRIT CARE MED, V38, P1197, DOI 10.1097/CCM.0b013e3181d69ccf; Lopes RD, 2012, LANCET, V380, P1749, DOI 10.1016/S0140-6736(12)60986-6; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Martini RP, 2012, NEUROCRIT CARE, V17, P191, DOI 10.1007/s12028-011-9573-0; Mees SMD, 2012, LANCET, V380, P44, DOI 10.1016/S0140-6736(12)60724-7; Moore CL, 2012, CLIN INFECT DIS, V54, P51, DOI 10.1093/cid/cir764; Muller L, 2012, CRIT CARE, V16, DOI 10.1186/cc11213; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Myburgh JA, 2008, INTENS CARE MED, V34, P2226, DOI 10.1007/s00134-008-1219-0; O'Keefe GE, 2012, J TRAUMA ACUTE CARE, V72, P713, DOI 10.1097/TA.0b013e3182349d14; Palmer AJ, 2013, CRIT CARE MED, V41, P307, DOI 10.1097/CCM.0b013e3182657578; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Park HY, 2012, CRIT CARE, V16, DOI 10.1186/cc10601; Park SH, 2012, J TRAUMA ACUTE CARE, V73, P1294, DOI 10.1097/TA.0b013e31827019b1; Parsons M, 2012, NEW ENGL J MED, V366, P1099, DOI 10.1056/NEJMoa1109842; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Pongprasobchai Supot, 2009, Journal of the Medical Association of Thailand, V92, P632; Pontes-Arruda A, 2012, JPEN-PARENTER ENTER, V36, P574, DOI 10.1177/0148607111427040; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rodriguez-Bano J, 2012, CLIN INFECT DIS, V54, P167, DOI 10.1093/cid/cir790; Schmittinger CA, 2012, INTENS CARE MED, V38, P950, DOI 10.1007/s00134-012-2531-2; Seymour CW, 2012, CRIT CARE MED, V40, P2788, DOI 10.1097/CCM.0b013e31825b8ade; Shah K, 2012, J TRAUMA ACUTE CARE, V72, P691, DOI 10.1097/TA.0b013e31823c5637; Silbergleit R, 2012, NEW ENGL J MED, V366, P591, DOI 10.1056/NEJMoa1107494; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Sufit A, 2012, JPEN-PARENTER ENTER, V36, P556, DOI 10.1177/0148607112448823; Swisher CB, 2012, NEUROCRIT CARE, V16, P109, DOI 10.1007/s12028-011-9626-4; Ranzani OT, 2012, CRIT CARE MED, V40, P2552, DOI 10.1097/CCM.0b013e318259203d; Treggiari MM, 2009, CRIT CARE MED, V37, P2527, DOI 10.1097/CCM.0b013e3181a5689f; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Walkey AJ, 2012, CHEST, V141, P1153, DOI 10.1378/chest.11-1908; Wang W, 2012, CRIT CARE MED, V40, P731, DOI 10.1097/CCM.0b013e3182376e4f; Wanzuita R, 2012, CRIT CARE, V16, DOI 10.1186/cc11250; Weijs PJM, 2012, JPEN-PARENTER ENTER, V36, P60, DOI 10.1177/0148607111415109; Witt DM, 2012, ARCH INTERN MED, V172, P1484, DOI 10.1001/archinternmed.2012.4261; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895; Yeon JY, 2012, J NEUROTRAUM, V29, P1334, DOI 10.1089/neu.2011.2074	107	6	6	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-2082	1535-2900		AM J HEALTH-SYST PH	Am. J. Health-Syst. Pharm.	JAN 1	2014	71	1					68	77		10.2146/ajhp130303			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	285IB	WOS:000329386300013	24352184				2022-02-06	
J	Xu, GZ; Wang, MD; Liu, KG; Bai, YA				Xu, Gang-Zhu; Wang, Mao-De; Liu, Kai-Ge; Bai, Yin-An			A Rare Remote Epidural Hematoma Secondary to Decompressive Craniectomy	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Acute subdural hematoma; craniectomy; epidural hematoma; remote; postoperative hemorrhage	ACUTE SUBDURAL-HEMATOMA; TRAUMATIC BRAIN-INJURY; COMPLICATION; CRANIOTOMY; HEMORRHAGE; SURGERY	Remote epidural hematoma (REDH) is an uncommon complication of decompressive craniectomy. Remote epidural hematomas of the parietal occiput region have been reported only rarely. We report a unique case of delayed-onset bilateral extensive straddle postsagittal sinus and bilateral lateral sinus parietal occiput REDH after decompressive craniectomy, of which volume was approximately 130 mL, with left deviating midline structures. The patient was immediately taken back to the operating room for evacuation of the REDH via bilateral parietal and occiput craniectomy. Postoperatively, serial computed tomographic scans performed 3 days later showed that the REDH had been completely evacuated. Two months later, the patient regained full consciousness and obtained a near-complete recovery except for right facial paralysis.	[Xu, Gang-Zhu; Wang, Mao-De] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Medican Coll, Xian 710061, Shaanxi, Peoples R China; [Xu, Gang-Zhu; Liu, Kai-Ge; Bai, Yin-An] Xian Med Univ, Affiliated Hosp, Dept Neurosurg, Xian, Shaanxi, Peoples R China		Xu, GZ (corresponding author), Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Coll Med, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.	xgz917@126.com					Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; HIGAZI I, 1963, J NEUROSURG, V20, P527, DOI 10.3171/jns.1963.20.6.0527; KONIG A, 1987, ACTA NEUROCHIR, V88, P104, DOI 10.1007/BF01404145; Landeiro JA, 2004, ARQ NEURO-PSIQUIAT, V62, P832, DOI 10.1590/S0004-282X2004000500017; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	9	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN	2014	25	1					E17	+		10.1097/SCS.0b013e3182a2ed26			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AH2CP	WOS:000335928600013	24275779				2022-02-06	
J	Lesko, MM; Jenks, T; Perel, P; O'Brien, S; Childs, C; Bouamra, O; Lecky, F				Lesko, Mehdi Moazzez; Jenks, Tom; Perel, Pablo; O'Brien, Sarah; Childs, Charmaine; Bouamra, Omar; Lecky, Fiona			Models of Mortality Probability in Severe Traumatic Brain Injury: Results of the Modelling by the UK Trauma Registry	JOURNAL OF NEUROTRAUMA			English	Article						outcome; prognosis; prognostic models; TBI; trauma care	PROGNOSTIC VALUE; ADMISSION CHARACTERISTICS; CLINICAL-TRIALS; IMPACT; EPIDEMIOLOGY; VALIDATION; SURVIVAL; DESIGN	Currently available prognostic models in Traumatic Brain Injury (TBI) are derived from historical data sets or from heterogeneous data sets, depending upon the trauma care delivered. The objective of our study was to develop models to predict survival in a recent cohort of TBI patients within a relatively homogeneous trauma care system. Records of patients with brain injury were extracted from the Trauma Audit and Research Network (TARN) database. The relationship of the variables (i.e., age, Glasgow Coma Score [GCS], pupillary reactivity, Injury Severity Score [ISS], Computed Tomography [CT] classifications, classification of various intracranial pathologies, systolic and mean blood pressure, oxygen saturation, and the presence of extracranial injury) to survival at discharge were determined. Stepwise logistical regression analysis was performed to determine the best prognostic model. Two models were derived from data of 802 patients (models A and B). Age, GCS, pupillary reactivity, hypoxia, and brainstem injury are significant predictors in both. However, model A contains ISS in contrast to model B, which contains the presence of brain swelling and major extracranial injury instead. Both models have good predictive performance (model A: area under the Receiver Operating Characteristic [ROC] curve [AUC]=0.92 [95% CI, 0.90-0.95], Nagelkerke R-2, 0.62; model B: AUC=0.93 [95% CI: 0.91-0.95], Nagelkerke R-2: 0.63). Hence, two accurate and reliable prognostic models were developed from a recent cohort of the TBI population.	[Lesko, Mehdi Moazzez; Jenks, Tom; Bouamra, Omar] Univ Manchester, Manchester Acad Hlth Sci Ctr, TARN, Salford Royal NHS Fdn Trust, Salford, Lancs, England; [Perel, Pablo] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [O'Brien, Sarah] Univ Liverpool, Dept Infect Epidemiol & Zoonoses, Inst Infect & Global Hlth, Natl Ctr Zoonosis Res, Neston, England; [Childs, Charmaine] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Lecky, Fiona] Univ Sheffield, Dept Emergency Med, Hlth Serv Res Grp, ScHARR, Sheffield, S Yorkshire, England		Lesko, MM (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, TARN, Salford Royal NHS Fdn Trust, Salford, Lancs, England.	mehdimlesko@gmail.com		O'Brien, Sarah Jane/0000-0003-2896-8999; /0000-0002-2342-301X; bouamra, omar/0000-0002-3155-4634	TARN; Overseas Research Students (ORS) Award Scheme, University of Manchester, United Kingdom	We thank all TARN participating hospitals. This work was in part funded by TARN and Overseas Research Students (ORS) Award Scheme, University of Manchester, United Kingdom.	Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005 U; Association for the Advancement of Automotive Medicine, 2001, ABBR INJ SCAL 1990 R; Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; David W.H., 2000, APPL LOGISTIC REGRES; Davis EG, 2003, J TRAUMA, V55, P53, DOI 10.1097/01.TA.0000075340.22097.B5; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KAUFMANN CR, 1991, J TRAUMA, V31, P691, DOI 10.1097/00005373-199105000-00014; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lesko M., BMC MED RES METHODOL, V10, P72; Lesko M.M., EUR J TRAUMA EMERG S, V38, P25; Lingsma H.F., LANCET NEUROL, V9, P543; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; Millham FH, 2004, J TRAUMA, V56, P1090, DOI 10.1097/01.TA.0000119689.81910.06; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640	26	6	6	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2013	30	24					2021	2030		10.1089/neu.2013.2988			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	271QK	WOS:000328406500003	23865489				2022-02-06	
J	D'Antonio, E; Tsaousides, T; Spielman, L; Gordon, W				D'Antonio, Emily; Tsaousides, Theodore; Spielman, Lisa; Gordon, Wayne			Depression and traumatic brain injury: symptom profiles of patients treated with cognitive-behavioral therapy or supportive psychotherapy	NEUROPSYCHIATRY			English	Article							MAJOR DEPRESSION; DISORDERS; DIAGNOSIS; INVENTORY; UTILITY; SCALE	Aims: This study aimed to examine the differential treatment effects of cognitive-behavioral therapy (CBT) and supportive psychotherapy (SPT) on self-reported symptoms of depression in individuals with traumatic brain injury (TBI) who sought treatment for major depressive disorder (MDD). Methods: Participants were individuals with a documented TBI meeting criteria for MDD who, as part of a larger randomized controlled trial comparing treatments for MDD after TBI, received CBT (n = 22) or SPT (n = 22). The average age of participants was 48.8 years (standard deviation = 10.2), 57.1% were female, 57.5% were Caucasian, 20% were Hispanic and 15% were African-American. The main outcome measure was the Beck Depression InventoryII (BDI-II). Results: Mean total BDI-II score for all participants combined at baseline was 25 (standard deviation = 10.0). There were no significant differences in total BDI-II score between treatment groups at either baseline or at the end of treatment. Participants treated with CBT reported significant improvements in sadness, loss of interest and loss of interest in sex, while participants treated with SPT reported significant improvements in symptoms of agitation and irritability. Conclusion: SPT may better target symptoms of behavioral disinhibition (agitation and irritability), while CBT may better target mood symptoms (sadness) and their behavioral manifestations (loss of interest and loss of interest in sex).	[D'Antonio, Emily; Tsaousides, Theodore; Spielman, Lisa; Gordon, Wayne] Mt Sinai, Brain Injury Res Ctr, Icahn Sch Med, New York, NY 10029 USA		D'Antonio, E (corresponding author), Mt Sinai, Brain Injury Res Ctr, Icahn Sch Med, Box 1163, New York, NY 10029 USA.	emily.d'antonio@mountsinai.org			National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133B040033, H133P100016/H133P050004]	This work was supported by grants H133B040033 and H133P100016/H133P050004 from the National Institute on Disability and Rehabilitation Research, US Department of Education. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck AT., 1979, COGNITIVE THERAPY DE; Benjamini Y, 2001, ANN STAT, V29, P1165; Bhar SS, 2008, J AFFECT DISORDERS, V110, P161, DOI 10.1016/j.jad.2007.12.227; Buckley TC, 2001, J SUBST ABUSE TREAT, V20, P197, DOI 10.1016/S0740-5472(00)00169-0; Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36; DIMASCIO A, 1979, ARCH GEN PSYCHIAT, V36, P1450; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; GROVE WM, 1992, HDB AFFECTIVE DISORD, P25; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hibbard MR, 1987, COGNITIVE THERAPY AP; HILL CE, 1992, J CONSULT CLIN PSYCH, V60, P73, DOI 10.1037/0022-006X.60.1.73; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.987.899; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; PASSERO S, 1995, PROG NEURO-PSYCHOPH, V19, P627, DOI 10.1016/0278-5846(95)00107-7; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; RUSH AJ, 1981, J AFFECT DISORDERS, V3, P221, DOI 10.1016/0165-0327(81)90024-0; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Siegle GJ, 2012, ARCH GEN PSYCHIAT, V69, P913, DOI 10.1001/archgenpsychiatry.2012.65; Tsaousides T, 2013, BRAIN IMPAIR, V14, P63, DOI 10.1017/BrImp.2013.8; Vanheule S, 2008, ASSESSMENT, V15, P177, DOI 10.1177/1073191107311261; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Vela-Bueno A, 2006, STUD NEUROPSYCH DEV, P163; Warden Diane, 2007, Curr Psychiatry Rep, V9, P449, DOI 10.1007/s11920-007-0061-3; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	34	6	6	0	15	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1758-2008	1758-2016		NEUROPSYCHIATRY-LOND	Neuropsychiatry	DEC	2013	3	6					601	609		10.2217/npy.13.75			9	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	266BW	WOS:000327998300013					2022-02-06	
J	Egea-Guerrero, JJ; Revuelto-Rey, J; Gordillo-Escobar, E; Rodriguez-Rodriguez, A; Enamorado-Enamorado, J; Lopez, ZRD; Aldabo-Pallas, T; Leon-Justel, A; Murillo-Cabezas, F; Vilches-Arenas, A				Egea-Guerrero, J. J.; Revuelto-Rey, J.; Gordillo-Escobar, E.; Rodriguez-Rodriguez, A.; Enamorado-Enamorado, J.; de Azua Lopez, Z. Ruiz; Aldabo-Pallas, T.; Leon-Justel, A.; Murillo-Cabezas, F.; Vilches-Arenas, A.			Serologic Behavior of S100B Protein in Patients Who Are Brain Dead: Preliminary Results	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	13th Congress of the Middle-East-Society-for-Organ-Transplantation (MESOT)	DEC 12-15, 2012	Abu Dhabi, U ARAB EMIRATES	Middle E Soc Organ Transplantat			INJURY	Objective. The objective of this study is to assess the S100B protein serum concentrations from brain dead (BD) donors to understand whether its level could provide clinical information during BD diagnosis as a potential confirmatory test. Methods. During 12 months, 26 patients declared BD were prospectively included in this study. Once the diagnosis of BD was achieved, serum S100B protein levels were measured using an electrochemiluminescence assay. For analytical purposes, we selected the maximum S100B serum value reached during the first 5 days of evolution from a historical cohort of 124 survived patients after a severe brain injury (SBI), as well as from 18 healthy donors (HD) and a subgroup of patients who had severe traumatic brain injuries (TBIs) without extracranial injuries. Results. Mean age was 53.48 years (SD, 18.91 years). The BD group had significantly higher S100B serum levels (1.44 mu g/L; interquartile ratio [IR], 0.63-3.68) than the SBI (0.34 mu g/L; IR, 0.21-0.60) and HD groups (0.06 mu g/L; IR, 0.03-0.07; P < .001). Analysis of S100B levels depending on the main cause responsible for BD development showed significant differences between subgroups (P = .012). S100B serum levels were higher in the isolated TBI BD group (P = .004). The S100B value showed an odds ratio for BD diagnosis of 8.38 (95% confidence interval [CI], 1.16-60.45; P = .035). Reciever operating characteristic analysis revealed an area under the curve of 0.92 (95% CI, 0.79-1.00; P = .007). We set a cut-off value of 2 mu g/L in S100B serum concentrations. At this level, the diagnostic properties of S100B would reach 100% of specificity and positive predictive value (PPV), and sensitivity and negative predictive value (NPV) of 60% and 86.7%, respectively. Conclusion. This preliminary analysis shows for the very first time that BD is associated with higher S100B serum levels, compared with other neurocritical care patients. We also found that the cause of BD development must be considered. Specifically, S100B serum levels in severe isolated TBI patients-with clinical exploration compatible with BD-could be used in a future as confirmatory test.	[Egea-Guerrero, J. J.; Revuelto-Rey, J.; Gordillo-Escobar, E.; Enamorado-Enamorado, J.; de Azua Lopez, Z. Ruiz; Aldabo-Pallas, T.; Murillo-Cabezas, F.] IBIS CSIC Univ Seville, NeuroCrit Care Unit, Virgen del Rocio Univ Hosp, Seville 41013, Spain; [Rodriguez-Rodriguez, A.; Leon-Justel, A.] IBIS CSIC Univ Seville, Dept Clin Biochem, Virgen del Rocio Univ Hosp, Seville 41013, Spain; [Vilches-Arenas, A.] IBIS CSIC Univ Seville, Dept Prevent Med & Publ Hlth, Seville 41013, Spain		Egea-Guerrero, JJ (corresponding author), IBIS CSIC Univ Seville, NeuroCrit Care Unit, Virgen del Rocio Univ Hosp, Avda Manuel Siurot S-N PC, Seville 41013, Spain.	juanjoegea@hotmail.com	Egea-Guerrero, Juan Jose JJ/P-5080-2014; Murillo-Cabezas, Francisco/AAO-3348-2021; Rodriguez-Rodriguez, Ana/F-4718-2016; IBIS, NEUROINMUNO/O-9306-2015; Vilches-Arenas, Angel/C-1167-2015	Egea-Guerrero, Juan Jose JJ/0000-0002-4166-313X; Rodriguez-Rodriguez, Ana/0000-0002-6854-9695; Vilches-Arenas, Angel/0000-0003-2197-3760; Revuelto-Rey, Jaume/0000-0001-8350-9555			Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Egea-Guerrero JJ, 2013, J NEUROTRAUM, V30, P1762, DOI 10.1089/neu.2012.2606; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20	6	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	DEC	2013	45	10					3569	3572		10.1016/j.transproceed.2013.10.021			4	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Immunology; Surgery; Transplantation	270FQ	WOS:000328304700034	24314961				2022-02-06	
J	Honeybul, S; Morrison, DA; Ho, K; Wiggins, A; Janzen, C; Kruger, K				Honeybul, Stephen; Morrison, David Anthony; Ho, Kwok; Wiggins, Anthony; Janzen, Courtney; Kruger, Kate			Complications and consent following decompressive craniectomy: An illustrative case study	BRAIN INJURY			English	Article						Cranioplasty complications; decompressive craniectomy; syndrome of the trephined	INTRACRANIAL HYPERTENSION; AUTOLOGOUS BONE; CRANIOPLASTY	Primary objective: To assess clinical outcome following restoration of cranial contour in a young male who had suffered a severe traumatic brain injury. Research design: Case report. Methods and procedures: A young male was assessed before and after cranial reconstructive surgery with a custom-made titanium plate. The patient had previously required a bifrontal decompressive craniectomy in order to control intractable intracranial hypertension due to neurotrauma. Following an autologous cranioplasty he made very little neurological recovery and remained wheelchair-bound with severe contractures and was only able to follow single stage commands. Over the following 2 years he developed extensive resorption of his bone flap such that it required augmentation. Main outcomes and results: After surgery he clinically improved such that he was able to communicate more effectively and, although he remained severely disabled and fully dependent, he was able to communicate that he would have provided consent for the initial decompressive procedure even if he had known that the eventual outcome would be survival with severe disability and total dependence. Conclusions: Long-term follow-up is required for patients with severe traumatic brain injury not only to assess outcome and complications, but also to assess how acceptable that outcome is for the patient and their families.	[Honeybul, Stephen; Wiggins, Anthony] Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia; [Honeybul, Stephen; Wiggins, Anthony] Royal Perth Hosp, Perth, WA 6001, Australia; [Morrison, David Anthony] Royal Perth Hosp, Dept Med Engn & Phys, Perth, WA 6001, Australia; [Ho, Kwok] Univ Western Australia, Royal Perth Hosp, Dept Intens Care, Perth, WA 6009, Australia; [Ho, Kwok] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Janzen, Courtney; Kruger, Kate] Sir Charles Gairdner Hosp, Dept Occupat Therapy, Perth, WA 6009, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Perth, WA 6009, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004; Morrison, David/0000-0003-1305-035X			Agrawal D, 2005, EUR J CLIN MICROBIOL, V24, P772, DOI 10.1007/s10096-005-0017-7; Cooper P R, 1976, Surg Neurol, V5, P25; Day RE, 2012, BRIT J ORAL MAX SURG, V50, P376, DOI 10.1016/j.bjoms.2011.05.001; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Di Rienzo A, 2008, ACTA NEUROCHIR, V150, P1057, DOI 10.1007/s00701-008-0019-1; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Honeybul S, 2009, J CLIN NEUROSCI, V16, P727, DOI 10.1016/j.jocn.2008.06.015; Honeybul S, 2012, PLAST RECONSTR SURG, V130, P1110, DOI 10.1097/PRS.0b013e318267d4de; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; Puetz V, 2007, LANCET NEUROL, V6, P580, DOI 10.1016/S1474-4422(07)70160-6; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43	20	6	6	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1732	1736		10.3109/02699052.2013.830194			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400034	24087881				2022-02-06	
J	Kurowski, BG; Wade, SL; Kirkwood, MW; Brown, TM; Stancin, T; Taylor, HG				Kurowski, Brad G.; Wade, Shari L.; Kirkwood, Michael W.; Brown, Tanya M.; Stancin, Terry; Taylor, H. Gerry			Behavioral Predictors of Outpatient Mental Health Service Utilization Within 6 Months After Traumatic Brain Injury in Adolescents	PM&R			English	Article							PSYCHIATRIC-DISORDERS; CHILDREN; CARE; ASSOCIATION; SURVIVORS; SCALE; ADULT; NEEDS	Objectives: To characterize utilization of mental health services and determine the ability of a behavior problem and clinical functioning assessment to predict utilization of such services within the first 6 months after moderate and severe traumatic brain injury in a large cohort Of adolescents. Design: Multicenter cross-sectional study. Setting: Outpatient setting of 4 tertiary pediatric hospitals, 2 tertiary general medical centers, and 1 specialized children's hospital. Participants: Adolescents age 12-17 years (n = 132), 1-6 months after moderate-to-severe traumatic brain injury. Methods: Logistic regression was used to determine the association of mental health service utilization with clinical functioning as assessed by the Child and Adolescent Functional Assessment Scale and behavior problems assessed by the Child Behavioral Checklist. Main Outcome Measurement: Mental health service utilization measured by the Service Assessment for Children and Adolescents. Results: Behavioral or functional impairment occurred in 37%-56%. Of the total study population, 24.2% reported receiving outpatient mental health services, 8.3% reported receiving school services, and 28.8% reported receiving any type of mental health service. Use of any (school or outpatient) mental health service was associated with borderline to impaired total Child and Adolescent Functional Assessment Scale (odds ratio 3.50 [95% confidence interval, 1.46-8.40]; P < .01) and the Child Behavioral Checklist Total Competence (odds ratio 5.08 [95% confidence interval, 2.02-12.76]; P < .01). Conclusions: A large proportion of participants had unmet mental health needs. Both the Child and Adolescent Functional Assessment Scale and the Child Behavioral Checklist identified individuals who would likely benefit from mental health services in outpatient or school settings. Future research should focus on methods to ensure early identification by health care providers of adolescents with traumatic brain injury in need of mental health services.	[Kurowski, Brad G.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Kurowski, Brad G.; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Brown, Tanya M.] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Psychiat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Childrens Hosp, Cleveland, OH USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave MLC 4009, Cincinnati, OH 45229 USA.	brad.kurowski@cchmc.org	Stancin, Terry/L-7993-2019		National Institute of Health from the National Institute of Mental Health [R01-MH073764]; Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; NIH/NICHD/NCMRR/AAP [2K12 HD001097-16]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097, K23HD074683] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported in part with National Institute of Health grant R01-MH073764 from the National Institute of Mental Health; a grant from the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; and Rehabilitation Medicine Scientist Training Program K-12 grant 2K12 HD001097-16 (NIH/NICHD/NCMRR/AAP).	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 1991, MANUAL SELF REPORT A; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Chabra A, 1999, WESTERN J MED, V170, P28; Dasarathi M, 2011, CHILD CARE HLTH DEV, V37, P418, DOI 10.1111/j.1365-2214.2010.01199.x; de Haan AM, 2012, ETHNIC HEALTH, V17, P105, DOI 10.1080/13557858.2011.645150; Faul M, 2010, TRAUMATIC BRAIN INJU; Greenspan A I, 1989, Md Med J, V38, P239; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Handwerk ML, 2006, AM J ORTHOPSYCHIAT, V76, P312, DOI 10.1037/0002-9432.76.3.312; Hodges K, 1998, J BEHAV HEALTH SER R, V25, P325, DOI 10.1007/BF02287471; HODGES K, 1999, J CHILD FAM STUD, V8, P109; Hodges K., 1996, J CHILD FAM STUD, V5, P445, DOI [10.1007/BF02233865, DOI 10.1007/BF02233865]; Hodges K., 2005, CAFAS MANUAL TRAININ; Hodges K, 2004, J CHILD FAM STUD, V13, P325, DOI DOI 10.1023/B:JCFS.0000022038.62940.A3; Horwitz SM, 2001, PSYCHIAT SERV, V52, P1088, DOI 10.1176/appi.ps.52.8.1088; Howell E, 2008, J HEALTH CARE POOR U, V19, P237, DOI 10.1353/hpu.2008.0008; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Ouellet MC, 2009, J REHABIL MED, V41, P179, DOI 10.2340/16501977-0306; Peterson RL, 2012, J HEAD TRAUMA REHABI; Reback R, 2010, J POLICY ANAL MANAG, V29, P698, DOI 10.1002/pam.20528; Sareen J, 2007, PSYCHIAT SERV, V58, P357, DOI 10.1176/appi.ps.58.3.357; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Stiffman AR, 2000, J AM ACAD CHILD PSY, V39, P1032, DOI 10.1097/00004583-200008000-00019; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2013, J HEAD TRAUMA REHABI; Walrath C, 2009, ADM POLICY MENT HLTH, V36, P361, DOI 10.1007/s10488-009-0231-1; Zatzick DF, 2011, PSYCHIAT SERV, V62, P264, DOI 10.1176/ps.62.3.pss6203_0264	36	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	DEC	2013	5	12					1026	1034		10.1016/j.pmrj.2013.08.589			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	277CJ	WOS:000328795700005	23973505	Green Accepted			2022-02-06	
J	Luo, P; Yang, YF; Liu, W; Rao, W; Bian, H; Li, X; Chen, T; Liu, MD; Zhao, YB; Dai, SH; Yan, X; Fei, Z				Luo, Peng; Yang, Yuefan; Liu, Wei; Rao, Wei; Bian, Huan; Li, Xin; Chen, Tao; Liu, Mengdong; Zhao, Yongbo; Dai, Shuhui; Yan, Xu; Fei, Zhou			Downregulation of postsynaptic density-95-interacting regulator of spine morphogenesis reduces glutamate-induced excitotoxicity by differentially regulating glutamate receptors in rat cortical neurons	FEBS JOURNAL			English	Article						apoptosis; excitotoxicity; glutamate receptor; postsynaptic density; scaffold protein	TRAUMATIC BRAIN-INJURY; MEDIATED EXCITOTOXICITY; NEUROPROTECTION; CONTRIBUTES; ACTIVATION; PHYSIOLOGY; INHIBITOR; SUBUNIT; RELEASE; DENSITY	Glutamate-induced excitotoxicity is involved in many neurological diseases. Preso, a novel postsynaptic scaffold protein, mediates excitatory synaptic transmission and various synaptic functions. In this study, we investigated the role of Preso in the regulation of glutamate-induced excitotoxicity in rat cortical neurons. Knockdown of Preso with small interfering RNA improved neuronal viability and attenuated the elevation of lactate dehydrogenase (LDH) release after glutamate treatment. Downregulation of Preso also inhibited an increase in the BAX/Bcl-2 ratio and cleavage of caspase-9 and caspase-3. Although the expression and distribution of metabotropic glutamate receptor (mGluR) 1/5, NR1, NR2A and NR2B were not changed by knockdown of Preso, downregulation of Preso protected neurons from glutamate-induced excitotoxicity by inhibiting mGluR and N-methyl-d-aspartate receptor function. However, downregulation of Preso neither affected the expression of GluR1 and GluR2 nor influenced the function of -amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor after glutamate treatment. Furthermore, intracellular Ca2+ was an important downstream effector of Preso in the regulation of excitotoxicity. These results suggest that expression of Preso promotes the induction of excitotoxicity by facilitating different glutamate receptor signaling pathways. Therefore, Preso might be a potential pharmacological target for preventing and treating neurological diseases.	[Luo, Peng; Yang, Yuefan; Liu, Wei; Rao, Wei; Bian, Huan; Chen, Tao; Liu, Mengdong; Zhao, Yongbo; Dai, Shuhui; Yan, Xu; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Li, Xin] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, 15 Changle Xi Rd, Xian 710032, Peoples R China.	zhoufei@fmmu.edu.cn	Yang, Yuefan/AAJ-9136-2020	Luo, Peng/0000-0003-0746-939X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301037, 30930093]; Science and Technology Project of Shaanxi [2012SF2-01-4, 2012SF2-04-4]	This work was supported by National Natural Science Foundation of China (No. 81301037 and No. 30930093) and the Science and Technology Project of Shaanxi (No. 2012SF2-01-4 and No. 2012SF2-04-4).	Castillo CA, 2010, NEUROCHEM RES, V35, P1050, DOI 10.1007/s11064-010-0154-y; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Bell KFS, 2013, J NEUROCHEM, V126, P274, DOI 10.1111/jnc.12176; Brennan-Minnella AM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.111; Brennan-Minnella AM, 2013, CELL DEATH DIS, V4, P1; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Degos V, 2013, ANN NEUROL, V73, P667, DOI 10.1002/ana.23868; Fan J, 2010, J NEUROCHEM, V115, P1045, DOI 10.1111/j.1471-4159.2010.06994.x; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Hilton GD, 2006, EUR J NEUROSCI, V24, P3008, DOI 10.1111/j.1460-9568.2006.05189.x; Hsieh MH, 2012, PHARMACOL BIOCHEM BE, V102, P64, DOI 10.1016/j.pbb.2012.03.022; Hu JH, 2012, NAT NEUROSCI, V15, P836, DOI 10.1038/nn.3103; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Huang G, 2007, J BIOL CHEM, V282, P14283, DOI 10.1074/jbc.M611529200; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lee HW, 2008, J NEUROSCI, V28, P14546, DOI 10.1523/JNEUROSCI.3112-08.2008; Luo P, 2012, FREE RADICAL RES, V46, P766, DOI 10.3109/10715762.2012.678340; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Mo J, 2012, EUR J NEUROSCI, V36, P1960, DOI 10.1111/j.1460-9568.2012.08124.x; Morales I, 2013, EUR J NEUROSCI, V38, P2172, DOI 10.1111/ejn.12205; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Ong WY, 2013, J ALZHEIMERS DIS, V35, P643, DOI 10.3233/JAD-121990; Padanyi R, 2009, BBA-MOL CELL RES, V1793, P1023, DOI 10.1016/j.bbamcr.2008.11.007; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Shen H, 2010, BRIT J PHARMACOL, V161, P127, DOI 10.1111/j.1476-5381.2010.00894.x; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shi ZQ, 2013, P NATL ACAD SCI USA, V110, P3137, DOI 10.1073/pnas.1215501110; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245; Zhou XJ, 2013, J BIOL CHEM, V288, P24151, DOI 10.1074/jbc.M113.482000	36	6	6	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	DEC	2013	280	23					6114	6127		10.1111/febs.12531			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253YO	WOS:000327126300015	24103031	Bronze			2022-02-06	
J	Thaler, NS; Linck, JF; Heyanka, DJ; Pastorek, NJ; Miller, B; Romesser, J; Sim, A; Allen, DN				Thaler, Nicholas S.; Linck, John F.; Heyanka, Daniel J.; Pastorek, Nicholas J.; Miller, Brian; Romesser, Jennifer; Sim, Anita; Allen, Daniel N.			Heterogeneity in Trail Making Test Performance in OEF/OIF/OND Veterans with Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Mild cognitive impairment; Statistical methods; Assessment	SERIAL-ADDITION TASK; METAANALYTIC METHODS; MEMORY; LIMITATIONS; PROFILES; VALIDITY; TBI	This study used cluster analysis to examine variability in Trail Making Test (TMT) performance in a sample of Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) veterans referred for mild traumatic brain injury (mTBI). Three clusters were extracted, two of which were characterized by level of performance and the third with a unique performance pattern characterized by slow performance on the TMT B (Low B). Clusters did not differ on demographic or psychiatric variables. The Above Average cluster had better performance on measures of processing speed, working memory, and phonemic fluency compared with the Low B cluster. Results suggest that a subset of patients with mTBI perform poorly on TMT B, which subsequently predicts poorer cognitive functioning on several other neuropsychological measures. This subset may be vulnerable to cognitive changes in the context of mTBI and multiple comorbidities while a number of other patients remain cognitively unaffected under the same circumstances.	[Thaler, Nicholas S.; Linck, John F.; Heyanka, Daniel J.] Oklahoma City Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; [Pastorek, Nicholas J.; Miller, Brian] Michael E DeBakey Dept Vet Affairs Med Ctr, Houston, TX USA; [Romesser, Jennifer] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA; [Sim, Anita] Minneapolis Dept Vet Affairs Med Ctr, Minneapolis, MN USA; [Allen, Daniel N.] Univ Nevada, Las Vegas, NV 89154 USA		Thaler, NS (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, 760 Westwood Plaza,C8-746, Los Angeles, CA 90095 USA.	nick.thaler@gmail.com		Pastorek, Nicholas/0000-0002-9290-380X; Allen, Daniel/0000-0003-4868-2242	Department of Veterans Affairs, Veterans Health Administration, Office of Research and DevelopmentUS Department of Veterans Affairs [B6812C]	This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; B6812C (PI- Levin HS) VA RR&D Traumatic Brain Injury Center of Excellence, Neurorehabilitation: Neurons to Networks.	Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Allen DN, 2013, CLUSTER ANAL NEUROPS; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Bayliss MS, 2003, QUAL LIFE RES, V12, P953, DOI 10.1023/A:1026167214355; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benton A.L., 1967, CORTEX, V3, P32, DOI [10.1016/s0010-9452(67)80005-4, DOI 10.1016/S0010-9452(67)80005-4]; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Butcher J.N., 2001, MINNESOTA MULTIPHASI; Cross CL., 2013, CLUSTER ANAL NEUROPS, P13; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; Delis D.C., 2000, CALIFORNIA VERBAL LE; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Diehr MC, 2003, J CLIN EXP NEUROPSYC, V25, P571, DOI 10.1076/jcen.25.4.571.13876; Golden CJ., 2002, STROOP COLOR WORD TE; Goldstein G, 2010, BRAIN INJURY, V24, P625, DOI 10.3109/02699051003670882; Green P., 2003, MANUAL WORD MEMORY T; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heled E, 2012, J CLIN EXP NEUROPSYC, V34, P151, DOI 10.1080/13803395.2011.625351; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MALEC JF, 1993, CLIN NEUROPSYCHOL, V7, P48, DOI DOI 10.1080/13854049308401887; MORRIS R, 1981, Journal of Clinical Neuropsychology, V3, P79, DOI 10.1080/01688638108403115; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; Otis JD, 2012, PTSD MILD TRAUMATIC, P105; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Roebuck-Spencer T., 2012, FORENSIC NEUROPSYCHO, P260; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Thaler NS, 2012, ARCH CLIN NEUROPSYCH, V27, P446, DOI 10.1093/arclin/acs042; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilkinson GaryS, 2006, WRAT4 WIDE RANGE ACH; Wolfson, 1993, HALSTEAD REITAN NEUR	50	6	6	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2013	28	8					798	807		10.1093/arclin/act080			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	262FC	WOS:000327718700007	24145667	Bronze			2022-02-06	
J	Wang, CC; Chen, YS; Lin, BS; Chio, CC; Hu, CY; Kuo, JR				Wang, Che-Chuan; Chen, Yuan-Shen; Lin, Bor-Shyh; Chio, Chung-Ching; Hu, Chiao-Ya; Kuo, Jinn-Rung			The neuronal protective effects of local brain cooling at the craniectomy site after lateral fluid percussion injury in a rat model	JOURNAL OF SURGICAL RESEARCH			English	Article						Fluid percussion injury; Local cooling; Craniectomy Brain temperature; Cell apoptosis; Infarction volume; Maximal angle	RANDOMIZED CONTROLLED-TRIAL; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; HEAD-INJURIES; HYPOTHERMIA; TEMPERATURE; MANAGEMENT; MECHANISMS; HEATSTROKE; ISCHEMIA	Background: The aim of the present study is to investigate whether local brain cooling at the craniectomy site causes attenuation of traumatic brain injury (TBI) induced by fluid percussion injury (FPI). Methods: Anesthetized male SpragueeDawley rats were divided into two major treatment groups. Immediately after the onset of fluid percussion TBI, a craniectomy window of 6 x 8 mm was made at the right parietal, and a cold water bag (0 x C-1 x degrees C or 5 x C-6 degrees C) was applied locally for 30 min. Additional groups of rats were used as craniectomy and craniectomy FPI controls. Physiological parameters, such as brain and colonic temperature, mean arterial pressure, and heart rate, were monitored during FPI. Functional motor outcomes were evaluated using the inclined plane test (maximal grasp angle). Cellular infarction volume was calculated using triphenyltetrazolium chloride staining. Apoptosis and neuronal markerepositive cells in the cortex were measured by immunofluorescence staining. All functional and morphologic parameters were assessed 72 h after injury. Results: Compared with the craniectomy + FPI control groups, the groups treated with 5 degrees C-6 degrees C local cold water therapy showed significant attenuation of the FPI-induced motor deficits, weight loss, and cerebral infarction but no effect on colonic temperature. The FPI-induced apoptosis and neuronal loss were also significantly reduced by local cooling. Conclusions: Our results suggest that local cooling with 5 degrees C-6 degrees C cold water therapy may ameliorate TBI in rats by reducing infarction volume, neuronal cell loss, and apoptosis, resulting in improved functional outcome. We propose that the use of local cooling at the craniectomy site after FPI might have clinical benefits in the future. (C) 2013 Elsevier Inc. All rights reserved.	[Wang, Che-Chuan; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Wang, Che-Chuan; Hu, Chiao-Ya; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wang, Che-Chuan] Natl Chiao Tung Univ, Inst Photon Syst, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Dept Child Care, Tainan, Taiwan; [Chen, Yuan-Shen] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Neurosurg, Yunlin, Taiwan; [Lin, Bor-Shyh] Natl Chiao Tung Univ, Inst Imaging & Biomed Photon, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan.	kuojinnrung@gmail.com			Chi-Mei Medical Center, Tainan, Taiwan	The authors thank the Chi-Mei Medical Center, Tainan, Taiwan for their instrumental support. The authors also thank Dr Kao-Chao, Lin for critical comments on the manuscript.	Andrews PJD, 2005, BRIT J ANAESTH, V94, P330, DOI 10.1093/bja/aei025; Cheng H, 2006, ACTA NEUROCHIR, V148, P559, DOI 10.1007/s00701-006-0735-3; Chio CC, 2007, SHOCK, V28, P284, DOI 10.1097/SHK.0b013e3180311e60; Chiu WT, 2010, J NEUROTRAUM, V27, P775, DOI 10.1089/neu.2009.1126; Christian E, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E9; Chuang TJ, 2012, J TRAUMA ACUTE CARE, V73, P1161, DOI 10.1097/TA.0b013e318265d128; Fay T, 1943, RES PUBL ASSOC RES N, V24, P611; Forte LV, 2009, ARQ NEURO-PSIQUIAT, V67, P480, DOI 10.1590/S0004-282X2009000300019; FREI HJ, 1973, ACTA NEUROCHIR, V29, P15, DOI 10.1007/BF01414613; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Hsu SF, 2006, SHOCK, V26, P210, DOI 10.1097/01.shk.0000223124.49265.10; Jiang JY, 2006, J NEUROTRAUM, V23, P1847, DOI 10.1089/neu.2006.23.1847; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; KUCHIWAKI H, 1990, ACT NEUR S, V51, P77; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Kuo JR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/145214; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Kuo JR, 2006, J CLIN NEUROSCI, V13, P218, DOI 10.1016/j.jocn.2005.01.012; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Marion DW, 2006, NEUROSURGERY, V58, P655; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Prandini Mirto Nelso, 2002, Acta Cir. Bras., V17, P232, DOI 10.1590/S0102-86502002000400006; Schneider GH, 2002, ACT NEUR S, V81, P77; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Wei G, 2008, J NEUROTRAUM, V25, P549, DOI 10.1089/neu.2007.0498; Wen YS, 2005, J TRAUMA, V58, P577, DOI 10.1097/01.TA.0000152635.99243.30; Wen YS, 2003, CRIT CARE MED, V31, P2641, DOI 10.1097/01.CCM.0000094229.39473.C1	38	6	6	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2013	185	2					753	762		10.1016/j.jss.2013.07.002			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	251OF	WOS:000326938500064	23938315				2022-02-06	
J	Yi, HS; Kim, HS; Seo, MR				Yi, Ho Sung; Kim, Hyoung Seop; Seo, Mi Ri			Trial of Oral Metoclopramide on Diurnal Bruxism of Brain Injury	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Bruxism; Dopamine receptors; Metoclopramide		Bruxism is a diurnal or nocturnal parafunctional activity that includes tooth clenching, bracing, gnashing, and grinding. The dopaminergic system seems to be the key pathophysiology of bruxism and diminution of dopaminergic transmission at the prefrontal cortex seems to induce it. We report two patients with diurnal bruxism in whom a bilateral frontal lobe injury resulted from hemorrhagic stroke or traumatic brain injury. These patients' bruxism was refractory to bromocriptine but responded to low-dose metoclopramide therapy. We propose that administering low doses of metoclopramide is possibly a sound method for treating bruxism in a brain injury patient with frontal lobe hypoperfusion on positron emission tomography imaging.	[Yi, Ho Sung; Seo, Mi Ri] Yonsei Univ, Coll Med, Dept Rehabil Med, Seoul, South Korea; [Kim, Hyoung Seop] Natl Hlth Insurance Corp Ilsan Hosp, Dept Phys Med & Rehabil, 100 Ilsan Ro, Goyang 410719, South Korea		Kim, HS (corresponding author), Natl Hlth Insurance Corp Ilsan Hosp, Dept Phys Med & Rehabil, 100 Ilsan Ro, Goyang 410719, South Korea.	rekhs@nhimc.or.kr					ALANDER T, 1980, N-S ARCH PHARMACOL, V312, P145, DOI 10.1007/BF00569723; Areso MP, 1999, J DENT RES, V78, P1204, DOI 10.1177/00220345990780060301; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; BANNON MJ, 1983, PHARMACOL REV, V35, P53; BROCKUTNE JG, 1976, ANAESTHESIA, V31, P1186, DOI 10.1111/j.1365-2044.1976.tb11970.x; Chen WH, 2005, J CLIN NEUROSCI, V12, P161, DOI 10.1016/j.jocn.2004.07.007; Lavigne GJ, 2008, J ORAL REHABIL, V35, P476, DOI 10.1111/j.1365-2842.2008.01881.x; Lobbezoo F, 1997, MOVEMENT DISORD, V12, P73, DOI 10.1002/mds.870120113; Seraidarian P, 2009, SLEEP BREATH, V13, P85, DOI 10.1007/s11325-008-0193-7; Winocur E, 2003, J OROFAC PAIN, V17, P99	10	6	6	0	0	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	DEC	2013	37	6					871	874		10.5535/arm.2013.37.6.871			4	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VC6DA	WOS:000433882200013	24466522	gold, Green Published, Green Submitted			2022-02-06	
J	Zgaljardic, DJ; Oden, KE; Dickson, S; Plenger, PM; Lambert, ME; Miller, R				Zgaljardic, Dennis J.; Oden, Kathryn E.; Dickson, Sid; Plenger, Patrick M.; Lambert, Matthew E.; Miller, Rebekah			Naming Test of the Neuropsychological Assessment Battery: Reliability and Validity in a Sample of Patients with Acquired Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Cerebrovascular disease; accident and stroke; Language and language disorders; Assessment; Rehabilitation	EDUCATION	The current study assessed the internal consistency, alternate forms reliability, and convergent/divergent validity of the Naming Test of the Neuropsychological Assessment Battery (NAB) in patients with acquired brain injury. Fifty-nine patients were administered the NAB Naming Test (forms 1 and 2) and the Boston Naming Test (BNT), as well as other tests of neuropsychological functioning. Forms 1 and 2 of the NAB Naming Test demonstrated adequate internal consistency and alternate forms reliability. The NAB Naming Test was significantly associated with scores from the BNT, as well as scores from tests that assess visuospatial skills, semantic fluency, and verbal memory. The divergent validity of the NAB Naming Test was demonstrated by non-significant associations with tests of attention and processing speed. BNT scores correlated significantly with the educational level and estimated premorbid intelligence but not age, whereas the NAB Naming Test scores only correlated significantly with estimated premorbid intelligence. The current study provides independent validation supporting the utility of the NAB Naming Test for patients with acquired brain injury.	[Zgaljardic, Dennis J.] Transit Learning Ctr, Dept Neuropsychol, Galveston, TX 77550 USA; [Zgaljardic, Dennis J.] Univ Texas Med Branch, Dept Rehabil Sci, Sch Hlth Profess, Galveston, TX 77555 USA; [Zgaljardic, Dennis J.] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Oden, Kathryn E.; Dickson, Sid; Plenger, Patrick M.] Pate Rehabil, Dept Neuropsychol, Dallas, TX USA; [Lambert, Matthew E.; Miller, Rebekah] Transit Learning Ctr, Dept Neuropsychol, Lubbock, TX USA		Zgaljardic, DJ (corresponding author), Transit Learning Ctr, Dept Neuropsychol, 1528 PO St, Galveston, TX 77550 USA.	dzgaljardic@tlc-galveston.org			Moody Endowment, Galveston, TX	This work was supported by the Moody Endowment, Galveston, TX.	Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; BENTON AL, 1978, ARCH NEUROL-CHICAGO, V35, P364, DOI 10.1001/archneur.1978.00500300038006; Benton AL, 1994, CONTRIBUTIONS TO NEU; Benton AL, 1994, MULTILINGUAL APHASIA; Blumenfeld H, 2002, NEUROANATOMY THROUGH; Delis D.C., 2000, CALIFORNIA VERBAL LE; Hawkins KA, 2002, APHASIOLOGY, V16, P1143, DOI 10.1080/02687030244000031; Kaplan E., 1978, THE BOSTON NAMING TE; Kaplan E., 2001, THE BOSTON NAMING TE; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Novack T., 2000, THEORIENTATIONLOG; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Ross TP, 1998, CLIN NEUROPSYCHOL, V12, P475, DOI 10.1076/clin.12.4.475.7244; Sachs B. C., 2011, POSTER PRESENTED AT; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; Smith A., 1982, SYMBOL DIGIT MODALIT; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Szatkowska I, 2000, ACTA NEUROBIOL EXP, V60, P503; Wechsler D., 1999, WASI WECHSLER ABBREV; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; White, 2009, NAB NAMING TEST PROF; White T, 2003, NEUROPSYCHOLOGICAL A; Yochim BP, 2009, ARCH CLIN NEUROPSYCH, V24, P575, DOI 10.1093/arclin/acp053; Zec RF, 2007, CLIN NEUROPSYCHOL, V21, P587, DOI 10.1080/13854040701220028; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P27, DOI 10.1080/09084280903297909	30	6	6	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2013	28	8					859	865		10.1093/arclin/act037			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	262FC	WOS:000327718700013	23714104	Bronze			2022-02-06	
J	da Silva, PGC; Correa, CL; de Carvalho, SL; Allodi, S				Chaves da Silva, Paula Grazielle; Correa, Clynton Lourenco; de Carvalho, Sergio Luiz; Allodi, Silvana			The Crustacean Central Nervous System in Focus: Subacute Neurodegeneration Induces a Specific Innate Immune Response	PLOS ONE			English	Article							LONG-TERM SURVIVAL; CRAB UCIDES-CORDATUS; ACUTE INFLAMMATORY RESPONSE; ASCIDIAN STYELA-PLICATA; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; NEURONAL DEGENERATION; SEVERED AXONS; GIANT-AXONS; GLIAL-CELLS	To date nothing is known about the subacute phase of neurodegeneration following injury in invertebrates. Among few clues available are the results published by our group reporting hemocytes and activated glial cells at chronic and acute phases of the lesion. In vertebrates, glial activation and recruitment of immunological cells are crucial events during neurodegeneration. Here, we aimed to study the subacute stage of neurodegeneration in the crab Ucides cordatus, investigating the cellular/molecular strategy employed 48 hours following ablation of the protocerebral tract (PCT). We also explored the expression of nitric oxide (NO) and histamine in the PCT during this phase of neurodegeneration. Three immune cellular features which seem to characterize the subacute phase of neurodegeneration were revealed by: 1) the recruitment of granulocytes and secondarily of hyalinocytes to the lesion site (inducible NO synthase-and histamine-positive cells); 2) the attraction of a larger number of cells than observed in the acute phase; 3) the presence of activated glial cells as shown by the round shaped nuclei and increased expression of glial fibrillary acidic protein. We suggest that molecules released from granulocytes in the acute phase attract the hyalinocytes thus moving the degeneration process to the subacute phase. The importance of our study resides in the characterization of cellular and biochemical strategies peculiar to the subacute stage of the neurodegeneration in invertebrates. Such events are worth studying in crustaceans because in invertebrates this issue may be addressed with less interference from complex strategies resulting from the acquired immune system.	[Chaves da Silva, Paula Grazielle; de Carvalho, Sergio Luiz; Allodi, Silvana] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Neurobiol, BR-21941 Rio De Janeiro, RJ, Brazil; [Chaves da Silva, Paula Grazielle; Allodi, Silvana] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Posgrad Morfol, Rio De Janeiro, RJ, Brazil; [Correa, Clynton Lourenco] Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, RJ, Brazil		Allodi, S (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Neurobiol, BR-21941 Rio De Janeiro, RJ, Brazil.	sallodi@biof.ufrj.br	Allodi, Silvana/G-1781-2012; S, Allodi/AAR-7968-2020	Allodi, Silvana/0000-0002-3053-3866; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [471250/2011-2, 303629/2010-0]	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grants numbers: 471250/2011-2 and 303629/2010-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allodi S, 1999, BRAZ J MED BIOL RES, V32, P327, DOI 10.1590/S0100-879X1999000300013; Allodi S, 1999, INVERTEBR BIOL, V118, P175, DOI 10.2307/3227058; ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169, DOI 10.1016/0306-4522(92)90347-5; ATWOOD HL, 1989, NEUROSCI LETT, V101, P121, DOI 10.1016/0304-3940(89)90517-X; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; BELL MD, 1995, J NEUROCYTOL, V24, P695, DOI 10.1007/BF01179819; BITTNER GD, 1991, TRENDS NEUROSCI, V14, P188, DOI 10.1016/0166-2236(91)90104-3; BITTNER GD, 1988, AM ZOOL, V28, P1165; Bittner GD, 2000, NEUROSCIENTIST, V6; BLUNDON JA, 1990, J COMP NEUROL, V297, P377, DOI 10.1002/cne.902970305; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chaves-Da-Silva PG, 2010, CELL TISSUE RES, V342, P179, DOI 10.1007/s00441-010-1045-x; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clatworthy AL, 1999, J EXP BIOL, V202, P623; Cochennec-Laureau N, 2003, J INVERTEBR PATHOL, V83, P23, DOI 10.1016/S0022-2011(03)00015-6; Correa CL, 2005, BRAIN BEHAV EVOLUT, V66, P145, DOI 10.1159/000087155; Crivellato E, 2010, BIOL REV, V85, P347, DOI 10.1111/j.1469-185X.2009.00105.x; de Barros CM, 2007, J BIOL CHEM, V282, P1615, DOI 10.1074/jbc.M604056200; de Barros CM, 2009, CELL TISSUE RES, V338, P117, DOI 10.1007/s00441-009-0851-5; Esposito P, 2002, J PHARMACOL EXP THER, V303, P1061, DOI 10.1124/jpet.102.038497; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fernandez-Novoa L, 2001, BEHAV BRAIN RES, V124, P213, DOI 10.1016/S0166-4328(01)00215-7; Ferstl R, 2012, FRONT BIOSCI-LANDMRK, V17, P40, DOI 10.2741/3914; GHIRETTIMAGALDI A, 1977, CELL DIFFER DEV, V6, P167, DOI 10.1016/0045-6039(77)90014-8; GOVIND CK, 1992, J COMP NEUROL, V322, P111, DOI 10.1002/cne.903220109; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Ibiza S., 2008, INMUNOLOGIA, V27, P103, DOI [10.1016/S0213-9626(08)70058-1, DOI 10.1016/S0213-9626(08)70058-1]; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Kapadia M, 2011, PROG NEUROBIOL, V95, P301, DOI 10.1016/j.pneurobio.2011.08.008; Kroncke KD, 1997, NITRIC OXIDE-BIOL CH, V1, P107, DOI 10.1006/niox.1997.0118; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; LIEBERMAN EM, 1994, PROG NEUROBIOL, V44, P333, DOI 10.1016/0301-0082(94)90032-9; Lockwood APM, 1961, COMP BIOCH PHYSL, V2; Majumdar A, 2008, NEUROBIOL AGING, V29, P707, DOI 10.1016/j.neurobiolaging.2006.12.001; Mde F. Rebelo, 2013, PLOS ONE, V8; Parnas I, 1998, J EXP BIOL, V201, P779; RADOMSKI MW, 1991, CANCER RES, V51, P6073; Raivich G, 1998, J NEUROSCI, V18, P5804; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Saha S, 2011, INDIAN J FUNDAMENTAL, V1; SHELLER RA, 1991, NEUROSCI LETT, V133, P113, DOI 10.1016/0304-3940(91)90070-A; SMITH VJ, 1983, CELL TISSUE RES, V233, P295; Soares HD, 1995, J NEUROSCI, V15, P8223; Soderhall K, 1986, CELL TISSUE RES, V245; TANNER SL, 1995, J NEUROSCI, V15, P540; THORNQVIST PO, 1994, DEV COMP IMMUNOL, V18, P3, DOI 10.1016/0145-305X(94)90247-X; Waller A, 1850, PHIL T R SOC LOND, V140; Wilhelm M, 2000, ENDOCRINOLOGY, V141, P1178, DOI 10.1210/en.141.3.1178; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Zhang ZF, 2006, FISH SHELLFISH IMMUN, V21, P159, DOI 10.1016/j.fsi.2005.11.003; [No title captured]	53	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80896	10.1371/journal.pone.0080896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	WOS:000327313100125		Green Published, gold, Green Submitted			2022-02-06	
J	Damkliang, J; Considine, J; Kent, B				Damkliang, Jintana; Considine, Julie; Kent, Bridie			Thai emergency nurses' management of patients with severe traumatic brain injury: Comparison of knowledge and clinical management with best available evidence	AUSTRALASIAN EMERGENCY NURSING JOURNAL			English	Article						Brain injury; Emergency nursing; Trauma; Neurotrauma; Evidence-based practice; Thailand		Background: In Thailand, the rate of TBI-related hospitalisation is increasing, however, little is known about the evidence-based management of severe TBI in the developing world. The aim of this study was to explore Thai emergency nurses' management of patients with severe TBI. Methods: An exploratory descriptive mixed method design was used to conduct this two stage study: survey methods were used to examine emergency nurses' knowledge regarding management of patients with severe TBI (Stage 1) and observational methods were used to examine emergency nurses' clinical management of patients with severe TBI (Stage 2). The study setting was the emergency department (ED) at a regional hospital in Southern Thailand. Results: 34 nurses participated in Stage 1 (response rate 91.9%) and the number of correct responses ranged from 33.3% to 95.2%. In Stage 2, a total of 160 points of measurement were observed in 20 patients with severe TBI over 40 h. In this study there were five major areas identified for the improvement of care of patients with severe TBI: (i) end-tidal carbon dioxide (ETCO2) monitoring and targets; (ii) use of analgesia and sedation; (iii) patient positioning; (iv) frequency of nursing assessment; and (v) dose of Mannitol diuretic. Conclusions: There is variation in Thai nurses' knowledge and care practices for patients with severe TBI. To increase consistency of evidence-based TBI care in the Thai context, a knowledge translation intervention that is ecologically valid, appropriate to the Thai healthcare context and acceptable to the multidisciplinary care team is needed. (C) 2013 College of Emergency Nursing Australasia Ltd. Published by Elsevier Ltd. All rights reserved.	[Damkliang, Jintana] Deakin Univ, Sch Nursing & Midwifery, 221 Burwood Hwy, Burwood, Vic 3125, Australia; [Damkliang, Jintana] Prince Songkla Univ, Fac Nursing, Hat Yai, Thailand; [Considine, Julie] Deakin Univ, Nursing & Midwifery Res Ctr, Eastern Hlth, Geelong, Vic, Australia; [Considine, Julie] Ctr Qual & Patient Safety Res, Geelong, Vic, Australia; [Kent, Bridie] Univ Plymouth, Plymouth, Devon, England		Damkliang, J (corresponding author), Deakin Univ, Sch Nursing & Midwifery, 221 Burwood Hwy, Burwood, Vic 3125, Australia.	jdamklia@deakin.edu.au; julie.considine@deakin.edu.au; brigid.kent@plymouth.ac.uk		Considine, Julie/0000-0003-3801-2456	Faculty of Nursing, Prince of Songkla University, Thailand	This study is an unfunded PhD study. Ms Damkliang is supported by a scholarship from Faculty of Nursing, Prince of Songkla University, Thailand.	[Anonymous], 2011, HLTH STATUS INFORM; [Anonymous], 2007, EMERG MED J, V24, P25; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brain Trauma Foundation, 2007, GUID PREH MAN TRAUM; Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; Bureau of Epidemiology [BOE], 2011, MIN PUBL HLTH THAIL; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; Douglas B, 2011, EMERGENCY TRAUMA CAR, P1169; Faul M, 2010, TRAUMATIC BRAIN INJU; Mittal R, 2009, EMERG MED J, V26, P513, DOI 10.1136/emj.2009.072041; National Institute for Emergency Medicine, 2011, STAT EM MED SERV; NICE, 2007, HEAD INJ TRIAG ASS I; NZGG, 2006, TRAUM BRAIN INJ DIAG; O'Phelan K, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P3; Price Ann M, 2003, Nurs Crit Care, V8, P126, DOI 10.1046/j.1478-5153.2003.00019.x; Reed D, 2011, ADULT TRAUMA CLIN PR; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; SIGN, 2009, EARL MAN PAT HEAD IN; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vickery D, 2001, EMERG MED J, V18, P51, DOI 10.1136/emj.18.1.51; Waltz CF, 2010, MEASUREMENT NURSING, V4th; Winter CD, 2005, SURG-J R COLL SURG E, V3, P329, DOI 10.1016/S1479-666X(05)80112-X; Wong F W, 2000, Crit Care Nurse, V20, P18	23	6	6	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1574-6267			AUSTRALAS EMERG NURS	Australas. Emerg. Nurs. J.	NOV	2013	16	4					127	135		10.1016/j.aenj.2013.09.001			9	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V16QK	WOS:000214630500002	24199897				2022-02-06	
J	Perroux, M; Lefebvre, H; Levert, MJ; Malo, D				Perroux, Melanie; Lefebvre, Helene; Levert, Marie-Josee; Malo, Denise			Perceived needs and social participation of people with mild traumatic brain injury	SANTE PUBLIQUE			French	Article						Social participation; Mild traumatic brain injury; Personalized support	COMMUNITY INTEGRATION; REHABILITATION	Introduction: Only limited data are available concerning the perception of quality of life and social participation of people with mild Traumatic Brain Injury (mTBI). The APIC personalized community integration support programme encourages people with TBI to achieve significant daily living or leisure activities. Objectives: To explore the social participation needs and expectations of people with mTBI Methods: 1) Qualitative multiple-case study; 2) Questionnaires based on Assessment of Activities of Daily Living Profile, Leisure Profile and Life Habits in the form of semi-structured interviews. Results: Participants reported deterioration of their quality of life after the accident, especially affecting leisure activities and social role. They would like to have someone to help reduce their loneliness, reassure them and motivate them to start changing their lives. Discussion: Unlike the main interventions provided by the social welfare and healthcare system and relatives, people with mTBI express the need for reassuring activities in public places to help them regain their social role and accept their new identity.	[Perroux, Melanie; Lefebvre, Helene; Levert, Marie-Josee; Malo, Denise] Ctr Rech Interdisciplinaire Readaptat CRIR Montre, Ctr Readaptat Lucie Bruneau, Montreal, PQ H2R 1Z3, Canada		Perroux, M (corresponding author), Ctr Rech Interdisciplinaire Readaptat CRIR Montre, Ctr Readaptat Lucie Bruneau, 2275 Ave Laurier Est, Montreal, PQ H2R 1Z3, Canada.	perrouxmelanie@gmail.com					American Psychiatric Association, 2003, DSM 4 T MAN DIAGN ST; Auxemery Y, 2011, ENCEPHALE, V39, P329; BANVILLE F, 2008, EPIDEMIE SILENCIEUSE; Banville F, 2008, EPIDEMIE SILENCIEUSE, P93; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Corbin J. M., 2007, BASICS QUALITATIVE R; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dumont C, 2005, REV CANADIENNE ERGOT, V72, P222; Dumont Claire, 2007, Can J Occup Ther, V74, P48; Dutil E, 2005, PROFIL AVQ DESCRIPTI; DUTIL E, 1996, REV QUEBECOISE ERGOT, V5, P112; Dutil Elisabeth, 2007, Can J Occup Ther, V74, P326; Fayol P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P497, DOI 10.1016/j.annrmp.2008.06.003; Gadoury M, 2001, CADRE REFERENCE CLIN; Gagne M, 2012, EVOLUTION HOSPITALIS; GIRAUD-BARO E, 2006, INFORM PSYCHIAT, V82, P281; Glasser B., 1967, DISCOVERY GROUNDED T; Guerin F, 2005, PUBLICATION CRIR, V2, P155; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; ICIS, 2007, FARD MAL TROUBL TRAU; Khelia I, 2011, DEV HUMAIN HANDICAP, V19, P103; Kielhofner G, 2004, CONCEPTUAL FDN OCCUP; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Lamontagne M, 2006, PROBLEMATIQUE HEBERG; Lawton CA, 1996, J ENVIRON PSYCHOL, V16, P137, DOI 10.1006/jevp.1996.0011; Lefebvre H, 2010, MODELES PRATIQUES ED, P18; Lefebvre H, 2006, J READAPTATION MED, V26, P53; Lefebvre H., 2007, INTERVENTION, V127, P99; Lefebvre H, 2010, INTERVENTION PERSONN; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McColl MA, 2007, BRAIN IMPAIR, V8, P238, DOI DOI 10.1375/BRIM.8.3.238; McKerral M, 2005, J REHABIL MED, V37, P61, DOI 10.1080/16501970510026647; Ministere de la sante et des services sociaux du Quebec & Societe d'assurance automobile du Quebec, 2005, OR MIN TRAUM CRAN LE; Organisation Mondiale de la Sante, 1993, DESCR CLIN DIR DIAGN; Pepin M, 2008, EPIDEMIE SILENCIEUSE, P27; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Proulx J, 2006, SERVICES PERSONNES A; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strauss A., 1990, BASICS QUALITATIVE R; TOCHON Francois V., 1996, REV SCI ED, V22, P467, DOI DOI 10.7202/031889AR; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	45	6	6	0	9	SOC FRANCAISE SANTE PUBLIQUE	VANDOEUVRE-LES-NANCY CEDEX	2 RUE DU DOYEN JACQUES PARISOT, BP 7, VANDOEUVRE-LES-NANCY CEDEX, 54501, FRANCE	0995-3914	2104-3841		SANTE PUBLIQUE	Sante Publique	NOV-DEC	2013	25	6					719	728		10.3917/spub.136.0719			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	AA2EQ	WOS:000330908300003	24451417				2022-02-06	
J	Takahashi, EA; Moran, SE; Hayashi, MS; Inouye, DS; Takanishi, DM; Yu, MH				Takahashi, Edwin A.; Moran, Sharon E.; Hayashi, Michael S.; Inouye, David S.; Takanishi, Danny M., Jr.; Yu, Mihae			Brain-type natriuretic peptide and right ventricular end-diastolic volume index measurements are imprecise estimates of circulating blood volume in critically ill subjects	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						BNP; RVEDVI; blood volume	PULMONARY-ARTERY CATHETER; FLUID RESUSCITATION; PERFORMANCE; DIAGNOSIS; PRELOAD; VALUES; BNP	BACKGROUND: Surrogate indicators have often been used to estimate intravascular volume to guide fluid management. Brain-type natriuretic peptide (BNP) has been used as a noninvasive adjunct in the diagnosis of fluid overload and as a marker of response to therapy, especially in individuals with congestive heart failure. Similarly, right ventricular end-diastolic volume index (RVEDVI) measurements represent another parameter used to guide fluid resuscitation. The aim of this study was to evaluate whether BNP and RVEDVI are clinically valuable parameters that can distinguish among hypovolemia, euvolemia, and hypervolemia, as measured by blood volume (BV) analysis in critically ill surgical subjects. METHODS: This observational study was part of a prospective, randomized controlled trial. Subjects with pulmonary artery catheters for the treatment of traumatic injuries, severe sepsis/septic shock, cardiovascular collapse, adult respiratory distress syndrome, and postsurgical care were studied. Circulating BV was measured by a radioisotope dilution technique using the BVA-100 Analyzer (Daxor Corporation, New York, NY) within the first 24 hours of acute resuscitation. BV results were reported as percent deviation from the patient's ideal BV based on height and percent deviation from optimum weight. Hypovolemia was defined as less than 0%, euvolemia was defined as 0% to + 16%, and hypervolemia was defined as greater than + 16% deviation from ideal BV. RVEDVI was measured by continuous cardiac output pulmonary artery catheters (Edwards Lifesciences, Irvine, CA). BNP and RVEDVI measurements obtained with BV analysis were evaluated with Fisher's exact test and regression analysis. RESULTS: In 81 subjects, there was no difference in BV status between those with BNP of 500 pg/mL or greater and BNP of less than 500 pg/mL (p = 0.82) or in those with RVEDVI of 140 mL/m(2) or greater and RVEDVI of less than 140 mL/m(2) (p = 0.43). No linear relationship existed between BV and these parameters. CONCLUSION: In critically ill surgical patients, BNP and RVEDVI were not associated with intravascular volume status, although they may be useful as indices that reflect increased cardiac preload. (J Trauma Acute Care Surg. 2013;75:813-818. Copyright (C) 2013 by Lippincott Williams & Wilkins)	Univ Hawaii, Dept Surg, John A Burns Sch Med, Honolulu, HI 96813 USA; Queens Med Ctr, Honolulu, HI USA		Yu, MH (corresponding author), Univ Hawaii, Dept Surg, 1356 Lusitana St,6th Floor, Honolulu, HI 96813 USA.	mihaey@hawaii.edu	Takahashi, Edwin/J-2760-2019	Takahashi, Edwin/0000-0002-8019-3337; Hayashi, Michael/0000-0001-9743-4945			ALEXANDER J K, 1962, Cardiovasc Res Cent Bull, V1, P39; Alrawi SJ, 2002, SAUDI MED J, V23, P1367; Chircop Robert, 2006, Emerg Med Australas, V18, P170, DOI 10.1111/j.1742-6723.2006.00825.x; Christenson RH, 2008, CLIN CHEM LAB MED, V46, P1524, DOI 10.1515/CCLM.2008.294; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; DIEBEL LN, 1992, ARCH SURG-CHICAGO, V127, P817; FELDSCHUH J, 1977, CIRCULATION, V56, P605, DOI 10.1161/01.CIR.56.4.605; Feldschuh J, 2007, AM J MED SCI, V334, P41, DOI 10.1097/MAJ.0b013e318063c707; Fouad-Tarazi F, 2007, AM J MED SCI, V334, P53, DOI 10.1097/MAJ.0b013e318063c6f7; Friese RS, 2007, J TRAUMA, V62, P1346, DOI 10.1097/TA.0b013e31804798c3; Goetze JP, 2003, FASEB J, V17, P1105, DOI 10.1096/fj.02-0796fje; Ikonomidis I, 2010, SHOCK, V33, P141, DOI 10.1097/SHK.0b013e3181ad31f8; James KB, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.07.031; Jason P, 2005, CRIT CARE MED, V33, P2094, DOI 10.1097/01.CCM.0000178351.03327.9F; Jones JG, 2000, BRIT J ANAESTH, V84, P226, DOI 10.1093/oxfordjournals.bja.a013407; Katz SD, 2007, AM J MED SCI, V334, P47, DOI 10.1097/MAJ.0b013e3180ca8c41; Kumar A, 2004, CRIT CARE MED, V32, P691, DOI 10.1097/01.CCM.0000114996.68110.C9; Leeper Barbara, 2003, AACN Clin Issues, V14, P208, DOI 10.1097/00044067-200305000-00010; Lobo SM, 2013, CURR OPIN CRIT CARE, V19, P346, DOI 10.1097/MCC.0b013e3283632ef1; Manzone TA, 2007, J NUCL MED TECHNOL, V35, P55, DOI 10.2967/jnmt.106.035972; Nelson LD, 2001, CRIT CARE MED, V29, P940, DOI 10.1097/00003246-200105000-00006; Omland Torbjorn, 2008, Crit Care Med, V36, pS17, DOI 10.1097/01.CCM.0000296266.74913.85; Pinsky MR, 2003, ANESTH ANALG, V96, P1245, DOI 10.1213/01.ANE.0000055821.40075.38; Rajaram SS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003408.pub3; REUSE C, 1990, CHEST, V98, P1450, DOI 10.1378/chest.98.6.1450; Sabatine MS, 2004, J AM COLL CARDIOL, V44, P1988, DOI 10.1016/j.jacc.2004.07.057; Safcsak K, 1999, AACN Clin Issues, V10, P22, DOI 10.1097/00044067-199902000-00003; SIBBALD WJ, 1986, CRIT CARE MED, V14, P852, DOI 10.1097/00003246-198610000-00003; Takanishi DM, 2008, ANESTH ANALG, V106, P1808, DOI 10.1213/ane.0b013e3181731d7c; Takanishi DM, 2009, AM J SURG, V197, P232, DOI 10.1016/j.amjsurg.2008.01.016; Tchorz KM, 2012, J TRAUMA ACUTE CARE, V72, P852, DOI 10.1097/TA.0b013e31824b1764; Vincent JL, 2008, CRIT CARE MED, V36, P3093, DOI 10.1097/CCM.0b013e31818c10c7; Vincent JL, 2012, J CLIN MONIT COMPUT, V26, P341, DOI 10.1007/s10877-012-9389-2; WEINSTEIN PD, 1992, CRIT CARE CLIN, V8, P439, DOI 10.1016/S0749-0704(18)30259-8; YU MH, 1995, CRIT CARE MED, V23, P681, DOI 10.1097/00003246-199504000-00016; Yu MH, 2011, SHOCK, V35, P220, DOI 10.1097/SHK.0b013e3181fc9178	37	6	10	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2013	75	5					813	818		10.1097/TA.0b013e3182a85f3a			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	300IP	WOS:000330457900009	24158199				2022-02-06	
J	Kim, YW				Kim, Yong-Wook			Clinical Usefulness of the Pendulum Test Using a NK Table to Measure the Spasticity of Patients with Brain Lesions	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						NK table; Pendulum test; Spasticity	ELECTRICAL-STIMULATION; CEREBRAL-PALSY; STROKE; RELIABILITY; MANAGEMENT; CHILDREN	[Purpose] The purpose of the present study was to investigate the clinical usefulness (reliability and validity) of the pendulum test using a Noland-Kuckhoff (NK) table with an attached electrogoniometer to measure the spasticity of patients with brain lesions. [Subjects] The subjects were 31 patients with stroke or traumatic brain injury. [Methods] The intraclass correlation coefficient (ICC) was used to verify the test-retest reliability of spasticity measures obtained using the pendulum test. Pearson's product correlation coefficient was used to examine the validity of the pendulum test using the amplitude of the patellar tendon reflex (PTR) test, an objective and quantitative measure of spasticity. [Results] The test-retest reliability was high, reflecting a significant correlation between the test and the retest (ICCs = 0.95-0.97). A significant negative correlation was found between the amplitude of the PTR test and the four variables measured in the pendulum test (r = -0.77--0.85). [Conclusion] The pendulum test using a NK table is an objective measure of spasticity and can be used in the clinical setting in place of more expensive and complicated equipment. Further studies are needed to investigate the therapeutic effect of this method on spasticity.	Jeonju Univ, Dept Phys Therapy, Coll Alternat Med, Jeonju 560759, Jeonbuk Do, South Korea		Kim, YW (corresponding author), Jeonju Univ, Dept Phys Therapy, Coll Alternat Med, 303 Cheonjam Ro, Jeonju 560759, Jeonbuk Do, South Korea.	ptkim@jj.ac.kr		Kim, Yongwook/0000-0002-0311-9766			Ada L, 2003, ARCH PHYS MED REHAB, V84, P1486, DOI 10.1016/S0003-9993(03)00349-6; [Anonymous], 2002, MP150 SYST GUID; BAJD T, 1982, J BIOMED ENG, V4, P90, DOI 10.1016/0141-5425(82)90067-X; BAJD T, 1984, J BIOMED ENG, V6, P9, DOI 10.1016/0141-5425(84)90003-7; Barnes Michael P., 2001, Age and Ageing, V30, P13; Barnes MP, 1998, AGE AGEING, V27, P239, DOI 10.1093/ageing/27.2.239; Bohannon RW, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-30; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BOHANNON RW, 1987, PHYS THER, V67, P659, DOI 10.1093/ptj/67.5.659; BOTTE MJ, 1989, J HAND SURG-AM, V14, P174, DOI 10.1016/0363-5023(89)90002-6; BROWN RA, 1988, J NEUROL NEUROSUR PS, V51, P1178, DOI 10.1136/jnnp.51.9.1178; Daly J J, 1996, IEEE Trans Rehabil Eng, V4, P218, DOI 10.1109/86.547922; Fowler EG, 2000, DEV MED CHILD NEUROL, V42, P182; Haas B. M., 1995, PHYSIOTHERAPY, V81, P474; Kumar RTS, 2006, AGE AGEING, V35, P371, DOI 10.1093/ageing/afj084; Kuruoglu R, 1993, Electromyogr Clin Neurophysiol, V33, P347; Lance J.W., 1980, SPASTICITY DISORDERE, P485; Pease WS, 1998, AM J PHYS MED REHAB, V77, P351, DOI 10.1097/00002060-199807000-00021; Peltonen M, 1998, STROKE, V29, P1358, DOI 10.1161/01.STR.29.7.1358; Sheean G, 2001, UPPER MOTOR NEURONE SYNDROME AND SPASTICITY, P12; Smith AW, 2000, ARCH PHYS MED REHAB, V81, P1428, DOI 10.1053/apmr.2000.9399; Sommerfeld DK, 2012, AM J PHYS MED REHAB, V91, P814, DOI 10.1097/PHM.0b013e31825f13a3; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; STILLMAN B, 1995, ARCH PHYS MED REHAB, V76, P166, DOI 10.1016/S0003-9993(95)80026-3; Syczewska M, 2009, J NEUROSCI METH, V178, P340, DOI 10.1016/j.jneumeth.2008.12.031; White H, 2007, GAIT POSTURE, V26, P97, DOI 10.1016/j.gaitpost.2006.07.012	26	6	6	0	2	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	OCT	2013	25	10					1279	1283					5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	246QU	WOS:000326555000017	24259775	Green Submitted, Bronze, Green Published			2022-02-06	
J	Lin, MY; Davis, JV; Wong, DT				Lin, Mayin; Davis, Joseph Vivian; Wong, David T.			Evaluation of Heparin Prophylaxis Protocol on Deep Venous Thrombosis and Pulmonary Embolism in Traumatic Brain Injury	AMERICAN SURGEON			English	Article							THROMBOEMBOLISM	There is currently no accepted standard for deep venous thrombosis (DVT) and pulmonary embolism (PE) prophylaxis in patients with traumatic brain injury (TBI). The objective of our study was to evaluate the effects of implementing a subcutaneous heparin prophylaxis protocol for patients with TBI that began in our hospital as of June 2009. In our retrospective cohort study, we examined 3812 TBI records between January 2007 and December 2011. A significant reduction in the risk of DVT/PE development was not demonstrated by comparing DVT and PE incidences before and after protocol implementation. A clear trend between heparin use and DVT occurrence could not be determined from a review of TBI records after June 2009. The use of heparin after initiation of our protocol among operative TBI cases without intracranial hemorrhage (ICH) based on admission head computed tomography was 58 per cent. ICH complication from heparin prophylaxis was 10.6 per cent for patients with TBI with ICH on admission (five of 47 cases) compared with 0.7 per cent for those without ICH on admission (four of 535 cases).	[Lin, Mayin] Western Univ Hlth Sci, Colton, CA USA; [Lin, Mayin; Davis, Joseph Vivian; Wong, David T.] Arrowhead Reg Med Ctr, Dept Gen Surg, Colton, CA 92324 USA		Wong, DT (corresponding author), Arrowhead Reg Med Ctr, Dept Gen Surg, 2285 Cartier Circle, Colton, CA 92324 USA.	davewo@msn.com	Wong, David/AAQ-5520-2021	Wong, David/0000-0003-4586-6134			Couldwell WT., 2004, NEUROSURG FOCUS, V17, P1, DOI [10.3171/foc.2004.17.4.1, DOI 10.3171/F0C.2004.17.4.1]; DALEN JE, 1986, CHEST, V89, pS370, DOI 10.1378/chest.89.5.370S; Danish Shabbar F, 2004, Neurosurg Focus, V17, pE2; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Pathak A, 2005, Neurol India, V53, P178	8	6	9	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	OCT	2013	79	10					1050	1053					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AI6EQ	WOS:000336964300019	24160797				2022-02-06	
J	Namdari, S; Baldwin, K; Horneff, JG; Keenan, MA				Namdari, Surena; Baldwin, Keith; Horneff, John G.; Keenan, Mary Ann			Orthopedic Evaluation and Surgical Treatment of the Spastic Shoulder	ORTHOPEDIC CLINICS OF NORTH AMERICA			English	Article						Spastic shoulder; Orthopedic evaluation; Surgical treatment; Brain injury	TRAUMATIC BRAIN-INJURY; BOTULINUM TOXIN; STROKE; PAIN; SUBLUXATION; PATHOPHYSIOLOGY; DISABILITY; HEMIPLEGIA; REDUCTION; OUTCOMES	The spastic shoulder can often result from brain injury that causes disruption in the upper motor neuron inhibitory pathways. Patients develop dyssynergic muscle activation, muscle weakness, and contractures and often present with fixed adduction and internal rotation deformity to the limb. This article reviews the importance of a comprehensive preoperative evaluation and discusses appropriate treatment strategies based on preoperative evaluation.	[Namdari, Surena] Thomas Jefferson Univ Hosp, Rothman Inst, Philadelphia, PA 19107 USA; [Baldwin, Keith; Horneff, John G.; Keenan, Mary Ann] Hosp Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA		Namdari, S (corresponding author), Thomas Jefferson Univ Hosp, Rothman Inst, 925 Chestnut St,5th Floor, Philadelphia, PA 19107 USA.	surena.namdari@gmail.com	Keenan, Mary Ann/ABB-1551-2020				[Anonymous], 2012, INJ PREV CONTR TRAUM; Anson CA, 1996, INT J REHABIL RES, V19, P55, DOI 10.1097/00004356-199603000-00006; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Bhakta BB, 1996, J NEUROL NEUROSUR PS, V61, P30, DOI 10.1136/jnnp.61.1.30; BLOOM MH, 1967, J BONE JOINT SURG AM, VA 49, P943, DOI 10.2106/00004623-196749050-00011; BOTTE MJ, 1988, J HAND SURG-AM, V13A, P147, DOI 10.1016/0363-5023(88)90220-1; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; Braun RM, 1999, CLIN ORTHOP RELAT R, P54; Chantraine A, 1999, ARCH PHYS MED REHAB, V80, P328, DOI 10.1016/S0003-9993(99)90146-6; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Epstein O, 2008, CLIN EXAMINATION, P439; Esquenazi A, 2013, TOXICON, V67, P115, DOI 10.1016/j.toxicon.2012.11.025; FAGHRI PD, 1994, ARCH PHYS MED REHAB, V75, P73; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Hattrup Steven J, 2007, J Shoulder Elbow Surg, V16, pe5, DOI 10.1016/j.jse.2006.08.009; HECHT JS, 1992, ARCH PHYS MED REHAB, V73, P1036; Kheder Ammar, 2012, Pract Neurol, V12, P289, DOI 10.1136/practneurol-2011-000155; Kobayashi H, 1999, J ELECTROMYOGR KINES, V9, P327, DOI 10.1016/S1050-6411(99)00008-5; Logan LR, 2011, TOP STROKE REHABIL, V18, P203, DOI 10.1310/tsr1803-203; Mailis A, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002918; Marciniak CM, 2012, AM J PHYS MED REHAB, V91, P1007, DOI 10.1097/PHM.0b013e31826ecb02; Namdari S, 2011, JBJS ESSENTIAL SURG, V01, P1; Namdari S, 2012, J SHOULDER ELB SURG, V21, P691, DOI 10.1016/j.jse.2011.03.026; Namdari Surena, 2011, J Bone Joint Surg Am, V93, pe1401, DOI 10.2106/JBJS.K.00201; Namdari S, 2011, J SHOULDER ELB SURG, V20, P802, DOI 10.1016/j.jse.2010.10.023; Namdari S, 2010, J BONE JOINT SURG AM, V92A, P2589, DOI 10.2106/JBJS.I.01390; Nielsen JB, 2007, ACTA PHYSIOL, V189, P171, DOI 10.1111/j.1748-1716.2006.01652.x; PILL SG, 2008, SPASTICITY OTHER FOR, P119; Posteraro F, 2010, J REHABIL MED, V42, P279, DOI 10.2340/16501977-0500; Stroke, 2012, STROK; Tafti MA, 2008, J AM ACAD ORTHOP SUR, V16, P462, DOI 10.5435/00124635-200808000-00005; Wedekind C, 2005, BRAIN INJURY, V19, P681, DOI 10.1080/02699050400025182; WILLIAMS R, 1988, PHYS THER, V68, P1209	33	6	6	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0030-5898	1558-1373		ORTHOP CLIN N AM	Orthop. Clin. North Am.	OCT	2013	44	4					605	+		10.1016/j.ocl.2013.06.012			11	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	242BB	WOS:000326211300018	24095075				2022-02-06	
J	Pachalska, M; Pronina, MV; Manko, G; Chantsoulis, M; Mirski, A; Kaczmarek, B; Luckos, M; Kropotov, JD				Pachalska, Maria; Pronina, Marina V.; Manko, Grzegorz; Chantsoulis, Marzena; Mirski, Andrzej; Kaczmarek, Bozydar; Luckos, Maria; Kropotov, Juri D.			EVALUATION OF NEUROTHERAPY PROGRAM FOR A PATIENT WITH CLINICAL SYMPTOMS OF SCHIZOPHRENIA AND SEVERE TBI USING EVENT-RELATED POTENTIALS	ACTA NEUROPSYCHOLOGICA			English	Article						hallucinations; perseveration; neuropsychological rehabilitation; art therapy; traumatic brain injury; ERPs	RELIABILITY; ASYMMETRY	Background: Despite recent interest in the brain/mind problem and the possible organic correlates of mental disease, relatively few case studies have examined the problem concretely. This article examines the effectiveness of neurotherapy for a 68-year-old male schizophrenic patient whose psychotic symptoms displayed qualitative and quantitative changes after a closed-head injury. We hypothesized that there would be good response to relative beta training applied to regulate the dynamics of brain function. The patient was diagnosed with schizophrenia in the early 1960s and frequently thereafter hospitalized. Visual hallucinations were the dominant symptom, and art therapy provided some relief, which led to a successful artistic career. In 1989, while actively hallucinating, he suffered a mild TBI in a pedestrian accident. Four years later, he presented with perseveration, hemispatial neglect, and disturbances of working memory. Case description: The patient took part in 20 sessions of relative beta training combined with behavioral training. We used standardized neuropsychological testing and ERPs before and after the completion of the program. As hypothesized, there was marked improvement of neurophysiological, neuropsychological, and psychiatric symptoms, as well as executive dysfunction and behavioral disorders. He also began to paint in a completely different style. Conclusions: The case described here shows that the pathomechanisms of schizophrenia and neurobehavioral disturbances resulting from organic brain damage are not unrelated. Microgenetic theory can provide a basis for explaining the course of symptoms in this and similar cases. Relative beta training produced behavioral changes and small physiological changes. ERPs can be used to assess functional brain changes induced by neurotherapeutic programs.	[Pachalska, Maria; Mirski, Andrzej] Andrzej Frycz Modrzewski Krakow Univ, Dept Neuropsychol, Krakow, Poland; [Pachalska, Maria] Ctr Cognit & Commun, New York, NY USA; [Pronina, Marina V.; Kropotov, Juri D.] Russian Acad Sci, Inst Human Brain, Lab Neurobiol Act Programming, St Petersburg, Russia; [Manko, Grzegorz] Jagiellonian Univ, Fac Hlth Sci, Inst Physiotherapy, Dept Ergon & Phys Exert Physiol,Coll Med, Krakow, Poland; [Chantsoulis, Marzena] Acad Phys Educ, Fac Physiotherapy, Wroclaw, Poland; [Kaczmarek, Bozydar] Univ Econ & Innovat, Lublin, Poland; [Luckos, Maria] Reintegrat Training Ctr Polish Soc Neuropsychol, Krakow, Poland; [Kropotov, Juri D.] Norwegian Univ Sci & Technol, Inst Psychol, Trondheim, Norway		Pachalska, M (corresponding author), Andrzej Frycz Modrzewski Cracow Univ, Herlinga Grudzinskiego 1, Krakow, Poland.	neuropsychologia23@o2.pl	Kaczmarek, Bozydar/AAI-3301-2020; Pronina, Marina/AAC-7916-2022; Pronina, Marina V/K-3592-2018	Kaczmarek, bozydar/0000-0001-8683-1128			Bradford D. T., 2003, ACTA NEUROPSYCHOLOGI, V1, P97; Brown J.W., 2000, MIND NATURE ESSAYS T; Brown J.W., 2010, NEUROPSYCHOLOGICAL F; Code C., 1989, CHARACTERISTICS APHA, P155; Davidson RJ, 1998, PSYCHOPHYSIOLOGY, V35, P607, DOI 10.1017/S0048577298000134; Gold C, 2013, SCAND J PSYCHOL, V54, P118, DOI 10.1111/sjop.12022; Grochmal- Bach B., 2004, TOZSAMOSC CZLOWIEKA; KACZMAREK BLJ, 1991, APHASIOLOGY, V5, P361, DOI 10.1080/02687039108248537; Kropotov JD, 2005, INT J PSYCHOPHYSIOL, V55, P23, DOI 10.1016/j.ijpsycho.2004.05.011; Kropotov JD, 2009, ACTA NEUROPSYCHOL, V7, P169; Kropotov Yu. D., 2013, FIZIOL CHEL, V39, P14; Kropotov YuD., 2009, QUANTITATIVE EEG EVE; Luria AR, 1963, RESTORATION FUNCTION; MacQueen B. D., 2002, IMAGINING BRAIN MED, V7, P564; McAllister, 1998, Semin Clin Neuropsychiatry, V3, P211; Nikolaenko N. N., 2003, ACTA NEUROPSYCH, V1, P34; Pachalska M, 2004, DISABIL REHABIL, V26, P549, DOI 10.1080/09638280410001663076; Pachalska M., 1999, AFAZJOLOGIA; PACHALSKA M, 2014, NEUROPSYCHOLOGIA KLI; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; Pachalska M, 2011, MED SCI MONITOR, V17, pCS120, DOI 10.12659/MSM.881970; SCHAFFER CE, 1983, BIOL PSYCHIAT, V18, P753; Williams LM, 2005, INT J NEUROSCI, V115, P1605, DOI 10.1080/00207450590958475	23	6	6	0	0	MEDSPORTPRESS PUBLISHING HOUSE	WARSAW	UL MARYMONCKA 34 SKR 23, WARSAW, 01813, POLAND	1730-7503	2084-4298		ACTA NEUROPSYCHOL	Acta Neuropsychol.	OCT-DEC	2013	11	4					435	449					15	Psychology	Emerging Sources Citation Index (ESCI)	Psychology	V1K9N	WOS:000216998200008					2022-02-06	
J	Wang, CC; Lin, KC; Lin, BS; Chio, CC; Kuo, JR				Wang, Che-Chuan; Lin, Kao-Chang; Lin, Bor-Shyh; Chio, Chung-Ching; Kuo, Jinn-Rung			Resuscitation from experimental traumatic brain injury by magnolol therapy	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Magnolol; Free radical scavenger; Neuronal apoptosis; Transforming growth factor beta 1	LATERAL FLUID-PERCUSSION; LIPID-PEROXIDATION; HYDROXYL RADICALS; ISCHEMIA-REPERFUSION; OXIDATIVE STRESS; RAT; APOPTOSIS; PHARMACOKINETICS; ANTIOXIDANTS; INHIBITION	Background: The purpose of the present study was to determine whether magnolol, a free radical scavenger, mitigates the deleterious effects of traumatic brain injury (TBI). Material and methods: Traumatic brain injuries were induced in anesthetized male Sprague-Dawley rats using fluid percussion, and the rats were divided into groups treated with magnolol (2 mg/kg, intravenously) or vehicle. A group of rats that did not undergo TBI induction was also studied as controls. Biomarkers of TBI, including glycerol and 2,3-dihydroxybenzoic acid, were evaluated by microdialysis. Infraction volume, extent of neuronal apoptosis, and antiapoptosis factor transforming growth factor beta 1 (TGF-beta 1) were also measured. Functional outcomes were assessed by motor assays. Results: Compared with the rats without TBI, the animals with TBI exhibited higher hippocampal glycerol and 2,3-dihydroxybenzoic acid. Relative to the vehicle-treated group, the magnolol-treated group showed decreased hippocampal levels of glycerol and hydroxyl radical levels. The magnolol-treated rats also exhibited decreased cerebral infarction volume and neuronal apoptosis and increased antiapoptosis-associated factor TGF-beta 1 expression. These effects were translated into improved motor function post TBI. Conclusions: Our results suggest that intravenous magnolol injection mitigates the deleterious effects of TBI in rats based on its potent free radical scavenging capability, and the mechanism of anti-neuronal apoptosis is partly due to an increase in TGF-beta 1 expression in the ischemic cortex. (C) 2013 Elsevier Inc. All rights reserved.	[Wang, Che-Chuan; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Lin, Kao-Chang] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wang, Che-Chuan; Lin, Bor-Shyh] Natl Chiao Tung Univ, Inst Imaging & Biomed Photon, Tainan, Taiwan; [Lin, Kao-Chang; Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan		Kuo, JR (corresponding author), Taiwan Univ Sci & Technol, Kuo Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Yung Kang, Tainan, Taiwan.	kuojinnrung@gmail.com					AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Chang CP, 2003, CLIN EXP PHARMACOL P, V30, P387, DOI 10.1046/j.1440-1681.2003.03847.x; Chiu JH, 1999, J SURG RES, V82, P11, DOI 10.1006/jsre.1998.5455; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; FUJITA M, 1972, CHEM PHARM BULL, V20, P212, DOI 10.1248/cpb.20.212; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HALLIWELL B, 1991, FREE RADICAL BIO MED, V10, P439, DOI 10.1016/0891-5849(91)90052-5; Hamada M, 1996, JPN J CLIN ONCOL, V26, P398, DOI 10.1093/oxfordjournals.jjco.a023255; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hong CY, 1996, CLIN EXP PHARMACOL P, V23, P660, DOI 10.1111/j.1440-1681.1996.tb01753.x; Hsu SF, 2006, SHOCK, V26, P210, DOI 10.1097/01.shk.0000223124.49265.10; Huang WT, 2006, NEUROPHARMACOLOGY, V50, P504, DOI 10.1016/j.neuropharm.2005.10.012; Jawan B, 2003, J SURG RES, V110, P378, DOI 10.1016/S0022-4804(03)00034-9; Jin YC, 2008, EXP BIOL MED, V233, P1280, DOI 10.3181/0803-RM-79; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; Kuo JR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/145214; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Lin SP, 2011, PLANTA MED, V77, P1800, DOI 10.1055/s-0030-1271159; LO YC, 1994, BIOCHEM PHARMACOL, V47, P549, DOI 10.1016/0006-2952(94)90187-2; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Ou HC, 2007, ARCH TOXICOL, V81, P421, DOI 10.1007/s00204-006-0172-3; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Shih HC, 2003, SHOCK, V20, P264, DOI 10.1097/00024382-200309000-00011; Shih HC, 2012, J SURG RES, V175, P305, DOI 10.1016/j.jss.2011.04.063; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; TAIRA J, 1993, FREE RADICAL RES COM, V19, pS71, DOI 10.3109/10715769309056s71; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Tsai TH, 1996, J PHARM PHARMACOL, V48, P57, DOI 10.1111/j.2042-7158.1996.tb05877.x; Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2; Yu CH, 2011, J VET SCI, V12, P299, DOI 10.4142/jvs.2011.12.3.299	38	6	7	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2013	184	2					1045	1052		10.1016/j.jss.2013.04.059			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	215XE	WOS:000324243500054	23721932				2022-02-06	
J	Onda, H; Fuse, A; Yamaguchi, M; Igarashi, Y; Watanabe, A; Suzum, G; Hashizume, A; Yokota, H				Onda, Hidetaka; Fuse, Akira; Yamaguchi, Masahiro; Igarashi, Yutaka; Watanabe, Akihiro; Suzum, Go; Hashizume, Akihiro; Yokota, Hiroyuki			Traumatic Cerebrovascular Injury Following Severe Head Injury: Proper Diagnostic Timetable and Examination Methods	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						traumatic cerebrovascular injury; severe head injury; cerebral angiography; three-dimensional computed tomography angiography; timetable	COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CEREBRAL BLOOD-FLOW; INTRACRANIAL ANEURYSMS; CAROTID-ARTERY; DISSECTIONS	Traumatic cerebrovascular injury (TCVI) is a serious complication of severe head injury, with a high mortality rate. To establish a proper treatment strategy for TCVI, we investigated patients with a high risk of TCVI according to the Guidelines for the Management of Severe Head Injury (hereafter "the Guidelines") to elucidate the validity of the criteria for TCVI in the Guidelines and the appropriate screening timing and methods. Of those transported to our facility between December 2008 and June 2012, 67 individuals with a high risk of TCVI were evaluated to reveal the proper timing and methods of vascular evaluation. Of the 67 patients, 21 had a diagnosis of TCVI based on cerebral angiography, three-dimensional computed tomography angiography (3DCTA), or magnetic resonance imaging (Mm), accounting for 6.4% of all patients with severe head injury and as high as 31.3% of patients with a high risk of TCVI according to the Guidelines. In addition, according to the Glasgow Outcome Scale (GOS), outcomes were three deaths due to primary brain injury, six cases of persistent vegetative state, five cases of severe disability, three cases of moderate disability, and four cases of good recovery. Although 3DCTA is a simple and convenient diagnostic method, cerebral angiography is necessary to evaluate dissecting lesions. If patients have any signs or symptoms of TCVI, as described in the Guidelines, cerebral angiography or 3DCTA should be performed as an initial screening method within 72 hours of admission, followed by cerebral angiography on postadmission Day 14 +/- 2 to prevent failed diagnosis.	[Onda, Hidetaka; Fuse, Akira; Yamaguchi, Masahiro; Igarashi, Yutaka; Watanabe, Akihiro; Suzum, Go; Hashizume, Akihiro; Yokota, Hiroyuki] Nippon Med Sch, Dept Emergency, Tokyo 1138603, Japan; [Onda, Hidetaka; Fuse, Akira; Yamaguchi, Masahiro; Igarashi, Yutaka; Watanabe, Akihiro; Suzum, Go; Hashizume, Akihiro; Yokota, Hiroyuki] Nippon Med Sch, Crit Care Med Ctr, Tokyo 1138603, Japan		Onda, H (corresponding author), Nippon Med Sch, Dept Emergency, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	hidetaka.onda@nifty.ne.jp					[Anonymous], 2007, JSNT JPN SOC NEUROTR; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; Berne JD, 2001, J AM COLL SURGEONS, V192, P314, DOI 10.1016/S1072-7515(01)00772-4; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; Cook A, 2011, J TRAUMA, V71, P114, DOI 10.1097/TA.0b013e31821c350f; Cothren CC, 1996, ANN SURG, V223, P513; DiCocco JM, 2011, ANN SURG, V253, P444, DOI 10.1097/SLA.0b013e31820d946b; Dubey A, 2008, J CLIN NEUROSCI, V15, P609, DOI 10.1016/j.jocn.2007.11.006; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; FABIAN TC, 1990, J TRAUMA, V30, P953, DOI 10.1097/00005373-199008000-00003; Fabian TC, 1990, J TRAUMA, V30, P961; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Larson P S, 2000, Neurosurg Focus, V8, pe4; Leys D, 2006, CEREBROVASC DIS, V22, P215, DOI 10.1159/000093958; Malhotra AK, 2007, ANN SURG, V246, P632, DOI 10.1097/SLA.0b013e3181568cab; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; MOKRI B, 1988, J NEUROSURG, V68, P189, DOI 10.3171/jns.1988.68.2.0189; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; Onda H, 2012, J JPN ASS ACUTE MED, V23, P265; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015	24	6	7	0	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	SEP	2013	53	9					573	579					7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	295EX	WOS:000330100500001	24067766				2022-02-06	
J	Wallesch, CW; Fries, W; Marx, P; de Rochemont, RD; Roschmann, R; Schmidt, R; Schwerdtfeger, K; Tegenthoff, M; Widder, B				Wallesch, C. W.; Fries, W.; Marx, P.; de Rochemont, R. du Mesnil; Roschmann, R.; Schmidt, R.; Schwerdtfeger, K.; Tegenthoff, M.; Widder, B.			The German Guideline "Legal Evaluation after Closed Head Injury	FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE			English	Article						closed head injury; evaluation; neuroradiology; neuropsychology; neurology; neurosurgery	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; FOCAL LESIONS; RECOVERY; COMA; TESTS; RISK; REHABILITATION; SEIZURES; SEQUELAE	In 2005, the " Deutsche Gesellschaft fur Neurowissenschaftliche Begutachtung" (German Society for Neuroscientific Legal Evaluation) together with other Societies published a guideline for the legal evaluation of patients with closed head injuries. Meanwhile, not only scientific progress in imaging techniques but also in other fields such as neuropsychology has necessitated a revision, which is presented here. In the mean time, the handling of guidelines has been systematised in Germany so that a registration with the Cooperation of German Medical Learned Societies is applied for and publication in the German Guideline Registry is expected.	[Wallesch, C. W.] BDH Klin Elzach GmbH, Klin Neurol Rehabil, D-79215 Elzach, Germany; [Fries, W.] Neurokompetenz GmbH, Munich, Germany; [de Rochemont, R. du Mesnil] Univ Frankfurt Klinikum, Inst Neuroradiol, Frankfurt, Germany; [Roschmann, R.] Klinikum Ingolstadt, Psychol Abt, Ingolstadt, Germany; [Schmidt, R.] Kliniken Schmieder, Constance, Germany; [Schwerdtfeger, K.] Univ Saarlandes Kliniken, Neurochirurg Klin, Homburg, Germany; [Tegenthoff, M.] BG Univ Klinikum Bergmannsheil, Neurol Klin & Poliklin, Bochum, Germany; [Widder, B.] Bezirkskrankenhaus Gunzburg, Klin Neurol & Neurol Rehabil, Gunzburg, Germany		Wallesch, CW (corresponding author), BDH Klin Elzach GmbH, Klin Neurol Rehabil, Tannwald 1, D-79215 Elzach, Germany.	cwallesch@neuroklinik-elzach.de	Fries, Walter/AAB-8703-2022				Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P457, DOI 10.1007/s11940-002-0013-5; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barry E, 1998, EPILEPSIA, V39, P427, DOI 10.1111/j.1528-1157.1998.tb01395.x; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dohrenbusch R, 2011, Versicherungsmedizin, V63, P81; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Evers S, 2010, NERVENHEILKUNDE, V4, P229; Foerster K, 2011, NERVENARZT, V82, P1557, DOI 10.1007/s00115-011-3290-y; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Froscher W, 2009, MED SACH, V105, P222; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1994, HEAD INJURY, P137; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; Hausotter W, 2006, NEUROLOGISCHE BEGUTA; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Karbowski P, 1981, NERVENARZT, V52, P718; Klosterkotter J, 2000, KLIN NEUROPSYCHIATRI; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Marx P, 2005, AKTUEL NEUROL, V32, P94, DOI 10.1055/s-2004-834544; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Neumann-Zielke L, 2008, AKTUEL NEUROL, V35, P443, DOI 10.1055/s-0028-1090083; Rauschelbach HH, 1977, MED SACHVERST, V73, P86; Ritter G, 1994, BEGUTACHTUNG HIRNORG, P117; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schneider HJ, 2004, DTSCH ARZTEBL, V101, P712; Schonberger A, 2010, ARBEITSUNFALL BERUFS, V8; Schutze M, 1999, ZBL NEUROCHIR, V60, P163; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 1997, NEUROPSYCHOL REHABIL, V7, P23, DOI 10.1080/713755521; Toschlog EA, 2003, AM SURGEON, V69, P491; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Widder B, 2000, NEUROLOGISCHE GUTACH; Widder B, 2005, NEUROTRAUMATOLOGIE; Widder B, 2011, BEGUTACHTUNG NEUROLO; Wurzer W, 1992, POSTTRAUMATISCHE ORG	62	6	6	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0720-4299	1439-3522		FORTSCHR NEUROL PSYC	Forschritte Neurol. Psychiatr.	SEP	2013	81	9					511	522		10.1055/s-0033-1350374			12	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	301LF	WOS:000330533100013	23986459				2022-02-06	
J	Greco, T; Prins, ML				Greco, Tiffany; Prins, Mayumi L.			Traumatic Brain Injury and Diet	JOURNAL OF CHILD NEUROLOGY			English	Article						brain; injury; metabolism; ketones; substrate; pituitary	CEREBRAL GLUCOSE-UTILIZATION; KETOGENIC DIET; DOCOSAHEXAENOIC ACID; SPINAL-CORD; HEAD-INJURY; CELL-DEATH; CORTICAL CONTUSION; PITUITARY-GLAND; GROWTH-HORMONE; AXONAL INJURY	Increasing attention is being paid to nutritional and metabolic management of traumatic brain injury patients. The gross metabolic changes that occur after injury have been found to be influenced by both macronutrients, that is, dietary ratios of fat, carbohydrates, and protein, and micronutrients, for example, vitamins and minerals. Alterations in diet and nutritional strategies have been shown to decrease both morbidity and mortality after injury. Despite this knowledge, defining optimal nutritional support following traumatic brain injury continues to be an ongoing challenge.	[Greco, Tiffany; Prins, Mayumi L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA		Prins, ML (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Semel Room 18-228,Box 957039, Los Angeles, CA 90095 USA.	mprins@mednet.ucla.edu	Greco, Tiffany/ABA-3519-2021; Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	UCLA Brain Injury Research Center;  [NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by UCLA Brain Injury Research Center and NS058489.	Aimaretti G, CLIN ENDOCRINOL OXF, V51, P771; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Arango MF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005400.pub3; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bielohuby M, 2011, ENDOCRINOLOGY, V152, P1948, DOI 10.1210/en.2010-1423; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Cheng CM, 2003, ENDOCRINOLOGY, V144, P2676, DOI 10.1210/en.2002-0057; Cheng CM, 2000, P NATL ACAD SCI USA, V97, P10236, DOI 10.1073/pnas.170008497; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2012, NUTR REV, V70, P410, DOI 10.1111/j.1753-4887.2012.00486.x; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Cosi C, 1998, BRAIN RES, V809, P58, DOI 10.1016/S0006-8993(98)00829-4; Czeiter E, 2008, J NEUROTRAUM, V25, P205, DOI 10.1089/neu.2007.0331; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Figueroa JD, 2013, J NEUROTRAUMA; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; HO KY, 1988, J CLIN INVEST, V81, P968, DOI 10.1172/JCI113450; Hoane MR, 2011, BEHAV BRAIN RES, V223, P119, DOI 10.1016/j.bbr.2011.04.028; Hovda D. A., 1994, Society for Neuroscience Abstracts, V20, P845; Hovda DA, 1996, J CEREBR BLOOD F MET, V16, P134, DOI 10.1097/00004647-199601000-00016; HOVDA DA, 1990, ACT NEUR S, V51, P331; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hu ZG, 2009, ANN CLIN LAB SCI, V39, P76; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KING LR, 1981, NEUROSURGERY, V9, P229, DOI 10.1227/00006123-198109000-00002; Lim SN, 2013, EXP NEUROL, V239, P13, DOI 10.1016/j.expneurol.2012.09.015; Liu SH, 2012, BRAIN RES, V1451, P19, DOI 10.1016/j.brainres.2012.02.060; Luchtman DW, 2013, NEUROPHARMACOLOGY, V64, P550, DOI 10.1016/j.neuropharm.2012.07.019; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Scheff SW, 2004, NEUROCHEM RES, V29, P469, DOI 10.1023/B:NERE.0000013753.22615.59; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Sheline CT, 2000, J NEUROSCI, V20, P3139, DOI 10.1523/JNEUROSCI.20-09-03139.2000; Shin SS, 2011, NEUROSCI LETT, V496, P168, DOI 10.1016/j.neulet.2011.04.009; Sonntag WE, 2006, AM J PHYSIOL-ENDOC M, V291, pE604, DOI 10.1152/ajpendo.00012.2006; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Vink R, 1996, J NEUROCHEM, V66, P2477; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Ward RE, 2010, J NEUROTRAUM, V27, P1769, DOI 10.1089/neu.2010.1348; Woolf PD, 1992, CRIT CARE MED; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Yeiser EC, 2002, NUTR NEUROSCI, V5, P345, DOI 10.1080/1028415021000033811; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	68	6	7	2	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	AUG	2013	28	8					983	988		10.1177/0883073813487594			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	188MW	WOS:000322198100004	23670252				2022-02-06	
J	Hux, K; Bush, E; Evans, K; Simanek, G				Hux, Karen; Bush, Erin; Evans, Kelli; Simanek, Gina			Misconceptions about traumatic brain injury among students preparing to be special education professionals	SUPPORT FOR LEARNING			English	Article						traumatic brain injury; special education; teacher preparation programmes; personnel preparation; higher education		The researchers performed a survey study to determine the effectiveness of collegiate programmes in dispelling common misconceptions about traumatic brain injury (TBI) while preparing undergraduate and graduate students for special education (SpEd) careers. Respondents included 136 undergraduate and 147 graduate SpEd students in their final semesters before obtaining degrees. Each completed an 18-item true/false survey about TBI and the associated recovery process. Results were compared with survey responses from 318 lay public respondents who participated in a previous study. Two major findings emerged: (a) no significant differences existed in misconception endorsement between SpEd students completing Bachelor's versus Master's degrees; and (b) graduating students in SpEd teacher preparation programmes endorsed similar misconceptions as lay public respondents; hence, these programmes do not appear effective in dispelling common TBI misconceptions. Improving academic preparation for special educators regarding TBI is imperative for effectively identifying, assessing and serving student survivors.			Hux, K (corresponding author), Univ Nebraska Lincoln, Barkley Mem Ctr 351, Lincoln, NE 68583 USA.	khux1@unl.edu	Hux, Karen/AAQ-2078-2020; Bush, Erin J/I-9606-2016	Bush, Erin J/0000-0003-1710-8619			Arroyos-Jurado E, 2008, INTERV SCH CLIN, V43, P252, DOI 10.1177/1053451208314907; BOULDIN K. V., 2005, ENGL J, V94, P52; CAVE B. K, 2004, CLEARING HOUSE, V77, P169; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; EVANS K, 2009, CONT ISSUES COMMUNIC, V36, P172; FAINARU S., 2013, CTE FOUND LIVING EXN; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Jantz PB, 2007, SUPPORT LEARN, V22, P84, DOI 10.1111/j.1467-9604.2007.00452.x; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; Ono MY, 2011, BRAIN INJURY, V25, P237, DOI 10.3109/02699052.2010.541893; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; WILNER B, 2013, NFL PLAYER JUNIOR SE; Yi JY, 2013, CURR SPORT MED REP, V12, P28, DOI 10.1249/JSR.0b013e31827ec9e3; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	22	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-2141	1467-9604		SUPPORT LEARN	Support Learn.	AUG	2013	28	3					109	114		10.1111/1467-9604.12028			6	Education, Special	Emerging Sources Citation Index (ESCI)	Education & Educational Research	V57XR	WOS:000210661000005					2022-02-06	
J	Hvas, CL; Fenger-Eriksen, C; Hoyer, S; Sorensen, B; Tonnesen, E				Hvas, Christine L.; Fenger-Eriksen, Christian; Hoyer, Soren; Sorensen, Benny; Tonnesen, Else			Hypercoagulation following brain death cannot be reversed by the neutralization of systemic tissue factor	THROMBOSIS RESEARCH			English	Article						Brain death; Experimental animal models; Hypercoagulability; Intracerebral hemorrhage; Protein C; Tissue factor	ACUTE TRAUMATIC COAGULOPATHY; THROMBIN GENERATION; PROTEIN-C; BLOOD-COAGULATION; WHOLE-BLOOD; DONOR MODEL; INJURY; ACTIVATION; TRANSPLANTATION; PORCINE	Background: Cerebral injury and brain death is associated with apparent hypercoagulation and poor organ outcome. This experimental study challenges the hypotheses that i) brain death causes hypercoagulation and microvascular thrombosis and that ii) neutralizing systemic tissue factor (TF) by in vitro addition of a TF inhibitor (recombinant active site-inhibited factor VIIa (ASIS)) can reverse the hypercoagulable profile. Methods: Using a validated pig model of intracranial hemorrhage and brain death, 20 pigs were randomized to either control or brain death. The primary endpoints were coagulation parameters measured with whole blood thromboelastometry (ROTEM), thrombin generation and a porcine TF-sensitive plasma clotting time assay. In vitro spiking experiments with ASIS were performed in parallel with the latter two assessments. The kidneys were examined histologically for microvascular thromboses. Results: Brain death induced hypercoagulation, as demonstrated with ROTEM, thrombin generation, and reduced TF-sensitive plasma clotting time. In vitro inhibition of TF with ASIS did not reverse the hypercoagulation. No microvascular thromboses were found in the kidneys. Conclusion: Brain death causes hypercoagulation; however, inhibition of TF does not reverse the coagulopathy. Thus, TF release does not seem to be the primary cause of this hypercoagulation. Minor changes in the levels of protein C suggest that the protein C pathway may be linked to the observed coagulopathy. (C) 2013 Elsevier Ltd. All rights reserved.	[Hvas, Christine L.; Fenger-Eriksen, Christian; Tonnesen, Else] Aarhus Univ Hosp, Dept Anaesthesiol & Intens Care Med, DK-8000 Aarhus C, Denmark; [Hoyer, Soren] Aarhus Univ Hosp, Dept Pathol, DK-8000 Aarhus C, Denmark; [Sorensen, Benny] Guys & St Thomas Hosp, Dept Haematol & Oncol, Ctr Haemostasis & Thrombosis, Haemostasis Res Unit, London SE1 7EH, England; [Sorensen, Benny] St Thomas Hosp, Kings Coll London, Sch Med, NHS Trust Fdn, London SE1 7EH, England; [Hvas, Christine L.; Sorensen, Benny] Aarhus Univ Hosp, Inst Clin Med, DK-8200 Aarhus N, Denmark		Hvas, CL (corresponding author), Aarhus Univ Hosp, Dept Anaesthesiol & Intens Care Med, Norrebrogade 44,Bldg 1C,1st Floor, DK-8000 Aarhus C, Denmark.	c.hvas@ki.au.dk		Hvas, Christine Lodberg/0000-0003-0826-4126; Hoyer, Soren/0000-0002-3135-3242; Fenger-Eriksen, Christian/0000-0003-0536-560X	Lundbeck FoundationLundbeckfonden; Foundation of Aase and Ejnar Danielsen; Foundation of Helga and Peter Korning	The work was funded by The Lundbeck Foundation, the Foundation of Aase and Ejnar Danielsen and the Foundation of Helga and Peter Korning. ASIS was kindly donated by NOVO Nordisk.	Ammollo CT, 2011, J THROMB HAEMOST, V9, P1795, DOI 10.1111/j.1538-7836.2011.04422.x; Barklin A, 2009, ANESTHESIOLOGY, V110, P1287, DOI 10.1097/ALN.0b013e3181a10352; BITTNER HB, 1995, J HEART LUNG TRANSPL, V14, P308; Bjarkam CR, 2004, J NEUROSCI METH, V139, P293, DOI 10.1016/j.jneumeth.2004.05.004; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brousseau C, 2009, CAN J PHYSIOL PHARM, V87, P694, DOI [10.1139/Y09-063, 10.1139/y09-063]; Butenas S, 2005, BLOOD, V105, P2764, DOI 10.1182/blood-2004-09-3567; Chen EP, 1996, CRIT CARE MED, V24, P1352, DOI 10.1097/00003246-199608000-00014; Clark J. Derrell, 1997, ILAR J, V38, P41; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; Ettinger MG, 1970, STROKE, V1, P139, DOI 10.1161/01.STR.1.3.139; FLETCHER AP, 1976, STROKE, V7, P337, DOI 10.1161/01.STR.7.4.337; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; HEMKER HC, 1993, THROMB HAEMOSTASIS, V70, P617; Hvas CL, 2012, ACTA ANAESTH SCAND, V56, P995, DOI 10.1111/j.1399-6576.2012.02682.x; Kessler U, 2011, THROMB RES, V128, P477, DOI 10.1016/j.thromres.2011.03.013; Larsen CC, 2010, ACTA NEUROCHIR, V152, P1577, DOI 10.1007/s00701-010-0699-1; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P378, DOI 10.1055/s-0030-1254047; Lisman T, 2011, J THROMB HAEMOST, V9, P1959, DOI 10.1111/j.1538-7836.2011.04442.x; Loubele ST, 2010, THROMB HAEMOSTASIS, V104; Luddington R, 2004, J THROMB HAEMOST, V2, P1954, DOI 10.1111/j.1538-7836.2004.00964.x; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Morariu AM, 2008, AM J TRANSPLANT, V8, P933, DOI 10.1111/j.1600-6143.2008.02166.x; Munster AMB, 2002, COMPARATIVE MED, V52, P39; Olanders K, 2005, ACTA ANAESTH SCAND, V49, P517, DOI 10.1111/j.1399-6576.2005.00633.x; Osterud B, 2010, THROMB RES, V125, pS31, DOI 10.1016/j.thromres.2010.01.032; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Snell GI, 2008, J HEART LUNG TRANSPL, V27, P662, DOI 10.1016/j.healun.2008.03.009; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Sorensen BB, 1998, BLOOD COAGUL FIBRIN, V9, pS67; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; Trulock EP, 1997, AM J RESP CRIT CARE, V155, P789, DOI 10.1164/ajrccm.155.3.9117010; von Kanel R, 2000, EUR J HAEMATOL, V65, P357, DOI 10.1034/j.1600-0609.2000.065006357.x; Ware LB, 2005, J HEART LUNG TRANSPL, V24, P1650, DOI 10.1016/j.healun.2004.11.011	39	6	6	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	AUG	2013	132	2					300	306		10.1016/j.thromres.2013.07.009			7	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	213LV	WOS:000324059600040	23910501				2022-02-06	
J	Nayak, NV; Medina, B; Patel, K; Homnick, AT; Mohr, AM; Livingston, DH; Prestigiacomo, CJ; Sifri, ZC				Nayak, Natasha V.; Medina, Benjamin; Patel, Kalpit; Homnick, Adena T.; Mohr, Alicia M.; Livingston, David H.; Prestigiacomo, Charles J.; Sifri, Ziad C.			Neurologic outcome of minimal head injury patients managed with or without a routine repeat head computed tomography	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; minimal head injury; repeat head computed tomography; intracranial bleed; neurologic deterioration	TRAUMATIC BRAIN-INJURY; CT; PROGRESSION; HEMORRHAGE; MODERATE; UTILITY	BACKGROUND: Previous studies proposed that routine repeat head computed tomography (RHCT) is of little value in patients with a minimal head injury (MHI) and normal neurologic examination (NE). As of 2003, routine RHCT in these MHI patients was ordered at the discretion of the attending physician. The goal of this study was to compare the neurologic outcomes of MHI patients with an intracranial bleed and a normal NE who were managed with or without a routine RHCT. METHODS: A retrospective chart review of adult patients with MHI presenting to a Level I trauma center from August 2003 to December 2008 was performed. Demographics, injury severity, and HCT findings were collected for patients managed with or without a routine RHCT. Outcome measures included delayed neurologic deterioration, neurosurgical interventions, Glasgow Outcome Scale, and hospital length of stay (LOS). RESULTS: A total of 321 MHI patients with an intracranial bleed had a normal NE 24 hours after presentation. There were no significant differences in demographics, arrival Glasgow Coma Scale score, or injury severity between the 142 (44%) patients managed with RHCT and the 179 (56%) managed without RHCT. No patient had a neurologic deterioration or required a neurosurgical intervention, regardless of initial management. There was no significant difference in the neurologic outcomes, mortality, or discharge dispositions between both groups. Patients managed without an RHCT had significantly shorter LOS (2.2 +/- 2.3 days vs. 4.3 +/- 6.0 days; p < 0.001) compared with those with RHCT. CONCLUSION: Our study is the first to compare early neurologic outcomes of MHI patients with or without a routine RHCT. Patients managed without an RHCT had similar neurologic outcomes and shorter hospital LOS. Our data suggest that initial HCT followed by serial NEs (not routine RHCT) should be the standard of care in this patient population. (Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Nayak, Natasha V.; Medina, Benjamin; Patel, Kalpit; Homnick, Adena T.; Mohr, Alicia M.; Livingston, David H.; Sifri, Ziad C.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Div Trauma & Crit Care, Newark, NJ 07103 USA; [Prestigiacomo, Charles J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA		Sifri, ZC (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, 50 Bergen St,Emergency Room, Newark, NJ 07103 USA.	sifrizi@umdnj.edu	Mohr, Alicia M/E-3016-2015; Prestigiacomo, Charles J/B-3911-2018	Prestigiacomo, Charles J/0000-0002-5979-2378; Mohr, Alicia/0000-0003-1732-1313			Aldrich EF CL, 2001, SABISTON TXB SURG, P1529; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Homnick A, 2012, INJURY, V43, P2122, DOI 10.1016/j.injury.2012.04.013; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; Levin HS, 1996, NEUROTRAUMA, P749; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; YAMAKI T, 1990, ACTA NEUROCHIR, V103, P112, DOI 10.1007/BF01407516	25	6	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2013	75	2					273	278		10.1097/TA.0b013e3182905eb4			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	300FL	WOS:000330449700014	23702628				2022-02-06	
J	Schafer, AY; Ustinova, KI				Schafer, Amanda Y.; Ustinova, Ksenia I.			Does use of a virtual environment change reaching while standing in patients with traumatic brain injury?	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Virtual reality; Arm-postural coordination; Visual perception; Rehabilitation; Balance; Postural control	FUNCTIONAL REACH; STABILITY LIMITS; VISUAL ANGLE; GAZE ANGLE; BALANCE; REALITY; DISTANCE; RELIABILITY; VALIDITY; GAIT	Background: Although numerous virtual reality applications have been developed for sensorimotor retraining in neurologically impaired individuals, it is unclear whether the virtual environment (VE) changes motor performance, especially in patients with brain injuries. To address this question, the movement characteristics of forward arm reaches during standing were compared in physical and virtual environments, presented at different viewing angles. Methods: Fifteen patients with traumatic brain injuries (TBI) and 15 sex-and age-matched healthy individuals performed virtual reaches in a computer-generated courtyard with a flower-topped hedge. The hedge was projected on a flat screen and viewed in 3D format in 1 of 3 angles: 10 degrees above horizon (resembling a real-world viewing angle), 50 degrees above horizon, or 90 degrees above horizon (directly overhead). Participants were instructed to reach with their dominant hand avatar and to touch the farthest flower possible without losing their balance or stepping. Virtual reaches were compared with reaches-to-point to a target in an equivalent physical environment. A set of kinematic parameters was used. Results: Reaches by patients with TBI were characterized by shorter distances, lower peak velocities, and smaller postural displacements than reaches by control individuals. All participants reached similar to 9% farther in the VE presented at a 50 degrees angle than they did in the physical environment. Arm displacement in the more natural 10 degrees angle VE was reduced by the same 9-10% compared to physical reaches. Virtual reaches had smaller velocity peaks and took longer than physical reaches. Conclusion: The results suggest that visual perception in the VE differs from real-world perception and the performance of functional tasks (e. g., reaching while standing) can be changed in TBI patients, depending on the viewing angle. Accordingly, the viewing angle is a critical parameter that should be adjusted carefully to achieve maximal therapeutic effect during practice in the VE.	[Schafer, Amanda Y.; Ustinova, Ksenia I.] Cent Michigan Univ, Dept Phys Therapy, Mt Pleasant, MI 48859 USA		Ustinova, KI (corresponding author), Cent Michigan Univ, Dept Phys Therapy, Mt Pleasant, MI 48859 USA.	ustin1k@cmich.edu	Ustinova, Ksenia I/M-8250-2016	Ustinova, Ksenia I/0000-0002-1531-7591	US Department of DefenseUnited States Department of Defense	The study was supported by the US Department of Defense.	Adamovich SV, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-28; Allison L, 1993, J NEUROL PHYS THER, V23, P13; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BERG K, 1989, Physiotherapy Canada, V41, P304; Bingham G, 2007, NEUROPSYCHOLOGIA, V45, P288, DOI 10.1016/j.neuropsychologia.2006.07.011; Bryanton C, 2006, CYBERPSYCHOL BEHAV, V9, P123, DOI 10.1089/cpb.2006.9.123; Chen HC, 2008, MOTOR CONTROL, V12, P122, DOI 10.1123/mcj.12.2.122; Colarusso R, 1996, MOTORFREE VISUAL PER; Corneil BD, 2004, NEURON, V42, P831, DOI 10.1016/S0896-6273(04)00267-3; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Creem-Regehr SH, 2005, PERCEPTION, V34, P191, DOI 10.1068/p5144; Deutsch JE, 2008, PHYS THER, V88, P1196, DOI 10.2522/ptj.20080062; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Engler SA, 2011, AM J PHYS MED REHAB, V90, P217, DOI 10.1097/PHM.0b013e31820b1367; Fidopiastis C, 2005, PRESENCE-TELEOP VIRT, V14, P550, DOI 10.1162/105474605774918697; Frzovic D, 2000, ARCH PHYS MED REHAB, V81, P215, DOI 10.1053/apmr.2000.0810215; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gardner PL, 2001, EXP BRAIN RES, V136, P379, DOI 10.1007/s002210000590; Geuss MN, 2012, J EXP PSYCHOL HUMAN, V38, P1242, DOI 10.1037/a0027524; Hibbard PB, 2003, EXP BRAIN RES, V148, P196, DOI 10.1007/s00221-002-1295-2; Holbein-Jenny MA, 2007, ERGONOMICS, V50, P631, DOI 10.1080/00140130601154814; Holden MK, 2001, ST HEAL T, V81, P192; Hulse P, 2010, NEUROREHABILITATION, V27, P269, DOI 10.3233/NRE-2010-0608; IWADATE Y, 1989, Neurosurgical Review, V12, P500, DOI 10.1007/BF01790695; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Kapoula Z, 2006, EXP BRAIN RES, V173, P438, DOI 10.1007/s00221-006-0382-1; Katz-Leurer Michal, 2008, Pediatr Phys Ther, V20, P254, DOI 10.1097/PEP.0b013e3181820dd8; Katz-Leurer M, 2009, DISABIL REHABIL, V31, P243, DOI 10.1080/09638280801927830; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kizony R, 2005, J REHABIL RES DEV, V42, P595, DOI 10.1682/JRRD.2005.01.0023; KLOCKGETHER T, 1990, J NEUROL NEUROSUR PS, V53, P297, DOI 10.1136/jnnp.53.4.297; Knaut LA, 2009, ARCH PHYS MED REHAB, V90, P793, DOI 10.1016/j.apmr.2008.10.030; LEVIN CA, 1993, PERCEPT PSYCHOPHYS, V54, P250, DOI 10.3758/BF03211761; Levin MF, 2009, STUD HEALTH TECHNOL, V145, P94, DOI 10.3233/978-1-60750-018-6-94; LORD SR, 1994, AGE AGEING, V23, P452, DOI 10.1093/ageing/23.6.452; Lott A, 2003, CYBERPSYCHOL BEHAV, V6, P477, DOI 10.1089/109493103769710505; Magdalon EC, 2011, ACTA PSYCHOL, V138, P126, DOI 10.1016/j.actpsy.2011.05.015; Meyers JE., 1995, REY COMPLEX FIGURE T; Mirelman A, 2011, J GERONTOL A-BIOL, V66, P234, DOI 10.1093/gerona/glq201; Mumford N, 2010, BRAIN INJURY, V24, P780, DOI 10.3109/02699051003652807; MYSIW W J, 1990, Brain Injury, V4, P247, DOI 10.3109/02699059009026174; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; Rouse, 2006, OPTOMETRIC MANAGEMEN; Schmidt R. A., 1999, MOTOR CONTROL LEARNI; Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083; Shieh KK, 2007, APPL ERGON, V38, P601, DOI 10.1016/j.apergo.2006.06.008; Spreitzer L, 2013, AM J PHYS MED REHAB, V92, P36, DOI 10.1097/PHM.0b013e318269d8f9; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; Subramanian SK, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-36; Takahashi T, 2006, ARCH GERONTOL GERIAT, V42, P167, DOI 10.1016/j.archger.2005.06.010; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; Turville KL, 1998, APPL ERGON, V29, P239, DOI 10.1016/S0003-6870(97)00048-3; Ustinova KI, 2011, BRAIN BEHAV, V1, P19, DOI 10.1002/brb3.10; Ustinova KI, 2010, ACTA PSYCHOL, V133, P180, DOI 10.1016/j.actpsy.2009.11.006; Vaillancourt DE, 2006, EXP BRAIN RES, V173, P742, DOI 10.1007/s00221-006-0454-2; Viau Antonin, 2004, J Neuroeng Rehabil, V1, P11, DOI 10.1186/1743-0003-1-11; WANN JP, 1995, VISION RES, V35, P2731, DOI 10.1016/0042-6989(95)00018-U; Wismeijer DA, 2008, EXP BRAIN RES, V184, P61, DOI 10.1007/s00221-007-1081-2; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	61	6	6	1	18	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	JUL 16	2013	10								76	10.1186/1743-0003-10-76			11	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Neurosciences & Neurology; Rehabilitation	193VH	WOS:000322589100001	23866962	Green Published, gold			2022-02-06	
J	Badjatia, N				Badjatia, Neeraj			Hypothermia in Neurocritical Care	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Therapeutic hypothermia; Traumatic brain injury; Cardiac arrest; Shivering; Spinal cord injury	TRAUMATIC BRAIN-INJURY; MILD THERAPEUTIC HYPOTHERMIA; MIDDLE CEREBRAL-ARTERY; HOSPITAL CARDIAC-ARREST; COLD INTRAVENOUS FLUID; ACUTE ISCHEMIC-STROKE; SPINAL-CORD-INJURY; SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE	Hypothermia has long been recognized as an effective therapy for acute neurologic injury. Recent advances in bedside technology and greater understanding of thermoregulatory mechanisms have made this therapy readily available at the bedside. Critical care management of the hypothermic patient can be divided into 3 phases: induction, maintenance, and rewarming. Each phase has known complications that require careful monitoring. At present, hypothermia has only been shown to be an effective neuroprotective therapy in cardiac arrest survivors. The primary use of hypothermia in the neurocritical care unit is to treat increased intracranial pressure.	Univ Maryland, Sect Neurocrit Care, R Adams Cowley Shock Trauma Ctr, Med Ctr, Baltimore, MD 21201 USA		Badjatia, N (corresponding author), Univ Maryland, Sect Neurocrit Care, R Adams Cowley Shock Trauma Ctr, Med Ctr, 22 S Greene St, Baltimore, MD 21201 USA.	nbadjatia@umm.edu	Badjatia, Neeraj/AAS-4855-2021	Badjatia, Neeraj/0000-0003-1509-9034			Abou-Chebl A, 2004, NEUROCRIT CARE, V1, P131, DOI 10.1385/NCC:1:2:131; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Bacher A, 2005, INTENS CARE MED, V31, P24, DOI 10.1007/s00134-004-2369-3; Badiatia N, 2009, CURR OPIN CRIT CARE, V15, P79, DOI 10.1097/MCC.0b013e32832922e9; Badjatia N, 2004, NEUROCRIT CARE, V1, P145, DOI 10.1385/NCC:1:2:145; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Badjatia N, 2009, CRIT CARE MED, V37, P1893, DOI 10.1097/CCM.0b013e31819fffd3; Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; BAKER AJ, 1991, STROKE, V22, P666, DOI 10.1161/01.STR.22.5.666; BENSON D W, 1959, Anesth Analg, V38, P423; Bergman R, 2010, EUR J ANAESTH, V27, P383, DOI 10.1097/EJA.0b013e3283333a7d; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BIGELOW WG, 1950, ANN SURG, V132, P849, DOI 10.1097/00000658-195011000-00001; Choi HA, 2011, NEUROCRIT CARE; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; Dietrich WD, 2011, NEUROTHERAPEUTICS, V8, P229, DOI 10.1007/s13311-011-0035-3; Doufas AG, 2003, STROKE, V34, P1218, DOI 10.1161/01.STR.0000068787.76670.A4; Eguchi Y, 1997, J NEUROTRAUM, V14, P109, DOI 10.1089/neu.1997.14.109; Els T, 2006, CEREBROVASC DIS, V21, P79, DOI 10.1159/000090007; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; Fingas M, 2007, EXP NEUROL, V208, P277, DOI 10.1016/j.expneurol.2007.08.018; Gasser S, 2003, J NEUROSURG ANESTH, V15, P240, DOI 10.1097/00008506-200307000-00012; Guluma KZ, 2008, NEUROCRIT CARE, V8, P42, DOI 10.1007/s12028-007-9009-z; Guluma KZ, 2010, RESUSCITATION, V81, P1642, DOI 10.1016/j.resuscitation.2010.08.003; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hemmen TM, 2010, STROKE, V41, P2265, DOI 10.1161/STROKEAHA.110.592295; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holzer M, 2002, NEW ENGL J MED, V346, P549; HOWELL D A, 1956, Can Med Assoc J, V75, P388; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kammersgaard LP, 2000, STROKE, V31, P2251, DOI 10.1161/01.STR.31.9.2251; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; Kasner SE, 2002, STROKE, V33, P130, DOI 10.1161/hs0102.101477; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100, DOI 10.1097/00004647-199601000-00012; Kliegel A, 2005, RESUSCITATION, V64, P347, DOI 10.1016/j.resuscitation.2004.09.002; KNIGHT DR, 1985, AM J PHYSIOL, V248, pR560, DOI 10.1152/ajpregu.1985.248.5.R560; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Lay C, 2010, CURR ATHEROSCLER REP, V12, P336, DOI 10.1007/s11883-010-0119-2; LENNON RL, 1990, ANESTH ANALG, V70, P424; Levi AD, 2009, J NEUROTRAUM, V26, P407, DOI 10.1089/neu.2008.0745; Linares G, 2009, CRIT CARE MED, V37, pS243, DOI 10.1097/CCM.0b013e3181aa5de1; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; LOUGHEED WM, 1955, J NEUROSURG, V12, P240, DOI 10.3171/jns.1955.12.3.0240; MATSUKAWA T, 1995, ANESTHESIOLOGY, V82, P1169, DOI 10.1097/00000542-199505000-00012; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Mokhtarani M, 2001, ANESTH ANALG, V93, P1233, DOI 10.1097/00000539-200111000-00038; Moran JL, 2007, CRIT CARE MED, V35, P155, DOI 10.1097/01.CCM.0000250318.31453.CB; Oddo M, 2010, NEUROCRIT CARE, V12, P10, DOI 10.1007/s12028-009-9280-2; OKU K, 1993, STROKE, V24, P1590, DOI 10.1161/01.STR.24.10.1590; Olsen TS, 2003, LANCET NEUROL, V2, P410, DOI 10.1016/S1474-4422(03)00436-8; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Polderman KH, 2004, INTENS CARE MED, V30, P1860, DOI 10.1007/s00134-004-2383-5; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; PRAKASH O, 1978, CRIT CARE MED, V6, P340, DOI 10.1097/00003246-197809000-00011; Rajek A, 2000, ANESTHESIOLOGY, V93, P629, DOI 10.1097/00000542-200009000-00010; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; Schefold JC, 2009, INT J CARDIOL, V132, P387, DOI 10.1016/j.ijcard.2007.12.008; Schreckinger M, 2009, NEUROCRIT CARE, V11, P427, DOI 10.1007/s12028-009-9256-2; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Sessler DI, 2009, STROKE, V40, pE614, DOI 10.1161/STROKEAHA.108.520858; Seule MA, 2009, NEUROSURGERY, V64, P86, DOI 10.1227/01.NEU.0000336312.32773.A0; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Steiner T, 2001, STROKE, V32, P2833, DOI 10.1161/hs1201.99511; Stub D, 2011, CIRCULATION, V123, P1428, DOI 10.1161/CIRCULATIONAHA.110.988725; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Thompson Hilaire J, 2010, J Trauma Nurs, V17, P173, DOI 10.1097/JTN.0b013e3181ff272e; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Tokutomi T, 2007, NEUROSURGERY, V61, P256, DOI [10.1227/01.NEU.00000038737.13185.C4, 10.1227/01.neu.0000279221.38257.1a]; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; WILLIAMS GR, 1958, ANN SURG, V148, P462, DOI 10.1097/00000658-195809000-00014; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; YOUNG RSK, 1980, JAMA-J AM MED ASSOC, V244, P1233, DOI 10.1001/jama.244.11.1233; Zeiner A, 2004, RESUSCITATION, V60, P253, DOI 10.1016/j.resuscitation.2003.11.006; Zweifler Richard M, 2003, J Stroke Cerebrovasc Dis, V12, P237, DOI 10.1016/j.jstrokecerebrovasdis.2003.09.006; Zweifler RM, 2004, STROKE, V35, P2331, DOI 10.1161/01.STR.0000141161.63181.f1	91	6	6	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2013	24	3					457	+		10.1016/j.nec.2013.02.001			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	191NY	WOS:000322421100013	23809038				2022-02-06	
J	Carrier, CS; Sama, AA; Girardi, FP; Lebl, DR				Carrier, C. S.; Sama, A. A.; Girardi, F. P.; Lebl, D. R.			Anterior transarticular screw fixation for atlantoaxial arthrodesis: A report of two cases	JOURNAL OF CRANIOVERTEBRAL JUNCTION AND SPINE			English	Article						Anterior approach; atlantoaxial instability; C1-C2 fixation; transarticular screw fixation		The sequelae of atlantoaxial instability (AAI) range from axial neck pain to life-threatening neurologic injury. Instrumentation and fusion of the C1-2 joint is often indicated in the setting of clinical or biomechanical instability. This is the first clinical report of anterior Smith-Robinson C1-2 transarticular screw (TAS) fixation for AAI. The first patient presented with ischemic brain tissue secondary to post-traumatic C1-2 segment instability from a MVC 7 years prior to presentation. The second patient presented with a 3 year history of persistent right-sided neck and upper scalp pain. Both were treated with transarticular C1-2 fusion through decortication of the atlantoaxial facet joints and TAS fixation via the anterior Smith-Robinson approach. At 16 months follow-up, the first patient maintained painless range of motion of the cervical spine and denied sensorimotor deficits. The second patient reported 90% improvement in her pre-operative symptoms of neck pain and paresthesia. Anterior Smith-Robinson C1-2 TAS fixation provides a useful alternative to the posterior Goel and Magerl techniques for C1-2 stabilization and fusion.	[Carrier, C. S.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Sama, A. A.; Girardi, F. P.; Lebl, D. R.] Hosp Special Surg, Dept Orthoped Surg, 535 East 72nd St, New York, NY 10021 USA		Lebl, DR (corresponding author), Hosp Special Surg, Dept Orthoped Surg, 535 East 72nd St, New York, NY 10021 USA.	drlebl@hss.edu					Abbas J, 2006, VASCULAR, V14, P43, DOI 10.2310/6670.2006.00003; AbouMadawi A, 1997, J BONE JOINT SURG BR, V79B, P820; BROOKS AL, 1978, J BONE JOINT SURG AM, V60, P279, DOI 10.2106/00004623-197860030-00001; COYNE TJ, 1995, NEUROSURGERY, V37, P688, DOI 10.1227/00006123-199510000-00012; Ebraheim N, 1996, SPINE, V21, P691, DOI 10.1097/00007632-199603150-00005; Gailloud P, 2000, AM J NEURORADIOL, V21, P941; Gallie WE, 1937, ANN SURG, V106, P770, DOI 10.1097/00000658-193710000-00026; GOEL A, 1994, ACTA NEUROCHIR, V129, P47, DOI 10.1007/BF01400872; Goel A, 2002, NEUROSURGERY, V51, P1351, DOI 10.1097/00006123-200212000-00004; Gunnarsson T, 2007, J SPINAL DISORD TECH, V20, P308, DOI 10.1097/01.bsd.0000211291.21766.4d; Haid RW, 2001, NEUROSURGERY, V49, P65, DOI 10.1097/00006123-200107000-00010; Harms J, 2001, SPINE, V26, P2467, DOI 10.1097/00007632-200111150-00014; Hasan I, 2002, CHILD NERV SYST, V18, P67, DOI 10.1007/s003810100511; Kandziora F, 2000, SPINE, V25, P1555, DOI 10.1097/00007632-200006150-00016; Kuroki Hiroshi, 2005, Neurosurgery, V56, P151; Layton KF, 2006, AM J NEURORADIOL, V27, P1541; Leonard JR, 2006, J NEUROSURG, V104, P59, DOI 10.3171/ped.2006.104.1.59; Magerl F, 1987, CERVICAL SPINE, P322, DOI DOI 10.1007/978-3-7091-8882-8_59; Mandel IM, 2000, SPINE, V25, P1542, DOI 10.1097/00007632-200006150-00014; Memtsoudis SG, 2011, CLIN ORTHOP RELAT R, V469, P649, DOI 10.1007/s11999-010-1549-4; Mo F, 2012, TECH ORTHOP, V27, P143; Mueller CA, 2010, EUR SPINE J, V19, P809, DOI 10.1007/s00586-010-1291-3; Naderi S, 1998, SPINE, V23, P1946, DOI 10.1097/00007632-199809150-00005; Olsen MA, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.F.01515; Paksoy Y, 2004, SPINE, V29, pE193, DOI 10.1097/00007632-200405010-00024; Paramore CG, 1996, J NEUROSURG, V85, P221, DOI 10.3171/jns.1996.85.2.0221; Reindl R, 2003, SPINE, V28, pE329, DOI 10.1097/01.BRS.0000083328.27907.3B; Schaeren S, 2005, EUR SPINE J, V14, P501, DOI 10.1007/s00586-004-0856-4; Sen MK, 2005, EUR SPINE J, V14, P512, DOI 10.1007/s00586-004-0823-0; Stulik J, 2007, EUR SPINE J, V16, P479, DOI 10.1007/s00586-006-0241-6; VACCARO AR, 1994, SPINE, V19, P2637; Wang MY, 2006, NEUROSURGERY, V59, P84, DOI 10.1227/01.NEU.0000219900.24467.32; Wang SL, 2011, SPINE, V36, P3, DOI 10.1097/BRS.0b013e3181c97dc7; WHITE AA, 1975, CLIN ORTHOP RELAT R, P85, DOI 10.1097/00003086-197506000-00011	34	6	6	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0974-8237	0976-9285		J CRANIOVERTEBRAL JU	J. Craniovertebral Junction Spine	JUL-DEC	2013	4	2					85	89		10.4103/0974-8237.128540			5	Otorhinolaryngology	Emerging Sources Citation Index (ESCI)	Otorhinolaryngology	V4M5Z	WOS:000219069000010	24737928	Green Published, gold			2022-02-06	
J	Choudhri, AF; Patel, BJ; Phillips, ME; Mills, KA; Whitehead, MT; Fleming, JC				Choudhri, Asim F.; Patel, Bhumin J.; Phillips, Margaret E.; Mills, Katie A.; Whitehead, Matthew T.; Fleming, James C.			Diamagnetic Susceptibility Artifact Associated With Graphite Foreign Body of the Orbit	OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							BODIES; BRAIN	Imaging in traumatic injury to the orbits plays an important role to identify malformation of the globe, retrobulbar pathology, such as hematoma, the presence of fractures, and identification of foreign bodies. MRI can be especially useful in characterizing soft tissue abnormalities without the use of ionizing radiation. The authors report a case of penetrating injury to the orbit with a retained foreign body where the graphite core of a pencil (pencil lead) resulted in metal-like diamagnetic susceptibility artifact. This was proven to have no metallic components by CT and surgical exploration. MRI performed in the setting of penetrating injury could aid in localization of a graphite foreign body, and if there is a known graphite foreign body, evaluation of immediately adjacent structures may be obscured.	[Choudhri, Asim F.; Whitehead, Matthew T.] Univ Tennessee, Hlth Sci Ctr, Dept Radiol, Memphis, TN USA; [Choudhri, Asim F.] Univ Tennessee, Hlth Sci Ctr, Dept Neurosurg, Memphis, TN USA; [Choudhri, Asim F.; Whitehead, Matthew T.] Le Bonheur Childrens Hosp, Dept Radiol, Memphis, TN 38103 USA; [Patel, Bhumin J.] Univ Tennessee, Coll Med, Hlth Sci Ctr, Memphis, TN USA; Univ Tennessee, Dept Ophthalmol, Hlth Sci Ctr, Memphis, TN USA; [Phillips, Margaret E.; Mills, Katie A.; Fleming, James C.] Hamilton Eye Inst, Memphis, TN USA		Choudhri, AF (corresponding author), Le Bonheur Childrens Hosp, Dept Radiol, 848 Adams Ave G216, Memphis, TN 38103 USA.	achoudhri@uthsc.edu	Choudhri, Asim/J-5266-2012	Choudhri, Asim/0000-0002-3154-6319			Close JK, 2009, OPHTHAL PLAST RECONS, V25, P335, DOI 10.1097/IOP.0b013e3181aadafe; Lagalla R, 2000, EUR RADIOL, V10, P1338, DOI 10.1007/s003309900306; Nelson EW, 1996, J HAND SURG-AM, V21A, P100, DOI 10.1016/S0363-5023(96)80161-4; Rahman NU, 1997, INT OPHTHALMOL, V21, P13, DOI 10.1023/A:1005834913614; Ripoll MA, 2004, NEURORADIOLOGY, V46, P435, DOI 10.1007/s00234-004-1191-5; Seider N, 2006, OPHTHAL PLAST RECONS, V22, P316, DOI 10.1097/01/iop.0000226920.54294.0c; Shah AD, 2011, INDIAN J OPHTHALMOL, V59, P501, DOI 10.4103/0301-4738.86325; Shelsta HN, 2010, OPHTHAL PLAST RECONS, V26, P238, DOI 10.1097/IOP.0b013e3181bd7509; Thomas B, 2008, NEURORADIOLOGY, V50, P105, DOI 10.1007/s00234-007-0316-z	9	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0740-9303	1537-2677		OPHTHAL PLAST RECONS	Ophthalmic Plast. Reconstr. Surg.	JUL-AUG	2013	29	4					E105	E107		10.1097/IOP.0b013e31827df017			3	Ophthalmology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology; Surgery	181VS	WOS:000321698400005	23381565				2022-02-06	
J	Hall, C; Friel, K; Dong, M; Engel, L; O'Boyle, L; Pasquarella, A; Serkes, D; Smith, K; Stoebe, L; Valle, D				Hall, Cheryl; Friel, Karen; Dong, Michelle; Engel, Lauren; O'Boyle, Lauren; Pasquarella, Andrea; Serkes, David; Smith, Kathryn; Stoebe, Lauren; Valle, Danielle			Epidemiology of Injuries in the Elite Level Female High School Lacrosse Player	RESEARCH IN SPORTS MEDICINE			English	Article						adolescent; athletic injury; epidemiology	SPORTS	Female lacrosse has grown 219% in the last decade. This descriptive study explored the epidemiology of elite female high school lacrosse injuries and compared them with those in the collegiate player. Five hundred surveys were completed at tournaments in the northeast United States. Over 60% played other sports; 50% experienced a new injury while playing lacrosse, and 16% had a recurrent injury from another sport. The ankle, knee, and head were most commonly injured. Eleven percent of respondents sustained a concussion; 35% of these experienced some loss of consciousness. Eighty-four percent of injuries occurred via contact. Forty-two percent (42%) of athletes lost 10 or more days of playing time. Frequency data showed that reported injuries are high for elite lacrosse, which is classified as a noncontact sport, and are comparable with those seen in the collegiate player.	[Hall, Cheryl; Friel, Karen; Dong, Michelle; Engel, Lauren; O'Boyle, Lauren; Pasquarella, Andrea; Serkes, David; Smith, Kathryn; Stoebe, Lauren; Valle, Danielle] New York Inst Technol, Dept Phys Therapy, Old Westbury, NY 11568 USA		Friel, K (corresponding author), New York Inst Technol, Dept Phys Therapy, Northern Blvd, Old Westbury, NY 11568 USA.	kfriel@nyit.edu					Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Brown J., 2001, LACROSSE MAGAZIN MAY, P26; Cassas KJ, 2006, AM FAM PHYSICIAN, V73, P1014; Chandrashekar N, 2005, AM J SPORT MED, V33, P1492, DOI 10.1177/0363546504274149; Comstock R. D., CONVENIENCE SUMMARY; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dick R, 2007, J ATHL TRAINING, V42, P262; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Ingersoll CD, 2009, J ATHL TRAINING, V44, P453, DOI 10.4085/1062-6050-44.5.453; Stirling A. E., 2006, ATHLETIC INSIGHT ONL, V8, P13	11	6	7	3	14	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1543-8627			RES SPORTS MED	Res. Sports Med.	JUL 1	2013	21	3					229	239		10.1080/15438627.2013.792085			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	166PT	WOS:000320570300004	23777378				2022-02-06	
J	Manes, RP; Kutz, JW; Isaacson, B; Batra, PS				Manes, R. Peter; Kutz, J. Walter; Isaacson, Brandon; Batra, Pete S.			Technical feasibility of endoscopic eustachian tube catheter placement: A cadaveric analysis	AMERICAN JOURNAL OF RHINOLOGY & ALLERGY			English	Article							SILASTIC MEDIALIZATION; MANAGEMENT; AUTOPHONY	Background: Patulous eustachian tube (pET) can result in transmission of sound from the pharynx to the middle ear (ME) via an abnormally patent ET. The objective of this study was to evaluate the technical feasibility of a reversible transnasal procedure for pET using an occluded silastic catheter to close the ET. Methods: Ten sides were evaluated in five cadaver heads. Size 14, 16, and 18G catheters were occluded with bone wax to create a semirigid solid tube. They were placed transnasally, under endoscopic guidance through the ET orifice to span the entire ET length. Proper placement in the ME was confirmed by tympanotomy. Each attempt was graded on a four-point scale based on ease of placement: 3+, 2+, 1+, and 0. Results: The 16G was the easiest to place with the best fit and was confirmed in the ME in eight cases. The 14G catheter was next easiest to place and was observed in the ME in seven cases. It generally had an extremely tight fit and propensity to impart mucosal trauma. The 18G was the most difficult to place and was observed in the ME in six cases. The catheter was noted to displace easily because of a loose fit. Tympanic membrane or ossicular injury was not noted in any trial. Conclusion: These cadaveric data suggest that a semirigid catheter provides the technical capability to reversibly occlude the ET via the transnasal endoscopic route. Further confirmation is necessary in human studies to determine its effectiveness for management of pET.	[Manes, R. Peter] Yale Univ, Sch Med, Dept Surg, Sect Otolaryngol, New Haven, CT 06510 USA; [Kutz, J. Walter; Isaacson, Brandon; Batra, Pete S.] Univ Texas SW Med Ctr Dallas, Dept Otolaryngol Head & Neck Surg, Dallas, TX 75390 USA		Batra, PS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Otolaryngol Head & Neck Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	pete.batra@utsouthwestern.edu	Kutz, Joe/ABF-4855-2020	Isaacson, Brandon/0000-0003-4725-1555	American Rhinologic Society (ARS); MedtronicMedtronic	RP Manes is a consultant for Medtronic. JW Kutz is a consultant for Medtronic, Stryker, and Purdue Pharma. B Isaacson is on the Speaker's Bureau for Medtronic Midas Rex Institute. PS Batra is a consultant for Medtronic and has received grants from the American Rhinologic Society (ARS) and Medtronic	BLUESTONE CD, 1981, LARYNGOSCOPE, V91, P149; Bluestone CD, 1991, OTOLARYNGOLOGY, P1289; Doherty JK, 2003, OTOLARYNG HEAD NECK, V128, P88, DOI 10.1067/mhn.2003.34; NETTERVILLE JL, 1993, ANN OTO RHINOL LARYN, V102, P413, DOI 10.1177/000348949310200602; OCONNOR AF, 1981, LARYNGOSCOPE, V91, P1427, DOI 10.1288/00005537-198109000-00003; Poe DS, 2007, OTOL NEUROTOL, V28, P668; PULEC JL, 1967, LARYNGOSCOPE, V77, P1543, DOI 10.1288/00005537-196708000-00019; Rotenberg BW, 2013, LARYNGOSCOPE, V123, P239, DOI 10.1002/lary.23635; Sato T, 2005, ACTA OTO-LARYNGOL, V125, P1158, DOI 10.1080/00016480510038167; Schwartze H., 1864, ARCH OHRENHEILKD, V1, P139; Simpson CB, 1999, LARYNGOSCOPE, V109, P1424, DOI 10.1097/00005537-199909000-00012; Takasaki K, 2007, LARYNGOSCOPE, V117, P1251, DOI 10.1097/MLG.0b013e318058a09f	12	6	6	0	0	OCEAN SIDE PUBLICATIONS INC	PROVIDENCE	95 PITMAN ST, PROVIDENCE, RI 02906 USA	1945-8924			AM J RHINOL ALLERGY	Am. J. Rhinol. Allergy	JUL-AUG	2013	27	4					314	316		10.2500/ajra.2013.27.3914			3	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	193HK	WOS:000322549600019	23883813				2022-02-06	
J	Mioni, G; Rendell, PG; Henry, JD; Cantagallo, A; Stablum, F				Mioni, Giovanna; Rendell, Peter G.; Henry, Julie D.; Cantagallo, Anna; Stablum, Franca			An investigation of prospective memory functions in people with traumatic brain injury using Virtual Week	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Prospective memory; Traumatic brain injury; Virtual Week; Event based; Time based	WORKING-MEMORY; EXECUTIVE FUNCTIONS; PERFORMANCE; TASK; INVOLVEMENT; EVENT; SCALE; TIME; INDIVIDUALS; IMPAIRMENT	Prospective memory (PM) refers to memory for future intentions and is critically linked to independent living. Previous laboratory research has shown that people who have sustained a traumatic brain injury (TBI) have difficulties with PM, but few of these have used measures of PM that closely represent the types of PM activities that occur in everyday life. One measure that incorporates more ecologically valid tasks, and which also allows systematic investigation of different PM task parameters (regular, irregular, and event and time based), is Virtual Week. Consequently, in the present study, Virtual Week was administered to participants with TBI (n=18) and demographically matched controls (n=18). Consistent with considerable prior literature, the results indicated that people with TBI had significant difficulties executing PM tasks, with these deficits more pronounced for time-based than for event-based tasks. These data point to there being a relatively global PM deficit in people with TBI. Of particular interest was the finding that the magnitude of TBI impairment was consistent across regular and irregular tasks. Because the key distinction between these tasks is that they place low and high demands on retrospective memory, respectively, these data suggest that failures of retrospective memory are not the major cause of TBI-related impairment in PM. The implications of these results for the assessment and rehabilitation of PM impairment in people with TBI are discussed.	[Mioni, Giovanna; Stablum, Franca] Univ Padua, Dipartimento Psicol Gen, I-35121 Padua, Italy; [Rendell, Peter G.] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia; [Henry, Julie D.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Cantagallo, Anna] BrainCare, Padua, Italy		Mioni, G (corresponding author), Univ Padua, Dipartimento Psicol Gen, Via Venezia 8, I-35121 Padua, Italy.	giovanna.mioni@unipd.it	Rendell, Peter/E-7539-2010	Rendell, Peter/0000-0002-4829-4322; Henry, Julie/0000-0002-2081-3717; mioni, Giovanna/0000-0002-1212-4591; Stablum, Franca/0000-0003-0123-5090			Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Bertsch S, 2007, MEM COGNITION, V35, P201, DOI 10.3758/BF03193441; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; Carlesimo GA, 2009, BEHAV NEUROL, V22, P101, DOI [10.3233/ben-2009-0251, 10.3233/BEN-2009-0251]; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cohen J., 2013, STAT POWER ANAL BEHA; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Einstein, 2007, PROSPECTIVE MEMORY O; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Foster ER, 2013, NEUROPSYCHOLOGY, V27, P170, DOI 10.1037/a0031946; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Griffiths A, 2012, ADDICTION, V107, P1809, DOI 10.1111/j.1360-0443.2012.03941.x; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Henry JD, 2007, SCHIZOPHR RES, V95, P179, DOI 10.1016/j.schres.2007.06.003; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; Henry JD, 2012, Q J EXP PSYCHOL, V65, P1274, DOI 10.1080/17470218.2011.651091; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Kim HJ, 2009, NEUROCASE, V15, P145, DOI 10.1080/13554790802709039; Kinch J., 2001, BRAIN IMPAIR, V2, P119, DOI [10.1375/brim.2.2.119, DOI 10.1375/BRIM.2.2.119]; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kinsella GJ, 2009, BRAIN IMPAIR, V10, P45, DOI 10.1375/brim.10.1.45; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Knight RG, 2009, BRAIN IMPAIR, V10, P3, DOI 10.1375/brim.10.1.3; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Laiacona M, 2000, NEUROL SCI, V21, P279, DOI 10.1007/s100720070065; Leitz JR, 2009, PSYCHOPHARMACOLOGY, V205, P379, DOI 10.1007/s00213-009-1546-z; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Levine B., 2002, PRINCIPLES FRONTAL L, P51; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; McQueen, 2003, BRAIN IMPAIR, V4, P135, DOI [10.1375/brim.4.2.135.270, DOI 10.1375/BRIM.4.2.135.27024]; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; Rendell PG, 2007, J INT NEUROPSYCH SOC, V13, P410, DOI 10.1017/S1355617707070579; Rendell PG, 2011, COGNITION EMOTION, V25, P916, DOI 10.1080/02699931.2010.508610; Rendell PG, 2009, BRAIN IMPAIR, V10, P14, DOI 10.1375/brim.10.1.14; Rendell PG, 2009, PSYCHOPHARMACOLOGY, V203, P609, DOI 10.1007/s00213-008-1408-0; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Rose NS, 2010, PSYCHOL AGING, V25, P595, DOI 10.1037/a0019771; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; TEASDALE G, 1974, LANCET, V2, P81; Thompson C, 2010, J INT NEUROPSYCH SOC, V16, P318, DOI 10.1017/S1355617709991354; Titov N, 2005, BRAIN INJURY, V19, P315, DOI 10.1080/02699050400013725; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; [No title captured]	61	6	6	0	19	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL 1	2013	35	6					617	630		10.1080/13803395.2013.804036			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	238BH	WOS:000325914900006	23734818				2022-02-06	
J	Puljula, J; Lesonen, S; Kortelainen, ML; Juvela, S; Hillbom, M				Puljula, Jussi; Lesonen, Saara; Kortelainen, Marja-Leena; Juvela, Seppo; Hillbom, Matti			Mortality from traumatic brain injury after reduction of alcohol prices: A population-based study from northern Finland	SCANDINAVIAN JOURNAL OF PUBLIC HEALTH			English	Article						alcohol consumption; alcohol prices; cause of death; mortality; traumatic brain injury	FOLLOW-UP; TAX CUTS; DEATHS	Aims: Traumatic brain injury (TBI) is the leading cause of death after trauma, and alcohol is a major risk factor for TBI. In Finland, alcohol taxes were cut by one third in 2004. This resulted in a marked increase of alcohol consumption. We investigated whether increased alcohol consumption influenced the number of fatal TBIs. Methods: All (n = 318) fatal TBIs were identified from medico-legal reports during the years 1999, 2006 and 2007 among the residents of Oulu Province, Finland. Mortality rates were compared before and after alcohol price reduction. Alcohol involvement based on the presence of alcohol in body fluids and/or alcohol-related diseases recorded in death certificates. Results: The proportion of alcohol-related TBI deaths of all TBI deaths increased (from 1999 to 2007) among middle-aged people from 48% to 91% (p = 0.001) but decreased among young adults from 74% to 41% (p = 0.015). The overall TBI mortality rate did not increase. Fatal TBIs due to falls were significantly more commonly alcohol-related in 2006-2007 than in 1999 (p = 0.003) and accumulated among middle-aged people. Conclusions: After the price reduction, alcohol-related fatal TBIs increased most among middle-aged people, and they were frequently caused by fall accidents. The reduction of alcohol prices did not increase the total number of fatal TBIs. Middle-aged and elderly subjects with TBI should be routinely asked for alcohol drinking and those with hazardous drinking habits should be guided for alcohol intervention.	[Puljula, Jussi; Lesonen, Saara; Hillbom, Matti] Oulu Univ Hosp, Dept Neurol, Oys 90029, Finland; [Kortelainen, Marja-Leena] Univ Oulu, Dept Forens Med, Oulu, Finland; [Juvela, Seppo] Univ Helsinki, FIN-00014 Helsinki, Finland		Puljula, J (corresponding author), Oulu Univ Hosp, Dept Neurol, Box 25, Oys 90029, Finland.	jpuljula@paju.oulu.fi		Juvela, Seppo/0000-0003-4944-4983			Adekoya N, 2004, PUBLIC HEALTH REP, V119, P486, DOI 10.1016/j.phr.2004.07.006; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Herttua K, 2008, J EPIDEMIOL COMMUN H, V62, P995, DOI 10.1136/jech.2007.069575; Herttua K, 2008, AM J EPIDEMIOL, V168, P1110, DOI 10.1093/aje/kwn216; Herttua K, 2007, ALCOHOL ALCOHOLISM, V42, P456, DOI 10.1093/alcalc/agl099; Hiltunen Laura, 2009, Duodecim, V125, P1802; HINGSON R, 1993, ADDICTION, V88, P877, DOI 10.1111/j.1360-0443.1993.tb02105.x; Koski A, 2007, ADDICTION, V102, P362, DOI 10.1111/j.1360-0443.2006.01715.x; Kugelberg FC, 2007, FORENSIC SCI INT, V165, P10, DOI 10.1016/j.forsciint.2006.05.004; MAKELA P, 2009, YHTEISKUNTAPOLITIIKK, V0074; Makela P, 2008, ADDICTION, V103, P181, DOI 10.1111/j.1360-0443.2007.02049.x; Makela P, 2009, ADDICTION, V104, P554, DOI 10.1111/j.1360-0443.2009.02517.x; MCCOY GF, 1989, INJURY, V20, P65, DOI 10.1016/0020-1383(89)90141-1; MUSTONEN H, 2009, YHTEISKUNTAPOLITIIKK, V0074; Ohshima T, 1998, J Clin Forensic Med, V5, P129, DOI 10.1016/S1353-1131(98)90031-1; Organization W.H, 2008, GLOBAL BURDEN DIS 20; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Puljula J, 2013, ACTA NEUROL SCAND, V127, P192, DOI 10.1111/j.1600-0404.2012.01697.x; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Sjogren H, 2000, J STUD ALCOHOL, V61, P507; Sjogren H, 2006, EUR J PUBLIC HEALTH, V16, P266, DOI 10.1093/eurpub/ckl039; Smith GS, 1999, ANN EMERG MED, V33, P659, DOI 10.1016/S0196-0644(99)70195-2; SMITH SM, 1989, AM J PREV MED, V5, P296, DOI 10.1016/S0749-3797(18)31070-5; Soderlund T, 2009, EUR J TRAUMA EMERG S, V35, P455, DOI 10.1007/s00068-009-8179-0; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Vaaramo K, 2012, NEUROEPIDEMIOLOGY, V39, P156, DOI 10.1159/000341241	29	6	6	0	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1403-4948	1651-1905		SCAND J PUBLIC HEALT	Scand. J. Public Health	JUL	2013	41	5					524	530		10.1177/1403494813481644			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	154NX	WOS:000319684100012	23503192				2022-02-06	
J	Sevagan, G; Zhu, F; Jiang, BH; Yang, KH				Sevagan, Gopinath; Zhu, Feng; Jiang, Binhui; Yang, King H.			Numerical simulations of the occupant head response in an infantry vehicle under blunt impact and blast loading conditions	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Occupant safety; infantry vehicle; head injury; blunt impact; blast impact; finite element analysis	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODEL	This article presents the results of a finite element simulation on the occupant head response in an infantry vehicle under two separated loading conditions: (1) blunt impact and (2) blast loading conditions. A Hybrid-III dummy body integrated with a previously validated human head model was used as the surrogate. The biomechanical response of the head was studied in terms of head acceleration due to the impact by a projectile on the vehicle and intracranial pressure caused by blast wave. A series of parametric studies were conducted on the numerical model to analyze the effect of some key parameters, such as seat configuration, impact velocity, and boundary conditions. The simulation results indicate that a properly designed seat and internal surface of the infantry vehicle can play a vital role in reducing the risk of head injury in the current scenarios. Comparison of the kinematic responses under the blunt impact and blast loading conditions reveals that under the current loading conditions, the acceleration pulse in the blast scenario has much higher peak values and frequency than blunt impact case, which may reflect different head response characteristics.	[Sevagan, Gopinath; Zhu, Feng; Jiang, Binhui; Yang, King H.] Wayne State Univ, Ctr Bioengn, Detroit, MI 48201 USA; [Jiang, Binhui] Hunan Univ, State Key Lab Adv Design & Mfg Vehicle Body, Changsha 410082, Hunan, Peoples R China		Zhu, F (corresponding author), Wayne State Univ, Ctr Bioengn, Detroit, MI 48201 USA.	fengzhume@gmail.com	Jiang, Binhui/V-9272-2019	Jiang, Binhui/0000-0001-9255-5780	General Dynamics Land Systems; Bioengineering Center, Wayne State University	This research is partially supported by General Dynamics Land Systems and partially supported by the Bioengineering Center, Wayne State University.	[Anonymous], 1991, CONWEP CONV WEAP EFF; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Claessens M, 1997, 41 STAPP CAR CRASH C; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; KANG HS, 1997, 41 STAPP CAR CRASH C; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Souli M, 2004, LS DYNA ADV COURSE A; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhu F, 2012, INT J NONLIN SCI NUM, V13, P25, DOI 10.1515/IJNSNS.2011.095; Zhu Feng, 2010, Stapp Car Crash J, V54, P211; Zhu F, 2011, COMPOS PART B-ENG, V42, P1202, DOI 10.1016/j.compositesb.2011.02.014; Zhu F, 2010, MATER DESIGN, V31, P4704, DOI 10.1016/j.matdes.2010.05.023; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015	20	6	6	0	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	JUL	2013	227	7					778	787		10.1177/0954411913483430			10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	287FT	WOS:000329527900006	23636759				2022-02-06	
J	Varelas, PN; Spanaki, MV; Mirski, MA				Varelas, Panayiotis N.; Spanaki, Marianna V.; Mirski, Marek A.			Seizures and the Neurosurgical Intensive Care Unit	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Seizures; Neurosurgical intensive care unit; Antiepileptic drugs	TRAUMATIC BRAIN-INJURY; REFRACTORY STATUS EPILEPTICUS; CONVULSIVE STATUS EPILEPTICUS; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; NONCONVULSIVE STATUS EPILEPTICUS; QUALITY STANDARDS SUBCOMMITTEE; ACUTE ISCHEMIC-STROKE; RISK-FACTORS; ANTICONVULSANT PROPHYLAXIS; SUBARACHNOID HEMORRHAGE	The cause of seizures in the neurosurgical intensive care unit (NICU) can be categorized as emanating from either a primary brain pathology or from physiologic derangements of critical care illness. Patients are typically treated with parenteral antiepileptic drugs. For early onset ICU seizures that are easily controlled, data support limited treatment. Late seizures have a more ominous risk for subsequent epilepsy and should be treated for extended periods of time or indefinitely. This review ends by examining the treatment algorithms for simple seizures and status epilepticus and the role newer antiepileptic use can play in the NICU.	[Varelas, Panayiotis N.; Spanaki, Marianna V.] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Varelas, Panayiotis N.] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Mirski, Marek A.] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA; [Mirski, Marek A.] Johns Hopkins Univ Hosp, Dept Anesthesiol & Crit Care, Baltimore, MD 21287 USA		Varelas, PN (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd,K-11, Detroit, MI 48202 USA.	varelas@neuro.hfh.edu	Varelas, Panayiotis/V-1702-2019				Aguiar D, 2004, J NEURO-ONCOL, V66, P345, DOI 10.1023/B:NEON.0000014538.31561.bc; Alvarez V, 2013, J NEUROL, V260, P55, DOI 10.1007/s00415-012-6583-6; Alvarez V, 2011, EPILEPSIA, V52, P1292, DOI 10.1111/j.1528-1167.2011.03056.x; Alvarez-Sabin J, 2002, NEUROLOGY, V59, P1991, DOI 10.1212/01.WNL.0000038388.57824.B6; Arboix A, 1996, NEUROLOGY, V47, P1429, DOI 10.1212/WNL.47.6.1429; ARMSTRONG PJ, 1986, ANESTH ANALG, V65, P536; Bahr O, 2012, ACTA NEUROCHIR, V154, P229, DOI 10.1007/s00701-011-1144-9; BAKER CJ, 1995, NEUROSURGERY, V37, P863, DOI 10.1227/00006123-199511000-00003; Bateman BT, 2007, NEUROCRIT CARE, V7, P187, DOI 10.1007/s12028-007-0056-2; Beghi E, 2011, NEUROLOGY, V77, P1785, DOI 10.1212/WNL.0b013e3182364878; Berger B, 2012, NEUROCRIT CARE, V16, P428, DOI 10.1007/s12028-011-9669-6; Berges S, 2000, EUR NEUROL, V43, P3, DOI 10.1159/000008120; Bhangoo SS, 2011, NEUROSURG CLIN N AM, V22, P97, DOI 10.1016/j.nec.2010.09.001; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Boswell Mark V, 2004, Pain Physician, V7, P103; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Breen JC, 1996, NEUROLOGY, V46, P175, DOI 10.1212/WNL.46.1.175; Brodie MJ, 2012, ACTA NEUROL SCAND, V126, P19, DOI 10.1111/ane.12016; Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; Byrne JV, 2003, NEUROSURGERY, V52, P545, DOI 10.1227/01.NEU.0000047672.25068.4A; CERVONI L, 1994, NEUROSURG REV, V17, P185, DOI 10.1007/BF00418427; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Cherry S, 2012, NEUROCRIT CARE, V16, P294, DOI 10.1007/s12028-011-9662-0; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Cleary P, 2004, LANCET, V363, P1184, DOI 10.1016/S0140-6736(04)15946-1; CLUITMANS FHM, 1990, AM J MED, V88, P161, DOI 10.1016/0002-9343(90)90467-R; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cordonnier C, 2005, J NEUROL NEUROSUR PS, V76, P1649, DOI 10.1136/jnnp.2005.064535; Cotton BA, 2011, J TRAUMA, V71, P375, DOI 10.1097/TA.0b013e318224d307; Coutts SB, 2003, NEUROSURGERY, V53, P1053, DOI 10.1227/01.NEU.0000088738.80838.74; Czuczwar P, 2010, PHARMACOL REP, V62, P211, DOI 10.1016/S1734-1140(10)70260-7; De Reuck J, 2008, EUR NEUROL, V59, P225, DOI 10.1159/000115635; De Reuck J, 2008, CEREBROVASC DIS, V25, P100, DOI 10.1159/000111998; Denier C, 2010, ARCH NEUROL-CHICAGO, V67, P1219, DOI 10.1001/archneurol.2010.263; Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; Englot DJ, 2012, J NEUROSURG, V117, P970, DOI 10.3171/2012.8.JNS122; FAUGHT E, 1989, NEUROLOGY, V39, P1089, DOI 10.1212/WNL.39.8.1089; Ferro JM, 2003, CEREBROVASC DIS, V15, P78, DOI 10.1159/000067133; Ferro JM, 2008, STROKE, V39, P1152, DOI 10.1161/STROKEAHA.107.487363; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gaida-Hommernick B, 2001, EPILEPSIA, V42, P793, DOI 10.1046/j.1528-1157.2001.44200.x; Garrett MC, 2009, J CRIT CARE, V24, P335, DOI 10.1016/j.jcrc.2008.10.015; Gilad R, 2012, DRUG AGING, V29, P533, DOI 10.2165/11631540-000000000-00000; GIROUD M, 1994, EPILEPSIA, V35, P959, DOI 10.1111/j.1528-1157.1994.tb02540.x; Glantz MJ, 2000, NEUROLOGY, V54, P1886, DOI 10.1212/WNL.54.10.1886; Goldstein LB, 1998, ARCH NEUROL-CHICAGO, V55, P454, DOI 10.1001/archneur.55.4.454; Guerrini R, 1999, BRAIN DEV-JPN, V21, P420, DOI 10.1016/S0387-7604(99)00048-0; HAINES SJ, 1988, AM J EMERG MED, V6, P173, DOI 10.1016/0735-6757(88)90057-5; Hamamura T, 2010, NEUROL MED-CHIR, V50, P1099, DOI 10.2176/nmc.50.1099; Hamidou B, 2012, J NEUROL; HART RG, 1981, NEUROSURGERY, V8, P417, DOI 10.1227/00006123-198104000-00002; HASAN D, 1993, ANN NEUROL, V33, P286; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; HENNIS A, 1992, J NEUROL NEUROSUR PS, V55, P195, DOI 10.1136/jnnp.55.3.195; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Ho DSW, 2000, CEREBROVASC DIS, V10, P374; Hofler J, 2013, EPILEPSIA, V54, P393, DOI 10.1111/epi.12058; Hoh BL, 2011, NEUROSURGERY, V69, P644, DOI 10.1227/NEU.0b013e31821bc46d; Hottinger A, 2012, CNS DRUGS, V26, P761, DOI 10.2165/11633090-000000000-00000; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; JORGENSEN LG, 1993, EUR J VASCULAR SURG, V7, P370, DOI 10.1016/S0950-821X(05)80252-X; Jung S, 2012, STROKE, V43, P1584, DOI 10.1161/STROKEAHA.111.645358; Kalita J, 2012, SEIZURE-EUR J EPILEP, V21, P639, DOI 10.1016/j.seizure.2012.07.005; KIEBURTZ K, 1990, ARCH NEUROL-CHICAGO, V47, P568, DOI 10.1001/archneur.1990.00530050092017; Ko SB, 2011, ARCH NEUROL-CHICAGO, V68, P1323, DOI 10.1001/archneurol.2011.240; Kwan J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005398.pub2; Lamy C, 2003, NEUROLOGY, V60, P400, DOI 10.1212/WNL.60.3.400; LANCMAN ME, 1993, EPILEPSIA, V34, P141, DOI 10.1111/j.1528-1157.1993.tb02386.x; Lanzino G, 2011, NEUROCRIT CARE, V15, P247, DOI 10.1007/s12028-011-9584-x; LEBLANC F, 1974, HDB CLIN NEUROLOGY, V15, P295; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; Leker RR, 2003, BRAIN RES REV, V42, P187, DOI 10.1016/S0165-0173(03)00170-X; Lin CL, 2003, J NEUROSURG, V99, P978, DOI 10.3171/jns.2003.99.6.0978; Lin YJ, 2008, EUR J NEUROL, V15, P451, DOI 10.1111/j.1468-1331.2008.02096.x; Lindgren C, 2012, NEUROCRIT CARE, V17, P367, DOI 10.1007/s12028-012-9771-4; Marino D, 2012, EPILEPTIC DISORD, V14, P85, DOI 10.1684/epd.2012.0487; Maschio M, 2012, J NEURO-ONCOL, V106, P651, DOI 10.1007/s11060-011-0689-z; Maschio M, 2012, CURR NEUROPHARMACOL, V10, P124, DOI 10.2174/157015912800604470; Masuhr F, 2006, EUR J NEUROL, V13, P852, DOI 10.1111/j.1468-1331.2006.01371.x; Mikkelsen T, 2010, J NEURO-ONCOL, V96, P97, DOI 10.1007/s11060-009-0056-5; Mink S, 2011, CLIN NEUROL NEUROSUR, V113, P644, DOI 10.1016/j.clineuro.2011.05.007; Mirski MA, 2008, CRIT CARE CLIN, V24, P115, DOI 10.1016/j.ccc.2007.11.005; Misra UK, 2012, J NEUROL, V259, P645, DOI 10.1007/s00415-011-6227-2; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Naeije G, 2011, ARCH NEUROL-CHICAGO, V68, P1303, DOI 10.1001/archneurol.2011.204; Naidech AM, 2005, STROKE, V36, P583, DOI 10.1161/01.STR.0000141936.36596.1e; Naidech AM, 2009, STROKE, V40, P3810, DOI 10.1161/STROKEAHA.109.559948; Naval NS, 2006, CRIT CARE MED, V34, P511, DOI 10.1097/01.CCM.0000198331.45998.85; Pandey C K, 2003, J Postgrad Med, V49, P285; Passero S, 2002, EPILEPSIA, V43, P1175, DOI 10.1046/j.1528-1157.2002.00302.x; Pinto AN, 1996, J NEUROL, V243, P161, DOI 10.1007/BF02444009; Pitkanen A, 2012, SOURCE JASPERS BASIC; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Raper DM, 2012, WORLD NEUROSURG; Reith J, 1997, STROKE, V28, P1585, DOI 10.1161/01.STR.28.8.1585; Rhoney DH, 2010, CURR CLIN NEUROL, P307, DOI 10.1007/978-1-60327-532-3_13; Rhoney DH, 2000, NEUROLOGY, V55, P258, DOI 10.1212/WNL.55.2.258; Rosengart AJ, 2007, J NEUROSURG, V107, P253, DOI 10.3171/JNS-07/08/0253; Rumbach L, 2000, NEUROLOGY, V54, P350, DOI 10.1212/WNL.54.2.350; Sakowitz OW, 2013, STROKE, V44, P220, DOI 10.1161/STROKEAHA.112.672352; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; Schuele SU, 2005, NEUROLOGY, V64, P1086, DOI 10.1212/01.WNL.0000154639.35941.21; Shah D, 2009, SEIZURE-EUR J EPILEP, V18, P676, DOI 10.1016/j.seizure.2009.09.003; Shepard PW, 2012, CURR TREAT OPTION NE, V14, P332, DOI 10.1007/s11940-012-0180-y; Shorvon S, 2012, BRAIN, V135, P2314, DOI 10.1093/brain/aws091; Shorvon S, 2011, EPILEPSIA, V52, P53, DOI 10.1111/j.1528-1167.2011.03238.x; Shorvon S, 2011, BRAIN, V134, P2802, DOI 10.1093/brain/awr215; Sirven JI, 2004, MAYO CLIN PROC, V79, P1489, DOI 10.4065/79.12.1489; Smith NL, 2012, CRIT CARE RESUSC, V14, P312; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Soupart A, 1996, CLIN NEPHROL, V46, P149; Sukhotinsky I, 2010, J CEREBR BLOOD F MET, V30, P1168, DOI 10.1038/jcbfm.2009.285; Sun DA, 2001, STROKE, V32, P2344, DOI 10.1161/hs1001.097242; Swisher CB, 2013, SEIZURE-EUR J EPILEP, V22, P116, DOI 10.1016/j.seizure.2012.11.004; Swisher CB, 2012, NEUROCRIT CARE, V16, P109, DOI 10.1007/s12028-011-9626-4; Szaflarski JP, 2008, EPILEPSIA, V49, P974, DOI 10.1111/j.1528-1167.2007.01513.x; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Tarulli A, 2004, NEUROLOGY, V62, P837, DOI 10.1212/WNL.62.5.837; Tatu L, 2000, EUR NEUROL, V43, P209, DOI 10.1159/000008177; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Tiras R, 2009, ANN SAUDI MED, V29, P313, DOI 10.4103/0256-4947.55319; Towne AR, 2003, NEUROLOGY, V60, P332, DOI 10.1212/01.WNL.0000042783.86439.27; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Trinka E, 2002, J NEUROL, V249, P1417, DOI 10.1007/s00415-002-0857-3; Trinka E, 2012, EPILEPSIA, V53, P127, DOI 10.1111/j.1528-1167.2012.03622.x; Trinka E, 2011, EPILEPSIA, V52, P35, DOI 10.1111/j.1528-1167.2011.03232.x; Tsai HC, 2012, BRIT J NEUROSURG, V26, P347, DOI 10.3109/02688697.2011.638996; Varelas PN, 2004, CLIN EEG NEUROSCI, V35, P173, DOI 10.1177/155005940403500406; Varelas RN, 2010, GUIDE DIAGNOSIS THER; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wallace KL, 1997, CRIT CARE CLIN, V13, P741, DOI 10.1016/S0749-0704(05)70367-5; Weller M, 2011, NEUROLOGY, V77, P1156, DOI 10.1212/WNL.0b013e31822f02e1; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; WIJDICKS EFM, 1993, NEUROLOGY, V43, P1042, DOI 10.1212/WNL.43.5.1042; Woitzik J, 2012, J CEREBR BLOOD F MET, V32, P203, DOI 10.1038/jcbfm.2011.169; Wong GKC, 2005, STROKE, V36, P2532, DOI 10.1161/01.STR.0000190837.63350.84; Yang TM, 2009, J NEUROSURG, V111, P87, DOI 10.3171/2009.2.JNS081622; Yeh HM, 2003, ANESTHESIOLOGY, V98, P270, DOI 10.1097/00000542-200301000-00042; Yoshimura I, 2001, EPILEPSY RES, V46, P283, DOI 10.1016/S0920-1211(01)00282-0; Zaatreh MM, 2005, CLIN NEUROPHARMACOL, V28, P243, DOI 10.1097/01.wnf.0000185828.80561.ad; Zelano J, 2012, SEIZURE-EUR J EPILEP, V21, P233, DOI 10.1016/j.seizure.2012.01.008	152	6	6	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2013	24	3					393	+		10.1016/j.nec.2013.03.005			15	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	191NY	WOS:000322421100008	23809033				2022-02-06	
J	Blain-Moraes, S; Chesser, S; Kingsnorth, S; Mckeever, P; Biddiss, E				Blain-Moraes, Stefanie; Chesser, Stephanie; Kingsnorth, Shauna; Mckeever, Patricia; Biddiss, Elaine			Biomusic: A Novel Technology for Revealing the Personhood of People with Profound Multiple Disabilities	AUGMENTATIVE AND ALTERNATIVE COMMUNICATION			English	Article						Communicative interaction; Complex continuing care; Biomusic; Personhood	BRAIN-COMPUTER INTERFACE; COMMUNICATION; QUALITY; ADULTS; CHILDREN; CARE; INTERVENTIONS; INDIVIDUALS; POPULATION; IMPAIRMENT	It is often difficult for family members and caregivers to interact with persons with profound multiple disabilities (PMD) because of the severely compromised communicative repertoire of this population. The resulting communication challenges may limit the ability of others to perceive personhood in individuals with PMD. This preliminary study investigated the effects of music generated in real time from physiological signals (biomusic) on caregiver perceptions of their interactions with persons with PMD. Caregivers (n - 10; parents and clinical staff) engaged in four, 10-min interactions with a person with PMD (n - 3; diagnoses - traumatic brain injury, pervasive developmental disorder, hypoxic brain injury), whose biomusic was projected throughout. Caregivers participated in two open-ended, semi-structured interviews to explore the effect of biomusic on these interactions. Most caregiver responses to biomusic were very positive, and many reported that biomusic caused an improvement in their interaction with and perceptions of the person with PMD. By providing audible evidence of the changing physiological state of persons with PMD, biomusic may enhance the perceived personhood of these individuals and enrich interactions with their family members and caregivers.	[Blain-Moraes, Stefanie] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Chesser, Stephanie] Univ Waterloo, Dept Leisure & Recreat, Waterloo, ON N2L 3G1, Canada; [Kingsnorth, Shauna; Mckeever, Patricia; Biddiss, Elaine] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada		Blain-Moraes, S (corresponding author), 7433 Med Sci I,1150 West Med Ctr Dr, Ann Arbor, MI 48105 USA.	stefanieb.moraes@gmail.com		Kingsnorth, Shauna/0000-0002-2051-7221; Chesser, Stephanie/0000-0003-4992-7475	Norman Saunders Complex Care Initiative Grant	This work was supported by the Norman Saunders Complex Care Initiative Grant administered by the Sick Kids Foundation.	Arslan B., 2005, P 1 SUMM WORKSH MULT, P21; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bellamy G, 2010, J INTELLECT DISABILI, V14, P221, DOI 10.1177/1744629510386290; Blain S, 2011, AUGMENT ALTERN COMM, V27, P1, DOI 10.3109/07434618.2011.556663; Blain-Moraes S., 2008, OPEN REHABIL J, V1, P27, DOI [DOI 10.2174/1874943700801010027, 10.2174/1874943700801010027]; Bradley M., 2009, PSYCHOPHYSIOLOGY, V17, P103; Cacioppo J.T., 2000, HDB EMOTIONS, V2nd ed, P173; Cacioppo JT., 2008, LONELINESS HUMAN NAT; Campo SF, 1997, MENT RETARD, V35, P329, DOI 10.1352/0047-6765(1997)035<0329:COTQOL>2.0.CO;2; Carnevale FA, 2008, J CHILD HEALTH CARE, V12, P4, DOI 10.1177/1367493508088552; Cooley C.H., 1972, SYMB INTERACT, P231; Costello J., 2000, AUGMENTATIVE ALTERNA, V16, P137, DOI DOI 10.1080/07434610012331279004; de Campo A., 2007, P 13 INT C AUD DISPL, P536; Durlach N, 2000, PRESENCE-TELEOP VIRT, V9, P214, DOI 10.1162/105474600566736; Emerson E, 2000, J INTELLECT DEV DIS, V25, P263, DOI 10.1080/13668250020019575; Etchels M., 2002, ASSETS 2002. Proceedings of the Fifth International ACM SIGCAPH Conference on Assistive Technologies, P213; Evenhuis HM, 2001, J INTELL DISABIL RES, V45, P457, DOI 10.1046/j.1365-2788.2001.00350.x; Fager S, 2006, AUGMENT ALTERN COMM, V22, P222, DOI 10.1080/07434610600650318; Fornefeld B., 1998, SCHWERSTBEHINDERTE K; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Goffman E., 1966, BEHAV PUBLIC PLACES; Goffman E., 1956, PRESENTATION SELF EV; Goldbart J., 1994, ED CHILDREN PROFOUND; Gomez P, 2008, BIOL PSYCHOL, V78, P138, DOI 10.1016/j.biopsycho.2008.01.013; Graham J., 2004, BRIT J LEARN DISABIL, V32, P24, DOI [10.1111/j.1468-3156.2004.00247.x, DOI 10.1111/J.1468-3156.2004.00247.X]; Grove N, 1999, J APPL RES INTELLECT, V12, P190, DOI 10.1111/j.1468-3148.1999.tb00076.x; Gubrium J. F., 1997, LIVING DYING MURRAY; Hallahan AR, 2000, CRIT CARE MED, V28, P3718, DOI 10.1097/00003246-200011000-00030; Happ M B, 2001, AACN Clin Issues, V12, P247, DOI 10.1097/00044067-200105000-00008; Happ MB, 2000, SOC SCI MED, V50, P1247, DOI 10.1016/S0277-9536(99)00367-6; Hashimoto Y, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-117; Hatton C, 1996, J INTELL DISABIL RES, V40, P466; Hewett D., 1998, INTERACTION ACTION R; Hogg J, 2001, J INTELL DISABIL RES, V45, P18, DOI 10.1046/j.1365-2788.2001.00289.x; Hogg J., 1986, PROFOUND RETARDATION, V1; Hubert BE, 2009, AUTISM, V13, P9, DOI 10.1177/1362361308091649; Janicki MP, 1998, J INTELLECT DEV DIS, V23, P3, DOI 10.1080/13668259800033541; Janssen JH, 2010, IEEE T AFFECT COMPUT, V1, P72, DOI 10.1109/T-AFFC.2010.13; Kingsnorth S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq008; Kitwood T., 1997, DEMENTIA RECONSIDERE; Kring AM, 1996, J ABNORM PSYCHOL, V105, P249, DOI 10.1037/0021-843X.105.2.249; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Laureys S, 2005, PROG BRAIN RES, V150, P495, DOI 10.1016/S0079-6123(05)50034-7; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Light J, 2012, AUGMENT ALTERN COMM, V28, P197, DOI 10.3109/07434618.2012.737024; Maes B, 2007, J INTELLECT DEV DIS, V32, P163, DOI 10.1080/13668250701549427; Mead G. H., 1970, SOCIAL PSYCHOL SYMBO, P537; Molm LD, 2007, SOC PSYCHOL QUART, V70, P199, DOI 10.1177/019027250707000208; Msall ME, 2002, MENT RETARD DEV D R, V8, P258, DOI 10.1002/mrdd.10046; Nakken H., 2007, J POLICY PRACT INTEL, V4, P83, DOI [10.1111/j.1741-1130.2007.00104.x, DOI 10.1111/J.1741-1130.2007.00104.X]; Neuper C, 2003, CLIN NEUROPHYSIOL, V114, P399, DOI 10.1016/S1388-2457(02)00387-5; Ogletree BT, 2011, COMMUN DISORD Q, V32, P164, DOI 10.1177/1525740109348791; Poh MZ, 2010, IEEE T BIO-MED ENG, V57, P1243, DOI 10.1109/TBME.2009.2038487; Rosenbaum P, 2008, REPORT PAEDIAT COMPL; Rowland C, 2010, J PEDIATR REHAB MED, V3, P319, DOI 10.3233/PRM-2010-0144; Sellers EW, 2010, AMYOTROPH LATERAL SC, V11, P449, DOI 10.3109/17482961003777470; Seys D, 1998, RES DEV DISABIL, V19, P261, DOI 10.1016/S0891-4222(98)00007-9; Soderholm S, 2001, J REHABIL MED, V33, P235; Stead L, 2004, PERS UBIQUIT COMPUT, V8, P282, DOI 10.1007/s00779-004-0289-4; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Tennant PWG, 2010, LANCET, V375, P649, DOI 10.1016/S0140-6736(09)61922-X; Vlaskamp C., 1993, KWESTIE PERSPECTIEF; Vlaskamp C, 2010, NEUROSCI RES PROG SE, P255; Vos P, 2010, J APPL RES INTELLECT, V23, P366, DOI 10.1111/j.1468-3148.2010.00553.x; Waksler F. C., 2006, HUMAN STUDIES, V28, P417, DOI DOI 10.1007/S10746-005-9007-0; Wong LYC, 2001, PAEDIATR PERINAT EP, V15, P374, DOI 10.1046/j.1365-3016.2001.00371.x; Wood N, 2004, SOC CULT GEOGR, V5, P533, DOI 10.1080/1464936042000317686; Yokoyama K, 2002, IEEE T BIO-MED ENG, V49, P729, DOI 10.1109/TBME.2002.1010857; Zhao SY, 2003, PRESENCE-VIRTUAL AUG, V12, P445, DOI 10.1162/105474603322761261	69	6	6	0	24	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0743-4618	1477-3848		AUGMENT ALTERN COMM	Augment. Altern. Commun.	JUN	2013	29	2					159	173		10.3109/07434618.2012.760648			15	Audiology & Speech-Language Pathology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Rehabilitation	151NN	WOS:000319467400005	23484489	Green Published			2022-02-06	
J	Tjahjadi, M; Arifin, MZ; Gill, AS; Faried, A				Tjahjadi, Mardjono; Arifin, Muhammad Z.; Gill, Arwinder Singh; Faried, Ahmad			Early mortality predictor of severe traumatic brain injury: A single center study of prognostic variables based on admission characteristics	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Traumatic brain injury; Prognosis; Early mortality		Objective: Traumatic brain injury (TBI) is one of the leading cause of death in many developing countries. The intention of this study was to develop a predictor model - to identify high death risk of severely head-injured patients in an early period in order to plan an effective and efficient treatment strategy. Method: We conducted a retrospective cross-sectional study with subjects of severe TBI patients (n = 61) from 1st of January to 31st December 2010. Variables included age, gender, blood pressure, mean arterial pressure, pulse rate, respiration rate, temperature, Glasgow Coma Scale (GCS) score, motor response, choice of treatment and head computed tomography (CT) profiles. These models - then analyzed using multiple logistic regression. Results: The outcome of this study produced five factors that correlated significantly with the survival of these patients: compression in basal cistern, low motor response (<4), presence of intradural lesion, mean arterial pressure, and midline shift. We divided these factors into major and minor factor according to their contribution to survival. Compression of basal cistern compression and low motor response (<4) are the most significant factors in predicting mortality (sensitivity greater than 90%). Conclusion: Basal cistern compression and motor response were the most valuable factors in determining the risk of death in severe TBI patients. Copyright (C) 2013, Neurotrauma Society of India. All rights reserved.	[Tjahjadi, Mardjono; Arifin, Muhammad Z.; Gill, Arwinder Singh; Faried, Ahmad] Univ Padjadjaran, Dr Hasan Sadikin Gen Hosp, Fac Med, Dept Neurosurg, Jl Pasteur 38, Bandung 40161, W Java, Indonesia		Gill, AS (corresponding author), Univ Padjadjaran, Dr Hasan Sadikin Gen Hosp, Fac Med, Dept Neurosurg, Jl Pasteur 38, Bandung 40161, W Java, Indonesia.	arwinsingh@hotmail.com	Tjahjadi, Mardjono/AAU-9055-2021	Tjahjadi, Mardjono/0000-0002-8264-8235			American Association of Neurological Surgery, 2010, J NEUROTRAUMA S1, V24, pS1; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Arifin M, 2010, THESIS; Athiappan S., 1993, Annals Academy of Medicine Singapore, V22, P452; Bolton CF, 2007, CHEST, V131, P1273, DOI 10.1378/chest.07-0367; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chestnut RM, 2000, J NEUROTRAUM, V17, P614; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Graham DI, 2000, NEUROSURGERY SCI BAS, P431; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hults K. N, 2005, HEAD INJURY PATHOPHY, P462; Jennet B., 1985, NEUROSURGERY SCI BAS, P117; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; LANGER M, 1987, INTENS CARE MED, V13, P342; Lee KR, 2000, NEUROSURGERY SCI BAS, P393; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Neurotrauma Team Dr. Soetomo General Hospital Surabaya, 2010, TRAUM BRIAN INJ PROT; Ono Jun-ichi, 1996, JPN J NEUROSURG, V5, P133; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; Signorini DF, 1996, J NEUROL NEUROSUR PS, V66, P20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Vollmer DG, 1991, J NEUROSURG S, V75, P37; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	34	6	6	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2013	10	1					3	8		10.1016/j.ijnt.2013.04.007			6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M4K	WOS:000218388900002					2022-02-06	
J	Senior, HEJ; McKinlay, L; Nikles, J; Schluter, PJ; Carmont, SA; Waugh, MC; Epps, A; Lloyd, O; Mitchell, GK				Senior, Hugh E. J.; McKinlay, Lynne; Nikles, Jane; Schluter, Philip J.; Carmont, Sue-Ann; Waugh, Mary-Clare; Epps, Adrienne; Lloyd, Owen; Mitchell, Geoffrey K.			Central nervous system stimulants for secondary attention deficit-hyperactivity disorder after paediatric traumatic brain injury: a rationale and protocol for single patient (n-of-1) multiple cross-over trials	BMC PEDIATRICS			English	Article						Traumatic brain injury; TBI; Children; Methylphenidate hydrochloride; MPH; Dexamphetamine; n-of-1 trial	DEFICIT/HYPERACTIVITY DISORDER; CHILDREN	Background: It is estimated that 22,800 children were living with an Acquired Brain Injury (ABI) (0.6% of children aged under 15 years) in Australia during 2003. Many children after a traumatic brain injury will experience difficulties with attention and concentration; a condition termed secondary Attention Deficit-Hyperactivity Disorder. There is conflicting evidence on whether treatment with stimulant therapy with medications such as methylphenidate or dexamphetamine will improve the attention and behavior of children with this condition. Methods/Design: Single patient trials (n-of-1s or SPTs) evaluate the effect of titrated doses of psychostimulants methylphenidate or dexamphetamine compared to placebo on attention and behavior, in children with TBI and secondary ADHD. The aggregation of multiple SPTs will produce a population estimate of the benefit. Forty-two children will be registered into the trial through rehabilitation services at three large children's hospitals in Australia. Patients will complete up to 3 cycles of treatment. Each cycle is 2 weeks long comprising seven days each of treatment and placebo, with the first two days of each cycle considered a washout period and the data not analysed. The order of treatment and placebo is randomly allocated for each cycle. The Conners' Parent Rating Scales long forms will be employed to measure change in attention-deficit/hyperactivity and related problems of the child, and the primary outcome measure is the Conners' Global Index Parent Version. Secondary outcomes include the teacher and child (if aged > 12 years) Conners' Rating Scales, the Behaviour Rating Inventory of Executive Function among other measures. This study will provide high-level evidence using a novel methodological approach to inform clinicians about the most appropriate treatment for individual children. Through aggregation of individual trials, a population estimate of treatment effect will be provided to guide clinical practice in the treatment of children with secondary ADHD after a traumatic brain injury. Discussion: This study employs an innovative methodological approach on the effectiveness of CNS stimulants for secondary ADHD from a brain injury. The findings will both guide clinicians on treatment recommendations, and inform the concept and acceptance of SPTs in paediatric research.	[Senior, Hugh E. J.; Nikles, Jane; Carmont, Sue-Ann; Mitchell, Geoffrey K.] Univ Queensland, Sch Med, Discipline Gen Practice, Ipswich, Qld 4305, Australia; [McKinlay, Lynne; Lloyd, Owen] Royal Childrens Hosp, Queensland Childrens Med Res Inst, Herston, Qld 4029, Australia; [Schluter, Philip J.] Univ Canterbury, Sch Hlth Sci, Ilam 8041, New Zealand; [Schluter, Philip J.] Univ Queensland, Sch Nursing & Midwifery, Brisbane, Qld 4305, Australia; [Waugh, Mary-Clare] Childrens Hosp Westmead, Rehabil Dept, Sydney, NSW 2145, Australia; [Epps, Adrienne] Sydney Childrens Hosp, Rehabil Dept, Randwick, NSW 2031, Australia		Senior, HEJ (corresponding author), Univ Queensland, Sch Med, Discipline Gen Practice, 11 Salisbury Rd, Ipswich, Qld 4305, Australia.	h.senior@uq.edu.au	Carmont, Sue-Ann S/G-4769-2011; Senior, Hugh/H-1579-2011; Nikles, Jane/F-4572-2010; Mitchell, Geoffrey/F-1489-2010	Carmont, Sue-Ann S/0000-0001-6266-7757; Nikles, Jane/0000-0001-5356-2291; Schluter, Philip/0000-0001-6799-6779; Senior, Hugh/0000-0002-7081-2499; Mitchell, Geoffrey/0000-0001-7817-6821; McKinlay, Lynne/0000-0002-6677-0628	Children's Health Foundation Queensland; Motor Accident Insurance Commission of Queensland; NHMRCNational Health and Medical Research Council of Australia [401780]	We thank the Children's Health Foundation Queensland and the Motor Accident Insurance Commission of Queensland for funding the study. Jane Nikles was funded by an NHMRC post-doctoral research fellowship 401780. We are grateful to Kath Bakker, who contributed to the study design.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Australian Bureau of Statistics, 2004, SURV DIS AG CAR 2003; Australian Institute of Health and Welfare (AIHW), 2006, BULLETIN, V42; Bakker K, 2008, MOTOR ACCIDENTS AUTH, P1; Brown RT, 2005, PEDIATRICS, V115, pE749, DOI 10.1542/peds.2004-2560; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Conners CK., 2008, CONNERS 3 EDITION MA; Dans AL, 1998, JAMA-J AM MED ASSOC, V279, P545, DOI 10.1001/jama.279.7.545; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Nikles CJ, 2006, PEDIATRICS, V117, P2040, DOI 10.1542/peds.2005-1328; Nikles J, 2011, J CLIN EPIDEMIOL, V64, P471, DOI 10.1016/j.jclinepi.2010.05.009; Schluter PJ, 2005, STAT MED, V24, P2625, DOI 10.1002/sim.2132; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zucker DR, 1997, J CLIN EPIDEMIOL, V50, P401, DOI 10.1016/S0895-4356(96)00429-5	20	6	6	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2431			BMC PEDIATR	BMC Pediatr.	MAY 28	2013	13								89	10.1186/1471-2431-13-89			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AC1EJ	WOS:000332236700001	23710976	Green Published, gold			2022-02-06	
J	Tee, JW; Chan, PCH; Fitzgerald, MCB; Liew, SM; Rosenfeld, JV				Tee, Jin W.; Chan, Patrick C. H.; Fitzgerald, Mark C. B.; Liew, Susan M.; Rosenfeld, Jeffrey V.			Early Predictors of Functional Disability After Spine Trauma A Level 1 Trauma Center Study	SPINE			English	Article						functional outcome; compliance study; SLIC; TLICS; GOS; spine trauma; predictive variables; benchmarking; quality	CORD-INJURY; ADMISSION HYPERGLYCEMIA; EPIDEMIOLOGY; BRAIN; CLASSIFICATION; MORTALITY; PREVALENCE; MANAGEMENT; MORPHOLOGY; FRACTURE	Study Design. Retrospective review on prospective cohort and explicit chart review. Objective. To identify early spine trauma predictors of functional disability and to assess management compliance to established spine trauma treatment algorithms. Summary of Background Data. Identification of early (within 48 hours) spine trauma predictors of functional disability is novel and may assist in the management of patients with trauma. Also, with significant global variation, spine trauma treatment algorithms are essential. Methods. Analysis was performed on patients with spine trauma from May 1, 2009, to January 1, 2011. Functional outcomes were determined using the Glasgow Outcome Scale (GOS) at 1 year. Univariate and multivariate regressions were applied to investigate the effects of the injury severity score, age, blood sugar level, vital signs, traumatic brain injury, comorbidities, coagulation profile, neurology, and spine injury characteristics. A compliance study was performed using the SLIC and TLICS spine trauma algorithms. Results. The completion rate for the GOS was 58.8%. The completed GOS cohort was 4.2 years younger in terms of mean age, had more number of patients with severe polytrauma, but less number of patients with severe spinal cord injuries (ASIA [American Spinal Injury Association] A, B, and C) in comparison with the uncompleted GOS cohort. Multivariate logistic regression revealed 3 independent early spine trauma predictors of functional disability with statistical significance (P < 0.05). They were (1) hypotension (OR [odds ratio] = 1.98; CI [confidence interval] = 1.13-3.49), (2) hyperglycemia (OR = 1.67; CI = 1.09-2.56), and (3) moderate/severe traumatic brain injury (OR = 5.88; CI = 1.71-20.16). There were 305 patients with subaxial cervical spine injuries and 653 patients with thoracolumbar spine injuries. The subaxial cervical spine injury classification and thoracolumbar injury classification and severity score compliance studies returned agreements of 96.1% and 98.9%, respectively. Conclusion. Early independent spine trauma predictors of functional disability identified in a level 1 trauma center with high compliance to the subaxial cervical spine injury classification and thoracolumbar injury classification and severity score algorithms were hypotension, hyperglycemia, and moderate or severe traumatic brain injury. Spine trauma injury variables alone were shown not to be predictive of functional disability.	[Tee, Jin W.; Chan, Patrick C. H.; Rosenfeld, Jeffrey V.] The Alfred, Dept Neurosurg, Melbourne, Vic 3004, Australia; [Tee, Jin W.; Fitzgerald, Mark C. B.] The Alfred, Trauma Serv, Melbourne, Vic 3004, Australia; [Tee, Jin W.; Chan, Patrick C. H.; Fitzgerald, Mark C. B.; Liew, Susan M.; Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Fitzgerald, Mark C. B.] The Alfred, Dept Emergency Med, Melbourne, Vic 3004, Australia; [Liew, Susan M.] The Alfred, Dept Orthopaed, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Natl Trauma Res Inst, Melbourne, Vic, Australia		Tee, JW (corresponding author), The Alfred, Level 1,Old Baker Bldg,Commercial Rd, Melbourne, Vic 3004, Australia.	Jin_Wee@hotmail.com	Rosenfeld, Jeffrey V/B-7249-2011	Fitzgerald, Mark/0000-0003-0183-7761			Akmal M, 2003, SPINE, V28, P180, DOI 10.1097/00007632-200301150-00016; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; BLUMER CE, 1995, NEUROEPIDEMIOLOGY, V14, P258, DOI 10.1159/000109801; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; Custer RL., 1999, CTE J, V15, DOI [10.21061/jcte.v15i2.702, DOI 10.21061/JCTE.V15I2.702]; DESAI D, 1989, J TRAUMA, V29, P719, DOI 10.1097/00005373-198906000-00003; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Fisher CG, 2006, SPINE, V31, pS2, DOI 10.1097/01.brs.0000217948.02567.3a; Glaser JA, 1998, SPINE, V23, P975, DOI 10.1097/00007632-199805010-00002; Grauer JN, 2004, SPINE, V29, P685, DOI 10.1097/01.BRS.0000115137.11276.0E; Hu R, 1996, SPINE, V21, P492, DOI 10.1097/00007632-199602150-00016; Hussain M, 2011, ASIAN SPINE J, V5, P208, DOI 10.4184/asj.2011.5.4.208; Jackson G, 2001, MAJOR TRAUMA DATA RE; JENNETT B, 1975, LANCET, V1, P480; Kraemer WJ, 1996, J ORTHOP TRAUMA, V10, P541, DOI 10.1097/00005131-199611000-00006; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lenehan B, 2010, SPINE, V35, pS174, DOI 10.1097/BRS.0b013e3181f32c82; Lu J, 2005, ACT NEUR S, V95, P281; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Middendorp JJ, 2010, SPINE, V35, P1079; Nassr A, 2008, SPINE, V33, pE188, DOI 10.1097/BRS.0b013e3181696118; Orimo Hajime, 2006, Nihon Ronen Igakkai Zasshi, V43, P27; Pickett W, 2003, J TRAUMA, V30, P113; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tee JW, 2012, GLOB SPINE J, V2, P71, DOI 10.1055/s-0032-1319772; Tee JW, 2013, SPINE PHILA PA 1976, V38, P169; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Urquhart DM, 2006, ANZ J SURG, V76, P600, DOI 10.1111/j.1445-2197.2006.03785.x; Vaccaro AR, 2007, SPINE, V32, P2365, DOI 10.1097/BRS.0b013e3181557b92; Vaccaro AR, 2005, SPINE, V30, P2325, DOI 10.1097/01.brs.0000182986.43345.cb; Victorian Orthopaedic Trauma Outcomes Registry (VOTOR), EP PREV MED MED NURS; Victorian State Trauma System (VSTS), VICT GOV HLTH INF; Whang PG, 2007, SPINE, V32, P791, DOI 10.1097/01.brs.0000258882.96011.47; World Health Organization, PROP WORK DEF OLD PE; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72	39	6	6	2	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAY 20	2013	38	12					999	1007		10.1097/BRS.0b013e31828432a3			9	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	148QR	WOS:000319261800016	23459136				2022-02-06	
J	Nedjat, MR; Wahmann, M; Bachli, H; Guresir, E; Vatter, H; Raabe, A; Heimann, A; Kempski, O; Alessandri, B				Nedjat, M. Rahimi; Waehmann, M.; Baechli, H.; Gueresir, E.; Vatter, H.; Raabe, A.; Heimann, A.; Kempski, O.; Alessandri, B.			ERYTHROPOIETIN NEUROPROTECTION IS ENHANCED BY DIRECT CORTICAL APPLICATION FOLLOWING SUBDURAL BLOOD EVACUATION IN A RAT MODEL OF ACUTE SUBDURAL HEMATOMA	NEUROSCIENCE			English	Article						acute subdural hemorrhage; clot evacuation; recombinant erythropoietin; neurotoxicity; rat	RECOMBINANT-HUMAN-ERYTHROPOIETIN; TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; INTRACRANIAL-PRESSURE; SURGICAL EVACUATION; NEURONAL APOPTOSIS; STIMULATING AGENTS; RECEPTOR AGONIST; CELL-DEATH; IN-VITRO	Recombinant human erythropoietin (EPO) has been successfully tested as neuroprotectant in brain injury models. The first large clinical trial with stroke patients, however, revealed negative results. Reasons are manifold and may include side-effects such as thrombotic complications or interactions with other medication, EPO concentration, penetration of the blood-brain-barrier and/or route of application. The latter is restricted to systemic application. Here we hypothesize that EPO is neuroprotective in a rat model of acute subdural hemorrhage (ASDH) and that direct cortical application is a feasible route of application in this injury type. The subdural hematoma was surgically evacuated and EPO was applied directly onto the surface of the brain. We injected NaCl, 200, 2000 or 20,000 IU EPO per rat i.v. at 15 min post-ASDH (400 mu l autologous venous blood) or NaCl, 0.02, 0.2 or 2 IU per rat onto the cortical surface after removal of the subdurally infused blood t at 70 min post-ASDH. Arterial blood pressure (MAP), blood chemistry, intracranial pressure (ICP), cerebral blood flow (CBF) and brain tissue oxygen (ptiO(2)) were assessed during the first hour and lesion volume at 2 days after ASDH. EPO 20,000 IU/rat (i.v.) elevated ICP significantly. EPO at 200 and 2000 IU reduced lesion volume from 38.2 +/- 0.6 mm(3) (NaCl-treated group) to 28.5 +/- 0.9 and 22.2 +/- 1.3 mm(3) (all p < 0.05 vs. NaCl). Cortical application of 0.02 IU EPO after ASDH evacuation reduced injury from 36.0 +/- 5.2 to 11.2 +/- 2.1 mm(3) (p = 0.007), whereas 0.2 IU had no effect (38.0 +/- 9.0 mm(3)). The highest dose of both application routes (i.v. 20,000 IU; cortical 2 IU) enlarged the ASDH-induced damage significantly to 46.5 +/- 1.7 and 67.9 +/- 10.4 mm(3) (all p < 0.05 vs. NaCl). In order to test whether Tween-20, a solvent of EPO formulation 'NeoRecomon (R) was responsible for adverse effects two groups were treated with NaCl or Tween-20 after the evacuation of ASDH, but no difference in lesion volume was detected. In conclusion, EPO is neuroprotective in a model of ASDH in rats and was most efficacious at a very low dose in combination with subdural blood removal. High systemic and topically applied concentrations caused adverse effects on lesion size which were partially due to increased ICP. Thus, patients with traumatic ASDH could be treated with cortically applied EPO but with caution concerning concentration. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.	[Nedjat, M. Rahimi; Waehmann, M.; Baechli, H.; Heimann, A.; Kempski, O.; Alessandri, B.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Neurosurg Pathophysiol, D-55131 Mainz, Germany; [Baechli, H.] Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany; [Gueresir, E.; Vatter, H.] Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; [Raabe, A.] Univ Bern, Dept Neurosurg, CH-3001 Bern, Switzerland		Alessandri, B (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Neurosurg Pathophysiol, D-55131 Mainz, Germany.	alessandri@unimedizin-mainz.de	Guresir, Erdem/AAL-4484-2020; Guresir, Erdem/AAV-7224-2021	Guresir, Erdem/0000-0001-8319-0847; Heimann, Axel/0000-0003-2510-3228			Alafaci C, 2000, EUR J PHARMACOL, V406, P219, DOI 10.1016/S0014-2999(00)00691-9; Alessandri B, 2006, BRAIN RES, V1111, P196, DOI 10.1016/j.brainres.2006.06.105; Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; Baechli H, 2010, J CEREBR BLOOD F MET, V30, P576, DOI 10.1038/jcbfm.2009.230; Banks WA, 2004, EUR J PHARMACOL, V505, P93, DOI 10.1016/j.ejphar.2004.10.035; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines M, 2010, BLOOD PURIFICAT, V29, P86, DOI 10.1159/000245630; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Chi OZ, 2008, PHARMACOLOGY, V82, P38, DOI 10.1159/000127839; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Fahrig T, 2005, MOL PHARMACOL, V67, P1544, DOI 10.1124/mol.104.008177; Frietsch T, 2007, J CEREBR BLOOD F MET, V27, P469, DOI 10.1038/sj.jcbfm.9600360; Gonzalez FF, 2009, DEV NEUROSCI-BASEL, V31, P403, DOI 10.1159/000232558; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2006, J NEUROSURG-SPINE, V4, P310, DOI 10.3171/spi.2006.4.4.310; Grasso G, 2001, J Neurosurg Sci, V45, P7; Hadland BK, 2009, J CLIN ONCOL, V27, P4217, DOI 10.1200/JCO.2008.21.6945; Hartley CE, 2008, J NEUROSURG, V109, P708, DOI 10.3171/JNS/2008/109/10/0708; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; Hlatky R, 2007, NEUROSURGERY, V61, P249, DOI [10.1227/01.NEU.0000143029.42638.2c, 10.1227/01.neu.0000279220.30633.45]; Hockel Konstantin, 2012, Exp Transl Stroke Med, V4, P5, DOI 10.1186/2040-7378-4-5; Jia LF, 2010, STROKE, V41, P2071, DOI 10.1161/STROKEAHA.110.586198; Jussen D, 2008, CRIT CARE MED, V36, P543, DOI 10.1097/01.CCM.0B013E3181620A0F; KABAYA K, 1995, LIFE SCI, V57, P1067, DOI 10.1016/0024-3205(95)02052-K; Kawata M, 2006, J THORAC CARDIOV SUR, V131, P1331, DOI 10.1016/j.jtcvs.2005.10.035; Kellert BA, 2007, PEDIATR RES, V61, P451, DOI 10.1203/pdr.0b013e3180332cec; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; KINOSHITA K, 1994, ACTA NEUROCHIR, P505; Klemm K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003924; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; KURODA Y, 1992, NEUROSURGERY, V30, P687; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; Kwon TH, 2003, J NEUROTRAUM, V20, P337, DOI 10.1089/089771503765172291; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Marion DW, 2006, NEUROSURGERY, V58, P655; Mauler F, 2004, EUR J NEUROSCI, V20, P1761, DOI 10.1111/j.1460-9568.2004.03615.x; Mauler F, 2003, BRAIN RES, V989, P99, DOI 10.1016/S0006-8993(03)03376-6; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Reinert M, 2002, NEUROL RES, V24, P601, DOI 10.1179/016164102101200438; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sawauchi S, 2004, J NEUROTRAUM, V21, P563, DOI 10.1089/089771504774129892; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Tsuchida E, 1996, J NEUROSURG, V85, P104, DOI 10.3171/jns.1996.85.1.0104; Tsuchida E, 1999, J NEUROTRAUM, V16, P595, DOI 10.1089/neu.1999.16.595; Tsuchimoto T, 2011, PEDIATR ANESTH, V21, P1209, DOI 10.1111/j.1460-9592.2011.03657.x; Uchida K, 2001, EUR J ANAESTH, V18, P295, DOI 10.1046/j.0265-0215.2000.00825.x; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wakida K, 2007, NEUROSCIENCE, V148, P105, DOI 10.1016/j.neuroscience.2007.04.063; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Weishaupt JH, 2004, INVEST OPHTH VIS SCI, V45, P1514, DOI 10.1167/iovs.03-1039; Xenocostas A, 2005, EUR J CLIN PHARMACOL, V61, P189, DOI 10.1007/s00228-005-0896-7; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhang F, 2006, J NEUROSCI RES, V83, P1241, DOI 10.1002/jnr.20816; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077	71	6	6	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 15	2013	238						125	134		10.1016/j.neuroscience.2013.01.067			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	141SH	WOS:000318746300012	23415790				2022-02-06	
J	Arun, P; Abu-Taleb, R; Valiyaveettil, M; Wang, Y; Long, JB; Nambiar, MP				Arun, Peethambaran; Abu-Taleb, Rania; Valiyaveettil, Manojkumar; Wang, Ying; Long, Joseph B.; Nambiar, Madhusoodana P.			Extracellular cyclophilin A protects against blast-induced neuronal injury	NEUROSCIENCE RESEARCH			English	Article						Traumatic brain injury; blast exposure; cyclophilin A; SH-SY5Y cells; neuroprotection	TRAUMATIC BRAIN-INJURY; CORTICAL-NEURONS; PHOSPHORYLATION; SURVIVAL	Blast-induced traumatic brain injury (TBI) and subsequent neurobehavioral deficits are major disabilities suffered by the military and civilian population worldwide. Rigorous scientific research is underway to understand the mechanism of blast TBI and thereby develop effective therapies for protection and treatment. By using an in vitro shock tube model of blast TBI with SH-SY5Y human neuroblastoma cells, we have demonstrated that blast exposure leads to neurobiological changes in an overpressure and time dependent manner. Paradoxically, repeated blast exposures resulted in less neuronal injury compared to single blast exposure and suggested a potential neuroprotective mechanism involving released cyclophilin A (CPA). In the present study, we demonstrate accumulation of CPA in the culture medium after repeated blast exposures supporting the notion of extracellular CPA mediated neuroprotection. Post-exposure treatment of the cells with purified recombinant CPA caused significant protection against blast-induced neuronal injury. Furthermore, repeated blast exposure was associated with phosphorylation of the proteins ERK1/2 and Bad suggesting a potential mechanism of neuroprotection by extracellular CPA and may aid in the development of targeted therapies for protection against blast-induced TBI. (c) 2013 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Arun, Peethambaran; Abu-Taleb, Rania; Valiyaveettil, Manojkumar; Wang, Ying; Long, Joseph B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Arun, P (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	peethambaran.arun@amedd.army.mil					ADOUR KK, 1981, JAMA-J AM MED ASSOC, V246, P1564, DOI 10.1001/jama.246.14.1564; Arun P, 2012, NEUROREPORT, V23, P342, DOI 10.1097/WNR.0b013e328351b58d; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; Boulos S, 2007, NEUROBIOL DIS, V25, P54, DOI 10.1016/j.nbd.2006.08.012; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Redell JB, 2007, J NEUROSCI RES, V85, P1980, DOI 10.1002/jnr.21324; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Seko Y, 2004, BIOCHEM BIOPH RES CO, V317, P162, DOI 10.1016/j.bbrc.2004.03.021; Singer CA, 1999, J NEUROSCI, V19, P2455; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990	15	6	6	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102			NEUROSCI RES	Neurosci. Res.	MAY-JUN	2013	76	1-2					98	100		10.1016/j.neures.2013.02.009			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179SH	WOS:000321541100013	23511555				2022-02-06	
J	Coco, K; Tossavainen, K; Jaaskelainen, JE; Turunen, H				Coco, Kirsi; Tossavainen, Kerttu; Jaaskelainen, Juha E.; Turunen, Hannele			The provision of emotional support to the families of traumatic brain injury patients: perspectives of finnish nurses	JOURNAL OF CLINICAL NURSING			English	Article						emotional support; family nursing; traumatic brain injury	NEEDS; EXPERIENCE; DISTRESS; LIFE; TBI; CAREGIVERS; RELATIVES; MEMBERS; MOTHERS	Aims and objectives To examine nursing staff's perceptions about how often they provide interventions of emotional support and the level of competence needed on neurosurgical wards to support traumatic brain injury patients' family members. Background Traumatic brain injury in one individual affects the health of their whole family. Studying the emotional support provided by nursing staff is important because such support is crucial for the family members of a traumatic brain injury patient during the acute phase of treatment. Members of the nursing staff provide emotional support to family members by consoling them; this alleviates insecurity, anxiety, hopelessness and depression. Design A structured self-reported questionnaire presented to 172 nurses working on neurosurgical wards. The response rate was 67% (n=115). Methods Descriptive statistics were used to determine how often nurses provided emotional support to the traumatic brain injury patients family members and one-way anova to examine the relationships between the background variables and the respondents' evaluations of how often they gave emotional support to brain injury patients' family members. Results Thirty-seven percentage of nurses stated that they always took account of family members' individuality and 65% that they were always respectful. All registered nurses and staff members with long work experience (21years or more) on a neurosurgical ward reported that they took family members' feelings of anger and guilt into consideration slightly more often than other nursing staff did. Most nurses considered these skills to represent basic competencies. Conclusion Further service training on dealing with difficult emotions of traumatic brain injury patients' family members could help nurses to face these situations. Both education and work experience affected the frequency at which nursing staff provided emotional support to traumatic brain injury patients' family members. Relevance to clinical practice The results are relevant for example when planning specialised studies or in-service training for neuro-nurses, as well as when selecting the subjects to be addressed during the orientation of a new staff member. In addition, the results should help nursing staff to understand their role in the emotional support of family members.	[Coco, Kirsi; Tossavainen, Kerttu] Univ Eastern Finland, Dept Nursing Sci, Kuopio 70211, Finland; [Jaaskelainen, Juha E.] Kuopio Univ Hosp, Neurosurg NeuroCtr, SF-70210 Kuopio, Finland; [Turunen, Hannele] Univ Eastern Finland, Kuopio Univ Hosp, Dept Nursing Sci, Kuopio 70211, Finland		Coco, K (corresponding author), Univ Eastern Finland, Dept Nursing Sci, Kuopio Campus,POB 1627, Kuopio 70211, Finland.	kirsi.coco@gmail.com		Turunen, Hannele/0000-0002-2897-9738	Finnish Nurses Educational Association; Department of Nursing Science, University of Eastern Finland	This study was supported by grants from The Finnish Nurses Educational Association and the Department of Nursing Science, University of Eastern Finland. We are grateful to all the nurses who participated in the study. We also thank Statistician Hannu Isoaho.	Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Burns N., 2001, PRACTICE NURSING RES; Calvin Amy O, 2007, J Neurosci Nurs, V39, P143; Chan J, 2007, INT J REHABIL RES, V30, P137, DOI 10.1097/MRR.0b013e32813a2f11; Charles N, 2007, NEUROREHABILITATION, V22, P61; Clinical Practice Guideline, 2009, MAN CONC MILD TRAUM; Coco K, 2011, J NEUROSCI NURS, V43, P337, DOI 10.1097/JNN.0b013e318234ea0b; DeVellis RF., 2012, SCALE DEV THEORY APP, V34; Finfgeld-Connett D, 2005, J NURS SCHOLARSHIP, V37, P4, DOI 10.1111/j.1547-5069.2005.00004.x; Hart T, 2007, J HEAD TRAUMA REHAB, V22, P122, DOI 10.1097/01.HTR.0000265100.37059.44; Heo S, 2005, NURS RES, V54, P265; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Kneafsey R, 2004, J CLIN NURS, V13, P601, DOI 10.1111/j.1365-2702.2004.00903.x; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lefebvre H, 2008, CAN J NURS RES, V40, P142; Lefebvre Helene, 2007, J Trauma Nurs, V14, P100; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; Nelms TP, 2010, J FAM NURS, V16, P462, DOI 10.1177/1074840710386608; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; Ohman J, 2008, AIVOVAMMAT KAYPAHOIT; Polit DF., 2012, NURSING RES GENERATI, V9th ed.; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Shyu YIL, 2006, NURS RES, V55, P411, DOI 10.1097/00006199-200611000-00005; Thompson HJ, 2009, J NEUROSCI NURS, V41, P148, DOI 10.1097/JNN.0b013e3181a23eda; Thompson HJ, 2009, AANN CLIN PRACT GUID; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wongvatunyu S, 2005, J NURS SCHOLARSHIP, V37, P48, DOI 10.1111/j.1547-5069.2005.00015.x; Wongvatunyu S, 2008, J FAM NURS, V14, P314, DOI 10.1177/1074840708321473	38	6	6	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	MAY	2013	22	9-10					1467	1476		10.1111/jocn.12136			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	126KC	WOS:000317612500026	23489840				2022-02-06	
J	Demir, H; Onur, OE; Denizbasi, A; Akoglu, H; Eroglu, SE; Ozpolat, C; Akoglu, E				Demir, Hasan; Onur, Ozge E.; Denizbasi, Arzu; Akoglu, Haldun; Eroglu, Serkan E.; Ozpolat, Cigdem; Akoglu, Ebru			The effects of adrenomedullin in traumatic brain injury	PEPTIDES			English	Article						Adrenomedullin; Traumatic brain injury; Myeloperoxidase; MDA; GSH; IL-6	CEREBRAL-ARTERY OCCLUSION; ISCHEMIC BRAIN; CELL-DEATH; RATS; MODEL	Traumatic brain injury (TBI) is a common cause of death and disability throughout the world. A multifunctional peptide adrenomedullin (AM) has protective effects in the central nervous system. We evaluated AM in an animal model as a therapeutic agent that reduces brain damage after traumatic brain injury. A total of 36 rats was divided into 3 groups as sham, head trauma plus intraperitoneal (ip) saline, and head trauma plus adrenomedullin ip. The diffuse brain injury model of Marmarou et al. was used. Blood samples were taken from all groups at the 1st, 6th and 24th hours for analysis of TNF-alpha (tumor necrosis factor-alpha), IL-1 beta (interleukin-1 beta) and IL-6 (interleukin-6) levels. At the end of the study (at the 24th hour) a neurological examination was performed and half of the rats were decapitated to obtain blood and tissue samples, the other half were perfused transcardiacally for studying the histopathology of the brain tissue. There were no statistically significant changes in plasma levels of IL-1 beta, IL-6 and TNF-alpha relative to the sham group. Also, changes in tissue levels of malonedialdehyde, myeloperoxidase and glutathione were not statistically significant. However, neurological scores and histopathological examinations revealed healing. AM individually exerts neuroprotective effects in animal models of acute brain injury. But the mechanisms of action remain to be assessed. (C) 2013 Elsevier Inc. All rights reserved.	[Demir, Hasan] Istanbul Fatih Sultan Mehmet Res & Training Hosp, Dept Emergency Med, Istanbul, Turkey; [Onur, Ozge E.; Denizbasi, Arzu; Akoglu, Haldun; Eroglu, Serkan E.; Ozpolat, Cigdem] Marmara Univ, Pendik Res & Training Hosp, Dept Emergency Med, Istanbul, Turkey; [Akoglu, Ebru] Zonguldak State Hosp, Dept Emergency Med, Zonguldak, Turkey		Onur, OE (corresponding author), Marmara Univ, Pendik Res & Training Hosp, Dept Emergency Med, Istanbul, Turkey.	ozberkozge@gmail.com	Akoglu, Haldun/E-8432-2013; /AAL-3967-2021; Altinok, Arzu Denizbasi/AAB-2917-2020	Akoglu, Haldun/0000-0002-1316-0308; /0000-0003-3674-133X; Altinok, Arzu Denizbasi/0000-0002-4589-8251	BAPKO (Marmara University, Scientific Research Board)Marmara University	Special thanks to BAPKO (Marmara University, Scientific Research Board) for funding. Special thanks also to R. W. Guillery, PhD for English addition.	BASKAYA MK, 1995, J CEREBR BLOOD F MET, V15, P827, DOI 10.1038/jcbfm.1995.103; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Biber N, 2009, BRAIN INJURY, V23, P577, DOI 10.1080/02699050902926317; Buege J A, 1978, Methods Enzymol, V52, P302; Cheyuo C, 2012, BIOL CHEM, V393, P429, DOI 10.1515/hsz-2012-0103; Dogan A, 1997, J CEREBR BLOOD F MET, V17, P19, DOI 10.1097/00004647-199701000-00004; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Honda M, 2006, CELL MOL NEUROBIOL, V26, P109, DOI 10.1007/s10571-006-9028-x; Kim HW, 2011, BRAIN RES, V1412, P73, DOI 10.1016/j.brainres.2011.07.018; Kondoh T, 2011, BRAIN RES BULL, V84, P69, DOI 10.1016/j.brainresbull.2010.11.005; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miyashita K, 2006, ENDOCRINOLOGY, V147, P1642, DOI 10.1210/en.2005-1038; Moosmann B, 2001, BIOL CHEM, V382, P1601, DOI 10.1515/BC.2001.195; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Onur OE, 2007, PEPTIDES, V28, P2179, DOI 10.1016/j.peptides.2007.08.028; Robertson CL, 2001, J NEUROTRAUM, V18, P861, DOI 10.1089/089771501750451785; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Toklu HZ, 2009, J SURG RES, V152, P238, DOI 10.1016/j.jss.2008.03.013; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Wang SM, 2009, BBA-GEN SUBJECTS, V1790, P361, DOI 10.1016/j.bbagen.2009.03.012	21	6	7	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781			PEPTIDES	Peptides	MAY	2013	43						27	31		10.1016/j.peptides.2013.02.018			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	160TV	WOS:000320144300005	23474144				2022-02-06	
J	Morimoto, K; Sakamoto, M; Fukuhara, T; Kato, K				Morimoto, Koji; Sakamoto, Masaaki; Fukuhara, Takashi; Kato, Kazuo			Electromyographic Study of Neck Muscle Activity According to Head Position in Rugby Tackles	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Sternocleidomastoid muscle; Trapezius muscle; Rugby	PROFESSIONAL FOOTBALL; UNION FOOTBALL; INJURIES; CONCUSSION; EXERCISES; PLAYERS	[Purpose] This study examined differences in neck muscle activity in two different head positions during tackles with the aim of contributing to the prevention of sports injuries. [Subjects] The subjects were 28 male high-school rugby players. [Methods] Two tackle positions were considered: a head-up position and a head-down position. Muscle activities of the sternocleidomastoid muscles and the upper, middle, and lower parts of the trapezius muscles were measured. [Results] Muscle activities of the sternocleidomastoid muscles and the right upper trapezius muscle were significantly increased in the head-up position, and the activity of the lower trapezius was significantly increased in the head-down position. [Conclusion] Tackling with the head-up position increases neck muscle activity and stability of the head and the neck.	[Morimoto, Koji; Fukuhara, Takashi; Kato, Kazuo] Seseragi Hosp, Asakura Clin, Maebashi, Gunma 3710081, Japan; [Morimoto, Koji; Sakamoto, Masaaki] Gunma Univ, Grad Sch Hlth Sci, Gunma, Japan		Morimoto, K (corresponding author), Seseragi Hosp, Asakura Clin, 249-1 Asakura Machi, Maebashi, Gunma 3710081, Japan.	kmorimot@health.gunma-u.ac.jp					Cools AM, 2007, AM J SPORT MED, V35, P1744, DOI 10.1177/0363546507303560; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Ebaugh DD, 2010, J ELECTROMYOGR KINES, V20, P199, DOI 10.1016/j.jelekin.2009.04.001; Garraway WM, 1999, BRIT J SPORT MED, V33, P37, DOI 10.1136/bjsm.33.1.37; Heck JF, 2004, J ATHL TRAINING, V39, P101; Hislop HJ, 1995, DANIELS WORTHINGHAMS, P28; Jackson JA, 2009, J ELECTROMYOGR KINES, V19, P416, DOI 10.1016/j.jelekin.2007.11.004; KESHNER EA, 1989, EXP BRAIN RES, V75, P335; Kuster D, 2012, BRIT J SPORT MED, V46, P550, DOI 10.1136/bjsports-2011-090360; MacLean JGB, 2012, BRIT J SPORT MED, V46, P591, DOI 10.1136/bjsports-2011-090183; Oi Nelson, 2004, Stapp Car Crash J, V48, P397; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Shelly MJ, 2006, J BONE JOINT SURG BR, V88B, P771, DOI 10.1302/0301-620X.88B6; Sommerich CM, 2000, J ELECTROMYOGR KINES, V10, P377, DOI 10.1016/S1050-6411(00)00033-X; Tucker WS, 2008, J ATHL TRAINING, V43, P464, DOI 10.4085/1062-6050-43.5.464; Tucker WS, 2010, ARCH PHYS MED REHAB, V91, P550, DOI 10.1016/j.apmr.2009.12.021; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C	18	6	7	3	12	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	MAY	2013	25	5					563	566		10.1589/jpts.25.563			4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	179PI	WOS:000321533400009	24259802	Green Submitted, Green Published, Bronze			2022-02-06	
J	Wang, W; Li, Q; Zou, FH; Yu, ZH; Wang, YF; Lu, T; Hu, T; Cui, G				Wang, Wei; Li, Qi; Zou, Feihui; Yu, Zhihua; Wang, Yunfeng; Lu, Ting; Hu, Tong; Cui, Gang			Increased expression of AGS3 in rat brain cortex after traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; AGS3; CREB; neuron; apoptosis	ELEMENT-BINDING PROTEIN; RECEPTOR-INDEPENDENT ACTIVATORS; CELL-DEATH MECHANISMS; GLIAL PROLIFERATION; CORTICAL INJURY; IN-VITRO; APOPTOSIS; BCL-2; NEURONS; PATHWAYS	Receptor-independent activators of G protein signaling (AGS) offer alternative modes of signal processing for the G protein signaling system that has broad mechanistic and functional significance. Previous studies have demonstrated that AGS3, which belongs to the AGS family, is involved in a number of different cellular activities. However, the distribution and function of AGS3 in the central nervous system (CNS) remain unclear. To investigate whether AGS3 is involved in CNS injury and repair, we used an acute traumatic brain injury (TBI) model in adult rats. Western blot analysis and immunohistochemistry showed a significant upregulation of AGS3 in ipsilateral peritrauma cortex. Double immunofluorescence staining showed that AGS3 was coexpressed with NeuN but rarely with glial fibrillary acidic protein. In addition, we detected that active caspase-3 had colocalization with NeuN and AGS3, suggesting that AGS3 might be involved in the neuron apoptosis after TBI. To investigate the potential function of AGS3 further, a neuronal cell line, PC12, was employed to establish a cell apoptosis model. Western blot analysis indicated that AGS3 shared a similar dynamic variation in animal experiments, and phosphorylated cyclic AMP response element-binding protein (CREB) increased in parallel. Additionally, knocking down AGS3 with siRNA partially attenuated the protein level of phosphorylated CREB in PC12 stimulated by H2O2, while reinforcing active caspase-3 expression, demonstrating a probable antiapoptotic role through CREB played by AGS3 in neuronal apoptosis. We hypothesize that AGS3 might play an important antiapoptotic role through enhancing phosphorylation of CREB. (c) 2013 Wiley Periodicals, Inc.	[Wang, Wei; Li, Qi; Zou, Feihui; Yu, Zhihua; Wang, Yunfeng; Lu, Ting; Hu, Tong; Cui, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Peoples R China		Cui, G (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Peoples R China.	cuigang33@yahoo.com.cn					Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Campbell A, 2004, ANN NY ACAD SCI, V1035, P117, DOI 10.1196/annals.1332.008; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Clark RSB, 1997, J NEUROSCI, V17, P9172; Crossin KL, 1997, P NATL ACAD SCI USA, V94, P2687, DOI 10.1073/pnas.94.6.2687; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Fan PD, 2009, MOL PHARMACOL, V76, P526, DOI 10.1124/mol.109.057802; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Hofler C, 2011, J NEUROSCI, V31, P11553, DOI 10.1523/JNEUROSCI.2072-11.2011; Jaworski J, 2003, J NEUROSCI, V23, P4519; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Marshall L F, 2000, Clin Neurosurg, V46, P105; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Nishihara H, 2004, J BIOL CHEM, V279, P26176, DOI 10.1074/jbc.M313346200; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; RINK A, 1995, AM J PATHOL, V147, P1575; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Shankar E, 2010, INT J ONCOL, V36, P883, DOI 10.3892/ijo_00000566; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177	36	6	7	0	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	MAY	2013	91	5					726	736		10.1002/jnr.23195			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	104CY	WOS:000315968700011	23404409				2022-02-06	
J	Helm, M; Hauke, J; Kohler, J; Lampl, L				Helm, M.; Hauke, J.; Kohler, J.; Lampl, L.			The concept of small volume resuscitation for preclinical trauma management. Experiences in the Air Rescue Service	UNFALLCHIRURG			German	Article						Small volume resuscitation; Fluid resuscitation; Hypovolemic shock; Trauma; Air rescue	FLUID RESUSCITATION; HYPERTONIC SALINE; GERMAN-ASSOCIATION; BRAIN-INJURY; HYPOTENSION; ESTABLISHMENT; SURGERY; DEXTRAN; NETWORK; TRIAL	Prompt hemorrhage control and adequate fluid resuscitation are the key components of early trauma care. However, the optimal resuscitation strategy remains controversial. In this context the small volume resuscitation (SVR) concept with hypertonic-hyperoncotic solutions is a new strategy. This was a retrospective study in the Helicopter Emergency Medical Service over a 5-year period. Included were all major trauma victims if they were candidates for SVR (initially 4 ml HyperHaesA (R)/kg body weight, followed by conventional fluid resuscitation with crystalloids and colloids). Demographic data, type and cause of injury and injury severity score (ISS) were recorded and the amount of fluid volume and the hemodynamic profile were analyzed. Negative side-effects as well as sodium chloride serum levels on hospital admission were recorded. A total of 342 trauma victims (male 70.2%, mean age 39.0 +/- 18.8 years, ISS 31.6 +/- 16.9, ISS > 16, 81.6%) underwent prehospital SVR. A blunt trauma mechanism was predominant (96.8%) and the leading cause of injury was motor vehicle accidents (61.5%) and motorcycle accidents (22.3%). Multiple trauma and polytrauma were noted in 87.4% of the cases. Predominant was traumatic brain injury (73.1%) as well as chest injury (73.1%) followed by limb injury (69.9%) and abdominal/pelvic trauma (45.0%). Within the whole study group in addition to 250 ml HyperHaesA (R), mean volumes of 1214 +/- 679 ml lactated Ringers and 1288 +/- 954 ml hydroxethylstarch were infused during the prehospital treatment phase. There were no statistically significant differences in the amount of crystalloids and colloids infused regarding the subgroups multisystem trauma (ISS > 16), severe traumatic brain injury (GCS < 9) and entrapment trauma compared to the total study group. In patients with an initial systolic blood pressure (SBP) > 80 mmHg significantly less colloids (1035 +/- 659ml vs. 1288 +/- 954ml, p < 0.006) were infused, whereas in patients with an initial SBP a parts per thousand currency sign80mmHg significantly more colloids were infused (1609 +/- 1159 ml vs. 1288 +/- 954 ml, p < 0.002). There was a statistically significant increase in systolic as well as diastolic blood pressure at all times of blood pressure measurement during prehospital treatment after bolus infusion of HyperHaesA (R) within the whole study group. The same applies to the subgroups multisystem trauma, severe traumatic brain injury and entrapment trauma. Minor negative side-effects were observed in 4 cases (1.2%). The mean serum sodium chloride profile on hospital admission was 146.9 +/- 5.0 mmol/l, the base excess (BE) was -5.7 +/- 5.3 mmol/l) and the pH was 7.3 +/- 0.1. The concept of small volume resuscitation provides early and effective hemodynamic control. Clinical side-effects associated with bolus infusion of hypertonic-hyperoncotic solutions are rare.	[Helm, M.; Hauke, J.; Kohler, J.; Lampl, L.] Bundeswehrkrankenhaus Ulm, Abt Anasthesiol & Intens Med, Sekt Notfallmed, D-89070 Ulm, Germany		Helm, M (corresponding author), Bundeswehrkrankenhaus Ulm, Abt Anasthesiol & Intens Med, Sekt Notfallmed, Oberer Eselsberg 40, D-89070 Ulm, Germany.	matthias.helm@extern.uni-ulm.de					Alam HB, 2006, SCAND J SURG, V95, P136, DOI 10.1177/145749690609500302; Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; [Anonymous], 2008, DGU TRAUMAREGISTER J; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1993, ACTA NEUROCHIR, V59, P121; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dubick MA, 2006, SHOCK, V25, P321, DOI 10.1097/01.shk.0000209525.50990.28; DuBose JJ, 2010, J TRAUMA, V68, P1172, DOI 10.1097/TA.0b013e3181d76d40; Helm M, 1996, NOTARZT, V12, P158; Kreimeier U, 1997, ANAESTHESIST, V46, P309, DOI 10.1007/s001010050406; Kreimeier U, 2001, NOTFALL RETTUNGSMED, V4, P608; KREIMEIER U, 1993, OXYGEN TRANSPORT PRI, P153; KREIMEIER U, 1998, NOTFALL RETTUNGSMED, V1, P119; KREIMEIER U, 1996, TRAUMA CARE UPDATE, P142; Kreimeier U, 2003, NOTFALL RETTUNGSMED, V6, P77; KROLL W, 1992, BEITRAGE ANASTHESIE, P40; Lampl L, 1994, Aktuelle Traumatol, V24, P163; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Mauritz Walter, 2002, Eur J Emerg Med, V9, P315; Messmer K, 1989, RESUSCITATION, V18, P51; MOLS P, 1999, JEUR, V3, P99; Nolte D, 1992, AM J PHYSIOL, V263, P411; Ruchholtz S, 2007, UNFALLCHIRURG, V110, P373, DOI 10.1007/s00113-007-1260-4; Thielemann FW, 2007, UNFALLCHIRURG, V110, P381, DOI 10.1007/s00113-007-1264-0; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1992, J INTENSIVE CARE MED, V7, P189; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; Westhoff J, 2008, UNFALLCHIRURG, V111, P155, DOI 10.1007/s00113-007-1380-x; Wutzler S, 2008, UNFALLCHIRURG, V111, P592, DOI 10.1007/s00113-008-1448-2	30	6	6	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	APR	2013	116	4					326	331		10.1007/s00113-011-2096-5			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	122XP	WOS:000317352200008	21909734				2022-02-06	
J	Janus, TJ; Smith, HL; Chigazola, A; Wortman, MR; Sidwell, RA; Piper, JG				Janus, Todd J.; Smith, Hayden L.; Chigazola, Angela; Wortman, Mikelle R.; Sidwell, Richard A.; Piper, John G.			Hospital Discharge Destinations for Hispanic and Non-Hispanic White Patients Treated for Traumatic Brain Injury	JOURNAL OF TRAUMA NURSING			English	Article						Brain injuries; Ethnic groups; Healthcare disparities; Patient discharge		Purpose : To examine hospital discharge destinations for Hispanic and non-Hispanic white patients treated for traumatic brain injury. Methods : Retrospective cohort study with patient matching. Findings: Ethnicity status not determined a signifi cant predictor of discharge destination (P = .2150). Patient hospital length of stay determined a signifi cant predictor of discharge destination (P = .0072), with every 1 day increase in length of stay, resulting in a 12% increase in odds of being discharged to care facility. Conclusions: Study data suggest that length of stay can predict discharge destination for both Hispanic and non-Hispanic white patients in a medium-sized trauma center in the Midwest.	[Janus, Todd J.] Iowa Health, Dept Neurol, Des Moines, IA USA; [Smith, Hayden L.] Iowa Health, Med Educ Serv, Des Moines, IA USA; [Sidwell, Richard A.] Iowa Health, Trauma Serv, Des Moines, IA USA; [Piper, John G.] Iowa Health, Dept Neurosurg, Des Moines, IA USA; [Chigazola, Angela] Drake Univ, Des Moines, IA 50311 USA; [Wortman, Mikelle R.] Cornell Coll, Cornell Fellows Program, Mt Vernon, IA 52314 USA		Janus, TJ (corresponding author), Iowa Methodist Med Ctr, Off Res & Clin Trials, 1415 Woodland St,Ste 218, Des Moines, IA 50309 USA.	JanusTJ@ihs.org					Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Iowa Department of Public Health, 2005, IOW TRAUM PAT DAT DI; Kim H, 2006, CAN J NEUROL SCI, V33, P48, DOI 10.1017/S0317167100004686; Rural Health Research Center, 2006, 2006 ZIP VERS 2 0 CO; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; US Census Bureau, 2010, 2010 STAT COUNT QUIC; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662	17	6	6	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	APR-JUN	2013	20	2					102	109		10.1097/JTN.0b013e318296003a			8	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	V37KD	WOS:000209273800006	23722220				2022-02-06	
J	Kerr, HA				Kerr, Hamish A.			Closed Head Injury	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Intracranial hemorrhage; Skull fracture; Facial fracture; Eye injuries; Scalp laceration; Pinna hematoma	TRAUMATIC DENTAL INJURIES; 3RD INTERNATIONAL-CONFERENCE; SPORT-RELATED CONCUSSION; CONSENSUS STATEMENT; AGREEMENT STATEMENT; FIELD-EVALUATION; BRAIN-INJURY; MANAGEMENT; GUIDELINES; FRACTURES	Closed head injuries vary from the very minor to the catastrophic. It is often difficult to differentiate the severity at initial presentation. Serial assessment is very valuable. Awareness of facial injuries is aided by familiarity with facial bone anatomy and the clinical presentation of orbital, zygomatic, maxillary, and mandibular fracture. Functional injury such as concussion may coexist with other injuries. This article will discuss closed head trauma and outline specific injuries to the face, brain, skull, and its surroundings.	Albany Med Coll, Div Internal Med Pediat, Latham, NY 12110 USA		Kerr, HA (corresponding author), Albany Med Coll, Div Internal Med Pediat, 724 Watervliet Shaker Rd, Latham, NY 12110 USA.	kerrh@mail.amc.edu					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barth JT, 2001, J ATHL TRAINING, V36, P253; BAVITZ JB, 1995, INT J ORAL MAX SURG, V24, P273, DOI 10.1016/S0901-5027(95)80027-1; Bayliss T, 1996, INJURY, V27, P353, DOI 10.1016/0020-1383(96)00017-4; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Bord SP, 2008, EMERG MED CLIN N AM, V26, P97, DOI 10.1016/j.emc.2007.11.006; Brady SM, 2001, AM J EMERG MED, V19, P147, DOI 10.1053/ajem.2001.21315; Burton JH, 2008, EMERGEN MED, V71, P661; Cantu RC, 1998, CLIN SPORT MED, V17, P137, DOI 10.1016/S0278-5919(05)70068-5; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Cappuccino GJ, 2008, MOSBY ELSEVIER, V27, P175; CARROLL SM, 1995, BRIT J SPORT MED, V29, P194, DOI 10.1136/bjsm.29.3.194; Chaze B, 2008, NEUROL CLIN, V26, P325, DOI 10.1016/j.ncl.2007.11.009; Choung YH, 2005, J LARYNGOL OTOL, V119, P27, DOI 10.1258/0022215053222932; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Ferrari L.R., 1996, ANESTHESIOL CLIN N A, V14, P125; Flores MT, 2007, DENT TRAUMATOL, V23, P196, DOI 10.1111/j.1600-9657.2007.00627.x; Flores MT, 2007, DENT TRAUMATOL, V23, P130, DOI 10.1111/j.1600-9657.2007.00605.x; Flores MT, 2007, DENT TRAUMATOL, V23, P66, DOI 10.1111/j.1600-9657.2007.00592.x; Fraioli RE, 2008, OTOLARYNG CLIN N AM, V41, P51, DOI 10.1016/j.otc.2007.10.003; Fuller CW, 2007, CLIN J SPORT MED, V17, P177, DOI 10.1097/JSM.0b013e31803220b3; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; George A, 2007, CLIN OTOLARYNGOL, V32, P77, DOI 10.1111/j.1365-2273.2007.01344.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grindel Scott H, 2003, Curr Sports Med Rep, V2, P18, DOI 10.1249/00149619-200302000-00005; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Higuera S, 2007, PLAST RECONSTR SURG, V120, p64S, DOI 10.1097/01.prs.0000260722.91183.50; Hislop WS, 1996, BRIT J ORAL MAX SURG, V34, P289, DOI 10.1016/S0266-4356(96)90004-2; Hollis SJ, 2011, BRIT J SPORT MED, V45, P997, DOI 10.1136/bjsm.2010.079707; Howe AS, 2008, THE SPORTS MEDICINE, P253; Hunte G., 2001, CLIN SPORTS MED, P713; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kelley P, 2007, PLAST RECONSTR SURG, V120, p5S, DOI 10.1097/01.prs.0000260720.73370.d7; Kellman RM, 2005, CUMMINGS OTOLARYNGOL, V23, P318; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; Kerr I L, 1993, Compendium, V14, P1144; Kerr IL, 1993, COMPENDIUM, V14, P56; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kucik CJ, 2004, AM FAM PHYSICIAN, V70, P1315; Macdonald DJM, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.015115; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; MANSON PN, 1980, PLAST RECONSTR SURG, V66, P54, DOI 10.1097/00006534-198007000-00010; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mourouzis C, 2005, INT J ORAL MAX SURG, V34, P635, DOI 10.1016/j.ijom.2005.01.008; Niedfeldt MW, 2011, CURR SPORT MED REP, V10, P324, DOI 10.1249/JSR.0b013e318237be53; Perry M, 2005, INJURY, V36, P875, DOI 10.1016/j.injury.2004.09.018; Petrigliano FA, 2003, SPORTS MED, V33, P317, DOI 10.2165/00007256-200333040-00005; Pizzarello L. D., 1987, SPORTS OPHTHALMOLOGY; Proctor MR, 2000, CLIN SPORT MED, V19, P693, DOI 10.1016/S0278-5919(05)70233-7; Purcell L., 2007, THE ADOLESCENT ATHLE, P61; Putukian M, 2002, PEDIATRIC SPORTS MED, P266; Ranalli Dennis N, 2005, Curr Sports Med Rep, V4, P12; Reehal P, 2010, CURR SPORT MED REP, V9, P27, DOI 10.1249/JSR.0b013e3181cd2c04; Rice Dale H, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P46, DOI 10.1097/00020840-200402000-00013; Roccia F, 2010, J CRANIO MAXILL SURG, V38, P314, DOI 10.1016/j.jcms.2009.10.002; Rodriguez JO, 2003, AM FAM PHYSICIAN, V67, P1481; Rohrich RJ, 2000, PLAST RECONSTR SURG, V106, P266, DOI 10.1097/00006534-200008000-00003; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; SESHUL MB, 1978, J TRAUMA, V18, P611, DOI 10.1097/00005373-197808000-00011; Shumrick KA, 2005, FACIAL TRAUMA SOFT T; Smith BW, 2009, CARE OF THE YOUNG AT, P171; Stewart MG, 2005, HEAD FACE AND NECK T; TEASDALE G, 1976, BRIT J ANAESTH, V48, P761, DOI 10.1093/bja/48.8.761; Toriumi DM, 1998, J LONG-TERM EFF MED, V8, P143; Trott AT, 2005, ROSENS EMERGENCY MED; VINGER PF, 1992, ARCH OPHTHALMOL-CHIC, V110, P765, DOI 10.1001/archopht.1992.01080180037024; Warren WL, 1998, CLIN SPORT MED, V17, P99, DOI 10.1016/S0278-5919(05)70064-8; Warren WL, 1998, CLIN SPORT MED, V17, P13, DOI 10.1016/S0278-5919(05)70057-0; Wilson BD, 1998, SPORTS MED, V25, P333, DOI 10.2165/00007256-199825050-00005	85	6	6	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	APR	2013	32	2					273	+		10.1016/j.csm.2012.12.008			16	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	138SI	WOS:000318529900010	23522509				2022-02-06	
J	Liu, W; Liu, XJ; Yang, HL; Zhu, XH; Yi, H; Zhu, XS; Zhang, J				Liu, Wei; Liu, Xiaojuan; Yang, Huilin; Zhu, Xinhui; Yi, Hong; Zhu, Xuesong; Zhang, Jie			Phosphorylated retinoblastoma protein (p-Rb) is involved in neuronal apoptosis after traumatic brain injury in adult rats	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Traumatic brain injury; Phosphorylated retinoblastoma protein; Neuronal apoptosis; Rat	CELL-CYCLE ACTIVATION; POSTMITOTIC NEURONS; TRANSCRIPTION FACTOR; INCREASED EXPRESSION; UP-REGULATION; AMYLOID-BETA; DEATH; PATHWAY; CORTEX; DEPRIVATION	Phosphorylated retinoblastoma protein (p-Rb), a well identified cell cycle related protein, is involved in regulating the biological functions of various cell types including neurons. One attractive biological function of p-Rb is releasing E2F transcription factor to induce S-phase entry and cellular proliferation of mitotic cells. However, some studies point out that the role of p-Rb in post-mitotic cells such as mature neurons is unique; it may induce cellular apoptosis rather than proliferation via regulating cell cycle reactivation. Up to now, the knowledge of p-Rb function in CNS is still limited. To investigate whether p-Rb is involved in CNS injury and repair, we performed a traumatic brain injury model in adult rats. Up-regulation of p-Rb was observed in the injured brain cortex by western blot analysis and immunohistochemistry staining. Terminal deoxynucleotidyl transferase deoxy-UTP-nick end labeling (TUNEL) and 4',6-diamidino-2-phenylindole (DAPI) staining suggested that p-Rb was relevant to neuronal apoptosis after brain injury. In addition, glutamate excitotoxic model of primary cortex neurons was introduced to further investigate the role of p-Rb in neuronal apoptosis; the result implied p-Rb was associated with cell cycle activation in the apoptotic neurons. Based on our data, we suggested that p-Rb might play an important role in neuronal apoptosis after traumatic brain injury in rat; which might also provide a basis for the further study on its role in regulating cell cycle re-entry in apoptotic neurons, and might gain a novel strategy for the clinical therapy for traumatic brain injury.	[Liu, Wei; Zhu, Xinhui; Yi, Hong] Nantong Univ, Dept Orthopaed, Affiliated Hosp 2, Nantong 226002, Jiangsu, Peoples R China; [Liu, Xiaojuan] Nantong Univ, Dept Pathogen Biol, Coll Med, Nantong 226001, Jiangsu, Peoples R China; [Yang, Huilin; Zhu, Xinhui] Suzhou Univ, Dept Orthoped, Affiliated Hosp, Suzhou 215002, Jiangsu, Peoples R China; [Zhang, Jie] Nantong Univ, Dept Immunol, Coll Med, Nantong 226001, Jiangsu, Peoples R China		Zhang, J (corresponding author), Nantong Univ, Dept Immunol, Coll Med, Nantong 226001, Jiangsu, Peoples R China.	zhangjie@ntu.edu.cn	ZHU, XUESONG/AAI-1933-2020		Open Science Foundation of the Jiangsu Province [KF200953]	The project funded by Open Science Foundation of the Jiangsu Province (KF200953).	Agostinho P, 2003, EUR J NEUROSCI, V17, P1189, DOI 10.1046/j.1460-9568.2003.02546.x; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Chen J, 2012, J MOL HISTOL; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chong ZZ, 2006, CURR NEUROVASC RES, V3, P25, DOI 10.2174/156720206775541741; Copani A, 1999, FASEB J, V13, P2225, DOI 10.1096/fasebj.13.15.2225; Dasgupta P, 2006, CURR MOL MED, V6, P719; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Folch J, 2012, NEUROTOX RES, V22, P195, DOI 10.1007/s12640-011-9277-4; Futatsugi A, 2012, CELL CYCLE, V11, P1603, DOI 10.4161/cc.20009; Gordon GM, 2011, PROTEIN CELL, V2, P864, DOI 10.1007/s13238-011-1117-z; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Hisanaga S, 2012, CELL CYCLE, V11, P2049, DOI 10.4161/cc.20536; Hou ST, 2001, J NEUROCHEM, V78, P287, DOI 10.1046/j.1471-4159.2001.00402.x; Jiang SY, 2012, J MOL HISTOL, V43, P195, DOI 10.1007/s10735-011-9383-x; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Konishi Y, 2003, J NEUROSCI, V23, P1649; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Liu ZQ, 2011, J MOL HISTOL, V42, P265, DOI 10.1007/s10735-011-9330-x; Lopes JP, 2009, CELL CYCLE, V8, P97, DOI 10.4161/cc.8.1.7506; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pelegri C, 2008, INT J DEV NEUROSCI, V26, P665, DOI 10.1016/j.ijdevneu.2008.07.016; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Schwartz EI, 2007, CELL CYCLE, V6, P318, DOI 10.4161/cc.6.3.3752; Shi W, 2012, J MOL HISTOL, V43, P37, DOI 10.1007/s10735-011-9366-y; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Stone JG, 2011, J NEUROPATH EXP NEUR, V70, P578, DOI 10.1097/NEN.0b013e3182204414; Viatour P, 2011, DIS MODEL MECH, V4, P581, DOI 10.1242/dmm.008060; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; Wu X, 2012, J MOL HISTOL; Xu T, 2012, J MOL HISTOL, V43, P335, DOI 10.1007/s10735-012-9408-0; Yan YH, 2012, J MOL HISTOL, V43, P543, DOI 10.1007/s10735-012-9431-1; Yang Y, 2003, J NEUROSCI, V23, P2557; Yu Y, 2012, NEUROCHEM RES, V37, P503, DOI 10.1007/s11064-011-0636-6; Yu Y, 2009, NEUROCHEM RES, V34, P1113, DOI 10.1007/s11064-008-9887-2; Zhao W, 2011, J MOL HISTOL, V42, P195, DOI 10.1007/s10735-011-9324-8	48	6	7	0	11	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	APR	2013	44	2					147	158		10.1007/s10735-013-9481-z			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122XI	WOS:000317351500003	23371354				2022-02-06	
J	Aslan, M; Concato, J; Peduzzi, PN; Proctor, SP; Schnurr, PP; Marx, BP; McFall, M; Gleason, T; Huang, GD; Vasterling, JJ				Aslan, Mihaela; Concato, John; Peduzzi, Peter N.; Proctor, Susan P.; Schnurr, Paula P.; Marx, Brian P.; McFall, Miles; Gleason, Theresa; Huang, Grant D.; Vasterling, Jennifer J.			Design of "Neuropsychological and Mental Health Outcomes of Operation Iraqi Freedom: A Longitudinal Cohort Study''	JOURNAL OF INVESTIGATIVE MEDICINE			English	Article						posttraumatic stress disorders; brain injuries; traumatic; neuropsychological tests; closed cohort studies; methods	CES-D; DEPLOYMENT; SCALE; PERSONNEL	Objective: This study aimed to describe methodological challenges encountered in designing a follow-up assessment of US Army Soldiers who served in Operation Iraqi Freedom. Study Design and Setting: The Neurocognition Deployment Health Study (NDHS) enrolled 1595 soldiers at 2 military installations, starting in 2003. Prior work compared predeployment and postdeployment assessments among Iraq-deployed and nondeployed soldiers. The current phase, as VA Cooperative Studies Program #566, is collecting follow-up data on participants who were deployed to Iraq or Afghanistan. Specific aims include evaluating the prevalence and course of posttraumatic stress disorder (PTSD), the persistence of previously observed neuropsychological changes, and the relationship of these changes-and traumatic brain injury-to subsequent PTSD. The target sample size is 817 participants, with 200 participants also receiving performance-based neuropsychological assessments. Results: We describe 6 methodological challenges and their implications for longitudinal research among a "closed,'' young, mobile study population: transitioning from cluster-based (battalion) sampling to individual-level sampling; overcoming practical barriers (such as location searches); selecting exposure and outcome measures that combine previously collected and current study data; accounting for loss of an exposed (deployed) versus (nonexposed) nondeployed comparison; determining timing of assessments; and developing a complex statistical analysis plan. Enrollment is ongoing. Conclusions: The study provides unique insights regarding elements of study design and analysis that are relevant to longitudinal research. In particular, the dynamic "real-life'' context of military deployment provides a basis for applying observational methodology to characterize mental health disorders associated with exposure to war-zone deployment and other contexts associated with exposure to extreme stress.	[Aslan, Mihaela; Concato, John] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT 06516 USA; [Aslan, Mihaela; Concato, John] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Peduzzi, Peter N.] Yale Univ, Yale Ctr Analyt Sci, New Haven, CT USA; [Peduzzi, Peter N.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Proctor, Susan P.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Proctor, Susan P.] VA Boston Healthcare Syst, Res Serv, Boston, MA USA; [Proctor, Susan P.] USA, Environm Med Res Inst, Natick, MA 01760 USA; [Schnurr, Paula P.] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA; [Schnurr, Paula P.] White River Junction VA Med Ctr, VA Natl Ctr Posttraumat Stress Disorder PTSD, White River Jct, VT USA; [Marx, Brian P.; Vasterling, Jennifer J.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Marx, Brian P.; Vasterling, Jennifer J.] VA Boston Healthcare Syst, Psychol Serv, Boston, MA USA; [Marx, Brian P.; Vasterling, Jennifer J.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [McFall, Miles] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [McFall, Miles] VA Puget Sound Healthcare Syst, Seattle, WA USA; [Gleason, Theresa; Huang, Grant D.] US Dept Vet Affairs, Off Res & Dev, NW, Washington, DC USA		Aslan, M (corresponding author), VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, 950 Campbell Ave,Mailcode 151B, West Haven, CT 06516 USA.	mihaela.aslan@va.gov	Marx, Brian/AAK-5072-2020		Department of Veterans Affairs Cooperative Studies ProgramUS Department of Veterans Affairs; Abt SRBI, Inc.	Supported by the Department of Veterans Affairs Cooperative Studies Program.; The authors thank all the participants in this study. Participants are enrolled by staff at sites in Boston and Seattle, with specific services provided via a contract with Abt SRBI, Inc. The study is managed by the CSP #566 Chair's office at the Boston VA Healthcare System, the VA Clinical Epidemiology Research Center (CERC) at VA Connecticut Healthcare System in West Haven, an Executive Committee, and a Data Monitoring Committee; the entire initiative is overseen by VA Office of Research and Development. In addition to the authors of the paper, the following persons have provided expertise or assistance in the conduct of the study. Boston site: Fabiana Cabral, Meredith Charney, May Chen, Kaitlyn Gorman, Sohyun Han, Darren Holowaka, Heather Kapson, Amy Lawrence, Mary Alice Mills, Nicole Rodier, Paola Rodriguez, and Erin Ulloa. Seattle site: Kate Hoerster, Matthew Jakupcak, David Slagle, David Tice, and Ollie (Richie) Yarbrough. Chair's Office: Molly Franz, Anna Graefe, and Helen MacDonald. West Haven CERC and CSP Coordinating Center: Margaret Antonelli, Donna Cavaliere, Patricia Crutchfield, Maria deAsis, Peter Guarino, Adrienne Hoey, John Ko, Kathy Newvine, Susan O'Neil, Diane Orlando, Thomas Roy, and Joseph Turner. Executive Committee members: Paul Amoroso, Paul Bliese, Charles Hoge, and Theresa O'Connor. Data Monitoring Committee: Haiqun Lin, Scott Orr, Margaret Ryan, Karen Schwab, and Ayumi Shintani. VA Central Office: Timothy O'Leary. CSP Clinical Research Pharmacy Coordinating Center (CSPCRPCC): Clair Haakenson, Darlene Krueger, Amanda Snodgrass, and Kathleen Swanson [Site Monitoring, Auditing and Review Team (SMART)].	[Anonymous], 2012, CSP 566 NEUROPSYCHOL; Belasco A., 2009, TROOP LEVELS IN THE; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Diggle P., 2002, ANAL LONGITUDINAL DA; Fischer H, 2010, US MILITARY CASUALTY; Friedman MJ, 2004, NEW ENGL J MED, V351, P75, DOI 10.1056/NEJMe048129; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P156, DOI 10.1097/01.jom.0000052967.43131.51; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Letz R., 2000, NES3 USERS MANUAL; Lovibond SH, 1995, MANUAL FOR THE DEPRE; Molenberghs G., 2000, LINEAR MIXED MODELS; Reeves D, 2002, NATIONAL COGNITIVE R; Rubin D.B., 1987, MULTIPLE IMPUTATION; SANTOR DA, 1995, PSYCHOL ASSESSMENT, V7, P131, DOI 10.1037/1040-3590.7.2.131; Santor DA, 1997, PSYCHOL ASSESSMENT, V9, P233, DOI 10.1037/1040-3590.9.3.233; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Stewart AL, 1992, MEASURING FUNCTIONIN; Vasterling J, 2005, NEUROPSYCHOLOGY OF P; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2006, MIL MED, V171, P253, DOI 10.7205/MILMED.171.3.253; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079	28	6	6	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1081-5589	1708-8267		J INVEST MED	J. Invest. Med.	MAR	2013	61	3					569	577		10.231/JIM.0b013e31828407ff			9	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Research & Experimental Medicine	097GU	WOS:000315462800012	23392054				2022-02-06	
J	Bouvier, D				Bouvier, Damien			Interest of S100B protein blood level determination in severe or moderate head injury	ANNALES DE BIOLOGIE CLINIQUE			French	Article						S100B protein; head injury	COMPUTED-TOMOGRAPHY FINDINGS; SERUM S-100B PROTEIN; ARTERIAL CONCENTRATIONS; BRAIN-DAMAGE; EPIDEMIOLOGY; MANAGEMENT; TRAUMA; ENOLASE; MARKERS	S100B, a suffering brain marker, echibits a different interest in traumatic brain injury (TBI) as the trauma is severe (sTBI) or mild (mTBI). Our works presented for the attribution of the SFBC 2012 price talked about both aspects. Firstly, the extent of S100B elevation has been found to be useful in predicting clinical outcome after sTBI. However, few studies were realized with jugular venous blood samples. After comparing the interest between jugular venous and arterial blood concentrations evaluation of serum S100B protein in patients with sTBI, determination of S100B concentration in jugular blood samples appears to be better than in arterial ones to predict clinical outcome after brain injury. Secondly, it's difficult to determine the indication of cranial computed tomography (CCT) for patients with mTBI. Actually, 90% of patients with mTBI have unnecessary CCT or short hospitalization for observation. Serum concentrations of S100B were found to provide useful information. We have investigated in 2 studies (1 for adult, 1 for children) whether S100B concentrations in patients with mTBI could provide additional information to improve indication of the need for an initial CCT scan or for a short hospitalization. Patients with intracerebral lesions on the CCT scan (CCT+) or with bad clinical evolution were identified with a sensitivity level of 100% and a specificity level of 30%. Adding the measurement of S-100B serum concentration to the clinical decision rules for a CCT scan or hospitalization in patients with mTBI could allow a 30% reduction in scans and in hospitalization for clinical observation.	CHU Gabriel Montpied, Ctr Biol, Lab Biochim Med, Clermont Ferrand, France		Bouvier, D (corresponding author), CHU Gabriel Montpied, Ctr Biol, Lab Biochim Med, Clermont Ferrand, France.	dbouvier@chu-clermontferrand.fr		Bouvier, Damien/0000-0002-2707-4320			Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Babcock L, 2012, BRAIN INJURY, V26, P1372, DOI 10.3109/02699052.2012.694565; Beaudeux JL, 1999, ANN BIOL CLIN-PARIS, V57, P261; Beaudeux JL, 2001, IMMUNOANAL BIOL SPEC, V16, P14; Beaudeux JL, 2002, IMMUNOANAL BIOL SPEC, V17, P280; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Bouvier D, 2012, ANN BIOL CLIN-PARIS, V70, P269, DOI 10.1684/abc.2012.0701; Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Hallen M, 2010, J TRAUMA, V69, P284, DOI 10.1097/TA.0b013e3181ca060b; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; McKeating EG, 1998, ACT NEUR S, V71, P117; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Rothoerl RD, 2000, ACT NEUR S, V76, P97; Rouxel JPM, 2004, ANN FR ANESTH, V23, P6, DOI 10.1016/j.annfar.2003.09.021; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Weiss N, 2006, ANESTHESIOLOGY, V104, P658, DOI 10.1097/00000542-200604000-00008; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	39	6	10	0	6	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	0003-3898	1950-6112		ANN BIOL CLIN-PARIS	Ann. Biol. Clin.	MAR-APR	2013	71	2					145	150		10.1684/abc.2013.0812			6	Medical Laboratory Technology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology; Research & Experimental Medicine	124MQ	WOS:000317469000003	23587577				2022-02-06	
J	Gobl, C; Mahshie, J				Gobl, Christer; Mahshie, James			Inverse Filtering of Nasalized Vowels Using Synthesized Speech	JOURNAL OF VOICE			English	Article						Nasalized vowels; Glottal parameters; Inverse filtering; Voice source	CLASSICALLY TRAINED SINGERS; CLOSED-HEAD INJURY; GLOTTAL AIR-FLOW; VOICE SOURCE; FORMANT SYNTHESIZER; DYSARTHRIA; SPEAKERS; FEMALE; PARAMETERS; WAVEFORM	The present study examines the extent to which increased nasal coupling affects estimates of glottal parameters derived from inverse filtering based on an all-pole assumption of the vocal tract. A series of steady-state tokens for five Swedish vowels were synthesized using the HLsyn quasi-articulatory synthesizer (Sensimetrics, Malden, MA). For each vowel, the parameter controlling the cross-sectional area of the nasal aperture, an, was systematically varied, while the other HLsyn parameters were kept constant. The resultant pressure signal for each utterance was subsequently inverse filtered, and estimates were made of five glottal source parameters (EE, RG, RA, RK, and OQ) derived from fitting the Liljencrants and Fant source model to the inverse filtered signal. The results show that when analyzing nasalized vowels using inverse filtering based on an all-pole assumption of the vocal tract, the RA parameter estimate-a main determinant of the source spectral slope-can be adversely affected by nasal coupling. The errors in our estimates were particularly high for the high vowels: this was true not only for RA, but for all the parameters measured. However, with the exception of the distortion in the RA estimate, the effects were relatively small, regardless of the degree of nasal coupling.	[Gobl, Christer] Trinity Coll Dublin, Phonet & Speech Lab, Sch Linguist Speech & Commun Sci, Dublin 2, Ireland; [Mahshie, James] George Washington Univ, Dept Speech & Hearing Sci, Washington, DC USA		Gobl, C (corresponding author), Trinity Coll Dublin, Ctr Language & Commun Studies, Coll Green, Arts Bldg, Dublin 2, Ireland.	cegobl@tcd.ie		Gobl, Christer/0000-0002-5958-3891	Science Foundation IrelandScience Foundation IrelandEuropean Commission [09/IN.1/I2631]	This research was supported by the Science Foundation Ireland (Grant 09/IN.1/I2631) as part of the FASTNET project.	ACKERMANN H, 1993, J NEUROL, V240, P357, DOI 10.1007/BF00839967; Alku P, 2006, FOLIA PHONIATR LOGO, V58, P102, DOI 10.1159/000089611; Alku P, 1996, SPEECH COMMUN, V18, P131, DOI 10.1016/0167-6393(95)00040-2; Ananthapadmanabha TV, 1984, STLQPSR, V25, P1; Arroabarren I, 2006, IEEE T AUDIO SPEECH, V14, P1422, DOI 10.1109/TSA.2005.858013; Austin SF, 1997, J VOICE, V11, P212, DOI 10.1016/S0892-1997(97)80080-X; Bickley C, 2002, PROCEEDINGS OF THE 2002 IEEE WORKSHOP ON SPEECH SYNTHESIS, P55; Birch P, 2002, J VOICE, V16, P61, DOI 10.1016/S0892-1997(02)00073-5; DELATTRE P, 1954, STUD LINGUISTICA, V8, P103, DOI DOI 10.1515/9783112416105-031; Fant G, 1997, SPEECH COMMUN, V22, P125, DOI 10.1016/S0167-6393(97)00017-4; FANT G., 1970, ACOUSTIC THEORY SPEE; Fant G., 1985, TL QPSR, V26, P1, DOI DOI 10.1016/0167-6393(89)90001-0; Fant G, 1985, STL QPSR, V2, P119; Fant G., 1979, STL QPSR, V1, P85; Feng G, 1996, J ACOUST SOC AM, V99, P3694, DOI 10.1121/1.414967; GAUFFIN J, 1989, J SPEECH HEAR RES, V32, P556, DOI 10.1044/jshr.3203.556; GOBL C, 1992, SPEECH COMMUN, V11, P481, DOI 10.1016/0167-6393(92)90055-C; GOBL C, 1995, P 13 INT C PHON SCI, V1, P74; Gobl C., 1989, STL QPSR, V30, P9; Gobl C, 1999, COARTICULATION THEOR, P300; GOBL C, 2003, THESIS ROYAL I TECHN; GOBL C, 1988, STL QPSR, V1, P123; Gobl Christer, 1999, COARTICULATION THEOR, P122; Gobl Christer., 2010, HDB PHONETIC SCI, V2nd edn., P378; Hanson HM, 2002, J ACOUST SOC AM, V112, P1158, DOI 10.1121/1.1498851; Hartelius L, 2000, FOLIA PHONIATR LOGO, V52, P160, DOI 10.1159/000021531; HAWKINS S, 1985, J ACOUST SOC AM, V77, P1560, DOI 10.1121/1.391999; HILLMAN RE, 1989, J SPEECH HEAR RES, V32, P373, DOI 10.1044/jshr.3202.373; Holmberg EB, 2003, J VOICE, V17, P269, DOI 10.1067/S0892-1997(03)00076-6; HOLMBERG EB, 1988, J ACOUST SOC AM, V84, P511, DOI 10.1121/1.396829; HOUSE AS, 1956, J SPEECH HEAR DISORD, V21, P218, DOI 10.1044/jshd.2102.218; HUFFMAN MK, 1987, J ACOUST SOC AM, V81, P495, DOI 10.1121/1.394915; Jennings JJ, 2008, J VOICE, V22, P75, DOI 10.1016/j.jvoice.2006.08.017; KANE P, 1992, J CLIN SPEECH LANGUA, V1, P17; KARLSSON I, 1992, SPEECH COMMUN, V11, P491, DOI 10.1016/0167-6393(92)90056-D; Karlsson I, 1996, TMH QPSR, V37, P143; Kent L., 1966, THESIS U IOWA IOWA C; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; LEDER SB, 1990, EAR HEARING, V11, P169, DOI 10.1097/00003446-199006000-00001; LINDQVISTGAUFFIN J, 1976, PHONETICA, V33, P161, DOI 10.1159/000259720; Lubker J, 1970, STL QPSR, p[32, 9]; Lubker J F, 1968, Cleft Palate J, V5, P1; Maeda S, 1982, P IEEE INT C AC SPEE, V1, P911; Mahshie J, 1991, STL QPSR, V11, P19; Mahshie J, 2003, P 15 INT C PHON SCI, P3257; McGowan RS, 1999, P 14 INT C PHON SCI, V1, P137; MOLL KL, 1962, J SPEECH HEAR RES, V5, P30, DOI 10.1044/jshr.0501.30; MOON JB, 1985, CLEFT PALATE J, V22, P1; Nguyen LHP, 2008, ENT-EAR NOSE THROAT, V87, P138, DOI 10.1177/014556130808700307; NICHASAIDE A, 1993, LANG SPEECH, V36, P303, DOI 10.1177/002383099303600310; Ogden R, 2000, COMPUT SPEECH LANG, V14, P177, DOI 10.1006/csla.2000.0141; PERKELL JS, 1991, J ACOUST SOC AM, V89, P1777, DOI 10.1121/1.401011; Pierrehumbert J., 1989, STL QPSR, V30, P23; ROTHENBERG M, 1973, J ACOUST SOC AM, V53, P1632, DOI 10.1121/1.1913513; Stevens K., 1998, ACOUSTIC PHONETICS; STEVENS KN, 1991, J PHONETICS, V19, P161, DOI 10.1016/S0095-4470(19)30310-9; STEVENS KN, 1987, FESTSCHRIFT ILSE LEH, P00241; Sundberg J., 1978, STL QPSR, V19, P35; Sundberg J, 2007, J VOICE, V21, P127, DOI 10.1016/j.jvoice.2005.11.005; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1994, BRAIN INJURY, V8, P667, DOI 10.3109/02699059409151021; THOMPSON EC, 1995, J COMMUN DISORD, V28, P261, DOI 10.1016/0021-9924(94)00013-P; Warren D W, 1966, Cleft Palate J, V3, P103; Yanushevskaya I, 2007, LECT NOTES COMPUT SC, V4738, P159; Yanushevskaya I, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P462	65	6	6	1	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0892-1997			J VOICE	J. Voice	MAR	2013	27	2					155	169		10.1016/j.jvoice.2012.09.004			15	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	110RM	WOS:000316463200005	23231805				2022-02-06	
J	Grottke, O; Frietsch, T; Maas, M; Lier, H; Rossaint, R				Grottke, O.; Frietsch, T.; Maas, M.; Lier, H.; Rossaint, R.			Recommended Action How to Deal with Massive Bleeding and associated perioperative Coagulation Disorders	ANASTHESIOLOGIE & INTENSIVMEDIZIN			German	Article							PROTHROMBIN COMPLEX CONCENTRATE; FRESH-FROZEN PLASMA; ACTIVATED FACTOR-VII; LIFE-THREATENING HEMORRHAGE; RECOMBINANT-FACTOR-VIIA; TRAUMATIC BRAIN-INJURY; DILUTIONAL COAGULOPATHY; FIBRINOGEN CONCENTRATE; TRANSFUSION PROTOCOL; MAJOR TRAUMA		[Grottke, O.; Rossaint, R.] Univ Klinikum Aachen, Klin Anasthesiol, D-52074 Aachen, Germany; [Frietsch, T.] Robert Bosch Krankenhaus, Klin Schillerhohe, Gerlingen, Germany; [Maas, M.] Univ Klinikum Munster, Klin Anasthesiol Operat Intens Med & Schmerzthera, Munster, Germany; [Lier, H.] Univ Klinikum Koln, Klin Anasthesiol & Operat Intens Med, Cologne, Germany		Grottke, O (corresponding author), Univ Klinikum Aachen, Klin Anasthesiol, Pauwelsstr 30, D-52074 Aachen, Germany.	ogrottke@ukaachen.de	Grottke, Oliver/F-1508-2018; Lier, Heiko/J-3005-2019; Frietsch, Thomas/ABE-1386-2021	Lier, Heiko/0000-0001-7374-4324; 			Adam S, 2010, CLIN APPL THROMB-HEM, V16, P454, DOI 10.1177/1076029609336855; Beekley AC, 2008, CRIT CARE MED, V36, pS267, DOI 10.1097/CCM.0b013e31817da7dc; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bruce D, 2008, CRIT CARE, V12, DOI 10.1186/cc6987; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Cap AP, 2011, J TRAUMA, V71, pS9, DOI 10.1097/TA.0b013e31822114af; Carless PA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub2; Carless PA, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001884.PUB2; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Cotton BA, 2009, J TRAUMA, V66, P41, DOI 10.1097/TA.0b013e31819313bb; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; Dente CJ, 2009, J TRAUMA, V66, P1616, DOI 10.1097/TA.0b013e3181a59ad5; Desmurs-Clavel H, 2009, THROMB RES, V123, P796, DOI 10.1016/j.thromres.2008.07.007; Dickneite G, 2009, BRIT J ANAESTH, V102, P345, DOI 10.1093/bja/aen391; Dickneite G, 2008, ANESTH ANALG, V106, P1070, DOI 10.1213/ane.0b013e318165dfbb; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Engstrom M, 2006, J TRAUMA, V61, P624, DOI 10.1097/01.ta.0000226739.30655.75; Franchini M, 2010, CLIN OBSTET GYNECOL, V53, P219, DOI 10.1097/GRF.0b013e3181cc4378; Fries D, 2005, BRIT J ANAESTH, V95, P172, DOI 10.1093/bja/aei160; Fries D, 2009, CURR OPIN ANESTHESIO, V22, P267, DOI 10.1097/ACO.0b013e32832678d9; Ganter MT, 2008, ANESTH ANALG, V106, P1366, DOI 10.1213/ane.0b013e318168b367; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Grottke O, 2011, BLOOD, V118, P1943, DOI 10.1182/blood-2011-03-343046; Grottke O, 2010, BEST PRACT RES-CLIN, V24, P95, DOI 10.1016/j.bpa.2009.09.005; Grottke O, 2010, CRIT CARE, V14, DOI 10.1186/cc8960; Hanke AA, 2010, ANAESTHESIA, V65, P688, DOI 10.1111/j.1365-2044.2010.06367.x; Hardy JF, 2006, CAN J ANAESTH, V53, pS40, DOI 10.1007/BF03022251; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hedner Ulla, 2003, Clin Adv Hematol Oncol, V1, P112; Henrich W, 2008, J PERINAT MED, V36, P467, DOI 10.1515/JPM.2008.093; Henry DA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub4; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Honickel M, 2011, THROMB HAEMOSTASIS, V106, P724, DOI 10.1160/TH11-02-0101; Inaba K, 2010, ARCH SURG-CHICAGO, V145, P899, DOI 10.1001/archsurg.2010.175; James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229; Johansson PI, 2010, TRANSFUSION, V50, P701, DOI 10.1111/j.1537-2995.2009.02458.x; Kalina U, 2008, INT J CLIN PRACT, V62, P1614, DOI 10.1111/j.1742-1241.2008.01859.x; Kozek-Langenecker S, 2011, CRIT CARE, V15, DOI 10.1186/cc10488; Kozek-Langenecker SA, 2010, BEST PRACT RES-CLIN, V24, P27, DOI 10.1016/j.bpa.2009.09.009; Levi M, 2011, VOX SANG, V101, P154, DOI 10.1111/j.1423-0410.2011.01472.x; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; Levy JH, 2010, LANCET, V376, P3, DOI 10.1016/S0140-6736(10)60939-7; Lier H, 2008, J TRAUMA, V65, P951, DOI 10.1097/TA.0b013e318187e15b; Lier H, 2011, INTENS CARE MED, V37, P572, DOI 10.1007/s00134-011-2139-y; Liesenfeld KH, 2006, BRIT J CLIN PHARMACO, V62, P527, DOI 10.1111/j.1365-2125.2006.02667.x; Lissauer ME, 2011, AM J SURG, V202, P53, DOI 10.1016/j.amjsurg.2010.05.002; Maegele M, 2011, VOX SANG, V100, P231, DOI 10.1111/j.1423-0410.2010.01387.x; Mellin-Olsen J, 2010, EUR J ANAESTH, V27, P592, DOI 10.1097/EJA.0b013e32833b1adf; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Mitterlechner T, 2011, J THROMB HAEMOST, V9, P729, DOI 10.1111/j.1538-7836.2011.04211.x; Morrison LJ, 2011, J CRIT CARE, V26, P363, DOI 10.1016/j.jcrc.2010.08.021; Murad MH, 2010, TRANSFUSION, V50, P1370, DOI 10.1111/j.1537-2995.2010.02630.x; Nunez TC, 2010, J TRAUMA, V68, P1498, DOI 10.1097/TA.0b013e3181d3cc25; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; O'Keeffe T, 2008, ARCH SURG-CHICAGO, V143, P686, DOI 10.1001/archsurg.143.7.686; Perel P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub4; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Sarani B, 2008, CRIT CARE MED, V36, P1114, DOI 10.1097/CCM.0b013e318168f89d; Schick KS, 2009, CRIT CARE, V13, DOI 10.1186/cc8186; Schochl H, 2012, HAMOSTASEOLOGIE, V32, P22, DOI 10.5482/ha-1178; Schochl H, 2010, ANAESTHESIA, V65, P199, DOI 10.1111/j.1365-2044.2009.06188.x; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Schochl H, 2009, J TRAUMA, V67, P125, DOI 10.1097/TA.0b013e31818b2483; Schreiber MA, 2004, CRIT CARE CLIN, V20, P101, DOI 10.1016/S0749-0704(03)00095-2; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shanwell A, 2009, VOX SANG, V96, P316, DOI 10.1111/j.1423-0410.2009.01167.x; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Spahn DR, 2005, BRIT J ANAESTH, V95, P130, DOI 10.1093/bja/aei169; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Stanworth SJ, 2004, BRIT J HAEMATOL, V126, P139, DOI 10.1111/j.1365-2141.2004.04973.x; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; van den Elsen MJLJ, 2010, CURR OPIN ANESTHESIO, V23, P269, DOI 10.1097/ACO.0b013e328336b8d0; Velik-Salchner C, 2007, J THROMB HAEMOST, V5, P1019, DOI 10.1111/j.1538-7836.2007.02481.x; Vincent JL, 2006, CRIT CARE, V10, DOI 10.1186/cc5026; VINCENT JL, 1983, CRIT CARE MED, V11, P449, DOI 10.1097/00003246-198306000-00012; Vivien B, 2005, CRIT CARE MED, V33, P1946, DOI 10.1097/01.CCM.0000171840.01892.36; Weber CF, 2012, ANESTHESIOLOGY, V117, P531, DOI 10.1097/ALN.0b013e318264c644; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Yank V, 2011, ANN INTERN MED, V154, P529, DOI 10.7326/0003-4819-154-8-201104190-00004; Yucel N, 2006, J TRAUMA, V60, P1228, DOI 10.1097/01.ta.0000220386.84012.bf; Zander R, 2010, WIEN KLIN WOCHENSCHR, V122, pS6	88	6	6	1	6	AKTIV DRUCK & VERLAG GMBH	EBELSBACH	AN DER LOHWIESE 36, EBELSBACH, 97500, GERMANY	0170-5334	1439-0256		ANASTH INTENSIVMED	Anasthesiol. Intensivmed.	MAR	2013	54						147	157					11	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	110II	WOS:000316435400008					2022-02-06	
J	Hartig, W; Michalski, D; Seeger, G; Voigt, C; Donat, CK; Dulin, J; Kacza, J; Meixensberger, J; Arendt, T; Schuhmann, MU				Haertig, Wolfgang; Michalski, Dominik; Seeger, Gudrun; Voigt, Cornelia; Donat, Cornelius K.; Dulin, Julia; Kacza, Johannes; Meixensberger, Juergen; Arendt, Thomas; Schuhmann, Martin U.			Impact of 5-lipoxygenase inhibitors on the spatiotemporal distribution of inflammatory cells and neuronal COX-2 expression following experimental traumatic brain injury in rats	BRAIN RESEARCH			English	Article						Traumatic brain injury; Neuronal death; Macrophage; Granulocyte; COX-2	BOSWELLIC ACIDS; IN-VITRO; CYCLOOXYGENASE-2; NEUROPROTECTION; LEUKOTRIENES; RECRUITMENT; NEUTROPHILS; ANTIBODIES; MICROGLIA; MOLECULES	The inflammatory response following traumatic brain injury (TBI) contributes to neuronal death with poor outcome. Although anti-inflammatory strategies were beneficial in the experimental TBI, clinical translations mostly failed, probably caused by the complexity of involved cells and mediators. We recently showed in a rat model of controlled cortical impact (CCI) that leukotriene inhibitors (LIs) attenuate contusion growth and improve neuronal survival. This study focuses on spatiotemporal characteristics of macrophages and granulocytes, typically involved in inflammatory processes, and neuronal COX-2 expression. Effects of treatment with LIs (Boscari/MK-886), started prior trauma, were evaluated by quantifying CD68(+), CD43(+) and COX-2(+) cells 24 h and 72 h post-CC in the parietal cortex (PC), CA3 region, dentate gyrus (DG) and visual/auditory cortex (v/aC). Correlations were applied to identify intercellular relationships. At 24 h, untreated animals showed granulocyte invasion in all regions, decreasing towards 72 h. Macrophages increased from 24 h to 72 h post-CCI in PC and v/aC. COX-(2+) neurones showed no temporal changes, except of an increase in the CA3 region at 72 h. Treatment reduced granulocytes at 24 h in the pericontusional zone and hippocampus, and macrophages at 72 h in the PC and v/aC. COX-2 expression remained unaffected by LIs, except of time-specific changes in the DG (increase/decrease at 24/72 h). Interrelations confirmed concomitant cellular reactions beyond the initial trauma site. In conclusion, LIs attenuated the cellular inflammatory response following CCI. Future studies have to clarify region-specific effects and explore the potential of a clinically more relevant therapeutic approach applying Ms after CCI. (C) 2012 Elsevier B.V. All rights reserved.	[Haertig, Wolfgang; Seeger, Gudrun; Arendt, Thomas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Michalski, Dominik] Univ Leipzig, Dept Neurol, D-04103 Leipzig, Germany; [Voigt, Cornelia; Dulin, Julia; Meixensberger, Juergen; Schuhmann, Martin U.] Univ Leipzig, Dept Neurosurg, D-04103 Leipzig, Germany; [Donat, Cornelius K.] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharm, Dept Neuroradiopharmaceut, D-04318 Leipzig, Germany; [Kacza, Johannes] Univ Leipzig, Fac Vet Med, Inst Anat Histol & Embryol, D-04103 Leipzig, Germany; [Schuhmann, Martin U.] Univ Tubingen, Dept Neurosurg, D-72076 Tubingen, Germany		Michalski, D (corresponding author), Univ Leipzig, Dept Neurol, Liebigstr 20, D-04103 Leipzig, Germany.	dominik.michalski@medizin.uni-leipzig.de	Seeger, Gudrun/A-5733-2017; Arendt, Thomas/C-8747-2012				Abdel-Tawab M, 2011, CLIN PHARMACOKINET, V50, P349, DOI 10.2165/11586800-000000000-00000; AHUJA V, 1995, CELL IMMUNOL, V163, P59, DOI 10.1006/cimm.1995.1099; AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Ammon H P, 1996, Eur J Med Res, V1, P369; Ammon HPT, 2006, PLANTA MED, V72, P1100, DOI 10.1055/s-2006-947227; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Bellander BM, 2010, EXP BRAIN RES, V205, P103, DOI 10.1007/s00221-010-2342-z; BRAIN SD, 1990, PHARMACOL THERAPEUT, V46, P57, DOI 10.1016/0163-7258(90)90035-Z; Brock TG, 2007, THESCIENTIFICWORLDJO, V7, P1273, DOI 10.1100/tsw.2007.180; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Conti AC, 1998, J NEUROSCI, V18, P5663; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Dhillon HS, 1996, J NEUROTRAUM, V13, P781, DOI 10.1089/neu.1996.13.781; Engel S, 1996, ACT NEUR S, V66, P87; Farias S, 2009, J NEUROTRAUM, V26, P1977, DOI 10.1089/neu.2009.0877; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GILLARD J, 1989, CAN J PHYSIOL PHARM, V67, P456, DOI 10.1139/y89-073; Gugliucci A, 2002, J BIOL CHEM, V277, P31789, DOI 10.1074/jbc.M204450200; Hartig W, 2009, J CHEM NEUROANAT, V37, P128, DOI 10.1016/j.jchemneu.2008.10.003; HARTIG W, 1995, HISTOCHEM CELL BIOL, V104, P467, DOI 10.1007/BF01464337; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Isaksson J, 1997, ACTA NEUROPATHOL, V94, P16, DOI 10.1007/s004010050666; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kaufmann WE, 1997, PROSTAG OTH LIPID M, V54, P601, DOI 10.1016/S0090-6980(97)00128-7; KIWAK KJ, 1985, J NEUROSURG, V62, P865, DOI 10.3171/jns.1985.62.6.0865; Klegeris A, 2002, NEUROBIOL AGING, V23, P787, DOI 10.1016/S0197-4580(02)00021-0; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Matsumoto H, 2007, J NEUROSCI RES, V85, P994, DOI 10.1002/jnr.21198; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Moussaieff A, 2008, J CEREBR BLOOD F MET, V28, P1341, DOI 10.1038/jcbfm.2008.28; Moussaieff A, 2009, J PHARM PHARMACOL, V61, P1281, DOI [10.1211/jpp/61.10.0003, 10.1211/jpp.61.10.0003]; Petraglia Anthony L, 2011, Surg Neurol Int, V2, P146, DOI 10.4103/2152-7806.85987; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; Roy S, 2005, DNA CELL BIOL, V24, P244, DOI 10.1089/dna.2005.24.244; SAFAYHI H, 1992, J PHARMACOL EXP THER, V261, P1143; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Serhan CN, 2008, BRIT J PHARMACOL, V153, pS200, DOI 10.1038/sj.bjp.0707489; Soares HD, 1995, J NEUROSCI, V15, P8223; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Voigt C, 2012, NEUROPATH APPL NEURO, V38, P354, DOI 10.1111/j.1365-2990.2011.01211.x; Wilson S, 2004, J NEUROTRAUM, V21, P239, DOI 10.1089/089771504322972031; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T	55	6	6	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 1	2013	1498						69	84		10.1016/j.brainres.2012.12.022			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	111LL	WOS:000316522700008	23268351				2022-02-06	
J	Hogan, M; Nangle, N; Morrison, TG; McGuire, BE				Hogan, Mark; Nangle, Niamh; Morrison, Todd G.; McGuire, Brian E.			Evaluation of the Patient Generated Index as a measure of quality-of-life in people with severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; quality-of-life; Patient Generated Index	COMMUNITY INTEGRATION QUESTIONNAIRE; DEPRESSION SCALE; HOSPITAL ANXIETY; PSYCHOSOCIAL OUTCOMES; EMOTIONAL ADJUSTMENT; VALIDATION; SATISFACTION; VALIDITY; EUROPE; WELL	Objectives: Quality-of-life (QoL) measures may be useful in quantifying the personal impact of an acquired brain injury and as an indicator of the effectiveness of service provision. This study investigated the validity of the Patient Generated Index (PGI) as a measure of QoL with a sample of adults who had sustained a severe traumatic brain injury. Method: Fifty-five participants with an acquired brain injury were selected from four regional rehabilitation centres. Each participant completed validated questionnaires measuring subjective satisfaction with life, community integration, emotional distress, socially desirable responding and the Patient Generated Index. Results: The criterion-related validity of the PGI was demonstrated through a statistically significant positive correlation with life satisfaction. Evidence of construct validity was observed through significant correlations with measures of emotional distress and community integration. Depression had a strong negative association with QoL. Social desirability correlated significantly with both indices of QoL, suggesting that this variable may be treated as a covariate. Conclusion: The results offer some preliminary evidence for the validity of the PGI as a measure of QoL in people with severe brain injury.	[Hogan, Mark; McGuire, Brian E.] Natl Univ Ireland, Sch Psychol, Galway, Ireland; [Hogan, Mark] Hlth Serv Execut, Dept Psychol, Letterkenny, Donegal, Ireland; [Nangle, Niamh] Acquired Brain Injury Ireland, Sligo, Ireland; [Morrison, Todd G.] Univ Saskatchewan, Dept Psychol, Saskatoon, SK S7N 0W0, Canada		Hogan, M (corresponding author), Cty Clin, Dept Psychol, Letterkenny, Donegal, Ireland.	markf.hogan@hse.ie		Morrison, Todd/0000-0001-8033-3822			Ahmed S, 2005, QUAL LIFE RES, V14, P2247, DOI 10.1007/s11136-005-8118-4; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bowling A, 2007, AGEING SOC, V27, P827, DOI 10.1017/S0144686X07006423; Callaghan BG, 2003, CLIN REHABIL, V17, P858, DOI 10.1191/0269215503cr689oa; CALMAN KC, 1984, J MED ETHICS, V10, P124, DOI 10.1136/jme.10.3.124; Camfield L, 2007, QUAL LIFE RES, V16, P1039, DOI 10.1007/s11136-007-9182-8; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; DEINER E, 1985, J PERS ASSESS, V49, P71, DOI DOI 10.1207/S15327752JPA4901_; Dempster M, 2000, QUAL LIFE RES, V9, P369, DOI 10.1023/A:1008959925664; Dijkers MP, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50241; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Herd RM, 1997, BRIT J DERMATOL, V136, P502, DOI 10.1046/j.1365-2133.1997.d01-1225.x; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Holzhausen M, 2010, EUR J AGEING, V7, P201, DOI 10.1007/s10433-010-0159-z; Johnston M, 2000, J PSYCHOSOM RES, V48, P579, DOI 10.1016/S0022-3999(00)00102-1; JOYCE CRB, 1999, INDIVIDUAL QUALITY L; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kaplan CP, 2000, AM J PHYS MED REHAB, V79, P243, DOI 10.1097/00002060-200005000-00005; Livneh H., 2004, PSYCHOL HEALTH MED, V9, P411, DOI [10.1080/1354850042000267030, DOI 10.1080/1354850042000267030]; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Martin F, 2007, QUAL LIFE RES, V16, P705, DOI 10.1007/s11136-006-9152-6; Martin F, 2010, APPL RES QUAL LIFE, V5, P219, DOI 10.1007/s11482-010-9106-6; McBrinn J, 2008, BRAIN INJURY, V22, P765, DOI 10.1080/02699050802372208; MCCRAE RR, 1983, J CONSULT CLIN PSYCH, V51, P882, DOI 10.1037/0022-006X.51.6.882; Murduff C, 1998, QUAL LIFE RES, V7, P761; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Patel KK, 2003, VALUE HEALTH, V6, P595, DOI 10.1046/j.1524-4733.2003.65236.x; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; Ruta D, 2007, QUAL LIFE RES, V16, P716; Ruta DA, 1999, QUAL HEALTH CARE, V8, P22, DOI 10.1136/qshc.8.1.22; RUTA DA, 1994, MED CARE, V32, P1109, DOI 10.1097/00005650-199411000-00004; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Stilwell P, 1999, NEUROPSYCHOL REHABIL, V9, P277, DOI 10.1080/096020199389374; Symon A, 2002, BIRTH-ISS PERINAT C, V29, P40, DOI 10.1046/j.1523-536X.2002.00154.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Uziel L, 2010, PERS SOC PSYCHOL B, V36, P1591, DOI 10.1177/0146167210386239; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	6	6	0	13	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2013	27	3					273	280		10.3109/02699052.2012.743177			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	096OG	WOS:000315413400003	23438348				2022-02-06	
J	Kasseckert, SA; Shahzad, T; Miqdad, M; Stein, M; Abdallah, Y; Scharbrodt, W; Oertel, M				Kasseckert, Sascha Andreas; Shahzad, Tayyab; Miqdad, Mohammed; Stein, Marco; Abdallah, Yaser; Scharbrodt, Wolfram; Oertel, Matthias			The Mechanisms of Energy Crisis in Human Astrocytes After Subarachnoid Hemorrhage	NEUROSURGERY			English	Article						Astrocytes; Calcium; Intracerebral hemorrhage; Purinergic receptors	TRAUMATIC BRAIN-INJURY; CELL-DEATH; RELEASE; ATP; MODULATION; NEURONS; LIFE; CA2+; P2X	BACKGROUND: Calcium (Ca2+) is a cofactor of multiple cellular processes. The mechanisms that lead to elevated cytosolic Ca2+ concentration are unclear. OBJECTIVE: To illuminate how bloody cerebrospinal fluid (bCSF) from patients with intraventricular hemorrhage causes cell death of cultured human astrocytes. METHODS: Cultured astrocytes were incubated with bCSF. In control experiments, native CSF was used. Cytosolic Ca2+ concentration was measured by fura-2 fluorescence. Apoptosis and necrosis were evaluated by staining with Hoechst-3342 and propidium iodide. RESULTS: Incubation of astrocytes with bCSF provoked a steep Ca2+ concentration peak that was followed by a slow Ca2+ rise during the observation period of 50 minutes. Necrosis, but not apoptosis, was induced. Blockade of ATP-sensitive P2 receptors with suramin inhibited the bCSF-induced initial Ca2+ peak and necrosis. Blockade of P1 receptors with 8-phenyltheophylline or of N-methyl-D-aspartate receptors with D(-)-2-amino-5-phosphopentanoic acid had no significant effect. Preincubation with xestospongin D, a blocker of inositol 1,4,5-trisphosphate receptors, prevented the initial Ca2+ rise and reduced the rate of necrosis. Preemptying of the endoplasmic reticulum with thapsigargin protected astrocytes from the bCSF-induced Ca2+ peak. Inhibition of mitochondrial permeability transition pores opening with cyclosporin A reduced the rate of astrocytic necrosis significantly, although it did not influence the initial Ca2+ peak. CONCLUSION: bCSF elicits a steep, transient Ca2+ rise when administered to human astrocytes by activation of ATP-sensitive P2 receptors and subsequent inositol 1,4,5-trisphosphate-dependent Ca2+ release from endoplasmic reticulum. This massive Ca2+ overload leads to subsequent mitochondrial permeability transition pores opening and necrosis of the cells.	[Kasseckert, Sascha Andreas; Shahzad, Tayyab; Miqdad, Mohammed; Abdallah, Yaser] Univ Giessen, Dept Physiol, D-35390 Giessen, Germany; [Miqdad, Mohammed; Stein, Marco; Scharbrodt, Wolfram; Oertel, Matthias] Univ Klinikum Giessen & Marburg GmbH, Dept Neurosurg, D-35385 Giessen, Germany		Oertel, M (corresponding author), Univ Klinikum Giessen & Marburg GmbH, Dept Neurosurg, Klin Str 29, D-35385 Giessen, Germany.	matthias.oertel@neuro.med.uni-giessen.de					ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Alberi S, 1997, BRAIN RES, V745, P55, DOI 10.1016/S0006-8993(96)01127-4; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; BURNSTOCK G, 1976, J THEOR BIOL, V62, P491, DOI 10.1016/0022-5193(76)90133-8; Burnstock GA, 1978, CELL MEMBRANE RECEPT, P107; CHOI DW, 1987, J NEUROSCI, V7, P357; Fam SR, 2003, J NEUROSCI, V23, P4437; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Fumagalli M, 2003, GLIA, V43, P218, DOI 10.1002/glia.10248; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Halestrap AP, 2009, J BIOENERG BIOMEMBR, V41, P113, DOI 10.1007/s10863-009-9206-x; HOVDA DA, 1990, ACT NEUR S, V51, P331; HUTTER BO, 1995, BRIT J NEUROSURG, V9, P465, DOI 10.1080/02688699550041106; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jacobson J, 2002, J CELL SCI, V115, P1175; Kukulski F, 2010, MOL IMMUNOL, V47, P991, DOI 10.1016/j.molimm.2009.11.020; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Macdonald RL, 2001, NEUROSURGERY, V48, P854, DOI 10.1097/00006123-200104000-00033; Macdonald RL, 2001, NEUROSURGERY, V48, P862; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Oertel MF, 2007, J CLIN NEUROSCI, V14, P948, DOI 10.1016/j.jocn.2006.11.002; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Rollins S, 2002, BRAIN RES, V945, P41, DOI 10.1016/S0006-8993(02)02562-3; ROMNER B, 1989, NEUROSURGERY, V25, P390, DOI 10.1227/00006123-198909000-00012; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; Schafer C, 2003, CARDIOVASC RES, V58, P149, DOI 10.1016/S0008-6363(02)00842-8; Scharbrodt W, 2009, J CLIN NEUROSCI, V16, P1409, DOI 10.1016/j.jocn.2009.01.011; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Zipfel GJ, 1999, NEW ENGL J MED, V341, P1543, DOI 10.1056/NEJM199911113412011	37	6	6	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2013	72	3					468	474		10.1227/NEU.0b013e31827d0de7			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	093LQ	WOS:000315193800047	23151619				2022-02-06	
J	Ruiz-Medina, J; Pinto-Xavier, A; Rodriguez-Arias, M; Minarro, J; Valverde, O				Ruiz-Medina, Jessica; Pinto-Xavier, Ana; Rodriguez-Arias, Marta; Minarro, Jose; Valverde, Olga			Influence of chronic caffeine on MDMA-induced behavioral and neuroinflammatory response in mice	PSYCHOPHARMACOLOGY			English	Article						Caffeine; MDMA; Neuroinflammation; Microglia; Astrocytes	ADENOSINE A(2A) RECEPTOR; 3,4-METHYLENEDIOXYMETHAMPHETAMINE ECSTASY; SUBSTITUTED AMPHETAMINES; MEDIATED MODULATION; LOCOMOTOR-ACTIVITY; DOPAMINE RELEASE; BODY-TEMPERATURE; BLOOD-PRESSURE; HEART-RATE; NEUROTOXICITY	Previous research suggests that chronic daily caffeine administration protects against brain injury in different animal models of neurodegenerative diseases, such as Parkinson's and Alzheimer's diseases, ischemic and traumatic brain injury, and allergic encephalitis. However, little is known about the effects of chronic caffeine administration on 3,4-methylenedioxymethamphetamine (MDMA)-induced neuroinflammation. The present study examines whether chronic caffeine (10, 20, or 30 mg/kg, i.p, for 21 consecutive days) protects against MDMA-induced astrocytic and microglial activation in mice striatum, impairing its neuroinflammatory effects. Additionally, locomotor activity, sensoriomotor reflexes, body temperature, and anxiety were evaluated after caffeine injection on days 0 (basal), 7, 14, and 21 of the chronic treatment in order to assess possible behavioral alterations due to caffeine administration. On day 22, mice pretreated with caffeine or saline received a neurotoxic regimen of MDMA (3 x 20 mg/kg, i.p., 2-h interval) or saline, and changes in body temperature were evaluated. Forty-eight hours after last MDMA or saline injection (day 24), the aforementioned behavioral parameters were investigated and microglia and astroglia activation to MDMA treatment was examined in the mouse striatum. Caffeine (10 mg/kg) chronically administered completely prevented MDMA-induced glial activation without inducing physiological or behavioral alterations in any of the assays performed. Chronic caffeine consumption at low doses exerts anti-inflammatory effects and prevents MDMA-induced neuroinflammation.	[Ruiz-Medina, Jessica; Pinto-Xavier, Ana; Valverde, Olga] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, GReNeC, Barcelona 08003, Spain; [Rodriguez-Arias, Marta; Minarro, Jose] Univ Valencia, Unidad Invest Psicobiol Drogodependencias, Dept Psicobiol, Valencia 46010, Spain		Valverde, O (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, GReNeC, C Dr Aiguader 88, Barcelona 08003, Spain.	olga.valverde@upf.edu	Valverde, Olga/D-8654-2012; Minarro, Jose/B-4414-2011; Rodriguez-Arias, Marta/B-5163-2011	Valverde, Olga/0000-0003-2264-7852; Minarro, Jose/0000-0002-5731-7821; Ruiz Medina, Jessica/0000-0001-9110-323X	Spanish Ministry of Science and InnovationSpanish Government [SAF 2010/15793]; Spanish Ministry of HealthInstituto de Salud Carlos IIISpanish Government; Red Tematica de Investigacion Cooperativa en Salud (ISCIII) [RTA 001/06/1001-FEDER]; Generalitat de CatalunyaGeneralitat de CatalunyaGeneral Electric [SGR 2009/684]; Spanish Ministry Economy and CompetitivenessSpanish Government [PSI2011-24762]; Red de Trastornos AdictivosInstituto de Salud Carlos III [RTA06/001/0016]; Generalitat ValencianaGeneralitat ValencianaEuropean CommissionGeneral Electric [PROMETEO/2009/072]	This work was supported by grants from the Spanish Ministry of Science and Innovation (SAF 2010/15793), the Spanish Ministry of Health (PNSD convocatoria 2010) and Red Tematica de Investigacion Cooperativa en Salud (ISCIII) (RETIC-Trastornos Adictivos RTA 001/06/1001-FEDER), and the Generalitat de Catalunya (SGR 2009/684) to OV, and by grants from the Spanish Ministry Economy and Competitiveness (PSI2011-24762), Red de Trastornos Adictivos (RTA06/001/0016) and Generalitat Valenciana, (PROMETEO/2009/072) to JM.	Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BILSKY EJ, 1991, PHARMACOL BIOCHEM BE, V40, P443, DOI 10.1016/0091-3057(91)90577-O; Borycz J, 2007, J NEUROCHEM, V101, P355, DOI 10.1111/j.1471-4159.2006.04386.x; BUTCHER RW, 1962, J BIOL CHEM, V237, P1244; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Camarasa J, 2006, BRAIN RES, V1111, P72, DOI 10.1016/j.brainres.2006.06.087; Cami J, 2000, J CLIN PSYCHOPHARM, V20, P455, DOI 10.1097/00004714-200008000-00010; Catlow BJ, 2010, EUR J PHARMACOL, V628, P96, DOI 10.1016/j.ejphar.2009.11.017; CHEEK TR, 1993, J BIOL CHEM, V268, P27076; Chen JH, 2007, COMM COM INF SC, V2, P21; Daza-Losada M, 2007, NEUROPSYCHOPHARMACOL, V32, P1750, DOI 10.1038/sj.npp.1301309; Deleu D, 2006, NEUROLOGY, V67, P897, DOI 10.1212/01.wnl.0000233916.57415.9d; Fantegrossi WE, 2008, NEUROSCIENCE, V151, P533, DOI 10.1016/j.neuroscience.2007.11.007; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; GREDEN JF, 1974, AM J PSYCHIAT, V131, P1089; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Green PJ, 1996, J BEHAV MED, V19, P111, DOI 10.1007/BF01857602; Gudelsky GA, 2003, METH MOLEC MED, V79, P55; Hamilton SP, 2004, NEUROPSYCHOPHARMACOL, V29, P558, DOI 10.1038/sj.npp.1300311; Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3; Hasko G, 2005, TRENDS PHARMACOL SCI, V26, P511, DOI 10.1016/j.tips.2005.08.004; HOLTZMAN SG, 1991, J PHARMACOL EXP THER, V256, P62; Kalant H, 2001, CAN MED ASSOC J, V165, P917; Khairnar A, 2010, NEUROTOX RES, V17, P435, DOI 10.1007/s12640-009-9125-y; Klingler W, 2005, J PHARMACOL EXP THER, V314, P1267, DOI 10.1124/jpet.105.086629; Lam P, 2005, NEUROSCI LETT, V378, P98, DOI 10.1016/j.neulet.2004.12.012; LAMB RJ, 1987, PSYCHOPHARMACOLOGY, V91, P268, DOI 10.1007/BF00518175; LAU CE, 1994, PHARMACOL BIOCHEM BE, V48, P337, DOI 10.1016/0091-3057(94)90535-5; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Lieberman HR, 2002, PSYCHOPHARMACOLOGY, V164, P250, DOI 10.1007/s00213-002-1217-9; Lyles J, 2003, BRAIN RES REV, V42, P155, DOI 10.1016/S0165-0173(03)00173-5; McNamara R, 2006, NEUROPHARMACOLOGY, V50, P69, DOI 10.1016/j.neuropharm.2005.08.006; McNamara R, 2007, EUR J PHARMACOL, V555, P194, DOI 10.1016/j.ejphar.2006.10.063; MUMFORD GK, 1991, J PHARMACOL EXP THER, V258, P857; O'Shea E, 2003, TRENDS PHARMACOL SCI, V24, P272, DOI 10.1016/S0165-6147(03)00133-0; Okuro M, 2010, SLEEP, V33, P930, DOI 10.1093/sleep/33.7.930; PARKER I, 1991, J PHYSIOL-LONDON, V433, P229, DOI 10.1113/jphysiol.1991.sp018423; Parrott AC, 2011, PSYCHOPHARMACOLOGY, V215, P527, DOI 10.1007/s00213-011-2184-9; Phillis JW, 1995, BRAIN RES, V705, P79, DOI 10.1016/0006-8993(95)01153-6; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; Quarta D, 2004, J NEUROCHEM, V91, P873, DOI 10.1111/j.1471-4159.2004.02761.x; Retey JV, 2007, CLIN PHARMACOL THER, V81, P692, DOI 10.1038/sj.clpt.6100102; Riksen NP, 2006, J AM COLL CARDIOL, V48, P700, DOI 10.1016/j.jacc.2006.04.083; Ros-Simo C, 2012, PSYCHOPHARMACOLOGY, V221, P511, DOI 10.1007/s00213-011-2598-4; Ruiz-Medina J, 2011, J PSYCHOPHARMACOL, V25, P550, DOI 10.1177/0269881110389210; Sanchez V, 2004, J PSYCHOPHARMACOL, V18, P412, DOI 10.1177/026988110401800312; Soria G, 2006, NEUROPSYCHOPHARMACOL, V31, P978, DOI 10.1038/sj.npp.1300876; Tourino C, 2008, BIOL PSYCHIAT, V63, P1030, DOI 10.1016/j.biopsych.2007.09.003; Tourino C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009143; Trigo JM, 2006, PSYCHOPHARMACOLOGY, V184, P212, DOI 10.1007/s00213-005-0229-7; Vanattou-Saifoudine N, 2010, BRIT J PHARMACOL, V116, P862; Vanattou-Saifoudine N, 2010, PSYCHOPHARMACOLOGY, V211, P15, DOI 10.1007/s00213-010-1864-1; Volkow ND, 2006, AM J PSYCHIAT, V163, P359, DOI 10.1176/appi.ajp.163.3.359; Wardas J, 2002, POL J PHARMACOL, V54, P313; Xie XB, 2007, COMPARATIVE MED, V57, P538; Xu K, 2002, NEUROSCI LETT, V322, P13, DOI 10.1016/S0304-3940(02)00069-1	58	6	8	0	20	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158			PSYCHOPHARMACOLOGY	Psychopharmacology	MAR	2013	226	2					433	444		10.1007/s00213-012-2918-3			12	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	096XR	WOS:000315438700021	23187789				2022-02-06	
J	Saban, KL; Hogan, TP; DeFrino, D; Evans, CT; Bauer, ED; Pape, TLB; Steiner, M; Proescher, EJ; Vlasses, FR; Smith, BM				Saban, Karen L.; Hogan, Timothy P.; DeFrino, Daniela; Evans, Charlesnika T.; Bauer, Erica D.; Pape, Theresa Louise-Bender; Steiner, Monica; Proescher, Eric J.; Vlasses, Frances R.; Smith, Bridget M.			Burnout and coping strategies of polytrauma team members caring for Veterans with traumatic brain injury	BRAIN INJURY			English	Article						Burnout; professional; stress; psychological; veterans; brain injuries	NURSE BURNOUT; CARE; SURGEONS; STRESS	Objective: The aims of this national study were to (1) examine the extent of job burnout among VA Polytrauma team members engaged in the diagnosis and treatment of traumatic brain injury (TBI); and (2) identify their coping strategies for dealing with job-related stress. Design: A cross-sectional sample of 233 VA Polytrauma team members completed the Maslach Burnout Inventory (MBI) and identified strategies for coping with work stress as part of an online survey. Results: VA Polytrauma team members experience moderate levels of emotional exhaustion, but low levels of depersonalization and high levels of personal accomplishment. Moreover, 24% of participants reported high levels of emotional exhaustion, which may be a precursor to job burnout. Participants who reported caring for Veterans with TBI >= 50% of their time experienced higher levels of emotional exhaustion than those who spent <50% of their time (p <= 0.001). Five major thematic categories related to coping strategies emerged from the data: (1) connecting with others, (2) promoting a healthy lifestyle, (3) pursuing outside interests, (4) managing work environment and (5) maintaining positive thinking. Conclusion: Polytrauma team members caring for Veterans with TBI may be at risk for job burnout.	[Saban, Karen L.; DeFrino, Daniela; Vlasses, Frances R.] Loyola Univ, Marcella Niehoff Sch Nursing, Chicago, IL 60611 USA; [Saban, Karen L.; DeFrino, Daniela; Evans, Charlesnika T.; Pape, Theresa Louise-Bender; Steiner, Monica; Smith, Bridget M.] Edward Hines Jr VA Hosp, Hines, IL USA; [Hogan, Timothy P.] Edith Nourse Rogers Mem Vet Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Hogan, Timothy P.] Edith Nourse Rogers Mem Vet Hosp, EHlth Qual Enhancement Res Initiat QUERI, Natl EHlth QUERI Coordinating Ctr, Bedford, MA USA; [Hogan, Timothy P.] Univ Massachusetts, Sch Med, Div Hlth Informat & Implementat Sci, Worcester, MA USA; [Evans, Charlesnika T.; Bauer, Erica D.; Pape, Theresa Louise-Bender] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Proescher, Eric J.] Jesse Brown Vet Adm Med Ctr, Chicago, IL USA; [Steiner, Monica; Smith, Bridget M.] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL 60153 USA		Saban, KL (corresponding author), Loyola Univ Chicago, Marcella Niehoff Sch Nursing, 2160S 1st Ave,Maguire Bldg,Room 2840, Maywood, IL 60153 USA.	ksaban@luc.edu	Saban, Karen/H-4837-2011	Saban, Karen/0000-0001-5767-5453; Bender Pape, Theresa/0000-0001-7738-5963	Department of Veterans Affairs, Office of Research and Development, Health Services Research and DevelopmentUS Department of Veterans Affairs [SDR 08-409]	This study was supported by the Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development (SDR 08-409). The views expressed in this paper are those of the authors and do not necessarily reflect the position and/or policy of the Department of Veterans Affairs or the United States Government.	Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Avellar S, 2003, J MARRIAGE FAM, V65, P597, DOI 10.1111/j.1741-3737.2003.00597.x; Ballenger-Browning KK, 2011, MIL MED, V176, P253, DOI 10.7205/MILMED-D-10-00269; Berg Jenny, 2004, Eur J Health Econ, V5 Suppl 1, pS84, DOI 10.1007/s10198-005-0293-2; Center for Disease Control and Prevention, 2012, FACTS TRAUM BRAIN IN; Contag SP, 2010, ARCH OTOLARYNGOL, V136, P950, DOI 10.1001/archoto.2010.175; De Oliveira GS, 2011, J CLIN ANESTH, V23, P176, DOI 10.1016/j.jclinane.2011.02.001; Department of Defense, 2011, DEP DEF NUMB TRAUM B; Doncevic S, 2010, NEUROREHABILITATION, V26, P285, DOI 10.3233/NRE-2010-0564; Drazen JM, 2005, NEW ENGL J MED, V352, P2121, DOI 10.1056/NEJMe048332; Dyrbye LN, 2011, ARCH SURG-CHICAGO, V146, P211, DOI 10.1001/archsurg.2010.310; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Keswani RN, 2011, AM J GASTROENTEROL, V106, P1734, DOI 10.1038/ajg.2011.148; Lasalvia A, 2009, BRIT J PSYCHIAT, V195, P537, DOI 10.1192/bjp.bp.108.060871; Leiter M P, 1997, J Occup Health Psychol, V2, P35; Leiter MP, 1996, INT J SOC PSYCHIATR, V42, P90, DOI 10.1177/002076409604200203; Leiter MP, 1998, SOC SCI MED, V47, P1611, DOI 10.1016/S0277-9536(98)00207-X; Leiter MP, 1225, CAN FAM PHYSICIAN, V55, P1224; Lemaire JB, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-208; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C., 1996, MBI MASLACH BURNOUT; National Institute of Neurological Disorders and Stroke, 2008, TRAUM BRAIN INJ HOP; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pasquina P, 2004, TRAUM AMP QUERI WORK; Peisah C, 2009, AGING MENT HEALTH, V13, P300, DOI 10.1080/13607860802459831; Poghosyan L, 2010, RES NURS HEALTH, V33, P288, DOI 10.1002/nur.20383; Rupert PA, 2005, PROF PSYCHOL-RES PR, V36, P544, DOI 10.1037/0735-7028.36.5.544; Sasaki M, 2009, J NURS MANAGE, V17, P359, DOI 10.1111/j.1365-2834.2008.00960.x; Shanafelt TD, 2010, ANN SURG, V251, P995, DOI 10.1097/SLA.0b013e3181bfdab3; Sherring Simon, 2009, Br J Nurs, V18, P1234; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Tanielian T., 2008, INVISIBLE WOUNDS WAR; United States Department of Veterans Affairs, 2007, QUERI POL BLAST REL; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Veterans Health Administration, 2010, SCREEN EV POSS TRAUM	38	6	6	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2013	27	3					301	309		10.3109/02699052.2012.743183			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	096OG	WOS:000315413400007	23438349				2022-02-06	
J	Kim, J; Avants, B; Whyte, J; Gee, JC				Kim, Junghoon; Avants, Brian; Whyte, John; Gee, James C.			Methodological considerations in longitudinal morphometry of traumatic brain injury	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						longitudinal; power; bias; magnetic resonance imaging; sparse canonical correlation analysis	DIFFEOMORPHIC IMAGE REGISTRATION; VOXEL-BASED MORPHOMETRY; CORTICAL THICKNESS; MRI; PROGRESSION; INTEGRITY; ATROPHY; TENSOR	Traumatic brain injury (TBI) has recently been reconceptualized as a chronic, evolving disease process. This new view necessitates quantitative assessment of post-injury changes in brain structure that may allow more accurate monitoring and prediction of recovery. In particular, TBI is known to trigger neurodegenerative processes and therefore quantifying progression of diffuse atrophy over time is currently of utmost interest. However, there are various methodological issues inherent to longitudinal morphometry in TBI. In this paper, we first overview several of these methodological challenges: lesion evolution, neurosurgical procedures, power, bias, and non-linearity. We then introduce a sensitive, reliable, and unbiased longitudinal multivariate analysis protocol that combines dimensionality reduction and region of interest approaches. This analysis pipeline is demonstrated using a small dataset consisting of four chronic TBI survivors.	[Kim, Junghoon; Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Avants, Brian; Gee, James C.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA		Kim, J (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	kimj@einstein.edu	Kim, Junghoon John/I-6702-2019	Kim, Junghoon John/0000-0001-5729-8993; Whyte, John/0000-0002-4381-1474; avants, brian/0000-0002-4212-3362	NINDS, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS065980-02]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065980] Funding Source: NIH RePORTER	This work was funded by grant 5R01NS065980-02 from the NINDS, NIH and a grant with the Pennsylvania Department of Health. The department specifically disclaims responsibility for any analyses, interpretations, or conclusions.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 1998, HUM BRAIN MAPP, V6, P348, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<348::AID-HBM4>3.0.CO;2-P; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants B, 2010, LECT NOTES COMPUT SC, V6361, P324; Avants BB, 2011, NEUROINFORMATICS, V9, P381, DOI 10.1007/s12021-011-9109-y; Avants BB, 2010, NEUROIMAGE, V50, P1004, DOI 10.1016/j.neuroimage.2010.01.041; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler E.D., 2005, TXB TRAUMATIC BRAIN, P79, DOI DOI 10.1007/S00417-005-0003-X; Bosc M, 2003, NEUROIMAGE, V20, P643, DOI 10.1016/S1053-8119(03)00406-3; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Ghosh N, 2011, J MAGN RESON IMAGING, V33, P772, DOI 10.1002/jmri.22488; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hillary FG, 2009, BRAIN IMAGING BEHAV, V3, P111, DOI 10.1007/s11682-008-9053-0; Holland D, 2012, HUM BRAIN MAPP, V33, P2586, DOI 10.1002/hbm.21386; Hua X, 2011, NEUROIMAGE, V57, P5, DOI 10.1016/j.neuroimage.2011.01.079; Hua X, 2010, NEUROIMAGE, V51, P63, DOI 10.1016/j.neuroimage.2010.01.104; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; Lee JW, 2011, J KOREAN NEUROSURG S, V50, P231, DOI 10.3340/jkns.2011.50.3.231; Lepore N, 2007, LECT NOTES COMPUT SC, V4792, P826; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Thompson WK, 2011, NEUROIMAGE, V57, P1, DOI 10.1016/j.neuroimage.2010.11.092; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; Yushkevich PA, 2010, NEUROIMAGE, V50, P434, DOI 10.1016/j.neuroimage.2009.12.007	38	6	6	0	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	FEB 26	2013	7								52	10.3389/fnhum.2013.00052			6	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	101NB	WOS:000315780600001	23549059	Green Published, gold			2022-02-06	
J	Cartagena, CM; Schmid, KE; Phillips, KL; Tortella, FC; Dave, JR				Cartagena, Casandra M.; Schmid, Kara E.; Phillips, Katie L.; Tortella, Frank C.; Dave, Jitendra R.			Changes in Apoptotic Mechanisms Following Penetrating Ballistic-Like Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; Penetrating brain injury; Apoptosis	NECROSIS-FACTOR-ALPHA; BCL-2 FAMILY-MEMBER; TRAUMATIC BRAIN; CELL-DEATH; NERVOUS-SYSTEM; RAT MODEL; NEUROPROTECTION; INFLAMMATION; INHIBITION; BARRIER	We investigated apoptotic pathways in a model of severe traumatic brain injury, penetrating ballistic-like brain injury (PBBI). TUNEL staining identified increasing apoptosis within 24 h. From targeted arrays, 11 genes were identified for temporal mRNA evaluation. In addition, mRNA levels and enzyme activity for caspases 3, 8, and 9 were examined. In the death receptor-mediated apoptosis pathway, the relative quantities (RQs) of mRNA for tnfr1, fas, and tnf were upregulated while trail mRNA was downregulated. In the anti-apoptotic TNF-R2 pathway, tnfr2 and flip were upregulated while xiap was downregulated. These findings indicate that increases in tnf levels following injury are not only pro-apoptotic but may also signal competing anti-apoptotic mechanisms. For the mitochondria-mediated apoptosis pathway, RQs of anti-apoptotic factors bcl2a1d and birc3 were upregulated while both bcl2 and bax were downregulated. RQs for casp 3 and casp 8 increased while casp9 decreased. Enzymatic activity increased for caspases 3, 8, and 9. While multiple mechanisms promoting and inhibiting apoptosis are at play during the first week after a PBBI, the cumulative result remains increased apoptosis. The ability to understand and dissect these events will assist in the development and evaluation of treatments targeting apoptosis following severe brain injury.	[Cartagena, Casandra M.; Schmid, Kara E.; Phillips, Katie L.; Tortella, Frank C.; Dave, Jitendra R.] Walter Reed Army Inst Res, Ctr Psychiat & Neurosci, Dept Brain Trauma Neuroprotect & Neurorestorat, Silver Spring, MD 20910 USA		Cartagena, CM (corresponding author), Walter Reed Army Inst Res, Ctr Psychiat & Neurosci, Dept Brain Trauma Neuroprotect & Neurorestorat, Silver Spring, MD 20910 USA.	casandra.cartagena@us.army.mil; kara.schmid@us.army.mil; katie.phillips@amedd.army.mil; frank.c.tortella@us.army.mil; jit.dave@amedd.army.mil	Dave, Jitendra R/A-8940-2011				ARNOLD K, 1978, MIL MED, V143, P161; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Esposito DP, 2009, NEUROSURG QUART, V19, P249, DOI 10.1097/WNQ.0b013e3181bd1d53; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Fitch MT, 1999, J NEUROSCI, V19, P8182; Karsan A, 1996, J BIOL CHEM, V271, P27201, DOI 10.1074/jbc.271.44.27201; Langley B, 2004, J NEUROSCI RES, V77, P621, DOI 10.1002/jnr.20210; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; MATSUYAMA T, 1995, MOL BRAIN RES, V34, P166, DOI 10.1016/0169-328X(95)00162-L; Menon DK, 2005, ANAEST INTENS CARE M, V6, P184, DOI 10.1383/anes.6.6.184.65786; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Quentmeier H, 2003, LEUKEMIA RES, V27, P539, DOI 10.1016/S0145-2126(02)00269-2; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	34	6	6	0	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696			J MOL NEUROSCI	J. Mol. Neurosci.	FEB	2013	49	2					301	311		10.1007/s12031-012-9828-z			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	070OW	WOS:000313519900008	22684621				2022-02-06	
J	Chen, J; Mao, H; Zou, HF; Jin, W; Ni, LC; Ke, KF; Cao, MH; Shi, W				Chen, Jian; Mao, Hui; Zou, HuiFei; Jin, Wei; Ni, Lanchun; Ke, Kaifu; Cao, MaoHong; Shi, Wei			Up-regulation of ski-interacting protein in rat brain cortex after traumatic brain injury	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Ski-interacting protein; Traumatic brain injury; Neuronal apoptosis; Rat	CELL-CYCLE ACTIVATION; INCREASED EXPRESSION; GLIAL PROLIFERATION; NEURONAL APOPTOSIS; GROWTH-FACTOR; DEATH; TRANSCRIPTION; DISEASE; RB; NEUROPROTECTION	SKIP (Ski-interacting protein), is part of nuclear regulatory complexes and interacts with factors involved in preinitiation, splicing and polyadenylation, potentiates the activity of important transcription factors, involved in an increasing number of signaling cascades. However, its distribution and function in the central nervous system remains poorly understood. In this study, western blot analysis, RT-PCR and immunohistochemistry showed a significant up-regulation of SKIP in ipsilateral peritrauma cortex compared with the sham group. Immunofluorescent labeling indicated that SKIP was localized striking in the neurons, but not astrocytes and oligodendrocytes; co-localization of SKIP and active caspase-3 and PCNA in the ipsilateral cortex. In addition, the expression patterns of active caspase-3 and PCNA were parallel with that of SKIP. Based on our data, we speculated that SKIP might play an important role in neuronal apoptosis following TBI; and might provide a basis for the further study on its role in cell cycle re-entry in traumatic brain injury.	[Chen, Jian; Mao, Hui; Zou, HuiFei; Ni, Lanchun; Shi, Wei] Hosp Nantong Univ, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China; [Jin, Wei; Ke, Kaifu; Cao, MaoHong] Hosp Nantong Univ, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China		Shi, W (corresponding author), Hosp Nantong Univ, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China.	maohui198616@hotmail.com; sw740104@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870320, 31070723, 81070275, 81171139, 81172879]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2009156, BK2009161, BK2010169]; Nature Science Foundation of China Ministry of Health [2010-2-025]	This work was supported by the National Natural Science Foundation of China (No. 30870320, No. 31070723, No. 81070275, No. 81171139 and No. 81172879); Natural Science Foundation of Jiangsu province (No. BK2009156, No. BK2009161 and No. BK2010169); Nature Science Foundation of China Ministry of Health (2010-2-025)	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chong ZZ, 2006, CURR NEUROVASC RES, V3, P25, DOI 10.2174/156720206775541741; Dasgupta P, 2006, CURR MOL MED, V6, P719; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Jiang SY, 2012, J MOL HISTOL, V43, P195, DOI 10.1007/s10735-011-9383-x; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Leong GM, 2001, J BIOL CHEM, V276, P18243, DOI 10.1074/jbc.M010815200; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Liu ZQ, 2011, J MOL HISTOL, V42, P265, DOI 10.1007/s10735-011-9330-x; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; LOGAN A, 1992, J NEUROSCI, V12, P3828; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; OKANO HJ, 1993, J NEUROSCI, V13, P2930; Prathapam T, 2002, NUCLEIC ACIDS RES, V30, P5261, DOI 10.1093/nar/gkf658; Prathapam T, 2001, NUCLEIC ACIDS RES, V29, P3469, DOI 10.1093/nar/29.17.3469; Shi W, 2012, J MOL HISTOL, V43, P37, DOI 10.1007/s10735-011-9366-y; Shi W, 2011, NEUROCHEM RES, V36, P375, DOI 10.1007/s11064-010-0332-y; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Wartiovaara K, 2002, J NEUROSCI, V22, P815, DOI 10.1523/JNEUROSCI.22-03-00815.2002; Xu T, 2012, J MOL HISTOL, V43, P335, DOI 10.1007/s10735-012-9408-0; Yan YH, 2012, J MOL HISTOL, V43, P543, DOI 10.1007/s10735-012-9431-1; Yang Y, 2003, J NEUROSCI, V23, P2557; Zhang C, 2001, J BIOL CHEM, V276, P40614, DOI 10.1074/jbc.M106263200; Zhao W, 2011, J MOL HISTOL, V42, P195, DOI 10.1007/s10735-011-9324-8; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000	33	6	8	1	11	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379			J MOL HISTOL	J. Mol. Histol.	FEB	2013	44	1					1	10		10.1007/s10735-012-9444-9			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	070GY	WOS:000313495800001	22965216				2022-02-06	
J	Ning, B; Li, Z; Zhu, NX; Hou, G; Pang, Q				Ning, Bo; Li, Zhen; Zhu, Ningxi; Hou, Gang; Pang, Qi			Traumatic Brain Injury Induces a Downregulation of MSK1 in Rat Brain Cortex	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; MSK1; Apoptosis; Proliferation	CENTRAL-NERVOUS-SYSTEM; KINASE-1 MSK1; GROWTH-FACTOR; CELL-CYCLE; PHOSPHORYLATION; MITOGEN; ACTIVATION; RECEPTORS; DEATH; SCAR	Mitogen- and stress-activated protein kinase (MSK) 1 protein was initially identified as a particularly interesting protein of mitogen-activated protein kinase. It was reported to enhance B cell lymphoma 2-associated death protein's phosphorylation to protect cell death, suggesting that MSK1 represents a new type of anti-cell death gene. Moreover, a recent study has shown that MSK1 is involved in negative feedback pathways that are crucial to prevent uncontrolled inflammation. However, its function and expression in the central nervous system lesion are not been understood very well. In this study, we performed a traumatic brain injury (TBI) model in adult rats and investigated the dynamic changes of MSK1 expression in the brain cortex. Double immunofluorescence staining revealed that MSK1 was co-expressed with neuronal nuclei (NeuN) and glial fibrillary acidic protein (GFAP). Besides, co-localization of MSK1/active caspase 3 and MSK1/proliferating cell nuclear antigen (PCNA) was detected in NeuN and GFAP. We also examined the expression profiles of PCNA and active caspase 3 whose changes were correlated with the expression of MSK1. All our findings suggested that MSK1 might be involved in the pathophysiology of brain after TBI.	[Ning, Bo; Pang, Qi] Shandong Univ, Shandong Prov Hosp, Dept Neurosurg, Jinan 250012, Peoples R China; [Ning, Bo; Li, Zhen; Zhu, Ningxi] Taian Cent Hosp, Dept Neurosurg, Tai An 271000, Shandong, Peoples R China; [Hou, Gang] Taian Cent Hosp, Dept Pathol, Tai An 271000, Shandong, Peoples R China		Ning, B (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Neurosurg, Jinan 250012, Peoples R China.	ningbo197410@163.com; pangqi6676688@163.com		Pang, Qi/0000-0001-8333-5647			Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Clark CJ, 2007, J NEUROCHEM, V102, P1024, DOI 10.1111/j.1471-4159.2007.04601.x; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Duncan EA, 2006, J BIOL CHEM, V281, P12521, DOI 10.1074/jbc.M513333200; Erhardt L, 1996, EUR HEART J, V17, P1781; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Heffron D, 2005, MOL BRAIN RES, V136, P134, DOI 10.1016/j.molbrainres.2005.01.014; Hughes JP, 2003, J NEUROCHEM, V86, P25, DOI 10.1046/j.1471-4159.2003.01830.x; Johansen KM, 2006, CHROMOSOME RES, V14, P393, DOI 10.1007/s10577-006-1063-4; Konigsmark B.W., 1970, CONT RES METHODS NEU, P315, DOI DOI 10.1007/978-3-642-85986-1_14; LOGAN A, 1992, J NEUROSCI, V12, P3828; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Simon, 2008, FRONT BIOSCI, V13, P5866; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	21	6	7	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696			J MOL NEUROSCI	J. Mol. Neurosci.	FEB	2013	49	2					380	386		10.1007/s12031-012-9893-3			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	070OW	WOS:000313519900016	23065332				2022-02-06	
J	Mao, ZL; Song, ZQ; Li, G; Lv, W; Zhao, X; Li, B; Feng, XL; Chen, YL				Mao, Zhenli; Song, Zhenquan; Li, Gang; Lv, Wei; Zhao, Xu; Li, Bin; Feng, Xinli; Chen, Youli			8-hydroxy-2-(di-n-propylamino)tetralin intervenes with neural cell apoptosis following diffuse axonal injury	NEURAL REGENERATION RESEARCH			English	Article						neural regeneration; brain injury; 8-hydroxy-2-(di-n-propylamino)tetralin; diffuse axonal injury; mild hypothermia; cell apoptosis; Bcl-2; Bax; caspase-3; neuroprotection; grant-supported paper; photographs-containing paper; neuroregeneration	TRAUMATIC BRAIN-INJURY; RECEPTOR AGONIST; 5-HT1A; RAT; DAMAGE; DEATH; 8-OH-DPAT; MODEL; HYPOTHERMIA; INHIBITION	Previous studies have reported a neuroprotective effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) against traumatic brain injury. In accordance with the Marmarou method, rat models of diffuse axonal injury were established. 8-OH-DPAT was intraperitoneally injected into model rats. 8-OH-DPAT treated rats maintained at constant temperature served as normal temperature controls. TUNEL results revealed that neural cell swelling, brain tissue necrosis and cell apoptosis occurred around the injured tissue. Moreover, the number of Bax-, Bcl-2- and caspase-3-positive cells increased at 6 hours after diffuse axonal injury, and peaked at 24 hours. However, brain injury was attenuated, the number of apoptotic cells reduced, Bax and caspase-3 expression decreased, and Bcl-2 expression increased at 6, 12, 24, 72 and 168 hours after diffuse axonal injury in normal temperature control and in 8-OH-DPAT-intervention rats. The difference was most significant at 24 hours. All indices in 8-OH-DPAT-intervention rats were better than those in the constant temperature group. These results suggest that 8-OH-DPAT inhibits Bax and caspase-3 expression, increases Bcl-2 expression, and reduces neural cell apoptosis, resulting in neuroprotection against diffuse axonal injury. This effect is associated with a decrease in brain temperature.	[Mao, Zhenli; Song, Zhenquan; Lv, Wei; Zhao, Xu; Li, Bin; Feng, Xinli; Chen, Youli] Gen Hosp Shenyang Mil Reg, Dept Neurosurg, Shenyang 110016, Liaoning Provin, Peoples R China; [Mao, Zhenli; Lv, Wei; Zhao, Xu; Li, Bin] Liaoning Med Univ, Postgrad Sch, Jinzhou 121001, Liaoning Provin, Peoples R China; [Li, Gang] Jilin Brain Hosp, Siping 136000, Jilin Province, Peoples R China		Song, ZQ (corresponding author), Gen Hosp Shenyang Mil Reg, Dept Neurosurg, Shenyang 110016, Liaoning Provin, Peoples R China.	szqlz@163.com			Natural Science Foundation of Technology Department of Liaoning Province [20032047]	This project was funded by the Natural Science Foundation of Technology Department of Liaoning Province, No. 20032047.	Adayev T, 2003, BBA-MOL CELL RES, V1640, P85, DOI 10.1016/S0167-4889(03)00023-5; Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; Audero E, 2008, SCIENCE, V321, P130, DOI 10.1126/science.1157871; Bezard E, 2006, NEUROBIOL DIS, V23, P77, DOI 10.1016/j.nbd.2006.02.003; BLACKSHEAR MA, 1981, EUR J PHARMACOL, V76, P325, DOI 10.1016/0014-2999(81)90103-5; Burke TF, 2012, INT J NEUROPSYCHOPHA; Chen CJ, 2000, NEUROSCI LETT, V287, P113, DOI 10.1016/S0304-3940(00)01151-4; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; COX B, 1980, J PHYSIOL-LONDON, V303, P9, DOI 10.1113/jphysiol.1980.sp013266; DUNCAN WC, 1995, NEUROPSYCHOPHARMACOL, V12, P17, DOI 10.1016/0893-133X(94)00055-5; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; GUDELSKY GA, 1986, NEUROPHARMACOLOGY, V25, P1307, DOI 10.1016/0028-3908(86)90101-2; Haynes RL, 2008, PEDIATR RES, V63, P656, DOI 10.1203/PDR.0b013e31816c825c; Hsiung SC, 2008, J NEUROSCI RES, V86, P2326, DOI 10.1002/jnr.21676; Kline AE, 2004, J NEUROTRAUM, V21, P175, DOI 10.1089/089771504322778631; Lima RR, 2008, INFLAMMATION, V31, P24, DOI 10.1007/s10753-007-9046-y; Liu WG, 2004, ZHONGHUA SHENJING WA, V20, P170; Lo Iacono L, 2008, J NEUROSCI, V28, P6250, DOI 10.1523/JNEUROSCI.5219-07.2008; MARAZZITI D, 1994, BRAIN RES, V658, P55, DOI 10.1016/S0006-8993(09)90010-5; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsukawa H, 2011, ACTA NEUROCHIR, V153, P1687, DOI 10.1007/s00701-011-1002-9; Mauler F, 2001, BRAIN RES, V888, P150, DOI 10.1016/S0006-8993(00)03074-2; Park CO, 2004, YONSEI MED J, V45, P908, DOI 10.3349/ymj.2004.45.5.908; Polter AM, 2010, CELL SIGNAL, V22, P1406, DOI 10.1016/j.cellsig.2010.03.019; Ramos AJ, 2004, BRAIN RES, V1030, P201, DOI 10.1016/j.brainres.2004.10.019; Reynolds CA, 2011, NEUROL RES, V33, P192, DOI 10.1179/016164111X12881719352453; RINK A, 1995, AM J PATHOL, V147, P1575; Salazar-Colocho P, 2008, BRAIN RES, V1199, P159, DOI 10.1016/j.brainres.2007.12.032; Schneider A, 2012, RESUSCITATION, V83, P232, DOI 10.1016/j.resuscitation.2011.07.023; Singh M, 2012, NEUROPSYCH DIS TREAT, V8, P123, DOI 10.2147/NDT.S20683; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; Yang XF, 2011, MED HYPOTHESES, V77, P60, DOI 10.1016/j.mehy.2011.03.023; Yelleswarapu NK, 2012, NEUROSCI LETT, V515, P153, DOI 10.1016/j.neulet.2012.03.033; Yu H, 2005, GUOJI SHENJING BINGX, V32, P377; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhao CP, 2009, ZHONGHUA SHENJING YI, V8, P1078	36	6	6	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JAN 15	2013	8	2					133	142		10.3969/j.issn.1673-5374.2013.02.005			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	145IG	WOS:000319008200005	25206483				2022-02-06	
J	Barnes, S				Barnes, Scott			Proper noun anomia in conversation: A description of how a man with chronic anomia constructed referencing turns	APHASIOLOGY			English	Article						Anomia; Conversation analysis; Proper nouns	APHASIC TALK; COMMON; NAMES; LANGUAGE; SPEAKERS; GRAMMAR	Background: Proper noun anomia has received significant attention as a source of evidence for the organisation of the lexicon, and the neuroanatomical bases of language. There is also some evidence that people with aphasia and related disorders may have particular difficulty producing proper nouns. However, very few studies have examined how proper noun anomia manifests in everyday conversation. Aims: This study uses conversation analysis (CA) to describe how a man with chronic anomia constructed turns that referred to people, places, and other entities that can be named with proper nouns. Methods & Procedures: A man with chronic anomia following a closed head injury (Paul) was recorded during everyday conversations involving two friends and the researcher. Approximately 2(1/2) hours of recordings were collected and transcribed. A collection of referencing turns was assembled from this dataset and analysed. Outcomes & Results: Two design features of Paul's referencing turns are identified and described. First, Paul recurrently delayed the production of reference forms in referencing turns. It is speculated that these practices generated extra time for Paul to produce proper nouns. Second, Paul recurrently utilised common noun phrases (e.g., that young bloke) as reference forms in place of proper nouns. These references were easier to produce than proper nouns, and solicited proper nouns from his conversation partners. Securing the involvement of conversation partners allowed Paul to partially distribute the productive and moral responsibility for proper noun generation. Conclusions: It is argued that these turn construction practices represent adaptations to proper noun anomia in conversation. These findings may contribute to the development of interaction-focused interventions targeting referencing by people with anomia. Future investigation should focus on how the referencing turns of people with anomia change over time.	[Barnes, Scott] Univ Sydney, Discipline Speech Pathol, Ctr Clin Res Excellence Aphasia Rehabil, Sydney, NSW 2006, Australia		Barnes, S (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, Cumberland C42,POB 170, Lidcombe, NSW 1825, Australia.	scott.barnes@sydney.edu.au		Barnes, Scott/0000-0001-5299-0550			Adamovich B. B., 1992, SCALES COGNITIVE ABI; Armstrong E, 2007, APHASIOLOGY, V21, P763, DOI 10.1080/02687030701192364; Armstrong E, 2010, APHASIOLOGY, V24, P480, DOI 10.1080/02687030902775157; AUER JCP, 1984, J PRAGMATICS, V8, P627, DOI 10.1016/0378-2166(84)90003-1; Beeke S, 2003, CLIN LINGUIST PHONET, V17, P81, DOI 10.1080/0269920031000061795; Beeke S, 2007, APHASIOLOGY, V21, P256, DOI 10.1080/02687030600911344; Beeke S, 2011, J NEUROLINGUIST, V24, P222, DOI 10.1016/j.jneuroling.2010.03.002; Bredart S, 1997, COGNITIVE NEUROPSYCH, V14, P209, DOI 10.1080/026432997381556; Cohen G, 1993, Memory, V1, P249, DOI 10.1080/09658219308258237; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Damico JS, 2007, CLINICAL APHASIOLOGY: FUTURE DIRECTIONS, P92; Enfield NJ, 2003, LANGUAGE, V79, P82, DOI 10.1353/lan.2003.0075; Evrard M, 2002, BRAIN LANG, V81, P174, DOI 10.1006/brln.2001.2515; Ford Cecilia E., 1996, INTERACTION GRAMMAR, P134, DOI DOI 10.1017/CBO9780511620874.003; Francis DR, 2002, APHASIOLOGY, V16, P243, DOI 10.1080/02687040143000564; Heeschen C, 1999, APHASIOLOGY, V13, P365, DOI 10.1080/026870399402145; Helasvuo ML, 2004, RES LANG SOC INTERAC, V37, P1, DOI 10.1207/s15327973rlsi3701_1; Heritage J, 2007, LANG CULT COGN, P255; Kaplan E, 1983, BOSTON NAMING TEST; Kertesz A., 2006, W APHASIA BATTERY RE; Klippi A., 2003, CONVERSATION BRAIN D, P117; Laakso M, 1999, APHASIOLOGY, V13, P345, DOI 10.1080/026870399402136; Laakso Minna., 1997, SELF INITIATED REPAI; Laury Ritva., 1997, DEMONSTRATIVES INTER; Levinson SC, 2007, LANG CULT COGN, P29; Martins IP, 2007, NEUROPSYCHOLOGIA, V45, P1744, DOI 10.1016/j.neuropsychologia.2006.12.016; Milders M, 1999, J CLIN EXP NEUROPSYC, V21, P171, DOI 10.1076/jcen.21.2.171.932; Oelschlaeger ML, 1999, AM J SPEECH-LANG PAT, V8, P62, DOI 10.1044/1058-0360.0801.62; Oelschlaeger ML, 1998, APHASIOLOGY, V12, P971, DOI 10.1080/02687039808249464; Pomerantz A., 1984, STRUCTURES SOCIAL AC, P57, DOI DOI 10.1017/CBO9780511665868.008; Robson J, 2004, APHASIOLOGY, V18, P917, DOI 10.1080/02687030444000462; Sacks Harvey, 1979, EVERYDAY LANGUAGE ST, P15; Schegloff EA, 1996, AM J SOCIOL, V102, P161, DOI 10.1086/230911; Schegloff EA, 2007, SEQUENCE ORGANIZATION IN INTERACTION: A PRIMER IN CONVERSATION ANALYSIS I, P1, DOI 10.2277/ 0521532795; Schegloff Emanuel A., 1996, STUDIES ANAPHORA, P437, DOI DOI 10.1075/TSL.33.14SCH; Schegloff Emanuel A., 1996, INTERACTION GRAMMAR, P52, DOI 10.1017/cbo9780511620874.002; SEMENZA C, 1989, NATURE, V342, P678, DOI 10.1038/342678a0; Semenza C, 2002, BRAIN COGNITION, V48, P542, DOI 10.1006/brcg.2001.1414; Semenza C, 2006, CORTEX, V42, P884, DOI 10.1016/S0010-9452(08)70432-5; Semenza C, 2009, MIND LANG, V24, P347, DOI 10.1111/j.1468-0017.2009.01366.x; Sidtis DV, 2006, APHASIOLOGY, V20, P411, DOI 10.1080/02687030500538148; Silverman, 1997, QUALITATIVE RES THEO, P161; Stivers T, 2005, RES LANG SOC INTERAC, V38, P131, DOI 10.1207/s15327973rlsi3802_1; Stivers T, 2007, LANG CULT COGN, P73; Tranel D, 2006, NEUROPSYCHOLOGY, V20, P1, DOI 10.1037/0894-4105.20.1.1; Wilkinson R, 1999, APHASIOLOGY, V13, P327, DOI 10.1080/026870399402127; Wilkinson R., 2003, CONVERSATION BRAIN D, P59; Wilkinson R, 2007, J PRAGMATICS, V39, P542, DOI 10.1016/j.pragma.2006.07.010; Wilkinson R, 2010, J INTERACT RES COM D, V1, P45, DOI 10.1558/jircd.v1i1.45; Wilkinson Ray, 2007, Commun Med, V4, P79, DOI 10.1515/CAM.2007.009; Wilkinson R, 2009, DISCOURSE PROCESS, V46, P206, DOI 10.1080/01638530902728892; Yasuda K, 2000, APHASIOLOGY, V14, P1067, DOI 10.1080/02687030050174638	52	6	6	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	JAN 1	2013	27	1					1	19		10.1080/02687038.2012.671928			19	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	065DH	WOS:000313127600001					2022-02-06	
B	Baron, DA; Baron, SH; Tompkins, J; Polat, A		Baron, DA; Reardon, CL; Baron, SH		Baron, David A.; Baron, Steven H.; Tompkins, Joshua; Polat, Aslihan			Assessing and Treating Depression in Athletes	CLINICAL SPORTS PSYCHIATRY: AN INTERNATIONAL PERSPECTIVE			English	Article; Book Chapter							PROFESSIONAL FOOTBALL; EXERCISE; SPORT; CONCUSSION; PERFORMANCE; DIAGNOSIS; PERSONALITY; PAROXETINE; CAPACITY; CHILDREN		[Baron, David A.; Tompkins, Joshua] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Baron, David A.] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Baron, David A.] Univ So Calif, Keck Med Ctr, Los Angeles, CA USA; [Baron, David A.] USC, Global Ctr Exercise Psychiat & Sports, Los Angeles, CA USA; [Baron, Steven H.] Montgomery Cty Community Coll, Blue Bell, PA USA; [Polat, Aslihan] Kocaeli Univ, Dept Psychiat, Sch Med, Kocaeli, Turkey; [Polat, Aslihan] Kocaeli Univ, Womens Mental Hlth Unit, Sch Med, Kocaeli, Turkey		Baron, DA (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.						Alyson S, 2010, THESIS CALIFORNIA; Appaneal RN, 2009, J SPORT EXERCISE PSY, V31, P60, DOI 10.1123/jsep.31.1.60; Armstrong LE, 2002, SPORTS MED, V32, P185, DOI 10.2165/00007256-200232030-00003; Backmand H, 2003, INT J SPORTS MED, V24, P609; Baron DA, 2009, ADV PSYCHIAT, V3; BEGEL D, 1992, AM J PSYCHIAT, V149, P606; Berryman JC, 2000, WOMEN HLTH MIND; BREWER BW, 1995, CLIN J SPORT MED, V5, P241, DOI 10.1097/00042752-199510000-00006; Burt VK, 2002, PSYCHIAT ILLNESS WOM; BURT VK, 2005, CLIN MANUAL WOMENS M; Burton RW, 2000, SPORT PSYCHIAT THEOR; CALLISTER R, 1990, MED SCI SPORT EXER, V22, P816, DOI 10.1249/00005768-199012000-00014; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Cogan KD, 2000, DOING SPORT PSYCHOL, P107; COSTILL DL, 1988, MED SCI SPORT EXER, V20, P249, DOI 10.1249/00005768-198806000-00006; Ekeland E, 2005, BRIT J SPORT MED, V39, P792, DOI 10.1136/bjsm.2004.017707; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Frydenberg E., 1993, ADOLESCENT COPING SC; Gerber M, 2011, PERCEPT MOTOR SKILL, V112, P581, DOI 10.2466/02.05.10.PMS.112.2.581-599; Glick ID, 2005, CLIN SPORT MED, V24, P771, DOI 10.1016/j.csm.2005.03.007; Glick ID, 2001, PHYSICIAN SPORTSMED, V29, P44, DOI 10.3810/psm.2001.08.913; Glick ID, 2012, J CLIN PSYCHIAT, V73, P640, DOI 10.4088/JCP.11r07381; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hackney A. C, 1990, J APPL SPORT PSYCHOL, V2, P21; KOBASA SC, 1982, J BEHAV MED, V5, P391, DOI 10.1007/BF00845369; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kuey L, 2010, OXFORD TXB WOMEN MEN; LINDER DE, 1991, J SPORT EXERCISE PSY, V13, P133, DOI 10.1123/jsep.13.2.133; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCann S., 1995, Sport psychology interventions., P347; Meeusen R, 2001, INT J SPORTS MED, V22, P329, DOI 10.1055/s-2001-15648; MORGAN WP, 1988, INT J SPORT PSYCHOL, V19, P247; O'Keane V, 2000, MOOD DISORDERS IN WOMEN, P119; Parise G, 2001, ARCH PHYS MED REHAB, V82, P867, DOI 10.1053/apmr.2001.23275; PATRIKSSON G, 1988, Scandinavian Journal of Sports Sciences, V10, P29; Polat A, 2001, J PSYCHIAT PSYCHOL P, V9, P609; Reardon CL, 2010, SPORTS MED, V40, P961, DOI 10.2165/11536580-000000000-00000; ROTH DL, 1985, PSYCHOSOM MED, V47, P164, DOI 10.1097/00006842-198503000-00008; Schmikli SL, 2011, BRIT J SPORT MED, V45, P631, DOI 10.1136/bjsm.2009.067462; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Strachan AT, 2004, EXP PHYSIOL, V89, P657, DOI 10.1113/expphysiol.2004.027839; Szabo A., 2000, PHYS ACTIVITY PSYCHO, P130; Turner AP, 2000, BRIT J SPORT MED, V34, P332, DOI 10.1136/bjsm.34.5.332; Waslick BD, 1999, J AM ACAD CHILD PSY, V38, P179, DOI 10.1097/00004583-199902000-00017; Weiss MR, 2002, J SPORT EXERCISE PSY, V24, P420, DOI 10.1123/jsep.24.4.420; WILSON WM, 1992, EXP PHYSIOL, V77, P921, DOI 10.1113/expphysiol.1992.sp003660	46	6	6	0	6	BLACKWELL SCIENCE PUBL	OXFORD	OSNEY MEAD, OXFORD OX2 0EL, ENGLAND			978-1-118-40488-1				2013							65	78			10.1002/9781118404904		14	Psychology, Clinical; Psychiatry; Sport Sciences	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Psychiatry; Sport Sciences	BGS34	WOS:000323967900010					2022-02-06	
J	Berthold, J; Dicianno, BE; Cooper, RA				Berthold, Justin; Dicianno, Brad E.; Cooper, Rory A.			Pressure mapping to assess seated pressure distributions and the potential risk for skin ulceration in a population of sledge hockey players and control subjects	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Brain injury; hockey; multiple sclerosis; paraplegia; spinal cord injury; sports; tetraplegia; veterans		Purpose: Ice sledge (or sled) hockey is a fast-paced sport that enables individuals with physical disabilities to play ice hockey. As the attraction to the sport continues to rise, the need for developing better equipment and installing preventative measures for injury will become increasingly important. One such injury includes skin pressure ulceration. Method: A total of 26 subjects including active controls and those with spinal cord injury, multiple sclerosis, limb amputation and traumatic brain injury were studied using a pressure mapping device at the 2012 National Disabled Veterans Winter Sports Clinic to determine the risk for skin pressure ulceration and the impact of cushioning and knee angle positioning on seated pressure distributions. Results: Sledge hockey athletes may be at increased risk for skin pressure ulceration based on seated pressure distribution data. This experiment failed to demonstrate a benefit for specialty cushioning in either group. Interestingly, knee angle positioning, particularly, knee extension significantly lowered the average seated pressures. Conclusions: When considering the risk for skin pressure ulceration, knee angle positioning is of particular clinical importance. More research is warranted, specifically targeting novel cushion and sledge designs and larger groups of individuals with sensory loss and severe spinal deformities.	[Berthold, Justin; Dicianno, Brad E.; Cooper, Rory A.] VA Pittsburgh Healthcare Syst, Ctr Excellence Wheelchairs & Related Technol, Pittsburgh, PA USA; [Berthold, Justin; Dicianno, Brad E.; Cooper, Rory A.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Dicianno, Brad E.; Cooper, Rory A.] Univ Pittsburgh, Human Engn Res Labs, Pittsburgh, PA USA; [Dicianno, Brad E.; Cooper, Rory A.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA; [Cooper, Rory A.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA		Dicianno, BE (corresponding author), VA Pittsburgh Healthcare Syst, Human Engn Res Labs, 6425 Penn Ave,Suite 400,Bakery Sq, Pittsburgh, PA 15206 USA.	dicianno@pitt.edu	Dicanno, Brad/AAC-5918-2019	Dicanno, Brad/0000-0003-0738-0192	Center of Excellence for Wheelchairs and Associated Rehabilitation Engineering [B6789C]; UPMC Mercy GME research fund; NDVWSC	The authors report no conflicts of interest. This study was supported by The Center of Excellence for Wheelchairs and Associated Rehabilitation Engineering (Grant no.: B6789C) and the UPMC Mercy GME research fund. We would like to thank the athletes, medical staff, volunteers, and trainers of the 2012 NDVWSC for their support and interest and Stacy Eckstein for her support in clinical coordination. We would also like to thank the Mighty Penguins Sled Hockey Team and the Comfort Company for their generous donation of the equipment used in this study. The contents of this paper do not necessarily represent the views of the Department of Veterans Affairs or the US Government.	Dicianno BE, 2009, ASSIST TECHNOL, V21, P13, DOI 10.1080/10400430902945769; DRUMMOND D, 1985, J PEDIATR ORTHOPED, V5, P396, DOI 10.1097/01241398-198507000-00002; DRUMMOND DS, 1982, J BONE JOINT SURG AM, V64, P1034, DOI 10.2106/00004623-198264070-00010; Fradet L, 2011, DISABIL REHABIL-ASSI, V6, P47, DOI 10.3109/17483107.2010.512969; IPC Ice Sledge Hockey, 2012, IPC ICC SLEDG HOCK; KILFOYLE RM, 1965, J BONE JOINT SURG AM, VA 47, P659, DOI 10.2106/00004623-196547040-00002; KOSIAK M, 1961, Arch Phys Med Rehabil, V42, P19; Kosiak M., 1959, J PEDIATR ORTHOPED, V40, P62; Landis EM, 1930, HEART-J STUD CIRC, V15, P209; Patel J, 2011, CLIN ORTHOP RELAT R, V469, P1302, DOI 10.1007/s11999-010-1687-8; Sprigle S, 2003, ASSIST TECHNOL, V15, P49, DOI 10.1080/10400435.2003.10131889	11	6	6	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2013	8	5					387	391		10.3109/17483107.2013.769123			5	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V06UG	WOS:000213964500005	23992457				2022-02-06	
J	Chen, H; Xue, LX; Cao, HL; Chen, SW; Guo, Y; Gao, WW; Ju, SM; Tian, HL				Chen, Hao; Xue, Li-Xia; Cao, He-Li; Chen, Shi-Wen; Guo, Yan; Gao, Wen-Wei; Ju, Shi-Ming; Tian, Heng-Li			Endostatin/Collagen XVIII Is Increased in Cerebrospinal Fluid after Severe Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLLAGEN-XVIII; ANGIOGENESIS; EXPRESSION; VEGF; LEADS	Recent studies have suggested that endogenous angiogenesis inhibitor endostatin/collagenXVIII might play an important role in the secondary brain injury following traumatic brain injury (TBI). In this study, we measured endostatin/collagen XVIII concentrations serially for 1 week after hospitalization by using the enzyme-linked immunosorbent assay method in the cerebrospinal fluid (CSF) of 30 patients with TBI and a Glasgow Coma Scale (GCS) score of 8 or less on admission. There was a significant trend toward increased CSF levels of endostatin after TBI versus control from 72 h after injury. In patients with GCS score of 3-5, CSF endostatin concentration was substantially higher at 72 h after injury than that in patients with GCS score of 6-8 (P < 0.05) and peaked rapidly at day 5 after injury, but decreased thereafter. The CSF endostatin concentration in 12 patients with an unfavorable outcome was significantly higher than that in 18 patients with a favorable outcome at day 5 (P = 0.043) and day 7 (P = 0.005) after trauma. Receiver operating characteristic curve analysis suggested a reliable operating point for the 7-day CSF endostatin concentration predicting poor prognosis to be 67.29 pg/mL. Our preliminary findings provide new evidence that endostatin/collagen XVIII concentration in the CSF increases substantially in patients with sTBI. Its dynamic change may have some clinical significance on the judgment of brain injury severity and the assessment of prognosis. This trial is registered with the ClinicalTrials.gov Identifier: NCT01846546.	[Chen, Hao; Cao, He-Li; Chen, Shi-Wen; Guo, Yan; Gao, Wen-Wei; Ju, Shi-Ming; Tian, Heng-Li] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China; [Xue, Li-Xia] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurol, Shanghai 200233, Peoples R China		Tian, HL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, 600 Yishan Rd, Shanghai 200233, Peoples R China.	tianhengli1964@yahoo.com.cn			Shanghai Science and Technology Council [10JC1412500, 13411951401]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271383]	The authors thank Jun Ding and Fang Yuan for their assistance in the statistical analysis of their data. This study was supported by the Shanghai Science and Technology Council (Grant nos. 10JC1412500 and 13411951401) and the National Natural Science Foundation of China (Grant no. 81271383).	Benezra R, 2004, CANCER CELL, V5, P205, DOI 10.1016/S1535-6108(04)00057-1; Bloch W, 2000, FASEB J, V14, P2373; Bullock MR, 1996, J NEUROTRAUM, V13, P643; Deininger MH, 2006, J NEUROTRAUM, V23, P1103, DOI 10.1089/neu.2006.23.1103; Gong D, 2011, J TRAUMA, V70, P1480, DOI 10.1097/TA.0b013e31821ac9e1; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Mueller CA, 2007, EXP NEUROL, V208, P228, DOI 10.1016/j.expneurol.2007.07.020; Mueller CA, 2007, J NEUROSURG-SPINE, V7, P205, DOI 10.3171/SPI-07/08/205; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nag S, 2002, J NEUROPATH EXP NEUR, V61, P778, DOI 10.1093/jnen/61.9.778; Pandya NM, 2006, VASC PHARMACOL, V44, P265, DOI 10.1016/j.vph.2006.01.005; Seppinen L, 2008, MATRIX BIOL, V27, P535, DOI 10.1016/j.matbio.2008.03.003; Shore PM, 2004, NEUROSURGERY, V54, P605, DOI 10.1227/01.NEU.0000108642.88724.DB; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Tao Q, 2005, MICROVASC RES, V69, P36, DOI 10.1016/j.mvr.2004.11.003; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wenzel D, 2006, CIRC RES, V98, P1203, DOI 10.1161/01.RES.0000219899.93384.ed; Zhang ZY, 2007, NEUROSCIENCE, V147, P720, DOI 10.1016/j.neuroscience.2007.04.052	20	6	6	0	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2013	2013								402375	10.1155/2013/402375			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	222DC	WOS:000324709200001	24089677	Green Published, Green Submitted, gold			2022-02-06	
J	Chinn, NR; Porter, P				Chinn, Nancy Resendes; Porter, Paul			Concussion Management in Community College Athletics: Revealing and Understanding the Gap Between Knowledge and Practice	COMMUNITY COLLEGE JOURNAL OF RESEARCH AND PRACTICE			English	Article								The seriousness of concussions in athletics is only recently becoming fully understood and appreciated. There are significant implications for the concussed student-athlete both in returning to the playing field and the classroom. Although practices are now in place to improve identification and management of concussions in professional sports, little is known about how it is managed in community colleges. This mixed method study identified the extent to which California Community College athletic trainers are implementing best practices set forth by the National Athletic Trainers' Association in their management of concussion. It also sought to understand the training, cultural pressures, and resources that may impact the degree to which community college athletic trainers implement these guidelines.	[Chinn, Nancy Resendes] Santa Rosa Jr Coll, Disabil Resources Dept, Santa Rosa, CA 95409 USA; [Porter, Paul] Sonoma State Univ, Dept Educ Leadership & Educ, Rohnert Pk, CA 94928 USA		Chinn, NR (corresponding author), Santa Rosa Jr Coll, Disabil Resources Dept, Santa Rosa, CA 95409 USA.	nchinn@santarosa.edu					Adler J., 2005, NUTR HLTH REV CONSUM, V93, P14; Anderson S., 2011, PITTSBURGH POSTGAZET; [Anonymous], NON TRADITIONAL REF; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Borden S., 2011, NY TIMES; Brady Erik, 2011, US TODAY; Brasfield K., 2010, NATL COLLEGIATE ATHL; Broglio SP, 2007, J ATHL TRAINING, V42, P504; California Community College Athletic Association, 2010, FOOTB ROST; Chancellor's Office California Community Colleges, 1997, IMPL GUID TITL 5 REG; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Delforge GD, 1999, J ATHL TRAINING, V34, P53; Diede T., 2005, THESIS; Etzel E. F, 2002, COUNSELING COLL STUD; Gay L. R., 2009, ED RES COMPETENCIES; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Howard-Hamilton Mary F., 2001, NEW DIRECTIONS STUDE, V93, P35, DOI DOI 10.1002/SS.3; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kondro W, 2012, CAN MED ASSOC J, V184, pE9, DOI 10.1503/cmaj.109-4070; Legislative Analyst's Office, 2010, 2011 2012 BUDG CAL F; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Mazerolle SM, 2008, J ATHL TRAINING, V43, P505, DOI 10.4085/1062-6050-43.5.505; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2009, J ATHL TRAINING, V44, P663, DOI 10.4085/1062-6050-44.6.663; Merriam, 2009, QUALITATIVE RES CASE; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; National Football League, 2011, NFL ANN NEW SID CONC; Nixon H. L. II, 1994, Journal of Sport and Social Issues, V18, P340, DOI 10.1177/019372394018004004; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Reisser L., 1993, ED IDENTITY, V2nd; Schwartz Alan, 2011, NY TIMES	36	6	6	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1066-8926	1521-0413		COMMUNITY COLL J RES	Community Coll. J. Res. Pract.		2013	37	6					409	423		10.1080/10668926.2012.710127			15	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	VA3FV	WOS:000409793400001					2022-02-06	
J	Ding, J; Li, QY; Yu, JZ; Wang, X; Lu, CZ; Ma, CG; Xiao, BG				Ding, Jing; Li, Qin-Ying; Yu, Jie-Zhong; Wang, Xin; Lu, Chuan-Zhen; Ma, Cun-Gen; Xiao, Bao-Guo			Carbamylated erythropoietin ameliorates hypoxia-induced cognitive and behavioral defects with the generation of choline acetyltransferase-positive neurons	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						carbamylated erythropoietin; hypoxia; cognitive defect; ChAT	TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; IN-VITRO; SIGNAL-TRANSDUCTION; METABOLIC STRESS; PROGENITOR CELLS; RAT MODEL; APOPTOSIS; VIVO; RED	Carbamylated erythropoietin (CEPO) is attracting widespread interest because of its neuroprotective effects without influencing erythropoiesis. Here we show that CEPO, unlike EPO, does not stimulate erythropoiesis. Both CEPO and EPO inhibit the death/apoptosis of neurons in the hypoxic model of primary neurons and induce neuron proliferation and differentiation in hypoxic mice. Hypoxic mice show apparent memory deficits at 3 and 30 days after hypoxia. The administration of CEPO/EPO significantly improves cognitive and behavioral defects after hypoxic insults. Further investigation shows that CEPO/EPO induces neuron proliferation and differentiation and promotes the generation of choline acetyltransferase (ChAT)+ neurons in hypoxic mice. Phosphorylated AKT was colabeled with ChAT+ neurons and coexpressed in bromodeoxyuridine-positive cells, suggesting that the PI3K/AKT pathway may play a pivotal role in CEPO/EPO-cholinergic neuron generation. These results reveal that CEPO/EPO ameliorates hypoxia-induced cognitive and behavioral defects possibly through the generation of ChAT-positive neurons. (c) 2012 Wiley Periodicals, Inc.	[Ding, Jing; Li, Qin-Ying; Lu, Chuan-Zhen; Xiao, Bao-Guo] Fudan Univ, Huashan Hosp, Inst Brain Sci, Inst Neurol, Shanghai 200040, Peoples R China; [Ding, Jing; Wang, Xin] Fudan Univ, Zhongshan Hosp, Dept Neurol, Shanghai 200040, Peoples R China; [Ding, Jing; Li, Qin-Ying; Lu, Chuan-Zhen; Xiao, Bao-Guo] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200040, Peoples R China		Xiao, BG (corresponding author), Fudan Univ, Huashan Hosp, Inst Brain Sci, Inst Neurol, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.	bgxiao@shmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30972715, 81070956]	Contract grant sponsor: National Natural Science Foundation of China; Contract grant number: 30972715; Contract grant number: 81070956.	ADAMSON JW, 1968, AM J MED, V44, P725, DOI 10.1016/0002-9343(68)90254-4; Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Andoh T, 2011, BRAIN RES, V1387, P8, DOI 10.1016/j.brainres.2011.02.077; Byts N, 2009, EXP TRANSL STROKE ME, V21, P1; Cariou A, 2008, RESUSCITATION, V76, P397, DOI 10.1016/j.resuscitation.2007.10.003; Chen G, 2009, CYTOKINE, V45, P162, DOI 10.1016/j.cyto.2008.11.015; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Ding J, 2010, MOL CELL NEUROSCI, V43, P201, DOI 10.1016/j.mcn.2009.11.001; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; Fantacci M, 2006, P NATL ACAD SCI USA, V103, P17531, DOI 10.1073/pnas.0608814103; Fiordaliso F, 2005, P NATL ACAD SCI USA, V102, P2046, DOI 10.1073/pnas.0409329102; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Ioka T, 2009, CLIN PHARMACOL THER, V86, P154, DOI 10.1038/clpt.2009.74; Kadota T, 2009, BRAIN RES, V1254, P120, DOI 10.1016/j.brainres.2008.11.094; Khan AA, 2007, P NATL ACAD SCI USA, V104, P19114, DOI 10.1073/pnas.0706167104; King VR, 2007, EUR J NEUROSCI, V26, P90, DOI 10.1111/j.1460-9568.2007.05635.x; Kirkeby A, 2008, THROMB HAEMOSTASIS, V99, P720, DOI 10.1160/TH07-03-0208; Kumral A, 2005, BIOL NEONATE, V87, P15, DOI 10.1159/000080490; Lapchak PA, 2008, BRAIN RES, V1238, P208, DOI 10.1016/j.brainres.2008.08.017; Leconte C, 2011, NEUROPHARMACOLOGY, V60, P354, DOI 10.1016/j.neuropharm.2010.09.025; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Li G, 2008, NEUROSCI LETT, V442, P143, DOI 10.1016/j.neulet.2008.07.007; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Mckoy JM, 2008, TRANSFUSION, V48, P1754, DOI 10.1111/j.1537-2995.2008.01749.x; Mennini T, 2006, MOL MED, V12, P153, DOI 10.2119/2006-00045.Mennini; Minnerup J, 2009, STROKE, V40, P3113, DOI 10.1161/STROKEAHA.109.555789; Moon C, 2006, J PHARMACOL EXP THER, V316, P999, DOI 10.1124/jpet.105.094854; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Naga A, 2001, J NEUROPATHOL EXP NE, V2001, P386; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Schmidt RE, 2008, EXP NEUROL, V209, P161, DOI 10.1016/j.expneurol.2007.09.018; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; TABIRA T, 1995, INT J DEV NEUROSCI, V13, P241, DOI 10.1016/0736-5748(94)00020-4; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Xu X, 2009, SURGERY, V146, P506, DOI 10.1016/j.surg.2009.03.022; Xue YQ, 2007, NEUROSCIENCE, V146, P1245, DOI 10.1016/j.neuroscience.2007.02.004; Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924	43	6	9	1	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	JAN	2013	91	1					73	82		10.1002/jnr.23124			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037LW	WOS:000311107500008	23074165				2022-02-06	
B	Drozdick, LW; Holdnack, JA; Weiss, LG; Zhou, XB		Holdnack, JA; Weiss, LG; Iverson, GL		Drozdick, Lisa Whipple; Holdnack, James A.; Weiss, Lawrence G.; Zhou, Xiaobin			Overview of the WAIS-IV/WMS-IV/ACS	WAIS-IV, WMS-IV, AND ACS: ADVANCED CLINICAL INTERPRETATION	Practical Resources for the Mental Health Professional		English	Article; Book Chapter							CONFIRMATORY FACTOR-ANALYSIS; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; WISC-IV; INTELLIGENCE SCALE; HIGHER-ORDER; PERFORMANCE; VALIDITY; VALIDATION; SCORES		[Drozdick, Lisa Whipple; Holdnack, James A.; Weiss, Lawrence G.; Zhou, Xiaobin] Pearson Assessment, San Antonio, TX USA		Drozdick, LW (corresponding author), Pearson Assessment, San Antonio, TX USA.						Adair JC, 1998, BRAIN COGNITION, V37, P351, DOI 10.1006/brcg.1998.1002; [Anonymous], 2001, WECHSLER TEST ADULT; Arnett PA, 1997, ARCH CLIN NEUROPSYCH, V12, P513; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Benson N, 2010, PSYCHOL ASSESSMENT, V22, P121, DOI 10.1037/a0017767; Bodin D, 2009, CHILD NEUROPSYCHOL, V15, P417, DOI 10.1080/09297040802603661; Bowden SC, 1999, PSYCHOL ASSESSMENT, V11, P339, DOI 10.1037/1040-3590.11.3.339; Carroll J.B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 10.1017/CBO9780511571312; Chen HY, 2009, J RES EDUC SCI, V54, P85; Chen HY, 2012, PERS INDIV DIFFER, V52, P161, DOI 10.1016/j.paid.2011.10.006; Chen HY, 2010, PERS INDIV DIFFER, V49, P677, DOI 10.1016/j.paid.2010.06.004; Cullum C. M., 2010, WAIS 4 CLIN USE INTE; Daniel MH, 2007, APPL NEUROPSYCHOL, V14, P291, DOI 10.1080/09084280701719401; Deary IJ, 1996, AM PSYCHOL, V51, P599; Deary IJ., 2001, INTELLIGENCE VERY SH; Delis D.C., 2000, MANUAL CALIFORNIA VE; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Dougherty TM, 1997, DEV PSYCHOL, V33, P146, DOI 10.1037/0012-1649.33.1.146; Drozdick L. W., 2011, CONT INTELLECTUAL AS, P197; Dunn, 2007, PPVT 4 PEABODY PICTU; Fallows RR, 2012, CLIN NEUROPSYCHOL, V26, P942, DOI 10.1080/13854046.2012.697193; Fiorello CA, 2007, APPL NEUROPSYCHOL, V14, P2, DOI 10.1080/09084280701280338; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Frazier TW, 2007, ARCH CLIN NEUROPSYCH, V22, P197, DOI 10.1016/j.acn.2006.12.007; Geldmacher DS, 2000, AGING NEUROPSYCHOL C, V7, P194, DOI 10.1076/1382-5585(200009)7:3;1-Q;FT194; Gierok SD, 2005, ARCH CLIN NEUROPSYCH, V20, P755, DOI 10.1016/j.acn.2005.04.008; Gottfredson L.S., 1998, SCI AM PRESENTS, V9, P24; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Harrison AG, 2008, J PSYCHOEDUC ASSESS, V26, P247, DOI 10.1177/0734282907304032; Hawkins KA, 2002, ARCH CLIN NEUROPSYCH, V17, P49, DOI 10.1016/S0887-6177(00)00099-8; Hilsabeck, 2011, ESSENTIALS WMS 4 ASS; Holdnack J., 2007, 35 ANN M INT NEUR SO; Holdnack J.A., 2010, WAIS 4 CLIN USE INTE, P237, DOI [10.1016/B978-0-12-375035-8.10009-6, DOI 10.1016/B978-0-12-375035-8.10009-6]; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; Jonides J, 2005, CURR DIR PSYCHOL SCI, V14, P2, DOI 10.1111/j.0963-7214.2005.00323.x; Joreskog K. G., 1993, LISREL 8 USERS REFER; Keith TZ, 2006, SCHOOL PSYCHOL REV, V35, P108; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Kesler SR, 2004, CEREB CORTEX, V14, P174, DOI 10.1093/cercor/bhg116; Kuncel NR, 2004, J PERS SOC PSYCHOL, V86, P148, DOI 10.1037/0022-3514.86.1.148; Lecerf T, 2010, SWISS J PSYCHOL, V69, P221, DOI 10.1024/1421-0185/a000026; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lichtenberger ElizabethO., 2009, ESSENTIALS WAIS 4 AS; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; McCrea S. M., 2011, INT SCHOLARLY RES NE, V2011, P1; MCGREW KS, 1998, INTELLIGENCE TEST DE; Messina MF, 2007, J PEDIATR ENDOCR MET, V20, P677; Milanovich JR, 1996, ARCH CLIN NEUROPSYCH, V11, P53, DOI 10.1016/0887-6177(95)00016-X; Na DL, 1999, NEUROLOGY, V52, P1569, DOI 10.1212/WNL.52.8.1569; Nelson H.E., 1982, NATL ADULT READING T; Pearson, 2010, MANUAL WECHSLER MEMO; Pearson, 2009, ADV CLIN SOLUTIONS U; Prifitera A., 1998, WISC 3 CLIN USE INTE, P1, DOI [10.1016/B978-012564930-8/50002-4, DOI 10.1016/B978-012564930-8/50002-4]; Prifitera A., 2008, WISC 4 CLIN ASSESSME; Prifitera A., 2005, WISC 4 CLIN USE INTE; Salthouse TA, 1996, PSYCHON B REV, V3, P287, DOI 10.3758/BF03210753; Salthouse TA, 2000, DEBATES PSYCHOL, P19; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SALTHOUSE TA, 2000, COGNITIVE AGING PRIM, P43; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Sattler J. M., 2008, RESOURCE GUIDE ACCOM; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tulsky DS, 2003, PSYCHOL ASSESSMENT, V15, P149, DOI 10.1037/1040-3590.15.2.149; Ward LC, 2012, PSYCHOL ASSESSMENT, V24, P328, DOI 10.1037/a0025614; Watkins MW, 2007, APPL NEUROPSYCHOL, V14, P13, DOI 10.1080/09084280701280353; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Weiss L. G., 2013, J PSYCHOEDU IN PRESS; Weiss L. G., 2006, WISC 4 ADV CLIN INTE; Weiss LG, 2010, PRACT RESOUR MENT, P1; Wilde M C, 2000, Appl Neuropsychol, V7, P208, DOI 10.1207/S15324826AN0704_2; Wojciulik E, 2001, NEUROPSYCHOLOGIA, V39, P390, DOI 10.1016/S0028-3932(00)00131-7	79	6	6	0	8	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-12-386953-1; 978-0-12-386934-0	PRACT RESOUR MENT			2013							1	73		10.1016/B978-0-12-386934-0.00001-8			73	Psychology, Clinical	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology	BGQ37	WOS:000323772000002					2022-02-06	
B	Iverson, GL; Holdnack, JA; Lange, RT		Holdnack, JA; Weiss, LG; Iverson, GL		Iverson, Grant L.; Holdnack, James A.; Lange, Rael T.			Using the WAIS-IV/WMS-IV/ACS Following Moderate-Severe Traumatic Brain Injury	WAIS-IV, WMS-IV, AND ACS: ADVANCED CLINICAL INTERPRETATION	Practical Resources for the Mental Health Professional		English	Article; Book Chapter							ADULT INTELLIGENCE SCALE; MAJOR DEPRESSION; HEAD-INJURY; MEMORY		[Iverson, Grant L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Holdnack, James A.] Pearson Assessment, San Antonio, TX USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC USA; [Lange, Rael T.] Univ British Columbia, Washington, DC USA		Iverson, GL (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.			Iverson, Grant/0000-0001-7348-9570			ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Clement PF, 2003, MIL MED, V168, P1025, DOI 10.1093/milmed/168.12.1025; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Hillier SL, 1997, BRAIN INJURY, V11, P661; Iverson G. I., 2008, MOTOR VEHICLE COLLIS, P243; Iverson G. L., 2012, NEUROPSYCHOLOGICAL A, P9; Iverson G. L., 2011, BLACK BOOK NEUROPSYC, P663; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2012, NEUROPSYCHOLOGICAL A, P360; Iverson GL, 2008, NEUROPSYCHOLOGY COUR, P243; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KAPOOR N, 2005, TXB TRAUMATIC BRAIN, P405; Kochanek PM, 2007, BRAIN INJURY MED PRI, P81; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Langeluddecke PM, 2005, J CLIN EXP NEUROPSYC, V27, P576, DOI 10.1080/13803390490918372; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; MEARNS J, 1993, J CLIN PSYCHOL, V49, P714, DOI 10.1002/1097-4679(199309)49:5<714::AID-JCLP2270490515>3.0.CO;2-H; O'Shanick GJ, 2005, TXB TRAUMATIC BRAIN, P245; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ord JS, 2008, CLIN NEUROPSYCHOL, V22, P689, DOI 10.1080/13854040701425437; PADULA W, 2007, BRAIN INJURY MED, P511; Pearson, 2009, ADV CLIN SOLUTIONS W; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; THAXTON L, 2007, BRAIN INJURY MED PRI, P557; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; WARDEN DL, 2005, TXB TRAUMATIC BRAIN, P231; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; ZASLER ND, 2007, BRAIN INJURY MED PRI, P697	52	6	6	0	4	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-12-386953-1; 978-0-12-386934-0	PRACT RESOUR MENT			2013							485	544		10.1016/B978-0-12-386934-0.00010-9			60	Psychology, Clinical	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology	BGQ37	WOS:000323772000011					2022-02-06	
J	Katirci, Y; Ocak, T; Karamercan, MA; Kocasaban, D; Yurdakul, MS; Baspinar, I; Coskun, F				Katirci, Yavuz; Ocak, Tarik; Karamercan, Mehmet Akif; Kocasaban, Dilber; Yurdakul, Mehmet Serkan; Baspinar, Isa; Coskun, Figen			COMPLIANCE WITH CATCH RULES IN ADMINISTERING COMPUTERIZED TOMOGRAPHY SCANS TO CHILDREN ADMITTED TO THE EMERGENCY DEPARTMENT WITH MINOR HEAD TRAUMA	ACTA MEDICA MEDITERRANEA			English	Article						Head trauma; emergency medicine; traumatic brain injury; computed tomography	BRAIN-INJURY; PREDICTION; ALGORITHM	Background: Traumatic brain injury (TBI) is a major health problem frequently encountered in children. Although TBI-associated acute brain damage is frequently observed in children, the need for neurosurgical intervention is rare. In many centers, it has become standard practice to assess children with minor TBI (Glasgow Coma Scale [GCS], 13-15) using head computerized tomography (CT). Therefore. preventing unnecessary CT imaging in children with minor TBI is important. The Canadian Assessment of Tomography for Childhood Head injury (CATCH) guidelines comprise precise rules aimed at reducing CT imaging in pediatric patients with minor TBI. In this study, we retrospectively investigated pediatric patients with head trauma who presented to our emergency clinic and assessed CATCH compliance in cases where CT scans were administered. Methods: This study was performed by retrospectively investigating children 0-18 years of age who had a record of head trauma and underwent brain CT imaging at the emergency clinic of a tertiary city hospital with an annual patient population of approximately 245.000. Children with minor TBI who met the CATCH criteria for CT imaging, including a decrease in GCS to <15 within 2 h following trauma, evidence of an open or depression fracture, irritability during examination, basal skull fracture. large or boggy hematoma on the scalp, fall from a height of 3 feet or down five steps, motorized vehicle accidents, and fall from a motorcycle without a hehnet. were included in this study. The findings regarding compliance with CATCH rules were analyzed statistically. Results: A total of 2.253 children with head trauma presenting over 1 year were examined, and 731 children (32.4%) who undenvent CT scans were included because they conformed to the CATCH rules. Approximately 20% (n = 148) of these cases were asymptomatic. Indications for CT imaging included a dangerous trauma mechanism (77.2%, n = 564), a linear fracture without acute brain damage (5.6%, n = 127), and acute brain damage (1.6%. n = 36). Four patients (0.2%) with depression fractures underwent surgery. Interpretation: It was difficult to reach a consensus on the decision for brain CT imaging for minor head trauma in the pediatric age group. The CATCH criterion related to falling from a height of >3 feet was the most frequent indication for CT imaging in our study. However, the trauma mechanism of simply falling from a height 3 feet was insufficient to justify a decision to perform a CT scan.	[Katirci, Yavuz; Kocasaban, Dilber; Yurdakul, Mehmet Serkan; Coskun, Figen] Ankara Numune Training & Res Hosp, Dept Emergency Med, Ankara, Turkey; [Ocak, Tarik] Abant Izzet Baysal Univ, Fac Med, Dept Emergency Med, Bolu, Turkey; [Karamercan, Mehmet Akif] Gazi Univ, Fac Med, Dept Emergency Med, Ankara, Turkey		Ocak, T (corresponding author), Abant Izzet Baysal Univ, Fac Med, Dept Emergency Med, Bolu, Turkey.		Karamercan, Mehmet Akif/AAG-5512-2019	Karamercan, Mehmet Akif/0000-0002-3895-7989			Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; BROOKES M, 1990, J EPIDEMIOL COMMUN H, V44, P147, DOI 10.1136/jech.44.2.147; Centers for Disease Control and Prevention (CDC), 2010, TRAUMATIC BRAIN INJU; Collins C., 2002, OCCUPATIONAL THERAPY, P395; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Ponsky TA, 2005, J TRAUMA, V59, P1292, DOI 10.1097/01.ta.0000197439.19171.25; Reed MJ, 2005, ARCH DIS CHILD, V90, P859, DOI 10.1136/adc.2004.053603; ROS SP, 1992, PEDIATR EMERG CARE, V8, P328, DOI 10.1097/00006565-199212000-00005; Sanchez JI, 1999, SURG CLIN N AM, V79, P1503, DOI 10.1016/S0039-6109(05)70090-6; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	19	6	6	1	5	CARBONE EDITORE	PALERMO	VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY	0393-6384	2283-9720		ACTA MEDICA MEDITERR	Acta Medica Mediterr.		2013	29	4					717	722					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	295YB	WOS:000330151200020					2022-02-06	
B	Katz, DI; Zasler, ND; Zafonte, RD		Zasler, ND; Katz, DI; Zafonte, RD		Katz, Douglas I.; Zasler, Nathan D.; Zafonte, Ross D.			Clinical Continuum of Care and Natural History	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; BLUNT HEAD-INJURY; POSTTRAUMATIC AMNESIA; COGNITIVE REHABILITATION; FOCAL LESIONS; RECOVERY; CONFUSION; SEVERITY; DURATION; OUTCOMES		[Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Acquired Brain Injury Program, Braintree, MA USA; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.] Sheltering Arms Hosp, iWalk Program, Richmond, VA USA; [Zasler, Nathan D.] VCU Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Zafonte, Ross D.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross D.] Spaulding Rehabil Network, Boston, MA USA; [Zafonte, Ross D.] Massachusetts Gen Hosp, Boston, MA 02114 USA		Katz, DI (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.						ALEXANDER MP, 1982, PSYCHIAT ASPECTS NEU, P251; [Anonymous], 1998, NIH Consens Statement, V16, P1; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Faul M, 2010, TRAUMATIC BRAIN INJU; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goodall P, 2001, J HEAD TRAUMA REHAB, V16, P94, DOI 10.1097/00001199-200102000-00010; Hagen C., 1972, LEVELS COGNITIVE FUN; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; Katz D, 1992, J HEAD TRAUMA REHAB, V72, P1, DOI [10.1097/00001199-200501000-00008, DOI 10.1097/00001199-200501000-00008]; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Katz DI, 1999, J INT NEUROPSYCH SOC, V5, P139; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Stuss D. T., 1992, J HEAD TRAUMA REHAB, V7, P40; Sumann Gunther, 2002, Curr Opin Crit Care, V8, P587, DOI 10.1097/00075198-200212000-00017; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P479, DOI DOI 10.1089/NEU.2000.17.479; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Von Wild K, 2001, BRAIN INJURY, V15, P273; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Watts Dorraine D, 2004, Prehosp Emerg Care, V8, P254; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	57	6	6	0	0	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							2	12					11	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100001					2022-02-06	
J	Konstantopoulos, K; Issidorides, M; Spengos, K				Konstantopoulos, Kostas; Issidorides, Marietta; Spengos, Konstantinos			A Normative Study of the Color Trails Test in the Greek Population	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						attention; CTT; executive function; Greek norms	ASSOCIATIONS; VALIDITY	The Color Trails Test (CTT) is a neuropsychological test that measures perceptual tracking and sustained and divided attention. Recently, its use has been increased in neurological diseases such as Alzheimer's disease, brain injury, and subclinical infarction. The aim of the present study was to provide normative data for the CTT in the Greek population. A total of 321 native Greek speakers with various professional backgrounds took part in the study. Exclusion criteria involved the existence of neurological and psychiatric diseases, history of alcohol and/or drug dependence, traumatic brain injury, and a Mini-Mental State Examination score below 27. Our results showed that age and education are important factors to consider for the interpretation of scores in all CTT variables. Older participants took more time and exhibited more errors, more near-misses, and more prompts compared with younger participants. Also, more-educated participants took less time, made fewer errors, had fewer near-misses, and rewired fewer prompts compared with less educated participants. CTT is a promising tool for the measurement of attention in the Greek population. Further research is needed to use this test in Greek patients with various neurological diseases.	[Konstantopoulos, Kostas] Idaho State Univ, Dept Commun Sci & Disorders, Pocatello, ID 83209 USA; [Konstantopoulos, Kostas] Idaho State Univ, Pocatello, ID 83209 USA; [Konstantopoulos, Kostas] European Univ, Nicosia, Cyprus; [Issidorides, Marietta] Theodor Theoxari Cozzika Fdn, Neurobiol Res Inst, Dept Psychiat, Athens, Greece; [Spengos, Konstantinos] Univ Athens, Eginit Hosp, Dept Neurol, Athens 11528, Greece		Konstantopoulos, K (corresponding author), Idaho State Univ, Dept Commun Sci & Disorders, 921 South 8th Ave, Pocatello, ID 83209 USA.	konstantok@hotmail.com	konstantopoulos, kostas/E-9922-2011	SPENGOS, KONSTANTINOS/0000-0002-2963-9006			FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fountoulakis K.N., 2000, AM J ALZHEIMERS DIS, V15, DOI [DOI 10.1177/153331750001500604, 10.1177/153331750001500604]; Hartman-Maeir A, 2008, BRAIN INJURY, V22, P994, DOI 10.1080/02699050802491305; HSIEH S, 1997, NAT AC NEUR LAS VEG; Kudiaki C, 2008, APPL NEUROPSYCHOL, V15, P194, DOI 10.1080/09084280802324416; La Rue A, 1999, CLIN NEUROPSYCHOL, V13, P474, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT474; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; McGuinness B, 2010, J NEUROL NEUROSUR PS, V81, P157, DOI 10.1136/jnnp.2008.164483; Messinis L, 2011, ARCH CLIN NEUROPSYCH, V26, P322, DOI 10.1093/arclin/acr027; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Ponton M O, 1996, J Int Neuropsychol Soc, V2, P96; Rabelo Ivan Sant' Ana, 2010, Psychol. Neurosci., V3, P93, DOI 10.3922/j.psns.2010.1.012; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sacktor N, 2009, NEUROLOGY, V72, P165, DOI 10.1212/01.wnl.0000339042.96109.86; White T., 1996, COLOR TRAILS TEST PR; Wright CB, 2008, STROKE, V39, P800, DOI 10.1161/STROKEAHA.107.484147; Zalonis I, 2008, CLIN NEUROPSYCHOL, V22, P842, DOI 10.1080/13854040701629301	18	6	7	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JAN 1	2013	20	1					47	52		10.1080/09084282.2012.670155			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	109PH	WOS:000316380000007	23373684				2022-02-06	
J	Kool, B; Chelimo, C; Ameratunga, S				Kool, Bridget; Chelimo, Carol; Ameratunga, Shanthi			Head Injury Incidence and Mortality in New Zealand over 10 Years	NEUROEPIDEMIOLOGY			English	Article						Head injury; Traumatic brain injury; Incidence; Mortality; Deprivation	TRAUMATIC BRAIN-INJURY; UNITED-STATES; OLDER-PEOPLE; CHILDREN; TRENDS; POPULATION; EPIDEMIOLOGY; PERSPECTIVE; PREVENTION; CHILDHOOD	Background: Although reducing the burden of head injuries is an important focus of several injury prevention initiatives, they remain a large proportion of injury-related deaths. In New Zealand, trends over time and the socio-economic distribution of the cause-specific incidence of head injuries have received little attention. Methods: We analyzed primary hospitalizations (2000-2009) and deaths (1999-2008) due to head injury using national mortality and hospital discharge databases, specifically exploring variations in age-specific rates by major causes over time and by socio-economic deprivation. Population-based incidence rate estimates were calculated using census denominators. Results: Children aged <5 years and adults aged >= 65years had the highest rates of hospitalization and mortality, respectively. Transport-related incidents and falls were the leading causes, with most fatal injuries occurring on roads and most hospitalized injuries occurring at home. There was a significant increase in mortality rates among older adults over the decade, and in most age groups, mortality rates increased with increasing levels of socio-economic deprivation. Conclusions: The findings of this review alongside the significant risks of premature death and disability reinforce the need to explore policies that address the specific causes as well as socio-economic inequalities in their distribution in New Zealand. (C) 2013 S. Karger AG, Basel	[Kool, Bridget; Chelimo, Carol; Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1142, New Zealand		Kool, B (corresponding author), Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Private Bag 92019, Auckland 1142, New Zealand.	b.kool@auckland.ac.nz		Ameratunga, Shanthi/0000-0001-8042-2251	Auckland Medical Research Foundation	The lead author was the recipient of a Post-doctoral Fellowship from the Auckland Medical Research Foundation.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Accident Compensation Corporation, 2005, PREV INJ FALLS NAT S; Ajwani S, 2003, PUBLIC HLTH INTELLIG, V16; Alcohol Advisory Council of New Zealand, 2009, MAOR ACT PLAN 2009 2; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; Berry JG, 2010, INJURY PREV, V16, P198, DOI 10.1136/ip.2009.022442; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brewin M, 2004, ETHNIC HEALTH, V9, P5, DOI 10.1080/1355785042000202754; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Civil Ian, 2004, N Z Med J, V117, pU1042; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dunn L, 2003, J NEUROL NEUROSUR PS, V74, P1060, DOI 10.1136/jnnp.74.8.1060; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Ferrell Richard B, 2002, Curr Psychiatry Rep, V4, P354; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Hosking J, 2013, AUST NZ J PUBL HEAL, V37, P162, DOI 10.1111/1753-6405.12034; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kool B, 2010, NEW ZEAL MED J, V123, P75; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Langley J, 2002, INJ PREV, V8, P332, DOI 10.1136/ip.8.4.332; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Morrison A, 1999, BRIT MED J, V318, P567, DOI 10.1136/bmj.318.7183.567; National Centre for Classification in Health, 2002, INT STAT CLASS DIS R, VThird; New Zealand Injury Prevention Secretariat, 2012, NZ INJ PREV OUTC REP; New Zealand Ministry of Health, 2004, ETHN DAT PROT HLTH D; Peel NM, 2002, INJ PREV, V8, P280, DOI 10.1136/ip.8.4.280; Phillips LA, 2009, CAN J NEUROL SCI, V36, P605, DOI 10.1017/S0317167100008118; Robertson C, 2008, OPTIMISATION ACCS FA; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; Robson B, 2007, HAUORA MAORI STANDAR; Rothman KJ., 2002, EPIDEMIOLOGY INTRO; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Salmond C, 2007, NZDEP2006 INDEX DEPR; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 2002, J Neurosurg Sci, V46, P111; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; SHARPLES PM, 1990, BRIT MED J, V301, P1193, DOI 10.1136/bmj.301.6762.1193; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Statistics New Zealand, 2006, NZ CENS DAT; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Williamson LM, 2002, J EPIDEMIOL COMMUN H, V56, P285, DOI 10.1136/jech.56.4.285; World Health Organization, 2009, GLOB STAT REP ROAD S; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	50	6	6	0	9	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2013	41	3-4					189	197		10.1159/000354782			9	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Neurosciences & Neurology	260FN	WOS:000327580500009	24135664				2022-02-06	
J	Liu, CR; Miao, J; Zhang, YL; Liu, YM; Yu, BG				Liu, Chun-rong; Miao, Jun; Zhang, Yong-liang; Liu, Ya-min; Yu, Bao-guo			Effects of Hypothyroidism on Expression of CRMP2B and ARPC5 during Development of the Rat Frontal Cortex	INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES			English	Article						CRMP2B; ARPC5; congenital hypothyroidism; frontal cortex; rat	TRAUMATIC BRAIN-INJURY; ARP2/3 COMPLEX; THYROID-HORMONE; NEURONS; CARCINOMA; AXONS	Congenital hypothyroidism (CH) can lead to irreversible central nervous system (CNS) damage. However, the pathogenesis of the developmental brain disorders caused by CH has not been completely elucidated. ARPC5 and CRMP2 are closely associated with neurite outgrowth in brain development. Thus, the aim of the present study was to determine whether CRMP2B and ARPC5 expression is altered in the developing cerebral cortex of rats with CH. Control rats and rats with hypothyroidism were sacrificed at birth and at 15 days postpartum. We performed qRT-PCR to detect differences in the crmp2B and arpc5 mRNA expression in the right half of the frontal cortex of these rats. Western blotting was then used to detect differences in CRMP2B and ARPC5 protein expression. Furthermore, immunohistochemical analysis was performed on the left half of the frontal cortex to detect abnormal localization of CRMP2B and ARPC5. Results showed increased expression of the nuclear short isoform of CRMP2B and decreased expression of full-length CRMP2B and ARPC5 in cortical neurons of rats with hypothyroidism. These findings demonstrate that reduced levels of thyroid hormones can inhibit the expression of full-length CRMP2B and ARPC5 and promote nuclear transformation of the short isoform of CRMP2B. CRMP2B and ARPC5 may participate in CNS injury mediated by hypothyroidism by inducing neurite outgrowth inhibition and cytoskeletal protein disorganization.	[Liu, Chun-rong; Miao, Jun; Zhang, Yong-liang; Liu, Ya-min; Yu, Bao-guo] Logist Univ Chinese Peoples Armed Police Force, Affiliated Hosp, Dept Pathol, Tianjin 300162, Peoples R China		Liu, CR (corresponding author), Logist Univ Chinese Peoples Armed Police Force, Affiliated Hosp, Dept Pathol, ChengLin Rd 220, Tianjin 300162, Peoples R China.	lcr68@163.com			National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [30471934]; Chinese People's Armed Police Force Foundation [WY200803]	This research was supported by the National Natural Science Foundation (30471934) and Chinese People's Armed Police Force Foundation (WY200803).	Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Babu S, 2011, EXP NEUROL, V228, P91, DOI 10.1016/j.expneurol.2010.12.012; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Bretin S, 2005, J COMP NEUROL, V486, P1, DOI 10.1002/cne.20465; Buck KB, 2002, J NEUROSCI, V22, P9358; Chan S, 2000, J ENDOCRINOL, V165, P1, DOI 10.1677/joe.0.1650001; Chung MA, 2005, NEUROREPORT, V16, P1647, DOI 10.1097/01.wnr.0000176520.49841.e6; HEYERDAHL S, 1991, J PEDIATR-US, V118, P850, DOI 10.1016/S0022-3476(05)82194-8; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kinoshita T, 2012, INT J ONCOL, V40, P1770, DOI 10.3892/ijo.2012.1390; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Legrand J, 1984, THYROID HORMONE META, P503; Liu CR, 2007, J ENDOCRINOL, V195, P429, DOI 10.1677/JOE-07-0253; Liu Chun-rong, 2011, Zhonghua Er Ke Za Zhi, V49, P209; Millard TH, 2003, CELL MOTIL CYTOSKEL, V54, P81, DOI 10.1002/cm.10087; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rogemond V, 2008, J BIOL CHEM, V283, P14751, DOI 10.1074/jbc.M708480200; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Suzuki Y, 2003, J NEUROCHEM, V86, P1042, DOI 10.1046/j.1471-4159.2003.01920.x; Uchida Y, 2009, J BIOL CHEM, V284, P27393, DOI 10.1074/jbc.M109.000240; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278	24	6	6	2	7	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1449-2288			INT J BIOL SCI	Int. J. Biol. Sci.		2013	9	2					209	218		10.7150/ijbs.5646			10	Biochemistry & Molecular Biology; Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	098RH	WOS:000315565900009	23459330	Green Submitted, Green Published, gold			2022-02-06	
B	Mayer, NH; Esquenazi, A		Zasler, ND; Katz, DI; Zafonte, RD		Mayer, Nathaniel H.; Esquenazi, Alberto			Managing Upper Motoneuron Muscle Overactivity	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TOXIN TYPE-A; UPPER-LIMB SPASTICITY; INTRATHECAL BACLOFEN THERAPY; UPPER EXTREMITY SPASTICITY; TRAUMATIC BRAIN-INJURY; BOTULINUM-TOXIN; DOUBLE-BLIND; RECIPROCAL INHIBITION; DRUG-THERAPY; PHENOL BLOCK		[Mayer, Nathaniel H.; Esquenazi, Alberto] Temple Univ, Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19122 USA; [Mayer, Nathaniel H.] MossRehab Einstein Elkins Pk, Drucker Brain Injury Ctr, Elkins Pk, PA USA; [Mayer, Nathaniel H.] MossRehab Einstein Elkins Pk, Motor Control Anal Lab, PM&R, Elkins Pk, PA USA; [Esquenazi, Alberto] MossRehab, Elkins Pk, PA USA; [Esquenazi, Alberto] MossRehab Einstein Elkins Pk, Gait & Motion Anal Lab, Dept Phys Med & Rehabil, Elkins Pk, PA USA		Mayer, NH (corresponding author), Temple Univ, Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19122 USA.						Ada L, 1996, HUM MOVEMENT SCI, V15, P671, DOI 10.1016/0167-9457(96)00015-2; AKESON WH, 1973, CLIN ORTHOP RELAT R, P356; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; Bakheit AMO, 2000, STROKE, V31, P2402, DOI 10.1161/01.STR.31.10.2402; Bakheit AMO, 2004, J NEUROL NEUROSUR PS, V75, P1558, DOI 10.1136/jnnp.2003.035139; Bakheit AMO, 2001, EUR J NEUROL, V8, P559, DOI 10.1046/j.1468-1331.2001.00277.x; BES A, 1988, CURR MED RES OPIN, V10, P709, DOI 10.1185/03007998809111122; Bhakta BB, 2000, J NEUROL NEUROSUR PS, V69, P217, DOI 10.1136/jnnp.69.2.217; BORGSTEIN J, 1993, J HEAD TRAUMA REHAB, V8, P103; Bourbonnais D., 1995, 32 DEP VET AFF, V32, P118; Brashear A, 2003, ARCH PHYS MED REHAB, V84, P103, DOI 10.1053/apmr.2003.50070; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burke D, 1983, Adv Neurol, V39, P133; Burke D, 1988, Adv Neurol, V47, P401; BURKE D, 1970, J NEUROL NEUROSUR PS, V33, P216, DOI 10.1136/jnnp.33.2.216; CAREY JR, 1993, PHYS THER, V73, P538, DOI 10.1093/ptj/73.8.538; CRONE C, 1994, BRAIN, V117, P1161, DOI 10.1093/brain/117.5.1161; DAVIDOFF RA, 1978, NEUROLOGY, V28, P46, DOI 10.1212/WNL.28.9_Part_2.46; Delwaide P. J., 1993, SPASTICITY MECH MANA, P296; DELWAIDE PJ, 1994, NEUROLOGY, V44, P21; Delwaide PJ, 1987, MOTOR DISTURBANCES, P153; Denny-Brown D., 1966, CEREBRAL CONTROL MOV; Dewald JPA, 1993, SPASTICITY MECH MANA, P123; DIETZ V, 1991, ANN NEUROL, V30, P767, DOI 10.1002/ana.410300605; DIMITRIJEVIC MR, 1980, J NEUROL NEUROSUR PS, V43, P321, DOI 10.1136/jnnp.43.4.321; Esquenazi A, 2010, EUR J NEUROL, V17, P1, DOI 10.1111/j.1468-1331.2010.03125.x; Esquenazi A, 2009, BOTULINUM TOXIN THER, P192; Esquenazi A, 2008, AM J PHYS MED REHAB, V87, P305, DOI 10.1097/PHM.0b013e318168d36c; FELLOWS SJ, 1994, ELECTROEN CLIN NEURO, V93, P106, DOI 10.1016/0168-5597(94)90073-6; Francisco G E, 2001, Phys Med Rehabil Clin N Am, V12, P875; Francisco GE, 2003, ARCH PHYS MED REHAB, V84, P1194, DOI 10.1016/S0003-9993(03)00134-5; Friden J, 2003, MUSCLE NERVE, V27, P157, DOI 10.1002/mus.10247; Gilmartin R, 2000, J CHILD NEUROL, V15, P71, DOI 10.1177/088307380001500201; GLENN MB, 1990, PRACTICAL MANAGEMENT; GOSSMAN MR, 1986, PHYS THER, V66, P516, DOI 10.1093/ptj/66.4.516; Gracies JM, 1997, ANN NEUROL, V42, pT183; GRACIES JM, 2002, SPASTICITY ETIOLOGY, P44; GRACIES JM, 2002, SPASTICITY ETIOLOGY, P65; Haranhalli N, 2011, CHILD NERV SYST, V27, P421, DOI 10.1007/s00381-010-1277-9; Herbert R, 1988, Aust J Physiother, V34, P141, DOI 10.1016/S0004-9514(14)60606-1; HERMAN R, 1970, BRAIN, V93, P273, DOI 10.1093/brain/93.2.273; HUFSCHMIDT A, 1985, J NEUROL NEUROSUR PS, V48, P676, DOI 10.1136/jnnp.48.7.676; Humphrey D R, 1983, Adv Neurol, V39, P347; JANKOWSKA E, 1994, EUR J NEUROSCI, V6, P1058, DOI 10.1111/j.1460-9568.1994.tb00601.x; Kanovsky P, 2009, CLIN NEUROPHARMACOL, V32, P259, DOI 10.1097/WNF.0b013e3181b13308; Kirazli Y, 1998, AM J PHYS MED REHAB, V77, P510, DOI 10.1097/00002060-199811000-00012; Lance J.W., 1980, SPASTICITY DISORDERE, P485; Lance JW, 1984, ELECTROMYOGRAPHY CNS, P1; Levin AB, 1995, STEREOT FUNCT NEUROS, V65, P147, DOI 10.1159/000098887; Lewis SL, 1999, NEUROLOGY NONNEUROLO, P17; LOUBSER PG, 1991, PARAPLEGIA, V29, P48, DOI 10.1038/sc.1991.7; MAYER N, 1973, AM J PHYS MED REHAB, V52, P18; Mayer NH, 2009, BOTULINUM TOXIN THER, P131; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; MEINCK HM, 1994, NEUROLOGY, V44, P2209, DOI 10.1212/WNL.44.11.2209; Meythaler JA, 2001, ARCH PHYS MED REHAB, V82, P1155, DOI 10.1053/apmr.2001.25141; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 2004, J HEAD TRAUMA REHAB, V19, P101, DOI 10.1097/00001199-200403000-00003; Meythaler JM, 1997, J HEAD TRAUMA REHAB, V12, P87, DOI 10.1097/00001199-199702000-00012; MIGLIETTA O, 1977, AM J PHYS MED REHAB, V56, P293; NANCE PW, 1994, NEUROLOGY, V44, P44; Nathan P, 1973, NEW DEV ELECTROMYOGR, V3, P13; Nielsen JB, 2007, ACTA PHYSIOL, V189, P171, DOI 10.1111/j.1748-1716.2006.01652.x; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Okuma Y, 1996, CAN J NEUROL SCI, V23, P15, DOI 10.1017/S0317167100039135; Olney RK, 2001, HARRISONS PRINCIPLES, V1, P118; PALMERI A, 1990, NEUROSCIENCE, V34, P177, DOI 10.1016/0306-4522(90)90311-Q; PEDERSEN E, 1974, ARCH PHYS MED REHAB, V55, P344; PENN RD, 1985, LANCET, V2, P125; RACK PMH, 1984, BRAIN, V107, P637, DOI 10.1093/brain/107.2.637; Rekand T, 2010, ACTA NEUROL SCAND, V122, P62, DOI 10.1111/j.1600-0404.2010.01378.x; Robinson K. M., 1990, PRACTICAL MANAGEMENT, P201; Saltuari L, 1992, Acta Neurol (Napoli), V14, P187; SANDYK R, 1985, CLIN NEUROPHARMACOL, V8, P294, DOI 10.1097/00002826-198509000-00011; Sheean G, 2006, DRUG SAFETY, V29, P31, DOI 10.2165/00002018-200629010-00003; Sheean G, 2001, UPPER MOTOR NEURONE SYNDROME AND SPASTICITY, P12; Sherrington C S, 1898, J Physiol, V22, P319; Sherrington CS, 1909, Q J EXP PHYSIOL, V2, P109, DOI 10.1113/expphysiol.1909.sp000032; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Simpson DM, 2009, J NEUROL NEUROSUR PS, V80, P380, DOI 10.1136/jnnp.2008.159657; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; SMITH C, 1994, NEUROLOGY, V44, P34; TABARY JC, 1972, J PHYSIOL-LONDON, V224, P231, DOI 10.1113/jphysiol.1972.sp009891; TARDIEU C, 1982, ARCH PHYS MED REHAB, V63, P97; Taricco M., 2000, COCHRANE DB SYST REV, P1131, DOI [10.1002/14651858.CD001131, DOI 10.1002/14651858.CD001131]; THILMANN AF, 1991, J NEUROL NEUROSUR PS, V54, P134, DOI 10.1136/jnnp.54.2.134; Van Schaeybroeck P, 2000, NEUROSURGERY, V46, P603, DOI 10.1097/00006123-200003000-00017; VEALE JL, 1973, NEW DEVELOPMENTS ELE, V3, P523; Walshe FMR, 1923, BRAIN, V46, P1, DOI 10.1093/brain/46.1.1; Whitlock JA, 1990, PRACTICAL MANAGEMENT, P8; WILLIAMS PE, 1978, J ANAT, V127, P459; Wissel J, 2009, J REHABIL MED, V41, P13, DOI 10.2340/16501977-0303; WITZMANN FA, 1982, J APPL PHYSIOL, V53, P335, DOI 10.1152/jappl.1982.53.2.335; Wong AMK, 2004, AM J PHYS MED REHAB, V83, P284, DOI 10.1097/01.PHM.0000118038.02326.CA; Yablon SA, 1996, NEUROLOGY, V47, P939, DOI 10.1212/WNL.47.4.939; Yelnik AP, 2010, J REHABIL MED, V42, P801, DOI 10.2340/16501977-0613; YOUNG RR, 1981, NEW ENGL J MED, V304, P28; YOUNG RR, 1981, NEW ENGL J MED, V304, P96	100	6	6	0	1	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							821	849					29	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100050					2022-02-06	
J	Ortega, HW; Vander Velden, H; Krause, E; Reid, S				Ortega, Henry W.; Vander Velden, Heidi; Krause, Ernest; Reid, Samuel			Traumatic Deaths in Children Is There a Difference Between Urban and Rural Populations?	PEDIATRIC EMERGENCY CARE			English	Article						death; trauma; child abuse; rural	BRAIN-INJURIES; RISK	Objective: Trauma is a leading cause of death among children. Detailed knowledge of the epidemiology of traumatic childhood deaths is necessary for allocating available treatment resources and for preventing injuries at both community and regional levels. To our knowledge, there has been no report comparing urban to rural pediatric deaths of this nature. Methods: A retrospective review of all deceased patients who were treated in an urban pediatric emergency department was performed. Patients were categorized into 2 groups, namely, urban versus rural, during analyses for comparison in this study. Results: A total of 1498 patients died at our institution during the study period, with 124 being attributable to an injury for a rate of 9.5 injury-related deaths per study period year. Overall, most injury-related deaths were accidental. Urban deaths involved younger patients and were more likely to be abusive and more likely to have been seen for an injury in a clinic or emergency department within 2 months of their death. Rural deaths involved older patients and were more likely to be a result of an accidental injury. Conclusions: Patterns of injury have been linked with injury locales that can aid the emergency provider in the assessment of children who die as a result of injury. Despite the challenges involved, there is a clear need to further identify differences in patterns of fatal injuries in urban and rural areas and to better translate and evaluate prevention and intervention programs in rural communities.	[Ortega, Henry W.; Reid, Samuel] Childrens Hosp & Clin Minnesota, Emergency Serv, Minneapolis, MN 55404 USA; [Vander Velden, Heidi; Krause, Ernest] Childrens Hosp & Clin Minnesota, Res Program, Minneapolis, MN 55404 USA; [Vander Velden, Heidi; Krause, Ernest] Childrens Hosp & Clin Minnesota, Sponsored Program, Minneapolis, MN 55404 USA		Ortega, HW (corresponding author), Childrens Hosp & Clin Minnesota, Emergency Serv, MS 17-750,2525 Chicago Ave S, Minneapolis, MN 55404 USA.	Henry.ortega@childrensmn.org					Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP D; Buhler JL, 1996, PEDIATR EMERG CARE, V45, P1; Eberhardt M., 2001, URBAN RURAL HLTH CHA; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; GOLDSMITH HF, 1993, IMPROVING OPERATIONA; Guenther E, 2009, J PEDIATR-US, V154, P272, DOI 10.1016/j.jpeds.2008.07.047; Hornor Gail, 2005, J Pediatr Health Care, V19, P4, DOI 10.1016/S0891-5245(04)00173-7; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; King WK, 2006, PEDIATR EMERG CARE, V22, P211, DOI 10.1097/01.pec.0000208180.94166.dd; Leff M, 2003, INJURY PREV, V9, P332, DOI 10.1136/ip.9.4.332; Nance ML, 2002, ARCH PEDIAT ADOL MED, V156, P781, DOI 10.1001/archpedi.156.8.781; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Peek-Asa C, 2004, AM J PUBLIC HEALTH, V94, P1689, DOI 10.2105/AJPH.94.10.1689; RAMENOFSKY ML, 1987, PEDIATR ANN, V16, P318, DOI 10.3928/0090-4481-19870401-07; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784	17	6	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2013	29	1					36	38		10.1097/PEC.0b013e31827b50a7			3	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	064FY	WOS:000313059600008	23283260				2022-02-06	
J	Rodrigues, TB; Vasconcelos, MIO; Brito, MD; Sales, DS; da Silva, RCC; Souza, AMAE				Rodrigues, Thamy Braga; Osawa Vasconcelos, Maristela Ines; Coelho Brito, Maria da Conceicao; Sales, Diane Sousa; Carvalho da Silva, Regina Celia; Alves e Souza, Angela Maria			PROFILE OF POTENTIAL ORGAN DONORS IN A REFERENCE HOSPITAL	REVISTA DA REDE DE ENFERMAGEM DO NORDESTE			English	Article						Transplants; Tissue Donors; Health Profile		The study aimed to characterize the profile of potential organ donors in a hospital in the northern zone of Ceara, Brazil. This is a quantitative, retrospective and documentary study, performed in a hospital of Ceara, from information contained in the medical records of potential donors, from May to September 2009. Data were tabulated, focusing on the identification process and logistic aspects. We identified that the most prevalent diagnoses were traumatic brain injury (51.4%) and stroke (31.4%), and that 57.1% completed the process in time for organ procurement. Thus, we hope that the assessment of policy and donation data contributes to increase the donation rates, supporting the recognition of the process's weaknesses, as well as the implementation of measures to promote its success.				bragathamy@hotmail.com; miosawa@gmail.com; marycey@hotmail.com; diane-enf@hotmail.com; reginacarvalho741@hotmail.com; amasplus@yahoo.com.br	Vasconcelos, Maristela Ines Osawa/AAD-5981-2019; da Conceicao Coelho Brito, Maria CC/O-1517-2018	Vasconcelos, Maristela Ines Osawa/0000-0002-1937-8850; da Conceicao Coelho Brito, Maria CC/0000-0002-3484-9876			Aguiar MIF, 2010, REV MIN ENFERM, V14, P353; Associacao Brasileira de Transplantes de Orgaos, 2011, J BRAS TRANSPL; Associacao Brasileira de Transplantes de Orgaos, 2009, J BRAS TRANSPL; Associacao Brasileira de Transplantes de Orgaos, 2008, J BRAS TRANSPL; Borges MF, 2011, REV RENE, V12, P453; Cinque VM, 2008, J BRAS TRANSPL, V11, P851; CINQUE VM, 2010, COGITARE ENFERM, V15, P69; dos Santos MJ, 2011, ACTA PAUL ENFERM, V24, P472, DOI 10.1590/S0103-21002011000400005; Instituto Brasileiro de Geografia Estatistica, 2010, RES AM CENS DEM 2008; Lopez JS, 2008, SPAN J PSYCHOL, V11, P125, DOI 10.1017/S1138741600004182; Marques SHB, 2007, J BRAS TRANSPL, V10, P722; Rech Tatiana H., 2007, Rev. bras. ter. intensiva, V19, P197, DOI 10.1590/S0103-507X2007000200010; Roza BD, 2010, ACTA PAUL ENFERM, V23, P417, DOI 10.1590/S0103-21002010000300017; Sancho LG, 2012, CIENC SAUDE COLETIVA, V17, P765, DOI 10.1590/S1413-81232012000300024; Schelemberg AM, 2007, ARQ CATARIN MED, V36, P30; Van Norman G, 2008, PERIOPER NURS CLIN, V3, P233	16	6	7	0	0	UNIV FEDERAL CEARA, DEPT ENFERMAGEM	CEARA	AVDA UNIVERSIDADE, CAIXA POSTAL 1000, FORTALEZA, CEARA, 00000, BRAZIL	2175-6783			REV REDE ENFERM NORD	Rev. Rede Enferm. Nordeste		2013	14	4					713	719					7	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V1Z7J	WOS:000217382600007					2022-02-06	
J	van der Heijden, P; van den Bos, P; Mol, B; Kessels, RPC				van der Heijden, Paul; van den Bos, Pancras; Mol, Bart; Kessels, Roy P. C.			Structural Validity of the Dutch-Language Version of the WAIS-III in a Psychiatric Sample	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Dutch-language version of the WAIS-III; factor analysis; intelligence; structural validity	CONFIRMATORY FACTOR-ANALYSIS; TRAUMATIC BRAIN-INJURY; INTELLIGENCE; DYSFUNCTION; INSTRUMENT; VIQ	The Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV; Wechsler, 2008) no longer provides the traditional Verbal IQ and Performance IQ deviation scores. In the current study, we investigated the structural validity of these scores in the scale's predecessor, the WAIS-Third Edition (WAIS-III; Wechsler, 1997c), which is still widely used in clinical practice, especially outside the United States. Confirmative (CFA) and exploratory factor analyses (EFA) were performed on WAIS-III data from a Dutch sample of 247 psychiatric patients. Four competing models were tested in the CFA on 11 subtests. The model that fit the data best was a model in which subtests loaded on the four factor indexes (i.e., 3 Verbal Comprehension subtests, 3 Perceptual Organization subtests, 3 Working Memory subtests, and 2 Processing Speed subtests) as proposed by the manual (Wechsler, 1997b). In the EFA on 13 subtests with four factors extracted, all subtests were found to load on the factors in accordance with the WAIS-III test manual. However, Picture Arrangement, Arithmetic, and Picture Completion showed only moderate loadings on the proposed factors. Implications for clinical practice are discussed.	[van der Heijden, Paul] Reinier van Arkel Mental Hlth Inst, Ctr Adolescent Psychiat, NL-5201 DZ Shertogenbosch, Netherlands; [van der Heijden, Paul] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [van den Bos, Pancras; Mol, Bart] Cerno Dev, Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands		van der Heijden, P (corresponding author), Reinier van Arkel Mental Hlth Inst, Ctr Adolescent Psychiat, POB 70058, NL-5201 DZ Shertogenbosch, Netherlands.	P.T.vander.Heijden@RvAGroep.nl	Kessels, Roy P.C./D-1902-2010	Kessels, Roy P.C./0000-0001-9500-9793			Arnau RC, 2000, ASSESSMENT, V7, P237, DOI 10.1177/107319110000700304; BORNSTEIN RA, 1982, J CLIN NEUROPSYCHOL, V4, P319, DOI 10.1080/01688638208401140; Browne MW, 1993, TESTING STRUCTURAL E, V154, P136, DOI DOI 10.1177/0049124192021002005; Byrne BM., 1998, STRUCTURAL EQUATION; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dugbartey AT, 1999, CLIN NEUROPSYCHOL, V13, P396, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT396; Evers A., 2002, PSYCHOLOOG, V37, P54; Golay P, 2011, PSYCHOL ASSESSMENT, V23, P143, DOI 10.1037/a0021230; Gorsuch R.L., 1983, FACTOR ANAL; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iverson GL, 2004, APPL NEUROPSYCHOL, V11, P85, DOI 10.1207/s15324826an1102_3; Joreskog K. G., 1993, LISREL 8 STRUCTURAL; Kaufman A. S., 1993, MANUAL KAUFMAN ADOLE; Kaufman AS, 2001, ASSESSMENT, V8, P267, DOI 10.1177/107319110100800303; KAUFMAN AS, 1999, ESSENTIALS WAIS 3 AS; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Luteijn F., 2004, HANDLEIDING GRONINGE; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Raven J. C., 1983, MANUAL RAVENS PROGR; Ryan JJ, 2001, ARCH CLIN NEUROPSYCH, V16, P151, DOI 10.1016/S0887-6177(99)00061-X; Saklofske DH, 2000, PSYCHOL ASSESSMENT, V12, P436, DOI 10.1037/1040-3590.12.4.436; Schmand BL., 1992, NEDERLANDSE LEESLIJS NEDERLANDSE LEESTEST; Spek AA, 2008, J AUTISM DEV DISORD, V38, P782, DOI 10.1007/s10803-007-0446-5; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed.; Taub G. E., 2001, PRACTICAL ASSESSMENT, V7, P1; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Tellegen P, 2003, PSYCHOLOOG, V38, P128; THOMPSON B, 1992, EDUC PSYCHOL MEAS, V52, P69, DOI 10.1177/001316449205200107; van der Heijden P, 2003, J CLIN EXP NEUROPSYC, V25, P59, DOI 10.1076/jcen.25.1.59.13627; Van Ravenzwaaij D., 2006, PSYCHOLOOG, V41, P268; Ward LC, 2000, PSYCHOL ASSESSMENT, V12, P341, DOI [10.1037/1040-3590.12.3.341, 10.1037//1040-3590.12.3.341]; WARRINGTON EK, 1986, NEUROPSYCHOLOGIA, V24, P223, DOI 10.1016/0028-3932(86)90055-2; Watkins M. W., 2004, J POSTSECONDARY ED D, V17, P105; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler, 1997, WAIS 3 NEDERLANDSTAL; Wechsler D., 2008, WECHSLER INTELLIGENC; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC	42	6	6	0	30	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282			APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JAN 1	2013	20	1					41	46		10.1080/09084282.2012.670166			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	109PH	WOS:000316380000006	23373683				2022-02-06	
J	Watanabe, S				Watanabe, Shu			Vocational rehabilitation for clients with cognitive and behavioral disorders associated with traumatic brain injury	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Multidisciplinary comprehensive rehabilitation; supported employment; vocational outcome	HEAD-INJURY; PROGRAM	OBJECTIVE: To report on functional outcomes of clients with traumatic brain injury (TBI) admitted to a sub-acute rehabilitation hospital and rehabilitation facility in Japan. PARTICIPANTS: The subjects included 300 adults with TBI who underwent a rehabilitation in-patient program at the hospital at the Kanagawa Rehabilitation Center. METHODS: Individual and group programs were designed for TBI clients using an interdisciplinary teamwork model including supported employment. All clients were evaluated by the Barthel Index, WAIS-R, and social outcome. RESULTS: Overall, at discharge from the hospital, 46.4% of 300 clients were placed in gainful employment or returned to the school they had attended previously. CONCLUSIONS: Despite a high prevalence of cognitive and behavioral disorders after moderate-to-severe TBI, long-term functional improvement is likely to occur in clients with TBI. Greater gains in both physical and cognitive functions are made through a multidisciplinary, wide-ranging, comprehensive approach to rehabilitation.	Jikei Univ Sch Med, Dept Rehabil Med, Komae, Tokyo, Japan		Watanabe, S (corresponding author), Jikei Univ Sch Med, Dept Rehabil Med, 4-11-1 Izumihoncho, Komae, Tokyo, Japan.	wa2ta@hs.tmu.ac.jp					BENYISHAY Y, 1981, INT J REHABIL RES, V4, P208, DOI 10.1097/00004356-198106000-00012; Hashimoto K, 2006, J REHABIL MED, V38, P20, DOI 10.1080/16501970510038473; Head Injury Rehabilitation Project, 1982, 13P591569 SANT CLAR; Mahoney FI, 1995, MD STATE MED J, V14, P56; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PRIGATANO GP, 1987, BNI Q, V3, P10; SCHERZER BP, 1986, ARCH PHYS MED REHAB, V67, P366; Watanabe Syu, 2009, JAPANESE J REHABILIT, V46, P118; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; [No title captured]	11	6	6	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815			WORK	Work		2013	45	2					273	277		10.3233/WOR-131594			5	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	160KW	WOS:000320119400017	23478365				2022-02-06	
B	Yokobori, S; Bullock, MR		Zasler, ND; Katz, DI; Zafonte, RD		Yokobori, Shoji; Bullock, M. Ross			Pathobiology of Primary Traumatic Brain Injury	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							FOCAL CEREBRAL-ISCHEMIA; ACUTE SUBDURAL-HEMATOMA; PROTEINS FOLLOWING OCCLUSION; METHYL-D-ASPARTATE; HEAD-INJURY; BLOOD-FLOW; AXONAL INJURY; THERAPEUTIC TARGET; COMATOSE PATIENTS; OXYGEN RADICALS		[Yokobori, Shoji; Bullock, M. Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA		Yokobori, S (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA.						ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Badruddin A, 2011, CURR NEUROL NEUROSCI, V11, P104, DOI 10.1007/s11910-010-0156-9; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOLLI R, 1989, CIRC RES, V65, P607, DOI 10.1161/01.RES.65.3.607; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Boto GR, 2001, J NEUROSURG, V94, P224, DOI 10.3171/jns.2001.94.2.0224; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Burger R, 2004, NEUROSURGERY, V54, P701, DOI 10.1227/01.NEU.0000108784.80585.EE; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Di X, 1996, RESTOR NEUROL NEUROS, V9, P231, DOI 10.3233/RNN-1996-9406; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; FREYTAG E, 1963, ARCH PATHOL, V76, P215; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GRAHAM DI, 1985, BRIT J ANAESTH, V57, P3, DOI 10.1093/bja/57.1.3; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Huang YF, 2007, CELL IMMUNOL, V248, P4, DOI 10.1016/j.cellimm.2007.03.009; INUZUKA T, 1990, BRAIN RES, V526, P177, DOI 10.1016/0006-8993(90)90269-H; INUZUKA T, 1990, STROKE, V21, P917, DOI 10.1161/01.STR.21.6.917; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Jung JE, 2010, MOL NEUROBIOL, V41, P172, DOI 10.1007/s12035-010-8102-z; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; KATZ DI, 1989, NEUROLOGY, V39, P897, DOI 10.1212/WNL.39.7.897; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KHALID MA, 1993, CIRC RES, V72, P725, DOI 10.1161/01.RES.72.4.725; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; KUIJPERS AHWM, 1995, J NEUROTRAUM, V12, P715, DOI 10.1089/neu.1995.12.715; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; KURODA Y, 1992, NEUROSURGERY, V30, P687; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; LI Y, 1995, STROKE, V26, P1252, DOI 10.1161/01.STR.26.7.1252; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; Litvack ZN, 2006, J NEUROSURG, V104, P828, DOI 10.3171/jns.2006.104.5.828; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lv M, 2011, NEUROSCIENCE, V176, P162, DOI 10.1016/j.neuroscience.2010.11.066; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MALONEY AFJ, 1969, BRIT J SURG, V56, P23, DOI 10.1002/bjs.1800560106; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shields DC, 2000, J NEUROSCI RES, V61, P146; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Simon RP, 2006, ARCH NEUROL-CHICAGO, V63, P1368, DOI 10.1001/archneur.63.10.1368; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Sugawara T, 2003, ANTIOXID REDOX SIGN, V5, P597, DOI 10.1089/152308603770310266; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1317, DOI 10.2174/156802609789869646; Wahlgren NG, 2004, CEREBROVASC DIS, V17, P153, DOI 10.1159/000074808; Wong CHY, 2008, CURR MED CHEM, V15, P1; Yokota H, 2002, J NEUROTRAUM, V19, P1007, DOI 10.1089/089771502760341929; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zauner A, 1996, ACT NEUR S, V67, P40	83	6	6	0	3	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							137	147					11	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100011					2022-02-06	
J	Burney, I				Burney, Ian			War on fear: Solly Zuckerman and civilian nerve in the Second World War	HISTORY OF THE HUMAN SCIENCES			English	Article						blast; civilian neurosis; home front; inter-war psychology; Second World War; Solly Zuckerman	PULMONARY CONCUSSION; BLAST; BRITISH; INJURY; LUNG	This article examines the processes through which civilian fear was turned into a practicable investigative object in the inter-war period and the opening stages of the Second World War, and how it was invested with significance at the level of science and of public policy. Its focus is on a single historical actor, Solly Zuckerman, and on his early war work for the Ministry of Home Security-funded Extra Mural Unit based in Oxford's Department of Anatomy (OEMU). It examines the process by which Zuckerman forged a working relationship with fear in the 1930s, and how he translated this work to questions of home front anxiety in his role as an operational research officer. In doing so it demonstrates the persistent work applied to the problem: by highlighting it as an ongoing research project, and suggesting links between seemingly disparate research objects (e. g. the phenomenon of 'blast' exposure as physical and physiological trauma), the article aims to show how civilian 'nerve' emerged from within a highly specific analytical and operational matrix which itself had complex foundations.	Univ Manchester, Ctr Hist Sci Technol & Med, Manchester M13 9PL, Lancs, England		Burney, I (corresponding author), Univ Manchester, Ctr Hist Sci Technol & Med, Simon Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.	ian.burney@manchester.ac.uk					[Anonymous], 1941, COMMUNICATION; [Anonymous], 1941, MANCHESTER GUAR 0823, V1, P89; [Anonymous], 1941, COMMUNICATION; [Anonymous], 1941, COMMUNICATION; [Anonymous], 1940, BRIT MED J, V1, P992; [Anonymous], 1940, SZOEMU5612; [Anonymous], 1942, SZOEMU5681617; [Anonymous], 1942, SZOEMU5744; [Anonymous], 1940, MANCHESTER GUAR 0125; [Anonymous], 1940, COMMUNICATION; [Anonymous], 1940, SZOEMU226; [Anonymous], 1940, SZOEMU56; [Anonymous], 1940, BRIT MED J; [Anonymous], 1941, COMMUNICATION; [Anonymous], 1940, COMMUNICATION; Bernal JD, 1941, NATURE, V147, P594, DOI 10.1038/147594a0; BERNARD LL, 1934, SOCIAL FORCES, V13, P306; BIDDLE TD, 1995, J STRATEGIC STUD, V18, P91, DOI 10.1080/01402399508437581; Burt J, 2006, STUD HIST PHI PART C, V37, P295, DOI 10.1016/j.shpsc.2006.03.007; David F. N., 1942, SZOEMU831; Fortes M, 1932, MAN, V32, P168, DOI 10.2307/2790785; Fraser R., 1941, SZOEMU3618; Glover E, 1942, INT J PSYCHOANAL, V23, P17; Glover Edward, 1940, PSYCHOL FEAR COURAGE; HALDANE JBS, 1938, APR AIR RAID PRECAUT; HARAWAY D, 1978, SIGNS, V4, P37, DOI 10.1086/493568; Hooker DR, 1924, AM J PHYSIOL, V67, P219; HORDER TJ, 1939, BRIT MED J, V2, P1200; Jones E, 2002, BRIT J PSYCHIAT, V180, P374, DOI 10.1192/bjp.180.4.374; Jones Edgar, 2005, SHELL SHOCK PTSD MIL; Kirby M, 1997, J OPER RES SOC, V48, P661, DOI 10.1057/palgrave.jors.2600420; Kuklick Henrika, 1992, SAVAGE SOCIAL HIST B; Langdon-Davies J., 1938, AIR RAID TECHNIQUE S; Langdon-Davies J., 1938, PSYCHOL GESCHICHTE; Logan DD, 1939, BRIT MED J, V2, P816, DOI 10.1136/bmj.2.4111.816; Mackay Robert, 2003, HALF BATTLE CIVILIAN; Maguire R, 2007, HIST WORKSHOP J, P113, DOI 10.1093/hwj/dbm002; Mott FW, 1916, LANCET, V1, P331; MOTT FW, 1916, P ROY SOC MED, V9, pR1, DOI DOI 10.1093/HWJ/DBM002; Osborn GR, 1941, BRIT MED J, V1941, P869; Osborn GR, 1941, BMJ-BRIT MED J, V1941, P506, DOI 10.1136/bmj.1.4187.506; Overy R., 2009, MORBID AGE BRITAIN C; Patterson I., 2007, GUERNICA TOTAL WAR; RICKMAN J, 1938, BRIT J MED PSYCHOL, V17, P361; Shephard B, 1999, HIST PSYCHIATR, V10, P491, DOI 10.1177/0957154X9901004005; Shephard Ben, 2000, WAR NERVES SOLDIERS; Smith H. W., 1944, BMJ-BRIT MED J, V30, P193; Smith HW, 1944, VA LAW REV, V30, P193, DOI 10.2307/1068394; Stevenson W. F., 1915, ROYAL UNITED SERVICE, V2, P450; Thomson Mathew, 2006, PSYCHOL SUBJECTS IDE; TITMUSS R. M., 1950, PROBLEMS SOCIAL POLI; WEBSTER C, 1961, STRATEGIC AIR OFFENS, V4; Zuckerman S, 1940, LANCET, V2, P219; Zuckerman S, 1941, BRIT MED J, V1941, P645; Zuckerman S., 1942, SZOEMU5745; ZUCKERMAN S, 1978, APES WARLORDS AUTOBI; Zuckerman S, 1933, FUNCTIONAL AFFINITIE; Zuckerman S., 1942, COMMUNICATION; ZUCKERMAN S, 1941, BRIT MED J, V1, P94; Zuckerman S., 1942, COMMUNICATION; Zuckerman S., 1939, SZOEMU3121; Zuckerman S., 1941, SZOEMU5741; Zuckerman S., 1940, SZOEMU5661; Zuckerman S., 1942, SZOEMU5733; Zuckerman S., 1932, SOCIAL LIFE MONKEYS; Zuckerman S., 1942, SZOEMU5734; Zuckerman S., 1942, SZOEMU4519; [No title captured]	68	6	6	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0952-6951	1461-720X		HIST HUM SCI	Hist. Hum. Sci.	DEC	2012	25	5					49	72		10.1177/0952695112470350			24	History & Philosophy Of Science; History Of Social Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	History & Philosophy of Science; Social Sciences - Other Topics	056PA	WOS:000312501900004	23626409	Green Published			2022-02-06	
J	Chatzipanteli, K; Vitarbo, E; Alonso, OF; Bramlett, HM; Dietrich, WD				Chatzipanteli, Katina; Vitarbo, Elizabeth; Alonso, Ofelia F.; Bramlett, Helen M.; Dietrich, W. Dalton			Temporal Profile of Cerebrospinal Fluid, Plasma, and Brain Interleukin-6 After Normothermic Fluid-Percussion Brain Injury: Effect of Secondary Hypoxia	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article								Interleukin-6 (IL-6) is a proinflammatory cytokine that may play multiple roles in the pathogenesis of traumatic brain injury (TBI). The present study determined time-dependent changes in IL-6 concentrations in vulnerable brain regions, cerebrospinal fluid (CSF) samples, and plasma after normothermic TBI. Because secondary insults are common in head injured patients, we also assessed the consequences of a post-traumatic secondary hypoxic insult on this pleiotropic cytokine. Male Sprague-Dawley rats were intubated, anesthetized, and underwent a moderate parasagittal fluid-percussion brain injury (1.8-2.1 atm, 37 degrees C) followed by either 30 minutes of normoxic or hypoxic (pO(2)=30-40 mmHg) gas levels. Rats were sacrificed 3, 6, or 24 hours after TBI or sham-operated procedures. Brain samples, including the ipsilateral cerebral cortex and hippocampus were dissected and analyzed. Plasma and CSF samples were collected at similar times and stored at -80 degrees C until analysis. IL-6 levels were significantly increased (p<0.05) at 3, 6, and 24 hours in the cerebral cortex and at 6 hours in the hippocampus after TBI. IL-6 levels in the TBI normoxic group for both structures returned to control levels by 24 hours. Plasma levels of IL-6 were elevated at all time points, while CSF levels were high at 3 and 6 hours, but normalized by 24 hours. Post-traumatic hypoxia led to significantly elevated (p<0.05) IL-6 protein levels in the cerebral cortex at 24 hours compared to sham-operated controls. These findings demonstrate that moderate TBI leads to an early increase in IL-6 brain, plasma, and CSF protein levels. Secondary post-traumatic hypoxia, a common secondary injury mechanism, led to prolonged elevations in plasma IL-6 levels that may participate in the pathophysiology of this complicated TBI model.	[Chatzipanteli, Katina; Vitarbo, Elizabeth; Alonso, Ofelia F.; Bramlett, Helen M.; Dietrich, W. Dalton] Univ Miami Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL USA; [Bramlett, Helen M.] Bruce W Carter Dept Vet Affairs Med Ctr, Miami, FL USA		Dietrich, WD (corresponding author), Univ Miami Sch Med, Dept Neurol Surg, Lois Pope LIFE Ctr, Miami Project Cure Paralysis R 48, 2nd Floor 1095 NW 14 Terrace, Miami, FL 33136 USA.	ddietrich@miami.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS30291, RO1NS42133]; Veterans AffairsUS Department of Veterans Affairs [1 I01 BX000521]	This study was supported by NIH/NINDS grants P50NS30291 and RO1NS42133 and Veterans Affairs 1 I01 BX000521. The authors would like to thank Jeremy Lytle for editorial assistance and manuscript preparation.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Bardenheuer M, 2000, UNFALLCHIRURG, V103, P355, DOI 10.1007/s001130050550; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bell MJ, 1999, ACTA NEUROCHIR WIE S, V70, P96; Bluthe RM, 2000, PHYSIOL BEHAV, V70, P367, DOI 10.1016/S0031-9384(00)00269-9; Bona E, 1999, PEDIATR RES, V45, P500, DOI 10.1203/00006450-199904010-00008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carlson NG, 1999, J IMMUNOL, V163, P3963; Chai Z, 1996, J EXP MED, V183, P311, DOI 10.1084/jem.183.1.311; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Cherian L, 1986, J NEUROTRAUM, V13, P371; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHIANG CS, 1994, DEV NEUROSCI-BASEL, V16, P212, DOI 10.1159/000112109; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Corbett D, 2000, BRAIN PATHOL, V10, P145; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dietrich WD, 1996, ADV NEUROL, V71, P177; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; Frink M, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-49; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Hagberg H, 1996, PEDIATR RES, V40, P603, DOI 10.1203/00006450-199610000-00015; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Herrmann O, 2003, J CEREBR BLOOD F MET, V23, P406, DOI 10.1097/01.WCB.0000055177.50448.FA; Howell JM, 2006, PROTEOMICS, V6, P2050, DOI 10.1002/pmic.200500517; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Juttler E, 2002, NEUROSCIENTIST, V8, P268, DOI 10.1177/1073858402008003012; KATSURADA K, 1973, SURGERY, V73, P191; Kim HM, 2000, J MOL NEUROSCI, V14, P191, DOI 10.1385/JMN:14:3:191; Kim JS, 1996, STROKE, V27, P1553, DOI 10.1161/01.STR.27.9.1553; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; KUSHIMA Y, 1992, NEUROSCI RES, V13, P267, DOI 10.1016/0168-0102(92)90039-F; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Loddick SA, 1998, J CEREBR BLOOD F MET, V18, P176, DOI 10.1097/00004647-199802000-00008; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Neher MD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-90; NIJSTEN MWN, 1987, LANCET, V2, P921; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Penkowa M, 1999, GLIA, V25, P343; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Reyes TM, 1999, BRAIN RES, V851, P215, DOI 10.1016/S0006-8993(99)02189-7; Rockswold GL, 2006, J NEUROSURG, V104, P170, DOI 10.3171/jns.2006.104.1.170; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; SINHA RP, 1973, JAMA-J AM MED ASSOC, V224, P1258, DOI 10.1001/jama.224.9.1258; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; TARKOWSKI E, 1995, STROKE, V26, P1393, DOI 10.1161/01.STR.26.8.1393; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TEREBUH PD, 1992, AM J PATHOL, V140, P649; Tilg H, 1997, IMMUNOL TODAY, V18, P428, DOI 10.1016/S0167-5699(97)01103-1; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; van Griensven M, 2003, EUR J TRAUMA, V29, P181, DOI DOI 10.1007/S00068-001-1324-Z; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; Volkmar H, 1999, NEUROREPORT, V10, P409; Waje-Andreassen U, 2005, ACTA NEUROL SCAND, V111, P360, DOI 10.1111/j.1600-0404.2005.00416.x; Wang MJ, 2001, J NEUROIMMUNOL, V112, P28, DOI 10.1016/S0165-5728(00)00374-X; WANG XK, 1995, J CEREBR BLOOD F MET, V15, P166, DOI 10.1038/jcbfm.1995.18; Weckbach S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/890816; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yan J, 2012, J NEUROIMMUNOL, V246, P78, DOI 10.1016/j.jneuroim.2012.02.013; ZILLES KJL, 1985, CORTEX BRAIN STEREOT	106	6	7	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	DEC 1	2012	2	4					167	175		10.1089/ther.2012.0016			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V38PM	WOS:000209355300005	23667780	Green Published			2022-02-06	
J	Daners, MS; Bottan, S; Guzzella, L; Poulikakos, D; Kurtcuoglu, V				Daners, Marianne Schmid; Bottan, Simone; Guzzella, Lino; Poulikakos, Dimos; Kurtcuoglu, Vartan			Craniospinal Pressure-Volume Dynamics in Phantom Models	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Adaptive compliance; brain elastance; cerebrospinal fluid (CSF); control system; intracranial pressure (ICP)	SUBARACHNOID SPACE; BRAIN; INFUSION; ICP; CSF	Regulation of intracranial pressure (ICP) is vital to proper brain function. Pathologic conditions such as traumatic brain injury and hydrocephalus can cause lethal changes in ICP through an imbalance of fluid passage into and out of the craniospinal space. The relationship between craniospinal volume and pressure determines to a large extent whether such imbalance can be compensated or if it will lead to neuronal damage. Phantom models are predisposed for the evaluation of medical procedures and devices that alter volume in the spinal or cranial space. However, current phantoms have substantial limitations in the reproduction of craniospinal pressure-volume relationships, which need to be overcome prior to their deployment outside the basic research setting. We present herein a novel feedback controlled phantom for the reproduction of any physiologic or pathologic pressure-volume relation. We compare its performance to those of existing passive methods, showing that it follows reference curves more precisely during both infusion of large volumes and fast oscillatory volume changes.	[Kurtcuoglu, Vartan] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Bottan, Simone; Poulikakos, Dimos] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Lab Thermodynam Emerging Technol, CH-8006 Zurich, Switzerland; [Daners, Marianne Schmid; Guzzella, Lino] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Inst Dynam Syst & Control, CH-8006 Zurich, Switzerland		Kurtcuoglu, V (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	marianne.schmid@idsc.mavt.ethz.ch; bottans@ethz.ch; lguzzella@ethz.ch; dimos.poulikakos@ethz.ch; vartan.kurtcuoglu@ethz.ch	Kurtcuoglu, Vartan/A-8940-2008; poulikakos, dimos/O-2853-2014; Schmid Daners, Marianne/E-1800-2013	Kurtcuoglu, Vartan/0000-0003-2665-0995; poulikakos, dimos/0000-0001-5733-6478; Schmid Daners, Marianne/0000-0002-6411-8871	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [K-32K1-120531]	This work was supported by the Swiss National Science Foundation: K-32K1-120531 SmartShunt-The Hydrocephalus Project. M. Schmid Daners and S. Bottan contributes equally. Asterisk indicates corresponding author.	Andersson N, 2005, PHYSIOL MEAS, V26, P1137, DOI 10.1088/0967-3334/26/6/022; [Anonymous], 2014, 5192014IEEE; AVEZAAT CJJ, 1986, NEUROSURG REV, V9, P113, DOI 10.1007/BF01743061; Berne R. M, 1990, PRINCIPLES PHYSL; Bottan S, 2012, IEEE T BIO-MED ENG, V59, P1532, DOI 10.1109/TBME.2012.2187448; Camm AJ, 1996, CIRCULATION, V93, P1043; Cipolla M.J., 2009, CEREBRAL CIRCULATION; Czosnyka M, 2004, PHYSIOL MEAS, V25, pR51, DOI 10.1088/0967-3334/25/5/R01; Edwards RJ, 2003, EUR J PEDIATR SURG, V13, pS13; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gallia GL, 2006, NAT CLIN PRACT NEURO, V2, P375, DOI 10.1038/ncpneuro0237; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gupta S, 2010, J R SOC INTERFACE, V7, P1195, DOI 10.1098/rsif.2010.0033; Hakim S, 1976, Surg Neurol, V5, P187; HAKIM S, 1971, ACTA NEUROLOGICA LAT, V0001, P00169; Iencean SM, 2003, MED HYPOTHESES, V61, P529, DOI 10.1016/S0306-9877(03)00209-3; Kasprowicz M, 2003, ACT NEUR S, V86, P529; KATZMAN R, 1970, NEUROLOGY, V20, P534, DOI 10.1212/WNL.20.6.534; Kurtcuoglu V, 2007, J BIOMECH ENG-T ASME, V129, P695, DOI 10.1115/1.2768376; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Marmarou A, 2005, ACT NEUR S, V95, P277; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Martin BA, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000089; Rekate HL, 2008, J NEUROSURG-PEDIATR, V2, P1, DOI 10.3171/PED/2008/2/7/001; SAINTEROSE C, 1987, J NEUROSURG, V66, P213, DOI 10.3171/jns.1987.66.2.0213; Sakka L, 2011, EUR ANN OTORHINOLARY, V128, P309, DOI 10.1016/j.anorl.2011.03.002; Santamarta D, 2010, CHILD NERV SYST, V26, P1683, DOI 10.1007/s00381-010-1244-5; Schuhmann MU, 2000, CHILD NERV SYST, V16, P856, DOI 10.1007/s003810000366; Sundstrom N, 2010, J NEUROSURG, V113, P1294, DOI 10.3171/2010.8.JNS10157; Taylor R, 2002, BRIT J NEUROSURG, V16, P30, DOI 10.1080/02688690120114200; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5	32	6	6	0	7	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	DEC	2012	59	12					3482	3490		10.1109/TBME.2012.2214220			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	047LX	WOS:000311843500025	23008242				2022-02-06	
J	Hirsch, KG; Spock, T; Koenig, MA; Geocadin, RG				Hirsch, Karen G.; Spock, Todd; Koenig, Matthew A.; Geocadin, Romergryko G.			Treatment of Elevated Intracranial Pressure with Hyperosmolar Therapy in Patients with Renal Failure	NEUROCRITICAL CARE			English	Article						Hypertonic saline; Intracranial pressure; Transtentorial herniation; ICP; Renal failure	TRAUMATIC BRAIN-INJURY; HYPERTONIC SALINE SOLUTIONS; TRANSTENTORIAL HERNIATION; CEREBRAL EDEMA; HYPERTENSION; OSMOTHERAPY; BLOOD; WATER; HEMORRHAGE; MANNITOL	Background To evaluate the use of hyperosmolar therapy in the management of elevated intracranial pressure (ICP) and transtentorial herniation (TTH) in patients with renal failure and supratentorial lesions. Methods Patients with renal failure undergoing renal replacement therapy treated with 23.4% saline (30-60 mL) and/or mannitol for high ICP or clinical evidence of TTH were analyzed in a retrospective cohort. Results The primary outcome measure was reversal of TTH or ICP crisis. Secondary outcome measures were modified Rankin scale on hospital discharge, survival to hospital discharge, and adverse effects. Of 254 subjects over 7 years, 6 patients with end-stage renal disease had 11 events. All patients received a 23.4% saline bolus, along with mannitol (91%), hypertonic saline (HS) maintenance fluids (82%), and surgical interventions (n = 2). Reversal occurred in 6/11 events (55%); 2 of 6 patients survived to discharge. ICP recording of 6 TTH events showed a reduction from ICP of 41 +/- A 3.8 mmHg (mean +/- A SEM) with TTH to 20.8 +/- A 3.9 mmHg (p = 0.05) 1 h after the 23.4% saline bolus. Serum sodium increased from 141.4 to 151.1 mmol/L 24 h after 23.4% saline bolus (p = 0.001). No patients were undergoing hemodialysis at the time of the event. There were no cases of pulmonary edema, clinical volume overload, or arrhythmia after HS. Conclusions Treatment with hyperosmolar therapy, primarily 23.4% saline solution, was associated with clinical reversal of TTH and reduction in ICP and had few adverse effects in this cohort. Hyperosmolar therapy may be safe and effective in patients with renal failure and these initial findings should be validated in a prospective study.	[Geocadin, Romergryko G.] Johns Hopkins Univ, Div Neurosci Crit Care, Sch Med, Baltimore, MD 21287 USA; [Hirsch, Karen G.] Univ Calif San Francisco, Div Neurocrit Care, San Francisco, CA 94143 USA; [Hirsch, Karen G.; Spock, Todd; Geocadin, Romergryko G.] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA; [Spock, Todd; Geocadin, Romergryko G.] Johns Hopkins Med Inst, Dept Neurosurg, Baltimore, MD 21205 USA; [Spock, Todd; Geocadin, Romergryko G.] Johns Hopkins Med Inst, Dept Anesthesia & Crit Care Med, Baltimore, MD 21205 USA; [Koenig, Matthew A.] Queens Med Ctr, Dept Neurocrit Care, Honolulu, HI USA; [Koenig, Matthew A.] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA		Geocadin, RG (corresponding author), Johns Hopkins Univ, Div Neurosci Crit Care, Sch Med, 600 N Wolfe St,Meyer 8-140, Baltimore, MD 21287 USA.	kghirsch@yahoo.com; rgeocad1@jhmi.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HL071568]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071568] Funding Source: NIH RePORTER	Dr. Geocadin was supported by NIH Grant #R01HL071568.	BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; Bhardwaj A, 2007, CURR NEUROL NEUROSCI, V7, P513, DOI 10.1007/s11910-007-0079-2; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Chen CH, 2006, J CEREBR BLOOD F MET, V26, P951, DOI 10.1038/sj.jcbfm.9600248; Davenport A, 2007, CONTRIB NEPHROL, V156, P333, DOI 10.1159/000102124; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Fletcher JJ, 2009, NEUROCRIT CARE, V11, P101, DOI 10.1007/s12028-009-9197-9; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Gondo G, 1989, Neurol Med Chir (Tokyo), V29, P1125, DOI 10.2176/nmc.29.1125; Harukuni Izumi, 2002, J Anesth, V16, P229, DOI 10.1007/s005400200030; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Jaradat MI, 2002, SEMIN NEPHROL, V22, P459, DOI 10.1053/snep.2002.35964; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KIEN ND, 1991, ANESTH ANALG, V73, P597; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; LO WD, 1987, STROKE, V18, P150, DOI 10.1161/01.STR.18.1.150; Paczynski RP, 1997, STROKE, V28, P1437, DOI 10.1161/01.STR.28.7.1437; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; Quinn RR, 2007, AM J KIDNEY DIS, V50, P421, DOI 10.1053/j.ajkd.2007.05.019; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 2002, J NEUROSURG ANESTH, V14, P22, DOI 10.1097/00008506-200201000-00005; Qureshi AI, 2000, CRIT CARE MED, V28, P1556, DOI 10.1097/00003246-200005000-00049; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Schell RM, 1996, J NEUROSURG ANESTH, V8, P178, DOI 10.1097/00008506-199604000-00022; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P521; Toung TJK, 2002, CRIT CARE MED, V30, P644, DOI 10.1097/00003246-200203000-00025; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; Zhang DM, 2009, CHINESE J PHYSIOL, V52, P8, DOI 10.4077/CJP.2009.AMG079; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021; Zubkov AY, 2009, NEUROLOGY, V72, P200, DOI 10.1212/01.wnl.0000344241.04543.94	38	6	6	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2012	17	3					388	394		10.1007/s12028-012-9676-2			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	050QP	WOS:000312069400012	22328033				2022-02-06	
J	Xia, XW; Dong, YW; Du, YQ; Yang, YD; Wang, WB; Li, Y				Xia, Xuewei; Dong, Yuwei; Du, Yiqing; Yang, Yongdong; Wang, Wenbo; Li, Yong			Relationship Between Learning and Memory Deficits and Arp2 Expression in the Hippocampus in Rats with Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Arp2; Learning and memory impairments; Traumatic brain injury	WORKING-MEMORY; DENDRITIC SPINES; SYNAPTIC PLASTICITY; COGNITIVE DEFICITS; HEAD-INJURY; WATER-MAZE; COMPLEX; CHILDREN; ACTIN; MICE	OBJECTIVE: To investigate the learning and memory impairments at acute phase after mild traumatic brain injury (TBI) in Sprague-Dawley rats and its relationship with the expression of Arp2. METHODS: Hundred adult male Sprague-Dawley rats were randomly assigned into a TBI group or a control group. TBI was produced by using an impact acceleration model. Learning and memory function was assessed using Morris Water Maze test after different injury intervals, and synaptic function was investigated after TBI treatment by using field excitatory postsynaptic and long-term potentials. Western blot, immunochemistry, and polymerase chain reaction (PCR) were used to detect the mRNA and protein expression of actin-related protein 2 (Arp2) after injury, whereas Nissl staining and DNA ladder assays were performed to detect neuron apoptosis. RESULTS: Using water maze measurement, the authors found escape latency to be significantly higher in the TBI group compared with the control group, and at 7 days postinjury, the difference almost reached up to 30 seconds. Field excitatory postsynaptic potential measurement further found that the long-term potential decreased by nearly 20% in the TBI group compared with the control group, which meant the synaptic excitatory function was downregulated in the TBI group. Further, no significant neuron apoptosis could be detected in the TBI group by Nissl staining, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, and DNA ladder assays. At last, we found that after TBI treatment, the Arp2 mRNA and protein levels were decreased in a time-dependent manner and reached 29.3% and 45.7% of control at 7 days postinjury, separately, and the decrease of mRNA of Arp2 was correlated with delayed escape latency. CONCLUSIONS: This study demonstrated that impairments of learning and memory function in the acute phase after mild TBI may be induced by a reduction in Arp2 expression.	[Xia, Xuewei; Dong, Yuwei; Du, Yiqing; Yang, Yongdong; Wang, Wenbo; Li, Yong] Guilin Med Univ, Affiliated Hosp, Dept Neurosurg, Guilin, Guangxi, Peoples R China		Xia, XW (corresponding author), Guilin Med Univ, Affiliated Hosp, Dept Neurosurg, Guilin, Guangxi, Peoples R China.	xxw7456@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81060094]; Guilin Science Administration Foundation	Supported by grants from the National Natural Science Foundation of China (81060094) and the Guilin Science Administration Foundation.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Bronisz A, 2002, J NEUROCHEM, V81, P1176, DOI 10.1046/j.1471-4159.2002.00896.x; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Campbell J.N., 2011, J NEUROTRAUMA; Chauhan NB, 2011, RESTOR NEUROL NEUROS, V29, P23, DOI 10.3233/RNN-2011-0573; Chen Y, 2008, PROG BIOCHEM BIOPHYS, V35, P610; CHUI DH, 1992, P SOC EXP BIOL MED, V199, P136; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; FRANK R G, 1990, Brain Injury, V4, P289, DOI 10.3109/02699059009026179; Fujimura M, 1999, J NEUROSCI, V19, P3414; Fujiwara S, 1993, Nihon Hoigaku Zasshi, V47, P387; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gong XW, 2004, PROGR PHYSL, V35, P306; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Howland JG, 2008, PROG BRAIN RES, V169, P145, DOI 10.1016/S0079-6123(07)00008-8; KEYSER L, 1995, NEUROREHABILITATION, V5, P255, DOI 10.3233/NRE-1995-5308; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; [林海英 LIN Haiying], 2006, [中华创伤杂志, Chinese Journal of Traumatology], V22, P753; Maaswinkel H, BEHAV BRAIN RES, V99, P143; MARKOWSKA AL, 1993, BEHAV NEUROSCI, V107, P627; Martin AC, 2006, NAT CELL BIOL, V8, P826, DOI 10.1038/ncb1443; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; MEANS LW, 1992, BEHAV NEURAL BIOL, V58, P144, DOI 10.1016/0163-1047(92)90387-J; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nolen BJ, 2004, P NATL ACAD SCI USA, V101, P15627, DOI 10.1073/pnas.0407149101; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	50	6	6	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750			WORLD NEUROSURG	World Neurosurg.	DEC	2012	78	6					689	696		10.1016/j.wneu.2011.07.042			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	062VC	WOS:000312950100034	22120305				2022-02-06	
J	Bowles, AP; Pasierb, L; Simunich, T; Updyke, M				Bowles, Alfred P.; Pasierb, Lisa; Simunich, Thomas; Updyke, Monica			Implications of neurophysiological parameters in persons with severe brain injury with respect to improved patient outcomes: A retrospective review	BRAIN INJURY			English	Article						Pressure reactivity index; autoregulation; cerebral perfusion pressure; intracranial pressure; cerebral oxygen perfusion; mean arterial pressure; TBI; ICP; CPP; MAP; COP; PRx	LUND CONCEPT; AUTOREGULATION; PRESSURE	Primary objective: To determine whether neurophysiologic parameters-intracranial pressure (ICP), mean arterial pressure (MAP), cerebral perfusion pressure (CPP), partial brain tissue oxygenation (PbtO(2)) and pressure reactivity index (PRx, calculated)-captured during the management of traumatic brain injury (TBI) have a relationship to patient outcome. Research design: A retrospective analysis of neurophysiologic data collected from persons under medical management of TBI per Conemaugh Memorial Medical Center (CMMC) standard treatment algorithms. Methods and procedures: Nine patients' medical records that matched International Statistical Classification of Diseases and Related Health Problems (ICD-9) code for head injury and a Current Procedural Terminology (CPT) code for an ICP monitoring device or ventriculostomy were analysed on the aforementioned parameters. Main outcomes and results: Statistical significance by mortality (alpha=0.05) was found for ICP, CPP and PbtO2. PRx showed a pattern of significance over the last 72 hours. The couplets (CPP & ICP) and (CPP & MAP) demonstrated significant correlations. Conclusions: Improved autoregulation was associated with PRx values near zero. Controlling those parameters that affect PRx, namely MAP, ICP and CPP and more importantly cerebral oxygen perfusion (COP), would likely increase the probability of a better outcome while guarding against secondary insult.	[Bowles, Alfred P.; Pasierb, Lisa; Simunich, Thomas; Updyke, Monica] Conemaugh Valley Mem Hosp, Johnstown, PA USA		Pasierb, L (corresponding author), John P Murtha Neurosci & Pain Inst, 1450 Scalp Ave,Suite 120, Johnstown, PA 15904 USA.	lpasierb@conemaugh.org			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-07-1-0679]	The authors report no declarations of interest and will declare such conflicts of interest, when and if they arise, taking appropriate action to manage such effectively. This work is supported by the US Army Medical Research and Materiel Command under Grant No. W81XWH-07-1-0679. The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as official Department of the Army position, policy or decision unless so designated by other documentation. In the conduct of research where humans are the subjects, the investigator(s) adhered to the policies regarding the protection of human subjects as prescribed in the Code of Federal Regulations (CFR) Title 45, Volume 1, Part 46; Title 32, Chapter 1, Part 219; and Title 21, Chapter 1 Part 50 (Protection of Human Subjects).	Agency for Healthcare Research and Quality, 2007, GUID MAN SEV TRAUM B; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; Lassen N, 1964, CIRCULATION RES S, V15, P204; Nordstrom CH, 2007, INTENS CARE MED, V33, P558, DOI 10.1007/s00134-006-0521-y; Rangel-Castilla L, 2008, NEUROSURG FOCUS, V25, P1; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312	11	6	6	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2012	26	12					1415	1424		10.3109/02699052.2012.694558			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	022DL	WOS:000309935400002	22823417				2022-02-06	
J	Kim, HJ; Kim, JY; Sun, W				Kim, Hyun Jung; Kim, Joo Yeon; Sun, Woong			Age-dependent changes in the subcallosal zone neurogenesis of mice	NEUROCHEMISTRY INTERNATIONAL			English	Article						Aging; Neural stem cell; Neurogenesis; Traumatic brain injury; Subcallosal zone	NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN BRAIN; SUBVENTRICULAR ZONE; DENTATE GYRUS; NEURONS; PROLIFERATION; HIPPOCAMPUS; DIFFERENTIATION; ORGANIZATION	There are several known neurogenic areas including subventricular zone and subgranular layer in the dentate gyrus of the hippocampus. Both germinal centers exhibit an age-dependent decline in cell proliferation and neurogenesis, which may be associated with age-related decline in brain function. We recently identified the subcallosal zone (SCZ) as a novel neural stem cell niche with a potential to spontaneously produce new neuroblasts. We examined whether SCZ neurogenesis is also regulated by the age of mice. The number of newly generated neuroblasts was reduced in the SCZ with age, and only marginal number of DCX-labeled neuroblasts was found in 6-month-old SCZ, which is most likely due to reduced proliferation of progenitor cells and loss of neural stem cells (NSCs). This age-dependent changes in the SCZ occurred earlier than that of other neurogenic brain regions. The neurosphere assay in vitro confirmed the depletion of NSCs within the SCZ of young adults. However, marked induction of neuroblast production in the SCZ was seen in 6-month-old mice after traumatic brain injury. Taken together, these results indicate that a rapid decline in SCZ neurogenesis in mice is due to depletion of NSCs and reduced capacity to produce neuroblasts. (C) 2012 Elsevier Ltd. All rights reserved.	[Kim, Hyun Jung; Kim, Joo Yeon; Sun, Woong] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea		Sun, W (corresponding author), Korea Univ, Coll Med, Dept Anat, 126-1 Anam Dong, Seoul 136705, South Korea.	woongsun@korea.ac.kr		sun, woong/0000-0003-1792-4894	National Research Foundation of Korea (NRF)National Research Foundation of Korea; Korea GovernmentKorean Government [20110019409, 20110019212]	This work is supported by the National Research Foundation of Korea (NRF) Grants funded by the Korea Government (20110019409, 20110019212).	Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Jovanov-Milosevic N, 2010, EUR J NEUROSCI, V32, P1423, DOI 10.1111/j.1460-9568.2010.07400.x; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim WR, 2007, J NEUROSCI, V27, P14392, DOI 10.1523/JNEUROSCI.3903-07.2007; Kim WR, 2011, EUR J NEUROSCI, V33, P599, DOI 10.1111/j.1460-9568.2010.07557.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Riddle DR, 2007, BRAIN AGING MODELS M; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tropepe V, 1997, J NEUROSCI, V17, P7850; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	36	6	6	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186			NEUROCHEM INT	Neurochem. Int.	NOV	2012	61	6					879	884		10.1016/j.neuint.2012.02.027			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	068NY	WOS:000313374600012	22417727				2022-02-06	
J	Renstrom, B; Soderman, K; Domellof, E; Emanuelson, I				Renstrom, Barbro; Soderman, Kerstin; Domellof, Erik; Emanuelson, Ingrid			Self-reported health and influence on life situation 5-8 years after paediatric traumatic brain injury	BRAIN INJURY			English	Article						SF-36; children; adolescents; paediatric; traumatic brain injury; outcome; rehabilitation; leisure activities; school performance; symptoms; future; questionnaire	QUALITY-OF-LIFE; CHILDHOOD HEAD-INJURY; WESTERN SWEDEN; YOUNG-ADULTS; CHILDREN; MODERATE; MILD; ADOLESCENTS; SF-36; EPIDEMIOLOGY	Primary objective: During childhood, the central nervous system is in a state of rapid development which can be interrupted by a traumatic brain injury (TBI). This study aimed to describe if and how TBI during childhood influences health and life situation, 5-8 years later. Research design: A case-control retrospective design was employed for the assessment of 61 adolescents and young adults with a mild, moderate or severe TBI and 229 matched controls from a normative group (16-24 years). Methods and procedures: SF-36 (Short Form 36 health survey) and a self-reported questionnaire measuring life situation were distributed to youths suffering TBI 5-8 years ago. Forty-five youths (74%) completed the questionnaires. Main outcomes and results: Participants with a TBI stated lower self-estimated health compared with the normative group. Remaining self-reported symptoms were physical and cognitive. Negative effects of TBI influencing school results, leisure activities and thoughts about future life situation were also described. Conclusion: Young individuals experience sustained negative effects of childhood TBI on health and life situation. More research is necessary to detect, understand and properly support these youths.	[Renstrom, Barbro; Domellof, Erik] Kolbacken Child Rehabil Ctr, SE-90733 Umea, Sweden; [Soderman, Kerstin] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden; [Domellof, Erik] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Emanuelson, Ingrid] Univ Gothenburg, Dept Pediat, Inst Clin Sci, Gothenburg, Sweden		Renstrom, B (corresponding author), Kolbacken Child Rehabil Ctr, SE-90733 Umea, Sweden.	barbro.renstrom@vll.se		Domellof, Erik/0000-0003-0240-3690	County Council of Vasterbotten	Supported by grants from the County Council of Vasterbotten to the first author.	Aaro Jonsson C, 2010, THESIS STOCKHOLM U S, P74; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cott CA, 1995, PHYSIOTHER CAN, V47, P87; Cronin AF, 2001, AM J OCCUP THER, V55, P377, DOI 10.5014/ajot.55.4.377; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Emanuelson I, 1998, Pediatr Rehabil, V2, P65; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; EWINGCOBBS L, 1998, TRAUMATIC BRAIN INJU, P11; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Helfaer Mark A., 1993, Current Opinion in Pediatrics, V5, P303; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nelson J E, 2002, Pediatr Rehabil, V5, P37, DOI 10.1080/1363849021000007088; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; Pinto PS, 2012, J NEUROIMAGING, P1; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Sakzewski L, 1996, AUS OCC THER J, V43, P113; Souza Ligia Maria Do N, 2007, Dev Neurorehabil, V10, P35, DOI 10.1080/13638490600822239; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; [No title captured]	43	6	6	0	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2012	26	12					1405	1414		10.3109/02699052.2012.694559			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	022DL	WOS:000309935400001	22720997				2022-02-06	
J	Sedney, CL; Harshbarger, T; Orphanos, J; Collins, JJ				Sedney, Cara L.; Harshbarger, Todd; Orphanos, John; Collins, John J.			Penetrating Injury to the Superior Sagittal Sinus by a Nail in a 4-Year-Old Child A Case Report	PEDIATRIC EMERGENCY CARE			English	Article						nonaccidental trauma; traumatic brain injury; penetrating injury	DEPRESSED SKULL FRACTURE; POPULATION CLINICAL ARTICLE; OF-THE-LITERATURE; INTRACRANIAL HYPERTENSION; ATTEMPTED INFANTICIDE; SEWING NEEDLES; GUN INJURY; INSERTION; OCCLUSION; SURGERY	Penetrating head injuries are rare in children, with most injuries being accidental as a result of unsupervised use of sharp objects by young children. We present the case of a 4-year-old boy brought to our emergency department with a nail embedded through a wooden board and into his skull. The nail was determined to be entering the superior sagittal sinus through radiographic imaging. Thus, surgical removal of the nail was determined to be necessary. Inspection revealed a likely through-and-through injury to the sinus, and therefore, because sinus reconstruction was not deemed possible, the sinus was occluded with suture ties both in front and behind the nail before nail removal. Post-operatively, the patient did well and remained neurologically intact. Investigation for possible nonaccidental trauma was conducted. Although most commonly accidental in nature, nonaccidental penetrating traumas have been reported in both pediatric and adult populations. This patient did well after occlusion of his superior sagittal sinus at the coronal suture after penetrating injury by a nail. Penetrating injury in the pediatric population is predominantly thought to be accidental, but a high index of suspicion should be maintained for possible nonaccidental etiology.	[Sedney, Cara L.] W Virginia Univ, Robert C Byrd Hlth Sci Ctr, Dept Neurosurg, Morgantown, WV 26506 USA		Sedney, CL (corresponding author), W Virginia Univ, Robert C Byrd Hlth Sci Ctr, Dept Neurosurg, POB 9183, Morgantown, WV 26506 USA.	csedney@hsc.wvu.edu		Sedney, Cara/0000-0003-1290-7083			ABBASSIOUN K, 1979, J NEUROL NEUROSUR PS, V42, P1046, DOI 10.1136/jnnp.42.11.1046; AMELI NO, 1970, J NEUROSURG, V33, P721, DOI 10.3171/jns.1970.33.6.0721; Amirjamshidi A, 2009, SURG NEUROL, V72, P635, DOI 10.1016/j.surneu.2009.02.029; Davidson L, 2011, J NEUROSURG-PEDIATR, V7, P527, DOI 10.3171/2011.2.PEDS10123; Englot DJ, 2010, NEUROSURG REV, V33, P501, DOI 10.1007/s10143-010-0268-3; Forbes JA, 2010, J NEUROSURG-PEDIATR, V6, P23, DOI 10.3171/2010.3.PEDS09441; Fuentes S, 2005, BRIT J NEUROSURG, V19, P438, DOI 10.1080/02688690500390193; Litvack ZN, 2006, J NEUROSURG, V104, P828, DOI 10.3171/jns.2006.104.5.828; Mathew Jacob Eapen, 2010, Surg Neurol Int, V1, P52, DOI 10.4103/2152-7806.69379; McNatt SA, 2011, J NEUROSURG-PEDIATR, V7, P224, DOI 10.3171/2010.11.PEDS09261; NOTERMANS NC, 1990, J NEUROSURG, V72, P818, DOI 10.3171/jns.1990.72.5.0818; OHAEGBULAM SC, 1980, SURG NEUROL, V14, P393; Sani S, 2005, J NEUROSURG, V103, P567, DOI 10.3171/jns.2005.103.3.0567; Shahpurkar VV, 2009, SINGAP MED J, V50, P443; Shenoy SN, 2003, NEUROL INDIA, V51, P411; Sood S, 2006, J NEUROSURG, V105, P210, DOI 10.3171/ped.2006.105.3.210; Tanaka H, 2004, NEUROL SURG TOKYO, V32, P753; Testerman GM, 2007, SOUTH MED J, V100, P608, DOI 10.1097/SMJ.0b013e3180398e47; Yadav YR, 2009, NEUROL INDIA, V57, P830, DOI 10.4103/0028-3886.59500	19	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	NOV	2012	28	11					1220	1223		10.1097/PEC.0b013e318271ff3b			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	033JY	WOS:000310793000023	23128650				2022-02-06	
J	Chiu, CY; Lynch, RT; Chan, F; Rose, L				Chiu, Chung-Yi; Lynch, Ruth Torkelson; Chan, Fong; Rose, Lindsey			The Health Action Process Approach as a Motivational Model of Dietary Self-Management for People With Multiple Sclerosis: A Path Analysis	REHABILITATION COUNSELING BULLETIN			English	Article						multiple sclerosis; health promotion; self-management; dietary behavior	SOCIAL-COGNITIVE PREDICTORS; TRAUMATIC BRAIN-INJURY; PHYSICAL-ACTIVITY; DISABILITY PREVENTION; VEGETABLE CONSUMPTION; SECONDARY CONDITIONS; DISEASE RISK; NUTRITION; BEHAVIORS; PROMOTION	The main objective of this study was to evaluate the health action process approach (HAPA) as a motivational model for dietary self-management for people with multiple sclerosis (MS). Quantitative descriptive research design using path analysis was used. Participants were 209 individuals with MS recruited from the National MS Society and a neurology clinic at a university teaching hospital in the Midwest. Outcome was measured by the Healthy Dietary Stages of Change Instrument, along with 10 predictor measures. The HAPA dietary self-management model fit the data relatively well (goodness-of-fit index = .95, normed fit index = .90, comparative fit index = .95, and root mean square error approximation = 0.07) explaining 15% of the variance in dietary self-management behavior. Recovery self-efficacy and action and coping planning directly contributed to the prediction of dietary health behaviors. Action self-efficacy, outcome expectancy, risk perception, and social support influenced intention, and the relationship between intention and dietary health behaviors is mediated by action and coping planning. Action self-efficacy, maintenance self-efficacy, and recovery self-efficacy directly or indirectly affected dietary health behaviors. Empirical support was found for the HAPA model of dietary self-management for people with MS. The HAPA model can be used to design behavioral health promotion interventions for people with disabilities in vocational rehabilitation.	[Chiu, Chung-Yi; Rose, Lindsey] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Lynch, Ruth Torkelson; Chan, Fong] Univ Wisconsin, Madison, WI 53706 USA		Chiu, CY (corresponding author), Univ Texas SW Med Ctr Dallas, 6011 Harry Hines Blvd,Room V3-818, Dallas, TX 75390 USA.	Chung-Yi.Chiu@UTSouthwestern.edu					Ajzen I., 1980, UNDERSTANDING ATTITU; Anderson ES, 2007, ANN BEHAV MED, V34, P304, DOI 10.1007/BF02874555; [Anonymous], 2008, 2008 PHYS ACT GUID A; Arbuckle J., 1999, AMOS 4 USERS REFEREN; Bandura A., 1997, SELF EFFICACY EXERCI; Becker H, 1991, Am J Health Promot, V5, P449; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Bishop M., 2000, J REHABILITATION ADM, V24, P57; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier Charles H, 2005, Phys Med Rehabil Clin N Am, V16, P557, DOI 10.1016/j.pmr.2005.01.002; Brawarsky P., 2002, TOB CONTROL, V11, P1129; Byrne B., 2001, STRUCTURAL EQUATION; Centers for Disease Control and Prevention, 2011, PREV SED LEIS TIM BE; Chiu CY, 2011, REHABIL PSYCHOL, V56, P171, DOI 10.1037/a0024583; Degeneffe CE, 2011, REHABIL PSYCHOL, V56, P243, DOI 10.1037/a0024465; Fleming JO., 2002, DIAGNOSIS MANAGEMENT; Ford ES, 2000, PREV MED, V30, P83, DOI 10.1006/pmed.1999.0606; Gao S, 2008, NONNORMALITY DATA ST; Ghaderi Ata, 2003, Eat Behav, V3, P387, DOI 10.1016/S1471-0153(02)00089-2; Habek M, 2010, CLIN NEUROL NEUROSUR, V112, P616, DOI 10.1016/j.clineuro.2010.03.029; HEWSON DC, 1984, HUM NUTR-APPL NUTR, V38A, P355; International Federation of Multiple Sclerosis Societies, 1984, ACTA NEUROL SCAND  S, V101, P1; Ipsen C, 2010, REHABIL COUNS BULL, V53, P67, DOI 10.1177/0034355209348238; Khan F, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007256.pub2; Khurana SR, 2009, AM J PHYS MED REHAB, V88, P83, DOI 10.1097/PHM.0b013e318194f8b5; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Limbert C, 2010, HEALTH CARE WOMEN IN, V31, P170, DOI 10.1080/07399330902893846; Luszczynska A, 2006, REHABIL PSYCHOL, V51, P314, DOI 10.1037/0090-5550.51.4.314; Lynch R. T., 2009, UNDERSTANDING PSYCHO, P277; McDevitt L. N., 1999, ISSUES DISABILITY HL, P221; National Multiple Sclerosis Society, 2011, AB MS; Nigg C, 2005, ANN BEHAV MED, V29, P35, DOI 10.1207/s15324796abm2902s_7; Payne A, 2001, J HUM NUTR DIET, V14, P349, DOI 10.1046/j.1365-277X.2001.00308.x; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Quintana SM, 1999, COUNS PSYCHOL, V27, P485, DOI 10.1177/0011000099274002; Ravesloot C, 2005, REHABIL PSYCHOL, V50, P239, DOI 10.1037/0090-5550.50.3.239; Ravesloot C, 1998, CLIN PSYCHOL PSYCHOT, V5, P76, DOI 10.1002/(SICI)1099-0879(199806)5:2<76::AID-CPP156>3.0.CO;2-5; Ravesloot C., 2011, HLTH BEHAV CHANGE DI; Ravesloot C, 2011, DISABIL HEALTH J, V4, P19, DOI 10.1016/j.dhjo.2010.05.006; Renner B., 2005, RISK HLTH BEHAV DOCU; Renner B, 2008, INT J BEHAV MED, V15, P4, DOI [10.1080/10705500701783785, 10.1007/BF03003068]; Rimmer JH, 1999, PHYS THER, V79, P495, DOI 10.1093/ptj/79.5.495; Schwarz S, 2005, NERVENARZT, V76, P131, DOI 10.1007/s00115-004-1783-7; Schwarzer R, 2000, HEALTH PSYCHOL, V19, P487, DOI 10.1037/0278-6133.19.5.487; Schwarzer R., 2000, BERLIN SOCIAL SUPPOR; Schwarzer R., 1992, SELF EFFICACY THOUGH; Schwarzer R, 2008, HEALTH PSYCHOL, V27, pS54, DOI 10.1037/0278-6133.27.1(Suppl.).S54; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; SEEKINS T, 1994, J REHABIL, V60, P47; Shaikh AR, 2008, AM J PREV MED, V34, P535, DOI 10.1016/j.amepre.2007.12.028; Slawta JN, 2003, ARCH PHYS MED REHAB, V84, P1823, DOI 10.1016/S0003-9993(03)00466-0; Sniehotta FF, 2005, EUR J SOC PSYCHOL, V35, P565, DOI 10.1002/ejsp.258; SOLARI A, 1993, ACTA NEUROL SCAND, V87, P43, DOI 10.1111/j.1600-0404.1993.tb04073.x; Steptoe A, 2004, HEALTH PSYCHOL, V23, P574, DOI 10.1037/0278-6133.23.6.574; Stuifbergen A. K., 1997, ARCH PHYSICAL MED S, V78, P3; Stuijbergen AK, 2003, ARCH PHYS MED REHAB, V84, P467, DOI 10.1053/apmr.2003.50028; TURNER RJ, 1989, REHABIL PSYCHOL, V34, P225, DOI 10.1037//0090-5550.34.4.225; U.S. Department of Agriculture U.S. Department of Health and Human Services Washington, 2010, DIET GUID AM; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039	60	6	6	1	23	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0034-3552			REHABIL COUNS BULL	Rehabil. Couns. Bull.	OCT	2012	56	1			SI		48	61		10.1177/0034355212440888			14	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	995SN	WOS:000308033100005					2022-02-06	
J	Dourado, CC; Engler, TMND; de Oliveira, SB				Dourado, Cinthia Carlos; Nascimento de Miranda Engler, Tania Mara; de Oliveira, Sandro Barbosa			BOWEL DYSFUNCTION IN PATIENTS WITH BRAIN DAMAGE RESULTING FROM STROKE AND TRAUMATIC BRAIN INJURY: A RETROSPECTIVE STUDY OF A CASE SERIES	TEXTO & CONTEXTO ENFERMAGEM			English	Article						Constipation; Fecal incontinence; Stroke; Traumatic brain injury	FECAL INCONTINENCE; NEUROLOGICAL DISEASES; RISK-FACTORS; CONSTIPATION; MANAGEMENT	Bowel dysfunction is a common complaint among patients with brain damage due to stroke and traumatic brain injury. The aim of this study was to investigate the prevalence of bowel dysfunction (anal incontinence and intestinal constipation) in patients with brain damage due to stroke and traumatic brain injury admitted for rehabilitation. This is a retrospective case series study, based on the analysis of data from 138 charts of patients admitted in the first half of 2009. The prevalence of bowel dysfunction was 41%, with 33 (24%) cases of anal incontinence and 37 (27%) cases of intestinal constipation. Motor impairment, mobility aid, changes in memory and communication were associated with the presence of anal incontinence. The prevalence of bowel dysfunction is high in this population. Early identification of the symptoms and its related factors promoting bowel retraining, may help to improve the quality of life of patients with bowel dysfunction.	[de Oliveira, Sandro Barbosa] SARAH Rehabil Hosp Network, Natl Qual Control Ctr, Mexico City, DF, Mexico		Dourado, CC (corresponding author), SMHS Quadra 301 Bloco, BR-70335901 Brasilia, DF, Brazil.	cinthiadourado@gmail.com; tania0877@hotmail.com; sndr@terra.com.br					Bracci F, 2007, WORLD J GASTROENTERO, V13, P3967, DOI 10.3748/wjg.v13.i29.3967; Coggrave M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002115.pub3; Dantas Roberto Oliveira, 2004, Medicina (Ribeirao Preto), V37, P262; Doshi V. S., 2003, SMJ Singapore Medical Journal, V44, P643; Eberhardie Chris, 2003, Nurs Older People, V15, P22; Foxx-Orenstein A, 2003, ARCH PHYS MED REHAB, V84, P231, DOI 10.1053/apmr.2003.50095; Harari D, 2004, STROKE, V35, P2549, DOI 10.1161/01.STR.0000144684.46826.62; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; Krogh K, 2009, BEST PRACT RES CL GA, V23, P531, DOI 10.1016/j.bpg.2009.04.012; Leary SM, 2006, CLIN REHABIL, V20, P1094, DOI 10.1177/0269215506071258; Engler TMND, 2011, ACTA PAUL ENFERM, V24, P804, DOI 10.1590/S0103-21002011000600013; Nazarko L., 2007, NURS RESID CARE, V9, P251; Oliveira L., 2006, J BRAS GASTROENTEROL, V6, P35; Pare P, 2001, AM J GASTROENTEROL, V96, P3130, DOI 10.1111/j.1572-0241.2001.05259.x; Pereira MG, 1995, EPIDEMIOLOGIA TEORIA; Robain G, 2002, REV NEUROL-FRANCE, V158, P589; Schmulson Wasserman Max, 2008, Gastroenterol Hepatol, V31, P59; Stewart WF, 1999, AM J GASTROENTEROL, V94, P3530, DOI 10.1111/j.1572-0241.1999.01642.x; Su YJ, 2009, STROKE, V40, P1304, DOI 10.1161/STROKEAHA.108.534776; Vieira EP, 2005, REV BRAS COLOPROCTOL, V5, P348; Winge K, 2003, J NEUROL NEUROSUR PS, V74, P13, DOI 10.1136/jnnp.74.1.13	21	6	6	0	13	UNIV FEDERAL SANTA CATARINA	FLORIANOPOLIS	CAMPUS UNIVERSITARIO REITOR JOAO DAVID FERREIRA LIMA, FLORIANOPOLIS, SC 88010-970, BRAZIL	0104-0707			TEXTO CONTEXTO ENFER	Texto Contexto Enferm.	OCT-DEC	2012	21	4					905	911		10.1590/S0104-07072012000400022			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	100CD	WOS:000315672000022		gold			2022-02-06	
J	Nesiama, JAO; Pirallo, RG; Lerner, EB; Hennes, H				Nesiama, Jo-Ann O.; Pirallo, Ronald G.; Lerner, E. Brooke; Hennes, Halim			Does a Prehospital Glasgow Coma Scale Score Predict Pediatric Outcomes?	PEDIATRIC EMERGENCY CARE			English	Article						prehospital; Glasgow Coma Scale score; Glasgow outcome score; disability rating scale	DISABILITY RATING-SCALE; HEAD TRAUMA; BRAIN-INJURY; CHILDREN; MANAGEMENT; EMERGENCY; RELIABILITY; MORTALITY; ADMISSION; FIELD	Background: Although the Glasgow Coma Scale (GCS) score is widely used by medical professionals to evaluate and predict neurological outcomes, studies using the prehospital (P) GCS score to predict neurological outcomes in children are few. Objective: The objective of this study was to determine the agreement between the P GCS score and the emergency department (ED) GCS score, and the association between P GCS score and outcomes at hospital discharge in pediatric patients 5 to 18 years of age. Methods: Medical record review of children 5 to 18 years old with traumatic brain injury (TBI) was conducted. Children with documented P and ED GCS scores were eligible for enrollment. The hospital records of each enrolled child were reviewed, and the Glasgow outcome score and the disability rating scale scores were calculated. Agreement between the P and ED GCS scores was calculated using chi(2) (kappa statistic). Results: One hundred eighty-five subjects were included. There was strong agreement between P and ED GCS scores (kappa = +0.69; confidence interval, 0.57-0.81). The Glasgow outcome score category improved with improving GCS category. The median disability rating scale score was also similar for P and ED GCS scores and was higher with decreasing GCS. Conclusions: Our data showed strong agreement between P and ED GCS scores. Also, there was strong association between P GCS scores and short-term outcomes in children with TBI. The results support the use of GCS in prehospital transport destination guidelines for children with TBI.	[Nesiama, Jo-Ann O.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Div Emergency Med, Dept Pediat, Dallas, TX 75235 USA; [Pirallo, Ronald G.; Lerner, E. Brooke] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA		Nesiama, JAO (corresponding author), Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Div Emergency Med, Dept Pediat, 1935 Med Dist Dr, Dallas, TX 75235 USA.	jo-ann.nesiama@utsouthwestern.edu	Hennes, Halim/H-6592-2019	Hennes, Halim/0000-0002-1230-7371			Adams J, 2001, J PEDIATR SURG, V36, P119, DOI 10.1053/jpsu.2001.20026; Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Atabaki SM, 2006, CLIN PEDIATR EMERG M, V7, P94, DOI 10.1016/j.cpem.2006.03.003; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Davis DH, 2005, PEDIATRICS, V115, P89, DOI 10.1542/peds.2004-0508; Densmore JC, 2006, J PEDIATR SURG, V41, P92; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Gedeit R, 2001, Pediatr Rev, V22, P118, DOI 10.1542/pir.22-4-118; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; JENNETT B, 1975, LANCET, V1, P480; Juarez V J, 1995, J Neurosci Nurs, V27, P283; Kapapa T, 2010, J CHILD NEUROL, V25, P146, DOI 10.1177/0883073809332698; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Lerner EB, 2006, PREHOSP EMERG CARE, V10, P303, DOI 10.1080/10903120600723921; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Miller L, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-7; Mooney DP, 2006, J TRAUMA, V61, P330, DOI 10.1097/01.ta.0000226167.44892.1d; MORRAY JP, 1984, CRIT CARE MED, V12, P1018, DOI 10.1097/00003246-198412000-00002; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Perez K, 1998, EMERGENCY MED SERVIC; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Pracht EE, 2008, J PEDIATR SURG, V43, P212, DOI 10.1016/j.jpedsurg.2007.09.047; Pryor JP, 2003, J TRAUMA, V55, P442; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roddy SP, 1998, PEDIATRICS, V101, P575, DOI 10.1542/peds.101.4.575; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Segui-Gomez M, 2003, J PEDIATR SURG, V38, P1162, DOI 10.1016/S0022-3468(03)00262-8; SIMPSON D, 1982, LANCET, V2, P450; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P289; Tatman A, 1997, ARCH DIS CHILD, V77, P519, DOI 10.1136/adc.77.6.519; TEASDALE G, 1974, LANCET, V2, P81; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; WINKLER J V, 1984, Journal of Emergency Medicine, V2, P1, DOI 10.1016/0736-4679(84)90038-6; WOOD PHN, 1980, WHO CHRON, V34, P376; Wright J, 2000, J HEAD TRAUMA REHAB, V15, P734, DOI 10.1097/00001199-200002000-00011; Wright J, 2001, CLIN PEDIAT EMERG ME, V2, P3	45	6	7	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	OCT	2012	28	10					1027	1032		10.1097/PEC.0b013e31826cac31			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	018JR	WOS:000309656900015	23023472				2022-02-06	
J	Yan, YH; Gong, PP; Jin, W; Xu, J; Wu, XH; Xu, T; Hang, QL; Fu, HR; Kei, KF; Gao, YL				Yan, Yaohua; Gong, Peipei; Jin, Wei; Xu, Jian; Wu, Xiaohong; Xu, Ting; Hang, Qinglei; Fu, Hongran; Kei, Kaifu; Gao, Yilu			The cell-specific upregulation of bone morphogenetic protein-10 (BMP-10) in a model of rat cortical brain injury	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						BMP-10; Traumatic brain injury; Proliferation; Astrocytes; Rat	CENTRAL-NERVOUS-SYSTEM; GLIAL PROLIFERATION; PROINFLAMMATORY CYTOKINE; SIGNALING PATHWAYS; TRAUMATIC INJURY; SCAR FORMATION; SPINAL-CORD; EXPRESSION; ADULT; ASTROCYTES	Previous studies have suggested that bone morphogenetic protein-6 (BMP-6) has a pronounced upregulation in rat brains subjected to traumatic brain injury. Bone morphogenetic protein-10 (BMP-10) is a newly identified cardiac-specific peptide growth factor that belongs to the TGF-beta superfamily. To elucidate the dynamic expression changes and cellular localization of BMP-10 during traumatic brain injury (TBI), we performed an acute traumatic brain injury model in adult rats. Western blot analysis, immunohistochemistry and RTPCR revealed that BMP-10 expression in impaired cerebral cortex was more strongly induced not only at protein level but also at mRNA level compared to that in normal group. Double immunofluorescence labeling suggested that BMP-10 was localized mainly in the cytoplasm of neurons, microglias, and astrocytes within 3 mm from the lesion site at day 3 post-injury. And there was a specific upregulation of BMP-10 in astrocytes following brain injury. Besides, co-localization of BMP-10 and proliferating cell nuclear antigen (PCNA) was detected in Glial fibrillary acidic protein (GFAP) (+) cells. We also examined the expression profiles of PCNA and GFAP whose change was correlated with the expression profiles of BMP-10 in the incised injury model used here. Another experiment in which astrocytes were treated with BMP-10 was also performed to confirm the relationship between the upregulation of BMP-10 and proliferation of astrocytes following TBI. Taken together, this is the first description of BMP-10 expression during the central nervous system (CNS) lesion and repair. Thus, the present data suggested that BMP-10 may be implicated in CNS pathophysiology after TBI. But, further studies are needed to understand the cell signal pathway which can direct the exact role of BMP-10 following traumatic brain injury.	[Yan, Yaohua; Gong, Peipei; Xu, Jian; Xu, Ting; Hang, Qinglei; Gao, Yilu] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China; [Jin, Wei; Wu, Xiaohong; Fu, Hongran; Kei, Kaifu] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China		Gao, YL (corresponding author), Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China.	kekaifu_nt@126.com; YiluGao123@hotmail.com	Yu, Hongwei/L-3754-2017	Yu, Hongwei/0000-0002-5607-0628	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070992]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the National Natural Science Foundation of China (No. 81070992) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Beckham JD, 2009, J VIROL, V83, P5035, DOI 10.1128/JVI.02433-08; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Fernandez-L A, 2006, CLIN MED RES, V4, P66, DOI 10.3121/cmr.4.1.66; Galter D, 1999, EUR J NEUROSCI, V11, P2444, DOI 10.1046/j.1460-9568.1999.00667.x; Goto K, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.114; Hall AK, 2004, J NEUROSCI RES, V76, P1, DOI 10.1002/jnr.20019; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Qi XA, 2010, EXP NEUROL, V221, P353, DOI 10.1016/j.expneurol.2009.12.003; Setoguchi T, 2001, BRAIN RES, V921, P219, DOI 10.1016/S0006-8993(01)03123-7; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; Teichmann U, 2004, DEV GENES EVOL, V214, P96, DOI 10.1007/s00427-003-0380-2; ten Dijke P, 2006, CURR MED RES OPIN, V22, pS7, DOI 10.1185/030079906X80576; Wozney JM, 1998, EUR J ORAL SCI, V106, P160, DOI 10.1111/j.1600-0722.1998.tb02170.x; Ye L, 2010, CANCER SCI, V101, P2137, DOI 10.1111/j.1349-7006.2010.01648.x; Ye L, 2009, J UROLOGY, V181, P2749, DOI 10.1016/j.juro.2009.01.098; Zhang Z, 2006, NEUROSCIENCE, V138, P47, DOI 10.1016/j.neuroscience.2005.11.036; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	38	6	6	0	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	OCT	2012	43	5					543	552		10.1007/s10735-012-9431-1			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	014FH	WOS:000309360100009	22797972				2022-02-06	
J	Bralic, M; Stemberga, V; Stifter, S				Bralic, Marina; Stemberga, Valter; Stifter, Sanja			Introduction of calpain inhibitors in traumatic brain injury: A novel approach?	MEDICAL HYPOTHESES			English	Article							MOUSE MODEL; NEURODEGENERATION; MECHANISMS; APOPTOSIS; DISEASE; STATES; RATS	Traumatic brain injury (TBI) is a major cause of death and disability throughout the world. In recent years, researchers focused on the pathological significance of calcium accumulation in the brain after TBI. Neuronal calcium homeostasis disturbances may result in the activation of calpain a ubiquitous calcium-sensitive protease. The calpain family has a well-established causal role in neuronal cell death following acute brain injury: their activation has been observed to progressively increase after either contusive or diffuse brain trauma in animals, suggesting calpain to be a mediator of early neuronal damage. We hypothesize that pretreatment with the calpain inhibitors in population at objective risk (military soldiers' pre combat) in appropriate dose would open therapeutic time window expected to prevent and reduce extensive brain damage by providing optimal TBI neuroprotection. Additional therapeutic strategy for TBI, based on calpain modulating actions such as pretreatment with calpain inhibitors has been proposed. Since calpain overexpression has been well established in acute neuronal injury and further subsequent neurodegeneration, from a clinical viewpoint, we speculate that if this hypothesis proves correct pretreatment inhibitors introduction may become a therapeutic option for different brain pathologies to be approached and treated with. (C) 2012 Elsevier Ltd. All rights reserved.	[Bralic, Marina] Clin Hosp Ctr Rijeka, Dept Neurol, Cambierieva 17, Rijeka, Croatia; [Stemberga, Valter] Univ Rijeka, Sch Med, Dept Forens Med & Criminalist, Rijeka, Croatia; [Stifter, Sanja] Univ Rijeka, Sch Med, Dept Pathol, Rijeka, Croatia		Bralic, M (corresponding author), Clin Hosp Ctr Rijeka, Dept Neurol, Cambierieva 17, Rijeka, Croatia.	marina.bralic@yahoo.com		Bralic, Marina/0000-0003-4206-2405; stifter, sanja/0000-0001-8678-5483			Anagli J, 2009, BIOCHEM BIOPH RES CO, V385, P94, DOI 10.1016/j.bbrc.2009.04.141; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Choi SC, 2001, NEUROL RES, V23, P190, DOI 10.1179/016164101101198325; Colak A, 2009, NEUROCIRUGIA, V20, P245; Cox CD, 2008, J NEUROTRAUM, V25, P1355, DOI 10.1089/neu.2008.0671; Frederick JR, 2008, CRIT CARE MED, V36, pS481, DOI 10.1097/CCM.0b013e31818a8ec8; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Kawamura M, 2005, BRAIN RES, V1037, P59, DOI 10.1016/j.brainres.2004.12.050; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	19	6	6	0	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877			MED HYPOTHESES	Med. Hypotheses	SEP	2012	79	3					358	360		10.1016/j.mehy.2012.05.034			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	998UD	WOS:000308265000020	22726623				2022-02-06	
J	Duchesne, JC; Guidry, C; Hoffman, JRH; Park, TS; Bock, J; Lawson, S; Meade, P; Mcswain, NE				Duchesne, Juan C.; Guidry, Chrissy; Hoffman, Jordan R. H.; Park, Timothy S.; Bock, Jiselle; Lawson, Sarah; Meade, Peter; Mcswain, Norman E., Jr.			Low-Volume Resuscitation for Severe Intraopemtive Hemorrhage: A Step in the Right Direction	AMERICAN SURGEON			English	Article							TRAUMATIC BRAIN-INJURY; COMBAT CASUALTY CARE; FRESH-FROZEN PLASMA; FLUID RESUSCITATION; DAMAGE CONTROL; HYDROXYETHYL STARCH; MASSIVE TRANSFUSION; HYPERTONIC SALINE; COAGULATION; SHOCK	The impact on outcomes resulting from crystalloids used with hemostatic close ratio resuscitation (HCRR) in intraoperative hemorrhage (IOH) has not been analyzed. We hypothesize a survival advantage in patients with IOH managed with a low-volume resuscitation (LVR) protocol during HCRR. A 4-year case control study was conducted to determine the impact on mortality of LVR versus conventional resuscitation efforts (CRE) during HCRR. A total of 45 patients managed with a HCRR + LVR protocol (combination Hextend (R) and 3% hypertonic saline) and 55 historical cohorts managed with HCRR + CRE (lactated Ringer's) were included. Patient demographics, number of intraoperative units of packed red blood cells (PRBCs) and fresh-frozen plasma (PEP) received, and FFP:PRBC ratio were similar between groups. The mean intraoperative fluid volume was 0.76 L in the HCRR + LVR group versus 4.7 L in the HCRR + CRE group (P = 0.003). In a linear regression model HCRR + LVR versus HCRR + CRE, mean trauma intensive care unit length of stay was 6 versus 11 days (P = 0.009); 30-day overall mortality was 11.1 versus 32.7 per cent (P = 0.009); perioperative mortality was 2.2 to 10.9 per cent (P = 0.13); and intensive care unit mortality 8.8 to 21.8 per cent (P = 0.07). LVR protocol conveyed a survival benefit to patients undergoing HCRR (odds ratio for mortality, 0.07 [95% confidence interval 0.07-0.54]). This is the first civilian study to analyze the impact of LVR in patients managed with HCRR during IOH. Patients with IOH managed with HCRR and a predefined LVR protocol with Hextend (R) and 3 per cent hypertonic saline had an overall survival advantage and shorter trauma intensive care unit length of stay. LVR can be an effective alternative to CRE when used in combination with HCRR in patients with IOH.	[Duchesne, Juan C.; Guidry, Chrissy; Hoffman, Jordan R. H.; Park, Timothy S.; Bock, Jiselle; Lawson, Sarah; Meade, Peter; Mcswain, Norman E., Jr.] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA		Duchesne, JC (corresponding author), Tulane Univ, Sch Med, Dept Surg & Anesthesia, Sect Trauma & Crit Care Surg,Surg Intens Care Uni, 1430 Tulane Ave,SL 22, New Orleans, LA 70112 USA.	jduchesn@tulane.edu					Aucar JA, 2003, SHOCK, V19, P404, DOI 10.1097/01.shk.0000048905.46342.6b; Avorn J, 2003, CHEST, V124, P1437, DOI 10.1378/chest.124.4.1437; BAXTER CR, 1970, POSTGRAD MED, V48, P95, DOI 10.1080/00325481.1970.11693553; Boldt J, 2002, BRIT J ANAESTH, V89, P722, DOI 10.1093/bja/aef242; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; CARRICO CJ, 1976, CRIT CARE MED, V4, P46, DOI 10.1097/00003246-197603000-00002; Champion HR, 2003, J TRAUMA, V54, pS7, DOI 10.1097/01.TA.0000056154.34788.C6; Cocchi MN, 2007, EMERG MED CLIN N AM, V25, P623, DOI 10.1016/j.emc.2007.06.001; Combat Lifesaver Course, 2006, COMB LIF COURS STUD; Cordts PR, 2008, J TRAUMA, V64, pS14, DOI 10.1097/TA.0b013e31816093bd; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Crookes BA, 2004, J TRAUMA, V57, P547, DOI 10.1097/01.TA.0000135162.85859.4C; DAMON L, 1987, NEW ENGL J MED, V317, P964; DuBose JJ, 2010, J TRAUMA, V68, P1172, DOI 10.1097/TA.0b013e3181d76d40; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Duchesne JC, 2010, J TRAUMA, V69, P46, DOI 10.1097/TA.0b013e3181df91fa; Earle SA, 2007, J AM COLL SURGEONS, V204, P261, DOI 10.1016/j.jamcollsurg.2006.11.014; FELICIANO DV, 1988, ANN SURG, V208, P362, DOI 10.1097/00000658-198809000-00014; Gan TJ, 1999, ANESTH ANALG, V88, P992, DOI 10.1097/00000539-199905000-00005; Gutierrez G, 2004, CRIT CARE, V8, P373, DOI 10.1186/cc2851; Hirshberg A, 2003, J TRAUMA, V54, P454, DOI 10.1097/01.TA.0000053245.08642.1F; Holcomb JB, 2003, J TRAUMA, V54, pS46, DOI 10.1097/01.TA.0000051936.91915.A2; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; Kelly ME, 2003, J TRAUMA, V55, P94, DOI 10.1097/01.TA.0000029042.37577.A6; Ketchum L, 2006, J TRAUMA, V60, pS51, DOI 10.1097/01.ta.0000199432.88847.0c; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; McCammon AT, 2002, ANESTH ANALG, V95, P844, DOI 10.1097/00000539-200210000-00010; Nielsen VG, 2001, ANESTH ANALG, V93, P1106, DOI 10.1097/00000539-200111000-00007; Nunez TC, 2009, J TRAUMA, V66, P346, DOI 10.1097/TA.0b013e3181961c35; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Rizoli SB, 2003, J TRAUMA, V54, pS82, DOI 10.1097/01.TA.0000064525.03761.0C; Roche AM, 2004, BRIT J ANAESTH, V92, pA154, DOI 10.1093/bja/aeh502; Rotondo MF, 1997, SURG CLIN N AM, V77, P761, DOI 10.1016/S0039-6109(05)70582-X; Stahel PF, 2009, INJURY, V40, pS27, DOI 10.1016/j.injury.2009.10.034; Vaid SU, 2006, CRIT CARE MED, V34, P1185, DOI 10.1097/01.CCM.0000207341.78696.3A; Watters JM, 2006, J TRAUMA, V61, P75, DOI 10.1097/01.ta.0000222723.54559.47	38	6	6	0	3	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2012	78	9					936	941					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	101AL	WOS:000315747300006	22964200				2022-02-06	
J	Echemendia, RJ				Echemendia, Ruben J.			Cerebral Concussion in Sport: An Overview	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						Concussion; MTBI; cerebral; neurocognitive; sport	TRAUMATIC BRAIN-INJURY; COMPUTERIZED COGNITIVE ASSESSMENT; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; SEX-DIFFERENCES; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; MONITORING RESOLUTION; UNITED-STATES	Sports-related concussions are ubiquitous in contact and collision sports at all levels of play and across a broad age range. Once thought to be a nuisance injury, it is now recognized that these brain injuries may lead to chronic neurocognitive impairment if not managed properly. This paper provides a broad overview of the research and clinical data that have emerged in this rapidly growing area. Included in the review are discussions of injury definition, pathophysiology, signs and symptoms, epidemiology, potential long-term consequences, assessment, and psychological factors. Issues of prevention and education are discussed in light of further increasing awareness of this injury..	[Echemendia, Ruben J.] Univ Missouri Kansas City, Kansas City, MO 64110 USA; [Echemendia, Ruben J.] Psychol & Neurobehav Associates Inc, State Coll, PA USA		Echemendia, RJ (corresponding author), Univ Missouri Kansas City, Kansas City, MO 64110 USA.		Echemendia, Ruben/R-6939-2019				Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 2001, J ATHL TRAINING, V36, P253; Barth JT, 1989, MILD HEAD INJURY, P257; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Bruce JM, 2004, NEUROLOGY, V63, P1516; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Darby D, 2002, NEUROLOGY, V59, P1042, DOI 10.1212/WNL.59.7.1042; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz K.M., 2009, ORTHOPAEDIC KNOWLEDG; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; HALL ED, 1991, J CEREBR BLOOD F MET, V11, P292, DOI 10.1038/jcbfm.1991.61; Hootman J.M., J ATHLETIC TRAINING, V42, P311; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Okonkwo DO, 2003, CLIN SPORT MED, V22, P467, DOI 10.1016/S0278-5919(02)00107-2; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Povlishock JT, 1996, ACT NEUR S, V66, P81; Povlishock JT, 1999, ACT NEUR S, V73, P15; Prabhu SP, 2011, CLIN SPORT MED, V30, P103, DOI 10.1016/j.csm.2010.09.003; Putukian M, 2003, CLIN SPORT MED, V22, P617, DOI 10.1016/S0278-5919(02)00100-X; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	109	6	6	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	SEP	2012	6	3					207	230		10.1123/jcsp.6.3.207			24	Psychology, Applied	Emerging Sources Citation Index (ESCI)	Psychology	V22SM	WOS:000215041500002					2022-02-06	
J	Feinsod, M; Langer, KG				Feinsod, Moshe; Langer, Karen G.			The Philosopher's Swoon-The Concussion of Michel de Montaigne: A Historical Vignette	WORLD NEUROSURGERY			English	Article						Concussion; Head injury; History of medicine; Jean-Jacques Rousseau; Michel de Montaigne	HOMERS ILIAD; INJURIES; SLEEP; HEAD	The French philosopher Michel Eyquem de Montaigne (1533-1592) sustained a transient loss of consciousness due to a head injury. Montaigne described his concussion as a "swoon," with astutely illustrative details of the symptoms he experienced, including brief loss of consciousness, with apparent (temporary) confusion, and post-traumatic amnesia. His vivid portrayal of the recovery period lends understanding of the process of conscious awakening after his near-death experience. Thanks to his power of introspection and literary talent we may gain insight into the feelings and perceptions of some patients during their recovery from concussion.	[Feinsod, Moshe] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Langer, Karen G.] NYU Langone Med Ctr, NYU Clin Canc Ctr, New York, NY USA		Feinsod, M (corresponding author), Technion Israel Inst Technol, Fac Med, Haifa, Israel.	moshe.feinsod@gmail.com		Langer, Karen G/0000-0001-9931-1383			Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; BOSINELLI M, 1995, BEHAV BRAIN RES, V69, P195, DOI 10.1016/0166-4328(95)00003-C; Cameron PC, 2008, THESIS U ST ANDREWS; DANNENFELDT KH, 1986, J HIST MED ALL SCI, V41, P415, DOI 10.1093/jhmas/41.4.415; de Montaigne Michel, 2009, COMPLETE ESSAYS M DE; Fontoura P, 2009, BRAIN, V132, P296, DOI 10.1093/brain/awn327; Frame DM, 1965, MONTAIGNE BIOGRAPHY; Gioia G, 2006, ACE; Goldhammer, 1985, MONTAIGNE MOTION; Harmon A, 1942, PMLA, V57, P988, DOI DOI 10.2307/458873; Koehler PJ, 2008, BRAIN, V131, P877, DOI 10.1093/brain/awm332; Lavie P., 1996, ENCHANTED WORLD SLEE; Macmillan M, 2010, NEUROPSYCHOL REHABIL, V20, P641, DOI 10.1080/09602011003760527; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; Mylonas AI, 2008, J CRANIO MAXILL SURG, V36, P1, DOI 10.1016/j.jcms.2007.07.010; Panourias IG, 2005, NEUROSURGERY, V57, P181, DOI 10.1227/01.NEU.0000163416.66374.48; Pearce JMS, 2008, EUR NEUROL, V59, P113, DOI 10.1159/000111872; Rousseau J-J, 1782, REVERIES SOLITARY WA; Sapounakis C, 2007, BRIT J ORAL MAX SURG, V45, P112, DOI 10.1016/j.bjoms.2006.04.003; Sorabji R, 2006, SELF ANCIENT MODERN, V313; Taylor GC, 1925, SHAKESPEARES DEBT MO, V29; Taylor JS, 1921, MONTAIGNE MED, P54	22	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750			WORLD NEUROSURG	World Neurosurg.	SEP-OCT	2012	78	3-4					371	374		10.1016/j.wneu.2011.12.007			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	021TK	WOS:000309908100041	22381306				2022-02-06	
J	Fuentes, L; Hernandez, D; Ruiz, P; Blanca, L; Lopez, V; Sola, E; Gutierrez, C; Cabello, M; Burgos, D; Gonzalez-Molina, M; Fernandez-Nebro, A				Fuentes, L.; Hernandez, D.; Ruiz, P.; Blanca, L.; Lopez, V.; Sola, E.; Gutierrez, C.; Cabello, M.; Burgos, D.; Gonzalez-Molina, M.; Fernandez-Nebro, A.			Survival of Lupus Nephritis Patients After Renal Transplantation In Malaga	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	35th Annual Congress of the Italian-Society-of-Organ-Transplantation (SITO)	OCT 27-29, 2011	Rome, ITALY	Italian Soc Organ Transplantat, Cathol Univ Sch Med Policlinico A. Gemelli, Div Organ Transplantat			ERYTHEMATOSUS	Background. Studies have shown that the survival of patients with lupus nephritis (LN) who receive a transplant has results similar to those of nondiabetic control subjects. Objective. The aim of this study was to evaluate the survival of lupus patients who received a transplant at our center, and to determine risk factors for mortality and graft loss. Methods. This case-control (1:2) study comprised patients with chronic kidney disease secondary to LN who received a kidney transplant (n = 32) in the Malaga area from 1985 to 2010. The controls subjects (n = 64) were matched by age, sex, and transplant period. We analyzed graft and patient survivals and risk factors compared with long-term transplant patients without LN. Results. No differences were found in the variables analyzed between groups, except for the most frequent cause of donor death, which was almost significant: stroke in LN and traumatic brain injury in control subjects (P = .05). of the whole study sample, 45% lost the graft, primarily owing to chronic kidney disease (53.5%), followed by vascular thrombosis (16.3%); P = .57. Censored graft losses occurred in 63% of the patients transplanted before 2000, whereas it occurred in 20% of those transplanted after 2000 (P < .001). Censored graft survival was similar between the groups throughout the followup, as was patient survival. Cox regression showed that only acute rejection was associated with a 2-fold increased risk of graft loss. Conclusions. Our lupus transplant population showed no differences in graft or patient survival compared with control subjects. Those patients who received a transplant from 2000 had better results, which may be related to several factors, such as immunosuppression, correction of cardiovascular conditions, or other factors. Risk factors for death and graft loss were similar to the control population.	[Fuentes, L.; Hernandez, D.; Ruiz, P.; Blanca, L.; Lopez, V.; Sola, E.; Gutierrez, C.; Cabello, M.; Burgos, D.; Gonzalez-Molina, M.] Hosp Univ Carlos Haya, Dept Nephrol, Malaga 29010, Spain; [Fernandez-Nebro, A.] Hosp Univ Carlos Haya, Reumatol Dept, Malaga 29010, Spain		Fuentes, L (corresponding author), Hosp Univ Carlos Haya, Dept Nephrol, Malaga 29010, Spain.	laura_fs@live.com	Hernandez, Domingo/R-4041-2019; Fernandez-Nebro, Antonio/K-7628-2012	Hernandez Marrero, Domingo Jeronimo/0000-0001-5469-2119; Fernandez-Nebro, Antonio/0000-0002-2962-9844; Sola, eugenia/0000-0002-9462-3342			Arns W, 2007, NEPHROL DIAL TRANSPL, V22, P336, DOI 10.1093/ndt/gfl637; Burgos PI, 2009, ARTHRITIS RHEUM-US, V60, P2757, DOI 10.1002/art.24776; Chew-Wong A, 2002, REV INVEST CLIN, V54, P21; Grimbert P, 1998, TRANSPLANTATION, V66, P1000, DOI 10.1097/00007890-199810270-00006	4	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345			TRANSPL P	Transplant. Proc.	SEP	2012	44	7					2067	2068		10.1016/j.transproceed.2012.07.063			2	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Immunology; Surgery; Transplantation	011ET	WOS:000309148300070	22974911				2022-02-06	
J	Jackson, AC				Jackson, Alan C.			Is minocycline useful for therapy of acute viral encephalitis?	ANTIVIRAL RESEARCH			English	Article						Minocycline; Viral encephalitis; Encephalomyelitis; Rabies; Rabies virus	REMITTING MULTIPLE-SCLEROSIS; RANDOMIZED-TRIAL; MICROGLIAL ACTIVATION; DOUBLE-BLIND; MULTICENTER; PROSPECTS; ISCHEMIA; DISEASE; INJURY; RABIES	Minocyline is a tetracycline derivative with anti-inflammatory, anti-apoptotic, and anti-oxidant properties. Therapy has proved useful in some experimental models of both noninfectious and infectious neurological diseases and also in clinical trials in humans, including acute traumatic cervical spinal cord injury. In models of viral encephalitis, treatment has shown both beneficial and deleterious effects. In reovirus infection in mice, minocycline delayed the disease, but did not improve either the morbidity or mortality of the disease. In neuroadapted Sindbis virus infection of mice, minocycline prevented disease, but therapy needed to be given before clinical signs were present in most of the animals. In experimental rabies in neonatal mice minocycline aggravated the disease, likely related to anti-inflammatory effects. Minocycline has also been shown to aggravate disease in a mouse model of Huntington disease, in a monkey model of Parkinson disease, and in a mouse model of hypoxic-ischemic brain injury. Hence, there is experimental evidence of benefit of minocycline in both infectious and noninfectious neurological diseases, but there is a lack of benefit and harmful effects in other diseases. This may reflect multiple mechanisms of actions that cannot be predicted in a new disease or in an infection caused by a specific viral agent. Minocycline therapy is a double-edged sword and this drug should not be given empirically to patients with acute viral encephalitis for anticipated neuroprotective effects. Much more work needs to be done in experimental models in animals as well as in clinical trials. Because patient enrollment in clinical trials on acute viral encephalitis has proven to be difficult, funding will be a challenge. (c) 2012 Elsevier B.V. All rights reserved.	[Jackson, Alan C.] Univ Manitoba, Dept Internal Med Neurol, Winnipeg, MB, Canada; [Jackson, Alan C.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada		Jackson, AC (corresponding author), Univ Manitoba, Dept Internal Med Neurol, Winnipeg, MB, Canada.	ajackson2@hsc.mb.ca	Jackson, Alan C/ABD-9312-2020	Jackson, Alan C/0000-0003-0413-4236			Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Chen XH, 2011, J NEUROIMMUNOL, V235, P1, DOI 10.1016/j.jneuroim.2011.04.006; Darman J, 2004, J NEUROSCI, V24, P7566, DOI 10.1523/JNEUROSCI.2002-04.2004; Diguet E, 2004, EUR J NEUROSCI, V19, P3266, DOI 10.1111/j.0953-816X.2004.03372.x; Dutta K, 2011, INDIAN J MED RES, V133, P467; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Irani DN, 2007, J NEUROPATH EXP NEUR, V66, P533, DOI 10.1097/01.jnen.0000263867.46070.e2; Jackson AC, 2007, J VIROL, V81, P6248, DOI 10.1128/JVI.00323-07; Jackson AC, 2011, ADV VIRUS RES, V79, P365, DOI 10.1016/B978-0-12-387040-7.00017-2; Martinez-Torres F, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-40; Metz LM, 2009, MULT SCLER, V15, P1183, DOI 10.1177/1352458509106779; Mishra MK, 2008, J NEUROCHEM, V105, P1582, DOI 10.1111/j.1471-4159.2008.05238.x; Nikodemova M, 2010, J NEUROIMMUNOL, V219, P33, DOI 10.1016/j.jneuroim.2009.11.009; Plane JM, 2010, ARCH NEUROL-CHICAGO, V67, P1442, DOI 10.1001/archneurol.2010.191; Ratai EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010523; Richardson-Burns SM, 2005, EXP NEUROL, V192, P331, DOI 10.1016/j.expneurol.2004.11.015; Sacktor N, 2011, NEUROLOGY, V77, P1135, DOI 10.1212/WNL.0b013e31822f0412; Seukeran DC, 1997, LANCET, V349, P1251, DOI 10.1016/S0140-6736(05)62445-2; Tsuji M, 2004, EXP NEUROL, V189, P58, DOI 10.1016/j.expneurol.2004.01.011; Yang LC, 2003, J NEUROSCI RES, V74, P278, DOI 10.1002/jnr.10709; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zhang Y, 2008, CAN J NEUROL SCI, V35, P185, DOI 10.1017/S0317167100008611; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003	25	6	7	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3542	1872-9096		ANTIVIR RES	Antiviral Res.	SEP	2012	95	3					242	244		10.1016/j.antiviral.2012.06.005			3	Pharmacology & Pharmacy; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Virology	002FM	WOS:000308517500009	22728256				2022-02-06	
J	Leung, GKK; Gloria, KBN; Ho, WD; Hung, KN; Yuen, WK				Leung, Gilberto Ka Kit; Gloria Kwok Bo Ng; Ho, Wendy; Kwan Ngai Hung; Yuen, Wai Kay			Impact of a multidisciplinary trauma team on the outcome of acute subdural haematoma	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma system; Acute subdural haematoma; Traumatic brain injury; Outcome; Hong Kong	SEVERE HEAD-INJURY; BRAIN INJURY; SYSTEM; MORTALITY; SURGEONS	Introduction: To review the outcome of patients with post-traumatic acute subdural haematoma (ASDH) before and after the establishment of a hospital trauma team at a designated trauma centre. Method: A retrospective analysis was conducted on 82 consecutive patients who underwent surgery for post-traumatic ASDH. The 'PRE' and 'POST' groups included patients admitted before and after the establishment of a hospital trauma team, respectively. Injury severity was assessed by the admission Glasgow coma score, imaging findings, and the revised trauma score. Clinical outcome measures were the hospital length of stay and the Glasgow outcome score (GOS) upon hospital discharge. Results: The overall mortality rate was 53.7%. No significant difference was found between the PRE and POST groups. The mean length of hospital stay was also comparable between the two groups. The functional status of those who survived acute hospital care was significantly better in the POST group. Good outcome (GOS of 4 or 5) was achieved in 66.7% of the survivors in the POST group, compared with 25.0% in the PRE group (p = 0.024). Conclusion: Post-traumatic ASDH carried a poor prognosis. The mortality rate and hospital length of stay of patients were not found to be reduced after the establishment of a hospital trauma team. The latter, however, was associated with significantly better functional outcome amongst survivors. Although causality cannot be established due to the multitude of factors which may have affected patient outcome, our findings nonetheless provide further support for the introduction of a multidisciplinary hospital trauma team for the optimal care of trauma patients. (C) 2011 Elsevier Ltd. All rights reserved.	[Leung, Gilberto Ka Kit; Gloria Kwok Bo Ng; Ho, Wendy; Kwan Ngai Hung; Yuen, Wai Kay] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China		Leung, GKK (corresponding author), Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Surg, 102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	gilberto@hkucc.hku.hk	Leung, Gilberto Ka Kit/C-4337-2009	Leung, Gilberto Ka Kit/0000-0003-3147-3057			BERRET C, 1984, SCHWEIZ MED WSCHR, V114, P1093; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Esposito Thomas J, 2006, Adv Surg, V40, P213, DOI 10.1016/j.yasu.2006.06.002; GENTLEMAN D, 1992, INJURY, V23, P471, DOI 10.1016/0020-1383(92)90066-2; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P191, DOI 10.1007/BF01808958; HUNT J, 1995, AUST NZ J SURG, V65, P83, DOI 10.1111/j.1445-2197.1995.tb07266.x; Khan S, 2002, BRAIN INJURY, V16, P537, DOI 10.1080/02699050110119862; Leung GKK, 1999, ANN COLL SURG HONG K, V3, P80; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; NORWOOD S, 1995, J TRAUMA, V39, P240, DOI 10.1097/00005373-199508000-00009; Rainer TH, 2007, RESUSCITATION, V73, P374, DOI 10.1016/j.resuscitation.2006.10.011; Ruchholtz S, 2002, INTENS CARE MED, V28, P1395, DOI 10.1007/s00134-002-1446-8; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; YUE CP, 1983, INJURY, V14, P489, DOI 10.1016/0020-1383(83)90051-7	20	6	8	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	SEP	2012	43	9					1419	1422		10.1016/j.injury.2011.03.017			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	977MK	WOS:000306666100015	21474130				2022-02-06	
J	Najafi, MR; Mehrbod, N				Najafi, Mohammad Reza; Mehrbod, Noushin			Isolated Third Nerve Palsy from Mild Closed Head Trauma	ARCHIVES OF IRANIAN MEDICINE			English	Article						Head trauma; mild; third never palsy	OCULOMOTOR NERVE; INJURY	Head injury is a common occurrence in motor vehicle accidents. There are numerous causes for cranial nerve injury that include head trauma or other lesions. Few studies regarding cranial nerve injury following mild head trauma (GCS: 14 - 15) exist in the literature.(1) The oculomotor nerve is a somatic and visceral motor nerve. When it is completely injured the result is ptosis, pupils that are non-reactive to light and a lack of eye movement. We report the case of a completely isolated oculomotor nerve palsy associated with minor head injury.	[Najafi, Mohammad Reza] Isfahan Univ Med Sci, Alzahra Hosp, Dept Neurol, Esfahan, Iran; [Mehrbod, Noushin] Isfahan Univ Med Sci, Isfahan Neurosci Res Ctr, Esfahan, Iran		Najafi, MR (corresponding author), Isfahan Univ Med Sci, Alzahra Hosp, Dept Neurol, Esfahan, Iran.	Najafi@med.mui.ac.ir		Najafi, Mohammad Reza/0000-0001-7913-7031			Bianchi-Marzoli S, 1997, Curr Opin Ophthalmol, V8, P45, DOI 10.1097/00055735-199712000-00008; Chen CC, 2005, BJ SPORT MED, V39, P34; Elston JS, 1984, ACTA NEURHIR, V68, P528; EYSTER EF, 1972, J AMER MED ASSOC, V220, P1083, DOI 10.1001/jama.220.8.1083; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; HEINZE J, 1969, MED J AUSTRALIA, V2, P1246, DOI 10.5694/j.1326-5377.1969.tb103371.x; Liu Yo-Tsen, 2004, J Chin Med Assoc, V67, P149; MEMON MY, 1971, J NEUROSURG, V35, P461, DOI 10.3171/jns.1971.35.4.0461; Muthu P, 2001, EMERG MED J, V18, P310, DOI 10.1136/emj.18.4.310; NAGASEKI Y, 1989, ACTA NEUROCHIR, V97, P117, DOI 10.1007/BF01772821; Solmons NB, 1980, S AFR MED J, V58, P109; Tiffin PAC, 1996, EYE, V10, P377, DOI 10.1038/eye.1996.77; TOKUNO T, 1995, NEUROL SURG TOKYO, V23, P497	13	6	6	0	6	ACAD MEDICAL SCIENCES I R IRAN	TEHRAN	PO BOX 19395-5655, TEHRAN, 00000, IRAN	1029-2977			ARCH IRAN MED	Arch. Iran. Med.	SEP	2012	15	9					583	584					2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	020YY	WOS:000309853700013	22924380				2022-02-06	
J	O'Dell, KM; Hannay, HJ; Biney, FO; Robertson, CS; Tian, TS				O'Dell, Keira M.; Hannay, H. Julia; Biney, Fedora O.; Robertson, Claudia S.; Tian, T. Siva			The Effect of Blood Alcohol Level and Preinjury Chronic Alcohol Use on Outcome From Severe Traumatic Brain Injury in Hispanics, Anglo-Caucasians, and African-Americans	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blood alcohol level; preinjury alcohol use; racial/ethnic diversity; traumatic brain injury	FUNCTIONAL OUTCOMES; DRINKING PATTERNS; HEAD-INJURY; INTOXICATION; ABUSE; ACCULTURATION; DISABILITY	Objective: To examine (a) ethnic differences in blood alcohol level (BAL) and preinjury chronic alcohol use (PI-ETOH) within a severe closed head injury (CHI) sample and (b) the main and interaction effects of BAL, PI-ETOH, and ethnicity on functional outcome following severe CHI. Participants: A total of 434 Hispanic, Anglo-Caucasian, and African-American individuals with severe CHI. Design: Retrospective cohort study. Setting: Consecutive admissions to a level 1 trauma center. Main measures: After admission to the trauma center, BAL was collected for each patient. Additional information regarding PI-ETOH was collected in a subset of patients (N = 116). Functional outcome was measured using the Disability Rating Scale (DRS) at 6 months after injury. Results: A one-way analysis of variance revealed ethnic differences in mean BAL. Hierarchical multiple regression indicated that BAL did not predict DRS outcomes after controlling for pertinent covariates. An interaction effect between PI-ETOH and ethnicity was observed, such that presence of chronic alcohol use predicted worse functional outcome for Anglo-Caucasians and African-Americans, but more favorable outcome for Hispanics. Conclusions: Ethnic differences in BALs within our severe traumatic brain injury sample mirrored ethnic drinking patterns observed in the general population, with Hispanics having the highest BALs. A paradoxical relationship between PI-ETOH and functional outcome was observed for Hispanics.	[O'Dell, Keira M.; Hannay, H. Julia; Biney, Fedora O.; Tian, T. Siva] Univ Houston, Dept Psychol, Houston, TX 77204 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		O'Dell, KM (corresponding author), Univ Houston, Dept Psychol, 126 Heyne Bldg,4800 Calhoun, Houston, TX 77204 USA.	odellkm@gmail.com		Hannay, H. Julia/0000-0001-7023-912X	National Institutes of Health National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This work was supported by grants from the National Institutes of Health National Institute of Neurological Disorders and Stroke (grant no. P01-NS38660). The authors specially thank the patients and staff of Harris County Hospital District's Ben Taub General Hospital.	Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; Christensen M A, 2001, J Neurosci Nurs, V33, P184; Cohen J., 2013, STAT POWER ANAL BEHA; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Drubach D A, 1993, Md Med J, V42, P989; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Field A., 2017, DISCOVERING STAT USI, V5th; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Hart T, 2007, J HEAD TRAUMA REHAB, V22, P122, DOI 10.1097/01.HTR.0000265100.37059.44; JURKOVICH GJ, 1992, ANN EMERG MED, V21, P704, DOI 10.1016/S0196-0644(05)82783-0; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Labi MLC, 2003, BRAIN INJURY, V17, P265, DOI 10.1080/0269905021000038410; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LEONARD BE, 1995, NEUROCHEM INT, V26, P343, DOI 10.1016/0197-0186(94)00141-G; MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; MENARD S, 1995, SAGE U PAPER SERIES, V7106; Myers R. H., 1990, CLASSICAL MODERN REG; NATH FP, 1986, INJURY, V17, P150, DOI 10.1016/0020-1383(86)90320-7; Neff J, 1986, ALCOHOL ALCOHOLISM, V2, P337; NEFF JA, 1987, HISPANIC J BEHAV SCI, V9, P151, DOI 10.1177/07399863870092004; NEFF JA, 1992, ALCOHOL ALCOHOLISM, V27, P293; NEVO I, 1995, NEUROCHEM INT, V26, P305, DOI 10.1016/0197-0186(94)00139-L; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; STEINBOK P, 1978, NEUROSURGERY, V3, P9, DOI 10.1227/00006123-197807000-00002; Substance Abuse and Mental Health Services Administration, 2005, RES 2002 NAT SURV DR; Tate PS, 1999, BRAIN INJURY, V13, P767; *US CENS BUR, 2008, 2006 2008 AM COMM SU; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397	44	6	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2012	27	5					361	369		10.1097/HTR.0b013e318266735c			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	004OQ	WOS:000308691400090	22955101	Green Accepted			2022-02-06	
J	Ponsford, J; Tweedly, L; Lee, N; Taffe, J				Ponsford, Jennie; Tweedly, Laura; Lee, Nicole; Taffe, John			Who Responds Better? Factors Influencing a Positive Response to Brief Alcohol Interventions for Individuals With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol; brain injury; intervention study; motivational interviewing; predictors; randomized controlled trial; substance use; treatment outcome	SUBSTANCE-ABUSE; CHANGE QUESTIONNAIRE; HOSPITAL ANXIETY; DEPRESSION SCALE; MANAGEMENT; DRINKING; VALIDITY; READINESS	Objective: To investigate variables associated with the frequency and quantity of alcohol consumption following a brief alcohol intervention in individuals with traumatic brain injury. Participants: Initial sample of 60 participants with traumatic brain injury (mean age = 35 years) with preinjury history of alcohol use; of whom, 50 were evaluated at follow-up. Research Design: Randomized controlled trial, stratified for gender, which used a random-effects regression model to examine the association of predictor variables with the frequency and quantity of alcohol use 6 months following a brief alcohol intervention. Main Measures: Alcohol Use Disorders Identification Test; Time Line Follow Back; California Verbal Learning Test-II; Modified Six Elements Test; Readiness to Change Questionnaire; and Hospital Anxiety and Depression Scale. Interventions: Participants received one of the following treatments: informal discussion; discussion plus information; and brief motivational interview plus information. Results: While both intervention groups showed less drinking, the intervention group membership effect was not significant. Being in the action stage of readiness to change was associated with lower drinking frequency and quantity. Higher education and higher levels of depression were associated with increased drinking. Memory and executive function, and heavy preinjury alcohol use, were not significant predictors. Conclusions: These findings support a focus on readiness to change behavior and treatment of depression in addressing alcohol use issues following traumatic brain injury. Treatment efficacy studies in larger samples are needed.	[Ponsford, Jennie; Tweedly, Laura; Taffe, John] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Ponsford, Jennie] Epworth Healthcare, Monash Epworth Rehabil Ctr, Melbourne, Vic, Australia; [Lee, Nicole] Flinders Univ S Australia, Natl Ctr Educ & Training Addict, Adelaide, SA 5001, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu					Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Bombardier CH, 1997, REHABIL PSYCHOL, V42, P259; Burgess P, 1996, BEHAV ASSESSMENT DYS; Carey KB, 2007, J CONSULT CLIN PSYCH, V75, P663, DOI 10.1037/0022-006X.75.4.663; Corrigan JD, 2005, PSYCHOL ADDICT BEHAV, V19, P131, DOI 10.1037/0893-164X.19.2.131; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; HEATHER N, 1993, ADDICTION, V88, P1667, DOI 10.1111/j.1360-0443.1993.tb02042.x; Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Ohio Valley Centre, 1996, US MAN FAST MOR REL; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Searles JS, 2000, PSYCHOL ADDICT BEHAV, V14, P277, DOI 10.1037/0893-164X.14.3.277; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Snaith R., 1994, HOSP ANXIETY DEPRESS; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Todd M, 2009, PSYCHOL ADDICT BEHAV, V23, P205, DOI 10.1037/a0014792; Tweedly L, 2012, J HEAD TRAUMA REHAB, V27, P331, DOI 10.1097/HTR.0b013e318262200a; Vungkhanching M, 2007, J HEAD TRAUMA REHAB, V22, P167, DOI 10.1097/01.HTR.0000271117.19652.98; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007	27	6	6	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2012	27	5					342	348		10.1097/HTR.0b013e318265a576			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	004OQ	WOS:000308691400088	22955099				2022-02-06	
J	Timmons, SD				Timmons, S. D.			An update on traumatic brain injuries	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain injury; Neuroimaging; Genomics; Biological markers	POSITRON-EMISSION-TOMOGRAPHY; SEVERE HEAD-INJURY; STATISTICAL IMAGE-ANALYSIS; DIFFUSE AXONAL INJURY; INTENSIVE-CARE-UNIT; MAGNETIZATION-TRANSFER; FUNCTIONAL MRI; WORKING-MEMORY; INTRAHOSPITAL TRANSPORT; COMBINED MICRODIALYSIS	Severe traumatic brain injury (TBI) represents a major cause of neurological mortality and morbidity throughout the world. Several challenges have been faced in the conduct of clinical research in TBI in past decades, including inclusion of a broad heterogeneity of injuries, difficulties with standardization and consistency of complex medical management, and lack of sophisticated outcomes measures to sufficiently detect differences in outcomes. Consequently, evidencebased guidelines for targeted therapeutic approaches remain for the most part at the level of Class II or III evidence. Harnessing the power of computing is paramount to our understanding of different prognostic groups in order to devise treatments of the future. Multimodality bedside monitoring of various physiological parameters and events can be deployed in the intensive care unit (ICU) but better data repositories and analytics are required. Recent developments in neuroimaging and definition of potential genetic and biological markers in TBI are also aiding in the subcategorization of patients into finer diagnostic and prognostic groups. Using mathematical prediction models incorporating the plethora of data gathered, future research will provide means of tailoring therapies to individuals based upon best evidence in populations similar to them, and according to their own biological and physiological situation.	Geisinger Hlth Syst, Dept Neurosurg, Danville, PA 17821 USA		Timmons, SD (corresponding author), Geisinger Hlth Syst, Dept Neurosurg, 100 N Acad Ave, Danville, PA 17821 USA.	stimmons@mac.com					Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Atighechi S, 2009, AM J RHINOL ALLERGY, V23, P409, DOI 10.2500/ajra.2009.23.3345; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Braga LW, 2007, J CHILD NEUROL, V22, P1084, DOI 10.1177/0883073807306246; BRATTON SL, 2007, J NEUROTRAUM, V24, P705; Carlson AP, 2012, J NEUROIMAGING, V22, P408, DOI 10.1111/j.1552-6569.2011.00621.x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Doring B L, 1999, J Neurosci Nurs, V31, P80; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Hattori N, 2009, J NUCL MED, V50, P1054, DOI 10.2967/jnumed.108.060368; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Herr DL, 2000, INTENS CARE MED, V26, pS452, DOI 10.1007/PL00003789; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Hutchinson P, 2009, ACTA NEUROCHIR, V151, P51, DOI 10.1007/s00701-008-0169-1; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jian X, 2009, BRAIN INJURY, V23, P445, DOI 10.1080/02699050902838157; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Karunanayaka PR, 2007, NEUROREHABILITATION, V22, P355; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kawai N, 2008, ACTA NEUROCHIR SUPPL, V102, P241, DOI 10.1007/978-3-211-85578-2_46; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P63, DOI 10.1097/WNF.0b013e31816f1bc1; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kumar R, 2003, MAGN RESON IMAGING, V21, P893, DOI 10.1016/S0730-725X(03)00189-9; Lahner D, 2007, WIEN KLIN WOCHENSCHR, V119, P412, DOI 10.1007/s00508-007-0813-4; LaRovere KL, 2012, NEUROCRIT CARE, V16, P251, DOI 10.1007/s12028-011-9627-3; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lombardi F, 2008, EUR J ANAESTH, V25, P131, DOI 10.1017/S0265021507003316; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Masaryk Thomas, 2008, Radiol Manage, V30, P50; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; Mehrazin M, 2011, HELL J NUCL MED, V14, P243; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Niogi SN, 2007, NEUROIMAGE, V35, P166, DOI 10.1016/j.neuroimage.2006.10.040; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Ozturk E, 2005, PROG NEURO-PSYCHOPH, V29, P920, DOI 10.1016/j.pnpbp.2005.04.028; Ozturk E, 2008, PROG NEURO-PSYCHOPH, V32, P81, DOI 10.1016/j.pnpbp.2007.07.016; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Peace K, 2011, J NEUROSURG, V114, P1479, DOI 10.3171/2010.11.JNS091148; Peace K, 2010, J NEUROSCI NURS, V42, P109, DOI 10.1097/JNN.0b013e3181ce5c5b; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Rising C J, 1993, J Neurosci Nurs, V25, P302; Robertson CS, 2011, J NEUROTRAUM, V28, P727, DOI 10.1089/neu.2010.1476; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rumboldt Z, 2009, AM J NEURORADIOL, V30, P1630, DOI 10.3174/ajnr.A1603; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; SCALFANI MT, 2011, J CRIT CARE; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Sun XC, 2008, CHIN J TRAUMATOL, V11, P247, DOI 10.1016/S1008-1275(08)60051-6; Timmons SD, 2010, CRIT CARE MED, V38, pS431, DOI 10.1097/CCM.0b013e3181ec57ab; TISDALL MM, 2011, NEUROCRIT CARE; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Turner H B, 1988, J Neurosci Nurs, V20, P236; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Wagner AK, 2010, EPILEPSY RES, V90, P259, DOI 10.1016/j.eplepsyres.2010.06.001; Wiese H, 2006, NEUROIMAGE, V30, P1292, DOI 10.1016/j.neuroimage.2005.11.012; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; Wong SBC, 2006, PROG BRAIN RES, V157, P173, DOI 10.1016/S0079-6123(06)57011-6; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Xiao FR, 2011, COMPUT BIOL MED, V41, P756, DOI 10.1016/j.compbiomed.2011.06.011; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	110	6	6	0	12	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	SEP	2012	56	3					191	202					12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	157JP	WOS:000319892700003	22854587				2022-02-06	
J	Walsh, ES; Post, A; Rousseau, P; Kendall, M; Karton, C; Oeur, A; Foreman, S; Hoshizaki, TB				Walsh, Evan S.; Post, Andrew; Rousseau, Philippe; Kendall, Marshall; Karton, Clara; Oeur, Anna; Foreman, Scott; Hoshizaki, Thomas B.			Dynamic impact response characteristics of a helmeted Hybrid III headform using a centric and non-centric impact protocol	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Linear acceleration; angular acceleration; mild traumatic brain injury; centric and non-centric test protocol; ice hockey; helmet; Hybrid III	ICE HOCKEY; INJURIES	A linear impactor system was used to apply a condensed version of the University of Ottawa Test Protocol, employing five centric and non-centric impact conditions, to a Hybrid III headform fitted with six certified ice hockey helmets. None of the helmeted conditions exceeded linear acceleration thresholds for traumatic or mild traumatic brain injury; however, five of the six helmets had angular acceleration results that were above the 80% risk of mild traumatic brain injury threshold proposed by Zhang et al. High risk of mild traumatic brain injury was associated with non-centric impact conditions and peak angular accelerations, supporting the need for improved three-dimensional helmet certification standards.	[Walsh, Evan S.; Post, Andrew; Rousseau, Philippe; Kendall, Marshall; Karton, Clara; Oeur, Anna; Foreman, Scott; Hoshizaki, Thomas B.] Univ Ottawa, Neurotrauma Impact Sci Lab, Ottawa, ON K1N 6N5, Canada		Walsh, ES (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, 200 Lees Ave, Ottawa, ON K1N 6N5, Canada.	ewals056@uottawa.ca		Post, Andrew/0000-0002-5960-5552	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [Engage EGP404844-10]	This work was supported by the Natural Sciences and Engineering Research Council of Canada [Engage EGP404844-10].	American Society for Testing and Materials, 10PF1045072007 ASTM; BISHOP PJ, 1976, ERGONOMICS, V19, P451, DOI 10.1080/00140137608931557; Canadian Standard Association, Z2621092009 CANCSA; COULSON NR, 2009, J ASTM INT, V6; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Foreman SG, 2011, THESIS U OTTAWA CANA; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gurdjian ES, 1975, IMPACT HEAD INJURY M; Holbourn AHS, 1943, LANCET, V2, P438; King AI, 2003, IRCOBI C LISB PORT; Oeur A, 2011, INT SOC BIOM C JUL B; Padagaonkar A. J., 1975, J APPL MECH, V42, P552; Post A, 2011, INT SOC BIOM C JUL B; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P89, DOI 10.1243/17543371JSET34; Rousseau P, 2009, INT SOC BIOM SPORTS; Sim F H, 1978, Am J Sports Med, V6, P378, DOI 10.1177/036354657800600612; Walsh ES, 2010, PROCEDIA ENGINEER, V2, P3487, DOI 10.1016/j.proeng.2010.04.202; Walsh ES, 2009, INT SOC BIOM SPORTS; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	22	6	6	2	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371			P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP-DEC	2012	226	P3-4			SI		220	225		10.1177/1754337112442299			6	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	999NH	WOS:000308320000009					2022-02-06	
J	Ko, SB; Choi, HA; Lee, K				Ko, Sang-Bae; Choi, H. Alex; Lee, Kiwon			Clinical Syndromes and Management of Intracerebral Hemorrhage	CURRENT ATHEROSCLEROSIS REPORTS			English	Article						Intracerebral hemorrhage; Clinical symptom; Syndrome; Onset; Hypertension; Amyloid angiopathy	CEREBRAL AMYLOID ANGIOPATHY; THALAMIC HEMORRHAGE; STROKE REGISTRY; SURGICAL TRIAL; HEAD-INJURY; BRAIN; SEIZURES; COMPLICATIONS; SURGERY; LESIONS	Spontaneous intracerebral hemorrhage (ICH) is a devastating disease with high morbidity and mortality. Acutely, ICH is associated with a sudden surge in intracranial pressure (ICP), as the volume of hematoma increases the pressure in the closed head, leading to non-specific symptoms of ICP: headache, nausea, vomiting, and alterations in consciousness. In the early phase, damage to the brain tissues surrounding the hematoma causes progression of neurologic symptoms. Expansion of supratentorial ICHs may result in transtentorial herniation, causing mental status deterioration and loss of pupillary light reflex. Compared to ischemic stroke, seizure is more common in ICH.	[Choi, H. Alex; Lee, Kiwon] Columbia Univ Coll Phys & Surg, Div Crit Care Neurol, Dept Neurol, New York, NY 10032 USA; [Ko, Sang-Bae] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea		Lee, K (corresponding author), Columbia Univ Coll Phys & Surg, Div Crit Care Neurol, Dept Neurol, Milstein Hosp Bldg 8 Ctr,177 Ft Washington Ave, New York, NY 10032 USA.	KL2356@columbia.edu		Ko, Sang-Bae/0000-0002-9429-9597	Ministry of Health & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [A102065]	This study was supported in part by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A102065).	Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Caplan LR, 2009, CAPLANS STROKE CLIN; Choi KD, 2004, ARCH NEUROL-CHICAGO, V61, P417, DOI 10.1001/archneur.61.3.417; Chowdhury F, 2010, TURK NEUROSURG, V20, P314, DOI 10.5137/1019-5149.JTN.3052-10.2; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; De Herdt V, 2011, NEUROLOGY, V77, P1794, DOI 10.1212/WNL.0b013e31823648a6; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Elijovich L, 2008, SEMIN NEUROL, V28, P657, DOI 10.1055/s-0028-1105974; Fernandes HM, 2000, STROKE, V31, P2511, DOI 10.1161/01.STR.31.10.2511; FLOHR H, 1991, THEOR PSYCHOL, V1, P245, DOI 10.1177/0959354391012006; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; FUH JL, 1995, CLIN NEUROL NEUROSUR, V97, P296, DOI 10.1016/0303-8467(95)00059-S; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; HUGENHOLTZ H, 1987, CHILD NERV SYST, V3, P266, DOI 10.1007/BF00271820; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Jensen MB, 2005, ARCH NEUROL-CHICAGO, V62, P537, DOI 10.1001/archneur.62.4.537; KENNEDY M, 1994, APHASIOLOGY, V8, P303, DOI 10.1080/02687039408248662; Ko SB, 2010, NEUROLOGIST, V16, P384, DOI 10.1097/NRL.0b013e3181b1cdff; KUMRAL E, 1995, STROKE, V26, P964, DOI 10.1161/01.STR.26.6.964; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; LUDLOW CL, 1987, ANN NEUROL, V22, P60, DOI 10.1002/ana.410220114; MANDYBUR TI, 1986, J NEUROPATH EXP NEUR, V45, P79, DOI 10.1097/00005072-198601000-00007; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Melo TP, 1996, NEUROLOGY, V47, P494, DOI 10.1212/WNL.47.2.494; Mendelow AD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-124; Mendelow AD, 2005, LANCET, V365, P387; MOHR JP, 1978, NEUROLOGY, V28, P754, DOI 10.1212/WNL.28.8.754; Morgan T, 2008, ACTA NEUROCHIR SUPPL, V105, P147; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Naff N, 2011, STROKE, V42, P3009, DOI 10.1161/STROKEAHA.110.610949; Newell DW, 2011, J NEUROSURG, V115, P592, DOI 10.3171/2011.5.JNS10505; Pamela JH, 2001, AM J MED, V111, P106; Qureshi AI, 2010, CRIT CARE MED, V38, P637, DOI 10.1097/CCM.0b013e3181b9e1a5; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; ROPPER AH, 1980, ANN NEUROL, V8, P141, DOI 10.1002/ana.410080203; Rosand J, 2005, ANN NEUROL, V58, P459, DOI 10.1002/ana.20596; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Russell C, 2010, BRAIN, V133, P1239, DOI 10.1093/brain/awq052; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; TAKEBAYASHI S, 1983, STROKE, V14, P28, DOI 10.1161/01.STR.14.1.28; TIJSSEN CC, 1994, STROKE, V25, P1516, DOI 10.1161/01.STR.25.7.1516; TORREALBA G, 1987, J NEUROL NEUROSUR PS, V50, P1539, DOI 10.1136/jnnp.50.11.1539; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; VINTERS HV, 1983, STROKE, V14, P924, DOI 10.1161/01.STR.14.6.924; Viswanathan A, 2011, ANN NEUROL, V70, P871, DOI 10.1002/ana.22516	51	6	8	0	6	CURRENT MEDICINE GROUP	PHILADELPHIA	400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA	1523-3804			CURR ATHEROSCLER REP	Curr. Atherosclerol. Rep.	AUG	2012	14	4					307	313		10.1007/s11883-012-0251-2			7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	968BT	WOS:000305952700003	22538430				2022-02-06	
J	Geiger, G; Aliyev, RM				Geiger, G.; Aliyev, R. M.			Whiplash injury as a function of the accident mechanism Neuro-otological differential diagnostic findings	UNFALLCHIRURG			German	Article						Neurootology; Whiplash injury; Accident mechanism; Linear injury mechanism; Rotational injury mechanism		Depending on the type of collision, car occupants who are involved in traffic accidents are often exposed to the unexpected effects on the cervical spine of traumatic stimuli from different directions. In a rear-end collision or a frontal collision of the car it is most likely that there is an effect of linear acceleration and a lateral or side impact acceleration of axial rotation on the cervical spine. The neuro-otological manifestations of whiplash injuries that can occur in response to various trauma mechanisms have not yet been sufficiently investigated. Method: Data from 64 patients who suffered a whiplash injury were selected for analysis. In 32 patients the trauma mechanism was a sudden action on the cervical spine from a linear impulse caused by a head-on collision of cars or rear-end collision. In the other 32 patients the trauma mechanism was a sudden action of an axial neck rotation at a side impact collision or a cross collision. The study compared the results of neuro-otological findings between the two patient groups. A comparison of the neuro-otological examination data of 64 patients revealed that there were 32 patients who had a sudden injury mechanism of cervical axial rotation, the prevalence of central vestibular and sensory impairments, such as pathological central nystagmus disinhibition, pathological changes in the auditory brainstem evoked potentials (ABEP), the auditory evoked cortical potentials (ALEP) and visual evoked potentials (VEP). In the second group of patients where the injury mechanism consisted of an unexpected linear momentum, peripheral vestibular and sensory disorders were predominant. The observed differences in neuro-otological manifestations of whiplash trauma, which occur depending on the trauma mechanism, can be used for differential diagnostic purposes. The whiplash injuries of the cervical spine induced by an axial rotation acceleration showed a prevalence of central vestibular and sensory disturbances, while the whiplash injuries of the cervical spine induced by a linear acceleration showed a prevalence of peripheral vestibular, sensory and vestibulospinal disorders. Our data thus show in the first group of patients a prevalence of retrocochlear, supratentorial and subcortical lesions of the auditory tract, and brain lesions of the optic tract in the occipital pole and in the visual cortex.	[Geiger, G.] Fachklin Med Rehabil Reinhardtshohe, D-34537 Bad Wildungen, Germany; [Aliyev, R. M.] Univ Duisburg Essen, Klin Orthopadie & Unfallchirurg, Marienhosp Gelsenkirchen, Akad Krankenhaus, Gelsenkirchen, Germany		Geiger, G (corresponding author), Fachklin Med Rehabil Reinhardtshohe, Quellenstr 8-12, D-34537 Bad Wildungen, Germany.	dr.geiger@klinik-reinhardshoehe.de; rauf.aliyev@gmx.de					BALLA JI, 1980, AUST NZ J SURG, V50, P610, DOI 10.1111/j.1445-2197.1980.tb04207.x; Claussen CF, 1994, 32 DEUTSCH VERK 1994, P234; Claussen CF, 1999, HWS SCHLEUDERTRAUMA; DELANK HW, 1988, UNFALLCHIRURG, V91, P381; Geiger G, 2000, THESIS U WURZBURG; Haasper C, 2010, UNFALLCHIRURG, V113, P366, DOI 10.1007/s00113-010-1778-8; Hiilse M, 1991, LARYN RHINOL OTOL, V70, P599; Holly A, 2006, MANUELLE THER, V10, P135, DOI 10.1055/s-2006-926921; Kandziora F, 2010, UNFALLCHIRURG, V11, P931; MERTZ HJ, 1967, P 11 STAPP CAR CRASH; Reinhold M, 2006, UNFALLCHIRURG, P471; Richter M, 2000, AKT TRAUMATOL S6, V30, P230; Sakata E, 1996, NEUROOTOLOGY NEWSLET, V2, P21; Saternus K S, 1982, Aktuelle Traumatol, V12, P4; Sellier KA, 1963, HEFTE UNFALLHEILKD, V76; Siegmund GP, 2009, TRAFFIC INJ PREV, V10, P101, DOI 10.1080/15389580802593269; Volle E, 1999, HWS SCHLEUDERTRAUMA, P34; Wolff H D, 1982, ZFA (Stuttgart), V58, P509; Wolff HD, 1997, MANUELLE MED, V35	19	6	6	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	JUL	2012	115	7					629	634		10.1007/s00113-011-2151-2			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	975XJ	WOS:000306544700009	22481629				2022-02-06	
J	Hadian, MR; Yekaninejad, MS; Salehin, F; Razavi, SHE; Javidan, AN; Pakpour, AH; Saberi, H; Safa, P				Hadian, Mohammad Reza; Yekaninejad, Mir Saeed; Salehin, Forough; Razavi, Seyed Hasan Emami; Javidan, Abbas Norouzi; Pakpour, Amir H.; Saberi, Hooshang; Safa, Parivash			Cross-cultural adaptation and reliability evaluation of Iranian version of Functional Assessment Measure in spinal cord injury patients	NEUROLOGIA I NEUROCHIRURGIA POLSKA			English	Article						spinal cord injury; outcome assessment; rehabilitation; validity; reliability	QUALITY-OF-LIFE; TRAUMATIC BRAIN INJURY; DISABILITY	Background and purpose: The aim of this study was to translate and validate the Iranian version of the Functional Assessment Measure (FAM) among patients with spinal cord injury (SCI). Material and methods: Two hundred patients with SCI participated in this study. A convenience sampling approach was used for selection of the patients. The PAM was translated into Persian language and then independently translated back into English. The reliability of the FAM was assessed by test-retest methods with a 14-day interval for interrater reliability. Intraclass correlation coefficient (ICCs) was calculated and interrater reliability and intrarater reliability were assessed. Results: The mean age of the patients was 35.7 years (SD, 7.2) and 86% of patients were male.The Cronbach alpha coefficient for both raters was above 0.70. Intrarater reliability of the Iranian version of the PAM ranged from good to excellent agreement. The highest level of intrirater reliability was observed for Community mobility (ICC = 0.93). There was good to excellent agreement for interrater reliability of the PAM. The PAM could differentiate between subgroups of patients based on the level of injury but not for the time elapsed from the injury. Conclusions: Based on the results of this study, the Iranian version of the FAM (FAM-Ir) was highly valid and reliable for evaluation of functional ability in patients with SCI. Therefore, we would suggest that the FAM could also be used as an assessment tool for SCI patients.	[Hadian, Mohammad Reza; Yekaninejad, Mir Saeed; Salehin, Forough; Razavi, Seyed Hasan Emami; Javidan, Abbas Norouzi; Saberi, Hooshang] Univ Tehran Med Sci, Imam Khomeini Hosp, Brain & Spinal Injury Res Ctr BASIR, Tehran, Iran; [Hadian, Mohammad Reza] Univ Tehran Med Sci, Fac Rehabil, Dept Postgrad Studies, Tehran, Iran; [Yekaninejad, Mir Saeed] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Pakpour, Amir H.] Qazvin Univ Med Sci, Dept Publ Hlth, Qazvin, Iran; [Saberi, Hooshang] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Neurosurg, Tehran, Iran; [Safa, Parivash] Tarbiat Modares Univ, Fac Humanity Sci, Tehran, Iran		Hadian, MR (corresponding author), TUMS IC, Imam Khomeini Hosp, Brain & Spinal Injury Res Ctr, Blvd Keshavarz, Tehran 147885, Iran.	hadianrs@sina.tums.ac.ir	Pakpour, Amir H./C-6160-2014; rasanani, Mohammad Reza Hadian/AAB-6593-2020; Yekaninejad, Mir Saeed/L-6752-2016; razavi, seyed hadi/AAS-4842-2021	Pakpour, Amir H./0000-0002-8798-5345; Yekaninejad, Mir Saeed/0000-0003-3648-5276; Hadian, Mohammad Reza/0000-0002-1558-2731	Brain and Spinal Injury Research Center (BASIR); Tehran University of Medical Sciences (TUNIS)	This study was supported by a grant from the Brain and Spinal Injury Research Center (BASIR), Tehran University of Medical Sciences (TUNIS). We acknowledge the generous assistance of the staff and colleagues in BASIR and TUMS-IC.	Alcott D, 1997, DISABIL REHABIL, V19, P355, DOI 10.3109/09638289709166551; Barker RN, 2009, SPINAL CORD, V47, P149, DOI 10.1038/sc.2008.82; Bartko JJ, 1996, PSYCHOL REP, V19, P3; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Blanes L, 2009, QUAL LIFE RES, V18, P15, DOI 10.1007/s11136-008-9411-9; Go B.K., 1995, SPINAL CORD INJURY C, P21; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hu Y, 2008, J REHABIL MED, V40, P126, DOI 10.2340/16501977-0150; Jamroz-Wisniewska A, 2011, NEUROL NEUROCHIR POL, V45, P235; Johnson RL, 1996, SPINAL CORD, V34, P470, DOI 10.1038/sc.1996.81; Jorge LL, 2011, INT J REHABIL RES, V34, P89, DOI 10.1097/MRR.0b013e32833ba55f; Lidal IB, 2008, SPINAL CORD, V46, P710, DOI 10.1038/sc.2008.17; Linn R T, 1999, J Outcome Meas, V3, P339; McPherson KM, 1997, INT J REHABIL RES, V20, P1, DOI 10.1097/00004356-199703000-00001; Middleton J, 2007, ARCH PHYS MED REHAB, V88, P1643, DOI 10.1016/j.apmr.2007.09.001; Rabeh SAN, 2010, ACTA PAUL ENFERM, V23, P321, DOI 10.1590/S0103-21002010000300002; Ng YS, 2007, ANN ACAD MED SINGAP, V36, P3; Rahimi-Movaghar V, 2009, J SPINAL CORD MED, V32, P428, DOI 10.1080/10790268.2009.11754572; Tesio L, 1998, J Outcome Meas, V2, P79; TurnerStokes L, 1997, CLIN REHABIL, V11, P306, DOI 10.1177/026921559701100407; [No title captured]	21	6	6	0	2	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	WENEDOW ST 9-1, POZNAN, 61-614, POLAND	0028-3843			NEUROL NEUROCHIR POL	Neurol. Neurochir. Pol.	JUL-AUG	2012	46	4					351	356		10.5114/ninp.2012.30268			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016CK	WOS:000309494700006	23023434				2022-02-06	
J	Hu, XQ; Li, Y; Hu, ZY; Rudd, JA; Ling, SC; Jiang, FZ; Davies, H; Fang, MR				Hu, Xueqing; Li, Yan; Hu, Zhiying; Rudd, John A.; Ling, Shucai; Jiang, Fangzhen; Davies, Henry; Fang, Marong			The alteration of 5-HT2A and 5-HT2C receptors is involved in neuronal apoptosis of goldfish cerebellum following traumatic experience	NEUROCHEMISTRY INTERNATIONAL			English	Article						Posttraumatic stress disorder; 5-HT2A receptor; 5-HT2C receptor; Apoptosis; Cerebellum; Anxiety; Doxepin; Fluoxetine	POSTTRAUMATIC-STRESS-DISORDER; C-FOS; REUPTAKE INHIBITION; CARASSIUS-AURATUS; MESSENGER-RNA; RAT-BRAIN; EXPRESSION; SEROTONIN; PERFORMANCE; BALANCE	5-HT receptor changes remain controversial in posttraumatic stress disorder (PTSD) models. This study looks at the relationship between traumatic injuries and the alterations in 5-HT2A and 5-HT2C receptors in the goldfish brain. The effect of treatment with doxepin and fluoxetine, known to be selective serotonin reuptake inhibitor (SSRI) antidepressants, on 5-HT receptor expression in goldfish with fin ablation was also investigated. We demonstrated that fin ablation induced anxiety-like behavioural alterations and significant up-regulation of c-fos expression in goldfish cerebellum. The behavioural alterations correlated well with an increased expression of 5-HT2A receptors in the cerebellum of the fish with traumatic injury. An increase in the number of apoptotic cells and a higher caspase-8 protein level was present in the brains of goldfish with fin ablation compared to the control. Our findings suggest that neuronal apoptosis occured in the cerebellum as a result of fin ablation and may be related to the alterations of 5-HT2A and 5-HT2c levels and that the beneficial clinical effects of doxepin/fluoxetine treatment are due to the down-regulation of 5-HT2A and up-regulation of 5-HT2C receptors in the brain. (c) 2012 Elsevier Ltd. All rights reserved.	[Li, Yan; Ling, Shucai; Fang, Marong] Zhejiang Univ, Coll Med, Inst Anat & Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Xueqing; Jiang, Fangzhen] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Div Plast & Reconstruct Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Zhiying] Hangzhou Red Cross Hosp, Dept Obstet & Gynaecol, Hangzhou, Zhejiang, Peoples R China; [Rudd, John A.] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China		Fang, MR (corresponding author), Zhejiang Univ, Coll Med, Inst Anat & Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China.	huxueqing@zju.edu.cn; yanlee20@126.com; huzhiyingf@yeah.net; jar@cuhk.edu.hk; lingshucai@zju.edu.cn; 9308260@qq.com; henrydavies2002@yahoo.ie; fangmaro@zju.edu.cn	Rudd, John A./R-6603-2018	Rudd, John A./0000-0002-8316-0792; Davies, Henry/0000-0002-8341-3585; Hu, Zhiying/0000-0003-2084-1010	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171240]; Foundation of Zhejiang Province Education [Y201017466]	This work was supported by the National Natural Science Foundation of China (No. 81171240) and the Foundation of Zhejiang Province Education (No. Y201017466). We thank JianYin Huang for assistance in the statistic analysis of data.	Alves SH, 2004, BEHAV PHARMACOL, V15, P37, DOI 10.1097/00008877-200402000-00005; Appierto V, 2004, CELL DEATH DIFFER, V11, P270, DOI 10.1038/sj.cdd.4401349; Balaban CD, 1998, J VESTIBUL RES-EQUIL, V8, P7; Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6; Balaban CD, 1999, CURR OPIN NEUROL, V12, P29, DOI 10.1097/00019052-199902000-00005; Bienvenu OJ, 2011, CURR PSYCHIAT REP, V13, P3, DOI 10.1007/s11920-010-0166-y; Bohnert KM, 2011, INT J METH PSYCH RES, V20, pE1, DOI 10.1002/mpr.331; Bosch TJ, 2001, J COMP NEUROL, V439, P306, DOI 10.1002/cne.1352; Bremner J. Douglas, 2006, CNS & Neurological Disorders-Drug Targets, V5, P503; Briski K, 2001, BRAIN RES BULL, V55, P401, DOI 10.1016/S0361-9230(01)00532-9; Butler A.B., 2002, NEUROSCI LETT, V93, P95; Challet E, 1997, BRAIN RES, V770, P228, DOI 10.1016/S0006-8993(97)00796-8; Cohen H, 2006, ANN NY ACAD SCI, V1071, P335, DOI 10.1196/annals.1364.026; Contestabile A, 1998, EXP BRAIN RES, V120, P519, DOI 10.1007/s002210050426; Copuroglu C, 2010, ACTA ORTHOP BELG, V76, P90; Ding JL, 2010, J PSYCHIATR RES, V44, P48, DOI 10.1016/j.jpsychires.2009.06.001; Dwivedi Y, 2005, NEUROPHARMACOLOGY, V48, P204, DOI 10.1016/j.neuropharm.2004.10.004; Ebrahimzadeh Mohammad H, 2007, J Foot Ankle Surg, V46, P429, DOI 10.1053/j.jfas.2007.08.011; Fan J, 2010, NEUROSCI LETT, V473, P196, DOI 10.1016/j.neulet.2010.02.045; Giraldez-Perez RM, 2009, J CHEM NEUROANAT, V37, P1, DOI 10.1016/j.jchemneu.2008.08.004; Haack D, 2008, NEUROSCI LETT, V438, P290, DOI 10.1016/j.neulet.2008.04.070; Harvey BH, 2004, ANN NY ACAD SCI, V1032, P267, DOI 10.1196/annals.1314.035; Harvey BH, 2003, BRAIN RES, V983, P97, DOI 10.1016/S0006-8993(03)03033-6; Hasegawa K, 1998, BRAIN RES, V785, P262, DOI 10.1016/S0006-8993(97)01410-8; Jason T.P., 2008, MOL CELL ENDOCRINOL, V293, P43; Krystal JH, 2009, BRAIN RES, V1293, P13, DOI 10.1016/j.brainres.2009.03.044; Leonard BE., 2003, FUNDAMENTALS PSYCHOP; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Norihcutt R.G., 1995, BRAIN BEHAV ECOL, V46, P275; Olson VG, 2011, BIOL PSYCHIAT, V70, P441, DOI 10.1016/j.biopsych.2010.11.029; PETER RE, 1975, J COMP NEUROL, V159, P69, DOI 10.1002/cne.901590106; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; POPOVICI T, 1990, BRAIN RES, V536, P183, DOI 10.1016/0006-8993(90)90024-6; Pritchard AL, 2008, NEUROBIOL AGING, V29, P341, DOI 10.1016/j.neurobiolaging.2006.10.011; RAMAEKERS JG, 1995, BRIT J CLIN PHARMACO, V39, P397, DOI 10.1111/j.1365-2125.1995.tb04468.x; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4; Riedel WJ, 2005, J PSYCHOPHARMACOL, V19, P12, DOI 10.1177/0269881105048887; Rinaman L, 2003, J NEUROSCI, V23, P10084; Schmitt JAJ, 2002, J PSYCHOPHARMACOL, V16, P207, DOI 10.1177/026988110201600303; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Sziray N, 2007, BRAIN RES BULL, V71, P376, DOI 10.1016/j.brainresbull.2006.10.006; Van Oekelen D, 2003, LIFE SCI, V72, P2429, DOI 10.1016/S0024-3205(03)00141-3; VIRGILI M, 1992, NEUROPHARMACOLOGY, V31, P469, DOI 10.1016/0028-3908(92)90085-4; Wingen M, 2007, PSYCHOPHARMACOLOGY, V190, P391, DOI 10.1007/s00213-006-0614-x; Wozniak G, 2011, MED SCI MONITOR, V17, pRA205, DOI 10.12659/MSM.881924	46	6	7	2	26	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186			NEUROCHEM INT	Neurochem. Int.	JUL	2012	61	2					207	218		10.1016/j.neuint.2012.04.022			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	991HH	WOS:000307691600009	22561958				2022-02-06	
J	Vink, R; Byard, RW				Vink, Robert; Byard, Roger W.			Alcohol Intoxication May Exacerbate the Effects of Blunt Cranial Trauma Through Changes in Brain Free Magnesium Levels	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; alcohol; blunt cerebral trauma; traumatic brain injury; magnesium; intoxication; death	INTRACELLULAR FREE MAGNESIUM; HEMORRHAGIC-SHOCK; IN-VIVO; HEAD TRAUMA; INJURY; RATS; ETHANOL; MODEL; DEFICIENCY; DAMAGE	Moderate to high levels of alcohol decrease brain intracellular free magnesium concentration, a factor known to be critical in brain injury. Phosphorus magnetic resonance spectroscopy was used to examine changes to brain free magnesium concentration after blunt cranial trauma in alcohol-intoxicated rats. Rats exposed acutely or chronically to alcohol sufficient to increase blood alcohol levels to between 150 and 350 mg/dL demonstrated a brain free magnesium level that was 2050% less than in nonintoxicated animals (p < 0.01). After injury, brain free magnesium levels declined more rapidly and to a greater extent in alcohol-affected animals than in nonintoxicated control animals (p < 0.001). As both preinjury depletion of magnesium and degree of magnesium decline after brain injury have been associated with poor recovery, these findings suggest that moderate to severe alcohol intoxication may predispose the brain to a worse outcome by reducing brain free magnesium levels, both before and after injury.	[Vink, Robert; Byard, Roger W.] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Sch Med Sci, Adelaide, SA 5005, Australia		Byard, RW (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Sch Med Sci, Frome Rd, Adelaide, SA 5005, Australia.	roger.byard@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Byard, Roger/0000-0002-0524-5942			Altura B. M., 1992, Magnesium and Trace Elements, V10, P122; Altura BM, 1998, ALCOHOL, V15, P181, DOI 10.1016/S0741-8329(97)00107-9; Altura BM, 1998, ALCOHOL, V15, P113, DOI 10.1016/S0741-8329(97)00105-5; Bara M., 1984, MAGNESIUM, V3, P212; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Byard RW, 2007, PEDIATR DEVEL PATHOL, V10, P348, DOI 10.2350/06-08-0154.1; Byard Roger W, 2009, Leg Med (Tokyo), V11 Suppl 1, pS128, DOI 10.1016/j.legalmed.2009.02.001; Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak I, 2004, J CEREBR BLOOD F MET, V24, P564, DOI 10.1097/00004647-200405000-00011; Collins MA, 1998, FASEB J, V12, P221, DOI 10.1096/fasebj.12.2.221; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Genetta T, 2007, J NEUROSCI RES, V85, P131, DOI 10.1002/jnr.21067; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Heath DL, 1999, MAGNESIUM RES, V12, P269; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kodikara S, 2007, Forensic Sci Med Pathol, V3, P283, DOI 10.1007/s12024-007-0041-2; LAMBLIN F, 1993, ALCOHOL ALCOHOLISM, V28, P639; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; Milovanovic AV, 1999, AM J FOREN MED PATH, V20, P6, DOI 10.1097/00000433-199903000-00002; MULLINS PGM, 1995, NEUROREPORT, V6, P1633, DOI 10.1097/00001756-199508000-00011; Muneer PMA, 2011, PSYCHOPHARMACOLOGY, V214, P707, DOI 10.1007/s00213-010-2076-4; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; RAMSAY DA, 1995, AM J FOREN MED PATH, V16, P107, DOI 10.1097/00000433-199506000-00004; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; SMOLEN TN, 1989, ALCOHOL, V6, P33, DOI 10.1016/0741-8329(89)90070-0; Sun H, 2008, BRAIN RES, V1194, P73, DOI 10.1016/j.brainres.2007.11.061; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; Vink R, 1996, J NEUROCHEM, V66, P2477; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7; Zink BJ, 2001, ALCOHOL CLIN EXP RES, V25, P916; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983	43	6	7	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198			J FORENSIC SCI	J. Forensic Sci.	JUL	2012	57	4					979	982		10.1111/j.1556-4029.2012.02108.x			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	967HE	WOS:000305896700018	22372670				2022-02-06	
J	Wu, JCC; Chen, KY; Yu, YW; Huang, SW; Shih, HM; Chiu, WT; Chiang, YH; Shiau, CY				Wu, John Chung-Che; Chen, Kai-Yun; Yu, Yu-Wen; Huang, Song-Wei; Shih, Hsiu-Ming; Chiu, Wen-Ta; Chiang, Yung-Hsiao; Shiau, Chia-Yang			Location and Level of Etk Expression in Neurons Are Associated with Varied Severity of Traumatic Brain Injury	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MEDIATED CYTOSKELETAL DEGRADATION; CALPAIN INHIBITOR MDL-28170; CORTICAL IMPACT INJURY; OXIDATIVE DAMAGE; SERUM MARKERS; PROTEIN; ENOLASE; PEROXYNITRITE; BIOMARKER	Background: Much recent research effort in traumatic brain injury (TBI) has been devoted to the discovery of a reliable biomarker correlating with severity of injury. Currently, no consensus has been reached regarding a representative marker for traumatic brain injury. In this study, we explored the potential of epithelial/endothelial tyrosine kinase (Etk) as a novel marker for TBI. Methodology/Principal Findings: TBI was induced in Sprague Dawley (SD) rats by controlled cortical impact. Brain tissue samples were analyzed by Western blot, Q-PCR, and immunofluorescence staining using various markers including glial fibrillary acidic protein, and epithelial/endothelial tyrosine kinase (Etk). Results show increased Etk expression with increased number and severity of impacts. Expression increased 2.36 to 7-fold relative to trauma severity. Significant upregulation of Etk appeared at 1 hour after injury. The expression level of Etk was inversely correlated with distance from injury site. Etk and trauma/inflammation related markers increased post-TBI, while other tyrosine kinases did not. Conclusion/Significance: The observed correlation between Etk level and the number of impacts, the severity of impact, and the time course after impact, as well as its inverse correlation with distance away from injury site, support the potential of Etk as a possible indicator of trauma severity.	[Wu, John Chung-Che; Shiau, Chia-Yang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Wu, John Chung-Che] Taitung Christian Hosp, Taitung, Taiwan; [Wu, John Chung-Che; Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chen, Kai-Yun; Yu, Yu-Wen; Chiang, Yung-Hsiao] Coll Med Sci & Technol, Neural Regenerat Program, Taipei, Taiwan; [Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan; [Chen, Kai-Yun; Yu, Yu-Wen; Huang, Song-Wei; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Shih, Hsiu-Ming] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chiu, Wen-Ta] Minist Hlth, Taipei, Taiwan		Wu, JCC (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	ychiang@tmu.edu.tw; cys@ndmctsgh.edu.tw	Shih, Hsiu-Ming/S-7023-2018	YU, YU-WEN/0000-0002-7279-2532	Taipei Medical University-Shuang Ho Hospital [100TMU-SHH-12]; National Taipei University of Technology-Taipei Medical University [NTUT-TMU-100-08]; Center of Excellence for Clinical Trial and Research in Neurology Neurosurgery [DOH99-TD-B-111-003]; National Science CouncilMinistry of Science and Technology, Taiwan [NSC98-2314-B038-011-MY3]; Cheng-Hsin Research [100-23]	Funding provided by Taipei Medical University-Shuang Ho Hospital 100TMU-SHH-12, National Taipei University of Technology-Taipei Medical University NTUT-TMU-100-08, Center of Excellence for Clinical Trial and Research in Neurology & Neurosurgery DOH99-TD-B-111-003, and National Science Council Grant NSC98-2314-B038-011-MY3, Cheng-Hsin Research Grant 100-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Cekic M, 2012, RESTORATIVE NEUROLOG; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen KY, 2011, CELL TRANSPLANTATION; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Das A, 2008, J PINEAL RES, V45, P117, DOI 10.1111/j.1600-079X.2008.00582.x; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gyorgy AB, 2011, J NEUROTRAUMA; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Jasielska M, 2010, INVEST OPHTH VIS SCI, V51, P3874, DOI 10.1167/iovs.09-5003; Kasahara Y, 2010, BRAIN RES, V1340, P70, DOI 10.1016/j.brainres.2010.03.101; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Paavonen K, 2004, MOL BIOL CELL, V15, P4226, DOI 10.1091/mbc.E04-03-0241; Palmer CD, 2008, BLOOD, V111, P1781, DOI 10.1182/blood-2007-07-102343; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Rothoerl RD, 2000, ACTA NEUROCHIR, V142, P199, DOI 10.1007/s007010050024; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Samantaray S, 2008, J PINEAL RES, V44, P348, DOI 10.1111/j.1600-079X.2007.00534.x; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Sribnick EA, 2006, J NEUROSCI RES, V84, P1064, DOI 10.1002/jnr.21016; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Wang Y, 1997, J NEUROSCI, V17, P4341; Woertgen C, 2002, ACT NEUR S, V81, P205; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Yu CG, 2008, J NEUROTRAUM, V25, P833, DOI 10.1089/neu.2007.0490; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhou P, 2012, J NEUROSCI, V32, P583, DOI 10.1523/JNEUROSCI.2849-11.2012; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39226	10.1371/journal.pone.0039226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	WOS:000305583300118	22723969	gold, Green Submitted, Green Published			2022-02-06	
J	Chaves, C; Trzesniak, C; Derenusson, GN; Araujo, D; Wichert-Ana, L; Machado-de-Sousa, JP; Carlotti, CG; Nardi, AE; Zuardi, AW; Crippa, JAD; Hallak, JEC				Chaves, Cristiano; Trzesniak, Clarissa; Derenusson, Guilherme Nogueira; Araujo, David; Wichert-Ana, Lauro; Machado-de-Sousa, Joao Paulo; Carlotti, Carlos Gilberto, Jr.; Nardi, Antonio E.; Zuardi, Antonio W.; Crippa, Jose Alexandre de S.; Hallak, Jaime E. C.			Late-onset social anxiety disorder following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; neuroimaging; neuropsychiatric	PSYCHIATRIC MORBIDITY; POSTTRAUMATIC-STRESS; PHOBIA; SCALE; NEUROBIOLOGY; SKULL; PTSD	Background: Neuropsychiatric sequelae are the predominant long-term disability after traumatic brain injury (TBI). This study reports a case of late-onset social anxiety disorder (SAD) following TBI. Case report: A patient that was spontaneous and extroverted up to 18-years-old started to exhibit significant social anxiety symptoms. These symptoms became progressively worse and he sought treatment at age 21. He had a previous history of traumatic brain injury (TBI) at age 17. Neuroimaging investigations (CT, SPECT and MRI) showed a bony protuberance on the left frontal bone, with mass effect on the left frontal lobe. He had no neurological signs or symptoms. The patient underwent neurosurgery with gross total resection of the lesion and the pathological examination was compatible with intradiploic haematoma. Conclusions: Psychiatric symptoms may be the only findings in the initial manifestation of slowly growing extra-axial space-occupying lesions that compress the frontal lobe from the outside. Focal neurological symptoms may occur only when the lesion becomes large. This case report underscores the need for careful exclusion of general medical conditions and TBI history in cases of late-onset SAD and may also contribute to the elucidation of the neurobiology of this disorder.	[Chaves, Cristiano; Trzesniak, Clarissa; Derenusson, Guilherme Nogueira; Araujo, David; Wichert-Ana, Lauro; Machado-de-Sousa, Joao Paulo; Carlotti, Carlos Gilberto, Jr.; Zuardi, Antonio W.; Crippa, Jose Alexandre de S.; Hallak, Jaime E. C.] USP, Dept Neurosci & Behav, Ribeirao Preto Med Sch, BR-14025048 Ribeirao Preto, SP, Brazil; [Chaves, Cristiano; Trzesniak, Clarissa; Derenusson, Guilherme Nogueira; Machado-de-Sousa, Joao Paulo; Nardi, Antonio E.; Zuardi, Antonio W.; Crippa, Jose Alexandre de S.; Hallak, Jaime E. C.] Univ Fed Rio de Janeiro, Inst Translat Med INCT TM, Rio De Janeiro, Brazil; [Nardi, Antonio E.] Univ Fed Rio de Janeiro, Pan & Respirat Lab, Inst Psychiat, Rio De Janeiro, Brazil		Hallak, JEC (corresponding author), USP, Dept Neurociencias & Ciencias Comportamento, FMRP, Av Bandeirantes 3900, BR-14025048 Ribeirao Preto, SP, Brazil.	jhallak@fmrp.usp.br	Carlotti, Carlos G/C-1608-2012; Nardi, Antonio E/A-7335-2014; Zuardi, Antonio W/B-6078-2016; Hallak, Jaime E C/J-3547-2012; de Souza Crippa, Jose Alexandre/A-1215-2008; Chaves, Cristiano/AAN-9977-2021; Machado-de-Sousa, Joao Paulo/H-2969-2012; Wichert-Ana, Lauro/C-8373-2012	Carlotti, Carlos G/0000-0002-7055-0564; Nardi, Antonio E/0000-0002-2152-4669; Machado-de-Sousa, Joao Paulo/0000-0002-2141-8487; Wichert-Ana, Lauro/0000-0003-2059-5120; Trzesniak, Clarissa/0000-0002-7552-9959			Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlsson G, 2010, CHILD NERV SYST, V26, P105, DOI 10.1007/s00381-009-0984-6; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Collimore KC, 2010, DEPRESS ANXIETY, V27, P1017, DOI [10.1002/da.20728, 10.1002/da.20771, 10.1002/da.20759]; Connor KM, 2000, BRIT J PSYCHIAT, V176, P379, DOI 10.1192/bjp.176.4.379; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; Gupta RK, 2004, AUST NZ J PSYCHIAT, V38, P316, DOI 10.1111/j.1440-1614.2004.01357.x; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kupchik M, 2007, DEPRESS ANXIETY, V24, P244, DOI 10.1002/da.20189; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Mathew SJ, 2006, J CLIN PSYCHIAT, V67, P9; MAURICEWILLIAMS RS, 1988, BMJ-BRIT MED J, V296, P1785, DOI 10.1136/bmj.296.6639.1785; Mennin DS, 2002, J ANXIETY DISORD, V16, P661, DOI 10.1016/S0887-6185(02)00134-2; Mobbs RJ, 2000, SURG NEUROL, V54, P87, DOI 10.1016/S0090-3019(00)00263-9; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Otto MW, 2001, DEPRESS ANXIETY, V14, P209, DOI 10.1002/da.1068; Rytwinski NK, 2009, DEPRESS ANXIETY, V26, P34, DOI 10.1002/da.20503; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Zayfert C, 2005, J NERV MENT DIS, V193, P93, DOI 10.1097/01.nmd.0000152795.47479.d9	25	6	6	0	15	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2012	26	6					882	886		10.3109/02699052.2012.666373			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500010	22583179				2022-02-06	
J	Kim, MD; Park, JH; Lee, CI; Kang, NR; Ryu, JS; Jeon, BH; Kim, KW; Bahk, WM; Yoon, BH; Won, S; Lee, JH; Kim, DS; Hong, SC				Kim, Moon-Doo; Park, Joon-Hyuk; Lee, Chang-In; Kang, Na-Ri; Ryu, Jae-Sung; Jeon, Bong-Hee; Kim, Ki-Woong; Bahk, Won-Myong; Yoon, Bo-Hyun; Won, Seunghee; Lee, Jun Hwa; Kim, Duk-Soo; Hong, Seong-Chul			Prevalence of Dementia and Its Correlates among Participants in the National Early Dementia Detection Program during 2006-2009	PSYCHIATRY INVESTIGATION			English	Article						Dementia; Prevalence; Correlates; MMSE-KC	EURODEM POOLED ANALYSES; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RISK-FACTORS; HEAD-INJURY; DEPRESSIVE SYMPTOMS; COGNITIVE RESERVE; MENTAL-HEALTH; OLDER-PEOPLE; COMMUNITY	Objective To investigate the prevalence of dementia and its correlates among people with poor socioeconomic status, poor social support systems, and poor performance on the Korean version of the Mini-Mental Status Exam (MMSE-KC). Methods We used 2006-2009 data of the National Early Dementia Detection Program (NEDDP) conducted on Jeju Island. This program included all residents >65 years old who were receiving financial assistance. We examined those who performed poorly (standard deviation from the norm of <-1.5) on the MMSE-KC administered as part of the NEDDP, using age-, gender-, and education-adjusted norms for Korean elders. A total of 1708 people were included in this category. Results The prevalence of dementia in this group was 20.5%. Multivariate logistic regression analysis revealed that the following factors were statistically significantly associated with dementia: age of 80 or older, no education, nursing home residence, and depression. Conclusion The prevalence of dementia is very high among those with lower MMSE-KC scores, and significant correlates include older age, no education, living in a nursing home, and depression. Enhancing lifetime education to improve individuals' cognitive reserves by providing intellectually challenging activities, encouraging living at home rather than in a nursing home, and preventing and treating depression in its early phase could reduce the prevalence of dementia in this population. Psychiatry Investig 2012;9:134-142	[Kim, Moon-Doo; Park, Joon-Hyuk; Lee, Chang-In; Kang, Na-Ri; Ryu, Jae-Sung; Jeon, Bong-Hee] Jeju Natl Univ, Sch Med, Dept Psychiat, Cheju 690756, South Korea; [Kim, Moon-Doo; Park, Joon-Hyuk; Lee, Chang-In; Kang, Na-Ri; Ryu, Jae-Sung; Jeon, Bong-Hee; Hong, Seong-Chul] Jeju Natl Univ, Sch Med, Inst Med Sci, Cheju 690756, South Korea; [Kim, Ki-Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea; [Bahk, Won-Myong] Catholic Univ Korea, Dept Psychiat, Coll Med, Seoul, South Korea; [Yoon, Bo-Hyun] Naju Natl Hosp, Dept Psychiat, Naju, South Korea; [Won, Seunghee] Kyungpook Natl Univ Hosp, Dept Psychiat, Taegu, South Korea; [Lee, Jun Hwa] Sungkyunkwan Univ, Sch Med, Dept Pediat, Samsung Changwon Hosp, Chang Won, South Korea; [Kim, Duk-Soo] Jeju Natl Univ, Coll Nat Sci, Dept Chem, Cheju 690756, South Korea; [Hong, Seong-Chul] Jeju Natl Univ, Sch Med, Dept Prevent Med, Cheju 690756, South Korea		Kim, MD (corresponding author), Jeju Natl Univ, Sch Med, Dept Psychiat, 15 Aran 13 Gil, Cheju 690756, South Korea.	mdkim66@jejunu.ac.kr	Kim, Ki Woong/D-5801-2012	Kim, Ki Woong/0000-0002-1103-3858; PARK, JOON HYUK/0000-0002-0396-5284; Lee, Jun Hwa/0000-0001-9717-3677	Hyocheon Academic Research Fund of the Cheju National University	This work was supported by the research grant from the Hyocheon Academic Research Fund of the Cheju National University in 2009.	Alzheimer's Association, 2010, Alzheimers Dement, V6, P158, DOI 10.1016/j.jalz.2010.01.009; American Psychiatric Association, 1994, DIAGN CRIT DSM 4; Bac JN, 2004, J PSYCHOSOM RES, V57, P297, DOI 10.1016/j.jpsychores.2004.01.004; Berger AK, 1999, NEUROLOGY, V53, P1998, DOI 10.1212/WNL.53.9.1998; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Chen PJ, 1999, ARCH GEN PSYCHIAT, V56, P261, DOI 10.1001/archpsyc.56.3.261; De Deyn PP, 2011, CLIN NEUROL NEUROSUR, V113, P736, DOI 10.1016/j.clineuro.2011.07.030; Devanand DP, 1996, ARCH GEN PSYCHIAT, V53, P175; Doraiswamy PM, 2002, J GERONTOL A-BIOL, V57, pM173, DOI 10.1093/gerona/57.3.M173; ERNST RL, 1994, AM J PUBLIC HEALTH, V84, P1261, DOI 10.2105/AJPH.84.8.1261; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Gureje O, 2011, J AM GERIATR SOC, V59, P869, DOI 10.1111/j.1532-5415.2011.03374.x; GUSSEKLOO J, 1995, J NEUROL NEUROSUR PS, V59, P507, DOI 10.1136/jnnp.59.5.507; Hamid TA, 2010, DEMENT GERIATR COGN, V30, P533, DOI 10.1159/000321672; Hartman RE, 2002, J NEUROSCI, V22, P10083; Jeon GS, 2007, J GERONTOL B-PSYCHOL, V62, pS323, DOI 10.1093/geronb/62.5.S323; Jorm AF, 2001, AUST NZ J PSYCHIAT, V35, P776, DOI 10.1046/j.1440-1614.2001.00967.x; KANG IO, 2005, ANAL SOCIOECONOMIC C; Kim JM, 2003, INT J GERIATR PSYCH, V18, P331, DOI 10.1002/gps.834; Kim KW, 2011, J ALZHEIMERS DIS, V23, P279, DOI 10.3233/JAD-2010-101221; Kim MD, 2009, GERONTOLOGY, V55, P106, DOI 10.1159/000176300; *KOR STAT OFF, POP PROJ KOR 2005; Korea Statistics Office, INT MIGR STAT 2005; Krishnaswamy S, 1997, NEUROL J SE ASIA, V2, P159; Kua E. H., 1993, Singapore Medical Journal, V34, P26; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lee DY, 2004, J INT NEUROPSYCH SOC, V10, P72, DOI 10.1017/s1355617704101094; Lee DY, 2002, J AM GERIATR SOC, V50, P1233, DOI 10.1046/j.1532-5415.2002.50310.x; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; Letenneur L, 2000, AM J EPIDEMIOL, V151, P1064, DOI 10.1093/oxfordjournals.aje.a010149; Lobo A, 2005, EUR J PSYCHIAT, V19, P40; Martin P JJ, 2009, GLOBAL PREVALENCE DE, P25; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mortimer JA, 2003, J CLIN EXP NEUROPSYC, V25, P671, DOI 10.1076/jcen.25.5.671.14584; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Ngandu T, 2007, NEUROLOGY, V69, P1442, DOI 10.1212/01.wnl.0000277456.29440.16; OECD (Organisation for Economic Co-operation and Development), 2005, EC SURV KOR 2005; PALLEY ML, 1990, ASIAN SURV, V30, P1136, DOI 10.1525/as.1990.30.12.00p0003h; Poddar K, 2011, ANN INDIAN ACAD NEUR, V14, P164, DOI 10.4103/0972-2327.85874; RABBITT P, 1995, PSYCHOL AGING, V10, P307, DOI 10.1037/0882-7974.10.3.307; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Richards SR SS, 2009, COMPREHENSIVE TXB PS, P1167; Roe CM, 2007, NEUROLOGY, V68, P223, DOI 10.1212/01.wnl.0000251303.50459.8a; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Sorensen S, 2006, LANCET NEUROL, V5, P961, DOI 10.1016/S1474-4422(06)70599-3; Statistics Korea, 2005, REP POP HOUS CENS, P7; STERN Y, 1995, ANN NEUROL, V37, P590, DOI 10.1002/ana.410370508; Stern Y, 2003, J CLIN EXP NEUROPSYC, V25, P589, DOI 10.1076/jcen.25.5.589.14571; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Suh GH, 2002, J KOREAN GERIATR PSY, V6, P79; TERI L, 1992, J CONSULT CLIN PSYCH, V60, P379, DOI 10.1037/0022-006X.60.3.379; *UN, WORLD POP PROSP 2006; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; Wilson RS, 2002, NEUROLOGY, V59, P364, DOI 10.1212/WNL.59.3.364; Wimo A, 2003, ALZ DIS ASSOC DIS, V17, P63, DOI 10.1097/00002093-200304000-00002; Youn J.C., 2005, PSYCHIAT INVEST, V2, P28; [No title captured]	62	6	6	0	8	KOREAN NEUROPSYCHIATRIC ASSOC	SEOUL	RN 522, G-FIVE CENTRAL PLAZA 1685-8 SEOCHO 4-DONG, SEOCHO-GU, SEOUL, 137-882, SOUTH KOREA	1738-3684	1976-3026		PSYCHIAT INVEST	Psychiatry Investig.	JUN	2012	9	2					134	142		10.4306/pi.2012.9.2.134			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	961DW	WOS:000305445100006	22707963	hybrid, Green Published, Green Submitted			2022-02-06	
J	McBride, DW; Hsu, MS; Rodgers, VGJ; Binder, DK				McBride, Devin W.; Hsu, Mike S.; Rodgers, Victor G. J.; Binder, Devin K.			Improved survival following cerebral edema using a novel hollow fiber-hydrogel device	JOURNAL OF NEUROSURGERY			English	Article						cytotoxic edema; vasogenic edema; hollow fiber-hydrogel device; mouse	TRAUMATIC BRAIN-INJURY; BOVINE SERUM-ALBUMIN; INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; OSMOTIC-PRESSURE; SALINE; MANNITOL; MICE	Object. Cerebral edema is a significant cause of morbidity and mortality in many disease states. Current therapies of cerebral edema are often ineffective in treating severe edema. Here, the authors develop a hollow fiber-hydrogel device (HFHD) for direct surface contact based treatment of severe cerebral edema. Methods. Brain edema was induced in adult mice via water intoxication by intraperitoneal water administration (30% body weight). Control mice received no treatment. A distinct group of mice was treated with craniectomy but no device application (craniectomy only). A third experimental group was treated with craniectomy and HFHD application. The HFHD contained a lumen solution of 350 g/L bovine serum albumin in room-temperature artificial CSF at pH 7.4. Survival and brain water content were assessed as end points. Results. Craniectomy and application of the HFHD enhanced survival in animals with severe cerebral edema. Animals treated with a craniectomy and HFHD (n = 5) survived up to 5 hours longer than animals treated with craniectomy only (n = 5) (p < 0.001) or no treatment (n = 5) (p < 0.001). Animals treated with craniectomy and HFHD (n = 5) had a survival rate of 80% within the observation period (360 minutes), whereas no animal treated with craniectomy only (n = 5) or no treatment (n = 5) survived longer than 50 and 33 minutes, respectively. Statistical significance was observed for the survival rate between the animals treated with a craniectomy + HFHD (n = 5) versus those treated with craniectomy only (n = 5) (p < 0.001), and craniectomy + HFHD versus no treatment (n = 5) (p < 0.001). Histological analysis demonstrated no significant cell loss in the cortex subjacent to HFHD application. Conclusions. Here, the authors demonstrate the feasibility of their HFHD to treat cerebral edema in this model. These results indicate that controlled water extraction from edematous brain tissue can be performed and can lead to increased survival compared with craniectomy only. Further studies remain to be performed to further optimize the HFHD and to test it in more clinically relevant models, such as traumatic brain injury. (http://thejns.org/doi/abs/10.3171/2012.2.JNS111540)	[Hsu, Mike S.; Binder, Devin K.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Hsu, Mike S.; Binder, Devin K.] Univ Calif Riverside, Ctr Glial Neuronal Interact, Riverside, CA 92521 USA; [McBride, Devin W.; Rodgers, Victor G. J.] Univ Calif Riverside, Grp B2K, Biotransport & Bioreact Kinet Grp, Dept Bioengn, Riverside, CA 92521 USA; [McBride, Devin W.; Rodgers, Victor G. J.] Univ Calif Riverside, Ctr Bioengn Res, Riverside, CA 92521 USA		Binder, DK (corresponding author), Univ Calif Riverside, Div Biomed Sci, 1247 Webber Hall, Riverside, CA 92521 USA.	dbinder@ucr.edu	McBride, Devin/A-7214-2013; Rodgers, Victor G. J./AAF-3838-2021; Rodgers, Victor G/G-3652-2016	McBride, Devin/0000-0001-8988-3353; Rodgers, Victor G. J./0000-0002-1857-8025; Rodgers, Victor G/0000-0002-1857-8025	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-059674]; NSF IGERTNational Science Foundation (NSF) [DGE 0903667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS059674] Funding Source: NIH RePORTER	This work was supported by NIH K08 Grant No. NS-059674 to Devin K. Binder. Devin W. McBride was supported by an NSF IGERT Video Bioinformatics Fellowship (Grant No. DGE 0903667). This device and its applications are described in a provisional patent application (#61/555,351) submitted by the authors and the University of California, Riverside. There is no commercial support at this time.	BINGAMAN WE, 1995, NEUROL CLIN, V13, P479, DOI 10.1016/S0733-8619(18)30031-8; Castillo LB, 2009, CRIT CARE RESUSC, V11, P151; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CSENKER E, 1982, ARCH PSYCHIAT NERVEN, V231, P251, DOI 10.1007/BF00343295; Gill AS, 2011, J NEUROSURG, V114, P470, DOI 10.3171/2010.2.JNS091017; Hariri R J, 1994, Neurosurg Clin N Am, V5, P687; Kettenmann H., 2005, NEUROGLIA, V2nd ed.; Keyrouz SG, 2008, NEUROCRIT CARE, V9, P204, DOI 10.1007/s12028-008-9118-3; Marmarou A, 2003, ACT NEUR S, V86, P7; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; VILKER VL, 1981, J COLLOID INTERF SCI, V79, P548, DOI 10.1016/0021-9797(81)90106-5; Yousef MA, 1998, J COLLOID INTERF SCI, V207, P273, DOI 10.1006/jcis.1998.5789; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	17	6	6	0	10	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUN	2012	116	6					1389	1394		10.3171/2012.2.JNS111540			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	945RP	WOS:000304294000035	22462505				2022-02-06	
J	Pickering, A; Grundy, K; Clarke, A; Townend, W				Pickering, Alastair; Grundy, Kathryn; Clarke, Andrea; Townend, Will			A cohort study of outcomes following head injury among children and young adults in full-time education	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; EARLY INTERVENTION; SYMPTOMS; EPIDEMIOLOGY; PREDICTORS; DISABILITY; PEOPLE; IMPACT; SCALE	Objective To estimate the prevalence of post-concussive symptoms (PCS) following head injury among adolescents in full-time education and to identify prognostic factors at presentation to the emergency department (ED) that may predict the development of PCS. Methods An observational cohort study of all head injured patients aged 13-21 and in full-time education presenting to an inner city ED was performed. Subjects were followed up at 1 and 6 months after injury by structured telephone interview to assess for the presence of symptoms or ongoing disability. Presentation data of those identified as having PCS underwent regression analysis to isolate potential prognostic indicators for such problems. Results Of the 188 patients recruited, 5.9% (95% CI 3.3% to 10.2%) still had some symptoms after 6 months, with half of these claiming that such symptoms were affecting everyday living. Of these patients, 82% were assaulted as the cause of their injury and nearly 40% had no conventional indicators of head injury severity at presentation. After 1 month, 46/188 (24.5%, 95% CI 18.9% to 31.1%) patients had some degree of symptoms, most of whom were discharged directly from the ED. Potential prognostic indicators identified were a reduced Glasgow Coma Score (GCS) (<15) at presentation and being assaulted as the cause of injury. Conclusion The prevalence of PCS 6 months following head injury for the selected sub-group was 5.9%, and 10.6% if assaulted. Most patients who developed PCS were discharged directly from the ED.	[Pickering, Alastair] ScHARR, Sheffield S1 4DA, S Yorkshire, England; [Grundy, Kathryn; Clarke, Andrea; Townend, Will] Hull & E Yorkshire Hosp NHS Trust, Emergency Dept, Kingston Upon Hull, N Humberside, England		Pickering, A (corresponding author), ScHARR, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England.	a.pickering@sheffield.ac.uk			British Association of Emergency Medicine	The authors would like to acknowledge the financial support of the British Association of Emergency Medicine towards research support staff in Hull.	Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hodgkinson D W, 1994, Eur J Emerg Med, V1, P9, DOI 10.1097/00063110-199403000-00003; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1975, LANCET, V1, P480; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; NICE, 2003, HEAD INJ TRIAG ASS I; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; SHEPHERD JP, 1990, BRIT MED J, V301, P849, DOI 10.1136/bmj.301.6756.849; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	24	6	6	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JUN	2012	29	6					451	454		10.1136/emj.2010.094755			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	964KN	WOS:000305693500004	21617161				2022-02-06	
J	Tanoue, K; Matsui, K; Nozawa, K; Aida, N				Tanoue, Koji; Matsui, Kiyoshi; Nozawa, Kumiko; Aida, Noriko			Predictive value of early radiological findings in inflicted traumatic brain injury	ACTA PAEDIATRICA			English	Article						Inflicted traumatic brain injury; Neuroimaging; Non-accidental head trauma; Outcome; Shaken baby syndrome	SHAKEN BABY SYNDROME; NONACCIDENTAL HEAD-INJURY; CHILD-ABUSE; IMPACT SYNDROME; YOUNG-CHILDREN; CT FINDINGS; SHAKING; TOMOGRAPHY; SEVERITY; INFANTS	Aim: The aim of this study was to evaluate the value of early radiological investigations in predicting the long-term neurodevelopmental outcome of patients with inflicted traumatic brain injury (ITBI). Methods: In 28 patients with ITBI, radiological investigations were performed during the acute phase of injury (03 days) and during the early post-injury phase (4 days to 1 month). The clinical outcome in survivors (n = 24) was based on the Glasgow Outcome Score. Results: Four of 28 infants died and five were severely disabled. Six infants had moderate disability. Detection of changes in the basal ganglia (p < 0.000005) or brainstem (p < 0.01), diffuse oedema (p < 0.005), transtentorial herniation (p < 0.01), subarachnoid haemorrhage (p < 0.05) or parenchymal injury (p < 0.05) by neuroimaging during the first 3 days, and detection of changes in the basal ganglia (p < 0.0005) or brainstem (p < 0.05) or parenchymal injury (p < 0.01) during 1 month were significantly associated with poor long-term outcome. Conclusion: Radiological findings during the first month were significantly associated with the long-term outcome. Especially, basal ganglia lesions were associated with a poor outcome.	[Tanoue, Koji] Kanagawa Childrens Med Ctr, Dept Gen Med, Minami Ku, Yokohama, Kanagawa 2328555, Japan; [Nozawa, Kumiko; Aida, Noriko] Kanagawa Childrens Med Ctr, Dept Radiol, Yokohama, Kanagawa 2328555, Japan		Tanoue, K (corresponding author), Kanagawa Childrens Med Ctr, Dept Gen Med, Minami Ku, 2-138-4 Mutukawa, Yokohama, Kanagawa 2328555, Japan.	ktanoue@kcmc.jp					ALEXANDER R, 1990, AM J DIS CHILD, V144, P724, DOI 10.1001/archpedi.1990.02150300124032; ALEXANDER RC, 1986, J PEDIATR-US, V109, P975, DOI 10.1016/S0022-3476(86)80279-7; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; BALL WS, 1989, RADIOLOGY, V173, P609, DOI 10.1148/radiology.173.3.2813759; BARKOVICH AJ, 1992, AM J NEURORADIOL, V13, P959; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bonnier C, 2003, PEDIATRICS, V112, P808, DOI 10.1542/peds.112.4.808; BRENNER SL, 1989, J NATL MED ASSOC, V81, P183; BROWN JK, 1993, DEV MED CHILD NEUROL, V35, P849; Chabrol B, 1999, CHILD ABUSE NEGLECT, V23, P217, DOI 10.1016/S0145-2134(98)00128-8; Conway EE, 1998, PEDIATR ANN, V27, P677, DOI 10.3928/0090-4481-19981001-11; Demaerel P, 2002, EUR RADIOL, V12, P849, DOI 10.1007/s00330-001-1145-9; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; FITCH SJ, 1985, RADIOLOGY, V156, P647, DOI 10.1148/radiology.156.3.4023223; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; FRANK Y, 1985, DEV MED CHILD NEUROL, V27, P312; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Ilves P, 2010, ACTA PAEDIATR, V99, P1329, DOI 10.1111/j.1651-2227.2010.01820.x; KJOS BO, 1983, AM J ROENTGENOL, V141, P1227, DOI 10.2214/ajr.141.6.1227; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; SINAL SH, 1987, SOUTHERN MED J, V80, P1505, DOI 10.1097/00007611-198712000-00006; Squier W, 2008, DEV MED CHILD NEUROL, V50, P10, DOI 10.1111/j.1469-8749.2007.02004.x; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; ZEPP F, 1992, NEUROPEDIATRICS, V23, P188, DOI 10.1055/s-2008-1071338	30	6	6	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253			ACTA PAEDIATR	Acta Paediatr.	JUN	2012	101	6					614	617		10.1111/j.1651-2227.2012.02635.x			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	931RV	WOS:000303237900023	22353249				2022-02-06	
J	Wei, SH; Fan, PC; Kuo, PH; Chiou, LC; Wang, JK				Wei, Shu-Hao; Fan, Pi-Chuan; Kuo, Ping-Hung; Chiou, Lih-Chu; Wang, Jou-Kou			Calcitonin Gene-Related Peptide and Size of the Atrial Septal Defect in New-Onset Migraine After Transcatheter Closure: Results of a Preliminary Study	HEADACHE			English	Article						calcitonin gene-related peptide; migraine; atrial septal defect; transcatheter	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; SPINAL-CORD NEUROCHEMICALS; NECROSIS-FACTOR-ALPHA; GLIAL ACTIVATION; BEHAVIORAL SENSITIVITY; TRIGEMINAL NUCLEUS; NITRIC-OXIDE; CHRONIC PAIN; SUBSTANCE-P	Background.-New-onset migraine headache attacks (MHAs) can occur after atrial septal device implantation in patients without previous migraine. Plasma calcitonin gene-related peptide (CGRP), which plays a crucial role in migraine pathophysiology, has shown to be released from specific cardiac tissues. Methods and Results.-We prospectively collected patients before and after closure and measured plasma CGRP levels using enzyme-linked immunosorbent assay. Forty atrial septal defect (ASD) patients who had no migraine previously were enrolled. Four (23.5%) of the 17 consecutive patients whose CGRP levels were checked before ASD closure had new-onset MHAs. The patients with MHAs had bigger ASD size (20 +/- 0.9 vs 16 +/- 1 mm, P =.009) and lower CGRP levels before closure (21.1 +/- 3.9 vs 90.1 +/- 27.1 pg/mL, P =.042) than those without. Among the 5 patients with blood samplings both during and between attacks, a paired comparison revealed a significantly increased level during attack (257.2 +/- 45.5 vs 45.6 +/- 25.5 pg/mL, P =.03). Conclusion.-Bigger ASD size and lower plasma CGRP levels before closure can be a potential predictor of new-onset MHAs. Furthermore, a significant increase of CGRP levels during migraine attack implies that the occurrences of new-onset MHAs after ASD closure correlate with the release of CGRP. This suggests CGRP sensitization from a lower baseline may be involved in the occurrence of new-onset MHAs after ASD closure.	[Fan, Pi-Chuan; Wang, Jou-Kou] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan; [Chiou, Lih-Chu] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Grad Inst Brain & Mind Sci, Taipei 100, Taiwan; [Kuo, Ping-Hung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Fan, Pi-Chuan; Chiou, Lih-Chu] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Grad Inst Pharmacol, Taipei 100, Taiwan; [Wei, Shu-Hao] I Shou Univ, Dept Pediat, Kaohsiung, Taiwan; [Wei, Shu-Hao] E Da Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chiou, Lih-Chu] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 100, Taiwan; [Kuo, Ping-Hung] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 100, Taiwan; [Fan, Pi-Chuan; Chiou, Lih-Chu] Natl Taiwan Univ, Coll Med, Grad Inst Pharmacol, Taipei 100, Taiwan; [Fan, Pi-Chuan; Wang, Jou-Kou] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei 100, Taiwan		Wang, JK (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pediat, 8 Chung Shan S Rd, Taipei 100, Taiwan.	jkww@ntuh.gov.tw	Chiou, Lih-Chu/F-3630-2012	Chiou, Lih-Chu/0000-0001-5356-940X; FAN, PI-CHUAN/0000-0002-6974-971X; Wang, Jou-Kou/0000-0002-3043-3873; KUO, PING-HUNG/0000-0003-3756-3395	National Taiwan University HospitalNational Taiwan University [NTUH96-M35]; E-Da Hospital-National Taiwan University Hospital [99EDN01]	This study was supported by grants from National Taiwan University Hospital (NTUH96-M35) and E-Da Hospital-National Taiwan University Hospital Joint Research Program (99EDN01).	Allen Institute for Brain Science, 2009, ALL MOUS BRAIN ATL; Amrutkar DV, 2011, NEUROSCIENCE, V172, P510, DOI 10.1016/j.neuroscience.2010.10.032; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Bates EA, 2010, CEPHALALGIA, V30, P170, DOI 10.1111/j.1468-2982.2009.01864.x; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Burstein R, 2005, J COMP NEUROL, V493, P9, DOI 10.1002/cne.20688; Burstein R, 1998, J NEUROPHYSIOL, V79, P964, DOI 10.1152/jn.1998.79.2.964; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; Eftekhari S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-112; Eftekhari Sajedeh, 2010, Ther Adv Neurol Disord, V3, P369, DOI 10.1177/1756285610388343; Eikermann-Haerter K, 2010, CURR NEUROL NEUROSCI, V10, P167, DOI 10.1007/s11910-010-0099-1; Elliott MB, 2010, NEUROSCIENCE, V170, P929, DOI 10.1016/j.neuroscience.2010.07.041; Elliott MB, 2009, NEUROSCIENCE, V158, P922, DOI 10.1016/j.neuroscience.2008.10.050; Elliott MB, 2008, BRAIN RES, V1218, P103, DOI 10.1016/j.brainres.2008.04.029; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; Elliott MB, 2009, NEUROSCI LETT, V454, P34, DOI 10.1016/j.neulet.2009.01.037; Flexman AM, 2010, CURR OPIN ANESTHESIO, V23, P551, DOI 10.1097/ACO.0b013e32833e15b9; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Goadsby PJ, 2009, NEUROSCIENCE, V161, P327, DOI 10.1016/j.neuroscience.2009.03.019; Goadsby PJ, 2010, NEUROLOGY, V75, P1494, DOI 10.1212/WNL.0b013e3181f9631e; Grinberg YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019294; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hang CH, 2004, WORLD J GASTROENTERO, V10, P875; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Jenkins DW, 2004, NEUROSCI LETT, V366, P241, DOI 10.1016/j.neulet.2004.05.067; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kerr BJ, 2007, EXP NEUROL, V206, P240, DOI 10.1016/j.expneurol.2007.04.014; Kosaras B, 2009, J COMP NEUROL, V515, P331, DOI 10.1002/cne.22049; Lee KE, 2009, J PAIN, V10, P436, DOI 10.1016/j.jpain.2008.11.009; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Levy D, 2009, HEADACHE, V49, P953, DOI 10.1111/j.1526-4610.2009.01444.x; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Linder Steven L, 2007, Curr Pain Headache Rep, V11, P396, DOI 10.1007/s11916-007-0223-3; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meents JE, 2010, TRENDS MOL MED, V16, P153, DOI 10.1016/j.molmed.2010.02.004; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Narita M, 2005, J NEUROSCI, V25, P10000, DOI 10.1523/JNEUROSCI.2507-05.2005; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Olechowski CJ, 2009, PAIN, V141, P156, DOI 10.1016/j.pain.2008.11.002; Olesen J, 2009, LANCET NEUROL, V8, P679, DOI 10.1016/S1474-4422(09)70090-0; Olesen J, 2008, PHARMACOL THERAPEUT, V120, P157, DOI 10.1016/j.pharmthera.2008.08.003; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Oshinsky ML, 2006, HEADACHE, V46, pS39, DOI 10.1111/j.1526-4610.2006.00489.x; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Recober A, 2009, J NEUROSCI, V29, P8798, DOI 10.1523/JNEUROSCI.1727-09.2009; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rothman SM, 2010, J NEUROTRAUM, V27, P803, DOI 10.1089/neu.2009.1045; Rothman SM, 2005, SPINE, V30, P2491, DOI 10.1097/01.brs.0000186316.38111.4b; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; Stokely ME, 2007, J NEUROSCI METH, V166, P217, DOI 10.1016/j.jneumeth.2007.07.010; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vink R, 2010, NEUROTHERAPEUTICS, V7, P1, DOI 10.1016/j.nurt.2009.12.001; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Wieseler J, 2010, J NEUROSCI METH, V185, P236, DOI 10.1016/j.jneumeth.2009.10.006; Wieseler-Frank J, 2004, NEUROCHEM INT, V45, P389, DOI 10.1016/j.neuint.2003.09.009; Winkelstein BA, 2008, SPINE, V33, P856, DOI 10.1097/BRS.0b013e31816b4710; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang XC, 2011, PAIN, V152, P140, DOI 10.1016/j.pain.2010.10.002	84	6	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUN	2012	52	6					985	992		10.1111/j.1526-4610.2012.02152.x			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	952OA	WOS:000304800600006	22486257				2022-02-06	
J	Tokmadzic, VS; Laskarin, G; Mahmutefendic, H; Lucin, P; Mrakovcic-Sutic, I; Zupan, Z; Sustic, A				Tokmadzic, Vlatka Sotosek; Laskarin, Gordana; Mahmutefendic, Hana; Lucin, Pero; Mrakovcic-Sutic, Ines; Zupan, Zeljko; Sustic, Alan			Expression of cytolytic protein-perforin in peripheral blood lymphocytes in severe traumatic brain injured patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Severe traumatic brain injury; Perforin; T lymphocytes; NK cells; NKT cells	CELLS; ACTIVATION; CYTOTOXICITY; MECHANISMS; IMMUNITY; DEATH	Purpose: The purpose of this study was to investigate the changes of cytotoxic protein-perforin in peripheral blood lymphocytes in severe TBI patients and possible correlation between severity of TBI and perforin expression. Methods: Flow cytometry was used for simultaneous detection of intracellular perforin and cell surface antigens of peripheral blood lymphocytes of 20 severe TBI patients on day 1, 4 and 7 after the onset of injury. Peripheral blood mononuclear cells from 20 healthy volunteers were used as control. Clinical and laboratory parameters were also recorded. Results: There was a statistically significant decrease of perforin-positive lymphocytes including T, natural killer (NK) and NKT cells on day 4 as compared with day 1 after the brain injury or healthy controls. On day 7, perforin expression was restored in lymphocyte of cytotoxic phenotype (CD8(+) T lymphocytes, NK cells, and NKT cells) compared with day 1. High positive correlation was found between the severity of TBI and frequency of perforin-positive cells on day 4 when the occurrence of the intra-hospital infections was the highest. Conclusion: Severe TBI significantly decreases perforin expression in T lymphocytes, NK and NKT cells, which indicate a possible mechanism underlying the high susceptibility to infections. (C) 2010 Elsevier Ltd. All rights reserved.	[Tokmadzic, Vlatka Sotosek; Zupan, Zeljko; Sustic, Alan] Univ Rijeka, Fac Med, Dept Anaesthesiol Reanimatol & Intens Care, Rijeka 51000, Croatia; [Laskarin, Gordana; Mahmutefendic, Hana; Lucin, Pero; Mrakovcic-Sutic, Ines] Univ Rijeka, Fac Med, Dept Physiol & Immunol, Rijeka 51000, Croatia		Tokmadzic, VS (corresponding author), Univ Rijeka, Fac Med, Dept Anaesthesiol Reanimatol & Intens Care, B Branchetta 20-1, Rijeka 51000, Croatia.	vsotosek@medri.hr	Mrakovcic-Sutic, Ines/S-6688-2018; Zupan, Zeljko/S-2786-2018; Lucin, Pero/R-8341-2018; Sotosek Tokmadzic, Vlatka/O-2359-2018; Laskarin, Gordana/O-6972-2018; Zupan, Zeljko/AAO-1749-2021; Mahmutefendic Lucin, Hana/Q-8500-2018	Mrakovcic-Sutic, Ines/0000-0003-0679-2849; Zupan, Zeljko/0000-0003-4576-7961; Lucin, Pero/0000-0001-8776-8634; Sotosek Tokmadzic, Vlatka/0000-0003-2645-5364; Laskarin, Gordana/0000-0002-6134-155X; Zupan, Zeljko/0000-0003-4576-7961; Mahmutefendic Lucin, Hana/0000-0001-8462-4686	Croatian Ministry of ScienceMinistry of Science, Education and Sports, Republic of Croatia [062-0000000-0220]	This investigation was supported by the grant from the Croatian Ministry of Science (project no. 062-0000000-0220).	Barbey C, 2007, J IMMUNOL, V178, P3566, DOI 10.4049/jimmunol.178.6.3566; Burger D, 2002, ANN NY ACAD SCI, V966, P464, DOI 10.1111/j.1749-6632.2002.tb04248.x; Cederarv M, 2009, IMMUNOBIOLOGY, V214, P331, DOI 10.1016/j.imbio.2008.10.009; Chavez-Galan L, 2009, CELL MOL IMMUNOL, V6, P15, DOI 10.1038/cmi.2009.3; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Ebert EC, 2009, IMMUNOLOGY, V127, P206, DOI 10.1111/j.1365-2567.2008.02941.x; Endsley JJ, 2006, J LEUKOCYTE BIOL, V79, P71, DOI 10.1189/jlb.0505239; Eugenin EA, 2003, METHODS, V29, P351, DOI 10.1016/S1046-2023(02)00359-6; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; MILLER C H, 1991, Neurological Research, V13, P117; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Podack ER, 2007, ADV EXP MED BIOL, V598, P325; QUATTROCCHI KB, 1991, J NEUROSURG, V75, P766, DOI 10.3171/jns.1991.75.5.0766; Rajeswari DN, 2006, INDIAN J MED RES, V123, P687; Rhodes J, 2009, J TRAUMA, V66, P1591, DOI 10.1097/TA.0b013e31819a0344; Rukavina D, 1998, BLOOD, V92, P2410, DOI 10.1182/blood.V92.7.2410.2410_2410_2420; RUKAVINA D, 1995, AM J REPROD IMMUNOL, V33, P394, DOI 10.1111/j.1600-0897.1995.tb00908.x; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; SMYTH MJ, 1990, J IMMUNOL, V145, P1159; Tokmadzic VS, 2009, INTENS CARE MED, V35, P73; Strbo N, 2006, AM J REPROD IMMUNOL, V55, P217, DOI 10.1111/j.1600-0897.2005.00351.x; Sumaria N, 2009, IMMUNOL CELL BIOL, V87, P559, DOI 10.1038/icb.2009.41; Tokmadzic VS, 2002, AM J REPROD IMMUNOL, V48, P191, DOI 10.1034/j.1600-0897.2002.01132.x; Trapani JA, 2007, ADV EXP MED BIOL, V601, P235; WOLACH B, 1993, BRAIN INJURY, V7, P401, DOI 10.3109/02699059309029683; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Woodworth JS, 2008, J IMMUNOL, V181, P8595, DOI 10.4049/jimmunol.181.12.8595	33	6	6	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2012	43	5					624	631		10.1016/j.injury.2010.05.009			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	918RC	WOS:000302267100015	20537642				2022-02-06	
J	Tumialan, LM; Theodore, N				Tumialan, Luis M.; Theodore, Nicholas			Basilar artery thrombosis after reduction of cervical spondyloptosis: a cautionary report Case report	JOURNAL OF NEUROSURGERY-SPINE			English	Article						basilar artery thrombosis; cervical spondyloptosis; cervical traction; complications	SPINE TRAUMA; PATIENT; MANAGEMENT; OCCLUSION	Traumatic cervical spondyloptosis is a rare clinical entity typically associated with complete neurological deficit. The inherent mechanics of this fracture-dislocation pattern contorts the vertebral arteries in such a way that it may result in dissection or compromised flow through those vessels. Thus, intimal injury or thrombus from stasis of flow may result. Reduction of the spondyloptosis restores flow to the vertebral arteries, but it also may mobilize thrombus or propagate an intimal dissection within the previously contorted vessel. The authors review their experience in the care of a 43-year-old man who sustained C4-5 spondyloptosis while riding an all-terrain vehicle. On arrival, the patient demonstrated no motor function below C-4 but had sensation to the nipple line (American Spinal Injury Association Spinal Cord Injury Classification B). The patient's cranial nerve examination was unremarkable. Computed tomography of the cervical spine demonstrated complete spondyloptosis at C4-5. The patient was immediately placed in cervical traction and taken to the operating room for open reduction of the fracture dislocation, decompression of the spinal cord, and stabilization with an interbody graft and cervical plate. Preoperative cervical traction was successful in only partial reduction of the fracture dislocation. Open reduction was achieved with exposure of the C-4 and C-5 bodies and sequential distraction. After anatomical alignment was achieved, an interbody graft was placed and a cervical plate secured. A subsequent decline in the patient's level of consciousness prompted CT of the head, which showed evidence of a basilar artery thrombosis. A CT angiographic study demonstrated patency of the vertebral arteries, but a mid basilar artery thrombosis. The patient progressed to brain death 24 hours after reduction of the fracture dislocation. The degree of contortion of the vertebral arteries in cervical spondyloptosis in the upper cervical spine may result in stasis of flow with subsequent formation of thrombus or intimal injury. After anatomical reduction, restoration of flow within the vertebral arteries may mobilize the thrombus or propagate an intimal dissection and result in subsequent embolic events. Endovascular evaluation may be warranted immediately after anatomical reduction of a high cervical spondyloptosis for evaluation of the vertebral arteries and possible thrombus dissolution or retrieval. (http://thejns.org/doi/abs/10.3171/2012.1.SPINE11967)	[Tumialan, Luis M.; Theodore, Nicholas] St Josephs Hosp, Barrow Neurol Inst, Div Neurol Surg, Phoenix, AZ 85013 USA		Tumialan, LM (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol Surg, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	neuropub@chw.edu		Theodore, Nicholas/0000-0001-5355-2683			Acikbas C, 2010, TURK NEUROSURG, V20, P257, DOI 10.5137/1019-5149.JTN.1991-09.3; Dickerman RD, 2005, SPINE, V30, pE658, DOI 10.1097/01.brs.0000184557.81864.19; Horsley M, 1997, SPINE, V22, P225, DOI 10.1097/00007632-199701150-00019; Menku A, 2004, MINIM INVAS NEUROSUR, V47, P242, DOI 10.1055/s-2004-818496; Nimityongskul P, 1992, Orthop Rev, V21, P764; Nimityongskul P., 1992, ORTHOP REV, V21, P764; Ozveren F, 1999, NEUROL MED-CHIR, V39, P28, DOI 10.2176/nmc.39.28; Srivastava Sudhir K, 2010, Spine J, V10, pe16, DOI 10.1016/j.spinee.2010.05.002; Tumialan LM, 2009, SPINE, V34, pE703, DOI 10.1097/BRS.0b013e3181b1fc3a; Veras LM, 2000, SPINE, V25, P1171, DOI 10.1097/00007632-200005010-00019	10	6	6	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654			J NEUROSURG-SPINE	J. Neurosurg.-Spine	MAY	2012	16	5					492	496		10.3171/2012.1.SPINE11967			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	929TU	WOS:000303089400010	22385083				2022-02-06	
J	Ciuffreda, KJ; Yadav, NK; Han, E; Ludlam, DP; Peddle, A; Hulse, P; Walter, S; Han, J				Ciuffreda, Kenneth J.; Yadav, Naveen K.; Han, Esther; Ludlam, Diana P.; Peddle, Angela; Hulse, Paul; Walter, Suzanne; Han, Jennifer			Distance Perception in Mild Traumatic Brain Injury (mTBI)	OPTOMETRY-JOURNAL OF THE AMERICAN OPTOMETRIC ASSOCIATION			English	Article						Traumatic brain injury; Visual perception; Distance perception; Depth perception; Stereoacuity; Binocular vision; Symptom-rating scale; Brain injury	EXTRAOCULAR-MUSCLE PROPRIOCEPTION; DEPTH-PERCEPTION; AREA MT; PHYSIOLOGY; CUES	Background: The purpose of this study was to assess monocular and binocular distance perception, and stereoacuity, in individuals with mild traumatic brain injury (mTBI) who reported the symptom of "poor depth perception." Methods: Ten patients with mTBI were tested and compared with 10 visually normal asymptomatic individuals in the following areas: perceived distance, stereoacuity at distance (3 meters) and near (40 cm), and a 9-item 5-point rating-scale questionnaire related to distance perception. Distance perception was assessed under monocular and binocular viewing conditions in both clustered and isolated static environments. Magnitude estimation was used to obtain the distance perception response function of physical versus perceived distance using common objects positioned at distances of 0.77 to 12.84 meters. Results: The mean distance perception response function slopes were not significantly different in the 2 groups for any of the test conditions. Stereoacuity (sec arc) was slightly reduced at both near and distance in the individuals with mTBI (36 +/- 24.58 and 84 +/- 68.34, respectively) as compared with the normal subjects (20 +/- 0 and 51 +/- 9.93, respectively). The mTBI group mean symptom score was 3.24 +/- 0.26 indicating a moderate problematic level. Conclusions: Similarity of the mean distance response functions in the mTBI group under monocular and binocular viewing conditions suggested that their misperception of distance was not due to a "binocular vergence" problem. Similarly, the slightly reduced stereoacuity in the mTBI group was not sufficient to explain their symptom of "poor depth perception." Thus, it is speculated that this problem reflects a higher-level cortical perceptual phenomenon related to diffuse brain damage in areas dealing with visuo-spatial mapping.	[Ciuffreda, Kenneth J.] SUNY State Coll Optometry, Dept Vis Sci, 33 West 42nd St, New York, NY 10036 USA		Ciuffreda, KJ (corresponding author), SUNY State Coll Optometry, Dept Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu					BUISSERET P, 1995, PHYSIOL REV, V75, P323, DOI 10.1152/physrev.1995.75.2.323; Caclin A, 2002, PERCEPT PSYCHOPHYS, V64, P616, DOI 10.3758/BF03194730; Chajka K, 2009, J VIS, V9, P283; Cuiffreda KJ, 2007, OPTOMETRY, V78, P155; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; Cutting JE, 1997, BEHAV RES METH INS C, V29, P27, DOI 10.3758/BF03200563; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Fricke T. R., 1997, CLIN EXP OPTOMETRY, V80, P165, DOI DOI 10.1111/J.1444-0938.1997.TB04876.X; Gibson JJ., 1950, PERCEPTION VISUAL WO; GOGEL WC, 1972, AM J PSYCHOL, V85, P477, DOI 10.2307/1421713; GRAVES AL, 1987, J NEUROPHYSIOL, V58, P816, DOI 10.1152/jn.1987.58.4.816; Haber RN, 2001, PERCEPT PSYCHOPHYS, V63, P1140, DOI 10.3758/BF03194530; Han M H Esther, 2008, Optometry, V79, P252, DOI 10.1016/j.optm.2008.01.001; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; LAMPTON DR, 1995, HUM FAC ERG SOC P, P1268; Loomis JM, 2004, SYNTH LIBR, V324, P421; Loomis JM, 1998, PERCEPT PSYCHOPHYS, V60, P966, DOI 10.3758/BF03211932; Loomis JM, 1996, CURR DIR PSYCHOL SCI, V5, P72, DOI 10.1111/1467-8721.ep10772783; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; Parsonson B., 1978, SINGLE SUBJECT RES S, P101, DOI DOI 10.1016/B978-0-12-425850-1.50009-0; Philbeck JW, 1997, J EXP PSYCHOL HUMAN, V23, P72, DOI 10.1037/0096-1523.23.1.72; Reading RW, 1983, BINOCULAR VISION, P1; Rowe F, 2009, STRABISMUS, V17, P24, DOI 10.1080/09273970802678537; Sedgwick H.A., 2001, HDB PERCEPTION, P128; Servos P, 2000, EXP BRAIN RES, V130, P35, DOI 10.1007/s002210050004; Szymanowicz D, J REHABIL R IN PRESS; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Ungerleider LG., 1982, ANAL VISUAL BEHAV; VANDENBERG AV, 1994, VISION RES, V34, P2153, DOI 10.1016/0042-6989(94)90324-7; Viguier A, 2001, PERCEPTION, V30, P115, DOI 10.1068/p3119; Von Hofstein C, 1970, VISION RES, V16, P193; Weir CR, 2000, GRAEF ARCH CLIN EXP, V238, P868, DOI 10.1007/s004170000166; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P144, DOI 10.1162/105474698565640; Yamada Tomohiko, 2008, Optometry, V79, P138, DOI 10.1016/j.optm.2007.05.013	39	6	6	0	3	AMER OPTOMETRIC ASSN INC	ST LOUIS	243 N LINDBERGH BLVD, ST LOUIS, MO 63141 USA	1529-1839	1558-1527		OPTOMETRY	Optometry	APR	2012	83	4					10	19					10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	V40IG	WOS:000209471700004	23231436				2022-02-06	
J	Foerch, C; You, ZR; Wang, H; Lo, EH; Whalen, MJ				Foerch, Christian; You, Zerong; Wang, Hui; Lo, Eng H.; Whalen, Michael J.			Traumatic Brain Injury during Warfarin Anticoagulation: An Experimental Study in Mice	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; in vivo studies; models of injury; traumatic brain injury	RECOMBINANT FACTOR VIIA; INTRACEREBRAL HEMORRHAGE; PREINJURY WARFARIN; INTRACRANIAL HEMORRHAGE; ATRIAL-FIBRILLATION; REDUCES HEMORRHAGE; HEAD-INJURY; MORTALITY; REVERSAL; OUTCOMES	The number of patients who are on long-term anticoagulation therapy while experiencing traumatic brain injury (TBI) is rising. This experimental study evaluated whether warfarin pre-treatment increases brain hemorrhage and worsens functional outcome after TBI, and whether the rapid reversal of anticoagulation after TBI prevents warfarin-exacerbated brain damage. Normal CD-1 mice (C) and mice pre-treated with warfarin (W) to an International Normalized Ratio of 3.5 +/- 0.9 underwent TBI using a controlled cortical impact model. Mean hemorrhage volume 24 h after TBI was 1.2 +/- 0.4 mu L in C mice and 10.9 +/- 6.9 mu L in W mice (p = 0.029, n = 4 per group). In a second study, anticoagulated mice received either saline (W-S) or prothrombin complex concentrate (W-PCC, 100 U/kg) intravenously 60 min after TBI. Anticoagulation reversal using PCC (W-PCC mice) reduced hemorrhage volumes as compared to W-S animals (7.3 +/- 6.0 versus 19.8 +/- 14.0 mu L, p = 0.045, n = 8 per group). In a third study, we examined motor deficits and lesion volume in C, W-S, and W-PCC mice until 33 days after injury. Functional outcome and lesion volume were no different between groups (n = 10 per group). In conclusion, we characterized an experimental model of TBI occurring during warfarin anticoagulation. Anticoagulation led to higher intracerebral blood volumes, but did not significantly worsen functional outcome. The rapid reversal of anticoagulation may be effective in preventing excess bleeding.	[Foerch, Christian] Goethe Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany; [Foerch, Christian; Lo, Eng H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neuroprotect Res Lab, Charlestown, MA USA; [You, Zerong; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Neurosci, Charlestown, MA USA; [You, Zerong; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat, Charlestown, MA USA; [Wang, Hui] Harvard Univ, Transplantat Biol Res Ctr, Massachusetts Gen Hosp, Bone Marrow Transplantat Sect,Sch Med, Charlestown, MA USA		Foerch, C (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	foerch@em.uni-frankfurt.de			CSL Behring, Marburg, Germany	Christian Foerch received a 3-month research grant from CSL Behring, Marburg, Germany, to complete this study.	Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Berwaerts J, 2000, STROKE, V31, P2558, DOI 10.1161/01.STR.31.11.2558; Dickneite G, 2007, THROMB RES, V119, P643, DOI 10.1016/j.thromres.2006.05.011; Ferrera PC, 1999, AM J EMERG MED, V17, P154, DOI 10.1016/S0735-6757(99)90050-5; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Foerch C, 2009, J CEREBR BLOOD F MET, V29, P1015, DOI 10.1038/jcbfm.2009.27; Foerch C, 2008, STROKE, V39, P3397, DOI 10.1161/STROKEAHA.108.517482; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Go AS, 2005, AM J GERIATR CARDIOL, V14, P56, DOI 10.1111/j.1076-7460.2005.02278.x; Huttner HB, 2006, STROKE, V37, P1465, DOI 10.1161/01.STR.0000221786.81354.d6; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2006, J TRAUMA, V61, P318, DOI 10.1097/01.ta.0000223944.25922.91; Karni A, 2001, AM SURGEON, V67, P1098; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Rowan SB, 2007, J AM COLL CARDIOL, V49, P1561, DOI 10.1016/j.jacc.2006.11.045; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580	20	6	6	0	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2012	29	6					1150	1155		10.1089/neu.2011.2104			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	927ZL	WOS:000302949100015	22142342				2022-02-06	
J	Chiang, WL; Huang, YT; Feng, JY; Lu, TH				Chiang, Wan-Lin; Huang, Yu-Tung; Feng, Jui-Ying; Lu, Tsung-Hsueh			Incidence of hospitalization due to child maltreatment in Taiwan, 1996-2007: A nationwide population-based study	CHILD ABUSE & NEGLECT			English	Article						Child abuse; Incidence; Trends; Hospitalization; Taiwan	TRAUMATIC BRAIN-INJURY; PHYSICAL ABUSE; EPIDEMIOLOGIC FEATURES; KAWASAKI-DISEASE; YOUNG-CHILDREN; UNITED-STATES; EXPERIENCE	Objectives: Little is known regarding the epidemiology of child maltreatment in Asian countries. This study aimed to examine the incidence of hospitalization coded as due to child maltreatment in Taiwan. Methods: We used inpatient claims data of the National Health Insurance for the years 1996 through 2007 for estimation. Hospitalization of children aged 0-12 years with an ICD-9-CM code 995.5 "maltreatment syndrome" or E960-E969 "assault" in the main or secondary discharge diagnosis in claims data was defined as hospitalization due to child maltreatment. Poisson regression was used to examine the trends. Results: A total of 1,726 children with 1,780 hospitalizations due to child maltreatment were identified during 1996-2007. The averaged annual incidence over 1996-2007 was 13.2/100,000 for infants, 3.5/100,000 for children aged 1-3 years, 2.1/100,000 for children aged 4-6 years and 3.3/100,000 for children aged 7-12 years. The incidence increased most among the infant group, from 4.8/100,000 in 1996-1997 to 25.4/100,000 in 2006-2007, a greater than 5-fold increase. The magnitude of the increase in incidence decreased with age, and no change in incidence was noted among children aged 7-12 years. The drastic increase in incidence in infants since 2003 corresponds with the introduction of use of ICD-9-CM code 995.55 "shaken infant syndrome" in Taiwan since 2003. Head injury was the main type of injury in all age groups. Conclusions:The incidence of hospitalization coded as due to child maltreatment in Taiwan differed by age group. Infants had the highest and the largest increase in incidence during the past decade. The increase might be due to improvement in awareness, competence and willingness to diagnose child maltreatment of medical staff in hospitals during the past decade after the revision of Child Welfare Law in 1993 and the new ICD-9-CM code for "shaken infant syndrome" being used since 2003. Practice implications: Physicians and nursing staff should be aware of and provide the detailed and specific information needed for proper discharge diagnosis coding, from which valid estimation of the incidence of hospitalization due to child maltreatment can be made. Administrative data should include both the N-code and E-code for each case of child maltreatment hospitalization to provide more complete information. (C) 2012 Elsevier Ltd. All rights reserved.	[Chiang, Wan-Lin; Lu, Tsung-Hsueh] Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med, Tainan 701, Taiwan; [Chiang, Wan-Lin; Lu, Tsung-Hsueh] Natl Cheng Kung Univ, NCKU Res Ctr Hlth Data, Tainan 701, Taiwan; [Huang, Yu-Tung] Chang Gung Inst Technol, Dept Gerontol Care & Management, Tao Yuan, Taiwan; [Feng, Jui-Ying] Natl Cheng Kung Univ, Dept Nursing, Coll Med, Tainan 701, Taiwan		Lu, TH (corresponding author), Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med, 1 Dah Hsueh Rd, Tainan 701, Taiwan.		Feng, Jui-Ying/AAT-4479-2021; Huang, Yu-Tung/S-4026-2018	Huang, Yu-Tung/0000-0003-3224-7238; Feng, Jui-Ying/0000-0002-0876-4430			Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bureau of National Health Insurance, 2010, NAT HLTH INS PROF 20; Chang LY, 2004, PEDIATRICS, V114, pE678, DOI 10.1542/peds.2004-0726; Child Welfare Bureau Ministry of Interior Taiwan, 2010, CHILD PROT MAN GUID; Crouch JL, 2008, CHILD ABUSE NEGLECT, V32, P702, DOI 10.1016/j.chiabu.2007.11.002; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Feng JY, 2005, CHILD ABUSE NEGLECT, V29, P783, DOI 10.1016/j.chiabu.2004.11.006; Flaherty EG, 2000, ARCH PEDIAT ADOL MED, V154, P489, DOI 10.1001/archpedi.154.5.489; Forjuoh SN, 2000, CHILD ABUSE NEGLECT, V24, P1019, DOI 10.1016/S0145-2134(00)00163-0; Gessner BD, 2004, CHILD ABUSE NEGLECT, V28, P9, DOI 10.1016/j.chiabu.2003.03.002; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Gilbert R, 2009, LANCET, V373, P167, DOI 10.1016/S0140-6736(08)61707-9; Gonzalez-Izquierdo A., 2010, ARCH DIS CHILDHOOD, DOI 10.1136; Gunn VL, 2005, AMBUL PEDIATR, V5, P96, DOI 10.1367/A04-094R.1; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; Jones R, 2008, PEDIATRICS, V122, P259, DOI 10.1542/peds.2007-2312; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Leventhal JM, 2008, PEDIATRICS, V122, P599, DOI 10.1542/peds.2007-1959; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Sanders T., 2003, CHILD ABUSE REV, V12, P358; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schnitzer PG, 2004, AM J PREV MED, V27, P379, DOI 10.1016/j.amepre.2004.08.007; Scott D, 2009, CHILD ABUSE NEGLECT, V33, P791, DOI 10.1016/j.chiabu.2009.08.005; Sibert JR, 2002, CHILD ABUSE NEGLECT, V26, P267, DOI 10.1016/S0145-2134(01)00324-6; United Nations, 2006, WORLD REP VIOL CHILD; Van Haeringen AR, 1998, CHILD ABUSE NEGLECT, V22, P159, DOI 10.1016/S0145-2134(97)00172-5; Vulliamy AP, 2000, CHILD ABUSE NEGLECT, V24, P1461, DOI 10.1016/S0145-2134(00)00199-X; WARNER JE, 1994, CHILD ABUSE NEGLECT, V18, P11, DOI 10.1016/0145-2134(94)90092-2; World Health Organization, 2006, PREV CHILD MALTR GLO; World Health Organization, 2002, WORLD REPORT VIOLENC	30	6	6	1	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	FEB	2012	36	2					135	141		10.1016/j.chiabu.2011.09.013			7	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	916MT	WOS:000302108600007	22405478				2022-02-06	
J	Reisinger, HS; Hunt, SC; Burgo-Black, AL; Agarwal, MA				Reisinger, Heather Schacht; Hunt, Stephen C.; Burgo-Black, A. Lucile; Agarwal, Madhulika A.			A Population Approach to Mitigating the Long-Term Health Effects of Combat Deployments	PREVENTING CHRONIC DISEASE			English	Article							TRAUMATIC BRAIN-INJURY; RISK-FACTORS; VETERANS; IRAQ; CARE; POLYTRAUMA; SOLDIERS; SYSTEM; PAIN; DIAGNOSES	A major focus of the mission of the US Department of Veterans Affairs (VA) is to respond to the needs of military personnel returning from war. Given the broad spectrum of the potential effects of combat deployment on the health and well being of service members, VA is increasingly oriented toward comprehensive postcombat support, health promotion, disease prevention, and proactive approaches to caring for combat veterans. This article briefly summarizes the health care needs of service members returning from Afghanistan and Iraq, describes VA's approaches to addressing their needs, and outlines VA's evolving vision for how to apply principles of population health management to ensure prompt and effective response to the postdeployment needs of veterans returning from future conflicts. At the heart of postcombat care will be population-based approaches oriented to health recovery using interdisciplinary, team-based platforms.	[Hunt, Stephen C.] VA Puget Sound Healthcare Syst, Seattle, WA USA; [Hunt, Stephen C.] Univ Washington, Sch Med, Seattle, WA USA; [Burgo-Black, A. Lucile] VA Connecticut Healthcare Syst, New Haven, CT USA; [Burgo-Black, A. Lucile] Yale Univ, Sch Med, New Haven, CT USA; [Agarwal, Madhulika A.] Off Hlth Policy & Serv, Dept Vet Affairs, Washington, DC USA		Reisinger, HS (corresponding author), Iowa City VA Healthcare Syst, CADRE, 601 Hwy 6 W, Iowa City, IA 52246 USA.	heather.reisinger@va.gov			VA career development award [CD1 08-013-1]	We thank our interdisciplinary team, Margaret Hammond, Ira Katz, Linda Kinsinger, Larry Mole, Joel Scholten, and Terry Walters, who reviewed this manuscript and provided important feedback. Dr. Reisinger acknowledges the support of her VA career development award (CD1 08-013-1), which focuses on VA outreach to OEF/OIF/OND service members and their families.	Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Hester J, 2010, PREV CHRONIC DIS, V7; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jemison T L, 1980, US Med, V16, P11; Jemison TL, 1980, US MED, V16, P11; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kinsinger LS, 2009, PREV CHRONIC DIS, V6; Kizer KW, 1997, HOSP HEALTH SERV ADM, V42, P283; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Schneiderman AI, 2006, MIL MED, V171, P577, DOI 10.7205/MILMED.171.7.577; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Tan G, 2009, PAIN MED, V10, P1237, DOI 10.1111/j.1526-4637.2009.00712.x; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Weaver FM, 2009, ARCH PHYS MED REHAB, V90, P517, DOI 10.1016/j.apmr.2008.09.560	23	6	6	0	3	CENTERS  DISEASE CONTROL & PREVENTION	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1545-1151			PREV CHRONIC DIS	Prev. Chronic Dis.	FEB	2012	9								110116	10.5888/pcd9.110116			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	977HC	WOS:000306646300007		Green Published			2022-02-06	
J	Ashley, MJ; Ashley, J; Kreber, L				Ashley, Mark J.; Ashley, Jessica; Kreber, Lisa			Remediation of information processing following traumatic brain injury: A community-based rehabilitation approach	NEUROREHABILITATION			English	Article						Cognitive rehabilitation; traumatic brain injury; information processing	OF-THE-LITERATURE; COGNITIVE REHABILITATION; MEMORY; CATEGORIZATION; ATTENTION; RETRIEVAL; SALIENCE; STIMULI; APHASIA; CORTEX	Traumatic brain injury (TBI) results in disruption of information processing via damage to primary, secondary, and tertiary cortical regions, as well as, subcortical pathways supporting information flow within and between cortical structures. TBI predominantly affects the anterior frontal poles, anterior temporal poles, white matter tracts and medial temporal structures. Fundamental information processing skills such as attention, perceptual processing, categorization and cognitive distance are concentrated within these same regions and are frequently disrupted following injury. Information processing skills improve in accordance with the extent to which residual frontal and temporal neurons can be encouraged to recruit and bias neuronal networks or the degree to which the functional connectivity of neural networks can be re-established and result in re-emergence or regeneration of specific cognitive skills. Higher-order cognitive processes, i.e., memory, reasoning, problem solving and other executive functions, are dependent upon the integrity of attention, perceptual processing, categorization, and cognitive distance. A therapeutic construct for treatment of attention, perceptual processing, categorization and cognitive distance deficits is presented along with an interventional model for encouragement of re-emergence or regeneration of these fundamental information processing skills.	[Ashley, Mark J.; Ashley, Jessica; Kreber, Lisa] Ctr Neuro Skills, Bakersfield, CA 93306 USA		Ashley, MJ (corresponding author), Ctr Neuro Skills, 2658 Mt Vernon Ave, Bakersfield, CA 93306 USA.	MAshley@neuroskills.com					ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Amaral DG, 2000, PRINCIPLES NEURAL SC, P337; Anderson, 1980, COGNITIVE PSYCHOL IT; Ashley MJ, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P513, DOI 10.1201/9781439849828-c17; Ashley MJ, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P583, DOI 10.1201/9781439849828-c19; Baddeley A. D., 1970, Q J EXPT PSYCHOL, V61, P13; BURGER RA, 1980, J PSYCHOLINGUIST RES, V9, P355, DOI 10.1007/BF01067448; CARON AJ, 1969, DEV PSYCHOL, V1, P333, DOI 10.1037/h0027698; CHANNON S, 1989, NEUROPSYCHOLOGIA, V27, P777, DOI 10.1016/0028-3932(89)90002-X; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Constantinidou F, 2004, BRAIN LANG, V89, P216, DOI 10.1016/S0093-934X(03)00399-7; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; CRAIK FIM, 1969, BRIT J PSYCHOL, V60, P315, DOI 10.1111/j.2044-8295.1969.tb01202.x; CRANNELL CW, 1957, J PSYCHOL, V44, P319, DOI 10.1080/00223980.1957.9713089; DARWIN CJ, 1972, COGNITIVE PSYCHOL, V3, P255, DOI 10.1016/0010-0285(72)90007-2; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; Galan RF, 2006, NEURAL COMPUT, V18, P10, DOI 10.1162/089976606774841558; Goldstein K., 1948, LANGUAGE LANGUAGE DI; GROSSMAN M, 1987, BRAIN COGNITION, V6, P55, DOI 10.1016/0278-2626(87)90046-7; HEILMAN KM, 1972, NEUROLOGY, V22, P660, DOI 10.1212/WNL.22.6.660; HIRST W, 1988, BRAIN COGNITION, V8, P379, DOI 10.1016/0278-2626(88)90060-7; Kaas AL, 2007, CEREB CORTEX, V17, P1637, DOI 10.1093/cercor/bhl074; Kahneman D., 1973, ATTENTION EFFORT; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; LHERMITTE F, 1971, REV NEUROL-FRANCE, V125, P81; MESULAM MM, 1978, J PSYCHIATR RES, V14, P249, DOI 10.1016/0022-3956(78)90027-4; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORAY N, 1965, J ACOUST SOC AM, V38, P196, DOI 10.1121/1.1909631; MUMA JR, 1978, LANGUAGE HDB CONCEPT; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Murdock B. B., 1972, PSYCHOL LEARN MOTIV, V5, P67; NAATANEN R, 1979, ORIENTING REFLEX HUM; Neisser U., 1967, COGNITIVE PSYCHOL; ODOM RD, 1973, CHILD DEV, V44, P425; Piaget J., 1962, PLAY DREAMS IMITATIO; Posner Michael I., 1995, P615; Prigatano G. P., 1987, J LEARNING DISABILIT, V20; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sohlberg M. M., 1989, ATTENTION PROCESS TR; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Speech-Language Hearing Association, 1990, ASHA, V32, P85; Spurling G. A., 1960, PSYCHOL MONOGR, V74, P498; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Thomas E, 2001, J COGNITIVE NEUROSCI, V13, P190, DOI 10.1162/089892901564252; TREISMAN AM, 1964, AM J PSYCHOL, V77, P206, DOI 10.2307/1420127; TREXLER LE, 1988, BRAIN COGNITION, V8, P291, DOI 10.1016/0278-2626(88)90056-5; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Tulving E., 1983, ELEMENTS EPISODIC ME; WAYLAND S, 1985, BRAIN COGNITION, V4, P338, DOI 10.1016/0278-2626(85)90026-0	51	6	6	1	15	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2012	31	1					31	39		10.3233/NRE-2012-0772			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	976SU	WOS:000306605900004	22523011				2022-02-06	
J	Chase, S; Ratcliff, G; Vernich, L; Al-Sukhni, E; Yasseen, B; Colantonio, A				Chase, Susan; Ratcliff, Graham; Vernich, Lee; Al-Sukhni, Eisar; Yasseen, Baseer; Colantonio, Angela			Preventive Health Practices and Behavioral Risk Factors in Women Surviving Traumatic Brain Injury	HEALTH CARE FOR WOMEN INTERNATIONAL			English	Article							DISABILITIES; OUTCOMES; EPIDEMIOLOGY; MAMMOGRAPHY; CHILDREN; ALCOHOL; TBI	Traumatic brain injury (TBI) affects millions globally and is considered a universal public health concern. Our study addresses a considerable knowledge gap about the health of female survivors of TBI. Using a retrospective cohort study design, we examined behavioral risk factors, access to health screenings, and primary care services among women with a history of moderate to severe TBI. We compared findings with a general female population. Female survivors (n = 75) appeared to have comparable use of primary care services with the general population. Significantly more women reported poor mental health postinjury; reported alcohol consumption was also greater.	[Al-Sukhni, Eisar; Yasseen, Baseer; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Fac Med, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Toronto Rehabil Inst UHN, Toronto, ON, Canada; [Vernich, Lee] Univ Toronto, Fac Med, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Ratcliff, Graham] Clin Neuropsychol Serv, Pittsburgh, PA USA; [Chase, Susan] Open Minds LLC, Natrona Hts, PA USA		Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Fac Med, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034740] Funding Source: NIH RePORTER; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [200603MOP-158609-GSH-OPAA-16872] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34740-2] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [F3 AGO5856-01A13] Funding Source: Medline		Altman BM., 2008, DISABILITY HLTH US 2; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Barr JK, 2008, AM J HEALTH PROMOT, V22, P381, DOI 10.4278/ajhp.22.6.381; Becker H, 2008, PUBLIC HEALTH NURS, V25, P526, DOI 10.1111/j.1525-1446.2008.00739.x; Branigan M., 2001, MEDSCAPE GEN MED, V3; Brawarsky P, 2002, TOB CONTROL, V11, pII29; Canadian Cancer Society's Steering Committee on Cancer Statistics, 2011, CAN CANC STAT 2011; Canadian Institute for Health Information, 2006, LIF TRAUM SPIN CORD; Centers for Disease Control and Prevention, 1999, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2000, DEF OV OB; Centers for Disease Control and Prevention (CDC), 2009, NAT CTR INJ PREV CON; Centers for Disease Control and Prevention (CDC), 2010, BEH RISK FACT SURV S; Chan L, 1999, ARCH PHYS MED REHAB, V80, P642, DOI 10.1016/S0003-9993(99)90166-1; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Froehlich-Grobe K, 2008, WOMEN HEALTH, V48, P21, DOI 10.1080/03630240802131981; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hannay HJ., 2004, NEUROPSYCHOLOGICAL A, V4, P157; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kraus J. F., 1999, REHABILITATION ADULT, P3; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; McGuire L. C., 2007, PREVENTING CHRONIC D, V4, pA09; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mobley LR, 2009, CANCER CAUSE CONTROL, V20, P1017, DOI 10.1007/s10552-009-9295-1; Multiple Sclerosis International Federation, 2008, ATL MULT SCLER DAT; Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3; NELSON DE, 1998, P SECT SURV RES METH, P214; Nosek MA, 1997, ARCH PHYS MED REHAB, V78, pS39, DOI 10.1016/S0003-9993(97)90220-3; Nosek MA, 2008, DISABIL REHABIL, V30, P174, DOI 10.1080/09638280701532219; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Public Health Agency of Canada, 2007, HIV AIDS EPI UPD NOV; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; SAS Institute, 2002, SAS WIND VERS 9 2; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stein K, 1999, BRIT MED J, V318, P641, DOI 10.1136/bmj.318.7184.641; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Veltman A., 2001, MEDSCAPE GEN MED, V3	49	6	6	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0739-9332	1096-4665		HEALTH CARE WOMEN IN	Health Care Women Int.		2012	33	7					631	645		10.1080/07399332.2012.673652			15	Public, Environmental & Occupational Health; Women's Studies	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Women's Studies	959EC	WOS:000305294400004	22681747				2022-02-06	
J	Settervall, CHC; de Sousa, RMC				Costanti Settervall, Cristina Helena; Cardoso de Sousa, Regina Marcia			Glasgow Coma Scale and quality of life after traumatic brain injury	ACTA PAULISTA DE ENFERMAGEM			English	Article						Brain injuries; Glasgow Coma Scale; Prognosis; Quality of life	SATISFACTION 12 MONTHS; GENERAL HEALTH; HEAD-INJURY; WORK STATUS; OUTCOMES; SF-36; MODERATE	Objective: To evaluate the behavior of different scores on the Glasgow Coma Scale (GCS) observed during the first 72 hours after trauma, before the perceived changes to quality of life and health status, and one year after the traumatic event. Methods: A study using a quantitative approach, observational, longitudinal, descriptive and correlational with victims of blunt head trauma (BHT) evaluated daily during hospitalization, and after one year by means of the Medical Outcome Study 36-Item Short Form Health Survey (SF -36). Results: Under the Reciever Operator Characteristic curves, the values of the GCS related to the perceived change of health status did not differ significantly and ranged from 0.63 to 0.71. A correlation, statistically significant, although weak, was observed between GCS scores and some of the domains of the SF-36. Conclusion: It was found that the different values of the GCS presented limitations for application in clinical practice for estimating the consequences of long term BHT.	[Cardoso de Sousa, Regina Marcia] Univ Sao Paulo, Med Surg Nursing Dept, Sch Nursing, Sao Paulo, Brazil		Settervall, CHC (corresponding author), Av Prof Ida Kolb,225,Bloco 04 Apt 191 Casa Verde, BR-02518000 Sao Paulo, Brazil.	settervall@usp.br	Sousa, Regina M/H-1108-2012	Sousa, Regina M/0000-0002-2575-7937			Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Brasel KJ, 2010, J TRAUMA, V68, P263, DOI 10.1097/TA.0b013e3181caa58f; Carrico CJ, 2000, J TRAUMA, V48, P848; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Ciconelli R.M., 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Comite do Trauma do Colegio Americano de Cirurgioes, 2008, SUP AV VID TRAUM MED, P131; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; Oliveira Nelson Luiz Batista de, 2003, Rev. Latino-Am. Enfermagem, V11, P749, DOI 10.1590/S0104-11692003000600008; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; Jumisko E, 2009, J CLIN NURS, V18, P2273, DOI 10.1111/j.1365-2702.2008.02738.x; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Martinez EZ., 2003, CADERNOS SAUDE COLET, V11, P7; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Murrell R, 1999, NEUROPSYCHOL REV, V9, P209, DOI 10.1023/A:1021686606648; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Pasquale MD, 2008, J TRAUMA, V64, P60, DOI 10.1097/TA.0b013e31815eb112; Sousa RM, 1999, REV ESC ENFERM USP, V33, P313; Souza José Carlos, 2006, J. bras. psiquiatr., V55, P184, DOI 10.1590/S0047-20852006000300002; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	23	6	8	2	12	UNIV FED SAO PAULO, DEPT ENFERMAGEN	SAO PAULO	RUA NAPOLEAO DE BARROS, 754 VILA CLEMENTINO, SAO PAULO, CEP04024-002, BRAZIL	0103-2100	1982-0194		ACTA PAUL ENFERM	Acta Paul. Enferm.		2012	25	3					364	370		10.1590/S0103-21002012000300008			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	170TA	WOS:000320875300008		gold, Green Published			2022-02-06	
J	Gokdemir, MT; Sogut, O; Kaya, H; Sayhan, MB; Cevik, M; Dokuzoglu, MA; Boleken, ME				Gokdemir, M. T.; Sogut, O.; Kaya, H.; Sayhan, M. B.; Cevik, M.; Dokuzoglu, M. A.; Boleken, M. E.			Role of Oxidative Stress in the Clinical Outcome of Patients with Multiple Blunt Trauma	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						MULTIPLE BLUNT TRAUMA; TOTAL OXIDANT STATUS; TOTAL ANTIOXIDANT STATUS; OXIDATIVE STRESS INDEX; INJURY SEVERITY SCORE; MORTALITY	CRITICALLY-ILL PATIENTS; INJURY SEVERITY SCORE; LIPID-PEROXIDATION; ANTIOXIDANT STATUS; ABDOMINAL-TRAUMA; BRAIN-INJURY; HEAD-INJURY; EPIDEMIOLOGY; PREDICTION; CORRELATE	OBJECTIVE: This prospective study evaluated serum total oxidant status (TOS), total antioxidant status (TAS) and oxidative stress index (OSI), along with the Revised Trauma Score (RTS) and Injury Severity Score (ISS), as predictors of clinical outcome in the early post-traumatic period in patients with multiple blunt trauma (MBT). METHODS: The study included 52 patients admitted to the emergency department with MBT and 40 age- and sex-matched healthy control subjects. RESULTS: The overall MBT patient mortality was 32.7% (17/52). There was no significant association between age and mortality in MBT patients, but there was a negative correlation between mortality and RTS, and a positive correlation between mortality and ISS. TOS levels were significantly higher in nonsurvivors compared with survivors. There was no correlation between TAS or OSI and survival. ISS and RTS showed positive and negative correlations with TOS level, respectively, but neither was significantly related to TAS or OSI. CONCLUSIONS: These findings suggest that TOS, as an early oxidative stress biomarker, may be an objective alternative criterion to the ISS and RTS for managing patients with MBT during the early period following traumatic injury.	[Gokdemir, M. T.; Sogut, O.; Kaya, H.; Dokuzoglu, M. A.] Harran Univ, Tip Fak, Acil Tip Anabilim Dali, TR-63300 Sanliurfa, Turkey; [Cevik, M.; Boleken, M. E.] Harran Univ, Fac Med, Dept Paediat Surg, TR-63300 Sanliurfa, Turkey; [Sayhan, M. B.] Trakya Univ, Fac Med, Dept Emergency Med, Edirne, Turkey		Sogut, O (corresponding author), Harran Univ, Tip Fak, Acil Tip Anabilim Dali, Morfol Binasi,Yenisehir Kampusu, TR-63300 Sanliurfa, Turkey.	drosogut@harran.edu.tr	Boleken, Mehmet Emin/ABG-5059-2021; Cevik, Muazez/X-6543-2018; Kaya, Halil/ABH-5489-2020; Boleken, Mehmet Emin/ABH-6627-2020	Boleken, Mehmet Emin/0000-0001-9006-8364; Cevik, Muazez/0000-0002-0604-7606; Kaya, Halil/0000-0003-2005-6100; 	Scientific Research Projects Committee of Harran University, Sanliurfa, TurkeyHarran University	This study was supported by the Scientific Research Projects Committee of Harran University, Sanliurfa, Turkey.	Ahmed JM, 2007, ANN EMERG MED, V50, P7, DOI 10.1016/j.annemergmed.2006.09.017; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Basoglu Ahmet, 2004, Ulus Travma Acil Cerrahi Derg, V10, P42; Bouillon B, 1997, J TRAUMA, V42, P652, DOI 10.1097/00005373-199704000-00012; Burch JM, 1999, PRINCIPLES SURG, P155; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cofta S, 2008, J PHYSIOL PHARMACOL, V59, P183; Eftekhar B, 2005, INJURY, V36, P900, DOI 10.1016/j.injury.2004.12.067; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; GOODE HF, 1995, CRIT CARE MED, V23, P646, DOI 10.1097/00003246-199504000-00011; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; Helmi I, 2001, INJURY, V32, P105, DOI 10.1016/S0020-1383(00)00155-8; Hoyt DB, 1997, SURG SCI PRINCIPLES, P267; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Lang JD, 2002, CHEST, V122, p314S, DOI 10.1378/chest.122.6_suppl.314S; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; Lemineur T, 2006, CURR OPIN CLIN NUTR, V9, P704, DOI 10.1097/01.mco.0000247467.41661.f3; Mishra V, 2005, ANN CLIN BIOCHEM, V42, P269, DOI 10.1258/0004563054255461; Miwa K, 2009, INT J CARDIOL, V136, P238, DOI 10.1016/j.ijcard.2008.04.051; Mulholland SA, 2008, J TRAUMA, V64, P754, DOI 10.1097/01.ta.0000244384.85267.c5; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; Nayak CD, 2008, NEUROL INDIA, V56, P31, DOI 10.4103/0028-3886.39309; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; Rael LT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-57; Rana SV, 2006, MOL CELL BIOCHEM, V291, P161, DOI 10.1007/s11010-006-9210-y; Roth E, 2004, CURR OPIN CLIN NUTR, V7, P161, DOI 10.1097/00075197-200403000-00010; Rutledge R, 1997, J TRAUMA, V42, P477, DOI 10.1097/00005373-199703000-00016; Selek S, 2008, BIOL PSYCHOL, V79, P256, DOI 10.1016/j.biopsycho.2008.06.005; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Sharma A, 2008, PARKINSONISM RELAT D, V14, P52, DOI 10.1016/j.parkreldis.2007.06.009; Soreide K, 2009, BRIT J SURG, V96, P697, DOI 10.1002/bjs.6643; Srivastava AR, 2007, INJURY, V38, P1069, DOI 10.1016/j.injury.2007.04.019; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Vagnozzi R, 1997, EXP BRAIN RES, V117, P411, DOI 10.1007/s002210050235; Wladis A, 2002, EUR J SURG, V168, P187, DOI 10.1080/110241502320127810	37	6	6	0	13	FIELD HOUSE PUBLISHING LLP	WORTHING	6 SOMPTING AVENUE, WORTHING, BN14 8HN, ENGLAND	0300-0605			J INT MED RES	J. Int. Med. Res.	JAN-FEB	2012	40	1					167	173		10.1177/147323001204000117			7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	918SV	WOS:000302272300017	22429356	gold			2022-02-06	
J	Juengst, S; Skidmore, E; Pramuka, M; Mccue, M; Becker, J				Juengst, Shannon; Skidmore, Elizabeth; Pramuka, Michael; McCue, Michael; Becker, James			Factors contributing to impaired self-awareness of cognitive functioning in an HIV positive and at-risk population	DISABILITY AND REHABILITATION			English	Article						self-awareness; HIV; cognitive impairment	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL IMPAIRMENT; ALZHEIMERS-DISEASE; REHABILITATION; COMPLAINTS; SCHIZOPHRENIA; ANOSOGNOSIA; PERFORMANCE; UNAWARENESS; INFECTION	Purpose: To examine the association between self-awareness of cognitive impairment and age, selected mood disorders, and type and severity of cognitive impairment in a sample of individuals with HIV/AIDS and at risk for HIV. Method: 75 subjects, 52 HIV+ and 23 at risk for HIV completed a psychosocial interview, the Patient's Assessment of Own Functioning (PAOF) questionnaire, and a battery of neuropsychological tests. Based upon the differences between their clinical impairment and self-reported impairment, subjects were classified as being "Underestimators", "Good Awareness", or "Impaired Awareness" with regard to self-awareness. Results: Those with more severe cognitive impairment were less aware than those with normal or borderline cognitive impairment. A one-way ANOVA suggested that the Impaired Awareness group differed significantly from the Underestimators on the Rey Figure Immediate and Delayed Recall tasks, and from both the Underestimators and Good Awarenesss groups on the Digit Symbol Substitution Task. There were significant differences among all awareness groups on the test of Simple Reaction Time. Furthermore there is some suggestion that age may contribute to impaired self-awareness. The role of HIV in self-awareness remains unclear, as both, individuals with HIV and at risk, demonstrated impaired self-awareness. Conclusions: Overall, impaired awareness was associated with poorer test performance, suggesting a relationship between awareness and sustained complex attention and visual spatial processing. This research has implications for understanding factors contributing to poor awareness among individuals with cognitive impairment.	[Juengst, Shannon; Pramuka, Michael; McCue, Michael] Univ Pittsburgh, Dept Rehabil Sci and Technol, Pittsburgh, PA USA; [Skidmore, Elizabeth] Univ Pittsburgh, Dept Occupat Therapy, Pittsburgh, PA USA; Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA		Juengst, S (corresponding author), Dept Rehabil & Technol, Pittsburgh, PA USA.	sbj7@pitt.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X; Becker, James/0000-0003-4425-4726	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG21431]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD055931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021431] Funding Source: NIH RePORTER	The Allegheny County Psychological Survey Study is supported by the National Institutes of Health (AG21431). This paper was submitted in partial fulfillment of a Master's of Science in Health and Rehabilitation Science at the University of Pittsburgh.	Bassel C, 2002, NEUROPSYCHOLOGY, V16, P400, DOI 10.1037//0894-4105.16.3.400; Becker JT, 2005, NEUROLOGY, V64, pA245; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Bowie CR, 2007, J PSYCHIATR RES, V41, P1012, DOI 10.1016/j.jpsychires.2006.08.003; Carone DA, 2005, J INT NEUROPSYCH SOC, V11, P574, DOI 10.1017/S135561770505068X; Clare L, 2005, AGING MENT HEALTH, V9, P394, DOI 10.1080/13607860500142903; Cysique LA, 2004, J NEUROVIROL, V10, P350, DOI 10.1080/13550280490521078; Delis DC, 1987, CALIFORNIA VERBAL LE; Feher EP., 1991, ANOSOGNOSIA ALZHEIME, V4, P136; Ferguson CJ, 2009, EFFECT SIZE PRIMER G; Gil R, 2001, ACTA NEUROL SCAND, V104, P296, DOI 10.1034/j.1600-0404.2001.00280.x; GOODGLASS H, 1987, ASSESSMENT APHASIA R; Gremley S, 2006, THESIS ILLINOIS I TE; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Heaton R. K., 2004, REVISED COMPREHENSIV; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Heaton RK, 1981, J CONSULT CLIN PSYCH, V49, P307; Hinkin CH, 1996, J CLIN EXP NEUROPSYC, V18, P413; Hoerold D, 2008, EXP BRAIN RES, V186, P509, DOI 10.1007/s00221-008-1341-9; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; MACINNES WD, 1983, INT J NEUROSCI, V18, P41, DOI 10.3109/00207458308985876; Mangone C A, 1991, J Geriatr Psychiatry Neurol, V4, P189, DOI 10.1177/089198879100400402; MCDANIEL KD, 1995, ALZ DIS ASSOC DIS, V9, P101, DOI 10.1097/00002093-199509020-00007; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MILLER EN, 1991, NEUROLOGY, V41, P1608, DOI 10.1212/WNL.41.10.1608; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Poutiainen E, 1996, J Int Neuropsychol Soc, V2, P219; Prigatano GP, 1999, REHABIL PSYCHOL, V44, P145, DOI 10.1037/0090-5550.44.2.145; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Prouteau A, 2004, SCHIZOPHR RES, V69, P85, DOI 10.1016/j.schres.2003.08.011; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1981, ARCH PSYCHOL; Richardson-Vejlgaard R, 2009, PSYCHIAT RES, V169, P70, DOI 10.1016/j.psychres.2008.06.018; Rourke SB, 1999, J CLIN EXP NEUROPSYC, V21, P737, DOI 10.1076/jcen.21.6.737.863; Spitzer R. L., 1990, STRUCTURED CLIN INTE; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P719, DOI 10.1136/jnnp.2005.085373; Wechsler, 1997, WECHSLER ADULT INTEL; Woods SP, 2004, J CLIN EXP NEUROPSYC, V26, P759, DOI 10.1080/13803390490509565	41	6	6	0	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2012	34	1					19	25		10.3109/09638288.2011.587088			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	851LV	WOS:000297272600003	21870997	Green Accepted			2022-02-06	
J	Kochanek, PM; Carney, N; Adelson, PD; Ashwal, S; Bell, MJ; Bratton, S; Carson, S; Chesnut, RM; Ghajar, J; Goldstein, B; Grant, GA; Kissoon, N; Peterson, K; Selden, NR; Tong, KA; Tasker, RC; Vavilala, MS; Wainwright, MS; Warden, CR				Kochanek, Patrick M.; Carney, Nancy; Adelson, P. David; Ashwal, Stephen; Bell, Michael J.; Bratton, Susan; Carson, Susan; Chesnut, Randall M.; Ghajar, Jamshid; Goldstein, Brahm; Grant, Gerald A.; Kissoon, Niranjan; Peterson, Kimberly; Selden, Nathan R.; Tong, Karen A.; Tasker, Robert C.; Vavilala, Monica S.; Wainwright, Mark S.; Warden, Craig R.			Chapter 17. Antiseizure prophylaxis	PEDIATRIC CRITICAL CARE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; POSTTRAUMATIC SEIZURES; RISK-FACTORS; EPILEPSY; PHENYTOIN; CHILDREN; PREVENTION; CHILDHOOD; THERAPY		[Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Carney, Nancy; Carson, Susan; Peterson, Kimberly] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Warden, Craig R.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Portland, OR 97201 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Ashwal, Stephen] Loma Linda Univ, Sch Med, Div Child Neurol, Dept Pediat, Loma Linda, CA 92350 USA; [Bratton, Susan] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA; [Chesnut, Randall M.; Vavilala, Monica S.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Ghajar, Jamshid] Weill Cornell Med Coll, New York, NY USA; [Goldstein, Brahm] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Newark, NJ 07103 USA; [Grant, Gerald A.] Duke Univ, Sch Med, Durham, NC 27706 USA; [Kissoon, Niranjan] Univ British Columbia, British Columbias Childrens Hosp, Vancouver, BC V5Z 1M9, Canada; [Tasker, Robert C.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Tasker, Robert C.] Childrens Hosp Boston, Boston, MA USA; [Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.		Bratton, Susan L./O-2353-2013; Kochanek, Patrick M/D-2371-2015; Tasker, Robert C/R-5837-2019; Kissoon, Niranjan/AAC-6140-2021; Adelson, David/W-2083-2019	Bratton, Susan L./0000-0002-4605-8078; Kochanek, Patrick M/0000-0002-2627-913X; 			Anderson GD, 2007, CLIN PHARMACOKINET, V46, P447; Anderson GD, 2007, CLIN PHARMACOKINET, V46, P307, DOI 10.2165/00003088-200746040-00004; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Ates O, 2006, CHILD NERV SYST, V22, P279, DOI 10.1007/s00381-005-1177-6; Boucher BA, 1998, CLIN PHARMACOKINET, V35, P209, DOI 10.2165/00003088-199835030-00004; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Formisano R, 2007, BRAIN INJURY, V21, P499, DOI 10.1080/02699050701310994; Frend V, 2007, CLIN NEUROPHARMACOL, V30, P362, DOI 10.1097/WNF.0b013e318059ae1c; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gavranovic Muhamed, 2005, Bosn J Basic Med Sci, V5, P58; GRIEBEL ML, 1990, CRIT CARE MED, V18, P385, DOI 10.1097/00003246-199004000-00007; Holmes GL, 2005, PEDIATR NEUROL, V33, P1, DOI 10.1016/j.pediatrneurol.2004.12.003; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Kieslich M, 2001, DISABIL REHABIL, V23, P665; KIESLICH M, 1995, LANCET, V345, P187, DOI 10.1016/S0140-6736(95)90188-4; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Medvdovsky M, 2006, EPILEPSY BEHAV, V8, P429, DOI 10.1016/j.yebeh.2005.12.010; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; YOUNG B, 1983, CHILD BRAIN, V10, P185; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016	29	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1529-7535			PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2012	13	1		S			S72	S82		10.1097/PCC.0b013e31823f681d			11	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	982DS	WOS:000307022500017					2022-02-06	
J	Ledic, D; Sosa, I; Linic, IS; Cvijanovic, O; Kovacevic, M; Desnica, A; Banicek, I				Ledic, Darko; Sosa, Ivan; Linic, Ines Strenja; Cvijanovic, Olga; Kovacevic, Miljenko; Desnica, Andrej; Banicek, Ivanka			Vomiting as a reliable sign of concussion	MEDICAL HYPOTHESES			English	Article							TRAUMATIC BRAIN-INJURY; CIRCUMVENTRICULAR ORGANS; AREA POSTREMA; MARTIAL ARTS; HEAD; SPORT; RISK; BIOMECHANICS; PHARMACOLOGY; FOOTBALL	Concussion is the most common type of traumatic brain injury, with headache being the most frequent symptom of mild traumatic brain injury (MTBI) (including dizziness, vomiting, nausea, lack of motor coordination or difficulty balancing). Concussion may be caused by a blow to the head, or by acceleration forces without a direct impact. Often, MTBI occurs as the result of a sports injury. Loss of consciousness is always present, unlike vomiting. Therefore, we hypothesize vomiting to be considered as a cardinal sign of concussion. Stimulation of vomiting centres finally triggers vomiting. Professional boxers and mixed martial arts competitions reluctantly agree with stringent rules and protective clothing. We discuss the issue of further protection for those engaged in these and other sports. (C) 2011 Elsevier Ltd. All rights reserved.	[Sosa, Ivan] Rijeka Univ, Fac Med, Dept Forens Med & Criminalist, Rijeka 51000, Croatia; [Ledic, Darko; Kovacevic, Miljenko] Rijeka Univ, Fac Med, Rijeka Univ Hosp, Rijeka 51000, Croatia; [Linic, Ines Strenja] Rijeka Univ Hosp, Neurol Clin, Rijeka, Croatia; [Cvijanovic, Olga] Rijeka Univ, Fac Med, Dept Anat, Rijeka 51000, Croatia; [Desnica, Andrej] Zagreb Univ Hosp, Neurosurg Clin, Zagreb, Croatia		Sosa, I (corresponding author), Rijeka Univ, Fac Med, Dept Forens Med & Criminalist, Brace Branchetta 20, Rijeka 51000, Croatia.	isosa@medri.hr	Sosa, Ivan/F-3562-2011; strenja, ines/AAB-7244-2020; Peloza, Olga Cvijanovic/S-4662-2018; Peloza, Olga Cvijanovic/AAM-4924-2020; Sosa, Ivan/I-6327-2013	Peloza, Olga Cvijanovic/0000-0002-4381-8529; Peloza, Olga Cvijanovic/0000-0002-4381-8529; Sosa, Ivan/0000-0002-6869-3734; Strenja, Ines/0000-0002-2910-2217			ANDREWS PLR, 1990, CAN J PHYSIOL PHARM, V68, P325, DOI 10.1139/y90-047; Asthagiri AR, 2003, CLIN SPORT MED, V22, P559, DOI 10.1016/S0278-5919(02)00111-4; BARNES JH, 1984, MOL ASPECTS MED, V7, P397, DOI 10.1016/0098-2997(84)90006-2; Berg JE, 2009, J ECT, V25, P250, DOI 10.1097/YCT.0b013e3181a2f23e; Bianco M, 2008, PHYSICIAN SPORTSMED, V36, P95, DOI 10.3810/psm.2008.12.17; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; BORISON HL, 1984, FED PROC, V43, P2955; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; DREW RH, 1986, J CLIN PSYCHOL, V42, P520, DOI 10.1002/1097-4679(198605)42:3<520::AID-JCLP2270420319>3.0.CO;2-6; Duvernoy HM, 2007, BRAIN RES REV, V56, P119, DOI 10.1016/j.brainresrev.2007.06.002; Forstl H, 2010, DTSCH ARZTEBL INT, V107, P835, DOI 10.3238/arztebl.2010.0835; Gambrell Robert C, 2007, Curr Sports Med Rep, V6, P317; Ganong WF, 2000, CLIN EXP PHARMACOL P, V27, P422, DOI 10.1046/j.1440-1681.2000.03259.x; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hornby PJ, 2001, AM J MED, V111, P106, DOI 10.1016/S0002-9343(01)00849-X; Jagoda A, 2000, EMERG MED CLIN N AM, V18, P355, DOI 10.1016/S0733-8627(05)70130-9; Jax SA, 2009, ADV EXP MED BIOL, V629, P377, DOI 10.1007/978-0-387-77064-2_19; Jordan B D, 1990, Am J Sports Med, V18, P561, DOI 10.1177/036354659001800520; KASTE M, 1982, LANCET, V2, P1186; KLARA PM, 1977, J COMP NEUROL, V171, P409, DOI 10.1002/cne.901710307; LACAVA G, 1983, J SPORT MED PHYS FIT, V23, P361; Macan J, 2006, BRIT J SPORT MED, V40, P326, DOI 10.1136/bjsm.2005.022459; McCrory P, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.006338; Metz A, 2007, AUST FAM PHYSICIAN, V36, P688; MILLER AD, 1994, FRONT NEUROENDOCRIN, V15, P301, DOI 10.1006/frne.1994.1012; Miller AD, 1999, DIGEST DIS SCI, V44, p39S; Moslener MD, 2010, CURR SPORT MED REP, V9, P134, DOI 10.1249/JSR.0b013e3181dfccd9; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Pieter W, 2005, MED SPORT SCI, V48, P59, DOI 10.1159/000084283; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rodriguez RG, 2009, REGULATION BOXING HI, P23; ROSS RJ, 1987, CLIN SPORT MED, V6, P41; Ryan AJ, 1998, CLIN SPORT MED, V17, P155, DOI 10.1016/S0278-5919(05)70070-3; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Schlaeger R, 2010, NEUROLOGY, V75, P1303, DOI 10.1212/WNL.0b013e3181f61354; SCHMIDTOLSEN S, 1990, AM J SPORT MED, V18, P98, DOI 10.1177/036354659001800117; Scoggin James F 3rd, 2010, Am J Orthop (Belle Mead NJ), V39, P247; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; TAKEDA N, 1993, ACTA OTO-LARYNGOL, P10; Toth C, 2005, SPORTS MED, V35, P685, DOI 10.2165/00007256-200535080-00003; Toth C, 2008, NEUROL CLIN, V26, P1, DOI 10.1016/j.ncl.2007.12.004; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Vigh B, 2004, HISTOL HISTOPATHOL, V19, P607, DOI 10.14670/HH-19.607; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Zazryn TR, 2003, BRIT J SPORT MED, V37, P448, DOI 10.1136/bjsm.37.5.448; Zazryn TR, 2009, CLIN J SPORT MED, V19, P20, DOI 10.1097/JSM.0b013e31818f1582; Zetaruk MN, 2005, BRIT J SPORT MED, V39, P29, DOI 10.1136/bjsm.2003.010322	53	6	6	0	16	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	JAN	2012	78	1					23	25		10.1016/j.mehy.2011.09.032			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	881AZ	WOS:000299453000006	21983351				2022-02-06	
J	McLean, AM; Jarus, T; Hubley, AM; Jongbloed, L				McLean, A. M.; Jarus, T.; Hubley, A. M.; Jongbloed, L.			Differences in social participation between individuals who do and do not attend brain injury drop-in centres: A preliminary study	BRAIN INJURY			English	Article						Traumatic brain injury; community integration; leisure; quality-of-life; social reintegration; community-based rehabilitation	QUALITY-OF-LIFE; PORTLAND ADAPTABILITY INVENTORY; COMMUNITY-BASED REHABILITATION; MONTREAL COGNITIVE ASSESSMENT; SERVICE NEEDS; INTEGRATION; SUPPORT; PEOPLE; QUESTIONNAIRE; PROGRAMS	Objective: To compare social participation for individuals with traumatic brain injury (TBI) >= 1 year post-injury who attend brain injury drop-in centres (BIDCs) with individuals who do not attend but were identified as potentially benefitting from attending. Research design: Cross-sectional study with 23 individuals attending BIDCs and a comparison group of 19 individuals not attending. Key outcome measures: Community Integration Questionnaire, Social Provisions Scale and Adult Subjective Assessment of Participation. Main results: The comparison group was found to consist of 12 participants who stated that they would attend a BIDC ('Yes sub-group') and seven participants who stated that maybe they would attend a BIDC but for the most part were too busy ('Maybe sub-group'). The BIDC group was found to have statistically significantly higher levels of social participation than the comparison group and particularly the 'Yes sub-group'. Conclusions: Findings provide support that attendance at BIDCs may benefit social participation. Future directions for research are suggested.	[McLean, A. M.] GF Strong Rehabil Ctr, Vancouver, BC, Canada; [McLean, A. M.; Jarus, T.; Jongbloed, L.] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC V5Z 1M9, Canada; [Jarus, T.] Univ British Columbia, CanDo Res Lab, Vancouver, BC V5Z 1M9, Canada; [Hubley, A. M.] Univ British Columbia, Dept Educ & Counselling Psychol & Special Educ, Vancouver, BC V5Z 1M9, Canada		McLean, AM (corresponding author), T-325,2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	almclean@interchange.ubc.ca		Jarus, Tal/0000-0003-4124-7782	University of British Columbia's College of Health Disciplines Cedar Lodge Endowment; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Canadian Occupational Therapy Foundation	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This study was supported by an operational grant from The University of British Columbia's College of Health Disciplines Cedar Lodge Endowment Award (awarded to the first and second authors) and the Frederick Banting and Charles Best Canada Graduate Scholarship Master's Award from the Canadian Institutes of Health Research and a Thelma Cardwell Scholarship from the Canadian Occupational Therapy Foundation (both awarded to the first author).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Cohen J., 2013, STAT POWER ANAL BEHA; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Cutrona EC., 1987, ADV PERSONAL RELATIO, V1, P37, DOI DOI 10.1037/0882-7974.1.1.47; Dijkers M, 2006, J HEAD TRAUMA REHAB, V21, P409, DOI 10.1097/00001199-200609000-00009; Driver S, 2005, BRAIN INJURY, V19, P1067, DOI 10.1080/02699050500149338; Eriksson G, 2006, J REHABIL MED, V38, P159, DOI 10.1080/16501970500415322; Evans L, 2008, INT J THER REHABIL, V15, P446, DOI 10.12968/ijtr.2008.15.10.31213; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Fischer J., 2007, MEASURES CLIN PRACTI; Fraas M, 2007, BRAIN INJURY, V21, P1267, DOI 10.1080/02699050701721794; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Glover A, 2003, DISABIL REHABIL, V25, P750, DOI 10.1080/0963828021000058503; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Grace M, 2001, FRONTAL SYSTEMS BEHA; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Hoofien D, 2001, BRAIN INJURY, V15, P189; HUBERTY CJ, 1989, PSYCHOL BULL, V105, P302, DOI 10.1037/0033-2909.105.2.302; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Jacobs HE, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199710000-00003; JARUS T, 2006, ISRAELI J OCCUPATION, V15, P62; Johnson K, 1998, BEHAV MODIF, V22, P502, DOI 10.1177/01454455980224004; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; KUIPERS P, 1999, J COGNITIVE REHABILI, V17, P6; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Olson RA, 2008, SUPPORT CARE CANCER, V16, P1273, DOI 10.1007/s00520-008-0431-3; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Pallant J.F., 2007, SPSS SURVIVAL MANUAL; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Ruta D A, 1994, Qual Health Care, V3, P180, DOI 10.1136/qshc.3.4.180; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shrive Fiona M, 2006, BMC Med Res Methodol, V6, P57, DOI 10.1186/1471-2288-6-57; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; TEASELL R, 2008, INTRO METHODOLOGY EV, pCH1; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; ZUNG WWK, 1967, ARCH GEN PSYCHIAT, V16, P543; [No title captured], DOI DOI 10.1375/BRIM.7.2.107; WHAT IS CLUBHOUSE; 2008, CLASSIFICATION COMA	60	6	6	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2012	26	1					83	94		10.3109/02699052.2011.635353			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	858HY	WOS:000297787900009	22149447				2022-02-06	
J	Murad, A; Ghostine, S; Colohan, ART				Murad, Ali; Ghostine, Samer; Colohan, Austin R. T.			A Case for Further Investigating the Use of Controlled Lumbar Cerebrospinal Fluid Drainage for the Control of Intracranial Pressure	WORLD NEUROSURGERY			English	Article						Adults; Cerebral edema; Intracranial hypertension; Lumbar drainage; Subarachnoid hemorrhage; Traumatic brain injury	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; HYPERTENSION; PUNCTURE; HYPOTENSION; SECONDARY; CATHETER; IMPACT	OBJECTIVE: Increased intracranial pressure (ICP) that is refractory to medical measures and ventriculostomy placement after severe traumatic brain injury or aneurysmal rupture is associated with high mortality. In some recent reports, authors have described the use of lumbar cerebrospinal fluid drainage in these patients. We report the results of a prospective study involving the use of lumbar drainage in 15 patients with elevated ICP that was refractory to medical management and ventriculostomy placement. METHODS: A prospective study was designed to enroll patients at Loma Linda University Medical Center. Ten patients with traumatic brain injury and five patients with ruptured aneurysms were enrolled. Medical management included maintaining serum Na >150 mEq/L, mild hyperventilation, deep sedation, and maintenance of normothermia. A lumbar drain was placed when ICP was >20 mm Hg for an average of 3 hours despite the optimization of the aforementioned parameters. RESULTS: After lumbar drain placement, ICP was reduced from a mean of 28.2 +/- 6.5 mm Hg to 10.1 +/- 7.1 mm Hg (P < 0.001). Requirements for hyperosmolar therapy, sedatives, and paralytics were also significantly decreased (P < 0.05) after lumbar drain placement. One patient had unilateral papillary changes four hours after lumbar drain placement. The pupil returned to its normal state after decompressive craniectomy. There was no incidence of CSF infection. Three of the 15 patients died during the study period. CONCLUSIONS: This study shows the beneficial role of lumbar cerebrospinal fluid drainage as an effective and safe treatment modality for elevated ICP.	[Murad, Ali] Swedish Neurosci Inst, Seattle, WA USA; [Ghostine, Samer] Univ Calif Irvine, Dept Neurosurg, Orange, CA 92668 USA; [Colohan, Austin R. T.] Loma Linda Univ, Med Ctr, Dept Neurosurg, Loma Linda, CA USA		Murad, A (corresponding author), Swedish Neurosci Inst, Seattle, WA USA.	ali_murad@yahoo.com					Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; [Anonymous], 2000, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD000033; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Basauri LT, 1999, CRIT REV NEUROSURG, V9, P21, DOI 10.1007/s003290050104; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; DUFFY GP, 1969, BRIT MED J, V1, P407, DOI 10.1136/bmj.1.5641.407; Joffe Ari R, 2007, J Intensive Care Med, V22, P194, DOI 10.1177/0885066607299516; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; KOREIN J, 1959, NEUROLOGY, V9, P290, DOI 10.1212/WNL.9.4.290; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Llompart-Pou JA, 2011, ANAESTH INTENS CARE, V39, P79, DOI 10.1177/0310057X1103900113; Manosuthi W, 2008, INT J STD AIDS, V19, P268, DOI 10.1258/ijsa.2007.007286; Marmarou A, 2005, ACT NEUR S, V95, P277; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Mason CB, 1927, RES NERV MENT DIS P, V8, P422; Munch EC, 2001, CRIT CARE MED, V29, P976; Murad A, 2011, ACTA NEUROCHIR SUPPL, V110, P183, DOI 10.1007/978-3-7091-0356-2_34; Murad A, 2008, ACT NEUR S, V102, P89, DOI 10.1007/978-3-211-85578-2_18; NASH CS, 1937, ANN OTO RHINOL LARYN, V46, P673; Schaller WF, 1933, J NEUROL PSYCHOPATHO, V14, P116; SHAPIRO SA, 1992, NEUROSURGERY, V30, P241, DOI 10.1227/00006123-199202000-00015; Tomosvari Adrienn, 2005, Orvosi Hetilap, V146, P159; Tuettenberg J, 2009, J NEUROSURG, V110, P1200, DOI 10.3171/2008.10.JNS08293; VOURCH G, 1963, BRIT J ANAESTH, V35, P118, DOI 10.1093/bja/35.2.118; Willemse RB, 1998, ACT NEUR S, V71, P37; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	32	6	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2012	77	1					160	165		10.1016/j.wneu.2011.06.018			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	919DD	WOS:000302300300045	22154151				2022-02-06	
J	Resnik, L; Reiber, G				Resnik, Linda; Reiber, Gayle			Long-term Disabilities Associated With Combat Casualties: Measuring Disability and Reintegration in Combat Veterans	JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS			English	Article							TRAUMATIC BRAIN-INJURY; INTERNATIONAL CLASSIFICATION; COMMUNITY REINTEGRATION; HEALTH; PARTICIPATION; SERVICEMEMBERS; OUTCOMES	Many physical and mental health problems associated with combat casualties affect the reintegration of service members into home and community life. Quantifying and measuring reintegration is important to answer questions about clinical, research, economic, and policy issues that directly affect combat veterans. Although the construct of participation presented in the International Statistical Classification of Diseases and Related Health Problems and in the International Classification of Functioning, Disability and Health provides a theoretical framework with which to understand and measure community reintegration in general, a measure was needed that specifically addressed the reintegration of combat veterans. To address this need, the Community Reintegration for Service Members global outcomes measure was developed. It consists of three scales, which measure extent of participation, perceived limitations, and satisfaction. The measure was validated in a general sample of veterans and in a sample of severely wounded service members. The computer-adapted test version shows good precision, reliability, construct validity, and predictive validity.	[Resnik, Linda] Brown Univ, Providence VA Med Ctr, Alpert Med Sch, Providence, RI 02912 USA; [Resnik, Linda] Brown Univ, Dept Hlth Serv Policy & Practice, Alpert Med Sch, Providence, RI 02912 USA; [Reiber, Gayle] Univ Washington, Hlth Serv Res & Dev Serv, Dept Vet Affairs, VA Puget Sound Hlth Care Syst, Seattle, WA 98195 USA; [Reiber, Gayle] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Reiber, Gayle] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA		Resnik, L (corresponding author), Brown Univ, Providence VA Med Ctr, Alpert Med Sch, Providence, RI 02912 USA.						Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Doyle ME, 2005, PSYCHIAT QUART, V76, P361, DOI 10.1007/s11126-005-4972-z; Fayed N, 2011, DISABIL REHABIL, V33, P1941, DOI 10.3109/09638288.2011.553704; Haley SM, 2008, ARCH PHYS MED REHAB, V89, P275, DOI 10.1016/j.apmr.2007.08.150; Litz B, 2003, IRAQ WAR CLIN GUIDE, P21; McConachie H, 2006, DISABIL REHABIL, V28, P1157, DOI 10.1080/09638280500534507; Reiber GE, 2010, J REHABIL RES DEV, V47, P275, DOI 10.1682/JRRD.2010.01.0009; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Ustun TB, 2003, DISABIL REHABIL, V25, P565, DOI 10.1080/0963828031000137063; Whiteneck G., 2006, WORKSH DIS AM NEW LO, P50; World Health Organization, 2002, COMM LANG FUNCT DIS; World Health Organization, 2007, INT CLASS FUNCT DIS	17	6	6	1	10	AMER ACAD ORTHOPAEDIC SURGEONS	ROSEMENT	6300 N RIVER ROAD, ROSEMENT, IL 60018-4262 USA	1067-151X			J AM ACAD ORTHOP SUR	J. Am. Acad. Orthop. Surg.		2012	20			1			S31	S34		10.5435/JAAOS-20-08-S31			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Surgery	984NZ	WOS:000307199000008	22865133				2022-02-06	
J	Rzheutskaya, RE				Rzheutskaya, Ryta E.			Characteristics of Hemodynamic Disorders in Patients with Severe Traumatic Brain Injury	CRITICAL CARE RESEARCH AND PRACTICE			English	Article							EXTRAVASCULAR LUNG WATER; END-DIASTOLIC VOLUME; SEVERE HEAD-INJURY; TRANSPULMONARY THERMODILUTION; FLUID RESPONSIVENESS; TISSUE OXYGENATION; CARDIAC PRELOAD; MANAGEMENT; INTERLEUKIN-6; INDICATOR	Purpose. To define specific features of central hemodynamic parameter changes in patients with isolated severe traumatic brain injury (STBI) and in patients with clinically established brain death and to determine the required course of treatment for their correction. Data and Research Methods. A close study of central hemodynamic parameters was undertaken. The study involved 13 patients with isolated STBI (group STBI) and 15 patients with isolated STBI and clinically established brain death (group STBIBD). The parameters of central hemodynamics were researched applying transpulmonary thermodilution. Results. In the present study, various types of hemodynamic reaction (normodynamic, hyperdynamic, and hypodynamic) were identified in patients with isolated STBI in an acute period of traumatic disease. Hyperdynamic type of blood circulation was not observed in patients with isolated STBI and clinically established brain death. Detected hemodynamic disorders led to the correction of the ongoing therapy under the control of central hemodynamic parameters. Conclusions. Monitoring of parameters of central hemodynamics allows to detect the cause of disorders, to timely carry out the required correction, and to coordinate infusion, inotropic, and vasopressor therapy.	[Rzheutskaya, Ryta E.] Belarusian State Med Univ, Dept Anesthesiol & Intens Care, Dzerzhinsky Ave 83, Minsk 220116, BELARUS		Rzheutskaya, RE (corresponding author), Belarusian State Med Univ, Dept Anesthesiol & Intens Care, Dzerzhinsky Ave 83, Minsk 220116, BELARUS.	rgeutskaja@mail.ru	Bonino, Ferruccio/B-7522-2013; Bonino, Ferruccio/C-6036-2018	Bonino, Ferruccio/0000-0001-9942-0328			[Anonymous], 2007, GUIDELINES MANAGEMEN; Belzberg H, 2007, J TRAUMA, V63, P1032, DOI 10.1097/01.ta.0000235995.86162.d2; Belzberg H, 2007, J TRAUMA, V62, P1192, DOI 10.1097/01.ta.0000219701.07295.b8; Berkenstadt H, 2001, ANESTH ANALG, V92, P984; Boulard G., ANNALES FRENCH ANAES, V24, P836; Boulard G., 2005, P SFAR 6STE AG BIOM; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COOKE RS, 1995, INJURY, V26, P395, DOI 10.1016/0020-1383(95)00003-R; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; Deleu D, 2007, SAUDI MED J, V28, P283; Della Rocca G, 2007, CURR OPIN CRIT CARE, V13, P297; DIEBEL LN, 1992, ARCH SURG-CHICAGO, V127, P817; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Godje O, 2002, CRIT CARE MED, V30, P52; Gravame V, 2000, Minerva Anestesiol, V66, P217; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; HILL DA, 1993, AUST NZ J SURG, V63, P604, DOI 10.1111/j.1445-2197.1993.tb00466.x; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kirov MY, 2005, INTENSIVE CARE MEDICINE: ANNUAL UPDATE 2005, P449; LichtwarckAschoff M, 1996, J CRIT CARE, V11, P180, DOI 10.1016/S0883-9441(96)90029-5; Mangat Halinder S, 2012, Continuum (Minneap Minn), V18, P532, DOI 10.1212/01.CON.0000415426.76524.e1; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marx G, 2004, EUR J ANAESTH, V21, P132, DOI 10.1017/S0265021504002091; Mascia L, 2009, MINERVA ANESTESIOL, V75, P125; McKeown DW, 2012, BRIT J ANAESTH, V108, pI96, DOI 10.1093/bja/aer351; Michard F, 2002, CHEST, V121, P2000, DOI 10.1378/chest.121.6.2000; Michard F, 2003, CHEST, V124, P1900, DOI 10.1378/chest.124.5.1900; Michard F, 2005, CRIT CARE MED, V33, P1243, DOI 10.1097/01.CCM.0000164566.23147.35; Michard F, 2003, YB INTENSIVE CARE EM, P508, DOI [10.1007/978-1-4757-5548-0_48, DOI 10.1007/978-1-4757-5548-0_48]; Murugan R, 2008, CRIT CARE MED, V36, P1810, DOI 10.1097/CCM.0b013e318174d89f; Murugan R, 2009, CRIT CARE MED, V37, P2387, DOI 10.1097/CCM.0b013e3181a960d6; Mutoh T, 2009, STROKE, V40, P2368, DOI 10.1161/STROKEAHA.109.547463; Nicholls TP, 2006, J AM COLL SURGEONS, V202, P120, DOI 10.1016/j.jamcollsurg.2005.09.007; Powner David J, 2005, Prog Transplant, V15, P226; REUSE C, 1990, CHEST, V98, P1450, DOI 10.1378/chest.98.6.1450; Sakka SG, 2000, INTENS CARE MED, V26, P180, DOI 10.1007/s001340050043; Sakka SG, 2002, CHEST, V122, P2080, DOI 10.1378/chest.122.6.2080; Titova Yu. V., 2010, Anesteziologiya i Reanimatologiya, P24; Yaroshetsky A. I., 2010, Anesteziologiya i Reanimatologiya, P4	39	6	7	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-1305	2090-1313		CRIT CARE RES PRACT	Crit. Care Res. Pract.		2012	2012								606179	10.1155/2012/606179			11	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V33WB	WOS:000215794400047	23056932	Green Submitted, gold, Green Published			2022-02-06	
J	Sams, R; LaBrie, DW; Norris, J; Schauer, J; Frantz, E				Sams, Richard; LaBrie, D. Walter; Norris, Jacob; Schauer, Judy; Frantz, Earl			IED Blast Postconcussive Syncope and Autonomic Dysregulation	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CONCUSSION; SEVERITY; IRAQ	Concussions are the most frequent battle injury sustained in Afghanistan. The Concussion Restoration Care Center provides multidisciplinary care to concussed service members in theater. The Concussion Restoration Care Center has managed over 500 concussions, the majority being from improvised explosive device (LED) blasts. Syncope following a concussion without a loss of consciousness is rarely reported in the literature. The pathophysiology of concussion from a blast injury may be distinct from a concussion secondary to blunt trauma. Two cases of syncope following concussions with an alteration of consciousness are presented, and a mechanism of action is proposed. Post-IED blast concussive symptom frequency at initial presentation on a cohort of patients is reported, with 1.3% of patients experiencing postconcussive syncope. Syncope following an IED blast may be related to centrally mediated autonomic dysregulation at the brain stem level. Syncope should be added to the list of possible symptoms that occur following concussions, in particular concussions following a blast injury.	[Sams, Richard] USN, Hosp Jacksonville, Dept Family Med, Jacksonville, FL 32214 USA; [LaBrie, D. Walter] USN, Med Ctr Portsmouth, Portsmouth, VA 23708 USA; [Norris, Jacob] USN, Hlth Res Ctr, Warfighter Performance Dept, San Diego, CA 92106 USA; [Schauer, Judy] USN, Med Clin, Basic Sch, Quantico, VA 22134 USA; [Frantz, Earl] USN, Hosp Camp Lejeune, Sports Med Dept, Camp Lejeune, NC 28547 USA		Sams, R (corresponding author), USN, Hosp Jacksonville, Dept Family Med, 2080 Child St, Jacksonville, FL 32214 USA.			Sams, Richard/0000-0003-3264-9616			Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; *MAN CONC MTBI WOR, 2009, VA DOD CLIN PRACT GU, P7; Mosqueda-Garcia R, 2000, CIRCULATION, V102, P2898; PELLERIN C, US DEP DEFENSE NEWS; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; STAKHOVSKAYA LV, 1984, SOV MEDITISINA, P16; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; WOOD D, HUFFINGTON POST; Zhang Jiangyue, 2009, Biomed Sci Instrum, V45, P119	16	6	6	0	8	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	JAN	2012	177	1					48	51		10.7205/MILMED-D-11-00214			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874RP	WOS:000298976100012	22338979	Bronze			2022-02-06	
J	Sanchez-Molina, D; Velazquez-Ameijide, J; Arregui-Dalmases, C; Crandall, JR; Untaroiu, CD				Sanchez-Molina, D.; Velazquez-Ameijide, J.; Arregui-Dalmases, C.; Crandall, J. R.; Untaroiu, C. D.			Minimization of Analytical Injury Metrics for Head Impact Injuries	TRAFFIC INJURY PREVENTION			English	Article						Head injury; HIC; Injury metrics; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; PREVENTION; PROTECTION; SIMULATION; CRITERION; ACCOUNT; SIMON; MODEL	Objective: To compare the predictions of the head injury criterion (HIC), currently used to predict the risk of traumatic brain injury in frontal vehicle impact and pedestrian impact tests, with the predictions of other empirical and analytical injury metrics. Methods: The appropriateness of different criteria relative to injury metrics derived from a head finite element (FE) model is investigated for different deceleration pulses in this research. Empirical injury metrics are computed by direct calculation for different analyzed pulses. In addition, for each pulse full FE model simulations of a complete human head were performed by means of the SIMon model. The computations are used to calculate the analytical injury metrics. Results: This article shows that an optimal head deceleration curve based on HIC does not minimize other analytical injury metrics. The results obtained in this study suggest that the HIC criterion does not necessarily provide the same severity ranking for different external loadings to the head as the injury metrics derived from the FE models. Conclusion: Countermeasures designed based only on HIC could differ significantly from those based on analytical injury measures computed by FE models. The use of multiple injury metrics is recommended given that no scalar measure seems to be positively and strongly correlated with relevant injury metrics.	[Sanchez-Molina, D.; Velazquez-Ameijide, J.] Univ Politecn Cataluna, Dept Strength Mat, Barcelona 08036, Spain; [Arregui-Dalmases, C.] Univ Politecn Cataluna, Dept Mech Engn, Barcelona 08036, Spain; [Arregui-Dalmases, C.; Crandall, J. R.; Untaroiu, C. D.] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA USA		Sanchez-Molina, D (corresponding author), Univ Politecn Cataluna, Dept Strength Mat, C Compte dUrgell 187, Barcelona 08036, Spain.	david.sanchez-molina@upc.edu	Untaroiu, Costin/D-4106-2009; Sanchez-Molina, David/I-2149-2014; Crandall, Jeff R/N-2210-2014	Untaroiu, Costin/0000-0002-1813-669X; Sanchez-Molina, David/0000-0002-0671-4106; Velazquez-Ameijide, Juan/0000-0001-6872-3609			Balandin DV, 2008, J COMPUT SYS SC INT+, V47, P93, DOI [10.1134/S1064230708010127, 10.1007/s11488-008-1012-0]; Balandin DV, 2007, SHOCK VIB, V14, P355, DOI 10.1155/2007/175156; Balandin DV, 2005, J COMPUT SYS SC INT+, V44, P247; BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; Darvish KK, 2002, INT RES COUNC BIOM I; Eppinger RH, 1995, STAPP CAR CRASH J, V38, P145; Gong SW, 2008, COMPUT STRUCT, V86, P758, DOI 10.1016/j.compstruc.2007.06.003; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Langlois JA, 2006, TRAUMATIC BRAIN INJU; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Okamoto Y, 1994, 14 INT TECHN C ENH S; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; Pilkey WD, 2010, INJURY BIOMECHANICS, P233; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Takhounts E.G., 2011, 22 INT TECHN C ENH S; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Untaroiu CD, 2007, INT J CRASHWORTHINES, V12, P581, DOI 10.1080/13588260701492947	21	6	6	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1538-9588			TRAFFIC INJ PREV	Traffic Inj. Prev.		2012	13	3					278	285		10.1080/15389588.2011.650803			8	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	945MF	WOS:000304277200008	22607250				2022-02-06	
B	Scremin, OU; Holschneider, DP		Watson, C; Paxinos, G; Puelles, L		Scremin, Oscar U.; Holschneider, Daniel P.			Vascular Supply	MOUSE NERVOUS SYSTEM			English	Article; Book Chapter							CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; MOUSE-BRAIN; STATISTICAL-ANALYSIS; RAT-BRAIN; COMPUTED-TOMOGRAPHY; ANESTHETIZED MOUSE; HYDROGEN CLEARANCE; GLUCOSE-METABOLISM		[Scremin, Oscar U.] VA Greater Los Angeles Healthcare Syst, Res Dept, Los Angeles, CA USA; [Scremin, Oscar U.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Holschneider, Daniel P.] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, Keck Sch Med, Dept Behav Sci Neurol Cell & Neurobiol, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA USA		Scremin, OU (corresponding author), VA Greater Los Angeles Healthcare Syst, Res Dept, Los Angeles, CA USA.						Abruzzo T, 2008, SYNAPSE, V62, P557, DOI 10.1002/syn.20511; Adamczak JM, 2010, NEUROIMAGE, V51, P704, DOI 10.1016/j.neuroimage.2010.02.083; Atlan M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2715184; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P744, DOI 10.1097/01.WCB.0000122745.72175.D5; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; Beckmann N, 1999, J MAGN RESON, V140, P442, DOI 10.1006/jmre.1999.1864; Bitner BR, 2010, J CEREBR BLOOD F MET, V30, P1105, DOI 10.1038/jcbfm.2010.47; BROWN JO, 1966, ANAT REC, V156, P99, DOI 10.1002/ar.1091560112; Capone C, 2009, HYPERTENSION, V54, P302, DOI 10.1161/HYPERTENSIONAHA.109.133249; Casteels C, 2006, J NUCL MED, V47, P1858; Craigie EH, 1920, J COMP NEUROL, V31, P429, DOI 10.1002/cne.900310504; Demchenko IT, 1998, UNDERSEA HYPERBAR M, V25, P147; Dorr A, 2007, NEUROIMAGE, V35, P1409, DOI 10.1016/j.neuroimage.2006.12.040; Dubois A, 2008, NEUROIMAGE, V40, P482, DOI 10.1016/j.neuroimage.2007.11.054; Dubois A, 2010, NEUROIMAGE, V51, P586, DOI 10.1016/j.neuroimage.2010.02.074; Duhamel G, 2008, MAGN RESON MED, V59, P846, DOI 10.1002/mrm.21567; Fan YY, 2011, J CEREBR BLOOD F MET, V31, P305, DOI 10.1038/jcbfm.2010.94; Gerard RW, 1938, RES PUBL ASSOC RES N, V18, P316; GOLDMAN H, 1973, AM J PHYSIOL, V224, P122, DOI 10.1152/ajplegacy.1973.224.1.122; GONZALEZLIMA F, 1993, PHYSIOL BEHAV, V54, P605, DOI 10.1016/0031-9384(93)90256-F; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; Hirase H, 2004, NEUROSCIENCE, V128, P209, DOI 10.1016/j.neuroscience.2004.07.002; Holschneider DP, 2008, BRAIN RES, V1234, P32, DOI 10.1016/j.brainres.2008.07.038; Holschneider DP, 2000, NEUROSCIENCE, V101, P869, DOI 10.1016/S0306-4522(00)00436-X; JAY TM, 1988, J CEREBR BLOOD F MET, V8, P121, DOI 10.1038/jcbfm.1988.16; Jia YL, 2011, J BIOPHOTONICS, V4, P57, DOI 10.1002/jbio.201000001; Jia YL, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3207121; Kennan RP, 2004, MAGN RESON MED, V51, P525, DOI 10.1002/mrm.20014; Kety SS, 1955, FED PROC, V14, P85; KLEIN B, 1986, AM J PHYSIOL, V251, pH1333, DOI 10.1152/ajpheart.1986.251.6.H1333; Kober F, 2008, NMR BIOMED, V21, P781, DOI 10.1002/nbm.1253; Lee JS, 2005, EUR J NUCL MED MOL I, V32, P696, DOI 10.1007/s00259-004-1739-y; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Littlewood CL, 2006, PSYCHOPHARMACOLOGY, V186, P64, DOI 10.1007/s00213-006-0344-0; MADAR I, 1994, SYNAPSE, V18, P79, DOI 10.1002/syn.890180202; Maeda K, 2000, J CEREBR BLOOD F MET, V20, P10, DOI 10.1097/00004647-200001000-00003; MATHIAS CJ, 1990, J NUCL MED, V31, P351; Mizuma H, 2010, J NUCL MED, V51, P1068, DOI 10.2967/jnumed.110.075184; MORI K, 1990, J NEUROCHEM, V54, P307, DOI 10.1111/j.1471-4159.1990.tb13316.x; Mostany R, 2008, JOVE-J VIS EXP, V12, DOI [10.3791/678, DOI 10.3791/678]; Muir ER, 2008, MAGN RESON MED, V60, P744, DOI 10.1002/mrm.21721; Murakami K, 1998, BRAIN RES, V780, P304, DOI 10.1016/S0006-8993(97)01217-1; Nakamachi T, 2010, ACTA NEUROCHIR SUPPL, V106, P43, DOI 10.1007/978-3-211-98811-4_6; NELSON SR, 1968, J NEUROCHEM, V15, P1271, DOI 10.1111/j.1471-4159.1968.tb05904.x; Nguyen PT, 2010, NEUROIMAGE, V52, P1243, DOI 10.1016/j.neuroimage.2010.04.259; Nguyen PT, 2004, NEUROIMAGE, V23, P252, DOI 10.1016/j.neuroimage.2004.05.014; Nishio K, 2010, STROKE, V41, P1278, DOI 10.1161/STROKEAHA.110.581686; Pissarek M, 2009, EUR J NUCL MED MOL I, V36, P1495, DOI 10.1007/s00259-009-1142-9; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Pruett SB, 2009, TOXICOL SCI, V109, P265, DOI 10.1093/toxsci/kfp073; Riviere C, 2007, RADIOLOGY, V244, P439, DOI 10.1148/radiol.2442060912; ROSENBLUM WI, 1977, STROKE, V8, P103, DOI 10.1161/01.STR.8.1.103; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Schambach SJ, 2009, STROKE, V40, P1444, DOI 10.1161/STROKEAHA.108.521740; Schmidt CF, 1938, RES PUBL ASSOC RES N, V18, P229; Schmitt O, 2007, INT J COMPUT VISION, V73, P5, DOI 10.1007/s11263-006-9780-x; SCHWARTZMAN RJ, 1986, BRAIN RES, V398, P113, DOI 10.1016/0006-8993(86)91256-4; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Scremin O, 1995, RAT NERVOUS SYSTEM, V2, P3; Scremin OU, 1999, BRAIN RES, V824, P36, DOI 10.1016/S0006-8993(99)01167-1; Shin HK, 2008, STROKE, V39, P1548, DOI 10.1161/STROKEAHA.107.499483; Stumpf W., 1995, AUTORADIOGRAPHY CORR; Suarez S, 2009, PSYCHOPHARMACOLOGY, V202, P599, DOI 10.1007/s00213-008-1338-x; Szczurkowski A, 2007, ANAT HISTOL EMBRYOL, V36, P147, DOI 10.1111/j.1439-0264.2006.00747.x; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tota S, 2010, BEHAV BRAIN RES, V209, P73, DOI 10.1016/j.bbr.2010.01.017; Tsukuda K, 2009, HYPERTENSION, V54, P782, DOI 10.1161/HYPERTENSIONAHA.109.136879; Verant P, 2007, J CEREBR BLOOD F MET, V27, P1072, DOI 10.1038/sj.jcbfm.9600415; Wong CHY, 2008, J NEUROCHEM, V107, P241, DOI 10.1111/j.1471-4159.2008.05605.x; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yamada A, 2009, NEUROREPORT, V20, P1538, DOI 10.1097/WNR.0b013e32833244f0; Yoneyama-Sarnecky T, 2010, DEV NEUROSCI-BASEL, V32, P81, DOI 10.1159/000258700; YOUNG H, 1994, EUR J NUCL MED, V21, P336, DOI 10.1007/BF00947969; Yu X, 2010, NEUROIMAGE, V49, P1667, DOI 10.1016/j.neuroimage.2009.09.021; Zeman W., 1963, CRAIGIES NEUROANATOM; Zhang WR, 2009, J CEREBR BLOOD F MET, V29, P1475, DOI 10.1038/jcbfm.2009.65; Zhen G, 2007, J NEUROSCI METH, V166, P73, DOI 10.1016/j.jneumeth.2007.06.029; Zhou Q, 2009, MAGN RESON IMAGING, V27, P155, DOI 10.1016/j.mri.2008.07.002	79	6	6	0	0	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-08-091918-8; 978-0-12-369497-3				2012							459	472		10.1016/B978-0-12-369497-3.10014-7			14	Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BFP24	WOS:000320856100015					2022-02-06	
J	Singh, R; Venkateshwara, G; Kirkland, J; Batterley, J; Bruce, S				Singh, Rajiv; Venkateshwara, Guruprasad; Kirkland, John; Batterley, Julie; Bruce, Sarah			Clinical pathways in head injury: improving the quality of care with early rehabilitation	DISABILITY AND REHABILITATION			English	Article						brain injury; clinical pathways; quality; rehabilitation	TRAUMATIC BRAIN-INJURY; ADULTS; INTERVENTION; GUIDELINES; MANAGEMENT; PREDICTORS; CAREGIVERS; IMPACT; COSTS	Purpose: To improve the management of all hospital admissions with head injuries, including mild and moderate by developing a clinical pathway and a head injury team. Methods: A head injury team was set up to take over the care of all admissions with head injury and to manage appropriate referrals and discharges. A key role was to facilitate communication between the different services involved in head injury care, arrange follow-up, support relatives and to educate healthcare staff. Results: In the first year, the team took over the care of 196 admissions of whom 128 attended for 3-month follow-up with 66% having a good outcome. Patients and relatives feedback was excellent with an average score of 4.8/5 on overall satisfaction rating. Other centers in the United Kingdom are aiming to set up similar pathways, and the team has presented on head injury pathways extensively. Conclusions: A clinical pathway can improve the quality of care for all admissions with head injury and enhance the role for rehabilitation at an early stage.	[Singh, Rajiv; Venkateshwara, Guruprasad; Kirkland, John; Batterley, Julie; Bruce, Sarah] No Gen Hosp, Sheffield Teaching Hosp, Osborn Unit, Sheffield S5 7AU, S Yorkshire, England		Singh, R (corresponding author), No Gen Hosp, Sheffield Teaching Hosp, Osborn Unit, Sheffield S5 7AU, S Yorkshire, England.	rajiv.singh@sth.nhs.uk		singh, rajiv/0000-0002-3173-9591			Beecham J, 2009, BRAIN INJURY, V23, P30, DOI 10.1080/02699050802590338; Davies R., 2009, INT J CARE PATHW, V13, P7, DOI [DOI 10.1258/JICP.2008.009004, 10.1258/jicp.2008.009004]; *DEP HLTH, 2000, NHS PLAN; Department of Health, 2007, NAT I HLTH CLIN EXC; Department of Health, 2005, NAT SERV FRAM LONG T; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Espinosa-Aguilar A, 2008, J TRAUMA, V64, P1327, DOI 10.1097/TA.0b013e3181469ebe; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; GARNICK DW, 1991, JAMA-J AM MED ASSOC, V266, P2856, DOI 10.1001/jama.266.20.2856; Kitchiner D, 1996, ARCH DIS CHILD, V75, P166, DOI 10.1136/adc.75.2.166; Kitchiner D, 1998, BRIT MED J, V317, P147, DOI 10.1136/bmj.317.7151.147b; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Kwan J, 2003, STROKE, V34, P587, DOI 10.1161/01.STR.0000054673.28010.1B; Maas Andrew I R, 2009, Crit Care, V13, P1016, DOI 10.1186/cc8163; Marwit SJ, 2006, BRAIN INJURY, V20, P1419, DOI 10.1080/02699050601082214; Mcilvoy L, 2001, J Neurosci Nurs, V33, P72; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Vitaz TW, 2001, J TRAUMA, V51, P369, DOI 10.1097/00005373-200108000-00025; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	24	6	6	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2012	34	5					439	442		10.3109/09638288.2011.608146			4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	876CV	WOS:000299085700009	21985127				2022-02-06	
J	Sitthinamsuwan, B; Chanvanitkulchai, K; Phonwijit, L; Nunta-aree, S; Kumthornthip, W; Ploypetch, T				Sitthinamsuwan, Bunpot; Chanvanitkulchai, Kannachod; Phonwijit, Luckchai; Nunta-aree, Sarun; Kumthornthip, Witsanu; Ploypetch, Teerada			Improvement of Sitting Ability and Ambulation Status after Selective Peripheral Neurotomy of the Sciatic Hamstring Nerve together with Obturator Branches for Severe Spasticity of the Lower Extremities	STEREOTACTIC AND FUNCTIONAL NEUROSURGERY			English	Article						Spasticity; Selective peripheral neurotomy; Sitting; Ambulation	TRAUMATIC BRAIN-INJURY; TIBIAL NEUROTOMY; EQUINOVARUS FOOT; CEREBRAL-PALSY; FOLLOW-UP; EQUINUS FOOT; MANAGEMENT; PATIENT; SERIES; ANKLE	Background: The authors used selective peripheral neurotomy (SPN) on the sciatic and obturator nerves to restore the sitting posture and ambulation in bedridden patients suffering from severe proximal lower limb spasticity. Objective: To study the surgical outcome of sciatic and obturator neurotomies. Methods: All patients with refractory hamstring spasticity who encountered SPN on the hamstring nerve were recruited. Obturator neurotomy was undertaken in some individuals. The clinical assessment included Modified Ashworth Scale (MAS), passive range of motion (PROM), sitting competency and ambulatory condition. These parameters were compared between before and after the surgery by using the Wilcoxon signed-rank test. Results: Among the sciatic neurotomy group (n = 15), the mean pre- and postoperative MAS and PROM were 3.3 and 0.8 (p < 0.01) and 78.3 and 121.7 degrees (p < 0.01), respectively. Those measurements of the obturator nerve surgery group (n = 11) were 3.7 and 1.1 (p < 0.01) as well as 21.0 and 45.0 degrees (p < 0.01), respectively. Seven and 8 of a total of 9 patients had statistically significant improvement in sitting ability (p = 0.016) and ambulation status (p < 0.01), respectively. Conclusion: Bedridden patients who suffer from severe proximal lower limb spasticity have an optimum to return to sitting and ambulate with a wheelchair after SPN of the sciatic and obturator nerves. Copyright (C) 2012 S. Karger AG, Basel	[Sitthinamsuwan, Bunpot; Chanvanitkulchai, Kannachod; Phonwijit, Luckchai; Nunta-aree, Sarun] Mahidol Univ, Siriraj Hosp, Fac Med, Div Neurosurg,Dept Surg, Bangkok 10700, Thailand; [Kumthornthip, Witsanu; Ploypetch, Teerada] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Rehabil Med, Bangkok 10700, Thailand		Sitthinamsuwan, B (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Div Neurosurg,Dept Surg, 12th Floor,Siammintara Bldg,2 Pran Nok Rd, Bangkok 10700, Thailand.	bunpotsi@yahoo.com		Sitthinamsuwan, Bunpot/0000-0002-6925-1954			Abbruzzese G, 2002, EUR J NEUROL, V9, P30, DOI 10.1046/j.1468-1331.2002.0090s1030.x; Abdennebi B, 1996, ACTA NEUROCHIR, V138, P917, DOI 10.1007/BF01411279; Anwar K, 2005, OPER TECH NEUROSURG, V7, P128; Azouvi P, 1996, ARCH PHYS MED REHAB, V77, P35, DOI 10.1016/S0003-9993(96)90217-8; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bollens B, 2011, J REHABIL MED, V43, P277, DOI 10.2340/16501977-0786; Boop FA, 2001, J CHILD NEUROL, V16, P54, DOI 10.1177/088307380101600109; Boviatsis EJ, 2005, CLIN NEUROL NEUROSUR, V107, P289, DOI 10.1016/j.clineuro.2004.09.007; Buffenoir K, 2004, NEUROSURGERY, V55, P1130, DOI 10.1227/01.NEU.0000140840.59586.CF; CARPENTER EB, 1983, FOOT ANKLE, V4, P164, DOI 10.1177/107110078300400309; Carrillo-Ruiz J., 2005, OPER TECH NEUROSURG, V7, P136; Collado H, 2006, J REHABIL MED, V38, P212, DOI 10.1080/16501970500538024; Decq P, 2000, NEUROSURGERY, V47, P1154, DOI 10.1097/00006123-200011000-00027; Decq P, 1996, NEUROCHIRURGIE, V42, P275; Decq P, 1998, NEUROCHIRURGIE, V44, P175; Deltombe T, 2006, AM J PHYS MED REHAB, V85, P82, DOI 10.1097/01.phm.0000193506.70371.cf; Deltombe T, 2010, ARCH PHYS MED REHAB, V91, P1025, DOI 10.1016/j.apmr.2010.04.010; Elovic EP, 2004, J HEAD TRAUMA REHAB, V19, P155, DOI 10.1097/00001199-200403000-00007; Jang SH, 2004, YONSEI MED J, V45, P743, DOI 10.3349/ymj.2004.45.4.743; Johnson GR, 2002, EUR J NEUROL, V9, P10, DOI 10.1046/j.1468-1331.2002.0090s1010.x; Kim JH, 2010, J KOREAN NEUROSURG S, V47, P247, DOI 10.3340/jkns.2010.47.4.247; Kwon JY, 2009, AM J PHYS MED REHAB, V88, P7, DOI 10.1097/PHM.0b013e31815b6381; Lazorthes Y, 2002, EUR J NEUROL, V9, P35, DOI 10.1046/j.1468-1331.2002.0090s1035.x; Ochs G, 1999, NEUROMODULATION, V2, P108, DOI 10.1046/j.1525-1403.1999.00108.x; Palacio A., 2010, Annals of Physical and Rehabilitation Medicine, V53, P417, DOI 10.1016/j.rehab.2010.06.001; Park YB, 2007, J KOREAN NEUROSURG S, V41, P22; Rousseaux M, 2009, J NEUROL SCI, V278, P71, DOI 10.1016/j.jns.2008.11.024; Sheean G, 2002, EUR J NEUROL, V9, P3, DOI 10.1046/j.1468-1331.2002.0090s1003.x; Sindou MP, 2007, CHILD NERV SYST, V23, P957, DOI 10.1007/s00381-007-0399-1; Sindou MP, 2000, STEREOT FUNCT NEUROS, V74, P217, DOI 10.1159/000056483; Sindou MP, 2005, OPER TECH NEUROSURG, V7, P96; Sindou MP, 2005, OPER TECH NEUROSURG, V7, P113; Sitthinamsuwan B, 2010, NEUROL SURG, V1, P44; Sitthinamsuwan B, 2010, SIRIRAJ MED J, V62, P106; Sitthinamsuwan B, 2010, STEREOT FUNCT NEUROS, V88, P187, DOI 10.1159/000313872; Smyth MD, 2000, MUSCLE NERVE, V23, P153, DOI 10.1002/(SICI)1097-4598(200002)23:2<153::AID-MUS3>3.0.CO;2-4; Tabtimsuwan S., 2011, Siriraj Medical Journal, V63, P32; Ward AB, 2002, EUR J NEUROL, V9, P48, DOI 10.1046/j.1468-1331.2002.0090s1048.x	38	6	6	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1011-6125	1423-0372		STEREOT FUNCT NEUROS	Stereotact. Funct. Neurosurg.		2012	90	5					335	343		10.1159/000338679			9	Neurosciences; Neuroimaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	027MP	WOS:000310356900007	22847252				2022-02-06	
J	Zhivolupov, SA; Samartsev, IN; Marchenko, AA; Puljatkina, OV				Zhivolupov, S. A.; Samartsev, I. N.; Marchenko, A. A.; Puljatkina, O. V.			The prognostic significance of brain-derived neurotrophic factor (BDNF) for phobic anxiety disorders, vegetative and cognitive impairments during conservative treatment including adaptol of some functional and organic diseases of nervous system	ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article						neuroplasticity; BDNF; consequences of closed head injury; adaptol	BIPOLAR DISORDER; DEPRESSION	We have studied the efficacy of adaptol in the treatment of 45 patients with somatoform dysfunction of the autonomic nervous system and 30 patients with closed head injury. The condition of patients during the treatment was evaluated with clinical and neuropsychological scales. The serum level of BDNF before and after the treatment has been studied as well. Adaptol has been shown to enhance the production of BDNF, reduce significantly the intensity of anxiety, autonomic disorders and improve intellectual processes. The dose-dependent effect of the drug has been demonstrated. In conclusion, adaptol can be recommended for treatment of diseases that demand stimulation of neuroplasticity in the CNS.	[Zhivolupov, S. A.; Samartsev, I. N.; Marchenko, A. A.; Puljatkina, O. V.] Mil Med Acad, Chair Nervous Dis & Psychiat, St Petersburg, Russia		Zhivolupov, SA (corresponding author), Mil Med Acad, Chair Nervous Dis & Psychiat, St Petersburg, Russia.	peroslava@yandex.ru	Zhivolupov, S./K-8147-2019				Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Banasr M, 2007, BIOL PSYCHIAT, V62, P496, DOI 10.1016/j.biopsych.2007.02.006; Barde Y.A., 1985, ANNU REV PHYSIOL, V45, P601; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Chen CH, 2006, BIOL PSYCHIAT, V59, P31, DOI 10.1016/j.biopsych.2005.06.008; D Kuipers S, 2006, CURR OPIN DRUG DISC, V9, P580; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Kauer-Sant'Anna M, 2008, BRIT J PSYCHIAT, V192, P458, DOI 10.1192/bjp.bp.107.040295; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; ODINAK MM, 2010, TOPICHESKAYA DIAGNOS, P232; Pearse A G, 1980, Basic Appl Histochem, V24, P63; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; Schmidt Heath D, 2008, Drug Discov Today Ther Strateg, V5, P151, DOI 10.1016/j.ddstr.2008.10.003; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; YUNKEROV VI, 2005, MATEMATIKO STATIST O, P292	23	6	9	0	1	IZDATELSTVO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	1997-7298			ZH NEVROL PSIKHIATR	Z. Nevrol. Psikhiatrii Im S S Korsakova		2012	112	4					37	41					5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	961EL	WOS:000305446700007	22810739				2022-02-06	
J	Allen, BB; Hoffman, CE; Traube, CS; Weinstein, SL; Greenfield, JP				Allen, Baxter B.; Hoffman, Caitlin E.; Traube, Chani S.; Weinstein, Steven L.; Greenfield, Jeffrey P.			Continuous Brain Tissue Oxygenation Monitoring in the Management of Pediatric Stroke	NEUROCRITICAL CARE			English	Article						Cerebral ischemia; Brain tissue oxygenation; Pediatric stroke; Critical care management; Stroke; Traumatic brain injury; Brain injury	CEREBRAL OXYGENATION; NORMOBARIC HYPEROXIA; TENSION; METABOLISM; CHILDREN; THERAPY; INJURY; DIFFUSION; PRESSURE; ISCHEMIA	Direct invasive monitoring of brain tissue oxygenation (PbtO(2)) has been routinely utilized to predict cerebral ischemia and to prevent secondary injury in patients with traumatic brain injury (TBI) and vasospasm secondary to subarachnoid hemorrhage (SAH). The safety and utility of these devices in the pediatric population have been examined in a few small studies. No studies, however, have examined the use of PbtO(2) monitoring in stroke patients. Retrospective chart review of the first two consecutive, critically ill pediatric patients in the pediatric intensive care unit requiring brain tissue oxygen monitoring for newly diagnosed cerebral ischemia. ICP, CPP, PbtO(2), SaO(2), BP, and RR were all continually monitored during their care and were retrospectively collected and reviewed. We present two pediatric stroke patients managed in a critical care setting with PbtO(2) monitoring in addition to ICP, MAP, CPP, and SaO(2). Both patients had multiple events of low brain tissue oxygen (PbtO(2) < 20 torr), independent of abnormal values in other monitoring parameters, which required physician intervention. No new ischemic damage occurred after PbtO(2) monitoring began in either patient. There is currently inadequate data to support the application of PbtO(2) monitoring in children with stroke to prevent progressive ischemia and to improve outcome. However, the positive results for these two patients support the need for further study in this area.	[Hoffman, Caitlin E.; Greenfield, Jeffrey P.] Weill Cornell Med Coll, Dept Neurol Surg, New York Presbyterian Hosp, New York, NY 10065 USA; [Allen, Baxter B.; Weinstein, Steven L.] Weill Cornell Med Coll, Div Child Neurol, Dept Pediat, New York, NY 10065 USA; [Traube, Chani S.] Weill Cornell Med Coll, Div Crit Care, Dept Pediat, New York, NY 10065 USA		Greenfield, JP (corresponding author), Weill Cornell Med Coll, Dept Neurol Surg, New York Presbyterian Hosp, 525 E 68th St,POB 99, New York, NY 10065 USA.	jpgreenf@med.cornell.edu	Traube, Chani/AAG-1028-2019; Allen, Baxter/X-3841-2019	Traube, Chani/0000-0003-1863-7950; Greenfield, Jeffrey/0000-0003-1904-1040			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Al-Rawi PG, 2010, STROKE, V41, P122, DOI 10.1161/STROKEAHA.109.560698; Chen HI, 2008, NEUROSURGERY, V63, P880, DOI 10.1227/01.NEU.0000327882.10629.06; Dani KA, 2010, ANN NEUROL, V68, P37, DOI 10.1002/ana.22032; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Du F, 2009, MAGN RESON MED, V62, P1385, DOI 10.1002/mrm.22146; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; Figaji AA, 2009, CHILD NERV SYST, V25, P1335, DOI 10.1007/s00381-009-0821-y; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Flynn EP, 2002, ANN NEUROL, V52, P566, DOI 10.1002/ana.10322; Gelabert-Gonzalez M, 2002, ACTA NEUROCHIR, V144, P863, DOI 10.1007/s00701-002-0975-9; Hoffman WE, 1999, SURG NEUROL, V51, P654, DOI 10.1016/S0090-3019(99)00011-7; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; Lee SH, 2010, J VET MED SCI, V72, P583, DOI 10.1292/jvms.09-0103; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; SEVERINGHAUS JW, 1989, J APPL PHYSIOL, V67, P902; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; Singhal AB, 2002, J CEREBR BLOOD F MET, V22, P861, DOI 10.1097/00004647-200207000-00011; Singhal AB, 2007, STROKE, V38, P2851, DOI 10.1161/STROKEAHA.107.487280; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Ushewokunze S, 2009, CHILD NERV SYST, V25, P341, DOI 10.1007/s00381-008-0752-z; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018	31	6	6	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2011	15	3					529	536		10.1007/s12028-011-9531-x			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	852NT	WOS:000297365400026	21416310				2022-02-06	
J	Howle, AA; Nott, MT; Baguley, IJ				Howle, Alison A.; Nott, Melissa T.; Baguley, Ian J.			Aspiration Pneumonia Following Severe Traumatic Brain Injury: Prevalence and Risk Factors for Long-Term Mortality	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; aspiration pneumonia; dysphagia; mortality; cause of death coding; rehabilitation	FUNCTIONAL ORAL INTAKE; HEAD-INJURY; OROPHARYNGEAL DYSPHAGIA; SWALLOWING DISORDERS; NURSING-HOME; OUTCOMES; STROKE; IMPACT; DEATH; REHABILITATION	Dysphagia and aspiration pneumonia are prevalent but infrequently studied complications following severe traumatic brain injury (TBI). Aspiration pneumonia is responsible for a significant number of long-term deaths in this population, however, the reported number of deaths attributed to aspiration pneumonia may be inaccurate. This multicentre inception cohort (n = 2545) study analysed consecutive discharges from 3 metropolitan inpatient brain injury rehabilitation units from January 1990 to October 2007 following inpatient rehabilitation following primary TBI. Subject data was linked to national death registries to determine cause of death where relevant. This study aimed to (a) evaluate the prevalence of aspiration pneumonia, percutaneous endoscopic gastrostomy (PEG) insertion and dysphagia following TBI, (b) identify the number of deaths ascribed to aspiration pneumonia, and (c) characterise associated risk factors for long-term aspiration pneumonia related deaths compared to all other causes of death. In-hospital PEG insertion occurred in 18.4% of the sample, two thirds of whom remained dysphagic at discharge. In-hospital aspiration pneumonia was recorded in 3.6% of the sample. Postdischarge, people with TBI were 79 times more likely to die from aspiration pneumonia than the general population. Risks were higher for subjects discharged to a nursing home, with severe ongoing functional disability, dysphagia at discharge, in those who had experienced in-hospital aspiration pneumonia or required PEG insertion. Early identification and risk management of dysphagia and aspiration pneumonia in TBI nursing home populations may maximise these individuals' quality and length of life.	[Howle, Alison A.; Nott, Melissa T.; Baguley, Ian J.] Westmead Hosp, Brain Injury Rehabil Serv, Sydney, NSW, Australia		Baguley, IJ (corresponding author), Brain Injury Rehabil Serv, POB 533, Wentworthville, NSW 2145, Australia.	ian.baguley@swahs.health.nsw.gov.au	Baguley, Ian/AAM-5828-2021; Baguley, Ian J/K-6878-2013; Nott, Melissa T/M-6778-2018	Baguley, Ian J/0000-0001-5650-3705; Nott, Melissa T/0000-0001-7088-5826	Lifetime Care and Support Authority of New South Wales [08157, 10588]	The authors gratefully acknowledge the contributions of Dr Karen Byth, Louise Brown and the members of the Multicentre Mortality Study group. The authors thank the Lifetime Care and Support Authority of New South Wales for their financial support (research grants 08157 and 10588).	Altman KW, 2010, ARCH OTOLARYNGOL, V136, P784, DOI 10.1001/archoto.2010.129; Australian Institute of Health and Welfare (AIHW), 2011, DAT HOLD DET NAT DEA; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley I.J., MED J AUSTR IN PRESS; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Doggett DL, 2001, DYSPHAGIA, V16, P279, DOI 10.1007/s00455-001-0087-3; Ekberg O, 2002, DYSPHAGIA, V17, P139, DOI 10.1007/s00455-001-0113-5; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; FINEGOLD SM, 1991, REV INFECT DIS, V13, pS737; Garcia-Peris P, 2007, CLIN NUTR, V26, P710, DOI 10.1016/j.clnu.2007.08.006; Groenewoud JH, 2000, ARCH INTERN MED, V160, P357, DOI 10.1001/archinte.160.3.357; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P2114, DOI 10.1016/j.apmr.2008.04.013; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P1556, DOI 10.1016/j.apmr.2007.11.063; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; Langmore SE, 2002, DYSPHAGIA, V17, P298, DOI 10.1007/s00455-002-0072-5; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Logemanin JA, 2008, J SPEECH LANG HEAR R, V51, P173, DOI 10.1044/1092-4388(2008/013); Logemann JA, 1998, EVALUATION TREATMENT; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; MARTENS L, 1990, Dysphagia, V5, P147; Martino R, 2009, J CLIN EPIDEMIOL, V62, P518, DOI 10.1016/j.jclinepi.2008.05.007; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Quagliarello V, 2005, CLIN INFECT DIS, V40, P1, DOI 10.1086/426023; Schurr MJ, 1999, J TRAUMA, V46, P817, DOI 10.1097/00005373-199905000-00009; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Smithard DG, 2007, AGE AGEING, V36, P90, DOI 10.1093/ageing/afl149; Smithard DG, 1996, STROKE, V27, P1200, DOI 10.1161/01.STR.27.7.1200; Terre R, 2009, NEUROGASTROENT MOTIL, V21, P361, DOI 10.1111/j.1365-2982.2008.01208.x; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; van der Steen JT, 2002, ARCH INTERN MED, V162, P1753, DOI 10.1001/archinte.162.15.1753; VANDENBROUCKE JP, 1982, AM J EPIDEMIOL, V115, P303, DOI 10.1093/oxfordjournals.aje.a113306; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; *WHO, 2007, INT CLASS DIS; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992	41	6	6	0	20	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	DEC	2011	12	3					179	186					8	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	887FJ	WOS:000299912000002					2022-02-06	
J	Park, S; Roederer, A; Mani, R; Schmitt, S; LeRoux, PD; Ungar, LH; Lee, I; Kasner, SE				Park, Soojin; Roederer, Alexander; Mani, Ram; Schmitt, Sarah; LeRoux, Peter D.; Ungar, Lyle H.; Lee, Insup; Kasner, Scott E.			Limitations of Threshold-Based Brain Oxygen Monitoring for Seizure Detection	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Physiologic monitoring; Subarachnoid hemorrhage; Non-convulsive seizure disorder; Oxygen/Metabolism; Brain injuries/physiopathology	STATUS EPILEPTICUS; CEREBRAL METABOLISM; INTENSIVE-CARE; INJURY; ELECTROENCEPHALOGRAPHY; PERFUSION; PRESSURE; INCREASE	Brain tissue oxygen (PbtO(2)) monitors are utilized in a threshold-based fashion, triggering actions based on the presumption of tissue compromise when PbtO(2) is less than 20 mmHg. Some early published practice guidelines suggest that seizure is a potential culprit when PbtO(2) crosses this threshold; evidence for this is not well defined. Data were collected manually as part of a prospective observational database. PbtO(2) monitors and continuous electroencephalogram (cEEG) were placed by clinical protocol in aneurysmal subarachnoid hemorrhage (aSAH) or traumatic brain injury (TBI) patients with a Glasgow Coma Scale (GCS) a parts per thousand currency sign 8. Eight patients with discrete seizures during an overlapping monitored period were identified. Probability of seizure when PbtO(2) value was < 20 mmHg (and the inverse) were calculated. There were 343 distinct seizure episodes and 1797 PbtO(2) measurements. 8.9% of seizures were followed by a PbtO(2) value below 20 mmHg. Of all observed low PbtO(2) values, 3.8% were associated with seizure. Seizure length did not influence PbtO(2). Two patients with the highest number of seizures developed low PbtO(2) values post-seizure. Seizures were neither associated with a PbtO(2) value of < 20 mmHg nor associated with a drop in PbtO(2) value across a clinically significant threshold. However, we cannot rule out the existence of any relationship between PbtO(2) and seizure with this limited data set. Prospective research using electronically recorded data is required to more effectively examine the relationship between PbtO(2) and seizure.	[Park, Soojin; Mani, Ram; Schmitt, Sarah; Kasner, Scott E.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Park, Soojin; LeRoux, Peter D.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Park, Soojin] Univ Penn, Sch Med, Dept Anesthesiol, Philadelphia, PA 19104 USA; [Park, Soojin] Univ Penn, Sch Med, Dept Crit Care, Philadelphia, PA 19104 USA; [Roederer, Alexander; Ungar, Lyle H.; Lee, Insup] Univ Penn, Dept Comp & Informat Sci, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA		Park, S (corresponding author), Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	soojin.park@uphs.upenn.edu		Schmitt, Sarah/0000-0003-1384-9794			Bhatia A, 2007, INTENS CARE MED, V33, P1322, DOI 10.1007/s00134-007-0660-9; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; Drislane FW, 2009, EPILEPSIA, V50, P1566, DOI 10.1111/j.1528-1167.2008.01993.x; GEIGER A, 1947, AM J PHYSIOL, V149, P517, DOI 10.1152/ajplegacy.1947.149.3.517; Gopinath SP, 1999, TRAUMATIC BRAIN INJU, P107; Grant IS, 1999, BRIT MED J, V319, P110, DOI 10.1136/bmj.319.7202.110; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P332, DOI 10.1097/00004691-199907000-00005; KRUMHOLZ A, 1995, NEUROLOGY, V45, P1499, DOI 10.1212/WNL.45.8.1499; Littlejohns Linda R, 2003, Crit Care Nurse, V23, P17; Littlejohns LR, 2003, CRIT CARE NURSE, V23, P6; McKhann GM, 2004, MANAGEMENT CEREBRAL, P431; MELDRUM BS, 1973, ARCH NEUROL-CHICAGO, V29, P82, DOI 10.1001/archneur.1973.00490260026003; MELDRUM BS, 1976, BRAIN, V99, P523, DOI 10.1093/brain/99.3.523; MEYER JS, 1966, ELECTROEN CLIN NEURO, V21, P10, DOI 10.1016/0013-4694(66)90054-X; PLUM F, 1968, ARCH NEUROL-CHICAGO, V18, P1; POSNER JB, 1969, ARCH NEUROL-CHICAGO, V20, P388, DOI 10.1001/archneur.1969.00480100064010; ROBERTSON C, 2004, YOUMANS NEUROLOGICAL, V4, P5103; Rossetti AO, 2010, CURR OPIN CRIT CARE, V16, P105, DOI 10.1097/MCC.0b013e3283374b5b; SCHMIDT CF, 1945, AM J PHYSIOL, V143, P33, DOI 10.1152/ajplegacy.1945.143.1.33; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; Wilensky Eileen Maloney, 2005, J Neurosci Nurs, V37, P278; YAHAGI N, 1995, ANESTH ANALG, V80, P404, DOI 10.1097/00000539-199502000-00033; Zhao MR, 2007, EPILEPSIA, V48, P2059, DOI 10.1111/j.1528-1167.2007.01229.x	30	6	6	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2011	15	3					469	476		10.1007/s12028-011-9540-9			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	852NT	WOS:000297365400017	21523525				2022-02-06	
J	Shirakawa, T; Nakano, K; Hachiya, N; Kato, N; Kaneko, K				Shirakawa, Takafumi; Nakano, Kenji; Hachiya, Naomi; Kato, Nobumasa; Kaneko, Kiyotoshi			The involvement of P2X(1) receptor in pyramidal cell degeneration in the rat hippocampus after trimethyltin administration	NEUROSCIENCE RESEARCH			English	Article						P2 receptors; Neuronal cell death; COX-2; Hippocampus; Trimethyltin; CA1	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN-INJURY; GLUCOSE DEPRIVATION; ALZHEIMERS-DISEASE; EXTRACELLULAR ATP; P2 RECEPTORS; TIME-COURSE; NEURONS; EXPRESSION; CYCLOOXYGENASE-2	The P2 family of receptors for adenosine 5'-triphosphate (ATP) is involved in several neuronal and glial cell functions in the central nervous system (CNS), and impaired function of these receptors is associated with both neuronal and glial dysfunction. Using quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and immunohistochemical analysis, we examined the expression profiles of P2 subtype receptors in the rat hippocampus following treatment with the neurotoxicant trimethyltin (TMT). Among the subtypes, P2X(1) exhibited a unique profile, with an increase in expression prior to the onset of cell death after TMT administration, and a gradual decrease thereafter in neuronal cells in the rat hippocampus. This expression pattern was similar to that of cyclooxygenase-2 (COX-2) following TMT administration. The P2X1 antagonist NF499 strongly prevented neuronal cell death induced by TMT in the CA1 region, and successfully suppressed locomotor hyperreactivity. Furthermore, NF449 administration also inhibited COX-2 expression in the CA1 region on day 3 following TMT treatment, whereas no change was observed in the CA3. These findings suggest that P2X(1) plays a primary role in TMT-induced neuronal cell death in the CA1 region. (C) 2011 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Shirakawa, Takafumi; Hachiya, Naomi; Kaneko, Kiyotoshi] Tokyo Med Univ, Dept Neurophysiol, Tokyo 1608402, Japan; [Shirakawa, Takafumi] Astellas Pharma Inc, Drug Safety Res Labs, Drug Discovery Res, Yodogawa Ku, Osaka 5328514, Japan; [Nakano, Kenji] Astellas Res Technol Co Ltd, Dept Pathol, Yodogawa Ku, Osaka 5328514, Japan; [Kato, Nobumasa] Showa Univ, Sch Med, Dept Psychiat, Karasuyama Hosp,Setagaya Ku, Tokyo 1578577, Japan		Hachiya, N (corresponding author), Tokyo Med Univ, Dept Neurophysiol, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	naomi@tokyo-med.ac.jp			Intractable Disease Division; Ministry of Health, Labor and WelfareMinistry of Health, Labour and Welfare, Japan; committee for the Epochal Diagnosis and Treatment of Amyloidosis in Japan	This study was supported by Grants-in-Aid from the Intractable Disease Division, the Ministry of Health, Labor and Welfare, and a research committee for the Epochal Diagnosis and Treatment of Amyloidosis in Japan.	ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Abdullah L, 2006, NEUROSCI LETT, V395, P240, DOI 10.1016/j.neulet.2005.10.090; Amadio S, 2002, NEUROPHARMACOLOGY, V42, P489, DOI 10.1016/S0028-3908(01)00197-6; BARNARD EA, 1994, TRENDS PHARMACOL SCI, V15, P67, DOI 10.1016/0165-6147(94)90280-1; Brambilla R, 2000, J AUTONOM NERV SYST, V81, P3, DOI 10.1016/S0165-1838(00)00152-1; Brambilla R, 2001, ANN NY ACAD SCI, V939, P54; Braun K, 2001, N-S ARCH PHARMACOL, V364, P285, DOI 10.1007/s002100100463; Cavaliere F, 2003, NEUROSCIENCE, V120, P85, DOI 10.1016/S0306-4522(03)00228-8; Cavaliere F, 2005, NEUROSCIENCE, V136, P615, DOI 10.1016/j.neuroscience.2005.04.038; Cavaliere F, 2001, NEUROCHEM INT, V38, P189, DOI 10.1016/S0197-0186(00)00088-7; Cavaliere F, 2007, J PHARMACOL EXP THER, V323, P70, DOI 10.1124/jpet.106.119024; Cham JL, 2006, EXP PHYSIOL, V91, P403, DOI 10.1113/expphysiol.2005.032409; CHANG LW, 1983, NEUROBEH TOXICOL TER, V5, P443; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; DYER RS, 1982, NEUROBEH TOXICOL TER, V4, P141; Ferrero Maria E, 2009, Recent Pat Antiinfect Drug Discov, V4, P108; Franke H, 2006, PHARMACOL THERAPEUT, V109, P297, DOI 10.1016/j.pharmthera.2005.06.002; Govoni S, 2001, NEUROSCI LETT, V303, P91, DOI 10.1016/S0304-3940(01)01675-5; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Ikeda M, 1996, BRAIN RES, V712, P168, DOI 10.1016/0006-8993(95)01530-2; Ishida N, 1997, NEUROSCIENCE, V81, P1183, DOI 10.1016/S0306-4522(97)00220-0; Kassack MU, 2004, EUR J MED CHEM, V39, P345, DOI 10.1016/j.ejmech.2004.01.007; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kharlamov A, 2002, EXP BRAIN RES, V147, P353, DOI 10.1007/s00221-002-1251-1; Kim DS, 2006, BRAIN RES, V1120, P151, DOI 10.1016/j.brainres.2006.08.057; Kittner H, 2003, NEUROPSYCHOPHARMACOL, V28, P435, DOI 10.1038/sj.npp.1300043; Koistinaho J, 1999, STROKE, V30, P1900, DOI 10.1161/01.STR.30.9.1900; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kunz T, 2006, RESTOR NEUROL NEUROS, V24, P55; Latini L, 2010, J NEUROSCI RES, V88, P500, DOI 10.1002/jnr.22238; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Liu M, 2006, EUR J NEUROSCI, V23, P2027, DOI 10.1111/j.1460-9568.2006.04724.x; Liu Y, 2005, NEUROSCI RES, V51, P317, DOI 10.1016/j.neures.2004.12.004; McLarnon JG, 2005, J NEUROSCI RES, V81, P349, DOI 10.1002/jnr.20475; Moran-Jimenez MJ, 2000, MOL BRAIN RES, V78, P50, DOI 10.1016/S0169-328X(00)00067-X; Morita M, 2008, NEUROSCIENCE, V153, P1135, DOI 10.1016/j.neuroscience.2008.01.078; Nilsberth C, 2002, NEUROTOX RES, V4, P625, DOI 10.1080/1029842021000045471; Nishimura T, 2001, MOL BRAIN RES, V97, P1, DOI 10.1016/S0169-328X(01)00278-9; North RA, 1997, CURR OPIN NEUROBIOL, V7, P346, DOI 10.1016/S0959-4388(97)80062-1; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rettinger J, 2005, NEUROPHARMACOLOGY, V48, P461, DOI 10.1016/j.neuropharm.2004.11.003; RUPPERT PH, 1982, NEUROBEH TOXICOL TER, V4, P135; Shirakawa T, 2007, NEUROSCI RES, V59, P117, DOI 10.1016/j.neures.2007.06.1468; Swanson LW, 1992, BRAIN MAPS STRUCTURE; Takemiya T, 2006, NEUROSCI RES, V56, P103, DOI 10.1016/j.neures.2006.06.003; Tsunashima K, 1998, SYNAPSE, V29, P333; Tsutsumi S, 2002, EXP NEUROL, V173, P86, DOI 10.1006/exnr.2001.7824; Volonte C, 2003, CNS NEUROL DISORD-DR, V2, P403, DOI 10.2174/1568007033482643; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; WOOFRUFF ML, 1994, TOXIN INDUCED MODELS, P319; Xiang ZH, 2006, BRAIN RES, V1099, P56, DOI 10.1016/j.brainres.2006.04.126; Xu J, 2003, PROSTAG LEUKOTR ESS, V69, P437, DOI 10.1016/j.plefa.2003.08.016; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027	55	6	6	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	DEC	2011	71	4					396	404		10.1016/j.neures.2011.08.005			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	859LD	WOS:000297877000011	21871932				2022-02-06	
J	Walimuni, IS; Abid, H; Hasan, KM				Walimuni, Indika S.; Abid, Humaira; Hasan, Khader M.			A computational framework to quantify tissue microstructural integrity using conventional MRI macrostructural volumetry	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Diffusion tensor imaging; DTI; FreeSurfer; Conventional MRI; cMRI; Relaxation; Segmentation; Registration; ANTS; FSL; FNIRT; Quality control; Brain atlas	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; IN-VIVO; DIFFUSION TRACTOGRAPHY; FRACTIONAL ANISOTROPY; THEORETICAL-ANALYSIS; PROBABILISTIC ATLAS; CORTICAL THICKNESS; DT-MRI; SEGMENTATION	In this work, we present a framework to fuse and quantify tissue microstructural attributes (e.g. diffusion, functional, relaxation and perfusion MRI) using high spatial resolution T1-weighted volumetric measurements. The proposed computational procedures can be implemented by utilizing advanced, image segmentation, registration and diffusion tensor image processing software. Feasibility of the framework is also demonstrated using in-house developed software and freely available software such as FreeSurfer for regional tissue segmentation, Advanced Normalization Tools (ANTs) for registration and DTIStudio for fiber tracking and diffusion tensor data processing. We also demonstrate the application of these methods in the provision of quality control measures to assess the fidelity of tissue segmentation and multi-modal MRI registration. (C) 2010 Elsevier Ltd. All rights reserved.	[Walimuni, Indika S.; Abid, Humaira; Hasan, Khader M.] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Imaging, Houston, TX 77030 USA		Hasan, KM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Imaging, 6431 Fannin St,MSB 2-100, Houston, TX 77030 USA.	Khader.M.Hasan@uth.tmc.edu	Hasan, Khader M./ABB-5767-2020		NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS052505-04]; Dunn Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052505] Funding Source: NIH RePORTER	This work was funded by the NIH-NINDS Grant R01 NS052505-04 and the Dunn Fund.	Allen JS, 2008, NEUROIMAGE, V42, P535, DOI 10.1016/j.neuroimage.2008.05.047; Ardekani S, 2005, MAGN RESON MED, V54, P1163, DOI 10.1002/mrm.20651; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants B, 2008, ACAD RADIOL, V15, P1360, DOI 10.1016/j.acra.2008.07.007; Ballester MAG, 2000, MED IMAGE ANAL, V4, P189, DOI 10.1016/S1361-8415(00)00013-X; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Boss A, 2010, INVEST RADIOL, V45, P270, DOI 10.1097/RLI.0b013e3181dc3671; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Cherubini A, 2009, NEUROIMAGE, V48, P29, DOI 10.1016/j.neuroimage.2009.06.035; Cherubini A, 2009, MAGN RESON MED, V61, P1066, DOI 10.1002/mrm.21978; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fjell AM, 2008, NEUROIMAGE, V42, P1654, DOI 10.1016/j.neuroimage.2008.06.005; Germond L, 2000, ARTIF INTELL MED, V20, P77, DOI 10.1016/S0933-3657(00)00054-3; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hasan KM, 2008, MAGN RESON MED, V59, P7, DOI 10.1002/mrm.21434; Hasan KM, 2007, MAGN RESON IMAGING, V25, P1196, DOI 10.1016/j.mri.2007.02.011; Hasan KM, 2007, NEUROIMAGE, V34, P1497, DOI 10.1016/j.neuroimage.2006.10.029; Hasan KM, 2010, MAGN RESON MED, V64, P1382, DOI 10.1002/mrm.22515; Hasan KM, 2009, MAGN RESON IMAGING, V27, P631, DOI 10.1016/j.mri.2008.10.007; Hasan KM, 2005, J MAGN RESON IMAGING, V21, P735, DOI 10.1002/jmri.20296; Hasan KM, 2003, MAGNET RESON MED, V50, P589, DOI 10.1002/mrm.10552; HASAN KM, 2010, DIFFUSION TENSOR BAS, DOI DOI 10.1002/HBM.21004; Hasan KM, 2010, ANN M INT SOC MAGN R, P606; HASAN KM, 2006, PROGR BRAIN MAPPING, P1; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kamada K, 2007, J NEUROSURG, V106, P90, DOI 10.3171/jns.2007.106.1.90; Kamali A, 2010, J NEUROSCI METH, V191, P249, DOI 10.1016/j.jneumeth.2010.06.026; Kaplan E, 2010, NEUROIMAGE, V52, P436, DOI 10.1016/j.neuroimage.2010.04.247; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kloppel S, 2008, BRAIN, V131, P196, DOI 10.1093/brain/awm275; Knaus TA, 2010, BRAIN LANG, V112, P113, DOI 10.1016/j.bandl.2009.11.005; Mabbott DJ, 2006, NEUROIMAGE, V33, P936, DOI 10.1016/j.neuroimage.2006.07.024; Makris N, 2009, CEREB CORTEX, V19, P777, DOI 10.1093/cercor/bhn124; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2005, MRI ATLAS HUMAN WHIT; Mori S., 2007, INTRO DIFFUSION TENS; Ostby Y, 2009, J NEUROSCI, V29, P11772, DOI 10.1523/JNEUROSCI.1242-09.2009; Pannek K, 2010, NEUROIMAGE, V50, P1044, DOI 10.1016/j.neuroimage.2010.01.020; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; PATENAUDE B, TR07BP1 FMRIB; Radlinska BA, 2009, ANN NEUROL, V66, P825, DOI 10.1002/ana.21796; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Simon JH, 2006, J MAGN RESON IMAGING, V24, P983, DOI 10.1002/jmri.20719; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Studholme C, 2008, MED IMAGE ANAL, V12, P742, DOI 10.1016/j.media.2008.03.010; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tang E.X., 2000, COMPUTERIZED MED IMA, V24, P349; Thottakara P, 2006, NEUROIMAGE, V29, P868, DOI 10.1016/j.neuroimage.2005.08.051; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Widjaja E, 2009, RADIOLOGY, V251, P206, DOI 10.1148/radiol.2511081092; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	62	6	6	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825			COMPUT BIOL MED	Comput. Biol. Med.	DEC	2011	41	12			SI		1073	1081		10.1016/j.compbiomed.2010.10.009			9	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	863XD	WOS:000298200700004	21130424				2022-02-06	
J	Yang, CC; Huang, SJ; Lin, WC; Tsai, YH; Hua, MS				Yang, Chi-Cheng; Huang, Sheng-Jean; Lin, Wei-Chi; Tsai, Yi-Hsin; Hua, Mau-Sun			National Taiwan University Irritability Scale: Evaluating Irritability in Patients With Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						irritability; traumatic brain injury; scale	NEUROPSYCHIATRIC SYMPTOMS; QUESTIONNAIRE; PREVALENCE; VALIDATION; INVENTORY	Irritability is not uncommon after traumatic brain injury (TBI). Unfortunately, no instruments are available to directly measure this clinical feature. This study thus aimed to develop a specific scale to evaluate the irritability for patients with TBI. A total of 144 participants, which include 80 healthy participants and 64 patients suffering from TBI, were recruited. Irritability was assessed by the National Taiwan University Irritability Scale (NTUIS). Our results showed the NTUIS has good reliability. The factor analysis further revealed 2 different components: annoyance, and verbal aggression. Moreover, both self-reported and family-reported irritability postinjury were significantly higher than the irritability reported by the healthy participants. Indeed patients with TBI have significant problems with irritability after injuries, and thus a more specific assessment tool to carefully evaluate patients' irritability should be used.	[Hua, Mau-Sun] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Yang, Chi-Cheng; Lin, Wei-Chi] Clin Psychol Program, Dept Occupat Therapy, Tao Yuan, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 10764, Taiwan; [Tsai, Yi-Hsin] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan		Hua, MS (corresponding author), Natl Taiwan Univ, Dept Psychol, 1,Sec 4,Roosevelt Rd, Taipei 10764, Taiwan.	ccyang@mail.cgu.edu.tw; huams@ntu.edu.tw			National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 99-2410-H-182-012-MY2]	This study is partially supported by the National Science Council of Taiwan. (NSC 99-2410-H-182-012-MY2).	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Alderman N, 2004, SCI PRACT NEUROPSYCH, P269; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Archer N, 2007, AM J GERIAT PSYCHIAT, V15, P202, DOI 10.1097/01.JGP.0000232510.77213.10; Aybek S, 2007, BEHAVIORAL AND COGNITIVE NEUROLOGY OF STROKE, P520, DOI 10.1017/CBO9780511544880.027; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benazzi F, 2005, J AFFECT DISORDERS, V84, P197, DOI 10.1016/j.jad.2004.07.006; BENDIG AW, 1962, J CONSULT PSYCHOL, V26, P200, DOI 10.1037/h0048664; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Buss A.H., 1961, PSYCHOL AGGRESSION; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; Chow TW, 2002, INT J GERIATR PSYCH, V17, P22, DOI 10.1002/gps.509; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Craig KJ, 2008, PSYCHIAT RES, V159, P367, DOI 10.1016/j.psychres.2007.03.002; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; DIKMEN SS, 1989, MILD HEAD INJURY, P229; Eslinger PJ, 2000, BEHAVIOR AND MOOD DISORDERS IN FOCAL BRAIN LESIONS, P217; GLADUE BA, 1991, PSYCHOL REP, V68, P675, DOI 10.2466/PR0.68.2.675-684; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Harris JA, 1997, BEHAV RES THER, V35, P1047, DOI 10.1016/S0005-7967(97)00064-8; HARRIS JA, 1995, BEHAV RES THER, V33, P991, DOI 10.1016/0005-7967(95)00038-Y; Hollingworth P, 2006, J AM GERIATR SOC, V54, P1348, DOI 10.1111/j.1532-5415.2006.00854.x; JENNETT B, 1975, LANCET, V1, P480; Kaufman H., 1970, AGGRESSION ALTRUISM; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim JS, 2002, NEUROLOGY, V58, P1106, DOI 10.1212/WNL.58.7.1106; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Perlis RH, 2005, J CLIN PSYCHIAT, V66, P159, DOI 10.4088/JCP.v66n0202; Robinson R.G., 2006, CLIN NEUROPSYCHIATRY, P414; SNAITH RP, 1978, BRIT J PSYCHIAT, V132, P164, DOI 10.1192/bjp.132.2.164; Spielberger C D, 1995, Issues Compr Pediatr Nurs, V18, P207, DOI 10.3109/01460869509087271; VANGOOZEN SHM, 1994, AGGRESSIVE BEHAV, V20, P79, DOI 10.1002/1098-2337(1994)20:2<79::AID-AB2480200202>3.0.CO;2-K; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	37	6	6	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2011	12	3					200	209					10	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	887FJ	WOS:000299912000004					2022-02-06	
J	Andover, MS; Schatten, HT; Crossman, DM; Donovick, PJ				Andover, Margaret S.; Schatten, Heather T.; Crossman, Donna M.; Donovick, Peter J.			NEUROPSYCHOLOGICAL FUNCTIONING IN PRISONERS WITH AND WITHOUT SELF-INJURIOUS BEHAVIORS Implications for the Criminal Justice System	CRIMINAL JUSTICE AND BEHAVIOR			English	Article						neuropsychology; neurocognitive; self-injury; nonsuicidal self-injury; suicide attempt; prisoner	DEPRESSED SUICIDE ATTEMPTERS; TRAUMATIC BRAIN-INJURY; INTELLECTUAL DISABILITY; DISTINGUISHING FEATURES; HARM; MUTILATION; PERFORMANCE; PREVALENCE; DISORDER; CUSTODY	Neuropsychological functioning has not yet been investigated among prisoners who engage in self-injurious behaviors, specifically attempted suicide and nonsuicidal self-injury (NSSI). The purpose of this study was to investigate neuropsychological functioning in prisoners with and without histories of NSSI and attempted suicide. The sample consisted of 173 male prisoners referred for neuropsychological evaluation. Of participants, 56% reported a history of self-injury. Performance on the neuropsychological domains of intelligence, memory, attention, motor functioning, and executive functioning was assessed. No group differences were found among those with NSSI, with NSSI and suicide attempts, and with no history of deliberate self-harm, although functioning was poor in all domains. Implications of the high prevalence of self-injury in this prison sample, as well as implications of impaired functioning on the treatment of self-injurious behaviors, are discussed.	[Andover, Margaret S.] Fordham Univ, Dept Psychol, Bronx, NY 10458 USA; [Schatten, Heather T.] Fordham Univ, Clin Psychol Program, Bronx, NY 10458 USA; [Crossman, Donna M.] SUNY Binghamton, Dept Psychol, Binghamton, NY 13902 USA		Andover, MS (corresponding author), Fordham Univ, Dept Psychol, 441 E Fordham Rd, Bronx, NY 10458 USA.	andover@fordham.edu	Andover, Peggy/ABA-7040-2021	Andover, Margaret/0000-0003-0440-462X	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH082824] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23 MH082824] Funding Source: Medline		Andover MS, 2010, PSYCHIAT RES, V178, P101, DOI 10.1016/j.psychres.2010.03.019; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; BARTFAI A, 1990, SUICIDE LIFE-THREAT, V20, P254; Benton AL, 1994, MULTILINGUAL APHASIA; Borrill Jo, 2003, Crim Behav Ment Health, V13, P229, DOI 10.1002/cbm.549; Briere J, 1998, AM J ORTHOPSYCHIAT, V68, P609, DOI 10.1037/h0080369; Cashin A, 2006, INT J PRISON HEALTH, V2, P115, DOI 10.1080/17449200600935752; Dear GE, 2000, CRIM JUSTICE BEHAV, V27, P160, DOI 10.1177/0093854800027002002; DeHart Dana D, 2009, J Correct Health Care, V15, P129, DOI 10.1177/1078345809331444; Delis D.C., 2000, CALIFORNIA VERBAL LE; Eccleston L, 2002, AUST PSYCHOL, V37, P237, DOI 10.1080/00050060210001706926; ELLIS TE, 1992, PERCEPT MOTOR SKILL, V75, P639, DOI 10.2466/pms.1992.75.2.639; Fagan Thomas J, 2010, J Correct Health Care, V16, P48, DOI 10.1177/1078345809348212; Fertuck EA, 2005, PSYCHOPATHOLOGY, V38, P75, DOI 10.1159/000084814; Fikke LT, 2011, PSYCHOL MED, V41, P601, DOI 10.1017/S0033291710001030; FRANKLIN RK, 1988, CRIM JUSTICE BEHAV, V15, P210, DOI 10.1177/0093854888015002007; Fruehwald S, 2003, EUR PSYCHIAT, V18, P161, DOI 10.1016/S0924-9338(03)00064-6; Fulwiler C, 1997, J AM ACAD PSYCHIATRY, V25, P69; HAYCOCK J, 1989, Psychiatric Quarterly (New York), V60, P85, DOI 10.1007/BF01064365; Hayes AJ, 2008, SUICIDE LIFE-THREAT, V38, P708, DOI 10.1521/suli.2008.38.6.708; Hayes SC, 1997, J INTELLECT DEV DIS, V22, P71, DOI 10.1080/13668259700033311; Jeglic EL, 2005, INT J OFFENDER THER, V49, P131, DOI 10.1177/0306624X04271130; Joiner TE, 2005, J ABNORM PSYCHOL, V114, P291, DOI 10.1037/0021-843X.114.2.291; Jollant F, 2005, AM J PSYCHIAT, V162, P304, DOI 10.1176/appi.ajp.162.2.304; Jollant F, 2010, NEUROIMAGE, V51, P1275, DOI 10.1016/j.neuroimage.2010.03.027; JONES A, 1986, CRIM JUSTICE BEHAV, V13, P286, DOI 10.1177/0093854886013003003; Keilp JG, 2001, AM J PSYCHIAT, V158, P735, DOI 10.1176/appi.ajp.158.5.735; King DA, 2000, J NEUROPSYCH CLIN N, V12, P64, DOI 10.1176/jnp.12.1.64; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Langbehn D R, 1993, Ann Clin Psychiatry, V5, P45, DOI 10.3109/10401239309148923; LeGris J, 2006, CAN J PSYCHIAT, V51, P131, DOI 10.1177/070674370605100303; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Linehan MM., 1993, COGNITIVE BEHAV TREA; Little RJA., 1987, STAT ANAL MISSING DA; Livingston M, 1997, SUICIDE SELF INJURY, V28, P21; Lohner J, 2007, INT J PRISON HEALTH, V3, P135, DOI 10.1080/17449200701321654; Lohner J, 2006, INT J LAW PSYCHIAT, V29, P370, DOI 10.1016/j.ijlp.2006.03.004; Marzuk PM, 2005, ACTA PSYCHIAT SCAND, V112, P294, DOI 10.1111/j.1600-0447.2005.00585.x; McClintock SA, 2010, NEUROPSYCHOLOGY, V24, P9, DOI 10.1037/a0017336; McKee GR, 1998, PSYCHOL REP, V82, P611, DOI 10.2466/PR0.82.2.611-614; Metzner JL, 2002, J FORENSIC PSYCHIATR, V13, P240, DOI 10.1080/09585180210150078; MEYERS J, 1995, MEYERS SCORING SYSTE; Muehlenkamp JJ, 2005, AM J ORTHOPSYCHIAT, V75, P324, DOI 10.1037/0002-9432.75.2.324; Mumola C. J., 2005, NCJ PUB; Nock MK, 2009, CURR DIR PSYCHOL SCI, V18, P78, DOI 10.1111/j.1467-8721.2009.01613.x; Nock MK, 2005, J ABNORM PSYCHOL, V114, P140, DOI 10.1037/0021-843X.114.1.140; Nock MK, 2004, J CONSULT CLIN PSYCH, V72, P885, DOI 10.1037/0022-006X.72.5.885; ODONNELL JP, 1994, J CLIN PSYCHOL, V50, P596, DOI 10.1002/1097-4679(199407)50:4<596::AID-JCLP2270500416>3.0.CO;2-S; Penn JV, 2003, J AM ACAD CHILD PSY, V42, P762, DOI 10.1097/01.CHI.0000046869.56865.46; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Roe-Sepowitz Dominique, 2007, Crim Behav Ment Health, V17, P312, DOI 10.1002/cbm.665; Royan J, 2004, ARCH CLIN NEUROPSYCH, V19, P131, DOI 10.1016/S0887-6177(02)00216-0; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Smith HP, 2010, CRIM JUSTICE BEHAV, V37, P81, DOI 10.1177/0093854809348474; Tiffin, 1968, PURDUE PEGBOARD EXAM; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Van Orden KA, 2005, CURR PSYCHIATRY REV, V1, P187, DOI 10.2174/1573400054065541; Weishaar M. E., 1992, INT REV PSYCHIATR, V4, P117; Westheide J, 2008, EUR ARCH PSY CLIN N, V258, P414, DOI 10.1007/s00406-008-0811-1; Williams B. R., 2011, CLIN NEUROPSYCHOLOGI	64	6	6	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0093-8548	1552-3594		CRIM JUSTICE BEHAV	Crim. Justice Behav.	NOV	2011	38	11					1103	1114		10.1177/0093854811420670			12	Psychology, Clinical; Criminology & Penology	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology	822WZ	WOS:000295082500003	28503002	Green Accepted			2022-02-06	
J	Kolodziej, MA; Koblitz, S; Nimsky, C; Hellwig, D				Kolodziej, Malgorzata A.; Koblitz, Stephan; Nimsky, Christopher; Hellwig, Dieter			Mechanisms and consequences of head injuries in soccer: a study of 451 patients	NEUROSURGICAL FOCUS			English	Article						head injury; trauma; soccer; mechanism of injury; outcome; disability	PROFESSIONAL FOOTBALL; UNIVERSITY FOOTBALL; NECK INJURIES; BRAIN-INJURY; PLAYERS; EPIDEMIOLOGY; CONCUSSIONS; BALL; IMPAIRMENT; IMPACT	Object. The goal of this study was to evaluate the incidence and mechanisms of head injury during soccer games and to describe the results after spontaneous resolution of symptoms or after treatment. Methods. In a retrospective study from 2005, records on 451 players from the German Soccer Association who had suffered various injuries were collected. The study used a questionnaire in which the player described the accident and the playing situation as well as the clinical course after trauma. This questionnaire also included information about the physical symptoms of the players and the length of their rehabilitation. Two groups were formed: one with head injuries (case group), and the other with injuries of other body parts (control group). Results. Of the injuries reported, 108 (23.9%) were related to the head, 114 (25.3%) to the knee, 58 (13%) to the ankle, 56 (12%) to the calf, and 30 (7%) to the shoulder. The areas of the head most frequently involved were the facial and occipital regions. In the head injury group, the head duel was the most common playing action to lead to trauma. In those cases, the body part that hit the injured player was the elbow, arm, or head of the opponent. The most common playing situation was combat in the penalty area. The median hospitalization time after the trauma was 2 days for the case group and 5 days for the control group. The rehabilitation time for the case group was also shorter (median 6.5 days) than for the control group (median 30 days). Conclusions. Trivial head injuries in soccer can have a long and complicated course. Nevertheless, the temporary disability is shorter in most cases than for players with injuries to other parts of the body. Modifying the rules of play would be necessary to reduce the incidence of head trauma. (DOI: 10.3171/2011.10.FOCUS11184)	[Kolodziej, Malgorzata A.; Nimsky, Christopher] Univ Marburg, Dept Neurosurg, D-35039 Marburg, Germany; [Koblitz, Stephan] Marien Hosp, Kassel, Germany; [Hellwig, Dieter] Int Neurosci Inst, Dept Neurosurg, Hannover, Germany		Kolodziej, MA (corresponding author), Univ Marburg, Dept Neurosurg, Baldingerstr, D-35039 Marburg, Germany.	kolodzie@med.uni-marburg.de	Nimsky, Christopher/E-3702-2014	Nimsky, Christopher/0000-0002-8216-9410			Al-Kashmiri A, 2006, TRAUMA, V8, P189, DOI 10.1177/1460408606071144; Andersen TE, 2003, BRIT J SPORT MED, V37, P226, DOI 10.1136/bjsm.37.3.226; [Anonymous], 1997, SCHWEIZ Z SPORTMED S, V45, P127; Arnason A, 1996, SCAND J MED SCI SPOR, V6, P40, DOI 10.1111/j.1600-0838.1996.tb00069.x; Baroff GS, 1998, J HEAD TRAUMA REHAB, V13, P45, DOI 10.1097/00001199-199804000-00007; Biros MH., 1998, EMERGENCY MED CONCEP, P416; Bjordal JM, 1997, AM J SPORT MED, V25, P341, DOI 10.1177/036354659702500312; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Bruzzone E, 2000, AM J SPORT MED, V28, P901, DOI 10.1177/03635465000280062201; Chomiak J, 2000, AM J SPORT MED, V28, pS58; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dvorak J, 2000, AM J SPORT MED, V28, pS3; EKSTRAND J, 1982, AM J SPORT MED, V10, P75, DOI 10.1177/036354658201000202; Elbe AM, 2005, Z F R SPORTPSYCHOLOG, V12, P57, DOI DOI 10.1026/1612-5010.12.2.57; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GRONWALL D, 1975, LANCET, V2, P995; Hawkins RD, 1999, BRIT J SPORT MED, V33, P196, DOI 10.1136/bjsm.33.3.196; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Junge A, 2002, AM J SPORT MED, V30, P652, DOI 10.1177/03635465020300050401; Kirkendall DT, 2002, CLIN ORTHOP RELAT R, pS81, DOI 10.1097/01.blo.0000031989.92980.2b; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; NIELSEN AB, 1989, AM J SPORT MED, V17, P803, DOI 10.1177/036354658901700614; Peterson L, 2000, AM J SPORT MED, V28, pS51; Pickett W, 2005, BRIT J SPORT MED, V39, P226, DOI 10.1136/bjsm.2004.013169; Tucker AM, 1997, SPORTS MED, V23, P21, DOI 10.2165/00007256-199723010-00003; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; [No title captured]	39	6	6	1	14	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2011	31	5							E1	10.3171/2011.10.FOCUS11184			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	844QL	WOS:000296762300002	22044098				2022-02-06	
J	Seshia, SS; Bingham, WT; Kirkham, FJ; Sadanand, V				Seshia, Shashi S.; Bingham, William T.; Kirkham, Fenella J.; Sadanand, Venkatraman			Nontraumatic Coma in Children and Adolescents: Diagnosis and Management	NEUROLOGIC CLINICS			English	Article						Nontraumatic; Coma; Children; Adolescents; Causes; Management; Increased intracranial pressure	ACUTE NECROTIZING ENCEPHALOPATHY; ACUTE DISSEMINATED ENCEPHALOMYELITIS; NON-TRAUMATIC COMA; CEREBRAL PERFUSION-PRESSURE; RAISED INTRACRANIAL-PRESSURE; PERSISTENT VEGETATIVE STATE; NERVOUS-SYSTEM INFECTIONS; BRAIN-INJURY; STATUS EPILEPTICUS; MYCOPLASMA-PNEUMONIAE	The causes of nontraumatic coma (NTC) vary by country, season and period of data collection. Infective diseases are among the major worldwide causes of NTC. Nonaccidental head injury must be in the differential diagnosis. Genetic and ethnic susceptibilities to causes of coma are being recognized. A systematic history and examination are essential for diagnosis, early recognition of herniation syndromes, and management. The management of NTC is discussed, with reference to clinical approach, treatment of seizures, and increased intracranial pressure. Public health measures, education, early diagnosis, and prompt appropriate treatment are the foundations needed to reduce incidence and improve outcome.	[Seshia, Shashi S.] Univ Saskatchewan, Div Pediat Neurol, Dept Pediat, Royal Univ Hosp, Saskatoon, SK S7N 0W8, Canada; [Kirkham, Fenella J.] UCL Inst Child Hlth, Neurosci Unit, London WC1N 1EH, England; [Kirkham, Fenella J.] Southampton Gen Hosp NHS Trust, Dept Child Hlth, Southampton SO16 6YD, Hants, England; [Sadanand, Venkatraman] Loma Linda Univ, Med Ctr, Dept Neurosurg, Loma Linda, CA 92354 USA		Seshia, SS (corresponding author), Univ Saskatchewan, Div Pediat Neurol, Dept Pediat, Royal Univ Hosp, 103 Hosp Dr, Saskatoon, SK S7N 0W8, Canada.	sseshia@yahoo.ca	Kirkham, Fenella/C-2442-2009	Kirkham, Fenella/0000-0002-2443-7958	Wellcome TrustWellcome TrustEuropean Commission	We thank Gregg Parchomchuk for the flow diagrams in Figs. 7 and 8, Molly Seshia for reviewing the manuscript, and Bryan Young for helpful suggestions. SSS is grateful to the Department of Pediatrics and the Faculty of Medicine, University of Saskatchewan, for continuing support. FJK was funded by the Wellcome Trust.	Abend NS, 2009, PEDIATR CRIT CARE ME, V10, P505, DOI 10.1097/PCC.0b013e3181a0e1cf; Aghakhani N, 2009, J NEUROS-PEDIATR, V3, P66, DOI 10.3171/2008.10.PEDS08116; Ahmad S, 2006, LANCET, V367, P1591, DOI 10.1016/S0140-6736(06)68696-0; Ali A. M., 2007, Eastern Mediterranean Health Journal, V13, P608; Appleton R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001905.pub2; Ashwal S, 2004, NEUROREHABILITATION, V19, P349; Ashwal S, 2003, BRAIN DEV-JPN, V25, P535, DOI 10.1016/S0387-7604(03)00095-0; Babl FE, 2009, J PAEDIATR CHILD H, V45, P541, DOI 10.1111/j.1440-1754.2009.01536.x; Balaka B, 2005, ARCH PEDIATRIE, V12, P475, DOI 10.1016/j.arcped.2004.12.018; Bansal Arun, 2005, Indian Journal of Pediatrics, V72, P467, DOI 10.1007/BF02724422; Baruah H C, 2002, Indian Pediatr, V39, P1143; Bassuk AG, 2003, NEUROLOGY, V60, P1552, DOI 10.1212/01.WNL.0000058757.52327.17; Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Bell DJ, 2007, EXPERT REV ANTI-INFE, V5, P141, DOI 10.1586/14787210.5.1.141; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bitnun Ari, 2003, Semin Pediatr Infect Dis, V14, P96, DOI 10.1053/spid.2003.127226; BONDI FS, 1991, TROP GEOGR MED, V43, P288; Bowker R, 2007, ANN CLIN BIOCHEM, V44, P506, DOI 10.1258/000456307782268228; BROWN JK, 1975, DEV MED CHILD NEUROL, V17, P659; BROWN JK, 1973, J NEUROL NEUROSUR PS, V36, P431, DOI 10.1136/jnnp.36.3.431; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Bruno MA, 2011, CURR OPIN CRIT CARE, V17, P146, DOI 10.1097/MCC.0b013e328343476d; Budhathoki S, 2009, Nepal Med Coll J, V11, P170; Carrai R, 2010, INTENS CARE MED, V36, P1112, DOI 10.1007/s00134-010-1884-7; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chambert-Loir C, 2009, PEDIATR NEUROL, V41, P375, DOI 10.1016/j.pediatrneurol.2009.05.008; Chen Y, 2005, FEBS LETT, V579, P2040, DOI 10.1016/j.febslet.2005.02.050; Chin RFM, 2004, J NEUROL NEUROSUR PS, V75, P1584, DOI 10.1136/jnnp.2003.032797; Christie LJ, 2008, EMERG INFECT DIS, V14, P1473, DOI 10.3201/eid1409.070264; Christie LJ, 2007, PEDIATRICS, V120, P305, DOI 10.1542/peds.2007-0240; Cochran JB, 2006, AM J EMERG MED, V24, P297, DOI 10.1016/j.ajem.2005.10.007; Crawley J, 1996, QJM-INT J MED, V89, P591; Dale RC, 2000, BRAIN, V123, P2407, DOI 10.1093/brain/123.12.2407; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006; DINE MS, 1982, PEDIATRICS, V70, P32; Dlamini N, 2010, NEUROSURG CLIN N AM, V21, P511, DOI 10.1016/j.nec.2010.03.006; Domenech C, 2009, EUR J CLIN MICROBIOL, V28, P91, DOI 10.1007/s10096-008-0591-6; Domi T, 2008, PEDIATRICS, V122, P1292, DOI 10.1542/peds.2007-1459; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Ekstrand JJ, 2010, ANN NEUROL, V68, P762, DOI 10.1002/ana.22184; Evans A. S., 2009, Morbidity and Mortality Weekly Report, V58, P773; Federman MD, 2009, CLIN NEUROPHARMACOL, V32, P340, DOI 10.1097/WNF.0b013e3181b77d07; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; Forsyth R, 2010, COCHRANE DB SYST REV, V2; Fouad H, 2011, J CHILD NEUROL, V26, P136, DOI 10.1177/0883073810374358; Fourtner SH, 2005, PEDIATR DIABETES, V6, P129, DOI 10.1111/j.1399-543X.2005.00113.x; Gable MS, 2009, EUR J CLIN MICROBIOL, V28, P1421, DOI 10.1007/s10096-009-0799-0; Garg RK, 2010, ACTA NEUROL SCAND, V122, P75, DOI 10.1111/j.1600-0404.2009.01316.x; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; GILLIES JD, 1980, DEV MED CHILD NEUROL, V22, P642; Glatstein M, 2009, PEDIATR EMERG CARE, V25, P109, DOI 10.1097/PEC.0b013e318196faff; GOITEIN KJ, 1983, J PEDIATR-US, V103, P40, DOI 10.1016/S0022-3476(83)80772-0; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Guyon G, 2009, ARCH PEDIATRIE, V16, pS85, DOI 10.1016/S0929-693X(09)75307-2; Gwer S, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-23; HAWORTH JC, 1991, CAN MED ASSOC J, V145, P123; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; Huang SM, 2004, J CHILD NEUROL, V19, P64, DOI 10.1177/08830738040190010709; Ibekwe RC, 2011, NIGER J CLIN PRACT, V14, P43, DOI 10.4103/1119-3077.79239; Idro Richard, 2003, Afr Health Sci, V3, P15; Idro R, 2010, PEDIATR RES, V68, P267, DOI [10.1203/PDR.0b013e3181eee738, 10.1203/00006450-201011001-00524]; Ishikura K, 2011, PEDIAT NEPHROL; Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI 10.1586/ERI.10.92; Jmor F, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-134; Joffe AR, 2009, PEDIATR NEUROL, V41, P378, DOI 10.1016/j.pediatrneurol.2009.05.007; JOHNSTON B, 1984, ACTA NEUROL SCAND, V69, P417, DOI 10.1111/j.1600-0404.1984.tb07825.x; Jordan LC, 2009, STROKE, V40, P400, DOI 10.1161/STROKEAHA.108.518761; Kawano G, 2010, ARCH DIS CHILD; Khan WA, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.2.e18; Khodapanahandeh F, 2009, IRAN J PEDIATR, V19, P393; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; Kirkham FJ, 1998, PEDIATR CARDIOL, V19, P331, DOI 10.1007/s002469900318; KIRKHAM FJ, 1986, DEV MED CHILD NEUROL, V28, P506; Kirkham FJ, 2001, ARCH DIS CHILD, V85, P303, DOI 10.1136/adc.85.4.303; Kirmani BF, 2009, PEDIATR NEUROL, V41, P37, DOI 10.1016/j.pediatrneurol.2009.02.016; Kneen R, 2002, ARCH DIS CHILD, V87, P181, DOI 10.1136/adc.87.3.181; Kneen Rachel, 2002, BMC Pediatr, V2, P8, DOI 10.1186/1471-2431-2-8; Kobayashi K, 2010, EPILEPSY RES, V91, P143, DOI 10.1016/j.eplepsyres.2010.07.005; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kubota M, 2011, BRAIN DEV; Lindsey NP, 2009, PEDIATRICS, V123, pE1084, DOI 10.1542/peds.2008-3278; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Mailles A, 2009, CLIN INFECT DIS, V49, P1838, DOI 10.1086/648419; McMahon MA, 2009, AM J PHYS MED REHAB, V88, P525, DOI 10.1097/PHM.0b013e3181a5ade3; MELCHIOR JC, 1971, EPILEPSIA, V12, P55, DOI 10.1111/j.1528-1157.1971.tb03915.x; Michelson David J, 2004, Semin Pediatr Neurol, V11, P105, DOI 10.1016/j.spen.2004.03.010; Mikaeloff Y, 2006, EPILEPSY RES, V69, P67, DOI 10.1016/j.eplepsyres.2006.01.002; MINNS RA, 1978, DEV MED CHILD NEUROL, V20, P561; Minns RA, 2005, CLIN DEV MED, P1; MINNS RA, 1989, ARCH DIS CHILD, V64, P814, DOI 10.1136/adc.64.6.814; Minns RA, 1991, CLIN DEV MED; Mizuguchi M, 1997, BRAIN DEV-JPN, V19, P81, DOI 10.1016/S0387-7604(96)00063-0; MIZUGUCHI M, 1995, J NEUROL NEUROSUR PS, V58, P555, DOI 10.1136/jnnp.58.5.555; Mizuguchi Masashi, 2010, Nihon Rinsho, V68, P2317; Nabbout R, 2011, LANCET NEUROL, V10, P99, DOI 10.1016/S1474-4422(10)70214-3; Nabbout R, 2010, EPILEPSIA, V51, P2033, DOI 10.1111/j.1528-1167.2010.02703.x; Naik N, 2009, INDIAN PEDIATR, V46, P681; Neilson DE, 2009, AM J HUM GENET, V84, P44, DOI 10.1016/j.ajhg.2008.12.009; Njuguna P, 2004, J Postgrad Med, V50, P45; Obiako OR, 2009, ANN AFR MED, V8, P115, DOI 10.4103/1596-3519.56240; Olgun H, 2009, PEDIATR EMERG CARE, V25, P170, DOI 10.1097/PEC.0b013e31819a8994; Pediatric care online, INCR INTR PRESS; Plum F, 1966, DIAGNOSIS STUPOR COM; PLUM F, 1972, DIAGNOSIS STUPOR COM; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; Prasad Asuri N, 2006, Adv Neurol, V97, P229; Prasad C, 2001, MOL GENET METAB, V73, P55, DOI 10.1006/mgme.2001.3149; Ramakrishnan M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-47; REBAUD P, 1988, INTENS CARE MED, V14, P522, DOI 10.1007/BF00263524; Roach ES, 2008, STROKE, V39, P2644, DOI 10.1161/STROKEAHA.108.189696; Roine I, 2010, PEDIATR INFECT DIS J, V29, P122, DOI 10.1097/INF.0b013e3181b6e7d3; ROTHER KI, 1995, MAYO CLIN PROC, V70, P62; Saengpattrachai M, 2006, EPILEPSIA, V47, P1510, DOI 10.1111/j.1528-1167.2006.00624.x; Sakuma H, 2010, ACTA NEUROL SCAND, V121, P251, DOI 10.1111/j.1600-0404.2009.01198.x; Sankhyan N, 2010, INDIAN J PEDIATR, V77, P1409, DOI 10.1007/s12098-010-0190-2; Sebire G, 2005, BRAIN, V128, P477, DOI 10.1093/brain/awh412; Segal S, 2001, INTENS CARE MED, V27, P236, DOI 10.1007/s001340000717; Seshia Shashi S, 2008, Handb Clin Neurol, V90, P329, DOI 10.1016/S0072-9752(07)01719-8; SESHIA SS, 1977, DEV MED CHILD NEUROL, V19, P614; SESHIA SS, 1983, DEV MED CHILD NEUROL, V25, P493; SESHIA SS, 1991, CAN J NEUROL SCI, V18, P472, DOI 10.1017/S0317167100032182; Shaoul R, 2005, PEDIATR EMERG CARE, V21, P594, DOI 10.1097/01.pec.0000177199.68408.3e; Sharma S, 2010, INDIAN J PEDIATR, V77, P1279, DOI 10.1007/s12098-010-0191-1; Shehab N, 2009, PEDIATR CRIT CARE ME, V10, P256, DOI 10.1097/PCC.0b013e31819a383c; Shemie SD, 2007, LANCET NEUROL, V6, P87, DOI 10.1016/S1474-4422(06)70680-9; Shemie SD, 2006, CAN MED ASSOC J, V175, pS1, DOI 10.1503/cmaj.060895; Shetty R, 2008, J CHILD NEUROL, V23, P192, DOI 10.1177/0883073807308716; Shinohara M, 2011, BRAIN DEV-JPN, V33, P512, DOI 10.1016/j.braindev.2010.09.002; Singhi PD, 2006, J CHILD NEUROL, V21, P851, DOI 10.1177/08830738060210100201; Singhi Pratibha D., 2005, Indian Journal of Pediatrics, V72, P475, DOI 10.1007/BF02724423; Singhi Sunit C, 2005, Pediatr Crit Care Med, V6, P86, DOI 10.1097/01.PCC.0000149309.45929.C5; Singhi SC, 2009, INDIAN J PEDIATR, V76, P519, DOI 10.1007/s12098-009-0137-7; Smith SE, 2011, DEV MED CHILD NEUROL, V53, P29, DOI 10.1111/j.1469-8749.2010.03775.x; Snyman N, 2010, NEUROPEDIATRICS, V41, P223, DOI 10.1055/s-0030-1269893; Society of Critical Medicine, 2003, PEDIAT CRIT CARE S3, V4, pS1; SOFER S, 1989, Pediatric Emergency Care, V5, P222, DOI 10.1097/00006565-198912000-00005; Sofiah A, 1997, ANN TROP PAEDIATR, V17, P327, DOI 10.1080/02724936.1997.11747906; Sofou K, 2009, J CHILD NEUROL, V24, P918, DOI 10.1177/0883073809332768; Soldatos T, 2009, EMERG MED J, V26, P630, DOI 10.1136/emj.2008.058453; Solomon T, 2002, BRAIN, V125, P1084, DOI 10.1093/brain/awf116; Specchio N, 2010, BRAIN DEV-JPN, V32, P51, DOI 10.1016/j.braindev.2009.09.017; Stam AH, 2009, J NEUROL NEUROSUR PS, V80, P1125, DOI 10.1136/jnnp.2009.177279; Stephenson DJ, 2000, NEUROPEDIATRICS, V31, P293, DOI 10.1055/s-2000-12952; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Sztajnbok J, 1998, PEDIATR EMERG CARE, V14, P36, DOI 10.1097/00006565-199802000-00010; Takanashi J, 2009, BRAIN DEV-JPN, V31, P521, DOI 10.1016/j.braindev.2009.02.012; TASKER RC, 1988, ARCH DIS CHILD, V63, P895, DOI 10.1136/adc.63.8.895; TASKER RC, 1988, ARCH DIS CHILD, V63, P888, DOI 10.1136/adc.63.8.888; Tatman A, 1997, ARCH DIS CHILD, V77, P519, DOI 10.1136/adc.77.6.519; TEASDALE G, 1983, LANCET, V2, P678; TEASDALE G, 1974, LANCET, V2, P81; Tenembaum S, 2002, NEUROLOGY, V59, P1224, DOI 10.1212/WNL.59.8.1224; The Paediatric Accident and Emergency Research Group, 2008, MAN CHILD AG 0 18 YE; Thebaud B, 1999, INTENS CARE MED, V25, P293, DOI 10.1007/s001340050838; Trubel HK, 2003, CURR OPIN PEDIATR, V15, P283, DOI 10.1097/00008480-200306000-00010; van Baalen A, 2010, EPILEPSIA, V51, P1323, DOI 10.1111/j.1528-1167.2010.02535.x; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9; Venkatraman R., 2006, Indian Journal of Pediatrics, V73, P55, DOI 10.1007/BF02758261; Verhulst L, 2002, ARCH DIS CHILD, V86, P352, DOI 10.1136/adc.86.5.352; Wagner B P, 2005, Ther Umsch, V62, P519, DOI 10.1024/0040-5930.62.8.519; Walter ND, 2008, J INFECT DIS, V198, P1365, DOI 10.1086/592281; Wermeling DP, 2009, NEUROTHERAPEUTICS, V6, P352, DOI 10.1016/j.nurt.2009.01.002; Wong CP, 2001, ARCH DIS CHILD, V84, P193, DOI 10.1136/adc.84.3.193; YAGER JY, 1990, AM J DIS CHILD, V144, P1088, DOI 10.1001/archpedi.1990.02150340032019; Zamani N, 2010, TROP DOCT, V40, P220, DOI 10.1258/td.2010.100134; ZIMMERMAN RA, 1978, RADIOLOGY, V126, P403, DOI 10.1148/126.2.403	167	6	8	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	NOV	2011	29	4					1007	+		10.1016/j.ncl.2011.07.011			38	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	853BN	WOS:000297401300017	22032671				2022-02-06	
J	Tekes, A; Pinto, PS; Huisman, TAGM				Tekes, Aylin; Pinto, Pedro S.; Huisman, Thierry A. G. M.			Birth-Related Injury to the Head and Cervical Spine in Neonates	MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA			English	Article						Neonate; Mechanical birth injury; Head and cervical spine	INTRACRANIAL HEMORRHAGE; CORD-INJURY; RISK-FACTORS; SUBDURAL HEMORRHAGE; SUBGALEAL HEMATOMA; NATURAL-HISTORY; NEWBORN; BRAIN; MANAGEMENT; DIAGNOSIS	Birth-related injury is defined as any traumatic or ischemic event sustained during the process of delivery. Perinatally acquired disease processes secondary to birth-related injury can be traumatic or ischemic in nature. In this article, the authors focus on traumatic/mechanical injuries. Other diseases of the perinatal time period, including germinal matrix hemorrhages and hypoxic-ischemic encephalopathy, are beyond the objective of this review.	[Tekes, Aylin; Pinto, Pedro S.; Huisman, Thierry A. G. M.] Johns Hopkins Univ Hosp, Dept Radiol & Radiol Sci, Div Pediat Radiol, Baltimore, MD 21287 USA		Tekes, A (corresponding author), Johns Hopkins Univ Hosp, Dept Radiol & Radiol Sci, Div Pediat Radiol, 600 N Wolfe St,B-172, Baltimore, MD 21287 USA.	atekes1@jhmi.edu					ABROMS IF, 1993, SEMIN NEUROL, V13, P100, DOI 10.1055/s-2008-1041113; AlQattan MM, 1996, J HAND SURG-BRIT EUR, V21B, P263, DOI 10.1016/S0266-7681(96)80112-4; Amar AP, 2003, NEUROSURGERY, V52, P1470, DOI 10.1227/01.NEU.0000065180.07961.54; BENNET GC, 1976, BRIT MED J, V1, P1520, DOI 10.1136/bmj.1.6024.1520; Bryant DR, 1998, AM J OBSTET GYNECOL, V179, P686, DOI 10.1016/S0002-9378(98)70065-1; Daneman A, 2006, PEDIATR RADIOL, V36, P636, DOI 10.1007/s00247-006-0201-7; Duckett S., 1995, PEDIAT NEUROPATHOLOG, P243; Dunn D W, 1985, Pediatr Neurol, V1, P367, DOI 10.1016/0887-8994(85)90074-8; FENICHEL GM, 1984, ARCH NEUROL-CHICAGO, V41, P30, DOI 10.1001/archneur.1984.04050130036018; GEAN AD, 1995, IMAGING HEAD TRAUMA; Gilbert WM, 1999, OBSTET GYNECOL, V93, P536, DOI 10.1016/S0029-7844(98)00484-0; Gonen R, 1996, OBSTET GYNECOL, V88, P526, DOI 10.1016/0029-7844(96)00230-X; HANIGAN WC, 1985, J NEUROSURG, V63, P977, DOI 10.3171/jns.1985.63.6.0977; HANKINS GDV, 1995, AM J PERINAT, V12, P44, DOI 10.1055/s-2007-994398; Harpold TL, 1998, NEUROSURG CLIN N AM, V9, P141; HEIBEL M, 1993, NEURORADIOLOGY, V35, P85, DOI 10.1007/BF00593960; Holden KR, 1999, J CHILD NEUROL, V14, P708, DOI 10.1177/088307389901401104; Hughes CA, 1999, ARCH OTOLARYNGOL, V125, P193, DOI 10.1001/archotol.125.2.193; Huisman TAGM, 2008, PEDIATR RADIOL, V38, pS415, DOI 10.1007/s00247-008-0895-9; Jhawar BS, 2003, NEUROSURGERY, V52, P581, DOI 10.1227/01.NEU.0000047819.33177.72; KEENEY SE, 1991, PEDIATRICS, V87, P431; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Lonergan GJ, 2003, RADIOGRAPHICS, V23, P811, DOI 10.1148/rg.234035030; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; MACKINNON JA, 1993, J PEDIATR-US, V122, P431, DOI 10.1016/S0022-3476(05)83437-7; MANNING JJ, 1972, PEDIATRICS, V49, P102; MATEOS F, 1987, PEDIATR NEUROSCI, V13, P125, DOI 10.1159/000120315; MCARDLE CB, 1987, RADIOLOGY, V163, P395, DOI 10.1148/radiology.163.2.3550882; McNeely PD, 2003, PEDIATR NEUROSURG, V38, P57, DOI 10.1159/000068045; McQuivey R W, 2004, J Matern Fetal Neonatal Med, V16, P171; MENTICOGLOU SM, 1995, OBSTET GYNECOL, V86, P589, DOI 10.1016/S0029-7844(95)80022-0; MICHELOW BJ, 1994, PLAST RECONSTR SURG, V93, P675, DOI 10.1097/00006534-199404000-00001; Morgan C, 2001, DEV MED CHILD NEUROL, V43, P274, DOI 10.1017/S0012162201000512; NEGISHI H, 1989, PEDIATR NEUROL, V5, P253, DOI 10.1016/0887-8994(89)90086-6; NG PC, 1995, ACTA PAEDIATR, V84, P1065, DOI 10.1111/j.1651-2227.1995.tb13826.x; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; PLAUCHE WC, 1980, JAMA-J AM MED ASSOC, V244, P1597, DOI 10.1001/jama.244.14.1597; Pollina J, 2001, PEDIATR NEUROSURG, V35, P113, DOI 10.1159/000050403; Reichard R, 2008, BRAIN PATHOL, V18, P565, DOI 10.1111/j.1750-3639.2008.00205.x; Reilingh TSD, 1998, J PEDIATR SURG, V33, P602, DOI 10.1016/S0022-3468(98)90325-6; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; ROSSITCH E, 1992, PEDIATR NEUROSURG, V18, P149; SACHS BP, 1987, CLIN PEDIATR, V26, P355, DOI 10.1177/000992288702600706; Sandberg DI, 2001, NEUROSURGERY, V48, P1042, DOI 10.1097/00006123-200105000-00015; Sandmire HF, 2000, OBSTET GYNECOL, V95, P941, DOI 10.1016/S0029-7844(00)00810-3; Society of Obstetricians and Gynaecologists of Canada, 2005, Int J Gynaecol Obstet, V89, P319; Sorantin E, 2006, EUR J RADIOL, V60, P199, DOI 10.1016/j.ejrad.2006.07.023; Squier W, 2009, FORENSIC SCI INT, V187, P6, DOI 10.1016/j.forsciint.2009.02.005; Steinbok P, 1995, PEDIATR NEUROSURG, V23, P206, DOI 10.1159/000120960; TAKAGI T, 1982, CHILD BRAIN, V9, P102; Tavani F, 2003, NEURORADIOLOGY, V45, P253, DOI 10.1007/s00234-003-0946-8; THACKER KE, 1987, AUST NZ J OBSTET GYN, V27, P210, DOI 10.1111/j.1479-828X.1987.tb00988.x; Uhing MR, 2005, CLIN PERINATOL, V32, P19, DOI 10.1016/j.clp.2004.11.007; VOLPE J J, 1977, Clinics in Perinatology, V4, P77; VOLPE JJ, 1995, NEUROLOGY NEWBORN, P377; WALLE T, 1993, ACTA OBSTET GYN SCAN, V72, P450, DOI 10.3109/00016349309021133; Wen SW, 2001, AM J EPIDEMIOL, V153, P103, DOI 10.1093/aje/153.2.103; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9	58	6	6	1	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1064-9689	1557-9786		MAGN RESON IMAGING C	Magn. Reson. Imaging Clin. N. Am.	NOV	2011	19	4					777	+		10.1016/j.mric.2011.08.004			15	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	865KP	WOS:000298310100006	22082737				2022-02-06	
J	von Dercks, N; Melz, R; Hepp, P; Marquass, B; Theopold, J; Josten, C				von Dercks, N.; Melz, R.; Hepp, P.; Marquass, B.; Theopold, J.; Josten, C.			Seasonal distribution of diagnoses and DRG in trauma surgery	UNFALLCHIRURG			German	Article						Seasonal variation; Diagnosis related groups; Main diagnosis; Spectrum of patient-centered care; Efficiency	DISTAL RADIUS; FRACTURES; WOMEN	Recording DRGs and diagnoses allows their distribution to be shown over the course of the year. Thus, cumulative seasonal occurrence of diseases can be detected. From 2004 to 2010 we recorded 22,293 main diagnoses and DRGs at the clinic for trauma surgery. Injuries with the same localization and treatment were pooled. The most frequent injuries were concussion, followed by spinal and lower leg fractures. They showed no seasonal accumulation. Proximal fractures of the humerus occurred approx. 25% more often in winter and ankle fractures about 33% more frequently. The diagnosis of osteoarthritis of the knee is twice as high in the winter as in the summer. It has to be verified if logistic conclusions of these results can lead to more efficiency in a hospital. The underlying analysis is applicable for every hospital and poses a valid controlling tool.	[von Dercks, N.; Hepp, P.; Marquass, B.; Theopold, J.; Josten, C.] Univ Klinikum Leipzig AoR, Klin & Poliklin Unfall Wiederherstellungs & Plast, D-04103 Leipzig, Germany; [Melz, R.] Cassidian Air Syst, Stat Anal Eurofighter, Manching, Germany		von Dercks, N (corresponding author), Univ Klinikum Leipzig AoR, Klin & Poliklin Unfall Wiederherstellungs & Plast, Liebigstr 20, D-04103 Leipzig, Germany.		Theopold, Jan/AAA-1575-2021	Theopold, Jan/0000-0003-2884-8030			Flinkkila T, 2011, OSTEOPOROSIS INT, V22, P2307, DOI 10.1007/s00198-010-1463-3; Gronskag AB, 2010, BONE, V46, P1294, DOI 10.1016/j.bone.2009.11.024; *ICD, 2011, ICD10GM; Thompson PW, 2004, INJURY, V35, P462, DOI 10.1016/S0020-1383(03)00117-7; Wareham K, 2003, INJURY, V34, P219, DOI 10.1016/S0020-1383(02)00212-7	5	6	6	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	NOV	2011	114	11					1029	1034		10.1007/s00113-011-2108-5			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	854TP	WOS:000297517700012	21993535				2022-02-06	
J	Crewe-Brown, SJ; Stipinovich, AM; Zsilavecz, U				Crewe-Brown, Samantha; Stipinovich, Alexandra; Zsilavecz, Ursula			Communication after mild traumatic brain injury - a spouse's perspective	SOUTH AFRICAN JOURNAL OF COMMUNICATION DISORDERS			English	Article						mild traumatic brain injury; spouse's perceptions; communicative competence; discourse analysis; social interaction		Individuals with mild traumatic brain injury (MTBI) often perform within normal limits on linguistic and cognitive assessments. However, they may present with debilitating communicative difficulties in daily life. A multifaceted approach to MTBI with a focus on everyday communication in natural settings is required. Significant others who interact with the individual with MTBI in a variety of settings may be sensitive to communicative difficulties experienced by the individual with MTBI. This article examines communication after MTBI from the perspective of the spouse. A case study design was implemented. The spouses of two individuals with MTBI served as the participants for this study. Semi-structured interviews were held, during which each participant was requested to describe the communication of their spouse with MTBI. The content obtained from the interviews was subjected to a discourse analysis. The results show that both participants perceived changes in the communication of their spouse following the MTBI. The results further show that MTBI affected communication of the two individuals in different ways. The value of a 'significant other' in providing information regarding communication in natural settings is highlighted. The implications of these findings for the assessment and management of the communication difficulties associated with MTBI are discussed.	[Crewe-Brown, Samantha; Stipinovich, Alexandra; Zsilavecz, Ursula] Univ Pretoria, Dept Commun Pathol, Pretoria, South Africa		Stipinovich, AM (corresponding author), Univ Pretoria, Dept Commun Pathol, Pretoria, South Africa.	alex_stipinovich@telkomsa.net					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Barrow IM, 2003, J TRAUMA, V54, P888, DOI 10.1097/01.TA.0000057150.60668.7C; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; De Vos A.S., 2002, RES GRASS ROOTS; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GREEN BS, 1997, MILD TRAUMATIC BRAIN; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Hartley L. L, 1995, COGNITIVE COMMUNICAT; JAWORSKI A, 1999, DISCOURSE READER; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim JS, 2009, J KOREAN NEUROSURG S, V46, P459, DOI 10.3340/jkns.2009.46.5.459; King KA, 2006, APHASIOLOGY, V20, P233, DOI 10.1080/02687030500473155; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kvale S., 1996, INTERVIEWS INTRO QUA, V1st ed.; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Leathem J, 1996, BRAIN INJURY, V10, P27; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; PRUTTING CA, 1982, J SPEECH HEAR DISORD, V47, P123, DOI 10.1044/jshd.4702.123; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Snow PC, 1995, TRAUMATIC BRAIN INJU; STRYDOM H., 2005, RES GRASS ROOTS SOCI, V3; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Titscher Stefan, 2000, METHODS TEXT DISCOUR; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Vyncke I. O., 2000, THESIS; Wetherell, 1987, DISCOURSE SOCIAL PSY; Wetherell M., 2001, DISCOURSE DATA GUIDE; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; Willig C., 1999, APPL DISCOURSE ANAL; Ylvisaker M., 2001, LANGUAGE INTERVENTIO; Ylvisaker M., 1998, COLLABORATIVE BRAIN; [No title captured]	43	6	6	0	0	AOSIS	CAPE TOWN	POSTNET SUITE 55, PRIVATE BAG X22, TYGERVALLEY, CAPE TOWN, 00000, SOUTH AFRICA	0379-8046	2225-4765		S AFR J COMMUN DISOR	S. Afr. J. Commun. Disord.	OCT	2011	58	1					48	55	PMID 22216558				8	Audiology & Speech-Language Pathology	Emerging Sources Citation Index (ESCI)	Audiology & Speech-Language Pathology	V52CZ	WOS:000210269200005	22216558	gold, Green Submitted			2022-02-06	
J	Naunheim, RS; Treaster, M; English, J; Casner, T				Naunheim, Rosanne S.; Treaster, Matthew; English, Joy; Casner, Teya			Automated electroencephalogram identifies abnormalities in the ED	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY	Background: Advances in analysis of electrical signals have now made it possible to create a handheld electroencephalogram (EEG). Methods: The BrainScope device, currently under development by BrainScope Co, Inc, Washington, DC, was used to assess 153 patients who presented to a tertiary referral hospital with headache or altered mental status. A limited array of 8 adhesive electrodes, similar to electrocardiographic leads, was applied to the forehead of the subjects. The data were analyzed, and the result given by the algorithm was compared with the clinical diagnosis given to the patient. Results: One hundred fifty-three patients were enrolled. The patient was determined to be normal or abnormal using the algorithm in the device, and blinded clinicians determined whether this was accurate. The sensitivity of the device was 96% and the specificity was 87% for detecting abnormality. Conclusions: The automated EEG device may be a useful tool for identifying brain abnormality in the emergency department. (C) 2011 Elsevier Inc. All rights reserved.	[Naunheim, Rosanne S.; Treaster, Matthew; English, Joy; Casner, Teya] Washington Univ, Sch Med, St Louis, MO 63110 USA		Naunheim, RS (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.	naunheir@wusm.wustl.edu					ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460; FAUGHT E, 1993, STROKE, V24, P609, DOI 10.1161/01.STR.24.4.609; GEVINS AS, 1987, HDB ELECTROENCEPHALO, V1, P449; Gurdjian ES, 1975, IMPACT HEAD INJURY; JACQUIN A, 2010, REV IEEE T  IN PRESS; John E.R., 1987, HDB ELECTROENCEPHALO, P449; John ER, 2005, ANESTHESIOLOGY, V102, P447, DOI 10.1097/00000542-200502000-00030; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Kondacs A, 1999, CLIN NEUROPHYSIOL, V110, P1708, DOI 10.1016/S1388-2457(99)00122-4; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Malloy, 1998, Semin Clin Neuropsychiatry, V3, P186; Prichep LS, 2005, CLIN EEG NEUROSCI, V36, P82, DOI 10.1177/155005940503600207; Ptito A, 2007, NEUROREHABILITATION, V22, P217; REMOND A, 1972, HDB ELECTROENCEPHALO, P1; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; Westmoreland B. F., 1982, AM J EEG TECHNOL, V22, P3; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004	20	6	6	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	OCT	2011	29	8					845	848		10.1016/j.ajem.2010.03.010			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	835SV	WOS:000296057000001	20825903				2022-02-06	
J	Nienaber, M; Lee, JS; Feng, RQ; Lim, JY				Nienaber, Matthew; Lee, Jeong Soon; Feng, Ruqiang; Lim, Jung Yul			Impulsive Pressurization of Neuronal Cells for Traumatic Brain Injury Study	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Bioengineering; Issue 56; Neuroscience; Traumatic Brain Injury; Neuronal Cells; Neurons; Impulsive Pressurization; Blast-TBI		A novel impulsive cell pressurization experiment has been developed using a Kolsky bar device to investigate blast-induced traumatic brain injury (TBI). We demonstrate in this video article how blast TBI-relevant impulsive pressurization is applied to the neuronal cells in vitro. This is achieved by using well-controlled pressure pulse created by a specialized Kolsky bar device, with complete pressure history within the cell pressurization chamber recorded. Pressurized neuronal cells are inspected immediately after pressurization, or further incubated to examine the long-term effects of impulsive pressurization on neurite/axonal outgrowth, neuronal gene expression, apoptosis, etc. We observed that impulsive pressurization at about 2 MPa induces distinct neurite loss relative to unpressurized cells. Our technique provides a novel method to investigate the molecular/cellular mechanisms of blast TBI, via impulsive pressurization of brain cells at well-controlled pressure magnitude and duration.	[Nienaber, Matthew; Lee, Jeong Soon; Feng, Ruqiang; Lim, Jung Yul] Univ Nebraska, Dept Engn Mech, Lincoln, NE 68583 USA		Feng, RQ (corresponding author), Univ Nebraska, Dept Engn Mech, Lincoln, NE 68583 USA.	rfeng1@unl.edu; jlim4@unl.edu			Army-UNL Center for Trauma Mechanics (DoD/ARO) [W911NF-11-1-0033]; UNL Layman Award [26-1110-0033-001]	The authors would like to thank the funding sources: Army-UNL Center for Trauma Mechanics (DoD/ARO, #W911NF-11-1-0033, PI: Dr. Namas Chandra), UNL Layman Award (26-1110-0033-001, PI: Lim).	Chen W, 2005, LAT AM J SOLIDS STRU, V2, P113; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Huang H, 2004, INT J SOLIDS STRUCT, V41, P2821, DOI 10.1016/j.ijsolstr.2004.01.005; Kolsky H., 1949, Proceedings of the Physical Society. Section B, V62, P676, DOI 10.1088/0370-1301/62/11/302; Lim JY, 2005, TISSUE ENG, V11, P19, DOI 10.1089/ten.2005.11.19; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056	9	6	6	0	2	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	OCT	2011		56							e2723	10.3791/2723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V36PB	WOS:000209222400002	22005926	Green Submitted, Green Published, Bronze			2022-02-06	
J	Ono, H; Uchida, M; Tanaka, Y; Tanaka, K; Hashimoto, T				Ono, Hajime; Uchida, Masashi; Tanaka, Yuichiro; Tanaka, Katsuyuki; Hashimoto, Takuo			Traumatic Longitudinal Clival Fracture in a Child-Case Report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						head injury; clival fracture; longitudinal fracture	BASILAR ARTERY; OCCLUSION; INCARCERATION; CT	A 7-year-old boy presented with a longitudinal clival fracture following a traffic accident. The boy presented only with temporary unconsciousness despite suffering a fracture of the clivus. Fractures of the clivus are often caused by severe head trauma, and the mortality rate is high due to coexisting injury of the adjacent vessels, brain stem, and lower cranial nerves. Review of the radiological and clinical findings of longitudinal clival fractures found that all reported pediatric patients with longitudinal clival fracture, including the present case, suffered an occipital impact, whereas the majority of longitudinal clival fractures in adults occur following frontal or axial impact.	[Ono, Hajime] St Marianna Univ, Sch Med, Dept Neurosurg, Miyamae Ku, Kanagawa 2168511, Japan		Ono, H (corresponding author), St Marianna Univ, Sch Med, Dept Neurosurg, Miyamae Ku, 2-16-1 Sugao, Kanagawa 2168511, Japan.	gen21@marianna-u.ac.jp					ANTHONY DC, 1987, J NEUROSURG, V66, P929, DOI 10.3171/jns.1987.66.6.0929; Bala A, 2004, J CLIN NEUROSCI, V11, P660, DOI 10.1016/j.jocn.2003.11.008; Cho J, 2008, J KOREAN MED SCI, V23, P747, DOI 10.3346/jkms.2008.23.4.747; CORRADINO G, 1990, NEUROSURGERY, V27, P592, DOI 10.1227/00006123-199010000-00015; GUHA A, 1989, CAN J NEUROL SCI, V16, P81, DOI 10.1017/S0317167100028560; Hirakawa K, 1978, Neurol Med Chir (Tokyo), V18, P615, DOI 10.2176/nmc.18pt2.615; JOSLYN JN, 1988, RADIOLOGY, V166, P817, DOI 10.1148/radiology.166.3.3340778; KAPILA A, 1985, J COMPUT ASSIST TOMO, V9, P1142, DOI 10.1097/00004728-198511000-00033; LINDENBERG R, 1966, J NEUROSURG, V24, P908, DOI 10.3171/jns.1966.24.5.0908; LOOP JW, 1964, RADIOLOGY, V83, P36, DOI 10.1148/83.1.36; Menku A, 2004, NEUROSURG REV, V27, P194, DOI 10.1007/s10143-004-0320-2; Ogungbo B, 2001, BRIT J NEUROSURG, V15, P159; Sasaki MTS, 2007, NIPPON GAISHO GAKKAI, V21, P19; SATO H, 1990, Neurological Surgery, V18, P1147; Sato S, 2001, NEUROL MED-CHIR, V41, P541, DOI 10.2176/nmc.41.541; SHAW CM, 1972, J NEUROL NEUROSUR PS, V35, P247, DOI 10.1136/jnnp.35.2.247; SIGHTS WP, 1968, J NEUROSURG, V28, P588, DOI 10.3171/jns.1968.28.6.0588; Taguchi Y, 2000, J TRAUMA, V48, P1148, DOI 10.1097/00005373-200006000-00023	18	6	6	0	2	JAPAN NEUROSURGICAL SOC	TOKYO	7-3-1 HONGO BUNKYO-KU, TOKYO, 113-8655, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	OCT	2011	51	10					707	710		10.2176/nmc.51.707			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	837FN	WOS:000296176600006	22027246	Bronze			2022-02-06	
J	Bush, E; Hux, K; Zickefoose, S; Simanek, G; Holmberg, M; Henderson, A				Bush, Erin; Hux, Karen; Zickefoose, Samantha; Simanek, Gina; Holmberg, Michelle; Henderson, Ambyr			Learning and Study Strategies of Students with Traumatic Brain Injury: A Mixed Method Study	JOURNAL OF POSTSECONDARY EDUCATION AND DISABILITY			English	Article						brain injury; accommodations; learning strategies	IMPAIRED AWARENESS; DISABILITIES; REHABILITATION; EDUCATION; TBI	The purpose of this research was to explore the perceptions of four college students with severe traumatic brain injury and people associated with them regarding the use of learning skills and study strategics. The researchers employed a concurrent mixed method design using descriptive quantitative data as well as qualitative multiple case study data. Qualitative data came from interviews with the students with traumatic brain injury and three to four people associated with each of them; quantitative data was from the participants with traumatic brain injury and 15 to 26 of their same-class peers using the Learning and Study Skills Strategies Inventory ([LASSI] Weinstein. Shulte, & Palmer, 1987). Findings revealed disparities in perception between the students with traumatic brain injury and participants associated with them as well as between the qualitative and quantitative data sets of the student participants with traumatic brain injury. These differences appeared to reflect limitations in the student participants' awareness of their deficits. Despite the apparent academic success of the student participants, questions exist about the appropriateness of various accommodation strategies in maximizing postsecondary achievement and facilitating self-awareness of challenges associated with traumatic brain injury.	[Bush, Erin] Univ Nebraska Kearney, Dept Commun Disorders, Kearney, NE 68849 USA; [Hux, Karen] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE USA; [Zickefoose, Samantha] Univ Nebraska, Dept Commun Disorders, Lincoln, NE USA; [Simanek, Gina] Univ Nebraska, Lincoln, NE USA; [Holmberg, Michelle; Henderson, Ambyr] Lincoln Publ Sch, Lincoln, NE USA		Bush, E (corresponding author), Univ Nebraska Kearney, Dept Commun Disorders, Kearney, NE 68849 USA.	bushej@unk.edu; khux1@unl.edu; samanthawrenz@huskers.unl.edu; gsimanek@neb.rr.com; mholmbe@lps.org; ambyr.henderson@gmail.com	Hux, Karen/AAQ-2078-2020; Bush, Erin J/I-9606-2016	Bush, Erin J/0000-0003-1710-8619			Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Barga NK, 1996, J LEARN DISABIL, V29, P413, DOI 10.1177/002221949602900409; Bowen JM, 2005, PREV SCH FAIL, V49, P34, DOI 10.3200/PSFL.49.4.34-41; CARNEY J, 1994, PEDIATR ANN, V23, P47, DOI 10.3928/0090-4481-19940101-10; Chinn N. R., 2009, J POSTSECOND EDUC DI, V21, P175; Creswell J.W ., 2007, QUAL INQ; Fenton A, 2006, WEFT QDA VERSION 1 0; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Guba E. G., 1988, QUALITATIVE APPROACH; Heiman T, 2003, J LEARN DISABIL-US, V36, P248, DOI 10.1177/002221940303600304; Hodgkin S, 2008, J MIX METHOD RES, V2, P296, DOI 10.1177/1558689808321641; Hux K., 2009, BRAIN INJURY, V24, P13; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Lindstrom J. H., 2007, LEARNING DIDABILITY, V22, P229, DOI DOI 10.1111/J.1540-5826.2007.00251.X; Reis SM, 2000, GIFTED CHILD QUART, V44, P123, DOI 10.1177/001698620004400205; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Schulte A.C., 1987, LEARNING STUDY STRAT; Semrud-Clikeman M, 2001, TBI CHILDREN ADOLESC; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Skinner M. E., 1992, SCH COUNSELOR, V39, P369; Sohlberg M., 2001, COGNITIVE REHABILITA; Tinto V., 1999, NACADA J, V19, P5, DOI DOI 10.12930/0271-9517-19.2.5; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Yin R., 2003, CASE STUDY RES; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M., 1998, COLLABORATIVE BRAIN; [No title captured]	35	6	6	0	1	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD	COLUMBUS	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD, COLUMBUS, OH 00000 USA	2379-7762	2328-3343		J POSTSECOND EDUC DI	J. Postsecond. Educ. Disabil.	FAL	2011	24	3					231	250					20	Education, Special	Emerging Sources Citation Index (ESCI)	Education & Educational Research	VE7ET	WOS:000440143100006					2022-02-06	
J	Cho, HK; Hong, JH; Kim, SH; Kim, OL; Ahn, SH; Jang, SH				Cho, Hee Kyung; Hong, Ji Heon; Kim, Seong Ho; Kim, Oh Lyong; Ahn, Sang Ho; Jang, Sung Ho			Clinical usefulness of diffusion tensor imaging in patients with transtentorial herniation following traumatic brain injury	BRAIN INJURY			English	Article						Diffusion tensor imaging; diffusion tensor tractography; corticospinal tract; transtentorial herniation; traumatic brain injury	KERNOHANS NOTCH PHENOMENON; IPSILATERAL MOTOR DEFICIT; CHRONIC SUBDURAL-HEMATOMA; AXONAL INJURY; CORTICOSPINAL TRACT; FIBER TRACTOGRAPHY; LESIONS; TUMOR; CRUS	Primary objective: This study investigated the clinical usefulness of diffusion tensor tractography (DTT) for elucidation of the corticospinal tract (CST) state in patients with transtentorial herniation (TH) following traumatic brain injury (TBI). Methods and procedures: Eleven consecutive patients with TH were recruited among 175 patients with TBI. Patients who showed TH were classified into two groups according to DTT findings: Group 1: the integrity of CST was preserved, Group 2: the integrity of CST was disrupted at the cerebral peduncle (CP) or pons. Outcomes and results: Five patients belonged to Group 1 of TH, six patients to Group 2 of TH. On DTT of Group 1, fractional anisotropy values of the CP and pons along the CST in the affected hemisphere were lower than those of the unaffected hemisphere; however, the difference was not significant (p > 0.05). In Group 2, fractional anisotropy values of the CP and pons in the affected hemisphere were significantly lower than those of the unaffected hemisphere (p < 0.05). Conclusions: It was found that DTT is useful in evaluation of the presence and the severity of CST injury in patients with TH following TBI.	[Cho, Hee Kyung; Ahn, Sang Ho; Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea; [Hong, Ji Heon] Yeungnam Coll Sci & Technol, Dept Phys Therapy, Taegu, South Korea; [Kim, Seong Ho; Kim, Oh Lyong] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Korean GovernmentKorean Government [KRF-2008-314-E00173]	This work was supported by National Research Foundation of Korea Grant funded by the Korean Government (KRF-2008-314-E00173).	Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Derakhshan I, 2009, J NEUROL SCI, V287, P296, DOI 10.1016/j.jns.2009.07.015; Evans AH, 2004, NEUROLOGY, V62, P2333, DOI 10.1212/01.WNL.0000130350.54120.09; Fuh JL, 2008, CEPHALALGIA, V28, P410, DOI 10.1111/j.1468-2982.2008.01598.x; Han BS, 2007, NEUROREHABILITATION, V22, P151; Hong JH, 2010, EUR NEUROL, V63, P252, DOI 10.1159/000277477; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Horowitz M, 2002, J NEUROIMAGING, V12, P78, DOI 10.1111/j.1552-6569.2002.tb00097.x; ITOYAMA Y, 1995, J NEUROSURG, V82, P645, DOI 10.3171/jns.1995.82.4.0645; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Jang SH, 2009, NEUROREHABILITATION, V24, P273, DOI 10.3233/NRE-2009-0478; JONES KM, 1991, AM J NEURORADIOL, V12, P1238; Kim DG, 2007, NEUROREHABILITATION, V22, P273; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Moon KS, 2007, J CLIN NEUROSCI, V14, P989, DOI 10.1016/j.jocn.2006.05.016; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; NAIDICH TP, 1986, RADIOLOGY, V158, P431, DOI 10.1148/radiology.158.2.3941868; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Namura Shobu, 1997, Neurologia Medico-Chirurgica, V37, P32, DOI 10.2176/nmc.37.32; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Skoglund TS, 2008, ACTA RADIOL, V49, P98, DOI 10.1080/02841850701561372; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Udayakumaran S, 2010, CHILD NERV SYST, V26, P267, DOI 10.1007/s00381-009-1027-z; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073; Yoo WK, 2008, J NEUROL NEUROSUR PS, V79, P1295, DOI 10.1136/jnnp.2007.138131; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P543, DOI 10.1016/S0003-9993(97)90174-X	31	6	6	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2011	25	10					1005	1009		10.3109/02699052.2011.605095			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	801TZ	WOS:000293464800011	21812586				2022-02-06	
J	Koneru, R; Kobiler, D; Lehrer, S; Li, JD; van Rooijen, N; Banerjee, D; Glod, J				Koneru, Rajeth; Kobiler, David; Lehrer, Shoshona; Li, Jiadong; van Rooijen, Nico; Banerjee, Debabrata; Glod, John			Macrophages play a key role in early blood brain barrier reformation after hypothermic brain injury	NEUROSCIENCE LETTERS			English	Article						Brain injury; Blood brain barrier; Macrophage	EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION; ENDOTHELIAL PROGENITOR CELLS; PERIVASCULAR MACROPHAGES; SCAVENGER FUNCTION; VASCULAR BARRIER; LINEAGE CELLS; NEURAL INJURY; COLD-INJURY; ANGIOGENESIS; DEPLETION	The inflammatory response following traumatic injury to the central nervous system (CNS) includes the infiltration of large numbers of macrophages. This response has been implicated in both ongoing tissue damage as well as recovery following CNS injury. We investigated the role of invading macrophages on one important aspect of tissue repair in the brain, the reformation of the blood brain barrier (BBB). We used liposomal clodronate to deplete monocytes and tissue macrophages. This method led to a marked reduction in the accumulation of F4/80-expressing cells at sites of hypothermic brain injury in a murine model. The integrity of the blood brain barrier over time following injury was assessed by permeability of fluorescent labeled albumin. The reduction in macrophages at the injury site was accompanied by a delay in early reformation of the blood brain barrier. In control animals the permeability of the BBB to FITC-labeled albumin returned to normal levels by seven days post-injury. In macrophage-depleted mice leakage of albumin was still observed at seven days post-injury. These results suggest that macrophages play an important role in early post-traumatic reformation of the BBB. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Banerjee, Debabrata] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Med, Newark, NJ 07103 USA; [Banerjee, Debabrata] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pharmacol, Newark, NJ 07103 USA; [Koneru, Rajeth; Kobiler, David; Lehrer, Shoshona; Li, Jiadong; Glod, John] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pediat, Newark, NJ 07103 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, Med Ctr, Amsterdam, Netherlands		Glod, J (corresponding author), RWJMS UMDNJ, Canc Inst New Jersey, 195 Little Albany St, New Brunswick, NJ 08903 USA.	glodjo@umdnj.edu	Glod, John/U-9925-2019; Van Rooijen, Nico/Z-1578-2019		New Jersey Commission on Brain Injury [08-3206-BIR-E-1]	This work was supported by the New Jersey Commission on Brain Injury, grant No. 08-3206-BIR-E-1 to J.G.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Glod J, 2006, BLOOD, V107, P940, DOI 10.1182/blood-2004-11-4403; Gray M, 2007, J NEUROSCI RES, V85, P766, DOI 10.1002/jnr.21166; Harraz M, 2001, STEM CELLS, V19, P304, DOI 10.1634/stemcells.19-4-304; Havemann K, 2003, ADV EXP MED BIOL, V522, P47; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Ladewig G, 2009, EXP NEUROL, V220, P207, DOI 10.1016/j.expneurol.2009.08.027; Lee HS, 2009, FEBS J, V276, P4622, DOI 10.1111/j.1742-4658.2009.07174.x; Manoonkitiwongsa PS, 2001, J CEREBR BLOOD F MET, V21, P1223, DOI 10.1097/00004647-200110000-00011; Mato M, 1996, P NATL ACAD SCI USA, V93, P3269, DOI 10.1073/pnas.93.8.3269; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; Mendes-Jorge L, 2009, INVEST OPHTH VIS SCI, V50, P5997, DOI 10.1167/iovs.09-3515; Moldovan NI, 2000, CIRC RES, V87, P378; Nag S, 2002, TRENDS MOL MED, V8, P38, DOI 10.1016/S1471-4914(01)02221-3; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nakul-Aquaronne D, 2003, CARDIOVASC RES, V57, P816, DOI 10.1016/S0008-6363(02)00776-9; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Pujol BF, 2000, DIFFERENTIATION, V65, P287, DOI 10.1046/j.1432-0436.2000.6550287.x; Pujol BF, 2001, EUR J CELL BIOL, V80, P99, DOI 10.1078/0171-9335-00136; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Schwartz M, 2010, BRAIN BEHAV IMMUN, V24, P1054, DOI 10.1016/j.bbi.2010.01.010; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Willis CL, 2007, NEUROSCIENCE, V150, P498, DOI 10.1016/j.neuroscience.2007.09.023; Zenker D, 2003, J PHYSIOL-LONDON, V551, P1023, DOI 10.1113/jphysiol.2003.045880	35	6	6	2	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 1	2011	501	3					148	151		10.1016/j.neulet.2011.06.062			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	817BY	WOS:000294647000006	21782894				2022-02-06	
J	Neumann, DR; Hammond, F; Norton, J; Blumenthal, T				Neumann, Dawn Radice; Hammond, Flora; Norton, James; Blumenthal, Terry			Using Startle to Objectively Measure Anger and Other Emotional Responses After Traumatic Brain Injury: A Pilot Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anger; emotions; modulated acoustic startle reflex; physiological responses; traumatic brain injury	BECK DEPRESSION INVENTORY; POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD-INJURY; PREPULSE INHIBITION; AFFECTIVE MODULATION; FACIAL EXPRESSION; REFLEX MODULATION; SKIN-CONDUCTANCE; NEGATIVE AFFECT; RECALL BIAS	Objective: To determine the effectiveness of a modulated acoustic startle reflex paradigm with emotional imagery in studying physiological changes associated with emotional responses in persons with traumatic brain injury (TBI). Setting: Outpatient rehabilitation hospital. Participants: Six individuals with moderate to severe TBI. Mean age was 32 years and mean years postinjury were 9.9. Method: The modulated acoustic startle reflex procedure involved imagery of emotional scripts (joy, anger, fear, and neutral) followed by a startle noise, versus startle noise alone (no script). Measures: Eyeblink and skin conductance response, subjective arousal and valence ratings of the scripts, and general anger questionnaire. Results: Startle blink responses following anger imagery were significantly smaller than those following fear (P = .006) and neutral (P = .023) imagery. Skin conductance response did not change significantly based on the content of the scripts (P = .070). Conclusions: Large startle blink responses indicate avoidance of a stimulus. Our findings suggest that participants with TBI did not have an avoidant reaction to anger-inducing stimuli. Skin conductance response findings may imply arousal impairments. The modulated acoustic startle reflex was effective in measuring emotional responses; however, larger studies comparing persons with TBI with control groups are needed to further explore these findings.	[Neumann, Dawn Radice; Hammond, Flora] Carolinas HealthCare Syst, Dept Phys Med & Rehabil, Carolinas Rehabil, Charlotte, NC 28203 USA; [Norton, James] Carolinas HealthCare Syst, Cannon Res, Charlotte, NC 28203 USA; [Hammond, Flora] Indiana Univ Sch Med, Indiana, PA USA; [Blumenthal, Terry] Wake Forest Univ, Dept Psychol, Winston Salem, NC 27109 USA		Neumann, DR (corresponding author), Carolinas HealthCare Syst, Dept Phys Med & Rehabil, Carolinas Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.	dmneuman@iupui.edu	Blumenthal, Terry D./AAG-2974-2021		Department of Physical Medicine and Rehabilitation at Carolinas Rehabilitation in Charlotte, North Carolina, Carolinas Health Care System	The authors would like to express their appreciation to Biopac Systems Inc (biopac.com) for lending them some of the equipment used in this project. In addition, the authors would like to recognize that this work was partially supported by the Department of Physical Medicine and Rehabilitation at Carolinas Rehabilitation in Charlotte, North Carolina (part of the Carolinas Health Care System), that contributed funding for participant stipends.	Allen NB, 1999, BIOL PSYCHIAT, V46, P542, DOI 10.1016/S0006-3223(99)00025-6; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Borgstrom A, 2008, PSYCHONEUROENDOCRINO, V33, P487, DOI 10.1016/j.psyneuen.2008.01.007; Braff DL, 1999, AM J PSYCHIAT, V156, P596; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brosschot JF, 1998, ANN BEHAV MED, V20, P326, DOI 10.1007/BF02886382; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Buchanan TW, 2004, BEHAV NEUROSCI, V118, P429, DOI 10.1037/0735-7044.118.2.429; COOK EW, 1991, J ABNORM PSYCHOL, V100, P5, DOI 10.1037/0021-843X.100.1.5; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Cuthbert BN, 1996, PSYCHOPHYSIOLOGY, V33, P103, DOI 10.1111/j.1469-8986.1996.tb02114.x; d'Alfonso AAL, 2000, NEUROSCI LETT, V280, P195, DOI 10.1016/S0304-3940(00)00781-3; Dichter GS, 2004, PSYCHOPHYSIOLOGY, V41, P433, DOI 10.1111/j.1469-8986.00162.x; Epley N, 2006, PERS SOC PSYCHOL B, V32, P641, DOI 10.1177/0146167205284007; Fairchild G, 2008, BIOL PSYCHIAT, V63, P279, DOI 10.1016/j.biopsych.2007.06.019; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Giakournaki SG, 2007, BIOL PSYCHIAT, V62, P1418, DOI 10.1016/j.biopsych.2006.12.002; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Grillon C, 1996, PSYCHIAT RES, V64, P169, DOI 10.1016/S0165-1781(96)02942-3; Guercio John M, 2002, Case Manager, V13, P55, DOI 10.1067/tcmg.2002.122043; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hanlon MC, 2009, INT J NEUROPSYCHOPH, V12, P701, DOI 10.1017/S1461145708009711; Harmon-Jones E, 1998, J PERS SOC PSYCHOL, V74, P1310, DOI 10.1037/0022-3514.74.5.1310; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Harmon-Jones E, 2009, EMOTION, V9, P183, DOI 10.1037/a0014959; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; JACCARD J, 1995, J APPL SOC PSYCHOL, V25, P1831, DOI 10.1111/j.1559-1816.1995.tb01820.x; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; McTeague LM, 2010, BIOL PSYCHIAT, V67, P346, DOI 10.1016/j.biopsych.2009.08.023; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Miller MW, 2002, PSYCHOPHYSIOLOGY, V39, P519, DOI 10.1017/S0048577202394095; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Morgan CA, 1996, AM J PSYCHIAT, V153, P64; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ORNITZ EM, 1992, PSYCHOPHYSIOLOGY, V29, P437, DOI 10.1111/j.1469-8986.1992.tb01717.x; PATRICK CJ, 1993, J ABNORM PSYCHOL, V102, P82, DOI 10.1037/0021-843X.102.1.82; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; Spielberger C.D., 1999, MANUAL STATE TRAIT A; Stemmler G, 2007, INT J PSYCHOPHYSIOL, V66, P141, DOI 10.1016/j.ijpsycho.2007.03.019; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; SWERDLOW NR, 1993, BIOL PSYCHIAT, V33, P298, DOI 10.1016/0006-3223(93)90300-3; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Vrana S. R., 1989, COGNITION EMOTION, V3, P179, DOI DOI 10.1080/02699938908415240; Vrana SR, 2007, INT J PSYCHOPHYSIOL, V66, P93, DOI 10.1016/j.ijpsycho.2007.03.013; VRANA SR, 1995, PSYCHOPHYSIOLOGY, V32, P351, DOI 10.1111/j.1469-8986.1995.tb01217.x; VRANA SR, 1988, J ABNORM PSYCHOL, V97, P487, DOI 10.1037/0021-843X.97.4.487; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Witvliet CV, 2000, BIOL PSYCHOL, V52, P187, DOI 10.1016/S0301-0511(00)00027-2	73	6	6	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2011	26	5					375	383		10.1097/HTR.0b013e3181f8d52d			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	814VO	WOS:000294485500006	21245768				2022-02-06	
J	Tak, S; Groenewold, M; Alterman, T; Park, RM; Calvert, GM				Tak, SangWoo; Groenewold, Matthew; Alterman, Toni; Park, Robert M.; Calvert, Geoffrey M.			Excess Risk of Head and Chest Colds Among Teachers and Other School Workers	JOURNAL OF SCHOOL HEALTH			English	Article						communicable diseases; employee health promotion; public health	TIME-SERIES ANALYSIS; 949 GERMAN TEACHERS; INDOOR AIR; PREVALENCE; INFECTION; PNEUMONIA; SAMPLE	BACKGROUND: Work-related injuries and illnesses in the educational services sector have not been well studied. This analysis examined whether teachers and other school workers are at higher risk of head/chest cold compared to all other workers in the United States. METHODS: Seven years (1998-2004) of National Health Interview Survey data on currently employed workers were combined to provide a basis for estimating the incidence proportion of head/chest cold. RESULTS: The adjusted odds ratio for head/chest cold was significantly elevated for teachers and other workers employed at schools compared to all other workers. When examined by month, an excess of increased head/chest cold risk during the school year suggested that a portion of head/chest cold among teachers and other school workers is attributable to their workplace, perhaps due to close contact with students at school. CONCLUSION: Head/chest cold, a surrogate for acute respiratory infection, was more common among school workers during the school year and less common during July than for all other workers in the United States. Targeted training for school workers and students may be beneficial to reduce work-related exposure to viruses and bacteria that infect the respiratory system.	[Tak, SangWoo; Groenewold, Matthew; Alterman, Toni; Park, Robert M.; Calvert, Geoffrey M.] Natl Inst Occupat Safety & Hlth, Ctr Dis Control & Prevent, Cincinnati, OH 45226 USA		Tak, S (corresponding author), Massachusetts Dept Publ Hlth, Occupat Hlth Surveillance Program, 250 Washington St,6th Floor, Boston, MA 02108 USA.	Sangwoo.Tak@state.ma.us; MGroenewold@cdc.gov; TAlterman@cdc.gov; RPark@cdc.gov; GCalvert@cdc.gov	Alterman, Toni/AAB-5639-2022	Alterman, Toni/0000-0003-1512-4367; Tak, Sangwoo/0000-0002-3576-4524			Alexander DL, 2001, OCCUP MED-STATE ART, V16, P65; Bauer J, 2007, INT ARCH OCC ENV HEA, V80, P442, DOI 10.1007/s00420-007-0170-7; *BUR LAB STAT, 2001, STAND OCC CLASS SOC; Bureau of Labor Statistics, 2008, OCC EMPL STAT; BURGE HA, 1989, OCCUP MED, V4, P713; *CDCP, 2008, KEY FACTS SEAS FLU V; *CDCP, 2009, CDC GUID HELP CHILD; Crighton EJ, 2004, EPIDEMIOL INFECT, V132, P1167, DOI 10.1017/S0950268804002924; Fowler FJ, 1996, PUBLIC HEALTH REP, V111, P508; Haverinen U, 1999, ENVIRON HEALTH PERSP, V107, P509, DOI 10.1289/ehp.99107s3509; Hayden FG, 2006, ACP MED; LARSON E, 1988, INFECT CONT HOSP EP, V9, P28, DOI 10.1086/645729; Mandell LA, 2005, CLIN INFECT DIS, V41, P503, DOI 10.1086/432019; Mattiske JA, 1998, J VOICE, V12, P489, DOI 10.1016/S0892-1997(98)80058-1; Mazurek JM, 2008, AM J IND MED, V51, P47, DOI 10.1002/ajim.20539; MOINEDDIN R, 2003, POPUL HEALTH METR, V1, DOI DOI 10.1186/1478-7954-1-10; *NAT HLTH INT SURV, 1999, VITAL HLTH STAT 2, V126, P1; Nielsen PV, 2009, J R SOC INTERFACE, V6, pS747, DOI 10.1098/rsif.2009.0228.focus; Patovirta Riitta-Liisa, 2003, Int J Occup Med Environ Health, V16, P221; Roy N, 2004, J SPEECH LANG HEAR R, V47, P281, DOI 10.1044/1092-4388(2004/023); Sahakian NM, 2008, J SCHOOL HEALTH, V78, P32, DOI 10.1111/j.1746-1561.2007.00263.x; *SAS I INC, 2007, SAS ETS US GUID; Unterbrink T, 2007, INT ARCH OCC ENV HEA, V80, P433, DOI 10.1007/s00420-007-0169-0; Upshur REG, 2006, EPIDEMIOL INFECT, V134, P1174, DOI 10.1017/S0950268806006236; van Gageldonk-Lafeber AB, 2005, CLIN INFECT DIS, V41, P490, DOI 10.1086/431982; Whelan EA, 2003, OCCUP ENVIRON MED, V60, P929, DOI 10.1136/oem.60.12.929	26	6	6	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391			J SCHOOL HEALTH	J. Sch. Health	SEP	2011	81	9					560	565		10.1111/j.1746-1561.2011.00627.x			6	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	806FB	WOS:000293790600007	21831069	Green Published			2022-02-06	
J	Tomaszewski, W; Manko, G				Tomaszewski, Wieslaw; Manko, Grzegorz			An evaluation of the strategic approach to the rehabilitation of traumatic brain injury (TBI) patients	MEDICAL SCIENCE MONITOR			English	Article						brain injury; coma; a goal-driven strategic plan; quality of life	QUALITY-OF-LIFE; SPINAL-CORD-INJURY; SHORT-TERM; ADJUSTMENT; BEHAVIOR; OUTCOMES; CHILDREN	Background: The objective of our study was to evaluate a goal-driven strategic plan for the step-by-step rehabilitation of traumatic brain injury (TBI) patients, with effectiveness measured in terms of quality of life, as compared to patients treated according to a standard, progressive rehabilitation program. Material/Methods: We studied 40 patients after TBI awakened from a long-term coma. The patients were divided into two equal groups: a control group (n=20) involving patients treated before the introduction of the strategic approach, and an experimental group (n=20) involving patients rehabilitated under the strategic approach. In evaluating the effectiveness of rehabilitation we used a structured interview with clinical observation and a scale for assessing the quality of life of patients after TBI. Results: The deterioration in the quality of life of TBI patients is mainly related to difficulties in satisfying physiological needs, self-care, reduced mobility and disorders of cognitive, regulatory, and social functions. In both groups, the feature most susceptible to rehabilitation related change was movement, while the least susceptible functions were associated with the use of different means of transport. This change is significantly greater in persons in the experimental group, as compared to controls. Conclusions: We found that a rehabilitation program controlled by a strategic plan, with the cooperation of the patient, is more effective in improving the quality of life, as the patient is more self-motivated to individually designed objectives.	[Tomaszewski, Wieslaw] Coll Physiotherapy, Wroclaw, Poland; [Manko, Grzegorz] Jagiellonian Univ Med Coll, Fac Hlth Sci, Dept Ergon & Exercise Physiol, Krakow, Poland; [Manko, Grzegorz] Elblag Univ Humanities & Econ, Dept Hlth Sci, Elblag, Poland		Tomaszewski, W (corresponding author), Medsportpress Publishers, Jagiellonska 3-20 Str, PL-03721 Warsaw, Poland.	w.tomaszewski@wp.pl	manko, grzegorz/I-5102-2012				Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Baranowski P, 2010, ORTOPEDIA TRAUMATOLO, V2, P31; Bulinski L, 2010, MED SCI MONITOR, V16, pPH14; Bulpitt CJ, 1997, POSTGRAD MED J, V73, P613, DOI 10.1136/pgmj.73.864.613; CLAYTON KS, 1994, ARCH PHYS MED REHAB, V75, P633, DOI 10.1016/0003-9993(94)90184-8; Craig A, 1999, SPINAL CORD, V37, P345, DOI 10.1038/sj.sc.3100829; CURCOLL ML, 1992, PARAPLEGIA, V30, P425, DOI 10.1038/sc.1992.93; Czamara A, 2011, MED SCI MONITOR, V17, pCR33; DENNIS RE, 1993, EXCEPT CHILDREN, V59, P499, DOI 10.1177/001440299305900603; Firsching R, 1998, SPINAL CORD, V36, P741, DOI 10.1038/sj.sc.3100713; Grady CL, 2002, CAN J PSYCHIAT, V47, P327, DOI 10.1177/070674370204700403; Grochmal-Bach B, 1996, SZTUKA LECZENIA, V2, P95; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; JUDD FK, 1986, PARAPLEGIA, V24, P6, DOI 10.1038/sc.1986.3; Kannisto M, 1998, SPINAL CORD, V36, P193, DOI 10.1038/sj.sc.3100543; Kennedy P, 1999, SPINAL CORD, V37, P136, DOI 10.1038/sj.sc.3100745; MacQueen BD, 2003, ORTOPEDIA TRAUMATOLO, V5, P797; MacQueen BD, 2003, NEUROPSYCHOLOGICZNE, P99; MacQueen BD, 2002, URAZY PNIA MOZGU KOM, P328; Manko G, 2004, OCENA SKUTECZNOSCI S; Pachalska M, 2000, Ortop Traumatol Rehabil, V2, P44; Pachalska M, 2001, Ortop Traumatol Rehabil, V3, P89; Pachalska M, 1998, SKALA OCENY JAKOSCI; Pachalska M., 2008, REHABILITACJA NEUROP; Pachalska M, 2000, ORTOPEDIA TRAUMATOLO, V3, P34; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; Pachalska M, 2001, ORTOPEDIA TRAUMATOLO, V2, P182; Pachalska M, 2010, ACTA NEUROPSYCHOL, V8, P69; Pachalska M, 2011, MED SCI MONITOR, V17, pCS18, DOI 10.12659/MSM.881381; Pruitt SD, 1998, SPINAL CORD, V36, P724, DOI 10.1038/sj.sc.3100649; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Rubin KH., 2006, HDB CHILD PSYCHOL, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Sapountzi-Krepia D, 1998, SPINAL CORD, V36, P432, DOI 10.1038/sj.sc.3100641; SINTONEN H, 1993, QUALITY OF LIFE ASSESSMENT : KEY ISSUES IN THE 1990S, P185; Snowdy Jr HA, 1992, CRITICAL CARE CLIN, V3, P449; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; STENSMAN R, 1994, PARAPLEGIA, V32, P416, DOI 10.1038/sc.1994.68; Talar J, 2002, URAZY PNIA MOZGU KOM, P207; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor-Sarno M, 1997, APHASIOLOGY, V11, P665; Vaidyananthan S, 1998, SPINAL CORD, V36, P409, DOI 10.1038/sj.sc.3100573; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	42	6	6	0	7	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	SEP	2011	17	9					CR510	CR516		10.12659/MSM.881938			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	840XT	WOS:000296476100014	21873948	Green Submitted, Green Published			2022-02-06	
J	Lin, ZX; Han, M; Li, H; Luo, HJ; Zhang, Y; Luo, WH				Lin, Zhexuan; Han, Ming; Li, Hui; Luo, Hongjun; Zhang, Yuan; Luo, Wenhong			Soluble vascular adhesion protein-1: Decreased activity in the plasma of trauma victims and predictive marker for severity of traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Soluble vascular adhesion protein-1; Trauma; Traumatic brain injury; Inflammation; Injury-severity score; Glasgow Coma Scale	SENSITIVE AMINE OXIDASE; MULTIPLE ORGAN FAILURE; SSAO ACTIVITY; DIABETES-MELLITUS; ENDOTHELIAL-CELLS; MAJOR TRAUMA; SERUM; INFLAMMATION; EXPRESSION; SEPSIS	Background: This study done was to investigate the clinical significance of soluble vascular adhesion protein-1 (sVAP-1) activity in trauma patients with different patterns. Methods: 96 patients with consecutive trauma 15 years who were admitted to emergency department of the Second Affiliated Hospital, Shantou University Medical College, China, between January 2007 and December 2009 were enrolled in this study. Plasma was collected at admission. Injury-severity score (ISS) and Glasgow Coma Scale (GCS) were used to determine the patient conditions. sVAP-1 activity was determined by using the high performance liquid chromatographic (HPLC) system. Results: Mean sVAP-1 activity in trauma patients was significantly lower than that of controls (P<0.0001), and the level was negatively correlated with circulating leucocytes and neutrophils (P<0.0001). There was a significant correlation between lower sVAP-1 activity and injury patterns. However, plasma sVAP-1 activity increased significantly in accordance with the severity of traumatic brain injury (TBI), and the patients with sVAP-1 value above 8.61 nmol/ml/h have much higher mortality rate (25.0%) than patients with sVAP-1 value lower than 8.61 nmol/ml/h (0.0%) (P = 0.011). Conclusions: Trauma patients had a decreased sVAP-1 activity. However, isolated TBI patients with higher activity of sVAP-1 at admission were more likely to have a poor outcome. (C) 2011 Elsevier B.V. All rights reserved.	[Lin, Zhexuan; Li, Hui; Luo, Hongjun; Zhang, Yuan; Luo, Wenhong] Shantou Univ Med Coll, Bioanalyt Lab, Shantou City 515041, Guangdong, Peoples R China; [Han, Ming] Shantou Univ Med Coll, Emergency Dept, Affiliated Hosp 2, Shantou City 515041, Guangdong, Peoples R China		Luo, WH (corresponding author), Shantou Univ Med Coll, Bioanalyt Lab, Xinling Rd 22, Shantou City 515041, Guangdong, Peoples R China.	whluo@stu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870911]; Guangdong Natural Science FoundationNational Natural Science Foundation of Guangdong Province [9351503102000001]	This study is supported by the National Natural Science Foundation of China (project number 30870911), and by Team Research Project of Guangdong Natural Science Foundation (No. 9351503102000001).	Abella A, 2004, DIABETOLOGIA, V47, P429, DOI 10.1007/s00125-004-1346-2; Airas L, 2006, J NEUROIMMUNOL, V177, P132, DOI 10.1016/j.jneuroim.2006.05.014; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; BAZIL V, 1995, IMMUNOL TODAY, V16, P135, DOI 10.1016/0167-5699(95)80130-8; Boldt J, 1996, INTENS CARE MED, V22, P122, DOI 10.1007/BF01720718; Boomsma F, 2005, DIABETOLOGIA, V48, P1002, DOI 10.1007/s00125-005-1716-4; Castelli GP, 2009, CRIT CARE MED, V37, P1845, DOI 10.1097/CCM.0b013e31819ffd5b; Dalfo E, 2003, BBA-MOL BASIS DIS, V1638, P278, DOI 10.1016/S0925-4439(03)00094-2; El Hadri K, 2002, ARTERIOSCL THROM VAS, V22, P89, DOI 10.1161/hq0102.101550; Freestone PP, 2002, SHOCK, V18, P465, DOI 10.1097/00024382-200211000-00014; Garpenstrand H, 1999, DIABETIC MED, V16, P514, DOI 10.1046/j.1464-5491.1999.00103.x; GECSE A, 1969, MED EXP, V19, P279; Jaakkola K, 2000, AM J PATHOL, V157, P463, DOI 10.1016/S0002-9440(10)64558-0; Karadi I, 2002, CLIN CHIM ACTA, V323, P139, DOI 10.1016/S0009-8981(02)00189-4; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Li H, 2004, J CHROMATOGR B, V810, P277, DOI 10.1016/j.jchromb.2004.08.011; Lin ZX, 2005, TOXICOL LETT, V159, P134, DOI 10.1016/j.toxlet.2005.05.003; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Madej A, 2007, J EUR ACAD DERMATOL, V21, P72, DOI 10.1111/j.1468-3083.2006.01869.x; Magyar Kalman, 2003, Inflammopharmacology, V11, P165, DOI 10.1163/156856003765764335; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Marshall JC, 2003, CRIT CARE MED, V31, P1560, DOI 10.1097/01.CCM.0000065186.67848.3A; McKeating EG, 1998, ANESTH ANALG, V86, P759, DOI 10.1097/00000539-199804000-00016; MEYER DM, 1995, J IMMUNOL, V155, P3578; Obata T, 2000, NEUROSCI LETT, V296, P58, DOI 10.1016/S0304-3940(00)01565-2; Pasvogel AE, 2008, BIOL RES NURS, V10, P113, DOI 10.1177/1099800408323218; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SCHLEIFFENBAUM B, 1992, J CELL BIOL, V119, P229, DOI 10.1083/jcb.119.1.229; Somfai GM, 2006, NEUROCHEM INT, V48, P746, DOI 10.1016/j.neuint.2005.12.009; Stanimirovic DB, 1997, ACT NEUR S, V70, P12; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Toiyama Y, 2009, J SURG ONCOL, V99, P368, DOI 10.1002/jso.21246; Vainio PJ, 2005, BASIC CLIN PHARMACOL, V96, P429, DOI 10.1111/j.1742-7843.2005.pto_96605.x; WANG ZG, 2007, J CLIN SURG, V15, P727; WANG ZG, 2006, J CHENGDU MED COLL, V1, P2; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yang Wei, 2009, Zhongguo Yaolixue Yu Dulixue Zazhi, V23, P337, DOI 10.3867/j.issn.1000-3002.2009.05.001; Zorzano A, 2003, BBA-PROTEINS PROTEOM, V1647, P3, DOI 10.1016/S1570-9639(03)00039-6	42	6	6	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981			CLIN CHIM ACTA	Clin. Chim. Acta	AUG 17	2011	412	17-18					1678	1682		10.1016/j.cca.2011.05.031			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	795SW	WOS:000292997100032	21645499				2022-02-06	
J	Cryer, C; Fingerhut, L; Segui-Gomez, M				Cryer, Colin; Fingerhut, Lois; Segui-Gomez, Maria		ICE Injury Indicators Working Grp	Injury mortality indicators: recommendations from the International Collaborative Effort on Injury Statistics	INJURY PREVENTION			English	Article								Background The International Collaborative Effort (ICE) on Injury Statistics called for an effort 'to reach consensus on what are the 10 most important indicators of injury incidence that offer the potential for international comparisons and for regional or global monitoring.' Objectives To describe the process of developing the ICE indicators and to present the specifications of selected injury mortality indicators, along with comparisons between selected countries for those specified indicators. Methods Participants on the ICE list had been asked to send to one of the authors what they considered the most important five indicators of injury incidence. These were synthesised and presented under six themes: mortality indicators (general); mortality indicators (motor vehicle); mortality indicators (other); hospital data-based (overall); hospital data-based (traumatic brain injury (TBI)); long-term disability (overall). Following two work group discussions and after drafting and revising indicator specifications, agreement was reached on mortality indicators and specifications. Specifications for those mortality indicators are presented. Morbidity indicators are still to be agreed. Results The mortality indicators proposed were age-adjusted rates of injury death; motor vehicle traffic crash-related death; self-harm/suicide; assault/homicide; and TBI death. The empirical work highlighted difficulties in identifying TBI in countries where mortality data do not capture multiple injuries, prompting us to drop the mortality indicator related to TBI and moving us instead to introduce an indicator to monitor the use of undetermined intent in the classification of injury mortality. Conclusion The ICE has reached a consensus on what injury mortality indicators should be used for comparison between countries. Specifications for each of these have been applied successfully to the mortality data of seven countries.	[Segui-Gomez, Maria] Univ Navarra, European Ctr Injury Prevent, E-31080 Pamplona, Spain; [Cryer, Colin] Univ Otago, Injury Prevent Res Unit, Otago, New Zealand; [Fingerhut, Lois] Int Collaborat Effort Injury Stat, Washington, DC USA		Segui-Gomez, M (corresponding author), Univ Navarra, European Ctr Injury Prevent, E-31080 Pamplona, Spain.	msegui@unav.es					BELANGER F, 2008, ANAL INJURED RELATED; *CDCP, INT COLL EFF ICE INJ; CONNOR J, 2007, 063 OR U OT INJ PREV; Cryer C., 2005, INT J INJ CONTROL SA, V12, P225; Cryer Colin, 2005, Int J Inj Contr Saf Promot, V12, P219, DOI 10.1080/17457300500172925; National Centre for Health Statistics, ICD 10 EXT CAUS INJ	6	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047			INJURY PREV	Inj. Prev.	AUG	2011	17	4					281	284		10.1136/injuryprev-2011-040037			4	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	796UH	WOS:000293077800015	21676959				2022-02-06	
J	Grimmelt, AC; Eitzen, S; Balakhadze, I; Fischer, B; Wolfer, J; Schiffbauer, H; Gorji, A; Greiner, C				Grimmelt, A. -C.; Eitzen, S.; Balakhadze, I.; Fischer, B.; Woelfer, J.; Schiffbauer, H.; Gorji, A.; Greiner, C.			Closed Traumatic Brain Injury Model in Sheep Mimicking High-Velocity, Closed Head Trauma in Humans	CENTRAL EUROPEAN NEUROSURGERY			English	Article						closed traumatic brain injury; experimental animal model; magnetic resonance imaging; multiparametric cerebral monitoring; sheep	AXONAL INJURY; ANIMAL-MODELS; AMINO-ACIDS; IMPACT; TRANSPORTER; TEMPERATURE; EXPRESSION; WHIPLASH; LESSONS; TRIALS	To date, there are only a few, non-evidence based, cerebroprotective therapeutic strategies for treatment and, accordingly, for prevention of secondary brain injuries following severe closed head trauma. In order to develop new therapy strategies, existing realistic animal models need to be advanced. The objective is to bridge standardized small animal models and actual patient medical care, since the results of experimental small animal studies often cannot be transferred to brain-injured humans. For improved standardization of high-velocity trauma, new trauma devices for initiating closed traumatic brain injury in sheep were developed. The following new devices were tested: 1. An anatomically shaped rubber bolt with an integrated oscillation absorber for prevention of skull fractures; 2. Stationary mounting of the bolt to guarantee stable experimental conditions; 3. Varying degrees of trauma severity, i.e., mild and severe closed traumatic brain injury, using different cartridges; and 4. Trauma analysis via high-speed video recording. Peritraumatic measurements of intracranial pressure, brain tissue pH, brain tissue oxygen, and carbon dioxide pressure, as well as neurotransmitter concentrations were performed. Cerebral injuries were documented with magnetic resonance imaging and compared to neuropathological results. Due to the new trauma devices, skull fractures were prevented. The high-speed video recording documented a realistic trauma mechanism for a car accident. Enhancement of extracellular glutamate, aspartate, and gamma amino butyric acid concentrations began 60 min after the trauma. Magnetic resonance imaging and neuropathological results showed characteristic injury patterns of mild, and severe, closed traumatic brain injury. The severe, closed traumatic brain injury group showed diffuse axonal injuries, traumatic subarachnoid hemorrhage, and hemorrhagic contusions with inconsistent distribution among the animals. The model presented here achieves a gain in standardization of severe, closed traumatic brain injury by increasing approximation to reality. The still existent heterogeneity of brain pathology mimics brain changes observed in patients after high-energy trauma. This model seems to close the gap between experimental small animal models and clinical studies. However, further investigations are needed to evaluate if this model can be used for testing new therapeutic strategies for these patients.	[Grimmelt, A. -C.; Eitzen, S.; Balakhadze, I.; Fischer, B.; Woelfer, J.] Univ Munster, Dept Neurosurg, D-48149 Munster, Germany; [Schiffbauer, H.] Univ Munster, Dept Clin Radiol, D-48149 Munster, Germany; [Gorji, A.] Univ Munster, Inst Physiol 1, D-48149 Munster, Germany; [Greiner, C.] Niels Stensen Kliniken, Marienhosp Osnabruck, Dept Neurosurg, Osnabruck, Germany		Grimmelt, AC (corresponding author), Univ Munster, Dept Neurosurg, Albert Schweizer Str 33, D-48149 Munster, Germany.	ann-christin.grimmelt@med.uni-muenchen.de					Adams J H, 1981, Acta Neuropathol Suppl, V7, P26; Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Centers for Disease Control and Prevention Department of Health and Human Services, 2006, FACTS TRAUM BRAIN IN; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Doppenberg EMR, 1998, ACT NEUR S, V71, P166; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Ewing C, 1975, 19TH P STAPP CAR CRA, P487; Finnie JW, 2003, AUST VET J, V81, P153, DOI 10.1111/j.1751-0813.2003.tb11078.x; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hlatky R, 2002, ACT NEUR S, V81, P347; KANTHAN R, 1995, J NEUROL NEUROSUR PS, V59, P326, DOI 10.1136/jnnp.59.3.326; Keidel M, 2001, PAIN, V92, P319, DOI 10.1016/S0304-3959(01)00272-X; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Menzel M, 1998, J NEUROTRAUM, V15, P265, DOI 10.1089/neu.1998.15.265; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Piper I, 1997, HEAD INJURY; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Stubbe HD, 2004, J CEREBR BLOOD F MET, V24, P1400, DOI 10.1097/01.WCB.0000141516.61418.82; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Zauner A, 2002, J NEUROSURG, V97, P643, DOI 10.3171/jns.2002.97.3.0643; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	36	6	9	2	10	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	1868-4904	1868-4912		CENT EUR NEUROSURG	Cent. Eur. Neurosurg.	AUG	2011	72	3					120	126		10.1055/s-0031-1271732			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	804ZZ	WOS:000293697000002	21739409				2022-02-06	
J	Geraci, A; Cantagallo, A				Geraci, Alessandra; Cantagallo, Anna			Inferential reasoning: Comparison of patients with schizophrenia and patients with traumatic brain injury	PSYCHIATRY RESEARCH			English	Article						Inferential reasoning; Second-order false beliefs; Traumatic brain injury; Schizophrenia; Ventromedial prefrontal cortex	MIND	We investigated the cognitive processes underlying inferential reasoning, comparing performance of patients suffering from schizophrenia with that of patients with brain injury in an attempt to understand the nature of the social impairments in schizophrenia. Inferential reasoning on mental and physical states and second-order false belief attribution were assessed in healthy controls, in patients with schizophrenia and in brain trauma patients with predominantly ventromedial prefrontal cortex or dosolateral prefrontal cortex lesions. Our finding that ventromedial prefrontal areas are involved in general inferential reasoning casts further light on the neural structures implicated in socio-cognitive impairments in schizophrenia. (C) 2010 Elsevier Ireland Ltd. All rights reserved.	[Geraci, Alessandra] Univ Trento, Dept Cognit Sci, I-38068 Rovereto, TN, Italy; [Cantagallo, Anna] Hosp Ferrara, Dept Neurosci Rehabil, Ferrara, Italy; [Cantagallo, Anna] Univ Ferrara, Dept Neurosci Rehabil, I-44100 Ferrara, Italy		Geraci, A (corresponding author), Univ Trento, Dept Cognit Sci, Corso Bettini 31, I-38068 Rovereto, TN, Italy.	geraci.ale@gmail.com	Geraci, Alessandra/ABC-5241-2020	Geraci, Alessandra/0000-0003-1375-9190			Abdel-Hamid M, 2009, PSYCHIAT RES, V165, P19, DOI 10.1016/j.psychres.2007.10.021; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bertrand MC, 2007, SCHIZOPHR RES, V95, P124, DOI 10.1016/j.schres.2007.05.033; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Brune M, 2003, SCHIZOPHR RES, V60, P57, DOI 10.1016/s0920-9964(02)00162-7; Coltheart M, 2001, COGNITIVE NEUROPSYCH, V6, P81, DOI DOI 10.1080/13546800042000061; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; Harari H, 2010, PSYCHIAT RES, V175, P277, DOI 10.1016/j.psychres.2009.03.002; Heaton KR, 1993, WISCONSIN CARD SORTI; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Janssen I, 2003, ACTA PSYCHIAT SCAND, V108, P110, DOI 10.1034/j.1600-0447.2003.00092.x; Jenkins AC, 2008, P NATL ACAD SCI USA, V105, P4507, DOI 10.1073/pnas.0708785105; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Laiacona M., 2001, J NEUROL SCI, V21, P279; Shamay-Tsoory SG, 2007, SCHIZOPHR RES, V90, P274, DOI 10.1016/j.schres.2006.09.020; SULLIVAN K, 1994, DEV PSYCHOL, V30, P395, DOI 10.1037/0012-1649.30.3.395	20	6	6	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	JUL 30	2011	188	2					291	293		10.1016/j.psychres.2010.12.012			3	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	791OM	WOS:000292674500020	21211853				2022-02-06	
J	Rapp, PE; Cellucci, CJ; Gilpin, AMK; Jimenez-Montano, MA; Korslund, KE				Rapp, Paul E.; Cellucci, Christopher J.; Gilpin, Adele M. K.; Jimenez-Montano, Miguel A.; Korslund, Kathryn E.			Communication patterns in a psychotherapy following traumatic brain injury: A quantitative case study based on symbolic dynamics	BMC PSYCHIATRY			English	Article						brain injury; psychotherapy; psychoanalysis; complexity; mutual information; entropy; information theory; symbolic dynamics	CLIENT-THERAPIST INTERACTION; WEAK CENTRAL COHERENCE; RESPONSE-MODE USE; NEUROPSYCHOLOGIC REHABILITATION; AUTOBIOGRAPHICAL SPEECH; ALGORITHMIC COMPLEXITY; EXECUTIVE DYSFUNCTION; PSYCHIATRIC-DISORDERS; NONLINEAR DYNAMICS; PRAGMATIC DEFICITS	Background: The role of psychotherapy in the treatment of traumatic brain injury is receiving increased attention. The evaluation of psychotherapy with these patients has been conducted largely in the absence of quantitative data concerning the therapy itself. Quantitative methods for characterizing the sequence-sensitive structure of patient-therapist communication are now being developed with the objective of improving the effectiveness of psychotherapy following traumatic brain injury. Methods: The content of three therapy session transcripts (sessions were separated by four months) obtained from a patient with a history of several motor vehicle accidents who was receiving dialectical behavior therapy was scored and analyzed using methods derived from the mathematical theory of symbolic dynamics. Results: The analysis of symbol frequencies was largely uninformative. When repeated triples were examined a marked pattern of change in content was observed over the three sessions. The context free grammar complexity and the Lempel-Ziv complexity were calculated for each therapy session. For both measures, the rate of complexity generation, expressed as bits per minute, increased longitudinally during the course of therapy. The between-session increases in complexity generation rates are consistent with calculations of mutual information. Taken together these results indicate that there was a quantifiable increase in the variability of patient-therapist verbal behavior during the course of therapy. Comparison of complexity values against values obtained from equiprobable random surrogates established the presence of a nonrandom structure in patient-therapist dialog (P = .002). Conclusions: While recognizing that only limited conclusions can be based on a case history, it can be noted that these quantitative observations are consistent with qualitative clinical observations of increases in the flexibility of discourse during therapy. These procedures can be of particular value in the examination of therapies following traumatic brain injury because, in some presentations, these therapies are complicated by deficits that result in subtle distortions of language that produce significant post-injury social impairment. Independently of the mathematical analysis applied to the investigation of therapy-generated symbol sequences, our experience suggests that the procedures presented here are of value in training therapists.	[Rapp, Paul E.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA; [Cellucci, Christopher J.] Aquinas LLC, Berwyn, PA 19312 USA; [Gilpin, Adele M. K.] Hunton & Williams LLP, Washington, DC 20037 USA; [Gilpin, Adele M. K.] Univ Maryland, Dept Epidemiol & Publ Hlth, Sch Med, Baltimore, MD 20201 USA; [Jimenez-Montano, Miguel A.] Univ Veracruzana, Fac Fis & Inteligencia Artificial, Xalapa 91000, Veracruz, Mexico; [Korslund, Kathryn E.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA		Rapp, PE (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	prapp@usuhs.mil			Sistema Nacional de Investigadores; PROMEP, MEXICO [UV-CA-197]; Uniformed Services University of the Health Sciences; Defense Medical Research and Development Program	PER would like to acknowledge training received at the Philadelphia School of Psychoanalysis and the Philadelphia Consultation Center and specifically Dr. Stephen Day Ellis, President, and Dr. Angela Sandone-Barr, Director of Clinical Services. Discussions with Dr. Arnold Feldman and with the members of the Entwurf Gruppe are acknowledged with gratitude. The opinions and assertions contained herein are the private opinions of the authors and are not to be construed as official or reflecting the views of the United States Department of Defense. MAJM acknowledges partial support from: Sistema Nacional de Investigadores; PROMEP, Project: UV-CA-197 MEXICO, and Universidad Veracruzana. PER would like to acknowledge support from the Traumatic Injury Research Program of the Uniformed Services University of the Health Sciences and from the Defense Medical Research and Development Program.	Alvarez-Lacalle E, 2006, P NATL ACAD SCI USA, V103, P7956, DOI 10.1073/pnas.0510673103; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Baltaxe, 1977, J PEDIATR PSYCHOL, V2, P176, DOI [10.1093/jpepsy/, DOI 10.1093/JPEPSY/2.4.176]; Barnard G. A., 1963, J R STAT SOC B, V25, P294; Bays C., 1976, ACM Transactions on Mathematical Software, V2, P59, DOI 10.1145/355666.355670; Beeferman D, 1999, MACH LEARN, V34, P177, DOI 10.1023/A:1007506220214; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Beutler LE, 2002, J CLIN PSYCHOL, V58, P1199, DOI 10.1002/jclp.10106; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; BLAKEMORE D, 1990, UNDERSTANDING UTTERA; Blanchet A., 2005, HIDDEN STRUCTURE INT, P123; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Booth R, 2003, PHILOS T ROY SOC B, V358, P387, DOI 10.1098/rstb.2002.1204; BRADLEY PS, 1998, P 15 C MACH LEARN; Brownell H, 1998, RIGHT HEMISPHERE LANGUAGE COMPREHENSION, P309; Burnette CP, 2005, J AUTISM DEV DISORD, V35, P63, DOI 10.1007/s10803-004-1035-5; BURTON N G, 1955, Am J Psychol, V68, P650, DOI 10.2307/1418794; BUTZ MR, 1993, PSYCHOL REP, V73, P543, DOI 10.2466/pr0.1993.73.2.543; Camarata SM, 1999, MENT RETARD DEV D R, V5, P207, DOI 10.1002/(SICI)1098-2779(1999)5:3<207::AID-MRDD7>3.0.CO;2-O; Cellucci CJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.066208; CHAITIN GJ, 1974, IEEE T INFORM THEORY, V20, P10, DOI 10.1109/TIT.1974.1055172; CHAMBERLAIN L, 1998, CLINICAL CHAOS THERA; Champagne-Lavau M, 2007, BRAIN, V130, DOI 10.1093/brain/awl311; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; CHOMSKY N, 1976, LINGUIST ANAL, V2, P303; Chomsky N., 1975, REFLECTIONS LANGUAGE; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho C.A., 1993, CLIN APHASIOLOGY, V21, P183; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; COELHO CA, 2007, MED SPEECH LANGUAGE, P71; COPE DN, 1994, J HEAD TRAUMA REHAB, V9, P1, DOI 10.1097/00001199-199409000-00003; COVER TM, 1978, IEEE T INFORM THEORY, V24, P413, DOI 10.1109/TIT.1978.1055912; DAHL H, 1978, PSYCHOANAL QUART, V47, P339, DOI 10.1080/21674086.1978.11926847; DAHL H, 1974, J AM PSYCHOANAL ASS, V22, P37, DOI 10.1177/000306517402200103; DAHL H, 1972, PSYCHOANALYSIS CONT, P237; Damico J. S., 1985, COMMUNICATION SKILLS, P165; DAMICO JS, 1991, COMMUNICATION SKILLS, P125; de Wit TD, 1999, EUR PHYS J B, V11, P513, DOI 10.1007/s100510050963; Deb S, 1999, AM J PSYCHIAT, V156, P374; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Doba K, 2008, NEW IDEAS PSYCHOL, V26, P295, DOI 10.1016/j.newideapsych.2007.07.004; Doba K, 2007, PSYCHOL REP, V101, P237, DOI 10.2466/PR0.101.1.237-249; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); EBELING W, 1980, MATH BIOSCI, V52, P53, DOI 10.1016/0025-5564(80)90004-8; EBELING W, 1987, PHYS SCRIPTA, V35, P761, DOI 10.1088/0031-8949/35/5/033; Ebeling W, 1997, PHYSICA D, V109, P42, DOI 10.1016/S0167-2789(97)00157-7; EBELING W, 1992, STAT PHYS THERMODYNA; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fast LA, 2008, J PERS SOC PSYCHOL, V94, P334, DOI 10.1037/0022-3514.94.2.334; Folzer SM, 2001, AM J ORTHOPSYCHIAT, V71, P245, DOI 10.1037/0002-9432.71.2.245; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Friedland D, 1998, BRAIN INJURY, V12, P1, DOI 10.1080/026990598122818; Frith U., 1989, AUTISM EXPLAINING EN; Gallager, 1968, INFORM THEORY RELIAB; Goldberg E., 2001, EXECUTIVE BRAIN FRON; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; GOTTSCHALK LA, 1969, ARCH GEN PSYCHIAT, V21, P574; GOTTSCHALK LA, 1973, AM J PSYCHIAT, V130, P1107, DOI 10.1176/ajp.130.10.1107; GOTTSCHALK LA, 1986, PSYCHIAT RES, V17, P153, DOI 10.1016/0165-1781(86)90070-3; Gottschalk LA, 1969, MEASUREMENT PSYCHOL; GRAMSS T, 1994, PHYS REV E, V50, P2616, DOI 10.1103/PhysRevE.50.2616; Granacher R. P., 2008, TRAUMATIC BRAIN INJU, VSecond; GRASSBERGER P, 1986, INT J THEOR PHYS, V25, P907, DOI 10.1007/BF00668821; GRUNZIG HJ, 1976, MED PSYCHOL, V2, P208; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Hart R.P., 2001, THEORY METHOD PRACTI, P43; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Haynal-Reymond V., 2005, HIDDEN STRUCTURE INT, P141; HENON M, 1976, COMMUN MATH PHYS, V50, P69, DOI 10.1007/BF01608556; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; HERZEL H, 1988, SYST ANAL MODEL SIM, V5, P435; HERZEL H, 1994, CHAOS SOLITON FRACT, V4, P97, DOI 10.1016/0960-0779(94)90020-5; Hibbard M. R., 2000, COGNITIVE BEHAV STRA, P219; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hirata Y, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016215; HITZL DL, 1985, PHYSICA D, V14, P305, DOI 10.1016/0167-2789(85)90092-2; Holt RR, 2008, J AM PSYCHOANAL ASS, V56, P997, DOI 10.1177/0003065108324232; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; JIMENEZMONTANO MA, 1984, B MATH BIOL, V46, P641, DOI 10.1007/BF02459508; Jolliffe T, 2001, Cogn Neuropsychiatry, V6, P193; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; Kolmogorov A.N., 1965, Problems of Information Transmission, V1, P1; Kowalik ZJ, 1997, PSYCHOTHER RES, V7, P197, DOI 10.1080/10503309712331331973; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; LAMBERT JD, 1976, COMPUTATIONAL METHOD; LANGS R, 1992, AM J PSYCHOTHER, V46, P183, DOI 10.1176/appi.psychotherapy.1992.46.2.183; LANGS R, 1988, PRIMER PSYCHOTHERAPY; LEBOVITS AH, 1983, PSYCHOSOM MED, V45, P305, DOI 10.1097/00006842-198308000-00005; LECUYER P, 1988, COMMUN ACM, V31, P742, DOI 10.1145/62959.62969; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Leroy F, 2005, PSYCHIAT RES, V133, P159, DOI 10.1016/j.psychres.2004.07.009; Lesne A, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046208; LEWIS L, 1990, J NERV MENT DIS, V178, P69, DOI 10.1097/00005053-199002000-00001; Linehan MM., 1993, SKILLS TRAINING MANU, V1st edn; Linehan MM., 1993, COGNITIVE BEHAV TREA; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; LOVELAND KA, 1988, J SPEECH HEAR RES, V31, P593, DOI 10.1044/jshr.3104.593; Magnusson MS, 1996, EUR J PSYCHOL ASSESS, V12, P112, DOI 10.1027/1015-5759.12.2.112; Magnusson MS, 2000, BEHAV RES METH INS C, V32, P93, DOI 10.3758/BF03200792; MAGNUSSON MS, 2005, HIDDEN STRUCTURE INT; Manning C.D., 1999, FDN STAT NATURAL LAN; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; MCDANIEL SH, 1981, J CONSULT CLIN PSYCH, V49, P571, DOI 10.1037/0022-006X.49.4.571; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McDonald S, 1999, BRAIN LANG, V68, P486, DOI 10.1006/brln.1999.2124; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; MERTEN J, 2005, HIDDEN STRUCTURE INT, P149; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell RLC, 2005, BRAIN, V128, P963, DOI 10.1093/brain/awh466; Montemurro MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019875; MORRIS J, 1986, INT J CLIN NEUROPSYC, V8, P133; Nicholas L.E., 1995, AM J SPEECH LANGUAGE, V4, P69, DOI [DOI 10.1044/1058-0360.0403.69, 10.1044/1058-0360.0403.69]; *NIH, 1998, NIH CONSENSUS STATE, V16, P26; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; Payne HC, 2000, BRAIN INJURY, V14, P479, DOI 10.1080/026990500120583; Pellicano E, 2006, DEV PSYCHOPATHOL, V18, P77, DOI 10.1017/S0954579406060056; Penn C, 1988, Brain Inj, V2, P3, DOI 10.3109/02699058809150928; Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041; Pennebaker JW, 2001, LINGUISTIC INQUIRY W; PERLEY J, 1971, COMPR PSYCHIAT, V12, P557, DOI 10.1016/0010-440X(71)90038-1; Press W., 1986, NUMERICAL RECIPES AR; PRIEL B, 1994, BRIT J MED PSYCHOL, V67, P209, DOI 10.1111/j.2044-8341.1994.tb01788.x; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; Prigatano GP., 1988, J HEAD TRAUMA REHAB, V3, P45; Radhakrishnan N, 2000, INT J BIFURCAT CHAOS, V10, P1773, DOI 10.1142/S0218127400001092; Rapp PE, 2007, COGN NEURODYNAMICS, V1, P287, DOI 10.1007/s11571-007-9027-8; RAPP PE, 1994, J NEUROSCI, V14, P4731; Rapp PE, 2005, INT J BIFURCAT CHAOS, V15, P1737, DOI 10.1142/S0218127405012764; Rapp PE, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016209; RAPP PE, 1991, MATH BIOSCI, V105, P207, DOI 10.1016/0025-5564(91)90082-T; RAPP PE, 1994, PHYS LETT A, V192, P27, DOI 10.1016/0375-9601(94)91010-3; RAPP PE, 2000, CHAOS BRAIN, P52; REDINGTON DJ, 1992, BIOL PSYCHIAT, V31, P993, DOI 10.1016/0006-3223(92)90093-F; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Rush A, 2008, HDB PSYCHIAT MEASURE; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; Schiepek G, 1997, PSYCHOTHER RES, V7, P173, DOI 10.1080/10503309712331331953; Schiepek G, 2009, EUR REV, V17, P331, DOI 10.1017/S1062798709000763; SCHMITT A, 1995, THESIS MATH NATURWIS; SCHMITT AO, EUROPHYSICS LETT, V23, P303; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; Snow P, 1997, BRAIN INJURY, V11, P409; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg MM., 2000, NEUROPSYCHOLOGICAL M, P137; SPARROW C, 1982, LORENZ EQUATIONS; Steuer R, 2001, EUR PHYS J B, V19, P265, DOI 10.1007/s100510170335; Stiles W. B., 1992, DESCRIBING TALK TAXO; STILES WB, 1979, J CONSULT CLIN PSYCH, V47, P795, DOI 10.1037/0022-006X.47.4.795; STILES WB, 1979, J CONSULT CLIN PSYCH, V47, P611, DOI 10.1037/0022-006X.47.3.611; STILES WB, 1989, PSYCHOTHER, V26, P314, DOI 10.1037/h0085441; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Tschacher W, 2000, PSYCHOTHER RES, V10, P296, DOI 10.1093/ptr/10.3.296; TSCHACHER W, 1998, NONLINEAR DYNAMICS P, V2, P195, DOI DOI 10.1023/A:1022324018097; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Van Dijk TA., 1983, STRATEGIES DISCOURSE; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; VINEY LL, 1986, CONTENT ANAL VERBAL, P157; Vitanyi P., 1993, INTRO KOLMOGOROV COM; Waskow I. E., 1984, PSYCHOTHERAPY RES AR, P150; Watanabe TAA, 2003, PSYCHOPHYSIOLOGY, V40, P77, DOI 10.1111/1469-8986.00009; WERMAN DS, 1988, PRACTICE SUPPORTIVE; Williams W H, 2003, Cogn Neuropsychiatry, V8, P1, DOI 10.1080/713752238; WINEFIELD HR, 1987, AM J PSYCHOTHER, V41, P117, DOI 10.1176/appi.psychotherapy.1987.41.1.117; XU JH, 1994, CHAOS SOLITON FRACT, V4, P2111; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zvonkin A., 1970, RUSS MATH SURV, V25, P83, DOI [10.1070/RM1970v025n06ABEH001269, DOI 10.1070/RM1970V025N06ABEH001269]; [No title captured]	179	6	6	1	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-244X		BMC PSYCHIATRY	BMC Psychiatry	JUL 27	2011	11								119	10.1186/1471-244X-11-119			28	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	807KO	WOS:000293896500001	21794113	gold, Green Published			2022-02-06	
J	Li, QY; Yang, Y; Zhang, Y; Zhang, ZJ; Gong, AH; Yuan, ZC; Lu, PS; Zhan, LP; Wang, P; Feng, Y; Xu, WL				Li Qiao-yu; Yang Yong; Zhang Yan; Zhang Zhi-jian; Gong Ai-hua; Yuan Zhi-cheng; Lu Pei-song; Zhan Li-ping; Wang Peng; Feng Yun; Xu Wen-lin			Nerve growth factor expression in astrocytoma and cerebrospinal fluid: a new biomarker for prognosis of astrocytoma	CHINESE MEDICAL JOURNAL			English	Article						nerve growth factor; astrocytoma; cell nucleus; prognosis	NUCLEAR TRANSLOCATION; FACTOR OVEREXPRESSION; AUTOCRINE LOOP; CELL-LINE; LOCALIZATION; RECEPTOR; PROGRESSION; U251; TRKA	Background Recent studies have discovered that nuclear translocation of nerve growth factor (NGF) and its receptor fragments function differently from the traditional model. This study aimed to uncover the nuclear expression of NGF in astrocytoma and its biological significance. Methods Ninety-four paraffin-embedded astrocytoma specimens were subjected to immunohistochemical (IHC) and hemotoxylin & eosin (HE) staining. Preoperative cerebrospinal fluid (CSF) specimens and intraoperative snap-frozen astrocytoma tissues were assayed for NGF expression by ELISA and Western blotting. The outcome of patients who contributed samples was tracked. Each ten tissue samples from patients with traumatic brain injury who had received decompression surgery and CSF samples from patients undergoing spinal anesthesia but with no history of nervous system disease were taken as control. Results NGF-positive immunoreactive products were distributed in both the cytoplasm and nucleus of astrocytoma, but were only located in the cytoplasm of traumatic brain injury (TBI) tissue. NGF nuclear-positive rate (NPR) of grades III-IV astrocytomas (70.0%) was higher than that of grades I-II astrocytoma (28.6%, P <0.05). NGF-NP expression positively correlated with the NGF concentration in cerebrospinal fluid (CSF) (r=0.755, P <0.01). Kaplan-Meier survival analysis indicated that the median survival time was 25 months for NGF-NP astrocytoma grade I-II patients and 42 months in NGF nuclear negative (NGF-NN) astrocytoma grade I-II patients (P <0.05). In astrocytoma III-IV patients, the median survival was 7 months for NGF-NP patients and 24 months for NGF-NN patients (P <0.01). Two types of NGF with molecular weights of 13 and 36 kDa were present in astrocytoma, but only the 36 kDa NGF was found in the CSF. NGF expression elevated as the malignancy increased. Conclusions NGF-NP expression and NGF level in CSF were significant prognostic factors in astrocytoma patients. Because of the easy access of CSF, it may be developed as an index for early diagnosis and surveillance of astrocytoma. Chin Med J 2011;124(14):2222-2227	[Xu Wen-lin] Jiangsu Univ, Cent Lab, Affiliated Peoples Hosp, Zhenjiang 212002, Jiangsu, Peoples R China; [Li Qiao-yu; Yang Yong; Zhang Yan; Yuan Zhi-cheng; Lu Pei-song; Zhan Li-ping; Wang Peng] Jiangsu Univ, Dept Neurosurg, Affiliated Peoples Hosp, Zhenjiang 212002, Jiangsu, Peoples R China; [Zhang Zhi-jian; Gong Ai-hua; Feng Yun] Jiangsu Univ, Inst Clin Lab Med, Zhenjiang 212013, Jiangsu, Peoples R China		Xu, WL (corresponding author), Jiangsu Univ, Cent Lab, Affiliated Peoples Hosp, Zhenjiang 212002, Jiangsu, Peoples R China.	wenlinxu@163.com		Yang, Yong/0000-0002-9093-0396	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30701031]; Science and Technology Development Fund of Zhenjiang [SH2007031]	This study was supported by National Natural Science Foundation of China (No. 30701031) and Science and Technology Development Fund of Zhenjiang (No. SH2007031).	Bonacchi A, 2008, HISTOL HISTOPATHOL, V23, P327, DOI 10.14670/HH-23.327; Brown MC, 2008, NEURO-ONCOLOGY, V10, P968, DOI 10.1215/15228517-2008-047; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Delsite R, 1999, PROSTATE, V41, P39, DOI 10.1002/(SICI)1097-0045(19990915)41:1<39::AID-PROS6>3.0.CO;2-E; Dolle L, 2003, ONCOGENE, V22, P5592, DOI 10.1038/sj.onc.1206805; Goda M, 2010, J PHARMACOL SCI, V112, P463, DOI 10.1254/jphs.09354SC; Gong AH, 2007, SCI CHINA SER C, V50, P141, DOI 10.1007/s11427-007-0022-4; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Tsunoda S, 2006, BRIT J CANCER, V95, P322, DOI 10.1038/sj.bjc.6603255; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Weis C, 2002, J NEURO-ONCOL, V56, P59, DOI 10.1023/A:1014410519935; Xin ZF, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-105; Xu WL, 2009, EUR J HAEMATOL, V83, P313, DOI 10.1111/j.1600-0609.2009.01285.x; Zhang ZJ, 2005, BIOCHEM BIOPH RES CO, V337, P68, DOI 10.1016/j.bbrc.2005.08.265	15	6	7	1	13	CHINESE MEDICAL ASSOC	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	JUL 20	2011	124	14					2222	2227		10.3760/cma.j.issn.0366-6999.2011.14.026			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	802EC	WOS:000293491100026	21933631				2022-02-06	
J	Aadal, L; Kirkevold, M				Aadal, L.; Kirkevold, M.			Integrating situated learning theory and neuropsychological research to facilitate patient participation and learning in traumatic brain injury rehabilitation patients	BRAIN INJURY			English	Article						Traumatic brain injury; rehabilitation; activities of daily living; learning	QUALITY-OF-LIFE; PEOPLE; FOCUS; EXPERIENCE; DISABILITY; AWARENESS; STROKE	Purpose: Traumatic brain injury (TBI) constitutes a major health problem throughout the world. Despite interdisciplinary efforts, patients reach varying outcomes in terms of every-day life functioning and quality-of-life. This paper suggests that a situated learning perspective supplemented with evidence from neurophysiologic and neuropsychological research provides a perspective to get a grasp of problems typically encountered in rehabilitation. Applying such a perspective may help to facilitate patient participation and learning during the rehabilitation process by taking their altered abilities into consideration. Method: Qualitative study. Theoretical analysis and synthesis of 'situated learning theory', neuropsychological theory and empirical studies of cognitive and emotional functioning following a TBI collected through interviews with 11 interdisciplinary rehabilitation experts and a field study of two patients at a rehabilitation hospital. The data were analysed from a hermeneutic perspective using N-VIVO 8. Results/conclusion: Patients with severe TBI pose challenges in terms of being participants in the 'rehabilitation practice community'. Two levels of pedagogical challenges seem to exist: Helping the patient regain or compensate for changed learning abilities and supporting the patient in learning or compensating for lost abilities. This study highlighted six main categories of changed abilities that need to be considered in developing a practice which fosters re-learning: Perception, attention, memory, language, physical competencies and emotion/model of behaviour.	[Aadal, L.] Hammel Neurorehabil & Res Ctr, Res Unit, DK-8450 Hammel, Denmark; [Kirkevold, M.] Univ Aarhus, Dept Nursing Sci, DK-8000 Aarhus C, Denmark; [Kirkevold, M.] Univ Oslo, Inst Hlth & Soc, N-0316 Oslo, Norway		Aadal, L (corresponding author), Hammel Neurorehabil & Res Ctr, Res Unit, Voldbyvej 15, DK-8450 Hammel, Denmark.	lena.aadal@hammel.rm.dk	Aadal, Lena/R-3444-2019	Aadal, Lena/0000-0001-7365-3916			Aadal L, 2010, INTENSIV NEUROREHABI; Abreu BC, 2002, BRAIN INJURY, V16, P691, DOI 10.1080/02699050210128942; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Antelius E, 2009, HEALTH, V13, P361, DOI 10.1177/1363459308101808; Baddeley A.D., 1997, HUMAN MEMORY THEORY; BARKLEY RA, 2001, OPMAERKSOMHEDSFORSTY; Bazeleley P, 2007, QUALITATIVE DATA ANA; BENETTO L, 2003, HDB NEUROPSYKOLOGY, P785; BORG T, 2003, THESIS AARHUS U; Bredland E.L., 2005, HANDLER VERDIGHET ID; Carlson PM, 2006, BRAIN INJURY, V20, P1111, DOI 10.1080/02699050600955337; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Damasio A., 1994, DESCARTES ERROR EMOT; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dowswell G, 2000, J CLIN NURS, V9, P507, DOI 10.1046/j.1365-2702.2000.00411.x; Emerson F., 1995, WRITING ETHNOGRAPHIC; EYSENCK MW, 1995, MEMORY STRUCTURE PRO, P123; EYSENCK MW, 1995, ATTENTION PERFORM, P95; EYSENCK MW, 1995, VISUAL PERCEPTION BA, P27; FRACKOWIACK RSJ, 1997, HUMAN BRAIN FUNCTION; Freeman T, 2006, J ADV NURS, V56, P491, DOI 10.1111/j.1365-2648.2006.04043.x; Fuhrer MJ, 1998, AM J PHYS MED REHAB, V77, P557, DOI 10.1097/00002060-199811000-00022; Gadamer H. G., 2004, SANDHED METODE WAHRH; Gade A., 1998, HJERNEPROCESSER KOGN; GADE A, 2004, KLIN NEUROLOGI NEURO, P133; Gregory R., 1974, CONCEPTS MECH PERCEP; GUTENBRUNNER C, 2006, MEDITERRANEAN J PHYS, V42, P290; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Hammersley M, 2004, GRUNNLAGET FELTARBEI; Hansen H. P., 1994, FELTARBEJDE EGEN KUL, V15, P1; Hastrup K., 2003, IND VERDEN GRUNDBOG; Hastrup K., 1988, FELTARBEJDE OPLEVELS, P11; Hastrup K., 1990, ETNOGRAFISK GRUNDBOG; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kapur N, 2004, NEUROPSYCHOL REHABIL, V14, P41, DOI 10.1080/09602010343000138; KOLB B, 1996, HUMAN NEUROPSYCHOLOG, P286; KOLB B, 1996, LANGUAGE FUNDAMENTAL, P387; KOLB B, 1996, HUMAN NEUROPSYCHOLOG, P305; KOLB B, 1996, MEMORY FUNDAMENTALS, P355; KOTTER JP, 1999, SPIDSEN FORANDRINGER; KVALE S, 2003, INTERVIEW INTRODUKTI; Lave J., 1991, SITUATED LEARNING, DOI [10.1017/CBO9780511815355, DOI 10.1017/CBO9780511815355]; LAVE J, 1997, NORDISK PEDAGOGIK, V17, P140; Ledoux J, 1999, WILD THINGS ARE EMOT, P225; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN M, 2004, HVORDAN MAN HUSKER L, P112; LEVINE M, 2004, PSYKOLOGISK FORLAG A, V1, P61; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P170; LILJEGREN J, 2009, KBH DANSK PSYKOLOG F, V17, P18; Manly T, 2003, STUD NEUROPSYCHOL DE, P23; Martin C, 2001, BRAIN INJURY, V15, P947, DOI 10.1080/02699050110065655; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; McLafferty I, 2004, J ADV NURS, V48, P187, DOI 10.1111/j.1365-2648.2004.03186.x; NIELSEN CS, 2005, LAEREPROCESSER HOS P; *NO NURS FED, 2003, ETH GUID NURS RES NO; OATLEY K, 1996, UNDERSTANDING EMOTIO, V1; Paulesu E., 1997, HUMAN BRAIN FUNCTION, P183; PAULSON GS, 2004, KLIN NEUROLOGI NEURO; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Pryor J, 2009, J CLIN NURS, V18, P1766, DOI 10.1111/j.1365-2702.2008.02322.x; Riley GA, 2000, NEUROPSYCHOL REHABIL, V10, P133, DOI 10.1080/096020100389219; Schmitter-Edgecombe M, 2006, J HEAD TRAUMA REHAB, V21, P131, DOI 10.1097/00001199-200603000-00006; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; STANDAL OF, 2007, SOBAMA J S1, V12, P125; Standal OF, 2008, ADAPT PHYS ACT Q, V25, P208, DOI 10.1123/apaq.25.3.208; *TAENK UND REH DAN, 2004, HVIDB REH; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Vanderploeg RD, 2006, J HEAD TRAUMA REHAB, V21, P179, DOI 10.1097/00001199-200603000-00010; Wenger E., 2009, COMMUNITIES PRACTICE; WENGER E, 1998, COMMUNITIES OPRACTIC; WHO rGSTD, 2003, ICF INT KLASS FUNKT; Wyller TB, 1999, DISABIL REHABIL, V21, P152; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	81	6	6	2	23	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2011	25	7-8					717	728		10.3109/02699052.2011.580314			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	769RJ	WOS:000291035600008	21604928				2022-02-06	
J	Finnie, JW; Blumbergs, PC; Manavis, J				Finnie, John W.; Blumbergs, Peter C.; Manavis, Jim			Aquaporin-4 expression after experimental contusional injury in an ovine impact-acceleration head injury model	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Aquaporin-4; Cerebral oedema; Contusion; Traumatic head injury	TRAUMATIC BRAIN-INJURY; EDEMA; RATS	Cerebral contusions are one of the principal lesions of traumatic brain injury and the attendant oedema formation contributes substantially to the clinicopathological manifestations. While it is now recognised that the membrane channel protein aquaporin-4 (AQP-4) plays a major role in the development and resolution of cerebral oedema, assessments of its expression in and around contusions have produced conflicting results. We used an ovine impact-acceleration model of closed head injury to examine contusion-related AQP-4 expression and found that there was a heterogeneous AQP-4 response within contusions, with some astrocytes being nonviable and immunonegative, while others showed increased AQP-4 expression. Pericontusional astrocytes in the penumbra region generally showed more robust AQP-4 immunopositivity than intracontusional glia. Thus, manipulation of AQP-4 expression could have therapeutic applications in controlling cerebral oedema associated with contusions. (C) 2011 Elsevier Ltd. All rights reserved.	[Finnie, John W.; Blumbergs, Peter C.; Manavis, Jim] Inst Med & Vet Sci, Hanson Inst Ctr Neurol Dis, SA Pathol, Adelaide, SA 5000, Australia		Blumbergs, PC (corresponding author), Inst Med & Vet Sci, Hanson Inst Ctr Neurol Dis, SA Pathol, POB 14 Rundle Mall, Adelaide, SA 5000, Australia.	peter.blumbergs@health.sa.gov.au					Blumbergs P. C., 2005, HEAD INJURY PATHOPHY, P41; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; LINDENBERG R, 1971, PATHOLOGY NERVOUS SY, P1705; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Tornheim P A, 1976, Surg Neurol, V5, P171; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Verkman AS, 2009, J EXP BIOL, V212, P1707, DOI 10.1242/jeb.024125; Zador Z, 2007, PROG BRAIN RES, V161, P185, DOI 10.1016/S0079-6123(06)61012-1	16	6	7	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2011	18	7					947	950		10.1016/j.jocn.2010.11.010			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783FK	WOS:000292066700017	21549608				2022-02-06	
J	Grande, PO				Grande, Per-Olof			PRO: The "Lund Concept" for Treatment of Patients With Severe Traumatic Brain Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						Lund concept; brain edema; cerebral perfusion pressure; intracranial pressure; PEEP; arterial blood pressure; blood-brain barrier; traumatic head injury; US Trauma Foundation guideline	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PHYSIOLOGICAL PRINCIPLES; VOLUME REGULATION; VENOUS-PRESSURE; HYPERTENSION; MANAGEMENT; ARTERIAL; ABSENCE	Two different main concepts for the treatment of severe traumatic brain injury have been established during the last 15 years, namely the more conventional concept recommended in well-established guidelines (eg, the US Guideline, European Guideline, Addelbrook's Guideline from Cambridge) on the one hand, and the Lund concept from the University Hospital of Lund, Sweden on the other. Owing to the lack of well-controlled randomized outcome studies comparing these 2 main therapeutic approaches, we cannot conclude that one is better than the other. This study is the PRO part in a PRO-CON debate on the Lund concept in the present journal. Although the Lund concept is based on a physiology-oriented approach dealing with hemodynamic principles of brain volume and brain perfusion regulation, traditional treatments are primarily based on a meta-analytic approach from clinical studies. High cerebral perfusion pressure has been an essential goal in the conventional treatments (the cerebral perfusion pressure-guided approach), even though it has been modified in a recent update of US guidelines. The Lund concept has instead concentrated on management of brain edema and intracranial pressure, simultaneously with improvement of cerebral perfusion and oxygenation (the intracranial pressure and perfusion-guided approach). Although conventional guidelines are restricted to clinical data from meta-analytic surveys, the physiological approach of the Lund therapy finds support in both experimental and clinical studies. It offers a wider base and can also give recommendations regarding fluid therapy, lung protection, optimal hemoglobin concentration, temperature control, the use of decompressive craniotomy, and ventricular drainage. This study puts forward arguments in support of the Lund therapy.	[Grande, Per-Olof] Lund Univ, Dept Anesthesia & Intens Care, SE-22185 Lund, Sweden; [Grande, Per-Olof] Univ Lund Hosp, Lund, Sweden		Grande, PO (corresponding author), Lund Univ, Dept Anesthesia & Intens Care, SE-22185 Lund, Sweden.	per-olof.grande@med.lu.se			Swedish Research CouncilSwedish Research CouncilEuropean Commission [11581]; Faculty of Medicine, Lund University, Sweden; Region Skane (ALF), Sweden	Supported by grants from the Swedish Research Council (#11581), from the Faculty of Medicine, Lund University, Sweden, and from Region Skane (ALF), Sweden.	ASGEIRSSON B, 1994, INTENS CARE MED, V20, P567, DOI 10.1007/BF01705723; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Dubniks M, 2007, INTENS CARE MED, V33, P2192, DOI 10.1007/s00134-007-0756-2; Grande PO, 2009, ACTA ANAESTH SCAND, V53, P1233, DOI 10.1111/j.1399-6576.2009.02074.x; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P264, DOI 10.1034/j.1399-6576.2002.460307.x; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Holbeck S, 2002, CRIT CARE MED, V30, P212, DOI 10.1097/00003246-200201000-00030; Jungner M, 2011, CRIT CARE MED, V39, P135, DOI 10.1097/CCM.0b013e3181fb7c94; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Kongstad L, 1999, ACTA ANAESTH SCAND, V43, P501, DOI 10.1034/j.1399-6576.1999.430503.x; Kongstad L, 2001, J TRAUMA, V51, P490, DOI 10.1097/00005373-200109000-00011; Liu Chang-Wen, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P610; LUCIA M, 2010, ANESTH ANALG, V111, P736; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Nygren A, 2010, ACTA ANAESTH SCAND, V54, P814, DOI 10.1111/j.1399-6576.2010.02244.x; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Rise IR, 1998, J NEUROSURG, V89, P454, DOI 10.3171/jns.1998.89.3.0454; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roberts I, 2007, BRIT MED J, V334, P392, DOI 10.1136/bmj.39118.480023.BE; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004	30	6	7	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2011	23	3					251	255		10.1097/ANA.0b013e31821a8f10			5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	774YY	WOS:000291423900015	21593694				2022-02-06	
J	Haubrich, C; Steiner, L; Kasprowicz, M; Diedler, J; Carrera, E; Diehl, RR; Smielewski, P; Czosnyka, M				Haubrich, Christina; Steiner, Luzius; Kasprowicz, Magdalena; Diedler, Jennifer; Carrera, Emmanuel; Diehl, Rolf R.; Smielewski, Piotr; Czosnyka, Marek			Short-Term Moderate Hypocapnia Augments Detection of Optimal Cerebral Perfusion Pressure	JOURNAL OF NEUROTRAUMA			English	Article						cerebral autoregulation; cerebral blood flow; CPP; intracranial pressure; multimodal monitoring; TBI	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; AUTOREGULATION; REACTIVITY	An autoregulation-oriented strategy has been proposed to guide neurocritical therapy toward the optimal cerebral perfusion pressure (CPPOPT). The influence of ventilation changes is, however, unclear. We sought to find out whether short-term moderate hypocapnia (HC) shifts the CPPOPT or affects its detection. Thirty patients with traumatic brain injury (TBI), who required sedation and mechanical ventilation, were studied during 20 min of normocapnia (5.1 +/- 0.4 kPa) and 30 min of moderate HC (4.4 +/- 3.0 kPa). Monitoring included bilateral transcranial Doppler of the middle cerebral arteries (MCA), invasive arterial blood pressure (ABP), and intracranial pressure (ICP). Mx -autoregulatory index provided a measure for the CPP responsiveness of MCA flow velocity. CPPOPT was assessed as the CPP at which autoregulation (Mx) was working with the maximal efficiency. During normocapnia, CPPOPT (left: 80.65 +/- 6.18; right: 79.11 +/- 5.84 mm Hg) was detectable in 12 of 30 patients. Moderate HC did not shift this CPPOPT but enabled its detection in another 17 patients (CPPOPT left: 83.94 +/- 14.82; right: 85.28 +/- 14.73 mm Hg). The detection of CPPOPT was achieved via significantly improved Mx-autoregulatory index and an increase of CPP mean. It appeared that short-term moderate HC augmented the detection of an optimum CPP, and may therefore usefully support CPP-guided therapy in patients with TBI.	[Haubrich, Christina; Kasprowicz, Magdalena; Smielewski, Piotr; Czosnyka, Marek] Addenbrookes Hosp, Dept Acad Neurosurg, Cambridge, England; [Haubrich, Christina] Univ Hosp Aachen, Dept Neurol, Aachen, Germany; [Steiner, Luzius; Carrera, Emmanuel] Univ Lausanne Hosp, Dept Anaesthesia, Lausanne, Switzerland; [Kasprowicz, Magdalena] Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland; [Diedler, Jennifer] Univ Heidelberg, Dept Neurol, Heidelberg, Germany; [Diehl, Rolf R.] Alfried Krupp Hosp, Dept Neurol, Essen, Germany		Haubrich, C (corresponding author), Univ Aachen, Dept Neurol, Pauweisstr 30, D-52074 Aachen, Germany.	chaubrich@ukaachen.de	Steiner, Luzius/C-9836-2011; Steiner, Luzius/J-1987-2019	Kasprowicz, Magdalena/0000-0002-2271-7737; Smielewski, Peter/0000-0001-5096-3938; Carrera, Emmanuel/0000-0003-0045-5382	Alexander-von-Humboldt FoundationAlexander von Humboldt Foundation; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, ID 65883]; University of Cambridge, Cambridge, EnglandUniversity of Cambridge; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0600986, G0001237] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G0600986] Funding Source: UKRI	Dr. C. Haubrich is supported by a Feodor-Lynen scholarship from the Alexander-von-Humboldt Foundation; Dr. M. Kasprowicz is a scholar of the Foundation for Polish Science; and Dr. M. Czosnyka and Dr. P. Smielewski are supported by MRC grant No.: G9439390, ID 65883. Dr. M. Czosnyka is on unpaid leave from Warsaw University.; ICM+ software (www.neurosurg.cam.ac.uk/icmplus) is licensed by University of Cambridge, Cambridge, England, and Dr. P. Smielewski and Dr. M. Czosnyka have a financial interest in the licensing fee.	Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; BRATTON S, 2007, HYPERVENTILATION J N, V24, pS87; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; POON WS, 2005, ACTA NEUROCHIR SUPP, P95; Reinhard M, 2004, STROKE, V35, P1381, DOI 10.1161/01.STR.0000127533.46914.31; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SIOUTOS PJ, 1995, NEUROSURGERY, V36, P943, DOI 10.1227/00006123-199505000-00009; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002	14	6	6	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1133	1137		10.1089/neu.2010.1577			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600001	21309725				2022-02-06	
J	Kang, WH; Simon, MJ; Gao, S; Banta, S; Morrison, B				Kang, Woo Hyeun; Simon, Melissa J.; Gao, Shan; Banta, Scott; Morrison, Barclay, III			Attenuation of Astrocyte Activation by TAT-Mediated Delivery of a Peptide JNK Inhibitor	JOURNAL OF NEUROTRAUMA			English	Article						astrogliosis; glycosaminoglycans; intracellular protein delivery; mitogen-activated protein kinases; TAT	TUMOR-NECROSIS-FACTOR; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; SPINAL-CORD-INJURY; HEPARAN-SULFATE PROTEOGLYCANS; CELL-PERMEABLE PEPTIDE; RAT PRIMARY ASTROCYTES; IN-VITRO MODEL; REACTIVE ASTROCYTES; FACTOR-ALPHA	Astrocyte activation contributes to the brain's response to disease and injury. Activated astrocytes generate harmful radicals that exacerbate brain damage including nitric oxide, peroxides and superoxides. Furthermore, reactive astrocytes hinder regeneration of damaged neural circuits by secreting neuro-developmental inhibitors and glycosaminoglycans (GAGs), which physically block growth cone extension. Therefore, targeted therapeutic strategies to limit astrocyte activation may enhance recovery from many neurodegenerative states. Previously, we demonstrated that the HIV-1 TAT cell-penetrating peptide, a short non-toxic peptide from the full-length TAT protein, delivered a protein cargo to astrocytes in a process dependent on cell-surface GAG. Since activated astrocytes produce GAG, in this study we tested whether TAT could transduce activated astrocytes, deliver a biologically active cargo, and produce a physiological effect. Astrocyte activation was induced by IL-1 beta, lipopolysaccharide (LPS), or mechanical stretch injury, and quantified by increased GAG and nitrite content. TAT-mediated delivery of a mock therapeutic protein, GFP, increased significantly after activation. Nitrite production, GAG expression, and GFP-TAT transduction were significantly attenuated by inhibitors of JNK, p38, or ERK. TAT fused to a peptide JNK inhibitor delivered the peptide inhibitor to activated astrocytes and significantly reduced activation. Our study is the first to report significant and direct modulation of astrocyte activation with a peptide JNK inhibitor. Our promising in vitro results warrant in vivo follow-up, as TAT-mediated protein delivery may have broad therapeutic potential for preventing astrocyte activation with the possibility of limiting off-target, negative side effects.	[Kang, Woo Hyeun; Simon, Melissa J.; Morrison, Barclay, III] Columbia Univ, Dept Biomed, New York, NY 10027 USA; [Gao, Shan; Banta, Scott] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed, 351 Engn Terrace,MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864			ALOISI F, 1992, J IMMUNOL, V149, P2358; Audouy S, 1999, GLIA, V25, P293, DOI 10.1002/(SICI)1098-1136(19990201)25:3<293::AID-GLIA9>3.0.CO;2-G; Bhat NR, 1998, J NEUROSCI, V18, P1633; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; CHUNG IY, 1990, J IMMUNOL, V144, P2999; Cole-Edwards KK, 2006, J NEUROSCI, V26, P8295, DOI 10.1523/JNEUROSCI.1986-05.2006; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Falsig J, 2004, J IMMUNOL, V173, P2762, DOI 10.4049/jimmunol.173.4.2762; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fu J, 2008, MED CHEM, V4, P597, DOI 10.2174/157340608786242106; Gao S, 2009, BBA-GEN SUBJECTS, V1790, P198, DOI 10.1016/j.bbagen.2009.01.001; GHIRNIKAR RS, 1994, J NEUROSCI RES, V38, P376, DOI 10.1002/jnr.490380403; Guan QH, 2006, NEUROSCIENCE, V139, P609, DOI 10.1016/j.neuroscience.2005.11.067; Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086; Hsiao HY, 2007, GLIA, V55, P214, DOI 10.1002/glia.20453; Hua LWL, 2002, J NEUROIMMUNOL, V126, P180, DOI 10.1016/S0165-5728(02)00055-3; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim YJ, 2006, J NEUROSCI RES, V84, P1037, DOI 10.1002/jnr.21011; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Lee SC, 1995, BRAIN BEHAV IMMUN, V9, P345, DOI 10.1006/brbi.1995.1032; Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5; Mandell JW, 2001, GLIA, V34, P283, DOI 10.1002/glia.1062; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Molina JA, 1998, DRUG AGING, V12, P251, DOI 10.2165/00002512-199812040-00001; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; MURPHY S, 1993, TRENDS NEUROSCI, V16, P323, DOI 10.1016/0166-2236(93)90109-Y; Nakajima K, 2004, NEUROCHEM INT, V44, P205, DOI 10.1016/S0197-0186(03)00163-3; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Piao CS, 2003, J NEUROSCI RES, V73, P537, DOI 10.1002/jnr.10671; Properzi F, 2008, EUR J NEUROSCI, V27, P593, DOI 10.1111/j.1460-9568.2008.06042.x; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; SALVEMINI D, 1992, BRIT J PHARMACOL, V106, P931, DOI 10.1111/j.1476-5381.1992.tb14437.x; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon MJ, 2009, BIOTECHNOL BIOENG, V104, P10, DOI 10.1002/bit.22377; SMITHTHOMAS LC, 1994, J CELL SCI, V107, P1687; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Spigolon G, 2010, EUR J NEUROSCI, V31, P1261, DOI 10.1111/j.1460-9568.2010.07158.x; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Stirling DP, 2008, NEUROSCIENCE, V155, P128, DOI 10.1016/j.neuroscience.2008.05.007; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Ughrin YM, 2003, J NEUROSCI, V23, P175; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Williams R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005709; Yang SF, 2008, NEUROCHEM RES, V33, P2044, DOI 10.1007/s11064-008-9675-z; Yoo BK, 2008, NEUROCHEM INT, V52, P1188, DOI 10.1016/j.neuint.2007.12.009; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; YU ACH, 1991, J NEUROSCI RES, V30, P72, DOI 10.1002/jnr.490300109; Zhang HQ, 2006, ANN NY ACAD SCI, V1086, P81, DOI 10.1196/annals.1377.014; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	65	6	6	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1219	1228		10.1089/neu.2011.1879			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600010	21510821				2022-02-06	
J	Mattusch, C; Diederich, KW; Schmidt, A; Scheinert, D; Thiele, H; Schuler, G; Desch, S				Mattusch, Christiane; Diederich, Klaus-Werner; Schmidt, Andrej; Scheinert, Dierk; Thiele, Holger; Schuler, Gerhard; Desch, Steffen			Effect of Carotid Artery Stenting on the Release of S-100B and Neurone-Specific Enolase	ANGIOLOGY			English	Article						carotid artery stenting; carotid artery stenosis; neurone-specific enolase; S-100B	ISCHEMIC-STROKE; POSSIBLE MARKER; CARDIAC-ARREST; BRAIN-INJURY; SERUM; PROTEIN; SURGERY; FLUID	Serum levels of S-100B and neurone-specific enolase (NSE) reflect cerebral injury in a variety of neurological conditions such as stroke, traumatic brain injury, and cardiac arrest. There are limited data on the release of S-100B and NSE following carotid artery stenting (CAS). In 22 patients undergoing CAS, serial blood samples for S-100B and NSE were collected before and 2, 4, and 6 to 8 hours after the procedure. A group of 20 patients with significant CAS undergoing purely diagnostic angiography served as controls. A significant increase in S-100B levels was observed 2 hours after the procedure in patients with CAS (P = .001) with a gradual decline over the next hours. In contrast, patients who underwent purely diagnostic angiography did not show significant changes in S-100B levels up to 8 hours after the procedure. Neither patients with CAS nor those undergoing diagnostic angiography displayed any significant changes in serial NSE levels.	[Mattusch, Christiane; Diederich, Klaus-Werner; Thiele, Holger; Schuler, Gerhard; Desch, Steffen] Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04289 Leipzig, Germany; [Schmidt, Andrej; Scheinert, Dierk] Pk Hosp & Heart Ctr, Dept Angiol, Leipzig, Germany		Desch, S (corresponding author), Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, Strumpellstr 39, D-04289 Leipzig, Germany.	stdesch@web.de					Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Brightwell RE, 2007, EUR J VASC ENDOVASC, V34, P552, DOI 10.1016/j.ejvs.2007.06.016; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Capoccia L, 2010, J VASC SURG, V51, P584, DOI 10.1016/j.jvs.2009.10.079; CUNNINGHAM RT, 1991, EUR J CLIN INVEST, V21, P497, DOI 10.1111/j.1365-2362.1991.tb01401.x; Dassan P, 2009, CEREBROVASC DIS, V27, P295, DOI 10.1159/000199468; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Johnsson P, 2000, ANN THORAC SURG, V69, P750, DOI 10.1016/S0003-4975(99)01393-4; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Jonsson H, 1999, ANN THORAC SURG, V68, P2202, DOI 10.1016/S0003-4975(99)00851-6; Jonsson H, 1998, ANN THORAC SURG, V65, P1639, DOI 10.1016/S0003-4975(98)00229-X; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Mussack T, 2006, J ENDOVASC THER, V13, P39, DOI 10.1583/05-1656.1; Petty GW, 1999, STROKE, V30, P2513, DOI 10.1161/01.STR.30.12.2513; ROINE RO, 1989, ARCH NEUROL-CHICAGO, V46, P753, DOI 10.1001/archneur.1989.00520430047015; Sahlein DH, 2003, NEUROSURGERY, V53, P1243, DOI 10.1227/01.NEU.0000093493.16850.11; SHASHOUA VE, 1984, J NEUROCHEM, V42, P1536, DOI 10.1111/j.1471-4159.1984.tb12739.x; Shinozaki K, 2009, CRIT CARE, V13, DOI 10.1186/cc7973; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Westaby S, 1996, ANN THORAC SURG, V61, P88, DOI 10.1016/0003-4975(95)00904-3; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	24	6	6	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-3197	1940-1574		ANGIOLOGY	Angiology	JUL	2011	62	5					376	380		10.1177/0003319710387920			5	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	766FI	WOS:000290766000005	21596696				2022-02-06	
